Citrus Sinensis ID: 000880
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1239 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LX30 | 1241 | Probable serine/threonine | yes | no | 0.975 | 0.974 | 0.695 | 0.0 | |
| Q9HGN1 | 1576 | Serine/threonine-protein | yes | no | 0.625 | 0.491 | 0.312 | 1e-83 | |
| Q550L8 | 1358 | Probable serine/threonine | yes | no | 0.556 | 0.508 | 0.275 | 3e-68 | |
| Q558U1 | 2258 | Probable serine/threonine | no | no | 0.556 | 0.305 | 0.275 | 3e-68 | |
| P15442 | 1659 | Serine/threonine-protein | yes | no | 0.476 | 0.355 | 0.302 | 1e-61 | |
| Q9QZ05 | 1648 | Eukaryotic translation in | yes | no | 0.533 | 0.401 | 0.299 | 2e-61 | |
| Q9P2K8 | 1649 | Eukaryotic translation in | yes | no | 0.529 | 0.397 | 0.287 | 2e-58 | |
| P19525 | 551 | Interferon-induced, doubl | no | no | 0.214 | 0.482 | 0.330 | 3e-36 | |
| Q63184 | 513 | Interferon-induced, doubl | yes | no | 0.240 | 0.580 | 0.311 | 1e-35 | |
| Q9Z1Z1 | 1108 | Eukaryotic translation in | no | no | 0.155 | 0.174 | 0.355 | 4e-32 |
| >sp|Q9LX30|GCN2_ARATH Probable serine/threonine-protein kinase GCN2 OS=Arabidopsis thaliana GN=GCN2 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 1717 bits (4446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 858/1234 (69%), Positives = 977/1234 (79%), Gaps = 25/1234 (2%)
Query: 19 QSKDHSSSTVDDNELLSEEITALCAIFQEDCKVVSGS--PPQILVKLRPYSKDMGYEDLD 76
Q KDH S+ +DNELLSEEITAL AIFQEDCKVVS S PPQI +KLRPYSKDMGYED D
Sbjct: 20 QLKDHGSNADEDNELLSEEITALSAIFQEDCKVVSDSRSPPQIAIKLRPYSKDMGYEDTD 79
Query: 77 VSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVE 136
+SA+L+VRCLPGYPYKCPKLQITPE+GLT +DA+ LL LL+DQANSNAREGRVMIFNLVE
Sbjct: 80 ISAMLIVRCLPGYPYKCPKLQITPEQGLTTADAEKLLSLLEDQANSNAREGRVMIFNLVE 139
Query: 137 AAQEFLSEIVPLGQSNESVPGLVTESSSQSFEGSAVS-ASKSCSSKVPFVYGFIDLFSGC 195
AAQEFLSEI+P ESVP L S+Q E +S +KSCS PFVYGFIDLFSG
Sbjct: 140 AAQEFLSEIIPESHDEESVPCLTAHRSTQFIEQPMLSNIAKSCSGG-PFVYGFIDLFSGL 198
Query: 196 GESWHWGLGIDENRGVVPSVPSHASDGSNYEVMWRKIDKNVKPLMIPDANQGTALIPSAK 255
++ +W L DENRG+V SV SH D S ++ +K DKN+K + P AK
Sbjct: 199 EDARNWSLTPDENRGIVSSVQSHPLDTSR--ILHQKPDKNLKRFEDHAKEEVALPAPIAK 256
Query: 256 LDTVKEENEDDNRSISTTDSSTSPMEEWVENGI-KGENRDSLLQDHGSNNDGGDTEIDRL 314
L+TV+EEN DD S S ++ + VE+G+ + E ++S LQD + +D ++E + L
Sbjct: 257 LNTVQEENVDDTSISSFDSSKST---DDVESGLFQNEKKESNLQDDTAEDDSTNSESESL 313
Query: 315 ESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATELYNLGIFSERGRD 374
S+S SL QDQ Q +KDL++VHLLR+AC S G L DALPQI EL+ LGI SE D
Sbjct: 314 GSWSSDSLAQDQVPQISKKDLLMVHLLRVACTSRGPLADALPQITDELHELGILSEEVLD 373
Query: 375 LASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGH 434
LASK S FN+TF F+Q M S+ V QFW+P DS PN SLPSSRYLNDFEEL+PLG
Sbjct: 374 LASKSSPDFNRTFEHAFNQNMASTSVPQFWEPPSDSCEPNASLPSSRYLNDFEELKPLGQ 433
Query: 435 GGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFE 494
GGFGHVVLCKNKLDGR YAVKKIRLKDK +PVN RI+REVATLSRLQHQHVVRYYQAWFE
Sbjct: 434 GGFGHVVLCKNKLDGRQYAVKKIRLKDKEIPVNSRIVREVATLSRLQHQHVVRYYQAWFE 493
Query: 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE 554
TGV D + WGS T SS FS A S ++ Q+N LESTYLYIQMEYCPRTLRQVFE
Sbjct: 494 TGVVDPFAGANWGSKTAGSSMFSYSGAVSTEIPEQDNNLESTYLYIQMEYCPRTLRQVFE 553
Query: 555 SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL 614
SY+HFDK+ AWHL RQIVEGLAHIHGQGIIHRD TPNNIFFDARNDIKIGDFGLAKFLKL
Sbjct: 554 SYNHFDKDFAWHLIRQIVEGLAHIHGQGIIHRDFTPNNIFFDARNDIKIGDFGLAKFLKL 613
Query: 615 EQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHP 674
EQLDQD F TD G VD TGQ GTYFYTAPEIEQ WPKIDEKADMYSLG+VFFELWHP
Sbjct: 614 EQLDQDGGFSTDVAGSGVDSTGQAGTYFYTAPEIEQDWPKIDEKADMYSLGVVFFELWHP 673
Query: 675 FSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734
F TAMER ++L++LK KGELP WV +F EQ SLLRRLMSPSPSDRPSATELL+ A PP+
Sbjct: 674 FGTAMERHVILTNLKLKGELPLKWVNEFPEQASLLRRLMSPSPSDRPSATELLKHAFPPR 733
Query: 735 MEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMK-HHAGTLRLNRDNTSSIQYSDL 793
ME ELLDNILR+M +SED+S+YD+VVS IFDEE L+MK H + RL D+ S IQY+++
Sbjct: 734 MESELLDNILRIMQTSEDSSVYDRVVSVIFDEEVLEMKSHQSSRSRLCADD-SYIQYTEI 792
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELR 853
+TELRDYVV++TKE+FRQHCAKHLE+ PM LL DCPQF R TVKLLT+GGD+LEL +ELR
Sbjct: 793 NTELRDYVVEITKEVFRQHCAKHLEVIPMRLLSDCPQFSRKTVKLLTNGGDMLELCYELR 852
Query: 854 LPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTM 913
LPF+ W NQKSSFKRYEIS VYRRAIGHSPPN LQ DFDI+GG +LTEAEVLKV +
Sbjct: 853 LPFVHWISVNQKSSFKRYEISHVYRRAIGHSPPNPCLQADFDIVGGTLSLTEAEVLKVIV 912
Query: 914 DIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKW 973
DI T FH SCDIHLNHGDLL+AIWSWAGIKAEHR KVAELL+MMGSLRPQSSE K KW
Sbjct: 913 DITTHIFHRGSCDIHLNHGDLLDAIWSWAGIKAEHRRKVAELLSMMGSLRPQSSERKLKW 972
Query: 974 VVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL---- 1029
V IRRQLLQEL L EAVVNRLQTV RFCG ADQALPRLRGAL AD+PTRKALDEL
Sbjct: 973 VFIRRQLLQELKLPEAVVNRLQTVASRFCGDADQALPRLRGALRADRPTRKALDELSNLL 1032
Query: 1030 -YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLH 1088
YLR+WRIE++++ID LMPP ESYHRNLFFQVF KE T +G LLAVGGRYD+L+
Sbjct: 1033 TYLRVWRIEEHVHIDVLMPPTESYHRNLFFQVFLTKENSSGTSNDGVLLAVGGRYDWLVQ 1092
Query: 1089 RMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLV 1148
+ DRE+ + N P VG SLALETI QH P+D +P+RNE TSVLVCSRGGGGLLV
Sbjct: 1093 EVCDREH-----KMNLPGAVGVSLALETIFQHLPMDLRPIRNEVSTSVLVCSRGGGGLLV 1147
Query: 1149 ERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGA---QKGLVKVR 1205
+RMELVAELWE++IKA+FVP PDPSLTEQYEYA+EH+IKCLVI+T++G Q VKVR
Sbjct: 1148 QRMELVAELWEKSIKAEFVPTPDPSLTEQYEYANEHEIKCLVIITESGVAQNQIEFVKVR 1207
Query: 1206 HLDVKKEKEVQRESLVRFLLDAIASQFRNPSLWS 1239
HL++KKEK V RE LV+FLLDA+A QFRNPS+WS
Sbjct: 1208 HLELKKEKVVGREELVKFLLDAMAVQFRNPSVWS 1241
|
Protein kinase that may be involved in the phosphorylation of the alpha subunit of eIF-2. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9HGN1|GCN2_SCHPO Serine/threonine-protein kinase gcn2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=gcn2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 290/928 (31%), Positives = 424/928 (45%), Gaps = 153/928 (16%)
Query: 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL--KDKSLPVNDRILREVATL 477
SRY DFEEL+ LG GGFG VV KN++DGR YAVKK+ L DK N RILREV TL
Sbjct: 550 SRYETDFEELEFLGRGGFGEVVKVKNRIDGRFYAVKKLVLLSDDKE---NSRILREVMTL 606
Query: 478 SRLQHQHVVRYYQAWFETGV----------------------ADFDGDSMWGSGTLASST 515
SRL H+HVVRYY AW ET DF S + L+S
Sbjct: 607 SRLHHEHVVRYYTAWVETEANDTVTEIISSDSESLSQSLNMAVDFRQSSSLPADKLSSLD 666
Query: 516 --FSNRAASSAD----------------------------------VTGQENKLESTYLY 539
F + SSAD V QEN L +T LY
Sbjct: 667 IHFEDDYNSSADEEDPEASDISFQYSNTSDKEGSSDKDSSIEEASSVKTQENGLNAT-LY 725
Query: 540 IQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
IQMEYC + +L+ + D + W LFRQI+E LA+IH +G++HRDL P NIF D
Sbjct: 726 IQMEYCEKLSLQDIIR--DKIPVDEMWRLFRQILEALAYIHSRGMMHRDLKPGNIFLDEN 783
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKID 656
++K+GDFGLA + Q + D + D T VGT Y APE+ + + D
Sbjct: 784 RNVKLGDFGLATENENYQDNNDKW--KNRQSADEDLTTGVGTALYVAPELLSRRNGVRYD 841
Query: 657 EKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSW--VAKFSEQESLLRRLMS 714
K DMYSLGI+ FE+ FST+MER ++ ++ PS ++ S + ++ L+
Sbjct: 842 AKVDMYSLGIILFEMCMTFSTSMERIRIIDTIRSPSISFPSTFPFSRASHEFKVIHCLLQ 901
Query: 715 PSPSDRPSATELLQ-DALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMKH 773
P+ RPS+ ELL+ +A+PP++ E + LR++ S+ +T Y K++ +F + + +H
Sbjct: 902 HDPTKRPSSQELLESEAIPPKVGEEFIQEGLRLL-SNPNTPYYLKLLKVLFGQ--VPDRH 958
Query: 774 HAGTLRLNRDNTSSI--QYSD------LDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLL 825
T N S + + SD L +RD+VV+V FR+H AK E E L
Sbjct: 959 KDFTYDFNLSEESGVLSKVSDRGWDSLLACLVRDHVVKV----FRRHGAK--ERESHILF 1012
Query: 826 GDCPQFKRN--TVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGH 883
Q+ ++ +V LL G LL+L ++ LP+ R N K Y IS V+R A G
Sbjct: 1013 PKSSQYDKDQASVSLLDKNGTLLQLPYDTVLPYARNVARNAVEEEKTYLISDVFREAKGG 1072
Query: 884 SPPNRYLQGDFDIIGGASALT--EAEVLKVTMDIVTRFFH-AESCDIHLNHGDLLEAIWS 940
P + FDI + L +AE +K +++T ESC I +NH D+L +I
Sbjct: 1073 GRPKAIKEISFDITTNSDNLDWYDAETIKALDEVLTEIPSLTESC-ILINHADILSSILD 1131
Query: 941 WAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLR 1000
+ + + R +L + S +R QL E + ++ L R
Sbjct: 1132 YLQVSKDKRRMATHILGQINQRLTLSQ--------VRNQLRIESLVPSTTLDDLSLFDFR 1183
Query: 1001 FCGAADQALPRLRGALPADKP--TRKALDEL-----YLRIWRIEKNIYIDAL-MPPIESY 1052
++ +LR + P R AL+ + LR +I +Y L + E Y
Sbjct: 1184 --ENYEEGASKLRKIFGKEMPQKMRTALNYMERVVKLLRALKISHQLYFMPLCVYNFEFY 1241
Query: 1053 HRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASL 1112
L FQ ++ EK L+ GGRYD L+ R +D + A + + VG
Sbjct: 1242 DGGLMFQAINLAEK-------SELICAGGRYDKLV-RFFDPPLMRTARKKHV---VGICF 1290
Query: 1113 ALETII----------------QHYPVDFKPVRNEAG------TSVLVCSRGGGGLLVER 1150
ALE ++ +H P P G VLV S G +L E+
Sbjct: 1291 ALEKLVFSMLRYIRFHNSKQSSKHSP---SPTLKSVGPWAPRRVDVLVTSIGKDSIL-EK 1346
Query: 1151 MELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQ-KGLVKVRHLDV 1209
L+ ELW NI+A V SL E + I ++++ Q + VK R++
Sbjct: 1347 CSLLQELWALNIQADIVLRGASSLEEIVTHYRSEGINWVLVVRQKNTQMEHSVKARNILK 1406
Query: 1210 KKEKEVQRESLVRFLLDAIASQFRNPSL 1237
++ E++ + + +LL I + RN S+
Sbjct: 1407 NEDDEIRFDEVGMWLLGEINERKRNESM 1434
|
Phosphorylates eIF-2. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q550L8|IFKB_DICDI Probable serine/threonine-protein kinase ifkB OS=Dictyostelium discoideum GN=ifkB PE=2 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 222/806 (27%), Positives = 361/806 (44%), Gaps = 116/806 (14%)
Query: 513 SSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQI 571
S SN + S + ++ E+ LYIQMEYC + TL+ + ++ +E A+ L RQI
Sbjct: 338 SRVVSNNSKLSTSSSRKKPPKETHTLYIQMEYCSKKTLKTLIDNVGGIAEEEAFRLLRQI 397
Query: 572 VEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK----FLKLEQLDQDAAFPTDT 627
VEGL HIH Q IIHRDL P NIF D ++KIGDFGLA K + L+ + +
Sbjct: 398 VEGLNHIHSQQIIHRDLKPANIFIDNEQNVKIGDFGLATSGAPVSKSDDLNSSTSNAANN 457
Query: 628 GGVS-------------------VDGTGQVGTYFYTAPEI-EQGWPKIDEKADMYSLGIV 667
+S + TG VGT FY PEI E+ K DMYSLGI+
Sbjct: 458 INLSSSTNSTAQQTPMWDLNDENLSMTGGVGTPFYCCPEILEKNTKHYGTKVDMYSLGII 517
Query: 668 FFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELL 727
FFE+ F T MER +L DL+ + PP + + +Q ++R L+S P+ RPS +LL
Sbjct: 518 FFEMCFQFQTQMERSNILRDLRDNLKFPPGFESTKPDQTQIIRSLLSRDPTQRPSTKQLL 577
Query: 728 QDA-LPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMKHHAGTLRLNRDNTS 786
+ LP +ME ++L ++ + ++ S++ ++ +F L H + L N S
Sbjct: 578 ESGLLPSKMEDDILKEAIKTI-ANPTISLFSYLMEKLF---CLSNDEHIMSRYLYTSNPS 633
Query: 787 SIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKR-----NTVKLLTH 841
+ + R+ +++F H + + I+ L P N K L
Sbjct: 634 ---LTPMHLICREKTFSRLEKIFLNHGS--IRIDTPTLFPKNPTNSTHPGAANVAKFLDE 688
Query: 842 GGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGAS 901
G ++ L ++L +P+ R + + KRY S VYRR+ P + DFDIIG +
Sbjct: 689 SGTVVYLPYDLTIPWARHVVIHNIQQAKRYTFSKVYRRSQPGFSPKELYECDFDIIGPSK 748
Query: 902 A--LTEAEVLKVTMDIVTRF-----------------FHAESCDIHLNHGDLLEAIWSWA 942
+ +++AE L++ ++I+ F + + I +NH LL++I S
Sbjct: 749 SRHISDAETLRIIIEIMEEFKDELFGNNSGSNSGSGSGGSINYKIRINHYGLLDSILSEC 808
Query: 943 GIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFC 1002
G++ V + +A + W+ W + Q L+E L+ ++V+ + T R
Sbjct: 809 GVEKRFFTVVYQTVAQL--------HWRLNWAQV-AQSLKEHGLSASIVSNISTY-FRQR 858
Query: 1003 GAADQALPRLRGALPADKPTRKALDELY-----LRIWRIEKNIYIDALMPPIESYHRNLF 1057
G Q + +L L K + +L L++ I +D + Y+ L
Sbjct: 859 GELAQCVTQLESLLANHKEATTGISDLKILVRNLQMINIIPRFLLDLSLIHNHQYYEGLV 918
Query: 1058 FQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETI 1117
FQ + ++ + ++ GGRYD L+ + + N SGVG +LA E I
Sbjct: 919 FQAY-IERPTLSNPSRTEIIMSGGRYDKLIKSLHPNPSLS----NNIVSGVGVTLACEKI 973
Query: 1118 I-------QHYPVD-FKPV---RN-------------------------EAGTSVLVCSR 1141
+ QH + F RN ++ V VCS
Sbjct: 974 VNSVLNYRQHLLNNCFNTTYTRRNKDPPNSNNNPNNNNLNNNVSIFTKFQSHIEVFVCSL 1033
Query: 1142 GGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGL 1201
G LL E++++ ++LW IKA + S + Y E+ I +VIL + Q G
Sbjct: 1034 -GSSLLGEKLQVASQLWSAGIKADYSQTDYYSSEDIYSNCRENGIPWVVILREKAFQIGK 1092
Query: 1202 VKVRHLDVKKEKEVQRESLVRFLLDA 1227
+KV+ ++ ++E+ V R+ LV F L +
Sbjct: 1093 LKVKQIETRQERTVARKDLVDFFLKS 1118
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q558U1|IFKA_DICDI Probable serine/threonine-protein kinase ifkA OS=Dictyostelium discoideum GN=ifkA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (666), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 222/806 (27%), Positives = 361/806 (44%), Gaps = 116/806 (14%)
Query: 513 SSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQI 571
S SN + S + ++ E+ LYIQMEYC + TL+ + ++ +E A+ L RQI
Sbjct: 1238 SRVVSNNSKLSTSSSRKKPPKETHTLYIQMEYCSKKTLKTLIDNVGGIAEEEAFRLLRQI 1297
Query: 572 VEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK----FLKLEQLDQDAAFPTDT 627
VEGL HIH Q IIHRDL P NIF D ++KIGDFGLA K + L+ + +
Sbjct: 1298 VEGLNHIHSQQIIHRDLKPANIFIDNEQNVKIGDFGLATSGAPVSKSDDLNSSTSNTANN 1357
Query: 628 GGVS-------------------VDGTGQVGTYFYTAPEI-EQGWPKIDEKADMYSLGIV 667
+S + TG VGT FY PEI E+ K DMYSLGI+
Sbjct: 1358 INLSSSTNSTAQQTPMWDLNDENLSMTGGVGTPFYCCPEILEKNTKHYGTKVDMYSLGII 1417
Query: 668 FFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELL 727
FFE+ F T MER +L DL+ + PP + + +Q ++R L+S P+ RPS +LL
Sbjct: 1418 FFEMCFQFQTQMERSNILRDLRDNLKFPPGFESTKPDQTQIIRSLLSRDPTQRPSTKQLL 1477
Query: 728 QDA-LPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMKHHAGTLRLNRDNTS 786
+ LP +ME ++L ++ + ++ S++ ++ +F L H + L N S
Sbjct: 1478 ESGLLPSKMEDDILKEAIKTI-ANPTISLFSYLMEKLF---CLSNDEHIMSRYLYTSNPS 1533
Query: 787 SIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKR-----NTVKLLTH 841
+ + R+ +++F H + + I+ L P N K L
Sbjct: 1534 ---LTPMHLICREKTFSRLEKIFLNHGS--IRIDTPTLFPKNPTNSTHPGAANVAKFLDE 1588
Query: 842 GGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGAS 901
G ++ L ++L +P+ R + + KRY S VYRR+ P + DFDIIG +
Sbjct: 1589 SGTVVYLPYDLTIPWARHVVIHNIQQAKRYTFSKVYRRSQPGFSPKELYECDFDIIGPSK 1648
Query: 902 A--LTEAEVLKVTMDIVTRF-----------------FHAESCDIHLNHGDLLEAIWSWA 942
+ +++AE L++ ++I+ F + + I +NH LL++I S
Sbjct: 1649 SRHISDAETLRIIIEIMEEFKDELFGNNSGSNSGSGSGGSINYKIRINHYGLLDSILSEC 1708
Query: 943 GIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFC 1002
G++ V + +A + W+ W + Q L+E L+ ++V+ + T R
Sbjct: 1709 GVEKRFFTVVYQTVAQL--------HWRLNWAQV-AQSLKEHGLSASIVSNISTY-FRQR 1758
Query: 1003 GAADQALPRLRGALPADKPTRKALDELY-----LRIWRIEKNIYIDALMPPIESYHRNLF 1057
G Q + +L L K + +L L++ I +D + Y+ L
Sbjct: 1759 GELAQCVTQLESLLANHKEATTGISDLKILVRNLQMINIIPRFLLDLSLIHNHQYYEGLV 1818
Query: 1058 FQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETI 1117
FQ + ++ + ++ GGRYD L+ + + N SGVG +LA E I
Sbjct: 1819 FQAY-IERPTLSNPSRTEIIMSGGRYDKLIKSLHPNPSLS----NNIVSGVGVTLACEKI 1873
Query: 1118 I-------QHYPVD-FKPV---RN-------------------------EAGTSVLVCSR 1141
+ QH + F RN ++ V VCS
Sbjct: 1874 VNSVLNYRQHLLNNCFNTTYTRRNKDPPNSNNNPNNNNLNNNVSIFTKFQSHIEVFVCSL 1933
Query: 1142 GGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGL 1201
G LL E++++ ++LW IKA + S + Y E+ I +VIL + Q G
Sbjct: 1934 -GSSLLGEKLQVASQLWSAGIKADYSQTDYYSSEDIYSNCRENGIPWVVILREKAFQIGK 1992
Query: 1202 VKVRHLDVKKEKEVQRESLVRFLLDA 1227
+KV+ ++ ++E+ V R+ LV F L +
Sbjct: 1993 LKVKQIETRQERTVARKDLVDFFLKS 2018
|
Phosphorylates eIF2-alpha, from 1 to 7 hours after the onset of development or during the preaggregation state, resulting in a shift from polysomes to free ribosomes for bulk mRNA. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15442|GCN2_YEAST Serine/threonine-protein kinase GCN2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=GCN2 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 206/682 (30%), Positives = 335/682 (49%), Gaps = 92/682 (13%)
Query: 538 LYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
L+IQMEYC RTL + S + + ++ W LFRQI+E L++IH QGIIHRDL P NIF
Sbjct: 784 LFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI 843
Query: 596 DARNDIKIGDFGLAKFL--KLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653
D ++KIGDFGLAK + L+ L D+ + G S + T +GT Y A E+ G
Sbjct: 844 DESRNVKIGDFGLAKNVHRSLDILKLDSQ---NLPGSSDNLTSAIGTAMYVATEVLDGTG 900
Query: 654 KIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKG-ELPPSW-VAKFSEQESLLRR 711
+EK DMYSLGI+FFE+ +PFST MER +L L+ E PP + K ++ ++R
Sbjct: 901 HYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 960
Query: 712 LMSPSPSDRPSATELLQDA-LPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLD 770
L+ P+ RP A LL LP + + E++ L+ + S+ + +V S+F++
Sbjct: 961 LIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALKSL-SNPSSPWQQQVRESLFNQS--- 1016
Query: 771 MKHHAGTLRLNRDNT--SSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDC 828
++ T + DN+ +S ++++ LR + + ++FR+H P +
Sbjct: 1017 ---YSLTNDILFDNSVPTSTPFANI---LRSQMTEEVVKIFRKHGGIENNAPPR-IFPKA 1069
Query: 829 PQF-KRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHS--- 884
P + +N ++L GG +L+L ++L P R+ N K+Y + VYR HS
Sbjct: 1070 PIYGTQNVYEVLDKGGTVLQLQYDLTYPMARYLSKNPSLISKQYRMQHVYRPP-DHSRSS 1128
Query: 885 -PPNRYLQGDFDIIGGASA---LTEAEVLKVTMDIVTRF--FHAESCDIHLNHGDLLEAI 938
P ++ + DFDII +S+ +AE LK+ +I+T F F + LNH D+LE++
Sbjct: 1129 LEPRKFGEIDFDIISKSSSESGFYDAESLKIIDEILTVFPVFEKTNTFFILNHADILESV 1188
Query: 939 WSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVG 998
+++ I R V+ +L+ +G R + ++ +L +LN++ +N L+
Sbjct: 1189 FNFTNIDKAQRPLVSRMLSQVGFAR--------SFKEVKNELKAQLNISSTALNDLELFD 1240
Query: 999 LRF-CGAADQALPRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESY 1052
R AA + L +L P K +L + YL+ + +N+ I L ++
Sbjct: 1241 FRLDFEAAKKRLYKLMIDSPHLKKIEDSLSHISKVLSYLKPLEVARNVVISPLSNYNSAF 1300
Query: 1053 HRN--LFFQVFSVKEKYPATLVEGT---LLAVGGRYDYLLHRMWDREYVGYASRTNPPSG 1107
++ +F V+ +G+ ++A GGRYD L+ + R +S T
Sbjct: 1301 YKGGIMFHAVYD----------DGSSRNMIAAGGRYDTLIS-FFARPSGKKSSNTR--KA 1347
Query: 1108 VGASLALETII---QHY-------------------PVDFKPVRNEAGTSVLVCSRGGGG 1145
VG +LA ETI Q+Y VD+KP R VL+ S
Sbjct: 1348 VGFNLAWETIFGIAQNYFKLASGNRIKKRNRFLKDTAVDWKPSR----CDVLISSFSNSL 1403
Query: 1146 LLVERMELVAELWEENIKAQFV 1167
L + ++ LW++NIKA +
Sbjct: 1404 LDTIGVTILNTLWKQNIKADML 1425
|
Stimulates GCN4 translation in amino acid-starved cells by phosphorylating the alpha subunit of eIF-2 (SUI2) on 'Ser-52'. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9QZ05|E2AK4_MOUSE Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Mus musculus GN=Eif2ak4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 220/734 (29%), Positives = 353/734 (48%), Gaps = 73/734 (9%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
YLYIQMEYC + TLR + D W LFR+I++GLA+IH +G+IHRDL P NIF
Sbjct: 795 YLYIQMEYCEKSTLRDTIDQGLFRDTSRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFL 854
Query: 596 DARNDIKIGDFGLAK-----FLKLEQLDQ--DAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648
D+ + +KIGDFGLA + +Q DQ D +D G TG VGT Y +PE+
Sbjct: 855 DSDDHVKIGDFGLATDHLAFTAEGKQDDQAGDGVIKSDPSG---HLTGMVGTALYVSPEV 911
Query: 649 EQGWPK--IDEKADMYSLGIVFFEL-WHPFSTAMERQIVLSDLKQKGELPPSWVAKF--- 702
QG K ++K D++SLGI+FFE+ +HP TA ER VL+ L+ P + F
Sbjct: 912 -QGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTS--PKFPDDFDDG 968
Query: 703 --SEQESLLRRLMSPSPSDRPSATELLQDAL--PPQMEYELLDNILRMMHSSEDTSIYDK 758
++Q+S++ L++ P+ RP+A ELL+ L PPQME L +L ++ D Y
Sbjct: 969 EHTKQKSVISWLLNHDPAKRPTAMELLKSELLPPPQMEESELHEVLHHTLANIDGKAYRT 1028
Query: 759 VVSSIFDEE---TLDMKHHAGTLRLN-RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCA 814
++S IF + +D + + L+ N T+ IQ +T +R +F++H A
Sbjct: 1029 MMSQIFCQHISPAIDYTYDSDILKGNFLIRTAKIQQLVCETIVR---------VFKRHGA 1079
Query: 815 KHLEIEPMYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEI 873
L P+ L + ++ N L + H G L+ L +LR+PF R+ N + KRY I
Sbjct: 1080 VQL-CTPLLLPRNRQIYEHNEAALFMDHSGMLVMLPFDLRVPFARYVARNNILNLKRYCI 1138
Query: 874 SSVYR-RAIGHSPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRF--FHAESCDIH 928
V+R R + P L+ FDI+ S+L AE + +I+ F + I+
Sbjct: 1139 ERVFRPRKLDRFHPKELLECAFDIVTSTTNSSLPTAETIYTIYEIIQEFPALQERNYSIY 1198
Query: 929 LNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAE 988
LNH LL+AI GI + +V +L + + E ++K+ L+L+
Sbjct: 1199 LNHTMLLKAILLHCGIPEDKLSQVYVILYDAVTEKLTRREVEAKFC--------NLSLSS 1250
Query: 989 AVVNRL-----QTVGLRFCGAADQALPRLR-GALPADKPTRKALDELY--LRIWRIEKNI 1040
+ RL Q L+ +L + + G K + K L+++ L+ ++ +
Sbjct: 1251 NSLCRLYKFIEQKGDLQDLTPTINSLIKQKTGVAQLVKYSLKDLEDVVGLLKKLGVKLQV 1310
Query: 1041 YIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYAS 1100
I+ + H + FQ + ++ + E +LA GGRYD L+ + + VG
Sbjct: 1311 SINLGLVYKVQQHTGIIFQFLAFSKRRQRVVPE--ILAAGGRYDLLIPKFRGPQTVGPV- 1367
Query: 1101 RTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEE 1160
P+ VG S+A++ I +PV + +LV S G + + L +LW
Sbjct: 1368 ----PTAVGVSIAIDKIFAAVLNMEEPV-TVSSCDLLVVSVGQMS-MSRAINLTQKLWTA 1421
Query: 1161 NIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESL 1220
I A+ + S E EY H+I + +++D VKV+ + KE++ ++ L
Sbjct: 1422 GITAEIMYDWSQSQEELQEYCRHHEITYVALVSDKEGSH--VKVKSFE--KERQTEKRVL 1477
Query: 1221 VRFLLDAIASQFRN 1234
L+D + + R
Sbjct: 1478 ESDLVDHVMQKLRT 1491
|
Can phosphorylate the alpha subunit of EIF2 and may mediate translational control. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9P2K8|E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 212/738 (28%), Positives = 348/738 (47%), Gaps = 82/738 (11%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
YLYIQMEYC + TLR + + D W LFR+I++GLA+IH +G+IHRDL P NIF
Sbjct: 797 YLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFL 856
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-----------TGQVGTYFYT 644
D+ + +KIGDFGLA AF D+ G TG VGT Y
Sbjct: 857 DSDDHVKIGDFGLAT--------DHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYV 908
Query: 645 APEIEQGWPK--IDEKADMYSLGIVFFEL-WHPFSTAMERQIVLSDLKQKGELPPSWVAK 701
+PE+ QG K ++K D++SLGI+FFE+ +HP TA ER VL+ L+ P +
Sbjct: 909 SPEV-QGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTS--PKFPED 965
Query: 702 F-----SEQESLLRRLMSPSPSDRPSATELLQDAL--PPQMEYELLDNILRMMHSSEDTS 754
F ++Q+S++ L++ P+ RP+ATELL+ L PPQME L +L ++ D
Sbjct: 966 FDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTLTNVDGK 1025
Query: 755 IYDKVVSSIFDEE---TLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQ 811
Y +++ IF + +D + + L+ N +S +++ +V + +F++
Sbjct: 1026 AYRTMMAQIFSQRISPAIDYTYDSDILKGN--------FSIRTAKMQQHVCETIIRIFKR 1077
Query: 812 HCAKHLEIEPMYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKR 870
H A L P+ L + ++ N L + H G L+ L +LR+PF R+ N + KR
Sbjct: 1078 HGAVQL-CTPLLLPRNRQIYEHNEAALFMDHSGMLVMLPFDLRIPFARYVARNNILNLKR 1136
Query: 871 YEISSVYR-RAIGHSPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRF--FHAESC 925
Y I V+R R + P L+ FDI+ S L AE++ +I+ F +
Sbjct: 1137 YCIERVFRPRKLDRFHPKELLECAFDIVTSTTNSFLPTAEIIYTIYEIIQEFPALQERNY 1196
Query: 926 DIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELN 985
I+LNH LL+AI GI + +V +L + + E ++K+ L+
Sbjct: 1197 SIYLNHTMLLKAILLHCGIPEDKLSQVYIILYDAVTEKLTRREVEAKFC--------NLS 1248
Query: 986 LAEAVVNRLQTVGLRFCGAADQALPRLR-------GALPADKPTRKALDEL--YLRIWRI 1036
L+ + RL + G +P + G K K L+E+ L+ I
Sbjct: 1249 LSSNSLCRLYKF-IEQKGDLQDLMPTINSLIKQKTGIAQLVKYGLKDLEEVVGLLKKLGI 1307
Query: 1037 EKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYV 1096
+ + I+ + H + FQ + ++ + E +LA GGRYD L+ + + +
Sbjct: 1308 KLQVLINLGLVYKVQQHNGIIFQFVAFIKRRQRAVPE--ILAAGGRYDLLIPQFRGPQAL 1365
Query: 1097 GYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAE 1156
G P+ +G S+A++ I ++ + + +LV S G + + L +
Sbjct: 1366 GPV-----PTAIGVSIAIDKISAAV-LNMEESVTISSCDLLVVSVGQMS-MSRAINLTQK 1418
Query: 1157 LWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQ 1216
LW I A+ + S E EY H+I + +++D VKV+ + KE++ +
Sbjct: 1419 LWTAGITAEIMYDWSQSQEELQEYCRHHEITYVALVSDKEGSH--VKVKSFE--KERQTE 1474
Query: 1217 RESLVRFLLDAIASQFRN 1234
+ L L+D + + R
Sbjct: 1475 KRVLETELVDHVLQKLRT 1492
|
Can phosphorylate the alpha subunit of EIF2 and may mediate translational control. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P19525|E2AK2_HUMAN Interferon-induced, double-stranded RNA-activated protein kinase OS=Homo sapiens GN=EIF2AK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 154 bits (390), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 104/315 (33%), Positives = 164/315 (52%), Gaps = 49/315 (15%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL 480
R+ DF+E++ +G GGFG V K+++DG+ Y +K+++ N++ REV L++L
Sbjct: 262 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKL 315
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H ++V Y W FD D +L SS + + ++ ++ ++ L+I
Sbjct: 316 DHVNIVHYNGCW-----DGFDYDPETSDDSLESSDYDPENSKNS------SRSKTKCLFI 364
Query: 541 QMEYCPR-TLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
QME+C + TL Q E + DK LA LF QI +G+ +IH + +IHRDL P+NIF
Sbjct: 365 QMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVD 424
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG--TGQVGTYFYTAPE--IEQGWP 653
+KIGDFGL LK DG T GT Y +PE Q +
Sbjct: 425 TKQVKIGDFGLVTSLK------------------NDGKRTRSKGTLRYMSPEQISSQDYG 466
Query: 654 KIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713
K + D+Y+LG++ EL H TA E +DL+ G + + K +++LL++L+
Sbjct: 467 K---EVDLYALGLILAELLHVCDTAFETSKFFTDLRD-GIISDIFDKK---EKTLLQKLL 519
Query: 714 SPSPSDRPSATELLQ 728
S P DRP+ +E+L+
Sbjct: 520 SKKPEDRPNTSEILR 534
|
Following activation by double-stranded RNA in the presence of ATP, the kinase becomes autophosphorylated and can catalyze the phosphorylation of the translation initiation factor EIF2S1, which leads to an inhibition of the initiation of protein synthesis. Double-stranded RNA is generated during the course of a viral infection. In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity: phosphorylates CDK1 upon DNA damage. CDK1 phosphorylation triggers CDK1 polyubiquitination and subsequent proteolysis, thus leading to G2 arrest. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q63184|E2AK2_RAT Interferon-induced, double-stranded RNA-activated protein kinase OS=Rattus norvegicus GN=Eif2ak2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (385), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 108/347 (31%), Positives = 170/347 (48%), Gaps = 49/347 (14%)
Query: 385 KTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCK 444
+ F +F + R S PS D +L R+ DFE+++ +G GGFG V K
Sbjct: 196 RDFEDIFMNGLREKRKSGVKVPSDDVLRNKYTL-DDRFSKDFEDIEEIGSGGFGQVFKAK 254
Query: 445 NKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504
+++DG+ YA+K+I K + REV L+ L H ++V+Y W E D+D ++
Sbjct: 255 HRIDGKTYAIKRITYNTK------KAKREVQALAELNHANIVQYRVCW-EGEDYDYDPEN 307
Query: 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHF--DK 561
G ++ ++ L+IQME+C + TL+Q E + DK
Sbjct: 308 --------------------STNGDTSRYKTRCLFIQMEFCDKGTLQQWLEKRNRSQEDK 347
Query: 562 ELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDA 621
L LF QIV G+ +IH +G+IHRDL P NIF IKIGDFGLA L ++
Sbjct: 348 ALVLELFEQIVTGVDYIHSKGLIHRDLKPGNIFLVDEKHIKIGDFGLATAL------END 401
Query: 622 AFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMER 681
P T GT Y +PE + + ++ D+++LG++ EL H T E+
Sbjct: 402 GNPR---------TKYTGTPQYMSPEQKSSLVEYGKEVDIFALGLILAELLHICKTDSEK 452
Query: 682 QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
I L + G ++++SLL++L+S P +RP+ +E+L+
Sbjct: 453 -IEFFQLLRNGIFSDDIFD--NKEKSLLQKLLSSKPRERPNTSEILK 496
|
Following activation by double-stranded RNA in the presence of ATP, the kinase becomes autophosphorylated and can catalyze the phosphorylation of the translation initiation factor EIF2S1, which leads to an inhibition of the initiation of protein synthesis. Double-stranded RNA is generated during the course of a viral infection. In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity: phosphorylates CDK1 upon DNA damage. CDK1 phosphorylation triggers CDK1 polyubiquitination and subsequent proteolysis, thus leading to G2 arrest. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q9Z1Z1|E2AK3_RAT Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Rattus norvegicus GN=Eif2ak3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 141 bits (355), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 74/208 (35%), Positives = 120/208 (57%), Gaps = 15/208 (7%)
Query: 537 YLYIQMEYCPR-------TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589
YLYIQM+ C + R E +H + H+F QI E + +H +G++HRDL
Sbjct: 875 YLYIQMQLCRKENLKDWMNRRCSMEDREH---RVCLHIFLQIAEAVQFLHSKGLMHRDLK 931
Query: 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649
P+NIFF + +K+GDFGL + ++ +Q P TGQVGT Y +PE
Sbjct: 932 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH---TGQVGTKLYMSPEQI 988
Query: 650 QGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLL 709
G K D++SLG++ FEL +PFST MER L+D++ + PP + K+ ++ ++
Sbjct: 989 HG-NNYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNL-KFPPLFTQKYPQEHMMV 1046
Query: 710 RRLMSPSPSDRPSATELLQDALPPQMEY 737
+ ++SPSP +RP AT+++++A+ +E+
Sbjct: 1047 QDMLSPSPMERPEATDIIENAVFENLEF 1074
|
Phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2 (EIF2), leading to its inactivation and thus to a rapid reduction of translational initiation and repression of global protein synthesis. Serves as a critical effector of unfolded protein response (UPR)-induced G1 growth arrest due to the loss of cyclin-D1 (CCND1). Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1239 | ||||||
| 359478149 | 1244 | PREDICTED: probable serine/threonine-pro | 0.972 | 0.968 | 0.736 | 0.0 | |
| 356544520 | 1222 | PREDICTED: probable serine/threonine-pro | 0.961 | 0.974 | 0.705 | 0.0 | |
| 255585505 | 1162 | eif2alpha kinase, putative [Ricinus comm | 0.905 | 0.965 | 0.729 | 0.0 | |
| 30694992 | 1241 | non-specific serine/threonine protein ki | 0.975 | 0.974 | 0.695 | 0.0 | |
| 297817238 | 1242 | kinase family protein [Arabidopsis lyrat | 0.974 | 0.972 | 0.694 | 0.0 | |
| 334186129 | 1265 | non-specific serine/threonine protein ki | 0.975 | 0.955 | 0.682 | 0.0 | |
| 449446446 | 1298 | PREDICTED: probable serine/threonine-pro | 0.968 | 0.924 | 0.633 | 0.0 | |
| 7801691 | 1271 | protein kinase like [Arabidopsis thalian | 0.974 | 0.949 | 0.657 | 0.0 | |
| 297743778 | 859 | unnamed protein product [Vitis vinifera] | 0.632 | 0.912 | 0.790 | 0.0 | |
| 357164402 | 1246 | PREDICTED: probable serine/threonine-pro | 0.969 | 0.963 | 0.521 | 0.0 |
| >gi|359478149|ref|XP_002264839.2| PREDICTED: probable serine/threonine-protein kinase GCN2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1801 bits (4665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 905/1229 (73%), Positives = 1014/1229 (82%), Gaps = 24/1229 (1%)
Query: 23 HSSSTVDDNELLSEEITALCAIFQEDCKVVSGSPPQILVKLRPYSKDMGYEDLDVSALLL 82
HS++ D LSEEITALC+IFQ+DCKVVS PQ+ +KLRPYSKD GY++LDVSALLL
Sbjct: 28 HSAAEND----LSEEITALCSIFQDDCKVVSDPYPQVTIKLRPYSKDTGYDNLDVSALLL 83
Query: 83 VRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFL 142
VRCLPGYPYKCPKLQITPEKGL+K DADNLL LLQDQAN+NAREGRVM+FNLVEAAQEFL
Sbjct: 84 VRCLPGYPYKCPKLQITPEKGLSKGDADNLLSLLQDQANANAREGRVMVFNLVEAAQEFL 143
Query: 143 SEIVPLGQSNESVPGLVTESSSQSFEGSAVSASKSCSSKVPFVYGFIDLFSGCGESWHWG 202
SEIVP+GQS+ +VP T++SSQ F +K CSSK P VYGFIDLFSG G+SWHWG
Sbjct: 144 SEIVPVGQSHAAVPCSNTDNSSQLFLQDVSICNKGCSSKGPMVYGFIDLFSGTGDSWHWG 203
Query: 203 LGIDENRGVVPSVPSHASDGSN--YEVMWRKIDKNVKPLMIPDANQGTALIPSAKLDTVK 260
+DE R + S +HASDGS Y + +K+DKN KPL + + NQG P+ KLD ++
Sbjct: 204 FEMDETR-ISSSSHAHASDGSKHGYGIEGKKLDKNTKPLTMQNTNQGQLPSPTVKLDALE 262
Query: 261 EENEDDNRSISTTDSSTSPMEEWVENGI--KGENRDSLLQDHGSNNDGGDTEIDRLESFS 318
EE EDD+ SIS SS S EE N K EN+D ++ + D GD E D ES S
Sbjct: 263 EEIEDDSESISFFGSSRSLREELAGNVTTEKQENKDFSPEEDTAEEDDGDIESDASESLS 322
Query: 319 FASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATELYNLGIFSERGRDLASK 378
+ S+ DQ S +EKDL++VHLLRLAC S G L DALP+I TELYNLGIFSE RDLA+K
Sbjct: 323 YVSVIHDQTSHTVEKDLLMVHLLRLACASKGGLADALPEITTELYNLGIFSEPVRDLATK 382
Query: 379 PSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFG 438
PSS FNKTF+ VF Q +VSSR+SQFWKP D G + SLPSSRYLNDFEELQPLGHGGFG
Sbjct: 383 PSSFFNKTFDHVFRQHVVSSRISQFWKPPSDFGGQSTSLPSSRYLNDFEELQPLGHGGFG 442
Query: 439 HVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498
HVVLCKNKLDGR YAVKKIRLKDKS PV DRILREVATLSRLQHQHVVRYYQAWFETGV+
Sbjct: 443 HVVLCKNKLDGRQYAVKKIRLKDKSPPVYDRILREVATLSRLQHQHVVRYYQAWFETGVS 502
Query: 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH 558
GD+ WGS T ASS+FS + ASSADV ENKLESTYLYIQMEYCPRTLRQ+FESY H
Sbjct: 503 GSFGDTTWGSMTPASSSFSYKGASSADVNVHENKLESTYLYIQMEYCPRTLRQMFESYSH 562
Query: 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD 618
FDKELAWHLFRQIVEGL HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD
Sbjct: 563 FDKELAWHLFRQIVEGLVHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD 622
Query: 619 QDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTA 678
QD P DT GVSVD TGQVGTYFYTAPEIEQGWPKIDEKADMYSLG+VFFELWHPF TA
Sbjct: 623 QDPGVPPDTTGVSVDRTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGVVFFELWHPFGTA 682
Query: 679 MERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYE 738
MER IVL+DLKQKGELP SWVA+F EQ SLL+ LMSPSPSDRP ATELLQ A PP+MEYE
Sbjct: 683 MERSIVLNDLKQKGELPSSWVAEFPEQASLLQHLMSPSPSDRPFATELLQHAFPPRMEYE 742
Query: 739 LLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMKH--HAGTLRLNRDNTSSIQYSDLDTE 796
LLDNILR M +SEDT +YDKVV++IFD+E L K+ H G LRL D+TSSIQY+D DTE
Sbjct: 743 LLDNILRTMQTSEDTGVYDKVVNAIFDKEMLSAKNLQHFGRLRLVGDDTSSIQYTDSDTE 802
Query: 797 LRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPF 856
LRD+V +VT+E+FR HCAK LE+ P+ LL DCPQ RNTVKLLTHGGD++EL HELRLPF
Sbjct: 803 LRDHVSEVTREVFRHHCAKRLEVVPIRLLDDCPQTIRNTVKLLTHGGDMIELCHELRLPF 862
Query: 857 IRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIV 916
+ W I+NQKSSFKRYE+S VYRRAIGHS PNRYLQGDFD+IGGA+ALTEAEV+KV MDIV
Sbjct: 863 VNWVITNQKSSFKRYEVSYVYRRAIGHSAPNRYLQGDFDMIGGATALTEAEVIKVAMDIV 922
Query: 917 TRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVI 976
T FFH+ SC IHLNHGDLLEAIWSW GIKAEHR+KVAELL+MM SLRPQS E K KWVVI
Sbjct: 923 THFFHSNSCGIHLNHGDLLEAIWSWIGIKAEHRQKVAELLSMMSSLRPQSPERKLKWVVI 982
Query: 977 RRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL-----YL 1031
RRQL QELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL YL
Sbjct: 983 RRQLQQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDELADLFSYL 1042
Query: 1032 RIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMW 1091
R+WRIEK+++IDALMPP ESYHR+LFFQ++ +KE P +L EG LLA+GGRYD LL M
Sbjct: 1043 RVWRIEKHVFIDALMPPTESYHRDLFFQIYLMKENNPGSLKEGVLLAIGGRYDQLLREMC 1102
Query: 1092 DREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERM 1151
+AS++NPP VG SLALET+IQH +D +P RNE G +VLVCSRGGGGLL ERM
Sbjct: 1103 ------FASKSNPPGAVGVSLALETVIQHSSMDIRPFRNEVGINVLVCSRGGGGLLEERM 1156
Query: 1152 ELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQ-KGLVKVRHLDVK 1210
ELVA LWEENIKA+FVPV DPSLTEQYEYA+EHDIKCLVI+TDTG VKVRHL++K
Sbjct: 1157 ELVAGLWEENIKAEFVPVSDPSLTEQYEYANEHDIKCLVIITDTGVSPTDFVKVRHLELK 1216
Query: 1211 KEKEVQRESLVRFLLDAIASQFRNPSLWS 1239
KEKEV+RE+LV+F L +IA+QFRN S+W+
Sbjct: 1217 KEKEVERENLVKF-LHSIATQFRNLSIWN 1244
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356544520|ref|XP_003540698.1| PREDICTED: probable serine/threonine-protein kinase GCN2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1719 bits (4452), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 868/1230 (70%), Positives = 991/1230 (80%), Gaps = 39/1230 (3%)
Query: 18 AQSKDHSSS-TVDDNELLSEEITALCAIFQEDCKVVSGSPPQILVKL-RPYSKDMGYEDL 75
QSKDH+S DD + LSEEITALCAIF+EDCKV+ GSPP++++KL RPYSKDMGYEDL
Sbjct: 22 TQSKDHASQFGSDDYDQLSEEITALCAIFEEDCKVLPGSPPRVVIKLSRPYSKDMGYEDL 81
Query: 76 DVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLV 135
DVSA+L VRCLPGYP+KCPKLQITPEKGL+++DA LL LLQDQA NAREGRVMI+NLV
Sbjct: 82 DVSAVLAVRCLPGYPFKCPKLQITPEKGLSEADAKKLLSLLQDQATLNAREGRVMIYNLV 141
Query: 136 EAAQEFLSEIVPLGQSNES-VPGLVTESSSQSFEGSAVSASKSCSSKVPFVYGFIDLFSG 194
EAAQEFLS I P+ ++N+S + + ES+ + F S +K S FVYGFIDLFSG
Sbjct: 142 EAAQEFLSGIEPIAKTNDSKLLHSMVESNEELFPKDMTSVNKKGS----FVYGFIDLFSG 197
Query: 195 CGESWHWGLGIDENRGVVPSVPSHASDGSNYEVMWRKIDKNVKPLMIPDANQGTALIPSA 254
CGE+W W G+DE S+ D S + + +K D PL++ + +P A
Sbjct: 198 CGETWSWSFGMDETAVKSSSLSPSKLDAS--KPLEKKSDSKETPLIMQE-------LP-A 247
Query: 255 KLDTVKEENEDDNRSISTTDSSTSPMEEWVENGIKGENRDSLLQDHGSNNDGGDTEIDRL 314
KLDTV E +ED N S+S T SS S +E++V N +GE ++ ++ + ++ G E +
Sbjct: 248 KLDTVGEVSEDSNNSLSLTSSSRSLVEDFVGNKNEGEKEYFIVDEYTTEHNEGINESESS 307
Query: 315 ESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATELYNLGIFSERGRD 374
ES S SL Q SQ +EKDLI+VH+LRL C S G+ D LPQ+ TEL NLGI S+ RD
Sbjct: 308 ESLSSESLPHHQPSQTVEKDLIMVHMLRLVCASKGTFADCLPQVVTELCNLGIISDSARD 367
Query: 375 LASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGH 434
+AS+P S FNKTFN+VF + + SSR+SQFWKP D G N SRYLNDFEEL+PLGH
Sbjct: 368 MASEPPSIFNKTFNRVFQKHLASSRISQFWKP--DIGGSNTVPHGSRYLNDFEELRPLGH 425
Query: 435 GGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFE 494
GGFGHVVLCKNKLDGR YAVKKIRLKDKS+P DRILREVATLSRLQHQHVVRYYQAWFE
Sbjct: 426 GGFGHVVLCKNKLDGRQYAVKKIRLKDKSMP--DRILREVATLSRLQHQHVVRYYQAWFE 483
Query: 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE 554
TGV+D GDS WGS T SSTFS +AA+S D G EN+LESTYLYIQMEYCPRTLRQVFE
Sbjct: 484 TGVSDSYGDSTWGSKTTVSSTFSYKAATSNDALGHENQLESTYLYIQMEYCPRTLRQVFE 543
Query: 555 SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL 614
SY+HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL
Sbjct: 544 SYNHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL 603
Query: 615 EQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHP 674
EQLDQD P D GVS+DGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG+VFFELWHP
Sbjct: 604 EQLDQDLGHPADATGVSIDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGVVFFELWHP 663
Query: 675 FSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734
F T MER ++LSDLKQK E+P +WV +F EQESLLR+LMSP+PSDRPSATELLQ+A P +
Sbjct: 664 FGTGMERHVILSDLKQKREVPHTWVVEFPEQESLLRQLMSPAPSDRPSATELLQNAFPQR 723
Query: 735 MEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMKHHAGTLRLNRDNTSSIQYSDLD 794
ME ELLD+ILR M SEDTSIYDKV+++IFDEE L KH R N+SSIQY+D +
Sbjct: 724 MESELLDDILRTMQKSEDTSIYDKVLNAIFDEEMLSTKH-------IRQNSSSIQYTDFE 776
Query: 795 TELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRL 854
TE+RDYVV +E+FRQHCAKHLEI M LL DCPQF RN VKLLTHGGD+LEL HELRL
Sbjct: 777 TEVRDYVVDANREIFRQHCAKHLEIPTMRLLDDCPQFNRNAVKLLTHGGDMLELCHELRL 836
Query: 855 PFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMD 914
PF+ W ISNQKSSFKRYEIS V+RRAIGHS PN YLQGDFDIIGG SALTEAEV+KVT D
Sbjct: 837 PFVNWIISNQKSSFKRYEISCVFRRAIGHSSPNHYLQGDFDIIGGTSALTEAEVIKVTRD 896
Query: 915 IVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWV 974
IVT FFH +SCDIHLNHGDLL+AIWSW G+K EHR KVAELL+MMGSLRPQSSE KSKWV
Sbjct: 897 IVTCFFHEDSCDIHLNHGDLLDAIWSWIGVKVEHRLKVAELLSMMGSLRPQSSERKSKWV 956
Query: 975 VIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL----- 1029
VIRRQLLQELNLAEA+VNRLQTVGLRFCG+ADQALPRLRGALP+DK KALDEL
Sbjct: 957 VIRRQLLQELNLAEAMVNRLQTVGLRFCGSADQALPRLRGALPSDKRAFKALDELSELVS 1016
Query: 1030 YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHR 1089
LRIWRI+KNIYIDALMPP ESYHR+LFFQV+ KE P +L EG LLAVGGRYDYL H+
Sbjct: 1017 LLRIWRIDKNIYIDALMPPTESYHRDLFFQVYLRKENSPGSLSEGALLAVGGRYDYLFHQ 1076
Query: 1090 MWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVE 1149
+W +Y G NPP+GVG SLALETIIQ+ PVDFKP RNEA ++LVCSRGGGGLLVE
Sbjct: 1077 LWSSDYKG-----NPPTGVGTSLALETIIQNCPVDFKPNRNEASINILVCSRGGGGLLVE 1131
Query: 1150 RMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTG-AQKGLVKVRHLD 1208
RMELVAELWEEN KA+FVP PDPSLTEQYEYA+EH IKCLVI+TDT + G VKVRHL+
Sbjct: 1132 RMELVAELWEENFKAEFVPTPDPSLTEQYEYANEHGIKCLVIITDTDFSLTGSVKVRHLE 1191
Query: 1209 VKKEKEVQRESLVRFLLDAIASQFRNPSLW 1238
K+EK V++++LV+FL DA+A+QFRNPS+W
Sbjct: 1192 HKREKNVEKKNLVKFLSDAMATQFRNPSIW 1221
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585505|ref|XP_002533444.1| eif2alpha kinase, putative [Ricinus communis] gi|223526706|gb|EEF28940.1| eif2alpha kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1719 bits (4452), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 859/1178 (72%), Positives = 952/1178 (80%), Gaps = 56/1178 (4%)
Query: 42 CAIFQEDCKVVSGSPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPE 101
CAIFQEDCK+VS SPPQI++KLRPYSKDMGYEDLDVSALL VRCLPGYP+KCPKLQITPE
Sbjct: 5 CAIFQEDCKIVSESPPQIIIKLRPYSKDMGYEDLDVSALLSVRCLPGYPFKCPKLQITPE 64
Query: 102 KGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFLSEIVPLGQSNESVPGLVTE 161
GLTK+D DNLL LL DQANSNAREGRVMIFNLVEAAQEFLSEI+P+ + E+V +
Sbjct: 65 NGLTKTDVDNLLSLLHDQANSNAREGRVMIFNLVEAAQEFLSEIIPVNPTPETVLCSARD 124
Query: 162 SSSQSFEGSAVSASKSCSSKVPFVYGFIDLFSGCGESWHWGLGIDENRGVVPSVPSHASD 221
S Q F+G AVS++K CSS PFVYGFIDLFSG GESW WGL +D+NRGV S+ SH D
Sbjct: 125 SVGQLFQGIAVSSNKICSSSWPFVYGFIDLFSGSGESWDWGLAVDDNRGVNSSIKSHLLD 184
Query: 222 GSN--YEVMWRKIDKNVKPLMIPDANQGTALIPSAKLDTVKEENEDDNRSISTTDSSTSP 279
GS YEV +K+DK KPLM+ D QG + P AKLDT++EE E+DN+SIST DSS S
Sbjct: 185 GSKAGYEVQEKKLDKVTKPLMLQDPKQGPLVSPGAKLDTLEEETEEDNKSIST-DSSRSL 243
Query: 280 MEEWVENGIKGENRDSLLQDHGSNNDGGDTEIDRLESFSFASLGQDQASQDIEKDLILVH 339
EE VEN + G+ S ++ G+ +D + E + E S ASLG + ++ IEKDLI+VH
Sbjct: 244 TEESVENEMGGKEVTST-EESGAEDDDAELESEPWELPSSASLGHHEVTRTIEKDLIMVH 302
Query: 340 LLRLACQSTGSLTDALPQIATELYNLGIFSERGRDLASKPSSQFNKTFNQVFHQKMVSSR 399
+LRLAC S G DALPQI EL NLG+FSE DLA KPSS FN+TF+ VFHQ MVSS+
Sbjct: 303 MLRLACASKGVSADALPQITRELCNLGVFSEGACDLACKPSSIFNETFDHVFHQHMVSSK 362
Query: 400 VSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL 459
VSQFWKP+ D G N SLP+SRYLNDFEELQPLGHGGFGHVVLCKNKLDGR YAVKKIRL
Sbjct: 363 VSQFWKPTSDLGGSNTSLPNSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRQYAVKKIRL 422
Query: 460 KDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNR 519
KDKSLPVNDRILREVATLSRLQH HVVRYYQAWFETGV GD+ W T ASST S
Sbjct: 423 KDKSLPVNDRILREVATLSRLQHLHVVRYYQAWFETGVVGSFGDTSWDYSTAASSTISYH 482
Query: 520 AASS---------ADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ 570
ASS AD+ GQ+ KL+STYLYIQMEYCPRTLRQVFESY HFDKEL WH FRQ
Sbjct: 483 GASSTISYHGASSADI-GQDVKLDSTYLYIQMEYCPRTLRQVFESYKHFDKELVWHQFRQ 541
Query: 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGV 630
IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD DA PTDT GV
Sbjct: 542 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDHDATLPTDTSGV 601
Query: 631 SVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQ 690
S DGTGQVGTYFYTAPEIEQGWPKIDEK DMYSLG+VFFELWHPF TAMER I+LSDLKQ
Sbjct: 602 SADGTGQVGTYFYTAPEIEQGWPKIDEKVDMYSLGVVFFELWHPFGTAMERHIILSDLKQ 661
Query: 691 KGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSS 750
KGELP SWVA+F EQ SLLR+LMSPSPSDRPSAT+LL++A PP+ME ELLD ILR M +S
Sbjct: 662 KGELPSSWVAQFPEQASLLRQLMSPSPSDRPSATDLLKNAFPPRMESELLDKILRTMQTS 721
Query: 751 EDTSIYDKVVSSIFDEETLDMK---HHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKE 807
ED S+YDKVV+SIFDEE L MK H G L + D++S IQY+DLDTELRDYVV+ +E
Sbjct: 722 EDRSVYDKVVNSIFDEEILSMKSHHQHVGLLGMGGDDSSCIQYADLDTELRDYVVEAARE 781
Query: 808 MFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSS 867
MF++HCAKHLEI P+ LL DCPQF R TVKLLTHGGDLLEL HELRLPF+ W I+NQK S
Sbjct: 782 MFKRHCAKHLEIIPVRLLDDCPQFSRKTVKLLTHGGDLLELCHELRLPFVSWLIANQKFS 841
Query: 868 FKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDI 927
FKRYE+SSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEV+KVTMDIVTRFF ++SCDI
Sbjct: 842 FKRYEVSSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVIKVTMDIVTRFFLSDSCDI 901
Query: 928 HLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLA 987
HLNHGDLL+AIWSW GIK EHR+KVAELL+MMGSLRPQSSE KSKWVVIRRQLLQELNLA
Sbjct: 902 HLNHGDLLDAIWSWVGIKPEHRQKVAELLSMMGSLRPQSSERKSKWVVIRRQLLQELNLA 961
Query: 988 EAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYI 1042
EAVVNRLQTVGLRFCGA DQALPRLRGALPAD PTRKALDEL YL++W+IE ++YI
Sbjct: 962 EAVVNRLQTVGLRFCGAVDQALPRLRGALPADSPTRKALDELSDLVIYLKVWKIEHHVYI 1021
Query: 1043 DALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRT 1102
+ALMPP E+YHR LFFQ YP + +T
Sbjct: 1022 NALMPPTENYHRGLFFQFL-----YP-----------------------------FVQKT 1047
Query: 1103 NPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENI 1162
+PP VG SLALETIIQH PVDF+P RNE T++LVCSRGGGGLLVERM LVAELWE NI
Sbjct: 1048 HPPGAVGTSLALETIIQHSPVDFRPTRNETSTNILVCSRGGGGLLVERMGLVAELWEANI 1107
Query: 1163 KAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKG 1200
KA+FVP+ DPSLTEQYEYASEHDI+CLVI+TD G G
Sbjct: 1108 KAEFVPISDPSLTEQYEYASEHDIRCLVIITDAGESNG 1145
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30694992|ref|NP_191500.2| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|68052253|sp|Q9LX30.2|GCN2_ARATH RecName: Full=Probable serine/threonine-protein kinase GCN2 gi|24940154|emb|CAD30860.1| GCN2 homologue [Arabidopsis thaliana] gi|332646397|gb|AEE79918.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1717 bits (4446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 858/1234 (69%), Positives = 977/1234 (79%), Gaps = 25/1234 (2%)
Query: 19 QSKDHSSSTVDDNELLSEEITALCAIFQEDCKVVSGS--PPQILVKLRPYSKDMGYEDLD 76
Q KDH S+ +DNELLSEEITAL AIFQEDCKVVS S PPQI +KLRPYSKDMGYED D
Sbjct: 20 QLKDHGSNADEDNELLSEEITALSAIFQEDCKVVSDSRSPPQIAIKLRPYSKDMGYEDTD 79
Query: 77 VSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVE 136
+SA+L+VRCLPGYPYKCPKLQITPE+GLT +DA+ LL LL+DQANSNAREGRVMIFNLVE
Sbjct: 80 ISAMLIVRCLPGYPYKCPKLQITPEQGLTTADAEKLLSLLEDQANSNAREGRVMIFNLVE 139
Query: 137 AAQEFLSEIVPLGQSNESVPGLVTESSSQSFEGSAVS-ASKSCSSKVPFVYGFIDLFSGC 195
AAQEFLSEI+P ESVP L S+Q E +S +KSCS PFVYGFIDLFSG
Sbjct: 140 AAQEFLSEIIPESHDEESVPCLTAHRSTQFIEQPMLSNIAKSCSGG-PFVYGFIDLFSGL 198
Query: 196 GESWHWGLGIDENRGVVPSVPSHASDGSNYEVMWRKIDKNVKPLMIPDANQGTALIPSAK 255
++ +W L DENRG+V SV SH D S ++ +K DKN+K + P AK
Sbjct: 199 EDARNWSLTPDENRGIVSSVQSHPLDTSR--ILHQKPDKNLKRFEDHAKEEVALPAPIAK 256
Query: 256 LDTVKEENEDDNRSISTTDSSTSPMEEWVENGI-KGENRDSLLQDHGSNNDGGDTEIDRL 314
L+TV+EEN DD S S ++ + VE+G+ + E ++S LQD + +D ++E + L
Sbjct: 257 LNTVQEENVDDTSISSFDSSKST---DDVESGLFQNEKKESNLQDDTAEDDSTNSESESL 313
Query: 315 ESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATELYNLGIFSERGRD 374
S+S SL QDQ Q +KDL++VHLLR+AC S G L DALPQI EL+ LGI SE D
Sbjct: 314 GSWSSDSLAQDQVPQISKKDLLMVHLLRVACTSRGPLADALPQITDELHELGILSEEVLD 373
Query: 375 LASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGH 434
LASK S FN+TF F+Q M S+ V QFW+P DS PN SLPSSRYLNDFEEL+PLG
Sbjct: 374 LASKSSPDFNRTFEHAFNQNMASTSVPQFWEPPSDSCEPNASLPSSRYLNDFEELKPLGQ 433
Query: 435 GGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFE 494
GGFGHVVLCKNKLDGR YAVKKIRLKDK +PVN RI+REVATLSRLQHQHVVRYYQAWFE
Sbjct: 434 GGFGHVVLCKNKLDGRQYAVKKIRLKDKEIPVNSRIVREVATLSRLQHQHVVRYYQAWFE 493
Query: 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE 554
TGV D + WGS T SS FS A S ++ Q+N LESTYLYIQMEYCPRTLRQVFE
Sbjct: 494 TGVVDPFAGANWGSKTAGSSMFSYSGAVSTEIPEQDNNLESTYLYIQMEYCPRTLRQVFE 553
Query: 555 SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL 614
SY+HFDK+ AWHL RQIVEGLAHIHGQGIIHRD TPNNIFFDARNDIKIGDFGLAKFLKL
Sbjct: 554 SYNHFDKDFAWHLIRQIVEGLAHIHGQGIIHRDFTPNNIFFDARNDIKIGDFGLAKFLKL 613
Query: 615 EQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHP 674
EQLDQD F TD G VD TGQ GTYFYTAPEIEQ WPKIDEKADMYSLG+VFFELWHP
Sbjct: 614 EQLDQDGGFSTDVAGSGVDSTGQAGTYFYTAPEIEQDWPKIDEKADMYSLGVVFFELWHP 673
Query: 675 FSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734
F TAMER ++L++LK KGELP WV +F EQ SLLRRLMSPSPSDRPSATELL+ A PP+
Sbjct: 674 FGTAMERHVILTNLKLKGELPLKWVNEFPEQASLLRRLMSPSPSDRPSATELLKHAFPPR 733
Query: 735 MEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMK-HHAGTLRLNRDNTSSIQYSDL 793
ME ELLDNILR+M +SED+S+YD+VVS IFDEE L+MK H + RL D+ S IQY+++
Sbjct: 734 MESELLDNILRIMQTSEDSSVYDRVVSVIFDEEVLEMKSHQSSRSRLCADD-SYIQYTEI 792
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELR 853
+TELRDYVV++TKE+FRQHCAKHLE+ PM LL DCPQF R TVKLLT+GGD+LEL +ELR
Sbjct: 793 NTELRDYVVEITKEVFRQHCAKHLEVIPMRLLSDCPQFSRKTVKLLTNGGDMLELCYELR 852
Query: 854 LPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTM 913
LPF+ W NQKSSFKRYEIS VYRRAIGHSPPN LQ DFDI+GG +LTEAEVLKV +
Sbjct: 853 LPFVHWISVNQKSSFKRYEISHVYRRAIGHSPPNPCLQADFDIVGGTLSLTEAEVLKVIV 912
Query: 914 DIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKW 973
DI T FH SCDIHLNHGDLL+AIWSWAGIKAEHR KVAELL+MMGSLRPQSSE K KW
Sbjct: 913 DITTHIFHRGSCDIHLNHGDLLDAIWSWAGIKAEHRRKVAELLSMMGSLRPQSSERKLKW 972
Query: 974 VVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL---- 1029
V IRRQLLQEL L EAVVNRLQTV RFCG ADQALPRLRGAL AD+PTRKALDEL
Sbjct: 973 VFIRRQLLQELKLPEAVVNRLQTVASRFCGDADQALPRLRGALRADRPTRKALDELSNLL 1032
Query: 1030 -YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLH 1088
YLR+WRIE++++ID LMPP ESYHRNLFFQVF KE T +G LLAVGGRYD+L+
Sbjct: 1033 TYLRVWRIEEHVHIDVLMPPTESYHRNLFFQVFLTKENSSGTSNDGVLLAVGGRYDWLVQ 1092
Query: 1089 RMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLV 1148
+ DRE+ + N P VG SLALETI QH P+D +P+RNE TSVLVCSRGGGGLLV
Sbjct: 1093 EVCDREH-----KMNLPGAVGVSLALETIFQHLPMDLRPIRNEVSTSVLVCSRGGGGLLV 1147
Query: 1149 ERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGA---QKGLVKVR 1205
+RMELVAELWE++IKA+FVP PDPSLTEQYEYA+EH+IKCLVI+T++G Q VKVR
Sbjct: 1148 QRMELVAELWEKSIKAEFVPTPDPSLTEQYEYANEHEIKCLVIITESGVAQNQIEFVKVR 1207
Query: 1206 HLDVKKEKEVQRESLVRFLLDAIASQFRNPSLWS 1239
HL++KKEK V RE LV+FLLDA+A QFRNPS+WS
Sbjct: 1208 HLELKKEKVVGREELVKFLLDAMAVQFRNPSVWS 1241
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297817238|ref|XP_002876502.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297322340|gb|EFH52761.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1707 bits (4422), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 858/1236 (69%), Positives = 982/1236 (79%), Gaps = 28/1236 (2%)
Query: 19 QSKDHSSSTVDDNELLSEEITALCAIFQEDCKVVSGS--PPQILVKLR-PYSKDMGYEDL 75
Q KDH S+ +DNELLSEEITAL AIFQEDCK+VS S PPQI++KLR YSKDMGYED+
Sbjct: 20 QLKDHGSNADEDNELLSEEITALSAIFQEDCKIVSDSRSPPQIVIKLRFSYSKDMGYEDI 79
Query: 76 DVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLV 135
D+SA+L+VRCLPGYPYKCPKLQITPE+GLT +DA+ LL LL+DQANSNAREGRVMIFNLV
Sbjct: 80 DISAMLVVRCLPGYPYKCPKLQITPEQGLTTADAEKLLSLLEDQANSNAREGRVMIFNLV 139
Query: 136 EAAQEFLSEIVPLGQSNESVPGLVTESSSQSFEGSAVS-ASKSCSSKVPFVYGFIDLFSG 194
EAAQEFLSEI+P E VP L S+Q E +S +KSC+ PFVYGFIDLFSG
Sbjct: 140 EAAQEFLSEIIPESHDEEPVPCLTAHRSAQFIEQPMLSNKAKSCTGG-PFVYGFIDLFSG 198
Query: 195 CGESWHWGLGIDENRGVVPSVPSHASDGSNYEVMWRKIDKNVKPLMIPDANQGTAL-IPS 253
++ +W L DENRG+V SV SH D S ++ K DKN+K + A + AL P+
Sbjct: 199 LEDARNWSLTPDENRGIVSSVQSHPLDTSR--ILHEKSDKNLKRF-VDHAKEEIALPAPT 255
Query: 254 AKLDTVKEENEDDNRSISTTDSSTSPMEEWVENGI-KGENRDSLLQDHGSNNDGGDTEID 312
AKL+TV+E+N DD S S ++ + VE+G+ + E ++S LQD + +D ++E +
Sbjct: 256 AKLNTVQEDNVDDTSISSFDSSKST---DDVESGLFQNEKKESNLQDDTAEDDSSNSESE 312
Query: 313 RLESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATELYNLGIFSERG 372
L S+S SL QDQ Q +KDL++VHLLR+AC S G L DALPQI EL+ LGI SE
Sbjct: 313 SLGSWSSDSLSQDQVPQISKKDLLMVHLLRVACTSRGPLADALPQITDELHQLGILSEEA 372
Query: 373 RDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPL 432
DLASK S FN+TF F+Q MVS+ V QFW+P DSG PN SLPSSRYLNDFEEL+PL
Sbjct: 373 LDLASKSSPDFNRTFEHAFNQNMVSTSVPQFWEPPSDSGEPNASLPSSRYLNDFEELKPL 432
Query: 433 GHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAW 492
G GGFGHVVLCKNKLDGR YAVKKIRLK+K +PVN RI+REVATLSRLQHQHVVRYYQAW
Sbjct: 433 GQGGFGHVVLCKNKLDGRQYAVKKIRLKEKEIPVNSRIVREVATLSRLQHQHVVRYYQAW 492
Query: 493 FETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQV 552
FETGV D + WGS T SS FS A S ++ Q+N LESTYLYIQMEYCPRTLRQV
Sbjct: 493 FETGVVDPFAGANWGSKTAGSSMFSYSGAVSTEIPEQDNNLESTYLYIQMEYCPRTLRQV 552
Query: 553 FESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612
FESY+HFDK+ AWHL RQIVEGLAHIHGQGIIHRD TPNNIFFDARNDIKIGDFGLAKFL
Sbjct: 553 FESYNHFDKDFAWHLIRQIVEGLAHIHGQGIIHRDFTPNNIFFDARNDIKIGDFGLAKFL 612
Query: 613 KLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW 672
KLEQLDQD F TD G VD TGQ GTYFYTAPEIEQ WPKIDEKADMYSLG+VFFELW
Sbjct: 613 KLEQLDQDGGFSTDVAGSGVDSTGQAGTYFYTAPEIEQDWPKIDEKADMYSLGVVFFELW 672
Query: 673 HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732
HPF TAMER ++L+DLK KGELP WV +F EQ SLLRRLMSPSPSDRPSATELL+ A P
Sbjct: 673 HPFGTAMERHVILTDLKLKGELPLKWVNEFPEQASLLRRLMSPSPSDRPSATELLKHAFP 732
Query: 733 PQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMK-HHAGTLRLNRDNTSSIQYS 791
P+ME ELLDNILR+M +SED+S+YD+VVS IFDEE L+MK H + + RL D+ S IQY+
Sbjct: 733 PRMESELLDNILRIMQTSEDSSVYDRVVSVIFDEEVLEMKSHQSSSSRLCADD-SYIQYT 791
Query: 792 DLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHE 851
+++TELRDYVV +TKE+FRQHCAKHLE+ PM LL DCPQF R TVKLLT+GGD+LEL +E
Sbjct: 792 EINTELRDYVVDITKEVFRQHCAKHLEVIPMRLLSDCPQFSRKTVKLLTNGGDMLELCYE 851
Query: 852 LRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKV 911
LRLPF+ W NQKSSFKRYEIS VYRRAIGHSPPN LQ DFDI+GG +LTEAEVLKV
Sbjct: 852 LRLPFVNWISVNQKSSFKRYEISHVYRRAIGHSPPNPCLQADFDIVGGTPSLTEAEVLKV 911
Query: 912 TMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKS 971
+DI T FH SCDIHLNHGDLL+AIWSWAGIKAEHR KVAELL+MMGSLRPQSSE K
Sbjct: 912 IVDITTHIFHRGSCDIHLNHGDLLDAIWSWAGIKAEHRRKVAELLSMMGSLRPQSSERKL 971
Query: 972 KWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL-- 1029
KWV IRRQLLQEL L EAVVNRLQTV RFCG ADQALPRLRGAL AD+PTRKALDEL
Sbjct: 972 KWVFIRRQLLQELKLPEAVVNRLQTVASRFCGDADQALPRLRGALRADRPTRKALDELSN 1031
Query: 1030 ---YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYL 1086
YLR+WRIE++++ID LMPP ESYHRNLFFQVF KE T +G LLAVGGRYD+L
Sbjct: 1032 LLTYLRVWRIEEHVHIDVLMPPTESYHRNLFFQVFLTKENSSGTSSDGVLLAVGGRYDFL 1091
Query: 1087 LHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGL 1146
+ + DREY + N P VG SLALETI QH P+D +P+RNE TSVLVCSRGGGGL
Sbjct: 1092 VQEVCDREY-----KMNLPGAVGVSLALETIFQHLPMDLRPIRNEVSTSVLVCSRGGGGL 1146
Query: 1147 LVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGA---QKGLVK 1203
LV+RMELVAELWE++IKA+FVP PDPSLTEQYEYA+EH+IKCLVI+ ++G Q VK
Sbjct: 1147 LVQRMELVAELWEKSIKAEFVPTPDPSLTEQYEYANEHEIKCLVIIAESGVAQNQIEFVK 1206
Query: 1204 VRHLDVKKEKEVQRESLVRFLLDAIASQFRNPSLWS 1239
VRHL++KKEK V RE LV+FLLDA+A QFRNPS+WS
Sbjct: 1207 VRHLELKKEKVVGREELVKFLLDAMAVQFRNPSVWS 1242
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334186129|ref|NP_001190135.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|332646398|gb|AEE79919.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1702 bits (4408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 858/1258 (68%), Positives = 977/1258 (77%), Gaps = 49/1258 (3%)
Query: 19 QSKDHSSSTVDDNELLSEEITAL------------------------CAIFQEDCKVVSG 54
Q KDH S+ +DNELLSEEITAL AIFQEDCKVVS
Sbjct: 20 QLKDHGSNADEDNELLSEEITALNCVNVGIMGFDRSDVTGKNNSNYFSAIFQEDCKVVSD 79
Query: 55 S--PPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNL 112
S PPQI +KLRPYSKDMGYED D+SA+L+VRCLPGYPYKCPKLQITPE+GLT +DA+ L
Sbjct: 80 SRSPPQIAIKLRPYSKDMGYEDTDISAMLIVRCLPGYPYKCPKLQITPEQGLTTADAEKL 139
Query: 113 LCLLQDQANSNAREGRVMIFNLVEAAQEFLSEIVPLGQSNESVPGLVTESSSQSFEGSAV 172
L LL+DQANSNAREGRVMIFNLVEAAQEFLSEI+P ESVP L S+Q E +
Sbjct: 140 LSLLEDQANSNAREGRVMIFNLVEAAQEFLSEIIPESHDEESVPCLTAHRSTQFIEQPML 199
Query: 173 S-ASKSCSSKVPFVYGFIDLFSGCGESWHWGLGIDENRGVVPSVPSHASDGSNYEVMWRK 231
S +KSCS PFVYGFIDLFSG ++ +W L DENRG+V SV SH D S ++ +K
Sbjct: 200 SNIAKSCSGG-PFVYGFIDLFSGLEDARNWSLTPDENRGIVSSVQSHPLDTSR--ILHQK 256
Query: 232 IDKNVKPLMIPDANQGTALIPSAKLDTVKEENEDDNRSISTTDSSTSPMEEWVENGI-KG 290
DKN+K + P AKL+TV+EEN DD S S ++ + VE+G+ +
Sbjct: 257 PDKNLKRFEDHAKEEVALPAPIAKLNTVQEENVDDTSISSFDSSKST---DDVESGLFQN 313
Query: 291 ENRDSLLQDHGSNNDGGDTEIDRLESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGS 350
E ++S LQD + +D ++E + L S+S SL QDQ Q +KDL++VHLLR+AC S G
Sbjct: 314 EKKESNLQDDTAEDDSTNSESESLGSWSSDSLAQDQVPQISKKDLLMVHLLRVACTSRGP 373
Query: 351 LTDALPQIATELYNLGIFSERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDS 410
L DALPQI EL+ LGI SE DLASK S FN+TF F+Q M S+ V QFW+P DS
Sbjct: 374 LADALPQITDELHELGILSEEVLDLASKSSPDFNRTFEHAFNQNMASTSVPQFWEPPSDS 433
Query: 411 GSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI 470
PN SLPSSRYLNDFEEL+PLG GGFGHVVLCKNKLDGR YAVKKIRLKDK +PVN RI
Sbjct: 434 CEPNASLPSSRYLNDFEELKPLGQGGFGHVVLCKNKLDGRQYAVKKIRLKDKEIPVNSRI 493
Query: 471 LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQE 530
+REVATLSRLQHQHVVRYYQAWFETGV D + WGS T SS FS A S ++ Q+
Sbjct: 494 VREVATLSRLQHQHVVRYYQAWFETGVVDPFAGANWGSKTAGSSMFSYSGAVSTEIPEQD 553
Query: 531 NKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTP 590
N LESTYLYIQMEYCPRTLRQVFESY+HFDK+ AWHL RQIVEGLAHIHGQGIIHRD TP
Sbjct: 554 NNLESTYLYIQMEYCPRTLRQVFESYNHFDKDFAWHLIRQIVEGLAHIHGQGIIHRDFTP 613
Query: 591 NNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650
NNIFFDARNDIKIGDFGLAKFLKLEQLDQD F TD G VD TGQ GTYFYTAPEIEQ
Sbjct: 614 NNIFFDARNDIKIGDFGLAKFLKLEQLDQDGGFSTDVAGSGVDSTGQAGTYFYTAPEIEQ 673
Query: 651 GWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLR 710
WPKIDEKADMYSLG+VFFELWHPF TAMER ++L++LK KGELP WV +F EQ SLLR
Sbjct: 674 DWPKIDEKADMYSLGVVFFELWHPFGTAMERHVILTNLKLKGELPLKWVNEFPEQASLLR 733
Query: 711 RLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLD 770
RLMSPSPSDRPSATELL+ A PP+ME ELLDNILR+M +SED+S+YD+VVS IFDEE L+
Sbjct: 734 RLMSPSPSDRPSATELLKHAFPPRMESELLDNILRIMQTSEDSSVYDRVVSVIFDEEVLE 793
Query: 771 MK-HHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCP 829
MK H + RL D+ S IQY++++TELRDYVV++TKE+FRQHCAKHLE+ PM LL DCP
Sbjct: 794 MKSHQSSRSRLCADD-SYIQYTEINTELRDYVVEITKEVFRQHCAKHLEVIPMRLLSDCP 852
Query: 830 QFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRY 889
QF R TVKLLT+GGD+LEL +ELRLPF+ W NQKSSFKRYEIS VYRRAIGHSPPN
Sbjct: 853 QFSRKTVKLLTNGGDMLELCYELRLPFVHWISVNQKSSFKRYEISHVYRRAIGHSPPNPC 912
Query: 890 LQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHR 949
LQ DFDI+GG +LTEAEVLKV +DI T FH SCDIHLNHGDLL+AIWSWAGIKAEHR
Sbjct: 913 LQADFDIVGGTLSLTEAEVLKVIVDITTHIFHRGSCDIHLNHGDLLDAIWSWAGIKAEHR 972
Query: 950 EKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQAL 1009
KVAELL+MMGSLRPQSSE K KWV IRRQLLQEL L EAVVNRLQTV RFCG ADQAL
Sbjct: 973 RKVAELLSMMGSLRPQSSERKLKWVFIRRQLLQELKLPEAVVNRLQTVASRFCGDADQAL 1032
Query: 1010 PRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVK 1064
PRLRGAL AD+PTRKALDEL YLR+WRIE++++ID LMPP ESYHRNLFFQVF K
Sbjct: 1033 PRLRGALRADRPTRKALDELSNLLTYLRVWRIEEHVHIDVLMPPTESYHRNLFFQVFLTK 1092
Query: 1065 EKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVD 1124
E T +G LLAVGGRYD+L+ + DRE+ + N P VG SLALETI QH P+D
Sbjct: 1093 ENSSGTSNDGVLLAVGGRYDWLVQEVCDREH-----KMNLPGAVGVSLALETIFQHLPMD 1147
Query: 1125 FKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEH 1184
+P+RNE TSVLVCSRGGGGLLV+RMELVAELWE++IKA+FVP PDPSLTEQYEYA+EH
Sbjct: 1148 LRPIRNEVSTSVLVCSRGGGGLLVQRMELVAELWEKSIKAEFVPTPDPSLTEQYEYANEH 1207
Query: 1185 DIKCLVILTDTGA---QKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQFRNPSLWS 1239
+IKCLVI+T++G Q VKVRHL++KKEK V RE LV+FLLDA+A QFRNPS+WS
Sbjct: 1208 EIKCLVIITESGVAQNQIEFVKVRHLELKKEKVVGREELVKFLLDAMAVQFRNPSVWS 1265
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446446|ref|XP_004140982.1| PREDICTED: probable serine/threonine-protein kinase GCN2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1624 bits (4205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 827/1306 (63%), Positives = 968/1306 (74%), Gaps = 106/1306 (8%)
Query: 14 SKGRAQSKDHSSSTVDDNELLSEEITALCAIFQEDCKVVSGSPPQILVKLRPYSKDMGYE 73
SKGR D+S S ++++L++EE+TALCAIFQEDCKVV+G PQ+ +KL+PYS DMG+E
Sbjct: 19 SKGRTPLTDYSFSG-EESDLITEEMTALCAIFQEDCKVVTGPSPQVTIKLKPYSNDMGFE 77
Query: 74 DLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFN 133
D DVSAL V+ LPGYPYKCPKL ITPE+GL K D + LL LL +QAN NAR+GR+MIFN
Sbjct: 78 DRDVSALFSVKYLPGYPYKCPKLLITPERGLAKGDTEKLLSLLHEQANYNARDGRIMIFN 137
Query: 134 LVEAAQEFLSEIVPLGQSNESVPGLVTESSSQSFEGSAVSASKSCSSKVPFVYGFIDLFS 193
L EAAQEFLSEIV +G+SNES T S+SQ S K K P+VYG+IDLFS
Sbjct: 138 LAEAAQEFLSEIVTIGESNESAVRSHTASTSQLLPEKTTSNEK----KGPYVYGYIDLFS 193
Query: 194 GCGESWHWGLGIDE--NRGVVPSVPSHASDGSNYEVMWRKIDKNVKPLMIPDANQGTALI 251
G GE W W +DE N P V G+ V +K+DK L ++ +G L
Sbjct: 194 GSGELWSWSFDMDEKLNSLAQPLVADSLKLGA---VQEKKLDKVQNLLARQNSKRGELLS 250
Query: 252 PSAKLDTVKEE---------------------NEDDNRS-----ISTTDSSTSPM----- 280
PS+ L T++EE NED N S TDS T+P
Sbjct: 251 PSSNLGTLEEETEGDSQSKSSSNSRRSLIVQRNEDGNEGEMQDRTSATDSLTTPAIDSAA 310
Query: 281 -------------------------EEW-------------VENGIKGENRDSLLQDHGS 302
++W +E+ + DS+L +
Sbjct: 311 FCAKSPSHDSERHNGKPIPICEHCKKQWHTRSSVGSYMVVSLEHEVLIPGLDSILTSDVA 370
Query: 303 NNDGGDTEIDRLESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATEL 362
D +E + E +SFAS +Q SQ ++D+++VHLL LAC G L DALP++A+EL
Sbjct: 371 EGDDHGSESEASE-WSFASFSNEQESQTTDRDIMMVHLLHLACAPKGPLADALPKLASEL 429
Query: 363 YNLGIFSERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRY 422
NLG+ S+ DLASKPSS F+K F F ++M ++ SQFW + D G S SSRY
Sbjct: 430 CNLGVLSKAALDLASKPSSTFHKKFKTAFQEQMNATSFSQFW--TSDFGGSASSQLSSRY 487
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
LNDFEEL+PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK LPVNDRILREVATLSRLQH
Sbjct: 488 LNDFEELKPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKILPVNDRILREVATLSRLQH 547
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
QHVVRYYQAW+E+GV+D G++ WGS T SSTFS + AS+ D ENK ESTYLYIQM
Sbjct: 548 QHVVRYYQAWYESGVSDSYGEAAWGSMTPLSSTFSYKGASATDAE-HENKTESTYLYIQM 606
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
EYCPRTLRQ FESY FDKELAWHLF QIVEGLAHIHGQGIIHRDLTP+NIFFDARNDIK
Sbjct: 607 EYCPRTLRQDFESYTRFDKELAWHLFHQIVEGLAHIHGQGIIHRDLTPSNIFFDARNDIK 666
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
IGDFGLAKFLKLEQLDQD P DT GVS+DGTGQVGTYFYTAPEIEQGWPKIDEKADMY
Sbjct: 667 IGDFGLAKFLKLEQLDQDVGVPLDTTGVSIDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 726
Query: 663 SLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722
SLGIVFFELWHPF+TAMER +VLSDLKQKGELP WVA+FSEQ SLLRRLMS SPS+RPS
Sbjct: 727 SLGIVFFELWHPFATAMERHLVLSDLKQKGELPTVWVAEFSEQASLLRRLMSQSPSERPS 786
Query: 723 ATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMK---HHAGTLR 779
A+ELLQ A PP+MEY+LLDNILR M SSED+SIYD+VV++IFDEE+L MK H G
Sbjct: 787 ASELLQHAFPPRMEYQLLDNILRTMKSSEDSSIYDRVVNAIFDEESLVMKDDRHDCG--- 843
Query: 780 LNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLL 839
T++IQY+DL TE+RD+V+ T+EMFR HCAKHLE+ MYLL Q RNTVKLL
Sbjct: 844 -----TATIQYTDLGTEVRDHVIDATREMFRLHCAKHLEMSSMYLLDSSTQINRNTVKLL 898
Query: 840 THGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGG 899
+HGGD+LEL HELRLPF+ W + +QKSSFKRY+IS VYRRAIGHSPPNRYLQGDFDIIGG
Sbjct: 899 SHGGDILELCHELRLPFLNWLVFSQKSSFKRYDISYVYRRAIGHSPPNRYLQGDFDIIGG 958
Query: 900 ASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMM 959
SALTEAEV+KVT+DI++ FF+++SCDIHLNHGDLL AIWSW G+KAEHR KVAELL+MM
Sbjct: 959 TSALTEAEVIKVTVDIISYFFNSDSCDIHLNHGDLLNAIWSWVGVKAEHRHKVAELLSMM 1018
Query: 960 GSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPAD 1019
SLRPQSSE KSKWVVIRRQLLQEL LA+AVVNRLQTV RFCGA DQALPRLRGALP D
Sbjct: 1019 VSLRPQSSERKSKWVVIRRQLLQELKLAQAVVNRLQTVVFRFCGAVDQALPRLRGALPTD 1078
Query: 1020 KPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEG 1074
K KALDEL YLR+WR+E N+YIDALM P E YHR++FFQV+ KE P + EG
Sbjct: 1079 KSMHKALDELLNLFNYLRVWRLETNVYIDALMSPTEGYHRDIFFQVYLTKENNPGSHPEG 1138
Query: 1075 TLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGT 1134
LLA+GGRYDYLL +MW R Y +++PP GVG S+ALETIIQ +D KP+RNE T
Sbjct: 1139 ALLAIGGRYDYLLQQMWSRSY-----KSSPPGGVGTSIALETIIQQSALDLKPIRNEGST 1193
Query: 1135 SVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTD 1194
SVL+CSR GGGLL+ERMELV ELWEE IKAQ VP PDPSLTEQYEYA+EHDIKCLVI+TD
Sbjct: 1194 SVLICSR-GGGLLLERMELVVELWEEKIKAQLVPTPDPSLTEQYEYANEHDIKCLVIITD 1252
Query: 1195 TG-AQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQFRNPSLWS 1239
+G + G VKVRHL++KKEK+V+R +V+FL +A+A+QF+NP +W+
Sbjct: 1253 SGVSNTGSVKVRHLELKKEKKVERTYIVKFLQEAMANQFKNPLIWN 1298
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7801691|emb|CAB91611.1| protein kinase like [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1617 bits (4188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 832/1266 (65%), Positives = 953/1266 (75%), Gaps = 59/1266 (4%)
Query: 19 QSKDHSSSTVDDNELLSEEITAL-------------CAIFQEDCKVVSGS--PPQILVKL 63
Q KDH S+ +DNELLSEEITAL AIFQEDCKVVS S PPQI +KL
Sbjct: 20 QLKDHGSNADEDNELLSEEITALGMIEVAMTFKVVLSAIFQEDCKVVSDSRSPPQIAIKL 79
Query: 64 RPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSN 123
RPYSKDMGYED D+SA+L+VRCLPGYPYKCPKLQITPE+G +++L +Q S
Sbjct: 80 RPYSKDMGYEDTDISAMLIVRCLPGYPYKCPKLQITPEQGHGNIFYNDILYGIQ--KCSM 137
Query: 124 AREGRVMIFNLVEAAQEFLSEIVPLGQSNESVPGLVTESSSQSFEGSAVS-ASKSCSSKV 182
+GRVMIFNLVEAAQEFLSEI+P ESVP L S+Q E +S +KSCS
Sbjct: 138 LTQGRVMIFNLVEAAQEFLSEIIPESHDEESVPCLTAHRSTQFIEQPMLSNIAKSCSGG- 196
Query: 183 PFVYGFIDLFSGCGESWHWGLGIDENRGVVPSVPSHASDGSNYEVMWRKIDKNVKPLMIP 242
PFVYGFIDLFSG ++ +W L DENRG+V SV SH D S ++ +K DKN+K
Sbjct: 197 PFVYGFIDLFSGLEDARNWSLTPDENRGIVSSVQSHPLDTSR--ILHQKPDKNLKRFEDH 254
Query: 243 DANQGTALIPSAKLDTVKEENEDDNRSISTTDSSTSPMEEWVENGI-KGENRDSLLQDHG 301
+ P AKL+TV+EEN DD S S ++ + VE+G+ + E ++S LQD
Sbjct: 255 AKEEVALPAPIAKLNTVQEENVDDTSISSFDSSKST---DDVESGLFQNEKKESNLQDDT 311
Query: 302 SNNDGGDTEIDRLESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATE 361
+ +D ++E + L S+S SL QDQ Q +KDL++VHLLR+AC S G L DALPQI E
Sbjct: 312 AEDDSTNSESESLGSWSSDSLAQDQVPQISKKDLLMVHLLRVACTSRGPLADALPQITDE 371
Query: 362 LYNLGIFSERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSR 421
L+ LGI SE DLASK S FN+TF F+Q M S+ V QFW+P DS PN SLPSSR
Sbjct: 372 LHELGILSEEVLDLASKSSPDFNRTFEHAFNQNMASTSVPQFWEPPSDSCEPNASLPSSR 431
Query: 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI----------- 470
YLNDFEEL+PLG GGFGHVVLCKNKLDGR YAVKKIRLKDK +PVN RI
Sbjct: 432 YLNDFEELKPLGQGGFGHVVLCKNKLDGRQYAVKKIRLKDKEIPVNSRIIGLEYNAKSVF 491
Query: 471 -------LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASS 523
LREVATLSRLQHQHVVRYYQAWFETGV D + WGS T SS FS A S
Sbjct: 492 TCARYEVLREVATLSRLQHQHVVRYYQAWFETGVVDPFAGANWGSKTAGSSMFSYSGAVS 551
Query: 524 ADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583
++ Q+N LESTYLYIQMEYCPRTLRQVFESY+HFDK+ AWHL RQIVEGLAHIHGQGI
Sbjct: 552 TEIPEQDNNLESTYLYIQMEYCPRTLRQVFESYNHFDKDFAWHLIRQIVEGLAHIHGQGI 611
Query: 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFY 643
IHRD TPNNIFFDARNDIKIGDFGLAKFLKLEQLDQD F TD G VD TGQ GTYFY
Sbjct: 612 IHRDFTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDGGFSTDVAGSGVDSTGQAGTYFY 671
Query: 644 TAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFS 703
TAPEIEQ WPKIDEKADMYSLG+VFFELWHPF TAMER ++L++LK KGELP WV +F
Sbjct: 672 TAPEIEQDWPKIDEKADMYSLGVVFFELWHPFGTAMERHVILTNLKLKGELPLKWVNEFP 731
Query: 704 EQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDN-ILRMMHSSEDTSIYDKVVSS 762
EQ SLLRRLMSPSPSDRPSATELL+ A PP+ME ELLD+ +++ + +S
Sbjct: 732 EQASLLRRLMSPSPSDRPSATELLKHAFPPRMESELLDSEFFAVLYLCQLHMNVLGRLSV 791
Query: 763 IFDEETLDMK-HHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEP 821
IFDEE L+MK H + RL D+ S IQY++++TELRDYVV++TKE+FRQHCAKHLE+ P
Sbjct: 792 IFDEEVLEMKSHQSSRSRLCADD-SYIQYTEINTELRDYVVEITKEVFRQHCAKHLEVIP 850
Query: 822 MYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAI 881
M LL DCPQF R TVKLLT+GGD+LEL +ELRLPF+ W NQKSSFKRYEIS VYRRAI
Sbjct: 851 MRLLSDCPQFSRKTVKLLTNGGDMLELCYELRLPFVHWISVNQKSSFKRYEISHVYRRAI 910
Query: 882 GHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSW 941
GHSPPN LQ DFDI+GG +LTEAEVLKV +DI T FH SCDIHLNHGDLL+AIWSW
Sbjct: 911 GHSPPNPCLQADFDIVGGTLSLTEAEVLKVIVDITTHIFHRGSCDIHLNHGDLLDAIWSW 970
Query: 942 AGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRF 1001
AGIKAEHR KVAELL+MMGSLRPQSSE K KWV IRRQLLQEL L EAVVNRLQTV RF
Sbjct: 971 AGIKAEHRRKVAELLSMMGSLRPQSSERKLKWVFIRRQLLQELKLPEAVVNRLQTVASRF 1030
Query: 1002 CGAADQALPRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNL 1056
CG ADQALPRLRGAL AD+PTRKALDEL YLR+WRIE++++ID LMPP ESYHRNL
Sbjct: 1031 CGDADQALPRLRGALRADRPTRKALDELSNLLTYLRVWRIEEHVHIDVLMPPTESYHRNL 1090
Query: 1057 FFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALET 1116
FFQVF KE T +G LLAVGGRYD+L+ + DRE+ + N P VG SLALET
Sbjct: 1091 FFQVFLTKENSSGTSNDGVLLAVGGRYDWLVQEVCDREH-----KMNLPGAVGVSLALET 1145
Query: 1117 IIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTE 1176
I QH P+D +P+RNE TSVLVCSRGGGGLLV+RMELVAELWE++IKA+FVP PDPSLTE
Sbjct: 1146 IFQHLPMDLRPIRNEVSTSVLVCSRGGGGLLVQRMELVAELWEKSIKAEFVPTPDPSLTE 1205
Query: 1177 QYEYASEHDIKCLVILTDTGA---QKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQFR 1233
QYEYA+EH+IKCLVI+T++G Q VKVRHL++KKEK V RE LV+FLLDA+A QFR
Sbjct: 1206 QYEYANEHEIKCLVIITESGVAQNQIEFVKVRHLELKKEKVVGREELVKFLLDAMAVQFR 1265
Query: 1234 NPSLWS 1239
NPS+WS
Sbjct: 1266 NPSVWS 1271
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743778|emb|CBI36661.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1303 bits (3373), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/798 (79%), Positives = 691/798 (86%), Gaps = 14/798 (1%)
Query: 433 GHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAW 492
GHGGFGHVVLCKNKLDGR YAVKKIRLKDKS PV DRILREVATLSRLQHQHVVRYYQAW
Sbjct: 30 GHGGFGHVVLCKNKLDGRQYAVKKIRLKDKSPPVYDRILREVATLSRLQHQHVVRYYQAW 89
Query: 493 FETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQV 552
FETGV+ GD+ WGS T ASS+FS + ASSADV ENKLESTYLYIQMEYCPRTLRQ+
Sbjct: 90 FETGVSGSFGDTTWGSMTPASSSFSYKGASSADVNVHENKLESTYLYIQMEYCPRTLRQM 149
Query: 553 FESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612
FESY HFDKELAWHLFRQIVEGL HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL
Sbjct: 150 FESYSHFDKELAWHLFRQIVEGLVHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 209
Query: 613 KLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW 672
KLEQLDQD P DT GVSVD TGQVGTYFYTAPEIEQGWPKIDEKADMYSLG+VFFELW
Sbjct: 210 KLEQLDQDPGVPPDTTGVSVDRTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGVVFFELW 269
Query: 673 HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732
HPF TAMER IVL+DLKQKGELP SWVA+F EQ SLL+ LMSPSPSDRP ATELLQ A P
Sbjct: 270 HPFGTAMERSIVLNDLKQKGELPSSWVAEFPEQASLLQHLMSPSPSDRPFATELLQHAFP 329
Query: 733 PQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMKH--HAGTLRLNRDNTSSIQY 790
P+MEYELLDNILR M +SEDT +YDKVV++IFD+E L K+ H G LRL D+TSSIQY
Sbjct: 330 PRMEYELLDNILRTMQTSEDTGVYDKVVNAIFDKEMLSAKNLQHFGRLRLVGDDTSSIQY 389
Query: 791 SDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSH 850
+D DTELRD+V +VT+E+FR HCAK LE+ P+ LL DCPQ RNTVKLLTHGGD++EL H
Sbjct: 390 TDSDTELRDHVSEVTREVFRHHCAKRLEVVPIRLLDDCPQTIRNTVKLLTHGGDMIELCH 449
Query: 851 ELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLK 910
ELRLPF+ W I+NQKSSFKRYE+S VYRRAIGHS PNRYLQGDFD+IGGA+ALTEAEV+K
Sbjct: 450 ELRLPFVNWVITNQKSSFKRYEVSYVYRRAIGHSAPNRYLQGDFDMIGGATALTEAEVIK 509
Query: 911 VTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWK 970
V MDIVT FFH+ SC IHLNHGDLLEAIWSW GIKAEHR+KVAELL+MM SLRPQS E K
Sbjct: 510 VAMDIVTHFFHSNSCGIHLNHGDLLEAIWSWIGIKAEHRQKVAELLSMMSSLRPQSPERK 569
Query: 971 SKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL- 1029
KWVVIRRQL QELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL
Sbjct: 570 LKWVVIRRQLQQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDELA 629
Query: 1030 ----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDY 1085
YLR+WRIEK+++IDALMPP ESYHR+LFFQ++ +KE P +L EG LLA+GGRYD
Sbjct: 630 DLFSYLRVWRIEKHVFIDALMPPTESYHRDLFFQIYLMKENNPGSLKEGVLLAIGGRYDQ 689
Query: 1086 LLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGG 1145
LL M +AS++NPP VG SLALET+IQH +D +P RNE G +VLVCSRGGGG
Sbjct: 690 LLREM------CFASKSNPPGAVGVSLALETVIQHSSMDIRPFRNEVGINVLVCSRGGGG 743
Query: 1146 LLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQ-KGLVKV 1204
LL ERMELVA LWEENIKA+FVPV DPSLTEQYEYA+EHDIKCLVI+TDTG VKV
Sbjct: 744 LLEERMELVAGLWEENIKAEFVPVSDPSLTEQYEYANEHDIKCLVIITDTGVSPTDFVKV 803
Query: 1205 RHLDVKKEKEVQRESLVR 1222
RHL++KKEKEV+RE+LV+
Sbjct: 804 RHLELKKEKEVERENLVK 821
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357164402|ref|XP_003580041.1| PREDICTED: probable serine/threonine-protein kinase GCN2-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 1235 bits (3195), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/1276 (52%), Positives = 856/1276 (67%), Gaps = 75/1276 (5%)
Query: 3 KKKKGGGSGRRSKGRAQSKDHSSSTVDDNELLSEEITALCAIFQEDCKVVSGSP-PQILV 61
KKKK GG+GR++ +KDH++ D L++E+TAL AIF ED KV S SP + +
Sbjct: 7 KKKKRGGAGRKA-----AKDHAAQLEGDQAALTDELTALAAIFLEDFKVTSESPHTRFNI 61
Query: 62 KLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQAN 121
+RPYS MG+ DL+VSA+L V C PGYP KCPKL+I PEK L+K DAD LL LL DQAN
Sbjct: 62 CVRPYSDGMGFGDLNVSAILDVICFPGYPNKCPKLRIIPEKNLSKEDADRLLSLLVDQAN 121
Query: 122 SNAREGRVMIFNLVEAAQEFLSEIVPLGQSNESVPGLVTESSSQSFEGSA-VSASKSCSS 180
+REGRVMIF+LVEAAQEFLSEI P S + P L + + Q+ V
Sbjct: 122 IYSREGRVMIFDLVEAAQEFLSEIAPANDSASTDPHLGSSTIQQTTNADVKVGIDSGPCP 181
Query: 181 KVPFVYGFIDLFSGCGESWHWGLGIDENRGVVPSVPSHASD-GSNYEVMWRKIDKNV--- 236
+ ++Y DL+S + W + +GV P+ S + GS + R K V
Sbjct: 182 GISYIYHLFDLYSQLSDDNSW-----QRQGVDPTTDSARKNVGSQVKSNVRSKRKTVDEK 236
Query: 237 -----------KPLMIPDANQGTAL--------IPSAKLDTVKEENEDDNRSISTTDS-- 275
K + +A Q + +PS L V EE ++D +++ST+D
Sbjct: 237 SRFSADKVNAAKSSSLDNAEQQHVMKHSFTRDAVPS--LHVVAEETDNDRKTLSTSDGGG 294
Query: 276 -STSPMEEW-VENGIKGENRDSLLQDHGSNNDGGDTEIDRLESFSFASLGQDQASQDIEK 333
S +P + V + + + D D + G ++ S+A D AS++ ++
Sbjct: 295 LSDTPERSFSVVHETEDSDADEAWNDEECGSASGSSQ-------SYAPDMFDDASRNKKR 347
Query: 334 DLILVHLLRLACQSTGSLTDALPQIATELYNLGIFSERGRDLASKPSSQFNKTFNQVFHQ 393
DLILVHLLRLAC S SL+ ALP I++EL N+G+ SE ++L S+ + F +TF+ VF Q
Sbjct: 348 DLILVHLLRLACASKDSLSGALPVISSELCNIGVLSEWAKELISESPADFGETFDHVFGQ 407
Query: 394 KMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYA 453
+M+SS S FW+ S PN SRYLNDFEEL+ LG GGFG V LCKNKLDGR YA
Sbjct: 408 QMISSECSLFWRADNSSSRPN-----SRYLNDFEELRSLGQGGFGRVALCKNKLDGRQYA 462
Query: 454 VKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLAS 513
VKKIRL D+S VN++ILREVATLSRLQHQHVVRYYQAW ET + GS T S
Sbjct: 463 VKKIRLNDRSPQVNEKILREVATLSRLQHQHVVRYYQAWVETEYGHHHVLNTGGSRTAES 522
Query: 514 STFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH-FDKELAWHLFRQIV 572
S FS S +D G NK ESTYLYIQMEYCPRTLRQ E+Y FD + AWHLFRQIV
Sbjct: 523 SMFSYDDISLSDA-GAGNKQESTYLYIQMEYCPRTLRQDLETYSSSFDFDRAWHLFRQIV 581
Query: 573 EGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSV 632
EGLAH+H QGIIHRDLTP+NIFFD RNDIKIGDFGLAKFLKLEQLD D PT+ GVS+
Sbjct: 582 EGLAHVHSQGIIHRDLTPSNIFFDVRNDIKIGDFGLAKFLKLEQLDNDQYLPTEAIGVSM 641
Query: 633 DGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKG 692
DGTGQVGTYFYTAPE+EQ WP+I+EK DMYS G++FFELWHPFSTAMER +VL+DLKQKG
Sbjct: 642 DGTGQVGTYFYTAPEVEQKWPQINEKVDMYSAGVIFFELWHPFSTAMERHLVLTDLKQKG 701
Query: 693 ELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSED 752
+ P SW A+F Q +LLRRL+ PSPSDRPSA ELLQ+ LPP+ME E L+++LRM+ + ED
Sbjct: 702 DSPISWAAQFPGQSNLLRRLLCPSPSDRPSAVELLQNELPPRMEDEWLNDVLRMIQTPED 761
Query: 753 TSIYDKVVSSIFDEETLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQH 812
T +YD+V+S+IF+E+ L K ++ R+++ + +E + +++V+KE+F++H
Sbjct: 762 TYVYDQVISTIFNEDRLVAK-----MQCQRESSKKSTCKNDYSEFLESIIEVSKEVFKRH 816
Query: 813 CAKHLEIEPMYLL-GDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRY 871
CAK +I P++ L G + TVK+L G++LEL +ELR PF+ W +NQ SS+KRY
Sbjct: 817 CAKRFQISPLHTLDGKSTEISGKTVKVLIQRGEMLELCYELRTPFVMWIAANQVSSYKRY 876
Query: 872 EISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNH 931
E+S V+RRA+GHS P R+LQGDFDIIGG+S +TEAEV+KV +D+V RF+ +++ I LNH
Sbjct: 877 EVSWVHRRAVGHSTPYRFLQGDFDIIGGSSPITEAEVIKVALDLVRRFYDSKATVIRLNH 936
Query: 932 GDLLEAIWSWAGIKAEHREKVAELL-AMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAV 990
L EA+ SWAG+ + R+ VAE L + + P ++ KS+W +IR QLLQ+L L+E V
Sbjct: 937 SKLAEAVCSWAGVPHDRRQNVAEFLSSTLVQYCPDKADRKSQWSLIRGQLLQDLRLSEEV 996
Query: 991 VNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDAL 1045
V +L RFCG+AD L RLRG L DK KALD+L LR+W +E++I ID L
Sbjct: 997 VEKLHKADQRFCGSADLVLARLRGTLFYDKSACKALDDLSTFLKCLRVWSVEEHITIDVL 1056
Query: 1046 MPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPP 1105
MPP + Y+ +LFFQV+S KE P LLAVGGRYD L+ + WD+ Y ++ PP
Sbjct: 1057 MPPSDYYYTDLFFQVYS-KEGNPVPSSHEKLLAVGGRYDMLMEQAWDKTY-----KSKPP 1110
Query: 1106 SGVGASLALETIIQHYP-VDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKA 1164
VG S+ALE + + P D R E SVLVCS+GGGGLL ERMELVAELWE NIKA
Sbjct: 1111 GAVGVSIALEKFLPNNPSSDVWLPRIEHSISVLVCSKGGGGLLNERMELVAELWEANIKA 1170
Query: 1165 QFVPVPDPSLTEQYEYASEHDIKCLVILTDTG-AQKGLVKVRHLDVKKEKEVQRESLVRF 1223
QFVP+ DPSL EQYEYAS+HDIKCLV +T+ G +Q L+KVRHLD KKEK+V+RE +V+F
Sbjct: 1171 QFVPLEDPSLQEQYEYASDHDIKCLVFITEAGLSQTDLMKVRHLDAKKEKDVKREDIVKF 1230
Query: 1224 LLDAIASQFRNPSLWS 1239
L DAI+ QF+NP++WS
Sbjct: 1231 LSDAISLQFKNPTIWS 1246
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1239 | ||||||
| UNIPROTKB|E2RS10 | 1651 | EIF2AK4 "Uncharacterized prote | 0.545 | 0.409 | 0.282 | 3.2e-74 | |
| POMBASE|SPBC36B7.09 | 1576 | gcn2 "eIF2 alpha kinase Gcn2" | 0.555 | 0.436 | 0.287 | 4.5e-72 | |
| UNIPROTKB|Q9P2K8 | 1649 | EIF2AK4 "Eukaryotic translatio | 0.541 | 0.406 | 0.270 | 8e-72 | |
| DICTYBASE|DDB_G0272837 | 2258 | ifkA "PEK family protein kinas | 0.366 | 0.201 | 0.248 | 8.3e-72 | |
| MGI|MGI:1353427 | 1648 | Eif2ak4 "eukaryotic translatio | 0.540 | 0.406 | 0.280 | 1.2e-71 | |
| UNIPROTKB|D4A7V9 | 1649 | Eif2ak4 "Protein Eif2ak4" [Rat | 0.540 | 0.406 | 0.276 | 3.5e-71 | |
| UNIPROTKB|E1BAL6 | 1649 | EIF2AK4 "Uncharacterized prote | 0.543 | 0.408 | 0.272 | 5.3e-71 | |
| DICTYBASE|DDB_G0276829 | 1358 | ifkB "PEK family protein kinas | 0.366 | 0.334 | 0.248 | 4e-67 | |
| SGD|S000002691 | 1659 | GCN2 "Protein kinase" [Sacchar | 0.481 | 0.359 | 0.295 | 1.9e-66 | |
| RGD|1311439 | 1572 | Eif2ak4 "eukaryotic translatio | 0.540 | 0.426 | 0.276 | 2.3e-66 |
| UNIPROTKB|E2RS10 EIF2AK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 3.2e-74, Sum P(4) = 3.2e-74
Identities = 202/715 (28%), Positives = 329/715 (46%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
YLYIQMEYC + TLR + + D W LFR+I++GLA+IH +G+IHRDL P NIF
Sbjct: 800 YLYIQMEYCEKSTLRDTIDQGLYQDTIRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFL 859
Query: 596 DARNDIKIGDFGLAK---FLKLEQLDQDAAFPXXXXXXXXXXXXXXXXYFYTAPEIE-QG 651
D+ + +KIGDFGLA + D A Y +PE++
Sbjct: 860 DSDDHVKIGDFGLATDHLAFTADGKQDDTADHLIKSDPSGHLTGMVGTALYVSPEVQGSS 919
Query: 652 WPKIDEKADMYSLGIVFFEL-WHPFSTAMERQIVLSDLKQ--KGELPPSWV-AKFSEQEX 707
P ++K D++SLGI+FFE+ +HP TA ER VL+ L+ + P + + ++Q+
Sbjct: 920 RPTYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHTKQKS 979
Query: 708 XXXXXXXXXXXXXXXATELLQDAL--PPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFD 765
ATELL+ L PPQME L +L ++ D Y +++ IF
Sbjct: 980 VISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTLANVDGKAYRTMMAQIFS 1039
Query: 766 EETLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLL 825
+ + T N SI+ S + + D +V++ F++H A L P+ L
Sbjct: 1040 QRVSPAIDY--TYDSNMPKGFSIRTSKIQQHVCDTIVRI----FKKHGAVQL-CTPLLLP 1092
Query: 826 GDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYR-RAIGH 883
+ ++ N L + H G L+ L +LR+PF R+ N + KRY I V+R R +
Sbjct: 1093 QNRQIYEHNEAALFMDHSGMLVMLPFDLRVPFARYVARNNILNLKRYCIERVFRPRKLDR 1152
Query: 884 SPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRF--FHAESCDIHLNHGDLLEAIW 939
P L+ FDI+ S+L AEV+ +I+ F + I+LNH LL+AI+
Sbjct: 1153 FHPKELLECAFDIVTSTTNSSLPTAEVIYTICEIIQEFPALQERNYSIYLNHTMLLKAIF 1212
Query: 940 SWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGL 999
GI + +V +L + + E ++K+ + L + + + L
Sbjct: 1213 LHCGIPEDKLSQVYVILYDAVTEKLTRREVEAKFCNLSLSSNSLCRLYKFIEQKGDLQDL 1272
Query: 1000 RFCGAADQALPRLRGALPADKPTRKALDELY--LRIWRIEKNIYID-ALMPPIESYHRNL 1056
A + + + G K K L+E+ L+ I+ + I+ L+ ++ H +
Sbjct: 1273 T--PAINSLIKQKTGVAQLVKYGLKDLEEIIGLLKKLGIKLQVLINLGLVYKVQQ-HNGV 1329
Query: 1057 FFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALET 1116
FQ +V + + E +LA GGRYD L+ + + +G P+ VG S+A++
Sbjct: 1330 IFQFVAVIRRRQRAISE--ILAAGGRYDLLIPQFRGPQALGPV-----PTAVGVSIAIDK 1382
Query: 1117 IIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTE 1176
I +PV + +L+ S G + + L +LW I AQ + S E
Sbjct: 1383 ISAAILNMEEPV-TISSCDLLIVSVGQMSMS-RAINLTQKLWSAGITAQIMYDWSQSQEE 1440
Query: 1177 QYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231
EY H+I + +++D G VK + + EK VQ L+ +L + ++
Sbjct: 1441 LQEYCRYHEITYVALVSDKGGSYVKVKSFEKERQTEKLVQESDLIDHVLQKLRTK 1495
|
|
| POMBASE|SPBC36B7.09 gcn2 "eIF2 alpha kinase Gcn2" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 4.5e-72, Sum P(3) = 4.5e-72
Identities = 222/772 (28%), Positives = 350/772 (45%)
Query: 513 SSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQI 571
SS + ++ V QEN L +T LYIQMEYC + +L+ + D + W LFRQI
Sbjct: 700 SSDKDSSIEEASSVKTQENGLNAT-LYIQMEYCEKLSLQDIIR--DKIPVDEMWRLFRQI 756
Query: 572 VEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPXXXXXXX 631
+E LA+IH +G++HRDL P NIF D ++K+GDFGLA + Q D + +
Sbjct: 757 LEALAYIHSRGMMHRDLKPGNIFLDENRNVKLGDFGLATENENYQ-DNNDKWKNRQSADE 815
Query: 632 XXXXXXXXXYFYTAPEI--EQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLK 689
Y APE+ + + D K DMYSLGI+ FE+ FST+MER ++ ++
Sbjct: 816 DLTTGVGTA-LYVAPELLSRRNGVRYDAKVDMYSLGIILFEMCMTFSTSMERIRIIDTIR 874
Query: 690 QKG-ELPPSW-VAKFSEQEXXXXXXXXXXXXXXXXATELLQ-DALPPQMEYELLDNILRM 746
P ++ ++ S + + ELL+ +A+PP++ E + LR+
Sbjct: 875 SPSISFPSTFPFSRASHEFKVIHCLLQHDPTKRPSSQELLESEAIPPKVGEEFIQEGLRL 934
Query: 747 MHSSEDTSIYDKVVSSIFDEETLDMKHHAGTLRLNRDNTSSI--QYSDL--DTEL----R 798
+ S+ +T Y K++ +F + + +H T N S + + SD D+ L R
Sbjct: 935 L-SNPNTPYYLKLLKVLFGQ--VPDRHKDFTYDFNLSEESGVLSKVSDRGWDSLLACLVR 991
Query: 799 DYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRN--TVKLLTHGGDLLELSHELRLPF 856
D+VV+V FR+H AK E E L Q+ ++ +V LL G LL+L ++ LP+
Sbjct: 992 DHVVKV----FRRHGAK--ERESHILFPKSSQYDKDQASVSLLDKNGTLLQLPYDTVLPY 1045
Query: 857 IRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALT--EAEVLKVTMD 914
R N K Y IS V+R A G P + FDI + L +AE +K +
Sbjct: 1046 ARNVARNAVEEEKTYLISDVFREAKGGGRPKAIKEISFDITTNSDNLDWYDAETIKALDE 1105
Query: 915 IVTRFFH-AESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKW 973
++T ESC I +NH D+L +I + + + R +L + R S+
Sbjct: 1106 VLTEIPSLTESC-ILINHADILSSILDYLQVSKDKRRMATHILGQINQ-RLTLSQ----- 1158
Query: 974 VVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPT--RKALDEL-- 1029
+R QL E + ++ L R ++ +LR + P R AL+ +
Sbjct: 1159 --VRNQLRIESLVPSTTLDDLSLFDFR--ENYEEGASKLRKIFGKEMPQKMRTALNYMER 1214
Query: 1030 ---YLRIWRIEKNIYIDAL-MPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDY 1085
LR +I +Y L + E Y L FQ ++ EK L+ GGRYD
Sbjct: 1215 VVKLLRALKISHQLYFMPLCVYNFEFYDGGLMFQAINLAEK-------SELICAGGRYDK 1267
Query: 1086 LLHRMWDREYVGYASRTNPPSGVGASLALETII----------------QHYPVD-FKPV 1128
L+ R +D + A + + VG ALE ++ +H P K V
Sbjct: 1268 LV-RFFDPPLMRTARKKHV---VGICFALEKLVFSMLRYIRFHNSKQSSKHSPSPTLKSV 1323
Query: 1129 RNEAG--TSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDI 1186
A VLV S G +L E+ L+ ELW NI+A V SL E + I
Sbjct: 1324 GPWAPRRVDVLVTSIGKDSIL-EKCSLLQELWALNIQADIVLRGASSLEEIVTHYRSEGI 1382
Query: 1187 KCLVILTDTGAQ-KGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQFRNPSL 1237
++++ Q + VK R++ ++ E++ + + +LL I + RN S+
Sbjct: 1383 NWVLVVRQKNTQMEHSVKARNILKNEDDEIRFDEVGMWLLGEINERKRNESM 1434
|
|
| UNIPROTKB|Q9P2K8 EIF2AK4 "Eukaryotic translation initiation factor 2-alpha kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 8.0e-72, Sum P(3) = 8.0e-72
Identities = 195/721 (27%), Positives = 330/721 (45%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
YLYIQMEYC + TLR + + D W LFR+I++GLA+IH +G+IHRDL P NIF
Sbjct: 797 YLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFL 856
Query: 596 DARNDIKIGDFGLAK---FLKLEQLDQDAAFPXXXXXXXXXXXXXXXXYFYTAPEIEQGW 652
D+ + +KIGDFGLA + D Y +PE+ QG
Sbjct: 857 DSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEV-QGS 915
Query: 653 PK--IDEKADMYSLGIVFFEL-WHPFSTAMERQIVLSDLKQ--KGELPPSWV-AKFSEQE 706
K ++K D++SLGI+FFE+ +HP TA ER VL+ L+ + P + + ++Q+
Sbjct: 916 TKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQK 975
Query: 707 XXXXXXXXXXXXXXXXATELLQDAL--PPQMEYELLDNILRMMHSSEDTSIYDKVVSSIF 764
ATELL+ L PPQME L +L ++ D Y +++ IF
Sbjct: 976 SVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTLTNVDGKAYRTMMAQIF 1035
Query: 765 DEE---TLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEP 821
+ +D + + L+ N +S +++ +V + +F++H A L P
Sbjct: 1036 SQRISPAIDYTYDSDILKGN--------FSIRTAKMQQHVCETIIRIFKRHGAVQL-CTP 1086
Query: 822 MYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYR-R 879
+ L + ++ N L + H G L+ L +LR+PF R+ N + KRY I V+R R
Sbjct: 1087 LLLPRNRQIYEHNEAALFMDHSGMLVMLPFDLRIPFARYVARNNILNLKRYCIERVFRPR 1146
Query: 880 AIGHSPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRF--FHAESCDIHLNHGDLL 935
+ P L+ FDI+ S L AE++ +I+ F + I+LNH LL
Sbjct: 1147 KLDRFHPKELLECAFDIVTSTTNSFLPTAEIIYTIYEIIQEFPALQERNYSIYLNHTMLL 1206
Query: 936 EAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQ 995
+AI GI + +V +L + + E ++K+ + L + + +
Sbjct: 1207 KAILLHCGIPEDKLSQVYIILYDAVTEKLTRREVEAKFCNLSLSSNSLCRLYKFIEQKGD 1266
Query: 996 TVGLRFCGAADQALPRLRGALPADKPTRKALDELY--LRIWRIEKNIYID-ALMPPIESY 1052
L + + + G K K L+E+ L+ I+ + I+ L+ ++
Sbjct: 1267 LQDLM--PTINSLIKQKTGIAQLVKYGLKDLEEVVGLLKKLGIKLQVLINLGLVYKVQQ- 1323
Query: 1053 HRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASL 1112
H + FQ + ++ + E +LA GGRYD L+ + + +G P+ +G S+
Sbjct: 1324 HNGIIFQFVAFIKRRQRAVPE--ILAAGGRYDLLIPQFRGPQALGPV-----PTAIGVSI 1376
Query: 1113 ALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDP 1172
A++ I ++ + + +LV S G + + L +LW I A+ +
Sbjct: 1377 AIDKISAAV-LNMEESVTISSCDLLVVSVGQMSMS-RAINLTQKLWTAGITAEIMYDWSQ 1434
Query: 1173 SLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQF 1232
S E EY H+I + +++D VKV+ + KE++ ++ L L+D + +
Sbjct: 1435 SQEELQEYCRHHEITYVALVSDKEGSH--VKVKSFE--KERQTEKRVLETELVDHVLQKL 1490
Query: 1233 R 1233
R
Sbjct: 1491 R 1491
|
|
| DICTYBASE|DDB_G0272837 ifkA "PEK family protein kinase IfkA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 8.3e-72, Sum P(6) = 8.3e-72
Identities = 126/507 (24%), Positives = 219/507 (43%)
Query: 642 FYTAPEI-EQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVA 700
FY PEI E+ K DMYSLGI+FFE+ F T MER +L DL+ + PP + +
Sbjct: 1391 FYCCPEILEKNTKHYGTKVDMYSLGIIFFEMCFQFQTQMERSNILRDLRDNLKFPPGFES 1450
Query: 701 KFSEQEXXXXXXXXXXXXXXXXATELLQDAL-PPQMEYELLDNILRMMHSSEDTSIYDKV 759
+Q +LL+ L P +ME ++L ++ + ++ S++ +
Sbjct: 1451 TKPDQTQIIRSLLSRDPTQRPSTKQLLESGLLPSKMEDDILKEAIKTI-ANPTISLFSYL 1509
Query: 760 VSSIFDEETLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLE- 818
+ +F L H + L N S + + R+ +++F H + ++
Sbjct: 1510 MEKLF---CLSNDEHIMSRYLYTSNPS---LTPMHLICREKTFSRLEKIFLNHGSIRIDT 1563
Query: 819 --IEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSV 876
+ P N K L G ++ L ++L +P+ R + + KRY S V
Sbjct: 1564 PTLFPKNPTNSTHPGAANVAKFLDESGTVVYLPYDLTIPWARHVVIHNIQQAKRYTFSKV 1623
Query: 877 YRRAI-GHSPPNRYLQGDFDIIGGASA--LTEAEVLKVTMDIVTRF----FHAESCD--- 926
YRR+ G SP Y + DFDIIG + + +++AE L++ ++I+ F F S
Sbjct: 1624 YRRSQPGFSPKELY-ECDFDIIGPSKSRHISDAETLRIIIEIMEEFKDELFGNNSGSNSG 1682
Query: 927 ----------IHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVI 976
I +NH LL++I S G++ V + +A + W+ W +
Sbjct: 1683 SGSGGSINYKIRINHYGLLDSILSECGVEKRFFTVVYQTVAQL--------HWRLNWAQV 1734
Query: 977 RRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDELYLRIWRI 1036
Q L+E L+ ++V+ + T R G Q + +L L K + +L + + +
Sbjct: 1735 A-QSLKEHGLSASIVSNISTY-FRQRGELAQCVTQLESLLANHKEATTGISDLKILVRNL 1792
Query: 1037 EK-NIY----IDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMW 1091
+ NI +D + Y+ L FQ + ++ + ++ GGRYD L+ +
Sbjct: 1793 QMINIIPRFLLDLSLIHNHQYYEGLVFQAY-IERPTLSNPSRTEIIMSGGRYDKLIKSLH 1851
Query: 1092 DREYVGYASRTNPPSGVGASLALETII 1118
+ N SGVG +LA E I+
Sbjct: 1852 PNPSLS----NNIVSGVGVTLACEKIV 1874
|
|
| MGI|MGI:1353427 Eif2ak4 "eukaryotic translation initiation factor 2 alpha kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 561 (202.5 bits), Expect = 1.2e-71, Sum P(3) = 1.2e-71
Identities = 203/723 (28%), Positives = 332/723 (45%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
YLYIQMEYC + TLR + D W LFR+I++GLA+IH +G+IHRDL P NIF
Sbjct: 795 YLYIQMEYCEKSTLRDTIDQGLFRDTSRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFL 854
Query: 596 DARNDIKIGDFGLAK----FLKLEQLDQDAAFPXXXXXXXXXXXXXXXXYFYTAPEIEQG 651
D+ + +KIGDFGLA F + D A Y +PE+ QG
Sbjct: 855 DSDDHVKIGDFGLATDHLAFTAEGKQDDQAGDGVIKSDPSGHLTGMVGTALYVSPEV-QG 913
Query: 652 WPK--IDEKADMYSLGIVFFEL-WHPFSTAMERQIVLSDLKQ--KGELPPSWV-AKFSEQ 705
K ++K D++SLGI+FFE+ +HP TA ER VL+ L+ + P + + ++Q
Sbjct: 914 STKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPDDFDDGEHTKQ 973
Query: 706 EXXXXXXXXXXXXXXXXATELLQDAL--PPQMEYELLDNILRMMHSSEDTSIYDKVVSSI 763
+ A ELL+ L PPQME L +L ++ D Y ++S I
Sbjct: 974 KSVISWLLNHDPAKRPTAMELLKSELLPPPQMEESELHEVLHHTLANIDGKAYRTMMSQI 1033
Query: 764 FDEE---TLDMKHHAGTLRLN-RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEI 819
F + +D + + L+ N T+ IQ +T +V+V F++H A L
Sbjct: 1034 FCQHISPAIDYTYDSDILKGNFLIRTAKIQQLVCET-----IVRV----FKRHGAVQL-C 1083
Query: 820 EPMYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYR 878
P+ L + ++ N L + H G L+ L +LR+PF R+ N + KRY I V+R
Sbjct: 1084 TPLLLPRNRQIYEHNEAALFMDHSGMLVMLPFDLRVPFARYVARNNILNLKRYCIERVFR 1143
Query: 879 -RAIGHSPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRF--FHAESCDIHLNHGD 933
R + P L+ FDI+ S+L AE + +I+ F + I+LNH
Sbjct: 1144 PRKLDRFHPKELLECAFDIVTSTTNSSLPTAETIYTIYEIIQEFPALQERNYSIYLNHTM 1203
Query: 934 LLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNR 993
LL+AI GI + +V +L + + E ++K+ + L + + +
Sbjct: 1204 LLKAILLHCGIPEDKLSQVYVILYDAVTEKLTRREVEAKFCNLSLSSNSLCRLYKFIEQK 1263
Query: 994 LQTVGLRFCGAADQALPRLRGALPADKPTRKALDELY--LRIWRIEKNIYID-ALMPPIE 1050
L + + + G K + K L+++ L+ ++ + I+ L+ ++
Sbjct: 1264 GDLQDLT--PTINSLIKQKTGVAQLVKYSLKDLEDVVGLLKKLGVKLQVSINLGLVYKVQ 1321
Query: 1051 SYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGA 1110
H + FQ + ++ + E +LA GGRYD L+ + + VG P+ VG
Sbjct: 1322 Q-HTGIIFQFLAFSKRRQRVVPE--ILAAGGRYDLLIPKFRGPQTVGPV-----PTAVGV 1373
Query: 1111 SLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVP 1170
S+A++ I +PV + +LV S G + + L +LW I A+ +
Sbjct: 1374 SIAIDKIFAAVLNMEEPV-TVSSCDLLVVSVGQMSMS-RAINLTQKLWTAGITAEIMYDW 1431
Query: 1171 DPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIAS 1230
S E EY H+I + +++D VKV+ + KE++ ++ L L+D +
Sbjct: 1432 SQSQEELQEYCRHHEITYVALVSDKEGSH--VKVKSFE--KERQTEKRVLESDLVDHVMQ 1487
Query: 1231 QFR 1233
+ R
Sbjct: 1488 KLR 1490
|
|
| UNIPROTKB|D4A7V9 Eif2ak4 "Protein Eif2ak4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 3.5e-71, Sum P(3) = 3.5e-71
Identities = 200/723 (27%), Positives = 332/723 (45%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
YLYIQMEYC + TLR + D W LFR+I++GLA+IH +G+IHRDL P NIF
Sbjct: 796 YLYIQMEYCEKSTLRDTIDQGLFRDTSRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFL 855
Query: 596 DARNDIKIGDFGLAK----FLKLEQLDQDAAFPXXXXXXXXXXXXXXXXYFYTAPEIEQG 651
D+ + +KIGDFGLA F + D A Y +PE+ QG
Sbjct: 856 DSDDHVKIGDFGLATDHLAFNAEGKQDDQAGDHVIKSDPSGHLTGMVGTALYVSPEV-QG 914
Query: 652 WPK--IDEKADMYSLGIVFFEL-WHPFSTAMERQIVLSDLKQ--KGELPPSWV-AKFSEQ 705
K ++K D++SLGI+ FE+ +HP TA ER VL+ L+ + P + + ++Q
Sbjct: 915 STKSAYNQKVDLFSLGIILFEMSYHPMVTASERIFVLNQLRDPTSPKFPDDFEDGEHTKQ 974
Query: 706 EXXXXXXXXXXXXXXXXATELLQDAL--PPQMEYELLDNILRMMHSSEDTSIYDKVVSSI 763
+ A ELL+ L PPQME L +L ++ D Y ++S +
Sbjct: 975 KSVISWLLNHDPAKRPTAMELLKSELLPPPQMEESELHEVLHHTLANTDGKAYRTMMSQL 1034
Query: 764 FDEET---LDMKHHAGTLRLN-RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEI 819
F + + +D + + L+ N T+ IQ +T +V+V F++H A L
Sbjct: 1035 FCQHSSPAIDYTYDSDILKGNFLIRTAKIQQLVCET-----IVRV----FKRHGAVQL-C 1084
Query: 820 EPMYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYR 878
P+ L + ++ N L + H G L+ L +LR+PF R+ N + KRY I V+R
Sbjct: 1085 TPLLLPRNRQIYEHNEAALFMDHSGMLVMLPFDLRVPFARYVARNNILNLKRYCIERVFR 1144
Query: 879 -RAIGHSPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRF--FHAESCDIHLNHGD 933
R + P L+ FDI+ S+L AE + +++ F + I+LNH
Sbjct: 1145 PRKLDRFHPKELLECAFDIVTSTANSSLPTAETIYTIYEVIQEFPALQERNYSIYLNHTM 1204
Query: 934 LLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNR 993
LL+AI GI + +V +L + + E ++K+ + L + + +
Sbjct: 1205 LLKAILLHCGIPEDKLSQVYVILYDAVTEKLTRREVEAKFCNLSLSSNSLCRLYKFIEQK 1264
Query: 994 LQTVGLRFCGAADQALPRLRGALPADKPTRKALDELY--LRIWRIEKNIYID-ALMPPIE 1050
L + + + G K + K L+E+ L+ ++ + I+ L+ ++
Sbjct: 1265 GDLQDLT--PTINSLIKQKTGIAQLVKYSLKDLEEVVGLLKKLGVKLQVSINLGLVYKVQ 1322
Query: 1051 SYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGA 1110
H + FQ + ++ + E +LA GGRYD L+ + + +G P+ VG
Sbjct: 1323 Q-HNGIIFQFLAFSKRRQRVVPE--ILAAGGRYDLLIPKFRGPQALGPV-----PTAVGV 1374
Query: 1111 SLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVP 1170
S+A++ I +PV + +LV S G + + L +LW I A+ +
Sbjct: 1375 SIAIDKIFAAVLNMGEPV-TVSSCDLLVVSAGQMSMS-RAINLTQKLWTAGITAEIMYDW 1432
Query: 1171 DPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIAS 1230
S E EY H+I + +++D VKV+ + KE++ ++ L L+D +
Sbjct: 1433 SQSQEELQEYCRHHEITYVALVSDKEGSH--VKVKSFE--KERQTEKRVLESDLVDHVMQ 1488
Query: 1231 QFR 1233
+ R
Sbjct: 1489 KLR 1491
|
|
| UNIPROTKB|E1BAL6 EIF2AK4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 5.3e-71, Sum P(3) = 5.3e-71
Identities = 196/720 (27%), Positives = 331/720 (45%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
YLYIQMEYC + TLR + + D W LFR+I++GLA+IH +G+IHRDL P NIF
Sbjct: 796 YLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFL 855
Query: 596 DARNDIKIGDFGLAK----FLKLEQLDQDAAFPXXXXXXXXXXXXXXXXYFYTAPEIEQG 651
D+ + +KIGDFGLA F + D + Y +PE+ QG
Sbjct: 856 DSDDHVKIGDFGLATDHLAFAADGKQDDTSGDHLIKSDPSGHLTGMVGTALYVSPEV-QG 914
Query: 652 WPK--IDEKADMYSLGIVFFEL-WHPFSTAMERQIVLSDLKQ--KGELPPSWV-AKFSEQ 705
K ++K D++SLGI+FFE+ +HP TA ER VL+ L+ + P + + ++Q
Sbjct: 915 STKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHTKQ 974
Query: 706 EXXXXXXXXXXXXXXXXATELLQDAL--PPQMEYELLDNILRMMHSSEDTSIYDKVVSSI 763
+ ATELL+ L PPQME L +L ++ D Y ++ I
Sbjct: 975 KSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTLANVDGKAYRTMMGQI 1034
Query: 764 FDEE---TLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIE 820
F + +D + + L+ + SI+ + + + + ++++ F++H A L
Sbjct: 1035 FAQRISPAIDYTYDSDILK----GSFSIRTAKIQQHVCETIIRI----FKRHGAVQL-CT 1085
Query: 821 PMYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYR- 878
P+ L + ++ N L + H G L+ L +LR+PF R+ N + KRY I V+R
Sbjct: 1086 PLLLPRNRQIYEHNEAALFMDHSGMLVMLPFDLRVPFARYVARNNILNLKRYCIERVFRP 1145
Query: 879 RAIGHSPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRF--FHAESCDIHLNHGDL 934
R + P L+ FDI+ S+L AE++ +I+ F + I+LNH L
Sbjct: 1146 RKLDRFHPKELLECAFDIVTSTTNSSLPTAEIIYTIYEIIQEFPALQERNYSIYLNHTML 1205
Query: 935 LEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRL 994
L+AI GI + +V +L + + E ++K+ + L + + +
Sbjct: 1206 LKAILLHCGIPEDKLSQVYVILYDAVTEKLTRREVEAKFCNLSLSSSSLCRLYKFIEQKG 1265
Query: 995 QTVGLRFCGAADQALPRLRGALPADKPTRKALDELY--LRIWRIEKNIYID-ALMPPIES 1051
+ L + + + G K K L+E+ L+ + I+ + I+ L+ ++
Sbjct: 1266 ELQDLT--PTINSLIKQKTGVAQLVKYGLKDLEEVVGLLKKFGIKLQVLINLGLVYKVQQ 1323
Query: 1052 YHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGAS 1111
H + FQ + + + E +LA GGRYD L+ + + +G P+ +G S
Sbjct: 1324 -HSGIIFQFVAFIRRRQRAISE--ILAAGGRYDLLIPQFRGPQALGPV-----PTAIGVS 1375
Query: 1112 LALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPD 1171
+A++ I +PV + +LV S G + + L +LW I A+ +
Sbjct: 1376 IAIDKITTAVLNMEEPV-TVSSCDLLVVSVGQMSMS-RAINLTQKLWSAGITAEIMYDWS 1433
Query: 1172 PSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231
S E EY H+I + +++D VK D + EK V LV ++ + ++
Sbjct: 1434 QSQEELQEYCRHHEITYVALVSDKEGSHVKVKSFEKDRQTEKRVPESDLVDHVVQKLRTK 1493
|
|
| DICTYBASE|DDB_G0276829 ifkB "PEK family protein kinase IfkB" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 4.0e-67, Sum P(4) = 4.0e-67
Identities = 126/507 (24%), Positives = 219/507 (43%)
Query: 642 FYTAPEI-EQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVA 700
FY PEI E+ K DMYSLGI+FFE+ F T MER +L DL+ + PP + +
Sbjct: 491 FYCCPEILEKNTKHYGTKVDMYSLGIIFFEMCFQFQTQMERSNILRDLRDNLKFPPGFES 550
Query: 701 KFSEQEXXXXXXXXXXXXXXXXATELLQDAL-PPQMEYELLDNILRMMHSSEDTSIYDKV 759
+Q +LL+ L P +ME ++L ++ + ++ S++ +
Sbjct: 551 TKPDQTQIIRSLLSRDPTQRPSTKQLLESGLLPSKMEDDILKEAIKTI-ANPTISLFSYL 609
Query: 760 VSSIFDEETLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLE- 818
+ +F L H + L N S + + R+ +++F H + ++
Sbjct: 610 MEKLF---CLSNDEHIMSRYLYTSNPS---LTPMHLICREKTFSRLEKIFLNHGSIRIDT 663
Query: 819 --IEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSV 876
+ P N K L G ++ L ++L +P+ R + + KRY S V
Sbjct: 664 PTLFPKNPTNSTHPGAANVAKFLDESGTVVYLPYDLTIPWARHVVIHNIQQAKRYTFSKV 723
Query: 877 YRRAI-GHSPPNRYLQGDFDIIGGASA--LTEAEVLKVTMDIVTRF----FHAESCD--- 926
YRR+ G SP Y + DFDIIG + + +++AE L++ ++I+ F F S
Sbjct: 724 YRRSQPGFSPKELY-ECDFDIIGPSKSRHISDAETLRIIIEIMEEFKDELFGNNSGSNSG 782
Query: 927 ----------IHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVI 976
I +NH LL++I S G++ V + +A + W+ W +
Sbjct: 783 SGSGGSINYKIRINHYGLLDSILSECGVEKRFFTVVYQTVAQL--------HWRLNWAQV 834
Query: 977 RRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDELYLRIWRI 1036
Q L+E L+ ++V+ + T R G Q + +L L K + +L + + +
Sbjct: 835 A-QSLKEHGLSASIVSNISTY-FRQRGELAQCVTQLESLLANHKEATTGISDLKILVRNL 892
Query: 1037 EK-NIY----IDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMW 1091
+ NI +D + Y+ L FQ + ++ + ++ GGRYD L+ +
Sbjct: 893 QMINIIPRFLLDLSLIHNHQYYEGLVFQAY-IERPTLSNPSRTEIIMSGGRYDKLIKSLH 951
Query: 1092 DREYVGYASRTNPPSGVGASLALETII 1118
+ N SGVG +LA E I+
Sbjct: 952 PNPSLS----NNIVSGVGVTLACEKIV 974
|
|
| SGD|S000002691 GCN2 "Protein kinase" [Saccharomyces cerevisiae (taxid:4932)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 1.9e-66, Sum P(4) = 1.9e-66
Identities = 203/687 (29%), Positives = 330/687 (48%)
Query: 532 KLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589
K +ST L+IQMEYC RTL + S + + ++ W LFRQI+E L++IH QGIIHRDL
Sbjct: 779 KKKST-LFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLK 837
Query: 590 PNNIFFDARNDIKIGDFGLAKFL--KLEQLDQDAA-FPXXXXXXXXXXXXXXXXYFYTAP 646
P NIF D ++KIGDFGLAK + L+ L D+ P Y A
Sbjct: 838 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA----MYVAT 893
Query: 647 EIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKG-ELPPSWVA-KFSE 704
E+ G +EK DMYSLGI+FFE+ +PFST MER +L L+ E PP + K
Sbjct: 894 EVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKV 953
Query: 705 QEXXXXXXXXXXXXXXXXATELLQDA-LPPQMEYELLDNILRMMHSSEDTSIYDKVVSSI 763
++ A LL LP + + E++ L+ + S+ + +V S+
Sbjct: 954 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALKSL-SNPSSPWQQQVRESL 1012
Query: 764 FDEETLDMKHHAGTLRLNRDNT--SSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEP 821
F++ ++ T + DN+ +S ++++ LR + + ++FR+H P
Sbjct: 1013 FNQS------YSLTNDILFDNSVPTSTPFANI---LRSQMTEEVVKIFRKHGGIENNAPP 1063
Query: 822 MYLLGDCPQF-KRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRA 880
+ P + +N ++L GG +L+L ++L P R+ N K+Y + VYR
Sbjct: 1064 R-IFPKAPIYGTQNVYEVLDKGGTVLQLQYDLTYPMARYLSKNPSLISKQYRMQHVYRPP 1122
Query: 881 IGHS----PPNRYLQGDFDIIGGASALT---EAEVLKVTMDIVTRF--FHAESCDIHLNH 931
HS P ++ + DFDII +S+ + +AE LK+ +I+T F F + LNH
Sbjct: 1123 -DHSRSSLEPRKFGEIDFDIISKSSSESGFYDAESLKIIDEILTVFPVFEKTNTFFILNH 1181
Query: 932 GDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVV 991
D+LE+++++ I R V+ +L+ +G R +K ++ +L +LN++ +
Sbjct: 1182 ADILESVFNFTNIDKAQRPLVSRMLSQVGFAR----SFKE----VKNELKAQLNISSTAL 1233
Query: 992 NRLQTVGLRF-CGAADQALPRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDAL 1045
N L+ R AA + L +L P K +L + YL+ + +N+ I
Sbjct: 1234 NDLELFDFRLDFEAAKKRLYKLMIDSPHLKKIEDSLSHISKVLSYLKPLEVARNVVIS-- 1291
Query: 1046 MPPIESYHRNLFFQVFSVKEKYPATLVEGT---LLAVGGRYDYLLHRMWDREYVGYASRT 1102
P+ +Y+ + F++ + + A +G+ ++A GGRYD L+ + R G S +
Sbjct: 1292 --PLSNYN-SAFYKGGIM---FHAVYDDGSSRNMIAAGGRYDTLIS-FFARPS-GKKS-S 1342
Query: 1103 NPPSGVGASLALETII---QHY-------------------PVDFKPVRNEAGTSVLVCS 1140
N VG +LA ETI Q+Y VD+KP R + VL+ S
Sbjct: 1343 NTRKAVGFNLAWETIFGIAQNYFKLASGNRIKKRNRFLKDTAVDWKPSRCD----VLISS 1398
Query: 1141 RGGGGLLVERMELVAELWEENIKAQFV 1167
L + ++ LW++NIKA +
Sbjct: 1399 FSNSLLDTIGVTILNTLWKQNIKADML 1425
|
|
| RGD|1311439 Eif2ak4 "eukaryotic translation initiation factor 2 alpha kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 2.3e-66, Sum P(3) = 2.3e-66
Identities = 200/723 (27%), Positives = 332/723 (45%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
YLYIQMEYC + TLR + D W LFR+I++GLA+IH +G+IHRDL P NIF
Sbjct: 719 YLYIQMEYCEKSTLRDTIDQGLFRDTSRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFL 778
Query: 596 DARNDIKIGDFGLAK----FLKLEQLDQDAAFPXXXXXXXXXXXXXXXXYFYTAPEIEQG 651
D+ + +KIGDFGLA F + D A Y +PE+ QG
Sbjct: 779 DSDDHVKIGDFGLATDHLAFNAEGKQDDQAGDHVIKSDPSGHLTGMVGTALYVSPEV-QG 837
Query: 652 WPK--IDEKADMYSLGIVFFEL-WHPFSTAMERQIVLSDLKQ--KGELPPSWV-AKFSEQ 705
K ++K D++SLGI+ FE+ +HP TA ER VL+ L+ + P + + ++Q
Sbjct: 838 STKSAYNQKVDLFSLGIILFEMSYHPMVTASERIFVLNQLRDPTSPKFPDDFEDGEHTKQ 897
Query: 706 EXXXXXXXXXXXXXXXXATELLQDAL--PPQMEYELLDNILRMMHSSEDTSIYDKVVSSI 763
+ A ELL+ L PPQME L +L ++ D Y ++S +
Sbjct: 898 KSVISWLLNHDPAKRPTAMELLKSELLPPPQMEESELHEVLHHTLANTDGKAYRTMMSQL 957
Query: 764 FDEET---LDMKHHAGTLRLN-RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEI 819
F + + +D + + L+ N T+ IQ +T +V+V F++H A L
Sbjct: 958 FCQHSSPAIDYTYDSDILKGNFLIRTAKIQQLVCET-----IVRV----FKRHGAVQL-C 1007
Query: 820 EPMYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYR 878
P+ L + ++ N L + H G L+ L +LR+PF R+ N + KRY I V+R
Sbjct: 1008 TPLLLPRNRQIYEHNEAALFMDHSGMLVMLPFDLRVPFARYVARNNILNLKRYCIERVFR 1067
Query: 879 -RAIGHSPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRF--FHAESCDIHLNHGD 933
R + P L+ FDI+ S+L AE + +++ F + I+LNH
Sbjct: 1068 PRKLDRFHPKELLECAFDIVTSTANSSLPTAETIYTIYEVIQEFPALQERNYSIYLNHTM 1127
Query: 934 LLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNR 993
LL+AI GI + +V +L + + E ++K+ + L + + +
Sbjct: 1128 LLKAILLHCGIPEDKLSQVYVILYDAVTEKLTRREVEAKFCNLSLSSNSLCRLYKFIEQK 1187
Query: 994 LQTVGLRFCGAADQALPRLRGALPADKPTRKALDELY--LRIWRIEKNIYID-ALMPPIE 1050
L + + + G K + K L+E+ L+ ++ + I+ L+ ++
Sbjct: 1188 GDLQDLT--PTINSLIKQKTGIAQLVKYSLKDLEEVVGLLKKLGVKLQVSINLGLVYKVQ 1245
Query: 1051 SYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGA 1110
H + FQ + ++ + E +LA GGRYD L+ + + +G P+ VG
Sbjct: 1246 Q-HNGIIFQFLAFSKRRQRVVPE--ILAAGGRYDLLIPKFRGPQALGPV-----PTAVGV 1297
Query: 1111 SLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVP 1170
S+A++ I +PV + +LV S G + + L +LW I A+ +
Sbjct: 1298 SIAIDKIFAAVLNMGEPV-TVSSCDLLVVSAGQMSMS-RAINLTQKLWTAGITAEIMYDW 1355
Query: 1171 DPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIAS 1230
S E EY H+I + +++D VKV+ + KE++ ++ L L+D +
Sbjct: 1356 SQSQEELQEYCRHHEITYVALVSDKEGSH--VKVKSFE--KERQTEKRVLESDLVDHVMQ 1411
Query: 1231 QFR 1233
+ R
Sbjct: 1412 KLR 1414
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9LX30 | GCN2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6952 | 0.9757 | 0.9742 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00001939001 | SubName- Full=Chromosome chr5 scaffold_124, whole genome shotgun sequence; (1255 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| GSVIVG00026837001 | SubName- Full=Chromosome chr15 scaffold_40, whole genome shotgun sequence; (64 aa) | • | 0.489 | ||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1239 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-56 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-47 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-31 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-31 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-30 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-29 | |
| PLN02972 | 763 | PLN02972, PLN02972, Histidyl-tRNA synthetase | 8e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-28 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-26 | |
| COG0124 | 429 | COG0124, HisS, Histidyl-tRNA synthetase [Translati | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-23 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-22 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-19 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-19 | |
| smart00591 | 107 | smart00591, RWD, domain in RING finger and WD repe | 7e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-18 | |
| pfam05773 | 113 | pfam05773, RWD, RWD domain | 4e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-17 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-14 | |
| cd00773 | 261 | cd00773, HisRS-like_core, Class II Histidinyl-tRNA | 6e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-13 | |
| PRK00037 | 412 | PRK00037, hisS, histidyl-tRNA synthetase; Reviewed | 9e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-12 | |
| TIGR00442 | 397 | TIGR00442, hisS, histidyl-tRNA synthetase | 6e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| PLN00181 | 793 | PLN00181, PLN00181, protein SPA1-RELATED; Provisio | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-11 | |
| cd00859 | 91 | cd00859, HisRS_anticodon, HisRS Histidyl-anticodon | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-08 | |
| pfam13393 | 308 | pfam13393, tRNA-synt_His, Histidyl-tRNA synthetase | 9e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-07 | |
| PRK12292 | 391 | PRK12292, hisZ, ATP phosphoribosyltransferase regu | 1e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-07 | |
| COG3705 | 390 | COG3705, HisZ, ATP phosphoribosyltransferase invol | 3e-07 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 5e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 5e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| TIGR00443 | 313 | TIGR00443, hisZ_biosyn_reg, ATP phosphoribosyltran | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 1e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-04 | |
| pfam03129 | 93 | pfam03129, HGTP_anticodon, Anticodon binding domai | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| PRK12420 | 423 | PRK12420, PRK12420, histidyl-tRNA synthetase; Prov | 6e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.002 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.003 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.004 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 1e-65
Identities = 87/309 (28%), Positives = 131/309 (42%), Gaps = 63/309 (20%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+E L+ LG G FG V L ++K G+ A+K I+ K K +RILRE+ L +L+H ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK-KKKIKKDRERILREIKILKKLKHPNI 59
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
VR Y FE LY+ MEYC
Sbjct: 60 VRLY-DVFED---------------------------------------EDKLYLVMEYC 79
Query: 546 P-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
L + + ++ A RQI+ L ++H +GI+HRDL P NI D +K+
Sbjct: 80 EGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLA 139
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGLA+ L + T VGT Y APE+ G + D++SL
Sbjct: 140 DFGLARQLDPGEKL----------------TTFVGTPEYMAPEVLLG-KGYGKAVDIWSL 182
Query: 665 GIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDR 720
G++ +EL PF + + + + P S + + L+R+L+ P R
Sbjct: 183 GVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKR 242
Query: 721 PSATELLQD 729
+A E LQ
Sbjct: 243 LTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 4e-59
Identities = 91/312 (29%), Positives = 128/312 (41%), Gaps = 63/312 (20%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+E L+ LG G FG V K+K G+ AVK ++ + + + RE+ L RL H ++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
VR FE +LY+ MEYC
Sbjct: 61 VRLI-DAFED---------------------------------------KDHLYLVMEYC 80
Query: 546 PRT-LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
L ++ A + QI+ GL ++H GIIHRDL P NI D +KI
Sbjct: 81 EGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIA 140
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGLAK L S T VGT +Y APE+ G K D++SL
Sbjct: 141 DFGLAKKL---------------LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSL 185
Query: 665 GIVFFEL---WHPFSTA-MERQIVLSDLKQKGELPPSWVAKFSEQE---SLLRRLMSPSP 717
G++ +EL PFS + Q+ L L S E L+++ ++ P
Sbjct: 186 GVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDP 245
Query: 718 SDRPSATELLQD 729
S RP+A E+LQ
Sbjct: 246 SKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 1e-56
Identities = 82/301 (27%), Positives = 128/301 (42%), Gaps = 90/301 (29%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
LG GGFG V L ++K G+ A+K I+ +D S + +LRE+ L +L H ++V+ Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLR 550
+ + +LY+ MEYC +L+
Sbjct: 60 FEDEN----------------------------------------HLYLVMEYCEGGSLK 79
Query: 551 QVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND-IKIGDFGL 608
+ + + ++ + QI+EGL ++H GIIHRDL P NI D+ N +K+ DFGL
Sbjct: 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGL 139
Query: 609 AKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVF 668
+K L VGT Y APE+ G EK+D++SLG++
Sbjct: 140 SKLL---------------TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184
Query: 669 FELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
+EL +LK L+R+++ P RPSA E+L+
Sbjct: 185 YEL--------------PELKD-----------------LIRKMLQKDPEKRPSAKEILE 213
Query: 729 D 729
Sbjct: 214 H 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 2e-53
Identities = 85/314 (27%), Positives = 134/314 (42%), Gaps = 70/314 (22%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
+E ++ +G G FG V L + K DG+ Y +K+I L + S + L EV L +L H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+++YY E+ E L I MEY
Sbjct: 61 IIKYY----------------------------------------ESFEEKGKLCIVMEY 80
Query: 545 CPR-TLRQVFESY----DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
L Q + F +E F Q+ L ++H + I+HRD+ P NIF +
Sbjct: 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG 140
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
+K+GDFG++K L VGT +Y +PE+ Q P + K+
Sbjct: 141 LVKLGDFGISK-----VLSSTVDL----------AKTVVGTPYYLSPELCQNKP-YNYKS 184
Query: 660 DMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGE-LPPSWVAKFSEQ-ESLLRRLMS 714
D++SLG V +EL HPF ++ L LK + +P +S + +L+ L+
Sbjct: 185 DIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQ----YSSELRNLVSSLLQ 240
Query: 715 PSPSDRPSATELLQ 728
P +RPS ++LQ
Sbjct: 241 KDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 7e-47
Identities = 91/307 (29%), Positives = 128/307 (41%), Gaps = 66/307 (21%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
LG G FG V L +K G AVK + L S + + RE+ LS LQH ++VRYY
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY-- 65
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLR 550
G E E L I +EY +L
Sbjct: 66 ------------------------------------GSERDEEKNTLNIFLEYVSGGSLS 89
Query: 551 QVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
+ + + + + RQI+EGLA++H GI+HRD+ NI D+ +K+ DFG AK
Sbjct: 90 SLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAK 149
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQV-GTYFYTAPE-IEQGWPKIDEKADMYSLGIVF 668
L + +GTG V GT ++ APE I + AD++SLG
Sbjct: 150 RLG--------------DIETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTV 193
Query: 669 FELW---HPFSTAMERQIVLSDLKQKGELP--PSWVAKFSEQ-ESLLRRLMSPSPSDRPS 722
E+ P+S L + GE P P SE+ + LR+ + P RP+
Sbjct: 194 IEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH---LSEEAKDFLRKCLRRDPKKRPT 250
Query: 723 ATELLQD 729
A ELLQ
Sbjct: 251 ADELLQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 66/311 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
DFE L +G G FG V K D R YA+K+I L + + + E L++L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++RYY+++ + G L I MEY
Sbjct: 61 IIRYYESFLDKGK----------------------------------------LNIVMEY 80
Query: 545 CPR-TLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
L ++ + ++ W F QI+ GLAH+H + I+HRD+ N+F DA +++
Sbjct: 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNV 140
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
KIGD G+AK L + VGT +Y +PE+ + P +EK+D+
Sbjct: 141 KIGDLGVAKLL---------------SDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDV 184
Query: 662 YSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQES-LLRRLMSPSP 717
++LG+V +E HPF + ++L + +G PP +S+Q + L+ + ++
Sbjct: 185 WALGVVLYECCTGKHPFDANNQGALILKII--RGVFPPV-SQMYSQQLAQLIDQCLTKDY 241
Query: 718 SDRPSATELLQ 728
RP +LL+
Sbjct: 242 RQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 89/324 (27%), Positives = 142/324 (43%), Gaps = 81/324 (25%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL-----KDKSLPVNDRILREVATLSR 479
D+E L+ +G G FG V + K DG+ K+I K+K V+ EV L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-----EVNILRE 55
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
L+H ++VRYY +R+ + LY
Sbjct: 56 LKHPNIVRYYD------------------------RIIDRSNQT--------------LY 77
Query: 540 IQMEYC-----PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH-----GQGIIHRDLT 589
I MEYC + +++ + + ++E W + Q++ L H G ++HRDL
Sbjct: 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137
Query: 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649
P NIF DA N++K+GDFGLAK L + T VGT +Y +PE
Sbjct: 138 PANIFLDANNNVKLGDFGLAKIL------GHDSSFAKT---------YVGTPYYMSPEQL 182
Query: 650 QGWPKIDEKADMYSLGIVFFE---LWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ- 705
DEK+D++SLG + +E L PF+ Q+ L+ ++G+ ++S +
Sbjct: 183 NHMS-YDEKSDIWSLGCLIYELCALSPPFTAR--NQLQLASKIKEGKFRR-IPYRYSSEL 238
Query: 706 ESLLRRLMSPSPSDRPSATELLQD 729
+++ +++ P RPS ELLQ
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 77/311 (24%), Positives = 138/311 (44%), Gaps = 68/311 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
FE L+ +G GGFG V ++K G+ A+K I+L+ S ++I+ E+ L + +H +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPN 58
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V+YY ++ D +W I ME+
Sbjct: 59 IVKYYGSYL-------KKDELW---------------------------------IVMEF 78
Query: 545 CPR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
C +L+ + +S + + ++ +++++GL ++H GIIHRD+ NI + ++K
Sbjct: 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVK 138
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
+ DFGL+ L + VGT ++ APE+ G P D KAD++
Sbjct: 139 LIDFGLSAQLSDTKARNTM----------------VGTPYWMAPEVINGKP-YDYKADIW 181
Query: 663 SLGIVFFELW-----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
SLGI EL + M+ ++ G P + E + L++ + +P
Sbjct: 182 SLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSD--EFKDFLKKCLQKNP 239
Query: 718 SDRPSATELLQ 728
RP+A +LL+
Sbjct: 240 EKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 79/315 (25%), Positives = 137/315 (43%), Gaps = 68/315 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
DF+ L+ LG G +G V K D + YA+K++ L S + + E+ L+ + H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++ Y +A+ L+ L I MEY
Sbjct: 61 IISYKEAF----------------------------------------LDGNKLCIVMEY 80
Query: 545 CP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
P + + + + ++ W +F Q++ GL +H Q I+HRDL NI A +
Sbjct: 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND 140
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
+KIGD G++K LK ++ A Q+GT Y APE+ +G P K+
Sbjct: 141 LVKIGDLGISKVLK-----KNMAKT------------QIGTPHYMAPEVWKGRP-YSYKS 182
Query: 660 DMYSLGIVFFELWHPFSTAMERQIVLSDLKQK---GELPPSWVAKFSEQESLLRRLMSPS 716
D++SLG + +E+ F+ E + + DL+ K G+ PP + ++ +R ++
Sbjct: 183 DIWSLGCLLYEM-ATFAPPFEAR-SMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVK 240
Query: 717 PSDRPSATELLQDAL 731
P RP+ ++L
Sbjct: 241 PKLRPNCDKILASPA 255
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 83/336 (24%), Positives = 130/336 (38%), Gaps = 89/336 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL--KDKSLPVNDRILREVATLSRLQHQ 483
+E+L+ LG G +G V ++K G A+KKIRL +++ +P LRE++ L L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST--ALREISLLKELKHP 58
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+ DV E KL Y+ E
Sbjct: 59 NIVKLL-----------------------------------DVIHTERKL-----YLVFE 78
Query: 544 YCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
YC L++ + L + Q++ GLA+ H I+HRDL P NI + +K
Sbjct: 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLK 138
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
+ DFGLA+ P T T +V T +Y APEI G D++
Sbjct: 139 LADFGLARAFG---------IPLRT------YTHEVVTLWYRAPEILLGSKHYSTAVDIW 183
Query: 663 SLGIVFFELW--HP-----------------FSTAMERQIV-LSDLKQKGELPPSWVAK- 701
S+G +F E+ P T E ++ L P + K
Sbjct: 184 SVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKD 243
Query: 702 ----FSEQES----LLRRLMSPSPSDRPSATELLQD 729
+ LL +++ +P+ R SA E L+
Sbjct: 244 LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 84/296 (28%), Positives = 120/296 (40%), Gaps = 58/296 (19%)
Query: 435 GGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-VNDRILREVATLSRLQHQHVVRYYQAWF 493
G +G V L K K G YA+K I+ D D++L E LS+ Q +VV+ Y +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-- 61
Query: 494 ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQV 552
F G LY+ MEY P L +
Sbjct: 62 ------FQGKK--------------------------------NLYLVMEYLPGGDLASL 83
Query: 553 FESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612
E+ D+++A +IV L ++H GIIHRDL P+NI D+ +K+ DFGL+K
Sbjct: 84 LENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143
Query: 613 KLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFE 670
+ + + + VGT Y APE+ QG K D +SLG + +E
Sbjct: 144 LVRRQINLNDDEKEDKRI-------VGTPDYIAPEVILGQGHSK---TVDWWSLGCILYE 193
Query: 671 L---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA 723
PF +I + L K E P V E L+ +L+ P P R A
Sbjct: 194 FLVGIPPFHGETPEEIFQNILNGKIE-WPEDVEVSDEAIDLISKLLVPDPEKRLGA 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (331), Expect = 5e-33
Identities = 90/415 (21%), Positives = 143/415 (34%), Gaps = 74/415 (17%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND-RILREVATLSRLQHQ 483
+ L+ LG G FG V L +++ + A+K + K +S R LRE+ L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 484 -HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V+ Y Q+ LY+ M
Sbjct: 58 PNIVKLYD------------------------------------FFQDEG----SLYLVM 77
Query: 543 EYCP-RTLRQVFESYDH---FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
EY +L + + + A + QI+ L ++H +GIIHRD+ P NI D
Sbjct: 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD 137
Query: 599 ND-IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKI 655
+K+ DFGLAK L T VGT Y APE+ G
Sbjct: 138 GRVVKLIDFGLAKLLPDPGSTSSIPALPST---------SVGTPGYMAPEVLLGLSLAYA 188
Query: 656 DEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVA----------KF 702
+D++SLGI +EL PF LK ELP +A
Sbjct: 189 SSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELIS 248
Query: 703 SEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDKVVSS 762
LL++L++ P +R S++ L L ++ + D + S
Sbjct: 249 KAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSL 308
Query: 763 IFDEETLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHL 817
+L+ +G+ D+ S + + + L
Sbjct: 309 EALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSL 363
|
Length = 384 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 86/314 (27%), Positives = 130/314 (41%), Gaps = 66/314 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ ++ LG G FG L + D K++ L S L E+ LS LQH ++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ YY + ++ L I+MEY
Sbjct: 62 IAYYNHF----------------------------------------MDDNTLLIEMEYA 81
Query: 546 PR-TLRQVFESYD--HFDKELA-WHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
TL F++E+ W+LF QIV +++IH GI+HRD+ NIF I
Sbjct: 82 NGGTLYDKIVRQKGQLFEEEMVLWYLF-QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLI 140
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
K+GDFG++K L E +V VGT +Y +PE+ QG K + K+D+
Sbjct: 141 KLGDFGISKILGSEYS----------MAETV-----VGTPYYMSPELCQG-VKYNFKSDI 184
Query: 662 YSLGIVFFE---LWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718
++LG V +E L F +V+ ++ G P SE SL+ L+ P
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYTPVVSVYSSELISLVHSLLQQDPE 242
Query: 719 DRPSATELLQDALP 732
RP+A E+L L
Sbjct: 243 KRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 94/309 (30%), Positives = 128/309 (41%), Gaps = 64/309 (20%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
+G G FG V N G AVK+IR++D I E+ L L+H ++V+YY
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY-- 65
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLR 550
GV ++ +YI MEYC TL
Sbjct: 66 ----GV----------------------------------EVHREKVYIFMEYCSGGTLE 87
Query: 551 QVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
++ E D+ + Q++EGLA++H GI+HRD+ P NIF D IK+GDFG A
Sbjct: 88 ELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE--KADMYSLGIVF 668
LK T T G V GT Y APE+ G AD++SLG V
Sbjct: 148 KLKN---------NTTTMGEEVQSL--AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196
Query: 669 FEL------WHPFSTAMERQIVLS-DLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP 721
E+ W E QI+ K +P S + E + L R + P RP
Sbjct: 197 LEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPDS-LQLSPEGKDFLDRCLESDPKKRP 253
Query: 722 SATELLQDA 730
+A+ELLQ
Sbjct: 254 TASELLQHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 89/317 (28%), Positives = 139/317 (43%), Gaps = 74/317 (23%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+D E ++ LG G G V ++K G+ YA+KKI + ++LRE+ TL +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESP 59
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+VV+ Y A+++ G + I +E
Sbjct: 60 YVVKCYGAFYKEG----------------------------------------EISIVLE 79
Query: 544 YCPR-TLRQVFESYDHF-DKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARND 600
Y +L + + + LA ++ RQI++GL ++H + IIHRD+ P+N+ +++ +
Sbjct: 80 YMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE 138
Query: 601 IKIGDFGLAKFLKLEQ-LDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE-K 658
+KI DFG++K LE LDQ F VGT Y +PE QG +
Sbjct: 139 VKIADFGISKV--LENTLDQCNTF--------------VGTVTYMSPERIQG--ESYSYA 180
Query: 659 ADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQK--GELPPSWVAK-FSEQ-ESLLRR 711
AD++SLG+ E PF Q +L Q PPS A+ FS + +
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPP--GQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238
Query: 712 LMSPSPSDRPSATELLQ 728
+ P RPSA ELLQ
Sbjct: 239 CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 86/328 (26%), Positives = 131/328 (39%), Gaps = 77/328 (23%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK---KIRL----KDKSLPVNDRILREVAT 476
+DF+ + +G G F VVL K K + YA+K K +L K K + E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY------VKIEKEV 54
Query: 477 LSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLES 535
L+RL H +++ Y TF + +EN
Sbjct: 55 LTRLNGHPGIIKLY------------------------YTFQD----------EEN---- 76
Query: 536 TYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
LY +EY P L Q Y D++ +I+ L ++H +GIIHRDL P NI
Sbjct: 77 --LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENIL 134
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ------VGTYFYTAPEI 648
D IKI DFG AK L + + T S + VGT Y +PE+
Sbjct: 135 LDKDMHIKITDFGTAKVLDPNSSPE-SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL 193
Query: 649 --EQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSW--VAK 701
E+ + +D+++LG + +++ PF + E LK + PP++ AK
Sbjct: 194 LNEK---PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAK 250
Query: 702 FSEQESLLRRLMSPSPSDRPSATELLQD 729
L+ +L+ P DR E +
Sbjct: 251 -----DLIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 55/248 (22%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
++ L +G G G V K++ G A+KK+ L+ + ++ LRE+ L QH +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
VV+ DV + + MEY
Sbjct: 61 VVKLL-----------------------------------DVF-----PHGSGFVLVMEY 80
Query: 545 CPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
P L +V + + R +++G+A++H GI+HRDL P N+ A +KI
Sbjct: 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
DFGLA+ + QV T +Y APE+ G K D D+++
Sbjct: 141 ADFGLARLFS--------------EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWA 186
Query: 664 LGIVFFEL 671
+G +F EL
Sbjct: 187 VGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 87/319 (27%), Positives = 139/319 (43%), Gaps = 84/319 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ +++ +G G FG +L K+K DG+ Y +K+I + S + +EVA LS ++H ++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V+Y QE+ E+ LYI M+YC
Sbjct: 62 VQY----------------------------------------QESFEENGNLYIVMDYC 81
Query: 546 PRTLRQVFESYDHF-------------DKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
E D + D+ L W F QI L H+H + I+HRD+ N
Sbjct: 82 --------EGGDLYKKINAQRGVLFPEDQILDW--FVQICLALKHVHDRKILHRDIKSQN 131
Query: 593 IFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652
IF IK+GDFG+A+ L V + T +GT +Y +PEI +
Sbjct: 132 IFLTKDGTIKLGDFGIARVL--------------NSTVELARTC-IGTPYYLSPEICENR 176
Query: 653 PKIDEKADMYSLGIVFFE---LWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLL 709
P + K+D+++LG V +E L H F + +VL + +G PP + +L+
Sbjct: 177 P-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII--RGSYPPVSSHYSYDLRNLV 233
Query: 710 RRLMSPSPSDRPSATELLQ 728
+L +P DRPS +L+
Sbjct: 234 SQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 81/307 (26%), Positives = 125/307 (40%), Gaps = 74/307 (24%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
+G G FG V N G A+K+I L+ I++E+ L L+H ++V+Y +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLR 550
ET S LYI +EY +LR
Sbjct: 68 -IET---------------------------------------SDSLYIILEYAENGSLR 87
Query: 551 QVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
Q+ + + F + L Q+++GLA++H QG+IHRD+ NI +K+ DFG+A
Sbjct: 88 QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA- 146
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFE 670
T VS D VGT ++ APE+ + +D++SLG E
Sbjct: 147 --------------TKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIE 191
Query: 671 LWH---PFST-----AMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRP 721
L P+ A+ R IV D LP S + + L + P+ RP
Sbjct: 192 LLTGNPPYYDLNPMAALFR-IVQDD---HPPLPEG----ISPELKDFLMQCFQKDPNLRP 243
Query: 722 SATELLQ 728
+A +LL+
Sbjct: 244 TAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 56/247 (22%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+++L +G G +G V ++KL G A+KKI+L+ +S + LRE+ L L H ++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ DV + L Y+ E+
Sbjct: 61 I-----------------------------------KLLDVFRHKGDL-----YLVFEFM 80
Query: 546 PRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
L ++ + + L Q+++GLA H GI+HRDL P N+ + +K+
Sbjct: 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLA 140
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGLA+ T V T +Y APE+ G D++S+
Sbjct: 141 DFGLAR-----SFGSPVRPYTH----------YVVTRWYRAPELLLGDKGYSTPVDIWSV 185
Query: 665 GIVFFEL 671
G +F EL
Sbjct: 186 GCIFAEL 192
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-30
Identities = 81/337 (24%), Positives = 127/337 (37%), Gaps = 84/337 (24%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+E L+P+G G +G V +K GR A+KKI L RILRE+ L L+H+++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ G+ D + F+ DV YI E
Sbjct: 62 I---------GLLDILRPP-------SPEDFN-------DV------------YIVTELM 86
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L +V +S + + QI+ GL ++H +IHRDL P+NI ++ D+KI D
Sbjct: 87 ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICD 146
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FGLA+ +D D T V T +Y APE+ + + D++S+G
Sbjct: 147 FGLAR-----GVDPDEDEKGFL-------TEYVVTRWYRAPELLLSSSRYTKAIDIWSVG 194
Query: 666 IVFFEL----------WH--------------------PFSTAMERQIVLSDLKQKGELP 695
+F EL + ++ R + S K+
Sbjct: 195 CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKP---K 251
Query: 696 PSWVAKFSEQES----LLRRLMSPSPSDRPSATELLQ 728
F LL +++ P R +A E L
Sbjct: 252 KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 74/312 (23%), Positives = 130/312 (41%), Gaps = 70/312 (22%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
++ L+ +G G G V ++ G+ A+KK+RL+ ++ + I+ E+ + +H ++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNI 77
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V YY ++ L L++ MEY
Sbjct: 78 VDYYDSY----------------------------------------LVGDELWVVMEYM 97
Query: 546 PR-TLRQVFESYDHFDKE--LAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+L + E +A+ + R++++GL ++H Q +IHRD+ +NI +K
Sbjct: 98 DGGSLTDIITQNFVRMNEPQIAY-VCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVK 156
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
+ DFG A L E+ + VGT ++ APE+ + K D++
Sbjct: 157 LADFGFAAQLTKEKSKR---------------NSVVGTPYWMAPEVIKRKD-YGPKVDIW 200
Query: 663 SLGIVFFELW--HP--FSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSP 717
SLGI+ E+ P R + L + KG P K+S + + L + + P
Sbjct: 201 SLGIMCIEMAEGEPPYLREPPLRALFL--ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDP 258
Query: 718 SDRPSATELLQD 729
RPSA ELLQ
Sbjct: 259 EKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 92/316 (29%), Positives = 137/316 (43%), Gaps = 77/316 (24%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+E ++ +G G FG + L K K D H +K+I L + + +EV L++++H ++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V ++ ++ E G L+I MEYC
Sbjct: 62 VTFFASFQENG----------------------------------------RLFIVMEYC 81
Query: 546 ------PRTLRQ---VFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
R RQ +F D+ L+W F QI GL HIH + I+HRD+ NIF
Sbjct: 82 DGGDLMKRINRQRGVLFSE----DQILSW--FVQISLGLKHIHDRKILHRDIKSQNIFLS 135
Query: 597 ARNDI-KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
+ K+GDFG+A+ QL+ VGT +Y +PEI Q P
Sbjct: 136 KNGMVAKLGDFGIAR-----QLNDSMELAYTC----------VGTPYYLSPEICQNRP-Y 179
Query: 656 DEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRL 712
+ K D++SLG V +EL HPF Q+VL +G P + SL+ +L
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--QGYFAPISPNFSRDLRSLISQL 237
Query: 713 MSPSPSDRPSATELLQ 728
SP DRPS T +L+
Sbjct: 238 FKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 82/300 (27%), Positives = 117/300 (39%), Gaps = 66/300 (22%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN--DRILREVATLSRLQHQHVVRYY 489
LG G FG V+L + K G+ YA+K ++ K K + + L E LSR+ H +V+ +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK-KKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-T 548
A F+T LY+ +EY P
Sbjct: 60 YA-FQT---------------------------------------EEKLYLVLEYAPGGE 79
Query: 549 LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGL 608
L F +E A +IV L ++H GII+RDL P NI DA IK+ DFGL
Sbjct: 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGL 139
Query: 609 AKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVF 668
AK L T+T GT Y APE+ G + D +SLG++
Sbjct: 140 AKELS------SEGSRTNT---------FCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLL 183
Query: 669 FEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725
+E+ PF ++I LK P E L+ L+ P+ R +
Sbjct: 184 YEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL---SPEARDLISGLLQKDPTKRLGSGG 240
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215525 PLN02972, PLN02972, Histidyl-tRNA synthetase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-29
Identities = 120/453 (26%), Positives = 203/453 (44%), Gaps = 64/453 (14%)
Query: 797 LRDYVVQVTKEMFRQHCAKHLEIEPMY-----LLGDCPQFKRNTVKLLTHGGDLLELSHE 851
+R+ + +F++H A L+ P++ L+G + + L GG+L L ++
Sbjct: 343 IREKAFSIITSVFKRHGATALDT-PVFELRETLMGKYGEDSKLIYDLADQGGELCSLRYD 401
Query: 852 LRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNR-----YLQGDFDIIGGASAL-TE 905
L +PF R+ N +SFKRY+I+ VYRR P++ + Q DFDI G + +
Sbjct: 402 LTVPFARYVAMNGITSFKRYQIAKVYRR----DNPSKGRYREFYQCDFDIAGVYEPMGPD 457
Query: 906 AEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQ 965
E++KV +++ ++ LNH LL+ + G+ EK + + + L Q
Sbjct: 458 FEIIKVLTELLDELDIGTY-EVKLNHRKLLDGMLEICGVPP---EKFRTICSSIDKLDKQ 513
Query: 966 SSEWKSKWVVIRRQLLQELNLAEAVVNRLQT-VGLRFCGAADQALPRLR---GALPADKP 1021
S + +++++++E L+ +++ V R G + L +LR +
Sbjct: 514 S------FEQVKKEMVEEKGLSNETADKIGNFVKER--GPPLELLSKLRQEGSEFLGNAS 565
Query: 1022 TRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTL----- 1076
+R ALDEL + +EK+ I ++ + S R L + Y + E
Sbjct: 566 SRAALDELEIMFKALEKSKAIGKIVFDL-SLARGL--------DYYTGVIYEAVFKGAQV 616
Query: 1077 --LAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALE---TIIQHYPVDFKPVRNE 1131
+A GGRYD L VG S P+ VG SL +E I++ + V
Sbjct: 617 GSIAAGGRYDNL---------VGMFSGKQVPA-VGVSLGIERVFAIMEQQEEEKSQVIRP 666
Query: 1132 AGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVI 1191
T VLV S G L ELV+ELW IKA++ + + A E I +V+
Sbjct: 667 TETEVLV-SIIGDDKLALAAELVSELWNAGIKAEY--KVSTRKAKHLKRAKESGIPWMVL 723
Query: 1192 LTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFL 1224
+ + KG VK+++L+ E+EV R V+ L
Sbjct: 724 VGEKELSKGFVKLKNLEAGVEEEVDRTCFVQEL 756
|
Length = 763 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 79/338 (23%), Positives = 132/338 (39%), Gaps = 90/338 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS--LPVNDRILREVATLSRLQHQ 483
+E++ +G G +G V +NK G A+KKIR++++ P+ +RE+ L +L+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT--AIREIKLLQKLRHP 58
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++VR E + G +Y+ E
Sbjct: 59 NIVRLK----EIVTSKGKGS----------------------------------IYMVFE 80
Query: 544 YCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
Y L + +S + F + +Q++EGL ++H GI+HRD+ +NI + +K
Sbjct: 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLK 140
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
+ DFGLA+ S D T +V T +Y PE+ G + + DM+
Sbjct: 141 LADFGLARPYTKRN--------------SADYTNRVITLWYRPPELLLGATRYGPEVDMW 186
Query: 663 SLGIVFFELWH-----PFSTAMERQIVL----------------------SDLKQKGELP 695
S+G + EL+ ST +E Q+ +LK K
Sbjct: 187 SVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYK 245
Query: 696 PSWVAKFSEQES-----LLRRLMSPSPSDRPSATELLQ 728
F LL +L++ P R SA + LQ
Sbjct: 246 RRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 84/348 (24%), Positives = 128/348 (36%), Gaps = 107/348 (30%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
N +E L +G G +G V+ C+NK G A+KK + + V LREV L +L+H+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V +A+ R LY+ E
Sbjct: 61 NIVNLKEAF------------RR----------KGR------------------LYLVFE 80
Query: 544 YCPRTLRQVFESYD-----HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
Y RTL ++ E+ + W Q+++ +A+ H IIHRD+ P NI
Sbjct: 81 YVERTLLELLEASPGGLPPDAVRSYIW----QLLQAIAYCHSHNIIHRDIKPENILVSES 136
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
+K+ DFG A+ L + T V T +Y APE+ G +
Sbjct: 137 GVLKLCDFGFARAL--------------RARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 659 ADMYSLGIVFFELWHPFSTAMERQIV--LSDLKQ-------KGELPPSWVAKFS------ 703
D++++G + EL + SD+ Q G LPPS FS
Sbjct: 183 VDVWAIGCIMAEL------LDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 704 --------EQESLLRR---------------LMSPSPSDRPSATELLQ 728
+ ESL RR + P +R + ELLQ
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 79/320 (24%), Positives = 133/320 (41%), Gaps = 70/320 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-VNDRILREVATLSRLQ 481
L +F+ + +G G F V LDGR A+KK+++ + L+E+ L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +V++Y ++ E N+L I
Sbjct: 61 HPNVIKYLASFIE-----------------------------------NNELN-----IV 80
Query: 542 MEYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
+E R ++ + + W F Q+ L H+H + I+HRD+ P N+F
Sbjct: 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPK 654
A +K+GD GL +F + AA VGT +Y +PE E G+
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTT---AAH------------SLVGTPYYMSPERIHENGY-- 183
Query: 655 IDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQK---GELPPSWVAKFSEQ-ESLLR 710
+ K+D++SLG + +E+ S ++ L L +K + PP +SE+ L+
Sbjct: 184 -NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 711 RLMSPSPSDRPSATELLQDA 730
R ++P P RP + +LQ A
Sbjct: 243 RCINPDPEKRPDISYVLQVA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 74/311 (23%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD---KSLPVNDRILREVATLSRLQHQHVV 486
+ LG G FG V N DG +AVK++ L D ++ +E+A LS+LQH ++V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP 546
+Y GT + E LYI +E P
Sbjct: 66 QYL-------------------GT---------------------EREEDNLYIFLELVP 85
Query: 547 R-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
+L ++ + Y F + + RQI+ GL ++H + +HRD+ NI D +K+ D
Sbjct: 86 GGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLAD 145
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI-----EQGWPKIDEKAD 660
FG+AK ++ + +F G+ ++ APE+ G AD
Sbjct: 146 FGMAK--QVVEFSFAKSF--------------KGSPYWMAPEVIAQQGGYGLA-----AD 184
Query: 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
++SLG E+ P+S V + + ELPP E + + + + P
Sbjct: 185 IWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKDFILKCLQRDP 243
Query: 718 SDRPSATELLQ 728
S RP+A ELL+
Sbjct: 244 SLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 83/311 (26%), Positives = 135/311 (43%), Gaps = 69/311 (22%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
+ L+ +G G FG +L ++ + YA+K+IRL S V D +E L++++H +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPN 59
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V + ++ F+ D +LYI MEY
Sbjct: 60 IVAFKES--------FEADG--------------------------------HLYIVMEY 79
Query: 545 CP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
C + ++ D L W F Q+ G+ HIH + ++HRD+ NIF
Sbjct: 80 CDGGDLMQKIKLQRGKLFPEDTILQW--FVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
+K+GDFG A+ L T + T VGT +Y PEI + P + K+
Sbjct: 138 KVKLGDFGSARLL--------------TSPGAYACT-YVGTPYYVPPEIWENMP-YNNKS 181
Query: 660 DMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716
D++SLG + +EL HPF + ++L +G P E SL++++ +
Sbjct: 182 DIWSLGCILYELCTLKHPFQANSWKNLILKVC--QGSYKPLPSHYSYELRSLIKQMFKRN 239
Query: 717 PSDRPSATELL 727
P RPSAT +L
Sbjct: 240 PRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 91/307 (29%), Positives = 136/307 (44%), Gaps = 63/307 (20%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR-------ILREVATLSRLQHQH 484
+G G FG V L N G AVK++ L S DR + RE+A L LQH++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V+Y L SS L++ +L I +EY
Sbjct: 68 IVQY----------------------LGSS------------------LDADHLNIFLEY 87
Query: 545 CPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
P ++ + +Y F++ L + RQI++GL ++H +GIIHRD+ NI D + IKI
Sbjct: 88 VPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKI 147
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
DFG++K L+ L T T G G V F+ APE+ + KAD++S
Sbjct: 148 SDFGISKKLEANSLS------TKTNGARPSLQGSV---FWMAPEVVKQ-TSYTRKADIWS 197
Query: 664 LGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
LG + E+ HPF + Q + + PS ++ SE L + + R
Sbjct: 198 LGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS--SEAIDFLEKTFEIDHNKR 255
Query: 721 PSATELL 727
P+A ELL
Sbjct: 256 PTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 86/322 (26%), Positives = 132/322 (40%), Gaps = 89/322 (27%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
F L+ +G G FG V +K + A+K I L++ + D I +E+ LS+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++ +YY GS F L+ + L+I ME
Sbjct: 60 YITKYY-----------------GS-------F----------------LKGSKLWIIME 79
Query: 544 YCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
YC + + + D+ + R+++ GL ++H +G IHRD+ NI D+K
Sbjct: 80 YCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVK 138
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADM 661
+ DFG++ L ++ F VGT F+ APE I+Q DEKAD+
Sbjct: 139 LADFGVSGQLTSTMSKRN-TF--------------VGTPFWMAPEVIKQS--GYDEKADI 181
Query: 662 YSLGIVFFEL---------WHPFSTAMERQIVLSDLKQKGELPPSWVA-KFSEQ-----E 706
+SLGI EL HP M ++ PPS KFS+
Sbjct: 182 WSLGITAIELAKGEPPLSDLHP----MRVLFLIPKNN-----PPSLEGNKFSKPFKDFVS 232
Query: 707 SLLRRLMSPSPSDRPSATELLQ 728
L + P +RPSA ELL+
Sbjct: 233 LCLNK----DPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 83/306 (27%), Positives = 123/306 (40%), Gaps = 85/306 (27%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR----ILREVATLSRLQHQHVVR 487
LG GGFG V L K K R +A+K ++ K V I E L H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVK---KRHIVETGQQEHIFSEKEILEECNHPFIVK 57
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP- 546
Y+ TF ++ Y+Y+ MEYC
Sbjct: 58 LYR------------------------TFKDKK----------------YIYMLMEYCLG 77
Query: 547 RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDF 606
L + FD+ A +V ++H +GII+RDL P N+ D+ +K+ DF
Sbjct: 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDF 137
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ-----VGTYFYTAPEIEQGWPK-IDEKAD 660
G AK LK +GQ GT Y APEI K D D
Sbjct: 138 GFAKKLK---------------------SGQKTWTFCGTPEYVAPEIILN--KGYDFSVD 174
Query: 661 MYSLGIVFFELWH---PFSTAMERQIVLSD--LKQKGELP-PSWVAKFSEQESLLRRLMS 714
+SLGI+ +EL PF E + + + LK G+L P+++ K + L+++L+
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDK--AAKDLIKQLLR 232
Query: 715 PSPSDR 720
+P +R
Sbjct: 233 RNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 82/316 (25%), Positives = 129/316 (40%), Gaps = 75/316 (23%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKI--------RLKDKSLPVNDRILREVATLSRLQHQ 483
+G G +G V L N G AVK++ R + + + E+ TL L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+Y G E E YL I +E
Sbjct: 69 NIVQYL--------------------------------------GFETTEE--YLSIFLE 88
Query: 544 YCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
Y P ++ +Y F+++L Q++EGLA++H +GI+HRDL +N+ DA K
Sbjct: 89 YVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK 148
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPKIDEK 658
I DFG++K +D + G+ F+ APE+ QG+ K
Sbjct: 149 ISDFGISK-------------KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGY---SAK 192
Query: 659 ADMYSLGIVFFELW---HPFST--AMERQIVLSDLKQKGELPPSWVAKFS-EQESLLRRL 712
D++SLG V E++ P+S A+ L + + +PP S L
Sbjct: 193 VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNAC 252
Query: 713 MSPSPSDRPSATELLQ 728
+ +P +RP+A ELLQ
Sbjct: 253 FTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 80/315 (25%), Positives = 131/315 (41%), Gaps = 70/315 (22%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+E+++ +G G FG V LC+ K D + +K+I ++ + E L L H ++
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ YY EN LE L I MEY
Sbjct: 62 IEYY----------------------------------------ENFLEDKALMIVMEYA 81
Query: 546 P-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
P +++ S D++ H F QI+ L H+H + I+HRDL NI D
Sbjct: 82 PGGTLAEYIQKRCNSL--LDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM 139
Query: 601 I-KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
+ KIGDFG++K L + A+ VGT Y +PE+ +G P ++K+
Sbjct: 140 VVKIGDFGISKILS----SKSKAYTV------------VGTPCYISPELCEGKP-YNQKS 182
Query: 660 DMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716
D+++LG V +EL F A +VL + G P + L+ +++
Sbjct: 183 DIWALGCVLYELASLKRAFEAANLPALVLKIM--SGTFAPISDRYSPDLRQLILSMLNLD 240
Query: 717 PSDRPSATELLQDAL 731
PS RP ++++ +
Sbjct: 241 PSKRPQLSQIMAQPI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|223202 COG0124, HisS, Histidyl-tRNA synthetase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 100/456 (21%), Positives = 164/456 (35%), Gaps = 71/456 (15%)
Query: 794 DTELRDYVVQVTKEMFRQHCAK-----HLEIEPMYLLGDCPQFKRNTVKLL----THGGD 844
D LR+Y+ +++F + E ++ + K + GG
Sbjct: 17 DMALREYIESTIRKVFESYGFSEIRTPIFEYTELFARK-SGEETDVVEKEMYTFKDKGGR 75
Query: 845 LLELSHELRLPFIRWAISN---QKSSFKRYEISSVYRRAIGHSPP--NRY---LQGDFDI 896
L L EL P R N K Y V+R + P RY Q ++
Sbjct: 76 SLALRPELTAPVARAVAENKLDLPKPLKLYYFGPVFR----YERPQKGRYRQFYQFGVEV 131
Query: 897 IGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELL 956
IG S +AEV+ + ++I+ + +N +LE + GI + RE + L
Sbjct: 132 IGSDSPDADAEVIALAVEILEALG-IGGFTLEINSRGILEGRLEYLGI--DQREALLRYL 188
Query: 957 AMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQAL----PRL 1012
K I + L E + N L+ L +DQ L P L
Sbjct: 189 --------------DKLDKIGKLELDEDSKRRLKTNPLRV--LDSKKDSDQELLKNAPEL 232
Query: 1013 RGALPADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPAT 1070
L D+ + + L+EL L I + ID + Y+ F+ +
Sbjct: 233 LDYL--DEESLEHLEELLALLDALGI--SYEIDPSLVRGLDYYTGTVFEAVTDGLG---- 284
Query: 1071 LVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPP-SGVGASLALETIIQHYPVDFKPVR 1129
+G++ GGRYD L+ P VG ++ +E +I + K
Sbjct: 285 -AQGSVCG-GGRYDGLVEEF-----------GGKPTPAVGFAIGVERLILALEEEGKEDP 331
Query: 1130 NEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCL 1189
E V V G E ++L +L I + V L +Q++YA + +
Sbjct: 332 VETRVDVYVVP-LGEDAEPEALKLAQKLRAAGISVE-VDYSGRKLKKQFKYADKLGARFA 389
Query: 1190 VILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLL 1225
VIL + G+V V+ L +++EV + LV L
Sbjct: 390 VILGEDELANGVVTVKDLATGEQEEVPLDELVEELK 425
|
Length = 429 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 84/330 (25%), Positives = 133/330 (40%), Gaps = 103/330 (31%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
F+ L+ LG G +G V +K G+ A+K + ++ I++E++ L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+YY GS F N T L+I ME
Sbjct: 59 YIVKYY-----------------GSY------FKN-----------------TDLWIVME 78
Query: 544 YCP------------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPN 591
YC +TL + +E+A L Q ++GL ++H IHRD+
Sbjct: 79 YCGAGSVSDIMKITNKTLTE---------EEIAAIL-YQTLKGLEYLHSNKKIHRDIKAG 128
Query: 592 NIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651
NI + K+ DFG++ QL D +T +GT F+ APE+ Q
Sbjct: 129 NILLNEEGQAKLADFGVS-----GQL-TDTMAKRNT---------VIGTPFWMAPEVIQE 173
Query: 652 WPKIDEKADMYSLGIVFFELWH---PFST--AMERQIVLSDLKQKGELPPSWVAKFSEQE 706
+ KAD++SLGI E+ P+S M R I + + K PP S+ E
Sbjct: 174 -IGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-RAIFM--IPNK---PPP---TLSDPE 223
Query: 707 -------SLLRRLMSPSPSDRPSATELLQD 729
+++ + P +RPSA +LLQ
Sbjct: 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 76/317 (23%), Positives = 112/317 (35%), Gaps = 82/317 (25%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
+ LG G FG V K K G AVK ++ +D S + LRE + +L H +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK-EDASEQQIEEFLREARIMRKLDHPN 62
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
VV+ GV E LYI MEY
Sbjct: 63 VVKLL------GVC----------------------------------TEEEPLYIVMEY 82
Query: 545 CPR-TLRQVFESYDHFDKELAWHLF-RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
L F QI G+ ++ + IHRDL N +K
Sbjct: 83 MEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVK 142
Query: 603 IGDFGLAKFLKLEQLD--QDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKA 659
I DFGL++ L + + P + APE +++G K K+
Sbjct: 143 ISDFGLSRDLYDDDYYRKRGGKLP----------------IRWMAPESLKEG--KFTSKS 184
Query: 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS- 714
D++S G++ +E++ P+ M + VL LK LP L LM
Sbjct: 185 DVWSFGVLLWEIFTLGEQPYP-GMSNEEVLEYLKNGYRLPQP-----PNCPPELYDLMLQ 238
Query: 715 ---PSPSDRPSATELLQ 728
P DRP+ +EL++
Sbjct: 239 CWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 79/323 (24%), Positives = 119/323 (36%), Gaps = 93/323 (28%)
Query: 429 LQPLGHGGFGHVVLC--KNKLDGRHY--AVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
+ LG G FG V K K DG+ AVK ++ +D S + LRE + +L H +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-EDASEQQIEEFLREARIMRKLDHPN 62
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V+ GV T +E L I MEY
Sbjct: 63 IVKLL------GV----------------------------CTEEEP------LMIVMEY 82
Query: 545 CP--------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
P R R S A QI G+ ++ + IHRDL N
Sbjct: 83 MPGGDLLDYLRKNRPKELSLSDL-LSFAL----QIARGMEYLESKNFIHRDLAARNCLVG 137
Query: 597 ARNDIKIGDFGLAKFLKLEQLD--QDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWP 653
+KI DFGL++ L + + P + APE +++G
Sbjct: 138 ENLVVKISDFGLSRDLYDDDYYKVKGGKLP----------------IRWMAPESLKEG-- 179
Query: 654 KIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLL 709
K K+D++S G++ +E++ P+ M VL LK+ LP L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYP-GMSNAEVLEYLKKGYRLPKP-----PNCPPEL 233
Query: 710 RRLMS----PSPSDRPSATELLQ 728
+LM P DRP+ +EL++
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 78/320 (24%), Positives = 125/320 (39%), Gaps = 79/320 (24%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+D E L LG G G V ++ G+ AVK IRL+ + +ILRE+ L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSP 59
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V +Y A++ +GD + I ME
Sbjct: 60 YIVGFYGAFYN------NGD----------------------------------ISICME 79
Query: 544 YCPRT-LRQVF-ESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARND 600
Y L ++ E + + + +++GL ++H + IIHRD+ P+NI ++R
Sbjct: 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ 139
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ--VGTYFYTAPEIEQGWPKIDEK 658
IK+ DFG++ L V+ + VGT Y APE QG K
Sbjct: 140 IKLCDFGVSGQL-------------------VNSLAKTFVGTSSYMAPERIQG-NDYSVK 179
Query: 659 ADMYSLGIVFFEL-------WHPFSTAMERQIVLSDLKQ--KGELPPSWVAKFSEQ-ESL 708
+D++SLG+ EL + L+ P KFS +
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDG---IFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 709 LRRLMSPSPSDRPSATELLQ 728
+ + P +RPS ELL+
Sbjct: 237 VNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 69/249 (27%), Positives = 110/249 (44%), Gaps = 59/249 (23%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+++++ +G G +G V ++KL G A+KKIRL+ + V +RE++ L L H ++
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
VR DV ENKL Y+ E+
Sbjct: 61 VRLL-----------------------------------DVVHSENKL-----YLVFEFL 80
Query: 546 PRTLRQVFESYDHF--DKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
L++ +S D L Q+++G+A+ H ++HRDL P N+ D +K+
Sbjct: 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKL 140
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKADMY 662
DFGLA+ AF GV V T +V T +Y APEI G + D++
Sbjct: 141 ADFGLAR-----------AF-----GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIW 184
Query: 663 SLGIVFFEL 671
S+G +F E+
Sbjct: 185 SIGCIFAEM 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 76/323 (23%), Positives = 131/323 (40%), Gaps = 78/323 (24%)
Query: 424 NDFEELQPLGHGGFGHV--VLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ 481
+D+E ++ +G G V +C A+K+I L +K D + +EV +S+
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCN 57
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +VV+YY ++ V G E L++
Sbjct: 58 HPNVVKYYTSF---------------------------------VVGDE-------LWLV 77
Query: 542 MEY-----CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
M Y ++ + D+ + + +++++GL ++H G IHRD+ NI
Sbjct: 78 MPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG 136
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ--VGTYFYTAPEIEQGWPK 654
+KI DFG++ L GG + VGT + APE+ +
Sbjct: 137 EDGSVKIADFGVSASLA-------------DGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 655 IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSW-----VAKFSEQ- 705
D KAD++S GI EL P+S ++++ L+ PPS K+S+
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---PPSLETGADYKKYSKSF 240
Query: 706 ESLLRRLMSPSPSDRPSATELLQ 728
++ + PS RP+A ELL+
Sbjct: 241 RKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 77/308 (25%), Positives = 133/308 (43%), Gaps = 67/308 (21%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRY 488
++ +G G +G V L +++ DG+ Y +KK+ L++ S +E LS+L+H ++V Y
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-- 546
++W + E LYI M +C
Sbjct: 65 RESW---------------------------------------EGEDGLLYIVMGFCEGG 85
Query: 547 ---RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
L++ ++ + W F QI L ++H + I+HRDL N+F N IK+
Sbjct: 86 DLYHKLKEQKGKLLPENQVVEW--FVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKV 143
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
GD G+A+ L+ Q D + +GT +Y +PE+ P + K+D+++
Sbjct: 144 GDLGIARVLE-NQCDMASTL--------------IGTPYYMSPELFSNKP-YNYKSDVWA 187
Query: 664 LGIVFFE---LWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
LG +E L H F+ +V + +G+LPP E L+ ++S P R
Sbjct: 188 LGCCVYEMATLKHAFNAKDMNSLVYRII--EGKLPPMPKDYSPELGELIATMLSKRPEKR 245
Query: 721 PSATELLQ 728
PS +L+
Sbjct: 246 PSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 70/252 (27%), Positives = 114/252 (45%), Gaps = 60/252 (23%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
D+ +++ +G G +G V +NK G+ A+KKIRL+ + V +RE++ L LQH +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V DV QE++L Y+ E+
Sbjct: 61 IVCL-----------------------------------QDVLMQESRL-----YLIFEF 80
Query: 545 CPRTLRQVFESY---DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
L++ +S + D EL QI++G+ H + ++HRDL P N+ D + I
Sbjct: 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVI 140
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKAD 660
K+ DFGLA+ AF G+ V T +V T +Y APE+ G P+ D
Sbjct: 141 KLADFGLAR-----------AF-----GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVD 184
Query: 661 MYSLGIVFFELW 672
++S+G +F E+
Sbjct: 185 IWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 79/317 (24%), Positives = 128/317 (40%), Gaps = 97/317 (30%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKK------IRLKDKSLPVNDRILREVATL 477
+DFE ++ LG G FG V+L ++K G++YA+K ++LK + +L E L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV-----EHVLNEKRIL 55
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
++H +V Y +F Q++
Sbjct: 56 QSIRHPFLVNLY------------------------GSF------------QDDS----N 75
Query: 538 LYIQMEYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
LY+ MEY P LR+ F + +A Q+V L ++H I++RDL P N
Sbjct: 76 LYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPEN 131
Query: 593 IFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV-GTYFYTAPEIEQG 651
+ D+ IKI DFG AK +K T + GT Y APEI
Sbjct: 132 LLLDSDGYIKITDFGFAKRVK-------------------GRTYTLCGTPEYLAPEIILS 172
Query: 652 WPKIDEKADMYSLGIVFFEL---WHPFST----AMERQIVLSDLKQKGELPPSWVAKFSE 704
+ D ++LGI+ +E+ + PF + +I+ ++ PS+ FS
Sbjct: 173 KGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF-----PSF---FSP 223
Query: 705 Q-ESLLRRLMSPSPSDR 720
+ L+R L+ + R
Sbjct: 224 DAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-23
Identities = 95/380 (25%), Positives = 151/380 (39%), Gaps = 105/380 (27%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN-DRILREVATLSRLQH 482
N + +LQP+G G FG V +++L G++ A+KKI +K S PV R RE+ L L+H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++++ ++D F + VT +L T L+ +
Sbjct: 69 ENII---------SLSDI---------------FISPLEDIYFVT----ELLGTDLHRLL 100
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
P +K+ + QI+ GL ++H G++HRDL P+NI + D+K
Sbjct: 101 TSRP------------LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK 148
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
I DFGLA+ QD TG V T +Y APEI W K D + D++
Sbjct: 149 ICDFGLARI-------QDPQM-----------TGYVSTRYYRAPEIMLTWQKYDVEVDIW 190
Query: 663 SLGIVFFELW------------HPFSTAME------------------RQIVLSDLKQKG 692
S G +F E+ + FS + + V S L ++
Sbjct: 191 SAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS-LPKRE 249
Query: 693 ELPPSWVAKFSEQE--SLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSS 750
+P S K ++ LL +++ P R SA E L L H
Sbjct: 250 PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA------------HPYLAPYHDP 297
Query: 751 EDTSIYDKVVSSIFDEETLD 770
D + ++ F++ L
Sbjct: 298 TDEPVAEEKFDWSFNDADLP 317
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 86/337 (25%), Positives = 132/337 (39%), Gaps = 88/337 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+E+L+ +G G +G V KN+ A+K++RL D V LRE+ L L+H+++
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
VR Y DV + KL + EYC
Sbjct: 62 VRLY-----------------------------------DVLHSDKKLT-----LVFEYC 81
Query: 546 PRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
+ L++ F+S + D E+ Q+++GLA H ++HRDL P N+ + ++K+
Sbjct: 82 DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLA 141
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
DFGLA+ AF G+ V + +V T +Y P++ G DM+S
Sbjct: 142 DFGLAR-----------AF-----GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 185
Query: 664 LGIVFFEL--------------------WHPFSTAMERQIV-LSDLKQKGELPP-----S 697
G +F EL + T E +S L P S
Sbjct: 186 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTS 245
Query: 698 WVAK----FSEQESLLRRLMSPSPSDRPSATELLQDA 730
V S LL+ L+ +P R SA E LQ
Sbjct: 246 LVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-23
Identities = 86/330 (26%), Positives = 138/330 (41%), Gaps = 97/330 (29%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHY-AVKKI-----------RLKDKSLPVNDRILRE 473
+ L+ LG G FG V + K +G++ A+K+I R +DKS+ I+ E
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSI---GDIVSE 58
Query: 474 VATL-SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENK 532
V + +L+H ++VRYY+ +
Sbjct: 59 VTIIKEQLRHPNIVRYYKTF---------------------------------------- 78
Query: 533 LESTYLYIQMEY---CPRTLRQVF----ESYDHFDKELAWHLFRQIVEGLAHIHGQG-II 584
LE+ LYI M+ P L + F E F +E W++F Q+V L ++H + I+
Sbjct: 79 LENDRLYIVMDLIEGAP--LGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIV 136
Query: 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYT 644
HRDLTPNNI + + I DFGLAK Q ++ T VGT Y+
Sbjct: 137 HRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKL-----------TSVVGTILYS 180
Query: 645 APEIEQGWPKIDEKADMYSLGIVFFE---LWHPFSTA----MERQIVLSDLKQKGELPPS 697
PEI + P EKAD+++ G + ++ L PF + + +IV + P
Sbjct: 181 CPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV------EAVYEPL 233
Query: 698 WVAKFSEQESLL-RRLMSPSPSDRPSATEL 726
+SE + + ++P RP ++
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 102/382 (26%), Positives = 154/382 (40%), Gaps = 86/382 (22%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+DFE ++ +G G FG V L ++K G+ YA+K +R D +++ R Q
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD--------MIK------RNQIA 46
Query: 484 HVVRYYQAWFETGVADF--DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
HV E D D DS W S F Q+ + +LY+
Sbjct: 47 HV------RAER---DILADADSPWIVKLYYS--F------------QDEE----HLYLV 79
Query: 542 MEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
MEY P L + D F +E A ++V L +H G IHRD+ P+NI DA
Sbjct: 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH 139
Query: 601 IKIGDFGLAK--------FLKLEQLDQDAAFPTDTGGVSVDGTGQ-------VGTYFYTA 645
IK+ DFGL K L + F + D + VGT Y A
Sbjct: 140 IKLADFGLCKKMNKAKDREYYLNDS-HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIA 198
Query: 646 PEIEQGWPKIDEKADMYSLGIVFFELWH---PFS--TAMERQIVLSDLKQKGELPPSWVA 700
PE+ +G P + D +SLG++ +E+ + PF T E + + K+ PP
Sbjct: 199 PEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPD--P 255
Query: 701 KFS-EQESLLRRLMSPSPSDR-PSATELLQDALPPQMEYELLDNILR-------MMHSSE 751
S E L+ RL+ P DR S E+ +++E N+ + S
Sbjct: 256 PVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKGIDWE---NLRETKPPFVPELSSPL 311
Query: 752 DTSIYDKVVSSIFDEETLDMKH 773
DTS +D F+++ +
Sbjct: 312 DTSNFDD-----FEDDKDLSDY 328
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 1e-22
Identities = 77/324 (23%), Positives = 125/324 (38%), Gaps = 87/324 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDRILREVATLSRLQ 481
E + LG G FG V K DG AVK ++ + S + L E + + +L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLS 59
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H ++VR GV T E LYI
Sbjct: 60 HPNIVRLL------GV----------------------------CTQGE------PLYIV 79
Query: 542 MEYCP----RT-LRQVFESYDHFDK-ELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
EY P LR+ E D ++A QI +G+ ++ + +HRDL N
Sbjct: 80 TEYMPGGDLLDFLRKHGEKLTLKDLLQMAL----QIAKGMEYLESKNFVHRDLAARNCLV 135
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPK 654
+KI DFGL++ + + D G + + APE ++ G K
Sbjct: 136 TENLVVKISDFGLSRDI----------YEDDYYRKRGGGKLPI---KWMAPESLKDG--K 180
Query: 655 IDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQ 705
K+D++S G++ +E++ P+ M + VL L+ LP P + +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYP-GMSNEEVLELLEDGYRLPRPENCPDELYE---- 235
Query: 706 ESLLRRLMSPSPSDRPSATELLQD 729
L+ + + P DRP+ +EL++D
Sbjct: 236 --LMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 70/251 (27%), Positives = 101/251 (40%), Gaps = 64/251 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI-LREVATLSRLQ-HQ 483
++ ++ LG G FG V L +NK G A+KK +K K + + LREV +L +L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKK--MKKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+ E E+ LY E
Sbjct: 59 NIVKLK----------------------------------------EVFRENDELYFVFE 78
Query: 544 YCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
Y L Q+ + F + + + QI++GLAHIH G HRDL P N+ +
Sbjct: 79 YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVV 138
Query: 602 KIGDFGLAKFLKLEQLDQDAAFP-TDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
KI DFGLA+ E + P TD V T +Y APEI D
Sbjct: 139 KIADFGLAR----EIRSRP---PYTD----------YVSTRWYRAPEILLRSTSYSSPVD 181
Query: 661 MYSLGIVFFEL 671
+++LG + EL
Sbjct: 182 IWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 7e-22
Identities = 80/350 (22%), Positives = 133/350 (38%), Gaps = 115/350 (32%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP---VNDRILREVATLSRLQH 482
+E+ + LG G + V ++K GR A+KKI+L ++ +N LRE+ L L+H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+++ DV G + + + +
Sbjct: 62 PNIIGLL-----------------------------------DVFGHK-----SNINLVF 81
Query: 543 EYCPRTLRQVFESYDHFDKEL--------AWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
E+ L +V + DK + ++ L + GL ++H I+HRDL PNN+
Sbjct: 82 EFMETDLEKVIK-----DKSIVLTPADIKSYML--MTLRGLEYLHSNWILHRDLKPNNLL 134
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654
+ +K+ DFGLA+ F + + T QV T +Y APE+ G
Sbjct: 135 IASDGVLKLADFGLARS-----------FGSP----NRKMTHQVVTRWYRAPELLFGARH 179
Query: 655 IDEKADMYSLGIVFFELWHPFSTAMERQIVL---SDLKQKG------------------E 693
DM+S+G +F EL + R L SD+ Q G
Sbjct: 180 YGVGVDMWSVGCIFAEL-------LLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 694 LP----------PSWVAKFS----EQESLLRRLMSPSPSDRPSATELLQD 729
LP F + LL+RL++ +P+ R +A + L+
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 75/326 (23%), Positives = 133/326 (40%), Gaps = 90/326 (27%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR--ILREVATLSRLQH 482
D+E +Q +G G +G V ++ G A+K I+L+ +D I +E++ L +H
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKECRH 59
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V Y+ ++ L L+I M
Sbjct: 60 PNIVAYFGSY----------------------------------------LRRDKLWIVM 79
Query: 543 EYCP-RTLRQVF-ESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
EYC +L+ ++ + + ++ R+ ++GLA++H G IHRD+ NI D
Sbjct: 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD 139
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEK 658
+K+ DFG++ L + + +F +GT ++ APE+ + D K
Sbjct: 140 VKLADFGVSAQLT-ATIAKRKSF--------------IGTPYWMAPEVAAVERKGGYDGK 184
Query: 659 ADMYSLGIVFFELWHPFSTAMERQIVLSDLK---------QKGELPPS------WVAKFS 703
D+++LGI EL E Q + DL + PP W F
Sbjct: 185 CDIWALGITAIEL-------AELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF- 236
Query: 704 EQESLLRRLMSPSPSDRPSATELLQD 729
+++ ++ P RP+AT+LLQ
Sbjct: 237 --HDFIKKCLTKDPKKRPTATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-21
Identities = 87/338 (25%), Positives = 146/338 (43%), Gaps = 89/338 (26%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
LN++E ++ +G+G FG V L K+K + K I + +++ EV + L+H
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+++VRY F N+A LYI M
Sbjct: 72 KNIVRYI------------------------DRFLNKANQK--------------LYILM 93
Query: 543 EYC-----PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH-------GQGIIHRDLTP 590
E+C R +++ ++ + ++ + RQ++ LA+ H G+ ++HRDL P
Sbjct: 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKP 153
Query: 591 NNIF-----------------FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633
NIF + R KIGDFGL+K + +E +
Sbjct: 154 QNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC------------ 201
Query: 634 GTGQVGTYFYTAPEIEQGWPK-IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLK 689
VGT +Y +PE+ K D+K+DM++LG + +EL PF A ++S+LK
Sbjct: 202 ----VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK 257
Query: 690 QKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELL 727
+ +LP K E L++ L++ S +RPSA + L
Sbjct: 258 RGPDLPIK--GKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 66/256 (25%), Positives = 100/256 (39%), Gaps = 67/256 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIR--LKDKSLPVNDRILREVATLSRLQ-- 481
+EEL +G G +G V ++ GR A+KK+R L ++ +P++ LRE+A L +L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS--TLREIALLKQLESF 58
Query: 482 -HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H ++VR DV L +
Sbjct: 59 EHPNIVRLL-----------------------------------DVCHGPRTDRELKLTL 83
Query: 541 QMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
E+ + L E L RQ++ G+ +H I+HRDL P NI +
Sbjct: 84 VFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD 143
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
+KI DFGLA+ + A T V T +Y APE+
Sbjct: 144 GQVKIADFGLARI-----YSFEMAL-----------TSVVVTLWYRAPEVLLQ----SSY 183
Query: 659 A---DMYSLGIVFFEL 671
A DM+S+G +F EL
Sbjct: 184 ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 70/251 (27%), Positives = 110/251 (43%), Gaps = 63/251 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
F++++ +G G +G V +NKL G A+KKIRL ++ V +RE++ L L H ++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V+ DV ENKL Y+ E+
Sbjct: 62 VKLL-----------------------------------DVIHTENKL-----YLVFEFL 81
Query: 546 PRTLRQVFESYDHFDKELAWHLFR----QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
+ L++ ++ + L + Q+++GLA H ++HRDL P N+ + I
Sbjct: 82 HQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI 139
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKAD 660
K+ DFGLA+ AF GV V T +V T +Y APEI G D
Sbjct: 140 KLADFGLAR-----------AF-----GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 183
Query: 661 MYSLGIVFFEL 671
++SLG +F E+
Sbjct: 184 IWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 83/307 (27%), Positives = 124/307 (40%), Gaps = 69/307 (22%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRL----KDKSLPVNDRILREVATLSRLQHQHVVR 487
LG G FG V LC + GR AVK++ + VN + E+ L LQH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVN-ALECEIQLLKNLQHERIVQ 68
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
YY G L + L I MEY P
Sbjct: 69 YY-------------------GCLR---------------------DDETLSIFMEYMPG 88
Query: 548 -TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDF 606
+++ ++Y + + RQI+EG+ ++H I+HRD+ NI D+ ++K+GDF
Sbjct: 89 GSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDF 148
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666
G +K L+ TG SV GT ++ +PE+ G KAD++S+G
Sbjct: 149 GASKRLQTICSSG-------TGMKSV-----TGTPYWMSPEVISG-EGYGRKADVWSVGC 195
Query: 667 VFFEL------WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
E+ W F AM ++ +LP LRR + R
Sbjct: 196 TVVEMLTEKPPWAEFE-AMAAIFKIATQPTNPQLPSHVSPDARN---FLRRTFVENAKKR 251
Query: 721 PSATELL 727
PSA ELL
Sbjct: 252 PSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 66/304 (21%), Positives = 109/304 (35%), Gaps = 70/304 (23%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRLQHQ 483
FE L+ +G G FG V + + + + +A+K + K K + +L E L L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V ++W +F + +Y+ ++
Sbjct: 61 FLV-----------------NLW-------YSFQDE----------------ENMYLVVD 80
Query: 544 YC-PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
LR F +E +IV L ++H +GIIHRD+ P+NI D + +
Sbjct: 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVH 140
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
I DF +A + + L T GT Y APE+ D +
Sbjct: 141 ITDFNIATKVTPDTL----------------TTSTSGTPGYMAPEVLCR-QGYSVAVDWW 183
Query: 663 SLGIVFFELWH---PF---STAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716
SLG+ +E P+ S + QI P +W +E + +L+
Sbjct: 184 SLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS---TEAIDAINKLLERD 240
Query: 717 PSDR 720
P R
Sbjct: 241 PQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 74/352 (21%), Positives = 128/352 (36%), Gaps = 80/352 (22%)
Query: 413 PNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS--LPVNDRI 470
P ++ +E+L +G G FG V ++K + A+KK+ ++++ P+
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT--A 58
Query: 471 LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQE 530
LRE+ L L+H++VV + T A+
Sbjct: 59 LREIKILQLLKHENVVNLIEI----------------CRTKAT---------------PY 87
Query: 531 NKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589
N+ + ++ Y+ E+C L + + F + + ++ GL +IH I+HRD+
Sbjct: 88 NRYKGSF-YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMK 146
Query: 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649
NI +K+ DFGLA+ AF T +V T +Y PE+
Sbjct: 147 AANILITKDGILKLADFGLAR-----------AFSLSKNSKPNRYTNRVVTLWYRPPELL 195
Query: 650 QGWPKIDEKADMYSLGIVFFELW--HPFSTAMERQIVLS--------------------D 687
G DM+ G + E+W P Q L+ +
Sbjct: 196 LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE 255
Query: 688 LKQKGELPPS---WV-----AKFSEQES--LLRRLMSPSPSDRPSATELLQD 729
L +K ELP V + + L+ +L+ P+ R A L
Sbjct: 256 LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 73/326 (22%), Positives = 117/326 (35%), Gaps = 96/326 (29%)
Query: 431 PLGHGGFGHVVLCK-NKLDGRHY--AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
LG G FG V K DG+ AVK ++ +D S L+E + +L H +VVR
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP- 546
GV + LY+ +EY
Sbjct: 61 LL------GVC---------------------------TEEEP-------LYLVLEYMEG 80
Query: 547 -------RTLRQVFESYDHFDKELAWHLF----RQIVEGLAHIHGQGIIHRDLTPNNIFF 595
R R VF S L+ QI +G+ ++ + +HRDL N
Sbjct: 81 GDLLDYLRKSRPVFPS--PEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV 138
Query: 596 DARNDIKIGDFGLAKFLKLEQ---LDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQG 651
+KI DFGL++ + + P + APE ++ G
Sbjct: 139 GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI----------------RWMAPESLKDG 182
Query: 652 WPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQE 706
K+D++S G++ +E++ P+ + + VL L++ LP P +
Sbjct: 183 --IFTSKSDVWSFGVLLWEIFTLGATPYPG-LSNEEVLEYLRKGYRLPKPEYCPDE---- 235
Query: 707 SLLRRLM----SPSPSDRPSATELLQ 728
L LM P DRP+ +EL++
Sbjct: 236 --LYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 70/255 (27%), Positives = 108/255 (42%), Gaps = 48/255 (18%)
Query: 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATL 477
SRY+ +L+PLG G G V + + AVKKI L D +S+ LRE+ +
Sbjct: 4 GSRYM----DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKII 56
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
RL H ++V+ Y+ L S S + E
Sbjct: 57 RRLDHDNIVKVYEV-------------------LGPS-------GSDLTEDVGSLTELNS 90
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
+YI EY L V E +E A Q++ GL +IH ++HRDL P N+F +
Sbjct: 91 VYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149
Query: 598 RNDI-KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+ + KIGDFGLA+ +D + G +S + T +Y +P +
Sbjct: 150 EDLVLKIGDFGLARI-----VDPHY---SHKGYLSEG----LVTKWYRSPRLLLSPNNYT 197
Query: 657 EKADMYSLGIVFFEL 671
+ DM++ G +F E+
Sbjct: 198 KAIDMWAAGCIFAEM 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 62/253 (24%), Positives = 101/253 (39%), Gaps = 57/253 (22%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH-QH 484
+E+L+ +G G +G V ++K G+ A+KK RL+ + LRE++ L L +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+VR DV E K LY+ EY
Sbjct: 63 IVRLL-----------------------------------DVEHVEEKNGKPSLYLVFEY 87
Query: 545 CPRTLRQVFESY-----DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD-AR 598
L++ +S + Q+++G+AH H G++HRDL P N+ D +
Sbjct: 88 LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK 147
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
+KI D GL + AF T ++ T +Y APE+ G
Sbjct: 148 GLLKIADLGLGR-----------AFSIPVKSY----THEIVTLWYRAPEVLLGSTHYSTP 192
Query: 659 ADMYSLGIVFFEL 671
D++S+G +F E+
Sbjct: 193 VDIWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 81/310 (26%), Positives = 130/310 (41%), Gaps = 72/310 (23%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILR---EVATLSRLQHQHVVRY 488
LG G FG V LC + GR A K+++ +S + + E+ L LQH+ +V+Y
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR- 547
Y G L ++ E T L I MEY P
Sbjct: 70 Y-------------------GCL------------------RDRAEKT-LTIFMEYMPGG 91
Query: 548 TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFG 607
+++ ++Y + + RQI+EG++++H I+HRD+ NI D+ ++K+GDFG
Sbjct: 92 SVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151
Query: 608 LAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ---VGTYFYTAPEIEQGWPKIDEKADMYSL 664
+K L+ + + GTG GT ++ +PE+ G KAD++SL
Sbjct: 152 ASKRLQT---------------ICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSL 195
Query: 665 GIVFFEL------WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718
G E+ W + AM ++ +LP + SE +
Sbjct: 196 GCTVVEMLTEKPPWAEYE-AMAAIFKIATQPTNPQLP----SHISEHARDFLGCIFVEAR 250
Query: 719 DRPSATELLQ 728
RPSA ELL+
Sbjct: 251 HRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 64/255 (25%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
++ +E+++ +G G +G V ++++ A+KKIRL+ + V +RE++ L +QH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++VR DV E +L Y+
Sbjct: 61 GNIVRLQ-----------------------------------DVVHSEKRL-----YLVF 80
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFR----QIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
EY L++ +S F K L + QI+ G+A+ H ++HRDL P N+ D R
Sbjct: 81 EYLDLDLKKHMDSSPDFAKNP--RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138
Query: 599 -NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKID 656
N +K+ DFGLA+ AF G+ V T +V T +Y APEI G
Sbjct: 139 TNALKLADFGLAR-----------AF-----GIPVRTFTHEVVTLWYRAPEILLGSRHYS 182
Query: 657 EKADMYSLGIVFFEL 671
D++S+G +F E+
Sbjct: 183 TPVDIWSVGCIFAEM 197
|
Length = 294 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 76/326 (23%), Positives = 132/326 (40%), Gaps = 82/326 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
EL LG G G V C+ K G +A+K I D + + +ILRE+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSP 59
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+YY F + ++SS + I ME
Sbjct: 60 YIVKYY------------------------GAFLDESSSS--------------IGIAME 81
Query: 544 YCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
YC ++V + +++ + +++GL+++H + IIHRD+ P+NI +
Sbjct: 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK 141
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP-KIDE 657
+K+ DFG++ L S+ GT GT FY APE QG P I
Sbjct: 142 GQVKLCDFGVSGEL----------------VNSLAGTF-TGTSFYMAPERIQGKPYSI-- 182
Query: 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSD------------LKQKGELPPSWVAKF 702
+D++SLG+ E+ PF E + + LK + W +F
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242
Query: 703 SEQESLLRRLMSPSPSDRPSATELLQ 728
+ +++ + P+ RP+ ++L+
Sbjct: 243 ---KDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 82/340 (24%), Positives = 126/340 (37%), Gaps = 92/340 (27%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI-LREVATLSRLQHQH 484
+E+L +G G +G V C+N+ G+ A+KK ++ + PV +I LRE+ L +L+H +
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPN 61
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE----STYLYI 540
+V N +E L++
Sbjct: 62 LV--------------------------------------------NLIEVFRRKRKLHL 77
Query: 541 QMEYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
EYC T+ E + L + Q ++ + H IHRD+ P NI +
Sbjct: 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG 137
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
IK+ DFG A+ L TG D T V T +Y APE+ G +
Sbjct: 138 QIKLCDFGFARIL--------------TGP-GDDYTDYVATRWYRAPELLVGDTQYGPPV 182
Query: 660 DMYSLGIVFFE------LWHPFSTAMERQIVLSDLKQK-------GELPPSWVAKFSEQE 706
D++++G VF E LW P SD+ Q G+L P FS
Sbjct: 183 DVWAIGCVFAELLTGQPLW-PGK---------SDVDQLYLIRKTLGDLIPRHQQIFS-TN 231
Query: 707 SLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
+ L P P R + P + + L L+M
Sbjct: 232 QFFKGLSIPEPETREPLESKFPNISSPALSF--LKGCLQM 269
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 91/321 (28%), Positives = 139/321 (43%), Gaps = 90/321 (28%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVND-------RILREVATLSRLQ 481
Q LG G FG V L K+K AV + RLK K +PV + + +E LS+L
Sbjct: 6 QRLGKGSFGTVYLVKDK-----KAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +V+++ ++ E ++ I
Sbjct: 61 HPAIVKFHASFLE----------------------------------RDA------FCII 80
Query: 542 MEYCP-RTLRQVFESYDHFDKELA------WHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
EYC R L E H K L+ W F Q++ G+ ++H + I+HRDL NIF
Sbjct: 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEW--FIQLLLGVHYMHQRRILHRDLKAKNIF 138
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGW 652
N +KIGDFG+++ L G T GT +Y +PE QG+
Sbjct: 139 L-KNNLLKIGDFGVSRLLM---------------GSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 653 PKIDEKADMYSLGIVFFE---LWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESL 708
D K+D++SLG + +E L H F +VL + +G PS +S Q S+
Sbjct: 183 ---DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV--EGP-TPSLPETYSRQLNSI 236
Query: 709 LRRLMSPSPSDRPSATELLQD 729
++ +++ PS RPSA E+L++
Sbjct: 237 MQSMLNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|214735 smart00591, RWD, domain in RING finger and WD repeat containing proteins and DEXDc-like helicases subfamily related to the UBCc domain | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 7e-19
Identities = 43/111 (38%), Positives = 59/111 (53%), Gaps = 6/111 (5%)
Query: 37 EITALCAIFQEDCKVV--SGSPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCP 94
E+ AL +I+ ED +V+ P+I +KL P S + ED VS L V+ YP + P
Sbjct: 1 ELEALESIYPEDFEVIDEDARIPEITIKLSPSSDE--GEDQYVSLTLQVKLPENYPDEAP 58
Query: 95 KLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFLSEI 145
+ + +GL+ LL L++ A N G VMIF LVE QEFLSE
Sbjct: 59 PISLLNSEGLSDEQLAELLKKLEEIAEEN--LGEVMIFELVEKLQEFLSEF 107
|
Length = 107 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-19
Identities = 82/317 (25%), Positives = 132/317 (41%), Gaps = 79/317 (24%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH--- 482
++ L+ +G G +G V K+ GR A+K I L V+D I REVA LS+L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD-IQREVALLSQLRQSQP 61
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++ +YY ++ L+ L+I M
Sbjct: 62 PNITKYYGSY----------------------------------------LKGPRLWIIM 81
Query: 543 EYCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
EY RTL + ++ + R+++ L +IH G+IHRD+ NI
Sbjct: 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT 137
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
++K+ DFG+A A ++ S VGT ++ APE+ D K
Sbjct: 138 GNVKLCDFGVA-----------ALLNQNSSKRST----FVGTPYWMAPEVITEGKYYDTK 182
Query: 659 ADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS- 714
AD++SLGI +E+ P+S + ++ K K PP + + LLR ++
Sbjct: 183 ADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPR--LEDNGYSKLLREFVAA 237
Query: 715 ---PSPSDRPSATELLQ 728
P +R SA ELL+
Sbjct: 238 CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 9e-19
Identities = 72/234 (30%), Positives = 114/234 (48%), Gaps = 38/234 (16%)
Query: 538 LYIQMEY-----CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
L + MEY + ++Q + + F + LF QIV L +H + ++HRDL N
Sbjct: 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199
Query: 593 IFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD-GTGQVGTYFYTAPEIEQG 651
IF IK+GDFG +K + VS+D + GT +Y APE+
Sbjct: 200 IFLMPTGIIKLGDFGFSK--------------QYSDSVSLDVASSFCGTPYYLAPEL--- 242
Query: 652 W--PKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQE 706
W + +KADM+SLG++ +EL PF +R+I+ L K + P V+ S +
Sbjct: 243 WERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVS--SGMK 300
Query: 707 SLLRRLMSPSPSDRPSATELLQDALPPQMEY--ELLDNILRMMHSSEDTSIYDK 758
+LL L+S +P+ RP+ +LL ++Y L +I+R SE S +D+
Sbjct: 301 ALLDPLLSKNPALRPTTQQLLHTEF---LKYVANLFQDIVR---HSETISPHDR 348
|
Length = 478 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 85/307 (27%), Positives = 134/307 (43%), Gaps = 66/307 (21%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILR---EVATLSRLQHQHVVRY 488
LG G FG V LC + GR AVK+++ +S + + E+ L L H+ +V+Y
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR- 547
Y G L + +E T L I ME+ P
Sbjct: 70 Y-------------------GCL------------------RDPMERT-LSIFMEHMPGG 91
Query: 548 TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFG 607
+++ +SY + + RQI+EG++++H I+HRD+ NI D+ ++K+GDFG
Sbjct: 92 SIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG 151
Query: 608 LAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667
+K L+ L + TG SV GT ++ +PE+ G KAD++S+G
Sbjct: 152 ASKRLQTICL-------SGTGMKSV-----TGTPYWMSPEVISG-EGYGRKADIWSVGCT 198
Query: 668 FFEL------WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP 721
E+ W F AM ++ LPP V+ L+R+ + RP
Sbjct: 199 VVEMLTEKPPWAEFE-AMAAIFKIATQPTNPVLPPH-VSDHCRD--FLKRIFVEA-KLRP 253
Query: 722 SATELLQ 728
SA ELL+
Sbjct: 254 SADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 62/256 (24%), Positives = 113/256 (44%), Gaps = 49/256 (19%)
Query: 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK--SLPVNDRILREVATL 477
R ++ F+ + +G G +G V ++K G A+KK+RL ++ P+ +RE+ L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPIT--AIREIKIL 60
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+L H+++V + V D D++ + K +
Sbjct: 61 RQLNHRNIVNLKEI-----VTD-KQDAL------------------------DFKKDKGA 90
Query: 538 LYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
Y+ EY L + ES HF ++ +Q++EGL + H + +HRD+ +NI +
Sbjct: 91 FYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN 150
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+ IK+ DFGLA+ + + + P T +V T +Y PE+ G +
Sbjct: 151 NKGQIKLADFGLARL-----YNSEESRPY---------TNKVITLWYRPPELLLGEERYG 196
Query: 657 EKADMYSLGIVFFELW 672
D++S G + EL+
Sbjct: 197 PAIDVWSCGCILGELF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|218742 pfam05773, RWD, RWD domain | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-18
Identities = 36/116 (31%), Positives = 53/116 (45%), Gaps = 5/116 (4%)
Query: 29 DDNELLSEEITALCAIFQEDCKVVSG--SPPQILVKLRPYSKDMGYEDLDVSALLLVRCL 86
+ EL EE+ AL +I+ ++ + SPP +KL+ VS +L
Sbjct: 1 ESKELQEEELEALESIYPDEFEDEVKESSPPTFTIKLKL-LTSEAESSPLVSLVLTFTLP 59
Query: 87 PGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFL 142
YP + PK+ ++ L D LL L++ A N G VMIF L+E QE L
Sbjct: 60 EDYPDEPPKISLSSPWLLRDQDKLQLLKELEELAEENL--GEVMIFELIEWLQENL 113
|
This domain was identified in WD40 repeat proteins and Ring finger domain proteins. The function of this domain is unknown. GCN2 is the alpha-subunit of the only translation initiation factor (eIF2 alpha) kinase that appears in all eukaryotes. Its function requires an interaction with GCN1 via the domain at its N-terminus, which is termed the RWD domain after three major RWD-containing proteins: RING finger-containing proteins, WD-repeat-containing proteins, and yeast DEAD (DEXD)-like helicases. The structure forms an alpha + beta sandwich fold consisting of two layers: a four-stranded antiparallel beta-sheet, and three side-by-side alpha-helices. Length = 113 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 64/247 (25%), Positives = 100/247 (40%), Gaps = 55/247 (22%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
++ L P+G G +G V + GR A+KK+ +S R RE+ L + H++V
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADV-TGQENKLESTYLYIQMEY 544
+ DV T + + +Y+
Sbjct: 77 I-----------------------------------GLLDVFTPASSLEDFQDVYLVTHL 101
Query: 545 CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
L + + D + + L QI+ GL +IH GIIHRDL P+NI + ++KI
Sbjct: 102 MGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGLA+ D + TG V T +Y APEI W ++ D++S+
Sbjct: 161 DFGLAR-----HTDDEM-------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202
Query: 665 GIVFFEL 671
G + EL
Sbjct: 203 GCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 80/324 (24%), Positives = 122/324 (37%), Gaps = 82/324 (25%)
Query: 429 LQPLGHGGFGHVVLCK----NKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
++ LG G FG V LC+ G AVK + + +D RE+ L L H++
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHEN 67
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V+Y GV + G L + MEY
Sbjct: 68 IVKY------KGVCEKPGGRS--------------------------------LRLIMEY 89
Query: 545 CPR-TLRQVFESYDHFDKELAWHLFR---QIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
P +LR + H D+ L QI +G+ ++ Q IHRDL NI ++ +
Sbjct: 90 LPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL 147
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKA 659
+KI DFGLAK L P D V G+ ++Y APE + K +
Sbjct: 148 VKISDFGLAKVL-----------PEDKDYYYVKEPGESPIFWY-APECLRTS--KFSSAS 193
Query: 660 DMYSLGIVFFELW-------HPFSTAMERQIVLSD----------LKQKGELPPSWVAKF 702
D++S G+ +EL+ P + + + LK+ LP +
Sbjct: 194 DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP-PSCP 252
Query: 703 SEQESLLRRLMSPSPSDRPSATEL 726
E L++ P DRPS +L
Sbjct: 253 DEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 93/390 (23%), Positives = 150/390 (38%), Gaps = 97/390 (24%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD---KSLPVNDRILREVATLSRL 480
+DFE ++ +G G FG V L + K G YA+KK+R + K + R R++ L+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAEA 58
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+ VV+ Y ++ Q+ YLY+
Sbjct: 59 DNPWVVKLYYSF------------------------------------QDEN----YLYL 78
Query: 541 QMEYCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
MEY P TL D F +E + + + IH G IHRD+ P+N+ D
Sbjct: 79 IMEYLPGGDMMTL---LMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD 135
Query: 597 ARNDIKIGDFGLAKFL-KLEQLDQDAAFPTDTGGVSVDGTGQ------------------ 637
A+ IK+ DFGL L K + + +D +
Sbjct: 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRAL 195
Query: 638 ----VGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDL 688
VGT Y APE+ + G+ K + D +SLG++ +E+ + PF + ++ +
Sbjct: 196 AYSTVGTPDYIAPEVFLQTGYNK---ECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII 252
Query: 689 KQKGELP-PSWVAKFSEQESLLRRLMSPSPSDR---PSATELLQDALPPQMEYELLDN-- 742
K L P V E + L++RL R E+ +++E +
Sbjct: 253 NWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERP 311
Query: 743 --ILRMMHSSEDTSIYDKVVSSIFDEETLD 770
I+ + S DTS +D F+E LD
Sbjct: 312 APIIPELKSITDTSNFDD-----FEEIDLD 336
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 79/306 (25%), Positives = 132/306 (43%), Gaps = 62/306 (20%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
F +L+ +G G FG V + + A+K I L++ + D I +E+ LS+ +V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYV 64
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+YY ++ L+ T L+I MEY
Sbjct: 65 TKYYGSY----------------------------------------LKGTKLWIIMEYL 84
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
FD+ + ++I++GL ++H + IHRD+ N+ + D+K+ D
Sbjct: 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLAD 144
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FG+A L Q+ ++ VGT F+ APE+ Q D KAD++SLG
Sbjct: 145 FGVAGQLTDTQIKRNTF---------------VGTPFWMAPEVIQQ-SAYDSKADIWSLG 188
Query: 666 IVFFEL--WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPS 722
I EL P ++ M VL + + PP+ +FS+ + + ++ PS RP+
Sbjct: 189 ITAIELAKGEPPNSDMHPMRVLFLIPKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRPT 246
Query: 723 ATELLQ 728
A ELL+
Sbjct: 247 AKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-17
Identities = 87/325 (26%), Positives = 139/325 (42%), Gaps = 62/325 (19%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIR--LKDKSLPVNDRILREVATLSRLQHQHVVRYY 489
+G GG G V L + + R A+KKIR L + L + R LRE + L H +V Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPL-LKKRFLREAKIAADLIHPGIVPVY 68
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTL 549
+ DGD ++ T YI+ L
Sbjct: 69 S------ICS-DGDPVY----------------------------YTMPYIEGYTLKSLL 93
Query: 550 RQVFESYDHFDKELA--------WHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
+ V++ + KELA +F +I + ++H +G++HRDL P+NI ++
Sbjct: 94 KSVWQK-ESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEV 152
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGT--GQ-VGTYFYTAPEIEQGWPKIDEK 658
I D+G A F KLE+ D + T G+ VGT Y APE G P E
Sbjct: 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SES 211
Query: 659 ADMYSLGIVFFE---LWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRL--- 712
D+Y+LG++ ++ L P+ R+I D+ L P VA + E L ++
Sbjct: 212 TDIYALGVILYQMLTLSFPYRRKKGRKISYRDVI----LSPIEVAPYREIPPFLSQIAMK 267
Query: 713 -MSPSPSDRPSATELLQDALPPQME 736
++ P++R S+ + L+ L P ++
Sbjct: 268 ALAVDPAERYSSVQELKQDLEPHLQ 292
|
Length = 932 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 60/246 (24%), Positives = 102/246 (41%), Gaps = 47/246 (19%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
++ ++ +G G +G V + G+ A+KKI + R LRE+ L +H ++
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ ADF DV Y+ M+
Sbjct: 67 IAIRDI-LRPPGADFK-----------------------DV------------YVVMDLM 90
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L + S +E + Q++ GL +IH +IHRDL P+N+ + +++IGD
Sbjct: 91 ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGD 150
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FG+A+ L ++ PT+ T V T +Y APE+ P+ DM+S+G
Sbjct: 151 FGMARGL--------SSSPTEHKYFM---TEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199
Query: 666 IVFFEL 671
+F E+
Sbjct: 200 CIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 81/316 (25%), Positives = 131/316 (41%), Gaps = 82/316 (25%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
LG G FG V ++K G A K I+++ + + D ++ E+ LS +H ++V Y+A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-ELEDFMV-EIDILSECKHPNIVGLYEA 70
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLR 550
+F ++ L+I +E+C L
Sbjct: 71 YF------YENK----------------------------------LWILIEFCDGGALD 90
Query: 551 QVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLA 609
+ + + ++ RQ++E L +H +IHRDL NI D+K+ DFG++
Sbjct: 91 SIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVS 150
Query: 610 KFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI-------EQGWPKIDEKADMY 662
K +D F +GT ++ APE+ + + D KAD++
Sbjct: 151 AKNKSTLQKRD-TF--------------IGTPYWMAPEVVACETFKDNPY---DYKADIW 192
Query: 663 SLGIVFFELWH--PFSTAMERQIVLSDLK-QKGELP----PS-WVAKFSEQESLLRRLMS 714
SLGI EL P + VL LK K E P PS W + F++ L+ +
Sbjct: 193 SLGITLIELAQMEPPHHELNPMRVL--LKILKSEPPTLDQPSKWSSSFND---FLKSCLV 247
Query: 715 PSPSDRPSATELLQDA 730
P DRP+A ELL+
Sbjct: 248 KDPDDRPTAAELLKHP 263
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 60/309 (19%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQ 481
L +F + +G G F V LDG A+KK+++ D ++E+ L +L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +V++YY ++ E +N+L
Sbjct: 61 HPNVIKYYASFIE-----------------------------------DNELNIVLELAD 85
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
R ++ + ++ W F Q+ L H+H + ++HRD+ P N+F A +
Sbjct: 86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVV 145
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKA 659
K+GD GL +F F + T VGT +Y +PE E G+ + K+
Sbjct: 146 KLGDLGLGRF-----------FSSKTTAAH----SLVGTPYYMSPERIHENGY---NFKS 187
Query: 660 DMYSLGIVFFE---LWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSP 715
D++SLG + +E L PF L ++ + PP +SE+ L+ ++P
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP 247
Query: 716 SPSDRPSAT 724
P RP T
Sbjct: 248 DPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 66/258 (25%), Positives = 109/258 (42%), Gaps = 60/258 (23%)
Query: 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL---KDKSLPVNDRILREV 474
R + +FE+L +G G +G V ++ G A+KK+R+ +D +P++ LRE+
Sbjct: 1 GRCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISS--LREI 57
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
L L+H ++V + V G L+
Sbjct: 58 TLLLNLRHPNIVELKEV----------------------------------VVG--KHLD 81
Query: 535 STYLYIQMEYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNI 593
S +L MEYC + L + ++ F + L Q++ GL ++H IIHRDL +N+
Sbjct: 82 SIFLV--MEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL 139
Query: 594 FFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653
+ +KI DFGLA+ G + T +V T +Y APE+ G
Sbjct: 140 LLTDKGCLKIADFGLAR---------------TYGLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 654 KIDEKADMYSLGIVFFEL 671
DM+++G + EL
Sbjct: 185 TYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 60/250 (24%), Positives = 108/250 (43%), Gaps = 61/250 (24%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
F++L+ LG G + V +N+ G A+K+I L D +RE++ + L+H+++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIREISLMKELKHENI 60
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
VR + DV ENKL + EY
Sbjct: 61 VRLH-----------------------------------DVIHTENKLMLVF-----EYM 80
Query: 546 PRTLRQVFESYDH---FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+ L++ +++ D Q+++G+A H ++HRDL P N+ + R ++K
Sbjct: 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELK 140
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKADM 661
+ DFGLA+ AF G+ V+ + +V T +Y AP++ G D+
Sbjct: 141 LADFGLAR-----------AF-----GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDI 184
Query: 662 YSLGIVFFEL 671
+S+G + E+
Sbjct: 185 WSVGCIMAEM 194
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 90/351 (25%), Positives = 139/351 (39%), Gaps = 89/351 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
DF ++ +G G FG V L + K G+ YA+K + KS E+ +L H
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL---KS---------EMFKKDQLAHV 48
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
R A + DS W + S +S + ++ YLY+ ME
Sbjct: 49 KAERDVLA---------ESDSPW----VVSLYYSFQ--------------DAQYLYLIME 81
Query: 544 YCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+ P L + YD F +++ + V + +H G IHRD+ P+NI D IK
Sbjct: 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIK 141
Query: 603 IGDFGLAK-FLKLEQ-------LDQDAAFPTDTG--GVSVDGT----------------- 635
+ DFGL+ F K L + V+VD
Sbjct: 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNR 201
Query: 636 -----GQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPF--STAME--R 681
VGT Y APEI +QG+ ++ D +SLG + FE W PF + E R
Sbjct: 202 RLMAYSTVGTPDYIAPEIFLQQGY---GQECDWWSLGAIMFECLIGWPPFCSENSHETYR 258
Query: 682 QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS--DRPSATELLQDA 730
+I+ + ++ P + E E L+RRL++ + + R A E+
Sbjct: 259 KII--NWRETLYFPDD-IHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHP 306
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 61/251 (24%), Positives = 96/251 (38%), Gaps = 65/251 (25%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQ 483
D E ++ +G G FG V L ++++ +YA+K + + + L + E L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++R + + +LY+ ME
Sbjct: 62 FIIRLFWTEHD----------------------------------------QRFLYMLME 81
Query: 544 YCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
Y P L + F +IV L ++H + I++RDL P NI D IK
Sbjct: 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIK 141
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV-GTYFYTAPEIEQGWPKIDEKA-D 660
+ DFG AK L D T + GT Y APE+ Q K KA D
Sbjct: 142 LTDFGFAKKL-------------------RDRTWTLCGTPEYLAPEVIQS--KGHNKAVD 180
Query: 661 MYSLGIVFFEL 671
++LGI+ +E+
Sbjct: 181 WWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 71/303 (23%), Positives = 117/303 (38%), Gaps = 75/303 (24%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD---KSLPVNDRILREVATLSRLQHQHV 485
L+P+ G FG V L K + G ++A+K ++ D K+ N + R + + + +V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYV 59
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ Y +F ++ YLY+ MEY
Sbjct: 60 AKLY------------------------YSFQSK----------------DYLYLVMEYL 79
Query: 546 P----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
+L + ++ A ++V G+ +H +GIIHRD+ P N+ D +
Sbjct: 80 NGGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHL 136
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
K+ DFGL++ G + VGT Y APE G D+ +D
Sbjct: 137 KLTDFGLSR----------------NGLENKK---FVGTPDYLAPETILGVGD-DKMSDW 176
Query: 662 YSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFS-EQESLLRRLMSPSP 717
+SLG V FE + PF + + L ++ P S E L+ RL+ P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 718 SDR 720
+ R
Sbjct: 237 AKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 90/332 (27%), Positives = 132/332 (39%), Gaps = 87/332 (26%)
Query: 426 FEE-----LQPLGHGGFGHVVLCK----NKLDGRHYAVKKIRLKDKSLPVNDRILREVAT 476
FEE +Q LG G FG V LC+ G AVKK++ + + D RE+
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRD-FEREIEI 58
Query: 477 LSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST 536
L LQH ++V+Y GV + +G
Sbjct: 59 LKSLQHDNIVKY------KGVC-------YSAGRRN------------------------ 81
Query: 537 YLYIQMEYCPR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
L + MEY P +LR + + D QI +G+ ++ + +HRDL NI
Sbjct: 82 -LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNIL 140
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654
++ N +KIGDFGL K L P D V G+ ++Y APE K
Sbjct: 141 VESENRVKIGDFGLTKVL-----------PQDKEYYKVREPGESPIFWY-APE-SLTESK 187
Query: 655 IDEKADMYSLGIVFFELW-------HPFSTAMER--------QIV---LSDLKQKGEL-- 694
+D++S G+V +EL+ P + M IV + LK G L
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA 247
Query: 695 PPSWVAKFSEQESLLRRLMSPSPSDRPSATEL 726
PP A E ++++ + PS RPS +EL
Sbjct: 248 PPGCPA---EIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 84/338 (24%), Positives = 127/338 (37%), Gaps = 83/338 (24%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
++ + +G G +G V + G A+KKI + + RILRE+ L L+H +
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V +F +Y+ E
Sbjct: 62 VEIKHIMLPPSRREFKD-----------------------------------IYVVFELM 86
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L QV ++ D E Q++ L +IH + HRDL P NI +A +KI D
Sbjct: 87 ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICD 146
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI-EQGWPKIDEKADMYSL 664
FGLA+ AF DT ++ T V T +Y APE+ + K D++S+
Sbjct: 147 FGLAR----------VAF-NDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 194
Query: 665 GIVFFE-----------------------LWHPFSTAMER------QIVLSDLKQKGELP 695
G +F E L P + R + LS +++K +P
Sbjct: 195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254
Query: 696 PSWVAKFSEQES----LLRRLMSPSPSDRPSATELLQD 729
S KF + LL RL++ P DRP+A E L D
Sbjct: 255 FS--QKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-16
Identities = 63/249 (25%), Positives = 105/249 (42%), Gaps = 53/249 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
D E +P+G+G FG V + DG+ A+KK+ ++L R+ RE+ L +H +
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADV--TGQENKLESTYLYIQM 542
V+ S+ D+ + E Y+ ++
Sbjct: 61 VL-----------------------------------SALDILQPPHIDPFEEIYVVTEL 85
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
L ++ S + QI+ GL ++H GI+HRD+ P N+ ++ +K
Sbjct: 86 MQS--DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLK 143
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
I DFGLA ++E+ D+ S T +V T +Y APEI G D++
Sbjct: 144 ICDFGLA---RVEEPDE-----------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIW 189
Query: 663 SLGIVFFEL 671
S+G +F EL
Sbjct: 190 SVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 59/252 (23%), Positives = 103/252 (40%), Gaps = 53/252 (21%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR------------ILREVATLSR 479
LG G +G V + L G+ A+KK+++ + S V LRE+ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
++H++++ DV + + ++
Sbjct: 77 IKHENIM-----------------------------------GLVDVYVEGD-----FIN 96
Query: 540 IQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
+ M+ L++V + + + QI+ GL +H +HRDL+P NIF +++
Sbjct: 97 LVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG 156
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
KI DFGLA+ D +T + T +V T +Y APE+ G K
Sbjct: 157 ICKIADFGLARRYGYPPY-SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV 215
Query: 660 DMYSLGIVFFEL 671
DM+S+G +F EL
Sbjct: 216 DMWSVGCIFAEL 227
|
Length = 335 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 62/258 (24%), Positives = 99/258 (38%), Gaps = 71/258 (27%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
++ L +G G +G V +K G A+KKI + R LRE+ L R +H++
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTLREIKILRRFKHEN 64
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++ D+ + +YI E
Sbjct: 65 IIGIL-----------------------------------DIIRPPSFESFNDVYIVQEL 89
Query: 545 CP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
+ ++ S DH + QI+ GL +IH ++HRDL P+N+ + D
Sbjct: 90 METDLYKLIKTQHLSNDH-----IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD 144
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ----VGTYFYTAPEI---EQGWP 653
+KI DFGLA+ E D TG V T +Y APEI +G+
Sbjct: 145 LKICDFGLARIADPEH----------------DHTGFLTEYVATRWYRAPEIMLNSKGYT 188
Query: 654 KIDEKADMYSLGIVFFEL 671
K D++S+G + E+
Sbjct: 189 K---AIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 60/255 (23%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL--KDKSLPVNDRILREVATLS 478
R ++++E+L + G +G V ++K G A+KK+++ + + P+ LRE+ L
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--LREINILL 59
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+LQH ++V E V G ++ +K+
Sbjct: 60 KLQHPNIVTVK----EVVV----GSNL-------------------------DKI----- 81
Query: 539 YIQMEYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
Y+ MEY L+ + E+ F + L Q++ G+AH+H I+HRDL +N+ +
Sbjct: 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN 141
Query: 598 RNDIKIGDFGLA-KFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
R +KI DFGLA ++ G T V T +Y APE+ G +
Sbjct: 142 RGILKICDFGLAREY----------------GSPLKPYTQLVVTLWYRAPELLLGAKEYS 185
Query: 657 EKADMYSLGIVFFEL 671
DM+S+G +F EL
Sbjct: 186 TAIDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 50/241 (20%)
Query: 431 PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQ 490
P+G G +G V KN A+KKI + R LRE+ L L H++V+
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVI---- 67
Query: 491 AWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLR 550
+ D+ ++ +YI E L
Sbjct: 68 -------------------------------AIKDIMPPPHREAFNDVYIVYELMDTDLH 96
Query: 551 QVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
Q+ S + + Q++ GL +IH ++HRDL P+N+ +A D+KI DFGLA+
Sbjct: 97 QIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFE 670
+ F T+ V T +Y APE+ + D++S+G +F E
Sbjct: 157 -----TTSEKGDFMTE----------YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 671 L 671
L
Sbjct: 202 L 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 61/246 (24%), Positives = 100/246 (40%), Gaps = 54/246 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ L+ +G G +G V +K G A+KK+ +S R RE+ L +QH++V
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ + T D F + Y+ M Y
Sbjct: 77 IGLLDVF--TSAVSGDE-------------FQD-------------------FYLVMPYM 102
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L+++ ++ +L Q++ GL +IH GIIHRDL P N+ + ++KI D
Sbjct: 103 QTDLQKIMGH--PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILD 160
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FGLA+ E TG V T +Y APE+ W ++ D++S+G
Sbjct: 161 FGLARHADAEM------------------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVG 202
Query: 666 IVFFEL 671
+ E+
Sbjct: 203 CIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 83/317 (26%), Positives = 129/317 (40%), Gaps = 76/317 (23%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+E + LG G FG V KNK G A K I K + + D ++ E+ L+ H ++
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYMV-EIEILATCNHPYI 71
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V+ A++ +DG L+I +E+C
Sbjct: 72 VKLLGAFY------WDGK----------------------------------LWIMIEFC 91
Query: 546 PR-TLRQVFESYDHFDKELAWHLF-RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
P + + D E + RQ++E L ++H IIHRDL N+ DIK+
Sbjct: 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKL 151
Query: 604 GDFGL-AKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI-----EQGWPKIDE 657
DFG+ AK +K L + +F +GT ++ APE+ + P D
Sbjct: 152 ADFGVSAKNVK--TLQRRDSF--------------IGTPYWMAPEVVMCETMKDTP-YDY 194
Query: 658 KADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPS------WVAKFSEQESLLRR 711
KAD++SLGI E+ E + LK PP+ W +F + L+
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD---FLKT 251
Query: 712 LMSPSPSDRPSATELLQ 728
+ P RPSA +LL+
Sbjct: 252 ALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 77/319 (24%), Positives = 132/319 (41%), Gaps = 68/319 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQ 481
L +F+ + +G G F V LD + A+KK+++ + ++E+ L +L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +V++Y ++ E + A + D++ Q
Sbjct: 61 HPNVIKYLDSFIEDNELNI----------------VLELADAGDLS-------------Q 91
Query: 542 M-EYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
M +Y + R + E W F Q+ + H+H + ++HRD+ P N+F A
Sbjct: 92 MIKYFKKQKRLIPE-------RTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV 144
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEK 658
+K+GD GL +F + T S+ VGT +Y +PE E G+ + K
Sbjct: 145 VKLGDLGLGRFFSSKT----------TAAHSL-----VGTPYYMSPERIHENGY---NFK 186
Query: 659 ADMYSLGIVFFE---LWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS- 714
+D++SLG + +E L PF L ++ + PP +SE+ LR L+S
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK---LRELVSM 243
Query: 715 ---PSPSDRPSATELLQDA 730
P P RP + Q A
Sbjct: 244 CIYPDPDQRPDIGYVHQIA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 62/306 (20%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
F +L+ +G G FG V + + A+K I L++ + D I +E+ LS+ +V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYV 64
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+YY ++ L+ T L+I MEY
Sbjct: 65 TKYYGSY----------------------------------------LKDTKLWIIMEYL 84
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
D+ + R+I++GL ++H + IHRD+ N+ ++K+ D
Sbjct: 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLAD 144
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FG+A L Q+ ++ VGT F+ APE+ + D KAD++SLG
Sbjct: 145 FGVAGQLTDTQIKRNTF---------------VGTPFWMAPEVIKQ-SAYDSKADIWSLG 188
Query: 666 IVFFEL--WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPS 722
I EL P + + VL + + PP+ +S+ + + ++ PS RP+
Sbjct: 189 ITAIELAKGEPPHSELHPMKVLFLIPKNN--PPTLEGNYSKPLKEFVEACLNKEPSFRPT 246
Query: 723 ATELLQ 728
A ELL+
Sbjct: 247 AKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 70/266 (26%), Positives = 113/266 (42%), Gaps = 60/266 (22%)
Query: 407 SVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPV 466
SV+ G ++ RY N L+P+G G G V + + G++ A+KK+ +++
Sbjct: 4 SVEVGDSTFTVLK-RYQN----LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH 58
Query: 467 NDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADV 526
R RE+ + + H++++ +
Sbjct: 59 AKRAYRELVLMKLVNHKNIIGLLNVF---------------------------------- 84
Query: 527 TGQENKLESTYLYIQMEYCPRTLRQVFE-SYDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585
T Q++ E +Y+ ME L QV + DH E +L Q++ G+ H+H GIIH
Sbjct: 85 TPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH---ERMSYLLYQMLCGIKHLHSAGIIH 141
Query: 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA 645
RDL P+NI + +KI DFGLA+ T G S T V T +Y A
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLAR----------------TAGTSFMMTPYVVTRYYRA 185
Query: 646 PEIEQGWPKIDEKADMYSLGIVFFEL 671
PE+ G E D++S+G + E+
Sbjct: 186 PEVILGMG-YKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 81/312 (25%), Positives = 127/312 (40%), Gaps = 76/312 (24%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKD--KSLPVNDRILREVATLSRLQHQHVVRYY 489
LG G +G V ++ A+K+I +D P+++ E+A S L+H+++V+Y
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE----EIALHSYLKHRNIVQY- 70
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-T 548
L S E+ + I ME P +
Sbjct: 71 ---------------------LGSD------------------SENGFFKIFMEQVPGGS 91
Query: 549 LRQVFESY--DHFDKELAWHLF-RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI-KIG 604
L + S D E + +QI+EGL ++H I+HRD+ +N+ + + + KI
Sbjct: 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKIS 151
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYS 663
DFG +K L G++ GT Y APE I++G AD++S
Sbjct: 152 DFGTSKRL---------------AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196
Query: 664 LGIVFFELWH---PFSTAMERQIVLSDL---KQKGELPPSWVAKFSEQESLLRRLMSPSP 717
LG E+ PF E Q + + K E+P S A E ++ + R P P
Sbjct: 197 LGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA---EAKNFILRCFEPDP 253
Query: 718 SDRPSATELLQD 729
R SA +LLQD
Sbjct: 254 DKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 60/249 (24%), Positives = 100/249 (40%), Gaps = 56/249 (22%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+E L +G G +G V+ CK+K G+ A+KK + V +RE+ L +L+H+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V + +V ++ +L Y+ E
Sbjct: 61 NLV-----------------------------------NLIEVFRRKKRL-----YLVFE 80
Query: 544 YCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+ T+ E Y + D+ QI+ G+ H IIHRD+ P NI +K
Sbjct: 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVK 140
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
+ DFG A+ L A P + T V T +Y APE+ G K D++
Sbjct: 141 LCDFGFARTL---------AAPGE------VYTDYVATRWYRAPELLVGDTKYGRAVDIW 185
Query: 663 SLGIVFFEL 671
++G + E+
Sbjct: 186 AVGCLVTEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-15
Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 53/246 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ +L+ +G G +G V ++ G A+KK+ +S R RE+ L ++H++V
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ G+ D T + Y+ M +
Sbjct: 77 I---------GLLDV-------------------------FTPDLSLDRFHDFYLVMPFM 102
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L ++ + ++ ++ L Q+++GL +IH GIIHRDL P N+ + ++KI D
Sbjct: 103 GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILD 161
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FGLA+ Q D + TG V T +Y APE+ W + D++S+G
Sbjct: 162 FGLAR-----QTDSEM-------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVG 203
Query: 666 IVFFEL 671
+ E+
Sbjct: 204 CIMAEM 209
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-15
Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 53/249 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
L ++ L+P+G G G V + + R+ A+KK+ ++ R RE+ + + H
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++++ + T Q++ E +YI M
Sbjct: 83 KNIIGLLNVF----------------------------------TPQKSLEEFQDVYIVM 108
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
E L QV + D E +L Q++ G+ H+H GIIHRDL P+NI + +K
Sbjct: 109 ELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
I DFGLA+ T G S T V T +Y APE+ G E D++
Sbjct: 167 ILDFGLAR----------------TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIW 209
Query: 663 SLGIVFFEL 671
S+G + E+
Sbjct: 210 SVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 74/307 (24%), Positives = 127/307 (41%), Gaps = 64/307 (20%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
F +L+ +G G FG V + A+K I L++ + D I +E+ LS+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYI 64
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
RYY ++ L+ T L+I MEY
Sbjct: 65 TRYYGSY----------------------------------------LKGTKLWIIMEYL 84
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
++ + R+I++GL ++H + IHRD+ N+ + D+K+ D
Sbjct: 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLAD 144
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FG+A L Q+ ++ VGT F+ APE+ + D KAD++SLG
Sbjct: 145 FGVAGQLTDTQIKRNTF---------------VGTPFWMAPEVIKQ-SAYDFKADIWSLG 188
Query: 666 IVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRP 721
I EL P S +++ K PP+ ++S+ + + ++ P RP
Sbjct: 189 ITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFKEFVEACLNKDPRFRP 245
Query: 722 SATELLQ 728
+A ELL+
Sbjct: 246 TAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 74/316 (23%), Positives = 117/316 (37%), Gaps = 69/316 (21%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRL----KDKSLPVNDRILREVATLSRLQHQHV 485
Q LG G F ++ G AVK++ + V + + +E+ ++RL H H+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+R A E F+ W +G S S A V + Y
Sbjct: 66 IRMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVI--------------INYT 109
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR-NDIKIG 604
Q++ GL+++H IIHRD+ N+ D+ ++I
Sbjct: 110 -----------------------EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIA 146
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ-VGTYFYTAPEIEQGWPKIDEKADMYS 663
DFG A L AA T G GQ +GT + APE+ +G D++S
Sbjct: 147 DFGAAARL--------AAKGTGAGEFQ----GQLLGTIAFMAPEVLRGEQ-YGRSCDVWS 193
Query: 664 LGIVFFEL------WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSE--QESLLRRLMSP 715
+G V E+ W+ + ++ PS S ++ LR L
Sbjct: 194 VGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT--APSIPEHLSPGLRDVTLRCLEL- 250
Query: 716 SPSDRPSATELLQDAL 731
P DRP + ELL+ +
Sbjct: 251 QPEDRPPSRELLKHPV 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 77/322 (23%), Positives = 127/322 (39%), Gaps = 73/322 (22%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND----RILREVATLSRL 480
F++++ LG G G V L + K G+ +A+K + DK + R+L E L+ L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL---DKKEMIKRNKVKRVLTEQEILATL 58
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H + Y A F+T TYL +
Sbjct: 59 DHPFLPTLY-ASFQT---------------------------------------ETYLCL 78
Query: 541 QMEYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
M+YCP R L++ +E+A +++ L ++H GI++RDL P NI
Sbjct: 79 VMDYCPGGELFRLLQRQPGKC--LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL 136
Query: 596 DARNDIKIGDFGLAKFLKLE--QLDQDAAFPTDTGGVS-------VDGTGQ-----VGTY 641
I + DF L+K +E + + + V+ + VGT
Sbjct: 137 HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTE 196
Query: 642 FYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSW 698
Y APE+ G D ++LGI+ +E+ + PF + + + LK++ P S
Sbjct: 197 EYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSP 255
Query: 699 VAKFSEQESLLRRLMSPSPSDR 720
S L+R+L+ PS R
Sbjct: 256 -PVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 84/309 (27%), Positives = 125/309 (40%), Gaps = 86/309 (27%)
Query: 429 LQPLGHGGFGHVVLCKNKL---DGRHYAVKKIRLKDKSLPVNDRI--LREVATLSRLQHQ 483
L+ LG G FG V L + G+ YA+K LK +L V DR+ E L+ + H
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKV--LKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM- 542
+V+ + A F+T E KL YL +
Sbjct: 59 FIVKLHYA-FQT----------------------------------EGKL---YLILDFL 80
Query: 543 ---EYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
+ R ++V F +E ++ L H+H GII+RDL P NI D
Sbjct: 81 RGGDLFTRLSKEVM-----FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG 135
Query: 600 DIKIGDFGLAKFLKLEQLDQDA---AFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPK 654
IK+ DFGL+K E +D + +F GT Y APE+ +G
Sbjct: 136 HIKLTDFGLSK----ESIDHEKKAYSF--------------CGTVEYMAPEVVNRRGH-- 175
Query: 655 IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR 711
+ AD +S G++ FE+ PF ++ + LK K +P E +SLLR
Sbjct: 176 -TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSP---EAQSLLRA 231
Query: 712 LMSPSPSDR 720
L +P++R
Sbjct: 232 LFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 81/331 (24%), Positives = 129/331 (38%), Gaps = 97/331 (29%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND----RILREVATLSR 479
+D E ++ LG G +G V ++ G AVK+IR VN R+L ++ R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT-----VNSQEQKRLLMDLDISMR 55
Query: 480 LQH-QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+ V +Y A F G DV
Sbjct: 56 SVDCPYTVTFYGALFREG----------------------------DV------------ 75
Query: 539 YIQMEYCPRTL----RQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNI 593
+I ME +L ++V++ +++ + IV+ L ++H + +IHRD+ P+N+
Sbjct: 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNV 135
Query: 594 FFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE---IEQ 650
+ +K+ DFG++ +L D SV T G Y APE E
Sbjct: 136 LINRNGQVKLCDFGISGYL------------VD----SVAKTIDAGCKPYMAPERINPEL 179
Query: 651 GWPKIDEKADMYSLGIVFFEL---------WH-PFSTAMERQIVLSDLKQKGELPPSWVA 700
D K+D++SLGI EL W PF LKQ E P +
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF----------QQLKQVVEEPSPQLP 229
Query: 701 --KFSEQ-ESLLRRLMSPSPSDRPSATELLQ 728
KFS + + + + + + +RP+ ELLQ
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-14
Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 25/187 (13%)
Query: 549 LRQVFESYDHFDKELAWH----LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
LRQ +S ++ H LF Q++ + H+H + +IHRD+ NI + +K+G
Sbjct: 126 LRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVD-GTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
DFG +K VS D G GT +Y APEI + P +KADM+S
Sbjct: 186 DFGFSKMY--------------AATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFS 230
Query: 664 LGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
LG++ +EL PF +++ L + + P ++ E + ++ L+S P R
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISP--EMQEIVTALLSSDPKRR 288
Query: 721 PSATELL 727
PS+++LL
Sbjct: 289 PSSSKLL 295
|
Length = 496 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-14
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 530 ENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDL 588
+ L+ EY P RTLR+V + L Q+++ LA H QGI+HRDL
Sbjct: 46 SGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDL 105
Query: 589 TPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA 645
P NI K+ DFG+ L + D D A T T V +GT Y A
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR-DADVATLTRTTEV-------LGTPTYCA 157
Query: 646 PEIEQGWPKIDEKADMYSLGIVFFELW--HPFSTAMERQIVLSDLKQKGELP---PSWVA 700
PE +G P + +D+Y+ G++F E +L +Q + P W+A
Sbjct: 158 PEQLRGEP-VTPNSDLYAWGLIFLECLTGQRVVQGASVAEIL--YQQLSPVDVSLPPWIA 214
Query: 701 KFSEQESLLRRLMSPSPSDRPSATELL 727
+ +LR+ ++ P R ++ L
Sbjct: 215 GHPLGQ-VLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 71/314 (22%), Positives = 132/314 (42%), Gaps = 62/314 (19%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQH 484
+E ++ +G G +G V NK +G AVK + D +++ I E L L H +
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVK---ILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
VV++Y +++ V + GD +W L + S D+
Sbjct: 77 VVKFYGMYYKKDVKN--GDQLWLVLELCN------GGSVTDL------------------ 110
Query: 545 CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
++ + + ++ + ++ + + GL H+H IHRD+ NNI +K+
Sbjct: 111 ----VKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPKIDEKAD 660
DFG++ L +L ++ + VGT F+ APE+ +Q D + D
Sbjct: 167 DFGVSAQLTSTRLRRNTS---------------VGTPFWMAPEVIACEQQLDSTYDARCD 211
Query: 661 MYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPS------WVAKFSEQESLLRRLMS 714
++SLGI EL + + + K PP+ W +F++ +R+ ++
Sbjct: 212 VWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFND---FIRKCLT 268
Query: 715 PSPSDRPSATELLQ 728
RP+ ++LLQ
Sbjct: 269 KDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-14
Identities = 69/271 (25%), Positives = 114/271 (42%), Gaps = 60/271 (22%)
Query: 401 SQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK 460
+QF+ SV+ G ++ L ++ L+P+G G G V + + R+ A+KK+
Sbjct: 1 NQFY--SVEVGDSTFTV-----LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53
Query: 461 DKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRA 520
++ R RE+ + + H++++ +
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVF---------------------------- 85
Query: 521 ASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580
T Q++ E +Y+ ME L QV + D E +L Q++ G+ H+H
Sbjct: 86 ------TPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS 137
Query: 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
GIIHRDL P+NI + +KI DFGLA+ T G S T V T
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----------------TAGTSFMMTPYVVT 181
Query: 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
+Y APE+ G E D++S+G + E+
Sbjct: 182 RYYRAPEVILGM-GYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 60/194 (30%), Positives = 86/194 (44%), Gaps = 37/194 (19%)
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKE------LAWHLFRQIVEGLAHIHGQGIIHRDLTPN 591
LY+ +EY E + H ++E A +I L H+H QGII+RDL P
Sbjct: 75 LYLILEYLSGG-----ELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPE 129
Query: 592 NIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ- 650
NI DA+ +K+ DFGL K E + + T GT Y APEI
Sbjct: 130 NILLDAQGHVKLTDFGLCK----ESIHEGTVTHT-----------FCGTIEYMAPEILMR 174
Query: 651 -GWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQE 706
G K D +SLG + +++ PF+ ++ + LK K LPP E
Sbjct: 175 SGHGK---AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLT---PEAR 228
Query: 707 SLLRRLMSPSPSDR 720
LL++L+ +PS R
Sbjct: 229 DLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 77/325 (23%), Positives = 129/325 (39%), Gaps = 97/325 (29%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR---ILREVATLSRLQH 482
F +L+ +GHG FG V ++ A+KK+ K N++ I++EV L +L+H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQQLRH 74
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+ + Y + L ++ M
Sbjct: 75 PNTIEYKGCY----------------------------------------LREHTAWLVM 94
Query: 543 EYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
EYC + + E + + E+A + ++GLA++H IHRD+ NI
Sbjct: 95 EYCLGSASDILEVHKKPLQEVEIA-AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT 153
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPKID 656
+K+ DFG A + P ++ VGT ++ APE+ ++G + D
Sbjct: 154 VKLADFGSASLVS----------PANSF---------VGTPYWMAPEVILAMDEG--QYD 192
Query: 657 EKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGEL-------PPS-----WVAKFSE 704
K D++SLGI EL ER+ L ++ L P+ W F
Sbjct: 193 GKVDVWSLGITCIEL-------AERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245
Query: 705 -QESLLRRLMSPSPSDRPSATELLQ 728
+S L+++ P DRPS+ ELL+
Sbjct: 246 FVDSCLQKI----PQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 6e-14
Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 47/193 (24%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q+++ L +IH +IHRDL P+NI ++ +K+ DFGLA+ L +L+++ P
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEENPENP----- 167
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW----------------- 672
T V T +Y APEI G + + DM+S+G + E+
Sbjct: 168 ---VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK 224
Query: 673 -----------------HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSP 715
PF+ M + K EL P + LL++L+
Sbjct: 225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK---ASDDALDLLKKLLVF 281
Query: 716 SPSDRPSATELLQ 728
+P+ R +A E L+
Sbjct: 282 NPNKRLTAEEALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|238396 cd00773, HisRS-like_core, Class II Histidinyl-tRNA synthetase (HisRS)-like catalytic core domain | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 40/174 (22%), Positives = 71/174 (40%), Gaps = 14/174 (8%)
Query: 794 DTELRDYVVQVTKEMFRQHCAK-----HLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLEL 848
+ LR Y+ +E+F ++ + E ++L + + + GG L L
Sbjct: 1 EAALRRYIEDTLREVFERYGYEEIDTPVFEYTELFLRKSGDEVSKEMYRFKDKGGRDLAL 60
Query: 849 SHELRLPFIRWAISNQKS---SFKRYEISSVYRR---AIGHSPPNRYLQGDFDIIGGASA 902
+L P R N S K Y I V+R G + Q +IIG S
Sbjct: 61 RPDLTAPVARAVAENLLSLPLPLKLYYIGPVFRYERPQKGR--YREFYQVGVEIIGSDSP 118
Query: 903 LTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELL 956
L +AEV+ + ++I+ + I +NH +L+ I + E+ E++ + L
Sbjct: 119 LADAEVIALAVEILEALG-LKDFQIKINHRGILDGIAGLLEDREEYIERLIDKL 171
|
HisRS is a homodimer. It is responsible for the attachment of histidine to the 3' OH group of ribose of the appropriate tRNA. This domain is primarily responsible for ATP-dependent formation of the enzyme bound aminoacyl-adenylate. Class II assignment is based upon its structure and the presence of three characteristic sequence motifs. This domain is also found at the C-terminus of eukaryotic GCN2 protein kinase and at the N-terminus of the ATP phosphoribosyltransferase accessory subunit, HisZ. HisZ along with HisG catalyze the first reaction in histidine biosynthesis. HisZ is found only in a subset of bacteria and differs from HisRS in lacking a C-terminal anti-codon binding domain. Length = 261 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-14
Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 53/246 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
++ L P+G G +G V + G AVKK+ +S+ R RE+ L ++H++V
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ G+ D F+ A S + E +Y+
Sbjct: 79 I---------GLLD---------------VFT--PARSLE--------EFNDVYLVTHLM 104
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L + + D + + L QI+ GL +IH IIHRDL P+N+ + ++KI D
Sbjct: 105 GADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 163
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FGLA+ E TG V T +Y APEI W ++ D++S+G
Sbjct: 164 FGLARHTDDEM------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 205
Query: 666 IVFFEL 671
+ EL
Sbjct: 206 CIMAEL 211
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-14
Identities = 70/271 (25%), Positives = 112/271 (41%), Gaps = 60/271 (22%)
Query: 401 SQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK 460
SQF+ SV ++ L +++L+P+G G G V + + G + AVKK+
Sbjct: 5 SQFY--SVQVADSTFTV-----LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP 57
Query: 461 DKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRA 520
++ R RE+ L + H++++ +
Sbjct: 58 FQNQTHAKRAYRELVLLKCVNHKNIISLLNVF---------------------------- 89
Query: 521 ASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580
T Q++ E +Y+ ME L QV + D E +L Q++ G+ H+H
Sbjct: 90 ------TPQKSLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLCGIKHLHS 141
Query: 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
GIIHRDL P+NI + +KI DFGLA+ T + T V T
Sbjct: 142 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----------------TACTNFMMTPYVVT 185
Query: 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
+Y APE+ G E D++S+G + EL
Sbjct: 186 RYYRAPEVILGM-GYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 9e-14
Identities = 71/260 (27%), Positives = 103/260 (39%), Gaps = 68/260 (26%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-PVNDR--ILREVATLSRL 480
DF+ L +G GG+G V L K K G A+K R+K L +N+ +L E L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALK--RMKKSLLFKLNEVRHVLTERDILTTT 58
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+ + +V+ A F D YLY+
Sbjct: 59 KSEWLVKLLYA--------FQDDE--------------------------------YLYL 78
Query: 541 QMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
MEY P R + + ++ A ++ E + +H G IHRDL P N DA
Sbjct: 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG 138
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
IK+ DFGL+K G V+ VG+ Y APE+ +G D
Sbjct: 139 HIKLTDFGLSK-----------------GIVTY-ANSVVGSPDYMAPEVLRG-KGYDFTV 179
Query: 660 DMYSLGIVFFEL---WHPFS 676
D +SLG + +E + PFS
Sbjct: 180 DYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 57/245 (23%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRL----KDKSLPVNDRILREVATLSRLQHQHVVR 487
LG G FG V LC + GR AVK++ ++ S VN + E+ L L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVN-ALECEIQLLKNLRHDRIVQ 68
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
YY G L E KL I +EY P
Sbjct: 69 YY-------------------GCLRDPE--------------EKKLS-----IFVEYMPG 90
Query: 548 -TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDF 606
+++ ++Y + + RQI++G++++H I+HRD+ NI D+ ++K+GDF
Sbjct: 91 GSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDF 150
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666
G +K ++ + TG SV GT ++ +PE+ G KAD++S+
Sbjct: 151 GASKRIQ-------TICMSGTGIKSV-----TGTPYWMSPEVISG-EGYGRKADVWSVAC 197
Query: 667 VFFEL 671
E+
Sbjct: 198 TVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 72/332 (21%), Positives = 131/332 (39%), Gaps = 93/332 (28%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QH 482
FE ++ +G G +G V ++K G+ A+K + + + + I E L + H
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSNH 62
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++ +Y A+ + + G +++L ++ M
Sbjct: 63 PNIATFYGAFIK-----------------------------KNPPGNDDQL-----WLVM 88
Query: 543 EYCP--------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
E C + LR+ + +E ++ R+ + GLA++H +IHRD+ NI
Sbjct: 89 ELCGGGSVTDLVKGLRKKGKR---LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNIL 145
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQ 650
++K+ DFG++ L +T +GT ++ APE+ EQ
Sbjct: 146 LTKNAEVKLVDFGVSAQLDSTLGR------RNTF---------IGTPYWMAPEVIACDEQ 190
Query: 651 GWPKIDEKADMYSLGIVFFEL---------WHPFSTAMERQIVLSD---LKQKGELPPSW 698
D ++D++SLGI EL HP +I + LK P +W
Sbjct: 191 PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF--KIPRNPPPTLKS----PENW 244
Query: 699 VAKFSE--QESLLRRLMSPSPSDRPSATELLQ 728
KF++ E L++ + RP ELL+
Sbjct: 245 SKKFNDFISECLIK-----NYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 74/328 (22%), Positives = 129/328 (39%), Gaps = 78/328 (23%)
Query: 408 VDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN 467
VD G P L E +G G G V + + K GR AVK + L+ +
Sbjct: 14 VDQGDPRSLL---------ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--R 62
Query: 468 DRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVT 527
+ + EV + QHQ+VV Y+++ +
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSY---------------------------------LV 89
Query: 528 GQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587
G+E L++ ME+ S ++E + +++ L ++H QG+IHRD
Sbjct: 90 GEE-------LWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
+ ++I +K+ DFG Q+ +D VGT ++ APE
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCA-----QISKDVP----------KRKSLVGTPYWMAPE 187
Query: 648 IEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSE 704
+ P E D++SLGI+ E+ P+ + + +K+ + PP + +
Sbjct: 188 VISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFS----DSPVQAMKRLRDSPPPKLKNAHK 242
Query: 705 QESLLR----RLMSPSPSDRPSATELLQ 728
+LR R+++ P +R +A ELL
Sbjct: 243 ISPVLRDFLERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 81/322 (25%), Positives = 125/322 (38%), Gaps = 79/322 (24%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
LND E L +G G G V + K G AVK++R N RIL ++ + H
Sbjct: 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVL-KSH 71
Query: 483 Q--HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
++V+ Y + + D D ++I
Sbjct: 72 DCPYIVKCYGYF----ITDSD------------------------------------VFI 91
Query: 541 QMEY----CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHI-HGQGIIHRDLTPNNIFF 595
ME + L+++ +++ + IV+ L ++ G+IHRD+ P+NI
Sbjct: 92 CMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL 148
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE---IEQGW 652
DA ++K+ DFG++ L D S T G Y APE
Sbjct: 149 DASGNVKLCDFGISGRL------------VD----SKAKTRSAGCAAYMAPERIDPPDPN 192
Query: 653 PKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKG--ELPPSWVAKFSEQ-E 706
PK D +AD++SLGI EL P+ VL+ + Q+ LPP+ FS
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN--EGFSPDFC 250
Query: 707 SLLRRLMSPSPSDRPSATELLQ 728
S + ++ RP ELLQ
Sbjct: 251 SFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 63/247 (25%), Positives = 106/247 (42%), Gaps = 55/247 (22%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
++ L P+G G +G V + + AVKK+ +SL R RE+ L ++H++V
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 486 VRYYQAWF-ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+ + T + +F+ ++ L + +N +
Sbjct: 77 IGLLDVFTPATSIENFN--EVYLVTNLMGADLNN-----------------------IVK 111
Query: 545 CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
C + S +H L Q++ GL +IH GIIHRDL P+N+ + +++I
Sbjct: 112 CQKL------SDEHVQ-----FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGLA+ Q D + TG V T +Y APEI W ++ D++S+
Sbjct: 161 DFGLAR-----QADDEM-------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202
Query: 665 GIVFFEL 671
G + EL
Sbjct: 203 GCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 66/264 (25%), Positives = 104/264 (39%), Gaps = 74/264 (28%)
Query: 426 FEELQPLGHGGFGHVVLCKNK--LDGRHYAVKKIR-LKDKSLPVNDRILREVATLSRLQH 482
+E +G G +G V K K DG+ YA+KK + K++ ++ RE+A L L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++VV + F A S +Y+
Sbjct: 62 ENVVSLVEV------------------------FLEHADKS--------------VYLLF 83
Query: 543 EYCPRTLRQVFESYDHFD---------KELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNI 593
+Y L Q+ + + K L W QI+ G+ ++H ++HRDL P NI
Sbjct: 84 DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW----QILNGVHYLHSNWVLHRDLKPANI 139
Query: 594 F----FDARNDIKIGDFGLAKFLK--LEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
R +KIGD GLA+ L+ L D V T +Y APE
Sbjct: 140 LVMGEGPERGVVKIGDLGLARLFNAPLKPL--------------ADLDPVVVTIWYRAPE 185
Query: 648 IEQGWPKIDEKADMYSLGIVFFEL 671
+ G + D++++G +F EL
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 51/172 (29%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 557 DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQ 616
+HF + +IV L H+H GII+RD+ NI D+ + + DFGL+K E+
Sbjct: 100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
Query: 617 LDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA-DMYSLGIVFFELW--- 672
++ +F GT Y APE+ +G +KA D +SLG++ FEL
Sbjct: 160 EERAYSF--------------CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA 205
Query: 673 HPFSTAMER----QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
PF+ E+ +I LK K P + A E +++L+ P R
Sbjct: 206 SPFTVDGEQNSQSEISRRILKSKPPFPKTMSA---EARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 23/156 (14%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
QI+ GL H+H + I++RDL P N+ D +++I D GLA LK +
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-------KI---- 151
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLS 686
G+ GT Y APE+ QG D D ++LG +E+ PF + ++
Sbjct: 152 -----KGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFR-QRKEKVEKE 204
Query: 687 DLKQKG-ELPPSWVAKFSEQ-ESLLRRLMSPSPSDR 720
+LK++ E+ + KFS + + L L+ P R
Sbjct: 205 ELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 7e-13
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 24/158 (15%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q++EG+ ++H I+HRD+ NI D + +KI DFGLA+ GG
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD----GPPPNPKGGGGG 178
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLK 689
+ T V T +Y PE+ G + D++ +G VF E++ R+ + L+
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF-------TRRPI---LQ 228
Query: 690 QKGELPPSWVAKFSEQESLLRRLM-SPSPSDRPSATEL 726
K ++ +Q L+ +L +P+ P L
Sbjct: 229 GKSDI---------DQLHLIFKLCGTPTEETWPGWRSL 257
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 59/251 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK-DKSLPVNDRILREVATLSRLQ 481
+ + +L+ LG G + V ++KL A+K+IRL+ ++ P +REV+ L L+
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT--AIREVSLLKDLK 62
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H ++V TL ++++ L +
Sbjct: 63 HANIV-----------------------TLHDIVHTDKS-----------------LTLV 82
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLF-RQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
EY + L+Q + + +F QI+ GLA+ H + ++HRDL P N+ + R +
Sbjct: 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE 142
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+K+ DFGLA+ + PT T + +V T +Y P++ G + + D
Sbjct: 143 LKLADFGLAR---------AKSVPTKT------YSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 661 MYSLGIVFFEL 671
M+ +G +FFE+
Sbjct: 188 MWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 75/313 (23%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRL----KDKSLPVNDRILREVATLSRLQHQHVVR 487
LG G +G V C G+ AVK++ L + +++ EV L L+H ++V+
Sbjct: 8 LGKGAYG-TVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
Y GT L+ + I ME+ P
Sbjct: 67 YL-------------------GTC---------------------LDDNTISIFMEFVPG 86
Query: 548 -TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDF 606
++ + + + + +QI++G+A++H ++HRD+ NN+ IK+ DF
Sbjct: 87 GSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDF 146
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGT------GQVGTYFYTAPEI--EQGWPKIDEK 658
G A+ L V + GT GT ++ APE+ E G+ + K
Sbjct: 147 GCARRLAW---------------VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGR---K 188
Query: 659 ADMYSLGIVFFEL--WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQE-SLLRRLMSP 715
+D++S+G FE+ P +M+R + + L P FS + ++
Sbjct: 189 SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTR 248
Query: 716 SPSDRPSATELLQ 728
+RPSA +LL+
Sbjct: 249 DQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-13
Identities = 76/300 (25%), Positives = 120/300 (40%), Gaps = 70/300 (23%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
DFE L+ +G G FG V L + K G YA+K ILR+ L + Q H
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMK--------------ILRKADMLEKEQVGH 47
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+ E DS+W S ++KL LY+ ME+
Sbjct: 48 IRAERDILVE-------ADSLWVVKMFYSF---------------QDKLN---LYLIMEF 82
Query: 545 CPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
P + + D +E + V + IH G IHRD+ P+N+ D++ +K+
Sbjct: 83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKL 142
Query: 604 GDFGLAKFLKLEQLDQ-----DAAFPTDTGGVSVDGT---------------GQVGTYFY 643
DFGL LK + + + P+D +++ VGT Y
Sbjct: 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDY 202
Query: 644 TAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPF--STAMERQIVLSDLKQKGELPP 696
APE+ + G+ K+ D +SLG++ +E+ + PF T E + + K+ PP
Sbjct: 203 IAPEVFMQTGYNKL---CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPP 259
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 59/251 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK-DKSLPVNDRILREVATLSRLQ 481
L + +L LG G + V ++KL A+K+IRL+ ++ P +REV+ L L+
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCT--AIREVSLLKDLK 62
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H ++V + D+ E L +
Sbjct: 63 HANIVTLH-----------------------------------DIIHTEKSLTLVF---- 83
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFR-QIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
EY + L+Q + + LF Q++ GL + H + ++HRDL P N+ + R +
Sbjct: 84 -EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE 142
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+K+ DFGLA+ + PT T + +V T +Y P+I G + D
Sbjct: 143 LKLADFGLAR---------AKSIPTKT------YSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 661 MYSLGIVFFEL 671
M+ +G +F+E+
Sbjct: 188 MWGVGCIFYEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 9e-13
Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 54/251 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNK--LDGRHYAVKKI-RLKDKSLPVNDRILREVATLSRLQ- 481
+E ++ LG G +G V +N + A+KKI + K + + R LRE+ L +
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI-LAKRALRELKLLRHFRG 60
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H+++ Y D D ++ YLY +
Sbjct: 61 HKNITCLY-----------DMDIVFPGN-----------------------FNELYLYEE 86
Query: 542 -MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
ME L Q+ S QI+ GL +IH ++HRDL P N+ +A +
Sbjct: 87 LMEA---DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE 143
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+KI DFGLA+ F + G + T V T +Y APEI + + D
Sbjct: 144 LKICDFGLAR-----------GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAID 192
Query: 661 MYSLGIVFFEL 671
++S+G + EL
Sbjct: 193 VWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|234586 PRK00037, hisS, histidyl-tRNA synthetase; Reviewed | Back alignment and domain information |
|---|
Score = 71.3 bits (176), Expect = 9e-13
Identities = 89/429 (20%), Positives = 147/429 (34%), Gaps = 128/429 (29%)
Query: 841 HGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYR--RAIGHSP-PNRY---LQGDF 894
GG L L E P +R I ++ FK Y I ++R R P RY Q
Sbjct: 72 KGGRSLTLRPEGTAPVVRAVIEHKLQPFKLYYIGPMFRYER-----PQKGRYRQFHQFGV 126
Query: 895 DIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAE 954
++IG S L +AEV+ + D+L+A+ G+K + +
Sbjct: 127 EVIGSDSPLADAEVIALAA-------------------DILKAL----GLK-GLKLLINS 162
Query: 955 LLAMMGSLRPQSSEWKSKWVVIR---RQLLQEL------NLAEAVVNRLQTVGLR----- 1000
L G IR R+ L L E RL+T LR
Sbjct: 163 L----GDF------------EIRANYRKALVGFLEKGLDELDEDSKRRLETNPLRILDKK 206
Query: 1001 --FCGAADQALPRLRGALPADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNL 1056
+ P+L L D+ +++ +EL L I Y +
Sbjct: 207 DKEDQELLKDAPKLLDYL--DEESKEHFEELKELLDALGIP--------------YVIDP 250
Query: 1057 F------------FQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNP 1104
F+ + GT+ GGRYD L+ + P
Sbjct: 251 RLVRGLDYYTGTVFEFVTDDLGAQ-----GTVCG-GGRYDGLVEQF-----------GGP 293
Query: 1105 P-SGVGASLALETII---QHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEE 1160
P VG ++ +E ++ + E V V G L ++L +L
Sbjct: 294 PTPAVGFAIGVERLLLLLEE--------LGEEPVDVYVVPLGEDAEL-AALKLAEKLRAA 344
Query: 1161 NIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESL 1220
I+ + + L +Q++YA + + ++IL + G V V+ L +++ V + L
Sbjct: 345 GIRVE-LDYGGRKLKKQFKYADKSGARFVLILGEDELANGTVTVKDLRTGEQQTVPLDEL 403
Query: 1221 VRFLLDAIA 1229
V L + +A
Sbjct: 404 VEALKELLA 412
|
Length = 412 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 74/316 (23%), Positives = 124/316 (39%), Gaps = 85/316 (26%)
Query: 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIR----LKDKSLPVNDRILREV 474
SS L+DFE + LG G FG V + K+K G +YA+K ++ LK K + + +E
Sbjct: 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV---QHVAQEK 69
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
+ L L H +V ++ + EN++
Sbjct: 70 SILMELSHPFIVNMMCSFQD-----------------------------------ENRV- 93
Query: 535 STYLYIQMEYCPRTLRQVFESYDH------FDKELAWHLFRQIVEGLAHIHGQGIIHRDL 588
Y +E+ E + H F ++A ++V ++H + II+RDL
Sbjct: 94 ----YFLLEFVVGG-----ELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDL 144
Query: 589 TPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648
P N+ D + +K+ DFG AK + D F GT Y APE+
Sbjct: 145 KPENLLLDNKGHVKVTDFGFAKKVP------DRTFTL------------CGTPEYLAPEV 186
Query: 649 EQGWPKIDEKA-DMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSE 704
Q K KA D +++G++ +E + PF +I L + + P+W
Sbjct: 187 IQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF-PNWFD--GR 241
Query: 705 QESLLRRLMSPSPSDR 720
L++ L+ + R
Sbjct: 242 ARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 43/181 (23%)
Query: 566 HLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPT 625
+ RQI+ G+A++H + I+HRD+ P+N+ ++ ++KI DFG+++ L + +D P
Sbjct: 172 DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA-QTMD-----PC 225
Query: 626 DTGGVSVDGTGQVGTYFYTAPE-----IEQGWPKIDEKA-DMYSLGIVFFELW---HPFS 676
++ VGT Y +PE + G D A D++SLG+ E + PF
Sbjct: 226 NS---------SVGTIAYMSPERINTDLNHG--AYDGYAGDIWSLGVSILEFYLGRFPF- 273
Query: 677 TAMERQ---------IVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELL 727
+ RQ I +S Q E P + +F + + P+ R SA +LL
Sbjct: 274 -GVGRQGDWASLMCAICMS---QPPEAPATASREF---RHFISCCLQREPAKRWSAMQLL 326
Query: 728 Q 728
Q
Sbjct: 327 Q 327
|
Length = 353 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/251 (24%), Positives = 109/251 (43%), Gaps = 59/251 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK-DKSLPVNDRILREVATLSRLQ 481
L +++L LG G + V ++KL G+ A+K+IRL+ ++ P +RE + L L+
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFT--AIREASLLKDLK 61
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H ++V TL D+ + L T ++
Sbjct: 62 HANIV-----------------------TLH------------DIIHTKKTL--TLVF-- 82
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFR-QIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
EY L+Q + LF Q++ GLA+ H + ++HRDL P N+ R +
Sbjct: 83 -EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE 141
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+K+ DFGLA+ + P+ T + +V T +Y P++ G + D
Sbjct: 142 LKLADFGLAR---------AKSVPSKT------YSNEVVTLWYRPPDVLLGSTEYSTSLD 186
Query: 661 MYSLGIVFFEL 671
M+ +G +F+E+
Sbjct: 187 MWGVGCIFYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 82/329 (24%), Positives = 129/329 (39%), Gaps = 66/329 (20%)
Query: 411 GSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI 470
G ++ P+ + +E ++ +G G +G V NK DG AVK + D V++ I
Sbjct: 13 GLESLGDPT----DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEI 65
Query: 471 LREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQ 529
E L L H +VV++Y +++ G +W L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKAD--KLVGGQLWLVLELC----------------- 106
Query: 530 ENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589
N T L + C + L + SY + L GL H+H IIHRD+
Sbjct: 107 -NGGSVTELVKGLLICGQRLDEAMISYILYGALL----------GLQHLHNNRIIHRDVK 155
Query: 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI- 648
NNI +K+ DFG++ L +L ++ + VGT F+ APE+
Sbjct: 156 GNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---------------VGTPFWMAPEVI 200
Query: 649 --EQGWP-KIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPS------WV 699
EQ + D + D++SLGI EL + V + K PP+ W
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWC 260
Query: 700 AKFSEQESLLRRLMSPSPSDRPSATELLQ 728
F+ + + + RPS T LL+
Sbjct: 261 RSFNH---FISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 71/259 (27%), Positives = 103/259 (39%), Gaps = 67/259 (25%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCK----NKLDGRHYAVKKIRLKDKSLPVNDRILREVAT 476
RYL ++++ LG G FG V L N G AVK ++ ++ +E+
Sbjct: 4 RYL---KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINI 59
Query: 477 LSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST 536
L L H+++V+Y G G
Sbjct: 60 LKTLYHENIVKY------KGCCSEQGGKG------------------------------- 82
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLF-RQIVEGLAHIHGQGIIHRDLTPNNIF 594
L + MEY P +LR + +L LF +QI EG+A++H Q IHRDL N+
Sbjct: 83 -LQLIMEYVPLGSLRDYLPKHKLNLAQLL--LFAQQICEGMAYLHSQHYIHRDLAARNVL 139
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPT--DTGGVSVDGTGQVGTYFYTAPEIEQGW 652
D +KIGDFGLAK A P + V DG V F+ A E +
Sbjct: 140 LDNDRLVKIGDFGLAK-----------AVPEGHEYYRVREDGDSPV---FWYAVECLKEN 185
Query: 653 PKIDEKADMYSLGIVFFEL 671
K +D++S G+ +EL
Sbjct: 186 -KFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 84/344 (24%), Positives = 134/344 (38%), Gaps = 73/344 (21%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
+G G FG V + K R YA+K + K V + EVA H +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL---SKKEIVAKK---EVA--------HTIGERNI 46
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY-CPRTLR 550
T + + S + FS + S LY+ +Y L
Sbjct: 47 LVRTLLDE--------SPFIVGLKFSFQTDSD--------------LYLVTDYMSGGELF 84
Query: 551 QVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
+ F ++ A ++V L H+H I++RDL P NI DA I + DFGL+K
Sbjct: 85 WHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK 144
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI---EQGWPKIDEKADMYSLGIV 667
L + T+T GT Y APE+ E+G+ K D +SLG++
Sbjct: 145 ----ANLTDNKT--TNTF---------CGTTEYLAPEVLLDEKGYTK---HVDFWSLGVL 186
Query: 668 FFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR---- 720
FE+ W PF +Q+ + K P + ++ E ++ L++ +P R
Sbjct: 187 VFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLS--DEGRQFVKGLLNRNPQHRLGAH 244
Query: 721 PSATELLQDALPPQMEYELLDNIL------RMMHSSEDTSIYDK 758
A EL + ++++LL ++ S ED S +D
Sbjct: 245 RDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDP 288
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 43/135 (31%), Positives = 60/135 (44%), Gaps = 29/135 (21%)
Query: 537 YLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
Y Y+ P + Q A + +QI+EGL ++H Q IIHRD+ NIF +
Sbjct: 144 YTYLTKRSRPLPIDQ------------ALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN 191
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+ + IGD G A+F P G GT APE+ K +
Sbjct: 192 DVDQVCIGDLGAAQF--------PVVAPAF--------LGLAGTVETNAPEV-LARDKYN 234
Query: 657 EKADMYSLGIVFFEL 671
KAD++S GIV FE+
Sbjct: 235 SKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 73/281 (25%), Positives = 110/281 (39%), Gaps = 80/281 (28%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVK----KIRLKDKSLPVNDRILREVATLSR-LQHQHVV 486
+G G FG V+L K K DG YAVK K LK K + I+ E L + L+H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE---QNHIMAERNVLLKNLKHPFLV 59
Query: 487 RYYQAWFETG-----VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
+ + F+T V D+ V G E + ++Q
Sbjct: 60 GLHYS-FQTAEKLYFVLDY-------------------------VNGGE-----LFFHLQ 88
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
E C R F + ++ + ++H II+RDL P NI D++ +
Sbjct: 89 RERCFLEPRARFYA-------------AEVASAIGYLHSLNIIYRDLKPENILLDSQGHV 135
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV--GTYFYTAPEIEQGWPKIDEKA 659
+ DFGL K GV + T GT Y APE+ + P D
Sbjct: 136 VLTDFGLCK-----------------EGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTV 177
Query: 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPS 697
D + LG V +E+ + PF + Q+ + L + +LP
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 76/305 (24%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQH 484
F + + LG GGFG V C+ + G+ YA K++ K K L E L ++ Q
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
VV A +ET A ++ G L ++ G E L+ E
Sbjct: 62 VVNLAYA-YETKDALCLVLTIMNGGDLKFHIYN---------MGNPGFEEERALFYAAEI 111
Query: 545 CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
GL +H + ++RDL P NI D I+I
Sbjct: 112 LC---------------------------GLEDLHRENTVYRDLKPENILLDDYGHIRIS 144
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
D GLA +K+ + G S+ G+VGT Y APE+ + D + L
Sbjct: 145 DLGLA--VKIPE------------GESI--RGRVGTVGYMAPEVLNN-QRYTLSPDYWGL 187
Query: 665 GIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDR 720
G + +E+ PF E+ ++ E + AKFSE+ +S+ + L++ P R
Sbjct: 188 GCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
Query: 721 PSATE 725
E
Sbjct: 248 LGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 77/323 (23%), Positives = 119/323 (36%), Gaps = 80/323 (24%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND-----RILREVATLS 478
D ++L +G G FG V +K G AVK+IR D R+L ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRS------TVDEKEQKRLLMDLDVVM 57
Query: 479 RLQH-QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
R ++V++Y A F G W L +
Sbjct: 58 RSSDCPYIVKFYGALFREGDC-------WICMELMDISLDK------------------- 91
Query: 538 LYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFF 595
Y + V+E +E+ + V+ L ++ + IIHRD+ P+NI
Sbjct: 92 FY----------KYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL 141
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE--IEQGWP 653
D +IK+ DFG++ L D S+ T G Y APE
Sbjct: 142 DRNGNIKLCDFGISGQL------VD----------SIAKTRDAGCRPYMAPERIDPSARD 185
Query: 654 KIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQ--KGE---LPPSWVAKFS-E 704
D ++D++SLGI +E+ P+ V L Q KG+ L S +FS
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEEREFSPS 242
Query: 705 QESLLRRLMSPSPSDRPSATELL 727
+ + + S RP ELL
Sbjct: 243 FVNFINLCLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 56/250 (22%), Positives = 107/250 (42%), Gaps = 58/250 (23%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
N FE L +G G +G V+ C++K A+KK + +++ V + LRE+ L L+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V +A+ G LY+ E
Sbjct: 61 NIVELKEAFRRRG----------------------------------------KLYLVFE 80
Query: 544 YCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
Y + + ++ E + +++ +++ Q+++ + H I+HRD+ P N+ + +
Sbjct: 81 YVEKNMLELLEEMPNGVPPEKVRSYIY-QLIKAIHWCHKNDIVHRDIKPENLLISHNDVL 139
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
K+ DFG A+ L + G + + T V T +Y +PE+ G P + DM
Sbjct: 140 KLCDFGFARNL--------------SEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDM 184
Query: 662 YSLGIVFFEL 671
+S+G + EL
Sbjct: 185 WSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 75/303 (24%), Positives = 116/303 (38%), Gaps = 65/303 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQH 484
F + + LG GGFG V C+ + G+ YA KK+ K K L E L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
VV A +ET A ++ G L + A
Sbjct: 62 VVSLAYA-YETKDALCLVLTLMNGGDLKFHIYHMGEAG---------------------- 98
Query: 545 CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
F++ A +I GL +H + I++RDL P NI D I+I
Sbjct: 99 --------------FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRIS 144
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
D GLA + Q + G+VGT Y APE+ + + D ++L
Sbjct: 145 DLGLAVHVPEGQTIK----------------GRVGTVGYMAPEVVKN-ERYTFSPDWWAL 187
Query: 665 GIVFFEL---WHPFST---AMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSP 717
G + +E+ PF ++R+ V +K E+ + KFS SL + L+ P
Sbjct: 188 GCLLYEMIAGQSPFQQRKKKIKREEVERLVK---EVQEEYSEKFSPDARSLCKMLLCKDP 244
Query: 718 SDR 720
+R
Sbjct: 245 KER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 58/190 (30%), Positives = 88/190 (46%), Gaps = 27/190 (14%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
+L+ MEY L +S FD+ A +I+ GL +H +GII+RDL +N+
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
D IKI DFG+ K E ++ + T GT Y APEI +G K
Sbjct: 130 DKDGHIKIADFGMCK----ENMNGEGKAST-----------FCGTPDYIAPEILKG-QKY 173
Query: 656 DEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELP--PSWVAKFSEQESLLR 710
+E D +S G++ +E+ PF E ++ S L + P P W++K E + L
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN---DRPHFPRWISK--EAKDCLS 228
Query: 711 RLMSPSPSDR 720
+L P+ R
Sbjct: 229 KLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 65/254 (25%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK-DKSLPVNDRILREVATLSRLQ 481
L + +L LG G + V ++KL A+K+IRL+ ++ P +REV+ L L+
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT--AIREVSLLKNLK 61
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H ++V TL + R L +
Sbjct: 62 HANIV-----------------------TLHDIIHTERC-----------------LTLV 81
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFR----QIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
EY L+Q D+ ++ H + Q++ GL++ H + I+HRDL P N+ +
Sbjct: 82 FEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE 138
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
+ ++K+ DFGLA+ + PT T + +V T +Y P++ G +
Sbjct: 139 KGELKLADFGLAR---------AKSVPTKT------YSNEVVTLWYRPPDVLLGSTEYST 183
Query: 658 KADMYSLGIVFFEL 671
DM+ +G + +E+
Sbjct: 184 PIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 80/331 (24%), Positives = 131/331 (39%), Gaps = 73/331 (22%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQH 484
F +L+ +GHG FG V ++ A+KK+ K S I++EV L R++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+ Y + A ++ MEY
Sbjct: 87 SIEYKGCYLREHTA----------------------------------------WLVMEY 106
Query: 545 CPRTLRQVFESYDHFDKELAWHLFRQ-IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
C + + E + +E+ ++GLA++H +IHRD+ NI +K+
Sbjct: 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKL 166
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPKIDEKA 659
DFG A A P ++ VGT ++ APE+ ++G + D K
Sbjct: 167 ADFGSASI----------ASPANSF---------VGTPYWMAPEVILAMDEG--QYDGKV 205
Query: 660 DMYSLGIVFFELWH--PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPS 716
D++SLGI EL P M L + Q E P ++S+ + + +
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSDYFRNFVDSCLQKI 264
Query: 717 PSDRPSATELLQD--ALPPQMEYELLDNILR 745
P DRP++ ELL+ L + E L+D I R
Sbjct: 265 PQDRPTSEELLKHMFVLRERPETVLIDLIQR 295
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|213530 TIGR00442, hisS, histidyl-tRNA synthetase | Back alignment and domain information |
|---|
Score = 68.6 bits (169), Expect = 6e-12
Identities = 94/452 (20%), Positives = 157/452 (34%), Gaps = 106/452 (23%)
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLEIE-PMYLLGDCPQFKRNT------VK-----LLTH 841
+ Y+ + +E+F + K EI P+ F R V+
Sbjct: 13 EMIKWQYIEETIREVFELYGFK--EIRTPI--FEYTELFARKVGEETDIVEKEMYTFKDK 68
Query: 842 GGDLLELSHELRLPFIRWAISN---QKSSFKRYEISSVYRRAIGHSPP--NRY---LQGD 893
GG L L E P R I N FK Y I ++R + P RY Q
Sbjct: 69 GGRSLTLRPEGTAPVARAVIENKLLLPKPFKLYYIGPMFR----YERPQKGRYRQFHQFG 124
Query: 894 FDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVA 953
++IG S L +AE++ + +I+ + + +N +LE E+RE +
Sbjct: 125 VEVIGSDSPLADAEIIALAAEILKA-LGIKDFTLEINSLGILEGR-------LEYREALL 176
Query: 954 ELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRF--CGA-ADQAL- 1009
L + L +L E V RL+ LR Q L
Sbjct: 177 RYL---------------------DKHLDKLG--EDSVRRLEKNPLRILDSKNEKIQELL 213
Query: 1010 ---PRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIE---------SYHRNLF 1057
P++ L + +R +EL +DAL P Y+
Sbjct: 214 KEAPKILDFLDEE--SRAHFEELKE---------LLDALGIPYVIDPSLVRGLDYYTGTV 262
Query: 1058 FQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPP-SGVGASLALET 1116
F+ + + A +G++ GGRYD L+ + PP VG ++ +E
Sbjct: 263 FEFVT--DGLGA---QGSICG-GGRYDGLVEEL-----------GGPPTPAVGFAIGIER 305
Query: 1117 IIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTE 1176
++ E+ V V G L E ++L +L + I+ + L +
Sbjct: 306 LLLLLEELGLLPPEESSPDVYVVPLGEEAEL-EALKLAQKLRKAGIRVEVDLGGR-KLKK 363
Query: 1177 QYEYASEHDIKCLVILTDTGAQKGLVKVRHLD 1208
Q +YA + + VI+ + G V ++ L
Sbjct: 364 QLKYADKLGARFAVIIGEDELANGTVTLKDLR 395
|
This model finds a histidyl-tRNA synthetase in every completed genome. Apparent second copies from Bacillus subtilis, Synechocystis sp., and Aquifex aeolicus are slightly shorter, more closely related to each other than to other hisS proteins, and actually serve as regulatory subunits for an enzyme of histidine biosynthesis. They were excluded from the seed alignment and score much lower than do single copy histidyl-tRNA synthetases of other genomes not included in the seed alignment. These putative second copies of HisS score below the trusted cutoff. The regulatory protein kinase GCN2 of Saccharomyces cerevisiae (YDR283c), and related proteins from other species designated eIF-2 alpha kinase, have a domain closely related to histidyl-tRNA synthetase that may serve to detect and respond to uncharged tRNA(his), an indicator of amino acid starvation; these regulatory proteins are not orthologous and so score below the noise cutoff [Protein synthesis, tRNA aminoacylation]. Length = 397 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 75/319 (23%), Positives = 127/319 (39%), Gaps = 78/319 (24%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
D E + LG G G V K+ G A K + + KS V +ILRE+ + + +
Sbjct: 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-SVRKQILRELQIMHECRSPY 64
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V +Y A+ L + + ME+
Sbjct: 65 IVSFYGAF----------------------------------------LNENNICMCMEF 84
Query: 545 CPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG-QGIIHRDLTPNNIFFDARNDIK 602
+L ++++ E+ + +VEGL +++ I+HRD+ P+NI ++R IK
Sbjct: 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIK 144
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ--VGTYFYTAPEIEQGWPKIDEKAD 660
+ DFG++ G ++ VGT Y +PE QG K K+D
Sbjct: 145 LCDFGVS-------------------GELINSIADTFVGTSTYMSPERIQG-GKYTVKSD 184
Query: 661 MYSLGIVFFELW---HPFSTAMER------QIVLSDLKQK--GELPPSWVA-KFSEQ-ES 707
++SLGI EL PF+ + + + DL Q+ E PP + F E
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244
Query: 708 LLRRLMSPSPSDRPSATEL 726
+ + P++RP+ +L
Sbjct: 245 FVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 23/187 (12%)
Query: 538 LYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
L+ MEY L + FD+ A +IV GL +H +GII+RDL +N+ D
Sbjct: 71 LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD 130
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+ IKI DFG+ K E + GGV+ + GT Y APEI P
Sbjct: 131 SEGHIKIADFGMCK----EGI---------LGGVTT--STFCGTPDYIAPEILSYQP-YG 174
Query: 657 EKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713
D ++LG++ +E+ PF E + + + + P W++K E +S+L+ +
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDE-LFQSILEDEVRYPRWLSK--EAKSILKSFL 231
Query: 714 SPSPSDR 720
+ +P R
Sbjct: 232 TKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 74/314 (23%), Positives = 125/314 (39%), Gaps = 75/314 (23%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR---ILREVATLSRLQH 482
F +L+ +GHG FG V ++ + A+KK+ K N++ I++EV L +L+H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRH 74
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+ ++Y + A ++ M
Sbjct: 75 PNTIQYRGCYLREHTA----------------------------------------WLVM 94
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFRQ-IVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
EYC + + E + +E+ ++GLA++H +IHRD+ NI +
Sbjct: 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 154
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPKIDE 657
K+GDFG A + P + VGT ++ APE+ ++G + D
Sbjct: 155 KLGDFGSASIMA----------PANXF---------VGTPYWMAPEVILAMDEG--QYDG 193
Query: 658 KADMYSLGIVFFELWH--PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMS 714
K D++SLGI EL P M L + Q E P +SE + + +
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPALQSGHWSEYFRNFVDSCLQ 252
Query: 715 PSPSDRPSATELLQ 728
P DRP++ LL+
Sbjct: 253 KIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 18/171 (10%)
Query: 557 DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQ 616
D+F ++ +I+ L H+H GI++RD+ NI D+ + + DFGL+K E+
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
Query: 617 LDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---H 673
++ +F GT Y APEI +G + D +SLGI+ FEL
Sbjct: 160 KERTYSF--------------CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
Query: 674 PFSTAMERQIVLSDLKQKGELPPSWVAKFS-EQESLLRRLMSPSPSDRPSA 723
PF+ ER ++ + P + + E + LL +L+ P R A
Sbjct: 206 PFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGA 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 59/252 (23%), Positives = 110/252 (43%), Gaps = 63/252 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQH 482
+ +E+L+ LG G + V K+K++G+ A+K IRL+++ P +RE + L L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKH 62
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V + D+ + L + Y+
Sbjct: 63 ANIVLLH-----------------------------------DIIHTKETLTLVFEYVHT 87
Query: 543 EYCPRTLRQVFESYD---HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
+ C Q + + H + + LF Q++ GL++IH + I+HRDL P N+
Sbjct: 88 DLC-----QYMDKHPGGLHPEN-VKLFLF-QLLRGLSYIHQRYILHRDLKPQNLLISDTG 140
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
++K+ DFGLA+ + P+ T + +V T +Y P++ G +
Sbjct: 141 ELKLADFGLAR---------AKSVPSHT------YSNEVVTLWYRPPDVLLGSTEYSTCL 185
Query: 660 DMYSLGIVFFEL 671
DM+ +G +F E+
Sbjct: 186 DMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 79/327 (24%), Positives = 129/327 (39%), Gaps = 90/327 (27%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
DFE+L LG G G V ++ G A K I L+ K + ++I+RE+ L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP-AIRNQIIRELKVLHECNSPY 60
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V +Y A++ DG+ + I ME+
Sbjct: 61 IVGFYGAFYS------DGE----------------------------------ISICMEH 80
Query: 545 CPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARNDIK 602
+L QV + + + + ++ GL ++ + I+HRD+ P+NI ++R +IK
Sbjct: 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIK 140
Query: 603 IGDFGLAKFLKLEQLDQDA-AFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
+ DFG++ L +D A +F VGT Y +PE QG ++D+
Sbjct: 141 LCDFGVSGQL----IDSMANSF--------------VGTRSYMSPERLQG-THYTVQSDI 181
Query: 662 YSLGIVFFELWH-----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716
+SLG+ E+ P A E + + +GE S R +S
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES------------HRPVSGH 229
Query: 717 PSDRPSATELLQDALPPQMEYELLDNI 743
P D P P +ELLD I
Sbjct: 230 PPDSP----------RPMAIFELLDYI 246
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 75/332 (22%), Positives = 130/332 (39%), Gaps = 95/332 (28%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-VNDRILREVATLSRLQ-HQHVVRYY 489
+G G F V+ +++ G++YA+K ++ KSL VN+ LRE+ L RL H +++R
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTL 549
+ F D G L E + Y I +
Sbjct: 65 EVLF---------DRKTGRLALVF----------------ELMDMNLYELI------KGR 93
Query: 550 RQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLA 609
++ ++ Q+++ L H+H GI HRD+ P NI + +K+ DFG
Sbjct: 94 KR------PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSC 146
Query: 610 KFLKLEQLDQDAAFPTDTGGVSVDG--TGQVGTYFYTAPE--IEQGWPKIDEKADMYSLG 665
+ G+ T + T +Y APE + G+ K D++++G
Sbjct: 147 R------------------GIYSKPPYTEYISTRWYRAPECLLTDGY--YGPKMDIWAVG 186
Query: 666 IVFFEL--WHP-FSTAME-RQI-------------VLSDLKQKGEL-------PPSWVAK 701
VFFE+ P F E QI VL ++ + + + K
Sbjct: 187 CVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRK 246
Query: 702 F-----SEQESLLRRLMSPSPSDRPSATELLQ 728
+E LL++L++ P +R +A + L+
Sbjct: 247 LLPNASAEGLDLLKKLLAYDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177776 PLN00181, PLN00181, protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-11
Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 37/260 (14%)
Query: 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE 554
+GV++F D GS +L+ + R+ + G + L+ + +E +LRQ +
Sbjct: 16 SGVSEFCTD---GSKSLSHIDYV-RSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLD 71
Query: 555 SYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTP--------NNIFF---------- 595
+ D D +H+FRQIVE + H QGI+ ++ P N++ F
Sbjct: 72 NPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131
Query: 596 -DARNDIKIGDFGLAKF------LKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648
D K + G ++ ++E+L++ P + + +YT+PE
Sbjct: 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA-----MEMSWYTSPEE 186
Query: 649 EQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESL 708
+ G + +D+Y LG++ FEL+ P S+ E+ +S L+ + LPP + + ++ S
Sbjct: 187 DNG-SSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR-VLPPQILLNWPKEASF 244
Query: 709 LRRLMSPSPSDRPSATELLQ 728
L+ P PS RPS +ELLQ
Sbjct: 245 CLWLLHPEPSCRPSMSELLQ 264
|
Length = 793 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 51/167 (30%), Positives = 79/167 (47%), Gaps = 22/167 (13%)
Query: 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD 618
F + A QI+ GL H+H + II+RDL P N+ D +++I D GLA LK Q
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-- 151
Query: 619 QDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PF 675
+ T G + GT + APE+ QG + D D ++LG+ +E+ PF
Sbjct: 152 ------SKTKGYA-------GTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPF 197
Query: 676 STAMERQIVLSDLKQKG-ELPPSWVAKFSEQ-ESLLRRLMSPSPSDR 720
E+ + +LKQ+ ++ KFS +S L++ P R
Sbjct: 198 RARGEK-VENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 77/315 (24%), Positives = 119/315 (37%), Gaps = 70/315 (22%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+DFE L+ +G G FG V L + K G YA+K ILR+ L + Q
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMK--------------ILRKADMLEKEQVA 46
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
H+ E D W S F ++ LY+ ME
Sbjct: 47 HIRAERDILVE-------ADGAWVVKMFYS--FQDKRN----------------LYLIME 81
Query: 544 YCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+ P + + D +E + V + IH G IHRD+ P+N+ DA+ +K
Sbjct: 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVK 141
Query: 603 IGDFGLAKFLKLEQLDQ-----------DAAFPTDTGGVSVD---------GTGQVGTYF 642
+ DFGL LK + D +F + VGT
Sbjct: 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPD 201
Query: 643 YTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPF--STAMERQIVLSDLKQKGELP 695
Y APE+ + G+ K+ D +SLG++ +E+ + PF T E + + K+ P
Sbjct: 202 YIAPEVFMQTGYNKL---CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFP 258
Query: 696 PSWVAKFSEQESLLR 710
P ++ +LR
Sbjct: 259 PEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|238436 cd00859, HisRS_anticodon, HisRS Histidyl-anticodon binding domain | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-11
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 2/92 (2%)
Query: 1133 GTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVIL 1192
V V G G L E +EL +L + IKA+ L +Q++YA + VIL
Sbjct: 1 EVDVYVVPLGEG-ALSEALELAEQLRDAGIKAEIDYG-GRKLKKQFKYADRSGARFAVIL 58
Query: 1193 TDTGAQKGLVKVRHLDVKKEKEVQRESLVRFL 1224
+ G+V V+ L+ +++ V + LV L
Sbjct: 59 GEDELAAGVVTVKDLETGEQETVALDELVEEL 90
|
HisRS belongs to class II aminoacyl-tRNA synthetases (aaRS). This alignment contains the anticodon binding domain, which is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only. Length = 91 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 64/263 (24%), Positives = 102/263 (38%), Gaps = 63/263 (23%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
DF+ +G G FG V + + K G YA+K + K L L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVM--KKSVL---------------LAQE 43
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
V + + + D + S ++ Q+ LY+ ME
Sbjct: 44 TVSFFEE----------ERDIL--------SISNSPWIPQLQYAFQDKD----NLYLVME 81
Query: 544 YCPR-TLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
Y P L + Y D FD+++A ++V + +H G +HRD+ P N+ D I
Sbjct: 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHI 141
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ---GWPK--ID 656
K+ DFG A +L + V+ VGT Y APE+ G K
Sbjct: 142 KLADFGSAA-----RLTANK---------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187
Query: 657 EKADMYSLGIVFFELWH---PFS 676
+ D +SLG++ +E+ + PF
Sbjct: 188 VECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 74/317 (23%), Positives = 117/317 (36%), Gaps = 81/317 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR---ILREVATLSRLQH 482
F L +GHG FG V N AVKK+ K N++ I++EV L +L+H
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT--NEKWQDIIKEVKFLQQLKH 80
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+ + Y + + A ++ M
Sbjct: 81 PNTIEYKGCYLKEHTA----------------------------------------WLVM 100
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFRQ-IVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
EYC + + E + +E+ ++GLA++H +IHRD+ NI +
Sbjct: 101 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQV 160
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPKIDE 657
K+ DFG A S VGT ++ APE+ ++G + D
Sbjct: 161 KLADFGSAS-------------------KSSPANSFVGTPYWMAPEVILAMDEG--QYDG 199
Query: 658 KADMYSLGIVFFELWH--PFSTAMERQIVLSDLKQKGELPP----SWVAKFSEQESLLRR 711
K D++SLGI EL P M L + Q + P W F +
Sbjct: 200 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWTDSF---RGFVDY 255
Query: 712 LMSPSPSDRPSATELLQ 728
+ P +RP++ ELL+
Sbjct: 256 CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 66/314 (21%), Positives = 128/314 (40%), Gaps = 69/314 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRLQH 482
DFE +Q +G G +G V +N G A+K I+L+ P D + +E+ + +H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQQEIIMMKDCKH 65
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V Y+ ++ D +W I M
Sbjct: 66 SNIVAYFGSYLRR-------DKLW---------------------------------ICM 85
Query: 543 EYC-PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
E+C +L+ ++ + ++ R+ ++GL ++H +G +HRD+ NI +
Sbjct: 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHV 145
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK--IDEKA 659
K+ DFG++ + + + +F +GT ++ APE+ K ++
Sbjct: 146 KLADFGVSAQIT-ATIAKRKSF--------------IGTPYWMAPEVAAVERKGGYNQLC 190
Query: 660 DMYSLGIVFFEL--WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQES---LLRRLMS 714
D++++GI EL P + L + + PP K S ++ ++
Sbjct: 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALT 250
Query: 715 PSPSDRPSATELLQ 728
+P RP+A +LLQ
Sbjct: 251 KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 76/335 (22%), Positives = 129/335 (38%), Gaps = 77/335 (22%)
Query: 408 VDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN 467
V G P YL+ F ++ G G G V + K G+ AVKK+ L+ +
Sbjct: 15 VSPGDPR------EYLDSFIKI---GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--R 63
Query: 468 DRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVT 527
+ + EV + H++VV Y ++ GD +W
Sbjct: 64 ELLFNEVVIMRDYHHENVVDMYNSYLV-------GDELW--------------------- 95
Query: 528 GQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587
+ ME+ ++ ++E + ++ L+++H QG+IHRD
Sbjct: 96 ------------VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
+ ++I + IK+ DFG + E + + VGT ++ APE
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---------------VGTPYWMAPE 188
Query: 648 IEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQES 707
+ P E D++SLGI+ E+ + + + + LPP V + S
Sbjct: 189 VISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-VKDSHKVSS 246
Query: 708 LLRR----LMSPSPSDRPSATELLQD-----ALPP 733
+LR ++ PS R +A ELLQ A PP
Sbjct: 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 41/168 (24%), Positives = 61/168 (36%), Gaps = 49/168 (29%)
Query: 453 AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLA 512
AVK ++ DK + D L+E A + L H++++R Y GV
Sbjct: 27 AVKCLK-SDKLSDIMDDFLKEAAIMHSLDHENLIRLY------GVV-------------- 65
Query: 513 SSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-----TLRQVFESYDHFDKELAWHL 567
VT E P LR+ ++ HF
Sbjct: 66 ------LTHPLMMVT---------------ELAPLGSLLDRLRK--DALGHFLISTLCDY 102
Query: 568 FRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE 615
QI G+ ++ + IHRDL NI + + +KIGDFGL + L
Sbjct: 103 AVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 50/169 (29%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD 618
FD+E A +I GL +H + I++RDL P NI D I+I D GLA + +
Sbjct: 99 FDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158
Query: 619 QDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PF 675
+ G+VGT Y APE+ + + D + LG + +E+ PF
Sbjct: 159 R----------------GRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPF 201
Query: 676 STAME---RQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDR 720
E R+ V +K E + KFSE S+ R+L++ P R
Sbjct: 202 RQRKEKVKREEVERRVK---EDQEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 62/265 (23%), Positives = 94/265 (35%), Gaps = 86/265 (32%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ + +G G FG V+L G+ AVK LKD S L E + ++ L+H
Sbjct: 5 SKELKLGATIGKGEFGDVML--GDYRGQKVAVKC--LKDDSTAA-QAFLAEASVMTTLRH 59
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V+ GV G+ LYI
Sbjct: 60 PNLVQL------LGVV-LQGNP---------------------------------LYIVT 79
Query: 543 EYCP--------RTL-RQVFESYDHFDKELAWHLF-RQIVEGLAHIHGQGIIHRDLTPNN 592
EY R+ R V F + EG+ ++ + +HRDL N
Sbjct: 80 EYMAKGSLVDYLRSRGRAVITLAQQ-------LGFALDVCEGMEYLEEKNFVHRDLAARN 132
Query: 593 IFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQG 651
+ K+ DFGLAK Q D+G + V +TAPE + +
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQ---------DSGKLPVK---------WTAPEALREK 174
Query: 652 WPKIDEKADMYSLGIVFFELWHPFS 676
K K+D++S GI+ LW +S
Sbjct: 175 --KFSTKSDVWSFGIL---LWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 51/157 (32%), Positives = 70/157 (44%), Gaps = 26/157 (16%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+I+ GL H+H + +++RDL P NI D ++I D GLA D P
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP----- 152
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PF---STAMERQI 683
VGT+ Y APE+ Q D AD +SLG + F+L PF T + +I
Sbjct: 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
Query: 684 VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
L ELP S+ E +SLL L+ S R
Sbjct: 208 DRMTLTVNVELPDSFS---PELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 89/367 (24%), Positives = 147/367 (40%), Gaps = 95/367 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
DFE ++ + +G +G V L ++K + +A+KKI + ILR Q Q
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-------KQNLILRN-------QIQ 46
Query: 484 HVVRYYQAWFETGVADFDGD----SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
Q + E + F + SM+ S F + +L
Sbjct: 47 ------QVFVERDILTFAENPFVVSMFCS-------FETK----------------RHLC 77
Query: 540 IQMEY-----CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
+ MEY C L+ + ++A F + V L ++H GI+HRDL P+N+
Sbjct: 78 MVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 595 FDARNDIKIGDFGLAKF--------LKLEQLDQDAAFPTDTGGVSVDGTGQV-GTYFYTA 645
+ IK+ DFGL+K L +++D D QV GT Y A
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK---------QVCGTPEYIA 184
Query: 646 PEI--EQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVA 700
PE+ QG+ K D +++GI+ +E PF ++ + E P A
Sbjct: 185 PEVILRQGYGK---PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 701 KFSEQESLLRRLMSPSPSDR---PSATELLQDALPPQMEYELLDNILRM-------MHSS 750
++ + L+ RL+ +P +R A E+ Q +++ L LR + S
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL---LRQKAEFIPQLESE 298
Query: 751 EDTSIYD 757
+DTS +D
Sbjct: 299 DDTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 79/308 (25%), Positives = 124/308 (40%), Gaps = 72/308 (23%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+DFE L+ +G G FG V + K K G+ YA+K IL + L R +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMK--------------ILNKWEMLKRAE-- 44
Query: 484 HVVRYYQAWF--ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
A F E V GD W ++ Q+ LY+
Sbjct: 45 ------TACFREERDVLVN-GDRRW--------------ITNLHYAFQDEN----NLYLV 79
Query: 542 MEYCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
M+Y TL FE D +++A ++V + +H G +HRD+ P+N+ D
Sbjct: 80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWP 653
I++ DFG L+L G +V VGT Y +PEI E G
Sbjct: 138 NGHIRLADFG--SCLRL-----------LADG-TVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 654 KIDEKADMYSLGIVFFELWH---PF--STAMERQIVLSDLKQKGELPPSWVAKFSEQESL 708
+ + D +SLG+ +E+ + PF + +E + + K+ + PP E + L
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDL 243
Query: 709 LRRLMSPS 716
+RRL+
Sbjct: 244 IRRLICSP 251
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 80/308 (25%), Positives = 132/308 (42%), Gaps = 78/308 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+DFE ++ +G G FG V + K K R YA+K + + +L+ T + +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE--------MLKRAETACFREER 52
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V+ +GD W T F + EN YLY+ M+
Sbjct: 53 NVL-------------VNGDCQWI--TTLHYAFQD-----------EN-----YLYLVMD 81
Query: 544 YCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
Y TL FE D +++A ++V + IH +HRD+ P+N+ D
Sbjct: 82 YYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG 139
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ----VGTYFYTAPEI----EQG 651
I++ DFG LK+ Q DGT Q VGT Y +PEI E G
Sbjct: 140 HIRLADFG--SCLKMNQ----------------DGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 652 WPKIDEKADMYSLGIVFFELWH---PF--STAMERQIVLSDLKQKGELPPSWVAKFSEQ- 705
K + D +SLG+ +E+ + PF + +E + + +++ + PS + SE+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF-PSHITDVSEEA 240
Query: 706 ESLLRRLM 713
+ L++RL+
Sbjct: 241 KDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 71/321 (22%), Positives = 133/321 (41%), Gaps = 83/321 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK---DKSLPVNDRILREVATLSRL 480
+D+E +Q +G G +G V +N G AVK I+L+ D SL I +E+ +
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-----IQQEIFMVKEC 63
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+H ++V Y+ ++ L L+I
Sbjct: 64 KHCNIVAYFGSY----------------------------------------LSREKLWI 83
Query: 541 QMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
MEYC +L+ ++ + ++ R+ ++GLA++H +G +HRD+ NI
Sbjct: 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG 143
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ-----GWPK 654
D+K+ DFG+A + + + +F +GT ++ APE+ G+ +
Sbjct: 144 DVKLADFGVAAKIT-ATIAKRKSF--------------IGTPYWMAPEVAAVEKNGGYNQ 188
Query: 655 IDEKADMYSLGIVFFEL--WHPFSTAMERQIVLSDLKQKGELPP------SWVAKFSEQE 706
+ D++++GI EL P + L + + PP W + F
Sbjct: 189 L---CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF---H 242
Query: 707 SLLRRLMSPSPSDRPSATELL 727
+ ++ ++ +P RP+A LL
Sbjct: 243 NFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 50/157 (31%), Positives = 69/157 (43%), Gaps = 26/157 (16%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+I+ GL H+H + +++RDL P NI D ++I D GLA D P
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP----- 152
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PF---STAMERQI 683
VGT+ Y APE+ Q D AD +SLG + F+L PF T + +I
Sbjct: 153 -----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
Query: 684 VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
L ELP S+ E SLL L+ + R
Sbjct: 208 DRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 14/103 (13%)
Query: 569 RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTG 628
R+++E LA++HG+GIIHRD+ NIF D + +GDFG A +LD P
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAAC-----KLDAHPDTPQC-- 244
Query: 629 GVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
G GT +PE+ P K D++S G+V FE+
Sbjct: 245 ------YGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 74/332 (22%), Positives = 128/332 (38%), Gaps = 86/332 (25%)
Query: 408 VDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN 467
VD G P YL++F ++ G G G V + +K GR AVKK+ L+ +
Sbjct: 12 VDPGDPR------SYLDNFVKI---GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR--R 60
Query: 468 DRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVT 527
+ + EV + QH ++V Y ++ GD +W
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLV-------GDELW--------------------- 92
Query: 528 GQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587
+ ME+ ++ ++E + +++ L+ +H QG+IHRD
Sbjct: 93 ------------VVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140
Query: 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ---VGTYFYT 644
+ ++I + +K+ DFG VS + + VGT ++
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFC------------------AQVSKEVPRRKSLVGTPYWM 182
Query: 645 APEIEQGWPKIDEKADMYSLGIVFFELWH---PFST-----AMERQIVLSDLKQKGELPP 696
APE+ P + D++SLGI+ E+ P+ AM+R + D
Sbjct: 183 APEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNLPPKLKNL 238
Query: 697 SWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
V+ S L R++ P+ R +A ELL
Sbjct: 239 HKVS--PRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-10
Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 23/141 (16%)
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLF--RQIVEGLAHIHGQGIIHRDLTPNNI 593
YLY+ MEY P L + +YD +K W F ++V L IH G IHRD+ P+N+
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYDIPEK---WARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 594 FFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI---EQ 650
D +K+ DFG ++D + DT VGT Y +PE+ +
Sbjct: 174 LLDKSGHLKLADFGTCM-----KMDANGMVRCDTA---------VGTPDYISPEVLKSQG 219
Query: 651 GWPKIDEKADMYSLGIVFFEL 671
G + D +S+G+ +E+
Sbjct: 220 GDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 75/331 (22%), Positives = 130/331 (39%), Gaps = 84/331 (25%)
Query: 408 VDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN 467
VD G P YL++F ++ G G G V + K G+ AVKK+ L+ +
Sbjct: 13 VDPGDPRT------YLDNFIKI---GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--R 61
Query: 468 DRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVT 527
+ + EV + QH++VV Y ++ GD +W
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYLV-------GDELW--------------------- 93
Query: 528 GQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587
+ ME+ ++ ++E + +++ L+ +H QG+IHRD
Sbjct: 94 ------------VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
+ ++I +K+ DFG + E + + VGT ++ APE
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---------------VGTPYWMAPE 186
Query: 648 IEQGWPKIDEKADMYSLGIVFFELWH---PF-------STAMERQIVLSDLKQKGELPPS 697
+ P E D++SLGI+ E+ P+ + M R + LK ++ PS
Sbjct: 187 LISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPS 245
Query: 698 WVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
+ L RL+ P+ R +A ELL+
Sbjct: 246 L-------KGFLDRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 66/253 (26%), Positives = 107/253 (42%), Gaps = 62/253 (24%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
D++ ++ +G G FG V L ++K + YA+K +L + + R
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMK--------------LLSKFEMIKRSDSAF 89
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
W E + F +S W + Q++K YLY+ MEY
Sbjct: 90 F------WEERDIMAF-ANSPWVVQLFCAF--------------QDDK----YLYMVMEY 124
Query: 545 CPR-TLRQVFESYDHFDKELAWHLF--RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
P L + +YD +K W F ++V L IH G+IHRD+ P+N+ D +
Sbjct: 125 MPGGDLVNLMSNYDVPEK---WAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI---EQGWPKIDEK 658
K+ DFG +K+++ TG V D VGT Y +PE+ + G +
Sbjct: 182 KLADFGTC--MKMDE----------TGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRE 227
Query: 659 ADMYSLGIVFFEL 671
D +S+G+ FE+
Sbjct: 228 CDWWSVGVFLFEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-10
Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 40/187 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
+F ++P+ G FG V L + K + + YAVK ++ K+ +N ++ +V
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK---KADMINKNMVHQV---------- 51
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
A+ D ++ S + +S ++A+ +Y+ MEY
Sbjct: 52 ------------QAERDALALSKSPFIVHLYYSLQSAN--------------NVYLVMEY 85
Query: 545 -CPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
++ + Y +FD+E+A ++ L ++H GIIHRDL P+N+ IK+
Sbjct: 86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKL 145
Query: 604 GDFGLAK 610
DFGL+K
Sbjct: 146 TDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 65/254 (25%), Positives = 104/254 (40%), Gaps = 61/254 (24%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK--DKSLPVNDRILREVATLSRLQ-- 481
+E + +G G +G V ++ G A+K +R++ + LP++ +REVA L RL+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS--TVREVALLKRLEAF 59
Query: 482 -HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H ++VR L ++R T +E K+ +
Sbjct: 60 DHPNIVR-----------------------LMDVCATSR-------TDRETKVTLVF--- 86
Query: 541 QMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
E+ + LR + E L RQ + GL +H I+HRDL P NI +
Sbjct: 87 --EHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG 144
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
+K+ DFGLA+ Q A P V T +Y APE+
Sbjct: 145 GQVKLADFGLARIYSC----QMALTPV------------VVTLWYRAPEVLLQ-STYATP 187
Query: 659 ADMYSLGIVFFELW 672
DM+S+G +F E++
Sbjct: 188 VDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 56/187 (29%), Positives = 82/187 (43%), Gaps = 23/187 (12%)
Query: 538 LYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
L+ MEY L +S FD A +I+ GL +H +GI++RDL +NI D
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD 130
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
IKI DFG+ K E + DA T GT Y APEI G K +
Sbjct: 131 TDGHIKIADFGMCK----ENMLGDAKTCT-----------FCGTPDYIAPEILLG-QKYN 174
Query: 657 EKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713
D +S G++ +E+ PF E ++ S ++ P W+ + E + +L +L
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-IRMDNPCYPRWLTR--EAKDILVKLF 231
Query: 714 SPSPSDR 720
P R
Sbjct: 232 VREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 52/174 (29%), Positives = 78/174 (44%), Gaps = 27/174 (15%)
Query: 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD 618
FD++ A ++ GL + + I++RDL P NI D R I+I D GLA
Sbjct: 99 FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA--------- 149
Query: 619 QDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PF 675
P G +V G+VGT Y APE+ K D + LG + +E+ PF
Sbjct: 150 --VQIPE---GETV--RGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPF 201
Query: 676 STAME---RQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATE 725
E R+ V +K+ E + KFSE +S+ R L++ +P +R
Sbjct: 202 RKRKERVKREEVDRRVKEDQE---EYSEKFSEDAKSICRMLLTKNPKERLGCRG 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 49/154 (31%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+IV GL +H +GII+RDL +N+ D IKI DFG+ K E + D T
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRAST---- 155
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLS 686
GT Y APEI QG K D +S G++ +E+ PF E ++ S
Sbjct: 156 -------FCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207
Query: 687 DLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
++ P W+ K E + +L +L P+ R
Sbjct: 208 -IRVDTPHYPRWITK--ESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+I GL +H +GII+RDL +N+ DA IKI DFG+ K + F T
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---------ENIFGGKTTR 159
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLS 686
GT Y APEI P + D ++ G++ +E+ PF E ++ S
Sbjct: 160 TF------CGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 687 DLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
++ P S ++K E S+ + L++ P+ R
Sbjct: 213 IMEHNVSYPKS-LSK--EAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 70/324 (21%), Positives = 130/324 (40%), Gaps = 84/324 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKK---IRLKDKSLPVNDRILREVATLSRL-Q 481
FE ++ +G+G +G V GRH + I++ D + + I +E+ L +
Sbjct: 8 FELVELVGNGTYGQV------YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH 61
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H+++ YY A+ + D D +W +
Sbjct: 62 HRNIATYYGAFIKKNPPGMD-DQLW---------------------------------LV 87
Query: 542 MEYC-PRTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
ME+C ++ + ++ + +E ++ R+I+ GL+H+H +IHRD+ N+
Sbjct: 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN 147
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPK 654
++K+ DFG++ QLD+ +GT ++ APE+ E
Sbjct: 148 AEVKLVDFGVSA-----QLDRTVGRRNTF----------IGTPYWMAPEVIACDENPDAT 192
Query: 655 IDEKADMYSLGIVFFEL---------WHPFSTAMERQIVLSDLKQKGEL-PPSWVAKFSE 704
D K+D++SLGI E+ HP R + L L W KF
Sbjct: 193 YDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFLIPRNPAPRLKSKKWSKKF-- 245
Query: 705 QESLLRRLMSPSPSDRPSATELLQ 728
+S + + + S RP+ +L++
Sbjct: 246 -QSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 80/336 (23%), Positives = 129/336 (38%), Gaps = 90/336 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRH-YAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
F +++ +G G FG V L + K+D YA+K +R D L R Q H
Sbjct: 3 FVKIKTIGIGAFGEVCLVR-KVDTNALYAMKTLRKAD--------------VLMRNQAAH 47
Query: 485 VVRYYQAWFETGVADFD----GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
V A+ D D+ W S F + ++N LY
Sbjct: 48 VK-----------AERDILAEADNEWVVKLYYS--FQD----------KDN------LYF 78
Query: 541 QMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
M+Y P + + F+++LA ++ + +H G IHRD+ P+NI D
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG 138
Query: 600 DIKIGDFGLAK----------FLKLEQLDQDAAFPTDTGG---------VSVDGTGQ--- 637
IK+ DFGL + K + QD+ P++ + Q
Sbjct: 139 HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQR 198
Query: 638 ------VGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFELW---HPF--STAMERQIV 684
VGT Y APE+ G+ ++ D +S+G++ +E+ PF T E Q+
Sbjct: 199 CLAHSLVGTPNYIAPEVLLRTGYTQL---CDWWSVGVILYEMLVGQPPFLADTPAETQLK 255
Query: 685 LSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
+ + + +P AK S + S L + DR
Sbjct: 256 VINWETTLHIPSQ--AKLSREASDLILRLCCGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 80/327 (24%), Positives = 133/327 (40%), Gaps = 76/327 (23%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+DFE + LG G G V ++K G A K I L+ K + ++I+RE+ L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 63
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V +Y A++ G + M G
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGG----------------------------------- 88
Query: 544 YCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARNDIK 602
+L QV + +E+ + ++ GLA++ + I+HRD+ P+NI ++R +IK
Sbjct: 89 ----SLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIK 144
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ--VGTYFYTAPEIEQGWPKIDEKAD 660
+ DFG++ G +D VGT Y +PE QG ++D
Sbjct: 145 LCDFGVS-------------------GQLIDSMANSFVGTRSYMSPERLQG-THYSVQSD 184
Query: 661 MYSLGIVFFELWHPFSTAMER-QIVLSDLKQKGEL--PPSWVAKFSEQESLLRRLMSPSP 717
++S+G+ EL A+ R I D K+ + P + E S+ R P P
Sbjct: 185 IWSMGLSLVEL------AIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR---PRP 235
Query: 718 SDRPSATELLQDALPPQMEYELLDNIL 744
RP + + D+ P +ELLD I+
Sbjct: 236 PGRPVSGHGM-DSRPAMAIFELLDYIV 261
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 68/311 (21%), Positives = 117/311 (37%), Gaps = 79/311 (25%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRY 488
L+ LG G FG V L K + A+K IR + ++ +D I E + +L H ++V+
Sbjct: 9 LKELGSGQFGVVHLGKWR-GKIDVAIKMIR--EGAMSEDDFI-EEAKVMMKLSHPNLVQL 64
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY---- 544
Y GV + ++I EY
Sbjct: 65 Y------GVC----------------------------------TKQRPIFIVTEYMANG 84
Query: 545 CPRT-LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
C LR+ E + + E + ++ G IHRDL N N +K+
Sbjct: 85 CLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKV 141
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPEIEQGWPKIDEKAD 660
DFGLA+++ LD T GT F + PE+ + + K+D
Sbjct: 142 SDFGLARYV----LDDQY-------------TSSQGTKFPVKWAPPEVFD-YSRFSSKSD 183
Query: 661 MYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716
++S G++ +E++ P+ + V+ + L +A +E +++
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPKLAP-TEVYTIMYSCWHEK 241
Query: 717 PSDRPSATELL 727
P DRP+ +LL
Sbjct: 242 PEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 15/102 (14%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q++ GLA+IHGQ I+HRDL P N+ ++K+ DFGLA+ + P+ T
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR---------AKSIPSQT-- 159
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
+ +V T +Y P++ G D++ G +F E+
Sbjct: 160 ----YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 62/253 (24%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
D+E ++ +G G FG V L ++K + YA+K +L + + R
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK--------------LLSKFEMIKRSDSAF 89
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
W E + F +S W + ++ + + YLY+ MEY
Sbjct: 90 F------WEERDIMAF-ANSPW----VVQLFYAFQ--------------DDRYLYMVMEY 124
Query: 545 CPR-TLRQVFESYDHFDKELAWHLF--RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
P L + +YD +K W F ++V L IH G IHRD+ P+N+ D +
Sbjct: 125 MPGGDLVNLMSNYDVPEK---WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI---EQGWPKIDEK 658
K+ DFG +++++ DT VGT Y +PE+ + G +
Sbjct: 182 KLADFGTCM-----KMNKEGMVRCDTA---------VGTPDYISPEVLKSQGGDGYYGRE 227
Query: 659 ADMYSLGIVFFEL 671
D +S+G+ +E+
Sbjct: 228 CDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 70/320 (21%), Positives = 120/320 (37%), Gaps = 86/320 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKN-KLDGRHYAVKKIRLK--DKSLPVNDRILREVATLSRLQ- 481
+E + +G G +G V ++ K GR A+K++R++ ++ +P++ +REVA L L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAVLRHLET 60
Query: 482 --HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
H +VVR + DV T L
Sbjct: 61 FEHPNVVRLF-----------------------------------DVCTVSRTDRETKLT 85
Query: 540 IQMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
+ E+ + L + E + Q++ GL +H ++HRDL P NI +
Sbjct: 86 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 145
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
IK+ DFGLA+ + T V T +Y APE+
Sbjct: 146 SGQIKLADFGLARIYSFQMAL----------------TSVVVTLWYRAPEVLLQ-SSYAT 188
Query: 658 KADMYSLGIVFFELWHPFSTAMERQIVL---SDLKQKGELPPSWVAKFSEQESLLRRLMS 714
D++S+G +F E++ R+ + SD+ Q G++ L +
Sbjct: 189 PVDLWSVGCIFAEMF-------RRKPLFRGSSDVDQLGKI--------------LDVIGL 227
Query: 715 PSPSDRPSATELLQDALPPQ 734
P D P L + A +
Sbjct: 228 PGEEDWPRDVALPRQAFHSK 247
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 30/171 (17%)
Query: 569 RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTG 628
+Q +E L ++H IIHRDL NI F DIK+ DFG++ + + +F
Sbjct: 110 KQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSF----- 163
Query: 629 GVSVDGTGQVGTYFYTAPEI-----EQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQI 683
+GT ++ APE+ + P D KAD++SLGI E+ E
Sbjct: 164 ---------IGTPYWMAPEVVMCETSKDRP-YDYKADVWSLGITLIEMAQIEPPHHELNP 213
Query: 684 VLSDLKQKGELPPS------WVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
+ LK PP+ W ++F + L++ + + R + T+LLQ
Sbjct: 214 MRVLLKIAKSEPPTLAQPSRWSSEFKD---FLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-09
Identities = 54/184 (29%), Positives = 74/184 (40%), Gaps = 33/184 (17%)
Query: 569 RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTG 628
R ++ + ++H IIHRD+ NIF + D+ +GDFG A FP D
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGA------------ACFPVDIN 236
Query: 629 GVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAME-------- 680
G GT APE+ P D++S GIV FE+ + E
Sbjct: 237 ANKY--YGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC 293
Query: 681 ---RQIVLSDLKQKG----ELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733
RQI L +++ G E P A E L + S P RP T L + LP
Sbjct: 294 DSDRQIKLI-IRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYE--LPI 350
Query: 734 QMEY 737
+EY
Sbjct: 351 DLEY 354
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-09
Identities = 35/102 (34%), Positives = 49/102 (48%), Gaps = 14/102 (13%)
Query: 569 RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTG 628
RQ++ + +IHG+GIIHRD+ N+ + DI +GDFG A F + F
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA---RGSWSTPFH---- 319
Query: 629 GVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFE 670
G GT APE+ G P D++S G+V FE
Sbjct: 320 ------YGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-09
Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 21/143 (14%)
Query: 534 ESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFR----QIVEGLAHIHGQGIIHRDLT 589
++ +L + ME+ P+T+ + + Y + L L + Q+ LA+IH + I HRDL
Sbjct: 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLK 197
Query: 590 PNNIFFDAR-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648
P N+ D + +K+ DFG AK L G SV + + FY APE+
Sbjct: 198 PQNLLIDPNTHTLKLCDFGSAKNLL-------------AGQRSVS---YICSRFYRAPEL 241
Query: 649 EQGWPKIDEKADMYSLGIVFFEL 671
G D++SLG + E+
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 23/158 (14%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+IV L H+H GII+RD+ NI D+ + + DFGL+K +++++ +F
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF------ 166
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKA-DMYSLGIVFFELW---HPFSTAMER--QI 683
GT Y AP+I +G +KA D +S+G++ +EL PF+ E+ Q
Sbjct: 167 --------CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
Query: 684 VLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDR 720
+S K E P P ++ + + +++RL+ P R
Sbjct: 219 EISRRILKSEPPYPQEMSALA--KDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 62/254 (24%), Positives = 100/254 (39%), Gaps = 70/254 (27%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
+G G FG V+L K KLDG+ YAVK +L++ L+R + +H+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVK--------------VLQKKIVLNRKEQKHI------ 42
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST-YLYIQMEYCPRTLR 550
+A + + G ++T LY +++
Sbjct: 43 -------------------MAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG-- 81
Query: 551 QVFESYDHFDKELAWHLFR------QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
E + H +E ++ R +I L ++H I++RDL P NI D++ + +
Sbjct: 82 ---ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLT 138
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGL K + Q D F GT Y APE+ + P D D + L
Sbjct: 139 DFGLCK-EGIAQSDTTTTF--------------CGTPEYLAPEVIRKQP-YDNTVDWWCL 182
Query: 665 GIVFFELWH---PF 675
G V +E+ + PF
Sbjct: 183 GAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 63/250 (25%), Positives = 107/250 (42%), Gaps = 54/250 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDG----RHYAVKKIRLKDKSLPVNDRILREVATLSRLQ 481
+ ++ LG G FG V LC+ +G AVK ++ + + D + +E+ L L
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLY 64
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H+++V+Y G+ DG G+G F L S L
Sbjct: 65 HENIVKY------KGICTEDG----GNGIKLIMEF----------------LPSGSL--- 95
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
EY PR ++ + ++L + + QI +G+ ++ + +HRDL N+ ++ + +
Sbjct: 96 KEYLPRNKNKI-----NLKQQLKYAV--QICKGMDYLGSRQYVHRDLAARNVLVESEHQV 148
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
KIGDFGL K A TD +V ++Y APE K +D+
Sbjct: 149 KIGDFGLTK-----------AIETDKEYYTVKDDLDSPVFWY-APECLIQ-SKFYIASDV 195
Query: 662 YSLGIVFFEL 671
+S G+ +EL
Sbjct: 196 WSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-09
Identities = 80/336 (23%), Positives = 129/336 (38%), Gaps = 86/336 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN-DRILREVATLSRLQHQH 484
F +++ LG G FG V L + YA+K +R KD L + E L+ ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
VVR Y + F+ D D+ LY M+Y
Sbjct: 63 VVRLYYS-FQ------DKDN---------------------------------LYFVMDY 82
Query: 545 CPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
P + + F ++LA ++ + +H G IHRD+ P+NI D IK+
Sbjct: 83 IPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKL 142
Query: 604 GDFGLAKFLKL----------EQLDQDAA-FPTDTGGVSVDGTGQ--------------- 637
DFGL + + + QD+ F + G + G
Sbjct: 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQR 202
Query: 638 ------VGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPF--STAMERQIV 684
VGT Y APE+ G+ ++ D +S+G++ +E+ PF T +E Q+
Sbjct: 203 CLAHSLVGTPNYIAPEVLLRTGYTQL---CDWWSVGVILYEMLVGQPPFLAQTPLETQMK 259
Query: 685 LSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
+ + + +PP AK S + S L + P DR
Sbjct: 260 VINWQTSLHIPPQ--AKLSPEASDLIIKLCRGPEDR 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 56/257 (21%), Positives = 107/257 (41%), Gaps = 66/257 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKK---IRLKDKSLPVNDRILREVATLSRL-Q 481
FE ++ +G+G +G V GRH + I++ D + + I E+ L +
Sbjct: 18 FELVEVVGNGTYGQV------YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH 71
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H+++ YY A+ + D D +W +
Sbjct: 72 HRNIATYYGAFIKKSPPGHD-DQLW---------------------------------LV 97
Query: 542 MEYC-PRTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
ME+C ++ + ++ + ++ ++ R+I+ GLAH+H +IHRD+ N+
Sbjct: 98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN 157
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPK 654
++K+ DFG++ QLD+ +GT ++ APE+ E
Sbjct: 158 AEVKLVDFGVSA-----QLDRTVGRRNTF----------IGTPYWMAPEVIACDENPDAT 202
Query: 655 IDEKADMYSLGIVFFEL 671
D ++D++SLGI E+
Sbjct: 203 YDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 22/165 (13%)
Query: 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD 618
FD+ + ++ L +H G+I+RDL +NI DA K+ DFG+ K E +
Sbjct: 93 FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK----EGIL 148
Query: 619 QDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PF 675
T GT Y APEI Q D ++LG++ +E+ PF
Sbjct: 149 NGVTTTT-----------FCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPF 196
Query: 676 STAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
E + S L L P W++K E S+L+ M+ +P+ R
Sbjct: 197 EADNEDDLFESILHDD-VLYPVWLSK--EAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 76/325 (23%), Positives = 131/325 (40%), Gaps = 74/325 (22%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+DFE++ LG G G V +K G A K I L+ K + ++I+RE+ L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 63
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V +Y A++ G + M G
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGG----------------------------------- 88
Query: 544 YCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARNDIK 602
+L QV + +++ + +++GL ++ + I+HRD+ P+NI ++R +IK
Sbjct: 89 ----SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 144
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ--VGTYFYTAPEIEQGWPKIDEKAD 660
+ DFG++ G +D VGT Y +PE QG ++D
Sbjct: 145 LCDFGVS-------------------GQLIDSMANSFVGTRSYMSPERLQG-THYSVQSD 184
Query: 661 MYSLGIVFFELWHPFSTAMER-QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSD 719
++S+G+ E+ A+ R I D K+ + V + R P P
Sbjct: 185 IWSMGLSLVEM------AIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR---PRPPG 235
Query: 720 RPSATELLQDALPPQMEYELLDNIL 744
RP ++ D+ PP +ELLD I+
Sbjct: 236 RPLSS-YGPDSRPPMAIFELLDYIV 259
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 27/166 (16%)
Query: 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGV 630
+V+GL ++ I+HRD+ P+N+ + R +K+ DFG++ L V
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-----------------V 146
Query: 631 SVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSD 687
+ VGT Y APE G + +D++SLGI F EL P+ + Q L
Sbjct: 147 NSIAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205
Query: 688 LKQ----KGELPPSW-VAKFSEQ-ESLLRRLMSPSPSDRPSATELL 727
L+ E PP V +FSE+ + + M P +RP+ L+
Sbjct: 206 LQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 52/250 (20%), Positives = 99/250 (39%), Gaps = 66/250 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ + +G G G V + G+ A+K++ L+ + P + I+ E+ + +H ++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNI 78
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V Y ++ GD +W + MEY
Sbjct: 79 VNYLDSYLV-------GDELW---------------------------------VVMEYL 98
Query: 546 PR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
+L V + ++A + R+ ++ L +H +IHRD+ +NI +K+
Sbjct: 99 AGGSLTDVVTETCMDEGQIA-AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 157
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI---EQGWPKIDEKADM 661
DFG + EQ + + VGT ++ APE+ + PK+ D+
Sbjct: 158 DFGFCAQITPEQSKR---------------STMVGTPYWMAPEVVTRKAYGPKV----DI 198
Query: 662 YSLGIVFFEL 671
+SLGI+ E+
Sbjct: 199 WSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 75/308 (24%), Positives = 121/308 (39%), Gaps = 75/308 (24%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--------RILREVATLSRLQ 481
+ LG G FG V+L + K GR YAVK ++ KD L +D RIL +L+R
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLK-KDVILQDDDVECTMTEKRIL----SLAR-N 54
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H + + Y F+T F F + D L
Sbjct: 55 HPFLTQLYCC-FQTPDRLF---------------FVMEFVNGGD------------LMFH 86
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
++ R FD+ A +I L +H +GII+RDL +N+ D
Sbjct: 87 IQKSRR-----------FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHC 135
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
K+ DFG+ K E + T GT Y APEI Q D
Sbjct: 136 KLADFGMCK----EGIFNGKTTST-----------FCGTPDYIAPEILQEM-LYGPSVDW 179
Query: 662 YSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718
+++G++ +E+ PF E + + L + + P+W+++ + +L+ M+ +P+
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQ--DAVDILKAFMTKNPT 236
Query: 719 DRPSATEL 726
R + L
Sbjct: 237 MRLGSLTL 244
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 62/269 (23%), Positives = 105/269 (39%), Gaps = 56/269 (20%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
+G G FG V+L ++K + + YAVK +L++ A L + + +H++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVK--------------VLQKKAILKKKEEKHIMSERNV 48
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQ 551
+ F L FS + A + ++Q E C R
Sbjct: 49 LLKNVKHPF----------LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA 98
Query: 552 VFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKF 611
F + +I L ++H I++RDL P NI D++ I + DFGL K
Sbjct: 99 RFYA-------------AEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK- 144
Query: 612 LKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
E ++ + T GT Y APE+ P D D + LG V +E+
Sbjct: 145 ---ENIEHNGTTST-----------FCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEM 189
Query: 672 WH---PFSTAMERQIVLSDLKQKGELPPS 697
+ PF + ++ + L + +L P+
Sbjct: 190 LYGLPPFYSRNTAEMYDNILNKPLQLKPN 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 65/361 (18%), Positives = 118/361 (32%), Gaps = 101/361 (27%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
H+ K AVKKI L S + +E+ T +LQH +++ Y +
Sbjct: 10 FEDLMIVHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY-----CP 546
+ + + LY+ C
Sbjct: 68 F----------------------------------------IVDSELYVVSPLMAYGSCE 87
Query: 547 RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDF 606
L+ F + + + + ++ L +IH +G IHR + ++I + +
Sbjct: 88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLS-- 143
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI-EQGWPKIDEKADMYSLG 665
GL + + + + D V + +PE+ +Q +EK+D+YS+G
Sbjct: 144 GLRYSVSMIKHGKRQRVVHDF------PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197
Query: 666 IVFFELWH---PFS----TAMERQIV----------------LSDLKQKGE--------- 693
I EL + PF T M + V + Q
Sbjct: 198 ITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD 257
Query: 694 -LPPSWVAKFSEQ-----ESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMM 747
+ + FSE E L+R P RPSA++LL + Q + ++L ++
Sbjct: 258 SVDHPYTRTFSEHFHQFVELCLQR----DPESRPSASQLLNHSFFKQCK-RRNTSLLDLL 312
Query: 748 H 748
Sbjct: 313 K 313
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD--QDAAFPTDT 627
QI EG+A++ + IHRDL NI KI DFGLA+ ++ ++ + A FP
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK- 169
Query: 628 GGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFEL 671
+TAPE G + K+D++S GI+ E+
Sbjct: 170 ---------------WTAPEAANYG--RFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 76/306 (24%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
DFE L+ +G G FG V + K K + +A+K + + +L+ T + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--------MLKRAETACFREERD 53
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
V+ +GD+ W T F + LY+ M+Y
Sbjct: 54 VL-------------VNGDNQWI--TTLHYAFQ----------------DENNLYLVMDY 82
Query: 545 CP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
TL FE D +++A ++V + +H +HRD+ P+NI D
Sbjct: 83 YVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH 140
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ----VGTYFYTAPEI----EQGW 652
I++ DFG LKL + DGT Q VGT Y +PEI E G
Sbjct: 141 IRLADFG--SCLKLME----------------DGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 653 PKIDEKADMYSLGIVFFELWH---PF--STAMERQIVLSDLKQKGELPPSWVAKFSEQES 707
K + D +SLG+ +E+ + PF + +E + + K++ + P + +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242
Query: 708 LLRRLM 713
L+RRL+
Sbjct: 243 LIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 549 LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGL 608
L V E D+ +L + QI +G+ ++ + ++HRDL N+ + N +KI DFGL
Sbjct: 96 LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL 155
Query: 609 AKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVF 668
A+ L+ ++ + +A D G + + + A E + K ++D++S G+
Sbjct: 156 ARLLEGDEKEYNA----DGGKMPIK---------WMALECIH-YRKFTHQSDVWSYGVTI 201
Query: 669 FELW----HPFSTAMERQIVLSDLKQKGE-LPPSWVAKFSEQESLLRRLMSPSPSDRPSA 723
+EL P+ R+I DL +KGE LP + +++ M + S RP
Sbjct: 202 WELMTFGGKPYDGIPTREI--PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADS-RPKF 258
Query: 724 TELLQD----ALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEE 767
EL + A PQ Y ++ RM S + S K ++ DEE
Sbjct: 259 KELAAEFSRMARDPQ-RYLVIQGDDRMKLPSPNDS---KFFQNLLDEE 302
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 16/102 (15%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q+ EG+A++ Q IHRDL NI K+ DFGLA+ +K + + +
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK------EDVYLSSDKK 165
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
+ Y +TAPE K+D++S GI+ +E+
Sbjct: 166 IP---------YKWTAPE-AASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-08
Identities = 76/311 (24%), Positives = 116/311 (37%), Gaps = 82/311 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
F +++ LG G FG V L YA+K +R KD L+R Q HV
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD--------------VLNRNQVAHV 48
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
E D+ W S F ++ LY M+Y
Sbjct: 49 KAERDILAE-------ADNEWVVKLYYS--FQDKDN----------------LYFVMDYI 83
Query: 546 PR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
P + + + F + LA ++ + +H G IHRD+ P+NI D IK+
Sbjct: 84 PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLT 143
Query: 605 DFGLAK----------FLKLEQLDQDAAFPTDT-GGVSVDGTGQ---------------- 637
DFGL + K + QD+ P+D VS G
Sbjct: 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC 203
Query: 638 -----VGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFELW---HPF--STAMERQIVL 685
VGT Y APE+ +G+ ++ D +S+G++ FE+ PF T E Q+ +
Sbjct: 204 LAHSLVGTPNYIAPEVLLRKGYTQL---CDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260
Query: 686 SDLKQKGELPP 696
+ + +PP
Sbjct: 261 INWENTLHIPP 271
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 21/105 (20%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q+ G+A++ Q IHRDL N+ N K+ DFGLA+ +K +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-------------- 156
Query: 630 VSVDGTGQVGTYF---YTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
+ G F +TAPE + + K+D++S GI+ E+
Sbjct: 157 ---IYEAREGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 16/134 (11%)
Query: 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTD 626
+ R I G+ ++ +HRDL NI ++ K+ DFGL++F L+ D + PT
Sbjct: 111 MLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-----LEDDTSDPTY 165
Query: 627 TGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQ 682
T + G++ +TAPE + K +D++S GIV +E+ P+ M Q
Sbjct: 166 TSSLG----GKIPIR-WTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQ 218
Query: 683 IVLSDLKQKGELPP 696
V++ ++Q LPP
Sbjct: 219 DVINAIEQDYRLPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|222097 pfam13393, tRNA-synt_His, Histidyl-tRNA synthetase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 9e-08
Identities = 53/227 (23%), Positives = 80/227 (35%), Gaps = 43/227 (18%)
Query: 875 SVYR-RAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIH----- 928
V R R G LQ ++IG A +AEV+ + ++ + ES +
Sbjct: 96 PVLRTRPDGLGGSREPLQIGAELIGHAGIEADAEVISLLLEAL------ESLGVKGVTLD 149
Query: 929 LNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAE 988
L H ++ A+ G+ E + + L K + +LL EL L
Sbjct: 150 LGHVGIVRALLEALGLSEAQEEALRDALQ-------------RKDLPELEELLAELGLDP 196
Query: 989 AVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYID 1043
A+ + L + G + L LP P ALDEL L + +D
Sbjct: 197 ALADALLAL-PELYGDPE-VLDEALELLP-GSPAAAALDELEALAALLEALGPGVRLTLD 253
Query: 1044 -ALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHR 1089
A + E Y+ L F ++ L A GGRYD L
Sbjct: 254 LAELRGYE-YYTGLVFAAYA--PGAGQAL------ARGGRYDNLGEV 291
|
This is a family of class II aminoacyl-tRNA synthetase-like and ATP phosphoribosyltransferase regulatory subunits. Length = 308 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 67/254 (26%)
Query: 432 LGHGGFGHVVLCKNK--LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYY 489
+G G +GHV K K D R YA+K+I S+ RE+A L L+H +V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISLQ 64
Query: 490 QAWFETG------VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+ + + D+ +W ++ +N+ +Q+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP------------------VQL- 105
Query: 544 YCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF----DARN 599
PR + + L QI++G+ ++H ++HRDL P NI R
Sbjct: 106 --PRGMVK--------------SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 149
Query: 600 DIKIGDFGLAKFLK--LEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
+KI D G A+ L+ L D V T++Y APE+ G +
Sbjct: 150 RVKIADMGFARLFNSPLKPL--------------ADLDPVVVTFWYRAPELLLGARHYTK 195
Query: 658 KADMYSLGIVFFEL 671
D++++G +F EL
Sbjct: 196 AIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 9e-08
Identities = 77/326 (23%), Positives = 122/326 (37%), Gaps = 96/326 (29%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-------KSLPVNDRILREVATLS 478
F L LG G FG V+L + K G YA+K ++ D +SL RI T +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFE---TAN 57
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+H +V + A F+T ++
Sbjct: 58 SERHPFLVNLF-ACFQT---------------------------------------EDHV 77
Query: 539 YIQMEYCP--RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
MEY + + D F + A +V GL ++H I++RDL +N+ D
Sbjct: 78 CFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135
Query: 597 ARNDIKIGDFGLAKFLKLEQL---DQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQG 651
+KI DFGL K E + D+ + F GT + APE+ E
Sbjct: 136 TEGFVKIADFGLCK----EGMGFGDRTSTF--------------CGTPEFLAPEVLTETS 177
Query: 652 WPKIDEKADMYSLGIVFFELW---HPFSTAMERQ----IVLSDLKQKGELPPSWVAKFSE 704
+ D + LG++ +E+ PF E + IV +++ L E
Sbjct: 178 Y---TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS-------RE 227
Query: 705 QESLLRRLMSPSPSDRPSATELLQDA 730
S++RRL+ +P R + E +DA
Sbjct: 228 AISIMRRLLRRNPERRLGSGE--KDA 251
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 55/190 (28%), Positives = 76/190 (40%), Gaps = 42/190 (22%)
Query: 432 LGHGGFGHVVL--CKN---KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVV 486
LG G FG V L C N D AVK LKD +L RE L+ LQH+H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 487 RYYQAWFETGVADFDGDSM------WGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
++Y GV DGD + G L ++ + V GQ + +
Sbjct: 71 KFY------GVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 541 QMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
QM H+ QI G+ ++ Q +HRDL N A
Sbjct: 124 QM----------------------LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161
Query: 601 IKIGDFGLAK 610
+KIGDFG+++
Sbjct: 162 VKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|237043 PRK12292, hisZ, ATP phosphoribosyltransferase regulatory subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-07
Identities = 69/331 (20%), Positives = 119/331 (35%), Gaps = 77/331 (23%)
Query: 875 SVYR-RAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHL--NH 931
+V+R + G +LQ ++IG A +AEV+ + ++ + + L H
Sbjct: 106 NVFRAQERGLGRSREFLQSGVELIGDAGLEADAEVILLLLEALK---ALGLPNFTLDLGH 162
Query: 932 GDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVV 991
L A+ AG+ E E + LA +K V +L+ +L+E +
Sbjct: 163 VGLFRALLEAAGLSEELEEVLRRALA-------------NKDYVALEELVL--DLSEELR 207
Query: 992 NRLQTVGLRFCGAADQALPRLRG---------ALPADKPTRKALDELYLRIWRI------ 1036
+ L ALPRLRG L P ++ALDEL +
Sbjct: 208 DALL------------ALPRLRGGREVLEEARKLLPSLPIKRALDELE-ALAEALEKYGY 254
Query: 1037 EKNIYID-ALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREY 1095
+ +D L+ + Y+ + F+ + G +A GGRYD LL + R
Sbjct: 255 GIPLSLDLGLLRHL-DYYTGIVFEGY--------VDGVGNPIASGGRYDDLL-GRFGR-- 302
Query: 1096 VGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVA 1155
G SL L+ +++ R + V+ L +
Sbjct: 303 --------ARPATGFSLDLDRLLELQLELPVEARKDL---VIAPDSEA---LAAALAAAQ 348
Query: 1156 ELWEENIKAQFVPVPDPSLTEQYEYASEHDI 1186
EL ++ + +P + + EYA + I
Sbjct: 349 ELRKKGEIVV-LALPGRNFEDAREYARDRQI 378
|
Length = 391 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 31/168 (18%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
QI + ++ + IHRDL N + +K+ DFGL++ + +
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY------------ 159
Query: 630 VSVDGTGQVGTYF---YTAPEIEQGWPKIDEKADMYSLGIVFFEL----WHPFSTAMERQ 682
T G F +TAPE + K K+D+++ G++ +E+ P+ ++
Sbjct: 160 -----TAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLS 212
Query: 683 IVLSDLKQ--KGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
V L++ + E P K E L+R +PSDRPS E+ Q
Sbjct: 213 QVYELLEKGYRMERPEGCPPKVYE---LMRACWQWNPSDRPSFAEIHQ 257
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL-EQLDQDAA-FPTDT 627
QI EG+A I + IHRDL NI KI DFGLA+ ++ E ++ A FP
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK- 168
Query: 628 GGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQ 682
+TAPE I G I K+D++S GI+ E+ P+ M
Sbjct: 169 ---------------WTAPEAINYGTFTI--KSDVWSFGILLTEIVTYGRIPYP-GMTNP 210
Query: 683 IVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731
V+ +L++ +P P E L+R P +RP+ E L+ L
Sbjct: 211 EVIQNLERGYRMPRPDNCP--EELYELMRLCWKEKPEERPT-FEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 56/190 (29%), Positives = 83/190 (43%), Gaps = 29/190 (15%)
Query: 538 LYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
LY MEY L + F + A +I GL +H +GII+RDL +N+ D
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ---VGTYFYTAPEIEQGWP 653
+ IKI DFG+ K E + VDG GT Y APEI P
Sbjct: 136 SEGHIKIADFGMCK----EHM--------------VDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 654 KIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLR 710
+ D ++ G++ +E+ PF E ++ S ++ P S ++K E S+ +
Sbjct: 178 -YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS-LSK--EAVSICK 233
Query: 711 RLMSPSPSDR 720
LM+ PS R
Sbjct: 234 GLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 18/134 (13%)
Query: 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTD 626
+ R I G+ ++ G +HRDL NI ++ K+ DFGL++ L + D +AA+ T
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTR 167
Query: 627 TGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQ 682
G + + +TAPE + K +D++S GIV +E+ P+ M Q
Sbjct: 168 GGKIPIR---------WTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWE-MSNQ 216
Query: 683 IVLSDLKQKGELPP 696
V+ +++ LP
Sbjct: 217 DVIKAIEEGYRLPA 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 59/254 (23%), Positives = 102/254 (40%), Gaps = 67/254 (26%)
Query: 432 LGHGGFGHVVLCKNK--LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYY 489
+G G +GHV K K D + YA+K+I S+ RE+A L L+H +V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIALQ 64
Query: 490 QAWFETG------VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+ + + D+ +W ++ +N+ +Q+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP------------------MQL- 105
Query: 544 YCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF----DARN 599
PR++ + L QI++G+ ++H ++HRDL P NI R
Sbjct: 106 --PRSMVK--------------SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 149
Query: 600 DIKIGDFGLAKFLK--LEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
+KI D G A+ L+ L D V T++Y APE+ G +
Sbjct: 150 RVKIADMGFARLFNSPLKPL--------------ADLDPVVVTFWYRAPELLLGARHYTK 195
Query: 658 KADMYSLGIVFFEL 671
D++++G +F EL
Sbjct: 196 AIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 533 LESTYLYIQMEYCP-----RTLR--QVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585
+ES + +E+CP LR + + K++ + ++ GL +H IH
Sbjct: 65 IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQADFIH 123
Query: 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA 645
DL N A +KIGD+GLA LEQ +D D V + + A
Sbjct: 124 SDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLR---------WLA 170
Query: 646 PEIEQGW------PKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLK-QKGEL 694
PE+ + +K++++SLG+ +EL+ P+ + Q++ ++ Q +L
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230
Query: 695 P-PSWVAKFSEQESLLRRLMSPSPSDRPSATEL 726
P P K+S++ + + P RP+A E+
Sbjct: 231 PKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|226228 COG3705, HisZ, ATP phosphoribosyltransferase involved in histidine biosynthesis [Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-07
Identities = 62/279 (22%), Positives = 98/279 (35%), Gaps = 33/279 (11%)
Query: 816 HLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYE-IS 874
LE L G +R KL G L L + +P R + + R
Sbjct: 43 TLEPADPLLDGAGEDLRRRLFKLEDETGGRLGLRPDFTIPVARIHATLLAGTPLRLSYAG 102
Query: 875 SVYRRAIGHS-PPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGD 933
V+R G +LQ +++G SA +AEV+ + + + D+ L G
Sbjct: 103 KVFRAREGRHGRRAEFLQAGIELLGDDSAAADAEVIALALAALKA---LGLADLKLELGH 159
Query: 934 --LLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVV 991
+ A+ + AG+ R ++ K ++ L+ L+ +
Sbjct: 160 AGIFRALLAAAGLPGGWRARLRRAFG-------------DKDLLGLELLVLAAPLSPELR 206
Query: 992 NRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDE---LYLRIWRIEKNIYIDALMPP 1048
RL + L G + L R RG L AL+E L R+ + I +D
Sbjct: 207 GRLSEL-LALLGGRE-VLERARGLLDELMAQGIALNEGRALADIARRLIEKIALDLGRLR 264
Query: 1049 IESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLL 1087
Y+ L F ++ LA GGRYD LL
Sbjct: 265 HFDYYTGLVFLAYADGLGDA--------LASGGRYDGLL 295
|
Length = 390 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 25/73 (34%), Positives = 35/73 (47%), Gaps = 9/73 (12%)
Query: 540 IQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
I MEY + L+ V E E L R+I + +H GI+H DLT +NI
Sbjct: 74 IVMEYIEGKPLKDVIE-------EGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDD 126
Query: 599 NDIKIGDFGLAKF 611
+ + DFGL K+
Sbjct: 127 -KLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 26/74 (35%), Positives = 36/74 (48%), Gaps = 8/74 (10%)
Query: 540 IQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN-IFFDA 597
I MEY L+ + S + EL+ + R + +H GIIH DLT +N I
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELELSREIGRLV----GKLHSAGIIHGDLTTSNMILSG- 130
Query: 598 RNDIKIGDFGLAKF 611
I + DFGLA+F
Sbjct: 131 -GKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 39/133 (29%), Positives = 55/133 (41%), Gaps = 37/133 (27%)
Query: 562 ELAWHLFRQ--------------IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFG 607
EL +HL R+ I L ++H II+RDL P NI D++ + + DFG
Sbjct: 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFG 141
Query: 608 LAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV--GTYFYTAPEIEQGWPKIDEKADMYSLG 665
L K G+ T GT Y APE+ + P D D + LG
Sbjct: 142 LCK-----------------EGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLG 183
Query: 666 IVFFELWH---PF 675
V +E+ + PF
Sbjct: 184 AVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 8e-07
Identities = 25/67 (37%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS--LPVNDRILREVATLSRL 480
L D+E L LG G FG V + GR A+KKI + ++ P+ LRE+ L +L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT--ALREIKILKKL 64
Query: 481 QHQHVVR 487
+H +VV
Sbjct: 65 KHPNVVP 71
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 8e-07
Identities = 35/142 (24%), Positives = 57/142 (40%), Gaps = 34/142 (23%)
Query: 557 DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNI-FFDARNDIKIGDFGLAKFLKLE 615
+ + RQ+VE L +H IIH D+ N+ + A++ I + D+GL K +
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163
Query: 616 QLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI-----DEKADMYSLGIVFFE 670
D GT Y +PE KI D D +++G++ +E
Sbjct: 164 SC-YD------------------GTLDYFSPE------KIKGHNYDVSFDWWAVGVLTYE 198
Query: 671 LW---HPFSTAMERQIVLSDLK 689
L HPF + ++ L L
Sbjct: 199 LLTGKHPFKEDEDEELDLESLL 220
|
Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 23/187 (12%)
Query: 538 LYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
LY MEY L + F + A +I GL +H +GII+RDL +N+ D
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+ IKI DFG+ K + GV+ GT Y APEI P
Sbjct: 136 SEGHIKIADFGMCKENMWD-------------GVTTKTF--CGTPDYIAPEIIAYQP-YG 179
Query: 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713
+ D ++ G++ +E+ PF E ++ S ++ P S E ++ + LM
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS---KEAVAICKGLM 236
Query: 714 SPSPSDR 720
+ P R
Sbjct: 237 TKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 33/187 (17%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
QI G+ H+H I++RD+ P N+ D + + ++ D GLA LK G
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--------------DG 148
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLS 686
++ T + GT Y APEI + P D +++G +E+ PF E+ +
Sbjct: 149 KTI--TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKE 204
Query: 687 DLKQKG------------ELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734
+LK++ + + + RL S +D P E + P+
Sbjct: 205 ELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264
Query: 735 MEYELLD 741
+E L+
Sbjct: 265 LEAGLIP 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 65/252 (25%), Positives = 96/252 (38%), Gaps = 59/252 (23%)
Query: 432 LGHGGFGHVVL--CKN---KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVV 486
LG G FG V L C N + D AVK LKD S RE L+ LQH+H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKT--LKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 487 RYYQAWFETGVADFDGDSM------WGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
++Y E GD + G L + F A + + N+
Sbjct: 71 KFYGVCVE-------GDPLIMVFEYMKHGDL--NKFLRAHGPDAVLMAEGNR-------- 113
Query: 541 QMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
P L Q H+ +QI G+ ++ Q +HRDL N
Sbjct: 114 -----PAELTQ----------SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+KIGDFG+++ + TD V G P + K ++D
Sbjct: 159 VKIGDFGMSR----------DVYSTDYYRVG----GHTMLPIRWMPPESIMYRKFTTESD 204
Query: 661 MYSLGIVFFELW 672
++SLG+V +E++
Sbjct: 205 VWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 40/182 (21%)
Query: 554 ESYDHFDKELAWHLFR------QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFG 607
E + H +E + L R +++ L ++H +I+RDL P NI D + I + DFG
Sbjct: 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 608 LAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLG 665
L K L ++ D+ F GT Y APE+ G+ K D ++LG
Sbjct: 139 LCK-LNMKDDDKTNTF--------------CGTPEYLAPELLLGHGYTKA---VDWWTLG 180
Query: 666 IVFFELWH---PF----STAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718
++ +E+ PF M R+I+ L+ P + + + LL L+S P+
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLR----FPDGFD---RDAKDLLIGLLSRDPT 233
Query: 719 DR 720
R
Sbjct: 234 RR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 21/105 (20%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD--QDAAFPTDT 627
QI EG+A+I + IHRDL N+ KI DFGLA+ ++ + + A FP
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 169
Query: 628 GGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFEL 671
+TAPE I G I K+D++S GI+ +E+
Sbjct: 170 ---------------WTAPEAINFGSFTI--KSDVWSFGILLYEI 197
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 72/317 (22%), Positives = 129/317 (40%), Gaps = 68/317 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
++ E L LG G +G V ++ G A+K+IRL+ N +I+ E+ L +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN-QIIMELDILHKAVSP 59
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V +Y A+F G + M G+L A A E+ L
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDA-GSLDKLY----AGGVATEGIPEDVLRRI------- 107
Query: 544 YCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARNDIK 602
+Y +V+GL + + IIHRD+ P N+ + +K
Sbjct: 108 -----------TY-------------AVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVK 143
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPK----IDE 657
+ DFG++ L S+ T +G Y APE I+ G P
Sbjct: 144 LCDFGVSGNLV----------------ASLAKT-NIGCQSYMAPERIKSGGPNQNPTYTV 186
Query: 658 KADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQ--KGELPPSWVAKFS-EQESLLRR 711
++D++SLG+ E+ +P+ I + L G+ PP+ + +S + + + +
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSAIVDGD-PPTLPSGYSDDAQDFVAK 244
Query: 712 LMSPSPSDRPSATELLQ 728
++ P+ RP+ +LL+
Sbjct: 245 CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|232978 TIGR00443, hisZ_biosyn_reg, ATP phosphoribosyltransferase, regulatory subunit | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-06
Identities = 66/267 (24%), Positives = 106/267 (39%), Gaps = 43/267 (16%)
Query: 835 TVKLLTHGGDLLELSHELRLPFIRWAIS----NQKSSFKRYEISSVYRRA-IGHSPPNRY 889
KL G +L L ++ P R +S ++ + +V+R G +
Sbjct: 52 LFKLFDQLGRVLGLRPDMTAPIAR-LVSTRLRDRPLPLRLCYAGNVFRTNESGGGRSREF 110
Query: 890 LQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLN--HGDLLEAIWSWAGIKAE 947
Q ++IG +AEV+ + ++ + D + H L+ A+ AG+ E
Sbjct: 111 TQAGVELIGAGGPAADAEVIALLIEALKA---LGLKDFKIELGHVGLVRALLEEAGLPEE 167
Query: 948 HREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQ 1007
RE + E LA K +V +L+ EL L+ V RL + R G ++
Sbjct: 168 AREALREALA-------------RKDLVALEELVAELGLSPEVRERLLAL-PRLRGDGEE 213
Query: 1008 ALPRLRGALPADKPTRKALDELYLRIWRI------EKNIYID-ALMPPIESYHRNLFFQV 1060
L R AL + ALDEL + + E+ I +D L+ Y+ L F+
Sbjct: 214 VLEEAR-ALAGSETAEAALDELE-AVLELLEARGVEEYISLDLGLVRGY-HYYTGLIFEG 270
Query: 1061 FSVKEKYPATLVEGTLLAVGGRYDYLL 1087
++ P LA GGRYD LL
Sbjct: 271 YAPGLGAP--------LAGGGRYDELL 289
|
Apparant second copies of histidyl-tRNA synthetase, found in Bacillus subtilis, Synechocystis sp., Aquifex aeolicus, and others, are in fact a regulatory subunit of ATP phosphoribosyltransferase, and usually encoded by a gene adjacent to that encoding the catalytic subunit [Amino acid biosynthesis, Histidine family]. Length = 313 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 39/179 (21%)
Query: 555 SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL 614
+ + +E ++V L +H +GI+ RDL PNNI D R I++ F ++
Sbjct: 78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE- 136
Query: 615 EQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW-- 672
+ D +A Y APE+ G + E D +SLG + FEL
Sbjct: 137 DSCDGEAV-----------------ENMYCAPEV-GGISEETEACDWWSLGAILFELLTG 178
Query: 673 ------HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725
HP + + P WV++ E SLL++L+ +P++R A
Sbjct: 179 KTLVECHPSGINTHTTLNI----------PEWVSE--EARSLLQQLLQFNPTERLGAGV 225
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
QI +G++++ ++HRDL N+ + N +KI DFGLA+ L +++ + A
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA-------- 168
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVL 685
DG G+V + I + ++D++S G+ +EL P+ R+I
Sbjct: 169 ---DG-GKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-- 220
Query: 686 SDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
DL +KGE P + ++ + RP EL+ +
Sbjct: 221 PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 52/245 (21%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+I L +H +GII+RDL +N+ DA IK+ D+G+ K + P DT
Sbjct: 104 EISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---------EGIRPGDTTS 154
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW-------------HP-- 674
GT Y APEI +G D ++LG++ FE+ +P
Sbjct: 155 TF------CGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
Query: 675 ------FSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
F +E+QI +P S K S S+L+ ++ P +R Q
Sbjct: 208 NTEDYLFQVILEKQI---------RIPRSLSVKAS---SVLKGFLNKDPKERLGC--HPQ 253
Query: 729 DALPPQMEYELLDNI-LRMMHSSEDTSIYDKVVSSIFDEETLDMKHHAGTLRLNRDNTSS 787
+ NI ++ + Y + S D + D + ++L D+
Sbjct: 254 TGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDDPDV 313
Query: 788 IQYSD 792
I D
Sbjct: 314 IARID 318
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 34/155 (21%), Positives = 64/155 (41%), Gaps = 25/155 (16%)
Query: 538 LYIQMEYCPR--TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
LYI E+ L + + K++ + + + EG+ ++ IHRDL N
Sbjct: 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQD--AAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653
+ +K+ DFG+ +++ ++ A FP ++ PE+ +
Sbjct: 134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----------------WSPPEVFN-FS 176
Query: 654 KIDEKADMYSLGI----VFFELWHPFSTAMERQIV 684
K K+D++S G+ VF E PF ++V
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633
G+ ++ + IHRDL N +N +KI DFG+++ +++ TGG+
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR-------EEEDGVYASTGGMK-- 156
Query: 634 GTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFS------TAMERQIVLSD 687
Q+ +TAPE + + ++D++S GI+ LW FS + Q
Sbjct: 157 ---QIPVK-WTAPE-ALNYGRYSSESDVWSFGIL---LWEAFSLGAVPYANLSNQQTREA 208
Query: 688 LKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
++Q LP + L+ R P RPS + + Q+
Sbjct: 209 IEQGVRLPCPELCP-DAVYRLMERCWEYDPGQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 48/246 (19%), Positives = 94/246 (38%), Gaps = 58/246 (23%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ + +G G G V + G+ A+K+I L+ + P + I+ E+ + L++ ++
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNI 78
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V + ++ + G E L++ MEY
Sbjct: 79 VNFLDSF---------------------------------LVGDE-------LFVVMEYL 98
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
+ D+ + R+ ++ L +H +IHRD+ +N+ +K+ D
Sbjct: 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTD 158
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FG + EQ + + VGT ++ APE+ K D++SLG
Sbjct: 159 FGFCAQITPEQSKR---------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLG 202
Query: 666 IVFFEL 671
I+ E+
Sbjct: 203 IMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 53/185 (28%), Positives = 73/185 (39%), Gaps = 33/185 (17%)
Query: 432 LGHGGFGHVVL--CKNKL---DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVV 486
LG G FG V L C N L D AVK LK+ S RE L+ LQHQH+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTVLQHQHIV 70
Query: 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC- 545
R+Y GV +G + NR S G + K+ + +
Sbjct: 71 RFY------GVCT-EGRPLLMVFEYMRHGDLNRFLRSH---GPDAKILAGG---EDVAPG 117
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
TL Q+ + QI G+ ++ +HRDL N +KIGD
Sbjct: 118 QLTLGQML------------AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGD 165
Query: 606 FGLAK 610
FG+++
Sbjct: 166 FGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 43/178 (24%), Positives = 69/178 (38%), Gaps = 53/178 (29%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q+ G+A++ + +HRDL N+ R+ KI DFG+++ L
Sbjct: 103 QVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALG---------------- 146
Query: 630 VSVDGTGQVGTYFYTAPEIEQG--WP------------KIDEKADMYSLGIVFFELWHPF 675
G+ +Y A WP K K+D++S G+ LW F
Sbjct: 147 --------AGSDYYRA---TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVT---LWEAF 192
Query: 676 STA------MERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATEL 726
S M+ V++ L+ LP P + E S++ P DRP+ +EL
Sbjct: 193 SYGAKPYGEMKGAEVIAMLESGERLPRPEECPQ--EIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 52/202 (25%)
Query: 548 TLRQVFESYDHF--------DKELAWHLFRQ--------------IVEGLAHIHGQGIIH 585
L+ F+++D EL +HL R+ IV L ++H + +++
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA 645
RD+ N+ D IKI DFGL K E + A T GT Y A
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKT-----------FCGTPEYLA 163
Query: 646 PEIEQGWPKIDEKADMYSLGIVFFELW---HPF-STAMER---QIVLSDLKQKGELPPSW 698
PE+ + D + LG+V +E+ PF + ER I++ +++ L P
Sbjct: 164 PEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP-- 220
Query: 699 VAKFSEQESLLRRLMSPSPSDR 720
E +SLL L+ P R
Sbjct: 221 -----EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 44/177 (24%), Positives = 77/177 (43%), Gaps = 25/177 (14%)
Query: 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD 618
F +E + + EG+A++ +IHRDL N +K+ DFG+ +F+ +Q
Sbjct: 97 FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155
Query: 619 QDAAFPTDTGGVSVDGTGQVGTYF---YTAPEIEQGWPKIDEKADMYSLGIVFFELWHPF 675
T GT F +++PE+ + K K+D++S G++ +E++
Sbjct: 156 ----------------TSSTGTKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEG 198
Query: 676 STAMERQI---VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
T E + V+ + L +A S E L++ P DRPS + LL
Sbjct: 199 KTPYENRSNSEVVETINAGFRLYKPRLASQSVYE-LMQHCWKERPEDRPSFSLLLHQ 254
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-06
Identities = 46/203 (22%), Positives = 74/203 (36%), Gaps = 38/203 (18%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPV---NDRILREVATLSR 479
+DF + LG G FG V + V K K+ + + E+ R
Sbjct: 131 KDDFVLGKKLGEGAFGVVY--------KASLVNKQSKKEGKYVLKKATEYGAVEIWMNER 182
Query: 480 LQH--QHVVRYYQAWFETGVADFDGDSMW------GSGTLASSTFSNRAASSADVTGQEN 531
++ + + F V+ D W G TLA S + +
Sbjct: 183 VRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE------ 236
Query: 532 KLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPN 591
YL +++ P+ L + + ++ + RQI+ L +H GI+HRD+ P
Sbjct: 237 ----PYLLGKVQDLPKGLER--------ENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284
Query: 592 NIFFD-ARNDIKIGDFGLAKFLK 613
NI F KI D G A L+
Sbjct: 285 NIIFSEGSGSFKIIDLGAAADLR 307
|
Length = 566 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 28/169 (16%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQL--DQDAAFPTDT 627
QI EG+A I + IHRDL NI A KI DFGLA+ ++ + + A FP
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK- 168
Query: 628 GGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQ 682
+TAPE I G I K+D++S GI+ E+ P+ +
Sbjct: 169 ---------------WTAPEAINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
Query: 683 IVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731
++ + ++G P E +++ R P +RP+ E +Q L
Sbjct: 212 VIRA--LERGYRMPRPENCPEELYNIMMRCWKNRPEERPT-FEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 25/159 (15%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD--QDAAFPTDT 627
QI +G+A+I IHRDL NI KI DFGLA+ ++ + Q A FP
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168
Query: 628 GGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQI 683
+TAPE + + K+D++S GI+ EL P+ + R+
Sbjct: 169 ---------------WTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE- 211
Query: 684 VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722
VL +++ +P S E L++ P +RP+
Sbjct: 212 VLEQVERGYRMPCPQGCPESLHE-LMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 17/44 (38%), Positives = 27/44 (61%)
Query: 569 RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612
QI +G++++ + ++HRDL N+ +KI DFGLAK L
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-06
Identities = 73/321 (22%), Positives = 121/321 (37%), Gaps = 98/321 (30%)
Query: 432 LGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKSLPVNDRI--LREVATLSRLQHQHVV 486
+G G FG V + KL G+ A+K LK S R+ L E + + + H +++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSD-KQRLDFLTEASIMGQFDHPNII 68
Query: 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP 546
R GV VT +S + I EY
Sbjct: 69 RLE------GV----------------------------VT------KSRPVMIITEY-- 86
Query: 547 RTLRQVFESYDHF----DKELAW----HLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
S D F D + + R I G+ ++ +HRDL NI ++
Sbjct: 87 ----MENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN 142
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
K+ DFGL++ L+ D +A + T G + + +TAPE + K
Sbjct: 143 LVCKVSDFGLSRRLE----DSEATYTTKGGKIPIR---------WTAPEAIA-YRKFTSA 188
Query: 659 ADMYSLGIVFFEL--------WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLR 710
+D++S GIV +E+ W M Q V+ ++ LPP + S L
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWD-----MSNQDVIKAVEDGYRLPPP-----MDCPSALY 238
Query: 711 RLM----SPSPSDRPSATELL 727
+LM ++RP+ ++++
Sbjct: 239 QLMLDCWQKDRNERPTFSQIV 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 58/250 (23%), Positives = 101/250 (40%), Gaps = 69/250 (27%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRH-YAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
L+ LG G FG V K + G++ A+K I+ S D + E + +L H+ +V+
Sbjct: 9 LKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQ 63
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
Y GV T Q +YI EY
Sbjct: 64 LY------GVC----------------------------TKQRP------IYIVTEYMSN 83
Query: 548 --TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L + E F + + + EG+A++ + IHRDL N D + +K+ D
Sbjct: 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSD 143
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPEIEQGWPKIDEKADMY 662
FGL++++ LD + T VG+ F ++ PE+ + K K+D++
Sbjct: 144 FGLSRYV----LDDEY-------------TSSVGSKFPVRWSPPEVLL-YSKFSSKSDVW 185
Query: 663 SLGIVFFELW 672
+ G++ +E++
Sbjct: 186 AFGVLMWEVY 195
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 43/193 (22%), Positives = 70/193 (36%), Gaps = 43/193 (22%)
Query: 429 LQPLGHGGFGHVVL--CKNKLDGRHYAVKKIR-LKDKSLPVNDR-ILREVATLSRLQHQH 484
+ LG G FG V L C + + ++ LK+ + + RE L+ QH++
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 485 VVRYYQAWFETGVADFDGDSMW------GSGTLASSTFSN-RAASSADVTGQENKLESTY 537
+V++Y GV +GD G L S+ A+
Sbjct: 70 IVKFY------GVC-TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG----- 117
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
TL Q+ + QI G+ ++ Q +HRDL N
Sbjct: 118 --------ELTLSQLL------------QIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157
Query: 598 RNDIKIGDFGLAK 610
+KIGDFG+++
Sbjct: 158 DLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 64/309 (20%), Positives = 113/309 (36%), Gaps = 67/309 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ + +G G G V + G+ A++++ L+ + P + I+ E+ + ++ ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNI 79
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V Y ++ GD +W + MEY
Sbjct: 80 VNYLDSYLV-------GDELW---------------------------------VVMEYL 99
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
+ D+ + R+ ++ L +H +IHRD+ +NI +K+ D
Sbjct: 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FG + EQ + + VGT ++ APE+ K D++SLG
Sbjct: 160 FGFCAQITPEQSKR---------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLG 203
Query: 666 IVFFELWH---PFSTAME-RQIVLSDLKQKGEL--PPSWVAKFSEQESLLRRLMSPSPSD 719
I+ E+ P+ R + L EL P A F + L R +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD---FLNRCLDMDVEK 260
Query: 720 RPSATELLQ 728
R SA ELLQ
Sbjct: 261 RGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 29/105 (27%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTD 626
+ R I G+ ++ +HRDL NI ++ + K+ DFGL++ L + D + + T
Sbjct: 112 MLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTS 168
Query: 627 TGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
G + + +TAPE + K +D++S GIV +E+
Sbjct: 169 GGKIPIR---------WTAPE-AIAYRKFTSASDVWSFGIVMWEV 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 57/253 (22%), Positives = 94/253 (37%), Gaps = 67/253 (26%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ + + LQ +G G FG V+L + G AVK I K+ L E + +++L+H
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRH 58
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V+ E E LYI
Sbjct: 59 SNLVQLLGVIVE---------------------------------------EKGGLYIVT 79
Query: 543 EYCPR-TLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
EY + +L S + + E + ++ +HRDL N+ N
Sbjct: 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN 139
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
K+ DFGL K +A+ DTG + V +TAPE + K K+
Sbjct: 140 VAKVSDFGLTK---------EASSTQDTGKLPVK---------WTAPEALRE-KKFSTKS 180
Query: 660 DMYSLGIVFFELW 672
D++S GI+ +E++
Sbjct: 181 DVWSFGILLWEIY 193
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 65/309 (21%), Positives = 113/309 (36%), Gaps = 67/309 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ + +G G G V + G+ A+K++ L+ + P + I+ E+ + ++ ++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNI 78
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V Y ++ GD +W + MEY
Sbjct: 79 VNYLDSYLV-------GDELW---------------------------------VVMEYL 98
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
+ D+ + R+ ++ L +H +IHRD+ +NI +K+ D
Sbjct: 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTD 158
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FG + EQ + + VGT ++ APE+ K D++SLG
Sbjct: 159 FGFCAQITPEQSKR---------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLG 202
Query: 666 IVFFELWH---PFSTAME-RQIVLSDLKQKGEL--PPSWVAKFSEQESLLRRLMSPSPSD 719
I+ E+ P+ R + L EL P A F + L R +
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD---FLNRCLEMDVDR 259
Query: 720 RPSATELLQ 728
R SA ELLQ
Sbjct: 260 RGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 24/73 (32%), Positives = 32/73 (43%), Gaps = 9/73 (12%)
Query: 540 IQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
I MEY L+ E E L R++ + +H GI+H DLT +NI
Sbjct: 76 IVMEYIEGELLKDALE-------EARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG 128
Query: 599 NDIKIGDFGLAKF 611
I DFGL +F
Sbjct: 129 RIYFI-DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 16/102 (15%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+I L ++H +GII+RDL +N+ D+ IK+ D+G+ K + P DT
Sbjct: 104 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---------EGLRPGDT-- 152
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
+ GT Y APEI +G D ++LG++ FE+
Sbjct: 153 ----TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 44/180 (24%)
Query: 562 ELAWHLFR--------------QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFG 607
EL +HL R +IV L ++H +++RDL N+ D IKI DFG
Sbjct: 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFG 140
Query: 608 LAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667
L K E + A T GT Y APE+ + D + LG+V
Sbjct: 141 LCK----EGISDGATMKT-----------FCGTPEYLAPEVLED-NDYGRAVDWWGLGVV 184
Query: 668 FFELW---HPF-STAMER---QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
+E+ PF + E+ I++ +++ L P E +SLL L+ P R
Sbjct: 185 MYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP-------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 16/102 (15%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+I L +H +GII+RDL +N+ DA IK+ D+G+ K + P DT
Sbjct: 104 EICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK---------EGLGPGDTTS 154
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
GT Y APEI +G + D ++LG++ FE+
Sbjct: 155 TF------CGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 42/156 (26%), Positives = 62/156 (39%), Gaps = 36/156 (23%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD--QDAAFPTDT 627
Q+ G+A+I IHRDL NI KI DFGLA+ ++ + Q A FP
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK- 168
Query: 628 GGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSD 687
+TAPE + + K+D++S G I+L++
Sbjct: 169 ---------------WTAPEAAL-YGRFTIKSDVWSFG-----------------ILLTE 195
Query: 688 LKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA 723
L KG +P + E + R P P D P +
Sbjct: 196 LVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-05
Identities = 73/315 (23%), Positives = 129/315 (40%), Gaps = 57/315 (18%)
Query: 432 LGHGGFGHVVLC-KNKLDGR----HYAVKKIRLKDKSLPVNDR-ILREVATLSRLQHQHV 485
LG G FG VV +L GR AVK LK+ + R +L E L ++ H HV
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKM--LKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 486 VRYYQAWFETG----VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
++ Y A + G + ++ + +GS L S +R + + G + S+YL
Sbjct: 66 IKLYGACSQDGPLLLIVEY---AKYGS--LRSFLRESRKVGPSYL-GSDGNRNSSYLDNP 119
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
E T+ + AW QI G+ ++ ++HRDL N+ +
Sbjct: 120 DER-ALTMGDLIS--------FAW----QISRGMQYLAEMKLVHRDLAARNVLVAEGRKM 166
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD--GTGQVGTYFYTAPEIEQGWPKIDEKA 659
KI DFGL++ + ++D+ G + V + + YT ++
Sbjct: 167 KISDFGLSR----DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT------------QS 210
Query: 660 DMYSLGIVFFEL----WHPF-STAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714
D++S G++ +E+ +P+ A ER L + E P + E +L+
Sbjct: 211 DVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCS---EEMYNLMLTCWK 267
Query: 715 PSPSDRPSATELLQD 729
P RP+ ++ ++
Sbjct: 268 QEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 56/248 (22%), Positives = 95/248 (38%), Gaps = 60/248 (24%)
Query: 432 LGHGGFGHVV--LCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYY 489
LG G FG V + K K + AVK ++ + + D +LRE + +L + ++VR
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM-EYCPRT 548
G+ + ES L +++ E P
Sbjct: 62 -----IGICE---------------------------------AESWMLVMELAELGP-- 81
Query: 549 LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGL 608
L + + H ++ L Q+ G+ ++ +HRDL N+ ++ KI DFGL
Sbjct: 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141
Query: 609 AKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVF 668
+K A D G+ +Y APE + K K+D++S G++
Sbjct: 142 SK-----------ALGADENYYKAKTHGKWPVKWY-APEC-MNYYKFSSKSDVWSFGVL- 187
Query: 669 FELWHPFS 676
+W FS
Sbjct: 188 --MWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 32/171 (18%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLD--QDAAFPTDT 627
QI G+A++ +HRDL NI K+ DFGLA+ ++ + Q A FP
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK- 168
Query: 628 GGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQI 683
+TAPE + + K+D++S GI+ EL P+ + R++
Sbjct: 169 ---------------WTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 212
Query: 684 VLSDLKQKG---ELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731
+ D ++G PP + L+ + P +RP+ E LQ L
Sbjct: 213 L--DQVERGYRMPCPPECPESLHD---LMCQCWRKEPEERPT-FEYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-04
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 18/121 (14%)
Query: 554 ESYDHFDKELAWH---LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
E++D D+ L + +Q++ + +IH + +IHRD+ NIF + I +GDFG A
Sbjct: 256 EAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFE 670
+ E+ D G VGT +PEI G E D++S G++ +
Sbjct: 316 PFEKEREAFD--------------YGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLD 360
Query: 671 L 671
+
Sbjct: 361 M 361
|
Length = 501 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 77/320 (24%), Positives = 123/320 (38%), Gaps = 74/320 (23%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
LG G FG V+L K K GR+YA+ KI LK + + D EVA L V++ +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAM-KI-LKKEVIVAKD----EVA--HTLTENRVLQNSRH 54
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQ 551
F T + + T F A+ ++ + ++ E
Sbjct: 55 PFLTALK-------YSFQTHDRLCFVMEYANGGEL----------FFHLSRERV------ 91
Query: 552 VFESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
F ++ A +IV L ++H + +++RDL N+ D IKI DFGL K
Sbjct: 92 -------FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFE 670
E + A T GT Y APE+ + D + LG+V +E
Sbjct: 145 ----EGIKDGATMKT-----------FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYE 188
Query: 671 LW---HPFSTAMERQ----IVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR--- 720
+ PF + I++ +++ L P E +SLL L+ P R
Sbjct: 189 MMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP-------EAKSLLSGLLKKDPKQRLGG 241
Query: 721 --PSATELLQDALPPQMEYE 738
A E++Q + ++
Sbjct: 242 GPDDAKEIMQHKFFAGIVWQ 261
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 60/254 (23%), Positives = 90/254 (35%), Gaps = 70/254 (27%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN----DRILREVATLSRL 480
DF ++ LG G FG V+L K + I+ +KS + D + E L+ +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYK--NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H V Y F +S YLY+
Sbjct: 89 NHPFCVNLY--------GSFKDES--------------------------------YLYL 108
Query: 541 QMEYC-PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
+E+ F ++ QIV ++ I++RDL P N+ D
Sbjct: 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG 168
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDE 657
IK+ DFG AK + DT ++ GT + Y APEI G K
Sbjct: 169 FIKMTDFGFAKVV-------------DTRTYTLCGTPE-----YIAPEILLNVGHGK--- 207
Query: 658 KADMYSLGIVFFEL 671
AD ++LGI +E+
Sbjct: 208 AADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-04
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 17/88 (19%)
Query: 525 DVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583
DV +E I MEY + L+ V E + EL R++ E +A +H GI
Sbjct: 405 DVDPEEKT-------IVMEYIGGKDLKDVLEG----NPELV----RKVGEIVAKLHKAGI 449
Query: 584 IHRDLTPNNIFFDARNDIKIGDFGLAKF 611
+H DLT +N + + + DFGL K+
Sbjct: 450 VHGDLTTSNFIVR-DDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 46/206 (22%), Positives = 63/206 (30%), Gaps = 69/206 (33%)
Query: 430 QPLGHGGFGHVVLCKN-----------KLDGRH-----YAVKKIRLKDKSLPVNDRILRE 473
+ LG G FG V LC+ + AVK +R D S + L+E
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR-PDASDNAREDFLKE 69
Query: 474 VATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKL 533
V LSRL ++ R L T
Sbjct: 70 VKILSRLSDPNIAR----------------------LLGVCT------------------ 89
Query: 534 ESTYLYIQMEY-CPRTLRQVFESYDHFDKELAW-----------HLFRQIVEGLAHIHGQ 581
L + MEY L Q + + LA ++ QI G+ ++
Sbjct: 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL 149
Query: 582 GIIHRDLTPNNIFFDARNDIKIGDFG 607
+HRDL N IKI DFG
Sbjct: 150 NFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 23/161 (14%)
Query: 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633
G+A++ + IHRDL N N +KI DFG+++ D G S
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR-------------QEDDGIYSSS 151
Query: 634 GTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGE 693
G Q+ +TAPE + + ++D++S GI+ LW FS + +++ + + +
Sbjct: 152 GLKQIPIK-WTAPE-ALNYGRYSSESDVWSYGIL---LWETFSLGVCPYPGMTNQQAREQ 206
Query: 694 LPPSWVAKFSEQ-----ESLLRRLMSPSPSDRPSATELLQD 729
+ + ++ +++R P +RP +EL ++
Sbjct: 207 VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
QI +G+ ++ + ++HRDL N+ +KI DFGLAK L ++ + + G
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE----KEYHAEGGK 172
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVL 685
V + + A E ++D++S G+ +EL P+ +I
Sbjct: 173 VPIK---------WMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-- 220
Query: 686 SDLKQKGE-LPPSWVAKFSEQESLLRRLMSPSPSDRPSATELL----QDALPPQMEYELL 740
S + +KGE LP + +++ M RP EL+ + A PQ Y ++
Sbjct: 221 SSILEKGERLPQPPICTIDVYMIMVKCWMI-DADSRPKFRELIIEFSKMARDPQ-RYLVI 278
Query: 741 DNILRM-MHSSEDTSIYDKVVSSIFDEETLD 770
RM + S D++ Y ++ ++ +D
Sbjct: 279 QGDERMHLPSPTDSNFYRALMDEEDMDDVVD 309
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 42/178 (23%)
Query: 566 HLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK------FLKLEQLDQ 619
L QI G+ H+ +HRDL N ++ ++K+ L+K + KL
Sbjct: 121 ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN--- 177
Query: 620 DAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PF 675
A P + APE Q K+D++S G++ +E++ PF
Sbjct: 178 -ALIPLR----------------WLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPF 219
Query: 676 STAMERQIVLSDLKQKG-ELPPSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQ 728
+ + VL+ L+ ELP S L +LM + +P DRPS +EL+
Sbjct: 220 YGLSDEE-VLNRLQAGKLELPVP-----EGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 52/218 (23%), Positives = 82/218 (37%), Gaps = 53/218 (24%)
Query: 417 LPSSRYLNDFEELQPLGHGGFGHVVLCK--------------NKLDGRHY--AVKKIRLK 460
P L F+E LG G FG V LC+ N GR AVK +R
Sbjct: 2 FPRGHLL--FKE--KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR-P 56
Query: 461 DKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETG----VADF--DGDSMWGSGTLASS 514
D + + L+EV LSRL+ +++R + + ++ +GD + L+S
Sbjct: 57 DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL---NQFLSSH 113
Query: 515 TFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEG 574
++ + D + L + SY H+ QI G
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAI------------------SY-----SSLLHVALQIASG 150
Query: 575 LAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612
+ ++ +HRDL N IKI DFG+++ L
Sbjct: 151 MKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 16/110 (14%)
Query: 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTD 626
L Q+ G+ ++ G+ +HRDL N+ ++ KI DFGL+K L + D+ +
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD----DSYYKAR 155
Query: 627 TGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFS 676
+ G+ +Y APE + K ++D++S GI +W FS
Sbjct: 156 SA-------GKWPLKWY-APECIN-FRKFSSRSDVWSYGIT---MWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 42/154 (27%), Positives = 65/154 (42%), Gaps = 22/154 (14%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+IV L ++H I++RDL N+ D IKI DFGL K E + A T
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKT---- 154
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLS 686
GT Y APE+ + D + LG+V +E+ PF ++
Sbjct: 155 -------FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
Query: 687 DLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
L + + P + ++ +SLL L+ P+ R
Sbjct: 207 ILMEDIKFPRTLS---ADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 43/195 (22%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 538 LYIQMEYCPR-TLRQVFESYDHFDKELAWHLF-RQIVEGLAHIHGQGIIHRDLTPNNIFF 595
++I ME P LR + + + L+ Q+ LA++ + +HRD+ N+
Sbjct: 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
+ + +K+GDFGL+++ L+ ++ + G + + + APE + +
Sbjct: 141 SSPDCVKLGDFGLSRY-----LEDESYYKASKGKLPIK---------WMAPE-SINFRRF 185
Query: 656 DEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR 711
+D++ G+ +E+ PF ++ V+ ++ GE P SL+ +
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN-GERLPMPPNCPPTLYSLMTK 243
Query: 712 LMSPSPSDRPSATEL 726
+ PS RP TEL
Sbjct: 244 CWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 22/106 (20%)
Query: 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGV 630
+ EG+ ++ + ++HRDL NI K+ DFGLA+ + D +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV---------GSMGVDNSKL 159
Query: 631 SVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFS 676
V +TAPE + K K+D++S G++ LW FS
Sbjct: 160 PVK---------WTAPEALKH-KKFSSKSDVWSYGVL---LWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|202547 pfam03129, HGTP_anticodon, Anticodon binding domain | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 4e-04
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 1/91 (1%)
Query: 1136 VLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDT 1195
V++ L +L EL E I+ + + SL +++ A I +++ +
Sbjct: 3 VVIPLGEKDELEDYAQKLAEELREAGIRVELDDR-NESLGKKFRDADLIGIPFRLVVGEK 61
Query: 1196 GAQKGLVKVRHLDVKKEKEVQRESLVRFLLD 1226
+ G V VR D +++ V E LV L +
Sbjct: 62 ELENGTVTVRDRDTGEKETVSLEELVEKLKE 92
|
This domain is found in histidyl, glycyl, threonyl and prolyl tRNA synthetases it is probably the anticodon binding domain. Length = 93 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 22/76 (28%), Positives = 39/76 (51%)
Query: 537 YLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
Y +I +E +++F+ +K+L ++ + ++ L +IH GI H D+ P NI D
Sbjct: 101 YRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD 160
Query: 597 ARNDIKIGDFGLAKFL 612
N I D+G+A
Sbjct: 161 GNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-04
Identities = 18/43 (41%), Positives = 26/43 (60%)
Query: 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLA 609
+ RQ++ GL +H GI+HRD+ P N+ +KI DFG A
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 23/77 (29%), Positives = 34/77 (44%), Gaps = 11/77 (14%)
Query: 539 YIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH---GQGIIHRDLTPNNIF 594
Y+ ME+ TL +V +KE + Q+ E LA +H + H DL P NI
Sbjct: 69 YLLMEWIEGETLDEV----SEEEKE---DIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL 121
Query: 595 FDARNDIKIGDFGLAKF 611
D + I D+ A +
Sbjct: 122 VDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|237097 PRK12420, PRK12420, histidyl-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-04
Identities = 34/132 (25%), Positives = 61/132 (46%), Gaps = 10/132 (7%)
Query: 797 LRDYVVQVTKEMFRQHCAKHLEIEPMYLL-------GDCPQFKRNTVKLLTHGGDLLELS 849
LR+ + + +++F ++ K LE + + G + + L G L L
Sbjct: 20 LRNKIKRALEDVFERYGCKPLETPTLNMYELMSSKYGGGDEILKEIYTLTDQGKRDLALR 79
Query: 850 HELRLPFIRWAISNQ--KSSFKRYEISSVYRRA-IGHSPPNRYLQGDFDIIGGASALTEA 906
++L +PF + N + FKRYEI V+R I ++Q D DI+G S + EA
Sbjct: 80 YDLTIPFAKVVAMNPNIRLPFKRYEIGKVFRDGPIKQGRFREFIQCDVDIVGVESVMAEA 139
Query: 907 EVLKVTMDIVTR 918
E++ + ++ R
Sbjct: 140 ELMSMAFELFRR 151
|
Length = 423 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-04
Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 28/185 (15%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q+ G+ ++ Q IHRDL N+ N +KI DFGLA+ + + D T G
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH----NIDYYKKTTNGR 197
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKI-DEKADMYSLGIVFFELWHPFSTAMERQIV--LS 686
+ V + APE + ++ ++D++S G++ +E++ + V L
Sbjct: 198 LPVK---------WMAPEAL--FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
Query: 687 DLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
L ++G E ++R PS RP+ +L++D LD +L +
Sbjct: 247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED----------LDRVLTV 296
Query: 747 MHSSE 751
+ E
Sbjct: 297 TSTDE 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 40/206 (19%)
Query: 538 LYIQMEYCP--RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
+YI ME P L + + + + + G+ ++ + IHRDL N
Sbjct: 67 IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV 126
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGV--SVDGTGQVGTYFYTAPEIEQGWP 653
N +KI DFG+++ + GG+ DG Q+ +TAPE +
Sbjct: 127 GENNVLKISDFGMSR--------------EEEGGIYTVSDGLKQIPIK-WTAPE-ALNYG 170
Query: 654 KIDEKADMYSLGIVFFELWHPFS------TAMERQIVLSDLKQKGELP-----PSWVAKF 702
+ ++D++S GI+ LW FS M Q ++ +P P + +
Sbjct: 171 RYTSESDVWSYGIL---LWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYR- 226
Query: 703 SEQESLLRRLMSPSPSDRPSATELLQ 728
L+ + + P +RPS +E+
Sbjct: 227 -----LMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 24/78 (30%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 538 LYIQMEYC-----PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
+ + EYC LR+ ES+ + L Q+ +G+A + + IHRDL N
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLL--SFSYQVAKGMAFLASKNCIHRDLAARN 171
Query: 593 IFFDARNDIKIGDFGLAK 610
+ +KI DFGLA+
Sbjct: 172 VLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 53/237 (22%), Positives = 98/237 (41%), Gaps = 51/237 (21%)
Query: 538 LYIQMEYCPR-TLRQVFESYDHFDKELAWHLFR----------------QIVEGLAHIHG 580
LY+ +EY + LR+ + E ++ + R Q+ G+ ++
Sbjct: 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155
Query: 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
Q IHRDL N+ N +KI DFGLA+ + + D T G + V
Sbjct: 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVN----NIDYYKKTTNGRLPVK------- 204
Query: 641 YFYTAPEIEQGWPKI-DEKADMYSLGIVFFELW----HPF-STAMERQIVLSDLKQKGEL 694
+ APE + ++ ++D++S G++ +E++ P+ +E L + +
Sbjct: 205 --WMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK 260
Query: 695 PPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSE 751
P + +E ++R PS RP+ +L++D LD IL + + E
Sbjct: 261 PANCT---NELYMMMRDCWHAIPSHRPTFKQLVED----------LDRILTLTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 32/168 (19%)
Query: 569 RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPT 625
+Q+ G+A++ + +HRDL N +KI DFGL++ + + ++ A P
Sbjct: 137 KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPI 196
Query: 626 DTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAME----- 680
+ PE + + ++D+++ G+V LW FS M+
Sbjct: 197 R----------------WMPPE-SIFYNRYTTESDVWAYGVV---LWEIFSYGMQPYYGM 236
Query: 681 -RQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATEL 726
+ V+ ++ L P E +L+R S PSDRPS +
Sbjct: 237 AHEEVIYYVRDGNVLSCPDNCP--LELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.002
Identities = 22/80 (27%), Positives = 35/80 (43%), Gaps = 8/80 (10%)
Query: 539 YIQMEYCPRTLRQVFESYDHFDKELAW--------HLFRQIVEGLAHIHGQGIIHRDLTP 590
Y++M + Q +S D D E +W Q+ +G+ + + IHRD+
Sbjct: 181 YVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAA 240
Query: 591 NNIFFDARNDIKIGDFGLAK 610
N+ KI DFGLA+
Sbjct: 241 RNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 41/177 (23%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPTD 626
+I G+ H+H +H DL N F + +K+GD+G+ E + + D P
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 627 TGGVSVDGTGQVGTYFYTAPEI-----------EQGWPKIDEKADMYSLGIVFFELW--- 672
+ APE+ EQ P +++++LG+ +EL+
Sbjct: 167 ----------------WLAPELVGEFHGGLITAEQTKP-----SNVWALGVTLWELFENA 205
Query: 673 -HPFSTAMERQIVLSDLK-QKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATEL 726
P+S +R+++ +K Q+ +L P +SE+ + + SP R +A E+
Sbjct: 206 AQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q+ G+ ++ + IHRDL N+ N +KI DFGLA+ + +D T G
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYKK--TTNGR 203
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKI-DEKADMYSLGIVFFELW----HPF-STAMERQI 683
+ V + APE + +I ++D++S G++ +E++ P+ +E
Sbjct: 204 LPVK---------WMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 684 VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNI 743
L + + P + +E ++R PS RP+ +L++D LD I
Sbjct: 253 KLLKEGHRMDKPSNCT---NELYMMMRDCWHAVPSQRPTFKQLVED----------LDRI 299
Query: 744 LRMMHSSE 751
L + + E
Sbjct: 300 LALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 27/103 (26%), Positives = 49/103 (47%), Gaps = 16/103 (15%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+I +G+A++ + +HRDL N +KIGDFG+ + + + D G
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI----YETDYYRKGGKGL 182
Query: 630 VSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFEL 671
+ V + APE ++ G K+D++S G+V +E+
Sbjct: 183 LPVR---------WMAPESLKDG--VFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 37/175 (21%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
+I GL H+H IH DL N A +KIGD+GL+ + +D D
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN----KYKEDYYVTPDQLW 163
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDE------------KADMYSLGIVFFELW----H 673
V + + APE+ +DE +++++SLG+ +EL+
Sbjct: 164 VPLR---------WIAPEL------VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ 208
Query: 674 PFSTAMERQIVLSDLK-QKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATEL 726
P+ + Q++ ++ Q+ +LP P S++ + + P RPSA E+
Sbjct: 209 PYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.004
Identities = 34/146 (23%), Positives = 50/146 (34%), Gaps = 29/146 (19%)
Query: 540 IQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
I M Y P T RQ SY H + + R + A +H G + D+ N+
Sbjct: 98 IHMIYSPATRRQ---SYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFL----- 149
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI---- 655
+ D +D D+ G VG +T PE+ Q P
Sbjct: 150 ---VSDDSKVVL-----VDSDSFQINANG---TLHLCPVGVSEFTPPEL-QTLPSFVGFE 197
Query: 656 -DEKADMYSLGIVFFELW----HPFS 676
D + L ++ F L HP+S
Sbjct: 198 RTANHDNFGLAVLIFHLLFGGRHPYS 223
|
Length = 637 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.004
Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 26/180 (14%)
Query: 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
Q+ G+ ++ + IHRDL N+ N +KI DFGLA+ + D D T G
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH----DIDYYKKTSNGR 197
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKI-DEKADMYSLGIVFFELW----HPF-STAMERQI 683
+ V + APE + ++ ++D++S GI+ +E++ P+ +E
Sbjct: 198 LPVK---------WMAPEAL--FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
Query: 684 VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ--DALPPQMEYELLD 741
L + + P + E L+R P+ RP+ +L++ D + + E LD
Sbjct: 247 KLLREGHRMDKPSNCT---HELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLD 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1239 | |||
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| COG0124 | 429 | HisS Histidyl-tRNA synthetase [Translation, riboso | 100.0 | |
| KOG1936 | 518 | consensus Histidyl-tRNA synthetase [Translation, r | 100.0 | |
| PLN02972 | 763 | Histidyl-tRNA synthetase | 100.0 | |
| PLN02530 | 487 | histidine-tRNA ligase | 100.0 | |
| PRK12420 | 423 | histidyl-tRNA synthetase; Provisional | 100.0 | |
| CHL00201 | 430 | syh histidine-tRNA synthetase; Provisional | 100.0 | |
| PRK12292 | 391 | hisZ ATP phosphoribosyltransferase regulatory subu | 100.0 | |
| PRK12421 | 392 | ATP phosphoribosyltransferase regulatory subunit; | 100.0 | |
| TIGR00442 | 397 | hisS histidyl-tRNA synthetase. This model finds a | 100.0 | |
| PRK00037 | 412 | hisS histidyl-tRNA synthetase; Reviewed | 100.0 | |
| TIGR00443 | 314 | hisZ_biosyn_reg ATP phosphoribosyltransferase, reg | 100.0 | |
| PRK12295 | 373 | hisZ ATP phosphoribosyltransferase regulatory subu | 100.0 | |
| PF13393 | 311 | tRNA-synt_His: Histidyl-tRNA synthetase; PDB: 3HRI | 100.0 | |
| PRK12293 | 281 | hisZ ATP phosphoribosyltransferase regulatory subu | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| COG3705 | 390 | HisZ ATP phosphoribosyltransferase involved in his | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd00773 | 261 | HisRS-like_core Class II Histidinyl-tRNA synthetas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| TIGR00418 | 563 | thrS threonyl-tRNA synthetase. This model represen | 100.0 | |
| PRK12294 | 272 | hisZ ATP phosphoribosyltransferase regulatory subu | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PRK00413 | 638 | thrS threonyl-tRNA synthetase; Reviewed | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK12305 | 575 | thrS threonyl-tRNA synthetase; Reviewed | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PRK12444 | 639 | threonyl-tRNA synthetase; Reviewed | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PRK14799 | 545 | thrS threonyl-tRNA synthetase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PRK09194 | 565 | prolyl-tRNA synthetase; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN02908 | 686 | threonyl-tRNA synthetase | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| PRK12325 | 439 | prolyl-tRNA synthetase; Provisional | 99.95 | |
| TIGR00409 | 568 | proS_fam_II prolyl-tRNA synthetase, family II. Pro | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PRK04173 | 456 | glycyl-tRNA synthetase; Provisional | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| TIGR00408 | 472 | proS_fam_I prolyl-tRNA synthetase, family I. Proly | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PRK08661 | 477 | prolyl-tRNA synthetase; Provisional | 99.91 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.91 | |
| PLN02837 | 614 | threonine-tRNA ligase | 99.91 | |
| PRK03991 | 613 | threonyl-tRNA synthetase; Validated | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0441 | 589 | ThrS Threonyl-tRNA synthetase [Translation, riboso | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG4018 | 215 | consensus Uncharacterized conserved protein, conta | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd00670 | 235 | Gly_His_Pro_Ser_Thr_tRS_core Gly_His_Pro_Ser_Thr_t | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd00771 | 298 | ThrRS_core Threonyl-tRNA synthetase (ThrRS) class | 99.76 | |
| cd00779 | 255 | ProRS_core_prok Prolyl-tRNA synthetase (ProRS) cla | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| smart00591 | 107 | RWD domain in RING finger and WD repeat containing | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1637 | 560 | consensus Threonyl-tRNA synthetase [Translation, r | 99.68 | |
| TIGR00389 | 551 | glyS_dimeric glycyl-tRNA synthetase, dimeric type. | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| cd00772 | 264 | ProRS_core Prolyl-tRNA synthetase (ProRS) class II | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| PF05773 | 113 | RWD: RWD domain; InterPro: IPR006575 The RWD eukar | 99.6 | |
| cd00774 | 254 | GlyRS-like_core Glycyl-tRNA synthetase (GlyRS)-lik | 99.59 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| COG0423 | 558 | GRS1 Glycyl-tRNA synthetase (class II) [Translatio | 99.58 | |
| PRK14894 | 539 | glycyl-tRNA synthetase; Provisional | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.57 | |
| PLN02734 | 684 | glycyl-tRNA synthetase | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| TIGR02367 | 453 | PylS pyrrolysyl-tRNA synthetase. PylS is the archa | 99.46 | |
| PF00587 | 173 | tRNA-synt_2b: tRNA synthetase class II core domain | 99.44 | |
| KOG2324 | 457 | consensus Prolyl-tRNA synthetase [Translation, rib | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.39 | |
| PRK04172 | 489 | pheS phenylalanyl-tRNA synthetase subunit alpha; P | 99.36 | |
| COG0442 | 500 | ProS Prolyl-tRNA synthetase [Translation, ribosoma | 99.36 | |
| cd00778 | 261 | ProRS_core_arch_euk Prolyl-tRNA synthetase (ProRS) | 99.33 | |
| PF03129 | 94 | HGTP_anticodon: Anticodon binding domain; InterPro | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| KOG4445 | 368 | consensus Uncharacterized conserved protein, conta | 99.28 | |
| cd00861 | 94 | ProRS_anticodon_short ProRS Prolyl-anticodon bindi | 99.24 | |
| cd00860 | 91 | ThrRS_anticodon ThrRS Threonyl-anticodon binding d | 99.24 | |
| cd00858 | 121 | GlyRS_anticodon GlyRS Glycyl-anticodon binding dom | 99.23 | |
| PRK09537 | 417 | pylS pyrolysyl-tRNA synthetase; Reviewed | 99.21 | |
| PTZ00326 | 494 | phenylalanyl-tRNA synthetase alpha chain; Provisio | 99.21 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.16 | |
| cd00862 | 202 | ProRS_anticodon_zinc ProRS Prolyl-anticodon bindin | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| cd00768 | 211 | class_II_aaRS-like_core Class II tRNA amino-acyl s | 99.12 | |
| cd00738 | 94 | HGTP_anticodon HGTP anticodon binding domain, as f | 99.12 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-93 Score=866.26 Aligned_cols=1117 Identities=39% Similarity=0.566 Sum_probs=728.6
Q ss_pred CCHHHHHHHHHHHhhhcCCceeeecCC----CCeEEEEEcCCCCCCCCCCCcEEEEEEEEcCCCCCCCCCccccccCCCC
Q 000880 29 DDNELLSEEITALCAIFQEDCKVVSGS----PPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGL 104 (1239)
Q Consensus 29 ~~~eeq~~ElEaL~sIy~d~~~~~~~~----~~~~~i~i~~~~~~~~~~~~~~~~~L~v~~p~~YP~~~P~~~~~~~~~l 104 (1239)
.+.|-|++|+|||.|||+++++-+... ...+.+.+.... . ..+..|++++++.||..+|.+.+.+..++
T Consensus 5 ~~~eiQ~~e~ea~k~i~~~d~e~l~~r~~w~~~i~l~~l~s~~-----~--~~~~~lh~~~~~~yp~~kp~i~lk~~~~~ 77 (1351)
T KOG1035|consen 5 LNYEIQENELEALKAIYMDDFEELKARWAWVCHILLIALRSCS-----L--KLSGRLHVKCKRKYPYSKPEIKLKDHQGV 77 (1351)
T ss_pred HHHHHHHHHHHhhcccccchHHHHHHHHhhhhhhhhhhhhhhh-----H--HHhhHhhhhhccccCCCCccccccccccc
Confidence 357899999999999999997654432 124444444332 1 36788999999999999999999999999
Q ss_pred CHHHHHHHHHHHHHHHHHhCCCCceeeehHHHHHHHHHHhhccCCCC--------Cc---------C-------------
Q 000880 105 TKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFLSEIVPLGQS--------NE---------S------------- 154 (1239)
Q Consensus 105 ~~~~~~~l~~~L~e~~~e~~~~G~~mif~lv~~lke~L~~~~~~~~~--------~~---------~------------- 154 (1239)
++++++.|.+.|+..+.... |++|||.|....||||.+.-..... .. +
T Consensus 78 ~d~~i~~L~~~l~~~~~~~~--G~~~i~eLa~~vqefl~~~~~~~~~~~dr~~~~~rr~~~~~~~~~q~ele~~~~e~~~ 155 (1351)
T KOG1035|consen 78 SDEDIELLSNELTALAKTLR--GEVMIAELASIVQEFLKDHQDRPSGFHDRMLQDIRRQYSKLMDYEQDELEAREIERCQ 155 (1351)
T ss_pred hHHHHHHHHHHHHHhhcccc--ccEEeeeHhhhhHHHHhccCCCCCcchHHHHHHHHHHHHhhhhhhhccHHHhhhHhhc
Confidence 99999999999999999999 9999999999999999986543331 00 0
Q ss_pred --CCCcc-------ccccc---------------------------------ccccC--c--------------------
Q 000880 155 --VPGLV-------TESSS---------------------------------QSFEG--S-------------------- 170 (1239)
Q Consensus 155 --~~~~~-------~~~~~---------------------------------~~~~~--~-------------------- 170 (1239)
.|... .++.. ++++. .
T Consensus 156 ~g~p~~~~~~~~t~~e~~~~~~~~~~vy~~ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~ 235 (1351)
T KOG1035|consen 156 RGSPRKTMSLQGTREESHGNIFYGKRVYPILSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELES 235 (1351)
T ss_pred cCCcchhhhhcCCCCCCcccceecceeeeeeccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHH
Confidence 00000 00000 00000 0
Q ss_pred cccccccCCCCcceeeeeeeeccC---CCCccccccccccCCCcccCCCCCCCCCCcchhh--hhhhccCCCcccccCCC
Q 000880 171 AVSASKSCSSKVPFVYGFIDLFSG---CGESWHWGLGIDENRGVVPSVPSHASDGSNYEVM--WRKIDKNVKPLMIPDAN 245 (1239)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 245 (1239)
.+|+ .-|--|.+|+|++.+++.+ .+.+|. ..-.++++.+-+|-++ .+|.. |++ -+.
T Consensus 236 l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~--~s~~~~~~~~q~v~~i-----~~~~~r~~~~-----------~~~ 296 (1351)
T KOG1035|consen 236 LSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEI--CSKVELRSLLQSVGSI-----PLETLRILHQ-----------KLL 296 (1351)
T ss_pred HHhh-ccccccceeEEeehhhcchHHHHHHHhh--cCccchHHHHhhcccc-----CHHHHHHHHH-----------HHh
Confidence 0111 2245678888999888887 122222 2334455544444332 23332 111 111
Q ss_pred CccccccCCccccccc-------c--ccCCCCceeccCC-CCCCCccccccccccccccchhhccCCCCCCCCCcccccc
Q 000880 246 QGTALIPSAKLDTVKE-------E--NEDDNRSISTTDS-STSPMEEWVENGIKGENRDSLLQDHGSNNDGGDTEIDRLE 315 (1239)
Q Consensus 246 ~~~~~~~~~~~~~~~~-------~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (1239)
-|.+..-++.++++.= + +.++...+|-++- +..|.+ ++..+.+.+...-
T Consensus 297 ~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~---------------------d~~~~~~~~~~~~ 355 (1351)
T KOG1035|consen 297 EGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP---------------------DNEKSFSDLLAEI 355 (1351)
T ss_pred hhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCC---------------------CcccchhhcCccc
Confidence 2233333334444331 1 1111111111010 011111 1111222222222
Q ss_pred cccccccCCCcCcccchhhHHHHHHHHHhcccCCCcCccHHHHHHHHhhc-----CCCCccccccCCCCcchhhhhhhHH
Q 000880 316 SFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATELYNL-----GIFSERGRDLASKPSSQFNKTFNQV 390 (1239)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~l~~~~~l~~lc~~~~~~~~~~~~~~~~l~~l-----~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (1239)
.+.-+.+-+.-.+....++|+..+++.+.-..+...+.-......-+-.. ......-.+...+-+.....-+...
T Consensus 356 ~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 356 RNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred cccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 33333333444444455666666666665555544442211111111000 0000000000000000000000000
Q ss_pred Hhh---hhcc--------ccccCCcCCCCCCCCCCCCCCCCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEec
Q 000880 391 FHQ---KMVS--------SRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL 459 (1239)
Q Consensus 391 ~~~---~~~s--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~ 459 (1239)
+.. ...+ ....+.+.+.....++. ....+||++||++++.||+||||.||+|+++.+|+.||||+|+.
T Consensus 436 f~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~-~r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl 514 (1351)
T KOG1035|consen 436 FLRFPTDNESSEFAPNDETSVPQFRLRFSGAMSPL-QRQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPL 514 (1351)
T ss_pred hcccccccccccccCccccccCccCCCCccccCcc-ccchhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccC
Confidence 000 0000 00111111111111221 22337999999999999999999999999999999999999998
Q ss_pred CCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC------CcCCC-------------------------
Q 000880 460 KDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD------SMWGS------------------------- 508 (1239)
Q Consensus 460 ~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~------~~~~~------------------------- 508 (1239)
+. +.....++.+|+++|++|+|||||+||.+|++.....-..+ .-|.-
T Consensus 515 ~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~ 593 (1351)
T KOG1035|consen 515 KA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSEL 593 (1351)
T ss_pred ch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchh
Confidence 76 66778899999999999999999999999998653100000 00000
Q ss_pred -----Ccccccccc------------------cc------cc-----------c-cccccccccccc-------ccEEEE
Q 000880 509 -----GTLASSTFS------------------NR------AA-----------S-SADVTGQENKLE-------STYLYI 540 (1239)
Q Consensus 509 -----g~~~s~~~~------------------~~------~~-----------~-~~~v~~~~~~~~-------~~~l~i 540 (1239)
+...++.+. +. +. . +..+...++..+ ..++||
T Consensus 594 ~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYI 673 (1351)
T KOG1035|consen 594 DSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYI 673 (1351)
T ss_pred hccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEE
Confidence 000000000 00 00 0 000111122222 278999
Q ss_pred EeeccCCCHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhcccc--c
Q 000880 541 QMEYCPRTLRQVFESYDHF--DKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE--Q 616 (1239)
Q Consensus 541 VmEy~~gsL~~~l~~~~~l--~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~--~ 616 (1239)
+||||+.++.+.+..++.+ ....+|++++||++||+|+|++|||||||||.||+++++++|||+|||+|+..... .
T Consensus 674 QMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~ 753 (1351)
T KOG1035|consen 674 QMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLES 753 (1351)
T ss_pred EHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhh
Confidence 9999998766666655555 48899999999999999999999999999999999999999999999999974311 1
Q ss_pred cccCCC-CCCCCCCccccCcccccCccCCCcccccCCC--CCCcchhhHHHHHHHHHhhcCCchhHHHHHHHHhhhhcCC
Q 000880 617 LDQDAA-FPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP--KIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGE 693 (1239)
Q Consensus 617 ~~~~~~-~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~ksDIwSlGviL~ELltPf~~~~~~~~~~~~~~~~~~ 693 (1239)
...... .....+....+.|+.+||..|+|||++.+.. .|+.|+|||||||||+||++||.+.|++...+..++ .+.
T Consensus 754 ~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR-~g~ 832 (1351)
T KOG1035|consen 754 IDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLR-KGS 832 (1351)
T ss_pred HhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcc-cCC
Confidence 111111 2223344455788999999999999998866 699999999999999999999999999999999998 888
Q ss_pred CCCc---cccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCchHHHHHHHHHhcCCCCCCcchhhhccccccchhhh
Q 000880 694 LPPS---WVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLD 770 (1239)
Q Consensus 694 ~p~~---~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~e~~~~ 770 (1239)
+|.. +.+..+....+|++||+.||++||||.++|++.|++....++. ..........+...+.......++++...
T Consensus 833 iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llppe~~el~-~~~~h~~~~~~~k~~~~~~~~~~~q~~~~ 911 (1351)
T KOG1035|consen 833 IPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPPEESELL-VFLQHLYIEQLGKAYKNLLQLIFEQEVLE 911 (1351)
T ss_pred CCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCccchHHH-HHHHHHHHHHHHHHHhchhhHHHHHhhhh
Confidence 8877 7777788999999999999999999999999999995333322 22222222223344444444455554444
Q ss_pred hhhccccccccCCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccceeccCCCccccccEEEEeccCCCeeeecC
Q 000880 771 MKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSH 850 (1239)
Q Consensus 771 ~~~~~~~~~ld~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~~~~~~~~~~~~~~~~~~D~~G~~l~LRP 850 (1239)
+..+ ++..+.. -.+++.+....+++++...+.++|++||+.+..||++.+.........+.+.+.|++|-.++|-.
T Consensus 912 ~~n~--~yd~~~~--~~~~~~~~~~~l~~~v~e~~~~ifr~Hga~~l~tpp~~~~~~~~~~~~~~v~~ld~sG~~v~Lp~ 987 (1351)
T KOG1035|consen 912 VLNH--QYDLDRL--SYIQYTEINNELREYVVEEVVKIFRKHGAIELETPPLSLRNACAYFSRKAVELLDHSGDVVELPY 987 (1351)
T ss_pred hhcc--ccccccc--cccccchhHHHHHHHHHHHHHHHHHHhcceeccCCccccccccchhccceeeeecCCCCEEEeec
Confidence 3332 2222222 34577788899999999999999999999999999985554455567889999999999999999
Q ss_pred CCcHHHHHHHHhCCCCceeEEeecCeEEcCCCCCCCCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEEC
Q 000880 851 ELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLN 930 (1239)
Q Consensus 851 D~T~~iaR~~~~~~~~P~r~~Y~g~VfR~e~~~~~~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg 930 (1239)
|++.|+||+++.|...-+|+|.++.|||..... ..+++++|+++|||...-..|||+|.++.|++...--..++.|.||
T Consensus 988 DLr~pfar~vs~N~~~~~Kry~i~rVyr~~~~~-hP~~~~ec~fDii~~t~sl~~AE~L~vi~Ei~~~~l~~~n~~i~ln 1066 (1351)
T KOG1035|consen 988 DLRLPFARYVSRNSVLSFKRYCISRVYRPAIHN-HPKECLECDFDIIGPTTSLTEAELLKVIVEITTEILHEGNCDIHLN 1066 (1351)
T ss_pred cccchHHHHhhhchHHHHHHhhhheeecccccC-CCccccceeeeEecCCCCccHHHHHHHHHHHHHHHhccCceeEEeC
Confidence 999999999999888899999999999987755 8889999999999988779999999999999987422335999999
Q ss_pred cHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHH----HHhcCChh
Q 000880 931 HGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVG----LRFCGAAD 1006 (1239)
Q Consensus 931 ~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~----~~~~g~~~ 1006 (1239)
|..++++++..+|++++++..+..++...-..+ ...++...-.. ...........+..++ ....|..
T Consensus 1067 H~~LL~Ai~~~~~i~~~~r~~v~~~l~~~~~~r-------~~~~~~~~~~~-~~~~~s~~~~~l~~~~~~~~~~~~~~~- 1137 (1351)
T KOG1035|consen 1067 HADLLEAILSHCGIPKDQRRKVAELLSDMGSSR-------PQRSEKELKWV-FIRRSSLQLAKLPEFVLNRLFLVAGRF- 1137 (1351)
T ss_pred hHHHHHHHHHHcCCCHHHHHHHHHHHHHHhhcc-------ccHHHHHHHHh-hhhHHHHHhhhhHHHHHhhhhhhhcch-
Confidence 999999999999999999999988877644322 11111111000 0111111112222211 1112322
Q ss_pred hHHHHHhccCCCChhHHHHHHHH-----HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccc
Q 000880 1007 QALPRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGG 1081 (1239)
Q Consensus 1007 ~~l~~l~~~~~~~~~~~~~l~~l-----~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GG 1081 (1239)
..+..++..+.....++ +|++| ++..+|+...+.|+.+..+....-.|++|.+.+..... +.+....++.||
T Consensus 1138 ~~l~~~~~~~~~~~~vr-~L~eLe~~~~~~~~~~i~~~~~i~~g~~~~~~~~~g~~~qi~a~~~~~--~~~~~~~la~Gg 1214 (1351)
T KOG1035|consen 1138 QALKLIRGKLRADSLVR-ALKELENVVGLLRSLGIEEHVHIYVGPTESRHRNGGIQFQITAEIKSN--TSGDPVLLAAGG 1214 (1351)
T ss_pred hhhHHHhhhhhhhHHHH-HHHHHHHHHHHHHHhccccceEEeeccceeEEcCCcEEEEEeecccCC--CcCCceeeeccc
Confidence 44555555444444444 88888 77888998888889887777777789999998875432 233445699999
Q ss_pred cccchhhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHHcC
Q 000880 1082 RYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEEN 1161 (1239)
Q Consensus 1082 RYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G 1161 (1239)
|||.|+..|++.+ .++ -.+|+|...- ..+...+..+..+.+.+..+||+||..+ ...+..++.+++.||..|
T Consensus 1215 Ryd~~~~~~~~~~---~~~---~p~a~gv~~~-~~~~~~~~~~~~~~~~~~~cdvlics~g-~~l~t~~~~l~~~LWs~g 1286 (1351)
T KOG1035|consen 1215 RYDSLLQEVRDEQ---KMN---LPGAIGVSAL-STIRQHAPKDLEPIKTPSSCDVLICSRG-SGLLTQRMELVAKLWSKG 1286 (1351)
T ss_pred chHHHHHHhhhhh---hhc---Ccccceehhh-HHHHHhhhccccCCCCcccccEEEEecC-CchHHHHHHHHHHHHHcC
Confidence 9999999997743 222 1357776522 2222222223333445568899999997 778999999999999999
Q ss_pred CeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEc--cCCcccccchHHHHHHHHHHH
Q 000880 1162 IKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHL--DVKKEKEVQRESLVRFLLDAI 1228 (1239)
Q Consensus 1162 ~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l--~~~~q~~v~~~el~~~i~~~l 1228 (1239)
|++++.+.+...+..+-.||+..-+.+++++- +++..||.. .......+-..+|++++.+.+
T Consensus 1287 I~a~i~~~~s~~~~e~~e~~~~~~i~~iliv~-----n~~~~vks~~~e~~se~~~~~~elv~f~~~~~ 1350 (1351)
T KOG1035|consen 1287 IKAEIVPDPSPSLEELTEYANEHEITCILIVT-----NQKEKVKSFELERKSEKVVGRTELVEFLLQAL 1350 (1351)
T ss_pred cccceeeCCCcchHHHHHHHhcCceEEEEEEe-----cceeeechhHHhhhhhhhhhHHHHHHHHHHhh
Confidence 99999999888899999999988888887775 566666654 444555566788888876654
|
|
| >COG0124 HisS Histidyl-tRNA synthetase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-74 Score=670.78 Aligned_cols=408 Identities=21% Similarity=0.295 Sum_probs=349.4
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-Ccc---ccccEEEEeccCCCeeeecCCCcH
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQ---FKRNTVKLLTHGGDLLELSHELRL 854 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~---~~~~~~~~~D~~G~~l~LRPD~T~ 854 (1239)
.|+|++|++|.++..+++++++++++|++|||.+|.||+| ++..+ |+. ..++||.|.|++|+.++||||+|+
T Consensus 6 ~prG~~D~lp~d~~~~~~i~~~~~~v~~~yGf~eI~TPifE~telf~r~~Ge~td~v~kemY~F~Dkggr~laLRpe~Ta 85 (429)
T COG0124 6 RPRGTRDFLPEDMALREYIESTIRKVFESYGFSEIRTPIFEYTELFARKSGEETDVVEKEMYTFKDKGGRSLALRPELTA 85 (429)
T ss_pred CCCCccccChHHHHHHHHHHHHHHHHHHHcCCEeccCccccchhHhhhccCCcccccccceEEEEeCCCCEEEecccCcH
Confidence 4899999999999999999999999999999999999999 44443 655 679999999999999999999999
Q ss_pred HHHHHHHhCCC---CceeEEeecCeEEcCCCCCCCCc-eeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEEC
Q 000880 855 PFIRWAISNQK---SSFKRYEISSVYRRAIGHSPPNR-YLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLN 930 (1239)
Q Consensus 855 ~iaR~~~~~~~---~P~r~~Y~g~VfR~e~~~~~~~e-f~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg 930 (1239)
|+||++++|.. .|+|+||+|+|||||+||+||+| |+|+|+|+||.+++.+|||||+|+.++|++||+.+ ++|+||
T Consensus 86 pv~R~~~en~~~~~~p~k~yy~g~vfRyErPQ~GR~RqF~Q~g~E~iG~~~~~~DAEvi~l~~~~l~~lGi~~-~~l~iN 164 (429)
T COG0124 86 PVARAVAENKLDLPKPLKLYYFGPVFRYERPQKGRYRQFYQFGVEVIGSDSPDADAEVIALAVEILEALGIGG-FTLEIN 164 (429)
T ss_pred HHHHHHHhccccccCCeeEEEecceecCCCCCCCCceeeEEcCeEEeCCCCcccCHHHHHHHHHHHHHcCCCc-EEEEEc
Confidence 99999998753 59999999999999999988875 99999999999999999999999999999999997 999999
Q ss_pred cHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHH
Q 000880 931 HGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALP 1010 (1239)
Q Consensus 931 ~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~ 1010 (1239)
|+++++++++.+|+ +.+..+.++|++.++. + +..+.+........+.+..|. ...+...++++
T Consensus 165 ~~g~l~~~~~~~gi--~~~~~l~~~ldk~~k~-------------~-~~~L~e~~~~r~~~n~lr~ld-~k~~~~~~~~~ 227 (429)
T COG0124 165 SRGILEGRLEYLGI--DQREALLRYLDKLDKI-------------G-KLELDEDSKRRLKTNPLRVLD-SKKDSDQELLK 227 (429)
T ss_pred CcccHHHHHHhhcc--hhHHHHHHHHhhhhhH-------------H-HHHhhhhhhhhhhhchHHHHH-hccchHHHHHh
Confidence 99999999999999 7888999999998742 1 122222233333455555554 33444456666
Q ss_pred HHhccCCC-ChhHHHHHHHH--HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccchh
Q 000880 1011 RLRGALPA-DKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLL 1087 (1239)
Q Consensus 1011 ~l~~~~~~-~~~~~~~l~~l--~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~ 1087 (1239)
.+..++.. ..+..+.++++ +|+++|+ .+.+|++++||||||||+|||++..+.+ .+++||||||||+|+
T Consensus 228 ~ap~i~~~~~~e~~~~~~~v~~~L~~~g~--~~~id~~lvRGLDYYtg~VFE~~~~~~~------~~~sI~gGGRYD~Lv 299 (429)
T COG0124 228 NAPELLDYLDEESLEHLEELLALLDALGI--SYEIDPSLVRGLDYYTGTVFEAVTDGLG------AQGSVCGGGRYDGLV 299 (429)
T ss_pred ccHHhhhhccHHHHHHHHHHHHHHHHcCC--CEEEccceecchhhccceEEEEEEcCCc------cccceecCccchHHH
Confidence 66555543 33566777777 8999995 3999999999999999999999988644 367899999999999
Q ss_pred hhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHHcCCeEEEe
Q 000880 1088 HRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFV 1167 (1239)
Q Consensus 1088 ~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G~~ve~~ 1167 (1239)
+.||++ ++||||||+|+|||+.+|+......+...+++|+|++.+ ++...+|+.+|+.||++|++|++.
T Consensus 300 ~~~gG~----------~~pavGFaiGveRl~~~l~~~~~~~~~~~~~~v~v~~~~-~~~~~~a~~la~~LR~~g~~~~~~ 368 (429)
T COG0124 300 EEFGGK----------PTPAVGFAIGVERLILALEEEGKEDPVETRVDVYVVPLG-EDAEPEALKLAQKLRAAGISVEVD 368 (429)
T ss_pred HHhCCC----------CCCceeEehHHHHHHHHHHHcCCCCCcCCCCCEEEEEcC-chhHHHHHHHHHHHHHcCCcEEEE
Confidence 999765 579999999999999998744333445678899999997 555789999999999999999998
Q ss_pred eCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHH
Q 000880 1168 PVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAI 1228 (1239)
Q Consensus 1168 ~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l 1228 (1239)
+. .+++++|+++|++.|++++||+|++|+++|+|+||||.+|+|..++++++++.+...+
T Consensus 369 ~~-~r~~k~q~k~A~~~g~~~~viiGe~E~~~g~v~vKdl~t~eq~~v~~~~~~~~~~~~~ 428 (429)
T COG0124 369 YS-GRKLKKQFKYADKLGARFAVILGEDELANGVVTVKDLATGEQEEVPLDELVEELKELL 428 (429)
T ss_pred ec-cccHHHHHHHHHHCCCCEEEEEcchHHhcCCEEEeeCCCCccceecHHHHHHHHHhhc
Confidence 88 6779999999999999999999999999999999999999999999999999887643
|
|
| >KOG1936 consensus Histidyl-tRNA synthetase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-73 Score=628.06 Aligned_cols=428 Identities=27% Similarity=0.453 Sum_probs=382.5
Q ss_pred cCCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCCCccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 781 NRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 781 d~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
-+.|+||+||.|.++.+++++.+.+.++|++||++.|+||+| ++.++..+..+.+|.|.|++|+.++||||+|+|+
T Consensus 60 lKtPKGTrD~~p~qm~lRe~if~~i~~vFkrhGa~~iDTPVFElkeiL~gKYGEdskLiYdlkDQGGEl~SLRYDLTVPf 139 (518)
T KOG1936|consen 60 LKTPKGTRDFSPEQMALREKIFSTIKEVFKRHGAETIDTPVFELKEILTGKYGEDSKLIYDLKDQGGELCSLRYDLTVPF 139 (518)
T ss_pred ecCCCCCCcCCHHHHHHHHHHHHHHHHHHHHcCCeeccccchhHHHHHhhhcccccceeEehhhcCCcEEEeecccccHH
Confidence 368999999999999999999999999999999999999999 7778833444999999999999999999999999
Q ss_pred HHHHHhCCCCceeEEeecCeEEcCCC---CCCCCceeEEeEEEeCCCC-cccHHHHHHHHHHHHHhcCCCCceEEEECcH
Q 000880 857 IRWAISNQKSSFKRYEISSVYRRAIG---HSPPNRYLQGDFDIIGGAS-ALTEAEVLKVTMDIVTRFFHAESCDIHLNHG 932 (1239)
Q Consensus 857 aR~~~~~~~~P~r~~Y~g~VfR~e~~---~~~~~ef~Q~GvEiiG~~s-~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~ 932 (1239)
||++|+|+...+++|+++.|||+++| ++|+||||||+++|.|.-+ ..+|+|++.++.++|+.|||.+ |.|++||+
T Consensus 140 ARylAmNki~sikRy~iAkVyRRd~P~mtrGR~REFYQcDFDIAG~~d~M~pdaE~lkiv~e~L~~l~Igd-~~iKvNhR 218 (518)
T KOG1936|consen 140 ARYLAMNKITSIKRYHIAKVYRRDQPAMTRGRYREFYQCDFDIAGQFDPMIPDAECLKIVVEILSRLGIGD-YGIKVNHR 218 (518)
T ss_pred HHHHHHcccccceeeeEEEEEeccCchhhchhhhhhhccCccccccCCCCCchHHHHHHHHHHHhhcCccc-eEEEecHH
Confidence 99999998889999999999999887 3556679999999999554 5899999999999999999985 99999999
Q ss_pred HHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHH
Q 000880 933 DLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRL 1012 (1239)
Q Consensus 933 ~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l 1012 (1239)
++++++++.+|+|++..+.++..+|++| |.+|++|++++..++|++++.++.+..++ .+.|. .+.++++
T Consensus 219 kiLdgmf~v~GVp~~~frtICSsIDKLd---------K~pwedVkkEmv~eKGlsee~ad~igeyv-~~~g~-~eL~e~l 287 (518)
T KOG1936|consen 219 KILDGMFAVCGVPEDKFRTICSSIDKLD---------KMPWEDVKKEMVFEKGLSEEAADRIGEYV-SLKGL-DELLEKL 287 (518)
T ss_pred HHHHHHHHHhCCCHHHhhhHHHhhhhhh---------cCCHHHHHHHHHHhcCCCHHHHHHHHHHh-hhccH-HHHHHHH
Confidence 9999999999999999999999999998 78999999999999999999999999999 56665 5666776
Q ss_pred hc--cCCCChhHHHHHHHH-----HHHHccCcccEEEccCCCCCCCccceeEEEEEecCC--CCcc---------ccccc
Q 000880 1013 RG--ALPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKE--KYPA---------TLVEG 1074 (1239)
Q Consensus 1013 ~~--~~~~~~~~~~~l~~l-----~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~--~~~~---------~~~~~ 1074 (1239)
.. .+..|+...+++++| +++.+|+.++|.||+|++||+|||||+|||++..+. ..|. ..+..
T Consensus 288 ~~d~~l~~n~~a~eal~dlk~Lf~y~~~fg~s~~isfDlSLARGLDYYTGvIyEav~~~~~~~~~a~~~~~~~~~e~~~v 367 (518)
T KOG1936|consen 288 IADPKLSQNEAAKEALADLKQLFEYLEIFGISERISFDLSLARGLDYYTGVIYEAVLRGLRLICPAGRYDQAGSTEPGGV 367 (518)
T ss_pred hcCCcccccHHHHHHHHHHHHHHHHHHHcCCcceEEeehHHhccchhhhceeeeeeeccccccCcchhhhccccccCCCc
Confidence 64 466788899999998 889999999999999999999999999999998651 1111 12334
Q ss_pred ccccccccccchhhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCc---CCCCCCCceEEEEecCCCccHHHHH
Q 000880 1075 TLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFK---PVRNEAGTSVLVCSRGGGGLLVERM 1151 (1239)
Q Consensus 1075 ~~i~~GGRYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~---~~~~~~~~~v~v~~~~~~~~~~~a~ 1151 (1239)
++||+|||||+|+++|+.. +..+|+||+++|++||+.+|++... .......++|+|...+ ...+.+++
T Consensus 368 GSvaaGGRYDnLv~mf~~k--------~~~vPcvG~S~GVeRiFsile~r~~~~~~~iR~t~t~V~V~~~~-k~~l~eR~ 438 (518)
T KOG1936|consen 368 GSVAAGGRYDNLVGMFDKK--------GDKVPCVGQSVGVERIFSILEQRAATVATKIRTTETQVYVAAAG-KNLLFERL 438 (518)
T ss_pred cccccCcchhhHHHHhccc--------cCcCCccceeehHhHHHHHHHHHHHhhhhccccCceEEEEEecC-CchHHHHH
Confidence 6899999999999998643 3468999999999999999973221 1234567889998886 67899999
Q ss_pred HHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHH
Q 000880 1152 ELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIA 1229 (1239)
Q Consensus 1152 ~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~ 1229 (1239)
++++.||..||.++..+..++++.+|+.||++.|||++||+|++|+++|.|+||++.+++.+.++.++++..|++.++
T Consensus 439 k~v~~Lw~agI~aE~~yk~~~~~~~q~~~~e~~~ip~~vi~Ge~El~~G~V~vk~~~~re~~~v~~e~~v~~l~~~l~ 516 (518)
T KOG1936|consen 439 KVVNALWDAGIKAEYLYKANPKLLKQFQYAEEAGIPLAVILGEEELADGSVKVKNVGTREEVLVKREQFVSELKDLLS 516 (518)
T ss_pred HHHHHHHhcCcchhhhhhcCccHHHHHHHHHhcCCCeEEEechhhhcCCeEEEEecccccceeccHHHHHHHHHHHhc
Confidence 999999999999999999889999999999999999999999999999999999999999999999999999998875
|
|
| >PLN02972 Histidyl-tRNA synthetase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-71 Score=674.41 Aligned_cols=416 Identities=25% Similarity=0.402 Sum_probs=366.8
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-CccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
+.|+|++|++|.++..++++++.++++|++|||++|.||+| .+.++ +++ .++||+|.|++|+.++||||+|+||
T Consensus 328 k~PkGtrD~lP~e~~~re~I~~~L~~vFk~hGy~eI~TPvfE~~Ell~~k~Ged-~k~mY~f~D~gGr~LaLRPDlTvPi 406 (763)
T PLN02972 328 KIPKGTRDFAKEQMAIREKAFSIITSVFKRHGATALDTPVFELRETLMGKYGED-SKLIYDLADQGGELCSLRYDLTVPF 406 (763)
T ss_pred CCCCCCccCCHHHHHHHHHHHHHHHHHHHHcCCEEccCCcccchHHhhcccCcc-hhheEEEECCCCCEEEeCCCChHHH
Confidence 78999999999999999999999999999999999999999 34445 444 5789999999999999999999999
Q ss_pred HHHHHhCCCCceeEEeecCeEEcCCCCCCCC-ceeEEeEEEeCCC-CcccHHHHHHHHHHHHHhcCCCCceEEEECcHHH
Q 000880 857 IRWAISNQKSSFKRYEISSVYRRAIGHSPPN-RYLQGDFDIIGGA-SALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDL 934 (1239)
Q Consensus 857 aR~~~~~~~~P~r~~Y~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~-s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~~i 934 (1239)
||+++++...|+|+||+|+|||+++|++|+. ||+|+||||||.. +..+|+|||.++.++|+.||+.+ |+|+|||+++
T Consensus 407 AR~vA~n~~~p~KrYyiG~VFR~e~pqkGR~REF~Q~G~EIIG~~~~~~aDAEVI~La~E~L~~LGi~d-f~I~INh~~i 485 (763)
T PLN02972 407 ARYVAMNGITSFKRYQIAKVYRRDNPSKGRYREFYQCDFDIAGVYEPMGPDFEIIKVLTELLDELDIGT-YEVKLNHRKL 485 (763)
T ss_pred HHHHHhCCCCcceEEEeccEEecCCCCCCCCccceEEeEEEEcCCCcchhhHHHHHHHHHHHHhCCCCc-eEEEeCCHHH
Confidence 9999998777999999999999999987765 6999999999974 45799999999999999999986 9999999999
Q ss_pred HHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhc
Q 000880 935 LEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRG 1014 (1239)
Q Consensus 935 ~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~ 1014 (1239)
++++++.+|++++..+.++.++++++ +.++++++++++...+++++.++.+..++ .+.|++.++++.++.
T Consensus 486 L~~ILe~lgi~~e~~~~v~~aIdkld---------k~~le~vk~eL~~~~gLs~e~~~~L~~L~-~L~G~~~evLd~L~~ 555 (763)
T PLN02972 486 LDGMLEICGVPPEKFRTICSSIDKLD---------KQSFEQVKKEMVEEKGLSNETADKIGNFV-KERGPPLELLSKLRQ 555 (763)
T ss_pred HHHHHHHcCCCHHHHHHHHHHHHHhh---------hhhHHHHHHHHhhhcCCCHHHHHHHHHHH-HhcCCHHHHHHHHHH
Confidence 99999999999999999999999987 56788888889888899999999999998 688887888888865
Q ss_pred c---CCCChhHHHHHHHH-----HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccch
Q 000880 1015 A---LPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYL 1086 (1239)
Q Consensus 1015 ~---~~~~~~~~~~l~~l-----~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L 1086 (1239)
. +..++.+.+++++| ++..+|+.+++.||++++||++||||+|||+|..+.+ .++||+|||||+|
T Consensus 556 ~~~~l~~~~~~~~aL~eL~~L~~~L~~~gv~~~I~fDlsLvRGLDYYTGiVFE~~~~g~~-------~gsIagGGRYD~L 628 (763)
T PLN02972 556 EGSEFLGNASSRAALDELEIMFKALEKSKAIGKIVFDLSLARGLDYYTGVIYEAVFKGAQ-------VGSIAAGGRYDNL 628 (763)
T ss_pred hhHhhccChHHHHHHHHHHHHHHHHHhcCCCccEEECCcccCCCcccCceEEEEEEcCCc-------cceeeecCCchhH
Confidence 3 34566677788877 7788888888999999999999999999999987532 1479999999999
Q ss_pred hhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCc-C--CCCCCCceEEEEecCCCccHHHHHHHHHHHHHcCCe
Q 000880 1087 LHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFK-P--VRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIK 1163 (1239)
Q Consensus 1087 ~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~-~--~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G~~ 1163 (1239)
+++||+. ++||||||||+|||+.+|+.... . ...+.+++|+|++.+ ++.+.+++++++.||+.||+
T Consensus 629 v~~FgG~----------~vPAVGFSiGIERL~~~L~~~~~~~~~~~~~~~~dVlV~s~g-~~~l~~alkia~~LR~aGI~ 697 (763)
T PLN02972 629 VGMFSGK----------QVPAVGVSLGIERVFAIMEQQEEEKSQVIRPTETEVLVSIIG-DDKLALAAELVSELWNAGIK 697 (763)
T ss_pred HHhcCCC----------CCCEEEEEecHHHHHHHHHHcccCCCCCCCCCCCcEEEEEeC-HHHHHHHHHHHHHHHHCCCE
Confidence 9999643 57999999999999988863221 1 123345789999985 66788999999999999999
Q ss_pred EEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHH
Q 000880 1164 AQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIA 1229 (1239)
Q Consensus 1164 ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~ 1229 (1239)
+++.+ .++++++++||++.|++++||+|++|.++|+|+||||.+++|..|++++++.+|+..+.
T Consensus 698 aE~~~--~~kl~kq~~~A~k~gi~~vVIIGe~E~~~g~VkVKnL~tgeq~~V~~delv~~l~~~l~ 761 (763)
T PLN02972 698 AEYKV--STRKAKHLKRAKESGIPWMVLVGEKELSKGFVKLKNLEAGVEEEVDRTCFVQELKAELL 761 (763)
T ss_pred EEEeC--CCCHHHHHHHHHHCCCCEEEEECchHHhCCeEEEEECCCCcceEeeHHHHHHHHHHHhc
Confidence 99644 46899999999999999999999999999999999999999999999999999988775
|
|
| >PLN02530 histidine-tRNA ligase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-67 Score=631.49 Aligned_cols=403 Identities=19% Similarity=0.245 Sum_probs=345.3
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-CccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
..|+|++|++|.++.+++++++.++++|++|||++|.||+| ++..+ ++...++||+|.|++|+.++||||+|+|+
T Consensus 71 ~~p~G~~D~lp~~~~~~~~i~~~~~~~~~~~Gy~~I~tP~lE~~el~~~~~g~~~~~~~y~f~D~~g~~l~LRpD~T~~i 150 (487)
T PLN02530 71 NPPKGTRDFPPEDMRLRNWLFDHFREVSRLFGFEEVDAPVLESEELYIRKAGEEITDQLYNFEDKGGRRVALRPELTPSL 150 (487)
T ss_pred CCCCCcCcCCHHHHHHHHHHHHHHHHHHHHcCCEeccccccchHHHhccccCcccccceEEEECCCCCEEecCCCCcHHH
Confidence 46899999999999999999999999999999999999999 44444 77789999999999999999999999999
Q ss_pred HHHHHhCC---CCceeEEeecCeEEcCCCCCCCC-ceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCC-ceEEEECc
Q 000880 857 IRWAISNQ---KSSFKRYEISSVYRRAIGHSPPN-RYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAE-SCDIHLNH 931 (1239)
Q Consensus 857 aR~~~~~~---~~P~r~~Y~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~-~~~i~lg~ 931 (1239)
||+++++. ..|+|+||+|+|||++++++++. ||+|+|+|+||.+++.+|+|||+++.++|+.||+++ +++|+|||
T Consensus 151 aR~~~~~~~~~~~P~r~~y~g~vfR~e~~q~gr~REf~Q~giEiiG~~~~~aDaEvi~l~~~~l~~lgl~~~~~~i~i~~ 230 (487)
T PLN02530 151 ARLVLQKGKSLSLPLKWFAIGQCWRYERMTRGRRREHYQWNMDIIGVPGVEAEAELLAAIVTFFKRVGITSSDVGIKVSS 230 (487)
T ss_pred HHHHHhcccccCCCeEEEEEcCEEcCcCCCCCCccceEEcCeeEeCCCCcchhHHHHHHHHHHHHHcCCCCCceEEEEcC
Confidence 99999864 35999999999999999887765 799999999999999999999999999999999962 49999999
Q ss_pred HHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHH
Q 000880 932 GDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPR 1011 (1239)
Q Consensus 932 ~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~ 1011 (1239)
+++++++++.++++++.+..++.++++++ +.+.++++.. +...+++.+.++.+..++ .+. .+++
T Consensus 231 ~~i~~~~l~~~~~~~~~~~~v~~~~d~l~---------k~~~~~l~~~-L~~~~~~~~~~~~l~~l~-~~~-----~~~~ 294 (487)
T PLN02530 231 RKVLQAVLKSYGIPEESFAPVCVIVDKLE---------KLPREEIEKE-LDTLGVSEEAIEGILDVL-SLK-----SLDD 294 (487)
T ss_pred HHHHHHHHHHcCCchhhHHHHHHHHHhhh---------hccHHHHHHH-HHHcCCCHHHHHHHHHHH-hcc-----CHHH
Confidence 99999999999999988888888888877 3455666555 456888888888887777 222 2445
Q ss_pred HhccCCCChhHHHHHHHH--HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccchhhh
Q 000880 1012 LRGALPADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHR 1089 (1239)
Q Consensus 1012 l~~~~~~~~~~~~~l~~l--~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~ 1089 (1239)
+..++.......+.|+++ +++.+|+.+++.|||+++||++||||+|||+|... +..++||+|||||+|++.
T Consensus 295 l~~~~~~~~~~l~~L~~l~~~l~~~g~~~~i~~Dl~lvrgldYYTGivFe~~~~~-------~~~~~I~gGGRYD~Li~~ 367 (487)
T PLN02530 295 LEALLGADSEAVADLKQLFSLAEAYGYQDWLVFDASVVRGLAYYTGIVFEGFDRA-------GKLRAICGGGRYDRLLST 367 (487)
T ss_pred HHHHhhhhHHHHHHHHHHHHHHHHcCCCccEEEecccccCccccCceEEEEEecC-------CCcceeeecccHHHHHHH
Confidence 555443222344555555 88889998889999999999999999999999742 123479999999999999
Q ss_pred ccccccccccCCCCCCceeeeeccHHHHHhhCCC-CCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHHcCCeEEEee
Q 000880 1090 MWDREYVGYASRTNPPSGVGASLALETIIQHYPV-DFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVP 1168 (1239)
Q Consensus 1090 fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~-~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G~~ve~~~ 1168 (1239)
||+. ++||||||+|++||+.+++. +..+. ...+.+|+|++.+ ++...+|+++|+.||+.|++|++.+
T Consensus 368 fgg~----------~~pAvGFa~g~~~l~~~l~~~g~~p~-~~~~~dVlVi~~~-~~~~~~A~~ia~~LR~~Gi~vevd~ 435 (487)
T PLN02530 368 FGGE----------DTPACGFGFGDAVIVELLKEKGLLPE-LPHQVDDVVFALD-EDLQGAAAGVASRLREKGRSVDLVL 435 (487)
T ss_pred hCCC----------CCCeeEEEEhHHHHHHHHHhcCCCCC-CCCCCcEEEEEcC-hHHHHHHHHHHHHHHHCCCeEEEec
Confidence 9754 46999999999999888763 33333 2356789999985 6678899999999999999999887
Q ss_pred CCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHH
Q 000880 1169 VPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESL 1220 (1239)
Q Consensus 1169 ~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el 1220 (1239)
. .+++++++++|++.|+++++++|++|.++++|+||||.+|+|..|++++|
T Consensus 436 ~-~~~l~k~ik~A~k~g~~~iviiG~~E~~~~~V~vK~l~sgeq~~v~~~el 486 (487)
T PLN02530 436 E-PKKLKWVFKHAERIGAKRLVLVGASEWERGMVRVKDLSSGEQTEVKLDEL 486 (487)
T ss_pred C-CCCHHHHHHHHHHCCCCEEEEEchhHHhCCeEEEEECCCCcceEechHHc
Confidence 7 56899999999999999999999999999999999999999999988765
|
|
| >PRK12420 histidyl-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-64 Score=604.74 Aligned_cols=402 Identities=21% Similarity=0.338 Sum_probs=342.9
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccC---CCccccccEEEEeccCCCeeeecCCCcH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLG---DCPQFKRNTVKLLTHGGDLLELSHELRL 854 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~---~~~~~~~~~~~~~D~~G~~l~LRPD~T~ 854 (1239)
..|+|++|++|.++.+++++++.++++|++|||++|.||+| ++.. .++...++||+|.|++|+.|+||||+|+
T Consensus 5 ~~p~G~~d~~p~~~~~~~~i~~~l~~~f~~~Gy~~i~tP~lE~~~~~~~~~~~~~~~~~~~~~~~D~~g~~l~LRpD~T~ 84 (423)
T PRK12420 5 RNVKGTKDYLPEEQVLRNKIKRALEDVFERYGCKPLETPTLNMYELMSSKYGGGDEILKEIYTLTDQGKRDLALRYDLTI 84 (423)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCEeccccccchHHHHhcccCCCcccccceEEEecCCCceecccccccH
Confidence 36899999999999999999999999999999999999999 3333 2466779999999999999999999999
Q ss_pred HHHHHHHhCC--CCceeEEeecCeEEcCCCCCCC-CceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEECc
Q 000880 855 PFIRWAISNQ--KSSFKRYEISSVYRRAIGHSPP-NRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNH 931 (1239)
Q Consensus 855 ~iaR~~~~~~--~~P~r~~Y~g~VfR~e~~~~~~-~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~ 931 (1239)
||||+++++. ..|+|+||+|+|||++++++++ +||+|+|+|+||.+++.+|+|||+++.++|+.||+ + +.|+|||
T Consensus 85 ~iaR~va~~~~~~~p~r~~y~g~vfR~~~~~~gr~rE~~Q~g~EiiG~~~~~adaEvi~la~~~l~~lg~-~-~~i~l~~ 162 (423)
T PRK12420 85 PFAKVVAMNPNIRLPFKRYEIGKVFRDGPIKQGRFREFIQCDVDIVGVESVMAEAELMSMAFELFRRLNL-E-VTIQYNN 162 (423)
T ss_pred HHHHHHHhCcCCCCCeeEEEEcceECCCCCCCCccceeEECCeeeECCCCCcccHHHHHHHHHHHHHCCC-C-EEEEEcC
Confidence 9999999864 4599999999999998877555 57999999999999999999999999999999999 4 9999999
Q ss_pred HHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHH
Q 000880 932 GDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPR 1011 (1239)
Q Consensus 932 ~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~ 1011 (1239)
+++++++++.+|++++.++.++.++++++ +.++.++++.+ .+.+++++.++.+..|+ .+++. ..++.
T Consensus 163 ~~l~~~il~~~~~~~~~~~~~~~~ld~~~---------~~~~~~~~~~l-~~~~l~~~~~~~l~~l~-~~~~~--~~~~~ 229 (423)
T PRK12420 163 RKLLNGILQAIGIPTELTSDVILSLDKIE---------KIGIDGVRKDL-LERGISEEMADTICNTV-LSCLQ--LSIAD 229 (423)
T ss_pred HHHHHHHHHHcCCChhhhhchhhheechh---------hcCHHHHHHHH-HHcCCCHHHHHHHHHHH-hccCh--hhHHH
Confidence 99999999999999998888877777665 44566665555 44789999999999988 45543 34666
Q ss_pred HhccCCCChhHHHHHHHH-----HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccch
Q 000880 1012 LRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYL 1086 (1239)
Q Consensus 1012 l~~~~~~~~~~~~~l~~l-----~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L 1086 (1239)
++..+ .++.+.+++++| .++.+|+..++.||++++|+++||||+|||+|..+.+ ...+||+|||||+|
T Consensus 230 ~~~~~-~~~~~~~~l~~l~~l~~~l~~~g~~~~i~~Dl~~vr~l~YYtG~vFe~~~~~~~------~~~~i~~GGRYD~L 302 (423)
T PRK12420 230 FKEAF-NNPLVAEGVNELQQLQQYLIALGINENCIFNPFLARGLTMYTGTVYEIFLKDGS------ITSSIGSGGRYDNI 302 (423)
T ss_pred HHHhc-cCHHHHHHHHHHHHHHHHHHHhCCCCcEEEeccccCCCcccceeEEEEEecCCC------ccccccCCccHHHH
Confidence 66533 456666677766 7888898888999999999999999999999987632 12369999999999
Q ss_pred hhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHH-cCCeEE
Q 000880 1087 LHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWE-ENIKAQ 1165 (1239)
Q Consensus 1087 ~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~-~G~~ve 1165 (1239)
+++||+. +.++||||||+++|||+.++..... ...+.+|+|++.+ + ...|++++++||+ .|++|+
T Consensus 303 ~~~f~~~--------~~~~pAvGfa~~~~~l~~~l~~~~~---~~~~~dvlI~~~~-~--~~~a~~ia~~Lr~~~Gi~ve 368 (423)
T PRK12420 303 IGAFRGD--------DMNYPTVGISFGLDVIYTALSQKET---ISSTADVFIIPLG-T--ELQCLQIAQQLRSTTGLKVE 368 (423)
T ss_pred HHHhCCC--------CCCCCceeEEEcHHHHHHHHHhcCC---CCCCceEEEEEcC-C--HHHHHHHHHHHHhhcCCeEE
Confidence 9998542 2357999999999999988763221 1246799999974 3 3579999999999 999999
Q ss_pred EeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHH
Q 000880 1166 FVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESL 1220 (1239)
Q Consensus 1166 ~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el 1220 (1239)
+... .+++++++++|++.|+++++++|++|.++++|+||++.+++|..++++++
T Consensus 369 ~~~~-~~~l~~~i~~A~~~g~~~iviig~~e~~~~~v~vr~~~~~~~~~v~~~~~ 422 (423)
T PRK12420 369 LELA-GRKLKKALNYANKENIPYVLIIGEEEVSTGTVMLRNMKEGSEVKVPLSSL 422 (423)
T ss_pred EecC-CcCHHHHHHHHHHcCCCEEEEEChhHHhcCeEEEEECCCCceeeeeHHHc
Confidence 8887 67899999999999999999999999999999999999999999998875
|
|
| >CHL00201 syh histidine-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-62 Score=587.52 Aligned_cols=402 Identities=15% Similarity=0.167 Sum_probs=313.1
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-Ccc---ccccEEEEeccCCCeeeecCCCc
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQ---FKRNTVKLLTHGGDLLELSHELR 853 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~---~~~~~~~~~D~~G~~l~LRPD~T 853 (1239)
..|+|++|++|.++..++.+++.++++|++|||++|.||+| ++... |+. ..++||+|.|.+|+.++||||+|
T Consensus 5 ~~p~G~~D~lp~~~~~~~~i~~~i~~~~~~~Gy~~I~TP~~E~~e~~~~~~G~~~~~~~~~my~~~d~~g~~l~LRpd~T 84 (430)
T CHL00201 5 QAIRGTKDILPDEINYWQFIHDKALTLLSLANYSEIRTPIFENSSLYDRGIGETTDIVNKEMYRFTDRSNRDITLRPEGT 84 (430)
T ss_pred CCCCCCCcCCHHHHHHHHHHHHHHHHHHHHcCCeeecCcccchHHHHhcccCCcccccccceEEEEcCCCCEEEeCCCCc
Confidence 36899999999999999999999999999999999999999 33333 433 46899999999999999999999
Q ss_pred HHHHHHHHhCC----CCceeEEeecCeEEcCCCCCCCC-ceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEE
Q 000880 854 LPFIRWAISNQ----KSSFKRYEISSVYRRAIGHSPPN-RYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIH 928 (1239)
Q Consensus 854 ~~iaR~~~~~~----~~P~r~~Y~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~ 928 (1239)
+|+||+++++. ..|+|+||+|+|||+++||.||. ||+|+|+|+||..++.||+|||.++.++|+.||+++ ++|+
T Consensus 85 ~~iaR~~~~~~~~~~~~p~R~~y~g~vfR~e~~q~GR~Ref~Q~g~EiiG~~~~~aD~Evi~l~~~~l~~lGl~~-~~i~ 163 (430)
T CHL00201 85 AGIVRAFIENKMDYHSNLQRLWYSGPMFRYERPQSGRQRQFHQLGIEFIGSIDARADTEVIHLAMQIFNELQVKN-LILD 163 (430)
T ss_pred HHHHHHHHHccccccCCCeEEEEEcceecCCCCcCCccceeEEeceEEECCCChhhHHHHHHHHHHHHHHcCCCc-eEEE
Confidence 99999887753 24899999999999999987665 699999999999999999999999999999999986 9999
Q ss_pred ECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHH----HHhcCC
Q 000880 929 LNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVG----LRFCGA 1004 (1239)
Q Consensus 929 lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~----~~~~g~ 1004 (1239)
|||++++... ....+.+..++.... ..++....+.+..++ ......
T Consensus 164 l~~~~~~~~~-------~~~~~~l~~~l~~~~-----------------------~~~~~~~~~~l~~~~~~~l~~k~~~ 213 (430)
T CHL00201 164 INSIGKLEDR-------QSYQLKLVEYLSQYQ-----------------------DDLDTDSQNRLYSNPIRILDSKNLK 213 (430)
T ss_pred ECCCCchhhH-------HHHHHHHHHHHHHHH-----------------------hhcCHHHHHHHHhhhHHHhhccCcc
Confidence 9998887631 111122222222210 001111111221111 000001
Q ss_pred hhhHHHHHhccCC-CChhHHHHHHHH--HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccc
Q 000880 1005 ADQALPRLRGALP-ADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGG 1081 (1239)
Q Consensus 1005 ~~~~l~~l~~~~~-~~~~~~~~l~~l--~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GG 1081 (1239)
..++++.+..+.. .+....+.|+++ .+..+|+ .+.+|++++||++||||+|||+|+...+ ..++|||||
T Consensus 214 ~~~~~~~a~~l~~~~~~~~~~~l~~~~~~l~~~g~--~~~~Dl~lvRgldYYTG~vFE~~~~~~~------~~~~i~gGG 285 (430)
T CHL00201 214 TQEILDGAPKISDFLSLESTEHFYDVCTYLNLLNI--PYKINYKLVRGLDYYNDTAFEIKTLSSN------GQDTICGGG 285 (430)
T ss_pred HHHHHhhhHHHHhhhhHHHHHHHHHHHHHHHHcCC--cEEECcccccCCccccccEEEEEECCCC------Ccceeeecc
Confidence 1122222222111 123344455555 6677787 4999999999999999999999986422 224799999
Q ss_pred cccchhhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHHcC
Q 000880 1082 RYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEEN 1161 (1239)
Q Consensus 1082 RYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G 1161 (1239)
|||+|+++||+. ++||||||+|+|||+.+|++... . ...+.+|+|++.+ +....+|+++++.||++|
T Consensus 286 RYD~L~~~fg~~----------~~PavGfa~g~erl~~~l~~~~~-~-~~~~~~v~v~~~~-~~~~~~a~~ia~~LR~~G 352 (430)
T CHL00201 286 RYDSLIHQLGGP----------KTPAVGCAIGLERLLLIAKDNII-L-PKQSIDVYIATQG-LKAQKKGWEIIQFLEKQN 352 (430)
T ss_pred chHHHHHHhCCC----------CCCeeEEEecHHHHHHHHhcccc-C-CCCCCCEEEEEcC-HHHHHHHHHHHHHHHhCC
Confidence 999999999754 46999999999999998864322 1 2245689999875 667889999999999999
Q ss_pred CeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHhhccCCC
Q 000880 1162 IKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQFRNPS 1236 (1239)
Q Consensus 1162 ~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~~~~~~~ 1236 (1239)
++|++++. .+++++++++|++.|+++++|+|++|.++++|+||||.+++|.+++++++++.+.++.+..--|++
T Consensus 353 i~veid~~-~~~l~k~~k~A~~~~~~~viiiG~~E~~~~~vtvk~l~~~~q~~i~~~~~~~~~~~~~~~~~~~~~ 426 (430)
T CHL00201 353 IKFELDLS-SSNFHKQIKQAGKKRAKACIILGDNEIMDNCITIKWLDEQVQENAQYSNFKQEISYLKKKIAFNKK 426 (430)
T ss_pred CeEEEeeC-CCCHHHHHHHHHHcCCCEEEEEechHHhCCcEEEEECCCCCcEEEcHHHHHHHHHHHHHhhhhhhc
Confidence 99998876 568999999999999999999999999999999999999999999999999999988877655544
|
|
| >PRK12292 hisZ ATP phosphoribosyltransferase regulatory subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-60 Score=560.86 Aligned_cols=360 Identities=21% Similarity=0.265 Sum_probs=309.1
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-CccccccEEEEecc-CCCeeeecCCCcHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQFKRNTVKLLTH-GGDLLELSHELRLP 855 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~~~~~~~~~~D~-~G~~l~LRPD~T~~ 855 (1239)
..|+|++|++|.++..++++++.++++|++|||++|.||+| .+... ++...++||+|.|+ +|+.++||||+|+|
T Consensus 4 ~~p~G~~D~lp~~~~~~~~i~~~l~~~f~~~Gy~~i~tP~lE~~e~~~~~~g~~~~~~~~~f~d~~~g~~l~LRpD~T~~ 83 (391)
T PRK12292 4 QLPEGIRDLLPEEARKIEEIRRRLLDLFRRWGYEEVITPTLEYLDTLLAGGGAILDLRTFKLVDQLSGRTLGLRPDMTAQ 83 (391)
T ss_pred CCCCcchhcCHHHHHHHHHHHHHHHHHHHHcCCceeeCcchhhHHHHhccCCccchhhhEEEeecCCCCEEEECCCCcHH
Confidence 46899999999999999999999999999999999999999 34344 66778999999999 89999999999999
Q ss_pred HHHHHHhCC---CCceeEEeecCeEEcCCCCCCCC-ceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEECc
Q 000880 856 FIRWAISNQ---KSSFKRYEISSVYRRAIGHSPPN-RYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNH 931 (1239)
Q Consensus 856 iaR~~~~~~---~~P~r~~Y~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~ 931 (1239)
+||+++++. ..|+|+||+|+|||+++++.++. ||+|+|+|+||.+++.+|+|||.++.++|+.+|+.+ +.|+|||
T Consensus 84 iaR~~a~~~~~~~~p~r~~y~g~vfR~~~~~~gr~ref~Q~g~EiiG~~~~~aDaEvi~l~~~~l~~lgl~~-~~i~i~~ 162 (391)
T PRK12292 84 IARIAATRLANRPGPLRLCYAGNVFRAQERGLGRSREFLQSGVELIGDAGLEADAEVILLLLEALKALGLPN-FTLDLGH 162 (391)
T ss_pred HHHHHHHhccCCCCCeEEEeeceeeecCCCcCCCccchhccceEEeCCCCchHHHHHHHHHHHHHHHcCCCC-eEEEecc
Confidence 999998853 45999999999999998886655 699999999999999999999999999999999985 9999999
Q ss_pred HHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHH
Q 000880 932 GDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPR 1011 (1239)
Q Consensus 932 ~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~ 1011 (1239)
+++++++++.+|+++++++.++.+++++|+ .+.+ ++.. +++.+.++.+..++ .+.| ..++++.
T Consensus 163 ~~i~~~il~~~~~~~~~~~~l~~~l~~~~~---------~~~~----~~~~--~l~~~~~~~l~~l~-~~~g-~~~~l~~ 225 (391)
T PRK12292 163 VGLFRALLEAAGLSEELEEVLRRALANKDY---------VALE----ELVL--DLSEELRDALLALP-RLRG-GREVLEE 225 (391)
T ss_pred HHHHHHHHHHcCCCHHHHHHHHHHHHhcCH---------HHHH----HHHh--cCCHHHHHHHHHHH-HhcC-CHHHHHH
Confidence 999999999999999999999999999883 2222 2222 68888899999998 5777 5688888
Q ss_pred HhccCCCChhHHHHHHHH-----HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccch
Q 000880 1012 LRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYL 1086 (1239)
Q Consensus 1012 l~~~~~~~~~~~~~l~~l-----~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L 1086 (1239)
+..+.. +..+.+++++| .+..+|+..++.|||+++||++||||+|||+|..+.+. +||+|||||+|
T Consensus 226 ~~~~~~-~~~~~~~l~~L~~l~~~l~~~~~~~~i~~D~~lvrgl~YYtG~vFe~~~~~~~~--------~i~~GGRYD~L 296 (391)
T PRK12292 226 ARKLLP-SLPIKRALDELEALAEALEKYGYGIPLSLDLGLLRHLDYYTGIVFEGYVDGVGN--------PIASGGRYDDL 296 (391)
T ss_pred HHHhcc-ChHHHHHHHHHHHHHHHHHHhCCCceEEEehhhccCCcCccceEEEEEECCCCC--------cccCCcchhhH
Confidence 887544 55556677777 67777887789999999999999999999999987654 59999999999
Q ss_pred hhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHHcCCeEEE
Q 000880 1087 LHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQF 1166 (1239)
Q Consensus 1087 ~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G~~ve~ 1166 (1239)
+++||. ++||||||+++|||+.+ . . .....+.+++|++.+ +....+|+++++.||+.|++|++
T Consensus 297 ~~~fg~-----------~~pAvGfai~ldrl~~~-~-~---~~~~~~~~~~v~~~~-~~~~~~a~~~~~~Lr~~G~~~~~ 359 (391)
T PRK12292 297 LGRFGR-----------ARPATGFSLDLDRLLEL-Q-L---ELPVEARKDLVIAPD-SEALAAALAAAQELRKKGEIVVL 359 (391)
T ss_pred HHHcCC-----------CCCCceEEeeHHHHHhh-c-c---ccccccCCcEEEEeC-cccHHHHHHHHHHHHHcCCEEEE
Confidence 998853 46999999999999874 1 1 112234567777764 56778999999999999999998
Q ss_pred eeCCCCCHHHHHHHHHhCCC
Q 000880 1167 VPVPDPSLTEQYEYASEHDI 1186 (1239)
Q Consensus 1167 ~~~~~~~l~k~~~~A~~~g~ 1186 (1239)
.+. .+++++++++|++.|+
T Consensus 360 ~~~-~~~~~~~~~~a~~~~~ 378 (391)
T PRK12292 360 ALP-GRNFEDAREYARDRQI 378 (391)
T ss_pred ecC-CCChHHHHHHHhhcCe
Confidence 877 5689999999999998
|
|
| >PRK12421 ATP phosphoribosyltransferase regulatory subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-58 Score=538.96 Aligned_cols=362 Identities=18% Similarity=0.206 Sum_probs=301.7
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-CccccccEEEEecc-CCCeeeecCCCcHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQFKRNTVKLLTH-GGDLLELSHELRLP 855 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~~~~~~~~~~D~-~G~~l~LRPD~T~~ 855 (1239)
..|+|++|++|.++..++++++.++++|++|||++|.||+| ++... ++..++.||+|.|+ +|+.++||||+|+|
T Consensus 8 ~~p~G~rD~lp~e~~~~~~i~~~l~~~f~~~Gy~~I~tP~~E~~e~~~~~~g~~~~~~~y~f~D~~~g~~l~LRpD~T~~ 87 (392)
T PRK12421 8 LLPDGVADVLPEEAQKIERLRRRLLDLFASRGYQLVMPPLIEYLESLLTGAGQDLKLQTFKLIDQLSGRLMGVRADITPQ 87 (392)
T ss_pred CCCCcccccCHHHHHHHHHHHHHHHHHHHHcCCEEeeCcchhhHHHHhccCCccchhceEEEEcCCCCcEEEECCcCCHH
Confidence 46899999999999999999999999999999999999999 34444 77778899999999 69999999999999
Q ss_pred HHHHHHhC--CCCceeEEeecCeEEcCCCCCC-CCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEECcH
Q 000880 856 FIRWAISN--QKSSFKRYEISSVYRRAIGHSP-PNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHG 932 (1239)
Q Consensus 856 iaR~~~~~--~~~P~r~~Y~g~VfR~e~~~~~-~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~ 932 (1239)
|||+++++ ...|+|+||+|+|||+++++.+ .+||+|+|+|+||.+++.+|+|||.++.++|++||+++ ++|+|||+
T Consensus 88 iaR~~a~~~~~~~p~R~~Y~g~VfR~~~~~~gr~rEf~Q~GvEiiG~~~~~aDaEvi~l~~e~l~~lgi~~-~~l~ig~~ 166 (392)
T PRK12421 88 VARIDAHLLNREGVARLCYAGSVLHTLPQGLFGSRTPLQLGAELYGHAGIEADLEIIRLMLGLLRNAGVPA-LHLDLGHV 166 (392)
T ss_pred HHHHHHhhcCCCCceEEEEeeeEEEcCCCcCCCcCccceeceEEeCCCCchhHHHHHHHHHHHHHHcCCCC-eEEEeCCH
Confidence 99998875 3469999999999999887754 45799999999999999999999999999999999986 99999999
Q ss_pred HHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHH
Q 000880 933 DLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRL 1012 (1239)
Q Consensus 933 ~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l 1012 (1239)
++++++++.+|++++.++.++++++++++. .. .+++...+++...++.+..++ .+.|+. +.++.+
T Consensus 167 ~i~~~il~~l~l~~~~~~~l~~~l~kk~~~---------~l----~~~~~~~~~~~~~~~~l~~L~-~~~g~~-~~l~~~ 231 (392)
T PRK12421 167 GIFRRLAELAGLSPEEEEELFDLLQRKALP---------EL----AEVCQNLGVGSDLRRMFYALA-RLNGGL-EALDRA 231 (392)
T ss_pred HHHHHHHHHcCCCHHHHHHHHHHHHhcCHH---------HH----HHHHHhcCCCHHHHHHHHHHH-HhcCCH-HHHHHH
Confidence 999999999999999999999999988832 22 334455678888888899988 567764 455665
Q ss_pred hccCC-CChhHHHHHHHH-----HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccch
Q 000880 1013 RGALP-ADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYL 1086 (1239)
Q Consensus 1013 ~~~~~-~~~~~~~~l~~l-----~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L 1086 (1239)
...+. .++.+.+++++| .+..++....+.||++++||++||||+|||+|.++.+. +||+|||||+|
T Consensus 232 ~~~~~~~~~~~~~~l~~L~~l~~~l~~~~~~~~~~~DlslvrgldYYTG~vFe~~~~~~~~--------~i~~GGRYD~L 303 (392)
T PRK12421 232 LSVLALQDAAIRQALDELKTLAAHLKNRWPELPVSIDLAELRGYHYHTGLVFAAYIPGRGQ--------ALARGGRYDGI 303 (392)
T ss_pred HhhcccCCHHHHHHHHHHHHHHHHHHhhCCCceEEEeeccccCCCCcCCCEEEEEECCCCC--------cccCCCCccch
Confidence 55443 567788888888 45555444569999999999999999999999987554 69999999999
Q ss_pred hhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHHcCCeEEE
Q 000880 1087 LHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQF 1166 (1239)
Q Consensus 1087 ~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G~~ve~ 1166 (1239)
+++||. +.||||||||+|||+.+++.. . ..++++++.+ +. ..+++++++||+.|++|++
T Consensus 304 ~~~fg~-----------~~pAvGfai~lerL~~~l~~~-----~--~~~~~~~~~~-~~--~~~~~~a~~LR~~G~~~~~ 362 (392)
T PRK12421 304 GEAFGR-----------ARPATGFSMDLKELLALQFLE-----E--EAGAILAPWG-DD--PDLLAAIAELRQQGERVVQ 362 (392)
T ss_pred hHhhCC-----------CCCCceEEeeHHHHHhhcccc-----c--CCceEEeecC-Cc--HHHHHHHHHHHhCCCEEEE
Confidence 998864 369999999999999876421 1 1266777764 32 5688999999999999998
Q ss_pred eeCCCCCHHHHHHHHHhCCCcEEEEEcCC
Q 000880 1167 VPVPDPSLTEQYEYASEHDIKCLVILTDT 1195 (1239)
Q Consensus 1167 ~~~~~~~l~k~~~~A~~~g~~~~viig~~ 1195 (1239)
.+.. .-.+| +.++...+++++.
T Consensus 363 ~~~~------~~~~~-~~~~~~~~~~~~~ 384 (392)
T PRK12421 363 LLPG------DDGSS-EPGCDHRLVLQDG 384 (392)
T ss_pred eCCC------cchhH-HhCCCeEEEEECC
Confidence 7652 22345 6699999999854
|
|
| >TIGR00442 hisS histidyl-tRNA synthetase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-56 Score=533.60 Aligned_cols=380 Identities=21% Similarity=0.280 Sum_probs=310.0
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-Ccc---ccccEEEEeccCCCeeeecCCCcH
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQ---FKRNTVKLLTHGGDLLELSHELRL 854 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~---~~~~~~~~~D~~G~~l~LRPD~T~ 854 (1239)
.|+|++|++|.++..++++++.++++|++|||++|.||+| .+... ++. ..++||+|.|++|+.++||||+|+
T Consensus 2 ~p~G~~d~~p~~~~~~~~i~~~i~~~f~~~Gy~~i~~P~le~~~~~~~~~g~~~~~~~~~~~~~~d~~g~~l~LRpD~T~ 81 (397)
T TIGR00442 2 APRGTRDFLPEEMIKWQYIEETIREVFELYGFKEIRTPIFEYTELFARKVGEETDIVEKEMYTFKDKGGRSLTLRPEGTA 81 (397)
T ss_pred CCCCcCCCCHHHHHHHHHHHHHHHHHHHHcCCeEecCcccchHHHhhhccCccccccccceEEEECCCCCEEeecCCCcH
Confidence 5899999999999999999999999999999999999999 33333 232 458999999999999999999999
Q ss_pred HHHHHHHhCC---CCceeEEeecCeEEcCCCCCC-CCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEEC
Q 000880 855 PFIRWAISNQ---KSSFKRYEISSVYRRAIGHSP-PNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLN 930 (1239)
Q Consensus 855 ~iaR~~~~~~---~~P~r~~Y~g~VfR~e~~~~~-~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg 930 (1239)
|+||+++++. ..|+|+||+|+|||+++++.+ .+||+|+|+|+||.++..+|+|+|.++.++|+.+|+++ ++|+||
T Consensus 82 ~iaR~~~~~~~~~~~p~r~~y~g~vfR~e~~~~gr~ref~Q~g~eiig~~~~~~d~E~i~l~~e~l~~lg~~~-~~i~i~ 160 (397)
T TIGR00442 82 PVARAVIENKLLLPKPFKLYYIGPMFRYERPQKGRYRQFHQFGVEVIGSDSPLADAEIIALAAEILKELGIKD-FTLEIN 160 (397)
T ss_pred HHHHHHHhcccccCCCeEEEEEcCeecCCCCCCCcccceEEcCeeeeCCCCHHHHHHHHHHHHHHHHHcCCCc-eEEEec
Confidence 9999998863 359999999999999877654 45799999999999999999999999999999999975 999999
Q ss_pred cHHHHHHHHHHcCCCHHHHHHHHHHHHh-hcCCCCCcccccchHHHHHHHHHHh-cCCCHHHHHHHHHHHHHhcCChhhH
Q 000880 931 HGDLLEAIWSWAGIKAEHREKVAELLAM-MGSLRPQSSEWKSKWVVIRRQLLQE-LNLAEAVVNRLQTVGLRFCGAADQA 1008 (1239)
Q Consensus 931 ~~~i~~~ll~~lgl~~~~~~~l~~~l~~-~d~~~~~~~~~~~~~~~~~~~l~~~-~~l~~~~~~~l~~l~~~~~g~~~~~ 1008 (1239)
|+++++++++ .+..+.++|++ +|++. .+.+. +++.. .++.++..+.+..++. . . ..+
T Consensus 161 ~~~i~~~~~~-------~~~~l~~~l~~~~~~~~---------~~~~~-~l~~~~~~~~~~~~~~~~~~~~-~--~-~~~ 219 (397)
T TIGR00442 161 SLGILEGRLE-------YREALLRYLDKHLDKLG---------EDSVR-RLEKNPLRILDSKNEKIQELLK-E--A-PKI 219 (397)
T ss_pred CcccHHHHHH-------HHHHHHHHHHHhHhhcC---------HHHHH-HHhhccccCchhhhHHHHHHHh-c--C-HHH
Confidence 9999999987 46788888888 56432 22222 23332 4566666666766652 1 1 122
Q ss_pred HHHHhccCCCChhHHHHHHHH--HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccch
Q 000880 1009 LPRLRGALPADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYL 1086 (1239)
Q Consensus 1009 l~~l~~~~~~~~~~~~~l~~l--~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L 1086 (1239)
+..+ .....+.|+++ .++.+|+ .+.|||+++|+++||||+||++|..+.+. ..+||+|||||+|
T Consensus 220 ~~~~------~~~~~~~l~~l~~~l~~~~~--~i~~dl~~~r~~~YYtG~vFe~~~~~~~~------~~~i~~GGRYD~L 285 (397)
T TIGR00442 220 LDFL------DEESRAHFEELKELLDALGI--PYKIDPSLVRGLDYYTGTVFEFVTDELGA------QGTICGGGRYDGL 285 (397)
T ss_pred HHHh------hHHHHHHHHHHHHHHHHcCC--CEEECCccccCchhhcceEEEEEECCCCc------cceeeeccchHHH
Confidence 2211 23455556655 6777787 39999999999999999999999876441 1369999999999
Q ss_pred hhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHHcCCeEEE
Q 000880 1087 LHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQF 1166 (1239)
Q Consensus 1087 ~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G~~ve~ 1166 (1239)
+++||+. +.||||||+++|||+.++.......+...+.+|+|++.+ ++...+++++++.||+.|++|++
T Consensus 286 ~~~f~~~----------~~~avGfs~~~~~l~~~l~~~~~~~~~~~~~~vlV~~~~-~~~~~~~~~i~~~Lr~~gi~v~~ 354 (397)
T TIGR00442 286 VEELGGP----------PTPAVGFAIGIERLLLLLEELGLEPPEESSPDVYVVPLG-EEAELEALKLAQKLRKAGIRVEV 354 (397)
T ss_pred HHHhCCC----------CCceEEeeecHHHHHHHHHhcCCCCCCCCCCcEEEEEeC-HHHHHHHHHHHHHHHhCCCeEEE
Confidence 9999653 369999999999999888633222222356789999875 66788999999999999999998
Q ss_pred eeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCC
Q 000880 1167 VPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVK 1210 (1239)
Q Consensus 1167 ~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~ 1210 (1239)
.+. .+++++++++|++.|++++|++|++|.+.++|+|||+.+|
T Consensus 355 ~~~-~~~l~k~~~~a~~~g~~~~i~ig~~e~~~~~v~vrnl~~~ 397 (397)
T TIGR00442 355 DLG-GRKLKKQLKYADKLGARFAVILGEDELANGTVTLKDLETG 397 (397)
T ss_pred eCC-CCCHHHHHHHHHHcCCCEEEEEChhHHhCCeEEEEeCCCC
Confidence 777 5789999999999999999999999999999999999875
|
This model finds a histidyl-tRNA synthetase in every completed genome. Apparent second copies from Bacillus subtilis, Synechocystis sp., and Aquifex aeolicus are slightly shorter, more closely related to each other than to other hisS proteins, and actually serve as regulatory subunits for an enzyme of histidine biosynthesis. They were excluded from the seed alignment and score much lower than do single copy histidyl-tRNA synthetases of other genomes not included in the seed alignment. These putative second copies of HisS score below the trusted cutoff. The regulatory protein kinase GCN2 of Saccharomyces cerevisiae (YDR283c), and related proteins from other species designated eIF-2 alpha kinase, have a domain closely related to histidyl-tRNA synthetase that may serve to detect and respond to uncharged tRNA(his), an indicator of amino acid starvation; these regulatory proteins are not orthologous and so score below the noise cutoff. |
| >PRK00037 hisS histidyl-tRNA synthetase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-56 Score=530.49 Aligned_cols=381 Identities=19% Similarity=0.285 Sum_probs=300.1
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-Cccc---cccEEEEeccCCCeeeecCCCc
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQF---KRNTVKLLTHGGDLLELSHELR 853 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~~---~~~~~~~~D~~G~~l~LRPD~T 853 (1239)
..|+|++|++|.++..++.+++.++++|++|||++|.||+| ++... ++.. .++||+|.|++|+.++||||+|
T Consensus 5 ~~p~G~~d~~p~~~~~~~~i~~~i~~~~~~~Gy~ei~tP~le~~~~~~~~~g~~~~~~~~~~~~~~d~~g~~l~LRpd~T 84 (412)
T PRK00037 5 QAPRGTRDILPEESAKWQYVEDTIREVFERYGFSEIRTPIFEYTELFKRKVGEETDIVEKEMYTFQDKGGRSLTLRPEGT 84 (412)
T ss_pred CCCCCCCcCCHHHHHHHHHHHHHHHHHHHHcCCeEeeccccchHHHhccccCcccccccceeEEEEcCCCCEEEecCCCc
Confidence 46899999999999999999999999999999999999999 33333 3333 6899999999999999999999
Q ss_pred HHHHHHHHhCCCCceeEEeecCeEEcCCCCCCC-CceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEECc-
Q 000880 854 LPFIRWAISNQKSSFKRYEISSVYRRAIGHSPP-NRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNH- 931 (1239)
Q Consensus 854 ~~iaR~~~~~~~~P~r~~Y~g~VfR~e~~~~~~-~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~- 931 (1239)
+|+||+++++...|+|+||+|+|||+++++.++ +||+|+|+|+||.+++.+|+|+|.++.++|+.||+.+ +.+.|||
T Consensus 85 ~~~ar~~~~~~~~p~r~~~~g~vfR~e~~~~gr~ref~Q~g~ei~g~~~~~~d~E~i~~~~~~l~~lg~~~-~~~~l~~~ 163 (412)
T PRK00037 85 APVVRAVIEHKLQPFKLYYIGPMFRYERPQKGRYRQFHQFGVEVIGSDSPLADAEVIALAADILKALGLKG-LKLLINSL 163 (412)
T ss_pred HHHHHHHHhCCCCCeEEEEEcCccccCCCCCCcccceEEcCeeeeCCCCcchhHHHHHHHHHHHHHcCCCc-eeeeeccC
Confidence 999999998766899999999999998776544 5799999999999999999999999999999999985 8886555
Q ss_pred ---------HHHHHHHHHHcCCCH---HHHHHHH-HHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHH
Q 000880 932 ---------GDLLEAIWSWAGIKA---EHREKVA-ELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVG 998 (1239)
Q Consensus 932 ---------~~i~~~ll~~lgl~~---~~~~~l~-~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~ 998 (1239)
+++++++++. ++++ ..++.+. .++...+ ..+ .
T Consensus 164 ~~~~~~~~~~~~l~~~l~~-~~~~l~~~~~~~~~~~~~~~~~----------------------~~~--~---------- 208 (412)
T PRK00037 164 GDFEIRANYRKALVGFLEK-GLDELDEDSKRRLETNPLRILD----------------------KKD--K---------- 208 (412)
T ss_pred CCHHHhHHHHHHHHHHHHh-CchhhchHHHHHHhhCchhhhc----------------------ccc--h----------
Confidence 4455555554 3332 0000000 0000000 000 0
Q ss_pred HHhcCChhhHHHHHhccC-CCChhHHHHHHHH--HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccc
Q 000880 999 LRFCGAADQALPRLRGAL-PADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGT 1075 (1239)
Q Consensus 999 ~~~~g~~~~~l~~l~~~~-~~~~~~~~~l~~l--~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~ 1075 (1239)
+. ...++.+..+. ..+.....++++| .++.+++ ++.|||+++||++||||+|||+|..+.+. .+
T Consensus 209 ----~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~l~~~~~--~i~~Dl~~~r~l~YYtG~vFe~~~~~~g~------~~ 275 (412)
T PRK00037 209 ----ED-QELLKDAPKLLDYLDEESKEHFEELKELLDALGI--PYVIDPRLVRGLDYYTGTVFEFVTDDLGA------QG 275 (412)
T ss_pred ----hh-HHHHhcchHHHHHhhHHHHHHHHHHHHHHHHcCC--CEEECCCcccChhhccceEEEEEECCCCc------cc
Confidence 00 00111100000 0123455566666 6677777 59999999999999999999999865432 24
Q ss_pred cccccccccchhhhccccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHH
Q 000880 1076 LLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVA 1155 (1239)
Q Consensus 1076 ~i~~GGRYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~ 1155 (1239)
+||+|||||+|+++||+. ++||||||+++|||+.++..... .+.+|+|++.+ ++...+|+++++
T Consensus 276 ~i~~GGRYD~L~~~f~~~----------~~pavGfs~~le~l~~~l~~~~~-----~~~~vlI~~~~-~~~~~~a~~i~~ 339 (412)
T PRK00037 276 TVCGGGRYDGLVEQFGGP----------PTPAVGFAIGVERLLLLLEELGE-----EPVDVYVVPLG-EDAELAALKLAE 339 (412)
T ss_pred eeeeccchhHHHHHhCCC----------CCceEEEEEcHHHHHHHHHhcCC-----CCCCEEEEEeC-hHHHHHHHHHHH
Confidence 799999999999998642 46999999999999988753321 46789999975 556788999999
Q ss_pred HHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHH
Q 000880 1156 ELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAI 1228 (1239)
Q Consensus 1156 ~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l 1228 (1239)
.||+.|++|++... .+++++++++|++.|++++|++|++|.++|+|+|||+.+|++..+++++++++|++.+
T Consensus 340 ~Lr~~Gi~v~i~~~-~~~~~~~~~~a~~~gi~~~viig~~e~~~~~v~vr~~~~~~~~~v~~~el~~~i~~~~ 411 (412)
T PRK00037 340 KLRAAGIRVELDYG-GRKLKKQFKYADKSGARFVLILGEDELANGTVTVKDLRTGEQQTVPLDELVEALKELL 411 (412)
T ss_pred HHHHCCCeEEEeCC-CCCHHHHHHHHHHcCCCEEEEEChhHHhCCeEEEEECCCCceEEeeHHHHHHHHHHhh
Confidence 99999999998665 5689999999999999999999999999999999999999999999999999998764
|
|
| >TIGR00443 hisZ_biosyn_reg ATP phosphoribosyltransferase, regulatory subunit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=479.54 Aligned_cols=300 Identities=23% Similarity=0.333 Sum_probs=262.6
Q ss_pred cccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCCCccccccEEEEeccCCCeeeecCCCcHHHHHHHHhC
Q 000880 788 IQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISN 863 (1239)
Q Consensus 788 ~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~~~ 863 (1239)
+|++|.++..++.+++.++++|++|||++|.||+| .+...+....++||+|.|++|+.++||||+|+|+||+++++
T Consensus 1 ~D~~p~~~~~~~~i~~~l~~~~~~~Gy~~i~tP~le~~~~~~~~~~~~~~~~~~~~d~~g~~l~LRpD~T~~iaR~~~~~ 80 (314)
T TIGR00443 1 RDLLPEEAARKEEIERQLQDVFRSWGYQEIITPTLEYLDTLSAGGGILNEDLFKLFDSLGRVLGLRPDMTTPIARAVSTR 80 (314)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCcchhhHHHhcccCCcchhceEEEECCCCCEEeecCcCcHHHHHHHHHh
Confidence 58999999999999999999999999999999999 34444336789999999999999999999999999998874
Q ss_pred ---CCCceeEEeecCeEEcCCCCCC-CCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEECcHHHHHHHH
Q 000880 864 ---QKSSFKRYEISSVYRRAIGHSP-PNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIW 939 (1239)
Q Consensus 864 ---~~~P~r~~Y~g~VfR~e~~~~~-~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~~i~~~ll 939 (1239)
...|+|+||+|+|||+++++.+ .+||+|+|+|+||.++..+|+|||.++.++|+.+|+++ +.|.|||++++++++
T Consensus 81 ~~~~~~p~r~~y~g~VfR~~~~~~gr~re~~Q~g~Eiig~~~~~adaEvi~l~~~~l~~lg~~~-~~i~l~~~~il~~il 159 (314)
T TIGR00443 81 LRDRPLPLRLCYAGNVFRTNESGAGRSREFTQAGVELIGAGGPAADAEVIALLIEALKALGLKD-FKIELGHVGLVRALL 159 (314)
T ss_pred cccCCCCeEEEEeceEeecCCCcCCCcccccccceEEeCCCCchhHHHHHHHHHHHHHHcCCCC-eEEEeCcHHHHHHHH
Confidence 2469999999999999887755 45799999999999999999999999999999999985 999999999999999
Q ss_pred HHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhccCCCC
Q 000880 940 SWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPAD 1019 (1239)
Q Consensus 940 ~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~~~ 1019 (1239)
+.+++++++++.++++++++++. .. .+++.+.+++++.++.+..++ .+.|++.+++++++.+. .+
T Consensus 160 ~~~~~~~~~~~~l~~~l~~~~~~---------~~----~~~~~~~~l~~~~~~~l~~l~-~~~g~~~~~l~~l~~~~-~~ 224 (314)
T TIGR00443 160 EEAGLPEEAREALREALARKDLV---------AL----EELLAELGLDPEVRERLLALP-RLRGDGEEVLEEARALA-GS 224 (314)
T ss_pred HHcCCCHHHHHHHHHHHHhcCHH---------HH----HHHHHhcCCCHHHHHHHHHHH-HhcCChHHHHHHHHHhc-cC
Confidence 99999999999999999998832 11 344556788999999999998 67888788999988844 46
Q ss_pred hhHHHHHHHH-----HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccchhhhccccc
Q 000880 1020 KPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDRE 1094 (1239)
Q Consensus 1020 ~~~~~~l~~l-----~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~fg~~~ 1094 (1239)
+.+.+++++| .++.+|+..++.||++++|+++||||+||++|..+.+. +||+|||||+|+++||.
T Consensus 225 ~~~~~~l~~l~~~~~~l~~~~~~~~i~~D~~~~r~~~YYtGivFe~~~~~~~~--------~i~~GGRYD~L~~~fg~-- 294 (314)
T TIGR00443 225 ETAEAALDELEAVLELLEARGVEEYISLDLGLVRGYHYYTGLIFEGYAPGLGA--------PIAGGGRYDNLLGRFGR-- 294 (314)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCeEEEecccccCCCCccceEEEEEECCCCC--------cccCCccHHHHHHHcCC--
Confidence 6667777777 77888887779999999999999999999999976544 69999999999988853
Q ss_pred cccccCCCCCCceeeeeccHHHHHhhCC
Q 000880 1095 YVGYASRTNPPSGVGASLALETIIQHYP 1122 (1239)
Q Consensus 1095 ~~~~~g~~~~~pAvGfaigldrl~~~L~ 1122 (1239)
++||||||+++|||+.++.
T Consensus 295 ---------~~~AvGfa~~~d~l~~~l~ 313 (314)
T TIGR00443 295 ---------PLPATGFALNLERLLEALT 313 (314)
T ss_pred ---------CCCCceEEecHHHHHHHhc
Confidence 4699999999999987753
|
Apparant second copies of histidyl-tRNA synthetase, found in Bacillus subtilis, Synechocystis sp., Aquifex aeolicus, and others, are in fact a regulatory subunit of ATP phosphoribosyltransferase, and usually encoded by a gene adjacent to that encoding the catalytic subunit. |
| >PRK12295 hisZ ATP phosphoribosyltransferase regulatory subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=478.96 Aligned_cols=305 Identities=20% Similarity=0.270 Sum_probs=253.5
Q ss_pred hHHHHHHHHHHHHHHHcCCccccccce----eccCC-CccccccEEEEeccCCCeeeecCCCcHHHHHHHHhC-CCCcee
Q 000880 796 ELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISN-QKSSFK 869 (1239)
Q Consensus 796 ~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~~~-~~~P~r 869 (1239)
...+++++.++++|++|||++|.||+| ++..+ ++...++||+|.|++|+.++||||+|+||||+++++ ...|.|
T Consensus 5 ~~~~~i~~~i~~~f~~~Gy~~I~tP~lE~~e~~~~~~g~~~~~~~~~f~D~~G~~l~LRpD~T~piaR~~~~~~~~~p~R 84 (373)
T PRK12295 5 SASAAAAEALLASFEAAGAVRVDPPILQPAEPFLDLSGEDIRRRIFVTSDENGEELCLRPDFTIPVCRRHIATAGGEPAR 84 (373)
T ss_pred hhHHHHHHHHHHHHHHcCCEEeeCCccccHHHhhhccCchhhcceEEEECCCCCEEeeCCCCcHHHHHHHHHcCCCCCeE
Confidence 345689999999999999999999999 33344 777789999999999999999999999999988774 456999
Q ss_pred EEeecCeEEcCCCCCCCCceeEEeEEEeCCC-CcccHHHHHHHHHHHHHhcCCCCceEEEECcHHHHHHHHHHcCCCHHH
Q 000880 870 RYEISSVYRRAIGHSPPNRYLQGDFDIIGGA-SALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEH 948 (1239)
Q Consensus 870 ~~Y~g~VfR~e~~~~~~~ef~Q~GvEiiG~~-s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~~i~~~ll~~lgl~~~~ 948 (1239)
+||+|+|||++ .++.+||+|+|+|+||.. ++.+|+|||.+++++|+.+|+.+ ++|+|||+++++++++.+++++++
T Consensus 85 ~~Y~g~VfR~~--~gr~rEf~Q~GvEiiG~~~~~~aDaEvi~l~~~~L~~lgl~~-~~i~ig~~~il~~ll~~l~l~~~~ 161 (373)
T PRK12295 85 YAYLGEVFRQR--RDRASEFLQAGIESFGRADPAAADAEVLALALEALAALGPGD-LEVRLGDVGLFAALVDALGLPPGW 161 (373)
T ss_pred EEEEccEEECC--CCCCCcceEeeEEeeCCCCCccchHHHHHHHHHHHHHcCCCc-eEEEeCCHHHHHHHHHHcCCCHHH
Confidence 99999999998 556778999999999975 57999999999999999999986 999999999999999999999999
Q ss_pred HHHHHHHHHhhcCCCC--Cc---------------------------------------ccccchHHHHHHHHHHhc---
Q 000880 949 REKVAELLAMMGSLRP--QS---------------------------------------SEWKSKWVVIRRQLLQEL--- 984 (1239)
Q Consensus 949 ~~~l~~~l~~~d~~~~--~~---------------------------------------~~~~~~~~~~~~~l~~~~--- 984 (1239)
+++++.+|+++++.+. .. ...+..+.++.+++....
T Consensus 162 ~~~l~~~i~kk~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~g~~~~~~r~~~ei~~~l~~~~~~~ 241 (373)
T PRK12295 162 KRRLLRHFGRPRSLDALLARLAGPRVDPLDEHAGVLAALADEAAARALVEDLMSIAGISPVGGRSPAEIARRLLEKAALA 241 (373)
T ss_pred HHHHHHHHhccchHHHHHHhhcccccccccchhhhhhhhccchhhhhhhhhhhhhccccccccccHHHHHHHHHhhhccc
Confidence 9999999999886310 00 000112333333333321
Q ss_pred ---CCCHHHHHHHHHHHHHhcCChhhHHHHHhccCCCCh-hHHHHHHHH-----HHHHccCc-ccEEEccCCCCCCCccc
Q 000880 985 ---NLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADK-PTRKALDEL-----YLRIWRIE-KNIYIDALMPPIESYHR 1054 (1239)
Q Consensus 985 ---~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~~~~-~~~~~l~~l-----~l~~~~~~-~~i~~Dl~~~rgl~YYt 1054 (1239)
+++.+.++.+..++ .+.|+.++++++++.+...++ .+.+++++| .++.+|+. +++.||++++||++|||
T Consensus 242 ~~~~~~~~~~~~l~~l~-~~~g~~~~~~~~l~~l~~~~~~~~~~al~~L~~l~~~l~~~g~~~~~v~~D~~~vrgl~YYT 320 (373)
T PRK12295 242 AAARLPAEALAVLERFL-AISGPPDAALAALRALAADAGLDLDAALDRFEARLAALAARGIDLERLRFSASFGRPLDYYT 320 (373)
T ss_pred ccCCCCHHHHHHHHHHH-HccCCHHHHHHHHHHHhccChHHHHHHHHHHHHHHHHHHHcCCCcceEEEecccccCCcccc
Confidence 78889999999998 688888889999998766556 677788777 77888886 67999999999999999
Q ss_pred eeEEEEEecCCCCcccccccccccccccccchhhhccccccccccCCCCCCceeeeeccHHHHHhh
Q 000880 1055 NLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQH 1120 (1239)
Q Consensus 1055 G~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~ 1120 (1239)
|+|||+|+.+.+ ..+||+|||||+|++.||+ +.++||||||+++|||+.+
T Consensus 321 GiVFe~~~~~~~-------~~~I~~GGRYD~Li~~fg~---------~~~~pAvGfai~~drl~~~ 370 (373)
T PRK12295 321 GFVFEIRAAGNG-------DPPLAGGGRYDGLLTRLGA---------GEPIPAVGFSIWLDRLAAL 370 (373)
T ss_pred ceEEEEEECCCC-------CCcccCCcCHHHHHHHhCC---------CCCCCeeEEEEcHHHHHhh
Confidence 999999987642 1369999999999988863 2357999999999999764
|
|
| >PF13393 tRNA-synt_His: Histidyl-tRNA synthetase; PDB: 3HRI_E 3HRK_A 3LC0_A 1Z7N_A 1Z7M_D 3NET_A 1H4V_B 3OD1_A 4E51_B 3RAC_A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=465.13 Aligned_cols=297 Identities=25% Similarity=0.385 Sum_probs=244.5
Q ss_pred cccccchhhhhHHHHHHHHHHHHHHHcCCccccccceec----cCCCccccccEEEEeccCCCeeeecCCCcHHHHHHHH
Q 000880 786 SSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYL----LGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAI 861 (1239)
Q Consensus 786 G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~~~----~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~ 861 (1239)
|++|++|.+++.++++++.++++|++|||++|.||+|+. ........+++|+|.|++|+.++||||+|+|+||+++
T Consensus 1 G~~d~~~~~~~~~~~i~~~l~~~f~~~Gy~~i~~P~le~~~~~~~~~~~~~~~~~~~~D~~G~~l~LR~D~T~~iaR~~a 80 (311)
T PF13393_consen 1 GFRDLLPEEARKRERIESKLREVFERHGYEEIETPLLEYYELFLDKSGEDSDNMYRFLDRSGRVLALRPDLTVPIARYVA 80 (311)
T ss_dssp T---B-HHHHHHHHHHHHHHHHHHHHTT-EE-B--SEEEHHHHHCHSSTTGGCSEEEECTTSSEEEE-SSSHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHHHHHHHHHHHcCCEEEECCeEeecHHhhhccccchhhhEEEEecCCcEeccCCCCcHHHHHHHH
Confidence 899999999999999999999999999999999999932 2333333559999999999999999999999999999
Q ss_pred hCC--CCceeEEeecCeEEcCCCCCC-CCceeEEeEEEeCCCCcccHHHHHHHHHHHHH-hcCCCCceEEEECcHHHHHH
Q 000880 862 SNQ--KSSFKRYEISSVYRRAIGHSP-PNRYLQGDFDIIGGASALTEAEVLKVTMDIVT-RFFHAESCDIHLNHGDLLEA 937 (1239)
Q Consensus 862 ~~~--~~P~r~~Y~g~VfR~e~~~~~-~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~-~lgi~~~~~i~lg~~~i~~~ 937 (1239)
++. ..|.|+||+|+|||+++++.+ .+||+|+|+|+||.+++.+|+|+|.++.++|+ .+|+.+ +.|+|||++++++
T Consensus 81 ~~~~~~~~~r~~y~g~vfR~~~~~~g~~re~~Q~g~Eiig~~~~~~daEvi~l~~e~l~~~l~~~~-~~i~i~h~~i~~~ 159 (311)
T PF13393_consen 81 RNLNLPRPKRYYYIGPVFRYERPGKGRPREFYQCGFEIIGSSSLEADAEVIKLADEILDRELGLEN-FTIRINHTGILDA 159 (311)
T ss_dssp HCCGSSSSEEEEEEEEEEEEETTTTTBESEEEEEEEEEESSSSHHHHHHHHHHHHHHHHHHHTTTS-EEEEEEEHHHHHH
T ss_pred HhcCcCCCceEEEEcceeeccccCCCCCceeEEEEEEEECCCCHHHHHHHHHHHHHHHHhhcCCCC-cEEEEcCchhhHH
Confidence 974 569999999999999877654 45799999999999999999999999999997 999976 9999999999999
Q ss_pred HHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhccCC
Q 000880 938 IWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALP 1017 (1239)
Q Consensus 938 ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~ 1017 (1239)
+++.+|++++.++.++.++.+++. .++ ++++.+.+++.+.++.+..++ .+.|+.+.+.+.+.. +.
T Consensus 160 il~~~gl~~~~~~~l~~~l~~~~~------------~~~-~~~~~~~~l~~~~~~~l~~l~-~~~g~~~~l~~~~~~-~~ 224 (311)
T PF13393_consen 160 ILEHLGLPEDLRRELLEALDKKDL------------SEL-KELLSELGLSSESLEILDKLP-ELEGDPEALEELLES-LP 224 (311)
T ss_dssp HHHHTTHHHHHHHHHHHHHHHTHH------------HHH-HHHHHHTTTTHHHHHHHHHHH-HHHHSHHHHHHHHHH-HT
T ss_pred HHhhcCCChhhhhhhhhheecccc------------ccc-hhhhcccccchhhhhhhhccc-cccchHHHHHHHHHH-Hh
Confidence 999999999999999999998762 233 356666889999999999988 567776555554444 44
Q ss_pred CChhHHHHHHHH-----HHHHcc-CcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccchhhhcc
Q 000880 1018 ADKPTRKALDEL-----YLRIWR-IEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMW 1091 (1239)
Q Consensus 1018 ~~~~~~~~l~~l-----~l~~~~-~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~fg 1091 (1239)
.++.+.+++++| .++.+| ...+|.||++++|+++||||+||++|..+.+. +||+|||||+|++.||
T Consensus 225 ~~~~~~~~~~~L~~l~~~l~~~~~~~~~i~~D~~~~r~~~YYtG~vFe~~~~~~~~--------~ia~GGRYD~L~~~fg 296 (311)
T PF13393_consen 225 SSPALQEALEELEELLKLLEALGYPSIKIIFDLSLVRGLDYYTGIVFEVYAPGRGS--------PIAGGGRYDNLLEQFG 296 (311)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHCTHTTTTEEEETT-GTSSTTEESEEEEEEETTSSS--------ESEEEEEETTHHHHTT
T ss_pred hhhhhHHHHHHHHHHHHHHHHhcccCceEEEChhhccchhhcCCEEEEEEEcCCCc--------eEecccChhHHHHHhC
Confidence 455555666666 778888 56789999999999999999999999987554 6999999999999885
Q ss_pred ccccccccCCCCCCceeeeeccHHHH
Q 000880 1092 DREYVGYASRTNPPSGVGASLALETI 1117 (1239)
Q Consensus 1092 ~~~~~~~~g~~~~~pAvGfaigldrl 1117 (1239)
. ++|||||||++|||
T Consensus 297 ~-----------~~~AvGfai~ld~L 311 (311)
T PF13393_consen 297 K-----------PIPAVGFAIGLDRL 311 (311)
T ss_dssp S-----------S-EEEEEEEEHHHH
T ss_pred C-----------CCceEEEEEEeccC
Confidence 3 46999999999997
|
... |
| >PRK12293 hisZ ATP phosphoribosyltransferase regulatory subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=435.69 Aligned_cols=268 Identities=18% Similarity=0.227 Sum_probs=216.8
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccceeccCC-CccccccEEEEeccCCCeeeecCCCcHHHHHHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGD-CPQFKRNTVKLLTHGGDLLELSHELRLPFIRWA 860 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~~~~~~-~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~ 860 (1239)
..|+|++|++|.++..++++++.++++|++|||++|.||+|++... .....++||+|.|++|+.++||||+|+||||++
T Consensus 6 ~~p~G~rD~lp~e~~~~~~i~~~l~~vf~~~Gy~~I~tP~lE~~e~~~~~~~~~~y~~~D~~g~~l~LRpD~T~~iaR~~ 85 (281)
T PRK12293 6 EIPQGSKLYFGKSAKLKREIENVASEILYENGFEEIVTPFFSYHQHQSIADEKELIRFSDEKNHQISLRADSTLDVVRIV 85 (281)
T ss_pred CCCCcccccCcHHHHHHHHHHHHHHHHHHHcCCeEeeccceeehhhhcccchhceEEEECCCCCEEEECCcCCHHHHHHH
Confidence 4689999999999999999999999999999999999999965544 445789999999999999999999999999999
Q ss_pred HhCC---CCceeEEeecCeEEcCCCCCCCCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEECcHHHHHH
Q 000880 861 ISNQ---KSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEA 937 (1239)
Q Consensus 861 ~~~~---~~P~r~~Y~g~VfR~e~~~~~~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~~i~~~ 937 (1239)
+++. ..|+|+||+|+|||+++ +||+|+|+|+||..++ +|||.+|.++|+++|++ +.|+|||++++++
T Consensus 86 a~~~~~~~~p~r~~Y~g~vfR~~~-----rEf~Q~GvEliG~~~~---~Evi~la~~~l~~lgl~--~~i~ig~~~i~~~ 155 (281)
T PRK12293 86 TKRLGRSTEHKKWFYIQPVFRYPS-----NEIYQIGAELIGEEDL---SEILNIAAEIFEELELE--PILQISNIKIPKL 155 (281)
T ss_pred HHhcccCCCceeEEEeccEEecCC-----CcccccCeEeeCCCCH---HHHHHHHHHHHHHcCCC--CEEEECCHHHHHH
Confidence 8853 35999999999999863 7999999999999986 69999999999999995 6799999999999
Q ss_pred HHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhccCC
Q 000880 938 IWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALP 1017 (1239)
Q Consensus 938 ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~ 1017 (1239)
+++.++++++..+.. .++ ++.. +.++.+..++ .+.+. + .++++...
T Consensus 156 ~l~~~~~~~~~~~~~--~~~---------------------~~~~------~~~~~l~~l~-~~~~~-~-~~~~~~~~-- 201 (281)
T PRK12293 156 VAEILGLDIEVFKKG--QIE---------------------KLLA------QNVPWLNKLV-RIKTL-E-DLDEVIEL-- 201 (281)
T ss_pred HHHHcCCCHHHHhHH--HHH---------------------HHHH------HhHHHHHHHH-hcCCH-H-HHHHHHhh--
Confidence 999999987654221 001 1111 1223344444 23332 2 23333331
Q ss_pred CChhHHHHHHHH--HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccchhhhcccccc
Q 000880 1018 ADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREY 1095 (1239)
Q Consensus 1018 ~~~~~~~~l~~l--~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~fg~~~~ 1095 (1239)
.+....+++++| .++.+++. .+.|||+++||++||||+|||+|.++ . +||+|||||+.
T Consensus 202 ~~~~~~~~l~~l~~~l~~l~~~-~~~~Dl~~vrgl~YYTGivFe~~~~~--~--------~i~~GGRYD~~--------- 261 (281)
T PRK12293 202 VPDEIKEELEKLKELAESIKYE-NLVIAPLYYAKMRYYDDLFFRFFDGN--S--------TLASGGNYEID--------- 261 (281)
T ss_pred CCHHHHHHHHHHHHHHHHcCCC-cEEEccccccCCCCccceEEEEEECC--c--------eeccccCCCCC---------
Confidence 235677888888 77777764 49999999999999999999999863 1 59999999931
Q ss_pred ccccCCCCCCceeeeeccHHHHHhhC
Q 000880 1096 VGYASRTNPPSGVGASLALETIIQHY 1121 (1239)
Q Consensus 1096 ~~~~g~~~~~pAvGfaigldrl~~~L 1121 (1239)
++||||||+|+|||+.+|
T Consensus 262 --------~~PAvGfa~~ld~l~~~l 279 (281)
T PRK12293 262 --------GISSSGFALYTDNLIEIL 279 (281)
T ss_pred --------CCCcceEEeeHHHHHHHh
Confidence 369999999999998775
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=428.39 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=217.8
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeeecC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-----PVNDRILREVATLSRLQHQHVVRYYQAWFETG 496 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~-----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~ 496 (1239)
+.+.|.+.+.||+|+||.|.+|..+.||+.||||+|+...... .....+.+|+++|++|+|||||++++.|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 4567888999999999999999999999999999998654221 122346799999999999999999998843
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL 575 (1239)
..+.||||||++ |.|.+.+...+.+.+...+.+++|++.|+
T Consensus 248 --------------------------------------~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~av 289 (475)
T KOG0615|consen 248 --------------------------------------PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAV 289 (475)
T ss_pred --------------------------------------CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHH
Confidence 356799999995 69999999999999999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCC---CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDAR---NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~---~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
.|||++||+||||||+|||+..+ ..+||+|||+|+...... .+.+.||||.|.|||++.+.
T Consensus 290 kYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s----------------fm~TlCGTpsYvAPEVl~~k 353 (475)
T KOG0615|consen 290 KYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS----------------FMKTLCGTPSYVAPEVLASK 353 (475)
T ss_pred HHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccce----------------ehhhhcCCccccChhheecC
Confidence 99999999999999999999876 789999999999864221 24678999999999999864
Q ss_pred C--CCCcchhhHHHHHHHHHhhc---CCchhHHHH-HHHHhhhhcCC-CCCccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 653 P--KIDEKADMYSLGIVFFELWH---PFSTAMERQ-IVLSDLKQKGE-LPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 653 ~--~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~-~~~~~~~~~~~-~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
+ .+..++||||+||+||-+++ ||.+..... ...++...... .|+.|..++.++.+||++||..||++|||+.+
T Consensus 354 g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e 433 (475)
T KOG0615|consen 354 GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADE 433 (475)
T ss_pred CeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence 3 25569999999999999997 776554433 22333333332 46789999999999999999999999999999
Q ss_pred HHhccCCCCchH
Q 000880 726 LLQDALPPQMEY 737 (1239)
Q Consensus 726 iL~~~~~~~~~~ 737 (1239)
+|+||||+-.+.
T Consensus 434 aL~hpW~~~~~~ 445 (475)
T KOG0615|consen 434 ALNHPWFKDAPC 445 (475)
T ss_pred HhcChhhhcccc
Confidence 999999986653
|
|
| >COG3705 HisZ ATP phosphoribosyltransferase involved in histidine biosynthesis [Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=433.47 Aligned_cols=368 Identities=20% Similarity=0.209 Sum_probs=289.6
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-CccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
..|.|++|.+|.++..++.|++++.+.|.+|||+.|+||++ .+... ++..++++|+|+|+.|+.+|||||||+||
T Consensus 4 ~lp~g~rd~Lp~e~~~~~~i~~~l~~~f~~~Gy~~v~tP~lE~~d~~l~~~g~~l~~~~f~l~d~~g~~l~LRpD~T~pV 83 (390)
T COG3705 4 QLPEGIRDVLPLEARRKEEIRDQLLALFRAWGYERVETPTLEPADPLLDGAGEDLRRRLFKLEDETGGRLGLRPDFTIPV 83 (390)
T ss_pred cCCCcchhcchhHHhhHHHHHHHHHHHHHHhCCccccccccchhhhhhhccchhhhhhheEEecCCCCeEEecccccHHH
Confidence 46899999999999999999999999999999999999999 33333 67789999999999999999999999999
Q ss_pred HHHHHhCCC-CceeEEeecCeEEcCCCCCCCC-ceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEECcHHH
Q 000880 857 IRWAISNQK-SSFKRYEISSVYRRAIGHSPPN-RYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDL 934 (1239)
Q Consensus 857 aR~~~~~~~-~P~r~~Y~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~~i 934 (1239)
||.+++... .|.|+||.|+|||..+...++. ||+|+|||+||.++..||+|||.+++.+|+++|+.+ ++|.|||.+|
T Consensus 84 aR~~~~~~~~~P~Rl~Y~G~Vfr~~~~~~g~~~Ef~QaGiEllG~~~~~ADaEvi~la~~~L~~~gl~~-~~l~LG~~gi 162 (390)
T COG3705 84 ARIHATLLAGTPLRLSYAGKVFRAREGRHGRRAEFLQAGIELLGDDSAAADAEVIALALAALKALGLAD-LKLELGHAGI 162 (390)
T ss_pred HHHHHHhcCCCCceeeecchhhhcchhccCcccchhhhhhHHhCCCcchhhHHHHHHHHHHHHHcCCcC-eEEEeccHHH
Confidence 999988554 5999999999999865555665 999999999999999999999999999999999986 9999999999
Q ss_pred HHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhc
Q 000880 935 LEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRG 1014 (1239)
Q Consensus 935 ~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~ 1014 (1239)
+++++..+++++.|+++|+++|.+++... + .++....+++++....+..++ .+.|. .+++.+++.
T Consensus 163 f~all~~~~l~~~~~~~L~~a~~~k~~~~------------~-~~~~~~~~~~~~~~~~l~~l~-~l~gg-~e~l~~~~~ 227 (390)
T COG3705 163 FRALLAAAGLPGGWRARLRRAFGDKDLLG------------L-ELLVLAAPLSPELRGRLSELL-ALLGG-REVLERARG 227 (390)
T ss_pred HHHHHHHcCCChhHHHHHHHHHhccchhh------------H-HHHhhccCCChhhhHHHHHHH-HHhCC-HHHHHHHHH
Confidence 99999999999999999999999998432 1 333334577778888888888 45555 356666666
Q ss_pred cCCCChhHHHHHHHH---HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccchhhhcc
Q 000880 1015 ALPADKPTRKALDEL---YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMW 1091 (1239)
Q Consensus 1015 ~~~~~~~~~~~l~~l---~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~fg 1091 (1239)
.+........+++++ .....+...++.+|++++++++||||++|++|..+.+. ++++|||||+|.+.||
T Consensus 228 ~l~~~~~~~~al~~~~~l~di~~~~~e~i~lDLg~l~~~~YyTg~~F~ay~~~~~~--------al~~GGRYd~l~~~f~ 299 (390)
T COG3705 228 LLDELMAQGIALNEGRALADIARRLIEKIALDLGRLRHFDYYTGLVFLAYADGLGD--------ALASGGRYDGLLGLFG 299 (390)
T ss_pred hhhhhhhhhhhhhhhhhHHHHHhccchhheehhhcccccchhhceeeeeeeccccc--------hhhcccchhhhhhhcC
Confidence 554443334444444 11122233569999999999999999999999888776 6999999999988886
Q ss_pred ccccccccCCCCCCceeeeeccHHHHHhhCCCCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHHcCCeEEEeeCCC
Q 000880 1092 DREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPD 1171 (1239)
Q Consensus 1092 ~~~~~~~~g~~~~~pAvGfaigldrl~~~L~~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G~~ve~~~~~~ 1171 (1239)
.. .||+||++++++|... ..+. .....++.+.... +.....++++++++|..|-.+.....
T Consensus 300 ~~-----------~patGf~~~l~~l~~~----~~~~-~~~~~~~~f~~~~-~~~~~~~~e~~~~~r~~g~~~~~~l~-- 360 (390)
T COG3705 300 RA-----------APATGFALRLDALAQG----GLPL-EERRYAALFGREL-DYYTGAAFEAAQALRLAGGGRYDRLL-- 360 (390)
T ss_pred cc-----------ccchhhHhhHHHHHhc----CCCc-ccchhhhccCccc-hhhHHHHHHHHHHhcccCCeEEEecc--
Confidence 53 4999999999999852 1221 2234455555442 33458899999999977655543222
Q ss_pred CCHHHHHHHHHhCCCcEEEEEcCC
Q 000880 1172 PSLTEQYEYASEHDIKCLVILTDT 1195 (1239)
Q Consensus 1172 ~~l~k~~~~A~~~g~~~~viig~~ 1195 (1239)
..+ -..+...++.+.+.+...
T Consensus 361 ~g~---~~~~~~~~~~~~~~~~~~ 381 (390)
T COG3705 361 TGL---GASEEIPGVGFSLWLDRG 381 (390)
T ss_pred ccc---chHhhhcccceeEeeccc
Confidence 112 234445677777766444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=418.50 Aligned_cols=263 Identities=30% Similarity=0.450 Sum_probs=228.1
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-PVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
...++|+++++||+|+||+|+.++.+.+++.||+|+++++.... ........|..+|..++||+||+++..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF------- 94 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF------- 94 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-------
Confidence 34689999999999999999999999999999999998765432 3567789999999999999999999887
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
++...+|+|+||++ |.|..+|++.+.|++..++.|+.+|+.||.||
T Consensus 95 ---------------------------------Qt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~L 141 (357)
T KOG0598|consen 95 ---------------------------------QTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYL 141 (357)
T ss_pred ---------------------------------ccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHH
Confidence 34678999999996 59999999999999999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|++|||||||||+|||||.+||++|+|||+|+...... ....++|||+.|||||++.+ ..|+.+
T Consensus 142 H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~---------------~~t~tfcGT~eYmAPEil~~-~gy~~~ 205 (357)
T KOG0598|consen 142 HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG---------------DATRTFCGTPEYMAPEILLG-KGYDKA 205 (357)
T ss_pred HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC---------------CccccccCCccccChHHHhc-CCCCcc
Confidence 99999999999999999999999999999998532111 12345899999999999998 579999
Q ss_pred hhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC----CHHHHHhccC
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP----SATELLQDAL 731 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP----ta~eiL~~~~ 731 (1239)
+|||||||++|||++ ||..........+++..+...++. ..+++++++|+++|..||.+|. ++.+|-+|||
T Consensus 206 vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~--~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf 283 (357)
T KOG0598|consen 206 VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG--YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF 283 (357)
T ss_pred cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc--cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence 999999999999997 888877777776666655344433 2456999999999999999995 6899999999
Q ss_pred CCCchHHHHH
Q 000880 732 PPQMEYELLD 741 (1239)
Q Consensus 732 ~~~~~~~~~~ 741 (1239)
|..+.|+.+.
T Consensus 284 F~~inW~~l~ 293 (357)
T KOG0598|consen 284 FKGINWEKLL 293 (357)
T ss_pred cccCCHHHHH
Confidence 9999987653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=436.11 Aligned_cols=251 Identities=31% Similarity=0.514 Sum_probs=224.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..|+..+.||+|||..||.+++..+|+.||+|++.++. ......+++.+||++.+.|+|||||+++++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F---------- 87 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF---------- 87 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe----------
Confidence 67999999999999999999999999999999998654 2344567899999999999999999999998
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
++..++|||.|+|. ++|..++..++.++|.+|+.|++||+.||.|||++
T Consensus 88 ------------------------------EDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 88 ------------------------------EDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred ------------------------------ecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 34678999999997 79999999999999999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
+|||||||..|+||+++.+|||+|||+|+.+..+. -...+.||||.|.|||++.. ..+++.+||
T Consensus 138 ~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~---------------Erk~TlCGTPNYIAPEVl~k-~gHsfEvDi 201 (592)
T KOG0575|consen 138 GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG---------------ERKKTLCGTPNYIAPEVLNK-SGHSFEVDI 201 (592)
T ss_pred CceecccchhheeecCcCcEEecccceeeeecCcc---------------cccceecCCCcccChhHhcc-CCCCCchhh
Confidence 99999999999999999999999999999876432 12356899999999999997 679999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
||+|||||-|+. ||....-.+...++......+|. ..+.++++||.+||++||.+|||+++||.|+||.
T Consensus 202 WSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~---~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 202 WSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS---HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred hhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc---ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 999999999996 88877677777776666666665 5567999999999999999999999999999994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=415.68 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=220.4
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
+....+++.+..||+|..|+||+|+|+.|++.+|+|+|. -.......+++.+|+++++.++|||||.+||+|+..+
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~--- 150 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG--- 150 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC---
Confidence 355678899999999999999999999999999999995 3455667889999999999999999999999996531
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
. .++|+||||+ |+|.+++...+++++....+++.+|++||.||
T Consensus 151 -----------------------------------~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YL 194 (364)
T KOG0581|consen 151 -----------------------------------E-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYL 194 (364)
T ss_pred -----------------------------------c-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 5899999996 69999999999999999999999999999999
Q ss_pred Hh-CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 579 HG-QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 579 Hs-~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
|. ++||||||||+||||+..|.|||||||.++.+... ...+++||..|||||.+++ ..|+.
T Consensus 195 h~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-----------------~a~tfvGT~~YMsPERi~g-~~Ys~ 256 (364)
T KOG0581|consen 195 HEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-----------------IANTFVGTSAYMSPERISG-ESYSV 256 (364)
T ss_pred hhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-----------------hcccccccccccChhhhcC-CcCCc
Confidence 95 99999999999999999999999999999976432 1367899999999999999 68999
Q ss_pred chhhHHHHHHHHHhhc---CCchh-----HHHHHHHHhhhhcCCCCCccc-cCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 658 KADMYSLGIVFFELWH---PFSTA-----MERQIVLSDLKQKGELPPSWV-AKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~-----~~~~~~~~~~~~~~~~p~~~~-~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
++||||||++++||++ ||.+. ...+.+..+... ..|..+. ..++++++||..||.+||.+|||+.|+++
T Consensus 257 ~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~--ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 257 KSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE--PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC--CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999996 66653 223333334332 2222222 37789999999999999999999999999
Q ss_pred ccCCCCchH
Q 000880 729 DALPPQMEY 737 (1239)
Q Consensus 729 ~~~~~~~~~ 737 (1239)
|||+.+...
T Consensus 335 Hpfi~~~~~ 343 (364)
T KOG0581|consen 335 HPFIKKFED 343 (364)
T ss_pred CHHHhhccc
Confidence 999887654
|
|
| >cd00773 HisRS-like_core Class II Histidinyl-tRNA synthetase (HisRS)-like catalytic core domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=410.94 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=208.1
Q ss_pred hhhHHHHHHHHHHHHHHHcCCccccccce----eccCC-CccccccEEEEeccCCCeeeecCCCcHHHHHHHHhCCC---
Q 000880 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQK--- 865 (1239)
Q Consensus 794 ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~-~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~~~~~--- 865 (1239)
++..++.+++.++++|++|||++|.||+| .+... ++...++||+|.|++|+.++||||+|+|+||+++++..
T Consensus 1 ~~~~~~~l~~~l~~~f~~~Gy~~v~tP~le~~~~~~~~~~~~~~~~~~~~~d~~g~~l~LRpd~T~~iaR~~a~~~~~~~ 80 (261)
T cd00773 1 EAALRRYIEDTLREVFERYGYEEIDTPVFEYTELFLRKSGDEVSKEMYRFKDKGGRDLALRPDLTAPVARAVAENLLSLP 80 (261)
T ss_pred ChHHHHHHHHHHHHHHHHcCCEEeeccceeeHHHhcccccccccceEEEEECCCCCEEEeCCCCcHHHHHHHHhcCccCC
Confidence 36788999999999999999999999999 33333 56778999999999999999999999999999998654
Q ss_pred CceeEEeecCeEEcCCCCC-CCCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEEECcHHHHHHHHHHcCC
Q 000880 866 SSFKRYEISSVYRRAIGHS-PPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGI 944 (1239)
Q Consensus 866 ~P~r~~Y~g~VfR~e~~~~-~~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~~i~~~ll~~lgl 944 (1239)
.|+|+||+|+|||++.++. +.+||+|+|+|+||.++..+|+|+|.++.++|+.+|+.+ +.|.|||+++++++++.+++
T Consensus 81 ~p~k~~y~g~vfR~e~~~~g~~re~~Q~g~Eiig~~~~~~daE~i~l~~~~l~~lg~~~-~~i~l~~~~i~~~l~~~~~~ 159 (261)
T cd00773 81 LPLKLYYIGPVFRYERPQKGRYREFYQVGVEIIGSDSPLADAEVIALAVEILEALGLKD-FQIKINHRGILDGIAGLLED 159 (261)
T ss_pred CCeEEEEEcCEEecCCCCCCCccceEEeceeeeCCCChHHHHHHHHHHHHHHHHcCCCc-eEEEECCHHHHHHHhhccCC
Confidence 6999999999999987664 556799999999999999999999999999999999986 99999999999999999999
Q ss_pred CHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhccCCCChhHHH
Q 000880 945 KAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRK 1024 (1239)
Q Consensus 945 ~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~~~~~~~~ 1024 (1239)
+++.+.++.+.+++ ...+
T Consensus 160 ~~~~~~~l~~~l~~--------------------------------------------------------------~~l~ 177 (261)
T cd00773 160 REEYIERLIDKLDK--------------------------------------------------------------EALA 177 (261)
T ss_pred CHHHHHHHHHHhhH--------------------------------------------------------------HHHH
Confidence 87665544322221 0111
Q ss_pred HHHHH--HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccchhhhccccccccccCCC
Q 000880 1025 ALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRT 1102 (1239)
Q Consensus 1025 ~l~~l--~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~fg~~~~~~~~g~~ 1102 (1239)
.|+.+ .++.+|+..++.||++++|+++||||+||++|.++.+. ..+||+|||||+|+++|++
T Consensus 178 ~l~~l~~~l~~~~~~~~i~~d~~~~r~~~YYtG~vF~~~~~~~~~------~~~i~~GGRYD~L~~~f~~---------- 241 (261)
T cd00773 178 HLEKLLDYLEALGVDIKYSIDLSLVRGLDYYTGIVFEAVADGLGA------QGSIAGGGRYDGLLEEFGG---------- 241 (261)
T ss_pred HHHHHHHHHHHcCCCceEEEcCccccCCcccCceEEEEEECCCCc------cCeEeeccCHHHHHHHhCC----------
Confidence 12222 45666776789999999999999999999999987521 2379999999999998733
Q ss_pred CCCceeeeeccHHHHHhhC
Q 000880 1103 NPPSGVGASLALETIIQHY 1121 (1239)
Q Consensus 1103 ~~~pAvGfaigldrl~~~L 1121 (1239)
.++|||||||++|||+.+|
T Consensus 242 ~~~~avGfa~~~d~l~~~~ 260 (261)
T cd00773 242 EDVPAVGFAIGLERLLLAL 260 (261)
T ss_pred CCCCeEEEEEcHHHHHHhh
Confidence 2469999999999998775
|
HisRS is a homodimer. It is responsible for the attachment of histidine to the 3' OH group of ribose of the appropriate tRNA. This domain is primarily responsible for ATP-dependent formation of the enzyme bound aminoacyl-adenylate. Class II assignment is based upon its structure and the presence of three characteristic sequence motifs. This domain is also found at the C-terminus of eukaryotic GCN2 protein kinase and at the N-terminus of the ATP phosphoribosyltransferase accessory subunit, HisZ. HisZ along with HisG catalyze the first reaction in histidine biosynthesis. HisZ is found only in a subset of bacteria and differs from HisRS in lacking a C-terminal anti-codon binding domain. |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=408.26 Aligned_cols=259 Identities=27% Similarity=0.481 Sum_probs=222.9
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+...+|.+.+.||+|+||+||+|+++.++..||||.|.++.......+.+..|+.+|+.++|||||++++++..
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~------ 80 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED------ 80 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec------
Confidence 44689999999999999999999999999999999998776566677788999999999999999999999743
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
..++|+|||||. |+|.++++..+.+++..++.++.||+.||++||
T Consensus 81 ----------------------------------~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~ 126 (429)
T KOG0595|consen 81 ----------------------------------DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH 126 (429)
T ss_pred ----------------------------------CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 468999999996 799999999999999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCC------CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC
Q 000880 580 GQGIIHRDLTPNNIFFDAR------NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~------~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 653 (1239)
+++||||||||+||||+.. -.+||+|||+|+.+.... ...+.||+|.|||||+++. .
T Consensus 127 ~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~----------------~a~tlcGSplYMAPEV~~~-~ 189 (429)
T KOG0595|consen 127 ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS----------------MAETLCGSPLYMAPEVIMS-Q 189 (429)
T ss_pred HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh----------------HHHHhhCCccccCHHHHHh-c
Confidence 9999999999999999875 458999999999875332 1245799999999999986 6
Q ss_pred CCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhcc
Q 000880 654 KIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 654 ~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~ 730 (1239)
.|+.|+|+||+|+|||+|++ ||......+....+.......|......++...+|+...+..+|.+|.++.+-+.|+
T Consensus 190 ~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 190 QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 89999999999999999996 887777776666544444444444444455677999999999999999999999998
Q ss_pred CCCCch
Q 000880 731 LPPQME 736 (1239)
Q Consensus 731 ~~~~~~ 736 (1239)
+.....
T Consensus 270 ~l~~~p 275 (429)
T KOG0595|consen 270 FLAANP 275 (429)
T ss_pred hcccCc
Confidence 766554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=420.25 Aligned_cols=274 Identities=30% Similarity=0.515 Sum_probs=238.5
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~ 497 (1239)
.+..+||.+.+.||.|+|++|++|+.+.+++.||||++.++... ......+.+|-.+|.+| .||.|+++|..|.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ---- 144 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ---- 144 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee----
Confidence 34468999999999999999999999999999999999765432 22345678899999999 8999999998873
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
+...+|+|+||++ |+|.++|.+.+.|++..++.|+.||+.||+
T Consensus 145 ------------------------------------D~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAle 188 (604)
T KOG0592|consen 145 ------------------------------------DEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALE 188 (604)
T ss_pred ------------------------------------cccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHH
Confidence 4578999999996 799999999999999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++|||||||||+|||||.|+++||+|||.|+.+......... +......+.+..+++||..|.+||+|.. ...+
T Consensus 189 ylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~--~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~ 265 (604)
T KOG0592|consen 189 YLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQEN--PVDPNQASSRRSSFVGTAEYVSPELLND-SPAG 265 (604)
T ss_pred HHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccC--ccCcccccCcccceeeeecccCHHHhcC-CCCC
Confidence 999999999999999999999999999999999998765543321 1111112222477999999999999998 6789
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
+.+|+|+||||||+|+. ||....+-.++.+++.....+|+.++ +.+.+||+++|..||.+|+|+.+|.+||||.
T Consensus 266 ~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 266 PSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFP---EDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred cccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCC---HHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 99999999999999995 99999998888888888888888765 6899999999999999999999999999999
Q ss_pred CchHHH
Q 000880 734 QMEYEL 739 (1239)
Q Consensus 734 ~~~~~~ 739 (1239)
.+.|+.
T Consensus 343 ~Vdw~n 348 (604)
T KOG0592|consen 343 GVDWEN 348 (604)
T ss_pred cCChhh
Confidence 999886
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=393.96 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=231.4
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
.+++|+.++.||.|+||.|.+++++.+|..||+|++++.. ......+...+|..+|+.+.||+++++++.|.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~------- 114 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK------- 114 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-------
Confidence 3689999999999999999999999999999999998654 24445677889999999999999999998873
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
+..++||||||++ |.|..++++.++|+++.+++|+.||+.||+|||
T Consensus 115 ---------------------------------d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH 161 (355)
T KOG0616|consen 115 ---------------------------------DNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH 161 (355)
T ss_pred ---------------------------------cCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH
Confidence 3578999999996 589999999999999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+++|++|||||+|||||.+|++||+|||+|+.+... ..+.||||.|+|||+++. ..|+.++
T Consensus 162 ~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r------------------T~TlCGTPeYLAPEii~s-k~ynkav 222 (355)
T KOG0616|consen 162 SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR------------------TWTLCGTPEYLAPEIIQS-KGYNKAV 222 (355)
T ss_pred hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc------------------EEEecCCccccChHHhhc-CCCCcch
Confidence 999999999999999999999999999999976422 245799999999999998 5699999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCC-----CCHHHHHhccC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR-----PSATELLQDAL 731 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~R-----Pta~eiL~~~~ 731 (1239)
|+|||||++|||+. ||....+..+..+++..+..+|+.+ ++++++||+++|+.|-.+| ....+|..|+|
T Consensus 223 DWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~f---s~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 223 DWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYF---SSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPW 299 (355)
T ss_pred hHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCccc---CHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcc
Confidence 99999999999995 9999999999999998888888765 4599999999999999999 46789999999
Q ss_pred CCCchHHHH
Q 000880 732 PPQMEYELL 740 (1239)
Q Consensus 732 ~~~~~~~~~ 740 (1239)
|....|..+
T Consensus 300 F~~v~W~~i 308 (355)
T KOG0616|consen 300 FKGVDWEAI 308 (355)
T ss_pred cccccHHHH
Confidence 999988754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=417.57 Aligned_cols=278 Identities=28% Similarity=0.483 Sum_probs=229.4
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
.++||+++.+||+|+||.||+|+.+.||..||+|+++++.. .......+..|-.+|....+|+||++|.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-------- 210 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-------- 210 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--------
Confidence 36899999999999999999999999999999999987653 334556788999999999999999999888
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
++..++|+||||++ |++..+|...+.+++..+++|+.+++.|++.||
T Consensus 211 --------------------------------QD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH 258 (550)
T KOG0605|consen 211 --------------------------------QDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH 258 (550)
T ss_pred --------------------------------cCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH
Confidence 34679999999996 599999999999999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhcccccccc------------CCCCCCCCCC----cc------------
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQ------------DAAFPTDTGG----VS------------ 631 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~------------~~~~~~~~~~----~~------------ 631 (1239)
+.|+|||||||+|+|||..||+||+|||||.-+....... ....+.+... .+
T Consensus 259 ~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~ 338 (550)
T KOG0605|consen 259 QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWK 338 (550)
T ss_pred HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHH
Confidence 9999999999999999999999999999996543211100 0000001110 00
Q ss_pred ----ccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--CCCCCccccCC
Q 000880 632 ----VDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK--GELPPSWVAKF 702 (1239)
Q Consensus 632 ----~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~ 702 (1239)
.-..+.+|||.|||||++.+ ..|+..+|+||||||+||||. ||....+.+...+++.-. ..+|.. ...+
T Consensus 339 ~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-~~~s 416 (550)
T KOG0605|consen 339 RNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-VDLS 416 (550)
T ss_pred hhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-Cccc
Confidence 01236799999999999999 569999999999999999985 898888888777665433 334443 3456
Q ss_pred HHHHHHHHHccCCCCCCCC---CHHHHHhccCCCCchHHHHHH
Q 000880 703 SEQESLLRRLMSPSPSDRP---SATELLQDALPPQMEYELLDN 742 (1239)
Q Consensus 703 ~e~~~LI~~~L~~dP~~RP---ta~eiL~~~~~~~~~~~~~~~ 742 (1239)
+++.|||.+||+ ||++|. +++||.+||||..+.|+.+..
T Consensus 417 ~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 417 DEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLRE 458 (550)
T ss_pred HHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhc
Confidence 899999999999 999998 599999999999999986644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=395.34 Aligned_cols=249 Identities=30% Similarity=0.554 Sum_probs=210.4
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeee-eeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQ-AWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~-~~~e~~~~~~~ 501 (1239)
+.+|+++++||+|+||+||++.+..+|..+|.|.++....+....+....|+.+|++|+|||||++++ .|.+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~------- 90 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE------- 90 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc-------
Confidence 57899999999999999999999999999999999877777777888999999999999999999996 3321
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
+...++||||||+ |+|.+.+.. ...+++..+|+++.|++.||.
T Consensus 91 --------------------------------~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~ 138 (375)
T KOG0591|consen 91 --------------------------------DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALY 138 (375)
T ss_pred --------------------------------cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHH
Confidence 2345899999996 799998863 345999999999999999999
Q ss_pred HHHh--CC--ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC
Q 000880 577 HIHG--QG--IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 577 yLHs--~g--IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
++|+ .. |+||||||.||+|+.+|.+||+|||+++++..... ...+.+|||.||+||.+.+
T Consensus 139 ~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t---------------fA~S~VGTPyYMSPE~i~~- 202 (375)
T KOG0591|consen 139 HCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT---------------FAHSLVGTPYYMSPERIHE- 202 (375)
T ss_pred HHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH---------------HHHhhcCCCcccCHHHHhc-
Confidence 9999 44 99999999999999999999999999998753321 1357899999999999998
Q ss_pred CCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCcc-ccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 653 PKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSW-VAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 653 ~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~-~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
..|++++||||+||++|||+. ||.+..--+...++ ..+..|+.+ ...+.++..||..|++.||..||+.-.+++
T Consensus 203 ~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI--~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 203 SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI--EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH--HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 679999999999999999973 99887444433333 355777666 455668899999999999999998654444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=386.51 Aligned_cols=258 Identities=28% Similarity=0.462 Sum_probs=213.5
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++.|+.+.++|+|+||.||+|+++.||+.||||++.-++.+....+-.+||+++|++|+|||+|.++.+|-
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--------- 71 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--------- 71 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH---------
Confidence 35788899999999999999999999999999999866666677778899999999999999999998872
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....+++|+|||+.++.+.|.... .++...+..+++|++.|+.|+|++
T Consensus 72 -------------------------------rkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~ 120 (396)
T KOG0593|consen 72 -------------------------------RKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN 120 (396)
T ss_pred -------------------------------hcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc
Confidence 357899999999998888887654 599999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
++|||||||+||||+.+|.+||||||+|+.+..+. -..|.++.|.||.|||.+.|...|+..+||
T Consensus 121 n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg---------------d~YTDYVATRWYRaPELLvGDtqYG~pVDi 185 (396)
T KOG0593|consen 121 NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG---------------DNYTDYVATRWYRAPELLVGDTQYGKPVDI 185 (396)
T ss_pred CeecccCChhheEEecCCcEEeccchhhHhhcCCc---------------chhhhhhhhhhccChhhhcccCcCCCcccc
Confidence 99999999999999999999999999999875321 113667999999999999998889999999
Q ss_pred HHHHHHHHHhhc--CCchh-HHHHHHHHhhhhcCC-------------------CC-----C----ccccCCHHHHHHHH
Q 000880 662 YSLGIVFFELWH--PFSTA-MERQIVLSDLKQKGE-------------------LP-----P----SWVAKFSEQESLLR 710 (1239)
Q Consensus 662 wSlGviL~ELlt--Pf~~~-~~~~~~~~~~~~~~~-------------------~p-----~----~~~~~~~e~~~LI~ 710 (1239)
||+||++.||++ |.++. ++-.....+...-+. +| . ..+..+.-+.+|++
T Consensus 186 WAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k 265 (396)
T KOG0593|consen 186 WAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLK 265 (396)
T ss_pred hhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHH
Confidence 999999999997 55443 332222222111111 11 1 12223345679999
Q ss_pred HccCCCCCCCCCHHHHHhccCCCCc
Q 000880 711 RLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
.||..||++|++.+++|.|++|.+.
T Consensus 266 ~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 266 KCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred HHhcCCccccccHHHHhcChHHHHH
Confidence 9999999999999999999999444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=404.28 Aligned_cols=261 Identities=31% Similarity=0.473 Sum_probs=215.7
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCcc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~ 498 (1239)
-.++++|.++++||.|+||.||+|+.+.+|..||||.++.+..+.+.. .-+||++.|++|+ |||||++.+++.++
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~--- 81 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDN--- 81 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhcc---
Confidence 345789999999999999999999999999999999998776664433 3568999999998 99999999887553
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~y 577 (1239)
...+|+|||||+.+|++++..+ ..|+++.++.|+.||+.||+|
T Consensus 82 ------------------------------------~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~h 125 (538)
T KOG0661|consen 82 ------------------------------------DRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAH 125 (538)
T ss_pred ------------------------------------CceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHH
Confidence 2389999999999999999765 459999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
+|.+|+.||||||+|||+.....+||+|||+|+.+... ...|.++-|.+|.|||+|.....|+.
T Consensus 126 iHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk----------------pPYTeYVSTRWYRAPEvLLrs~~Ys~ 189 (538)
T KOG0661|consen 126 IHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK----------------PPYTEYVSTRWYRAPEVLLRSGYYSS 189 (538)
T ss_pred HHhcCcccccCChhheEecccceeEecccccccccccC----------------CCcchhhhcccccchHHhhhccccCC
Confidence 99999999999999999999999999999999965321 12367899999999999988788999
Q ss_pred chhhHHHHHHHHHhhc--C-CchhHHHHHHHHhhh-------------------hcCCCC--------CccccCCHHHHH
Q 000880 658 KADMYSLGIVFFELWH--P-FSTAMERQIVLSDLK-------------------QKGELP--------PSWVAKFSEQES 707 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt--P-f~~~~~~~~~~~~~~-------------------~~~~~p--------~~~~~~~~e~~~ 707 (1239)
+.||||+|||++|+++ | |.+..+.....++.. .+..+| .-.+..++++.+
T Consensus 190 pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~ 269 (538)
T KOG0661|consen 190 PVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAAS 269 (538)
T ss_pred chHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHH
Confidence 9999999999999975 5 333444333322211 011122 123346678999
Q ss_pred HHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 708 LLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 708 LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||.+|++.||.+||||.++|+||||+.-.
T Consensus 270 li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 270 LIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhcCCCccCccHHHHhcCccccccc
Confidence 99999999999999999999999998653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=413.12 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=227.7
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~ 497 (1239)
...+++|.++++||+|+||+|+++..+.+++.||||++++... ..+..+....|..++... +||.++.++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 4468999999999999999999999999999999999987653 444567788899998888 599999999887
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
+...++|+||||+.|+-..++...+.|++..++.|+..|+.||+|
T Consensus 439 -----------------------------------QT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~f 483 (694)
T KOG0694|consen 439 -----------------------------------QTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQF 483 (694)
T ss_pred -----------------------------------ccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHH
Confidence 346899999999965334444556789999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++||||||||.+|||||.+|++||+|||+++..-.. -..++++||||.|||||++++ ..|+.
T Consensus 484 LH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~---------------g~~TsTfCGTpey~aPEil~e-~~Yt~ 547 (694)
T KOG0694|consen 484 LHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ---------------GDRTSTFCGTPEFLAPEVLTE-QSYTR 547 (694)
T ss_pred HHhcCceeeecchhheEEcccCcEEecccccccccCCC---------------CCccccccCChhhcChhhhcc-Ccccc
Confidence 99999999999999999999999999999999853111 113467899999999999998 78999
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhc
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~ 729 (1239)
++|||||||+||||+. ||.+.++.+..-.++.....+|.. .+.++.++|+++|.+||++|.. +.+|.+|
T Consensus 548 aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~---ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 548 AVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF---LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc---ccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 9999999999999995 999999999888888766666643 3459999999999999999985 6889999
Q ss_pred cCCCCchHHHHHH
Q 000880 730 ALPPQMEYELLDN 742 (1239)
Q Consensus 730 ~~~~~~~~~~~~~ 742 (1239)
|||....|+.+..
T Consensus 625 pFFr~i~w~~L~~ 637 (694)
T KOG0694|consen 625 PFFRSIDWDDLLN 637 (694)
T ss_pred CccccCCHHHHhh
Confidence 9999999876543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=399.82 Aligned_cols=268 Identities=27% Similarity=0.431 Sum_probs=222.4
Q ss_pred CCCCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecC
Q 000880 417 LPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETG 496 (1239)
Q Consensus 417 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~ 496 (1239)
....+..+.|+.+++||+|.||.||+|++..+|+.||+|+++.............|||.+|++|+||||+++.+...+.
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~- 188 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK- 188 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec-
Confidence 3345567889999999999999999999999999999999998776666677889999999999999999999887543
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL 575 (1239)
....+|||+|||+.+|..++... -+|++.++..|+.||+.||
T Consensus 189 -------------------------------------~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl 231 (560)
T KOG0600|consen 189 -------------------------------------LSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGL 231 (560)
T ss_pred -------------------------------------CCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHH
Confidence 24578999999999999999864 4799999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 655 (1239)
+|||++||+|||||.+|||||.+|.+||+|||+|+++.... ....|+.+-|++|.|||.|.|...|
T Consensus 232 ~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~--------------~~~~T~rVvTLWYRpPELLLG~t~Y 297 (560)
T KOG0600|consen 232 EYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG--------------SAPYTSRVVTLWYRPPELLLGATSY 297 (560)
T ss_pred HHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC--------------CcccccceEEeeccChHHhcCCccc
Confidence 99999999999999999999999999999999999874332 1235778999999999999998899
Q ss_pred CcchhhHHHHHHHHHhhc--C-CchhHHHHHHHHhhhhcCCC----------C----------------CccccCCHHHH
Q 000880 656 DEKADMYSLGIVFFELWH--P-FSTAMERQIVLSDLKQKGEL----------P----------------PSWVAKFSEQE 706 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt--P-f~~~~~~~~~~~~~~~~~~~----------p----------------~~~~~~~~e~~ 706 (1239)
+.++|+||.||||.||+. | |.+..+.+.+..+....+.. | ..+...++.+.
T Consensus 298 g~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l 377 (560)
T KOG0600|consen 298 GTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASAL 377 (560)
T ss_pred ccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHH
Confidence 999999999999999996 4 34444444443333222211 1 01122334667
Q ss_pred HHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 707 SLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 707 ~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
+|+..||+.||.+|.||.++|+++||...+
T Consensus 378 ~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 378 DLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred HHHHHHhccCccccccHHHHhcCcccccCC
Confidence 999999999999999999999999995443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=388.62 Aligned_cols=264 Identities=26% Similarity=0.372 Sum_probs=223.4
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
..++|++..+||.|..++||+|++..++..||||+++...+... ...+.+|+..|+.++||||++++.+|+.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv------- 95 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV------- 95 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe-------
Confidence 45899999999999999999999999999999999998877644 6789999999999999999999988843
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
...+|+||.||. ||+.+++... ..+++..+..++++++.||.||
T Consensus 96 ---------------------------------~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL 142 (516)
T KOG0582|consen 96 ---------------------------------DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL 142 (516)
T ss_pred ---------------------------------cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH
Confidence 467899999995 7999999764 3599999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccc-ccCCCCCCc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI-EQGWPKIDE 657 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~-l~~~~~~~~ 657 (1239)
|.+|.||||||+.||||+.+|.|||+|||.+..+...... ...+.++++|||+|||||+ .+....|+.
T Consensus 143 H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R-----------~~~rf~tfvgtp~wmAPEvl~q~~~GYdf 211 (516)
T KOG0582|consen 143 HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR-----------QVTRFNTFVGTPCWMAPEVLMQQLHGYDF 211 (516)
T ss_pred HhcCceecccccccEEEcCCCcEEEcCceeeeeecccCce-----------eeEeeccccCcccccChHHhhhcccCccc
Confidence 9999999999999999999999999999998766432200 0111267899999999999 555567999
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCC-------ccccCCHHHHHHHHHccCCCCCCCCCHHHHH
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-------SWVAKFSEQESLLRRLMSPSPSDRPSATELL 727 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-------~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL 727 (1239)
|+|||||||+..||.+ ||....++..++..+...+..+. ........++.+|..||.+||.+|||+.++|
T Consensus 212 KaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 212 KADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred hhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 9999999999999997 99998888888877764433221 1111223678999999999999999999999
Q ss_pred hccCCCCchH
Q 000880 728 QDALPPQMEY 737 (1239)
Q Consensus 728 ~~~~~~~~~~ 737 (1239)
+|+||++...
T Consensus 292 kh~FFk~~k~ 301 (516)
T KOG0582|consen 292 KHAFFKKAKS 301 (516)
T ss_pred ccHHHhhccc
Confidence 9999988753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=399.24 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=223.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++|.+.+.||+|+||.||+|+.+.|.+.||||.+.+..........+.+|+++++.|+|||||.+++.|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf---------- 70 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF---------- 70 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh----------
Confidence 4688999999999999999999999999999999987777767778899999999999999999999765
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
+....+|+|.|||-|+|..++...+.++++.+..++.|++.||.|||+++
T Consensus 71 ------------------------------Et~~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r 120 (808)
T KOG0597|consen 71 ------------------------------ETSAHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR 120 (808)
T ss_pred ------------------------------cccceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 23578999999999999999999999999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+|||+||.|||++..+++|+||||+|+..... ....++..|||.|||||.+.+ ..|+..+|+|
T Consensus 121 ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~---------------t~vltsikGtPlYmAPElv~e-~pyd~~sDlW 184 (808)
T KOG0597|consen 121 ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN---------------TSVLTSIKGTPLYMAPELVEE-QPYDHTSDLW 184 (808)
T ss_pred cccccCCcceeeecCCCceeechhhhhhhcccC---------------ceeeeeccCcccccCHHHHcC-CCccchhhHH
Confidence 999999999999999999999999999975422 122366789999999999998 6799999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|+|||+|||++ ||....-.+....++......|+ ..++.+.+|+..+|.+||.+|.|+.+++.|||.++.
T Consensus 185 slGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~---~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 185 SLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS---TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc---cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999996 78776665555555543333332 667799999999999999999999999999987654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=366.60 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=216.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|..+++||+|.||.||+|++..||+.||||+|+..+.........+||++.|+.++||||+.++++|-
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~---------- 71 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP---------- 71 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc----------
Confidence 4677889999999999999999999999999999988777677788999999999999999999999883
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...++.||+||++.+|..+++.. ..++...+..|+.++++||+|||++.
T Consensus 72 ------------------------------~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~ 121 (318)
T KOG0659|consen 72 ------------------------------HKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW 121 (318)
T ss_pred ------------------------------CCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh
Confidence 24578999999999999999754 45999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||.|+||+++|.+||+|||+|+.+..+... .+..+-|.+|.|||.+-|...|+..+|||
T Consensus 122 IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~---------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmW 186 (318)
T KOG0659|consen 122 ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI---------------QTHQVVTRWYRAPELLFGSRQYGTGVDMW 186 (318)
T ss_pred hhcccCCccceEEcCCCcEEeecccchhccCCCCcc---------------cccceeeeeccChHHhccchhcCCcchhh
Confidence 999999999999999999999999999987543311 23348899999999999988999999999
Q ss_pred HHHHHHHHhhc--CCchhHHH-HHHHHhhhhcCC--------------------CC-----CccccCCHHHHHHHHHccC
Q 000880 663 SLGIVFFELWH--PFSTAMER-QIVLSDLKQKGE--------------------LP-----PSWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 663 SlGviL~ELlt--Pf~~~~~~-~~~~~~~~~~~~--------------------~p-----~~~~~~~~e~~~LI~~~L~ 714 (1239)
|.|||+.||+. ||.+.... +..-.+.+.-+. .| ..++..++++.+|+..||.
T Consensus 187 avGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ 266 (318)
T KOG0659|consen 187 AVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLT 266 (318)
T ss_pred hHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhc
Confidence 99999999984 77654332 222222111110 11 1233445677899999999
Q ss_pred CCCCCCCCHHHHHhccCCCCchH
Q 000880 715 PSPSDRPSATELLQDALPPQMEY 737 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~~~~~~~~~ 737 (1239)
.||.+|+|+.|+|+|+||.+.+.
T Consensus 267 ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 267 YNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred cCchhcccHHHHhcchhhhcCCC
Confidence 99999999999999999987653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=400.73 Aligned_cols=256 Identities=30% Similarity=0.522 Sum_probs=218.8
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC---chhHHHHHHHHHHHHhcC-CCceeeeeeeeeecC
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS---LPVNDRILREVATLSRLQ-HQHVVRYYQAWFETG 496 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~---~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~ 496 (1239)
...+.|.+.+.||+|+||+|++|.+..+|..||||+++..... ......+.+|+.+++.++ ||||++++.++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--- 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--- 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence 3467899999999999999999999999999999987654211 134556779999999998 999999998872
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL 575 (1239)
....+|||||||. |+|.+.+...+++.+..++.+++||+.|+
T Consensus 91 -------------------------------------t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav 133 (370)
T KOG0583|consen 91 -------------------------------------TPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAV 133 (370)
T ss_pred -------------------------------------cCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHH
Confidence 2345999999996 59999999989999999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCC-CCEEEeecCcchhcc-ccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLK-LEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~-~~vKL~DFGlA~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 653 (1239)
+|||++||+||||||+|||++.+ +++||+|||++.... .. ....+.||||.|+|||++.+..
T Consensus 134 ~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~----------------~~l~t~cGsp~Y~aPEvl~~~~ 197 (370)
T KOG0583|consen 134 AYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED----------------GLLKTFCGSPAYAAPEVLSGKG 197 (370)
T ss_pred HHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC----------------CcccCCCCCcccCCHHHhCCCC
Confidence 99999999999999999999999 999999999998752 11 1135679999999999999965
Q ss_pred CC-CcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 654 KI-DEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 654 ~~-~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.| +.++||||+||+||.|++ ||...........+......+|.... ++++++||++||..||.+|+|+.+|+.|
T Consensus 198 ~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 198 TYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 25 589999999999999997 88886666666665555555565443 7899999999999999999999999999
Q ss_pred cCCCC
Q 000880 730 ALPPQ 734 (1239)
Q Consensus 730 ~~~~~ 734 (1239)
+||+.
T Consensus 276 ~w~~~ 280 (370)
T KOG0583|consen 276 PWFQK 280 (370)
T ss_pred hhhcc
Confidence 99997
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=374.53 Aligned_cols=269 Identities=27% Similarity=0.402 Sum_probs=220.5
Q ss_pred CCCCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecC
Q 000880 417 LPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETG 496 (1239)
Q Consensus 417 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~ 496 (1239)
+...+.+++|+.+.+|++|+||.||+|+++.|++.||+|+++.........-.-+||+.+|.+++|||||.+-.+.+..
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~- 147 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS- 147 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc-
Confidence 5567778999999999999999999999999999999999987654444445678999999999999999998775321
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL 575 (1239)
+...+|||||||..+|..+++... +|...+++.++.|+++|+
T Consensus 148 -------------------------------------~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~gl 190 (419)
T KOG0663|consen 148 -------------------------------------NMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGL 190 (419)
T ss_pred -------------------------------------ccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHH
Confidence 345699999999999999998766 799999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 655 (1239)
+|||++.|+||||||+|+|+...|.+||+|||+|+.+..+-. ..|..+-|.+|.|||.|.|...|
T Consensus 191 k~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k---------------~~T~lVVTLWYRaPELLLG~~ty 255 (419)
T KOG0663|consen 191 KHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK---------------PYTPLVVTLWYRAPELLLGAKTY 255 (419)
T ss_pred HHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc---------------cCcceEEEeeecCHHHhcCCccc
Confidence 999999999999999999999999999999999998764421 13667899999999999998899
Q ss_pred CcchhhHHHHHHHHHhhc--C-CchhHHHHHHHHhhhhcCC-------------------CCC--------cccc--CCH
Q 000880 656 DEKADMYSLGIVFFELWH--P-FSTAMERQIVLSDLKQKGE-------------------LPP--------SWVA--KFS 703 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt--P-f~~~~~~~~~~~~~~~~~~-------------------~p~--------~~~~--~~~ 703 (1239)
+.+.||||+|||+.||++ | |.+..+.....++...-+. ++. .+.. .+.
T Consensus 256 st~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse 335 (419)
T KOG0663|consen 256 STAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSE 335 (419)
T ss_pred CcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccch
Confidence 999999999999999996 4 3344443333333221111 010 0001 224
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHhccCCCCchHH
Q 000880 704 EQESLLRRLMSPSPSDRPSATELLQDALPPQMEYE 738 (1239)
Q Consensus 704 e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~~~ 738 (1239)
...+|+..+|..||.+|.||.+.|+|.||...+..
T Consensus 336 ~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 336 QGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred hHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 56799999999999999999999999999886543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=398.89 Aligned_cols=257 Identities=32% Similarity=0.514 Sum_probs=228.1
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecC-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK-DKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~-~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+..-|++.+.||+|+-|.|.+|+|..||+.+|||+|.+. ..+......+.+|+-+|+.+.||||+++|++|.
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe------- 82 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE------- 82 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-------
Confidence 456788999999999999999999999999999999876 344445567899999999999999999999983
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
+..++|+|.||++ |.|.+++...+++++.++.+++.||+.|+.|||
T Consensus 83 ---------------------------------~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH 129 (786)
T KOG0588|consen 83 ---------------------------------NKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH 129 (786)
T ss_pred ---------------------------------cCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh
Confidence 3578999999996 689999999999999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
..+|+||||||+|+|||..++|||+|||+|..-..... -.+.||+|.|+|||++.|.++-+.++
T Consensus 130 ~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl----------------LeTSCGSPHYA~PEIV~G~pYdG~~s 193 (786)
T KOG0588|consen 130 AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL----------------LETSCGSPHYAAPEIVSGRPYDGRPS 193 (786)
T ss_pred hhcceeccCCchhhhhhcccCEeeeccceeecccCCcc----------------ccccCCCcccCCchhhcCCCCCCCcc
Confidence 99999999999999999999999999999986432221 24569999999999999987778999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||||.|||||.|++ ||.+..-+..+.+.......+|. .+++++++||++||..||.+|.|.++|++|||.....
T Consensus 194 DVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs---~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 194 DVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS---NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred ccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC---cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 99999999999998 99988888888887776777773 5677999999999999999999999999999987664
Q ss_pred H
Q 000880 737 Y 737 (1239)
Q Consensus 737 ~ 737 (1239)
.
T Consensus 271 ~ 271 (786)
T KOG0588|consen 271 S 271 (786)
T ss_pred C
Confidence 3
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=393.96 Aligned_cols=248 Identities=33% Similarity=0.487 Sum_probs=209.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcE-EEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRH-YAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~-vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++.+.+.||+|+||+||+|.|+ |+. ||||++.....+......|.+|+.+|++++|||||+++|+|.++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~------- 111 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP------- 111 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-------
Confidence 45566677999999999999998 667 99999986655544577899999999999999999999998543
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES--YDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...++|||||++ |+|.++++. ...++...+..++.||++||.|||
T Consensus 112 --------------------------------~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH 159 (362)
T KOG0192|consen 112 --------------------------------PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH 159 (362)
T ss_pred --------------------------------CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh
Confidence 115799999996 799999987 577999999999999999999999
Q ss_pred hCC-ccccCCCcccEEEcCCC-CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC-CCCCC
Q 000880 580 GQG-IIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG-WPKID 656 (1239)
Q Consensus 580 s~g-IiHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~ 656 (1239)
+++ ||||||||+|||++.++ ++||+|||+++...... ...+...||+.|||||++.+ ...|+
T Consensus 160 ~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---------------~~~~~~~GT~~wMAPEv~~~~~~~~~ 224 (362)
T KOG0192|consen 160 SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---------------TSMTSVAGTYRWMAPEVLRGEKSPYT 224 (362)
T ss_pred cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc---------------ccccCCCCCccccChhhhcCCCCcCC
Confidence 999 99999999999999997 99999999998653211 12344689999999999995 25799
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
.|+|||||||+||||+| ||......+...... .....|+....+++.+..||.+||+.||..||++.+|+.
T Consensus 225 ~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~-~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 225 EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV-VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999997 999888844444433 355566655568889999999999999999999999985
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=376.27 Aligned_cols=275 Identities=27% Similarity=0.408 Sum_probs=222.6
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
.|..++.||+|+||.|+.+.++.+|+.||||+|..........++.+||+++|+.++|+||+.+++.+..+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~--------- 93 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP--------- 93 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc---------
Confidence 44457899999999999999999999999999975556666788999999999999999999999887321
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
....-..+|+|+|+|+.+|.++++....+++..+..+++||++||+|+|+.+|+
T Consensus 94 --------------------------~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnVi 147 (359)
T KOG0660|consen 94 --------------------------SRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVI 147 (359)
T ss_pred --------------------------cccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccccc
Confidence 112345789999999999999999988899999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
||||||+|+|++.++.+||||||+|+..... ......|.++-|.+|.|||++.....|+.+.||||+
T Consensus 148 HRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSv 214 (359)
T KOG0660|consen 148 HRDLKPSNLLLNADCDLKICDFGLARYLDKF-------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSV 214 (359)
T ss_pred ccccchhheeeccCCCEEeccccceeecccc-------------CcccchhcceeeeeecCHHHHhccccccchhhhhhh
Confidence 9999999999999999999999999976422 112235788999999999999887889999999999
Q ss_pred HHHHHHhhc--C---CchhHHH-------------HH--------HHHhhhhcCCCC-----CccccCCHHHHHHHHHcc
Q 000880 665 GIVFFELWH--P---FSTAMER-------------QI--------VLSDLKQKGELP-----PSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 665 GviL~ELlt--P---f~~~~~~-------------~~--------~~~~~~~~~~~p-----~~~~~~~~e~~~LI~~~L 713 (1239)
||||.||++ | +...... +. ...-+...+..| ..+++..|.+.+|+.+||
T Consensus 215 GCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL 294 (359)
T KOG0660|consen 215 GCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKML 294 (359)
T ss_pred hHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHh
Confidence 999999996 3 2211111 00 011111122222 244567789999999999
Q ss_pred CCCCCCCCCHHHHHhccCCCCchHHHHHHHHHhcCCCCCCcchhhh
Q 000880 714 SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDKV 759 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 759 (1239)
..||.+|+|++++|+||+ ++.+++++|++.....
T Consensus 295 ~fdP~kRita~eAL~hPY------------l~~~hdp~dEP~~~~~ 328 (359)
T KOG0660|consen 295 VFDPKKRITAEEALAHPY------------LAPYHDPEDEPVCQPI 328 (359)
T ss_pred ccCccccCCHHHHhcChh------------hhhhcCCccCCCCCCC
Confidence 999999999999999984 4456777777765443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=383.27 Aligned_cols=261 Identities=34% Similarity=0.529 Sum_probs=212.7
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.++...+.||+|+||.||++.++.+|..+|||.+...... ..+.+.+|+.+|++|+|||||+++|.....
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~-------- 86 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSR-------- 86 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccc--------
Confidence 4577789999999999999999999999999998765322 266789999999999999999999863111
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....++|.|||++ |+|.+++...+ .++++.++.+++||++||+|||++
T Consensus 87 ------------------------------~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~ 136 (313)
T KOG0198|consen 87 ------------------------------ENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK 136 (313)
T ss_pred ------------------------------cCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0147899999996 69999999877 799999999999999999999999
Q ss_pred CccccCCCcccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 582 GIIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
|||||||||+|||++. ++.+||+|||+++...... ..........|||.|||||++.......+++|
T Consensus 137 g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~------------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sD 204 (313)
T KOG0198|consen 137 GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG------------TKSDSELSVQGTPNYMAPEVIRNGEVARRESD 204 (313)
T ss_pred CEeccCcccceEEEeCCCCeEEeccCcccccccccc------------ccccccccccCCccccCchhhcCCCcCCccch
Confidence 9999999999999999 7999999999998754200 00112345789999999999985223345999
Q ss_pred hHHHHHHHHHhhc---CCch-hHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 661 MYSLGIVFFELWH---PFST-AMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~-~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||||||++.||+| ||.. .........+... ...|......++++++||.+|+..||..||||.++|+|||..+..
T Consensus 205 iWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 205 IWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE-DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred hhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc-CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999998 6665 2334444444443 355656666788999999999999999999999999999988765
Q ss_pred H
Q 000880 737 Y 737 (1239)
Q Consensus 737 ~ 737 (1239)
.
T Consensus 284 ~ 284 (313)
T KOG0198|consen 284 I 284 (313)
T ss_pred c
Confidence 4
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=378.00 Aligned_cols=278 Identities=25% Similarity=0.401 Sum_probs=232.8
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+++|++++.||+|.-|+||+|+.+.++..+|+|++.+... +.....+...|-.||+.++||.++.+|+.|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--------- 146 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--------- 146 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee---------
Confidence 5789999999999999999999999999999999986543 233456788899999999999999999887
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
+...+.|++||||+ |+|..+++++ ..|+++.+++|+.+++.||+||
T Consensus 147 -------------------------------et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL 195 (459)
T KOG0610|consen 147 -------------------------------ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL 195 (459)
T ss_pred -------------------------------eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH
Confidence 23578999999996 5899888765 4599999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccc-cccccC-----------------CCCC-----CCC--------
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL-EQLDQD-----------------AAFP-----TDT-------- 627 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~-~~~~~~-----------------~~~~-----~~~-------- 627 (1239)
|-+|||+|||||+||||.++|||.|+||-++..... +..... ..+. ...
T Consensus 196 HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~ 275 (459)
T KOG0610|consen 196 HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDES 275 (459)
T ss_pred HhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccc
Confidence 999999999999999999999999999999976532 111100 0000 000
Q ss_pred ----------CCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhh---cCCchhHHHHHHHHhhhhcCCC
Q 000880 628 ----------GGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGEL 694 (1239)
Q Consensus 628 ----------~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELl---tPf~~~~~~~~~~~~~~~~~~~ 694 (1239)
........+++||-.|+|||++.| ...+.++|||+|||+||||+ |||.+....+....++.+...+
T Consensus 276 ~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F 354 (459)
T KOG0610|consen 276 ASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF 354 (459)
T ss_pred ccccchhhhcCCCCccccccccccccccceeeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC
Confidence 111234567899999999999999 56899999999999999998 5999999999998888877777
Q ss_pred CCccccCCHHHHHHHHHccCCCCCCCCC----HHHHHhccCCCCchHHHHHH
Q 000880 695 PPSWVAKFSEQESLLRRLMSPSPSDRPS----ATELLQDALPPQMEYELLDN 742 (1239)
Q Consensus 695 p~~~~~~~~e~~~LI~~~L~~dP~~RPt----a~eiL~~~~~~~~~~~~~~~ 742 (1239)
|... ..+..++|||+++|.+||.+|.. |.+|-+||||+++.|.++..
T Consensus 355 p~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 355 PEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRC 405 (459)
T ss_pred CCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheec
Confidence 7654 55678999999999999999998 99999999999999996543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=364.15 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=226.7
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
.+.+.|++.++||+|+|+.||++.+..+|+.+|+|+|+.+.-+....+++.+|+.+-+.|+|||||+++..+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-------- 79 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-------- 79 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh--------
Confidence 456789999999999999999999999999999999987776666778899999999999999999998665
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....+.|||+|++.| +|..-+-.+--+++..+-.+++||++||.|+|
T Consensus 80 --------------------------------~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH 127 (355)
T KOG0033|consen 80 --------------------------------QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH 127 (355)
T ss_pred --------------------------------cccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 235678999999964 78776666667899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCC---CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 580 GQGIIHRDLTPNNIFFDAR---NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~---~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
.+||||||+||+|+|+-+. --+||+|||+|..+.... ...+++|||.|||||++.. ..|+
T Consensus 128 ~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~----------------~~~G~~GtP~fmaPEvvrk-dpy~ 190 (355)
T KOG0033|consen 128 SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE----------------AWHGFAGTPGYLSPEVLKK-DPYS 190 (355)
T ss_pred hcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc----------------ccccccCCCcccCHHHhhc-CCCC
Confidence 9999999999999999654 349999999998765211 1256799999999999998 5699
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCC-ccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
..+|||+.|||||-|+. ||++........++......+|+ .|...++++++|+++||..||.+|.|+.+.|+|||.
T Consensus 191 kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 191 KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 99999999999999985 99987777777777776666665 999999999999999999999999999999999999
Q ss_pred CCchH
Q 000880 733 PQMEY 737 (1239)
Q Consensus 733 ~~~~~ 737 (1239)
.+.+.
T Consensus 271 ~~r~~ 275 (355)
T KOG0033|consen 271 CNRER 275 (355)
T ss_pred cchHH
Confidence 87653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=380.64 Aligned_cols=268 Identities=27% Similarity=0.487 Sum_probs=219.8
Q ss_pred CCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC------------chhHHHHHHHHHHHHhcCCCcee
Q 000880 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS------------LPVNDRILREVATLSRLQHQHVV 486 (1239)
Q Consensus 419 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~------------~~~~~~~~~Ev~iL~~L~HpnIv 486 (1239)
....+++|++++.||+|.||+|.+|++..+++.||||++.+.... ....+++.+|+.+|++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 345689999999999999999999999999999999999754321 11235789999999999999999
Q ss_pred eeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCC-CCHHHHH
Q 000880 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH-FDKELAW 565 (1239)
Q Consensus 487 ~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~-l~~~~~~ 565 (1239)
+++.+.-++ ....+|||+|||...-..+....+. +++.+|+
T Consensus 172 ~LiEvLDDP--------------------------------------~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar 213 (576)
T KOG0585|consen 172 KLIEVLDDP--------------------------------------ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQAR 213 (576)
T ss_pred EEEEeecCc--------------------------------------ccCceEEEEEeccCCccccCCCCcccccHHHHH
Confidence 999886332 3578999999997544445555555 9999999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCC
Q 000880 566 HLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA 645 (1239)
Q Consensus 566 ~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 645 (1239)
+|+++++.||+|||.+|||||||||+|+||+++|+|||+|||.+....... ..+........+|||+|||
T Consensus 214 ~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~----------~~~~d~~L~~tvGTPAF~A 283 (576)
T KOG0585|consen 214 KYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGS----------DEGSDDQLSRTVGTPAFFA 283 (576)
T ss_pred HHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCC----------ccccHHHHhhcCCCccccc
Confidence 999999999999999999999999999999999999999999998653211 1111222234689999999
Q ss_pred cccccC---CCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCC
Q 000880 646 PEIEQG---WPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSD 719 (1239)
Q Consensus 646 PE~l~~---~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~ 719 (1239)
||...+ ....+++.||||+||+||-|+. ||.+....+..-+++.....+|.. +...+.+++||++||++||.+
T Consensus 284 PE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~ 362 (576)
T KOG0585|consen 284 PELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQ 362 (576)
T ss_pred hHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCc-ccccHHHHHHHHHHhhcChhh
Confidence 998876 2235689999999999999984 999998888888877755555543 356779999999999999999
Q ss_pred CCCHHHHHhccCCCCc
Q 000880 720 RPSATELLQDALPPQM 735 (1239)
Q Consensus 720 RPta~eiL~~~~~~~~ 735 (1239)
|.+..+|..|||..+.
T Consensus 363 Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 363 RITLPDIKLHPWVTRD 378 (576)
T ss_pred eeehhhheecceeccC
Confidence 9999999999997655
|
|
| >TIGR00418 thrS threonyl-tRNA synthetase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=408.65 Aligned_cols=348 Identities=13% Similarity=0.060 Sum_probs=274.6
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc--CCCccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL--GDCPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~--~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
.+.|+.||+|.++.+++.|++.+++.+.++||++|.||+| ++. ++.+...++||+|.|.+|+.++|||+.|+++
T Consensus 188 ~~~G~~~~~p~g~~~~~~i~~~~~~~~~~~G~~ev~tP~l~~~~l~~~sg~~~~~~~emy~~~d~~~~~~~LrP~~~~~i 267 (563)
T TIGR00418 188 IGPGLPFWLPKGATIRNLLEDFVRQKQIKYGYMEVETPIMYDLELWEISGHWDNYKERMFPFTELDNREFMLKPMNCPGH 267 (563)
T ss_pred cCCcceEEeccHHHHHHHHHHHHHHHHHHcCCEEEECCccCCHHHHHhcCCcccchhhcceeccCCCceEEEecCCCHHH
Confidence 4789999999999999999999999999999999999999 322 3467789999999999999999999999999
Q ss_pred HHHHHhCC----CCceeEEeecCeEEcCCCCC-----CCCceeEEeEEEeCCCCcccHHH---HHHHHHHHHHhcCCCCc
Q 000880 857 IRWAISNQ----KSSFKRYEISSVYRRAIGHS-----PPNRYLQGDFDIIGGASALTEAE---VLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 857 aR~~~~~~----~~P~r~~Y~g~VfR~e~~~~-----~~~ef~Q~GvEiiG~~s~~aDaE---vi~la~~~l~~lgi~~~ 924 (1239)
+|+++++. ..|+|+||+|+|||+|.... |.+||+|.|+|+||. ...+|+| +|.++.++++.||++.
T Consensus 268 ~~~~~~~~~s~~~lP~rl~~~g~~fR~E~~g~~~Gl~R~reF~q~~~~~~~~-~~~~~~e~~~~i~~~~~~~~~lgl~~- 345 (563)
T TIGR00418 268 FLIFKSSLRSYRDLPLRIAELGYSHRYEQSGELHGLMRVRGFTQDDAHIFCT-EDQIKEEFKNQFRLIQKVYSDFGFSF- 345 (563)
T ss_pred HHHHhCcCCChHHCCceeeEeccccCCCCCcCCcCcccccceEEeeeEEEcC-HHHHHHHHHHHHHHHHHHHHHcCCCe-
Confidence 99998753 25999999999999996542 556799999999998 5677777 9999999999999985
Q ss_pred eEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCC
Q 000880 925 CDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGA 1004 (1239)
Q Consensus 925 ~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~ 1004 (1239)
+.+.+|.... . +.++-+..|..
T Consensus 346 ~~~~l~~~~~-~---~~~~~~~~~~~------------------------------------------------------ 367 (563)
T TIGR00418 346 DKYELSTRDP-E---DFIGEDELWEK------------------------------------------------------ 367 (563)
T ss_pred EEEEEeCCCh-h---hhcCCHHHHHH------------------------------------------------------
Confidence 8888885210 0 01111000000
Q ss_pred hhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCccccc-ccccccccccc
Q 000880 1005 ADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLV-EGTLLAVGGRY 1083 (1239)
Q Consensus 1005 ~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~-~~~~i~~GGRY 1083 (1239)
....+.. .|+.+|+ ...+|+. ||++||+.++|++ ....+..-+.+ .+..+++||||
T Consensus 368 ---~~~~~~~---------------~l~~~~i--~~~~~~~--~g~~y~~~~~f~~-~~~lg~~~~~~t~q~~~~~g~ry 424 (563)
T TIGR00418 368 ---AEAALEE---------------ALKELGV--PYEIDPG--RGAFYGPKIDFAF-KDALGREWQCATVQLDFELPERF 424 (563)
T ss_pred ---HHHHHHH---------------HHHhCCC--ceEEcCC--CcceecceEEEEe-ecCCCCceeeceeeeccCCHhhc
Confidence 0000000 2344455 3567777 9999999999996 44333210111 12458999999
Q ss_pred cch-hhhccccccccccCCCCCCcee---eeeccHHHHHhhCC-C--CCcCCCCCCCceEEEEecCCCccHHHHHHHHHH
Q 000880 1084 DYL-LHRMWDREYVGYASRTNPPSGV---GASLALETIIQHYP-V--DFKPVRNEAGTSVLVCSRGGGGLLVERMELVAE 1156 (1239)
Q Consensus 1084 D~L-~~~fg~~~~~~~~g~~~~~pAv---Gfaigldrl~~~L~-~--~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~ 1156 (1239)
|.+ ....|++ .+|++ |||+|+|||+.+|. + +..+. ...+.+|+|++.+ +....+|+++|+.
T Consensus 425 d~~~~~~~g~~----------~~p~ii~~Gfa~gieRli~~l~e~~~~~~p~-~~~p~~v~vi~~~-~~~~~~a~~ia~~ 492 (563)
T TIGR00418 425 DLTYVDEDNEE----------KRPVMIHRAILGSIERFIAILLEKYAGNFPL-WLAPVQVVVIPVN-ERHLDYAKKVAQK 492 (563)
T ss_pred CCEEECCCCCE----------EeeEEEEeeccCcHHHHHHHHHHhccCCCCC-cCCCceEEEEEcc-chHHHHHHHHHHH
Confidence 995 5665544 35885 99999999998873 2 22332 2367889999986 6678999999999
Q ss_pred HHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHH
Q 000880 1157 LWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLD 1226 (1239)
Q Consensus 1157 Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~ 1226 (1239)
||+.|++|+++.. .+++++++++|++.|++++|++|++|+++|+|+||||.+|+|.+++++++++.+++
T Consensus 493 LR~~Gi~v~~d~~-~~sl~~q~k~A~~~g~~~~iiiG~~E~~~~~v~vk~~~~g~q~~v~~~el~~~i~~ 561 (563)
T TIGR00418 493 LKKAGIRVDVDDR-NERLGKKIREAQKQKIPYMLVVGDKEMESLAVNVRTRKGQKLEKMSLDEFLEKLRK 561 (563)
T ss_pred HHHcCCEEEEECC-CCCHHHHHHHHHhcCCCEEEEEchhhhhCCeEEEEECCCCccceeeHHHHHHHHHh
Confidence 9999999998776 67999999999999999999999999999999999999999999999999888764
|
This model represents the threonyl-tRNA synthetase found in most organisms. This protein is a class II tRNA synthetase, and is recognized by the pfam model tRNA-synt_2b. Note that B. subtilis has closely related isozymes thrS and thrZ. The N-terminal regions are quite dissimilar between archaeal and eubacterial forms, while some eukaryotic forms are missing sequence there altogether.. |
| >PRK12294 hisZ ATP phosphoribosyltransferase regulatory subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=364.63 Aligned_cols=255 Identities=14% Similarity=0.155 Sum_probs=194.8
Q ss_pred hhhHHHHHHHHHHHHHHHcCCccccccceecc----CCCccccccEEE-EeccCCCeeeecCCCcHHHHHHHHhCCCCce
Q 000880 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPMYLL----GDCPQFKRNTVK-LLTHGGDLLELSHELRLPFIRWAISNQKSSF 868 (1239)
Q Consensus 794 ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~~~~----~~~~~~~~~~~~-~~D~~G~~l~LRPD~T~~iaR~~~~~~~~P~ 868 (1239)
....++.+++.++++|++|||++|.||+|++. ..++.....+++ |.|.+|+.++||||+|+||||+++++...|.
T Consensus 6 ~~~~~~~ie~~l~~~f~~~GY~~I~tP~~E~~d~~~~~~~~~~~~~~~~~~~~~Gr~laLRpD~T~~iAR~~a~~~~~~~ 85 (272)
T PRK12294 6 QLIALKESETAFLKYFNKADYELVDFSVIEKLDWKQLNHEDLQQMGERSFWQHEHQIYALRNDFTDQLLRYYSMYPTAAT 85 (272)
T ss_pred HHHHHHHHHHHHHHHHHHcCCeEeeCCcchhHHhhhccccchhhhheeeeecCCCCEEEEcCCCCHHHHHHHHhcCCCCc
Confidence 45567899999999999999999999999322 224344455555 4466899999999999999999987655677
Q ss_pred eEEeecCeEEcCCCCCCCCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceE-EEECcHHHHHHHHHHcCCCHH
Q 000880 869 KRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCD-IHLNHGDLLEAIWSWAGIKAE 947 (1239)
Q Consensus 869 r~~Y~g~VfR~e~~~~~~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~-i~lg~~~i~~~ll~~lgl~~~ 947 (1239)
|+||+|+|||++++ ++|+|||+|| .+..+|+|+|.+|+++++.+|..+ +. |.|||+++++++++. ++
T Consensus 86 Rl~Y~g~VfR~~~~------~~Q~GvEliG-~~~~a~~e~l~la~~~l~~~g~~~-~~~i~lGh~~~~~~l~~~----~~ 153 (272)
T PRK12294 86 KVAYAGLIIRNNEA------AVQVGIENYA-PSLANVQQSFKLFIQFIQQQLRDN-VHFVVLGHYQLLDALLDK----SL 153 (272)
T ss_pred eEEEeccEeccCCC------cceeceEEEC-CCchhHHHHHHHHHHHHHHhCCCC-CcEEEeccHHHHHHHHhC----HH
Confidence 99999999998643 8999999999 447999999999999999998765 53 899999999999984 56
Q ss_pred HHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhccCCCChhHHHHHH
Q 000880 948 HREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALD 1027 (1239)
Q Consensus 948 ~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~~~~~~~~~l~ 1027 (1239)
.+++++++|.+||.. ++ ++++... ..+..++.. ....+++++..+........+.|.
T Consensus 154 ~~~~l~~~l~~Kn~~------------~l-~~~l~~~-------~~l~~~l~~---~~~~~l~~a~~l~~~~~~~~~~L~ 210 (272)
T PRK12294 154 QTPDILSMIEERNLS------------GL-VTYLSTE-------HPIVQILKE---NTQQQLNVLEHYIPNDHPALVELK 210 (272)
T ss_pred HHHHHHHHHHhcCHH------------HH-HHHHhhh-------hhHHHHHHh---chHHHHHHHHHhhhhhHHHHHHHH
Confidence 778899999998832 11 2232211 112233321 124567777765533234444555
Q ss_pred HH--HHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccccchhhhccc
Q 000880 1028 EL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWD 1092 (1239)
Q Consensus 1028 ~l--~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~fg~ 1092 (1239)
.+ .+...++. .+.||++++|+++||||+||++|.++.+. +|++|||||+|+++||.
T Consensus 211 ~l~~~l~~~~~~-~i~~Dl~~~r~~~YYTG~vF~~y~~~~~~--------~i~~GGRYD~Ll~~Fg~ 268 (272)
T PRK12294 211 IWERWLHTQGYK-DIHLDITAQPPRSYYTGLFIQCHFAENES--------RVLTGGYYKGSIEGFGL 268 (272)
T ss_pred HHHHHHHhcCCC-eEEEcccccCCCCCcCCeEEEEEECCCCC--------cccCCcCchhHHHhcCC
Confidence 54 55666765 49999999999999999999999987665 69999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=387.51 Aligned_cols=253 Identities=24% Similarity=0.430 Sum_probs=213.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
..|....+||+|+.|.||.|+...+++.||||.+.+.... ..+-+++|+.+|+..+|+|||.++..|+.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv--------- 341 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLV--------- 341 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcc---------
Confidence 4566678999999999999999999999999999876654 34568999999999999999999988743
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|+||||++ |+|.+++.. ..+++.++..++++++.||+|||.+|
T Consensus 342 -------------------------------~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g 389 (550)
T KOG0578|consen 342 -------------------------------GDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG 389 (550)
T ss_pred -------------------------------cceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc
Confidence 357899999996 588777765 34999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+|||||.+|||++.+|.+||+|||||..+..... ...+.+|||.|||||++.. ..|++++|||
T Consensus 390 IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---------------KR~TmVGTPYWMAPEVvtr-k~YG~KVDIW 453 (550)
T KOG0578|consen 390 IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---------------KRSTMVGTPYWMAPEVVTR-KPYGPKVDIW 453 (550)
T ss_pred eeeeccccceeEeccCCcEEEeeeeeeeccccccC---------------ccccccCCCCccchhhhhh-cccCccccch
Confidence 99999999999999999999999999998754331 2356799999999999998 6799999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
||||+++||+- ||....+......+..........+...++.+++|+.+||+.||.+|++|.++|+|||++..
T Consensus 454 SLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 454 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred hhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99999999994 77755554444444332222334556778899999999999999999999999999998544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=365.91 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=217.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
..+|++.+.||+|.||+|-+|+....|+.||||.|++... +..+.-.+.+|+++|+.|+||||+.+|.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--------- 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--------- 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh---------
Confidence 4679999999999999999999988999999999986543 444556789999999999999999999887
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
.+...+.|||||.. |.|++++.+++.+++.+++.|++||++|+.|+|.
T Consensus 123 -------------------------------ENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk 171 (668)
T KOG0611|consen 123 -------------------------------ENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK 171 (668)
T ss_pred -------------------------------cCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh
Confidence 24578899999995 7999999999999999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
++++|||||.+|||+|.++++||+|||++..+..... .+++||+|.|.+||+++|.++-++.+|
T Consensus 172 nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf----------------LqTFCGSPLYASPEIvNG~PY~GPEVD 235 (668)
T KOG0611|consen 172 NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF----------------LQTFCGSPLYASPEIVNGTPYKGPEVD 235 (668)
T ss_pred ccceecccchhheeecCCCCeeeeccchhhhhccccH----------------HHHhcCCcccCCccccCCCCCCCCccc
Confidence 9999999999999999999999999999987653321 256899999999999999887789999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
.|||||+||-|++ ||.+.+....+.++-+....-|+. +.++.-||++||-.||++|.|+++|..|=|..
T Consensus 236 sWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~----PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 236 SWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET----PSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred hhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC----CchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 9999999999985 998877666655554433333432 34788899999999999999999999996643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=352.93 Aligned_cols=259 Identities=25% Similarity=0.443 Sum_probs=221.1
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC--C----chhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK--S----LPVNDRILREVATLSRL-QHQHVVRYYQAWFE 494 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~--~----~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e 494 (1239)
+.+.|+..+.||+|..+.|.+|.++.+|+.+|+|+|..... + .+..+.-.+|+.+|+++ .||||+.+.+.|.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye- 93 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE- 93 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc-
Confidence 34667777899999999999999999999999999975432 1 12334566899999999 6999999998872
Q ss_pred cCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHH
Q 000880 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVE 573 (1239)
Q Consensus 495 ~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~ 573 (1239)
....+|+|+|.|+ |.|.++|.+.-.+++..++++++|+..
T Consensus 94 ---------------------------------------s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfe 134 (411)
T KOG0599|consen 94 ---------------------------------------SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFE 134 (411)
T ss_pred ---------------------------------------CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHH
Confidence 2457799999997 799999999999999999999999999
Q ss_pred HHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--
Q 000880 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG-- 651 (1239)
Q Consensus 574 gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-- 651 (1239)
|++|||.++||||||||+|||++++.++||+|||+|+.+..... .+..||||+|+|||.+..
T Consensus 135 gVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek----------------LrelCGTPgYLAPEtikC~m 198 (411)
T KOG0599|consen 135 GVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK----------------LRELCGTPGYLAPETIKCSM 198 (411)
T ss_pred HHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchh----------------HHHhcCCCcccChhheeeec
Confidence 99999999999999999999999999999999999998754431 245699999999998753
Q ss_pred ---CCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC-CCccccCCHHHHHHHHHccCCCCCCCCCHH
Q 000880 652 ---WPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL-PPSWVAKFSEQESLLRRLMSPSPSDRPSAT 724 (1239)
Q Consensus 652 ---~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~-p~~~~~~~~e~~~LI~~~L~~dP~~RPta~ 724 (1239)
.+.|+..+|+||+|||||-|+. ||+....+.....+...+..+ .|.|.+.+.+.++||.+||+.||.+|.|++
T Consensus 199 ~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritak 278 (411)
T KOG0599|consen 199 YENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAK 278 (411)
T ss_pred ccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHH
Confidence 4569999999999999999984 887766655555555555553 578999999999999999999999999999
Q ss_pred HHHhccCCCCch
Q 000880 725 ELLQDALPPQME 736 (1239)
Q Consensus 725 eiL~~~~~~~~~ 736 (1239)
++|+||||.++.
T Consensus 279 e~LaHpff~q~~ 290 (411)
T KOG0599|consen 279 EALAHPFFIQIA 290 (411)
T ss_pred HHhcChHHHHHH
Confidence 999999997764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=373.53 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=213.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--------- 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--------- 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc---------
Confidence 478999999999999999999999999999999975432 2234566889999999999999999987652
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
+...+|+||||++ ++|.+++.....+++..++.++.||+.||+|||++
T Consensus 72 -------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 120 (291)
T cd05612 72 -------------------------------DQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120 (291)
T ss_pred -------------------------------cCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2457899999996 69999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++||
T Consensus 121 ~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------------------~~~~~gt~~y~aPE~~~~-~~~~~~~Di 181 (291)
T cd05612 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------------------TWTLCGTPEYLAPEVIQS-KGHNKAVDW 181 (291)
T ss_pred CeeecCCCHHHeEECCCCCEEEEecCcchhccCC------------------cccccCChhhcCHHHHcC-CCCCchhhH
Confidence 9999999999999999999999999999764211 123579999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhccCCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDALPP 733 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~~~~~ 733 (1239)
|||||++|+|++ ||...........+......+|. ..++.+++||++||+.||.+||+ +.++++|+|+.
T Consensus 182 wSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 182 WALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR---HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc---cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 999999999997 88766655555444443333433 33678999999999999999995 99999999999
Q ss_pred CchHHH
Q 000880 734 QMEYEL 739 (1239)
Q Consensus 734 ~~~~~~ 739 (1239)
...+..
T Consensus 259 ~~~~~~ 264 (291)
T cd05612 259 SVDWDD 264 (291)
T ss_pred CCCHHH
Confidence 877653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=380.66 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=216.0
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
...+++|++.+.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|+.++||||++++++|..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 89 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD---- 89 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc----
Confidence 3446899999999999999999999999999999999975432 22334678899999999999999999988732
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
...+|++||||+ ++|.+++.....+++..++.++.||+.||+|
T Consensus 90 ------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~ 133 (329)
T PTZ00263 90 ------------------------------------ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133 (329)
T ss_pred ------------------------------------CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 457899999996 5999999988889999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++||+||||||+|||++.++.+||+|||+++..... ....+||+.|+|||++.+ ..++.
T Consensus 134 LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------------------~~~~~gt~~y~aPE~~~~-~~~~~ 194 (329)
T PTZ00263 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------------------TFTLCGTPEYLAPEVIQS-KGHGK 194 (329)
T ss_pred HHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC------------------cceecCChhhcCHHHHcC-CCCCC
Confidence 99999999999999999999999999999999754211 123579999999999987 56899
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhc
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~ 729 (1239)
++|||||||++|||++ ||...........+......+|. ..++.+++||++||+.||.+||+ +.+++.|
T Consensus 195 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN---WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999997 88766554444444332222332 34568999999999999999997 7999999
Q ss_pred cCCCCchHHHH
Q 000880 730 ALPPQMEYELL 740 (1239)
Q Consensus 730 ~~~~~~~~~~~ 740 (1239)
|||....+..+
T Consensus 272 p~f~~~~~~~~ 282 (329)
T PTZ00263 272 PYFHGANWDKL 282 (329)
T ss_pred CccCCCCHHHH
Confidence 99998766543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=368.27 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=204.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++|++.++||.|+||.||+|+++.+++.||+|+++..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 74 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT-------- 74 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC--------
Confidence 57899999999999999999999999999999999754322 233467899999999999999999988632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++++|.+++.... .+++..+..++.||+.||+|||++
T Consensus 75 --------------------------------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 122 (288)
T cd07871 75 --------------------------------ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122 (288)
T ss_pred --------------------------------CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 35689999999999999887554 478999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+...++.++||
T Consensus 123 ~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 187 (288)
T cd07871 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT---------------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187 (288)
T ss_pred CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC---------------ccccCceecccccChHHhcCCcccCcHHHH
Confidence 99999999999999999999999999997532111 012335789999999998765668999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-------------------CCC--------ccccCCHHHHHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-------------------LPP--------SWVAKFSEQESLLRR 711 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-------------------~p~--------~~~~~~~e~~~LI~~ 711 (1239)
||+||++|||++ ||......+.........+. +|. .....++++.+||++
T Consensus 188 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 267 (288)
T cd07871 188 WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSS 267 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHH
Confidence 999999999997 67654433332222111100 000 112345688999999
Q ss_pred ccCCCCCCCCCHHHHHhccCC
Q 000880 712 LMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~ 732 (1239)
||+.||.+|||+.++++||||
T Consensus 268 mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 268 LLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hcCcCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=375.80 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=208.5
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.++||+|+||.||+|+++.+|+.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-------- 72 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS-------- 72 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccC--------
Confidence 488999999999999999999999999999998754333344567889999999999999999998874321
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
......+|+|||||+++|.+++.....+++..++.++.||+.||.|||++||+
T Consensus 73 ---------------------------~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 125 (338)
T cd07859 73 ---------------------------RREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVF 125 (338)
T ss_pred ---------------------------CCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 01234689999999999999998888899999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC-CCCCcchhhHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW-PKIDEKADMYS 663 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~ksDIwS 663 (1239)
||||||+|||++.++.+||+|||+++....... ........+||+.|+|||++.+. ..++.++||||
T Consensus 126 H~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwS 193 (338)
T cd07859 126 HRDLKPKNILANADCKLKICDFGLARVAFNDTP------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 193 (338)
T ss_pred cCCCCHHHeEECCCCcEEEccCccccccccccC------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHH
Confidence 999999999999999999999999975421110 00112346799999999998652 45899999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHH--------------------------HHhhhhcCC--CCCccccCCHHHHHHHHHc
Q 000880 664 LGIVFFELWH---PFSTAMERQIV--------------------------LSDLKQKGE--LPPSWVAKFSEQESLLRRL 712 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~--------------------------~~~~~~~~~--~p~~~~~~~~e~~~LI~~~ 712 (1239)
|||++|||++ ||......... ...+..... ....++..++.+.++|.+|
T Consensus 194 lGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 273 (338)
T cd07859 194 IGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERL 273 (338)
T ss_pred HHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHH
Confidence 9999999997 66443221110 000000000 1112234567889999999
Q ss_pred cCCCCCCCCCHHHHHhccCCCCch
Q 000880 713 MSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|+.||++|||+.++++||||.+..
T Consensus 274 l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 274 LAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred cCcCcccCCCHHHHhcCchhhhcC
Confidence 999999999999999999998764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=370.47 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=205.8
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||+|+||.||+|+++.+|+.||||+++..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT-------- 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--------
Confidence 36899999999999999999999999999999998754322 223467889999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+|||||+++|.+++... ..+++..++.++.||+.||+|||++
T Consensus 75 --------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 122 (303)
T cd07869 75 --------------------------------KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122 (303)
T ss_pred --------------------------------CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3578999999999998888654 5689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+...++.++||
T Consensus 123 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 187 (303)
T cd07869 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187 (303)
T ss_pred CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---------------ccCCCCcccCCCCChHHHcCCCCCCcHHHH
Confidence 99999999999999999999999999987532111 112345789999999998775668999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhc-CC-----------------------CCCcc------ccCCHHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQK-GE-----------------------LPPSW------VAKFSEQESL 708 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-~~-----------------------~p~~~------~~~~~e~~~L 708 (1239)
|||||++|||++ ||....+.......+... +. .+..+ ...++++.+|
T Consensus 188 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 267 (303)
T cd07869 188 WGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDL 267 (303)
T ss_pred HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHH
Confidence 999999999997 776543322211111000 00 00000 0123578899
Q ss_pred HHHccCCCCCCCCCHHHHHhccCCCCchH
Q 000880 709 LRRLMSPSPSDRPSATELLQDALPPQMEY 737 (1239)
Q Consensus 709 I~~~L~~dP~~RPta~eiL~~~~~~~~~~ 737 (1239)
|.+||+.||.+|||+.++++||||.....
T Consensus 268 i~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 268 ASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred HHHHhccCchhccCHHHHhcCcccccCCh
Confidence 99999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=376.28 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=213.5
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
.|..++.||+|.||.||+|.+..+++.||||++.+.... ...+++.+|+.+|..++||||.++|++++.
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~---------- 82 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLK---------- 82 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheee----------
Confidence 466678999999999999999999999999999876543 456789999999999999999999998843
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
...++|+||||+ |++.+++.....+++..+..++++++.||.|||+++.
T Consensus 83 ------------------------------g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~k 132 (467)
T KOG0201|consen 83 ------------------------------GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKK 132 (467)
T ss_pred ------------------------------cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcce
Confidence 456799999996 6999999988888999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+|||||+.|||+..+|.+||+|||.+.++.... ....+++|||.|||||++++ ..|+.|+||||
T Consensus 133 iHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---------------~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWS 196 (467)
T KOG0201|consen 133 IHRDIKAANILLSESGDVKLADFGVAGQLTNTV---------------KRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWS 196 (467)
T ss_pred ecccccccceeEeccCcEEEEecceeeeeechh---------------hccccccccccccchhhhcc-ccccchhhhhh
Confidence 999999999999999999999999998764321 12266899999999999996 67999999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccc-cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWV-AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~-~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|||+++||.+ |+....++....-+ ....||... ..++.+++||..||++||+.||+|.++|+|.|.+...
T Consensus 197 LGITaiEla~GePP~s~~hPmrvlflI---pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 197 LGITAIELAKGEPPHSKLHPMRVLFLI---PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred hhHHHHHHhcCCCCCcccCcceEEEec---cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 9999999997 77666654332222 222344333 4556799999999999999999999999999887754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=359.08 Aligned_cols=266 Identities=30% Similarity=0.503 Sum_probs=214.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCc-eeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH-VVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~~e~~~~~~~ 501 (1239)
+..|..+++||+|+||+||+|+.+.+|+.||+|+++........-....+|+.+|+.|+|+| ||++++.+....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~----- 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN----- 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc-----
Confidence 56788889999999999999999999999999999876554334556889999999999999 999999875421
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD----HFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~----~l~~~~~~~i~~qI~~gL~y 577 (1239)
.......+++|+||+..+|..++.... .++...++.+++||+.||+|
T Consensus 85 -----------------------------~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~ 135 (323)
T KOG0594|consen 85 -----------------------------NHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAF 135 (323)
T ss_pred -----------------------------cccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHH
Confidence 012345789999999999999998765 58888999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||+++|+||||||+||||+.+|.+||+|||+|+...-+. ...++.++|.+|.|||++.|...|+.
T Consensus 136 ~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~---------------~~yt~evvTlWYRaPEvLlGs~~Ys~ 200 (323)
T KOG0594|consen 136 LHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM---------------RTYTPEVVTLWYRAPEVLLGSTSYST 200 (323)
T ss_pred HHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCc---------------ccccccEEEeeccCHHHhcCCCcCCC
Confidence 999999999999999999999999999999999654221 11356789999999999999778999
Q ss_pred chhhHHHHHHHHHhhc--C-CchhHHHHHHHHhhhhcCCC-CCcc--------------------------ccCCHHHHH
Q 000880 658 KADMYSLGIVFFELWH--P-FSTAMERQIVLSDLKQKGEL-PPSW--------------------------VAKFSEQES 707 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt--P-f~~~~~~~~~~~~~~~~~~~-p~~~--------------------------~~~~~e~~~ 707 (1239)
..||||+|||++||++ | |.+.++......+...-+.. ...| +...++..+
T Consensus 201 ~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~d 280 (323)
T KOG0594|consen 201 SVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIE 280 (323)
T ss_pred CcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHH
Confidence 9999999999999997 4 44444444333332211110 0011 112246789
Q ss_pred HHHHccCCCCCCCCCHHHHHhccCCCCchH
Q 000880 708 LLRRLMSPSPSDRPSATELLQDALPPQMEY 737 (1239)
Q Consensus 708 LI~~~L~~dP~~RPta~eiL~~~~~~~~~~ 737 (1239)
++.+||+.+|.+|.|++.+|.|++|.....
T Consensus 281 ll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 281 LLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred HHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 999999999999999999999999987753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=365.30 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=202.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||+|+||.||+|+++.+++.||||++............+.+|+.+++.++||||++++++|..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--------- 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec---------
Confidence 47999999999999999999999999999999998654444455678899999999999999999987732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE-SYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~-~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|+||||+++++.+.+. ....+++..++.++.||+.||.|||++|
T Consensus 72 -------------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ 120 (287)
T cd07848 72 -------------------------------RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120 (287)
T ss_pred -------------------------------CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35789999999876555554 4457999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+|||++.++.+||+|||++....... ........||+.|+|||++.+ ..++.++|||
T Consensus 121 i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diw 185 (287)
T cd07848 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--------------NANYTEYVATRWYRSPELLLG-APYGKAVDMW 185 (287)
T ss_pred eecCCCCHHHEEEcCCCcEEEeeccCcccccccc--------------cccccccccccccCCcHHHcC-CCCCCchhHH
Confidence 9999999999999999999999999998643211 001233579999999999987 5689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC-------------------CC----------ccccCCHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL-------------------PP----------SWVAKFSEQESLLR 710 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~-------------------p~----------~~~~~~~e~~~LI~ 710 (1239)
||||++|||++ ||................+.. |. .....++++.+||+
T Consensus 186 slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~ 265 (287)
T cd07848 186 SVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMK 265 (287)
T ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHH
Confidence 99999999996 776544333222211111111 00 01124567899999
Q ss_pred HccCCCCCCCCCHHHHHhccCC
Q 000880 711 RLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+||+.||++|||++++++||||
T Consensus 266 ~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 266 NLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=376.89 Aligned_cols=254 Identities=33% Similarity=0.548 Sum_probs=222.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++|+.++++|+|+||.+++++++.+++.||+|.|.....+....+...+|+.++++++|||||.|++.|++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~------- 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED------- 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-------
Confidence 5789999999999999999999999999999999998888777777899999999999999999999998653
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
..+++|||+||+ |++.+.+.+.. .|+++.++.++.||+.|+.|||
T Consensus 76 --------------------------------~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH 123 (426)
T KOG0589|consen 76 --------------------------------GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH 123 (426)
T ss_pred --------------------------------CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 456899999996 58999887544 5999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+++|+|||||+.|||++.++.|||+|||+|+.+..... ...+.+|||.||.||++.+ -.|+.|+
T Consensus 124 ~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~---------------~a~tvvGTp~YmcPEil~d-~pYn~KS 187 (426)
T KOG0589|consen 124 ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS---------------LASTVVGTPYYMCPEILSD-IPYNEKS 187 (426)
T ss_pred hhhhhcccchhhhhhccccCceeecchhhhhhcCCchh---------------hhheecCCCcccCHHHhCC-CCCCccC
Confidence 99999999999999999999999999999998754420 1256799999999999999 5699999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
|||||||++|||++ +|...+......++.... ..|.....+.+++.+|+.||..+|..||++.++|.+|...
T Consensus 188 DiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 188 DIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred cchhhcchHHHHHhcccccCccchHHHHHHHhhcc--CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 99999999999996 787777666666666543 4555556677999999999999999999999999986443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=374.30 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=208.3
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
+.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+++.++||||++++++|..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-------------- 66 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-------------- 66 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--------------
Confidence 369999999999999999999999999975432 22334568899999999999999999987732
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
...+|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++||+|||
T Consensus 67 --------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrD 120 (323)
T cd05571 67 --------------------------HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120 (323)
T ss_pred --------------------------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 457899999996 58999998888899999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 121 lkp~NIll~~~~~~kl~DfG~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~i 184 (323)
T cd05571 121 LKLENLMLDKDGHIKITDFGLCKEGISDG---------------ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVV 184 (323)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcccccCC---------------CcccceecCccccChhhhcC-CCCCccccCcccchh
Confidence 99999999999999999999987431110 11234579999999999987 568999999999999
Q ss_pred HHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCCCchHHH
Q 000880 668 FFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPPQMEYEL 739 (1239)
Q Consensus 668 L~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~~~~~~~ 739 (1239)
+|||++ ||...........+......+| ...++++.+||++||+.||++|| ++.++++|+||....+..
T Consensus 185 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~ 261 (323)
T cd05571 185 MYEMMCGRLPFYNQDHEKLFELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQD 261 (323)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999997 7866555444444333333333 34567999999999999999999 899999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=401.69 Aligned_cols=279 Identities=24% Similarity=0.418 Sum_probs=234.4
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.+||+++++||+|+||.|.+++++.+++.||+|++++-... .....-|..|-.+|..-+.+.|+.++.+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--------- 144 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--------- 144 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh---------
Confidence 37999999999999999999999999999999999753322 22334688899999999999999999887
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
++..++|+||||++ |+|..++.+.+++++..|++|+..|+.||.-||+
T Consensus 145 -------------------------------QD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~ 193 (1317)
T KOG0612|consen 145 -------------------------------QDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS 193 (1317)
T ss_pred -------------------------------cCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh
Confidence 45789999999996 6999999999999999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC----CCCCC
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKID 656 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~~ 656 (1239)
.|+|||||||+|||||..||+||+|||.|-.+.... .......+|||.|.|||+|+. .+.|+
T Consensus 194 mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG--------------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG 259 (1317)
T KOG0612|consen 194 MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG--------------TVRSSVAVGTPDYISPEVLQSQGDGKGEYG 259 (1317)
T ss_pred ccceeccCCcceeEecccCcEeeccchhHHhcCCCC--------------cEEeccccCCCCccCHHHHHhhcCCccccC
Confidence 999999999999999999999999999988764322 122355699999999999863 25699
Q ss_pred cchhhHHHHHHHHHhh---cCCchhHHHHHHHHhhhh--cCCCCCccccCCHHHHHHHHHccCCCCCCCCC---HHHHHh
Q 000880 657 EKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQ--KGELPPSWVAKFSEQESLLRRLMSPSPSDRPS---ATELLQ 728 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELl---tPf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt---a~eiL~ 728 (1239)
+.+||||+||++|||+ |||+...-.+.+-+++.. ...+| ....+++++++||.++++ +|..|.. ++++-.
T Consensus 260 ~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 260 RECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred CccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 9999999999999999 599988887777777765 34466 344588999999999887 4788887 999999
Q ss_pred ccCCCCchHHHHHH----HHHhcCCCCCCcchh
Q 000880 729 DALPPQMEYELLDN----ILRMMHSSEDTSIYD 757 (1239)
Q Consensus 729 ~~~~~~~~~~~~~~----~~~~~~~~~d~~~~~ 757 (1239)
||||.+..|..+.. +.+.+.++.|++.++
T Consensus 338 HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd 370 (1317)
T KOG0612|consen 338 HPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFD 370 (1317)
T ss_pred CccccCCChhhhhhcCCCCCCcCCCCCcccccc
Confidence 99999999976654 344555666666663
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=375.04 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=214.9
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCC-cEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDG-RHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
....++|++.+.||+|+||.||+|.++.++ ..||+|++..... .......+.+|+.+++.++||||++++++|..
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--- 102 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--- 102 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe---
Confidence 345689999999999999999999987655 6899999875432 22345678899999999999999999998733
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
...+|+|||||+ |+|.+++.....+++..++.++.||+.||.
T Consensus 103 -------------------------------------~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~ 145 (340)
T PTZ00426 103 -------------------------------------ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145 (340)
T ss_pred -------------------------------------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH
Confidence 357899999995 699999998889999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++||+||||||+|||++.++++||+|||+++..... ....+||+.|||||++.+ ..++
T Consensus 146 ~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~------------------~~~~~gt~~y~aPE~~~~-~~~~ 206 (340)
T PTZ00426 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------------------TYTLCGTPEYIAPEILLN-VGHG 206 (340)
T ss_pred HHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC------------------cceecCChhhcCHHHHhC-CCCC
Confidence 999999999999999999999999999999999754211 134579999999999987 5689
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQ 728 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~ 728 (1239)
.++|||||||++|||++ ||...........+......+|+ ..++.+.++|++||+.||.+|+ +++++++
T Consensus 207 ~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 207 KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK---FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC---CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 99999999999999997 78766554444444433333443 3456899999999999999995 8999999
Q ss_pred ccCCCCchHHH
Q 000880 729 DALPPQMEYEL 739 (1239)
Q Consensus 729 ~~~~~~~~~~~ 739 (1239)
||||.+..+..
T Consensus 284 hp~f~~~~~~~ 294 (340)
T PTZ00426 284 HPWFGNIDWVS 294 (340)
T ss_pred CCCcCCCCHHH
Confidence 99999987653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.88 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=221.6
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
.-+++|++.+.||+|-||.||+|+.+.++-.||+|++.++.. ......++.+|+++-+.|+||||+++|++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd----- 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD----- 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-----
Confidence 347899999999999999999999999999999999976542 22345689999999999999999999999854
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFE--SYDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~--~~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
...+|+++||.+ |++...|. ...++++..++.|+.|++.||.
T Consensus 94 -----------------------------------~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~ 138 (281)
T KOG0580|consen 94 -----------------------------------SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALL 138 (281)
T ss_pred -----------------------------------cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHH
Confidence 467899999996 79999998 5677999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|+|.+++|||||||+|+|++..+.+||+|||.+.... +...++.|||..|.|||...+ ..++
T Consensus 139 y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-----------------~~kR~tlcgt~dyl~pEmv~~-~~hd 200 (281)
T KOG0580|consen 139 YCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----------------SNKRKTLCGTLDYLPPEMVEG-RGHD 200 (281)
T ss_pred HhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-----------------CCCceeeecccccCCHhhcCC-CCcc
Confidence 9999999999999999999999999999999987532 122467899999999999998 5789
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
..+|+|++|++.||++. ||...+..+...++......+| ...+.+++++|.+|+.++|.+|.+..+++.|||..
T Consensus 201 ~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 201 KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 99999999999999985 8988887777666666555566 45567999999999999999999999999999975
Q ss_pred Cc
Q 000880 734 QM 735 (1239)
Q Consensus 734 ~~ 735 (1239)
..
T Consensus 278 a~ 279 (281)
T KOG0580|consen 278 AN 279 (281)
T ss_pred hc
Confidence 43
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=375.07 Aligned_cols=275 Identities=26% Similarity=0.425 Sum_probs=214.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||+||+|+++.+++.||||+++.... .......+.+|+.++..++||||++++++|.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-------- 72 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-------- 72 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--------
Confidence 479999999999999999999999999999999975332 22334568889999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus 73 --------------------------------~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 120 (363)
T cd05628 73 --------------------------------KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120 (363)
T ss_pred --------------------------------CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999996 59999998888999999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccC-----CCCCCCC------C---------CccccCcccccCc
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQD-----AAFPTDT------G---------GVSVDGTGQVGTY 641 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~-----~~~~~~~------~---------~~~~~~~~~~GT~ 641 (1239)
||+||||||+|||++.++++||+|||+++.+........ ...+.+. . .......+.+||+
T Consensus 121 givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 200 (363)
T cd05628 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP 200 (363)
T ss_pred CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence 999999999999999999999999999986532110000 0000000 0 0000123468999
Q ss_pred cCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhh--cCCCCCccccCCHHHHHHHHHccCCC
Q 000880 642 FYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQ--KGELPPSWVAKFSEQESLLRRLMSPS 716 (1239)
Q Consensus 642 ~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~e~~~LI~~~L~~d 716 (1239)
.|+|||++.+ ..++.++|||||||++|||++ ||......+....+... ...+|+ ....+++++++|.+|+. +
T Consensus 201 ~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~ 277 (363)
T cd05628 201 DYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-E 277 (363)
T ss_pred cccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-C
Confidence 9999999987 568999999999999999996 88766555554444332 222333 23457799999999775 4
Q ss_pred CC---CCCCHHHHHhccCCCCchHHHHH
Q 000880 717 PS---DRPSATELLQDALPPQMEYELLD 741 (1239)
Q Consensus 717 P~---~RPta~eiL~~~~~~~~~~~~~~ 741 (1239)
|. .||++++|++||||....+..+.
T Consensus 278 ~~~r~~r~~~~ei~~hp~f~~~~~~~~~ 305 (363)
T cd05628 278 WEHRIGAPGVEEIKTNPFFEGVDWEHIR 305 (363)
T ss_pred hhhcCCCCCHHHHhCCCCCCCCCHHHHH
Confidence 44 56899999999999999877553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=370.94 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=213.5
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-------- 72 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-------- 72 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--------
Confidence 479999999999999999999999999999999975422 22334578899999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
..++|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++
T Consensus 73 --------------------------------~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 120 (333)
T cd05600 73 --------------------------------DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120 (333)
T ss_pred --------------------------------CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457899999996 69999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+ ..++.++||
T Consensus 121 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 181 (333)
T cd05600 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------------------YANSVVGSPDYMAPEVLRG-KGYDFTVDY 181 (333)
T ss_pred CccccCCCHHHEEECCCCCEEEEeCcCCccccc------------------ccCCcccCccccChhHhcC-CCCCCccce
Confidence 999999999999999999999999999975421 1234579999999999988 579999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--CCCCCc---cccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQK--GELPPS---WVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--~~~p~~---~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
|||||++|||++ ||......+......... ...|.. ....++++.+||.+||..+|.+||++.++++|+||.
T Consensus 182 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred ecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 999999999996 776555444333222211 111211 124567899999999999999999999999999999
Q ss_pred CchHHHH
Q 000880 734 QMEYELL 740 (1239)
Q Consensus 734 ~~~~~~~ 740 (1239)
...+...
T Consensus 262 ~~~~~~~ 268 (333)
T cd05600 262 EVDWNEL 268 (333)
T ss_pred CCCHHHH
Confidence 8876544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=371.27 Aligned_cols=243 Identities=29% Similarity=0.459 Sum_probs=199.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
..+.+++.||+|.||+||+|.|. ....||+|.++....+ .+.|.+|+.+|++|+|+|||+++++|..
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~--------- 272 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTK--------- 272 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEec---------
Confidence 45677889999999999999997 3348999999855333 4678899999999999999999999843
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES--YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|||||||+ |+|.++|.. ...+...+.+.++.|||+||+||++
T Consensus 273 -------------------------------~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes 321 (468)
T KOG0197|consen 273 -------------------------------QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES 321 (468)
T ss_pred -------------------------------CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh
Confidence 235899999996 899999986 4569999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+++|||||..+|||++++..+||+|||+|+......... ..+..-..-|.|||++.. ..++.|||
T Consensus 322 ~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~--------------~~~~kfPIkWtAPEa~~~-~~FS~kSD 386 (468)
T KOG0197|consen 322 KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA--------------SEGGKFPIKWTAPEALNY-GKFSSKSD 386 (468)
T ss_pred CCccchhhhhhheeeccCceEEEcccccccccCCCceee--------------cCCCCCCceecCHHHHhh-CCcccccc
Confidence 999999999999999999999999999999543332110 111223457999999987 67999999
Q ss_pred hHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHH
Q 000880 661 MYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELL 727 (1239)
Q Consensus 661 IwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL 727 (1239)
||||||+||||+| |+......+. +..+. .+...+.+..+++++.++|..||..+|++|||++.+.
T Consensus 387 VWSFGVlL~E~fT~G~~py~~msn~ev-~~~le-~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 387 VWSFGVLLWELFTYGRVPYPGMSNEEV-LELLE-RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred eeehhhhHHHHhccCCCCCCCCCHHHH-HHHHh-ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999997 6555544444 44444 3444445567889999999999999999999999665
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=375.18 Aligned_cols=273 Identities=24% Similarity=0.397 Sum_probs=212.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.|++++.||+|+||+||+|+++.+++.||||+++.... .......+.+|+.+++.++||||++++++|.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--------- 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--------- 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec---------
Confidence 68999999999999999999999999999999975432 22345678899999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
..++|+|||||+ |+|.+++.....+++..++.++.||+.||+|||++|
T Consensus 73 -------------------------------~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g 121 (381)
T cd05626 73 -------------------------------KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121 (381)
T ss_pred -------------------------------CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 457899999996 599999988888999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccC----CCCCCC----------------------------CCCc
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQD----AAFPTD----------------------------TGGV 630 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~----~~~~~~----------------------------~~~~ 630 (1239)
|+||||||+||||+.++++||+|||+++.+........ ...... ....
T Consensus 122 ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (381)
T cd05626 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQ 201 (381)
T ss_pred eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccc
Confidence 99999999999999999999999999864321100000 000000 0000
Q ss_pred cccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-CCCccccCCHHHH
Q 000880 631 SVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-LPPSWVAKFSEQE 706 (1239)
Q Consensus 631 ~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~e~~ 706 (1239)
.....+.+||+.|+|||++.+ ..++.++|||||||++|||++ ||......+....+...... ..+.....++++.
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 280 (381)
T cd05626 202 RCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAV 280 (381)
T ss_pred ccccccccCCccccCHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHH
Confidence 001234689999999999987 568999999999999999997 88766555444444322211 1223345678999
Q ss_pred HHHHHcc--CCCCCCCCCHHHHHhccCCCCchHH
Q 000880 707 SLLRRLM--SPSPSDRPSATELLQDALPPQMEYE 738 (1239)
Q Consensus 707 ~LI~~~L--~~dP~~RPta~eiL~~~~~~~~~~~ 738 (1239)
+||.+|+ ..+|..||++.++++|+||.+..+.
T Consensus 281 dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 281 DLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 9999955 4555669999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=372.92 Aligned_cols=275 Identities=29% Similarity=0.461 Sum_probs=218.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||+||+|++..+|+.||||+++..... ......+.+|+.+++.++||||++++++|.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--------- 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--------- 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee---------
Confidence 4799999999999999999999999999999999754322 234567889999999999999999997763
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...++|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++
T Consensus 72 -------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 120 (350)
T cd05573 72 -------------------------------DEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120 (350)
T ss_pred -------------------------------cCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2457899999996 69999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCC--------------CCCCCCCccccCcccccCccCCCcc
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAA--------------FPTDTGGVSVDGTGQVGTYFYTAPE 647 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~GT~~Y~APE 647 (1239)
||+||||||+|||++.++.+||+|||++............. ................||+.|+|||
T Consensus 121 giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 99999999999999999999999999998654322000000 0000000011223457999999999
Q ss_pred cccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhh--hcCCCCCccccCCHHHHHHHHHccCCCCCCCCC
Q 000880 648 IEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLK--QKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722 (1239)
Q Consensus 648 ~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt 722 (1239)
++.+ ..++.++|||||||++|||++ ||...........+.. ....+|. ....++++.+||.+||. ||.+||+
T Consensus 201 ~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~ 277 (350)
T cd05573 201 VLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLG 277 (350)
T ss_pred HHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCC
Confidence 9988 578999999999999999997 7876655544444333 2222333 23367899999999997 9999999
Q ss_pred -HHHHHhccCCCCchHHHHH
Q 000880 723 -ATELLQDALPPQMEYELLD 741 (1239)
Q Consensus 723 -a~eiL~~~~~~~~~~~~~~ 741 (1239)
+.++++|||+....+....
T Consensus 278 s~~~ll~hp~~~~~~~~~~~ 297 (350)
T cd05573 278 SFEEIKSHPFFKGIDWENLR 297 (350)
T ss_pred CHHHHhcCCCcCCCCHHHHh
Confidence 9999999999998776443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=368.67 Aligned_cols=258 Identities=30% Similarity=0.512 Sum_probs=223.8
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGV 497 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~ 497 (1239)
......|++.+.||+|.||.||+|+++.+|+.||+|+|++.... ......+.+|+.+|+.+. |||||.++++|..
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--- 107 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--- 107 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc---
Confidence 34456899999999999999999999999999999999865532 234568999999999998 9999999998832
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
...+|+|||+|. |.|.+.+... .+++..+..++.||+.|++
T Consensus 108 -------------------------------------~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~ 149 (382)
T KOG0032|consen 108 -------------------------------------PDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVK 149 (382)
T ss_pred -------------------------------------CCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHH
Confidence 457899999996 6899888766 5999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCC----CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDAR----NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~----~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
|||+.||+||||||+|+|+... +.+|++|||+|....... .....+|||.|+|||++..
T Consensus 150 ~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~----------------~~~~~~Gtp~y~APEvl~~- 212 (382)
T KOG0032|consen 150 YLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE----------------RLHTIVGTPEYVAPEVLGG- 212 (382)
T ss_pred HHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc----------------eEeeecCCccccCchhhcC-
Confidence 9999999999999999999754 479999999999865311 2356799999999999997
Q ss_pred CCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCC-CccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 653 PKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 653 ~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
..|+..+||||+||++|.|++ ||...........+......++ +.|...+..++++|++||..||.+|+|+.++|+
T Consensus 213 ~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 213 RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 569999999999999999985 9998888888877777666554 578888899999999999999999999999999
Q ss_pred ccCCCCc
Q 000880 729 DALPPQM 735 (1239)
Q Consensus 729 ~~~~~~~ 735 (1239)
|||....
T Consensus 293 HpWi~~~ 299 (382)
T KOG0032|consen 293 HPWIKSI 299 (382)
T ss_pred CccccCC
Confidence 9997765
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=359.67 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=206.8
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.|+..+.||+|+||+||+|.++.+|+.||||++...... ......+.+|+.+++.++||||++++++|.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--------- 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--------- 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc---------
Confidence 378889999999999999999999999999998754322 2223467899999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...++++||||+ ++|.+++... ..+++..++.++.||+.||+|||+
T Consensus 72 -------------------------------~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05631 72 -------------------------------KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120 (285)
T ss_pred -------------------------------CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 357899999996 5888777543 358999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+ ..++.++|
T Consensus 121 ~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----------------~~~~~~g~~~y~aPE~~~~-~~~~~~~D 183 (285)
T cd05631 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----------------TVRGRVGTVGYMAPEVINN-EKYTFSPD 183 (285)
T ss_pred CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----------------eecCCCCCCCccCHhhhcC-CCCCcccC
Confidence 999999999999999999999999999997542111 1134579999999999987 57899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHH---HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhc
Q 000880 661 MYSLGIVFFELWH---PFSTAMER---QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQD 729 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~ 729 (1239)
||||||++|||++ ||...... ......+. . .........++++.+||++||+.||.+||+ ++++++|
T Consensus 184 vwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-E-DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred chhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-c-ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 9999999999996 77654322 11111111 1 111222345678999999999999999997 9999999
Q ss_pred cCCCCchHHHHH
Q 000880 730 ALPPQMEYELLD 741 (1239)
Q Consensus 730 ~~~~~~~~~~~~ 741 (1239)
|||.+..+..+.
T Consensus 262 ~~~~~~~~~~~~ 273 (285)
T cd05631 262 PIFKNINFKRLE 273 (285)
T ss_pred HhhcCCCHHHHH
Confidence 999998876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=372.60 Aligned_cols=275 Identities=28% Similarity=0.465 Sum_probs=214.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||++++++|..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-------- 72 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-------- 72 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--------
Confidence 479999999999999999999999999999999975432 22334567889999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
..++|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus 73 --------------------------------~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 120 (364)
T cd05599 73 --------------------------------ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120 (364)
T ss_pred --------------------------------CCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457899999996 68999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCC---------------CCCCCC--------CccccCcccc
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAA---------------FPTDTG--------GVSVDGTGQV 638 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~---------------~~~~~~--------~~~~~~~~~~ 638 (1239)
||+||||||+|||++.++.+||+|||++..+.......... .+.... .......+.+
T Consensus 121 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (364)
T cd05599 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV 200 (364)
T ss_pred CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence 99999999999999999999999999997643221100000 000000 0000112457
Q ss_pred cCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCC-CccccCCHHHHHHHHHccC
Q 000880 639 GTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 639 GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~e~~~LI~~~L~ 714 (1239)
||+.|+|||++.+ ..++.++|||||||++|||++ ||......+............+ +.....++++.+||++||.
T Consensus 201 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~ 279 (364)
T cd05599 201 GTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC 279 (364)
T ss_pred cCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence 9999999999987 568999999999999999997 7766655544444332222111 2223457899999999997
Q ss_pred CCCCCCCC---HHHHHhccCCCCchHHHH
Q 000880 715 PSPSDRPS---ATELLQDALPPQMEYELL 740 (1239)
Q Consensus 715 ~dP~~RPt---a~eiL~~~~~~~~~~~~~ 740 (1239)
+|.+|++ +.++++||||....+...
T Consensus 280 -~p~~R~~~~~~~~ll~h~~~~~~~~~~~ 307 (364)
T cd05599 280 -EAERRLGNNGVNEIKSHPFFKGVDWEHI 307 (364)
T ss_pred -CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 9999998 999999999999877643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=372.85 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=215.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
+.|+++..||.|+||+||+|.++.++-..|.|+|.. .+.+..++++-|+.+|+.+.||+||+++++|+-
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~--------- 100 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYF--------- 100 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc---------
Confidence 457889999999999999999999999999999864 345667889999999999999999999988742
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+||..|||+| ....++-. ...+++.++..+++|++.||.|||++
T Consensus 101 -------------------------------enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~ 149 (1187)
T KOG0579|consen 101 -------------------------------ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ 149 (1187)
T ss_pred -------------------------------cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc
Confidence 4678999999976 55555544 45699999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC----CCCCCc
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKIDE 657 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~~~ 657 (1239)
+|||||||..|||++-+|.++|+|||.+....... -...+++|||+|||||++.. ...|+.
T Consensus 150 ~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~---------------qkRDsFIGTPYWMAPEVvmCET~KD~PYDy 214 (1187)
T KOG0579|consen 150 NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR---------------QKRDSFIGTPYWMAPEVVMCETFKDQPYDY 214 (1187)
T ss_pred chhhhhccccceEEEecCcEeeecccccccchhHH---------------hhhccccCCcccccchheeeccccCCCchh
Confidence 99999999999999999999999999987543211 12356899999999998754 245999
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
++|||||||+|.||.. |.....++.+.+++....+...-.+...+..+.+|+++||.+||..||++.++|+|||+.+
T Consensus 215 kaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 215 KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred hhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 9999999999999985 7777788888888776554433344455568999999999999999999999999999996
Q ss_pred ch
Q 000880 735 ME 736 (1239)
Q Consensus 735 ~~ 736 (1239)
..
T Consensus 295 ~~ 296 (1187)
T KOG0579|consen 295 AP 296 (1187)
T ss_pred CC
Confidence 64
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=358.10 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=201.4
Q ss_pred CCceEEeeeccCCceEEEEEEEcc-CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc---CCCceeeeeeeeeecCccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKL-DGRHYAVKKIRLKDKSLPVNDRILREVATLSRL---QHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~e~~~~~ 499 (1239)
++|++.+.||+|+||+||+|++.. +|+.||||+++...........+.+|+.+++.+ +||||++++++|....
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~--- 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR--- 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc---
Confidence 368999999999999999999854 468899999976544433445567788877766 6999999998874211
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY--DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~y 577 (1239)
......+++||||++++|.+++... ..+++..++.++.||+.||.|
T Consensus 78 --------------------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 125 (290)
T cd07862 78 --------------------------------TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125 (290)
T ss_pred --------------------------------CCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 0123568999999999999998753 358999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.
T Consensus 126 lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~-~~~~~ 188 (290)
T cd07862 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----------------MALTSVVVTLWYRAPEVLLQ-SSYAT 188 (290)
T ss_pred HHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC----------------cccccccccccccChHHHhC-CCCCC
Confidence 99999999999999999999999999999999754211 01234579999999999987 56899
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC-CC-----------------------ccccCCHHHHHHHH
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL-PP-----------------------SWVAKFSEQESLLR 710 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~-p~-----------------------~~~~~~~e~~~LI~ 710 (1239)
++|||||||++|||++ ||...........+....+.. +. .....++.+.+||.
T Consensus 189 ~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (290)
T cd07862 189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 268 (290)
T ss_pred ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHH
Confidence 9999999999999996 676554444333332211100 00 11234567789999
Q ss_pred HccCCCCCCCCCHHHHHhccCC
Q 000880 711 RLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+||+.||++|||+.++|+||||
T Consensus 269 ~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 269 KCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHhccCchhcCCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=364.36 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=205.9
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCc
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGT 510 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~ 510 (1239)
||+|+||.||+|+++.+++.||+|+++... ........+.+|+.+|+.++||||++++++|..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------------- 64 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS---------------- 64 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec----------------
Confidence 799999999999999999999999997532 223345678899999999999999999987632
Q ss_pred ccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 000880 511 LASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589 (1239)
Q Consensus 511 ~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLK 589 (1239)
...+|+|||||+ ++|.+++.....+++..+..++.||+.||.|||++||+|||||
T Consensus 65 ------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlk 120 (312)
T cd05585 65 ------------------------PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120 (312)
T ss_pred ------------------------CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC
Confidence 457899999996 5999999888889999999999999999999999999999999
Q ss_pred cccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHH
Q 000880 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFF 669 (1239)
Q Consensus 590 p~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ 669 (1239)
|+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 121 p~Nili~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ 184 (312)
T cd05585 121 PENILLDYQGHIALCDFGLCKLNMKDD---------------DKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLY 184 (312)
T ss_pred HHHeEECCCCcEEEEECcccccCccCC---------------CccccccCCcccCCHHHHcC-CCCCCccceechhHHHH
Confidence 999999999999999999987532110 01234579999999999987 56899999999999999
Q ss_pred Hhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC---CHHHHHhccCCCCchHH
Q 000880 670 ELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP---SATELLQDALPPQMEYE 738 (1239)
Q Consensus 670 ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP---ta~eiL~~~~~~~~~~~ 738 (1239)
||++ ||......+...........+|. ..++++.+||.+||..||.+|| ++.+++.||||.+..+.
T Consensus 185 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~ 256 (312)
T cd05585 185 EMLTGLPPFYDENVNEMYRKILQEPLRFPD---GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWK 256 (312)
T ss_pred HHHhCCCCcCCCCHHHHHHHHHcCCCCCCC---cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHH
Confidence 9997 77765555544444443333333 4567899999999999999997 58999999999987544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PRK00413 thrS threonyl-tRNA synthetase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=404.45 Aligned_cols=358 Identities=15% Similarity=0.143 Sum_probs=268.4
Q ss_pred cccCCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccC--CCccccccEEEEeccCCCeeeecCCC
Q 000880 779 RLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLG--DCPQFKRNTVKLLTHGGDLLELSHEL 852 (1239)
Q Consensus 779 ~ld~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~--~~~~~~~~~~~~~D~~G~~l~LRPD~ 852 (1239)
..+..+.|++||+|.++.+++.+++.++++|.+|||++|.||+| ++.. +++...++||+|.|.+|+.++|||+.
T Consensus 254 ~~~~~~~G~~~~lp~~~~~~~~i~~~~~~~~~~~Gy~ei~tP~le~~~l~~~~g~~~~~~~~my~~~d~~~~~~~LRP~~ 333 (638)
T PRK00413 254 HFQEEAPGLPFWHPKGWTIRRELERYIRRKLRKAGYQEVKTPQILDRELWETSGHWDHYRENMFPTTESDGEEYALKPMN 333 (638)
T ss_pred EecCCCCcceEEcccHHHHHHHHHHHHHHHHHHCCCEEEECCeeCCHHHHHhcCChhhhhhccceeecCCCcEEEEecCC
Confidence 34566799999999999999999999999999999999999999 3332 23566899999999999999999999
Q ss_pred cHHHHHHHHhCC----CCceeEEeecCeEEcCCCC---C--CCCceeEEeEEEeCCCCccc-H-HHHHHHHHHHHHhcCC
Q 000880 853 RLPFIRWAISNQ----KSSFKRYEISSVYRRAIGH---S--PPNRYLQGDFDIIGGASALT-E-AEVLKVTMDIVTRFFH 921 (1239)
Q Consensus 853 T~~iaR~~~~~~----~~P~r~~Y~g~VfR~e~~~---~--~~~ef~Q~GvEiiG~~s~~a-D-aEvi~la~~~l~~lgi 921 (1239)
|++++|+++++. ..|+|+||+|+|||+|+++ + |.+||+|+|+|+||..++.+ | +|+|.++.++++.||+
T Consensus 334 ~~~~~r~~~~~~~s~~~lP~r~~~~g~~fR~E~~~~~~Gl~R~reF~q~~~~~~g~~~~~~~e~~eii~l~~~~~~~lg~ 413 (638)
T PRK00413 334 CPGHVQIYKQGLRSYRDLPLRLAEFGTVHRYEPSGALHGLMRVRGFTQDDAHIFCTPEQIEEEVKKVIDLILDVYKDFGF 413 (638)
T ss_pred cHHHHHHHhCcCCChhhCCceeeeccCeecCCCCCCCcCcceeeeeEEeeEEEEcCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 999999998753 3599999999999999986 2 45679999999999988754 6 9999999999999999
Q ss_pred CCceEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHh
Q 000880 922 AESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRF 1001 (1239)
Q Consensus 922 ~~~~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~ 1001 (1239)
++ +.+.||++ +. ..+|.++.|......+. +.+...+++.+......+ +
T Consensus 414 ~~-~~i~l~~r--~~---~~~g~~~~~~~~~~~l~----------------------~~l~~~g~~~~~~~~~~~----~ 461 (638)
T PRK00413 414 ED-YEVKLSTR--PE---KRIGSDEMWDKAEAALK----------------------EALDELGLDYEIAPGEGA----F 461 (638)
T ss_pred ce-EEEEEecC--Cc---ccCCCHHHHHHHHHHHH----------------------HHHHHcCCCceecCCccc----c
Confidence 85 99999997 22 24566543322111111 111112222111111111 1
Q ss_pred cCChhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCC-ccceeEEEEEecCCCCccccccccccccc
Q 000880 1002 CGAADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIES-YHRNLFFQVFSVKEKYPATLVEGTLLAVG 1080 (1239)
Q Consensus 1002 ~g~~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~-YYtG~vFe~~~~~~~~~~~~~~~~~i~~G 1080 (1239)
.|+. +.. .+..++.++ ..+ ..+.+|+++.++++ ||||.+++.
T Consensus 462 ~~~~------~~~------~~~~~~~~~----~~l-~~~~~d~~~~~~~dl~Yt~~~~~~-------------------- 504 (638)
T PRK00413 462 YGPK------IDF------QLKDALGRE----WQC-GTIQLDFNLPERFDLTYVGEDGEK-------------------- 504 (638)
T ss_pred ccce------EEE------EeecCCCCe----EEe-ccEeecccChhhcCCEEECCCCCc--------------------
Confidence 1110 000 000111111 000 23667777777777 677663211
Q ss_pred ccccchhhhccccccccccCCCCCCcee---eeeccHHHHHhhCC---CCCcCCCCCCCceEEEEecCCCccHHHHHHHH
Q 000880 1081 GRYDYLLHRMWDREYVGYASRTNPPSGV---GASLALETIIQHYP---VDFKPVRNEAGTSVLVCSRGGGGLLVERMELV 1154 (1239)
Q Consensus 1081 GRYD~L~~~fg~~~~~~~~g~~~~~pAv---Gfaigldrl~~~L~---~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia 1154 (1239)
..|++ |++-++||++.+|. .+..|.+ ..|.+|+|++.+ +....+|.+++
T Consensus 505 -----------------------~~p~~i~~~~~g~~eRli~~l~e~~~~~~p~~-~~p~~v~Ii~~~-~~~~~~a~~i~ 559 (638)
T PRK00413 505 -----------------------HRPVMIHRAILGSMERFIGILIEHYAGAFPTW-LAPVQVVVLPIT-DKHADYAKEVA 559 (638)
T ss_pred -----------------------cCcEEEEecceehHHHHHHHHHHHcCCCCCcc-cCcceEEEEEeC-hhHHHHHHHHH
Confidence 13677 77778999998884 2444443 357789999986 66788999999
Q ss_pred HHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHhh
Q 000880 1155 AELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1155 ~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~~ 1231 (1239)
+.||+.|++|+++.. .+++++++++|++.|++++|++|++|.++|+|+||||.+++|.+++++++++.|++.++++
T Consensus 560 ~~Lr~~gi~v~~d~~-~~~l~kki~~A~~~g~~~~iiiG~~E~~~~~v~vr~~~~~~q~~i~~~~l~~~i~~~~~~~ 635 (638)
T PRK00413 560 KKLKAAGIRVEVDLR-NEKIGYKIREAQLQKVPYMLVVGDKEVEAGTVSVRRRGGKDLGTMSLDEFIERLLEEIASR 635 (638)
T ss_pred HHHHhCCCEEEEECC-CCCHhHHHHHhhccCCCEEEEEcchhhhcCeEEEEECCCCccceeeHHHHHHHHHHHHhhc
Confidence 999999999998877 6799999999999999999999999999999999999999999999999999999888753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=374.14 Aligned_cols=275 Identities=27% Similarity=0.446 Sum_probs=212.1
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||+||+|.++.+|+.||||++..... .......+.+|+.+++.++||||++++++|.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-------- 72 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-------- 72 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--------
Confidence 479999999999999999999999999999999865322 22334578899999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
..++|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++
T Consensus 73 --------------------------------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~ 120 (377)
T cd05629 73 --------------------------------AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120 (377)
T ss_pred --------------------------------CCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999996 69999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhcccccccc--------CCCCCC---------CCC---------------C
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQ--------DAAFPT---------DTG---------------G 629 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~--------~~~~~~---------~~~---------------~ 629 (1239)
||+||||||+|||++.++.+||+|||+|+.+....... ...... +.. .
T Consensus 121 givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (377)
T cd05629 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKN 200 (377)
T ss_pred CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc
Confidence 99999999999999999999999999997432111000 000000 000 0
Q ss_pred ccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC-CCccccCCHHH
Q 000880 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL-PPSWVAKFSEQ 705 (1239)
Q Consensus 630 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~-p~~~~~~~~e~ 705 (1239)
......+.+||+.|+|||++.+ ..++.++|||||||++|||++ ||...........+....... .+.....++++
T Consensus 201 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 279 (377)
T cd05629 201 RRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEA 279 (377)
T ss_pred ccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHH
Confidence 0001123579999999999987 568999999999999999997 776555544443333211111 12233467799
Q ss_pred HHHHHHccCCCCCCC---CCHHHHHhccCCCCchHHHH
Q 000880 706 ESLLRRLMSPSPSDR---PSATELLQDALPPQMEYELL 740 (1239)
Q Consensus 706 ~~LI~~~L~~dP~~R---Pta~eiL~~~~~~~~~~~~~ 740 (1239)
++||.+||. +|.+| +|+.++++||||....+..+
T Consensus 280 ~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~ 316 (377)
T cd05629 280 EDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTI 316 (377)
T ss_pred HHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 999999998 67665 59999999999998877654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=365.81 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=207.4
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
+.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--------------- 65 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--------------- 65 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE---------------
Confidence 369999999999999999999999999975432 2334567889999999999999999998763
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
....+|+||||++ ++|..++.....+++..++.++.||+.||+|||++||+|||
T Consensus 66 -------------------------~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 120 (328)
T cd05593 66 -------------------------TKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120 (328)
T ss_pred -------------------------cCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 2457899999996 58998988888899999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 121 ikp~NIll~~~~~~kL~DfG~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvi 184 (328)
T cd05593 121 LKLENLMLDKDGHIKITDFGLCKEGITDA---------------ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVV 184 (328)
T ss_pred cCHHHeEECCCCcEEEecCcCCccCCCcc---------------cccccccCCcCccChhhhcC-CCCCccCCccccchH
Confidence 99999999999999999999987531110 01234579999999999987 568999999999999
Q ss_pred HHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCCCchHHH
Q 000880 668 FFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPPQMEYEL 739 (1239)
Q Consensus 668 L~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~~~~~~~ 739 (1239)
+|||++ ||..................+|. ..++++.+||++||..||.+|| ++.++++|+||....+..
T Consensus 185 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~ 261 (328)
T cd05593 185 MYEMMCGRLPFYNQDHEKLFELILMEDIKFPR---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD 261 (328)
T ss_pred HHHHhhCCCCCCCCCHHHHHHHhccCCccCCC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999997 88665554444433333333333 4567899999999999999997 899999999999887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=365.23 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=207.9
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
+.||+|+||.||+|+++.+|+.||+|+++.... .......+.+|+.+++.++||||++++++|..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-------------- 66 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-------------- 66 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--------------
Confidence 369999999999999999999999999975322 22344567889999999999999999988732
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
...+|+|||||+ ++|..++.....+++..++.++.||+.||+|||++||+|||
T Consensus 67 --------------------------~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 120 (323)
T cd05595 67 --------------------------HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120 (323)
T ss_pred --------------------------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 357899999996 58999988888899999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 184 (323)
T cd05595 121 IKLENLMLDKDGHIKITDFGLCKEGISDG---------------ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVV 184 (323)
T ss_pred CCHHHEEEcCCCCEEecccHHhccccCCC---------------CccccccCCcCcCCcccccC-CCCCchhchhhhHHH
Confidence 99999999999999999999987431110 01134579999999999987 568999999999999
Q ss_pred HHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCCCchHHH
Q 000880 668 FFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPPQMEYEL 739 (1239)
Q Consensus 668 L~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~~~~~~~ 739 (1239)
+|||++ ||..................+|. ..++++.+||.+||+.||.+|| ++.++++|+||.+..+..
T Consensus 185 l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~ 261 (323)
T cd05595 185 MYEMMCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261 (323)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999997 88766555444444433333443 4567999999999999999998 899999999999887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=379.18 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=201.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||+++++|.....
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~------ 133 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECF------ 133 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeeccc------
Confidence 57999999999999999999999999999999885322 234579999999999999999987743210
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE----SYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~----~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
.......++++|||||+++|.+++. ....+++..++.++.||+.||+|||
T Consensus 134 --------------------------~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH 187 (440)
T PTZ00036 134 --------------------------KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187 (440)
T ss_pred --------------------------ccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 0011235688999999998887765 3456999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCC-CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 580 GQGIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
++||+||||||+|||++.++ .+||+|||+|+.+.... .....+||+.|+|||++.+...|+.+
T Consensus 188 ~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~ 251 (440)
T PTZ00036 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ----------------RSVSYICSRFYRAPELMLGATNYTTH 251 (440)
T ss_pred HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC----------------CcccCCCCcCccCHHHhcCCCCCCcH
Confidence 99999999999999999765 69999999998653211 11345789999999998775579999
Q ss_pred hhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcC-----------------CCCC----c-----cccCCHHHHHHH
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKG-----------------ELPP----S-----WVAKFSEQESLL 709 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~-----------------~~p~----~-----~~~~~~e~~~LI 709 (1239)
+|||||||+||||++ ||...........++...+ .+|. . ....++++.+||
T Consensus 252 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li 331 (440)
T PTZ00036 252 IDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFI 331 (440)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHH
Confidence 999999999999997 7765544333322221110 0110 0 112456899999
Q ss_pred HHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 710 RRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 710 ~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
.+||..||.+|||+.++++||||...
T Consensus 332 ~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 332 SQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHCCCChhHCcCHHHHhCChhHHhh
Confidence 99999999999999999999998654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=373.18 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=200.7
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
..++|++++.||+|+||.||+|.+..+++.||||+.. ...+.+|+.+|+.++|||||+++++|..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~------- 154 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY------- 154 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-------
Confidence 4568999999999999999999999999999999653 2346789999999999999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....+++||++.++|..++.....+++..++.++.||+.||+|||++
T Consensus 155 ---------------------------------~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~ 201 (391)
T PHA03212 155 ---------------------------------NKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN 201 (391)
T ss_pred ---------------------------------CCeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34679999999999999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+|+...... .......+||+.|+|||++.+ ..++.++||
T Consensus 202 ~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 266 (391)
T PHA03212 202 RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN--------------ANKYYGWAGTIATNAPELLAR-DPYGPAVDI 266 (391)
T ss_pred CcccCCCChHhEEEcCCCCEEEEeCCccccccccc--------------ccccccccCccCCCChhhhcC-CCCCcHHHH
Confidence 99999999999999999999999999997532111 001234589999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhH-------HHHHHHHhhhhcC--------------------------CCC---Ccc---c
Q 000880 662 YSLGIVFFELWH---PFSTAM-------ERQIVLSDLKQKG--------------------------ELP---PSW---V 699 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~-------~~~~~~~~~~~~~--------------------------~~p---~~~---~ 699 (1239)
|||||++|||++ ||.... .......++...+ ..+ +.| .
T Consensus 267 wSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (391)
T PHA03212 267 WSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLY 346 (391)
T ss_pred HHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHh
Confidence 999999999997 443211 0000000000000 000 111 1
Q ss_pred cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 700 AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 700 ~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
..+.++.+||.+||+.||.+|||+.++|+|+||....
T Consensus 347 ~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 347 ELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 2344788999999999999999999999999997653
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=372.39 Aligned_cols=272 Identities=25% Similarity=0.408 Sum_probs=212.6
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.|+++++||+|+||+||+|+++.+++.||||++..... .......+.+|+.+++.++||||++++++|..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--------- 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--------- 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe---------
Confidence 58999999999999999999999999999999975432 22344678899999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++|
T Consensus 73 -------------------------------~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ 121 (382)
T cd05625 73 -------------------------------KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG 121 (382)
T ss_pred -------------------------------CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 457899999996 589999988888999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCC-----------CCCC---------------------CCCCc
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDA-----------AFPT---------------------DTGGV 630 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~-----------~~~~---------------------~~~~~ 630 (1239)
|+||||||+|||++.++++||+|||+|+.+......... .+.. .....
T Consensus 122 ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (382)
T cd05625 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQ 201 (382)
T ss_pred eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 999999999999999999999999998643211000000 0000 00000
Q ss_pred cccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-CCCccccCCHHHH
Q 000880 631 SVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-LPPSWVAKFSEQE 706 (1239)
Q Consensus 631 ~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~e~~ 706 (1239)
.....+.+||+.|+|||++.+ ..|+.++|||||||+||||++ ||......+....+...... ..+.....++++.
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 280 (382)
T cd05625 202 RCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEAS 280 (382)
T ss_pred cccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHH
Confidence 001234589999999999987 568999999999999999997 88766555554444432222 1223345678999
Q ss_pred HHHHHccCCCCCCCCC---HHHHHhccCCCCchHH
Q 000880 707 SLLRRLMSPSPSDRPS---ATELLQDALPPQMEYE 738 (1239)
Q Consensus 707 ~LI~~~L~~dP~~RPt---a~eiL~~~~~~~~~~~ 738 (1239)
++|.+|+ .+|.+|++ +.++++||||....+.
T Consensus 281 ~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 281 DLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999976 59999997 9999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=367.45 Aligned_cols=260 Identities=28% Similarity=0.386 Sum_probs=204.7
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
..++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK----- 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-----
Confidence 468999999999999999999999999999999999755444445667889999999999999999998874321
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
.......+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++
T Consensus 94 -----------------------------~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~ 142 (359)
T cd07876 94 -----------------------------SLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA 142 (359)
T ss_pred -----------------------------CccccceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0012346899999999988887743 488999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++..... ...+...||+.|+|||++.+ ..++.++||
T Consensus 143 ~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di 205 (359)
T cd07876 143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN----------------FMMTPYVVTRYYRAPEVILG-MGYKENVDI 205 (359)
T ss_pred CcccCCCCHHHEEECCCCCEEEecCCCccccccC----------------ccCCCCcccCCCCCchhccC-CCCCcchhh
Confidence 9999999999999999999999999999753211 01234578999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhh----------------------hhcCCCCC--------c---------cc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDL----------------------KQKGELPP--------S---------WV 699 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~----------------------~~~~~~p~--------~---------~~ 699 (1239)
|||||++|+|++ ||............. ......+. . ..
T Consensus 206 wSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (359)
T cd07876 206 WSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDK 285 (359)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccccccccc
Confidence 999999999996 776443221111000 00111100 0 01
Q ss_pred cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 700 AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 700 ~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
..++++++||.+||+.||.+|||+.++|+|||+..
T Consensus 286 ~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 286 LKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred ccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 12357899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=344.49 Aligned_cols=285 Identities=25% Similarity=0.389 Sum_probs=230.9
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
-+++|..+++||+|.||+|.+|+.+.+|+.||||++++.-. .......-+.|-.+|...+||.+..+...|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-------- 237 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-------- 237 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--------
Confidence 47899999999999999999999999999999999975432 233344567899999999999998876554
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
+....+++||||+. |.|.-+|.....|+++.++.+-.+|+.||.|||
T Consensus 238 --------------------------------Qt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH 285 (516)
T KOG0690|consen 238 --------------------------------QTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH 285 (516)
T ss_pred --------------------------------ccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh
Confidence 33578999999995 689999988888999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+++||+||||.+|+|+|.+||+||+|||+++.-. .. -.++.++||||.|+|||++.. ..|+.++
T Consensus 286 s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I----~~-----------g~t~kTFCGTPEYLAPEVleD-nDYgraV 349 (516)
T KOG0690|consen 286 SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI----KY-----------GDTTKTFCGTPEYLAPEVLED-NDYGRAV 349 (516)
T ss_pred hCCeeeeechhhhheeccCCceEeeecccchhcc----cc-----------cceeccccCChhhcCchhhcc-cccccee
Confidence 9999999999999999999999999999998421 11 123467899999999999998 6899999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDAL 731 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~ 731 (1239)
|+|.+||++|||++ ||.........--++.....+|. ..+++++.|+..+|.+||.+|. .+.+|.+|+|
T Consensus 350 DWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr---~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 350 DWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR---TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred ehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc---cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 99999999999997 99877665555444544555554 4567999999999999999997 4899999999
Q ss_pred CCCchHHHHHHHHHhcCCCCCCcchhhhccccccch
Q 000880 732 PPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEE 767 (1239)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~e~ 767 (1239)
|..+.|... +...+.+|.....-+.....-||++
T Consensus 427 F~~v~W~~~--~~Kki~PPfKPqVtSetDTryFD~E 460 (516)
T KOG0690|consen 427 FASVDWEAT--YRKKIEPPFKPQVTSETDTRYFDEE 460 (516)
T ss_pred hccCCHHHH--HHhccCCCCCCCcccccchhhhhhh
Confidence 999988643 4445554433333333333334433
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=372.30 Aligned_cols=275 Identities=24% Similarity=0.403 Sum_probs=213.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||.||+|+++.+++.||||++..... .......+.+|+.+|+.++||||+++++.|.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-------- 72 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-------- 72 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--------
Confidence 479999999999999999999999999999999864322 12234568899999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||++
T Consensus 73 --------------------------------~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~ 120 (376)
T cd05598 73 --------------------------------KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120 (376)
T ss_pred --------------------------------CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 457899999996 69999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhcccccccc----------C-CCCCCC-----------------CCCcccc
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQ----------D-AAFPTD-----------------TGGVSVD 633 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~----------~-~~~~~~-----------------~~~~~~~ 633 (1239)
||+||||||+|||++.++++||+|||+|..+....... . ...+.. .......
T Consensus 121 ~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (376)
T cd05598 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL 200 (376)
T ss_pred CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence 99999999999999999999999999986432100000 0 000000 0000011
Q ss_pred CcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-CCCccccCCHHHHHHH
Q 000880 634 GTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-LPPSWVAKFSEQESLL 709 (1239)
Q Consensus 634 ~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~e~~~LI 709 (1239)
..+.+||+.|||||++.+ ..++.++|||||||++|||++ ||......+....+...... ..+.....++++.++|
T Consensus 201 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 279 (376)
T cd05598 201 AHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLI 279 (376)
T ss_pred ccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHH
Confidence 234689999999999987 568999999999999999997 88766554443333322211 1223345678999999
Q ss_pred HHccCCCCCCCC---CHHHHHhccCCCCchHHHH
Q 000880 710 RRLMSPSPSDRP---SATELLQDALPPQMEYELL 740 (1239)
Q Consensus 710 ~~~L~~dP~~RP---ta~eiL~~~~~~~~~~~~~ 740 (1239)
.+|+ .+|.+|+ |+.++++|+||.+..+...
T Consensus 280 ~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~ 312 (376)
T cd05598 280 LRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASL 312 (376)
T ss_pred HHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHH
Confidence 9976 5999999 9999999999999876544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=369.19 Aligned_cols=263 Identities=28% Similarity=0.383 Sum_probs=209.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI------- 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc-------
Confidence 5788899999999999999999999999999986543343445678999999999999999999988743210
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
.....+|+||||++++|.+.+.....+++..++.++.||+.||+|||++||+
T Consensus 74 ----------------------------~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 125 (372)
T cd07853 74 ----------------------------DPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGIL 125 (372)
T ss_pred ----------------------------cccceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 0123689999999999999998888899999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
||||||+|||++.++.+||+|||+++...... ....+...+|+.|+|||++.+...++.++|||||
T Consensus 126 H~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 191 (372)
T cd07853 126 HRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSV 191 (372)
T ss_pred CCCCChHHEEECCCCCEEeccccceeecccCc--------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhH
Confidence 99999999999999999999999997542111 0112345789999999999875668999999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhh----------------------hhcCCCCCc-------cccCCHHHHHHHHHc
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDL----------------------KQKGELPPS-------WVAKFSEQESLLRRL 712 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~----------------------~~~~~~p~~-------~~~~~~e~~~LI~~~ 712 (1239)
||++|||++ ||...........+. ......++. ....++++.+||.+|
T Consensus 192 G~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 271 (372)
T cd07853 192 GCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRM 271 (372)
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHh
Confidence 999999996 775443322211111 111111111 123456889999999
Q ss_pred cCCCCCCCCCHHHHHhccCCCCch
Q 000880 713 MSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|+.||.+|||+.++++|||+....
T Consensus 272 L~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 272 LVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CCCChhhCcCHHHHhcCHhhCCCc
Confidence 999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.67 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=204.8
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
.|...+++|.|+||.||+|....+++.||||+...... .-.+|+.+|+.+.|||||++..+|..+..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~------- 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTE------- 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCC-------
Confidence 57778999999999999999999999999998753322 23479999999999999999988855420
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES----YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
.+..++.+||||+|.+|.+.++. ..+++.-.++-++.||++||.|||+
T Consensus 92 ----------------------------~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~ 143 (364)
T KOG0658|consen 92 ----------------------------SDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS 143 (364)
T ss_pred ----------------------------CchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence 12457789999999999999985 4678888999999999999999999
Q ss_pred CCccccCCCcccEEEcCC-CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 581 QGIIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
.||+||||||.|+|+|.+ |.+||||||.|+.+...+. ..++.-|..|.|||.+.|...|+.+.
T Consensus 144 ~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep----------------niSYicSRyYRaPELifga~~Yt~~I 207 (364)
T KOG0658|consen 144 HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP----------------NISYICSRYYRAPELIFGATEYTTSI 207 (364)
T ss_pred cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC----------------ceeEEEeccccCHHHHcCccccCcee
Confidence 999999999999999987 8899999999998754331 25678899999999999988999999
Q ss_pred hhHHHHHHHHHhhc--CC-chhHHHHHHHHhhhh------------cC-----CCC----C-----ccccCCHHHHHHHH
Q 000880 660 DMYSLGIVFFELWH--PF-STAMERQIVLSDLKQ------------KG-----ELP----P-----SWVAKFSEQESLLR 710 (1239)
Q Consensus 660 DIwSlGviL~ELlt--Pf-~~~~~~~~~~~~~~~------------~~-----~~p----~-----~~~~~~~e~~~LI~ 710 (1239)
||||.||++.||+. |. .+.+.......++.. ++ .+| . .....++++.+|+.
T Consensus 208 DiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~ 287 (364)
T KOG0658|consen 208 DIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLS 287 (364)
T ss_pred EEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHH
Confidence 99999999999995 43 333322222211110 00 011 1 12335578999999
Q ss_pred HccCCCCCCCCCHHHHHhccCCCCch
Q 000880 711 RLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
++|..+|.+|.++.++++|+||....
T Consensus 288 ~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 288 KLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred HHhccChhhcCCHHHHhcchhhHHhh
Confidence 99999999999999999999887653
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=367.52 Aligned_cols=275 Identities=26% Similarity=0.427 Sum_probs=214.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||.||+|+++.+++.||||+++.... .......+.+|+.++..++||||+++++.|.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--------- 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--------- 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE---------
Confidence 479999999999999999999999999999999974322 2234567888999999999999999998873
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....+|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++
T Consensus 72 -------------------------------~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~ 120 (360)
T cd05627 72 -------------------------------DKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120 (360)
T ss_pred -------------------------------cCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2457899999996 58999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCC----CC-CC-------CC--------CCccccCcccccCc
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDA----AF-PT-------DT--------GGVSVDGTGQVGTY 641 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~----~~-~~-------~~--------~~~~~~~~~~~GT~ 641 (1239)
||+||||||+|||++.++++||+|||++..+......... .. +. .. ........+.+||+
T Consensus 121 givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 200 (360)
T cd05627 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP 200 (360)
T ss_pred CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence 9999999999999999999999999999755321100000 00 00 00 00000123468999
Q ss_pred cCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--CCCCCccccCCHHHHHHHHHccCCC
Q 000880 642 FYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK--GELPPSWVAKFSEQESLLRRLMSPS 716 (1239)
Q Consensus 642 ~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~e~~~LI~~~L~~d 716 (1239)
.|+|||++.+ ..++.++|||||||++|||++ ||...........+.... ..+|+. ...++++++||.+|+ .|
T Consensus 201 ~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~-~~ 277 (360)
T cd05627 201 DYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPE-VPISEKAKDLILRFC-TD 277 (360)
T ss_pred cccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCC-CCCCHHHHHHHHHhc-cC
Confidence 9999999987 568999999999999999997 887665555444433211 222322 235678999999977 49
Q ss_pred CCCCC---CHHHHHhccCCCCchHHHHH
Q 000880 717 PSDRP---SATELLQDALPPQMEYELLD 741 (1239)
Q Consensus 717 P~~RP---ta~eiL~~~~~~~~~~~~~~ 741 (1239)
|.+|+ ++.++++||||.+..+..+.
T Consensus 278 p~~R~~~~~~~ei~~hp~f~~~~~~~~~ 305 (360)
T cd05627 278 SENRIGSNGVEEIKSHPFFEGVDWGHIR 305 (360)
T ss_pred hhhcCCCCCHHHHhcCCCCCCCCHHHHh
Confidence 99998 58999999999999887553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=351.98 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=199.3
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc---CCCceeeeeeeeeecCccccC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL---QHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+|++.+.||+|+||+||+|+++.+|+.||+|.++...........+.+|+.+++.+ +||||++++++|....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~----- 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR----- 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc-----
Confidence 48899999999999999999999999999999876443333334566777777665 7999999998874321
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
......++++|||++++|.+++... ..+++..++.++.||+.||.|||
T Consensus 76 ------------------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 125 (288)
T cd07863 76 ------------------------------TDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125 (288)
T ss_pred ------------------------------CCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 0124568999999999999988764 34899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++||+||||||+|||++.++.+||+|||+++...... ..+...||+.|+|||++.+ ..++.++
T Consensus 126 ~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~ 188 (288)
T cd07863 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM----------------ALTPVVVTLWYRAPEVLLQ-STYATPV 188 (288)
T ss_pred hCCeecCCCCHHHEEECCCCCEEECccCccccccCcc----------------cCCCccccccccCchHhhC-CCCCCcc
Confidence 9999999999999999999999999999998643111 1133578999999999987 5689999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcC----------------CCC--------CccccCCHHHHHHHHHc
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKG----------------ELP--------PSWVAKFSEQESLLRRL 712 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~----------------~~p--------~~~~~~~~e~~~LI~~~ 712 (1239)
|||||||++|+|++ ||................+ .+. .........+.++|.+|
T Consensus 189 DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (288)
T cd07863 189 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEM 268 (288)
T ss_pred hhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHH
Confidence 99999999999996 5544433322222111000 000 01123445778999999
Q ss_pred cCCCCCCCCCHHHHHhccCC
Q 000880 713 MSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~ 732 (1239)
|+.||.+|||+.+++.||||
T Consensus 269 L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 269 LTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=360.62 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=210.5
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCC-ceeeeeeeeeecCccccCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQ-HVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~Hp-nIv~l~~~~~e~~~~~~~~ 502 (1239)
+|++++.||+|+||.||+|+++.+++.||||+++.... .......+..|..+++.+.|+ +|+.+++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-------- 72 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-------- 72 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--------
Confidence 58999999999999999999999999999999975322 223445688899999999775 57777777632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++
T Consensus 73 --------------------------------~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05587 73 --------------------------------MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120 (324)
T ss_pred --------------------------------CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 357899999996 69999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+ ..++.++||
T Consensus 121 ~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 184 (324)
T cd05587 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---------------KTTRTFCGTPDYIAPEIIAY-QPYGKSVDW 184 (324)
T ss_pred CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC---------------CceeeecCCccccChhhhcC-CCCCcccch
Confidence 99999999999999999999999999986421100 01234579999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH-----HHHHhccCCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA-----TELLQDALPP 733 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta-----~eiL~~~~~~ 733 (1239)
|||||++|||++ ||......+....+......+|. ..++++.++|++||..||.+|++. .++++||||.
T Consensus 185 wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~ 261 (324)
T cd05587 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK---SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261 (324)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcC
Confidence 999999999997 88766555555444443333333 456789999999999999999976 8999999999
Q ss_pred CchHHHH
Q 000880 734 QMEYELL 740 (1239)
Q Consensus 734 ~~~~~~~ 740 (1239)
...+...
T Consensus 262 ~~~~~~~ 268 (324)
T cd05587 262 RIDWEKL 268 (324)
T ss_pred CCCHHHH
Confidence 9876543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=364.52 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=213.6
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-------- 72 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-------- 72 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--------
Confidence 479999999999999999999999999999999975432 22344568899999999999999999987632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|+|||||+ ++|.+++... ..+++..++.++.||+.||.|||+
T Consensus 73 --------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 120 (330)
T cd05601 73 --------------------------------KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120 (330)
T ss_pred --------------------------------CCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356899999996 6999999876 679999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC-----CCCC
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG-----WPKI 655 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~~ 655 (1239)
+||+||||||+|||++.++.+||+|||++..+..... .......||+.|+|||++.. ...+
T Consensus 121 ~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 186 (330)
T cd05601 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186 (330)
T ss_pred CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--------------eeeecccCCccccCHHHhccccccccCCC
Confidence 9999999999999999999999999999986532110 01123479999999999863 2457
Q ss_pred CcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-CCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 656 DEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-LPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
+.++|||||||++|||++ ||...........+...... ..+.....++++.+||.+||+ +|.+|||+.++++|||
T Consensus 187 ~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 187 GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred CCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 899999999999999997 88665554444333322211 112233467789999999998 9999999999999999
Q ss_pred CCCchHHHHHH
Q 000880 732 PPQMEYELLDN 742 (1239)
Q Consensus 732 ~~~~~~~~~~~ 742 (1239)
|....+..+..
T Consensus 266 ~~~~~~~~~~~ 276 (330)
T cd05601 266 FSKIDWNNIRN 276 (330)
T ss_pred cCCCCHHHHhh
Confidence 99987765543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=359.24 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=206.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++++.||+|+||.||+++++.+|..||+|++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------- 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--------
Confidence 478999999999999999999999999999999987542 33445679999999999999999999998743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++
T Consensus 75 --------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (331)
T cd06649 75 --------------------------------DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122 (331)
T ss_pred --------------------------------CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 346899999997 59999998888899999999999999999999986
Q ss_pred -CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 582 -GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 582 -gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+|+||||||+|||++.++.+||+|||++...... ......||+.|+|||++.+ ..++.++|
T Consensus 123 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----------------~~~~~~g~~~y~aPE~~~~-~~~~~~~D 184 (331)
T cd06649 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----------------MANSFVGTRSYMSPERLQG-THYSVQSD 184 (331)
T ss_pred CCEEcCCCChhhEEEcCCCcEEEccCccccccccc-----------------ccccCCCCcCcCCHhHhcC-CCCCchHh
Confidence 6999999999999999999999999998754211 1133579999999999987 56899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhh---------------------------------------------cC
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQ---------------------------------------------KG 692 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~---------------------------------------------~~ 692 (1239)
||||||++|||++ ||......+.. ..+.. ..
T Consensus 185 iwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T cd06649 185 IWSMGLSLVELAIGRYPIPPPDAKELE-AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE 263 (331)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhC
Confidence 9999999999996 77543322211 10000 00
Q ss_pred CCCC-ccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 693 ELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 693 ~~p~-~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
..+. .....++++++||.+||..||++|||+.++++|+|+....
T Consensus 264 ~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 264 PPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred CCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0111 1113456899999999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=361.41 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=206.2
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||+||+|+++.+++.||||+++.... .......+.+|..++..+ +||||+++++++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~------------- 67 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT------------- 67 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-------------
Confidence 369999999999999999999999999974321 223345677888888877 79999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~ 120 (320)
T cd05590 68 ---------------------------PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120 (320)
T ss_pred ---------------------------CCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 357899999996 5999999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 184 (320)
T cd05590 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNG---------------KTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGV 184 (320)
T ss_pred CCCHHHeEECCCCcEEEeeCCCCeecCcCC---------------CcccccccCccccCHHHHcC-CCCCCccchhhhHH
Confidence 999999999999999999999987431110 01234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH------HHHHhccCCCCchH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA------TELLQDALPPQMEY 737 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta------~eiL~~~~~~~~~~ 737 (1239)
++|||++ ||...........+.......|. ..++++.++|++||+.||.+||++ +++++||||....+
T Consensus 185 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 185 LLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT---WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC---CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999996 88766655554444433323332 356789999999999999999998 99999999998876
Q ss_pred HH
Q 000880 738 EL 739 (1239)
Q Consensus 738 ~~ 739 (1239)
..
T Consensus 262 ~~ 263 (320)
T cd05590 262 EK 263 (320)
T ss_pred HH
Confidence 54
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=364.94 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=205.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|.+++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||++++++|.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 88 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS----- 88 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc-----
Confidence 367999999999999999999999999999999987544333445668899999999999999999987743210
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
.......|++|++++++|.+++. ...+++..++.++.||+.||+|||++|
T Consensus 89 -----------------------------~~~~~~~~~~~~~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ 138 (343)
T cd07878 89 -----------------------------IENFNEVYLVTNLMGADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG 138 (343)
T ss_pred -----------------------------ccccCcEEEEeecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 01234579999999999988775 356999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+|||++.++.+||+|||+++.... ..+..+||+.|+|||++.+...++.++|||
T Consensus 139 ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (343)
T cd07878 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADD------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIW 200 (343)
T ss_pred eecccCChhhEEECCCCCEEEcCCccceecCC------------------CcCCccccccccCchHhcCCccCCchhhhH
Confidence 99999999999999999999999999975421 123457999999999998755689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhc-----------------------CCCCC-----ccccCCHHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQK-----------------------GELPP-----SWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-----------------------~~~p~-----~~~~~~~e~~~LI~~ 711 (1239)
||||++|+|++ ||................ ...+. .+....+.+.+||.+
T Consensus 201 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 280 (343)
T cd07878 201 SVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEK 280 (343)
T ss_pred hHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHH
Confidence 99999999996 665433222211111000 00110 112344568899999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCch
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||..||.+|||+.++++||||.+..
T Consensus 281 mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 281 MLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HcCCChhhCCCHHHHhcCcchhccC
Confidence 9999999999999999999997653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=354.78 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=222.1
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+...=|.+.+.||+|.|..|.+|+|..||..||||+|.+...+.-....+++|+..|+.++|||||++|.+.
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-------- 86 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-------- 86 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--------
Confidence 334567888999999999999999999999999999987665555566899999999999999999999764
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
.....+|+|+|+-+ |+|++++.+. ..+.++.+.+|+.||+.|+.|+
T Consensus 87 --------------------------------DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YC 134 (864)
T KOG4717|consen 87 --------------------------------DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYC 134 (864)
T ss_pred --------------------------------cccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHH
Confidence 13578999999996 5999998765 4699999999999999999999
Q ss_pred HhCCccccCCCcccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 579 HGQGIIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
|...+|||||||+||.+-+ -|-|||.|||++..+.+.. ..++.||++.|.|||+|.|..+-.+
T Consensus 135 HqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~----------------kL~TsCGSLAYSAPEILLGDsYDAP 198 (864)
T KOG4717|consen 135 HQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK----------------KLTTSCGSLAYSAPEILLGDSYDAP 198 (864)
T ss_pred hhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc----------------hhhcccchhhccCchhhhcCccCCc
Confidence 9999999999999998765 4889999999998764332 1356799999999999999655568
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
++||||||||||-|++ ||....+.+.+..++.-+...|.. .+.++++||..||..||.+|.+.++|..++|.+.
T Consensus 199 AVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh---vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 199 AVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH---VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred chhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh---hhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 9999999999999986 999888888877777766666654 4459999999999999999999999999999987
Q ss_pred chH
Q 000880 735 MEY 737 (1239)
Q Consensus 735 ~~~ 737 (1239)
...
T Consensus 276 ~D~ 278 (864)
T KOG4717|consen 276 GDR 278 (864)
T ss_pred CCC
Confidence 653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=364.60 Aligned_cols=261 Identities=28% Similarity=0.387 Sum_probs=205.5
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK----- 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc-----
Confidence 467999999999999999999999999999999998755444455677889999999999999999998874321
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
.......+|++||||+++|.+.+.. .+++..++.++.||+.||+|||++
T Consensus 90 -----------------------------~~~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~ 138 (355)
T cd07874 90 -----------------------------SLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 138 (355)
T ss_pred -----------------------------cccccceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0012346899999999988887753 488999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||
T Consensus 139 givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~----------------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di 201 (355)
T cd07874 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----------------FMMTPYVVTRYYRAPEVILG-MGYKENVDI 201 (355)
T ss_pred CcccCCCChHHEEECCCCCEEEeeCcccccCCCc----------------cccCCccccCCccCHHHHcC-CCCCchhhH
Confidence 9999999999999999999999999999754211 11234579999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhh----------------------cCC-----CCC------------ccc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQ----------------------KGE-----LPP------------SWV 699 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~----------------------~~~-----~p~------------~~~ 699 (1239)
|||||++|+|++ ||............+.. ... .+. ...
T Consensus 202 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (355)
T cd07874 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281 (355)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccccccccc
Confidence 999999999996 77543322211111100 000 000 001
Q ss_pred cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 700 AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 700 ~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
....++++||.+||..||.+|||+.++|+|||+...
T Consensus 282 ~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 282 LKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred ccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 123467899999999999999999999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=365.12 Aligned_cols=260 Identities=28% Similarity=0.386 Sum_probs=206.1
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~----- 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK----- 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc-----
Confidence 357999999999999999999999999999999999755444455667889999999999999999998763221
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
.......+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++
T Consensus 97 -----------------------------~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~ 145 (364)
T cd07875 97 -----------------------------SLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA 145 (364)
T ss_pred -----------------------------cccccCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC
Confidence 0112356899999999998888753 488899999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++..... ...+...||+.|+|||++.+ ..++.++||
T Consensus 146 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----------------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di 208 (364)
T cd07875 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----------------FMMTPYVVTRYYRAPEVILG-MGYKENVDI 208 (364)
T ss_pred CeecCCCCHHHEEECCCCcEEEEeCCCccccCCC----------------CcccCCcccCCcCCHHHHhC-CCCCchhhH
Confidence 9999999999999999999999999999754211 11234579999999999988 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-------------------CC--------------------Cccc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-------------------LP--------------------PSWV 699 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-------------------~p--------------------~~~~ 699 (1239)
|||||++|||++ ||............+...+. .| ....
T Consensus 209 wSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (364)
T cd07875 209 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288 (364)
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccc
Confidence 999999999997 77654433322222111000 00 0001
Q ss_pred cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 700 AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 700 ~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
....++++||.+||+.||.+|||+.++|+|||+..
T Consensus 289 ~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred cccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 12346789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=355.46 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=205.7
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++|.+.+.||+|+||.||+|+++.+++.||+|+++..... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 75 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT-------- 75 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--------
Confidence 47899999999999999999999999999999999754322 233467889999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++++|.+.+.... .+++..++.++.||+.||+|||++
T Consensus 76 --------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~ 123 (309)
T cd07872 76 --------------------------------DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123 (309)
T ss_pred --------------------------------CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35689999999999988886544 589999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+...++.++||
T Consensus 124 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 188 (309)
T cd07872 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT---------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188 (309)
T ss_pred CeecCCCCHHHEEECCCCCEEECccccceecCCCc---------------cccccccccccccCCHHHhCCCCCCcHHHH
Confidence 99999999999999999999999999987532111 011234689999999998765668999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhc-------------------CCCCC--------ccccCCHHHHHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQK-------------------GELPP--------SWVAKFSEQESLLRR 711 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-------------------~~~p~--------~~~~~~~e~~~LI~~ 711 (1239)
|||||++|+|++ ||................ ...+. .....++++.+||.+
T Consensus 189 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 268 (309)
T cd07872 189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTK 268 (309)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHH
Confidence 999999999997 675443322221111100 00010 112345688999999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCch
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||+.||.+|||+.++++|+||....
T Consensus 269 ~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 269 FLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=366.62 Aligned_cols=262 Identities=23% Similarity=0.393 Sum_probs=211.5
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.... .......+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-------- 113 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-------- 113 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--------
Confidence 5799999999999999999999999999999999974321 2223345778999999999999999998773
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
....+|+|||||+ |+|.+++.. ..+++..+..++.||+.||+|||+
T Consensus 114 --------------------------------~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~ 160 (370)
T cd05596 114 --------------------------------DDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHS 160 (370)
T ss_pred --------------------------------cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2457899999996 689988865 458999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC---CCCCc
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW---PKIDE 657 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~~~~ 657 (1239)
+||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||++.+. ..++.
T Consensus 161 ~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 226 (370)
T cd05596 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM--------------VRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (370)
T ss_pred CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc--------------ccCCCCCCCcCeECHHHhccCCCCCCCCC
Confidence 9999999999999999999999999999976432110 011345799999999998753 23789
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC-CCccccCCHHHHHHHHHccCCCCCC--CCCHHHHHhccC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL-PPSWVAKFSEQESLLRRLMSPSPSD--RPSATELLQDAL 731 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~-p~~~~~~~~e~~~LI~~~L~~dP~~--RPta~eiL~~~~ 731 (1239)
++|||||||++|||++ ||...........+....... .+.....+.++.+||++||..+|.+ |+|+.++++|+|
T Consensus 227 ~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred ceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 9999999999999997 887665544444443322221 1233346789999999999999988 999999999999
Q ss_pred CCCchHHH
Q 000880 732 PPQMEYEL 739 (1239)
Q Consensus 732 ~~~~~~~~ 739 (1239)
|.+..+..
T Consensus 307 ~~~~~~~~ 314 (370)
T cd05596 307 FKNDQWTF 314 (370)
T ss_pred cCCCChhh
Confidence 99876653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PRK12305 thrS threonyl-tRNA synthetase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=381.47 Aligned_cols=350 Identities=13% Similarity=0.125 Sum_probs=271.5
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc--CCCccccccEEEEeccCCCeeeecCCCcHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL--GDCPQFKRNTVKLLTHGGDLLELSHELRLP 855 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~--~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~ 855 (1239)
..+.|+++|+|.++.+++.|++.++++|.+|||++|.||+| ++. ++.+...++||+|.|.+|+.++|||+.|++
T Consensus 193 ~~~~G~~~~~p~~~~~~~~l~~~~~~~~~~~Gy~ev~tP~le~~~l~~~sg~~~~~~~~my~~~d~~~~~~~LRP~~~~~ 272 (575)
T PRK12305 193 EIGPGLPVWHPKGAIIRREIEDYLRKEHLKRGYEFVYTPHIGKSDLWKTSGHLDNYKENMFPPMEIDEEEYYLKPMNCPG 272 (575)
T ss_pred ccCCcceEEeccHHHHHHHHHHHHHHHHHHcCCEEEECCccCCHHHHhhcCCcccchhhcccccccCCceEEEecCCCHH
Confidence 34789999999999999999999999999999999999999 332 335577899999999999999999988888
Q ss_pred HHHHHHhCC----CCceeEEeecCeEEcCCCC-----CCCCceeEEeEEEeCCCCcccH--HHHHHHHHHHHHhcCCCCc
Q 000880 856 FIRWAISNQ----KSSFKRYEISSVYRRAIGH-----SPPNRYLQGDFDIIGGASALTE--AEVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 856 iaR~~~~~~----~~P~r~~Y~g~VfR~e~~~-----~~~~ef~Q~GvEiiG~~s~~aD--aEvi~la~~~l~~lgi~~~ 924 (1239)
++|+++++. ..|+|+||+|+|||+|+++ .|.+||+|+|+|+||..++.+| +|+|.++.++++.||+++
T Consensus 273 ~~~~~~~~~~s~~~lP~r~~~~g~~fR~E~~~~~~Gl~R~reF~q~~~~if~~~~~~~~e~~e~i~l~~~~~~~lgl~~- 351 (575)
T PRK12305 273 HILIYKSRLRSYRDLPLRLAEFGTVYRYEKSGVLHGLTRVRGFTQDDAHIFCTPDQIEDEILKVLDFVLELLKDFGFKD- 351 (575)
T ss_pred HHHHHhcccCChhhCCHhhEEecccccCCCCCCCcCcccccCeEEcceEEEeCHHHHHHHHHHHHHHHHHHHHHcCCCe-
Confidence 899988743 3599999999999999875 2556799999999999888888 999999999999999985
Q ss_pred eEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCC
Q 000880 925 CDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGA 1004 (1239)
Q Consensus 925 ~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~ 1004 (1239)
+.+.||++.+ .. .+|..+.|... .+.+..
T Consensus 352 ~~i~l~~r~~-~~---~~g~~~~~~~~---------------------------------------~~~l~~-------- 380 (575)
T PRK12305 352 YYLELSTREP-EK---YVGDDEVWEKA---------------------------------------TEALRE-------- 380 (575)
T ss_pred EEEEEeCCCh-hh---ccCCHHHHHHH---------------------------------------HHHHHH--------
Confidence 9999999755 21 12322211000 000000
Q ss_pred hhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecC-CCCcccccccccc----cc
Q 000880 1005 ADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVK-EKYPATLVEGTLL----AV 1079 (1239)
Q Consensus 1005 ~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~-~~~~~~~~~~~~i----~~ 1079 (1239)
.+...|+. ...+.+ +.+||. ..|++.... .+.. -..+++ ..
T Consensus 381 -------------------------~l~~~g~~--~~~~~~---~~~~y~-~~~~~~~~d~~g~~---~~~~t~~~~~~~ 426 (575)
T PRK12305 381 -------------------------ALEELGLE--YVEDPG---GAAFYG-PKIDVQIKDALGRE---WQMSTIQLDFNL 426 (575)
T ss_pred -------------------------HHHhcCCC--cEecCC---Cccccc-ccEEEEeeccCCCc---eeccceeeeccc
Confidence 11222332 234554 778885 557774432 2321 111223 35
Q ss_pred cccccc-hhhhccccccccccCCCCCCcee---eeeccHHHHHhhCCC---CCcCCCCCCCceEEEEecCCCccHHHHHH
Q 000880 1080 GGRYDY-LLHRMWDREYVGYASRTNPPSGV---GASLALETIIQHYPV---DFKPVRNEAGTSVLVCSRGGGGLLVERME 1152 (1239)
Q Consensus 1080 GGRYD~-L~~~fg~~~~~~~~g~~~~~pAv---Gfaigldrl~~~L~~---~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ 1152 (1239)
|+|||- +... .| +...|++ |++-++|||+.+|.+ +..+.+ .+|.+|+|++.+ ++...+|.+
T Consensus 427 ~~~fdl~y~~~---------~~-~~~~p~~ih~~~~G~~eRl~~~l~e~~~~~~p~~-~~p~~v~Ii~~~-~~~~~~a~~ 494 (575)
T PRK12305 427 PERFDLEYTAE---------DG-KRQRPVMIHRALFGSIERFIGILTEHYAGAFPFW-LAPVQVVIIPVA-DAHNEYAEE 494 (575)
T ss_pred HhhCCCEEECC---------CC-CccCceEEEccccccHHHHHHHHHHHhCCCCCCC-CCCccEEEEEeC-hHHHHHHHH
Confidence 689994 4322 22 2235888 777789999999852 334444 457799999996 677889999
Q ss_pred HHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHh
Q 000880 1153 LVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIAS 1230 (1239)
Q Consensus 1153 ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~ 1230 (1239)
+++.||+.|++|++++. +.++++++++|++.|+|++||+|++|.++|+|+||||.+++|.+++++++++.|++.+++
T Consensus 495 i~~~Lr~~gi~v~~d~~-~~~l~kk~~~A~~~g~p~~iivG~~E~~~~~v~vr~~~~~~q~~v~~~~l~~~l~~~~~~ 571 (575)
T PRK12305 495 VAKKLRAAGIRVEVDTS-NERLNKKIRNAQKQKIPYMLVVGDKEVEAGTVSVRTRDGEQLNGMPLDEFIELIKEKIAE 571 (575)
T ss_pred HHHHHHHCCCEEEEECC-CCCHHHHHHHHHhcCCCEEEEEechhhhCCEEEEEEcCCCceeeeeHHHHHHHHHHHHhc
Confidence 99999999999998876 678999999999999999999999999999999999999999999999999999888775
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=358.63 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=211.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+|++++.||+|+||.||+|+++.+++.||||+++.... .......+..|..++..+ +||+|+++++++..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-------- 72 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-------- 72 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--------
Confidence 68899999999999999999999999999999975432 222334567788888877 58889999887632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+|||||+ |+|.+.+.....+++..++.++.||+.||+|||++
T Consensus 73 --------------------------------~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 120 (323)
T cd05616 73 --------------------------------MDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120 (323)
T ss_pred --------------------------------CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 357899999996 69999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++||
T Consensus 121 ~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 184 (323)
T cd05616 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---------------VTTKTFCGTPDYIAPEIIAY-QPYGKSVDW 184 (323)
T ss_pred CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC---------------CccccCCCChhhcCHHHhcC-CCCCCccch
Confidence 99999999999999999999999999987432110 11234579999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhccCCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDALPP 733 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~~~~~ 733 (1239)
|||||++|||++ ||...........+......+|. ..++++.+++.+||+.||.+|++ ..++++|+||.
T Consensus 185 wSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~ 261 (323)
T cd05616 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261 (323)
T ss_pred hchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence 999999999997 88766655555444443333333 45679999999999999999997 48999999999
Q ss_pred CchHHHH
Q 000880 734 QMEYELL 740 (1239)
Q Consensus 734 ~~~~~~~ 740 (1239)
...+...
T Consensus 262 ~~~~~~~ 268 (323)
T cd05616 262 YIDWEKL 268 (323)
T ss_pred CCCHHHH
Confidence 8876644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=359.80 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=207.4
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||.||+|+++.+++.||||+++.... .......+..|..++..+ +||||++++++|..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~------------- 67 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT------------- 67 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-------------
Confidence 369999999999999999999999999975321 223345677899998876 89999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|...+.....+++..++.++.||+.||.|||++||+||
T Consensus 68 ---------------------------~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 120 (321)
T cd05591 68 ---------------------------KDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120 (321)
T ss_pred ---------------------------CCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 356899999996 5999999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 Dikp~Nill~~~~~~kL~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~ 184 (321)
T cd05591 121 DLKLDNILLDAEGHCKLADFGMCKEGILNG---------------VTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGV 184 (321)
T ss_pred CCCHHHeEECCCCCEEEeecccceecccCC---------------ccccccccCccccCHHHHcC-CCCCCccceechhH
Confidence 999999999999999999999987532111 01234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-------CHHHHHhccCCCCch
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-------SATELLQDALPPQME 736 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-------ta~eiL~~~~~~~~~ 736 (1239)
++|||++ ||...........+.......|. ..++++.++|++||+.||.+|| ++.++++||||....
T Consensus 185 il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 185 LMYEMMAGQPPFEADNEDDLFESILHDDVLYPV---WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 9999997 88766655555444433322332 3457899999999999999999 999999999999887
Q ss_pred HHHH
Q 000880 737 YELL 740 (1239)
Q Consensus 737 ~~~~ 740 (1239)
+..+
T Consensus 262 ~~~~ 265 (321)
T cd05591 262 WVLL 265 (321)
T ss_pred HHHH
Confidence 7644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.88 Aligned_cols=340 Identities=19% Similarity=0.248 Sum_probs=288.6
Q ss_pred chhhccCCCC---CCCCCcccccccccccccCCCcCcccchhhHHHHHHHHHhcccCCCcC--ccHHHHHHHHhhcCCCC
Q 000880 295 SLLQDHGSNN---DGGDTEIDRLESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLT--DALPQIATELYNLGIFS 369 (1239)
Q Consensus 295 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~~lc~~~~~~~--~~~~~~~~~l~~l~~~~ 369 (1239)
++++...+.| .-|.+|+-- +-| -|+ .+|++||+..++++++||++|.+| +|.+.+.+++.+++...
T Consensus 85 kll~~kadvnavnehgntplhy-acf----wgy----dqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~ 155 (448)
T KOG0195|consen 85 KLLSRKADVNAVNEHGNTPLHY-ACF----WGY----DQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKH 155 (448)
T ss_pred HHHHHhcccchhhccCCCchhh-hhh----hcH----HHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHh
Confidence 4555555544 666777221 111 133 479999999999999999999999 89999999999999999
Q ss_pred ccc-cccCCCCcchhhhhhhHHHhhhhccccccCCcCCCCCCCCCCCCCCCCcccCCceEEeeeccCCceEEEEEEEccC
Q 000880 370 ERG-RDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLD 448 (1239)
Q Consensus 370 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~ 448 (1239)
++. ++++++++.|.+ .++++++.+++..++....++.++.+|.....|+.|+|+|+
T Consensus 156 gq~~nripfkdt~wkg---------------------tktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwq-- 212 (448)
T KOG0195|consen 156 GQSPNRIPFKDTTWKG---------------------TKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQ-- 212 (448)
T ss_pred CCCCCccccccccccc---------------------ccccccccccccccCcchhhhhhhhhhccCCCccccccccc--
Confidence 988 789999988876 56778888999999999999999999999999999999998
Q ss_pred CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCccccccccccccccccccc
Q 000880 449 GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTG 528 (1239)
Q Consensus 449 g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~ 528 (1239)
|..+++|+++..+.+.+..++|..|...|+.+.||||++++++|..
T Consensus 213 gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns---------------------------------- 258 (448)
T KOG0195|consen 213 GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS---------------------------------- 258 (448)
T ss_pred CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC----------------------------------
Confidence 7889999999999998899999999999999999999999999843
Q ss_pred ccccccccEEEEEeeccC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcccEEEcCCCCEEE
Q 000880 529 QENKLESTYLYIQMEYCP-RTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQG--IIHRDLTPNNIFFDARNDIKI 603 (1239)
Q Consensus 529 ~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~--l~~~~~~~i~~qI~~gL~yLHs~g--IiHrDLKp~NILl~~~~~vKL 603 (1239)
.+++.++.+||+ |+|+.+++.... ++..++.+++.+|++||+|||+.. |....|++.+++||++.+++|
T Consensus 259 ------ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltari 332 (448)
T KOG0195|consen 259 ------PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARI 332 (448)
T ss_pred ------CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhe
Confidence 467899999998 799999997665 788999999999999999999975 666789999999999998887
Q ss_pred eecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC--CCcchhhHHHHHHHHHhhc---CCchh
Q 000880 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK--IDEKADMYSLGIVFFELWH---PFSTA 678 (1239)
Q Consensus 604 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--~~~ksDIwSlGviL~ELlt---Pf~~~ 678 (1239)
+ +...+++++..+....|.||+||.++..+. .-.++|||||+|++|||.| ||.+.
T Consensus 333 s--------------------mad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl 392 (448)
T KOG0195|consen 333 S--------------------MADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL 392 (448)
T ss_pred e--------------------cccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence 6 111233444566788999999999997554 4578999999999999997 99999
Q ss_pred HHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHH
Q 000880 679 MERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELL 727 (1239)
Q Consensus 679 ~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL 727 (1239)
.+++..+++.. .+..+..+++.++.+..||+-|++.||.+||.++.|+
T Consensus 393 spmecgmkial-eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 393 SPMECGMKIAL-EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred Cchhhhhhhhh-ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999998876 4555556667788999999999999999999998875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=359.23 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=206.7
Q ss_pred CceEEeeeccCCceEEEEEEEc---cCCcEEEEEEEecCCC--CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCcc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNK---LDGRHYAVKKIRLKDK--SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAVK~i~~~~~--~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~ 498 (1239)
+|++++.||+|+||.||+|++. .+|+.||+|++..... .......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 5899999999999999999874 4789999999974321 222345688899999999 5999999998763
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....+|+|||||+ ++|.+++.....+++..++.++.||+.||+|
T Consensus 76 -----------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~ 120 (332)
T cd05614 76 -----------------------------------TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120 (332)
T ss_pred -----------------------------------cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 2456899999996 5999999888889999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++||+||||||+|||++.++.+||+|||+++...... .......+||+.|||||++.+...++.
T Consensus 121 lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 186 (332)
T cd05614 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE--------------KERTYSFCGTIEYMAPEIIRGKGGHGK 186 (332)
T ss_pred HHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC--------------CCccccccCCccccCHHHhcCCCCCCC
Confidence 999999999999999999999999999999997542211 001234579999999999987555889
Q ss_pred chhhHHHHHHHHHhhc---CCchhH----HHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHH
Q 000880 658 KADMYSLGIVFFELWH---PFSTAM----ERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATE 725 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~----~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~e 725 (1239)
++|||||||++|||++ ||.... ............ ++.....++.+.++|.+||+.||++|| ++.+
T Consensus 187 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 263 (332)
T cd05614 187 AVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD---PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263 (332)
T ss_pred ccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 9999999999999997 774321 112222222222 222234567899999999999999999 8899
Q ss_pred HHhccCCCCchHHHH
Q 000880 726 LLQDALPPQMEYELL 740 (1239)
Q Consensus 726 iL~~~~~~~~~~~~~ 740 (1239)
+++|+||....+...
T Consensus 264 ~l~h~~~~~~~~~~~ 278 (332)
T cd05614 264 IKEHPFFKGLDWEAL 278 (332)
T ss_pred HHcCCCcCCCCHHHH
Confidence 999999998765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.70 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=207.7
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
|.-++.||.|+||.||-|++..+.+.||||++.... .+.+..++++.||..|++++|||+|.|.|||..
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr---------- 97 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR---------- 97 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec----------
Confidence 555688999999999999999999999999997655 456677899999999999999999999999854
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....|+|||||-||-.+++.- ..++.+-++..|+.+.+.||+|||+.+.
T Consensus 98 ------------------------------e~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~ 147 (948)
T KOG0577|consen 98 ------------------------------EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNR 147 (948)
T ss_pred ------------------------------cchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhH
Confidence 344689999999888888764 3568899999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCcchhh
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDEKADM 661 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ksDI 661 (1239)
||||||..|||+++.|.|||+|||.|....+ .++++|||.|||||++.. .+.|+-++||
T Consensus 148 IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDv 208 (948)
T KOG0577|consen 148 IHRDIKAGNILLSEPGLVKLADFGSASIMAP-------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDV 208 (948)
T ss_pred HhhhccccceEecCCCeeeeccccchhhcCc-------------------hhcccCCccccchhHheeccccccCCccce
Confidence 9999999999999999999999999986432 367899999999998753 3579999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
|||||+..||.- |+.....+..+..+.. +....-.....+..+++|+..||.+-|.+|||.+++|.|+|...
T Consensus 209 WSLGITCIELAERkPPlFnMNAMSALYHIAQ-NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 209 WSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred eeccchhhhhhhcCCCccCchHHHHHHHHHh-cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 999999999984 6655555555555443 22211112233457899999999999999999999999998643
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=361.97 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=205.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
+.||+|+||.||+|+++.+|+.||+|+++.... .......+.+|+.+++.++||||++++++|..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-------------- 66 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-------------- 66 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--------------
Confidence 369999999999999999999999999975332 22334567889999999999999999987732
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccc
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG-QGIIHR 586 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs-~gIiHr 586 (1239)
...+|+|||||+ ++|..++.....+++..++.++.||+.||+|||+ +||+||
T Consensus 67 --------------------------~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr 120 (325)
T cd05594 67 --------------------------HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120 (325)
T ss_pred --------------------------CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 357899999996 5899988888889999999999999999999997 799999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 184 (325)
T cd05594 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDG---------------ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGV 184 (325)
T ss_pred CCCCCeEEECCCCCEEEecCCCCeecCCCC---------------cccccccCCcccCCHHHHcc-CCCCCccccccccc
Confidence 999999999999999999999987431110 01134579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCCCchHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPPQMEYE 738 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~~~~~~ 738 (1239)
++|||++ ||...........+......+|. ..++++.+||++||+.||.+|+ ++.++++|+||.+..+.
T Consensus 185 il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 185 VMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR---TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred eeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC---CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999997 77655544443333333333333 4567999999999999999997 99999999999987765
Q ss_pred H
Q 000880 739 L 739 (1239)
Q Consensus 739 ~ 739 (1239)
.
T Consensus 262 ~ 262 (325)
T cd05594 262 D 262 (325)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=375.83 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=196.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCC------ceeeeeeeeeecC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ------HVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~Hp------nIv~l~~~~~e~~ 496 (1239)
.++|+++++||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.++|. +|+.++++|..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-- 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-- 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc--
Confidence 368999999999999999999999999999999986322 2234556677777777554 47777766522
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
...++|+||++++++|.+++...+.+++..++.++.||+.||+
T Consensus 203 -------------------------------------~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~ 245 (467)
T PTZ00284 203 -------------------------------------ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALD 245 (467)
T ss_pred -------------------------------------CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH
Confidence 2356899999999999999988888999999999999999999
Q ss_pred HHHh-CCccccCCCcccEEEcCCC----------------CEEEeecCcchhccccccccCCCCCCCCCCccccCccccc
Q 000880 577 HIHG-QGIIHRDLTPNNIFFDARN----------------DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639 (1239)
Q Consensus 577 yLHs-~gIiHrDLKp~NILl~~~~----------------~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 639 (1239)
|||+ .|||||||||+|||++.++ .+||+|||+++.... ..+..+|
T Consensus 246 yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------------------~~~~~~g 307 (467)
T PTZ00284 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------------------SRTAIVS 307 (467)
T ss_pred HHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc------------------ccccccC
Confidence 9998 5999999999999998765 499999998764210 1245689
Q ss_pred CccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccc-----------------
Q 000880 640 TYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWV----------------- 699 (1239)
Q Consensus 640 T~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~----------------- 699 (1239)
|+.|+|||++.+ ..|+.++|||||||++|||++ ||......+....+....+.+|..|.
T Consensus 308 t~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 386 (467)
T PTZ00284 308 TRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQ 386 (467)
T ss_pred CccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccc
Confidence 999999999988 579999999999999999997 77654433322211111111111110
Q ss_pred ----------------------cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 700 ----------------------AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 700 ----------------------~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
...+.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 387 LRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred ccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 012356799999999999999999999999999865
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=345.96 Aligned_cols=251 Identities=26% Similarity=0.463 Sum_probs=210.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
+-|.++.+||+|+||.||+|.|+.+|+.+|||++... ...+++..|+.++.++..|++|+|||.++.+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-------- 100 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-------- 100 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccC--------
Confidence 4578899999999999999999999999999988743 2467899999999999999999999988543
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
..+|||||||+ |+..++++. +.++++.++..+++..+.||+|||..
T Consensus 101 --------------------------------sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~ 148 (502)
T KOG0574|consen 101 --------------------------------SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL 148 (502)
T ss_pred --------------------------------CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH
Confidence 45899999997 899999874 56799999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
.-||||||..|||++.+|++||+|||.|-.+.... ...++..|||.|||||+++. -.|+.++||
T Consensus 149 ~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM---------------AKRNTVIGTPFWMAPEVI~E-IGY~~~ADI 212 (502)
T KOG0574|consen 149 KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM---------------AKRNTVIGTPFWMAPEVIEE-IGYDTKADI 212 (502)
T ss_pred HHHHhhcccccEEEcccchhhhhhccccchhhhhH---------------HhhCccccCcccccHHHHHH-hccchhhhH
Confidence 99999999999999999999999999998764321 22356799999999999987 569999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCcc---ccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSW---VAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~---~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
||||++..||.- |+.+-.++.....+-. ..||.+ ...+.++.++++.||-+.|++|-|+.++++|+|.++.
T Consensus 213 WSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 213 WSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hhhcchhhhhhcCCCCcccccccceeEeccC---CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999999984 7766655544332222 122222 1233478899999999999999999999999999876
Q ss_pred hH
Q 000880 736 EY 737 (1239)
Q Consensus 736 ~~ 737 (1239)
+-
T Consensus 290 ~g 291 (502)
T KOG0574|consen 290 PG 291 (502)
T ss_pred Cc
Confidence 53
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=357.13 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=205.1
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHH---HhcCCCceeeeeeeeeecCccccC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATL---SRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL---~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
|++++.||+|+||.||+|.++.+|+.||||+++.... .......+.+|+.++ +.++||||+++++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~------- 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT------- 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-------
Confidence 6789999999999999999999999999999975432 222345667776655 56689999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|+|||||+ ++|...+.. ..+++..++.++.||+.||+|||+
T Consensus 74 ---------------------------------~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~ 119 (324)
T cd05589 74 ---------------------------------EDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119 (324)
T ss_pred ---------------------------------CCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 357899999996 588777754 579999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+||+||||||+|||++.++.+||+|||+++...... ......+||+.|||||++.+ ..++.++|
T Consensus 120 ~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---------------~~~~~~~g~~~y~aPE~~~~-~~~~~~~D 183 (324)
T cd05589 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---------------DRTSTFCGTPEFLAPEVLTE-TSYTRAVD 183 (324)
T ss_pred CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC---------------CcccccccCccccCHhHhcC-CCCCcccc
Confidence 999999999999999999999999999986421110 11234679999999999987 57899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCC
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALP 732 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~ 732 (1239)
||||||++|||++ ||...................|. ..++++.++|++||+.||.+|| ++.++++|+||
T Consensus 184 iwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR---FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred hhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 9999999999996 78765555544444433333333 3467899999999999999999 79999999999
Q ss_pred CCchHHH
Q 000880 733 PQMEYEL 739 (1239)
Q Consensus 733 ~~~~~~~ 739 (1239)
....+..
T Consensus 261 ~~~~~~~ 267 (324)
T cd05589 261 RDINWDD 267 (324)
T ss_pred CCCCHHH
Confidence 9886543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=364.22 Aligned_cols=261 Identities=24% Similarity=0.401 Sum_probs=209.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.++|++.+.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.++||||++++++|..
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~------- 114 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD------- 114 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-------
Confidence 4689999999999999999999999999999999974322 22234567899999999999999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
..++|+|||||+ |+|.+++... .+++..+..++.||+.||+|||+
T Consensus 115 ---------------------------------~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~ 160 (370)
T cd05621 115 ---------------------------------DKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS 160 (370)
T ss_pred ---------------------------------CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH
Confidence 457899999996 6899988654 58999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC---CCCc
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP---KIDE 657 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~ 657 (1239)
+||+||||||+|||++.++.+||+|||+|....... .......+||+.|||||++.+.. .++.
T Consensus 161 ~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~--------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~ 226 (370)
T cd05621 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG--------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (370)
T ss_pred CCeEecCCCHHHEEECCCCCEEEEecccceecccCC--------------ceecccCCCCcccCCHHHHhccCCCCCCCc
Confidence 999999999999999999999999999998643111 01123457999999999987532 3789
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC-CCccccCCHHHHHHHHHccCCCCCC--CCCHHHHHhccC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL-PPSWVAKFSEQESLLRRLMSPSPSD--RPSATELLQDAL 731 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~-p~~~~~~~~e~~~LI~~~L~~dP~~--RPta~eiL~~~~ 731 (1239)
++|||||||++|||++ ||...........+....... .+.....++.++++|.+||..+|.+ |+|+.++++|||
T Consensus 227 ~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 227 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred ccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 9999999999999996 887665554444444322221 1222345778999999999866544 899999999999
Q ss_pred CCCchHH
Q 000880 732 PPQMEYE 738 (1239)
Q Consensus 732 ~~~~~~~ 738 (1239)
|....+.
T Consensus 307 ~~~~~~~ 313 (370)
T cd05621 307 FKNDQWN 313 (370)
T ss_pred cCCCCcC
Confidence 9886543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=357.07 Aligned_cols=250 Identities=29% Similarity=0.450 Sum_probs=204.4
Q ss_pred eeeccCCceEEEEEEEc---cCCcEEEEEEEecCCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 430 QPLGHGGFGHVVLCKNK---LDGRHYAVKKIRLKDK--SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~---~~g~~vAVK~i~~~~~--~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+.||+|+||.||+|++. .+++.||||+++.... .......+.+|+.+|+.++||||++++++|..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~---------- 71 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT---------- 71 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec----------
Confidence 67999999999999874 4688999999975321 22234567889999999999999999988732
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
...+|+||||++ ++|.+++...+.+.+..+..++.||+.||+|||++||
T Consensus 72 ------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (323)
T cd05584 72 ------------------------------GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121 (323)
T ss_pred ------------------------------CCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 356899999996 5999999888889999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++||||
T Consensus 122 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 185 (323)
T cd05584 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---------------TVTHTFCGTIEYMAPEILMR-SGHGKAVDWWS 185 (323)
T ss_pred ecCCCCHHHeEECCCCCEEEeeCcCCeecccCC---------------CcccccCCCccccChhhccC-CCCCCcceecc
Confidence 999999999999999999999999987431110 01133579999999999987 56899999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCCCc
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPPQM 735 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~~~ 735 (1239)
|||++|||++ ||..................+|+ ..++++.+||++||+.||.+|| ++.++++|+||...
T Consensus 186 lG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 186 LGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred cHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999997 77665554444444433333333 3567899999999999999999 89999999999887
Q ss_pred hHH
Q 000880 736 EYE 738 (1239)
Q Consensus 736 ~~~ 738 (1239)
.+.
T Consensus 263 ~~~ 265 (323)
T cd05584 263 NWD 265 (323)
T ss_pred CHH
Confidence 654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=356.18 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=203.0
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||.||+|++..+++.||||+++.... .......+..|..++..+ +||||+++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~------------- 67 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT------------- 67 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-------------
Confidence 369999999999999999999999999975321 122334566677777654 89999999987632
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~ 120 (316)
T cd05592 68 ---------------------------KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120 (316)
T ss_pred ---------------------------CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 357899999996 6999999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~ 184 (316)
T cd05592 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGE---------------GKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGV 184 (316)
T ss_pred CCCHHHeEECCCCCEEEccCcCCeECCCCC---------------CccccccCCccccCHHHHcC-CCCCCcccchhHHH
Confidence 999999999999999999999997532111 11234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH-HHHHhccCCCCchHHHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA-TELLQDALPPQMEYELL 740 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta-~eiL~~~~~~~~~~~~~ 740 (1239)
++|||++ ||......+...........+| ...+.++.+||.+||+.||.+||++ .++++|+||....+..+
T Consensus 185 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05592 185 LLYEMLIGQSPFHGEDEDELFDSILNDRPHFP---RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERL 259 (316)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHHH
Confidence 9999996 8876655544444333222222 3356789999999999999999986 58889999998876644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=357.79 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=202.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||.||+|+++.+++.||||+++.... .......+.+|..+++.+ +||||++++++|..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~------------- 67 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT------------- 67 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-------------
Confidence 369999999999999999999999999985432 223345688899999998 79999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|..++.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 120 (329)
T cd05588 68 ---------------------------ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120 (329)
T ss_pred ---------------------------CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 357899999996 5899998888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 184 (329)
T cd05588 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---------------DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGV 184 (329)
T ss_pred CCCHHHeEECCCCCEEECcCccccccccCC---------------CccccccCCccccCHHHHcC-CCCCCccceechHH
Confidence 999999999999999999999987421110 01234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchh--------HHHHHHHHhhh-hcCCCCCccccCCHHHHHHHHHccCCCCCCCCC------HHHHHh
Q 000880 667 VFFELWH---PFSTA--------MERQIVLSDLK-QKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS------ATELLQ 728 (1239)
Q Consensus 667 iL~ELlt---Pf~~~--------~~~~~~~~~~~-~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt------a~eiL~ 728 (1239)
++|||++ ||... .........+. ....+| ...++++.++|++||+.||.+||| +.++++
T Consensus 185 ~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 185 LMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 9999996 77421 11111222222 122233 245678999999999999999987 799999
Q ss_pred ccCCCCchHHHH
Q 000880 729 DALPPQMEYELL 740 (1239)
Q Consensus 729 ~~~~~~~~~~~~ 740 (1239)
||||....+...
T Consensus 262 hp~~~~~~~~~~ 273 (329)
T cd05588 262 HPFFRNIDWDLL 273 (329)
T ss_pred CCCCCCCCHHHH
Confidence 999998876644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=355.88 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=203.7
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||.||+|+++.+|+.||||+++.... .......+..|..++..+ +||||+++++++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~------------- 67 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT------------- 67 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-------------
Confidence 369999999999999999999999999975321 122345567788888754 89999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
..++|+|||||+ ++|..++.....+++..+..++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr 120 (316)
T cd05620 68 ---------------------------KEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120 (316)
T ss_pred ---------------------------CCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 457899999996 5999999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv 184 (316)
T cd05620 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGD---------------NRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGV 184 (316)
T ss_pred CCCHHHeEECCCCCEEeCccCCCeecccCC---------------CceeccCCCcCccCHHHHcC-CCCCcccchhhhHH
Confidence 999999999999999999999986421100 01234679999999999987 57899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH-HHHHhccCCCCchHHHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA-TELLQDALPPQMEYELL 740 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta-~eiL~~~~~~~~~~~~~ 740 (1239)
++|||++ ||...................| ...++++.+||.+||..||.+||++ +++++|+||....+...
T Consensus 185 il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~~ 259 (316)
T cd05620 185 LLYEMLIGQSPFHGDDEDELFESIRVDTPHYP---RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTAL 259 (316)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHHH
Confidence 9999996 7876555444333322222222 2356789999999999999999997 58899999999876644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=358.26 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=201.6
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
+++.+...||+|.||+||+|+|- -.||||+++....+.+..+.|.+||.+|++-+|.||+=+.|+|..+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-------- 460 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-------- 460 (678)
T ss_pred HHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--------
Confidence 45667889999999999999997 3799999999888888899999999999999999999999998543
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
.+.||+.+|.| +|+.+++-. ..|+....+.|++||+.||.|||.+
T Consensus 461 ---------------------------------~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK 507 (678)
T KOG0193|consen 461 ---------------------------------PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK 507 (678)
T ss_pred ---------------------------------ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh
Confidence 23899999986 899999744 5699999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCcch
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ks 659 (1239)
+|||||||+.|||+.++++|||+|||++.........++. ....|...|||||++.. ...|++.+
T Consensus 508 ~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~-------------~qp~gsilwmAPEvIRmqd~nPfS~qS 574 (678)
T KOG0193|consen 508 NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL-------------EQPHGSLLWMAPEVIRMQDDNPFSFQS 574 (678)
T ss_pred hhhhhhccccceEEccCCcEEEecccceeeeeeecccccc-------------CCCccchhhhcHHHHhhcccCCCCccc
Confidence 9999999999999999999999999999865433211111 22358889999998753 24589999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--CCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK--GELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
|||||||++|||++ ||......++....-+.. .........+..++++|+..||..++++||.+.+||.
T Consensus 575 DVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 575 DVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred chhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 99999999999998 888444444433222210 1111223344458999999999999999999999986
|
|
| >PRK12444 threonyl-tRNA synthetase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=380.23 Aligned_cols=350 Identities=13% Similarity=0.091 Sum_probs=277.5
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc--CCCccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL--GDCPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~--~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
...|+++|+|.+..+++.|++.+++.+.++||++|.||+| ++. ++.+...++|| +.|.+|+.++|||+.|+++
T Consensus 262 ~~~G~~~~~p~g~~~~~~i~~~~~~~~~~~G~~~v~tP~l~~~~l~~~sG~~~~~~~emy-~~d~~~~~~~LrP~~~~~~ 340 (639)
T PRK12444 262 EAPGMPFYLPKGQIIRNELEAFLREIQKEYNYQEVRTPFMMNQELWERSGHWDHYKDNMY-FSEVDNKSFALKPMNCPGH 340 (639)
T ss_pred ccCcceEEeeCHHHHHHHHHHHHHHHHHHcCCEEEECCccCCHHHHhhcCChhhhhhhcC-eecCCCcEEEEccCCCHHH
Confidence 4689999999999999999999999999999999999999 222 33567789999 8899999999999999999
Q ss_pred HHHHHhCC----CCceeEEeecCeEEcCCCC---C--CCCceeEEeEEEeCCCCcccHHH---HHHHHHHHHHhcCCCCc
Q 000880 857 IRWAISNQ----KSSFKRYEISSVYRRAIGH---S--PPNRYLQGDFDIIGGASALTEAE---VLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 857 aR~~~~~~----~~P~r~~Y~g~VfR~e~~~---~--~~~ef~Q~GvEiiG~~s~~aDaE---vi~la~~~l~~lgi~~~ 924 (1239)
+|++.... ..|+|+||+|+|||+|+++ + |.++|+|.|+|+||..+. +++| ++.++.++++.||+ +
T Consensus 341 ~~~~~~~~~sy~~LP~r~~~~g~~fR~E~~~~~~Gl~R~reF~q~d~~~f~~~~~-~~~e~~~~~~~~~~i~~~lgl-~- 417 (639)
T PRK12444 341 MLMFKNKLHSYRELPIRMCEFGQVHRHEFSGALNGLLRVRTFCQDDAHLFVTPDQ-IEDEIKSVMAQIDYVYKTFGF-E- 417 (639)
T ss_pred HHHHhCcccChhhCCceeEEeccccCCCCCcCCcCcceeeeeEEccEEEECCHHH-HHHHHHHHHHHHHHHHHHcCC-c-
Confidence 99886532 3499999999999999976 3 556799999999998766 6666 99999999999999 3
Q ss_pred eEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCC
Q 000880 925 CDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGA 1004 (1239)
Q Consensus 925 ~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~ 1004 (1239)
+.+.++++. -+.+|-++.|.... ..+..
T Consensus 418 ~~~~~~~r~-----~~~~G~~e~~~~~~---------------------------------------~~l~~-------- 445 (639)
T PRK12444 418 YEVELSTRP-----EDSMGDDELWEQAE---------------------------------------ASLEN-------- 445 (639)
T ss_pred EEEEEECCc-----cccCCCHHHHHHHH---------------------------------------HHHHH--------
Confidence 999998852 12344433321110 00101
Q ss_pred hhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCccccccccccccccccc
Q 000880 1005 ADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYD 1084 (1239)
Q Consensus 1005 ~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD 1084 (1239)
.|...|+ .+.+|++ ||. || |++|++.....+ .+...|+|||||
T Consensus 446 -------------------------~l~~~~~--~y~~~~~--~ga-~Y-~~~~e~~~~~~~------~~~~~~~t~~~d 488 (639)
T PRK12444 446 -------------------------VLQSLNY--KYRLNEG--DGA-FY-GPKIDFHIKDAL------NRSHQCGTIQLD 488 (639)
T ss_pred -------------------------HHHHcCC--CceeccC--Ccc-cc-cceEEEEeecCC------CChhcccceeee
Confidence 2233344 3567877 888 99 999999876532 234799999999
Q ss_pred c-hhhhccccccccccCCCCCCceee---eeccHHHHHhhC-CC--CCcCCCCCCCceEEEEecCCC-ccHHHHHHHHHH
Q 000880 1085 Y-LLHRMWDREYVGYASRTNPPSGVG---ASLALETIIQHY-PV--DFKPVRNEAGTSVLVCSRGGG-GLLVERMELVAE 1156 (1239)
Q Consensus 1085 ~-L~~~fg~~~~~~~~g~~~~~pAvG---faigldrl~~~L-~~--~~~~~~~~~~~~v~v~~~~~~-~~~~~a~~ia~~ 1156 (1239)
. |-++|+-. +....| +...|++| |+.++|||+.+| +. +..|.+ .++.+|+|++.+ + .....|+++++.
T Consensus 489 ~~~~~~f~l~-~~~~~g-~~~~P~i~~~~~~g~ieRli~~L~e~~~~~~p~~-~ap~qV~Ii~~~-~~~~~~~a~~la~~ 564 (639)
T PRK12444 489 FQMPEKFDLN-YIDEKN-EKRRPVVIHRAVLGSLDRFLAILIEHFGGAFPAW-LAPVQVKVIPVS-NAVHVQYADEVADK 564 (639)
T ss_pred cccccccceE-EECCCC-CccccEEEEECCCCCHHHHHHHHHHhcCCCCCCc-cCCceEEEEEcc-cHHHHHHHHHHHHH
Confidence 8 33444321 122222 33579999 788999999887 42 334433 368899999986 5 578999999999
Q ss_pred HHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHh
Q 000880 1157 LWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIAS 1230 (1239)
Q Consensus 1157 Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~ 1230 (1239)
||+.|++|+++.. .+++++++++|++.|++++++||++|.++|+|+||+|.+++|..++++++++.+++.+++
T Consensus 565 LR~~Gi~veid~~-~~sl~kq~k~A~k~g~~~~iiiG~~E~~~~~v~vr~~~t~~q~~i~l~el~~~l~~~~~~ 637 (639)
T PRK12444 565 LAQAGIRVERDER-DEKLGYKIREAQMQKIPYVLVIGDKEMENGAVNVRKYGEEKSEVIELDMFVESIKEEIKN 637 (639)
T ss_pred HHHCCCEEEEECC-CCCHHHHHHHHHHcCCCEEEEEcchhhhcCeEEEEECCCCceeeeeHHHHHHHHHHHhhc
Confidence 9999999998776 679999999999999999999999999999999999999999999999999999887764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=360.04 Aligned_cols=237 Identities=27% Similarity=0.404 Sum_probs=198.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
....++-||.|+-|.||+|+.+ ++.||||+++- .-..+++-|++|+||||+.+.|+|..
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtq---------- 183 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQ---------- 183 (904)
T ss_pred HhhhhhhhccCcccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecC----------
Confidence 3445677999999999999987 89999997652 11246888999999999999999833
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
.+.++||||||. |-|..+|.....++......+..+|+.||.|||.+.|
T Consensus 184 ------------------------------sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKI 233 (904)
T KOG4721|consen 184 ------------------------------SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKI 233 (904)
T ss_pred ------------------------------CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhH
Confidence 467899999996 7999999999999999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
||||||+-||||..+..|||+|||.++...... +..+++||..|||||++.+ ...+.|+||||
T Consensus 234 IHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S----------------TkMSFaGTVaWMAPEvIrn-ePcsEKVDIwS 296 (904)
T KOG4721|consen 234 IHRDLKSPNILISYDDVVKISDFGTSKELSDKS----------------TKMSFAGTVAWMAPEVIRN-EPCSEKVDIWS 296 (904)
T ss_pred hhhccCCCceEeeccceEEeccccchHhhhhhh----------------hhhhhhhhHhhhCHHHhhc-CCcccccceeh
Confidence 999999999999999999999999998764321 2356899999999999998 56899999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhcc
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~ 730 (1239)
|||+||||+| ||.+.....+....-. +....+-...++..++-||+.||+..|..||++.+||.|-
T Consensus 297 fGVVLWEmLT~EiPYkdVdssAIIwGVGs-NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 297 FGVVLWEMLTGEIPYKDVDSSAIIWGVGS-NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred hHHHHHHHHhcCCCccccchheeEEeccC-CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 9999999998 8876655444332211 1122233445666888999999999999999999999983
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=358.19 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=195.5
Q ss_pred CCceEEeeeccCCceEEEEEEEc-----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNK-----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~ 497 (1239)
++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 57899999999999999999863 34578999998743 2333456789999999999 899999999987432
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--------------------
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-------------------- 556 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-------------------- 556 (1239)
...+|++||||+ |+|.+++...
T Consensus 84 -------------------------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 126 (338)
T cd05102 84 -------------------------------------NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRA 126 (338)
T ss_pred -------------------------------------CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhh
Confidence 235799999996 6999888642
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEE
Q 000880 557 ------------------------------------------DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594 (1239)
Q Consensus 557 ------------------------------------------~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NIL 594 (1239)
..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil 206 (338)
T cd05102 127 MVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNIL 206 (338)
T ss_pred hhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEE
Confidence 23778888999999999999999999999999999999
Q ss_pred EcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc-
Q 000880 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH- 673 (1239)
Q Consensus 595 l~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt- 673 (1239)
++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 207 ~~~~~~~kl~DfG~a~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~ 272 (338)
T cd05102 207 LSENNVVKICDFGLARDIYKDPD-------------YVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSL 272 (338)
T ss_pred EcCCCcEEEeecccccccccCcc-------------hhcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhC
Confidence 99999999999999986421110 011123456789999999987 568999999999999999984
Q ss_pred ---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 674 ---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 674 ---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
||............+. .+..+......++++.++|.+||+.||.+|||+.++++
T Consensus 273 g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 273 GASPYPGVQINEEFCQRLK-DGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCCCccHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7765433332222222 22223333456678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=372.25 Aligned_cols=267 Identities=27% Similarity=0.421 Sum_probs=215.8
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|.+.+.||+|+||+||+|++..+|+.||||++.....+......+.+|+.++..++|+||++++..+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~----- 105 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP----- 105 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc-----
Confidence 468999999999999999999999999999999998766655566778999999999999999998877643210
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~y 577 (1239)
........+++||||++ |+|.+++... ..+++..++.++.||+.||.|
T Consensus 106 ---------------------------~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~ 158 (496)
T PTZ00283 106 ---------------------------RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158 (496)
T ss_pred ---------------------------cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 00112345789999996 6999988643 468999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||+++|+||||||+|||++.++.+||+|||+++.+..... .......+||+.|+|||++.+ ..++.
T Consensus 159 lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~-------------~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ 224 (496)
T PTZ00283 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS-------------DDVGRTFCGTPYYVAPEIWRR-KPYSK 224 (496)
T ss_pred HHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecccccc-------------ccccccccCCcceeCHHHhCC-CCCCc
Confidence 9999999999999999999999999999999986532110 001234689999999999987 56899
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
++|||||||++|||++ ||.............. +..++.....++++.++|.+||+.||.+||++.++++|||++.
T Consensus 225 k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 225 KADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA--GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999997 8876555444443332 2233334456789999999999999999999999999998776
Q ss_pred chH
Q 000880 735 MEY 737 (1239)
Q Consensus 735 ~~~ 737 (1239)
...
T Consensus 303 ~~~ 305 (496)
T PTZ00283 303 FIS 305 (496)
T ss_pred hhh
Confidence 543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=355.24 Aligned_cols=264 Identities=24% Similarity=0.417 Sum_probs=211.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||+||+++++.+++.||||++..... .......+.+|+.+++.++||||++++++|.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------- 72 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-------- 72 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--------
Confidence 479999999999999999999999999999999974321 22234568889999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
..++|+|||||+ ++|.+++.. ...+++..++.++.||+.||+|||+
T Consensus 73 --------------------------------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 120 (331)
T cd05597 73 --------------------------------ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120 (331)
T ss_pred --------------------------------CCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457899999995 699999976 4579999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC----CCCCC
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKID 656 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~~ 656 (1239)
+||+||||||+|||++.++.+||+|||++........ ......+||+.|||||++.+ ...++
T Consensus 121 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 186 (331)
T cd05597 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--------------VQSNVAVGTPDYISPEILQAMEDGKGRYG 186 (331)
T ss_pred CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--------------ccccceeccccccCHHHHhhccccccCCC
Confidence 9999999999999999999999999999875422110 01123479999999999863 24578
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--CCCCCccccCCHHHHHHHHHccCCCCCC--CCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK--GELPPSWVAKFSEQESLLRRLMSPSPSD--RPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~e~~~LI~~~L~~dP~~--RPta~eiL~~ 729 (1239)
.++|||||||++|||++ ||......+....+.... ..+++.....+++++++|++||+.++.+ ||++.++++|
T Consensus 187 ~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 89999999999999996 886655444443333222 2344555556789999999998765444 8899999999
Q ss_pred cCCCCchHHHHH
Q 000880 730 ALPPQMEYELLD 741 (1239)
Q Consensus 730 ~~~~~~~~~~~~ 741 (1239)
|||....+....
T Consensus 267 p~~~~~~~~~~~ 278 (331)
T cd05597 267 PFFEGIDWDNIR 278 (331)
T ss_pred CCCCCCCHHHHh
Confidence 999988766543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=358.77 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=206.5
Q ss_pred eeeccCCceEEEEEEEc---cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcC
Q 000880 430 QPLGHGGFGHVVLCKNK---LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
+.||+|+||.||++++. .+|+.||+|+++...........+.+|+.+|++++||||++++++|..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------------ 69 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT------------ 69 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc------------
Confidence 57999999999999873 578999999997543333334567889999999999999999988732
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiH 585 (1239)
...+|+|||||+ ++|.+.+.....+++..++.++.||+.||+|||++||+|
T Consensus 70 ----------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 121 (318)
T cd05582 70 ----------------------------EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121 (318)
T ss_pred ----------------------------CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 357899999996 699999988888999999999999999999999999999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHH
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlG 665 (1239)
|||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++||||||
T Consensus 122 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---------------~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG 185 (318)
T cd05582 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHE---------------KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFG 185 (318)
T ss_pred CCCCHHHeEECCCCcEEEeeccCCcccCCCC---------------CceecccCChhhcCHHHHcC-CCCCCccceeccc
Confidence 9999999999999999999999987542110 01234579999999999987 5689999999999
Q ss_pred HHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhccCCCCchH
Q 000880 666 IVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDALPPQMEY 737 (1239)
Q Consensus 666 viL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~~~~~~~~~ 737 (1239)
|++|||++ ||...........+......+|. ..++++.+||++||+.||.+||+ +.+++.|+||....+
T Consensus 186 ~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 186 VLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ---FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred eEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 99999997 77765555544444433333333 34678999999999999999999 788999999998875
Q ss_pred HH
Q 000880 738 EL 739 (1239)
Q Consensus 738 ~~ 739 (1239)
..
T Consensus 263 ~~ 264 (318)
T cd05582 263 NK 264 (318)
T ss_pred HH
Confidence 53
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=355.26 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=206.5
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||+||+|+++.+++.||||+++.... .......+.+|..+++.+ +||||+++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~------------- 67 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT------------- 67 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-------------
Confidence 369999999999999999999999999975421 223345677899999888 79999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|...+.....+++..+..++.||+.||.|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~ 120 (318)
T cd05570 68 ---------------------------KDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120 (318)
T ss_pred ---------------------------CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEcc
Confidence 357899999996 5899999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGv 184 (318)
T cd05570 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGG---------------VTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGV 184 (318)
T ss_pred CCCHHHeEECCCCcEEecccCCCeecCcCC---------------CcccceecCccccCHHHhcC-CCCCcchhhhhHHH
Confidence 999999999999999999999986421110 01133579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH-----HHHHhccCCCCchHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA-----TELLQDALPPQMEYE 738 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta-----~eiL~~~~~~~~~~~ 738 (1239)
++|+|++ ||...........+.......|. ..++++.+||++||..||.+|||+ .++++|+|+....+.
T Consensus 185 il~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 185 LLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC---cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999996 88665554444443333333332 356789999999999999999999 999999999998765
Q ss_pred HH
Q 000880 739 LL 740 (1239)
Q Consensus 739 ~~ 740 (1239)
..
T Consensus 262 ~~ 263 (318)
T cd05570 262 KL 263 (318)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=356.18 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=202.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||+||+|+++.+++.||+|+++.... .......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~------------- 67 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT------------- 67 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-------------
Confidence 369999999999999999999999999975432 233445678899988877 89999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|..++.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 120 (329)
T cd05618 68 ---------------------------ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120 (329)
T ss_pred ---------------------------CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 357899999996 5898888888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 184 (329)
T cd05618 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------------DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGV 184 (329)
T ss_pred CCCHHHEEECCCCCEEEeeCCccccccCCC---------------CccccccCCccccCHHHHcC-CCCCCccceecccH
Confidence 999999999999999999999987431110 01234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchh--------HHHHHHHHh-hhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC------HHHHHh
Q 000880 667 VFFELWH---PFSTA--------MERQIVLSD-LKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS------ATELLQ 728 (1239)
Q Consensus 667 iL~ELlt---Pf~~~--------~~~~~~~~~-~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt------a~eiL~ 728 (1239)
++|||++ ||... ......... ......+| ...++.+.++|++||+.||.+||+ +.++++
T Consensus 185 il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 185 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred HHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 9999997 77411 111111222 22222233 345678999999999999999998 589999
Q ss_pred ccCCCCchHHHHH
Q 000880 729 DALPPQMEYELLD 741 (1239)
Q Consensus 729 ~~~~~~~~~~~~~ 741 (1239)
||||.+..+....
T Consensus 262 hp~f~~~~~~~~~ 274 (329)
T cd05618 262 HPFFRNVDWDLME 274 (329)
T ss_pred CCCCCCCCHHHHH
Confidence 9999998776543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=354.17 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=210.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+|+..+.||+|+||+||+|+++.+|+.||||+++.... .......+..|..+++.+. ||+|+++++++..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-------- 72 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-------- 72 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--------
Confidence 47888999999999999999999999999999975321 2223456778999998886 5677778776632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+|||||+ ++|.+++.....+++.+++.++.||+.||+|||++
T Consensus 73 --------------------------------~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~ 120 (323)
T cd05615 73 --------------------------------VDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120 (323)
T ss_pred --------------------------------CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 357899999996 69999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++||
T Consensus 121 ~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 184 (323)
T cd05615 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---------------VTTRTFCGTPDYIAPEIIAY-QPYGKSVDW 184 (323)
T ss_pred CeeccCCCHHHeEECCCCCEEEeccccccccCCCC---------------ccccCccCCccccCHHHHcC-CCCCCccch
Confidence 99999999999999999999999999987432110 01234579999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhccCCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDALPP 733 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~~~~~ 733 (1239)
|||||++|||++ ||...........+.......|. ..++++.+++.+||+.||.+|++ ..++++|+||.
T Consensus 185 wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~ 261 (323)
T cd05615 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK---SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR 261 (323)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence 999999999997 88766555555444443333333 35678999999999999999997 57999999999
Q ss_pred CchHHHHH
Q 000880 734 QMEYELLD 741 (1239)
Q Consensus 734 ~~~~~~~~ 741 (1239)
...+....
T Consensus 262 ~~~~~~~~ 269 (323)
T cd05615 262 RIDWDKLE 269 (323)
T ss_pred CCCHHHHh
Confidence 98776443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=344.63 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=202.8
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++++.||.|+||.||+|+++.+|+.||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 70 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ---------- 70 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee----------
Confidence 5889999999999999999999999999999987654443445678899999999999999999998743
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY---DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++++|.+++... ..+++..++.++.||+.||+|||++
T Consensus 71 ------------------------------~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 120 (285)
T cd07861 71 ------------------------------ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120 (285)
T ss_pred ------------------------------CCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3568999999999998888643 4589999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+|||++.++.+||+|||++....... .......+++.|+|||++.+...++.++||
T Consensus 121 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 185 (285)
T cd07861 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDI 185 (285)
T ss_pred CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---------------ccccCCcccccccChHHhcCCCCcCcHHHH
Confidence 99999999999999999999999999997542111 011334678999999998775567899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--------------------------CCCCCccccCCHHHHHHHHHc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQK--------------------------GELPPSWVAKFSEQESLLRRL 712 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--------------------------~~~p~~~~~~~~e~~~LI~~~ 712 (1239)
|||||++|+|++ ||................ ..........++++.++|++|
T Consensus 186 ~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 265 (285)
T cd07861 186 WSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKM 265 (285)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHH
Confidence 999999999997 665433222211111100 000111233567889999999
Q ss_pred cCCCCCCCCCHHHHHhccCC
Q 000880 713 MSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~ 732 (1239)
|+.||.+|||+.+++.|+||
T Consensus 266 l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 266 LIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hcCChhhCCCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=347.39 Aligned_cols=253 Identities=30% Similarity=0.493 Sum_probs=201.1
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||+|+||.||+|+++.+|+.||+|.++...........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---------- 70 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS---------- 70 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc----------
Confidence 4788999999999999999999999999999997654443344568889999999999999999987632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
...+|++|||++++|.+++.. ...+++..++.++.||+.||.|||++||
T Consensus 71 ------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i 120 (284)
T cd07839 71 ------------------------------DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120 (284)
T ss_pred ------------------------------CCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 356899999999999888765 4679999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+||+++.++.+||+|||+++...... .......+++.|+|||++.+...++.++||||
T Consensus 121 ~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 185 (284)
T cd07839 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPV---------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 185 (284)
T ss_pred ecCCCCHHHEEEcCCCcEEECccchhhccCCCC---------------CCcCCCccccCCcChHHHhCCcccCcHHHHHH
Confidence 999999999999999999999999997542211 01123467899999999877556799999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhh------------------cCCCC---------CccccCCHHHHHHHHHcc
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQ------------------KGELP---------PSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~------------------~~~~p---------~~~~~~~~e~~~LI~~~L 713 (1239)
|||++|+|++ ||............+.. ....+ ......++++.++|.+||
T Consensus 186 lG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (284)
T cd07839 186 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLL 265 (284)
T ss_pred HHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHh
Confidence 9999999996 54332222111111100 00000 011234568899999999
Q ss_pred CCCCCCCCCHHHHHhccCC
Q 000880 714 SPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~~~~ 732 (1239)
+.||.+|||+++++.|+||
T Consensus 266 ~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 266 VCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCChhhcCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=361.21 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=209.8
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.++|++.+.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.++||||++++++|..
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~------- 114 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD------- 114 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-------
Confidence 4799999999999999999999999999999999875332 22234567889999999999999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
..++|+|||||+ ++|.+++.. ..+++..+..++.||+.||+|||+
T Consensus 115 ---------------------------------~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~ 160 (371)
T cd05622 115 ---------------------------------DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS 160 (371)
T ss_pred ---------------------------------CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 457899999996 589888865 458999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC---CCCc
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP---KIDE 657 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~ 657 (1239)
+||+||||||+|||++.++++||+|||+++...... .......+||+.|||||++.+.. .++.
T Consensus 161 ~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~ 226 (371)
T cd05622 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (371)
T ss_pred CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC--------------cccccCcccCccccCHHHHhccCCCccCCC
Confidence 999999999999999999999999999998643211 01123467999999999987532 3789
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC-CCccccCCHHHHHHHHHccCCCCCC--CCCHHHHHhccC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL-PPSWVAKFSEQESLLRRLMSPSPSD--RPSATELLQDAL 731 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~-p~~~~~~~~e~~~LI~~~L~~dP~~--RPta~eiL~~~~ 731 (1239)
++|||||||++|||++ ||...........+....... .+.....++.++++|.+||..++.+ |+++.++++|+|
T Consensus 227 ~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred ccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 9999999999999996 887665544444443322222 2233456789999999999854443 789999999999
Q ss_pred CCCchHHH
Q 000880 732 PPQMEYEL 739 (1239)
Q Consensus 732 ~~~~~~~~ 739 (1239)
|.+..+..
T Consensus 307 ~~~~~~~~ 314 (371)
T cd05622 307 FKNDQWAW 314 (371)
T ss_pred cCCCChhH
Confidence 98876544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=353.87 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=203.4
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||+||+|+++.+++.||||+++.... .......+..|..+++.+ +||||+++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~------------- 67 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT------------- 67 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-------------
Confidence 369999999999999999999999999975421 122334567788888764 99999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+||||++ |+|.+++.....+++.++..++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHr 120 (316)
T cd05619 68 ---------------------------KENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120 (316)
T ss_pred ---------------------------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence 356899999996 6999999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~ 184 (316)
T cd05619 121 DLKLDNILLDTDGHIKIADFGMCKENMLGD---------------AKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGV 184 (316)
T ss_pred CCCHHHEEECCCCCEEEccCCcceECCCCC---------------CceeeecCCccccCHHHHcC-CCCCchhhhhhHHH
Confidence 999999999999999999999987421110 01134579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHH-HHHhccCCCCchHHHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSAT-ELLQDALPPQMEYELL 740 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~-eiL~~~~~~~~~~~~~ 740 (1239)
++|||++ ||......+............|. ..+.++.++|.+||+.||.+||++. ++++||||....+..+
T Consensus 185 il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05619 185 LLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR---WLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSAL 259 (316)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---cCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence 9999997 77665554443333222222222 3456899999999999999999996 8999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=356.08 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=202.6
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHH-HHHhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVA-TLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||+||+|+++.+|+.||||++..... .......+.+|.. +++.++||||++++++|..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~------------- 67 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT------------- 67 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-------------
Confidence 369999999999999999999999999975322 1222344555555 5678999999999987732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|..++.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~ 120 (323)
T cd05575 68 ---------------------------ADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120 (323)
T ss_pred ---------------------------CCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 357899999996 5899999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~ 184 (323)
T cd05575 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHS---------------KTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGA 184 (323)
T ss_pred CCCHHHeEECCCCcEEEeccCCCcccccCC---------------CccccccCChhhcChhhhcC-CCCCccccccccch
Confidence 999999999999999999999987431110 11234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH----HHHHhccCCCCchHHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA----TELLQDALPPQMEYEL 739 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta----~eiL~~~~~~~~~~~~ 739 (1239)
++|||++ ||......+....+.......++ ..++.+.++|++||+.||.+||++ .++++|+||....+..
T Consensus 185 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 185 VLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP---NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 9999997 88765554444444433333333 346789999999999999999987 6999999999877643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=354.74 Aligned_cols=264 Identities=23% Similarity=0.386 Sum_probs=212.6
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||.||+++++.+++.||+|++..... .......+.+|+.++..++||||+++++++..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------- 72 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-------- 72 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--------
Confidence 479999999999999999999999999999999864321 22233457889999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|+|||||+ |+|.+++.. ...+++..++.++.||+.||.|||+
T Consensus 73 --------------------------------~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~ 120 (332)
T cd05623 73 --------------------------------ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120 (332)
T ss_pred --------------------------------CCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 457899999996 699999976 4679999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC----CCCCC
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKID 656 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~~ 656 (1239)
+||+||||||+|||++.++.+||+|||++....... .......+||+.|+|||++.+ ...++
T Consensus 121 ~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 186 (332)
T cd05623 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--------------TVQSSVAVGTPDYISPEILQAMEDGKGKYG 186 (332)
T ss_pred CCeEecCCCHHHEEECCCCCEEEeecchheecccCC--------------cceecccccCccccCHHHHhccccCCCCCC
Confidence 999999999999999999999999999987542111 011233579999999999863 24588
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--CCCCCccccCCHHHHHHHHHccCCCCCC--CCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK--GELPPSWVAKFSEQESLLRRLMSPSPSD--RPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~e~~~LI~~~L~~dP~~--RPta~eiL~~ 729 (1239)
.++|||||||++|||++ ||......+....+.... ..+|......++++.+||++||+.+|.+ |+++.++++|
T Consensus 187 ~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 99999999999999996 887665555544443322 2345555567889999999999765554 7899999999
Q ss_pred cCCCCchHHHHH
Q 000880 730 ALPPQMEYELLD 741 (1239)
Q Consensus 730 ~~~~~~~~~~~~ 741 (1239)
+||.+..+..+.
T Consensus 267 ~~f~~~~~~~~~ 278 (332)
T cd05623 267 PFFTGIDWDNIR 278 (332)
T ss_pred CCcCCCCHHHHh
Confidence 999998876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=347.21 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=206.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++|++++.||.|+||.||+|+++.+++.||+|.++..... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-------- 75 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT-------- 75 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--------
Confidence 57899999999999999999999999999999998754322 223467789999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++++|.+++... ..+++..++.++.||+.||+|||++
T Consensus 76 --------------------------------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~ 123 (301)
T cd07873 76 --------------------------------EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123 (301)
T ss_pred --------------------------------CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3568999999999999888754 4689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||++....... .......+++.|+|||++.+...++.++||
T Consensus 124 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 188 (301)
T cd07873 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188 (301)
T ss_pred CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC---------------CcccccceeecccCcHHHhCCCCCccHHHH
Confidence 99999999999999999999999999997532111 011234678999999998775568899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhc-------------------CCCCC--------ccccCCHHHHHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQK-------------------GELPP--------SWVAKFSEQESLLRR 711 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-------------------~~~p~--------~~~~~~~e~~~LI~~ 711 (1239)
|||||++|||++ ||......+......... ...|. .....++.+++||.+
T Consensus 189 ~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 268 (301)
T cd07873 189 WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSK 268 (301)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHH
Confidence 999999999997 665443322221111100 00110 112346688999999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCch
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||+.||.+|||+.++++|+||....
T Consensus 269 ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 269 LLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred HhcCCcccCcCHHHHhcCccccccc
Confidence 9999999999999999999998775
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.58 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=198.1
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCc
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGT 510 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~ 510 (1239)
||+|+||+||+|.++.+|+.||||++...... ......+..|+.+++.++||||+++++++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~---------------- 64 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT---------------- 64 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC----------------
Confidence 79999999999999999999999998754322 1233567889999999999999999887632
Q ss_pred ccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 000880 511 LASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585 (1239)
Q Consensus 511 ~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLHs~gIiH 585 (1239)
...+|+|||||+ ++|.+.+.. ...+++..++.++.||+.||+|||++||+|
T Consensus 65 ------------------------~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 120 (280)
T cd05608 65 ------------------------KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120 (280)
T ss_pred ------------------------CCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 356899999996 588877642 346999999999999999999999999999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHH
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlG 665 (1239)
|||||+|||++.++.+||+|||++..+.... .......||+.|+|||++.+ ..++.++||||||
T Consensus 121 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG 184 (280)
T cd05608 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQ---------------SKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALG 184 (280)
T ss_pred CCCCHHHEEECCCCCEEEeeCccceecCCCC---------------ccccccCCCcCccCHHHhcC-CCCCccccHHHHH
Confidence 9999999999999999999999997543211 01133579999999999987 5789999999999
Q ss_pred HHHHHhhc---CCchhHHH----HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCC
Q 000880 666 IVFFELWH---PFSTAMER----QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPP 733 (1239)
Q Consensus 666 viL~ELlt---Pf~~~~~~----~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~ 733 (1239)
|++|||++ ||...... .......... .......++++.+++.+||+.||.+|| +++++++||||.
T Consensus 185 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~ 261 (280)
T cd05608 185 VTLYEMIAARGPFRARGEKVENKELKQRILNDS---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261 (280)
T ss_pred HHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence 99999996 77643221 1111111111 112234567899999999999999999 889999999999
Q ss_pred CchHHH
Q 000880 734 QMEYEL 739 (1239)
Q Consensus 734 ~~~~~~ 739 (1239)
...+..
T Consensus 262 ~~~~~~ 267 (280)
T cd05608 262 DLNWRQ 267 (280)
T ss_pred cCCHhH
Confidence 877653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=352.91 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=205.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||.|+||.||+|.++.+|..+|+|++.... .......+.+|+.+++.++||||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------- 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--------
Confidence 368999999999999999999999999999999987542 33445678999999999999999999998843
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+|||||+ ++|.+++.....+++..+..++.||+.||.|||++
T Consensus 75 --------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 122 (333)
T cd06650 75 --------------------------------DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122 (333)
T ss_pred --------------------------------CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 356899999996 59999998888899999999999999999999985
Q ss_pred -CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 582 -GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 582 -gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+|+||||||+|||++.++.+||+|||++...... ......||+.|+|||++.+ ..++.++|
T Consensus 123 ~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~D 184 (333)
T cd06650 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----------------MANSFVGTRSYMSPERLQG-THYSVQSD 184 (333)
T ss_pred CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-----------------ccccCCCCccccCHHHhcC-CCCCcHHH
Confidence 7999999999999999999999999999754211 0123479999999999987 56899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHh------------------------------------------hhhcCCCC
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSD------------------------------------------LKQKGELP 695 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~------------------------------------------~~~~~~~p 695 (1239)
||||||++|||++ ||............ .......+
T Consensus 185 vwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (333)
T cd06650 185 IWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPP 264 (333)
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCc
Confidence 9999999999996 66543322211000 00000001
Q ss_pred Ccc-ccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 696 PSW-VAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 696 ~~~-~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
... ...++++++||.+||+.||++|||+.++++|+|++...
T Consensus 265 ~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 265 KLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 100 12346789999999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=350.44 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=188.8
Q ss_pred eeeccCCceEEEEEEEc--cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNK--LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+|+.++||||++++++|...
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~------------ 70 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSH------------ 70 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecC------------
Confidence 68999999999999976 3678999999864322 34578899999999999999999887432
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHH
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY---------DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~---------~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
....+|++|||++++|.+++... ..+++..++.++.||+.||.||
T Consensus 71 --------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 124 (317)
T cd07868 71 --------------------------ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124 (317)
T ss_pred --------------------------CCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence 23568999999999998887532 2489999999999999999999
Q ss_pred HhCCccccCCCcccEEE----cCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC
Q 000880 579 HGQGIIHRDLTPNNIFF----DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl----~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 654 (1239)
|++||+||||||+|||+ +.++.+||+|||+|+........ .......+||+.|+|||++.+...
T Consensus 125 H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~ 192 (317)
T cd07868 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP------------LADLDPVVVTFWYRAPELLLGARH 192 (317)
T ss_pred HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcc------------ccccCCccccccccCCHHHcCCCC
Confidence 99999999999999999 45578999999999865321100 011234679999999999987566
Q ss_pred CCcchhhHHHHHHHHHhhc---CCchhHHH---------HHHHHhhhhcC-----------CCC----------------
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMER---------QIVLSDLKQKG-----------ELP---------------- 695 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt---Pf~~~~~~---------~~~~~~~~~~~-----------~~p---------------- 695 (1239)
++.++||||+||++|||++ ||...... ..........+ ..+
T Consensus 193 ~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (317)
T cd07868 193 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTN 272 (317)
T ss_pred cCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCc
Confidence 8999999999999999997 66421110 00000000000 000
Q ss_pred --------CccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 696 --------PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 696 --------~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
.......+++.+||++||+.||.+|||++++|+||||
T Consensus 273 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 273 CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred ccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0001123467899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=357.99 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=194.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|++++.||+|+||.||+|++..+++.||+|+.... ....|+.+++.++||||++++++|..
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 128 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS--------- 128 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe---------
Confidence 4799999999999999999999999999999975321 23569999999999999999988743
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....|+||||+.++|.+++.. ...+++..++.++.||+.||.|||++|
T Consensus 129 -------------------------------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 177 (357)
T PHA03209 129 -------------------------------GAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177 (357)
T ss_pred -------------------------------CCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346789999999999988865 456999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||
T Consensus 178 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 240 (357)
T PHA03209 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA----------------PAFLGLAGTVETNAPEVLAR-DKYNSKADIW 240 (357)
T ss_pred eecCCCCHHHEEECCCCCEEEecCccccccccC----------------cccccccccccccCCeecCC-CCCCchhhHH
Confidence 999999999999999999999999999753211 01134579999999999987 5689999999
Q ss_pred HHHHHHHHhhc----CCchhH---------HHHHHHHhhhhcCCCCCcc-------------------------------
Q 000880 663 SLGIVFFELWH----PFSTAM---------ERQIVLSDLKQKGELPPSW------------------------------- 698 (1239)
Q Consensus 663 SlGviL~ELlt----Pf~~~~---------~~~~~~~~~~~~~~~p~~~------------------------------- 698 (1239)
||||++|||++ +|.... ........+...+..|..+
T Consensus 241 SlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (357)
T PHA03209 241 SAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQR 320 (357)
T ss_pred HHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhc
Confidence 99999999985 222110 0111111111111111110
Q ss_pred ccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 699 VAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 699 ~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
...+.++.+||.+||+.||.+|||+.++|+||||.++
T Consensus 321 ~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 321 VNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred cCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 1233466789999999999999999999999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=353.70 Aligned_cols=264 Identities=24% Similarity=0.403 Sum_probs=212.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||.||+++++.+++.||+|++..... .......+.+|+.++..++||||+++++++..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-------- 72 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-------- 72 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--------
Confidence 479999999999999999999999999999999874321 22234457889999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
..++|+|||||+ |+|.+++.. ...+++..+..++.||+.||+|||+
T Consensus 73 --------------------------------~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~ 120 (331)
T cd05624 73 --------------------------------ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120 (331)
T ss_pred --------------------------------CCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 457899999996 699999986 4679999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC----CCCC
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW----PKID 656 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~~~ 656 (1239)
+||+||||||+|||++.++.+||+|||+++...... .......+||+.|+|||++.+. ..++
T Consensus 121 ~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 186 (331)
T cd05624 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--------------TVQSSVAVGTPDYISPEILQAMEDGMGKYG 186 (331)
T ss_pred CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC--------------ceeeccccCCcccCCHHHHhccccCCCCCC
Confidence 999999999999999999999999999997643211 0111235799999999998752 3478
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--CCCCCccccCCHHHHHHHHHccCCCCCC--CCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK--GELPPSWVAKFSEQESLLRRLMSPSPSD--RPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~e~~~LI~~~L~~dP~~--RPta~eiL~~ 729 (1239)
.++|||||||+||||++ ||......+....+.... ..+|..+...++++.++|.+||+.++.+ |++++++++|
T Consensus 187 ~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 89999999999999997 887655544444433322 2344555566789999999999976654 5699999999
Q ss_pred cCCCCchHHHHH
Q 000880 730 ALPPQMEYELLD 741 (1239)
Q Consensus 730 ~~~~~~~~~~~~ 741 (1239)
+||....+....
T Consensus 267 ~~f~~~~~~~~~ 278 (331)
T cd05624 267 AFFEGIDWENIR 278 (331)
T ss_pred CCcCCCCHHHHh
Confidence 999998877554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=380.76 Aligned_cols=262 Identities=31% Similarity=0.543 Sum_probs=212.4
Q ss_pred CCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 419 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
....+++|++++.||+|+||+||+|+++.++..||+|++............+.+|+.+|+.|+|||||+++++|...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de--- 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK--- 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---
Confidence 34457899999999999999999999999999999999986655555667899999999999999999999988542
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----CCCCHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----DHFDKELAWHLFRQIVE 573 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----~~l~~~~~~~i~~qI~~ 573 (1239)
....+|||||||+ ++|.++|... ..+++..++.|+.||+.
T Consensus 85 -----------------------------------~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ 129 (1021)
T PTZ00266 85 -----------------------------------ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129 (1021)
T ss_pred -----------------------------------CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHH
Confidence 2356899999996 6999988652 56999999999999999
Q ss_pred HHHHHHhC-------CccccCCCcccEEEcC-----------------CCCEEEeecCcchhccccccccCCCCCCCCCC
Q 000880 574 GLAHIHGQ-------GIIHRDLTPNNIFFDA-----------------RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629 (1239)
Q Consensus 574 gL~yLHs~-------gIiHrDLKp~NILl~~-----------------~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~ 629 (1239)
||.|||+. +||||||||+||||+. .+.+||+|||++..+....
T Consensus 130 ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------------- 196 (1021)
T PTZ00266 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES------------- 196 (1021)
T ss_pred HHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-------------
Confidence 99999984 4999999999999964 2359999999997642111
Q ss_pred ccccCcccccCccCCCcccccCC-CCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHH
Q 000880 630 VSVDGTGQVGTYFYTAPEIEQGW-PKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ 705 (1239)
Q Consensus 630 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~ 705 (1239)
.....+||+.|+|||++.+. ..++.++||||||||||||++ ||.........+..+.....+| ....++++
T Consensus 197 ---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--i~~~S~eL 271 (1021)
T PTZ00266 197 ---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--IKGKSKEL 271 (1021)
T ss_pred ---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--cCCCCHHH
Confidence 11345799999999998642 358899999999999999997 8865554444444443333222 23456789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 706 ESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 706 ~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
.+||..||+.+|.+||++.++|+|+|+....
T Consensus 272 ~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 272 NILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 9999999999999999999999999876553
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=344.13 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=205.7
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.|++.+.||+|+||+||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--------- 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC---------
Confidence 478899999999999999999999999999998754322 1223457889999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|+|||||+ ++|.+++... ..+++..+..++.||+.||.|||+
T Consensus 72 -------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05605 72 -------------------------------KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120 (285)
T ss_pred -------------------------------CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 357899999996 6898877543 459999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+||+||||||+||++++++.++|+|||++....... .....+||+.|+|||++.+ ..++.++|
T Consensus 121 ~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~D 183 (285)
T cd05605 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----------------TIRGRVGTVGYMAPEVVKN-ERYTFSPD 183 (285)
T ss_pred CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----------------ccccccCCCCccCcHHhcC-CCCCcccc
Confidence 999999999999999999999999999987542111 1123479999999999987 56899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHH---HHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhc
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQI---VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQD 729 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~ 729 (1239)
||||||++|||++ ||........ ....+.. ..+......++.+.+||.+||..||.+|| +++++++|
T Consensus 184 iws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred chhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999996 7765433211 1111111 11122234567899999999999999999 99999999
Q ss_pred cCCCCchHHHH
Q 000880 730 ALPPQMEYELL 740 (1239)
Q Consensus 730 ~~~~~~~~~~~ 740 (1239)
+||....+.-.
T Consensus 262 ~~~~~~~~~~~ 272 (285)
T cd05605 262 PFFRTANFKRL 272 (285)
T ss_pred cCccCCCHHHH
Confidence 99998776644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=355.42 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=198.7
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.+++|+.+++||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++||||++++++|..
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 143 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH------- 143 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-------
Confidence 3578999999999999999999999999999999986432 33445678999999999999999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|+|||||.+ +|... ...++..+..++.||+.||+|||+
T Consensus 144 ---------------------------------~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~ 186 (353)
T PLN00034 144 ---------------------------------NGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHR 186 (353)
T ss_pred ---------------------------------CCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH
Confidence 3568999999974 66432 345678888999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC----CCCC
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW----PKID 656 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~~~ 656 (1239)
+||+||||||+|||++.++.+||+|||+++.+.... ......+||+.|+|||++... ...+
T Consensus 187 ~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 251 (353)
T PLN00034 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM---------------DPCNSSVGTIAYMSPERINTDLNHGAYDG 251 (353)
T ss_pred CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc---------------ccccccccCccccCccccccccccCcCCC
Confidence 999999999999999999999999999998643111 011345799999999987531 2345
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHH--HHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAME--RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
.++|||||||++|||++ ||..... ......... ....+......++++.+||.+||+.||++|||+.++++|+|
T Consensus 252 ~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 252 YAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 68999999999999996 7752211 111111111 12223333456678999999999999999999999999999
Q ss_pred CCCc
Q 000880 732 PPQM 735 (1239)
Q Consensus 732 ~~~~ 735 (1239)
+...
T Consensus 331 ~~~~ 334 (353)
T PLN00034 331 ILRA 334 (353)
T ss_pred cccC
Confidence 9875
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=356.11 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=202.4
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc---CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL---QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
||+|+||+||+|+++.+|+.||||++..... .......+..|..++..+ .||||++++++|..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~------------- 67 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT------------- 67 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-------------
Confidence 7999999999999999999999999975322 112234456677777665 69999999987732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|..++.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHr 120 (330)
T cd05586 68 ---------------------------DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120 (330)
T ss_pred ---------------------------CCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 457899999996 5899999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+...++.++|||||||
T Consensus 121 Dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv 185 (330)
T cd05586 121 DLKPENILLDATGHIALCDFGLSKANLTDN---------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185 (330)
T ss_pred cCCHHHeEECCCCCEEEecCCcCcCCCCCC---------------CCccCccCCccccCHHHHcCCCCCCCccceecccc
Confidence 999999999999999999999987532110 01234579999999999976556899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC----CHHHHHhccCCCCchHHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP----SATELLQDALPPQMEYEL 739 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP----ta~eiL~~~~~~~~~~~~ 739 (1239)
++|+|++ ||......+....+......+|.. ..++++.+||++||+.||.+|| ++.++++||||....+..
T Consensus 186 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~ 263 (330)
T cd05586 186 LVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN--VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263 (330)
T ss_pred EEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc--cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence 9999996 776655544443333333333322 3467899999999999999998 799999999999877654
Q ss_pred H
Q 000880 740 L 740 (1239)
Q Consensus 740 ~ 740 (1239)
.
T Consensus 264 ~ 264 (330)
T cd05586 264 L 264 (330)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=351.71 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=203.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||+||+|+++.+++.||+|+++.... .......+.+|+.++.++ +||||+++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------------- 67 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT------------- 67 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-------------
Confidence 369999999999999999999999999975432 223445688999999888 69999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|..++.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHr 120 (327)
T cd05617 68 ---------------------------TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120 (327)
T ss_pred ---------------------------CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 357899999996 5899988888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGv 184 (327)
T cd05617 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPG---------------DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGV 184 (327)
T ss_pred CCCHHHEEEeCCCCEEEeccccceeccCCC---------------CceecccCCcccCCHHHHCC-CCCCchheeehhHH
Confidence 999999999999999999999987421110 01134579999999999987 57899999999999
Q ss_pred HHHHhhc---CCchh------HHHHHHHHhhhhc-CCCCCccccCCHHHHHHHHHccCCCCCCCCC------HHHHHhcc
Q 000880 667 VFFELWH---PFSTA------MERQIVLSDLKQK-GELPPSWVAKFSEQESLLRRLMSPSPSDRPS------ATELLQDA 730 (1239)
Q Consensus 667 iL~ELlt---Pf~~~------~~~~~~~~~~~~~-~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt------a~eiL~~~ 730 (1239)
++|||++ ||... ............. ..+| ...++.+.++|++||+.||.+|++ +.++++|+
T Consensus 185 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 185 LMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP---RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred HHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 9999997 77421 1122222222222 2223 234578999999999999999997 57999999
Q ss_pred CCCCchHHHHH
Q 000880 731 LPPQMEYELLD 741 (1239)
Q Consensus 731 ~~~~~~~~~~~ 741 (1239)
||....++.+.
T Consensus 262 ~f~~~~~~~~~ 272 (327)
T cd05617 262 FFRSIDWDLLE 272 (327)
T ss_pred CCCCCCHHHHH
Confidence 99999877553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=339.20 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=223.9
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~ 497 (1239)
.....||..+.+||+|+||+|.+|..+.+.+.||||++++.-. .....+--+.|-++|+.. +-|.+++++.||
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF----- 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF----- 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----
Confidence 4456899999999999999999999999999999999875421 122233445677777776 567888888776
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
+....+|+||||+. |+|...+++.+++.++.|..|+.+|+-||-
T Consensus 420 -----------------------------------QTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLF 464 (683)
T KOG0696|consen 420 -----------------------------------QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLF 464 (683)
T ss_pred -----------------------------------hhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhh
Confidence 23578999999995 699999999999999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++|||+||||..|||++.+|++||+|||+++..-.. ..++.++||||.|+|||++.. ..|+
T Consensus 465 FLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~---------------~~TTkTFCGTPdYiAPEIi~Y-qPYg 528 (683)
T KOG0696|consen 465 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD---------------GVTTKTFCGTPDYIAPEIIAY-QPYG 528 (683)
T ss_pred hhhcCCeeeeeccccceEeccCCceEeeecccccccccC---------------CcceeeecCCCcccccceEEe-cccc
Confidence 999999999999999999999999999999999842111 123467899999999999886 6799
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQ 728 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~ 728 (1239)
.++|||||||+||||+. ||.+..+.+....+...+..+|.+++ .++.++.+.+|.+.|.+|.. -.+|-.
T Consensus 529 ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslS---kEAv~ickg~ltK~P~kRLGcg~~ge~di~~ 605 (683)
T KOG0696|consen 529 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLS---KEAVAICKGLLTKHPGKRLGCGPEGERDIRE 605 (683)
T ss_pred cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccccc---HHHHHHHHHHhhcCCccccCCCCccccchhh
Confidence 99999999999999995 99999999988888887877887654 49999999999999999974 467899
Q ss_pred ccCCCCchHHHHHH
Q 000880 729 DALPPQMEYELLDN 742 (1239)
Q Consensus 729 ~~~~~~~~~~~~~~ 742 (1239)
||||....|+-++.
T Consensus 606 H~FFR~iDWek~E~ 619 (683)
T KOG0696|consen 606 HPFFRRIDWEKLER 619 (683)
T ss_pred CcchhhccHHHHhh
Confidence 99999999886544
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=353.57 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=202.9
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHH-HHHhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVA-TLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||+||+|+++.+|+.||||++..... .......+.+|.. +++.++||||++++++|..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~------------- 67 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT------------- 67 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-------------
Confidence 369999999999999999999999999975422 2223345566655 4677899999999987732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|...+.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~ 120 (325)
T cd05604 68 ---------------------------TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120 (325)
T ss_pred ---------------------------CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 357899999996 5899998888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~ 184 (325)
T cd05604 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQS---------------DTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGA 184 (325)
T ss_pred CCCHHHeEECCCCCEEEeecCCcccCCCCC---------------CCcccccCChhhCCHHHHcC-CCCCCcCccccccc
Confidence 999999999999999999999987421110 01234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH----HHHHhccCCCCchHHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA----TELLQDALPPQMEYEL 739 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta----~eiL~~~~~~~~~~~~ 739 (1239)
++|||++ ||......+............++ ..+..+.++|++||..||.+||++ .++++|+||....+..
T Consensus 185 il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~ 261 (325)
T cd05604 185 VLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP---GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTD 261 (325)
T ss_pred eehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC---CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999996 77765555444444332222222 456789999999999999999976 6999999999887654
Q ss_pred H
Q 000880 740 L 740 (1239)
Q Consensus 740 ~ 740 (1239)
.
T Consensus 262 ~ 262 (325)
T cd05604 262 L 262 (325)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=357.29 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=209.3
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCc
Q 000880 431 PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGT 510 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~ 510 (1239)
+||+|.||+||.|++..|...+|||-|..+ ..+..+-+..|+.+.+.|+|.|||+|+|+|-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se---------------- 643 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE---------------- 643 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCC----------------
Confidence 699999999999999999999999988643 33456678899999999999999999998732
Q ss_pred ccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 511 LASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHF--DKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 511 ~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l--~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
..++-|.||-++ |+|..+|+. -+++ .+...-+|.+||++||.|||++.||||
T Consensus 644 ------------------------nGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHR 699 (1226)
T KOG4279|consen 644 ------------------------NGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHR 699 (1226)
T ss_pred ------------------------CCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeec
Confidence 347789999996 599999975 4666 788889999999999999999999999
Q ss_pred CCCcccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc-CCCCCCcchhhHHH
Q 000880 587 DLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ-GWPKIDEKADMYSL 664 (1239)
Q Consensus 587 DLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~ksDIwSl 664 (1239)
|||-.||||+. .|.+||+|||.++++. +....+.++.||..|||||++. |...|+.++|||||
T Consensus 700 DIKGDNVLvNTySGvlKISDFGTsKRLA---------------ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~ 764 (1226)
T KOG4279|consen 700 DIKGDNVLVNTYSGVLKISDFGTSKRLA---------------GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSF 764 (1226)
T ss_pred cccCCcEEEeeccceEEecccccchhhc---------------cCCccccccccchhhhChHhhccCCcCCCchhhhhhc
Confidence 99999999975 6899999999999763 2223346689999999999885 44569999999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
||++.||.| ||......+..+-.+..-...|+.+...+.+++.+|.+|+.+||.+||+|.++|++||.+-.
T Consensus 765 GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 765 GCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999998 78766555555444433444667767777899999999999999999999999999987655
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.37 Aligned_cols=255 Identities=28% Similarity=0.472 Sum_probs=207.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS---LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD------ 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc------
Confidence 4688899999999999999999999999999998754322 2234568899999999999999999988732
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...+|++|||++ ++|.+++.....+++..++.++.|++.||.|||
T Consensus 76 ----------------------------------~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 121 (263)
T cd06625 76 ----------------------------------DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121 (263)
T ss_pred ----------------------------------CCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347899999996 589999988888999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+.|++||||||+||+++.++.++|+|||+++........ ........|++.|+|||++.+ ..++.++
T Consensus 122 ~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 188 (263)
T cd06625 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS------------GTGMKSVTGTPYWMSPEVISG-EGYGRKA 188 (263)
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc------------cccccCCCcCccccCcceecc-CCCCchh
Confidence 999999999999999999999999999998754321100 000123468899999999988 5689999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|||||||++|||++ ||.............. ....+......++.+.++|++||..+|.+|||+.++++|+||
T Consensus 189 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 189 DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred hhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999997 7765544443333322 222233334556789999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.54 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=214.8
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-VNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.+.|+..++||+||||.||-|+.+.||+.||+|++.++....+ -....++|-.+|.+++.|.||.+-.+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--------- 254 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--------- 254 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee---------
Confidence 4678889999999999999999999999999998865443222 234578899999999999999988776
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yL 578 (1239)
.....+++||..|+ |+|.-+|-+.+ .|+++.+++|+.+|+.||++|
T Consensus 255 -------------------------------eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl 303 (591)
T KOG0986|consen 255 -------------------------------ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL 303 (591)
T ss_pred -------------------------------cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH
Confidence 23577999999996 68988886655 699999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|..+||+|||||+|||+|+.|||+|+|.|+|..+.... ..++.+||.+|||||++++ ..|+..
T Consensus 304 H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~----------------~~~~rvGT~GYMAPEvl~n-e~Y~~s 366 (591)
T KOG0986|consen 304 HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK----------------PIRGRVGTVGYMAPEVLQN-EVYDFS 366 (591)
T ss_pred HhcceeeccCChhheeeccCCCeEeeccceEEecCCCC----------------ccccccCcccccCHHHHcC-CcccCC
Confidence 99999999999999999999999999999999764332 1355699999999999998 569999
Q ss_pred hhhHHHHHHHHHhhc---CCchhHHH----HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHH
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMER----QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATEL 726 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~----~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~ei 726 (1239)
+|+|||||+||||+. ||....+. ++-...+.....++. ..++++++|.+.+|++||.+|. ++.++
T Consensus 367 ~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~---kFS~eakslc~~LL~Kdp~~RLGcrg~ga~ev 443 (591)
T KOG0986|consen 367 PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD---KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEV 443 (591)
T ss_pred ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc---ccCHHHHHHHHHHHccCHHHhccCCCcCcchh
Confidence 999999999999994 88755432 333333333333443 4457999999999999999997 57899
Q ss_pred HhccCCCCchHHHHH
Q 000880 727 LQDALPPQMEYELLD 741 (1239)
Q Consensus 727 L~~~~~~~~~~~~~~ 741 (1239)
.+||||+.+.|.-+.
T Consensus 444 k~HpfFk~lnw~rle 458 (591)
T KOG0986|consen 444 KEHPFFKDLNWRRLE 458 (591)
T ss_pred hhCcccccCCHhHHh
Confidence 999999999876543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=351.04 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=200.3
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHH-HHHhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVA-TLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||.||+|+++.+|+.||+|++..... .......+.+|.. +++.++||||+++++++..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~------------- 67 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT------------- 67 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-------------
Confidence 369999999999999999999999999975322 1222344555654 6788999999999987632
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|...+.....+++..++.++.||+.||.|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~ 120 (321)
T cd05603 68 ---------------------------AEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120 (321)
T ss_pred ---------------------------CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 357899999996 5898888887889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 184 (321)
T cd05603 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPE---------------ETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGA 184 (321)
T ss_pred cCCHHHeEECCCCCEEEccCCCCccCCCCC---------------CccccccCCcccCCHHHhcC-CCCCCcCcccccch
Confidence 999999999999999999999987421110 01234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH----HHHHhccCCCCchHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA----TELLQDALPPQMEYE 738 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta----~eiL~~~~~~~~~~~ 738 (1239)
++|||++ ||..................+| ...+..+.++|.+||+.||.+||++ .++++|+|+....+.
T Consensus 185 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 185 VLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP---GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC---CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 9999997 7766554444433333222233 2455689999999999999999875 599999999887655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=351.65 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=201.0
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHH-HHHhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVA-TLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~-iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||+||+|+++.+++.||+|++..... .......+.+|.. +++.++||||+++++++..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~------------- 67 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT------------- 67 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-------------
Confidence 369999999999999999999999999975322 1122234455544 5678899999999987732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|+|||||+ ++|.+++.....+++..++.++.||+.||+|||++||+||
T Consensus 68 ---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHr 120 (325)
T cd05602 68 ---------------------------ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120 (325)
T ss_pred ---------------------------CCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 356899999996 5899999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+ ..++.++|||||||
T Consensus 121 Dlkp~Nili~~~~~~kl~DfG~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 184 (325)
T cd05602 121 DLKPENILLDSQGHIVLTDFGLCKENIEHN---------------GTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGA 184 (325)
T ss_pred CCCHHHeEECCCCCEEEccCCCCcccccCC---------------CCcccccCCccccCHHHHcC-CCCCCccccccccH
Confidence 999999999999999999999987532110 01234579999999999987 56899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHH----HHHhccCCCCchHHH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSAT----ELLQDALPPQMEYEL 739 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~----eiL~~~~~~~~~~~~ 739 (1239)
++|||++ ||......+............+ ...++.+.++|.+||+.||.+||++. ++++|+|+....+.-
T Consensus 185 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 185 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 9999997 7776555444443333222222 34567899999999999999999865 899999998877653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.86 Aligned_cols=252 Identities=35% Similarity=0.561 Sum_probs=203.4
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
|++++.||+|+||+||+|++..+++.||+|++..............+|+.+++.++||||+++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------- 69 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD----------- 69 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----------
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----------
Confidence 788999999999999999999999999999998765444444455679999999999999999988732
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
...++++||||++ +|.+++.....+++..++.++.||+.||+|||++||+
T Consensus 70 -----------------------------~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~ 120 (260)
T PF00069_consen 70 -----------------------------DNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIV 120 (260)
T ss_dssp -----------------------------SSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -----------------------------ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4678899999987 9999999888899999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
||||||+|||++.++.++|+|||.+...... ........+|+.|+|||++.....++.++|||||
T Consensus 121 H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 185 (260)
T PF00069_consen 121 HRDIKPENILLDENGEVKLIDFGSSVKLSEN---------------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSL 185 (260)
T ss_dssp ESSBSGGGEEESTTSEEEESSGTTTEESTST---------------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccc---------------cccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999998753110 0112445789999999999833678999999999
Q ss_pred HHHHHHhhc---CCchh---HHHHHHHHhhhhcCCC-CCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 665 GIVFFELWH---PFSTA---MERQIVLSDLKQKGEL-PPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~---~~~~~~~~~~~~~~~~-p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|+++|+|++ ||... ................ ........+++.++|.+||+.||++|||+.++++||||
T Consensus 186 G~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 186 GIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999997 77655 2222222221111000 01111112689999999999999999999999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.25 Aligned_cols=251 Identities=28% Similarity=0.519 Sum_probs=206.0
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||+|+||.||++.++.+++.||+|.+............+.+|+.+++.++||||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------- 70 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG---------- 70 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----------
Confidence 4889999999999999999999999999999997655554556678899999999999999999876521
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....+|++||||+ ++|.+++... ..+++.+++.++.|++.||+|||++
T Consensus 71 -----------------------------~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~ 121 (257)
T cd08223 71 -----------------------------EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121 (257)
T ss_pred -----------------------------CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1346899999997 5899888753 4589999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+||+++.++.++|+|||++....... .......|++.|+|||++.+ ..++.++|+
T Consensus 122 ~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 185 (257)
T cd08223 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---------------DMASTLIGTPYYMSPELFSN-KPYNYKSDV 185 (257)
T ss_pred CeeccCCCchhEEEecCCcEEEecccceEEecccC---------------CccccccCCcCccChhHhcC-CCCCchhhh
Confidence 99999999999999999999999999997653211 01133568999999999887 568899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|||||++|+|++ ||............. .+..++.....++++.++|.+||+.||.+|||+.++++|||+
T Consensus 186 ~slG~il~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 186 WALGCCVYEMATLKHAFNAKDMNSLVYRII--EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999997 665444333332222 223333334566789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=339.93 Aligned_cols=271 Identities=23% Similarity=0.381 Sum_probs=207.3
Q ss_pred CCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 419 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
-...+++|++.+.||+|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++++.+......
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 34456889999999999999999999999999999999875543333344567899999999999999999987543110
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~y 577 (1239)
........|+||||++++|.+.+.... .+++..++.++.||+.||+|
T Consensus 87 --------------------------------~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~ 134 (310)
T cd07865 87 --------------------------------YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134 (310)
T ss_pred --------------------------------ccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 012245789999999999988887553 68999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++|++|+||||+||+++.++.+||+|||++.......... ........++..|+|||++.+...++.
T Consensus 135 lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (310)
T cd07865 135 IHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK-----------PNRYTNRVVTLWYRPPELLLGERDYGP 203 (310)
T ss_pred HHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccC-----------CCCccCcccCccccCcHHhcCCcccCc
Confidence 999999999999999999999999999999998653221110 011234568899999999877555789
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCc-----------------------------cccCCHHH
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPS-----------------------------WVAKFSEQ 705 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~-----------------------------~~~~~~e~ 705 (1239)
++||||||+++|||++ ||................+..++. .....+.+
T Consensus 204 ~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 283 (310)
T cd07865 204 PIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHA 283 (310)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHH
Confidence 9999999999999996 555443322211111111111110 00123567
Q ss_pred HHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 706 ESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 706 ~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
.+||.+||..||.+|||++++++|+||
T Consensus 284 ~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 284 LDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.99 Aligned_cols=250 Identities=31% Similarity=0.581 Sum_probs=208.7
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||+|+||.||+|.++.+|+.||+|.+............+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 70 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD---------- 70 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc----------
Confidence 5888999999999999999999999999999998665555566789999999999999999999988732
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++|||++ ++|.+++... ..+++..++.++.||+.||.|||++
T Consensus 71 ------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~ 120 (256)
T cd08529 71 ------------------------------KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120 (256)
T ss_pred ------------------------------CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 357899999996 5999998764 5689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+||+++.++.++|+|||+++....... ......|++.|+|||++.+ ..++.++|+
T Consensus 121 ~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 184 (256)
T cd08529 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---------------FANTIVGTPYYLSPELCED-KPYNEKSDV 184 (256)
T ss_pred CcccCCCCcceEEEeCCCCEEEcccccceeccCccc---------------hhhccccCccccCHHHhcC-CCCCCccch
Confidence 999999999999999999999999999886532110 1133468899999999987 568899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|||||++|+|++ ||.............. ...++.....++++.++|.+||+.+|++||++.++++|+|.
T Consensus 185 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 185 WALGVVLYECCTGKHPFDANNQGALILKIIR--GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999996 7766554444433332 33333333566789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=363.86 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=207.1
Q ss_pred CCceEEeeeccCCceEEEEEEEccC-CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLD-GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~-g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+|+.++|||||+++++|..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-------- 136 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKS-------- 136 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--------
Confidence 4599999999999999999999877 788999977533 23344567889999999999999999998743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
...+|||||||+ |+|.+++.. ...+++..+..++.||+.||.|
T Consensus 137 --------------------------------~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 184 (478)
T PTZ00267 137 --------------------------------DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDE 184 (478)
T ss_pred --------------------------------CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999996 699887753 3468999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++||+||||||+|||++.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.
T Consensus 185 lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ 250 (478)
T PTZ00267 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-------------LDVASSFCGTPYYLAPELWER-KRYSK 250 (478)
T ss_pred HHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc-------------cccccccCCCccccCHhHhCC-CCCCc
Confidence 9999999999999999999999999999999986532110 001234679999999999987 57899
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
++|||||||++|||++ ||......+....... +..++.....++++.++|.+||..||++||++.+++.|+|+..
T Consensus 251 ~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 251 KADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY--GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999997 8876555554444333 2233333456678999999999999999999999999988765
Q ss_pred c
Q 000880 735 M 735 (1239)
Q Consensus 735 ~ 735 (1239)
.
T Consensus 329 ~ 329 (478)
T PTZ00267 329 V 329 (478)
T ss_pred H
Confidence 4
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=341.92 Aligned_cols=263 Identities=27% Similarity=0.423 Sum_probs=208.8
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+..++|++.+.||.|+||.||+|.++.+|+.||+|+++...........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 78 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK----- 78 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC-----
Confidence 346899999999999999999999999999999999976544333334567899999999999999999887432
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....+|+||||++++|.+++... ..+++..++.++.||+.||+|||
T Consensus 79 ---------------------------------~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH 125 (309)
T cd07845 79 ---------------------------------HLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125 (309)
T ss_pred ---------------------------------CCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 12467999999999998888753 56999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++||||||+||+++.++.+||+|||++....... ...+...+++.|+|||++.+...++.++
T Consensus 126 ~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 190 (309)
T cd07845 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA---------------KPMTPKVVTLWYRAPELLLGCTTYTTAI 190 (309)
T ss_pred hCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc---------------CCCCcccccccccChhhhcCCCCcCchH
Confidence 9999999999999999999999999999998653211 0112335688999999987656689999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcC-------------------CCCC--------ccccCCHHHHHHH
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKG-------------------ELPP--------SWVAKFSEQESLL 709 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~-------------------~~p~--------~~~~~~~e~~~LI 709 (1239)
|||||||++|||++ ||................+ ..+. .+...++++.++|
T Consensus 191 DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 270 (309)
T cd07845 191 DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLL 270 (309)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHH
Confidence 99999999999997 6655444433322221100 0000 0112356789999
Q ss_pred HHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 710 RRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 710 ~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
.+||+.||.+|||+.++++|+||....
T Consensus 271 ~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 271 NFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred HHHhcCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.38 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=201.6
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|+.++.||.|+||.||+|+++.+|+.||||+++...........+.+|+.++++++||||+++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---------- 70 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT---------- 70 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc----------
Confidence 4889999999999999999999999999999987654444444678899999999999999999987632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES--YDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|++|||++++|..++.. ...+++..++.++.||+.||+|||+++
T Consensus 71 ------------------------------~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 120 (284)
T cd07860 71 ------------------------------ENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120 (284)
T ss_pred ------------------------------CCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356799999998899888865 346899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++||||+|+||+++.++.+||+|||++....... .......+++.|+|||++.+...++.++|||
T Consensus 121 i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 185 (284)
T cd07860 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 185 (284)
T ss_pred eecCCCCHHHEEECCCCCEEEeeccchhhcccCc---------------cccccccccccccCCeEEecCCCCCcHHHHH
Confidence 9999999999999999999999999987543211 0112345789999999987755578899999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC------------------CC--------CccccCCHHHHHHHHHcc
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGE------------------LP--------PSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~------------------~p--------~~~~~~~~e~~~LI~~~L 713 (1239)
||||++|||+| ||....+...........+. ++ ......++++.++|.+||
T Consensus 186 slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (284)
T cd07860 186 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQML 265 (284)
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhc
Confidence 99999999997 66544332222221111000 00 011234567889999999
Q ss_pred CCCCCCCCCHHHHHhccCC
Q 000880 714 SPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~~~~ 732 (1239)
+.||.+|||+.++++||||
T Consensus 266 ~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 266 HYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=336.35 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=201.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||+|+||.||+|+++.+|+.||+|++............+.+|+.+++.++||||++++++|..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------- 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--------- 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee---------
Confidence 46899999999999999999999999999999987544333344568899999999999999999988733
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...++++|||+++ .|..++.....+++..++.++.||+.||+|||++|
T Consensus 72 -------------------------------~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~ 120 (286)
T cd07847 72 -------------------------------KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120 (286)
T ss_pred -------------------------------CCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3568999999986 55556556667999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++||||||+||+++.++.+||+|||++........ ......++..|+|||++.+...++.++|||
T Consensus 121 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 185 (286)
T cd07847 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---------------DYTDYVATRWYRAPELLVGDTQYGPPVDVW 185 (286)
T ss_pred ceecCCChhhEEEcCCCcEEECccccceecCCCcc---------------cccCcccccccCCHHHHhCCCCcCchhhhH
Confidence 99999999999999999999999999986532110 112346788999999987655688999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcC-------------------CCCC---------ccccCCHHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKG-------------------ELPP---------SWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~-------------------~~p~---------~~~~~~~e~~~LI~~ 711 (1239)
||||++|+|++ ||......+.......... ..|. .+...+..+.+||.+
T Consensus 186 slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 265 (286)
T cd07847 186 AIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKG 265 (286)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHH
Confidence 99999999997 6654443332221111000 0111 122345678999999
Q ss_pred ccCCCCCCCCCHHHHHhccCC
Q 000880 712 LMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~ 732 (1239)
||+.||++|||+.+++.|+||
T Consensus 266 ~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 266 CLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HhcCCccccCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=354.16 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=202.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEc--cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNK--LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++|||||+++++|..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~------ 157 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW------ 157 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee------
Confidence 457999999999999999999864 34678999987532 235689999999999999999987732
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|++||++.++|.+++.....+++..++.++.||+.||.|||+
T Consensus 158 ----------------------------------~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~ 203 (392)
T PHA03207 158 ----------------------------------KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG 203 (392)
T ss_pred ----------------------------------CCEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3568999999999999999777889999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+||+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..|+.++|
T Consensus 204 ~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 269 (392)
T PHA03207 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD-------------TPQCYGWSGTLETNSPELLAL-DPYCAKTD 269 (392)
T ss_pred CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc-------------cccccccccccCccCHhHhcC-CCCCchhh
Confidence 9999999999999999999999999999976432110 111234579999999999987 56899999
Q ss_pred hHHHHHHHHHhhc---CCchhHH---HHHHHHhhhhc------------------------CC-----CCCcc--ccCCH
Q 000880 661 MYSLGIVFFELWH---PFSTAME---RQIVLSDLKQK------------------------GE-----LPPSW--VAKFS 703 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~---~~~~~~~~~~~------------------------~~-----~p~~~--~~~~~ 703 (1239)
||||||++|||++ ||..... ......++... .. .|..+ .....
T Consensus 270 vwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (392)
T PHA03207 270 IWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHM 349 (392)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcch
Confidence 9999999999986 6653221 11111110000 00 01000 12245
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHhccCCCCchHHHH
Q 000880 704 EQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELL 740 (1239)
Q Consensus 704 e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~~~~~ 740 (1239)
+++++|++||..||.+|||+.++|.||||...+.+.+
T Consensus 350 ~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~ 386 (392)
T PHA03207 350 DVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL 386 (392)
T ss_pred hHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence 7889999999999999999999999999988776654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.28 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=196.2
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCc
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGT 510 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~ 510 (1239)
||+|+||.||+++++.+|+.||+|++...... ......+..|+.+++.++||||+++++++.
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~----------------- 63 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE----------------- 63 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----------------
Confidence 79999999999999999999999998643322 112344667999999999999999988762
Q ss_pred ccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 511 LASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 511 ~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
....+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+|||
T Consensus 64 -----------------------~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~d 120 (277)
T cd05607 64 -----------------------SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120 (277)
T ss_pred -----------------------cCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEcc
Confidence 2357899999996 58988875433 588999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|||+|||++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 121 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~ 183 (277)
T cd05607 121 MKPENVLLDDQGNCRLSDLGLAVELKDGK----------------TITQRAGTNGYMAPEILKE-EPYSYPVDWFAMGCS 183 (277)
T ss_pred CChHhEEEcCCCCEEEeeceeeeecCCCc----------------eeeccCCCCCccCHHHHcc-CCCCCchhHHHHHHH
Confidence 99999999999999999999987643111 0123468999999999987 459999999999999
Q ss_pred HHHhhc---CCchhHH---HHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH----HHHHhccCCCCchH
Q 000880 668 FFELWH---PFSTAME---RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA----TELLQDALPPQMEY 737 (1239)
Q Consensus 668 L~ELlt---Pf~~~~~---~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta----~eiL~~~~~~~~~~ 737 (1239)
+|||++ ||..... ......... ....+......++++.+||++||+.||.+||++ .+++.|+||+...+
T Consensus 184 l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 184 IYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred HHHHHhCCCCCCCCcchhhHHHHHHHhh-ccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 999997 7754322 111111111 112222233567789999999999999999999 67889999988765
Q ss_pred H
Q 000880 738 E 738 (1239)
Q Consensus 738 ~ 738 (1239)
.
T Consensus 263 ~ 263 (277)
T cd05607 263 P 263 (277)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=351.50 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=222.9
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
++-...|.+...||+|.|++|.+|++..+|..||||.|............+.+|+++|+.|+|||||+++.+..
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~------ 125 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE------ 125 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee------
Confidence 44467899999999999999999999999999999999877666566667999999999999999999998762
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
....+|+||||+ +|.+.+++...+++.+..+..++.|+++|++||
T Consensus 126 ----------------------------------t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYc 171 (596)
T KOG0586|consen 126 ----------------------------------TEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYC 171 (596)
T ss_pred ----------------------------------ecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHH
Confidence 256899999999 579999999999999999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|+++|||||||++||||+.+.++||+|||++.++..... ..+.||+|.|+|||++++..+.++.
T Consensus 172 H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~----------------lqt~cgsppyAaPEl~~g~~y~gpe 235 (596)
T KOG0586|consen 172 HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM----------------LQTFCGSPPYAAPELFNGKKYDGPE 235 (596)
T ss_pred hhcceeccccchhhcccccccceeeeccccceeeccccc----------------ccccCCCCCccChHhhcCcccCCcc
Confidence 999999999999999999999999999999998753321 2457999999999999998777899
Q ss_pred hhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
+|+||+|++||-|++ ||.+..-.+.....+..+..+|... +.++.+||+++|-.+|.+|++.+++..|.|..-.
T Consensus 236 ~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~m---s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 236 VDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYM---SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred eehhhhhhhheeeeecccccCCcccccccchheeeeeccccee---echhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 999999999999986 9986655444444555555555443 3489999999999999999999999999986543
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=341.48 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=188.1
Q ss_pred eeeccCCceEEEEEEEcc--CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKL--DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~--~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
.+||+|+||+||+|+++. ++..||+|.+..... ...+.+|+.+|+.++||||++++++|...
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~------------ 70 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSH------------ 70 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEecc------------
Confidence 689999999999999764 568899998864322 34578999999999999999999887432
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHH
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY---------DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~---------~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
....+|++|||++++|.+++... ..+++..++.++.||+.||.||
T Consensus 71 --------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l 124 (317)
T cd07867 71 --------------------------SDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124 (317)
T ss_pred --------------------------CCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH
Confidence 23568999999999988887521 2488999999999999999999
Q ss_pred HhCCccccCCCcccEEE----cCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC
Q 000880 579 HGQGIIHRDLTPNNIFF----DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl----~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 654 (1239)
|++||+||||||+|||+ +.++.+||+|||+++........ .......+||+.|+|||++.+...
T Consensus 125 H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~ 192 (317)
T cd07867 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP------------LADLDPVVVTFWYRAPELLLGARH 192 (317)
T ss_pred HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccc------------ccccCcceecccccCcHHhcCCCc
Confidence 99999999999999999 45678999999999865322100 011234578999999999987556
Q ss_pred CCcchhhHHHHHHHHHhhc---CCchhHHH---------HHHHHhhh--------------hcCCCC-------------
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMER---------QIVLSDLK--------------QKGELP------------- 695 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt---Pf~~~~~~---------~~~~~~~~--------------~~~~~p------------- 695 (1239)
++.++|||||||++|||++ ||....+. ........ .....+
T Consensus 193 ~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (317)
T cd07867 193 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYAN 272 (317)
T ss_pred cCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCC
Confidence 8999999999999999997 55422110 00000000 000000
Q ss_pred --------CccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 696 --------PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 696 --------~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
.........+.+||.+||..||.+|||+.++|+||||
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 273 SSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred chhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0001123457789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.83 Aligned_cols=243 Identities=17% Similarity=0.241 Sum_probs=198.1
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-PVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
..||+|++|.||+|.+ +|+.||||+++...... ...+.+.+|+.+|++++|||||++++++.+..
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~------------ 91 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV------------ 91 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc------------
Confidence 5799999999999988 59999999987543322 23467889999999999999999999885410
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccc
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG-QGIIHR 586 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs-~gIiHr 586 (1239)
....+++++||||+ |+|.+++.....+++...+.++.|++.||.|||+ .+++||
T Consensus 92 ------------------------~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hr 147 (283)
T PHA02988 92 ------------------------DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK 147 (283)
T ss_pred ------------------------cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 12356899999996 5899999988889999999999999999999998 499999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC-CCCCcchhhHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW-PKIDEKADMYSLG 665 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~ksDIwSlG 665 (1239)
||||+|||++.++.+||+|||+++..... ....+||+.|+|||++.+. ..++.++||||||
T Consensus 148 dlkp~nill~~~~~~kl~dfg~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlG 209 (283)
T PHA02988 148 NLTSVSFLVTENYKLKIICHGLEKILSSP------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLG 209 (283)
T ss_pred cCChhhEEECCCCcEEEcccchHhhhccc------------------cccccCcccccCHHHhhhccccccchhhhhHHH
Confidence 99999999999999999999999864311 1234789999999998752 4689999999999
Q ss_pred HHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 666 IVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 666 viL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|++|||++ ||......+......... ..++.....++++.+||.+||+.||.+|||+.++++.
T Consensus 210 vil~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 210 VVLWEIFTGKIPFENLTTKEIYDLIINKN-NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhcC-CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999997 887766555444433322 2222233567899999999999999999999999864
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=357.98 Aligned_cols=249 Identities=27% Similarity=0.337 Sum_probs=196.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++++|||||++++++..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-------- 231 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVV-------- 231 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEE--------
Confidence 457999999999999999999999999999999642 1235689999999999999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....|++|+++.++|..++... ..+++..++.++.||+.||.|||++
T Consensus 232 --------------------------------~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 279 (461)
T PHA03211 232 --------------------------------GGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE 279 (461)
T ss_pred --------------------------------CCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3467899999999999888654 4699999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+||||+.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++||
T Consensus 280 gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-------------~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDv 345 (461)
T PHA03211 280 GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-------------TPFHYGIAGTVDTNAPEVLAG-DPYTPSVDI 345 (461)
T ss_pred CEEECcCCHHHEEECCCCCEEEcccCCceecccccc-------------cccccccCCCcCCcCHHHHcC-CCCCchHHH
Confidence 999999999999999999999999999986432110 001234579999999999988 568999999
Q ss_pred HHHHHHHHHhhc---CCchh--------HHHHHHHHhhhhcC----CCC-------------------------Cccc--
Q 000880 662 YSLGIVFFELWH---PFSTA--------MERQIVLSDLKQKG----ELP-------------------------PSWV-- 699 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~--------~~~~~~~~~~~~~~----~~p-------------------------~~~~-- 699 (1239)
|||||+||||++ |+... ...+ ...++.... .++ +.|.
T Consensus 346 wSlGviL~El~~g~~~lf~~~~~~~~~~~~~~-l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 424 (461)
T PHA03211 346 WSAGLVIFEAAVHTASLFSASRGDERRPYDAQ-ILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY 424 (461)
T ss_pred HHHHHHHHHHHHcCCCcccCCcccccCCcHHH-HHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhh
Confidence 999999999974 22111 1111 111111100 011 1111
Q ss_pred -cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 700 -AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 700 -~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
...+++.+||.+||+.||.+|||+.|+|+|+||++
T Consensus 425 ~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 425 YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 23347889999999999999999999999999975
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=335.63 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=212.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 72 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-------- 72 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--------
Confidence 478999999999999999999999999999999874332 22345678899999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++|||+ +++|.+++.....+++..++.++.||+.||.|||++
T Consensus 73 --------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~ 120 (290)
T cd05580 73 --------------------------------DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120 (290)
T ss_pred --------------------------------CCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45789999999 579999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||+|+|||++.++.+||+|||++...... ....+|++.|+|||.+.+ ..++.++||
T Consensus 121 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di 181 (290)
T cd05580 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------------------TYTLCGTPEYLAPEIILS-KGYGKAVDW 181 (290)
T ss_pred CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------------------CCCCCCCccccChhhhcC-CCCCccccH
Confidence 9999999999999999999999999998764211 123468999999999887 467899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPP 733 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~ 733 (1239)
||||+++|+|++ ||..................+|. ..++.++++|.+||..||.+|+ +++++++||||.
T Consensus 182 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 258 (290)
T cd05580 182 WALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS---FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258 (290)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc---cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence 999999999997 77655543333333332333333 3357899999999999999999 999999999999
Q ss_pred CchHHHH
Q 000880 734 QMEYELL 740 (1239)
Q Consensus 734 ~~~~~~~ 740 (1239)
...+...
T Consensus 259 ~~~~~~~ 265 (290)
T cd05580 259 GIDWIAL 265 (290)
T ss_pred cCCHHHH
Confidence 8876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=336.02 Aligned_cols=275 Identities=23% Similarity=0.355 Sum_probs=213.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||.||++.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--------- 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE--------- 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe---------
Confidence 478999999999999999999999999999999875432 2233457889999999999999999998763
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...++|+||||++ ++|.+++.....+++..+..++.|++.||+|||++
T Consensus 72 -------------------------------~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 120 (305)
T cd05609 72 -------------------------------TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120 (305)
T ss_pred -------------------------------cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2457899999996 59999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+||+++.++.+||+|||+++............................|++.|+|||.+.+ ..++.++|+
T Consensus 121 ~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 199 (305)
T cd05609 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDW 199 (305)
T ss_pred CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhH
Confidence 9999999999999999999999999998742111100000000000000111123468899999999877 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC---HHHHHhccCCCCc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS---ATELLQDALPPQM 735 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt---a~eiL~~~~~~~~ 735 (1239)
|||||++|||++ ||......+............|......++++.++|.+||+.||.+||+ +.++++||||...
T Consensus 200 ~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 200 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 999999999997 7765554444433333223333333356678999999999999999998 7999999999887
Q ss_pred hHHH
Q 000880 736 EYEL 739 (1239)
Q Consensus 736 ~~~~ 739 (1239)
.+..
T Consensus 280 ~~~~ 283 (305)
T cd05609 280 DWNG 283 (305)
T ss_pred CHHH
Confidence 6543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=337.60 Aligned_cols=257 Identities=29% Similarity=0.435 Sum_probs=204.5
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||.|+||.||+|.++.+++.||+|.++...........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------- 76 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS------- 76 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec-------
Confidence 4689999999999999999999999999999999986554434445678899999999999999999887432
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....+|++|||++++|.+++.... .+++..++.++.||+.||+|||++
T Consensus 77 -------------------------------~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 125 (293)
T cd07843 77 -------------------------------NLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125 (293)
T ss_pred -------------------------------CCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 135789999999999999887644 589999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+|||++.++.+||+|||++....... .......+++.|+|||++.+...++.++|+
T Consensus 126 ~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 190 (293)
T cd07843 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL---------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDM 190 (293)
T ss_pred CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc---------------cccccccccccccCchhhcCCccccchhhH
Confidence 99999999999999999999999999998653221 011234678999999998775557899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcC---------------------------CCCCcccc--CCHHHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKG---------------------------ELPPSWVA--KFSEQESLL 709 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~--~~~e~~~LI 709 (1239)
||||+++|+|++ ||................+ .....+.. .++.+.++|
T Consensus 191 ~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 270 (293)
T cd07843 191 WSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLL 270 (293)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHH
Confidence 999999999997 5554333222211111000 00011112 256788999
Q ss_pred HHccCCCCCCCCCHHHHHhccCC
Q 000880 710 RRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 710 ~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
++||+.||++|||+.++++|+||
T Consensus 271 ~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 271 NRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHhccCccccCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=346.13 Aligned_cols=267 Identities=24% Similarity=0.393 Sum_probs=210.5
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|++.+.||.|+||.||+|.++.+|+.||+|++............+.+|+.+|+.++||||++++++|....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG------- 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-------
Confidence 6799999999999999999999999999999999765444445567889999999999999999998763221
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
.....+|+||||++++|.+++.....+++..++.++.||+.||.|||++||
T Consensus 78 -----------------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 128 (334)
T cd07855 78 -----------------------------ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANV 128 (334)
T ss_pred -----------------------------CCCceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 124578999999999999999887889999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+|||++.++.+||+|||++......... ........+|+..|+|||++.+...++.++||||
T Consensus 129 vH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 197 (334)
T cd07855 129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE-----------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197 (334)
T ss_pred ecCCCCHHHEEEcCCCcEEecccccceeecccCcC-----------CCcccccccccccccChHHhcCCcccccccchHH
Confidence 99999999999999999999999999765322110 0011134578999999999876556899999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhh-----------------------hcCCC-CC----ccccCCHHHHHHHHHc
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLK-----------------------QKGEL-PP----SWVAKFSEQESLLRRL 712 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~-----------------------~~~~~-p~----~~~~~~~e~~~LI~~~ 712 (1239)
|||++|||++ ||.............. ..... +. .....++++.++|++|
T Consensus 198 lG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 277 (334)
T cd07855 198 VGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277 (334)
T ss_pred HHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHH
Confidence 9999999996 6644322111100000 00000 01 1134567899999999
Q ss_pred cCCCCCCCCCHHHHHhccCCCCchH
Q 000880 713 MSPSPSDRPSATELLQDALPPQMEY 737 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~~~~~~ 737 (1239)
|+.+|.+|||+.++++|||+.+...
T Consensus 278 l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 278 LQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred ccCChhhCcCHHHHHhChhhhhccC
Confidence 9999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=343.20 Aligned_cols=264 Identities=19% Similarity=0.284 Sum_probs=201.4
Q ss_pred EEeeeccC--CceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 428 ELQPLGHG--GFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 428 ~~~~LG~G--~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
++++||+| +||+||++.++.+|+.||||+++...........+.+|+.+++.++||||++++++|..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----------- 70 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----------- 70 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----------
Confidence 45789999 78999999999999999999997655444555678889999999999999999988743
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES--YDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|+|||||+ ++|.+++.. ...+++..++.++.||+.||+|||++|
T Consensus 71 -----------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 121 (327)
T cd08227 71 -----------------------------DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121 (327)
T ss_pred -----------------------------CCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356899999996 689998864 345899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC-CCCCcchhh
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW-PKIDEKADM 661 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~ksDI 661 (1239)
|+||||||+|||++.++.++++|||.+.......... .. .........++..|+|||++.+. ..++.++||
T Consensus 122 iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~--~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (327)
T cd08227 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL--RV------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 193 (327)
T ss_pred EecCCCChhhEEEecCCcEEEcccchhhccccccccc--cc------cccccccccceecccChHHhhcccCCCCchhhH
Confidence 9999999999999999999999998765432111000 00 00001224678889999998753 358999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-------C------------------------------------C
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-------L------------------------------------P 695 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-------~------------------------------------p 695 (1239)
|||||++|||++ ||.................. . .
T Consensus 194 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (327)
T cd08227 194 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH 273 (327)
T ss_pred HHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccc
Confidence 999999999996 77644333322222110000 0 0
Q ss_pred CccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCchHHH
Q 000880 696 PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYEL 739 (1239)
Q Consensus 696 ~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~~~~ 739 (1239)
+.....++++.+||.+||+.||.+|||+.++++||||.+.....
T Consensus 274 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~~ 317 (327)
T cd08227 274 PYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 317 (327)
T ss_pred ccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchhh
Confidence 01112346788999999999999999999999999998865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=351.82 Aligned_cols=250 Identities=27% Similarity=0.394 Sum_probs=200.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-C-----CceeeeeeeeeecCcc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-H-----QHVVRYYQAWFETGVA 498 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-H-----pnIv~l~~~~~e~~~~ 498 (1239)
+|++++.||+|+||+|.+|.+..|++.||||+++.. .....+...|+.+|..|+ | -|||+++++|+.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f---- 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF---- 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc----
Confidence 789999999999999999999999999999999743 345677888999999997 4 389999999843
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD--HFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~ 576 (1239)
..++|||+|++..+|++++..+. .++...++.|+.||+.||.
T Consensus 260 ------------------------------------r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~ 303 (586)
T KOG0667|consen 260 ------------------------------------RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALL 303 (586)
T ss_pred ------------------------------------ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 57899999999999999998654 5999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCC--CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDAR--NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~--~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 654 (1239)
+||+.||||+||||+||||... ..|||+|||.|++.... ..+++-+..|.|||++.| ..
T Consensus 304 ~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~------------------vytYiQSRfYRAPEVILG-lp 364 (586)
T KOG0667|consen 304 FLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR------------------VYTYIQSRFYRAPEVILG-LP 364 (586)
T ss_pred HHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc------------------ceeeeeccccccchhhcc-CC
Confidence 9999999999999999999764 46999999999975321 124677889999999999 56
Q ss_pred CCcchhhHHHHHHHHHhhc--CCchh-HHHHHHHHhhh------------------------------------------
Q 000880 655 IDEKADMYSLGIVFFELWH--PFSTA-MERQIVLSDLK------------------------------------------ 689 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt--Pf~~~-~~~~~~~~~~~------------------------------------------ 689 (1239)
|+.+.||||||||+.||++ |+.+. .+...+..+..
T Consensus 365 Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~ 444 (586)
T KOG0667|consen 365 YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSP 444 (586)
T ss_pred CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccch
Confidence 9999999999999999997 43332 22211111100
Q ss_pred ----------hcCCCCCc---cccC-----CHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 690 ----------QKGELPPS---WVAK-----FSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 690 ----------~~~~~p~~---~~~~-----~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
.....|+. +... -..+.++|++||..||.+|+|+.++|+|||+....
T Consensus 445 ~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 445 EVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred hhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 00001110 0000 12457999999999999999999999999998654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=333.84 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=200.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHH-HHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVAT-LSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~i-L~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++++.||+|+||.||+|.++.+|+.||||+++...... ...++..|+.. ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-------- 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR-------- 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec--------
Confidence 47999999999999999999999999999999987543332 23456666665 666799999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES----YDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
...+|++|||++++|.+++.. ...+++..++.++.||+.||+||
T Consensus 72 --------------------------------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 119 (283)
T cd06617 72 --------------------------------EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119 (283)
T ss_pred --------------------------------CCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345799999999998887754 24689999999999999999999
Q ss_pred HhC-CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC---CC
Q 000880 579 HGQ-GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW---PK 654 (1239)
Q Consensus 579 Hs~-gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~ 654 (1239)
|++ +++||||||+|||++.++.+||+|||++....... ..+...|+..|+|||++.+. ..
T Consensus 120 H~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~ 183 (283)
T cd06617 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV----------------AKTIDAGCKPYMAPERINPELNQKG 183 (283)
T ss_pred hhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc----------------ccccccCCccccChhhcCCcccccc
Confidence 997 99999999999999999999999999987642110 11234688999999988642 33
Q ss_pred CCcchhhHHHHHHHHHhhc---CCchhHHH-HHHHHhhhhcCCCCCc-cccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMER-QIVLSDLKQKGELPPS-WVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt---Pf~~~~~~-~~~~~~~~~~~~~p~~-~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
++.++|+|||||++|+|++ ||...... +....... ...+.. ....+.++.++|.+||..+|.+||++.++++|
T Consensus 184 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 184 YDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6889999999999999997 66543221 22222211 111111 12356789999999999999999999999999
Q ss_pred cCCCCchHH
Q 000880 730 ALPPQMEYE 738 (1239)
Q Consensus 730 ~~~~~~~~~ 738 (1239)
+||......
T Consensus 262 ~~~~~~~~~ 270 (283)
T cd06617 262 PFFELHLSK 270 (283)
T ss_pred chhhhcccc
Confidence 999877543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=338.66 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=203.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||+|+||.||++.+..+|..||+|.+.... ......++.+|+.+++.++||||++++++|..
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 70 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--------- 70 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee---------
Confidence 47999999999999999999999999999999987432 33445678899999999999999999998843
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG-Q 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs-~ 581 (1239)
...+|++|||++ ++|.+++.....+++..+..++.||+.||.|||+ +
T Consensus 71 -------------------------------~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 119 (308)
T cd06615 71 -------------------------------DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119 (308)
T ss_pred -------------------------------CCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 357899999996 5999999888889999999999999999999998 6
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
+++||||||+|||++.++.+||+|||++...... .....+|++.|+|||++.+ ..++.++|+
T Consensus 120 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di 181 (308)
T cd06615 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----------------MANSFVGTRSYMSPERLQG-THYTVQSDI 181 (308)
T ss_pred CEEECCCChHHEEEecCCcEEEccCCCccccccc-----------------ccccCCCCcCccChhHhcC-CCCCccchH
Confidence 9999999999999999999999999998753211 0134578999999999887 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcC----------------------------------CCCCcc--ccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKG----------------------------------ELPPSW--VAKF 702 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~----------------------------------~~p~~~--~~~~ 702 (1239)
|||||++|+|++ ||......... ....... ..++.. ...+
T Consensus 182 wslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (308)
T cd06615 182 WSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFS 260 (308)
T ss_pred HHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccC
Confidence 999999999997 66433221111 1000000 000110 1245
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 703 SEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 703 ~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
+++.+||.+||..||++|||+.++++|+|+.+.
T Consensus 261 ~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 261 DEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 678999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=328.41 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=206.4
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC----chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS----LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+|++.+.||.|+||+||+|... +|+.+|||.+...... ......+.+|+.+++.++||||++++++|.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD------ 73 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec------
Confidence 4677899999999999999874 8899999998754322 2233568899999999999999999988732
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...+|++|||++ ++|.+++.+...+++..++.++.||+.||+|||
T Consensus 74 ----------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 119 (265)
T cd06631 74 ----------------------------------DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119 (265)
T ss_pred ----------------------------------CCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357899999996 599999988788999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+.+|+|+||||+||+++.++.++|+|||++.......... ..........||+.|+|||++.+ ..++.++
T Consensus 120 ~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~ 189 (265)
T cd06631 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG---------THSNMLKSMHGTPYWMAPEVINE-SGYGRKS 189 (265)
T ss_pred hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc---------cccccccccCCCccccChhhhcC-CCCcchh
Confidence 9999999999999999999999999999998653211100 00111234578999999999987 5688999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|+|||||++|+|++ ||...................++.....+.++.++|.+||..+|.+||++.++++|||+
T Consensus 190 Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 190 DIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred hHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999997 77654443333333322233444444566789999999999999999999999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=332.39 Aligned_cols=251 Identities=24% Similarity=0.438 Sum_probs=202.4
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++.++||||+++++.+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-------- 77 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-------- 77 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--------
Confidence 3588999999999999999999999999999999875432 234567889999999999999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++||||+ ++|.+++...+.+++.+++.++.||+.||.|||++
T Consensus 78 --------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 125 (267)
T cd06645 78 --------------------------------RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125 (267)
T ss_pred --------------------------------CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356799999997 59999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCcch
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ks 659 (1239)
|++|+||||+||+++.++.+||+|||++....... .......||+.|+|||++.. ...++.++
T Consensus 126 ~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 190 (267)
T cd06645 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190 (267)
T ss_pred CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc---------------cccccccCcccccChhhhccccCCCCCchh
Confidence 99999999999999999999999999987542110 01234579999999998742 24588999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCc---cccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPS---WVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~---~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
|+|||||++|+|++ ||....+......... ....++. ....+..+.++|.+||+.+|++|||+.++++|||
T Consensus 191 DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMTK-SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999987 6654433332222211 1111221 1234567899999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=332.57 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=199.7
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++++.||+|+||.||+|.+..+++.||+|++... ........+.+|+.++++++||||+++++.+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 70 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--------- 70 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE---------
Confidence 4688899999999999999999999999999998753 233445678999999999999999999998743
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....+++|||+++ +|... ..+++..+..++.||+.||.|||++|
T Consensus 71 -------------------------------~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ 115 (279)
T cd06619 71 -------------------------------ENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK 115 (279)
T ss_pred -------------------------------CCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3467899999975 55433 35789999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+|+||||+|||++.++.++|+|||++...... ..+..+||+.|+|||++.+ ..++.++|+|
T Consensus 116 i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvw 177 (279)
T cd06619 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----------------IAKTYVGTNAYMAPERISG-EQYGIHSDVW 177 (279)
T ss_pred EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-----------------cccCCCCChhhcCceeecC-CCCCCcchHH
Confidence 999999999999999999999999999754211 1234579999999999987 5689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHH------HHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 663 SLGIVFFELWH---PFSTAMERQ------IVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~------~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
||||++|+|++ ||....... ...................++++.++|.+||+.||.+||++.++++|+|+.
T Consensus 178 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred HHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 99999999997 665322110 111111111111111233567899999999999999999999999999998
Q ss_pred CchH
Q 000880 734 QMEY 737 (1239)
Q Consensus 734 ~~~~ 737 (1239)
+...
T Consensus 258 ~~~~ 261 (279)
T cd06619 258 QYND 261 (279)
T ss_pred cccC
Confidence 7643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=329.01 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=204.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK---SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
.+|+..+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR----- 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC-----
Confidence 478889999999999999999999999999999875432 223345788999999999999999999876432
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....++++|||++ ++|.+++.....+++...+.++.||+.||+|||
T Consensus 77 ---------------------------------~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH 123 (266)
T cd06651 77 ---------------------------------AEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123 (266)
T ss_pred ---------------------------------CCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1356899999997 589999988788999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+++|+||||||+||+++.++.+||+|||++......... ........++..|+|||++.+ ..++.++
T Consensus 124 ~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 190 (266)
T cd06651 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS------------GTGIRSVTGTPYWMSPEVISG-EGYGRKA 190 (266)
T ss_pred hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc------------CCccccCCccccccCHHHhCC-CCCCchh
Confidence 999999999999999999999999999999764321100 001123468899999999987 5689999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
|||||||++|||++ ||.............. ....|.......+.+.++| +||..+|++||+++++++||||+
T Consensus 191 Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 191 DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99999999999997 7765544333332221 2222222233456788888 67778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=343.90 Aligned_cols=292 Identities=24% Similarity=0.391 Sum_probs=222.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-PVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.-|..++.||-|+||+|.+++...|...||+|.+++.+.-. .....+..|-.||.....+.||++|..|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF---------- 698 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF---------- 698 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe----------
Confidence 35788999999999999999999999999999997655321 2234567799999999999999999777
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
++..++|+||+|++ |++..+|.+.+-|.+..|++|+.++..|+++.|.+
T Consensus 699 ------------------------------QDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm 748 (1034)
T KOG0608|consen 699 ------------------------------QDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM 748 (1034)
T ss_pred ------------------------------ccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 35678999999996 59999999999999999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhcccc---ccccCCCCC-CC-----------------------CCCccccC
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFP-TD-----------------------TGGVSVDG 634 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~---~~~~~~~~~-~~-----------------------~~~~~~~~ 634 (1239)
|+|||||||+|||||.+|+|||+|||||.-+..- ...+....+ .+ .....+..
T Consensus 749 GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~a 828 (1034)
T KOG0608|consen 749 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILA 828 (1034)
T ss_pred cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhh
Confidence 9999999999999999999999999999633210 000000000 00 00011223
Q ss_pred cccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHh--hhhcCCCCCccccCCHHHHHHH
Q 000880 635 TGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSD--LKQKGELPPSWVAKFSEQESLL 709 (1239)
Q Consensus 635 ~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~--~~~~~~~p~~~~~~~~e~~~LI 709 (1239)
.+.+||+.|+|||++.. ..|+..||+||.|||||||+. ||....+.+...++ ++.. ...+...+.++++.++|
T Consensus 829 hslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~-l~~~~~~~ls~e~~~li 906 (1034)
T KOG0608|consen 829 HSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNF-LHIPYQGNLSKEALDLI 906 (1034)
T ss_pred hhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhc-cccccccccCHHHHHHH
Confidence 46799999999999998 679999999999999999994 78665544333222 2211 22234456678999999
Q ss_pred HHccCCCCCCCC---CHHHHHhccCCCCchHHHHHH----HHHhcCCCCCCcchhh
Q 000880 710 RRLMSPSPSDRP---SATELLQDALPPQMEYELLDN----ILRMMHSSEDTSIYDK 758 (1239)
Q Consensus 710 ~~~L~~dP~~RP---ta~eiL~~~~~~~~~~~~~~~----~~~~~~~~~d~~~~~~ 758 (1239)
.++. .+++.|. .+++|..||||+.+.+..+.. ++..+..+.|.+.++.
T Consensus 907 ~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdp 961 (1034)
T KOG0608|consen 907 QKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDP 961 (1034)
T ss_pred HHHh-cChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccCCCccccCCc
Confidence 8754 4567777 578899999999998876644 4455666667666653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=327.19 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=205.6
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS---LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
++|++.+.||+|+||.||+|.+..+|..||||.+...... ......+.+|+.+++.++||||++++++|.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP----- 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC-----
Confidence 5799999999999999999999999999999998654322 23346788999999999999999999887432
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....+|++|||++ ++|.+++.....+++..++.++.|++.||+|||
T Consensus 77 ---------------------------------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH 123 (265)
T cd06652 77 ---------------------------------MERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123 (265)
T ss_pred ---------------------------------CCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1346789999996 589999988788999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+++++|+||||+|||++.++.++|+|||++......... ........||..|+|||++.+ ..++.++
T Consensus 124 ~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 190 (265)
T cd06652 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS------------GTGMKSVTGTPYWMSPEVISG-EGYGRKA 190 (265)
T ss_pred hCCEecCCCCHHHEEecCCCCEEECcCcccccccccccc------------ccccccCCCCccccChhhhcC-CCCCcch
Confidence 999999999999999999999999999999864321100 001133468999999999987 5689999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
|+|||||++|||++ ||.............. ....+......+..+.++|.+||. +|.+||+++++++|+|+.
T Consensus 191 Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 191 DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc-CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999999999996 7765544333333222 222233333445678899999995 999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=330.29 Aligned_cols=256 Identities=22% Similarity=0.402 Sum_probs=202.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+.|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.+++.+ +||||+++++.|.....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~----- 77 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP----- 77 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC-----
Confidence 457888999999999999999999999999999875432 245688999999998 79999999998854310
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
......+|++|||++ ++|.+++... ..+++..++.++.||+.||+|||
T Consensus 78 -----------------------------~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH 128 (272)
T cd06637 78 -----------------------------PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128 (272)
T ss_pred -----------------------------CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 012357899999997 5899988753 45899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC----CCC
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW----PKI 655 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~~ 655 (1239)
+++|+||||||+||+++.++.+||+|||++....... .......|++.|+|||++.+. ..+
T Consensus 129 ~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~ 193 (272)
T cd06637 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV---------------GRRNTFIGTPYWMAPEVIACDENPDATY 193 (272)
T ss_pred HCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc---------------ccCCcccccccccCHhHhccccCcCCCC
Confidence 9999999999999999999999999999987542111 012345799999999998631 347
Q ss_pred CcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 656 DEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+.++|||||||++|||++ ||.............. ...........+.++.+||.+||..||.+|||+.+++.||||
T Consensus 194 ~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 194 DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 889999999999999997 6654444333332222 111111223455689999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=346.65 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=203.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK------ 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC------
Confidence 57899999999999999999999999999999998654444445567889999999999999999998874321
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+...+|+|||||+++|.+.+... +++..+..++.||+.||+|||++|
T Consensus 89 ----------------------------~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g 138 (353)
T cd07850 89 ----------------------------SLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG 138 (353)
T ss_pred ----------------------------CccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 00123467999999999999888654 899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||
T Consensus 139 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvw 201 (353)
T cd07850 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----------------MMTPYVVTRYYRAPEVILG-MGYKENVDIW 201 (353)
T ss_pred eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC----------------CCCCCcccccccCHHHHhC-CCCCCchhhH
Confidence 9999999999999999999999999997642211 1133468999999999987 5689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhh----------------------cCC--------------CCCc----cc
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQ----------------------KGE--------------LPPS----WV 699 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~----------------------~~~--------------~p~~----~~ 699 (1239)
||||++|+|++ ||............... ... .+.. ..
T Consensus 202 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
T cd07850 202 SVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNK 281 (353)
T ss_pred hHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccc
Confidence 99999999996 66533221111111000 000 0000 11
Q ss_pred cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 700 AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 700 ~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
...+.+.++|.+||+.||.+|||+.++|+|+|+..
T Consensus 282 ~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 282 LKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred cchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 22346789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=334.73 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=203.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||.|+||.||+|.+..+|+.||||+++...........+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~------ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE------ 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC------
Confidence 4689999999999999999999999999999998765443334467889999999995 699999998874321
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-----DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-----~~l~~~~~~~i~~qI~~gL~y 577 (1239)
......+|++|||++++|.+++... ..+++..++.++.||+.||.|
T Consensus 75 -----------------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~ 125 (295)
T cd07837 75 -----------------------------KNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125 (295)
T ss_pred -----------------------------CCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 0123458999999999998887642 357999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 578 IHGQGIIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
||++||+||||||+||+++. ++.+||+|||++....... ...+...+++.|+|||++.+...++
T Consensus 126 LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~ 190 (295)
T cd07837 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV---------------KSYTHEIVTLWYRAPEVLLGSTHYS 190 (295)
T ss_pred HHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc---------------cccCCcccccCCCChHHhhCCCCCC
Confidence 99999999999999999998 8899999999987542111 0112336789999999887645689
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-----------------CC--------CccccCCHHHHHH
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-----------------LP--------PSWVAKFSEQESL 708 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-----------------~p--------~~~~~~~~e~~~L 708 (1239)
.++|||||||++|+|++ ||....+............. .+ ......++++.++
T Consensus 191 ~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (295)
T cd07837 191 TPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDL 270 (295)
T ss_pred chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHH
Confidence 99999999999999997 66544433333222111000 00 0112356788999
Q ss_pred HHHccCCCCCCCCCHHHHHhccCCC
Q 000880 709 LRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 709 I~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
|.+||..||.+||++.+++.|+|++
T Consensus 271 i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 271 LQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHccCChhhcCCHHHHhcCCCcC
Confidence 9999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=336.92 Aligned_cols=275 Identities=28% Similarity=0.444 Sum_probs=214.6
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-PVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--------- 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--------- 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee---------
Confidence 47899999999999999999999899999999997654332 34567889999999999999999998763
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
.....|++|||+. ++|.+++... ..+++..++.++.||+.||+|||
T Consensus 72 -------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH 120 (316)
T cd05574 72 -------------------------------TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120 (316)
T ss_pred -------------------------------cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH
Confidence 2457899999996 5999988754 56999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCC--CC------------CCCCCccccCcccccCccCCC
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAA--FP------------TDTGGVSVDGTGQVGTYFYTA 645 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~--~~------------~~~~~~~~~~~~~~GT~~Y~A 645 (1239)
++|++||||||+||+++.++.++|+|||++............. .. .............+||..|+|
T Consensus 121 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a 200 (316)
T cd05574 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA 200 (316)
T ss_pred HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence 9999999999999999999999999999998653221100000 00 000000112234579999999
Q ss_pred cccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC
Q 000880 646 PEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722 (1239)
Q Consensus 646 PE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt 722 (1239)
||++.+ ..++.++|||||||++|+|++ ||...................+. ....++.+.++|.+||..||++|||
T Consensus 201 PE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 201 PEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred HHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCC-ccccCHHHHHHHHHHccCCHhHCCC
Confidence 999987 568999999999999999997 77655544444443332222332 2235678999999999999999999
Q ss_pred ----HHHHHhccCCCCchHHHH
Q 000880 723 ----ATELLQDALPPQMEYELL 740 (1239)
Q Consensus 723 ----a~eiL~~~~~~~~~~~~~ 740 (1239)
++++++|+||.+..+..+
T Consensus 279 ~~~~~~~ll~~~~~~~~~~~~~ 300 (316)
T cd05574 279 SKRGAAEIKQHPFFRGVNWALI 300 (316)
T ss_pred chhhHHHHHcCchhhcCChhhc
Confidence 999999999998876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=332.75 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=204.6
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-PVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~-~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
|+..+.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.+|+.++|+||+++++++..
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~---------- 71 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET---------- 71 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec----------
Confidence 677899999999999999999999999999987543222 223457889999999999999999887632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...++++|||++ ++|.+++... ..+++..+..++.|++.||.|||++
T Consensus 72 ------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 121 (285)
T cd05632 72 ------------------------------KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121 (285)
T ss_pred ------------------------------CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 357899999997 5888877543 3699999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|+
T Consensus 122 ~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----------------~~~~~~g~~~~~aPE~~~~-~~~~~~~Di 184 (285)
T cd05632 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----------------SIRGRVGTVGYMAPEVLNN-QRYTLSPDY 184 (285)
T ss_pred CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----------------cccCCCCCcCccChHHhcC-CCCCcccch
Confidence 99999999999999999999999999987532110 1123579999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-CCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-LPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDALP 732 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~~~~ 732 (1239)
|||||++|||++ ||....+............. .+......++++.+|+.+||+.||.+||+ +.+++.|+||
T Consensus 185 ~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05632 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264 (285)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence 999999999996 77654433221111111111 11122345678899999999999999999 8999999999
Q ss_pred CCchHHH
Q 000880 733 PQMEYEL 739 (1239)
Q Consensus 733 ~~~~~~~ 739 (1239)
..+.+..
T Consensus 265 ~~~~~~~ 271 (285)
T cd05632 265 RNMNFKR 271 (285)
T ss_pred hcCCHHH
Confidence 9987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=327.13 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=208.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 70 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--------- 70 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee---------
Confidence 47999999999999999999999899999999987544433 56789999999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY---DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....|++|||++ ++|.+++... ..+++..++.++.||+.||+|||
T Consensus 71 -------------------------------~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh 119 (267)
T cd06610 71 -------------------------------GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119 (267)
T ss_pred -------------------------------CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356899999996 5899988753 45899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++||||||+||++++++.++|+|||++..+....... .......+|++.|+|||++.....++.++
T Consensus 120 ~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~-----------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~ 188 (267)
T cd06610 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT-----------RKVRKTFVGTPCWMAPEVMEQVHGYDFKA 188 (267)
T ss_pred hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc-----------ccccccccCChhhcChHHHccccCcCccc
Confidence 9999999999999999999999999999998764322110 00123347899999999988744689999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-CCCc--cccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-LPPS--WVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-~p~~--~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|+|||||++|+|++ ||.................. .+.. +...++.+.+++.+||..||++|||+.++++||||
T Consensus 189 Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 189 DIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred chHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999997 77655544444433332211 1111 12456788999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=330.92 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=203.9
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||.|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---------- 70 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH---------- 70 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec----------
Confidence 5889999999999999999999999999999998665444556789999999999999999999988732
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
...+|+||||++++|.+++.. ...+++..++.++.||+.||+|||++|+
T Consensus 71 ------------------------------~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 120 (286)
T cd07832 71 ------------------------------GSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120 (286)
T ss_pred ------------------------------CCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 457899999997799998864 4569999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+|+||||+||+++.++.++|+|||++........ .......|+..|+|||++.+...++.++||||
T Consensus 121 ~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 186 (286)
T cd07832 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEP--------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWA 186 (286)
T ss_pred ecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--------------CccccccCcccccCceeeeccccCCchhHHHH
Confidence 9999999999999999999999999986532110 01133478999999999876556789999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-------------------CC--------CccccCCHHHHHHHHHcc
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGE-------------------LP--------PSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-------------------~p--------~~~~~~~~e~~~LI~~~L 713 (1239)
+||++|||++ ||....+.......+..... .+ .........+.++|.+||
T Consensus 187 lG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 266 (286)
T cd07832 187 VGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLL 266 (286)
T ss_pred HHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHh
Confidence 9999999997 44333332222111110000 00 011234467899999999
Q ss_pred CCCCCCCCCHHHHHhccCCC
Q 000880 714 SPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~~~~~ 733 (1239)
+.||.+|||++++++||||.
T Consensus 267 ~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 267 VYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccChhhCCCHHHHhhCcCcC
Confidence 99999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=336.25 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=192.3
Q ss_pred CCceEEeeeccCCceEEEEEEEcc----------------CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceee
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKL----------------DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~----------------~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~ 487 (1239)
++|++.++||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 578899999999999999998642 3447999998743 23334567999999999999999999
Q ss_pred eeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC---------
Q 000880 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--------- 557 (1239)
Q Consensus 488 l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--------- 557 (1239)
++++|.+ ...+|++||||+ ++|.+++....
T Consensus 84 ~~~~~~~----------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 123 (304)
T cd05096 84 LLGVCVD----------------------------------------EDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123 (304)
T ss_pred EEEEEec----------------------------------------CCceEEEEecCCCCcHHHHHHhccccccccccc
Confidence 9998743 245799999996 69998885431
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCC
Q 000880 558 ----------HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDT 627 (1239)
Q Consensus 558 ----------~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~ 627 (1239)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 124 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~---------- 193 (304)
T cd05096 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY---------- 193 (304)
T ss_pred cccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCce----------
Confidence 367788999999999999999999999999999999999999999999999975422110
Q ss_pred CCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc-----CCchhHHHHHHHHh---hhhc--CCCCCc
Q 000880 628 GGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH-----PFSTAMERQIVLSD---LKQK--GELPPS 697 (1239)
Q Consensus 628 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt-----Pf~~~~~~~~~~~~---~~~~--~~~p~~ 697 (1239)
........+++.|||||++.+ ..++.++|||||||++|||++ ||......+..... .... ...+..
T Consensus 194 ---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (304)
T cd05096 194 ---YRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFR 269 (304)
T ss_pred ---eEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccC
Confidence 001123456889999999876 568999999999999999974 66654433322111 1111 111122
Q ss_pred cccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 698 WVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 698 ~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
...+++.+.+||.+||+.||.+|||+.+|.+
T Consensus 270 ~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 270 PPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 2345678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=334.22 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=202.8
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.|+..+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++|+||+++++.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--------- 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--------- 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec---------
Confidence 377889999999999999999999999999998754322 2223457889999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|++|||++ ++|.+++... ..+++..+..++.|++.||.|||+
T Consensus 72 -------------------------------~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 120 (285)
T cd05630 72 -------------------------------KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120 (285)
T ss_pred -------------------------------CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356899999996 6898888543 358999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+||+||||||+||+++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++|
T Consensus 121 ~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~----------------~~~~~~g~~~y~aPE~~~~-~~~~~~~D 183 (285)
T cd05630 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----------------TIKGRVGTVGYMAPEVVKN-ERYTFSPD 183 (285)
T ss_pred CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----------------cccCCCCCccccChHHHcC-CCCCCccc
Confidence 999999999999999999999999999987532110 1123479999999999987 56899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHH---HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhc
Q 000880 661 MYSLGIVFFELWH---PFSTAMER---QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQD 729 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~ 729 (1239)
||||||++|+|++ ||...... ........ .. ........++++.+||.+||+.||.+||| +.++++|
T Consensus 184 iwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EV-QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh-hh-hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999996 77643221 11111111 00 01122345678999999999999999999 9999999
Q ss_pred cCCCCchHH
Q 000880 730 ALPPQMEYE 738 (1239)
Q Consensus 730 ~~~~~~~~~ 738 (1239)
+||.+..+.
T Consensus 262 ~~~~~~~~~ 270 (285)
T cd05630 262 PLFKQINFK 270 (285)
T ss_pred hhhhccCHH
Confidence 999887655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=333.68 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=201.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||++++++|.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------- 70 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR---------- 70 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc----------
Confidence 4789999999999999999999989999999998655444344567889999999999999999998873
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....+|+||||+++ +|..+......+++..++.++.||+.||+|||++|
T Consensus 71 ------------------------------~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (286)
T cd07846 71 ------------------------------RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120 (286)
T ss_pred ------------------------------cCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 24578999999976 56666666667999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++||||+|+||+++.++.++|+|||++....... ...+...++..|+|||++.+...++.++|||
T Consensus 121 i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 185 (286)
T cd07846 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185 (286)
T ss_pred ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---------------cccCcccceeeccCcHHhccccccCchHhHH
Confidence 9999999999999999999999999987642211 0123356899999999987655678999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhh-------------------cCCCC---------CccccCCHHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQ-------------------KGELP---------PSWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~-------------------~~~~p---------~~~~~~~~e~~~LI~~ 711 (1239)
||||++|||++ ||............... ....+ ..++..+..+.+|+.+
T Consensus 186 slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 265 (286)
T cd07846 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ 265 (286)
T ss_pred HHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHH
Confidence 99999999997 55433322211111100 00000 0123445688999999
Q ss_pred ccCCCCCCCCCHHHHHhccCC
Q 000880 712 LMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~ 732 (1239)
||+.+|.+||++.++++|+||
T Consensus 266 ~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 266 CLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HhcCCcccchhHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=329.97 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=201.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||+|+||.||+|+++.+++.||+|++..... .....+.+|+.+++.++||||+++++.+..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-------- 77 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLS-------- 77 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEe--------
Confidence 4689999999999999999999999999999999875432 234567899999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++ ++|.+++.....+++..+..++.|++.||.|||++
T Consensus 78 --------------------------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 125 (267)
T cd06646 78 --------------------------------REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125 (267)
T ss_pred --------------------------------CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346799999997 58999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCcch
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ks 659 (1239)
||+||||||+||+++.++.+||+|||++....... .......|++.|+|||++.+ ...++.++
T Consensus 126 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~ 190 (267)
T cd06646 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI---------------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190 (267)
T ss_pred CccccCCCHHHEEECCCCCEEECcCccceeecccc---------------cccCccccCccccCHhHcccccCCCCcchh
Confidence 99999999999999999999999999998642111 01133578999999998853 23478899
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC--CCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL--PPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~--p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
|||||||++|||++ ||................... +......+..+.++|++||+.+|.+|||++++++|+|
T Consensus 191 Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999997 664433322221111111111 1112234578999999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=325.79 Aligned_cols=251 Identities=26% Similarity=0.449 Sum_probs=203.7
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||.|+||.||+|.+..+++.+|+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------- 71 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLR--------- 71 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEe---------
Confidence 6899999999999999999999989999999999765432 45678999999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++|||+++ +|.+++... ..+++..++.++.|++.||+|||++
T Consensus 72 -------------------------------~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~ 120 (262)
T cd06613 72 -------------------------------RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120 (262)
T ss_pred -------------------------------CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3568999999974 898888765 6899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC--CCCCcch
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW--PKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~ks 659 (1239)
|++|+||||+||+++.++.+||+|||++....... .......++..|+|||.+.+. +.++.++
T Consensus 121 ~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~ 185 (262)
T cd06613 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI---------------AKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185 (262)
T ss_pred CceecCCChhhEEECCCCCEEECccccchhhhhhh---------------hccccccCCccccCchhhcccccCCcCchh
Confidence 99999999999999999999999999998643211 011234788999999998763 2688999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC--CCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE--LPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~--~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
|+|||||++|||++ ||.................. ........+.++.++|.+||..+|.+|||+.+++.|+|
T Consensus 186 Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 186 DIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999997 66655443333222221111 11122234567899999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=333.64 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=204.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++|++.+.||+|+||.||+|.++.+|+.||+|.+............+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 72 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-------- 72 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--------
Confidence 368999999999999999999999999999999987554433344678899999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHh
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~--l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
....|+||||++++|.+.+..... +++..++.++.||+.||+|||+
T Consensus 73 --------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 120 (294)
T PLN00009 73 --------------------------------EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120 (294)
T ss_pred --------------------------------CCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 357899999999899888865443 5788899999999999999999
Q ss_pred CCccccCCCcccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 581 QGIIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++++||||||+||+++. ++.+||+|||++....... ...+...|++.|+|||++.+...++.++
T Consensus 121 ~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~ 185 (294)
T PLN00009 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---------------RTFTHEVVTLWYRAPEILLGSRHYSTPV 185 (294)
T ss_pred CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc---------------cccccCceeecccCHHHHhCCCCCCcHH
Confidence 99999999999999985 4579999999997542110 0113346789999999987645588999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC------------------C---CC-----ccccCCHHHHHHHH
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE------------------L---PP-----SWVAKFSEQESLLR 710 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~------------------~---p~-----~~~~~~~e~~~LI~ 710 (1239)
|||||||++|+|++ ||.................. . ++ .....++++.++|.
T Consensus 186 Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 265 (294)
T PLN00009 186 DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLS 265 (294)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHH
Confidence 99999999999997 66544333333222111000 0 00 11234567899999
Q ss_pred HccCCCCCCCCCHHHHHhccCCCCch
Q 000880 711 RLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
+||+.+|.+||++.++++|+||....
T Consensus 266 ~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 266 KMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred HHccCChhhCcCHHHHhcCchHhHHh
Confidence 99999999999999999999987653
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=331.18 Aligned_cols=255 Identities=27% Similarity=0.373 Sum_probs=204.5
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
-|++.+.||.|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.++||||+++++.|..
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~---------- 73 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY---------- 73 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee----------
Confidence 367889999999999999999999999999988643 23445678899999999999999999988743
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....|+||||++ ++|..++.. ...+++..++.++.||+.||.|||+.|
T Consensus 74 ------------------------------~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ 123 (282)
T cd06643 74 ------------------------------ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123 (282)
T ss_pred ------------------------------CCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346799999997 577777654 456999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC----CCCCCcc
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKIDEK 658 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~~~k 658 (1239)
++||||||+|||++.++.+||+|||++....... .......||+.|+|||++.. ...++.+
T Consensus 124 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 188 (282)
T cd06643 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188 (282)
T ss_pred eeecCCCcccEEEccCCCEEEccccccccccccc---------------cccccccccccccCHhhccccCCCCCCCCcc
Confidence 9999999999999999999999999987542110 01233578999999999842 2347789
Q ss_pred hhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
+|||||||++|||++ ||..........................+.++.++|.+||+.||.+||++.++++|+|+...
T Consensus 189 ~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred chhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 999999999999996 77665554444443332222222223456789999999999999999999999999998765
Q ss_pred h
Q 000880 736 E 736 (1239)
Q Consensus 736 ~ 736 (1239)
.
T Consensus 269 ~ 269 (282)
T cd06643 269 S 269 (282)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=332.56 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=205.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
+.|+++++||.|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 80 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--------- 80 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe---------
Confidence 5689999999999999999999999999999998643 33456678899999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||+++ +|..++.+ ...+++..++.++.||+.||+|||++
T Consensus 81 -------------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 129 (292)
T cd06644 81 -------------------------------DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129 (292)
T ss_pred -------------------------------CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 3468999999975 77776654 45689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC----CCCCCc
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKIDE 657 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~~~ 657 (1239)
|++||||||+||+++.++.+||+|||++....... .......+++.|+|||++.+ ...++.
T Consensus 130 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 194 (292)
T cd06644 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL---------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194 (292)
T ss_pred CeeecCCCcceEEEcCCCCEEEccCccceeccccc---------------cccceecCCccccCceeeccccccCCCCCc
Confidence 99999999999999999999999999987532110 11234568899999999853 234688
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
++|||||||++|||++ ||..........................+.++.++|.+||..||++||++.++++|+|+..
T Consensus 195 ~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred hhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 9999999999999997 6665544443333322211111222345578999999999999999999999999999987
Q ss_pred chH
Q 000880 735 MEY 737 (1239)
Q Consensus 735 ~~~ 737 (1239)
...
T Consensus 275 ~~~ 277 (292)
T cd06644 275 VTS 277 (292)
T ss_pred ccc
Confidence 654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=332.27 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=206.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 73 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--------- 73 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec---------
Confidence 5789999999999999999999989999999998743 33345678899999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||+++ +|.+++... ..+++..++.++.|++.||.|||++
T Consensus 74 -------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~ 122 (280)
T cd06611 74 -------------------------------ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122 (280)
T ss_pred -------------------------------CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3567999999974 898888764 4699999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC----CCCCCc
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKIDE 657 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~~~ 657 (1239)
||+||||||+||+++.++.++|+|||++....... .......||+.|+|||++.. ...++.
T Consensus 123 ~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~ 187 (280)
T cd06611 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL---------------QKRDTFIGTPYWMAPEVVACETFKDNPYDY 187 (280)
T ss_pred CcccCCCChhhEEECCCCCEEEccCccchhhcccc---------------cccceeecchhhcCHHHHhhcccCCCCCCc
Confidence 99999999999999999999999999987542111 01234578999999998752 134678
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
++|+|||||++|||++ ||..........................+.++.++|.+||+.+|.+||++.++++|+|+..
T Consensus 188 ~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 188 KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred cccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 9999999999999997 7765544443333322111111122345678999999999999999999999999999987
Q ss_pred ch
Q 000880 735 ME 736 (1239)
Q Consensus 735 ~~ 736 (1239)
..
T Consensus 268 ~~ 269 (280)
T cd06611 268 QS 269 (280)
T ss_pred cc
Confidence 63
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.36 Aligned_cols=265 Identities=22% Similarity=0.385 Sum_probs=206.5
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCC----cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecC
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDG----RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETG 496 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g----~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~ 496 (1239)
..+..|+.+..||+|.||.||+|..+.++ +.||||+++-............||+.+++.++||||+.+..+|..+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~- 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH- 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-
Confidence 34678999999999999999999665443 3799999976544444566788999999999999999998887542
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-----CCCCHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-----DHFDKELAWHLFRQI 571 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-----~~l~~~~~~~i~~qI 571 (1239)
...+++++||.+.+|..+++-. ..++...++.++.||
T Consensus 100 --------------------------------------d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQi 141 (438)
T KOG0666|consen 100 --------------------------------------DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQI 141 (438)
T ss_pred --------------------------------------CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHH
Confidence 4678999999999999998632 358999999999999
Q ss_pred HHHHHHHHhCCccccCCCcccEEEcCC----CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcc
Q 000880 572 VEGLAHIHGQGIIHRDLTPNNIFFDAR----NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647 (1239)
Q Consensus 572 ~~gL~yLHs~gIiHrDLKp~NILl~~~----~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 647 (1239)
+.|+.|||++-|+||||||.|||+..+ |.|||+|||+|+.+..+-.. .......+-|.+|.|||
T Consensus 142 l~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkp------------l~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 142 LDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKP------------LASLDPVVVTIWYRAPE 209 (438)
T ss_pred HhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccc------------cccCCceEEEEEecChH
Confidence 999999999999999999999999888 89999999999987544211 11234467899999999
Q ss_pred cccCCCCCCcchhhHHHHHHHHHhhc--CCchhHHH-------------HHHHHh------------------------h
Q 000880 648 IEQGWPKIDEKADMYSLGIVFFELWH--PFSTAMER-------------QIVLSD------------------------L 688 (1239)
Q Consensus 648 ~l~~~~~~~~ksDIwSlGviL~ELlt--Pf~~~~~~-------------~~~~~~------------------------~ 688 (1239)
.|.|...|+++.||||+|||+.||++ |.....+. ...+.. .
T Consensus 210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f 289 (438)
T KOG0666|consen 210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF 289 (438)
T ss_pred HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence 99998889999999999999999986 32211110 000110 0
Q ss_pred hhcCCCCC-------ccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 689 KQKGELPP-------SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 689 ~~~~~~p~-------~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
......+. .+...++.+.+|+.+||..||.+|.|++++|+|++|..++
T Consensus 290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 00000010 1112334577999999999999999999999999998774
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=331.25 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=201.9
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
|++.+.||.|++|.||+|.++.+|..||||++............+.+|+.+++.++||||+++++++..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~----------- 69 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----------- 69 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----------
Confidence 567889999999999999999999999999998654444445678899999999999999999988732
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....|++|||++++|.+++.... .+++..++.++.||+.||+|||++++
T Consensus 70 -----------------------------~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~ 120 (283)
T cd07835 70 -----------------------------ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120 (283)
T ss_pred -----------------------------CCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35789999999989999987765 69999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||+|+||+++.++.++|+|||++....... .......+++.|+|||++.+...++.++||||
T Consensus 121 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 185 (283)
T cd07835 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPV---------------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWS 185 (283)
T ss_pred eCCCCCHHHEEEcCCCcEEEeecccccccCCCc---------------cccCccccccCCCCCceeecCcccCcHHHHHH
Confidence 999999999999999999999999997542111 01123467899999998876455789999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcC--------------------------CCCCccccCCHHHHHHHHHccC
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKG--------------------------ELPPSWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~--------------------------~~p~~~~~~~~e~~~LI~~~L~ 714 (1239)
|||++|+|++ ||................. .........++.+.++|.+||+
T Consensus 186 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 265 (283)
T cd07835 186 IGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLV 265 (283)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhc
Confidence 9999999997 6654433222222111000 0001123345688999999999
Q ss_pred CCCCCCCCHHHHHhccCC
Q 000880 715 PSPSDRPSATELLQDALP 732 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~~~~ 732 (1239)
.||.+|||+.++++|+||
T Consensus 266 ~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 266 YDPAKRISAKAALQHPYF 283 (283)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=331.45 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=198.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++|++.+.||.|+||.||+|.++.+++.||||.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------- 73 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIH--------- 73 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEe---------
Confidence 57899999999999999999999989999999998754322 22345678999999999999999998873
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
.....|+||||++++|.+++... ..+++..++.++.||+.||.|||++
T Consensus 74 -------------------------------~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~ 122 (291)
T cd07844 74 -------------------------------TKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122 (291)
T ss_pred -------------------------------cCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 24578999999999999988754 4689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+...++.++||
T Consensus 123 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv 187 (291)
T cd07844 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS---------------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187 (291)
T ss_pred CeecccCCHHHEEEcCCCCEEECccccccccCCCC---------------ccccccccccccCCcHHhhcCcccCcHHHH
Confidence 99999999999999999999999999987532111 011233578899999998765568899999
Q ss_pred HHHHHHHHHhhc---CCchhHH-HHHHHHhhhhcCC-------------------C----CC----ccccCC--HHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAME-RQIVLSDLKQKGE-------------------L----PP----SWVAKF--SEQESL 708 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~-~~~~~~~~~~~~~-------------------~----p~----~~~~~~--~e~~~L 708 (1239)
|||||++|+|++ ||..... .+........... . +. ...... +++.++
T Consensus 188 ~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (291)
T cd07844 188 WGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEEL 267 (291)
T ss_pred HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHH
Confidence 999999999996 6643321 1111111000000 0 00 001122 677899
Q ss_pred HHHccCCCCCCCCCHHHHHhccCC
Q 000880 709 LRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 709 I~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|.+||+.+|.+|||+.++++|+||
T Consensus 268 i~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 268 ALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHhccCcccccCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.85 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=204.9
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCc-------hhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-------PVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~-------~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
|.+...||.|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 77 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---- 77 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----
Confidence 566789999999999999999899999999987543321 123568899999999999999999988733
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
..+.+++|||++ ++|.+++.....+++..+..++.|++.||+|
T Consensus 78 ------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~ 121 (267)
T cd06628 78 ------------------------------------ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121 (267)
T ss_pred ------------------------------------CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHH
Confidence 356789999996 5899999888889999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++|++||||||+||+++.++.++|+|||+++......... ..........|++.|+|||.+.+ ..++.
T Consensus 122 lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~~y~~pe~~~~-~~~~~ 191 (267)
T cd06628 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST---------KTNGARPSLQGSVFWMAPEVVKQ-TSYTR 191 (267)
T ss_pred HHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccC---------CccccccccCCCcCccChhHhcc-CCCCc
Confidence 999999999999999999999999999999998654211100 00011223568999999999987 56889
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
++|+|||||++|+|++ ||.............. ...+......+..+.++|++||+.||.+||++.++++|+||
T Consensus 192 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 192 KADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE--NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred hhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc--cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999996 7765544333332221 22333334456789999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=332.41 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=205.8
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..+|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.+.||||+++++.|..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-------- 88 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-------- 88 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEe--------
Confidence 3689999999999999999999999999999999875443 234678899999999999999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....|+||||++ ++|.+++.. ..+++.++..++.|++.||+|||++
T Consensus 89 --------------------------------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~ 135 (296)
T cd06654 89 --------------------------------GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 135 (296)
T ss_pred --------------------------------CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346899999996 589988854 4689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||++....... .......|++.|+|||.+.+ ..++.++||
T Consensus 136 gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 199 (296)
T cd06654 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------------SKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199 (296)
T ss_pred CcccCCCCHHHEEEcCCCCEEECccccchhccccc---------------cccCcccCCccccCHHHHcC-CCCCccchH
Confidence 99999999999999999999999999987642211 01123478999999999887 568899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|||||++|+|++ ||....................+.....++.+.++|.+||..||.+|||+.++++|+|+...
T Consensus 200 ~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999997 77655443333222221111112233456788999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=348.41 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=194.8
Q ss_pred cCCceEEeeeccCCceEEEEEEE-----ccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKN-----KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~ 496 (1239)
.++|++.+.||+|+||.||+|++ ..++..||||+++... .......+.+|+.+|+.+ +||||++++++|..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 35799999999999999999975 3456789999986433 233456788999999999 89999999998743
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC------------------
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD------------------ 557 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~------------------ 557 (1239)
....|+|||||+ |+|.+++....
T Consensus 111 --------------------------------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~ 152 (375)
T cd05104 111 --------------------------------------GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYK 152 (375)
T ss_pred --------------------------------------CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHH
Confidence 245689999996 68888875421
Q ss_pred ---------------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 000880 558 ---------------------------------------------------------HFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 558 ---------------------------------------------------------~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
.+++..++.++.||+.||+|||+
T Consensus 153 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 232 (375)
T cd05104 153 NLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS 232 (375)
T ss_pred hhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36788899999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+||+||||||+|||++.++.+||+|||+++....... ........+++.|+|||++.+ ..++.++|
T Consensus 233 ~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sD 298 (375)
T cd05104 233 KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-------------YVVKGNARLPVKWMAPESIFN-CVYTFESD 298 (375)
T ss_pred CCeeccCCchhhEEEECCCcEEEecCccceeccCccc-------------ccccCCCCCCcceeChhHhcC-CCCCCCCC
Confidence 9999999999999999999999999999976432110 000112345678999999987 56899999
Q ss_pred hHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 661 MYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 661 IwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
||||||++|||++ ||............+. .+..+......++++.+||.+||+.||++|||+.++++.
T Consensus 299 i~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH-hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999985 6655443333333333 222222223345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=339.04 Aligned_cols=257 Identities=27% Similarity=0.449 Sum_probs=207.7
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
-..|+++++||+||.++||++... +.+.||+|++.....+.....-+.+|+..|.+| .|.+||++|++=+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-------- 430 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-------- 430 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec--------
Confidence 357999999999999999999886 567888888776666767778899999999999 5999999997631
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDK-ELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~-~~~~~i~~qI~~gL~yLHs 580 (1239)
...++||||||-+.+|..+|.+...... -..+.|..|++.|+.++|.
T Consensus 431 --------------------------------~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~ 478 (677)
T KOG0596|consen 431 --------------------------------TDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ 478 (677)
T ss_pred --------------------------------cCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH
Confidence 2578999999999999999998766433 4788999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC-------
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP------- 653 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------- 653 (1239)
+||||-||||.|+|+- .|.+||+|||+|..+... ..++...+.+||+.|||||++....
T Consensus 479 ~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D-------------TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~ 544 (677)
T KOG0596|consen 479 HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD-------------TTSIVKDSQVGTVNYMSPEALTDMSSSRENGK 544 (677)
T ss_pred hceeecCCCcccEEEE-eeeEEeeeechhcccCcc-------------ccceeeccccCcccccCHHHHhhccccccCCC
Confidence 9999999999999985 599999999999876432 2334456789999999999986421
Q ss_pred ---CCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc-C--CCCCccccCCHHHHHHHHHccCCCCCCCCCHH
Q 000880 654 ---KIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK-G--ELPPSWVAKFSEQESLLRRLMSPSPSDRPSAT 724 (1239)
Q Consensus 654 ---~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-~--~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~ 724 (1239)
+.++++||||||||||+|++ ||....+....+..+... . .+|... .. .++.++++.||..||++|||..
T Consensus 545 ~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~-~~-~~li~~mK~CL~rdPkkR~si~ 622 (677)
T KOG0596|consen 545 SKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIP-EN-DELIDVMKCCLARDPKKRWSIP 622 (677)
T ss_pred cceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCC-Cc-hHHHHHHHHHHhcCcccCCCcH
Confidence 25689999999999999994 888776555544444322 1 223221 11 2489999999999999999999
Q ss_pred HHHhccCCCCch
Q 000880 725 ELLQDALPPQME 736 (1239)
Q Consensus 725 eiL~~~~~~~~~ 736 (1239)
++|+|||.....
T Consensus 623 eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 623 ELLQHPFLQIQP 634 (677)
T ss_pred HHhcCccccccc
Confidence 999999887643
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.38 Aligned_cols=250 Identities=33% Similarity=0.532 Sum_probs=208.8
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|+.++.||.|+||.||.+++..+++.+++|.+.....+......+.+|+.++++++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---------- 70 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD---------- 70 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec----------
Confidence 4889999999999999999999999999999998766555666788999999999999999999998843
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...++++||||+ ++|.+++... ..+++..+..++.|++.||.|||++
T Consensus 71 ------------------------------~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (256)
T cd08221 71 ------------------------------DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120 (256)
T ss_pred ------------------------------CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356899999996 5999998764 4589999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+||+++.++.+||+|||++........ ......|++.|+|||.+.+ ..++.++|+
T Consensus 121 ~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---------------~~~~~~~~~~y~ape~~~~-~~~~~~~Dv 184 (256)
T cd08221 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---------------MAETVVGTPYYMSPELCQG-VKYNFKSDI 184 (256)
T ss_pred CccccCCChHhEEEeCCCCEEECcCcceEEcccccc---------------cccccCCCccccCHhhcCC-CCCCCcchh
Confidence 999999999999999999999999999976432110 1234578999999999887 458899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
||||+++|||++ ||......+....... +..++.....+.++.++|.+||..+|.+||++.++++|+|+
T Consensus 185 ~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999997 6655444444433332 33333334566789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=340.13 Aligned_cols=265 Identities=26% Similarity=0.370 Sum_probs=204.5
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||+|+||.||+|.+..+|+.||||+++... .......+.+|+.+++.++||||+++++.+....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS------ 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc------
Confidence 368999999999999999999999999999999986422 2234567889999999999999999998764321
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
......+|++|||++++|.+++.. ..+++..++.++.||+.||+|||++|
T Consensus 77 -----------------------------~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ 126 (336)
T cd07849 77 -----------------------------FESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN 126 (336)
T ss_pred -----------------------------ccccceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 012346799999999999887754 56999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+|||++.++.+||+|||++......... ........||+.|+|||++.+...++.++|||
T Consensus 127 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw 194 (336)
T cd07849 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH------------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIW 194 (336)
T ss_pred eeccCCCHHHEEECCCCCEEECcccceeeccccccc------------cCCcCCcCcCCCccChHHhhCCCCCCcHHHHH
Confidence 999999999999999999999999999764321100 00123457899999999876545689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhh-----------------------h---hcCCCC--CccccCCHHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDL-----------------------K---QKGELP--PSWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~-----------------------~---~~~~~p--~~~~~~~~e~~~LI~~ 711 (1239)
||||++|+|++ ||............. . .....+ ...+..++++.++|.+
T Consensus 195 slGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (336)
T cd07849 195 SVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDK 274 (336)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHH
Confidence 99999999997 664322111110000 0 000000 0112345678999999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCch
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||+.||.+|||+.++++|||+.+..
T Consensus 275 ~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 275 MLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HcCCChhhCcCHHHHhcCccccccC
Confidence 9999999999999999999998663
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=333.88 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=203.6
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS---LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~---~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+|++.+.||+|+||.||+|.+..+|+.||||.++..... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------- 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH------- 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-------
Confidence 478889999999999999999989999999999765433 3344567889999999999999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|+||||++++|.+++.... .+++..++.++.||+.||.|||+
T Consensus 74 ---------------------------------~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~ 120 (298)
T cd07841 74 ---------------------------------KSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120 (298)
T ss_pred ---------------------------------CCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 35789999999889999998766 79999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+||+|+||||+|||++.++.++|+|||+++...... .......+++.|+|||.+.+...++.++|
T Consensus 121 ~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 185 (298)
T cd07841 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN---------------RKMTHQVVTRWYRAPELLFGARHYGVGVD 185 (298)
T ss_pred CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---------------ccccccccceeeeCHHHHhCCCCCCcHHH
Confidence 999999999999999999999999999998653211 01122357889999999876456889999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC--------------------CC-----CccccCCHHHHHHHHHc
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE--------------------LP-----PSWVAKFSEQESLLRRL 712 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~--------------------~p-----~~~~~~~~e~~~LI~~~ 712 (1239)
+|||||++|||++ ||....+............. .+ ..+...+.++.++|.+|
T Consensus 186 v~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 265 (298)
T cd07841 186 MWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRL 265 (298)
T ss_pred HHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHH
Confidence 9999999999997 34332222211111110000 00 01123356788999999
Q ss_pred cCCCCCCCCCHHHHHhccCCCCch
Q 000880 713 MSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|+.||++|||+.++++|+||.+..
T Consensus 266 l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 266 LTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred hcCCcccCcCHHHHhhCccccCCC
Confidence 999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=332.89 Aligned_cols=275 Identities=27% Similarity=0.379 Sum_probs=208.5
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.+++|++.+.||.|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++++.+.+...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 81 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD---- 81 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc----
Confidence 3689999999999999999999999999999999987654433334467889999999999999999987754310
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
........+|++|+|++++|...+.. ...+++..++.++.||+.||+|||+
T Consensus 82 ----------------------------~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~ 133 (311)
T cd07866 82 ----------------------------KSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE 133 (311)
T ss_pred ----------------------------cccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 00123457899999999888887765 3479999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+||+||||||+|||++.++.+||+|||++............ .........+...||+.|+|||++.+...++.++|
T Consensus 134 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 209 (311)
T cd07866 134 NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG----GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVD 209 (311)
T ss_pred CCeecCCCCHHHEEECCCCCEEECcCccchhccCCCccccc----CCcccccccccceeccCcCChHHhhCCCccCchhH
Confidence 99999999999999999999999999999865432211000 00001122345678999999998876456899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-----------------------CCC----ccccCCHHHHHHHH
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-----------------------LPP----SWVAKFSEQESLLR 710 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-----------------------~p~----~~~~~~~e~~~LI~ 710 (1239)
||||||++|||++ ||................+. .++ .+....+.+.++|.
T Consensus 210 v~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 289 (311)
T cd07866 210 IWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLS 289 (311)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHH
Confidence 9999999999997 55443333222211110000 010 11223357889999
Q ss_pred HccCCCCCCCCCHHHHHhccCC
Q 000880 711 RLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+||..||.+|||+.+++.|+||
T Consensus 290 ~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 290 KLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHcccCcccCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=325.58 Aligned_cols=249 Identities=27% Similarity=0.470 Sum_probs=202.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||.|+||.||+|.+..+++.||+|.++.... ...+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~--------- 69 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFK--------- 69 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeec---------
Confidence 678999999999999999999998899999999864321 5689999999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++|||++ ++|.+++.. ...+++..++.++.||+.||.|||++
T Consensus 70 -------------------------------~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~ 118 (256)
T cd06612 70 -------------------------------NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118 (256)
T ss_pred -------------------------------CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356899999997 589998875 45689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
+++||||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+ ..++.++||
T Consensus 119 ~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---------------~~~~~~~~~~y~~PE~~~~-~~~~~~~Di 182 (256)
T cd06612 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---------------KRNTVIGTPFWMAPEVIQE-IGYNNKADI 182 (256)
T ss_pred CcccCCCCcceEEECCCCcEEEcccccchhcccCcc---------------ccccccCCccccCHHHHhc-CCCCchhhH
Confidence 999999999999999999999999999986532110 1123458899999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|||||++|+|++ ||..........................+.++.++|.+||+.||.+|||+.++++|+|+
T Consensus 183 ~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 183 WSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999997 66554443333222211111111222345688999999999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.31 Aligned_cols=250 Identities=31% Similarity=0.591 Sum_probs=206.7
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||+|+||.||++++..+|+.||+|.+............+.+|+.+++.++||||+++++++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----------- 69 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE----------- 69 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----------
Confidence 488999999999999999999999999999999865444445568899999999999999999998762
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
.....|+||||+. ++|.+.+.... .+++..++.++.|++.||.|||++
T Consensus 70 -----------------------------~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (256)
T cd08218 70 -----------------------------ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120 (256)
T ss_pred -----------------------------CCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2357899999996 58999887543 588999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++|+||+|+|||++.++.++|+|||++........ ......|++.|+|||++.+ ..++.++|+
T Consensus 121 ~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv 184 (256)
T cd08218 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---------------LARTCIGTPYYLSPEICEN-RPYNNKSDI 184 (256)
T ss_pred CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---------------hhhhccCCccccCHHHhCC-CCCCCccch
Confidence 999999999999999999999999999976432110 0122468899999999987 568899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|||||++|+|++ ||............+. +..++.....+.++.++|.+||+.+|.+||++.++++|+||
T Consensus 185 ~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999997 6655544444444432 33333344556789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=327.73 Aligned_cols=247 Identities=18% Similarity=0.244 Sum_probs=196.8
Q ss_pred CCceEEeeeccCCceEEEEEEEc---cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNK---LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
++|++.+.||+|+||.||+|.++ ..+..||+|.++.. .+......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 77 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR------ 77 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec------
Confidence 57899999999999999999875 34678999998743 333445678999999999999999999988732
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
...+|+||||++ ++|.+++... ..+++..++.++.||+.||+||
T Consensus 78 ----------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~l 123 (266)
T cd05064 78 ----------------------------------GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123 (266)
T ss_pred ----------------------------------CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 346799999997 5888888764 5689999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|++|++||||||+|||++.++.+|++|||.+....... ........+++.|+|||.+.+ ..++.+
T Consensus 124 H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~ 188 (266)
T cd05064 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA--------------IYTTMSGKSPVLWAAPEAIQY-HHFSSA 188 (266)
T ss_pred HHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc--------------hhcccCCCCceeecCHHHHhh-CCccch
Confidence 99999999999999999999999999999876432110 001122346788999999887 678999
Q ss_pred hhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 659 ADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 659 sDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
+|||||||++||+++ ||.......... .+. ....++.....+..+.+++.+||+.+|.+||++.+|++
T Consensus 189 ~Di~slG~~l~ell~~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 189 SDVWSFGIVMWEVMSYGERPYWDMSGQDVIK-AVE-DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHH-CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999774 776554443322 222 22233344556678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=337.82 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=209.3
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSG 509 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g 509 (1239)
++||+|.||+||-|+++.+|+.||||+|.+-.-......++.+|+.+|.++.||.||.+-..| +
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-E--------------- 633 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-E--------------- 633 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-c---------------
Confidence 689999999999999999999999999976554445567899999999999999999987554 2
Q ss_pred cccccccccccccccccccccccccccEEEEEeeccCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 510 TLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE--SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 510 ~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~--~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
....+|+|||-+.|+....+- +.+++++....+++.||+.||.|||.++|+|.|
T Consensus 634 ------------------------T~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCD 689 (888)
T KOG4236|consen 634 ------------------------TPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCD 689 (888)
T ss_pred ------------------------CCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeecc
Confidence 356789999999998666553 457899999999999999999999999999999
Q ss_pred CCcccEEEcCC---CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 588 LTPNNIFFDAR---NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 588 LKp~NILl~~~---~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
|||+|||+.+. ..+||||||+|+.+..... ..+.+|||+|+|||+|+. ..|+..-||||+
T Consensus 690 LKPENVLLas~~~FPQvKlCDFGfARiIgEksF----------------RrsVVGTPAYLaPEVLrn-kGyNrSLDMWSV 752 (888)
T KOG4236|consen 690 LKPENVLLASASPFPQVKLCDFGFARIIGEKSF----------------RRSVVGTPAYLAPEVLRN-KGYNRSLDMWSV 752 (888)
T ss_pred CCchheeeccCCCCCceeeccccceeecchhhh----------------hhhhcCCccccCHHHHhh-ccccccccceee
Confidence 99999999764 4699999999998764431 356799999999999998 579999999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhhhhcCCCC-CccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|||+|--++ ||....+....+ ......+| ..|..+++++.+||..+|+..-.+|.|.+..|.|+|++...
T Consensus 753 GVIiYVsLSGTFPFNEdEdIndQI--QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 753 GVIIYVSLSGTFPFNEDEDINDQI--QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred eEEEEEEecccccCCCccchhHHh--hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 999998885 776544333322 22234444 47889999999999999999999999999999999999764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=347.01 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=194.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCC-----cEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDG-----RHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g-----~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~ 496 (1239)
.++|++.+.||+|+||.||+|++..+| ..||||+++.... ......+.+|+.+++.+ +|||||+++++|..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 368999999999999999999975544 5799999975432 23456788999999999 89999999998743
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-------------------
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY------------------- 556 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~------------------- 556 (1239)
...+|+|||||+ |+|.+++...
T Consensus 114 --------------------------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~ 155 (374)
T cd05106 114 --------------------------------------GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSS 155 (374)
T ss_pred --------------------------------------CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccc
Confidence 345789999996 6888887532
Q ss_pred ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 000880 557 ---------------------------------------------------DHFDKELAWHLFRQIVEGLAHIHGQGIIH 585 (1239)
Q Consensus 557 ---------------------------------------------------~~l~~~~~~~i~~qI~~gL~yLHs~gIiH 585 (1239)
..+++..+++++.||+.||+|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiH 235 (374)
T cd05106 156 DYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIH 235 (374)
T ss_pred cccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 23678889999999999999999999999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHH
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlG 665 (1239)
|||||+|||++.++++||+|||+++....... ........+++.|||||++.+ ..++.++||||||
T Consensus 236 rDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG 301 (374)
T cd05106 236 RDVAARNVLLTDGRVAKICDFGLARDIMNDSN-------------YVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 301 (374)
T ss_pred ccCchheEEEeCCCeEEEeeceeeeeccCCcc-------------eeeccCCCCccceeCHHHhcC-CCCCccccHHHHH
Confidence 99999999999999999999999975422110 000112345678999999877 5699999999999
Q ss_pred HHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 666 IVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 666 viL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|++|||++ ||.............. ....+......++++.++|.+||+.||.+|||+.++++.
T Consensus 302 vil~ellt~G~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 302 ILLWEIFSLGKSPYPGILVNSKFYKMVK-RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred HHHHHHHhCCCCCCccccccHHHHHHHH-cccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999984 7765544333333332 221222222346799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=329.16 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=197.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|.+++.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--------- 74 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--------- 74 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec---------
Confidence 6899999999999999999999999999999998754322 223467789999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....|+||||++++|.+.+.. ...+++..+..++.||+.||+|||++|
T Consensus 75 -------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ 123 (291)
T cd07870 75 -------------------------------KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123 (291)
T ss_pred -------------------------------CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356899999999888777654 356888899999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+...++.++|||
T Consensus 124 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 188 (291)
T cd07870 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIW 188 (291)
T ss_pred cccCCCChHHEEEcCCCcEEEeccccccccCCCC---------------CCCCCccccccccCCceeecCCCCCcHHHHH
Confidence 9999999999999999999999999987532111 0112346799999999987645578899999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHH-Hhhhh--------------cCC---------CCCc------cccCCHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVL-SDLKQ--------------KGE---------LPPS------WVAKFSEQESLL 709 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~-~~~~~--------------~~~---------~p~~------~~~~~~e~~~LI 709 (1239)
||||++|||++ ||.......... ..... ... .+.. .....+++.+++
T Consensus 189 slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 268 (291)
T cd07870 189 GAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA 268 (291)
T ss_pred HHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHH
Confidence 99999999997 665443321111 11000 000 0000 011245788999
Q ss_pred HHccCCCCCCCCCHHHHHhccCC
Q 000880 710 RRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 710 ~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
.+||..||.+|||+.+++.||||
T Consensus 269 ~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 269 SQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHhCcCcccCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=347.72 Aligned_cols=256 Identities=29% Similarity=0.517 Sum_probs=215.4
Q ss_pred CCCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCC--CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeec
Q 000880 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD--KSLPVNDRILREVATLSRLQHQHVVRYYQAWFET 495 (1239)
Q Consensus 418 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~--~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~ 495 (1239)
+.+||+ +...+||+|+|-+||+|.+..+|..||.-.++..+ .+....++|..|+.+|+.|+|||||++|..|.+.
T Consensus 37 p~gRy~---k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 37 PTGRYL---KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred CCCcee---ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 355653 33467999999999999999999999987666554 3455568999999999999999999999999654
Q ss_pred CccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 000880 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEG 574 (1239)
Q Consensus 496 ~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~g 574 (1239)
....+.+|+|++. |+|..++.+.++++...++.|++||++|
T Consensus 114 --------------------------------------~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkG 155 (632)
T KOG0584|consen 114 --------------------------------------DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKG 155 (632)
T ss_pred --------------------------------------CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHH
Confidence 2367889999995 8999999999999999999999999999
Q ss_pred HHHHHhCC--ccccCCCcccEEEcCC-CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC
Q 000880 575 LAHIHGQG--IIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651 (1239)
Q Consensus 575 L~yLHs~g--IiHrDLKp~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 651 (1239)
|.|||++. |||||||-.||||+.+ |.|||+|+|+|+...... ..+.+|||.|||||.+..
T Consensus 156 L~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-----------------aksvIGTPEFMAPEmYEE 218 (632)
T KOG0584|consen 156 LVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-----------------AKSVIGTPEFMAPEMYEE 218 (632)
T ss_pred hhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-----------------cceeccCccccChHHHhh
Confidence 99999985 9999999999999876 899999999999764221 245799999999999984
Q ss_pred CCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCcccc-CCHHHHHHHHHccCCCCCCCCCHHHHH
Q 000880 652 WPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVA-KFSEQESLLRRLMSPSPSDRPSATELL 727 (1239)
Q Consensus 652 ~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~-~~~e~~~LI~~~L~~dP~~RPta~eiL 727 (1239)
.|+..+||||||.+|+||.| ||..-.+.....+.+. .+..|..+.. ..|++++||.+||.. .++|||+.++|
T Consensus 219 --~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 219 --NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred --hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHh
Confidence 69999999999999999997 8877665555555444 4555554433 347999999999999 99999999999
Q ss_pred hccCCCCc
Q 000880 728 QDALPPQM 735 (1239)
Q Consensus 728 ~~~~~~~~ 735 (1239)
+|+||...
T Consensus 295 ~d~Ff~~d 302 (632)
T KOG0584|consen 295 KDPFFDED 302 (632)
T ss_pred hChhhccc
Confidence 99999865
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.30 Aligned_cols=252 Identities=35% Similarity=0.620 Sum_probs=207.1
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||.|+||.||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR--------- 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---------
Confidence 58889999999999999999999999999999986655555667899999999999999999999876432
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....+|++|||++ ++|.+++.. ...+++..++.++.||+.||.|||
T Consensus 72 -----------------------------~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 122 (265)
T cd08217 72 -----------------------------SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122 (265)
T ss_pred -----------------------------CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 2356799999996 589988865 356899999999999999999999
Q ss_pred -----hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC
Q 000880 580 -----GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654 (1239)
Q Consensus 580 -----s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 654 (1239)
+.+++|+||||+||+++.++.+||+|||++....... .......|++.|+|||++.+ ..
T Consensus 123 ~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~---------------~~~~~~~~~~~~~~pE~~~~-~~ 186 (265)
T cd08217 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS---------------SFAKTYVGTPYYMSPEQLNH-MS 186 (265)
T ss_pred cCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc---------------ccccccccCCCccChhhhcC-CC
Confidence 9999999999999999999999999999998653211 00123478999999999987 56
Q ss_pred CCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
++.++|+||||+++|+|++ ||.......... ... .+..+......++.+.+++.+||+.+|++||++.+|++|||
T Consensus 187 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~ 264 (265)
T cd08217 187 YDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS-KIK-EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264 (265)
T ss_pred CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHH-HHh-cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence 8899999999999999996 676554333222 222 33333333455678999999999999999999999999998
Q ss_pred C
Q 000880 732 P 732 (1239)
Q Consensus 732 ~ 732 (1239)
.
T Consensus 265 ~ 265 (265)
T cd08217 265 I 265 (265)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.55 Aligned_cols=257 Identities=24% Similarity=0.425 Sum_probs=200.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+ +||||++++++|....
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~----- 88 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD----- 88 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc-----
Confidence 578999999999999999999999999999999876322 2235678899999999 6999999999875421
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
......+|++|||++ ++|.+++.. ...+++..++.++.||+.||.
T Consensus 89 ------------------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ 138 (286)
T cd06638 89 ------------------------------VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138 (286)
T ss_pred ------------------------------cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence 013457899999996 589887752 346889999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC----
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW---- 652 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---- 652 (1239)
|||+++++||||||+||+++.++.+||+|||+++...... .......||+.|+|||++...
T Consensus 139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (286)
T cd06638 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---------------LRRNTSVGTPFWMAPEVIACEQQLD 203 (286)
T ss_pred HHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC---------------CccccccCCCcccChhhhchhhhcc
Confidence 9999999999999999999999999999999987643211 011234699999999987531
Q ss_pred CCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 653 PKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 653 ~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
..++.++|||||||++|||++ ||..........................+..+.++|.+||+.||++|||+.++++|
T Consensus 204 ~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 204 STYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 347889999999999999996 66655443333222111111111112235689999999999999999999999999
Q ss_pred cCC
Q 000880 730 ALP 732 (1239)
Q Consensus 730 ~~~ 732 (1239)
+|+
T Consensus 284 ~~~ 286 (286)
T cd06638 284 VFI 286 (286)
T ss_pred ccC
Confidence 986
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=330.81 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=206.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++.+..
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 87 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--------- 87 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec---------
Confidence 579999999999999999999999999999999875432 335678899999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|+||||++ ++|..++.. ..+++.++..++.|++.||+|||++|
T Consensus 88 -------------------------------~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~ 135 (296)
T cd06655 88 -------------------------------GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ 135 (296)
T ss_pred -------------------------------CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356899999996 588887764 46899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++||||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+ ..++.++|+|
T Consensus 136 i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~ 199 (296)
T cd06655 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ---------------SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIW 199 (296)
T ss_pred cccCCCCHHHEEECCCCCEEEccCccchhccccc---------------ccCCCcCCCccccCcchhcC-CCCCchhhHH
Confidence 9999999999999999999999999987643211 01123468999999999887 5688999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
||||++|+|++ ||..........................++.+.++|++||..||.+|||+.++++|+|+...
T Consensus 200 slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 99999999997 77665544333322221111222334566789999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=328.15 Aligned_cols=252 Identities=25% Similarity=0.445 Sum_probs=200.9
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++++.||.|++|.||+|+++.+|..||||+++..... .....+.+|+.+++.++||||++++++|..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---------- 69 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT---------- 69 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee----------
Confidence 588999999999999999999999999999999754322 234567889999999999999999988743
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY---DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++++|.+++... ..+++..+..++.||+.||+|||++
T Consensus 70 ------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (284)
T cd07836 70 ------------------------------ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119 (284)
T ss_pred ------------------------------CCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 3467999999999999888654 3589999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+||++++++.++|+|||++....... .......+|+.|+|||++.+...++.++||
T Consensus 120 ~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 184 (284)
T cd07836 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---------------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDI 184 (284)
T ss_pred CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---------------cccccccccccccChHHhcCCCCCCcHHHH
Confidence 99999999999999999999999999997543211 011234678999999998775568899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhh------------------cCCCCC--------ccccCCHHHHHHHHHc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQ------------------KGELPP--------SWVAKFSEQESLLRRL 712 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~------------------~~~~p~--------~~~~~~~e~~~LI~~~ 712 (1239)
|||||++|+|++ ||......+........ ....|. ..+..++.+.++|.+|
T Consensus 185 ~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 264 (284)
T cd07836 185 WSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRL 264 (284)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHH
Confidence 999999999997 66544333222211110 000010 0123356788999999
Q ss_pred cCCCCCCCCCHHHHHhccCC
Q 000880 713 MSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~ 732 (1239)
|+.||.+||++.++++||||
T Consensus 265 l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 265 LQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=330.20 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=201.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCC-----cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDG-----RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g-----~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
+++|++.+.||+|+||.||+|.+...+ ..||+|.++.. ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--- 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--- 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC---
Confidence 468899999999999999999987555 68999988643 233445678999999999999999999988732
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------------CCCC
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------DHFD 560 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~~l~ 560 (1239)
....|++|||++ ++|.+++... ..++
T Consensus 80 -------------------------------------~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~ 122 (283)
T cd05048 80 -------------------------------------EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122 (283)
T ss_pred -------------------------------------CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCC
Confidence 245789999996 6999988754 4478
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccC
Q 000880 561 KELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640 (1239)
Q Consensus 561 ~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 640 (1239)
+..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++....... ........+|
T Consensus 123 ~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~-------------~~~~~~~~~~ 189 (283)
T cd05048 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY-------------YRVQSKSLLP 189 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeecccccc-------------ccccCCCccc
Confidence 889999999999999999999999999999999999999999999999975421110 0112334678
Q ss_pred ccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCC
Q 000880 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716 (1239)
Q Consensus 641 ~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~d 716 (1239)
+.|+|||.+.+ ..++.++|||||||++|||++ ||......+.... +. ....++.....++++.+|+++||+.|
T Consensus 190 ~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i~-~~~~~~~~~~~~~~~~~l~~~c~~~~ 266 (283)
T cd05048 190 VRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-IR-SRQLLPCPEDCPARVYALMIECWNEI 266 (283)
T ss_pred ccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HH-cCCcCCCcccCCHHHHHHHHHHccCC
Confidence 99999999877 568999999999999999986 7766554443332 22 33334444566789999999999999
Q ss_pred CCCCCCHHHHHhc
Q 000880 717 PSDRPSATELLQD 729 (1239)
Q Consensus 717 P~~RPta~eiL~~ 729 (1239)
|.+||++.+|+++
T Consensus 267 p~~Rp~~~~i~~~ 279 (283)
T cd05048 267 PARRPRFKDIHTR 279 (283)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.36 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=207.7
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||.|+||.||+|++..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 70 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--------- 70 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE---------
Confidence 46888899999999999999999999999999987543 23445678899999999999999999988743
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|+|+||++ ++|.+++... .+++..++.++.||+.||.|||+++
T Consensus 71 -------------------------------~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~ 118 (274)
T cd06609 71 -------------------------------GSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG 118 (274)
T ss_pred -------------------------------CCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999996 5899988765 7899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++||||+|+||+++.++.++|+|||+++...... .......|++.|+|||.+.+ ..++.++|||
T Consensus 119 i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~ 182 (274)
T cd06609 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM---------------SKRNTFVGTPFWMAPEVIKQ-SGYDEKADIW 182 (274)
T ss_pred cccCCCCHHHEEECCCCCEEEcccccceeecccc---------------cccccccCCccccChhhhcc-CCCCchhhHH
Confidence 9999999999999999999999999998653221 01233578899999999987 4589999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCcccc-CCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCchH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVA-KFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEY 737 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~-~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~~ 737 (1239)
||||++|+|++ ||.............. ...+..... .++.+.+++.+||..+|++|||+.++++|+|+.....
T Consensus 183 slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 183 SLGITAIELAKGEPPLSDLHPMRVLFLIPK--NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHHHHHHHHhCCCCcccCchHHHHHHhhh--cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 99999999997 6655443333322222 111211112 5678999999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.56 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=209.3
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+++.+.+..||.|+.|+||+++++.+|..+|||.+.... ..+...+++..+.++...+ .|+||+.+|+|+..
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n------ 163 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN------ 163 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC------
Confidence 577888899999999999999999999999999998544 4456778888888877664 89999999999643
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
..++|.||.|..-+..++.. .+++++..+-++...++.||.||..
T Consensus 164 ----------------------------------~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe 209 (391)
T KOG0983|consen 164 ----------------------------------TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE 209 (391)
T ss_pred ----------------------------------chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH
Confidence 34578999998777777654 4569999999999999999999986
Q ss_pred -CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCc
Q 000880 581 -QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDE 657 (1239)
Q Consensus 581 -~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ 657 (1239)
+||||||+||+|||+|..|++||||||++-++.... .++...|.+.|||||.+.- .+.|+-
T Consensus 210 KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk----------------AhtrsAGC~~YMaPERidp~~~~kYDi 273 (391)
T KOG0983|consen 210 KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----------------AHTRSAGCAAYMAPERIDPPDKPKYDI 273 (391)
T ss_pred hcceeecccCccceEEccCCCEEeecccccceeeccc----------------ccccccCCccccCccccCCCCCCccch
Confidence 579999999999999999999999999998764322 2355689999999999864 356999
Q ss_pred chhhHHHHHHHHHhhc---CCchhHH-HHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAME-RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~-~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
++|||||||+|+||.| ||..... -+...+++...+...+.-.+.++.+++|+..||.+|+.+||...++|+|+|..
T Consensus 274 RaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 274 RADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred hhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 9999999999999997 7766433 33333344333333333344678999999999999999999999999999876
Q ss_pred Cch
Q 000880 734 QME 736 (1239)
Q Consensus 734 ~~~ 736 (1239)
..+
T Consensus 354 ~ye 356 (391)
T KOG0983|consen 354 RYE 356 (391)
T ss_pred ecc
Confidence 554
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=327.16 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=196.3
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccCCCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
|++++.||+|+||.||+|.+..+++.||+|+++....+.. .....+|+.+++++. ||||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--------- 70 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR--------- 70 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC---------
Confidence 6788999999999999999999999999999875433322 234567999999985 99999999887432
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....+++||||++++|.+.+... ..+++..++.++.||+.||+|||++|+
T Consensus 71 -----------------------------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 71 -----------------------------KTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred -----------------------------CCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 12467999999999988888753 568999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+||+++. +.+||+|||+++...... ..+...+|+.|+|||++.+...++.++||||
T Consensus 122 ~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 184 (282)
T cd07831 122 FHRDIKPENILIKD-DILKLADFGSCRGIYSKP----------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWA 184 (282)
T ss_pred eecccCHHHEEEcC-CCeEEEecccccccccCC----------------CcCCCCCCcccCChhHhhcCCCCCcchhHHH
Confidence 99999999999999 999999999997642111 1123468899999998765456789999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhc------------------CCCCC--------ccccCCHHHHHHHHHccC
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQK------------------GELPP--------SWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~------------------~~~p~--------~~~~~~~e~~~LI~~~L~ 714 (1239)
|||++|||++ ||................ ...|. .....+.++.++|.+||+
T Consensus 185 lGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 264 (282)
T cd07831 185 VGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLA 264 (282)
T ss_pred HHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhc
Confidence 9999999996 665433322211111100 00111 112345788999999999
Q ss_pred CCCCCCCCHHHHHhccCC
Q 000880 715 PSPSDRPSATELLQDALP 732 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~~~~ 732 (1239)
++|.+|||+.++++||||
T Consensus 265 ~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 265 YDPDERITAKQALRHPYF 282 (282)
T ss_pred cCcccccCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=320.71 Aligned_cols=249 Identities=31% Similarity=0.557 Sum_probs=204.9
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|+..+.||+|+||.||+|.+..+++.+|||.+............+.+|+.+|+.++||||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---------- 70 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE---------- 70 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec----------
Confidence 5889999999999999999999999999999998665555566789999999999999999999977632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+++||||++ ++|.+++... ..+++..++.++.|++.||+|||++
T Consensus 71 ------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 120 (256)
T cd08220 71 ------------------------------DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120 (256)
T ss_pred ------------------------------CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356899999996 5999999764 3489999999999999999999999
Q ss_pred CccccCCCcccEEEcCCC-CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 582 GIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
|++||||||+||+++.++ .+||+|||++....... ......|++.|+|||.+.+ ..++.++|
T Consensus 121 ~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~D 183 (256)
T cd08220 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS----------------KAYTVVGTPCYISPELCEG-KPYNQKSD 183 (256)
T ss_pred CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc----------------cccccccCCcccCchhccC-CCCCcccc
Confidence 999999999999998654 58999999998653211 0123468999999999987 56889999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|||||+++|+|++ ||.............. ...++.....++++.+++.+||+.||.+|||+.++++|||+
T Consensus 184 v~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 184 IWALGCVLYELASLKRAFEAANLPALVLKIMS--GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred hHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999999997 7765544444433332 22222233456789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=338.96 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=206.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|.+.+.||+|+||+||+|++..+|+.||||.+............+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~------- 77 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH------- 77 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc-------
Confidence 5799999999999999999999999999999998754333344556789999999999999999998764321
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
......+|++|||++++|.+++.....+++..++.++.||+.||.|||++++
T Consensus 78 ----------------------------~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 129 (337)
T cd07858 78 ----------------------------REAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANV 129 (337)
T ss_pred ----------------------------ccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 0112457999999999999999888889999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+|||++.++.+||+|||+++...... .......+|..|+|||++.+...++.++||||
T Consensus 130 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 194 (337)
T cd07858 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWS 194 (337)
T ss_pred ecCCCCHHHEEEcCCCCEEECcCccccccCCCc---------------ccccccccccCccChHHHhcCCCCCCcccHHH
Confidence 999999999999999999999999997643211 01133568899999998875445899999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHh-----------------------hhhcCC-----CCCccccCCHHHHHHHHHc
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSD-----------------------LKQKGE-----LPPSWVAKFSEQESLLRRL 712 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~-----------------------~~~~~~-----~p~~~~~~~~e~~~LI~~~ 712 (1239)
|||++|+|++ ||............ +..... ........++++.++|++|
T Consensus 195 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 274 (337)
T cd07858 195 VGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKM 274 (337)
T ss_pred HHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHH
Confidence 9999999996 56432211100000 000000 0111234567889999999
Q ss_pred cCCCCCCCCCHHHHHhccCCCCc
Q 000880 713 MSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|+.||.+|||+.++++|+|+...
T Consensus 275 l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 275 LVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCChhhccCHHHHHcCcchhhh
Confidence 99999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=319.02 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=207.5
Q ss_pred ccCCceEE-eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccc
Q 000880 422 YLNDFEEL-QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 422 ~~~~y~~~-~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~ 499 (1239)
..+||.+- ++||-|-.|+|..|.++.||+.+|+|++.- ..+..+||++.-.. .|||||.++++|-..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs---- 127 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENS---- 127 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhh----
Confidence 45777764 579999999999999999999999998852 34567888876555 799999999887221
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDH--FDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~--l~~~~~~~i~~qI~~gL~ 576 (1239)
.....++.||||.+. |.|...++.++. |++.++..|+.||..|+.
T Consensus 128 --------------------------------~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~ 175 (400)
T KOG0604|consen 128 --------------------------------YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVR 175 (400)
T ss_pred --------------------------------ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHH
Confidence 123578999999995 689999987765 999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcC---CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDA---RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 653 (1239)
|||+.+|.||||||+|+|... +..+||+|||+|+....+ ....+.|.||.|.|||++.. .
T Consensus 176 ~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~----------------~~L~TPc~TPyYvaPevlg~-e 238 (400)
T KOG0604|consen 176 YLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP----------------GDLMTPCFTPYYVAPEVLGP-E 238 (400)
T ss_pred HHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC----------------ccccCCcccccccCHHHhCc-h
Confidence 999999999999999999975 456999999999864211 12356789999999999977 6
Q ss_pred CCCcchhhHHHHHHHHHhhc---CCchhHH----HHHHHHhhhhcCCCC-CccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 654 KIDEKADMYSLGIVFFELWH---PFSTAME----RQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 654 ~~~~ksDIwSlGviL~ELlt---Pf~~~~~----~~~~~~~~~~~~~~p-~~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
.|+..+|+||+||++|-|++ ||+.... .....++......+| +.|...+..++++|+.+|..+|.+|.|+.+
T Consensus 239 KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 79999999999999999997 5653322 112223334445566 478888889999999999999999999999
Q ss_pred HHhccCCCCch
Q 000880 726 LLQDALPPQME 736 (1239)
Q Consensus 726 iL~~~~~~~~~ 736 (1239)
++.|||..+..
T Consensus 319 ~m~hpwi~~~~ 329 (400)
T KOG0604|consen 319 VMDHPWINQYE 329 (400)
T ss_pred hhcCchhcccc
Confidence 99999987664
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=326.89 Aligned_cols=256 Identities=21% Similarity=0.390 Sum_probs=202.1
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+.|++.+.||.|+||.||+|+++.+++.||+|++.... .....+..|+.+++.+ +||||++++++|....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~------ 86 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS------ 86 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc------
Confidence 57888999999999999999999999999999986432 2345688899999998 7999999999875421
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
.......+|++||||+ ++|.+++... ..+++..++.++.||+.||.|||
T Consensus 87 ----------------------------~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 138 (282)
T cd06636 87 ----------------------------PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138 (282)
T ss_pred ----------------------------ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 0113467899999997 5899888653 35889999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC----CCCC
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKI 655 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~ 655 (1239)
++||+||||||+||+++.++.++|+|||++....... .......|++.|+|||++.. ...+
T Consensus 139 ~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~ 203 (282)
T cd06636 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV---------------GRRNTFIGTPYWMAPEVIACDENPDATY 203 (282)
T ss_pred HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc---------------cCCCcccccccccCHhhcCcccCcCcCC
Confidence 9999999999999999999999999999987542111 01133578999999998753 2457
Q ss_pred CcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 656 DEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+.++|+|||||++|||++ ||.............. ...........++++.+||.+||+.||.+|||+.+|++|||+
T Consensus 204 ~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 204 DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 889999999999999997 7755443333222211 111112223456789999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=356.74 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=205.3
Q ss_pred cCCceEEeeeccCCceEEEEEEEcc-----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
..+.+..+.||+|+||+||+|+... +...||||.++. ..+.....+|.||+.+|+.|+|||||+++|+|.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--- 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRLLGVCRE--- 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc---
Confidence 3566778999999999999998752 346799998873 3344467889999999999999999999999943
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--------------CCCHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--------------HFDKE 562 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--------------~l~~~ 562 (1239)
...+++|+|||. |+|.++|.... +++..
T Consensus 561 -------------------------------------~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~ 603 (774)
T KOG1026|consen 561 -------------------------------------GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTS 603 (774)
T ss_pred -------------------------------------CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHH
Confidence 456899999995 89999996431 27889
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCcc
Q 000880 563 LAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF 642 (1239)
Q Consensus 563 ~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 642 (1239)
+.+.|+.|||.||.||-++.+|||||..+|+||.++..|||+|||+++.....+..+. .....-..+
T Consensus 604 q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~-------------~~~t~lPIR 670 (774)
T KOG1026|consen 604 QFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKV-------------RGNTLLPIR 670 (774)
T ss_pred HHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcc-------------cCCceeeee
Confidence 9999999999999999999999999999999999999999999999996543332110 011234578
Q ss_pred CCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCC
Q 000880 643 YTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718 (1239)
Q Consensus 643 Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~ 718 (1239)
|||||.+.. ++|+.+||||||||+|||+++ |+.+..+.++...+. .+...+-...+++++.+||..||+.+|.
T Consensus 671 WMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~--~g~lL~~Pe~CP~~vY~LM~~CW~~~P~ 747 (774)
T KOG1026|consen 671 WMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR--AGQLLSCPENCPTEVYSLMLECWNENPK 747 (774)
T ss_pred cCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH--cCCcccCCCCCCHHHHHHHHHHhhcCcc
Confidence 999999886 689999999999999999996 999988877765543 3444555567888999999999999999
Q ss_pred CCCCHHHHHh
Q 000880 719 DRPSATELLQ 728 (1239)
Q Consensus 719 ~RPta~eiL~ 728 (1239)
+||++.+|-.
T Consensus 748 ~RPsF~eI~~ 757 (774)
T KOG1026|consen 748 RRPSFKEIHS 757 (774)
T ss_pred cCCCHHHHHH
Confidence 9999999843
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.44 Aligned_cols=262 Identities=27% Similarity=0.436 Sum_probs=224.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+.+++.+..||.||||.|-++..+.....+|+|++++... .....+.+..|-.+|..++.|.||++|..|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--------- 489 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF--------- 489 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh---------
Confidence 4678888999999999999999885555699999987663 445567899999999999999999999776
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
.+..++|+.||-| +|.|+..++.++.|++..+++++..+++|++|||+
T Consensus 490 -------------------------------rd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~ 538 (732)
T KOG0614|consen 490 -------------------------------RDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHR 538 (732)
T ss_pred -------------------------------ccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh
Confidence 3467899999999 78999999999999999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+|||+|||||+|+|++.+|.+||.|||+|+.+.... .+-++||||.|.|||++.+ ...+.++|
T Consensus 539 k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~----------------KTwTFcGTpEYVAPEIILn-KGHD~avD 601 (732)
T KOG0614|consen 539 KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR----------------KTWTFCGTPEYVAPEIILN-KGHDRAVD 601 (732)
T ss_pred cCceeccCChhheeeccCCceEEeehhhHHHhccCC----------------ceeeecCCcccccchhhhc-cCcchhhH
Confidence 999999999999999999999999999999875432 2356899999999999988 45899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhccCC
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDALP 732 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~~~~ 732 (1239)
.|||||++|||++ ||...+++.....++..-..+ ..+..+...+.+||+++...+|.+|.. +.+|-.|-||
T Consensus 602 yWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 602 YWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred HHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 9999999999996 999888888776666532221 112344558899999999999999985 8999999999
Q ss_pred CCchHHHHHH
Q 000880 733 PQMEYELLDN 742 (1239)
Q Consensus 733 ~~~~~~~~~~ 742 (1239)
.++.|+-+..
T Consensus 681 ~gfdweglr~ 690 (732)
T KOG0614|consen 681 EGFDWEGLRS 690 (732)
T ss_pred hcCChhhhhh
Confidence 9999876543
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.87 Aligned_cols=255 Identities=23% Similarity=0.415 Sum_probs=203.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++++.||+|+||.||+|++..+|+.||+|.++... .......+.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--------- 70 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--------- 70 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec---------
Confidence 47889999999999999999999999999999987532 33345678999999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESY---DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...+|+|||||++ +|..++... ..+++..+..++.||+.||.|||
T Consensus 71 -------------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 119 (286)
T cd06622 71 -------------------------------EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119 (286)
T ss_pred -------------------------------CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3578999999975 888887753 36999999999999999999999
Q ss_pred h-CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC-----
Q 000880 580 G-QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP----- 653 (1239)
Q Consensus 580 s-~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----- 653 (1239)
+ .+|+||||||+||+++.++.+||+|||++..+... ......|++.|+|||++.+..
T Consensus 120 ~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (286)
T cd06622 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-----------------LAKTNIGCQSYMAPERIKSGGPNQNP 182 (286)
T ss_pred hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-----------------ccccCCCccCccCcchhcCCCCCccC
Confidence 7 59999999999999999999999999998754211 012346888999999986522
Q ss_pred CCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhh-hhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 654 KIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDL-KQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 654 ~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~-~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.++.++|||||||++|+|++ ||............. ......+......++++.++|.+||..+|.+||++.++++|
T Consensus 183 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 35889999999999999997 775433322211111 11222233333466789999999999999999999999999
Q ss_pred cCCCCch
Q 000880 730 ALPPQME 736 (1239)
Q Consensus 730 ~~~~~~~ 736 (1239)
+|+....
T Consensus 263 ~~~~~~~ 269 (286)
T cd06622 263 PWLVKYK 269 (286)
T ss_pred hhhhhcc
Confidence 9986553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.87 Aligned_cols=253 Identities=29% Similarity=0.448 Sum_probs=206.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|+..+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--------- 70 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--------- 70 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec---------
Confidence 468888999999999999999999999999999875433 2455678999999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHG- 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs- 580 (1239)
...+|++|||++ ++|.+++... ..+++..++.++.||+.||+|||+
T Consensus 71 -------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (265)
T cd06605 71 -------------------------------NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119 (265)
T ss_pred -------------------------------CCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC
Confidence 357899999998 6999999876 779999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
.|++|+||||+||+++.++.++|+|||.+....... .....|+..|+|||.+.+ ..++.++|
T Consensus 120 ~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-----------------~~~~~~~~~y~~PE~~~~-~~~~~~~D 181 (265)
T cd06605 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----------------AKTFVGTSSYMAPERIQG-NDYSVKSD 181 (265)
T ss_pred CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-----------------hhcccCChhccCHHHHcC-CCCCchhh
Confidence 999999999999999999999999999987653211 011578899999999988 57899999
Q ss_pred hHHHHHHHHHhhc---CCchhH----HHHHHHHhhhhcCCCCCcccc-CCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 661 MYSLGIVFFELWH---PFSTAM----ERQIVLSDLKQKGELPPSWVA-KFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~----~~~~~~~~~~~~~~~p~~~~~-~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|||||+++|+|++ ||.... .......... ....+..... .++++.++|.+||..||.+|||+.+++.||||
T Consensus 182 v~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred HHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 9999999999997 665431 1111111111 1112222122 56789999999999999999999999999999
Q ss_pred CCch
Q 000880 733 PQME 736 (1239)
Q Consensus 733 ~~~~ 736 (1239)
++.+
T Consensus 261 ~~~~ 264 (265)
T cd06605 261 KKYE 264 (265)
T ss_pred hccc
Confidence 7653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.32 Aligned_cols=257 Identities=22% Similarity=0.375 Sum_probs=204.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||.|+||.||+|.++.+++.||+|++..... ....+.+|+.+++++ +||||++++++|.....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~----- 77 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP----- 77 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC-----
Confidence 689999999999999999999998999999999875432 346789999999999 79999999999865320
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
......+|++|||++ ++|.+++.. ...+++..++.++.|++.||.|
T Consensus 78 -----------------------------~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~ 128 (275)
T cd06608 78 -----------------------------PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128 (275)
T ss_pred -----------------------------CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 013467899999997 488888764 3579999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC----C
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW----P 653 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~ 653 (1239)
||+++++|+||+|+||+++.++.+||+|||++....... .......|++.|+|||++... .
T Consensus 129 lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 193 (275)
T cd06608 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL---------------GRRNTFIGTPYWMAPEVIACDEQPDA 193 (275)
T ss_pred HhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch---------------hhhcCccccccccCHhHhcccccccC
Confidence 999999999999999999999999999999987542211 011335689999999987542 3
Q ss_pred CCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhcc
Q 000880 654 KIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 654 ~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~ 730 (1239)
.++.++|||||||+||+|++ ||..........................+.++.+||.+||..||.+|||+.++++||
T Consensus 194 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~ 273 (275)
T cd06608 194 SYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP 273 (275)
T ss_pred CccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence 47889999999999999997 776554444433333221111111122456889999999999999999999999999
Q ss_pred CC
Q 000880 731 LP 732 (1239)
Q Consensus 731 ~~ 732 (1239)
|+
T Consensus 274 ~~ 275 (275)
T cd06608 274 FI 275 (275)
T ss_pred CC
Confidence 85
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.40 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=202.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||.|+||.||+|.++.+++.||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--------- 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE---------
Confidence 46899999999999999999999999999999987655444455788999999999999999999988733
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQ-VFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~-~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|++|||+++++.+ +......+++..++.++.||+.||.|||+++
T Consensus 72 -------------------------------~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (288)
T cd07833 72 -------------------------------KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120 (288)
T ss_pred -------------------------------CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35689999999876554 4445566999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++||||+|+||+++.++.+||+|||++........ .......+++.|+|||++.+...++.++|||
T Consensus 121 i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~ 186 (288)
T cd07833 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPA--------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVW 186 (288)
T ss_pred eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--------------ccccCcccccCCcCCchhcCCCCcCchhhHH
Confidence 99999999999999999999999999986532210 0113357889999999998844789999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcC-------------------CCCC---------ccc-cCCHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKG-------------------ELPP---------SWV-AKFSEQESLLR 710 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~-------------------~~p~---------~~~-~~~~e~~~LI~ 710 (1239)
|||+++|+|++ ||................+ ..++ ... ..++++.+||+
T Consensus 187 slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 266 (288)
T cd07833 187 AIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLK 266 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHH
Confidence 99999999997 5544333222211110000 0000 001 12567899999
Q ss_pred HccCCCCCCCCCHHHHHhccCC
Q 000880 711 RLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+||..+|++|||+.++++|+||
T Consensus 267 ~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 267 ACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHhccCchhcccHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=334.52 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=197.3
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcE----EEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRH----YAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~----vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
..+|++.+.||+|+||.||+|++..+|.. ||||+++.. .......++.+|+.+++.++||||++++++|..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT---- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC----
Confidence 36899999999999999999998766664 899988632 333455678999999999999999999998732
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~ 576 (1239)
...+++++|++ |+|.+++... ..+++..++.++.||+.||+
T Consensus 81 -------------------------------------~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~ 123 (316)
T cd05108 81 -------------------------------------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123 (316)
T ss_pred -------------------------------------CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHH
Confidence 13478999996 6899988764 45889999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++||+||||||+|||++.++.+||+|||+++....... ........++..|+|||++.+ ..++
T Consensus 124 ~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-------------~~~~~~~~~~~~y~apE~~~~-~~~~ 189 (316)
T cd05108 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK-------------EYHAEGGKVPIKWMALESILH-RIYT 189 (316)
T ss_pred HHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc-------------ceeccCCccceeecChHHhcc-CCCC
Confidence 99999999999999999999999999999999986532210 011122345778999999987 5689
Q ss_pred cchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.++|||||||++|||++ ||......+. ..... ....++.......++.+++.+||..||.+||++.+++.+
T Consensus 190 ~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 190 HQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred chhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHh-CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999874 6654433332 22222 333333344556789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=325.41 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=202.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.++|.+.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++++ +||||++++++|.....
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~---- 93 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK---- 93 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc----
Confidence 578999999999999999999999999999999986432 2345678899999999 89999999998854210
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
.....+|+||||++ ++|.+++.. ...+++..++.++.|++.||+
T Consensus 94 -------------------------------~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 142 (291)
T cd06639 94 -------------------------------LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142 (291)
T ss_pred -------------------------------cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Confidence 12356899999996 589888753 356899999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC---
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP--- 653 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--- 653 (1239)
|||++|++||||||+||+++.++.+||+|||++........ ......|++.|+|||++....
T Consensus 143 ~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~ 207 (291)
T cd06639 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---------------RRNTSVGTPFWMAPEVIACEQQYD 207 (291)
T ss_pred HHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc---------------cccCccCCccccChhhhcCCCCcc
Confidence 99999999999999999999999999999999886432110 112346899999999986422
Q ss_pred -CCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 654 -KIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 654 -~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.++.++|||||||++|||++ ||.............................+.++|.+||+.+|++||++.++++|
T Consensus 208 ~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 208 YSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 36889999999999999997 66654443333332221111111122345678999999999999999999999999
Q ss_pred cCCC
Q 000880 730 ALPP 733 (1239)
Q Consensus 730 ~~~~ 733 (1239)
|||.
T Consensus 288 ~~~~ 291 (291)
T cd06639 288 PFIK 291 (291)
T ss_pred cccC
Confidence 9984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=343.53 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=204.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCc---E-EEEEEEecCC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGR---H-YAVKKIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~-vAVK~i~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
++-.+.++||+|+||+||+|+.+..+. . ||||..+... .......+|.+|.++|++++|||||++||++..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~---- 232 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL---- 232 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC----
Confidence 455566899999999999999886533 3 8999887533 556677889999999999999999999998743
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~ 576 (1239)
...+|||||+|. |+|.++|.+.+ .++..+...++.+.+.||+
T Consensus 233 ------------------------------------~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~ 276 (474)
T KOG0194|consen 233 ------------------------------------EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLE 276 (474)
T ss_pred ------------------------------------CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHH
Confidence 456799999996 69999999877 4999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++++|||||-.+|+|++.++.+||+|||+++.-..-. .......-...|+|||.++. ..|+
T Consensus 277 YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~---------------~~~~~~klPirWLAPEtl~~-~~~s 340 (474)
T KOG0194|consen 277 YLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV---------------MKKFLKKLPIRWLAPETLNT-GIFS 340 (474)
T ss_pred HHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee---------------eccccccCcceecChhhhcc-Cccc
Confidence 9999999999999999999999999999999987532100 00011134568999999998 5899
Q ss_pred cchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+++|||||||++||+++ ||.+....+....+.......+. ....+.++..++.+||..||++|||+.++.+.
T Consensus 341 ~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~-~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 341 FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI-PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC-CCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence 99999999999999985 88888877776666553333332 23556688999999999999999999999763
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=319.34 Aligned_cols=257 Identities=33% Similarity=0.489 Sum_probs=206.7
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|.+.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++||||+++++.+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~----------- 69 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV----------- 69 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----------
Confidence 478889999999999999999989999999999876555456778999999999999999999998752
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....+++++||++ ++|.+++.....+++..++.++.||+.||.|||++|+
T Consensus 70 -----------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 120 (264)
T cd06626 70 -----------------------------HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120 (264)
T ss_pred -----------------------------cCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence 2356899999996 5999999887779999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC--CCCcchhh
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP--KIDEKADM 661 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~ksDI 661 (1239)
+|+||||+||+++.++.+||+|||++.......... ........+++.|+|||++.+.. .++.++||
T Consensus 121 ~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv 189 (264)
T cd06626 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM-----------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189 (264)
T ss_pred ccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc-----------cccccCCcCCcCccChhhccCCCCCCCCcccch
Confidence 999999999999999999999999998754322110 00012346889999999988632 27899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHH-HhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVL-SDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~-~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
||||+++|+|++ ||.......... ..........+.+...++.+.++|.+||+.+|.+|||+.+++.|+|+
T Consensus 190 ~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 190 WSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999996 776543222222 22211111122333446789999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.69 Aligned_cols=270 Identities=26% Similarity=0.436 Sum_probs=216.9
Q ss_pred CCcccCCceE-EeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecC
Q 000880 419 SSRYLNDFEE-LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 419 ~~~~~~~y~~-~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~ 496 (1239)
+++|.+-|++ .+.||+|+|+.|--|....+|..||||+|.+.. .....++.||++++..+ .|+||+++++.|
T Consensus 72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefF---- 145 (463)
T KOG0607|consen 72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFF---- 145 (463)
T ss_pred cchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHh----
Confidence 4445455554 357999999999999999999999999997542 23456899999999999 599999999877
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESYDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL 575 (1239)
.+...+|+|||-| +|.|..+++++..|++.+|.++.++|+.||
T Consensus 146 ------------------------------------Edd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aL 189 (463)
T KOG0607|consen 146 ------------------------------------EDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASAL 189 (463)
T ss_pred ------------------------------------cccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHH
Confidence 3467899999999 569999999999999999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCCCC---EEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc--
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ-- 650 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~~~---vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-- 650 (1239)
.|||.+||.||||||+|||-....+ ||||||.+..-.....-... .......+.+|+..|||||+..
T Consensus 190 dFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp--------astP~L~tPvGSAEfMAPEVVd~f 261 (463)
T KOG0607|consen 190 DFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP--------ASTPELLTPVGSAEFMAPEVVDVF 261 (463)
T ss_pred HHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC--------CCCccccCcccchhhcchhHHhhh
Confidence 9999999999999999999977654 89999999875432211111 1122345679999999999753
Q ss_pred -C-CCCCCcchhhHHHHHHHHHhhc---CCchhHH---------------HHHHHHhhhhcCCCCC-ccccCCHHHHHHH
Q 000880 651 -G-WPKIDEKADMYSLGIVFFELWH---PFSTAME---------------RQIVLSDLKQKGELPP-SWVAKFSEQESLL 709 (1239)
Q Consensus 651 -~-~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~---------------~~~~~~~~~~~~~~p~-~~~~~~~e~~~LI 709 (1239)
+ ...|+.++|.||||||||-|++ ||.+.-. ...+-.+...+..+|. .|..++.++++||
T Consensus 262 v~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdli 341 (463)
T KOG0607|consen 262 VDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLI 341 (463)
T ss_pred ccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHH
Confidence 2 2459999999999999999996 6643211 1223344445566775 7889999999999
Q ss_pred HHccCCCCCCCCCHHHHHhccCCCCchHH
Q 000880 710 RRLMSPSPSDRPSATELLQDALPPQMEYE 738 (1239)
Q Consensus 710 ~~~L~~dP~~RPta~eiL~~~~~~~~~~~ 738 (1239)
+.+|..|+.+|.++.++++|||++....+
T Consensus 342 snLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 342 SNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHhccHHhhhhhhhccCCccccccchh
Confidence 99999999999999999999999887543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=330.32 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=205.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..+|++++.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|..
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------- 87 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-------- 87 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec--------
Confidence 3689999999999999999999999999999999875433 234668899999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.
T Consensus 88 --------------------------------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~ 134 (297)
T cd06656 88 --------------------------------GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN 134 (297)
T ss_pred --------------------------------CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356899999996 588888754 4588999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+|||++.++.++|+|||++....... .......|++.|+|||.+.+ ..++.++|+
T Consensus 135 ~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 198 (297)
T cd06656 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------------SKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198 (297)
T ss_pred CcccCCCCHHHEEECCCCCEEECcCccceEccCCc---------------cCcCcccCCccccCHHHHcC-CCCCcHHHH
Confidence 99999999999999999999999999987542111 01123468999999999987 568899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|||||++|+|++ ||..........................++.+.+||.+||..||++||++.++++|+|+....
T Consensus 199 ~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 999999999997 776544332222221111111112234556789999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.99 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=201.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|...+.||+|+||.||++.+..+|+.||||.+...... .....+.+|+.++.++. ||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-------- 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-------- 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--------
Confidence 4677788999999999999999999999999998754333 44567889999999996 9999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE-----SYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~-----~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....+++|||++.++.++.. ....+++..+..++.|++.||+|
T Consensus 75 --------------------------------~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 75 --------------------------------EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred --------------------------------CCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 34568999999877665432 23569999999999999999999
Q ss_pred HHhC-CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC--CC
Q 000880 578 IHGQ-GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW--PK 654 (1239)
Q Consensus 578 LHs~-gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~ 654 (1239)
||+. +++||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+. ..
T Consensus 123 lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~ 186 (288)
T cd06616 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI----------------AKTRDAGCRPYMAPERIDPSARDG 186 (288)
T ss_pred HhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC----------------ccccccCccCccCHHHhccccccC
Confidence 9974 99999999999999999999999999997643211 11234689999999999874 36
Q ss_pred CCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhh-c-CCCCC-ccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQ-K-GELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~-~-~~~p~-~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
++.++|||||||++|||++ ||............... . ..++. .....++++.+||.+||+.||++|||++++++
T Consensus 187 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999996 66544321111111111 1 11111 22345678999999999999999999999999
Q ss_pred ccCCCCch
Q 000880 729 DALPPQME 736 (1239)
Q Consensus 729 ~~~~~~~~ 736 (1239)
|+|+....
T Consensus 267 ~~~~~~~~ 274 (288)
T cd06616 267 HPFIKDYE 274 (288)
T ss_pred Chhhhchh
Confidence 99997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=321.56 Aligned_cols=249 Identities=25% Similarity=0.467 Sum_probs=199.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||.||+|+++.+++.||||.++... ........+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 73 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-------- 73 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--------
Confidence 68999999999999999999999999999999887533 233445678899999999999999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....|++|||++ ++|.+++.. ...+++..++.++.||+.||.|
T Consensus 74 --------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 121 (267)
T cd08228 74 --------------------------------DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121 (267)
T ss_pred --------------------------------CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 346799999997 588887753 3448999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++|++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+ ..++.
T Consensus 122 LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~---------------~~~~~~~~~~~~aPE~~~~-~~~~~ 185 (267)
T cd08228 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---------------AAHSLVGTPYYMSPERIHE-NGYNF 185 (267)
T ss_pred HhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH---------------HHhcCCCCccccChhhhcc-CCCCc
Confidence 9999999999999999999999999999999886532110 1123468899999999987 56889
Q ss_pred chhhHHHHHHHHHhhc---CCchhHH-HHHHHHhhhhcCCCCCc-cccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 658 KADMYSLGIVFFELWH---PFSTAME-RQIVLSDLKQKGELPPS-WVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~-~~~~~~~~~~~~~~p~~-~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
++|+||||+++|||++ ||..... .......+. ....++. ....+..+.++|.+||+.+|++||++.++++.
T Consensus 186 ~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred hhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh-cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999997 6654322 122222222 2223332 22455689999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=336.89 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=204.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 88 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS----- 88 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc-----
Confidence 368999999999999999999999899999999987544333344568899999999999999999988743210
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
......+|++|||++.+|..++. ..+++..++.++.||+.||+|||++|
T Consensus 89 -----------------------------~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ 137 (342)
T cd07879 89 -----------------------------GDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG 137 (342)
T ss_pred -----------------------------CCCCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 01234579999999888877653 46899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+...++.++|||
T Consensus 138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 199 (342)
T cd07879 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADA------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIW 199 (342)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC------------------CCCCceeeecccChhhhcCccccCchHHHH
Confidence 99999999999999999999999999875311 113457899999999987645688999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhc-----------------------CCCC-----CccccCCHHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQK-----------------------GELP-----PSWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-----------------------~~~p-----~~~~~~~~e~~~LI~~ 711 (1239)
||||++|||++ ||............+... ...+ ..++..++++.+||.+
T Consensus 200 slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 279 (342)
T cd07879 200 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK 279 (342)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHH
Confidence 99999999997 776543322221111100 0001 1122455678999999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCch
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||+.||.+||++.+++.|+||....
T Consensus 280 ~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 280 MLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HcCCChhhCcCHHHHhcCcchhhcc
Confidence 9999999999999999999997764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.99 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=205.0
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
+|++.+.||.|+||.||+|++..+++.||+|++...... ......+.+|+.++++++||||+++++++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------- 70 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ---------- 70 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc----------
Confidence 488999999999999999999999999999999754432 245678999999999999999999987762
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....+|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++|
T Consensus 71 ------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 120 (258)
T cd05578 71 ------------------------------DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120 (258)
T ss_pred ------------------------------CCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 2457899999996 599999987778999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++|+||||+||+++.++.++|+|||++....... ......|+..|+|||++.+ ..++.++|+|
T Consensus 121 i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----------------~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~ 183 (258)
T cd05578 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----------------LTTSTSGTPGYMAPEVLCR-QGYSVAVDWW 183 (258)
T ss_pred eeccCCCHHHeEEcCCCCEEEeecccccccCCCc----------------cccccCCChhhcCHHHHcc-cCCCCcccch
Confidence 9999999999999999999999999988643211 1123468889999999987 5589999999
Q ss_pred HHHHHHHHhhc---CCchhHH--HHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH--HHHHhccCC
Q 000880 663 SLGIVFFELWH---PFSTAME--RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA--TELLQDALP 732 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta--~eiL~~~~~ 732 (1239)
|||+++|+|++ ||..... .......... ..+......++.+.++|.+||..||.+||++ .++++|+||
T Consensus 184 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 184 SLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred hhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999996 6665442 2222222221 2222233455789999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=319.32 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=205.2
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK---SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
|+..+.||+|+||+||+|.+..+++.||+|.+..... ..+....+.+|+.+++.++||||+++++.+..
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------- 73 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-------- 73 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--------
Confidence 5667899999999999999998999999999876442 23345678999999999999999999987632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++|||++ ++|.+++.....+++..++.++.||+.||+|||++
T Consensus 74 --------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (258)
T cd06632 74 --------------------------------EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121 (258)
T ss_pred --------------------------------CCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356899999997 59999998877899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++|+||+|+||+++.++.+||+|||++....... ......|++.|+|||.+.....++.++|+
T Consensus 122 ~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~ 185 (258)
T cd06632 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----------------FAKSFKGSPYWMAPEVIAQQGGYGLAADI 185 (258)
T ss_pred CcccCCCCHHHEEECCCCCEEEccCccceeccccc----------------cccccCCCcceeCHHHhcCCCCCCchhhh
Confidence 99999999999999999999999999987643211 11345689999999998763338999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|||||++|+|++ ||.............. ....+.......+++.+++++||+.+|.+||++.++++|||+
T Consensus 186 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 186 WSLGCTVLEMATGKPPWSQLEGVAAVFKIGR-SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHHHHhCCCCcccCcHHHHHHHHHh-cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999997 7765554333333222 123333334556789999999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=335.97 Aligned_cols=265 Identities=28% Similarity=0.390 Sum_probs=210.4
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||.|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------- 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP------- 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc-------
Confidence 4788999999999999999999889999999987554434456789999999999999999999988743210
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
.....+|++|+|++++|.+++.....+++..++.++.||+.||+|||++||+
T Consensus 74 ----------------------------~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~ 125 (330)
T cd07834 74 ----------------------------EDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVI 125 (330)
T ss_pred ----------------------------ccccceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 1224679999999999999998877899999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
||||||.|||++.++.++|+|||++......... ........+|+.|+|||++.+...++.++|+|||
T Consensus 126 H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 193 (330)
T cd07834 126 HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSV 193 (330)
T ss_pred cCCCCHHHEEEcCCCCEEEcccCceEeecccccc------------cccccccccccCcCCceeeecccCCCcchhHHHH
Confidence 9999999999999999999999999865332100 0112345789999999999885478999999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhhhhcCCCC----------------------------CccccCCHHHHHHHHHcc
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDLKQKGELP----------------------------PSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p----------------------------~~~~~~~~e~~~LI~~~L 713 (1239)
||++|+|++ ||......+.........+..+ ......++++.++|.+||
T Consensus 194 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 273 (330)
T cd07834 194 GCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML 273 (330)
T ss_pred HHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHc
Confidence 999999997 6654433322221111111000 011234568899999999
Q ss_pred CCCCCCCCCHHHHHhccCCCCch
Q 000880 714 SPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
+.+|.+|||+.++++|+||.+..
T Consensus 274 ~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 274 VFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cCChhhCCCHHHHHhCccHHhhc
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=336.34 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=204.7
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~------ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR------ 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc------
Confidence 36899999999999999999999989999999998754433334567889999999999999999998774321
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
........|+++++++++|.+++.. ..+++..++.++.||+.||+|||++|
T Consensus 90 ----------------------------~~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ 140 (345)
T cd07877 90 ----------------------------SLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD 140 (345)
T ss_pred ----------------------------cccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 0012345789999999999888764 46999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+||+++.++.+||+|||+++..... .....||+.|+|||++.+...++.++|||
T Consensus 141 ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw 202 (345)
T cd07877 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIW 202 (345)
T ss_pred eeecCCChHHEEEcCCCCEEEeccccccccccc------------------ccccccCCCccCHHHHhCccCCCchhhHH
Confidence 999999999999999999999999998753210 12346899999999987655688999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhc-----------------------CCCC-----CccccCCHHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQK-----------------------GELP-----PSWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-----------------------~~~p-----~~~~~~~~e~~~LI~~ 711 (1239)
||||++|||++ ||................ ...+ ..+...++++.++|.+
T Consensus 203 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 282 (345)
T cd07877 203 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282 (345)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHH
Confidence 99999999996 664332222111111100 0011 1112346788999999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCch
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||+.||.+||++.++++|+||.+..
T Consensus 283 ~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 283 MLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HcCCChhhcCCHHHHhcChhhhhcC
Confidence 9999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=324.21 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=202.8
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++.+...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------- 70 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---------- 70 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC----------
Confidence 6788999999999999999998999999999986543344456788999999999999999999887431
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
....+|+||||++++|..++... ..+++..++.++.||+.||+|||++|++
T Consensus 71 ----------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~ 122 (287)
T cd07840 71 ----------------------------GKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122 (287)
T ss_pred ----------------------------CCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 02578999999999999988765 5799999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
|+||||+|||++.++.+||+|||++........ ...+...++..|+|||.+.+...++.++|||||
T Consensus 123 h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 188 (287)
T cd07840 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNS--------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSV 188 (287)
T ss_pred eccCcHHHeEEcCCCCEEEccccceeeccCCCc--------------ccccccccccccCCceeeEccccCChHHHHHHH
Confidence 999999999999999999999999986532210 012334678899999988764568899999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhhhhcCCC-----------------------C----Ccccc-CCHHHHHHHHHcc
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDLKQKGEL-----------------------P----PSWVA-KFSEQESLLRRLM 713 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~-----------------------p----~~~~~-~~~e~~~LI~~~L 713 (1239)
|+++|||++ ||................... + ..... .++.+.++|++||
T Consensus 189 G~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 268 (287)
T cd07840 189 GCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLL 268 (287)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHc
Confidence 999999997 665444322222111100000 0 00111 1567889999999
Q ss_pred CCCCCCCCCHHHHHhccCC
Q 000880 714 SPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~~~~ 732 (1239)
+.+|.+||++.++++|+||
T Consensus 269 ~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 269 TLDPKKRISADQALQHEYF 287 (287)
T ss_pred CCChhhCcCHHHHhhCcCC
Confidence 9999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=359.70 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=198.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+++|++.++||+|+||.||+|++..+|+.||||+++.... ......++.+|+.+++.++||||+++++++.+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d------- 73 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD------- 73 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-------
Confidence 3689999999999999999999999999999999875332 23345679999999999999999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-----------CCCCHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-----------DHFDKELAWHLFR 569 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-----------~~l~~~~~~~i~~ 569 (1239)
....|++||||+ ++|.+++... ..++...++.++.
T Consensus 74 ---------------------------------~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~ 120 (932)
T PRK13184 74 ---------------------------------GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120 (932)
T ss_pred ---------------------------------CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHH
Confidence 356799999996 5899888642 2355677889999
Q ss_pred HHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccC-CCCCC--CCCCccccCcccccCccCCCc
Q 000880 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQD-AAFPT--DTGGVSVDGTGQVGTYFYTAP 646 (1239)
Q Consensus 570 qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~GT~~Y~AP 646 (1239)
||+.||+|||++||+||||||+|||++.++.+||+|||+++.......... ..... ............+||+.||||
T Consensus 121 QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP 200 (932)
T PRK13184 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200 (932)
T ss_pred HHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence 999999999999999999999999999999999999999987522110000 00000 000000011235799999999
Q ss_pred ccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH
Q 000880 647 EIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA 723 (1239)
Q Consensus 647 E~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta 723 (1239)
|++.+ ..++.++|||||||++|||++ ||................+.....+...++.+.+++.+||+.||++||+.
T Consensus 201 E~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 201 ERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred HHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence 99987 568999999999999999997 77654433332222111111112234566789999999999999999876
Q ss_pred HHHHhc
Q 000880 724 TELLQD 729 (1239)
Q Consensus 724 ~eiL~~ 729 (1239)
.+.+.+
T Consensus 280 ~eeLl~ 285 (932)
T PRK13184 280 VQELKQ 285 (932)
T ss_pred HHHHHH
Confidence 665543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=336.20 Aligned_cols=266 Identities=26% Similarity=0.368 Sum_probs=208.2
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccc
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~ 499 (1239)
...++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++++ +||||++++++|...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---- 79 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---- 79 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC----
Confidence 456789999999999999999999998999999998864433334455678899999999 999999999887321
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....+|+||||++++|..++... .+++..++.++.||+.||+|||
T Consensus 80 ----------------------------------~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH 124 (337)
T cd07852 80 ----------------------------------NDKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIH 124 (337)
T ss_pred ----------------------------------CCceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Confidence 23568999999999999988765 7899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++||+||||||+|||++.++.+||+|||++.......... .........||+.|+|||++.+...++.++
T Consensus 125 ~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~s 194 (337)
T cd07852 125 SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP----------ENPVLTDYVATRWYRAPEILLGSTRYTKGV 194 (337)
T ss_pred HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc----------cCcchhcccccccccCceeeeccccccccc
Confidence 9999999999999999999999999999998653221100 001123457899999999887655688999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc--------------------------C--CCCCccccCCHHHHHH
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK--------------------------G--ELPPSWVAKFSEQESL 708 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~--------------------------~--~~p~~~~~~~~e~~~L 708 (1239)
|||||||++|+|++ ||................ . .........+.++.++
T Consensus 195 Di~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 274 (337)
T cd07852 195 DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDL 274 (337)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHH
Confidence 99999999999997 664333222111110000 0 0111122346788999
Q ss_pred HHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 709 LRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 709 I~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|.+||+.||.+|||+.++++|+|+.++
T Consensus 275 i~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 275 LKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhccCCcccccCHHHHhhChhhhhh
Confidence 999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=321.32 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=202.4
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC----chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS----LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+|+..+.||+|+||.||++.+..+++.||+|+++..... ......+.+|+.+++.++||||+++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE------ 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc------
Confidence 467778999999999999999999999999999754321 1234678999999999999999999988732
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...+++||||++ ++|.+++.....+++..++.++.||+.||.|||
T Consensus 75 ----------------------------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH 120 (268)
T cd06630 75 ----------------------------------DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120 (268)
T ss_pred ----------------------------------CCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356899999997 589999988888999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCC-CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 580 GQGIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
++|++||||||+||+++.++ .+||+|||++.......... ........||..|+|||++.+ ..++.+
T Consensus 121 ~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~PE~~~~-~~~~~~ 188 (268)
T cd06630 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA-----------GEFQGQLLGTIAFMAPEVLRG-EQYGRS 188 (268)
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccC-----------CccccccccccceeCHhHhcc-CCCCcc
Confidence 99999999999999998876 59999999998654221000 001123468999999999877 568999
Q ss_pred hhhHHHHHHHHHhhc---CCchhHHH--HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMER--QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
+|+||+||++|+|++ ||...... .............+......++++.+++.+||..+|.+||++.++++||||.
T Consensus 189 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 189 CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999996 66432211 1111111111222223334567899999999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=318.36 Aligned_cols=247 Identities=30% Similarity=0.552 Sum_probs=201.4
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||.|+||.||++.++.+++.||+|.++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 69 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA---------- 69 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE----------
Confidence 58899999999999999999999999999999875432 3345678899999999999999999988732
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++|||++ ++|.+++... ..+++..++.++.||+.||.|||++
T Consensus 70 ------------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 119 (255)
T cd08219 70 ------------------------------DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119 (255)
T ss_pred ------------------------------CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 457899999996 5898887643 4589999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+|+||||+||+++.++.++|+|||++........ ......|++.|+|||++.+ ..++.++|+
T Consensus 120 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---------------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv 183 (255)
T cd08219 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---------------YACTYVGTPYYVPPEIWEN-MPYNNKSDI 183 (255)
T ss_pred CcccCCCCcceEEECCCCcEEEcccCcceeeccccc---------------ccccccCCccccCHHHHcc-CCcCchhhh
Confidence 999999999999999999999999999875432110 1123578999999999987 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhcc
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~ 730 (1239)
||||+++|+|++ ||............. .+..++.....+..+.++|.+||+.||.+|||+.+++...
T Consensus 184 ~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 184 WSLGCILYELCTLKHPFQANSWKNLILKVC--QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred hhhchhheehhhccCCCCCCCHHHHHHHHh--cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence 999999999996 776554444333332 2233333334567899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=289.93 Aligned_cols=257 Identities=27% Similarity=0.511 Sum_probs=208.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|...++||+|.||+||+|+++.+++.||+|.++..+.+.......++|+-+|+.++|.|||++++...
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh---------- 71 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH---------- 71 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc----------
Confidence 3566778999999999999999999999999999988777667778999999999999999999997652
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....+-+|+|||..+|..++.+ ++.++.+.++.++.|+++||.|+|+++
T Consensus 72 ------------------------------sdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn 121 (292)
T KOG0662|consen 72 ------------------------------SDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN 121 (292)
T ss_pred ------------------------------cCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh
Confidence 2467889999999999998875 456999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
+.||||||.|.||+.+|.+||+|||+|+.+..+-. ..+..+-|.+|.+|.++-|..-|+...|||
T Consensus 122 vlhrdlkpqnllin~ngelkladfglarafgipvr---------------cysaevvtlwyrppdvlfgakly~tsidmw 186 (292)
T KOG0662|consen 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR---------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186 (292)
T ss_pred hhhccCCcceEEeccCCcEEecccchhhhcCCceE---------------eeeceeeeeeccCcceeeeeehhccchHhh
Confidence 99999999999999999999999999997653321 113346799999999999977799999999
Q ss_pred HHHHHHHHhhc---CCchhHH-HHHHHHhhhhcCCC--------------------C--CccccCCH----HHHHHHHHc
Q 000880 663 SLGIVFFELWH---PFSTAME-RQIVLSDLKQKGEL--------------------P--PSWVAKFS----EQESLLRRL 712 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~-~~~~~~~~~~~~~~--------------------p--~~~~~~~~----e~~~LI~~~ 712 (1239)
|.|||+.|+.. |..+..+ .....++...-+.. | ..|....| .-++|+.++
T Consensus 187 sagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkl 266 (292)
T KOG0662|consen 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKL 266 (292)
T ss_pred hcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHH
Confidence 99999999974 4433332 22223322211110 0 02222222 236999999
Q ss_pred cCCCCCCCCCHHHHHhccCCCCc
Q 000880 713 MSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|..+|.+|.+++..++||+|...
T Consensus 267 l~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 267 LKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred hccCcccccCHHHHhcCcccccc
Confidence 99999999999999999988654
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=320.80 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=194.5
Q ss_pred eeccCCceEEEEEEE--ccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 431 PLGHGGFGHVVLCKN--KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~--~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
+||+|+||.||+|.+ +.++..+|+|+++...........+.+|+.+++.++||||+++++.+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------- 66 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--------------- 66 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---------------
Confidence 589999999999975 456889999998755555555678999999999999999999998751
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
....+++|||++ ++|.+++.....+++..+..++.||+.||+|||++||+|||
T Consensus 67 --------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 120 (257)
T cd05116 67 --------------------------AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120 (257)
T ss_pred --------------------------CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 124589999997 58999998878899999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|||.|||++.++.+||+|||++......... ........+++.|+|||.+.+ ..++.++|||||||+
T Consensus 121 lkp~nill~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~ 187 (257)
T cd05116 121 LAARNVLLVTQHYAKISDFGLSKALGADENY------------YKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVL 187 (257)
T ss_pred cchhhEEEcCCCeEEECCCccccccCCCCCe------------eeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHH
Confidence 9999999999999999999999865322100 001122345689999999876 568899999999999
Q ss_pred HHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 668 FFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 668 L~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+|||++ ||........... +. ....++.....++++.++|.+||+.||.+||++.+|.+.
T Consensus 188 l~el~t~g~~p~~~~~~~~~~~~-i~-~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~ 251 (257)
T cd05116 188 MWEAFSYGQKPYKGMKGNEVTQM-IE-SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELR 251 (257)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHH-HH-CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHH
Confidence 999985 7765544433322 22 223333344567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=326.37 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=204.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------- 74 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN-------- 74 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--------
Confidence 368899999999999999999999999999999987543 33456789999999999999999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG- 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs- 580 (1239)
...+|+||||++ ++|.+++...+.+++..++.++.|++.||.|||+
T Consensus 75 --------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 122 (284)
T cd06620 75 --------------------------------ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122 (284)
T ss_pred --------------------------------CCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 357899999997 5899988887889999999999999999999997
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
++++||||||+||+++.++.++|+|||++....... ....+||..|+|||++.+ ..++.++|
T Consensus 123 ~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-----------------~~~~~~~~~~~aPE~~~~-~~~~~~~D 184 (284)
T cd06620 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-----------------ADTFVGTSTYMSPERIQG-GKYTVKSD 184 (284)
T ss_pred cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-----------------cCccccCcccCCHHHHcc-CCCCccch
Confidence 689999999999999999999999999986532110 123478999999999877 57899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHH-----------HHHHHhhhhcCCCCC-ccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 661 MYSLGIVFFELWH---PFSTAMER-----------QIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~-----------~~~~~~~~~~~~~p~-~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
+|||||++|+|++ ||...... ........ . ..+. .....++++.+||.+||+.||.+|||+.+
T Consensus 185 i~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-E-PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred HHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-c-cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 9999999999996 76543321 11111111 1 1111 11225568999999999999999999999
Q ss_pred HHhccCCCCc
Q 000880 726 LLQDALPPQM 735 (1239)
Q Consensus 726 iL~~~~~~~~ 735 (1239)
+++|+||.+.
T Consensus 263 ~~~~~~~~~~ 272 (284)
T cd06620 263 LCAMPPFIQA 272 (284)
T ss_pred HhcCcccccc
Confidence 9999988664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.11 Aligned_cols=272 Identities=24% Similarity=0.412 Sum_probs=212.1
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
..+.|+-+.+||+|.||+||+|+++.+|+.||+|++-..+.....-...++|+.+|..|+|+|++.++..|-...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~----- 89 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA----- 89 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc-----
Confidence 345677788999999999999999999999999987654433334456889999999999999999998873211
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
+ ....+...+|+||.+|..+|..+|... .+++..++.+++.+++.||.|||+
T Consensus 90 ----------------T-----------p~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr 142 (376)
T KOG0669|consen 90 ----------------T-----------PTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR 142 (376)
T ss_pred ----------------C-----------CcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH
Confidence 0 001245678999999999999999866 679999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+.|+|||+||+|+||+.+|.+||+|||+|+.+......... ..+.++-|.+|.+||.+.|...|+++.|
T Consensus 143 ~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kp-----------rytnrvvTLwYrppEllLG~r~yg~~iD 211 (376)
T KOG0669|consen 143 NKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKP-----------RYTNRVVTLWYRPPELLLGDREYGPPID 211 (376)
T ss_pred hhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCC-----------CcccceeeeecCCHHHhhcccccCCcch
Confidence 99999999999999999999999999999876544322211 2356788999999999999889999999
Q ss_pred hHHHHHHHHHhhc--CCchhHHHHHHHHhhh-hcCCC-CCccc-------------------------------cCCHHH
Q 000880 661 MYSLGIVFFELWH--PFSTAMERQIVLSDLK-QKGEL-PPSWV-------------------------------AKFSEQ 705 (1239)
Q Consensus 661 IwSlGviL~ELlt--Pf~~~~~~~~~~~~~~-~~~~~-p~~~~-------------------------------~~~~e~ 705 (1239)
||..|||+.||+| |.......+..+..+. ..+.+ +..|+ ...+++
T Consensus 212 iWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a 291 (376)
T KOG0669|consen 212 IWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEA 291 (376)
T ss_pred hHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhH
Confidence 9999999999997 5433322222211111 01111 00111 112367
Q ss_pred HHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 706 ESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 706 ~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
.+|+.+||..||.+|+++++++.|.||...+
T Consensus 292 ~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 292 LDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred HHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 8999999999999999999999999987654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=334.28 Aligned_cols=261 Identities=24% Similarity=0.388 Sum_probs=206.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----- 88 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS----- 88 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc-----
Confidence 468999999999999999999999999999999986543333445678899999999999999999988743210
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
......+|+||+|++++|.+++.. ..+++..++.++.||+.||+|||++|
T Consensus 89 -----------------------------~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g 138 (343)
T cd07880 89 -----------------------------LDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG 138 (343)
T ss_pred -----------------------------ccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 011245799999998899888764 56999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+||+++.++.+||+|||++...... .....+++.|+|||++.+...++.++|+|
T Consensus 139 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 200 (343)
T cd07880 139 IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE------------------MTGYVVTRWYRAPEVILNWMHYTQTVDIW 200 (343)
T ss_pred eecCCCCHHHEEEcCCCCEEEeecccccccccC------------------ccccccCCcccCHHHHhCCCCCCcHHHHH
Confidence 999999999999999999999999998753211 12346789999999987644588999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC----------------------------CCccccCCHHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL----------------------------PPSWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~----------------------------p~~~~~~~~e~~~LI~~ 711 (1239)
||||++|+|++ ||................... ...+...++.+.++|.+
T Consensus 201 slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 280 (343)
T cd07880 201 SVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEK 280 (343)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHH
Confidence 99999999996 776443322222211111000 01123455678999999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCch
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||+.||.+|||+.++++|+||....
T Consensus 281 ~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 281 MLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HcCCChhhCCCHHHHhcCccHhhhc
Confidence 9999999999999999999998663
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=327.76 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=203.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..|+..+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||++++++|..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-------- 86 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-------- 86 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--------
Confidence 458888999999999999999999999999999875432 33344678899999999999999999998843
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....|+||||++|++.+++.. ...+++..+..++.||+.||.|||++
T Consensus 87 --------------------------------~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~ 134 (307)
T cd06607 87 --------------------------------EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134 (307)
T ss_pred --------------------------------CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345799999999998887764 45699999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCcch
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ks 659 (1239)
||+||||+|+||+++.++.+||+|||++..... .....|++.|+|||++.+ ...++.++
T Consensus 135 ~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~s 195 (307)
T cd06607 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-------------------ANSFVGTPYWMAPEVILAMDEGQYDGKV 195 (307)
T ss_pred CceecCCCcccEEECCCCCEEEeecCcceecCC-------------------CCCccCCccccCceeeeccCCCCCCccc
Confidence 999999999999999999999999999875321 123468889999998752 24588999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||||||+++|||++ ||.............. ...........+..+.++|.+||+.||++||++.+++.|+|+....
T Consensus 196 Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred chHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999999997 5654433332222221 1111111123456889999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=318.55 Aligned_cols=254 Identities=30% Similarity=0.479 Sum_probs=209.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||.|++|.||+|.+..+++.||||++...... .....+.+|+..++.++||||+++++++..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 70 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--------- 70 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc---------
Confidence 4789999999999999999999999999999998765432 456789999999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG-Q 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs-~ 581 (1239)
...+|++|||++ ++|.+++.....+++..++.++.||+.||+|||+ +
T Consensus 71 -------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~ 119 (264)
T cd06623 71 -------------------------------EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119 (264)
T ss_pred -------------------------------CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC
Confidence 357899999997 6999999888889999999999999999999999 9
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
+++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+
T Consensus 120 ~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~---------------~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv 183 (264)
T cd06623 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD---------------QCNTFVGTVTYMSPERIQG-ESYSYAADI 183 (264)
T ss_pred CCccCCCCHHHEEECCCCCEEEccCccceecccCCC---------------cccceeecccccCHhhhCC-CCCCchhhH
Confidence 999999999999999999999999999876532110 0123468899999999887 578999999
Q ss_pred HHHHHHHHHhhc---CCchhH--HHHHHHHhhhhcCCCCCcccc-CCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 662 YSLGIVFFELWH---PFSTAM--ERQIVLSDLKQKGELPPSWVA-KFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~--~~~~~~~~~~~~~~~p~~~~~-~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
||||+++|+|++ ||.... ........+. ....+..... .+..+.++|.+||..+|++|||+.++++|+|++..
T Consensus 184 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999997 665543 2222222222 2222222233 56789999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=319.99 Aligned_cols=250 Identities=28% Similarity=0.376 Sum_probs=195.4
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
+.....||+|+||.||+|++..++..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------- 76 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE----------- 76 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----------
Confidence 334468999999999999999899999999886432 3345678999999999999999999988732
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhC
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHF--DKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l--~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...++++|||++ ++|.+++... ..+ ++..+..++.||+.||+|||++
T Consensus 77 -----------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 127 (268)
T cd06624 77 -----------------------------NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127 (268)
T ss_pred -----------------------------CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence 356899999996 5999988754 445 8888999999999999999999
Q ss_pred CccccCCCcccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC-CCCCcch
Q 000880 582 GIIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW-PKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~ks 659 (1239)
||+||||||+||+++. ++.++|+|||++....... .......|++.|+|||++.+. ..++.++
T Consensus 128 ~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~ 192 (268)
T cd06624 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---------------PCTETFTGTLQYMAPEVIDKGPRGYGAPA 192 (268)
T ss_pred CEeecCCCHHHEEEcCCCCeEEEecchhheecccCC---------------CccccCCCCccccChhhhccccccCCchh
Confidence 9999999999999986 6789999999987542111 011234689999999998652 2478999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
||||||+++|+|++ ||...................+.......+++.+++.+||+.+|.+|||+.+++.|||+
T Consensus 193 Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999997 66543222211111111122222333456789999999999999999999999999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=329.62 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=198.9
Q ss_pred CceEEeeeccCCceEEEEEEEcc--CCcEEEEEEEecCC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKL--DGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~--~g~~vAVK~i~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.|++.+.||+|+||.||+|.++. +++.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH------ 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC------
Confidence 47889999999999999999998 89999999987533 1222345678999999999999999999987432
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-----DHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-----~~l~~~~~~~i~~qI~~gL~ 576 (1239)
....+|+||||++++|.+++... ..+++..++.++.||+.||+
T Consensus 75 --------------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 122 (316)
T cd07842 75 --------------------------------ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122 (316)
T ss_pred --------------------------------CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHH
Confidence 23578999999998888777532 26899999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcC----CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDA----RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~----~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
|||+++|+||||||+|||++. ++.+||+|||+++....... .........+|+.|+|||++.+.
T Consensus 123 ~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK------------PLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred HHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcc------------cccccCCccccccccCHHHHhCC
Confidence 999999999999999999999 89999999999986532210 01122345789999999988775
Q ss_pred CCCCcchhhHHHHHHHHHhhc---CCchhHHHH---------H---HHHhh-----------------------hhcCCC
Q 000880 653 PKIDEKADMYSLGIVFFELWH---PFSTAMERQ---------I---VLSDL-----------------------KQKGEL 694 (1239)
Q Consensus 653 ~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~---------~---~~~~~-----------------------~~~~~~ 694 (1239)
..++.++|||||||++|+|++ ||....... . ....+ ......
T Consensus 191 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (316)
T cd07842 191 RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTY 270 (316)
T ss_pred CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCC
Confidence 568999999999999999996 654322111 0 00000 000001
Q ss_pred C-C-------ccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 695 P-P-------SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 695 p-~-------~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+ . .+....+++.++|.+||+.||.+|||+.++++||||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 271 PSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1 0 001344578899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=326.50 Aligned_cols=268 Identities=26% Similarity=0.422 Sum_probs=206.1
Q ss_pred cccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+..++|++.+.||.|+||.||+|.++.+|+.||||+++...........+.+|+.+++.++||||+++++.+.+....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~-- 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA-- 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh--
Confidence 346789999999999999999999999999999999976544333445678899999999999999999887543100
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
+ ........+|++|||+++++...+... ..+++..++.++.||+.||+|||
T Consensus 82 ----~------------------------~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH 133 (302)
T cd07864 82 ----L------------------------DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH 133 (302)
T ss_pred ----h------------------------hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 0 001123478999999999888877654 46999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++||+||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+...++.++
T Consensus 134 ~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~ 199 (302)
T cd07864 134 KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES--------------RPYTNKVITLWYRPPELLLGEERYGPAI 199 (302)
T ss_pred hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc--------------cccccceeccCccChHHhcCCCCCCchh
Confidence 99999999999999999999999999999986532210 0112235688999999887645578999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC-CC--------------------------CccccCCHHHHHHH
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE-LP--------------------------PSWVAKFSEQESLL 709 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~-~p--------------------------~~~~~~~~e~~~LI 709 (1239)
|||||||++|||++ ||.................. .+ ..+...++.+.++|
T Consensus 200 Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 279 (302)
T cd07864 200 DVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLL 279 (302)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHH
Confidence 99999999999997 56543332222111111000 00 01223457889999
Q ss_pred HHccCCCCCCCCCHHHHHhccCC
Q 000880 710 RRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 710 ~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
.+||+.||.+|||+.+++.|+|+
T Consensus 280 ~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 280 DHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHccCChhhCCCHHHHhcCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=336.47 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=195.8
Q ss_pred CCceEEeeeccCCceEEEEEEEcc-----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~ 497 (1239)
++|++.+.||.|+||.||+|.+.. +++.||+|+++... .......+.+|+.++..+ +||||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-- 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-- 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence 478999999999999999997543 45789999987432 233446788999999999 899999999887432
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--------------------
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-------------------- 556 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-------------------- 556 (1239)
...++++|||++ ++|.+++...
T Consensus 84 -------------------------------------~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~ 126 (337)
T cd05054 84 -------------------------------------GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQK 126 (337)
T ss_pred -------------------------------------CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccc
Confidence 346789999996 5888887532
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEE
Q 000880 557 -----------------------------------------DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595 (1239)
Q Consensus 557 -----------------------------------------~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl 595 (1239)
..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill 206 (337)
T cd05054 127 EGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL 206 (337)
T ss_pred cccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE
Confidence 257889999999999999999999999999999999999
Q ss_pred cCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc--
Q 000880 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH-- 673 (1239)
Q Consensus 596 ~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt-- 673 (1239)
+.++.+||+|||+++.+.... .........++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 207 ~~~~~vkL~DfG~a~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g 272 (337)
T cd05054 207 SENNVVKICDFGLARDIYKDP-------------DYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLG 272 (337)
T ss_pred eCCCcEEEeccccchhcccCc-------------chhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcC
Confidence 999999999999998653211 0111233456788999999987 568999999999999999985
Q ss_pred --CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 674 --PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 674 --Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
||......+.....+. ....+......++++.+++.+||+.+|++||++.+++++
T Consensus 273 ~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 273 ASPYPGVQIDEEFCRRLK-EGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCCCCCCccHHHHHHHh-ccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6654332222222222 222222233456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.53 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=205.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK---SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
.+|++.+.||+|+||.||+|+++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~----- 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP----- 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC-----
Confidence 478999999999999999999999999999999864321 233456788999999999999999999887432
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....++++|||++ ++|.+.+.....+++..++.++.||+.||.|||
T Consensus 77 ---------------------------------~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH 123 (264)
T cd06653 77 ---------------------------------EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123 (264)
T ss_pred ---------------------------------CCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2356789999996 589999988778999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++|+||||+||+++.++.++|+|||+++........ ....+...|+..|+|||++.+ ..++.++
T Consensus 124 ~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 190 (264)
T cd06653 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS------------GTGIKSVTGTPYWMSPEVISG-EGYGRKA 190 (264)
T ss_pred hCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc------------CccccccCCcccccCHhhhcC-CCCCccc
Confidence 999999999999999999999999999999864311100 001133568999999999987 5688999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
|+|||||++|+|++ ||.............. .+..+..+...++.+.++|.+||. +|..||++.+++.|||
T Consensus 191 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 191 DVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred cHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc-CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 99999999999996 7765544444443332 222233334556789999999999 5799999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=329.65 Aligned_cols=256 Identities=29% Similarity=0.496 Sum_probs=203.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||.|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||++++++|...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------- 81 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP------- 81 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-------
Confidence 4689999999999999999999999999999999865444434456788999999999999999999887432
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|++|||++++|..++.. ..+++..+..++.||+.||.|||++|
T Consensus 82 --------------------------------~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~ 128 (328)
T cd07856 82 --------------------------------LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG 128 (328)
T ss_pred --------------------------------CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 245789999999899888764 45888999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+|||++.++.++|+|||++..... ......+++.|+|||++.+...++.++|||
T Consensus 129 iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 190 (328)
T cd07856 129 VVHRDLKPSNILINENCDLKICDFGLARIQDP------------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIW 190 (328)
T ss_pred cccCCCCHHHEeECCCCCEEeCccccccccCC------------------CcCCCcccccccCceeeeccCCcCcHHHHH
Confidence 99999999999999999999999999874321 012346789999999987645689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHH--------------------------hhhhcCCCC--CccccCCHHHHHHHHH
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLS--------------------------DLKQKGELP--PSWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~--------------------------~~~~~~~~p--~~~~~~~~e~~~LI~~ 711 (1239)
||||++|+|++ ||........... ........| ......++++.++|.+
T Consensus 191 slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 270 (328)
T cd07856 191 SAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEK 270 (328)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHH
Confidence 99999999997 6643322111000 000000111 1122345689999999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCch
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||+.+|.+|||+.+++.|+|+....
T Consensus 271 ~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 271 MLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HcCCChhhCCCHHHHhcCCcccccc
Confidence 9999999999999999999997553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=323.40 Aligned_cols=250 Identities=19% Similarity=0.291 Sum_probs=198.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEc----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNK----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
+++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 78 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ---- 78 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----
Confidence 468999999999999999999863 356789999986432 23344678899999999999999999988632
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-----------------CCCC
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-----------------DHFD 560 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-----------------~~l~ 560 (1239)
....|++|||++ ++|.+++... ..++
T Consensus 79 ------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 122 (283)
T cd05090 79 ------------------------------------EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122 (283)
T ss_pred ------------------------------------CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccC
Confidence 345799999996 5899988532 2378
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccC
Q 000880 561 KELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640 (1239)
Q Consensus 561 ~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 640 (1239)
+..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....... ........++
T Consensus 123 ~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~ 189 (283)
T cd05090 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY-------------YRVQPKSLLP 189 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcc-------------eecccCCCcc
Confidence 889999999999999999999999999999999999999999999999986532210 0112334567
Q ss_pred ccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCC
Q 000880 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716 (1239)
Q Consensus 641 ~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~d 716 (1239)
..|+|||++.+ ..++.++|||||||++|||++ ||........ ...+. ....++.....++.+.+++.+||+.|
T Consensus 190 ~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~ 266 (283)
T cd05090 190 IRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-IEMVR-KRQLLPCSEDCPPRMYSLMTECWQEG 266 (283)
T ss_pred ceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH-cCCcCCCCCCCCHHHHHHHHHHcccC
Confidence 88999999987 568999999999999999996 7765544332 22222 22233344456789999999999999
Q ss_pred CCCCCCHHHHHhc
Q 000880 717 PSDRPSATELLQD 729 (1239)
Q Consensus 717 P~~RPta~eiL~~ 729 (1239)
|.+||++.+|+++
T Consensus 267 p~~Rp~~~~i~~~ 279 (283)
T cd05090 267 PSRRPRFKDIHTR 279 (283)
T ss_pred cccCcCHHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=330.90 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=204.1
Q ss_pred CceEEeeeccCCceEEEEEEEccC--CcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLD--GRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~--g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+|++.+.||+|+||.||+|++..+ +..||||++............+.+|+.+++.+ +||||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----- 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP----- 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-----
Confidence 478899999999999999999988 89999999874433333456788999999999 5999999997653210
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
.....+|++|+|++++|.+++.....+++..++.++.||+.||.|||++
T Consensus 76 -------------------------------~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 124 (332)
T cd07857 76 -------------------------------GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA 124 (332)
T ss_pred -------------------------------ccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1134578999999999999998888899999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+++.+...... .........||+.|+|||++.+...++.++||
T Consensus 125 givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di 193 (332)
T cd07857 125 NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-----------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193 (332)
T ss_pred CcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccc-----------ccccccCcccCccccCcHHHhCCCCCCcHHHH
Confidence 9999999999999999999999999999865322110 00112345799999999988764568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhh-----------------------h---c--CCCCCccccCCHHHHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLK-----------------------Q---K--GELPPSWVAKFSEQESLLR 710 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~-----------------------~---~--~~~p~~~~~~~~e~~~LI~ 710 (1239)
|||||++|+|++ ||............+. . . ..++......++.+.+++.
T Consensus 194 ~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (332)
T cd07857 194 WSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273 (332)
T ss_pred HHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHH
Confidence 999999999996 6643322111111000 0 0 0011122234568899999
Q ss_pred HccCCCCCCCCCHHHHHhccCCCCc
Q 000880 711 RLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
+||+.||.+|||+.+++.|||+...
T Consensus 274 ~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 274 KLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHccCCcccCCCHHHHhcChhhhhh
Confidence 9999999999999999999987433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=323.45 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=192.2
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEEecCCCCchh-HHHHHHHHHHHHh---cCCCceeeeeeeeeecCccccCCCCcC
Q 000880 431 PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPV-NDRILREVATLSR---LQHQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~-~~~~~~Ev~iL~~---L~HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
.||+|+||.||++.+..+|+.||+|.+......... ...+.+|..+++. .+||||+.+++.+..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~------------ 68 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT------------ 68 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec------------
Confidence 489999999999999999999999998754332221 2234455444443 479999999887732
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiH 585 (1239)
...+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||+++|+|
T Consensus 69 ----------------------------~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH 120 (279)
T cd05633 69 ----------------------------PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120 (279)
T ss_pred ----------------------------CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCC
Confidence 346799999996 589999988888999999999999999999999999999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHH
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlG 665 (1239)
|||||+|||++.++.++|+|||++...... ......||+.|+|||.+.+...++.++|+||||
T Consensus 121 ~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 183 (279)
T cd05633 121 RDLKPANILLDEHGHVRISDLGLACDFSKK-----------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLG 183 (279)
T ss_pred CCCCHHHEEECCCCCEEEccCCcceecccc-----------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHH
Confidence 999999999999999999999998743211 012246899999999986435588999999999
Q ss_pred HHHHHhhc---CCchhHH--HHHHHH-hhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCCC
Q 000880 666 IVFFELWH---PFSTAME--RQIVLS-DLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPPQ 734 (1239)
Q Consensus 666 viL~ELlt---Pf~~~~~--~~~~~~-~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~~ 734 (1239)
|++|+|++ ||..... ...... ........ ....++++.++|++||..||.+|| |+.++++||||..
T Consensus 184 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 184 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 99999997 7753321 111111 11111122 234567899999999999999999 6999999999998
Q ss_pred chHH
Q 000880 735 MEYE 738 (1239)
Q Consensus 735 ~~~~ 738 (1239)
..+.
T Consensus 261 ~~~~ 264 (279)
T cd05633 261 IDWQ 264 (279)
T ss_pred CCHh
Confidence 7643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=317.22 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=195.6
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||+|+||.||++.++ ++..+|+|.+...... ...+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 70 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--------- 70 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc---------
Confidence 57999999999999999999886 5678999987643322 3568899999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++|||++ ++|.+++.. ...+++..++.++.||+.||+|||++
T Consensus 71 -------------------------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 119 (256)
T cd05114 71 -------------------------------QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119 (256)
T ss_pred -------------------------------CCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345799999996 689998875 34689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+ ..++.++||
T Consensus 120 ~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 184 (256)
T cd05114 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT--------------SSSGAKFPVKWSPPEVFNF-SKYSSKSDV 184 (256)
T ss_pred CccccccCcceEEEcCCCeEEECCCCCccccCCCcee--------------ccCCCCCchhhCChhhccc-Cccchhhhh
Confidence 9999999999999999999999999998764321100 1122346678999999887 568999999
Q ss_pred HHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 662 YSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 662 wSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
||||+++|||++ ||......+........ ..+......+..+.+++.+||+.+|.+||++.++++.
T Consensus 185 ~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG--FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999996 67655544444433322 2222222345689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=317.09 Aligned_cols=250 Identities=33% Similarity=0.560 Sum_probs=203.3
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||+|+||.||+|.++.+|..||+|.+............+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~---------- 70 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE---------- 70 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc----------
Confidence 4788999999999999999999999999999997654433445678899999999999999999987632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+++||++ ++|.+++.... .+++..++.++.||+.||.|||++
T Consensus 71 ------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (257)
T cd08225 71 ------------------------------NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120 (257)
T ss_pred ------------------------------CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356899999996 59999887543 479999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCC-EEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 582 GIIHRDLTPNNIFFDARND-IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~-vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+++|+||||+||+++.++. +||+|||.+........ ......|++.|+|||++.+ ..++.++|
T Consensus 121 ~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---------------~~~~~~~~~~~~ape~~~~-~~~~~~~D 184 (257)
T cd08225 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---------------LAYTCVGTPYYLSPEICQN-RPYNNKTD 184 (257)
T ss_pred CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc---------------cccccCCCccccCHHHHcC-CCCCchhh
Confidence 9999999999999998864 69999999976532110 0122468999999999887 46889999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+|||||++|||++ ||............. ....++.....+.++.++|.+||..+|++|||+.++++|+||
T Consensus 185 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 185 IWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--QGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHHHHHHhCCCCCCCccHHHHHHHHh--cccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999999999996 776554444433332 222333334456789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=352.13 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=192.6
Q ss_pred CcccCCceEEeeeccCCceEEEEEEEccCC-cEEEEEEEe--------------c-CCCCchhHHHHHHHHHHHHhcCCC
Q 000880 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDG-RHYAVKKIR--------------L-KDKSLPVNDRILREVATLSRLQHQ 483 (1239)
Q Consensus 420 ~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g-~~vAVK~i~--------------~-~~~~~~~~~~~~~Ev~iL~~L~Hp 483 (1239)
..+.++|++++.||+|+||+||+|.++... ..+++|.+. . ..........+.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345689999999999999999999875432 222222111 0 011222345688999999999999
Q ss_pred ceeeeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-----CC
Q 000880 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-----DH 558 (1239)
Q Consensus 484 nIv~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-----~~ 558 (1239)
|||++++++.. ....|++|+++.++|..++... ..
T Consensus 224 nIv~l~~~~~~----------------------------------------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~ 263 (501)
T PHA03210 224 NILKIEEILRS----------------------------------------EANTYMITQKYDFDLYSFMYDEAFDWKDR 263 (501)
T ss_pred CcCcEeEEEEE----------------------------------------CCeeEEEEeccccCHHHHHhhcccccccc
Confidence 99999988733 3467999999998888776432 22
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccc
Q 000880 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV 638 (1239)
Q Consensus 559 l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (1239)
.....++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ......+
T Consensus 264 ~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--------------~~~~~~~ 329 (501)
T PHA03210 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE--------------AFDYGWV 329 (501)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc--------------ccccccc
Confidence 44667889999999999999999999999999999999999999999999986532110 0123457
Q ss_pred cCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchh--HHHHHHHHhhhhcC----CCC-------------
Q 000880 639 GTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTA--MERQIVLSDLKQKG----ELP------------- 695 (1239)
Q Consensus 639 GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~--~~~~~~~~~~~~~~----~~p------------- 695 (1239)
||+.|+|||++.+ ..++.++|||||||++|||++ ||... .........+.... .+|
T Consensus 330 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~ 408 (501)
T PHA03210 330 GTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSA 408 (501)
T ss_pred CCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhh
Confidence 9999999999988 569999999999999999996 44321 11111111111000 011
Q ss_pred ----------Ccc--ccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCchHHH
Q 000880 696 ----------PSW--VAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYEL 739 (1239)
Q Consensus 696 ----------~~~--~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~~~~ 739 (1239)
+.+ .....++.++|.+||+.||.+|||+.++|+||||.......
T Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~~ 464 (501)
T PHA03210 409 EIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEEE 464 (501)
T ss_pred hcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCchH
Confidence 000 11234567889999999999999999999999998765443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=319.94 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=196.5
Q ss_pred eEEeeeccCCceEEEEEEEccCCc--EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 427 EELQPLGHGGFGHVVLCKNKLDGR--HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 427 ~~~~~LG~G~fG~Vy~a~~~~~g~--~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
.+.+.||+|+||.||+|.+..++. .||+|.++....+......+.+|+.+++.++||||+++++.+.....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------- 74 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE------- 74 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc-------
Confidence 456889999999999999987765 69999987655555556788999999999999999999988743210
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHH
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES------YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~------~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
.......+++|||++ ++|.+++.. ...+++..++.++.||+.||+|
T Consensus 75 ---------------------------~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 127 (272)
T cd05075 75 ---------------------------SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEY 127 (272)
T ss_pred ---------------------------ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHH
Confidence 011235789999996 688887742 2348899999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||+++|+||||||+|||++.++.+||+|||+++....... ........+++.|+|||.+.+ ..++.
T Consensus 128 lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~~~~pe~~~~-~~~~~ 193 (272)
T cd05075 128 LSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-------------YRQGRIAKMPVKWIAIESLAD-RVYTT 193 (272)
T ss_pred HHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccc-------------eecCCcccCCcccCCHHHccC-CCcCh
Confidence 9999999999999999999999999999999986532210 011123356788999999987 56899
Q ss_pred chhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
++|||||||++|||++ ||........... +. .+..++.....+..+.++|.+||+.||.+|||+.+++++
T Consensus 194 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 194 KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LR-QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999986 6655444333222 22 222233334556789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.72 Aligned_cols=261 Identities=24% Similarity=0.405 Sum_probs=213.7
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCcccc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+++|.++++||+|+|.+|.+++++.|.+.||+|++++.-. ..+...-+..|-.+..+. +||.+|.++.||
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-------- 320 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-------- 320 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--------
Confidence 6899999999999999999999999999999999976432 223344566677777666 799999999877
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
+....+|+|.||++ |+|.-++++..+++++.|+.|..+|+.||.|||
T Consensus 321 --------------------------------qtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh 368 (593)
T KOG0695|consen 321 --------------------------------QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH 368 (593)
T ss_pred --------------------------------cccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh
Confidence 23567899999996 589999999999999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|||+||||..|+|||..|++||+|+|+++.--.+. -.++++||||.|.|||++.| ..|++.+
T Consensus 369 ~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g---------------d~tstfcgtpnyiapeilrg-eeygfsv 432 (593)
T KOG0695|consen 369 ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG---------------DTTSTFCGTPNYIAPEILRG-EEYGFSV 432 (593)
T ss_pred hcCeeeeeccccceEEccCCceeecccchhhcCCCCC---------------cccccccCCCcccchhhhcc-cccCcee
Confidence 9999999999999999999999999999998521111 12467899999999999999 6899999
Q ss_pred hhHHHHHHHHHhhc---CCc------hhHHHH-HHHHhh-hhcCCCCCccccCCHHHHHHHHHccCCCCCCCC------C
Q 000880 660 DMYSLGIVFFELWH---PFS------TAMERQ-IVLSDL-KQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP------S 722 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~------~~~~~~-~~~~~~-~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP------t 722 (1239)
|+|+|||+++||+. ||. +.++.+ ...+.+ ....++|.+.+ -.+..+++..|++||.+|. .
T Consensus 433 dwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls---vkas~vlkgflnkdp~erlgc~~~~g 509 (593)
T KOG0695|consen 433 DWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS---VKASHVLKGFLNKDPKERLGCRPQTG 509 (593)
T ss_pred hHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee---hhhHHHHHHhhcCCcHHhcCCCcccc
Confidence 99999999999994 875 122222 233333 33344554433 3677899999999999996 5
Q ss_pred HHHHHhccCCCCchHHHHHH
Q 000880 723 ATELLQDALPPQMEYELLDN 742 (1239)
Q Consensus 723 a~eiL~~~~~~~~~~~~~~~ 742 (1239)
+.++-.|+||....|+.++.
T Consensus 510 ~~dik~h~ffr~idwd~leq 529 (593)
T KOG0695|consen 510 FSDIKSHAFFRSIDWDLLEQ 529 (593)
T ss_pred hhhhhcchhhhhCCHHHHhh
Confidence 88999999999999987754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=335.46 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=207.9
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
..++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 88 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS---- 88 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc----
Confidence 3578999999999999999999999999999999987544344455678899999999999999999876632210
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
......+|+|+||++++|.+++.. ..+++..++.++.||+.||+|||++
T Consensus 89 ------------------------------~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~ 137 (343)
T cd07851 89 ------------------------------LEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA 137 (343)
T ss_pred ------------------------------ccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 012345899999999999998875 5699999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
||+||||||+||+++.++.+||+|||++...... .....+|+.|+|||.+.+...++.++||
T Consensus 138 gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 199 (343)
T cd07851 138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------------------MTGYVATRWYRAPEIMLNWMHYNQTVDI 199 (343)
T ss_pred CeecCCCCHHHeEECCCCCEEEcccccccccccc------------------ccCCcccccccCHHHHhCCCCCCchHhH
Confidence 9999999999999999999999999999754211 1334688999999998764467899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC----------------------------CCccccCCHHHHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL----------------------------PPSWVAKFSEQESLLR 710 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~----------------------------p~~~~~~~~e~~~LI~ 710 (1239)
|||||++|||++ ||...........+....+.. ...+...++++.++|.
T Consensus 200 wslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~ 279 (343)
T cd07851 200 WSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLE 279 (343)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHH
Confidence 999999999997 665443333222221111100 0111234678899999
Q ss_pred HccCCCCCCCCCHHHHHhccCCCCch
Q 000880 711 RLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
+||+.||.+|||+.++++|||+.+..
T Consensus 280 ~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 280 KMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HhCCCChhhCCCHHHHhcCCCccccC
Confidence 99999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=328.82 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=202.1
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
+.|.....||.|+||.||++.+..++..||||.+.... ......+.+|+.+++.++||||+++++.+..
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--------- 90 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--------- 90 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec---------
Confidence 44555678999999999999999999999999986432 2345678899999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....|++|||+++ +|.+++. ...+++..++.++.||+.||.|||++|
T Consensus 91 -------------------------------~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ 138 (292)
T cd06658 91 -------------------------------GDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQG 138 (292)
T ss_pred -------------------------------CCeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3567999999975 7888774 356899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+||||||+||+++.++.++|+|||++....... .......||+.|+|||.+.+ ..++.++|+|
T Consensus 139 ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~ 202 (292)
T cd06658 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---------------PKRKSLVGTPYWMAPEVISR-LPYGTEVDIW 202 (292)
T ss_pred EeecCCCHHHEEEcCCCCEEEccCcchhhccccc---------------ccCceeecCccccCHHHHcc-CCCCchhhHH
Confidence 9999999999999999999999999987542111 01133578999999999877 5689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||||++|||++ ||....................+.....+..+.++|.+||..||.+|||+.++++|+||....
T Consensus 203 slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 99999999997 776544433322221111122222234566889999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=319.19 Aligned_cols=248 Identities=29% Similarity=0.458 Sum_probs=202.1
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCc
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGT 510 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~ 510 (1239)
||.|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------------- 64 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD---------------- 64 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc----------------
Confidence 6999999999999999999999999975443 23345679999999999999999999987632
Q ss_pred ccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 000880 511 LASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589 (1239)
Q Consensus 511 ~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLK 589 (1239)
...+|++|||++ ++|.+++.....+++..+..++.||+.||.|||+++++|+|||
T Consensus 65 ------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~ 120 (262)
T cd05572 65 ------------------------KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120 (262)
T ss_pred ------------------------CCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence 356799999996 6999999888889999999999999999999999999999999
Q ss_pred cccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHH
Q 000880 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFF 669 (1239)
Q Consensus 590 p~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ 669 (1239)
|+||+++.++.++|+|||++....... ......|++.|+|||.+.+ ..++.++|+||||+++|
T Consensus 121 ~~nilv~~~~~~~l~df~~~~~~~~~~----------------~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~ 183 (262)
T cd05572 121 PENLLLDSNGYVKLVDFGFAKKLKSGQ----------------KTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLY 183 (262)
T ss_pred HHHEEEcCCCCEEEeeCCcccccCccc----------------ccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHH
Confidence 999999999999999999998653211 1123468999999999877 56899999999999999
Q ss_pred Hhhc---CCchhH--HHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhccCCCCchH
Q 000880 670 ELWH---PFSTAM--ERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDALPPQMEY 737 (1239)
Q Consensus 670 ELlt---Pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~~~~~~~~~ 737 (1239)
+|++ ||.... .......... ....+......++++.++|.+||+.||.+||+ +.++++||||....+
T Consensus 184 ~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 184 ELLTGRPPFGEDDEDPMEIYNDILK-GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred HHHhCCCCcCCCCCCHHHHHHHHhc-cCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 9996 776554 3223332221 11122222233678999999999999999999 999999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=319.65 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=201.3
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC--------chhHHHHHHHHHHHHhcCCCceeeeeeeeeecC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS--------LPVNDRILREVATLSRLQHQHVVRYYQAWFETG 496 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~--------~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~ 496 (1239)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 467788999999999999999989999999988643211 1123467889999999999999999987632
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL 575 (1239)
...+++||||++ ++|.+++...+.+++..+..++.||+.||
T Consensus 80 --------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l 121 (272)
T cd06629 80 --------------------------------------EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121 (272)
T ss_pred --------------------------------------CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHH
Confidence 356799999996 59999998888899999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC-C
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP-K 654 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~ 654 (1239)
.|||+++++||||||+||+++.++.++|+|||+++...... . ........|+..|+|||.+.+.. .
T Consensus 122 ~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~-----------~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (272)
T cd06629 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY--D-----------NDQNMSMQGSVFWMAPEVIHSYSQG 188 (272)
T ss_pred HHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccc--c-----------ccccccccCCccccCHHHhccccCC
Confidence 99999999999999999999999999999999997532110 0 00123456899999999987633 4
Q ss_pred CCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhh--cCCCCC-ccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQ--KGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~--~~~~p~-~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
++.++|+||||+++|+|++ ||......+........ ....+. .....+..+.++|.+||..+|.+|||+.++++
T Consensus 189 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 189 YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 7899999999999999997 66544333333222211 112222 22344678999999999999999999999999
Q ss_pred ccCC
Q 000880 729 DALP 732 (1239)
Q Consensus 729 ~~~~ 732 (1239)
|||+
T Consensus 269 ~~~~ 272 (272)
T cd06629 269 HPFI 272 (272)
T ss_pred CCCC
Confidence 9986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=349.40 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=202.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..+++.+.|.+|||+.||+|+....|..||+|++-.. +....+.+.+||.+|+.|+ |||||.|++......
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~------ 108 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR------ 108 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc------
Confidence 3578889999999999999999988899999988654 4456778999999999996 999999997431110
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
........++|.||||. |+|-+++..+ ..|++.++++|+.|+++|+++||
T Consensus 109 ---------------------------~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH 161 (738)
T KOG1989|consen 109 ---------------------------SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH 161 (738)
T ss_pred ---------------------------cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh
Confidence 00111356789999997 6999999843 56999999999999999999999
Q ss_pred hCC--ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccc--cCcccccCccCCCcccccCC--C
Q 000880 580 GQG--IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSV--DGTGQVGTYFYTAPEIEQGW--P 653 (1239)
Q Consensus 580 s~g--IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~--~ 653 (1239)
... |||||||-+||||+.+++.||||||.|+-.... ++....... ......-|+.|.|||++.-+ .
T Consensus 162 ~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~--------~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~ 233 (738)
T KOG1989|consen 162 YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS--------PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGL 233 (738)
T ss_pred cCCCccchhhhhhhheEEcCCCCEEeCcccccccccCC--------CccHHHHHHHHHHHHhhCCccccChHHHhhhcCC
Confidence 998 999999999999999999999999999743211 100000000 11223579999999985421 4
Q ss_pred CCCcchhhHHHHHHHHHhh---cCCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 654 KIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 654 ~~~~ksDIwSlGviL~ELl---tPf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
..+.|+|||+|||+||-|+ +||..... +.++..+..+|+. +..+..+.+||+.||+.||.+||++.+++.+
T Consensus 234 pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 234 PIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 5899999999999999998 49865432 3455556677765 5667799999999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=339.19 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=195.4
Q ss_pred cCCceEEeeeccCCceEEEEEEEccC-----CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLD-----GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~ 496 (1239)
.++|.+.+.||+|+||.||+|.+... +..||||+++... .....+.+.+|+.+|+.+. |||||+++++|.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 36788999999999999999987533 3479999986433 2334567999999999996 9999999998832
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-------------------
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY------------------- 556 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~------------------- 556 (1239)
...+|||||||+ |+|.+++...
T Consensus 113 --------------------------------------~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~ 154 (400)
T cd05105 113 --------------------------------------SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIF 154 (400)
T ss_pred --------------------------------------CCceEEEEEecCCCcHHHHHHHhhhhhhcccccccccccccc
Confidence 346799999996 6898887542
Q ss_pred -----------------------------------------------------------------------------CCC
Q 000880 557 -----------------------------------------------------------------------------DHF 559 (1239)
Q Consensus 557 -----------------------------------------------------------------------------~~l 559 (1239)
..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 234 (400)
T cd05105 155 GINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGL 234 (400)
T ss_pred CCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCC
Confidence 236
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCccccc
Q 000880 560 DKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639 (1239)
Q Consensus 560 ~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 639 (1239)
++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ........+
T Consensus 235 ~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~-------------~~~~~~~~~ 301 (400)
T cd05105 235 TTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN-------------YVSKGSTFL 301 (400)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceecccccc-------------ccccCCcCC
Confidence 7788899999999999999999999999999999999999999999999986432110 011123457
Q ss_pred CccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCC
Q 000880 640 TYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSP 715 (1239)
Q Consensus 640 T~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~ 715 (1239)
++.|+|||++.+ ..++.++|||||||++|||++ ||............+.. ...++.....++++.++|.+||+.
T Consensus 302 ~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~ 379 (400)
T cd05105 302 PVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-GYRMAKPDHATQEVYDIMVKCWNS 379 (400)
T ss_pred CcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHCcc
Confidence 889999999987 568999999999999999984 66554333333333332 222333345667899999999999
Q ss_pred CCCCCCCHHHHHhc
Q 000880 716 SPSDRPSATELLQD 729 (1239)
Q Consensus 716 dP~~RPta~eiL~~ 729 (1239)
||++|||+.++.+.
T Consensus 380 dP~~RPt~~~l~~~ 393 (400)
T cd05105 380 EPEKRPSFLHLSDI 393 (400)
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.58 Aligned_cols=250 Identities=21% Similarity=0.284 Sum_probs=194.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEcc-----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
.++|++.+.||+|+||.||+|.++. ++..||||++... ........+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--- 80 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 80 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 3679999999999999999998752 3568999988532 223345578999999999999999999988732
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC----------CCCHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD----------HFDKELAWH 566 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~----------~l~~~~~~~ 566 (1239)
....++||||++ ++|.+++.... .++...+..
T Consensus 81 -------------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~ 123 (277)
T cd05062 81 -------------------------------------GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123 (277)
T ss_pred -------------------------------------CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHH
Confidence 345789999997 59999886532 356788899
Q ss_pred HHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCc
Q 000880 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP 646 (1239)
Q Consensus 567 i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 646 (1239)
++.|++.||.|||++|++||||||+|||++.++.++|+|||+++........ .......+++.|+||
T Consensus 124 ~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aP 190 (277)
T cd05062 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-------------RKGGKGLLPVRWMSP 190 (277)
T ss_pred HHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCccee-------------ecCCCCccCHhhcCh
Confidence 9999999999999999999999999999999999999999998754321110 011223567899999
Q ss_pred ccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC
Q 000880 647 EIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722 (1239)
Q Consensus 647 E~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt 722 (1239)
|++.+ ..++.++|||||||++|||++ ||............. ....++.....++.+.+++.+||+.||.+|||
T Consensus 191 E~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 267 (277)
T cd05062 191 ESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM--EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 267 (277)
T ss_pred hHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 99987 568999999999999999985 665544433322222 22223333345678999999999999999999
Q ss_pred HHHHHhc
Q 000880 723 ATELLQD 729 (1239)
Q Consensus 723 a~eiL~~ 729 (1239)
+.+++++
T Consensus 268 ~~e~l~~ 274 (277)
T cd05062 268 FLEIISS 274 (277)
T ss_pred HHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=329.77 Aligned_cols=272 Identities=25% Similarity=0.384 Sum_probs=205.9
Q ss_pred CCceE-EeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCch------------hHHHHHHHHHHHHhcCCCceeeeee
Q 000880 424 NDFEE-LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP------------VNDRILREVATLSRLQHQHVVRYYQ 490 (1239)
Q Consensus 424 ~~y~~-~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~------------~~~~~~~Ev~iL~~L~HpnIv~l~~ 490 (1239)
++|.. .+.||.|+||+||+|.++.+++.||||+++....... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45554 4679999999999999999999999999875432210 0124779999999999999999998
Q ss_pred eeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHH
Q 000880 491 AWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ 570 (1239)
Q Consensus 491 ~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~q 570 (1239)
++.. ...+|++|||++++|.+++.....+++..+..++.|
T Consensus 88 ~~~~----------------------------------------~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~q 127 (335)
T PTZ00024 88 VYVE----------------------------------------GDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQ 127 (335)
T ss_pred EEec----------------------------------------CCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHH
Confidence 8732 356899999999999999988888999999999999
Q ss_pred HHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc
Q 000880 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650 (1239)
Q Consensus 571 I~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 650 (1239)
|+.||+|||++|++||||||+||+++.++.+||+|||++............... .............+++.|+|||.+.
T Consensus 128 l~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~y~aPE~~~ 206 (335)
T PTZ00024 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD-ETMQRREEMTSKVVTLWYRAPELLM 206 (335)
T ss_pred HHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccc-ccccccccccccccccCCCCChhcc
Confidence 999999999999999999999999999999999999999865422211100000 0000111223456789999999988
Q ss_pred CCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCC---------------------CCC----ccccCC
Q 000880 651 GWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE---------------------LPP----SWVAKF 702 (1239)
Q Consensus 651 ~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~---------------------~p~----~~~~~~ 702 (1239)
+...++.++|+|||||++|||++ ||...........+....+. .+. .....+
T Consensus 207 ~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
T PTZ00024 207 GAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNAS 286 (335)
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCC
Confidence 75557999999999999999997 66544433322221110000 000 112335
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 703 SEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 703 ~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
.++.++|.+||+.+|.+|||+++++.|+||....
T Consensus 287 ~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 287 DDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred hHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 6788999999999999999999999999998775
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=368.15 Aligned_cols=252 Identities=31% Similarity=0.458 Sum_probs=208.5
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSG 509 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g 509 (1239)
..||.|.||.||-|.+..+|...|+|-|+...........+.+|..+|..++|||+|+|||+=+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv---------------- 1304 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV---------------- 1304 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee----------------
Confidence 5799999999999999999999999999876655556677899999999999999999998732
Q ss_pred cccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 000880 510 TLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDL 588 (1239)
Q Consensus 510 ~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDL 588 (1239)
+...++|.||||. |+|.+++...+-.++.....|..|++.|++|||++|||||||
T Consensus 1305 ------------------------HRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDI 1360 (1509)
T KOG4645|consen 1305 ------------------------HREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDI 1360 (1509)
T ss_pred ------------------------cHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCC
Confidence 3456789999995 799999988888889999999999999999999999999999
Q ss_pred CcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC--CCCcchhhHHHHH
Q 000880 589 TPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP--KIDEKADMYSLGI 666 (1239)
Q Consensus 589 Kp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~~~~ksDIwSlGv 666 (1239)
||.||+|+.+|.+|++|||.|..+..+... ....-.+.+|||.|||||++.+.. ....++||||+||
T Consensus 1361 K~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~-----------~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1361 KPANILLDFNGLIKYGDFGSAVKIKNNAQT-----------MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGC 1429 (1509)
T ss_pred CccceeeecCCcEEeecccceeEecCchhc-----------CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccc
Confidence 999999999999999999999987544211 111234679999999999998732 2567999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
++.||+| ||....+.=..+-.+. -+..|+.+...+++.++||.+||..||++|+++.|++.|.|-.
T Consensus 1430 VVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1430 VVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred eEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 9999998 7765544333333322 2444555555788999999999999999999999999997644
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.81 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=197.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCc----EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGR----HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.++|++++.||+|+||+||+|++..+|. .||+|+++.. ........+.+|+.+++.++||||+++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC----
Confidence 4689999999999999999999987776 4899988643 333445678999999999999999999988732
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~ 576 (1239)
...+++|+|++ |+|.+++... ..+++..++.++.||+.||+
T Consensus 81 -------------------------------------~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~ 123 (279)
T cd05109 81 -------------------------------------STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123 (279)
T ss_pred -------------------------------------CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 23578999996 6999988764 56999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||+++|+||||||+|||++.++.+||+|||+++........ .......+++.|+|||++.+ ..++
T Consensus 124 ~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~-------------~~~~~~~~~~~y~~PE~~~~-~~~~ 189 (279)
T cd05109 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE-------------YHADGGKVPIKWMALESILH-RRFT 189 (279)
T ss_pred HHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce-------------eecCCCccchhhCCHHHhcc-CCCC
Confidence 999999999999999999999999999999999865321100 01122345778999999887 5689
Q ss_pred cchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.++|||||||++|||++ ||......... ..+. ....++.....+.++.++|.+||+.||++||++.+++..
T Consensus 190 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLE-KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHH-CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999875 65543333222 2222 333333445567789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=331.71 Aligned_cols=272 Identities=28% Similarity=0.385 Sum_probs=205.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..+|.+.+.||.|+||.||+|.++.+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~--- 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL--- 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc---
Confidence 3689999999999999999999999999999999876543 34567889999999999999999998764332100
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
.+ ..........+|++|||++++|.+++.. ..+++..++.++.||+.||.|||++|
T Consensus 79 --~~---------------------~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g 134 (342)
T cd07854 79 --TE---------------------DVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN 134 (342)
T ss_pred --cc---------------------ccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 00 0001123457899999999999888754 46899999999999999999999999
Q ss_pred ccccCCCcccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 583 IIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 583 IiHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|+||||||+||+++. ++.+||+|||+++........ ........||..|+|||++.+...++.++||
T Consensus 135 ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 202 (342)
T cd07854 135 VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH------------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM 202 (342)
T ss_pred cccCCCCHHHEEEcCCCceEEECCcccceecCCcccc------------ccccccccccccccCHHHHhCccccCchhhH
Confidence 999999999999985 457899999999764321100 0001223688999999987654568899999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhc----------------------CC---CC--CccccCCHHHHHHHHH
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQK----------------------GE---LP--PSWVAKFSEQESLLRR 711 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~----------------------~~---~p--~~~~~~~~e~~~LI~~ 711 (1239)
|||||++|+|++ ||....+.......+... .. .+ ........++.+||.+
T Consensus 203 wSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 282 (342)
T cd07854 203 WAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ 282 (342)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHH
Confidence 999999999996 776444333222211100 00 00 0112345678899999
Q ss_pred ccCCCCCCCCCHHHHHhccCCCCc
Q 000880 712 LMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 712 ~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
||+.||.+|||+.++++|+||+..
T Consensus 283 ~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 283 ILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HhCCCchhccCHHHHhCCCccccc
Confidence 999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=321.09 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=203.4
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC---CCceeeeeeeeeecCccccC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ---HQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.|+..+.||.|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.++ ||||++++++|..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~------- 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK------- 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-------
Confidence 4778899999999999999999999999999987542 2334567889999999996 9999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
....|++|||++ ++|.+++.. ..+++..++.++.||+.||.|||+
T Consensus 74 ---------------------------------~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~ 119 (277)
T cd06917 74 ---------------------------------GPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK 119 (277)
T ss_pred ---------------------------------CCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356799999996 589888865 479999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
.||+|+||+|+||+++.++.++|+|||++....... .......|++.|+|||.+.+...++.++|
T Consensus 120 ~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 184 (277)
T cd06917 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---------------SKRSTFVGTPYWMAPEVITEGKYYDTKAD 184 (277)
T ss_pred CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---------------cccccccCCcceeCHHHhccCCccccchh
Confidence 999999999999999999999999999997653221 01133468999999999876455789999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccc-cCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWV-AKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~-~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
+|||||++|+|++ ||............. ....+.... ..+.++.++|.+||..||++||++.+++.|+|+.+..
T Consensus 185 v~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 185 IWSLGITIYEMATGNPPYSDVDAFRAMMLIP--KSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChhhhhhccc--cCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999996 776544333222111 111111111 2567899999999999999999999999999997765
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=314.22 Aligned_cols=242 Identities=22% Similarity=0.342 Sum_probs=189.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSG 509 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g 509 (1239)
+.||+|+||.||+|+++.+++.||+|.+... ........+.+|+.+++.++||||++++++|..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------------- 64 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--------------- 64 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---------------
Confidence 3699999999999999999999999987632 333445679999999999999999999988732
Q ss_pred cccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 510 TLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 510 ~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
...+|+||||++ ++|.+++.... .+++..++.++.|++.||+|||++|++|||
T Consensus 65 -------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~d 119 (252)
T cd05084 65 -------------------------KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119 (252)
T ss_pred -------------------------CCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 345799999996 58999987544 589999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|||+|||++.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||+
T Consensus 120 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i 185 (252)
T cd05084 120 LAARNCLVTEKNVLKISDFGMSREEEDGVY-------------ASTGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGIL 185 (252)
T ss_pred cchheEEEcCCCcEEECccccCcccccccc-------------cccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHH
Confidence 999999999999999999999875421100 000111233567999999987 568999999999999
Q ss_pred HHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 668 FFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 668 L~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
+|||++ ||.......... ... ....++.....+..+.+++.+||+.+|++|||+.++++
T Consensus 186 l~e~~~~~~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 186 LWEAFSLGAVPYANLSNQQTRE-AIE-QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHhCCCCCccccCHHHHHH-HHH-cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999985 565443333222 221 11222233345678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=321.52 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=197.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEcc-----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
..+|.+.+.||+|+||.||+|.+.. ++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec---
Confidence 3578889999999999999998853 36789999986432 22345689999999999999999999988732
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--------------CCCCHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--------------DHFDKE 562 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--------------~~l~~~ 562 (1239)
...+|++|||++ ++|.+++... ..+++.
T Consensus 80 -------------------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~ 122 (280)
T cd05049 80 -------------------------------------GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122 (280)
T ss_pred -------------------------------------CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHH
Confidence 246799999996 6999998754 237888
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCcc
Q 000880 563 LAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF 642 (1239)
Q Consensus 563 ~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 642 (1239)
.+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....... ........+++.
T Consensus 123 ~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~-------------~~~~~~~~~~~~ 189 (280)
T cd05049 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY-------------YRVGGHTMLPIR 189 (280)
T ss_pred HHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcc-------------eecCCCCcccce
Confidence 9999999999999999999999999999999999999999999999875421110 001123356789
Q ss_pred CCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCC
Q 000880 643 YTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718 (1239)
Q Consensus 643 Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~ 718 (1239)
|+|||++.+ ..++.++|||||||++|||++ ||............. .+..+......+..+.+++.+||+.||+
T Consensus 190 y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~ 266 (280)
T cd05049 190 WMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT--QGRLLQRPRTCPSEVYDIMLGCWKRDPQ 266 (280)
T ss_pred ecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCcCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 999999987 568999999999999999996 665544443333322 2333333345667899999999999999
Q ss_pred CCCCHHHHHhc
Q 000880 719 DRPSATELLQD 729 (1239)
Q Consensus 719 ~RPta~eiL~~ 729 (1239)
+||++.++++.
T Consensus 267 ~Rp~~~eil~~ 277 (280)
T cd05049 267 QRINIKDIHER 277 (280)
T ss_pred cCCCHHHHHHH
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=320.52 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=197.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEcc-----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
.++|++.+.||+|+||.||+|.++. .+..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--- 80 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 3689999999999999999998752 35589999876432 23334568899999999999999999988632
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------CCCCHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------DHFDKELAWH 566 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------~~l~~~~~~~ 566 (1239)
....|++|||++ |+|.+++... ..++...+..
T Consensus 81 -------------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 123 (288)
T cd05061 81 -------------------------------------GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123 (288)
T ss_pred -------------------------------------CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHH
Confidence 235699999996 6999998653 2246678899
Q ss_pred HHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCc
Q 000880 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP 646 (1239)
Q Consensus 567 i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 646 (1239)
++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....... ........++..|+||
T Consensus 124 ~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~~p 190 (288)
T cd05061 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-------------YRKGGKGLLPVRWMAP 190 (288)
T ss_pred HHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccccccc-------------ccccCCCcccccccCH
Confidence 999999999999999999999999999999999999999999985432110 0011223567889999
Q ss_pred ccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC
Q 000880 647 EIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722 (1239)
Q Consensus 647 E~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt 722 (1239)
|.+.+ ..++.++|+|||||++|||++ ||............. .+..++.....++.+.+++.+||+.||.+|||
T Consensus 191 E~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 267 (288)
T cd05061 191 ESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM--DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 267 (288)
T ss_pred HHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 99887 568999999999999999985 776544443322222 22223333345678999999999999999999
Q ss_pred HHHHHh------ccCCCCc
Q 000880 723 ATELLQ------DALPPQM 735 (1239)
Q Consensus 723 a~eiL~------~~~~~~~ 735 (1239)
+.++++ ||||...
T Consensus 268 ~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 268 FLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHHHHHHhhcCCCCCCC
Confidence 999986 6666554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=316.44 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=196.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|.+.+.||+|+||.||+|.++.+++.||+|++... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 73 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--------- 73 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcC---------
Confidence 5788999999999999999999999999999988632 2234578899999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...++++|||++ ++|.+++... ..+++..++.++.|++.||+|||+
T Consensus 74 -------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~ 122 (263)
T cd05052 74 -------------------------------EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122 (263)
T ss_pred -------------------------------CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345799999996 6899988653 358999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+|++||||||+|||++.++.+||+|||++......... ......+++.|+|||.+.+ ..++.++|
T Consensus 123 ~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~D 187 (263)
T cd05052 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--------------AHAGAKFPIKWTAPESLAY-NKFSIKSD 187 (263)
T ss_pred CCEeecccCcceEEEcCCCcEEeCCCccccccccceee--------------ccCCCCCccccCCHHHhcc-CCCCchhH
Confidence 99999999999999999999999999999865322100 0112245678999999887 56899999
Q ss_pred hHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 661 MYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 661 IwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
||||||++|||++ ||......... ..+. ....++.....++++.++|.+||+.||++|||+.++++.
T Consensus 188 v~slG~il~el~t~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 188 VWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLE-KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHH-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 9999999999986 66544333222 2222 122223334566799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=326.39 Aligned_cols=252 Identities=24% Similarity=0.434 Sum_probs=201.3
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
.|+....||.|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++.+..
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~---------- 89 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV---------- 89 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee----------
Confidence 34445689999999999999999999999999875433 234568899999999999999999987632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....|++|||++ ++|..++.. ..+++..++.++.||+.||.|||++|+
T Consensus 90 ------------------------------~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i 138 (297)
T cd06659 90 ------------------------------GEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGV 138 (297)
T ss_pred ------------------------------CCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 356899999997 478776644 568999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+||+++.++.+||+|||++....... .......|++.|+|||++.+ ..++.++||||
T Consensus 139 vH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s 202 (297)
T cd06659 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---------------PKRKSLVGTPYWMAPEVISR-TPYGTEVDIWS 202 (297)
T ss_pred ecCCCCHHHeEEccCCcEEEeechhHhhccccc---------------ccccceecCccccCHHHHcc-CCCCchhhHHH
Confidence 999999999999999999999999987542211 01133578999999999987 56899999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|||++|||++ ||......+...............+...++.+.++|.+||+.+|.+||++.++++|+|+.+.
T Consensus 203 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 9999999997 66554443333222111111222333456788999999999999999999999999988755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=318.95 Aligned_cols=248 Identities=27% Similarity=0.512 Sum_probs=197.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||+|+||.||+|.++.+|+.||||.+..... .......+.+|+.+++.++||||++++++|.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------- 73 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-------- 73 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--------
Confidence 578899999999999999999999999999998875432 23344678899999999999999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
...++++|||++ ++|.+++.. ...+++..++.++.||+.||.|
T Consensus 74 --------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 121 (267)
T cd08229 74 --------------------------------DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121 (267)
T ss_pred --------------------------------CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 356899999997 589888763 3458999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||++.+ ..++.
T Consensus 122 LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~~~ape~~~~-~~~~~ 185 (267)
T cd08229 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---------------TAAHSLVGTPYYMSPERIHE-NGYNF 185 (267)
T ss_pred HHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC---------------cccccccCCcCccCHHHhcC-CCccc
Confidence 999999999999999999999999999999987653211 01123468999999999987 56889
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHH-HHHHHhhhhcCCCCC-ccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMER-QIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~-~~~~~~~~~~~~~p~-~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
++|+||||+++|+|++ ||...... ......+. ....++ .....++++.++|.+||+.||.+|||+.+|++
T Consensus 186 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh-cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999997 66533221 12222222 122222 22345678999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.87 Aligned_cols=253 Identities=29% Similarity=0.445 Sum_probs=204.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
..|+.++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 73 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--------- 73 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE---------
Confidence 357778999999999999999998999999999875432 3445678999999999999999999998743
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+++
T Consensus 74 -------------------------------~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ 121 (277)
T cd06640 74 -------------------------------GTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK 121 (277)
T ss_pred -------------------------------CCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999996 589888864 56899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++|+|
T Consensus 122 ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~ 185 (277)
T cd06640 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---------------IKRNTFVGTPFWMAPEVIQQ-SAYDSKADIW 185 (277)
T ss_pred ccCcCCChhhEEEcCCCCEEEcccccceeccCCc---------------cccccccCcccccCHhHhcc-CCCccHHHHH
Confidence 9999999999999999999999999997542211 01123468889999999887 5689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||||++|||++ ||............ .....+......+..+.++|.+||..+|.+||++.++++|+|+.+..
T Consensus 186 slG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 186 SLGITAIELAKGEPPNSDMHPMRVLFLI--PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHHHHHHHCCCCCCCcChHhHhhhh--hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 99999999997 66544433322221 11222333334456889999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=317.11 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=197.8
Q ss_pred ceEEeeeccCCceEEEEEEEccC---CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLD---GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
|.+.+.||+|+||.||+|.+..+ +..||||.++...........+.+|+..++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASS----- 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCc-----
Confidence 46778999999999999998754 4789999998655555556789999999999999999999988743210
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY------DHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~------~~l~~~~~~~i~~qI~~gL 575 (1239)
.......+++|||++ ++|..++... ..+++..++.++.||+.||
T Consensus 76 -----------------------------~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL 126 (273)
T cd05035 76 -----------------------------LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126 (273)
T ss_pred -----------------------------cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHH
Confidence 012356799999996 6898887432 3589999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 655 (1239)
.|||+++++||||||+||+++.++.+||+|||+++........ .......++..|+|||.+.+ ..+
T Consensus 127 ~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~~~~pe~~~~-~~~ 192 (273)
T cd05035 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY-------------RQGRIAKMPVKWIAIESLAD-RVY 192 (273)
T ss_pred HHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccc-------------cccccccCCccccCHhhccc-CCC
Confidence 9999999999999999999999999999999999865322110 01122345678999999876 568
Q ss_pred CcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 656 DEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+.++|||||||++|||++ ||......+..... . .+..+......++++.++|.+||+.||.+|||+.+++++
T Consensus 193 ~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 193 TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-R-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-H-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999985 56554443333222 2 222333344567799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=321.47 Aligned_cols=245 Identities=29% Similarity=0.498 Sum_probs=191.4
Q ss_pred eEEeeeccCCceEEEEEEEc----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 427 EELQPLGHGGFGHVVLCKNK----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 427 ~~~~~LG~G~fG~Vy~a~~~----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++.+.||.|.||.||+|.+. ..+..|+||.++. .........+.+|+..+++++||||+++++++...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~------- 73 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN------- 73 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-------
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-------
Confidence 46789999999999999998 4467899999953 33444578899999999999999999999998532
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
..+++|||||+ |+|.+++... ..+++...+.++.||+.||.|||
T Consensus 74 ---------------------------------~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh 120 (259)
T PF07714_consen 74 ---------------------------------EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH 120 (259)
T ss_dssp ---------------------------------SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 23789999997 6999999876 67999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+++++|++|+++|||++.++.+||+|||++........ ........+...|+|||.+.+ ..++.++
T Consensus 121 ~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~~~~-~~~~~ks 186 (259)
T PF07714_consen 121 SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-------------YKNDSSQQLPLRYLAPEVLKD-GEYTKKS 186 (259)
T ss_dssp HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-------------EEESTTSESGGGGS-HHHHHH-SEESHHH
T ss_pred cccccccccccccccccccccccccccccccccccccc-------------ccccccccccccccccccccc-ccccccc
Confidence 99999999999999999999999999999986521110 011223457789999999987 4589999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
||||||+++|||++ ||......+..... . .+..++.....+..+.++|.+||+.||.+|||+.+|++
T Consensus 187 DVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 187 DVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-K-QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-H-TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccccccccccccccccccccc-c-ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999997 67665444433333 2 33334444456778999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=319.91 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=194.1
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEEecCCCCchh-HHHHHHHH---HHHHhcCCCceeeeeeeeeecCccccCCCCcC
Q 000880 431 PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPV-NDRILREV---ATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~-~~~~~~Ev---~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
.||+|+||.||+|.+..+++.||+|++......... ...+..|. ..++...||||+++++++..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~------------ 68 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT------------ 68 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec------------
Confidence 489999999999999989999999998754322111 22233443 34445689999999877632
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiH 585 (1239)
...+|+||||++ ++|.+++...+.+++..++.++.|++.||+|||+++|+|
T Consensus 69 ----------------------------~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H 120 (278)
T cd05606 69 ----------------------------PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120 (278)
T ss_pred ----------------------------CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEc
Confidence 357899999996 589998888788999999999999999999999999999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHH
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlG 665 (1239)
|||||+||+++.++.+||+|||++...... .....+||+.|+|||++.+...++.++||||+|
T Consensus 121 ~di~p~nili~~~~~~kl~dfg~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G 183 (278)
T cd05606 121 RDLKPANILLDEHGHVRISDLGLACDFSKK-----------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLG 183 (278)
T ss_pred CCCCHHHEEECCCCCEEEccCcCccccCcc-----------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHH
Confidence 999999999999999999999998753211 012347999999999987644689999999999
Q ss_pred HHHHHhhc---CCchhHH---HHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCCC
Q 000880 666 IVFFELWH---PFSTAME---RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPPQ 734 (1239)
Q Consensus 666 viL~ELlt---Pf~~~~~---~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~~ 734 (1239)
|++|||++ ||..... ..............| ...++++.+++.+||..+|.+|| ++.++++|+||..
T Consensus 184 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 184 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred HHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 99999996 7754421 111111111111222 23467999999999999999999 9999999999998
Q ss_pred chHHH
Q 000880 735 MEYEL 739 (1239)
Q Consensus 735 ~~~~~ 739 (1239)
..+..
T Consensus 261 ~~~~~ 265 (278)
T cd05606 261 LDWQM 265 (278)
T ss_pred CCchH
Confidence 87553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=319.01 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=201.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||++++++|...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDE-------- 71 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc--------
Confidence 478999999999999999999998999999999875433 24456799999999999999999999887432
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
....+|+||||++ ++|.+++.. ...+++..+..++.||+.||.||
T Consensus 72 ------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l 121 (287)
T cd06621 72 ------------------------------SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121 (287)
T ss_pred ------------------------------CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 2346899999996 588887653 34588999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|+.|++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+ ..++.+
T Consensus 122 H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~y~~pE~~~~-~~~~~~ 183 (287)
T cd06621 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-----------------AGTFTGTSFYMAPERIQG-KPYSIT 183 (287)
T ss_pred HHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-----------------cccccCCccccCHHHhcC-CCCCch
Confidence 99999999999999999999999999999987542110 112357889999999887 568999
Q ss_pred hhhHHHHHHHHHhhc---CCchhH-----HHHHHHHhhhhc-CCCCCcc---ccCCHHHHHHHHHccCCCCCCCCCHHHH
Q 000880 659 ADMYSLGIVFFELWH---PFSTAM-----ERQIVLSDLKQK-GELPPSW---VAKFSEQESLLRRLMSPSPSDRPSATEL 726 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~-----~~~~~~~~~~~~-~~~p~~~---~~~~~e~~~LI~~~L~~dP~~RPta~ei 726 (1239)
+|||||||++|+|++ ||.... ..+......... ...+... ...++.+.++|.+||..+|.+|||+.++
T Consensus 184 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei 263 (287)
T cd06621 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM 263 (287)
T ss_pred hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999999999999997 665431 111111111101 1111111 1224578999999999999999999999
Q ss_pred HhccCCCCchH
Q 000880 727 LQDALPPQMEY 737 (1239)
Q Consensus 727 L~~~~~~~~~~ 737 (1239)
++|+|+.+...
T Consensus 264 l~~~~~~~~~~ 274 (287)
T cd06621 264 LEHPWIKAQMK 274 (287)
T ss_pred HhCcccccccc
Confidence 99999976643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=314.65 Aligned_cols=248 Identities=28% Similarity=0.522 Sum_probs=198.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.... .......+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-------- 73 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-------- 73 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--------
Confidence 579999999999999999999999999999999875433 22335678999999999999999999988733
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....+++|||++ ++|..++.. ...+++..++.++.||+.||.|
T Consensus 74 --------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 121 (267)
T cd08224 74 --------------------------------NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121 (267)
T ss_pred --------------------------------CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHH
Confidence 346799999997 599988854 3458999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+ ..++.
T Consensus 122 lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~~~~~~~y~apE~~~~-~~~~~ 185 (267)
T cd08224 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---------------TAAHSLVGTPYYMSPERIHE-NGYNF 185 (267)
T ss_pred HHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC---------------cccceecCCccccCHHHhcc-CCCCc
Confidence 999999999999999999999999999999987543211 01123468899999999887 56899
Q ss_pred chhhHHHHHHHHHhhc---CCchhH-HHHHHHHhhhhcCCCCCccc-cCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 658 KADMYSLGIVFFELWH---PFSTAM-ERQIVLSDLKQKGELPPSWV-AKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~-~~~~~~~~~~~~~~~p~~~~-~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
++|||||||++|+|++ ||.... .......... .+..++... ..+..+.++|.+||..+|++|||+.+|++
T Consensus 186 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999997 664322 1111222222 222332222 45568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=310.66 Aligned_cols=256 Identities=32% Similarity=0.497 Sum_probs=208.8
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|...+.||+|++|.||+|.+..+++.|++|++............+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE--------- 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---------
Confidence 47788999999999999999999999999999976654445667899999999999999999999887431
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....++++|||++ ++|.+++.....+++..++.++.|++.||+|||+.|+
T Consensus 72 -----------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~ 122 (260)
T cd06606 72 -----------------------------EKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122 (260)
T ss_pred -----------------------------CCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 0257899999995 6999999888899999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+ ..++.++||||
T Consensus 123 ~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-------------~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~s 188 (260)
T cd06606 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-------------EGTGSVRGTPYWMAPEVIRG-EEYGRAADIWS 188 (260)
T ss_pred cccCCCHHHEEEcCCCCEEEcccccEEeccccccc-------------ccccCCCCCccccCHhhhcC-CCCCchhhHHH
Confidence 99999999999999999999999999865432110 00123468899999999887 45899999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
||+++|+|++ ||............+......+......+..+.++|.+||+.||.+||++.++++|||+
T Consensus 189 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 189 LGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999997 77655422222222222223333333446789999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=322.32 Aligned_cols=252 Identities=23% Similarity=0.277 Sum_probs=196.7
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCC----------------cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCcee
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDG----------------RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVV 486 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g----------------~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv 486 (1239)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 358899999999999999999887543 568999887432 334556789999999999999999
Q ss_pred eeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--------
Q 000880 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-------- 557 (1239)
Q Consensus 487 ~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-------- 557 (1239)
+++++|.. ...++++|||++ ++|.+++....
T Consensus 83 ~~~~~~~~----------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 122 (296)
T cd05051 83 RLLGVCTV----------------------------------------DPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122 (296)
T ss_pred EEEEEEec----------------------------------------CCCcEEEEecCCCCCHHHHHHhcccccccccc
Confidence 99988732 246799999996 68999987655
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccC
Q 000880 558 ---HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG 634 (1239)
Q Consensus 558 ---~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (1239)
.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+++....... ....
T Consensus 123 ~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------------~~~~ 189 (296)
T cd05051 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-------------YRVQ 189 (296)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcc-------------eeec
Confidence 689999999999999999999999999999999999999999999999999875432110 0112
Q ss_pred cccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc-----CCchhHHHHHHHHhhhh-----cCCCCCccccCCHH
Q 000880 635 TGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH-----PFSTAMERQIVLSDLKQ-----KGELPPSWVAKFSE 704 (1239)
Q Consensus 635 ~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt-----Pf~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~e 704 (1239)
....+|+.|+|||++.+ ..++.++|||||||++|||++ ||............... .....+.....+.+
T Consensus 190 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (296)
T cd05051 190 GRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD 268 (296)
T ss_pred CcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHH
Confidence 23457889999999887 568999999999999999985 55544333332222111 01111222344578
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 705 QESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 705 ~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+.++|.+||+.||.+|||+.++++.
T Consensus 269 l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 269 IYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred HHHHHHHHhccChhcCCCHHHHHHH
Confidence 9999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=319.57 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=198.9
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc---CCCceeeeeeeeeecCccccCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL---QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
|++.+.||.|+||.||+|+++.+++.||+|.++...........+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~----- 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT----- 75 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC-----
Confidence 6788999999999999999998899999999976544333345677788877666 69999999999854310
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
.....++++|||++++|.+++.... .+++..++.++.||+.||.|||+
T Consensus 76 ------------------------------~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~ 125 (287)
T cd07838 76 ------------------------------DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125 (287)
T ss_pred ------------------------------CCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 1234589999999999998887643 58999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
++++|+||||+||+++.++.+||+|||++....... ......+++.|+|||++.+ ..++.++|
T Consensus 126 ~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~~~~PE~~~~-~~~~~~~D 188 (287)
T cd07838 126 HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM----------------ALTSVVVTLWYRAPEVLLQ-SSYATPVD 188 (287)
T ss_pred CCeeeccCChhhEEEccCCCEEEeccCcceeccCCc----------------ccccccccccccChHHhcc-CCCCCcch
Confidence 999999999999999999999999999987653211 0122357899999999987 56899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcC----------------CCCC--------ccccCCHHHHHHHHHcc
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKG----------------ELPP--------SWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~----------------~~p~--------~~~~~~~e~~~LI~~~L 713 (1239)
+|||||++|||++ ||......+.......... .++. .....++.+.++|.+||
T Consensus 189 i~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 268 (287)
T cd07838 189 MWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKML 268 (287)
T ss_pred hhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHh
Confidence 9999999999996 5654443332222211000 0000 01123456789999999
Q ss_pred CCCCCCCCCHHHHHhccCC
Q 000880 714 SPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~~~~ 732 (1239)
+.||.+||++.++++|+||
T Consensus 269 ~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 269 TFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccCCccCCCHHHHhcCcCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=319.18 Aligned_cols=249 Identities=20% Similarity=0.272 Sum_probs=194.8
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcE----EEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRH----YAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~----vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.++|++.+.||+|+||+||+|.+..+|.. +++|.+... ........+..|+..++.++||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~----- 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP----- 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----
Confidence 36889999999999999999999877764 677766422 22233457888999999999999999998762
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~ 576 (1239)
....+++|||++ |+|.+++... ..+++..++.++.||+.||+
T Consensus 80 ------------------------------------~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~ 123 (279)
T cd05111 80 ------------------------------------GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123 (279)
T ss_pred ------------------------------------CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence 123578999996 7999999754 56899999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++|++||||||+|||++.++.+||+|||+++....... ....+...++..|+|||++.+ ..++
T Consensus 124 ~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~~pE~~~~-~~~~ 189 (279)
T cd05111 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-------------KYFYSEHKTPIKWMALESILF-GRYT 189 (279)
T ss_pred HHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc-------------ccccCCCCCcccccCHHHhcc-CCcC
Confidence 99999999999999999999999999999999986432110 011123457788999999987 5689
Q ss_pred cchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.++|||||||++|||++ ||........ ...+ ..+..++....+..++.+++.+||..||.+|||+.++++.
T Consensus 190 ~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 190 HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLL-EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHH-HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999986 6655433322 2222 2334333333456688999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=330.07 Aligned_cols=261 Identities=19% Similarity=0.298 Sum_probs=197.8
Q ss_pred eeeccC--CceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHG--GFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G--~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
..||+| +||+||++++..+|+.||||++..........+.+.+|+.+++.++||||++++++|..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------------- 70 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT------------- 70 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-------------
Confidence 456777 99999999999999999999987655554555788999999999999999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
...+|++|||++ ++|.+++... ..+++..+..++.||+.||+|||++||+
T Consensus 71 ---------------------------~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv 123 (328)
T cd08226 71 ---------------------------GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI 123 (328)
T ss_pred ---------------------------CCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 356799999997 5899888764 3589999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC-CCCCcchhhHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW-PKIDEKADMYS 663 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~ksDIwS 663 (1239)
||||||+|||++.++.++++||+.+............. ........++..|+|||++.+. ..++.++||||
T Consensus 124 HrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws 195 (328)
T cd08226 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV--------YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195 (328)
T ss_pred cCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc--------ccccccccCccCccChhhhcCCCCCCCchhhHHH
Confidence 99999999999999999999998765432211000000 0001112456789999998763 34789999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCC--------------------------------------------CC
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGEL--------------------------------------------PP 696 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~--------------------------------------------p~ 696 (1239)
|||++|||++ ||............+...... .+
T Consensus 196 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (328)
T cd08226 196 VGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTP 275 (328)
T ss_pred HHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccch
Confidence 9999999996 665544333332222211100 01
Q ss_pred ccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCchHH
Q 000880 697 SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYE 738 (1239)
Q Consensus 697 ~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~~~ 738 (1239)
......+.+.+||++||+.||++|||+.++++|+||.+....
T Consensus 276 ~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 276 SSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 111234578899999999999999999999999998776544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=316.81 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=197.5
Q ss_pred cCCceEEeeeccCCceEEEEEEEccC-----CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLD-----GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
.++|.+.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC---
Confidence 46899999999999999999998744 3789999986432 23344578899999999999999999988732
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------CCCCHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------DHFDKELAWH 566 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------~~l~~~~~~~ 566 (1239)
....|++|||++ ++|.+++... ..+++..++.
T Consensus 81 -------------------------------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 123 (277)
T cd05032 81 -------------------------------------GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123 (277)
T ss_pred -------------------------------------CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHH
Confidence 245799999996 6999988643 2367889999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCc
Q 000880 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP 646 (1239)
Q Consensus 567 i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 646 (1239)
++.||+.||.|||+++++||||||+|||++.++.+||+|||+++........ .......+|..|+||
T Consensus 124 ~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aP 190 (277)
T cd05032 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY-------------RKGGKGLLPVRWMAP 190 (277)
T ss_pred HHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCccc-------------ccCCCCCccccccCH
Confidence 9999999999999999999999999999999999999999999865322110 011234578899999
Q ss_pred ccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC
Q 000880 647 EIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722 (1239)
Q Consensus 647 E~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt 722 (1239)
|++.+ ..++.++|||||||++|||++ ||.......... ... ....++.....++++.++|.+||+.+|++|||
T Consensus 191 E~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 267 (277)
T cd05032 191 ESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-FVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPT 267 (277)
T ss_pred HHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH-HHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCC
Confidence 99876 568999999999999999986 665544433332 222 22333333345678999999999999999999
Q ss_pred HHHHHhc
Q 000880 723 ATELLQD 729 (1239)
Q Consensus 723 a~eiL~~ 729 (1239)
+.++++.
T Consensus 268 ~~~l~~~ 274 (277)
T cd05032 268 FLEIVSS 274 (277)
T ss_pred HHHHHHH
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=314.69 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=198.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccC---CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLD---GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
++|++.+.||+|+||.||+|.++.+ ...||||+++... .......+.+|+.+++.++||||+++++.+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 76 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK------ 76 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec------
Confidence 5799999999999999999999754 4589999886432 33345678999999999999999999987632
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
...+|++|||++ ++|.+++... ..+++..++.++.|++.||+||
T Consensus 77 ----------------------------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L 122 (266)
T cd05033 77 ----------------------------------SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122 (266)
T ss_pred ----------------------------------CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 345799999996 5999998764 4689999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|+++|+||||||+|||++.++.++|+|||+++....... ........+++.|+|||.+.+ ..++.+
T Consensus 123 h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~~Pe~~~~-~~~~~~ 188 (266)
T cd05033 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA-------------TYTTKGGKIPIRWTAPEAIAY-RKFTSA 188 (266)
T ss_pred HhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc-------------ceeccCCCCCccccChhhhcc-CCCccc
Confidence 999999999999999999999999999999987631110 001112345788999999887 568999
Q ss_pred hhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 659 ADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 659 sDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+||||||+++|+|++ ||............. ....++.....++.+.+++.+||+.+|++||++.+++++
T Consensus 189 ~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 189 SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE--DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred cchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999985 776554444332222 222223334567789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=353.91 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=203.6
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCc-----EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGR-----HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~-----~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
...++.+.||+|+||.||.|....-.. .||||.++ +..+.....+|++|..+|+.++|||||+++|.|++.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~-~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--- 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK-RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--- 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc-ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC---
Confidence 456778899999999999999864322 48999886 345566778999999999999999999999999653
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-------CCCCHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-------DHFDKELAWHLFRQ 570 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-------~~l~~~~~~~i~~q 570 (1239)
...+|++|||. |+|..+|++. ..++....+.++.|
T Consensus 768 -------------------------------------~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~d 810 (1025)
T KOG1095|consen 768 -------------------------------------GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALD 810 (1025)
T ss_pred -------------------------------------CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHH
Confidence 34589999995 7999999865 34888999999999
Q ss_pred HHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc
Q 000880 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650 (1239)
Q Consensus 571 I~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 650 (1239)
||.|+.|||++++|||||..+|+||+....|||+|||+|+.+...+..+. +....-...|||||.++
T Consensus 811 vA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~-------------~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 811 VAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRK-------------HGEAMLPVKWMPPESLK 877 (1025)
T ss_pred HhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheec-------------cCccccceecCCHHHHh
Confidence 99999999999999999999999999999999999999995443332211 11112345899999999
Q ss_pred CCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHH
Q 000880 651 GWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATEL 726 (1239)
Q Consensus 651 ~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~ei 726 (1239)
. ..++.|+|||||||+|||++| ||....+.++....+. .++ .+.+..++..+.++|..||+.+|++||++..|
T Consensus 878 d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~-ggR-L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i 954 (1025)
T KOG1095|consen 878 D-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE-GGR-LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTI 954 (1025)
T ss_pred h-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-CCc-cCCCCCCChHHHHHHHHHccCChhhCccHHHH
Confidence 7 689999999999999999996 8888777776654444 343 33445677789999999999999999999999
Q ss_pred Hh
Q 000880 727 LQ 728 (1239)
Q Consensus 727 L~ 728 (1239)
+.
T Consensus 955 ~~ 956 (1025)
T KOG1095|consen 955 VE 956 (1025)
T ss_pred Hh
Confidence 97
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=318.82 Aligned_cols=253 Identities=24% Similarity=0.432 Sum_probs=202.5
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|...+.||.|++|.||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~---------- 87 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLV---------- 87 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEc----------
Confidence 34455799999999999999998999999999864332 334568899999999999999999987732
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....|+++||++ ++|.+++.. .++++..++.++.||+.||+|||++|+
T Consensus 88 ------------------------------~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i 136 (285)
T cd06648 88 ------------------------------GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGV 136 (285)
T ss_pred ------------------------------CCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 346799999996 599998877 679999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+ ..++.++|+||
T Consensus 137 ~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s 200 (285)
T cd06648 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---------------PRRKSLVGTPYWMAPEVISR-LPYGTEVDIWS 200 (285)
T ss_pred ecCCCChhhEEEcCCCcEEEcccccchhhccCC---------------cccccccCCccccCHHHhcC-CCCCCcccHHH
Confidence 999999999999999999999999887542110 01123468999999999887 56899999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|||++|+|++ ||..........................++.+.++|.+||+.+|.+|||+.++++|+|+.+..
T Consensus 201 lGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 201 LGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 9999999997 776544433332222211111112223567899999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.62 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=196.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccC-----CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLD-----GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
+.+|++.+.||+|+||.||+|.+..+ ++.||||+++... .......+.+|+.+++.++||||+++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--- 79 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--- 79 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---
Confidence 35688889999999999999998643 5789999987432 33345678899999999999999999988732
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------------CCCC
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------DHFD 560 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~~l~ 560 (1239)
...+++++||++ ++|.+++... ..++
T Consensus 80 -------------------------------------~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 122 (283)
T cd05091 80 -------------------------------------EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122 (283)
T ss_pred -------------------------------------CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccC
Confidence 345789999996 5888887532 2478
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccC
Q 000880 561 KELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640 (1239)
Q Consensus 561 ~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 640 (1239)
+..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 123 ~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~~~ 189 (283)
T cd05091 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY-------------KLMGNSLLP 189 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchhe-------------eeccCccCC
Confidence 8889999999999999999999999999999999999999999999998864322100 011223567
Q ss_pred ccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCC
Q 000880 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716 (1239)
Q Consensus 641 ~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~d 716 (1239)
+.|+|||++.+ ..++.++|||||||++|||++ ||......+....+.. ...++.....++.+.+|+.+||+.+
T Consensus 190 ~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~li~~cl~~~ 266 (283)
T cd05091 190 IRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN--RQVLPCPDDCPAWVYTLMLECWNEF 266 (283)
T ss_pred ccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--CCcCCCCCCCCHHHHHHHHHHhCCC
Confidence 89999999876 568999999999999999986 6665554444333222 2223333456678999999999999
Q ss_pred CCCCCCHHHHHhc
Q 000880 717 PSDRPSATELLQD 729 (1239)
Q Consensus 717 P~~RPta~eiL~~ 729 (1239)
|.+||++.+|++.
T Consensus 267 p~~RP~~~~i~~~ 279 (283)
T cd05091 267 PSRRPRFKDIHSR 279 (283)
T ss_pred cccCCCHHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=331.05 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=193.7
Q ss_pred CCceEEeeeccCCceEEEEEEEc-----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNK-----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~ 497 (1239)
++|++.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+|..+ +||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 57899999999999999999853 467899999997433 233456788999999999 789999999887432
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--------------------
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-------------------- 556 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-------------------- 556 (1239)
...++++||||+ |+|.+++...
T Consensus 84 -------------------------------------~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~ 126 (343)
T cd05103 84 -------------------------------------GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSG 126 (343)
T ss_pred -------------------------------------CCceEEEEeccCCCcHHHHHHhcCCcccccccccccccccccc
Confidence 345789999996 6899888642
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 000880 557 -----------------------------------------------DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589 (1239)
Q Consensus 557 -----------------------------------------------~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLK 589 (1239)
..++...+..++.||+.||+|||++||+|||||
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik 206 (343)
T cd05103 127 YGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLA 206 (343)
T ss_pred ccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCc
Confidence 136778888999999999999999999999999
Q ss_pred cccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHH
Q 000880 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFF 669 (1239)
Q Consensus 590 p~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ 669 (1239)
|+|||++.++.+||+|||+++....... ........+++.|+|||++.+ ..++.++|||||||++|
T Consensus 207 p~Nil~~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ 272 (343)
T cd05103 207 ARNILLSENNVVKICDFGLARDIYKDPD-------------YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLW 272 (343)
T ss_pred cCeEEEcCCCcEEEEecccccccccCcc-------------hhhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHH
Confidence 9999999999999999999976421110 001122346778999999877 56899999999999999
Q ss_pred Hhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 670 ELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 670 ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+|++ ||............+. .+..++.....++++.+++.+||+.||.+|||+.+|++|
T Consensus 273 el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 273 EIFSLGASPYPGVKIDEEFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHCCCCCCCCccccHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9985 6654332222222222 222222222345789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=310.28 Aligned_cols=250 Identities=34% Similarity=0.582 Sum_probs=206.7
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||.|+||.||++.+..+++.||+|++............+.+|+.+++.++|||++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~---------- 70 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE---------- 70 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec----------
Confidence 5888999999999999999999999999999998665554566789999999999999999999987632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESY----DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....+++|||+++ +|.+.+... ..+++..++.++.||+.||.|||
T Consensus 71 ------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 120 (258)
T cd08215 71 ------------------------------KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120 (258)
T ss_pred ------------------------------CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 3578999999974 899988764 67999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++|+||+|+||+++.++.++|+|||++....... .......|++.|+|||.+.+ ..++.++
T Consensus 121 ~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~~~~~~~y~~pe~~~~-~~~~~~~ 184 (258)
T cd08215 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---------------DLAKTVVGTPYYLSPELCQN-KPYNYKS 184 (258)
T ss_pred hCCEecccCChHHeEEcCCCcEEECCccceeecccCc---------------ceecceeeeecccChhHhcc-CCCCccc
Confidence 9999999999999999999999999999997643221 01123478999999999887 4588999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
|+||+|+++|+|++ ||.............. ...++.....+..+.+++.+||..+|++|||+.++++||||
T Consensus 185 Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 185 DIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999996 6655443333333222 22233333556789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=323.57 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=193.4
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcE--EEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRH--YAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~--vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~ 499 (1239)
.++|++.+.||+|+||.||+|.++.++.. +|+|.++. ..+......+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----- 79 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 79 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----
Confidence 47899999999999999999999878765 46666542 22334456788999999999 89999999988732
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC----------------CCCHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD----------------HFDKE 562 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~----------------~l~~~ 562 (1239)
...+|++|||++ ++|.+++.... .+++.
T Consensus 80 -----------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~ 124 (303)
T cd05088 80 -----------------------------------RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124 (303)
T ss_pred -----------------------------------CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHH
Confidence 346799999996 69999986532 47899
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCcc
Q 000880 563 LAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF 642 (1239)
Q Consensus 563 ~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 642 (1239)
.++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++...... .......+++.
T Consensus 125 ~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~----------------~~~~~~~~~~~ 188 (303)
T cd05088 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY----------------VKKTMGRLPVR 188 (303)
T ss_pred HHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh----------------hhcccCCCccc
Confidence 99999999999999999999999999999999999999999999998632100 00112235678
Q ss_pred CCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCC
Q 000880 643 YTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718 (1239)
Q Consensus 643 Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~ 718 (1239)
|+|||++.+ ..++.++|||||||++|||++ ||......+.... .. ....+......++++.+||.+||+.+|+
T Consensus 189 y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 265 (303)
T cd05088 189 WMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LP-QGYRLEKPLNCDDEVYDLMRQCWREKPY 265 (303)
T ss_pred ccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH-Hh-cCCcCCCCCCCCHHHHHHHHHHcCCChh
Confidence 999999877 558999999999999999985 6654433333222 21 1222223334567899999999999999
Q ss_pred CCCCHHHHHhc
Q 000880 719 DRPSATELLQD 729 (1239)
Q Consensus 719 ~RPta~eiL~~ 729 (1239)
+||++.+++++
T Consensus 266 ~Rp~~~~il~~ 276 (303)
T cd05088 266 ERPSFAQILVS 276 (303)
T ss_pred hCcCHHHHHHH
Confidence 99999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=313.79 Aligned_cols=245 Identities=22% Similarity=0.388 Sum_probs=194.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||+|+||.||+|.+. .+..+|||.+..... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 70 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--------- 70 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEcc---------
Confidence 57899999999999999999886 455799998864332 23568999999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|++|||+. ++|.+++... ..+++..++.++.||+.||+|||++
T Consensus 71 -------------------------------~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 119 (256)
T cd05113 71 -------------------------------QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119 (256)
T ss_pred -------------------------------CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 235699999996 5899988764 4689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++|+||||+|||++.++.+||+|||+++....... .......++..|+|||++.+ ..++.++||
T Consensus 120 ~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--------------~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di 184 (256)
T cd05113 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--------------TSSVGSKFPVRWSPPEVLLY-SKFSSKSDV 184 (256)
T ss_pred CeeccccCcceEEEcCCCCEEECCCccceecCCCce--------------eecCCCccChhhCCHHHHhc-CcccchhHH
Confidence 999999999999999999999999999875422110 01122346678999999987 568999999
Q ss_pred HHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 662 YSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 662 wSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|||||++|+|++ ||.............. ...+......++.+.+++.+||+.||.+||++.+++.+
T Consensus 185 ~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 185 WAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ--GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 999999999986 6654444333333322 22222223345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=318.11 Aligned_cols=246 Identities=21% Similarity=0.353 Sum_probs=193.5
Q ss_pred ccCCceEEeee--ccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCcc
Q 000880 422 YLNDFEELQPL--GHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 422 ~~~~y~~~~~L--G~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~ 498 (1239)
+.++|++.+.+ |.|+||.||++.++.++..+|+|.+....... .|+.....+ +||||++++++|..
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~---- 80 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT---- 80 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec----
Confidence 34566666666 99999999999999999999999987543221 122222222 79999999988743
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
...+|+||||++ ++|.+++.....+++..++.++.||+.||.|
T Consensus 81 ------------------------------------~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~ 124 (267)
T PHA03390 81 ------------------------------------LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALND 124 (267)
T ss_pred ------------------------------------CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 347899999996 6999999887789999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCC-CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 578 IHGQGIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
||+.|++||||||+||+++.++ .++|+|||++..... .....||+.|+|||++.+ ..++
T Consensus 125 lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-------------------~~~~~~~~~y~aPE~~~~-~~~~ 184 (267)
T PHA03390 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-------------------PSCYDGTLDYFSPEKIKG-HNYD 184 (267)
T ss_pred HHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-------------------CccCCCCCcccChhhhcC-CCCC
Confidence 9999999999999999999998 999999999875421 122468899999999987 5689
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc-CCCCCccccCCHHHHHHHHHccCCCCCCCCC-HHHHHhccC
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK-GELPPSWVAKFSEQESLLRRLMSPSPSDRPS-ATELLQDAL 731 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-a~eiL~~~~ 731 (1239)
.++|||||||++|+|++ ||............+... ...++.+...++.+.++|.+||+.||.+||+ ++++|+|+|
T Consensus 185 ~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 185 VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 99999999999999996 776433222111111111 1222333456789999999999999999996 699999999
Q ss_pred CCC
Q 000880 732 PPQ 734 (1239)
Q Consensus 732 ~~~ 734 (1239)
|.+
T Consensus 265 ~~~ 267 (267)
T PHA03390 265 LKI 267 (267)
T ss_pred ccC
Confidence 864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=315.44 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=196.6
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHH-HhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATL-SRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL-~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||.|+||.||+|.+..+|+.||||+++..... ......+..|..++ ..++||||++++++|..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------------- 68 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS------------- 68 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-------------
Confidence 5699999999999999999999999998644321 12223445555444 45589999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+|++|||++ ++|.+++.....+++..+..++.||+.||.|||+++++||
T Consensus 69 ---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~ 121 (260)
T cd05611 69 ---------------------------KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121 (260)
T ss_pred ---------------------------CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 357899999996 5999999888889999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||+|+||+++.++.+||+|||++..... .....|++.|+|||.+.+ ..++.++||||||+
T Consensus 122 dl~p~nil~~~~~~~~l~dfg~~~~~~~-------------------~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~ 181 (260)
T cd05611 122 DIKPENLLIDQTGHLKLTDFGLSRNGLE-------------------NKKFVGTPDYLAPETILG-VGDDKMSDWWSLGC 181 (260)
T ss_pred CCCHHHeEECCCCcEEEeecccceeccc-------------------cccCCCCcCccChhhhcC-CCCcchhhhHHHHH
Confidence 9999999999999999999999875321 123468899999999987 45899999999999
Q ss_pred HHHHhhc---CCchhHHHHHHHHhhhhcCCCCCc-cccCCHHHHHHHHHccCCCCCCCCC---HHHHHhccCCCCchH
Q 000880 667 VFFELWH---PFSTAMERQIVLSDLKQKGELPPS-WVAKFSEQESLLRRLMSPSPSDRPS---ATELLQDALPPQMEY 737 (1239)
Q Consensus 667 iL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~-~~~~~~e~~~LI~~~L~~dP~~RPt---a~eiL~~~~~~~~~~ 737 (1239)
++|+|++ ||...................+.. ....++++.++|.+||+.||++||+ +.+++.|||+....|
T Consensus 182 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 182 VIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 9999996 776555444333322222222322 2245678999999999999999995 579999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PRK14799 thrS threonyl-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=339.27 Aligned_cols=358 Identities=15% Similarity=0.154 Sum_probs=264.2
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ec--cCCCccccccEEEEeccCCCeeeecCCCcHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YL--LGDCPQFKRNTVKLLTHGGDLLELSHELRLP 855 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~--~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~ 855 (1239)
....|+++|+|.++.+++.+++.+++.+.++||++|.||.+ ++ .++.+...++||.+ |.+|+.++|||+.|++
T Consensus 155 ~~~~G~~~~lP~G~~i~~~L~~~~r~~~~~~Gy~eV~TP~i~~~eL~k~SGh~~~y~~~mf~~-~~~~e~~~LrPm~cp~ 233 (545)
T PRK14799 155 EAGSGLVLFHPKGQTIRNELIAFMREINDSMGYQEVYTSHVFKTDIWKISGHYTLYRDKLIVF-NMEGDEYGVKPMNCPA 233 (545)
T ss_pred ccCCcceEEcChHHHHHHHHHHHHHHHHHHcCCeEEECCccchHHHHhhccccccchhhccee-eccCceEEeccCCCHH
Confidence 35689999999999999999999999999999999999999 22 23345588999988 8889999999999999
Q ss_pred HHHHHHhCC----CCceeEEeecCeEEcCCCCC-----CCCceeEEeEEEeCCCCcc-cHH-HHHHHHHHHHHhcCCC-C
Q 000880 856 FIRWAISNQ----KSSFKRYEISSVYRRAIGHS-----PPNRYLQGDFDIIGGASAL-TEA-EVLKVTMDIVTRFFHA-E 923 (1239)
Q Consensus 856 iaR~~~~~~----~~P~r~~Y~g~VfR~e~~~~-----~~~ef~Q~GvEiiG~~s~~-aDa-Evi~la~~~l~~lgi~-~ 923 (1239)
++|+++++. ..|+|+|++|+|||+|.++. |.|+|+|+|+++||..++. +|+ |++.++.++++.||++ .
T Consensus 234 ~~~~~~~~~~SyrdLPlR~~e~g~vfR~E~sg~l~GL~RvReF~Q~DaHif~~~~q~~~E~~~~l~~i~~vy~~fG~~~~ 313 (545)
T PRK14799 234 HILIYKSKPRTYRDLPIRFSEFGHVYRWEKKGELYGLLRVRGFVQDDGHIFLREDQLREEIKMLISKTVEVWHKFGFKDD 313 (545)
T ss_pred HHHHHhccccChhhCCHhhEEecceecCCCCCCccccccceeEEEcccEEEeCHHHHHHHHHHHHHHHHHHHHHhCCCcc
Confidence 999988742 45999999999999998874 5667999999999999875 888 9999999999999996 2
Q ss_pred ceEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcC
Q 000880 924 SCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCG 1003 (1239)
Q Consensus 924 ~~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g 1003 (1239)
++.+.++++. .+.+|.++.|.+....+ ++.+.+.+++....+...+|+ |
T Consensus 314 ~~~i~ls~Rp-----e~~~G~~~~wdka~~~l----------------------~~~L~~~gl~~~~~~g~gafy----g 362 (545)
T PRK14799 314 DIKPYLSTRP-----DESIGSDELWEKATNAL----------------------ISALQESGLKFGIKEKEGAFY----G 362 (545)
T ss_pred cEEEEEEcCh-----hhhcCCHHHHHHHHHHH----------------------HHHHHHcCCCeEEecceeccc----c
Confidence 4999999975 34567655433222111 222333444443333333332 2
Q ss_pred ChhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccccc
Q 000880 1004 AADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRY 1083 (1239)
Q Consensus 1004 ~~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRY 1083 (1239)
+.. +-.+..++.+. ... ..+.+|+.+.+.++ + +.+..+ + .
T Consensus 363 pki------------D~~v~dalgr~-~q~----~Tiqldf~lp~rf~----L--ey~~~~-~--------------~-- 402 (545)
T PRK14799 363 PKI------------DFEIRDSLGRW-WQL----STIQVDFNLPERFK----L--EYIDKD-G--------------I-- 402 (545)
T ss_pred Ccc------------ceEehhhcCch-hhh----hhhhhhcCcccccc----e--EEEcCC-C--------------C--
Confidence 110 01111222221 000 11234555444443 1 211111 0 0
Q ss_pred cchhhhccccccccccCCCCCC-ceeeeeccHHHHHhhCC---CCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHHH
Q 000880 1084 DYLLHRMWDREYVGYASRTNPP-SGVGASLALETIIQHYP---VDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWE 1159 (1239)
Q Consensus 1084 D~L~~~fg~~~~~~~~g~~~~~-pAvGfaigldrl~~~L~---~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr~ 1159 (1239)
...++ ...|+..|+|||+.+|. .+..|.+ .++.+|+|++.+ +.....|.++++.||+
T Consensus 403 -----------------~~~pv~ihr~~~GgiERli~iL~e~~~G~~P~w-laP~qV~Iipi~-e~~~~~A~~Ia~~LR~ 463 (545)
T PRK14799 403 -----------------KKRPVMVHRAIYGSIDRFVAILLEHFKGKLPTW-LSSVQVRVLPIT-DEVNEYAEKVLNDMRK 463 (545)
T ss_pred -----------------CcccEEEEccCCCCHHHHHHHHHHHcCCCCCCC-CCCceEEEEEcC-HHHHHHHHHHHHHHHh
Confidence 00111 12267779999998884 2444443 357899999996 6678899999999999
Q ss_pred cCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHhh
Q 000880 1160 ENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1160 ~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~~ 1231 (1239)
+|++|+++.. ++++++++++|++.|++++||||++|+++++|+||++.+++|.+++++++++.+.+.+.+.
T Consensus 464 ~GirVelD~~-~~~lgkkir~A~k~gip~viIIG~~E~e~~~VtVR~r~~~eq~~v~l~eli~~l~~~i~~~ 534 (545)
T PRK14799 464 RRIRAEIDYA-GETLSKRIKNAYDQGVPYILIVGKKEASEGTVTVRARGNIEVRNVKFEKFLELLITEIAQR 534 (545)
T ss_pred CCCEEEEECC-CCCHHHHHHHHHHcCCCEEEEEChhHhhcCeEEEEECCCCceEEEcHHHHHHHHHHHHhhc
Confidence 9999998876 6799999999999999999999999999999999999999999999999999998887654
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=322.79 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=203.5
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..|+..+.||+|+||.||++++..+|..||+|++..... .......+.+|+.+++.++|||++++++++.+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 96 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-------- 96 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--------
Confidence 457788999999999999999999999999999875432 33345678899999999999999999998743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....|+||||++|+|.+++.. ...+++..+..++.||+.||.|||++
T Consensus 97 --------------------------------~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~ 144 (317)
T cd06635 97 --------------------------------EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144 (317)
T ss_pred --------------------------------CCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346799999999988887754 45689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCcch
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ks 659 (1239)
|++||||+|+||+++.++.+||+|||++..... .....|++.|+|||++.+ ...++.++
T Consensus 145 ~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 205 (317)
T cd06635 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------------------ANSFVGTPYWMAPEVILAMDEGQYDGKV 205 (317)
T ss_pred CcccCCCCcccEEECCCCCEEEecCCCccccCC-------------------cccccCCccccChhhhhcCCCCCCCccc
Confidence 999999999999999999999999999864321 123468899999998742 24588999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|||||||++|||++ ||.............. ....+......++.+.++|.+||+.+|.+||++.++++|+|+...
T Consensus 206 Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred cHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 99999999999996 6665544433333322 222222233455689999999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=316.57 Aligned_cols=265 Identities=28% Similarity=0.436 Sum_probs=208.7
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~ 501 (1239)
++|.+.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-------- 72 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-------- 72 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--------
Confidence 478999999999999999999999999999999875332 2334467889999999998 999999987762
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
....+|++|||+ +++|.+++.....+++..++.++.||+.||.|||+
T Consensus 73 --------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~ 120 (280)
T cd05581 73 --------------------------------DEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120 (280)
T ss_pred --------------------------------CCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 235689999999 57999999988889999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCC-----CCCCCCccccCcccccCccCCCcccccCCCCC
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAF-----PTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 655 (1239)
+|++|+||||+||+++.++.++|+|||++.............. ...............|+..|+|||++.+ ..+
T Consensus 121 ~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~ 199 (280)
T cd05581 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPA 199 (280)
T ss_pred CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCC
Confidence 9999999999999999999999999999987643321110000 0000000112234578999999999887 568
Q ss_pred CcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH----HHHHh
Q 000880 656 DEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA----TELLQ 728 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta----~eiL~ 728 (1239)
+.++|+||||+++|++++ ||...................|. ..++.+.++|.+||+.+|.+||++ .++++
T Consensus 200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 200 GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP---NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCC---ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 899999999999999997 66655443333333322223333 335689999999999999999999 99999
Q ss_pred ccCC
Q 000880 729 DALP 732 (1239)
Q Consensus 729 ~~~~ 732 (1239)
|+||
T Consensus 277 ~~~~ 280 (280)
T cd05581 277 HPFF 280 (280)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=309.25 Aligned_cols=250 Identities=29% Similarity=0.459 Sum_probs=208.4
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||+|++|.||++.+..+++.||+|.+............+.+|+.+++.++|||++++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------- 70 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET---------- 70 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe----------
Confidence 4788999999999999999999899999999997665444556789999999999999999999987632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....|++|||++ ++|.+++.....+++..++.++.|++.||.|||++||
T Consensus 71 ------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i 120 (254)
T cd06627 71 ------------------------------SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120 (254)
T ss_pred ------------------------------CCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 356899999997 4999999888889999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||||
T Consensus 121 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---------------~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~ 184 (254)
T cd06627 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSK---------------DDASVVGTPYWMAPEVIEM-SGASTASDIWS 184 (254)
T ss_pred ccCCCCHHHEEECCCCCEEEeccccceecCCCcc---------------cccccccchhhcCHhhhcC-CCCCcchhHHH
Confidence 9999999999999999999999999986532210 0123468899999999887 44889999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+|+++|+|++ ||............. ....+......++.+.++|.+||..+|++|||+.+++.|+||
T Consensus 185 lG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 185 LGCTVIELLTGNPPYYDLNPMAALFRIV--QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHHhCCCCCCCccHHHHHHHHh--ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9999999997 776555444333332 223333334556789999999999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=320.36 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=197.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccC-----CcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLD-----GRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~ 496 (1239)
.++|++.+.||+|+||.||++.++.. ...+|+|.+... ........+.+|+.+++.+ +||||+++++.+..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 36789999999999999999998744 378999988743 2333456788999999999 89999999988732
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----------------cCCC
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----------------YDHF 559 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----------------~~~l 559 (1239)
...+|++|||++ ++|..++.. ...+
T Consensus 88 --------------------------------------~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l 129 (293)
T cd05053 88 --------------------------------------EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129 (293)
T ss_pred --------------------------------------CCCeEEEEEeCCCCcHHHHHHhcCCCcccccccccccccccc
Confidence 245799999996 699998854 2458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCccccc
Q 000880 560 DKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639 (1239)
Q Consensus 560 ~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 639 (1239)
++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+...... .......+
T Consensus 130 ~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-------------~~~~~~~~ 196 (293)
T cd05053 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY-------------RKTTNGRL 196 (293)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccce-------------eccCCCCC
Confidence 89999999999999999999999999999999999999999999999999865322110 01122345
Q ss_pred CccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCC
Q 000880 640 TYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSP 715 (1239)
Q Consensus 640 T~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~ 715 (1239)
+..|+|||++.+ ..++.++|||||||++|||++ ||......+.. .... ....+......++++.+|+.+||..
T Consensus 197 ~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 273 (293)
T cd05053 197 PVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-KLLK-EGYRMEKPQNCTQELYHLMRDCWHE 273 (293)
T ss_pred CccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-HHHH-cCCcCCCCCCCCHHHHHHHHHHccc
Confidence 678999999877 568999999999999999985 66544333322 2222 2223333445667899999999999
Q ss_pred CCCCCCCHHHHHhc
Q 000880 716 SPSDRPSATELLQD 729 (1239)
Q Consensus 716 dP~~RPta~eiL~~ 729 (1239)
||.+|||+.+++++
T Consensus 274 ~p~~Rps~~eil~~ 287 (293)
T cd05053 274 VPSQRPTFKQLVED 287 (293)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=319.03 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=202.4
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
.++|++.+.||+|+||.||+|.+..+++.||||.++..... .....+.+|+.++..+ .||||++++++|..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~------- 85 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT------- 85 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec-------
Confidence 57899999999999999999999988999999999754332 3345677788777676 49999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|++|||+++++.+++.. ...+++..+..++.||+.||+|||+
T Consensus 86 ---------------------------------~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 132 (296)
T cd06618 86 ---------------------------------DSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132 (296)
T ss_pred ---------------------------------CCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356899999999888877765 4568999999999999999999997
Q ss_pred -CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC---CCCC
Q 000880 581 -QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW---PKID 656 (1239)
Q Consensus 581 -~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~~~ 656 (1239)
+||+||||+|+||+++.++.+||+|||++..+.... ......+++.|+|||.+.+. +.++
T Consensus 133 ~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 196 (296)
T cd06618 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK----------------AKTRSAGCAAYMAPERIDPPDPNPKYD 196 (296)
T ss_pred hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC----------------cccCCCCCccccCHhhcCCCCCccccc
Confidence 599999999999999999999999999987643211 01223578899999998763 2378
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHH-HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMER-QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~-~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
.++||||||+++|+|++ ||...... +.............+.....+.++.+||.+||+.||.+||++.++++|+|+
T Consensus 197 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 197 IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 89999999999999997 76543222 222222222211112222356789999999999999999999999999998
Q ss_pred CCchH
Q 000880 733 PQMEY 737 (1239)
Q Consensus 733 ~~~~~ 737 (1239)
.....
T Consensus 277 ~~~~~ 281 (296)
T cd06618 277 RRYET 281 (296)
T ss_pred hccch
Confidence 86543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=317.51 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=191.7
Q ss_pred CCc-eEEeeeccCCceEEEEEEE----ccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDF-EELQPLGHGGFGHVVLCKN----KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y-~~~~~LG~G~fG~Vy~a~~----~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
++| ++++.||+|+||+||++.. ..++..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 344 8889999999999988753 3568899999987442 223456788999999999999999999887432
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....+|++|||++ ++|.+++.. ..+++..++.++.|++.||.|
T Consensus 79 -----------------------------------~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~ 122 (283)
T cd05080 79 -----------------------------------GGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAY 122 (283)
T ss_pred -----------------------------------CCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHH
Confidence 2346899999997 589888865 459999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++||+||||||+|||++.++.+||+|||+++........ ........++..|+|||++.+ ..++.
T Consensus 123 lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~~~~~PE~~~~-~~~~~ 189 (283)
T cd05080 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------------YRVREDGDSPVFWYAVECLKE-NKFSY 189 (283)
T ss_pred HHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh------------hccCCCCCCCceeeCHhHhcc-cCCCc
Confidence 99999999999999999999999999999999865321100 000122346678999999887 56899
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHH-H------------HHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQ-I------------VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP 721 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~-~------------~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP 721 (1239)
++|||||||++|||++ ||....... . ...........++.....+.++.+++.+||+.||++||
T Consensus 190 ~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 269 (283)
T cd05080 190 ASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRP 269 (283)
T ss_pred ccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCC
Confidence 9999999999999997 553221110 0 00001111122222334567899999999999999999
Q ss_pred CHHHHHh
Q 000880 722 SATELLQ 728 (1239)
Q Consensus 722 ta~eiL~ 728 (1239)
|+.++++
T Consensus 270 s~~~i~~ 276 (283)
T cd05080 270 TFRSLIP 276 (283)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=322.00 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=203.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||.|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.|..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-------- 87 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLV-------- 87 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeee--------
Confidence 4789999999999999999999988999999999864332 234678999999999999999999987732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....|+|+||++ ++|.+++.+ ..+++..+..++.|++.||.|||++
T Consensus 88 --------------------------------~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~ 134 (293)
T cd06647 88 --------------------------------GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 134 (293)
T ss_pred --------------------------------CCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 346799999996 589888865 3588999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+ ..++.++|+
T Consensus 135 gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv 198 (293)
T cd06647 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------------SKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198 (293)
T ss_pred CEeeccCCHHHEEEcCCCCEEEccCcceecccccc---------------cccccccCChhhcCchhhcc-CCCCchhhH
Confidence 99999999999999999999999999987543211 01123468999999999887 568999999
Q ss_pred HHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|||||++|+|++ ||..........................+..+.++|.+||..+|.+||++.+++.|+||....
T Consensus 199 ~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999996 776544333222111111111112233456789999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=316.88 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=195.4
Q ss_pred CCceEEeeeccCCceEEEEEEEcc-----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
++|.+.+.||+|+||.||+|.+.. ++..||+|.++.. ........+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 678999999999999999999987 6788999987633 223334578999999999999999999988743
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-------CCCHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-------HFDKELAWHLFRQ 570 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-------~l~~~~~~~i~~q 570 (1239)
....|++|||++ ++|.+++.... .+++..++.++.|
T Consensus 81 ------------------------------------~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~q 124 (277)
T cd05036 81 ------------------------------------RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124 (277)
T ss_pred ------------------------------------CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Confidence 234689999995 69999987543 4889999999999
Q ss_pred HHHHHHHHHhCCccccCCCcccEEEcCCC---CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcc
Q 000880 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARN---DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647 (1239)
Q Consensus 571 I~~gL~yLHs~gIiHrDLKp~NILl~~~~---~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 647 (1239)
|+.||+|||+++++||||||+|||++.++ .+||+|||+++........ .......+++.|+|||
T Consensus 125 i~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE 191 (277)
T cd05036 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY-------------RKGGRAMLPIKWMPPE 191 (277)
T ss_pred HHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccce-------------ecCCCCCccHhhCCHH
Confidence 99999999999999999999999998764 5999999999865211100 0011223457899999
Q ss_pred cccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH
Q 000880 648 IEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA 723 (1239)
Q Consensus 648 ~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta 723 (1239)
++.+ ..++.++|||||||++|||++ ||.............. ...+......++.+.+++.+||+.+|++|||+
T Consensus 192 ~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~ 268 (277)
T cd05036 192 AFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG--GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF 268 (277)
T ss_pred HHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 9987 569999999999999999985 7765544333322221 11222234456789999999999999999999
Q ss_pred HHHHhc
Q 000880 724 TELLQD 729 (1239)
Q Consensus 724 ~eiL~~ 729 (1239)
.++++|
T Consensus 269 ~~vl~~ 274 (277)
T cd05036 269 ATILER 274 (277)
T ss_pred HHHHHH
Confidence 999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=318.68 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=195.9
Q ss_pred CCceEEeeeccCCceEEEEEEEc-----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNK-----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.+|.+.+.||+|+||+||++.+. .++..||+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE---- 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 57899999999999999999863 34567999987632 33445679999999999999999999988732
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-------------CCCHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-------------HFDKELA 564 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-------------~l~~~~~ 564 (1239)
...+|++|||++ ++|.+++.... .+++..+
T Consensus 79 ------------------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~ 122 (288)
T cd05093 79 ------------------------------------GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122 (288)
T ss_pred ------------------------------------CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHH
Confidence 346799999996 69999886443 3899999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCC
Q 000880 565 WHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYT 644 (1239)
Q Consensus 565 ~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 644 (1239)
+.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....... ........+++.|+
T Consensus 123 ~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~ 189 (288)
T cd05093 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-------------YRVGGHTMLPIRWM 189 (288)
T ss_pred HHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCce-------------eecCCCCCcccccc
Confidence 99999999999999999999999999999999999999999999975421110 01112345678999
Q ss_pred CcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCC
Q 000880 645 APEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720 (1239)
Q Consensus 645 APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~R 720 (1239)
|||++.+ ..++.++|||||||++|+|++ ||.............. +..+......++++.+|+.+||+.||.+|
T Consensus 190 aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~R 266 (288)
T cd05093 190 PPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ--GRVLQRPRTCPKEVYDLMLGCWQREPHMR 266 (288)
T ss_pred CHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CCcCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999987 568999999999999999986 5655444443333322 22233333456789999999999999999
Q ss_pred CCHHHHHh
Q 000880 721 PSATELLQ 728 (1239)
Q Consensus 721 Pta~eiL~ 728 (1239)
||+.+++.
T Consensus 267 pt~~~v~~ 274 (288)
T cd05093 267 LNIKEIHS 274 (288)
T ss_pred CCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=330.49 Aligned_cols=247 Identities=31% Similarity=0.487 Sum_probs=188.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|.....||+|+||.||+|... +|..||||.+....... ..+|.+|+.+|.+++|||+|+++|+|.+.+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~------- 144 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGG------- 144 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCC-------
Confidence 67777789999999999999987 55999999776433321 455999999999999999999999996531
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...++|+||++ |+|.++|+... .++|....+|+.++|.||+|||.
T Consensus 145 --------------------------------~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~ 192 (361)
T KOG1187|consen 145 --------------------------------EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHE 192 (361)
T ss_pred --------------------------------ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHcc
Confidence 15789999996 79999998655 89999999999999999999998
Q ss_pred CC---ccccCCCcccEEEcCCCCEEEeecCcchhccc-cccccCCCCCCCCCCccccCccc-ccCccCCCcccccCCCCC
Q 000880 581 QG---IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL-EQLDQDAAFPTDTGGVSVDGTGQ-VGTYFYTAPEIEQGWPKI 655 (1239)
Q Consensus 581 ~g---IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~GT~~Y~APE~l~~~~~~ 655 (1239)
.. ||||||||+|||||.++++||+|||+|+.... .. ..... .||.+|+|||++.. +..
T Consensus 193 ~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~----------------~~~~~~~gt~gY~~PEy~~~-g~l 255 (361)
T KOG1187|consen 193 GCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT----------------SVSTTVMGTFGYLAPEYAST-GKL 255 (361)
T ss_pred CCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc----------------ceeeecCCCCccCChhhhcc-CCc
Confidence 54 99999999999999999999999999965321 10 00111 79999999999987 679
Q ss_pred CcchhhHHHHHHHHHhhc---CCchhH---HH--HHHHHhhhhcCC----CCCcc--cc-----CCHHHHHHHHHccCCC
Q 000880 656 DEKADMYSLGIVFFELWH---PFSTAM---ER--QIVLSDLKQKGE----LPPSW--VA-----KFSEQESLLRRLMSPS 716 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt---Pf~~~~---~~--~~~~~~~~~~~~----~p~~~--~~-----~~~e~~~LI~~~L~~d 716 (1239)
+.|+|||||||+|.||+| |..... .. ..........+. +.+.. .. ....+..+..+|++.+
T Consensus 256 t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~ 335 (361)
T KOG1187|consen 256 TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPD 335 (361)
T ss_pred CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcC
Confidence 999999999999999997 222111 10 111011111111 11111 11 1123567888999999
Q ss_pred CCCCCCHHHHHhc
Q 000880 717 PSDRPSATELLQD 729 (1239)
Q Consensus 717 P~~RPta~eiL~~ 729 (1239)
|.+||++.++++.
T Consensus 336 ~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 336 PKERPTMSQVVKE 348 (361)
T ss_pred CCcCcCHHHHHHH
Confidence 9999999998653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=321.46 Aligned_cols=252 Identities=28% Similarity=0.439 Sum_probs=201.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
+.|+.++.||+|+||.||+|.+..++..||+|.++.... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 73 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--------- 73 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc---------
Confidence 346777899999999999999998999999999874432 2345678999999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++|
T Consensus 74 -------------------------------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ 121 (277)
T cd06642 74 -------------------------------GTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER 121 (277)
T ss_pred -------------------------------CCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 356799999997 588888754 56899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++|+||+|+||+++.++.++|+|||++..+.... .......|+..|+|||++.+ ..++.++|+|
T Consensus 122 ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~ 185 (277)
T cd06642 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---------------IKRNTFVGTPFWMAPEVIKQ-SAYDFKADIW 185 (277)
T ss_pred eeccCCChheEEEeCCCCEEEccccccccccCcc---------------hhhhcccCcccccCHHHhCc-CCCchhhhHH
Confidence 9999999999999999999999999987643211 01123468899999999987 5689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
||||++|||++ ||............ . ....+......+.++.++|.+||+.+|++||++.++++|+|+...
T Consensus 186 slG~il~el~tg~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 186 SLGITAIELAKGEPPNSDLHPMRVLFLI-P-KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHHHHHhCCCCCcccchhhHHhhh-h-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 99999999997 55433332222211 1 112222222345688999999999999999999999999987644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=312.77 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=195.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|+++++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 72 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTK-------- 72 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcC--------
Confidence 478999999999999999999975 667899998764322 35678999999999999999999987632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....|++|||++ ++|.+++... ..++...++.++.||+.||+|||
T Consensus 73 --------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH 120 (261)
T cd05072 73 --------------------------------EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120 (261)
T ss_pred --------------------------------CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345799999996 6999988653 45888999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+++++||||||+||+++.++.++|+|||++........ .......++..|+|||++.+ ..++.++
T Consensus 121 ~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 185 (261)
T cd05072 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY--------------TAREGAKFPIKWTAPEAINF-GSFTIKS 185 (261)
T ss_pred HCCeeccccchhhEEecCCCcEEECCCccceecCCCce--------------eccCCCccceecCCHHHhcc-CCCChhh
Confidence 99999999999999999999999999999986432110 01122346778999999887 5689999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
|||||||++|+|++ ||............ . .....+.....+.++.+++.+||..+|++||+++++++
T Consensus 186 Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-Q-RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred hhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-H-cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999996 66554443333222 2 12222333456678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=317.34 Aligned_cols=248 Identities=29% Similarity=0.408 Sum_probs=197.6
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCc
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGT 510 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~ 510 (1239)
||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||+++++.+..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------------- 64 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET---------------- 64 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec----------------
Confidence 69999999999999999999999998754322 2234456789999999999999999987732
Q ss_pred ccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 511 LASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 511 ~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
...+|+||||++ ++|.+++.... .+++..++.++.|++.||.|||++|++|||
T Consensus 65 ------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d 120 (277)
T cd05577 65 ------------------------KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120 (277)
T ss_pred ------------------------CCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 356799999997 59999887655 699999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|+|+||+++.++.+||+|||++....... ......++..|+|||++.+ ..++.++|||||||+
T Consensus 121 i~p~Nil~~~~~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i 183 (277)
T cd05577 121 LKPENVLLDDHGNVRISDLGLAVELKGGK----------------KIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCT 183 (277)
T ss_pred CCHHHEEECCCCCEEEccCcchhhhccCC----------------ccccccCCCCcCCHHHhcC-CCCCchhhhHHHHHH
Confidence 99999999999999999999987643210 1123468889999999887 458999999999999
Q ss_pred HHHhhc---CCchhHH---HHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHHHHhccCCCCch
Q 000880 668 FFELWH---PFSTAME---RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALPPQME 736 (1239)
Q Consensus 668 L~ELlt---Pf~~~~~---~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~eiL~~~~~~~~~ 736 (1239)
+|+|++ ||..... ......... ..........++++.++|.+||+.||.+|| ++.++++|||+....
T Consensus 184 l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 184 LYEMIAGRSPFRQRKEKVEKEELKRRTL--EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HHHHhhCCCCCCCCcccccHHHHHhccc--cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 999996 7754322 111111111 111112223467899999999999999999 899999999998876
Q ss_pred HH
Q 000880 737 YE 738 (1239)
Q Consensus 737 ~~ 738 (1239)
+.
T Consensus 262 ~~ 263 (277)
T cd05577 262 WR 263 (277)
T ss_pred hh
Confidence 54
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=320.94 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=193.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCC--------------cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeee
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDG--------------RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYY 489 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g--------------~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~ 489 (1239)
++|++.++||+|+||.||+|++..++ ..||+|+++.. ........+.+|+.+++.++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 57899999999999999999875432 35899998643 3334456799999999999999999999
Q ss_pred eeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-----------
Q 000880 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD----------- 557 (1239)
Q Consensus 490 ~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~----------- 557 (1239)
+++.. ...+|+|||||+ ++|.+++....
T Consensus 84 ~~~~~----------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 123 (295)
T cd05097 84 GVCVS----------------------------------------DDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123 (295)
T ss_pred EEEcC----------------------------------------CCccEEEEecCCCCcHHHHHHhccccccccccccC
Confidence 88732 345799999996 58999886432
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcc
Q 000880 558 -HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTG 636 (1239)
Q Consensus 558 -~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (1239)
.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++........ ......
T Consensus 124 ~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~ 190 (295)
T cd05097 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY-------------YRIQGR 190 (295)
T ss_pred CcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcc-------------eeccCc
Confidence 367889999999999999999999999999999999999999999999999975421110 011123
Q ss_pred cccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc-----CCchhHHHHHHHHhh---hh--cCCCCCccccCCHHHH
Q 000880 637 QVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH-----PFSTAMERQIVLSDL---KQ--KGELPPSWVAKFSEQE 706 (1239)
Q Consensus 637 ~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt-----Pf~~~~~~~~~~~~~---~~--~~~~p~~~~~~~~e~~ 706 (1239)
..+++.|+|||++.+ ..++.++|||||||++|+|++ ||............. .. ...........++.+.
T Consensus 191 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (295)
T cd05097 191 AVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVF 269 (295)
T ss_pred CcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHH
Confidence 356789999999887 568999999999999999985 776544433322211 10 1111222334567899
Q ss_pred HHHHHccCCCCCCCCCHHHHHh
Q 000880 707 SLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 707 ~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
+||.+||+.||.+|||+.+|++
T Consensus 270 ~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 270 KLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=316.12 Aligned_cols=252 Identities=29% Similarity=0.453 Sum_probs=203.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
-|++++.||+|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||++++++|..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 73 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK---------- 73 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe----------
Confidence 46778999999999999999998999999998864432 2345678899999999999999999998743
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
...+|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||++|+
T Consensus 74 ------------------------------~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (277)
T cd06641 74 ------------------------------DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122 (277)
T ss_pred ------------------------------CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCe
Confidence 356899999997 488888764 468999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+|+||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+ ..++.++|+||
T Consensus 123 ~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~s 186 (277)
T cd06641 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---------------IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWS 186 (277)
T ss_pred ecCCCCHHhEEECCCCCEEEeecccceecccch---------------hhhccccCCccccChhhhcc-CCCCchhhHHH
Confidence 999999999999999999999999987542211 01123468899999999876 56789999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|||++|+|++ ||............. ....+......+.++.++|.+||+.+|.+||++.++++|+|+.+..
T Consensus 187 lG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 187 LGITAIELAKGEPPHSELHPMKVLFLIP--KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHHHHHHHHcCCCCCCccchHHHHHHHh--cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 9999999997 665544333322221 2222222234557899999999999999999999999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=312.47 Aligned_cols=245 Identities=24% Similarity=0.405 Sum_probs=194.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|++.+.||+|+||.||+|.++ ++..+|+|++...... ...+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 70 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--------- 70 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC---------
Confidence 46888999999999999999987 5678999988643322 3468899999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....|++|||++ ++|.+++... ..+++..++.++.||+.||+|||++
T Consensus 71 -------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 119 (256)
T cd05059 71 -------------------------------QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119 (256)
T ss_pred -------------------------------CCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345799999996 5899988753 4689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
|++||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+ ..++.++||
T Consensus 120 ~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~--------------~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di 184 (256)
T cd05059 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT--------------SSQGTKFPVKWAPPEVFDY-SRFSSKSDV 184 (256)
T ss_pred CcccccccHhhEEECCCCcEEECCcccceeccccccc--------------ccCCCCCCccccCHHHhcc-CCCCchhhH
Confidence 9999999999999999999999999998764321100 0111234568999999987 568999999
Q ss_pred HHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 662 YSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 662 wSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|||||++|||++ ||......+...... ....++.....++++.+++.+||+.+|++|||+.++++.
T Consensus 185 ~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 185 WSFGVLMWEVFSEGKMPYERFSNSEVVESVS--AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHH--cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999986 665544443332222 122222233457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=312.19 Aligned_cols=242 Identities=22% Similarity=0.324 Sum_probs=189.4
Q ss_pred eeccCCceEEEEEEEc--cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 431 PLGHGGFGHVVLCKNK--LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--------------- 65 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--------------- 65 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---------------
Confidence 4899999999999875 345679999886432 3344567899999999999999999998761
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHr 586 (1239)
...+++||||++ ++|.+++.. ...+++..++.++.||+.||+|||++|++||
T Consensus 66 --------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 119 (257)
T cd05115 66 --------------------------AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119 (257)
T ss_pred --------------------------CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeec
Confidence 234689999996 589998874 4569999999999999999999999999999
Q ss_pred CCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHH
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||++......... ....+...+++.|+|||++.+ ..++.++|||||||
T Consensus 120 dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ 186 (257)
T cd05115 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSY------------YKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGI 186 (257)
T ss_pred ccchheEEEcCCCcEEeccCCccccccCCccc------------eeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHH
Confidence 99999999999999999999999754321100 001122334678999999887 56899999999999
Q ss_pred HHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 667 VFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 667 iL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
++|||++ ||.......... .+. .+..++.....++++.++|.+||..||++||++.+|.+.
T Consensus 187 ~l~el~~~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 187 TMWEAFSYGQKPYKKMKGPEVMS-FIE-QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHHHhcCCCCCcCcCCHHHHHH-HHH-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999984 776554444332 222 222233334567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=309.95 Aligned_cols=247 Identities=30% Similarity=0.557 Sum_probs=204.8
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|++.+.||.|+||.||++.++.+++.||+|.+............+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------- 70 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD---------- 70 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc----------
Confidence 5889999999999999999999999999999998655444556678899999999999999999877632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....|++|||++ ++|.+++.. ...+++..++.++.|++.||+|||
T Consensus 71 ------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh 120 (256)
T cd08530 71 ------------------------------GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120 (256)
T ss_pred ------------------------------CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 356899999996 589988865 356899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++|+||+|.||+++.++.+||+|||++...... ......|++.|+|||.+.+ ..++.++
T Consensus 121 ~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-----------------~~~~~~~~~~~~~Pe~~~~-~~~~~~~ 182 (256)
T cd08530 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----------------MAKTQIGTPHYMAPEVWKG-RPYSYKS 182 (256)
T ss_pred hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-----------------CcccccCCccccCHHHHCC-CCCCchh
Confidence 999999999999999999999999999999865321 0122468899999999987 5688999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
|+||||+++|+|++ ||............. ....++.....+.++.++|.+||+.+|++|||+.++++||+
T Consensus 183 D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 183 DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 99999999999986 776554433332222 23334333456678999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=311.37 Aligned_cols=243 Identities=26% Similarity=0.364 Sum_probs=192.1
Q ss_pred eeeccCCceEEEEEEEccCC---cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcC
Q 000880 430 QPLGHGGFGHVVLCKNKLDG---RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g---~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
++||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.+.||||+++++.+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------------- 66 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK------------- 66 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-------------
Confidence 46999999999999886555 78999998754433 44567899999999999999999998652
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiH 585 (1239)
....+++|||++ ++|.+++.....+++..++.++.|++.||+|||+++++|
T Consensus 67 ----------------------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H 118 (257)
T cd05060 67 ----------------------------GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118 (257)
T ss_pred ----------------------------CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeec
Confidence 234689999996 699999988778999999999999999999999999999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHH
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlG 665 (1239)
|||||+|||++.++.+||+|||+++........ ........++..|+|||.+.+ ..++.++||||||
T Consensus 119 ~di~p~nili~~~~~~kl~df~~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG 185 (257)
T cd05060 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDY------------YRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYG 185 (257)
T ss_pred cCcccceEEEcCCCcEEeccccccceeecCCcc------------cccccCccccccccCHHHhcC-CCCCccchHHHHH
Confidence 999999999999999999999999865322100 000112235678999999887 5689999999999
Q ss_pred HHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 666 IVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 666 viL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|++|+|++ ||......+.... +. .....+.....++.+.++|.+||+.+|.+||++.++++.
T Consensus 186 ~~l~~~~~~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~ 251 (257)
T cd05060 186 VTLWEAFSYGAKPYGEMKGAEVIAM-LE-SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELEST 251 (257)
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHH-HH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999985 6655444333222 22 222223334556789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=319.45 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=193.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCc--EEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGR--HYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~--~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~ 500 (1239)
++|++.+.||+|+||.||+|.++.++. .+++|.++. .........+.+|+.+++++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACEN------ 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc------
Confidence 589999999999999999999987765 468887762 22333456789999999999 79999999988732
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC----------------CCCHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD----------------HFDKEL 563 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~----------------~l~~~~ 563 (1239)
...+|++|||++ ++|.+++.... .+++..
T Consensus 75 ----------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 120 (297)
T cd05089 75 ----------------------------------RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120 (297)
T ss_pred ----------------------------------CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHH
Confidence 245799999996 69999986532 478899
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccC
Q 000880 564 AWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFY 643 (1239)
Q Consensus 564 ~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 643 (1239)
++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ........+..|
T Consensus 121 ~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----------------~~~~~~~~~~~y 184 (297)
T cd05089 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY----------------VKKTMGRLPVRW 184 (297)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccce----------------eccCCCCcCccc
Confidence 9999999999999999999999999999999999999999999998632110 001112335679
Q ss_pred CCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCC
Q 000880 644 TAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSD 719 (1239)
Q Consensus 644 ~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~ 719 (1239)
+|||++.+ ..++.++|||||||++|||++ ||.............. +..++.....++.+.+||.+||..+|.+
T Consensus 185 ~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~ 261 (297)
T cd05089 185 MAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--GYRMEKPRNCDDEVYELMRQCWRDRPYE 261 (297)
T ss_pred cCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 99999887 568999999999999999985 7765554443333222 2222233346678999999999999999
Q ss_pred CCCHHHHHhc
Q 000880 720 RPSATELLQD 729 (1239)
Q Consensus 720 RPta~eiL~~ 729 (1239)
|||++++++.
T Consensus 262 Rp~~~~i~~~ 271 (297)
T cd05089 262 RPPFAQISVQ 271 (297)
T ss_pred CcCHHHHHHH
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=351.69 Aligned_cols=149 Identities=30% Similarity=0.563 Sum_probs=133.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+++|.++++||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------- 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS------- 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-------
Confidence 5789999999999999999999999999999999975432 23344678899999999999999999977632
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
..++|||||||. ++|.+++...+.+++..++.++.||+.||.|||+
T Consensus 76 ---------------------------------~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~ 122 (669)
T cd05610 76 ---------------------------------ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122 (669)
T ss_pred ---------------------------------CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 357899999995 6999999888889999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKF 611 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~ 611 (1239)
++|+||||||+||||+.++.+||+|||+++.
T Consensus 123 ~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred CCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=317.75 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=195.0
Q ss_pred CceEEeeeccCCceEEEEEEE----ccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 425 DFEELQPLGHGGFGHVVLCKN----KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~----~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
.|++++.||+|+||.||+|++ +.++..||+|.++.. ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTED----- 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC-----
Confidence 468889999999999999985 457889999998643 2334456799999999999999999999887432
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
....+|++|||++ ++|.+++.+. ..+++..++.++.||+.||+||
T Consensus 79 ---------------------------------~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~l 125 (284)
T cd05079 79 ---------------------------------GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125 (284)
T ss_pred ---------------------------------CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 1345799999996 6999998764 3589999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|++|++||||||+|||++.++.+||+|||+++.+...... ........|+..|+|||++.+ ..++.+
T Consensus 126 H~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~apE~~~~-~~~~~~ 192 (284)
T cd05079 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------------YTVKDDLDSPVFWYAPECLIQ-SKFYIA 192 (284)
T ss_pred HHCCeeecccchheEEEcCCCCEEECCCccccccccCccc------------eeecCCCCCCccccCHHHhcc-CCCCcc
Confidence 9999999999999999999999999999999865321100 001123457788999999887 568999
Q ss_pred hhhHHHHHHHHHhhc---CCchhH--------------HHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC
Q 000880 659 ADMYSLGIVFFELWH---PFSTAM--------------ERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP 721 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~--------------~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP 721 (1239)
+|||||||++|||++ |+.... .......... .+...+.+...++.+.+||.+||+.||.+||
T Consensus 193 ~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 271 (284)
T cd05079 193 SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE-EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT 271 (284)
T ss_pred ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCCcccCc
Confidence 999999999999986 221110 0011111111 2223333455678999999999999999999
Q ss_pred CHHHHHhc
Q 000880 722 SATELLQD 729 (1239)
Q Consensus 722 ta~eiL~~ 729 (1239)
|+.+++++
T Consensus 272 t~~~il~~ 279 (284)
T cd05079 272 TFQNLIEG 279 (284)
T ss_pred CHHHHHHH
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=316.88 Aligned_cols=255 Identities=25% Similarity=0.452 Sum_probs=208.3
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------- 86 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV-------- 86 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--------
Confidence 4568888999999999999999998999999999975433 45678899999999999999999998743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
....|+++||++ ++|.+++.... .+++..++.++.||+.||+|||+
T Consensus 87 --------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~ 134 (286)
T cd06614 87 --------------------------------GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134 (286)
T ss_pred --------------------------------CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356899999997 69999998876 89999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+|++|+||||+||+++.++.++|+|||++........ ......+++.|+|||++.+ ..++.++|
T Consensus 135 ~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---------------~~~~~~~~~~y~~PE~~~~-~~~~~~~D 198 (286)
T cd06614 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---------------KRNSVVGTPYWMAPEVIKR-KDYGPKVD 198 (286)
T ss_pred CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh---------------hhccccCCcccCCHhHhcC-CCCCCccc
Confidence 9999999999999999999999999999875432110 1123458899999999887 56899999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
+|||||++|+|++ ||..........................+.++.++|.+||+.+|.+|||+.++++|+|+.+..
T Consensus 199 v~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 199 IWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred cHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 9999999999997 666554433333322211111112223567899999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=310.21 Aligned_cols=243 Identities=25% Similarity=0.347 Sum_probs=198.0
Q ss_pred eeeccCCceEEEEEEEccC---CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcC
Q 000880 430 QPLGHGGFGHVVLCKNKLD---GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~---g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
+.||+|+||.||+|.+... +..||+|.++...... ....+.+|+..++.++||||+++++++..
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------------ 67 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE------------ 67 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC------------
Confidence 3699999999999999866 8999999987544332 45788999999999999999999987632
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHH
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESY---------DHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~---------~~l~~~~~~~i~~qI~~gL~ 576 (1239)
...++++|||+ +++|.+++... ..+++..++.++.||+.||+
T Consensus 68 ----------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~ 119 (262)
T cd00192 68 ----------------------------EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119 (262)
T ss_pred ----------------------------CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 35679999999 57999999875 67999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++|++||||||+||+++.++.+||+|||.+........ ........+++.|+|||.+.+ ..++
T Consensus 120 ~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~-~~~~ 185 (262)
T cd00192 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-------------YRKKTGGKLPIRWMAPESLKD-GIFT 185 (262)
T ss_pred HHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc-------------cccccCCCcCccccCHHHhcc-CCcc
Confidence 99999999999999999999999999999999986532210 011234568899999999887 4689
Q ss_pred cchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.++|||||||++|+|++ ||.............. ...+......++++.+++.+||+.+|.+|||+.+++++
T Consensus 186 ~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 186 SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999985 6665544433333222 22333334556799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=305.81 Aligned_cols=248 Identities=30% Similarity=0.546 Sum_probs=201.8
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+|+..+.||+|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------- 68 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK---------- 68 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec----------
Confidence 58889999999999999999998999999999875433 345689999999999999999999988732
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....++++||++ ++|.+++... ..+++..++.++.|++.||.|||++|
T Consensus 69 ------------------------------~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 118 (253)
T cd05122 69 ------------------------------KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118 (253)
T ss_pred ------------------------------CCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 246799999998 6999998776 57999999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++||||+|+||+++.++.++|+|||++........ .....|+..|+|||.+.+ ..++.++|||
T Consensus 119 i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----------------~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~ 181 (253)
T cd05122 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----------------RNTMVGTPYWMAPEVING-KPYDYKADIW 181 (253)
T ss_pred EecCCCCHHHEEEccCCeEEEeecccccccccccc----------------ccceecCCcccCHHHHcC-CCCCccccHH
Confidence 99999999999999999999999999876532210 133568899999999987 4588999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
|||+++|+|++ ||....................+.....+..+.++|.+||+.||.+|||+.++++|||
T Consensus 182 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 182 SLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 99999999997 6665533333222222111111111222568999999999999999999999999997
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=312.74 Aligned_cols=256 Identities=32% Similarity=0.494 Sum_probs=203.5
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCc
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGT 510 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~ 510 (1239)
||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++.+.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~----------------- 63 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ----------------- 63 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----------------
Confidence 6899999999999998999999999865432 2234567889999999999999999987652
Q ss_pred ccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 000880 511 LASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589 (1239)
Q Consensus 511 ~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLK 589 (1239)
....+|++|||++ ++|.+++.....+++..++.++.||+.||+|||++|++||||+
T Consensus 64 -----------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~ 120 (265)
T cd05579 64 -----------------------GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120 (265)
T ss_pred -----------------------cCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCC
Confidence 2457899999996 5999999887789999999999999999999999999999999
Q ss_pred cccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHH
Q 000880 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFF 669 (1239)
Q Consensus 590 p~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ 669 (1239)
|+||+++.++.++|+|||++.......... ............+++.|+|||.+.+ ..++.++||||||+++|
T Consensus 121 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~ 192 (265)
T cd05579 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQIN-------LNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILY 192 (265)
T ss_pred HHHeEEcCCCCEEEEecccchhcccCcccc-------cccccccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHH
Confidence 999999999999999999988643221000 0000112234568899999999887 45889999999999999
Q ss_pred Hhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH---HHHHhccCCCCch
Q 000880 670 ELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA---TELLQDALPPQME 736 (1239)
Q Consensus 670 ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta---~eiL~~~~~~~~~ 736 (1239)
+|++ ||...................+ .....++.+.++|.+||+.+|.+|||+ .++++||||..+.
T Consensus 193 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 193 EFLVGIPPFHGETPEEIFQNILNGKIEWP-EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHhCCCCCCCCCHHHHHHHHhcCCcCCC-ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 9997 7765555544433333222222 222246789999999999999999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=316.25 Aligned_cols=252 Identities=30% Similarity=0.486 Sum_probs=201.6
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
|+..+.||+|+||.||+|++..+++.||+|++............+.+|+.+++.++||||+++++++..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----------- 69 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT----------- 69 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----------
Confidence 567789999999999999999999999999998654334445678899999999999999999987632
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
...+|+||||++++|.+++... ..+++..++.++.|++.||+|||++||+
T Consensus 70 -----------------------------~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 120 (282)
T cd07829 70 -----------------------------ERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120 (282)
T ss_pred -----------------------------CCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3568999999999999999876 5799999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
||||+|+||+++.++.+||+|||+++....... ......++..|+|||.+.+...++.++|||||
T Consensus 121 H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl 185 (282)
T cd07829 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLR---------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSV 185 (282)
T ss_pred cCCCChheEEEcCCCCEEEecCCcccccCCCcc---------------ccCccccCcCcCChHHhcCCcCCCccccHHHH
Confidence 999999999999999999999999976432110 11234567889999998774478999999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhhhh------------------cCCCC--------CccccCCHHHHHHHHHccCC
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDLKQ------------------KGELP--------PSWVAKFSEQESLLRRLMSP 715 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~~~------------------~~~~p--------~~~~~~~~e~~~LI~~~L~~ 715 (1239)
||++|||++ ||............... ....+ ..+...++.+.++|++||..
T Consensus 186 G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 265 (282)
T cd07829 186 GCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQY 265 (282)
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhcc
Confidence 999999997 56443322222111110 00000 11122356789999999999
Q ss_pred CCCCCCCHHHHHhccCC
Q 000880 716 SPSDRPSATELLQDALP 732 (1239)
Q Consensus 716 dP~~RPta~eiL~~~~~ 732 (1239)
||.+||++.+++.||||
T Consensus 266 ~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 266 NPAKRISAKEALKHPYF 282 (282)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=316.24 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=201.6
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
|++.+.||.|++|.||+|.+..+|+.+|+|.++...........+.+|+.+++.++||||+++++.+..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------- 69 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----------- 69 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----------
Confidence 567789999999999999999999999999987655444456678899999999999999999987632
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
...+|++|||++++|.+.+... ..+++..++.++.||+.||.|||+++|+
T Consensus 70 -----------------------------~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 120 (283)
T cd05118 70 -----------------------------KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120 (283)
T ss_pred -----------------------------CCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3568999999999998888764 5799999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+...++.++|+|||
T Consensus 121 H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~sl 185 (283)
T cd05118 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPV---------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV 185 (283)
T ss_pred ecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---------------ccccCccCcccccCcHHHhcCCCCCchhHHHHH
Confidence 99999999999999999999999997653221 011234688899999998874468999999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhhhhcCC---------------------------CCCccccCCHHHHHHHHHccC
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDLKQKGE---------------------------LPPSWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~~~~~~---------------------------~p~~~~~~~~e~~~LI~~~L~ 714 (1239)
|+++|+|++ ||......+.........+. .+..+...+.++.++|.+||+
T Consensus 186 G~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 265 (283)
T cd05118 186 GCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLH 265 (283)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhc
Confidence 999999997 56443332222111110000 001122345688999999999
Q ss_pred CCCCCCCCHHHHHhccCC
Q 000880 715 PSPSDRPSATELLQDALP 732 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~~~~ 732 (1239)
.||.+||++.+++.|||+
T Consensus 266 ~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 266 YDPHKRITAEQALAHPYF 283 (283)
T ss_pred cCcccCcCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=318.70 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=202.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
-|...++||+|+||+||+|++..+|..||+|++..... .......+.+|+.+++.++|||++++++++.+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------- 92 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--------- 92 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe---------
Confidence 35666889999999999999999999999999875433 23344578899999999999999999988743
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....|++||||++++.+++.. ...+++..++.++.||+.||.|||++|
T Consensus 93 -------------------------------~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 141 (313)
T cd06633 93 -------------------------------EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141 (313)
T ss_pred -------------------------------CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356799999999988888765 456899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCcchh
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDEKAD 660 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ksD 660 (1239)
++||||||+||+++.++.+||+|||++.... ......|++.|+|||++.. ...++.++|
T Consensus 142 i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sD 202 (313)
T cd06633 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSS-------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVD 202 (313)
T ss_pred eecCCCChhhEEECCCCCEEEeecCCCcccC-------------------CCCCccccccccChhhccccCCCCCCchhh
Confidence 9999999999999999999999999986321 0123578999999999852 245888999
Q ss_pred hHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCC-ccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
||||||++|+|++ ||............... ..+. .....+..+++||.+||+.+|.+||++.++++|+|+....
T Consensus 203 v~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999996 66655444433333221 1121 1223445789999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=319.98 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=202.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~-~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+.|...+.||+|+||.||+|+++.+++.+|+|.+.... .......++.+|+.+++.++|||++++++++..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 86 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-------- 86 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--------
Confidence 45777889999999999999999999999999987532 233345678899999999999999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....|+||||+.+++.+++.. ...+++..++.++.|++.||.|||++
T Consensus 87 --------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~ 134 (308)
T cd06634 87 --------------------------------EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (308)
T ss_pred --------------------------------CCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 346799999999988887754 45689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC--CCCCCcch
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG--WPKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~ks 659 (1239)
+++||||||+||+++.++.++|+|||++..... .....|++.|+|||++.+ ...++.++
T Consensus 135 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 195 (308)
T cd06634 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------------------ANXFVGTPYWMAPEVILAMDEGQYDGKV 195 (308)
T ss_pred CcccCCCCHHhEEECCCCcEEECCcccceeecC-------------------cccccCCccccCHHHHhhcccCCCCccc
Confidence 999999999999999999999999999875421 123468899999999752 23578899
Q ss_pred hhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCC-ccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|||||||++|+|++ ||.............. ...+. .....+..+.+||++||+.+|.+||++.++++|+|+...
T Consensus 196 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred chHHHHHHHHHHHcCCCCCccccHHHHHHHHhh--cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999996 6655443333322222 12222 122445678999999999999999999999999998775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=316.00 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=195.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEcc-----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAV--- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC---
Confidence 3689999999999999999999753 6789999998643 233445678899999999999999999987732
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-------------------
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD------------------- 557 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~------------------- 557 (1239)
...+|++|||++ ++|.+++....
T Consensus 80 -------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 122 (288)
T cd05050 80 -------------------------------------GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122 (288)
T ss_pred -------------------------------------CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccc
Confidence 245799999997 59999886432
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccC
Q 000880 558 ---HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG 634 (1239)
Q Consensus 558 ---~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (1239)
.+++..++.++.||+.||+|||+++++||||||+|||++.++.++|+|||++......... ...
T Consensus 123 ~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-------------~~~ 189 (288)
T cd05050 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-------------KAS 189 (288)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccc-------------ccc
Confidence 3678889999999999999999999999999999999999999999999998754221100 001
Q ss_pred cccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHH
Q 000880 635 TGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLR 710 (1239)
Q Consensus 635 ~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~ 710 (1239)
....+++.|+|||.+.+ ..++.++|||||||++|||++ ||......+..... . ....++.....++++.+||.
T Consensus 190 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~l~~li~ 266 (288)
T cd05050 190 ENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV-R-DGNVLSCPDNCPLELYNLMR 266 (288)
T ss_pred CCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-h-cCCCCCCCCCCCHHHHHHHH
Confidence 12245678999999887 568999999999999999985 66554444433322 2 23333333345678999999
Q ss_pred HccCCCCCCCCCHHHHHh
Q 000880 711 RLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~ 728 (1239)
+||+.||.+|||+.++++
T Consensus 267 ~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 267 LCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=318.67 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=196.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEc-----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNK-----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~ 496 (1239)
.++|.+.+.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 468999999999999999999863 345689999886432 233456789999999999 89999999988732
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVE 573 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~ 573 (1239)
...+|++|||++ ++|.+++.... .+++.+++.++.||+.
T Consensus 111 --------------------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~ 152 (302)
T cd05055 111 --------------------------------------GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152 (302)
T ss_pred --------------------------------------CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHH
Confidence 245799999996 69999987543 3899999999999999
Q ss_pred HHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC
Q 000880 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653 (1239)
Q Consensus 574 gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 653 (1239)
||+|||+++|+|+||||+|||++.++.++|+|||+++....... ........+++.|+|||++.+ .
T Consensus 153 ~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~-~ 218 (302)
T cd05055 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN-------------YVVKGNARLPVKWMAPESIFN-C 218 (302)
T ss_pred HHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCc-------------eeecCCCCcccccCCHhhhcc-C
Confidence 99999999999999999999999999999999999975432110 001122356789999999887 5
Q ss_pred CCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 654 KIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 654 ~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.++.++|||||||++|||++ ||.............. .+..+......++++.+++.+||+.+|++|||+.++++.
T Consensus 219 ~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK-EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 68999999999999999985 6654433333322222 222222333456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=314.00 Aligned_cols=250 Identities=31% Similarity=0.473 Sum_probs=196.6
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccCCCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
|++.+.||.|+||+||+|....+++.||||.+...... .......+|+..++.++ ||||+++++++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~---------- 69 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE---------- 69 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc----------
Confidence 67789999999999999999988999999998654332 22234567999999999 9999999987632
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....|+||||++++|.+.+.... .+++..++.++.|++.||.|||++|
T Consensus 70 ------------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~ 119 (283)
T cd07830 70 ------------------------------NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119 (283)
T ss_pred ------------------------------CCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35679999999989999887764 7899999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
++|+||||+||+++.++.++|+|||++....... ..+...|+..|+|||++.+...++.++|+|
T Consensus 120 i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~----------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 183 (283)
T cd07830 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----------------PYTDYVSTRWYRAPEILLRSTSYSSPVDIW 183 (283)
T ss_pred cccCCCChhhEEEcCCCCEEEeecccceeccCCC----------------CcCCCCCcccccCceeeecCcCcCCccchh
Confidence 9999999999999999999999999997542111 112346889999999886655689999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhh-------------------cCCCC--------CccccCCHHHHHHHHHc
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQ-------------------KGELP--------PSWVAKFSEQESLLRRL 712 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~-------------------~~~~p--------~~~~~~~~e~~~LI~~~ 712 (1239)
|||+++|||++ ||............... ....+ ......++++.++|++|
T Consensus 184 s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 263 (283)
T cd07830 184 ALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDM 263 (283)
T ss_pred hHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHh
Confidence 99999999997 55433222211111100 00000 01112346789999999
Q ss_pred cCCCCCCCCCHHHHHhccCC
Q 000880 713 MSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 713 L~~dP~~RPta~eiL~~~~~ 732 (1239)
|+.||.+|||+.+++.|+||
T Consensus 264 l~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 264 LRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccCcccCCCHHHHhhCCCC
Confidence 99999999999999999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=309.09 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=194.5
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||+|+||.||+|.+. +++.||||.++.... ....+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 72 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTL--------- 72 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEec---------
Confidence 57899999999999999999976 567899999864332 24568899999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
...+|++|||+ +++|.+++.... .+++..+..++.|++.||.|||+
T Consensus 73 -------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 121 (261)
T cd05068 73 -------------------------------EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121 (261)
T ss_pred -------------------------------CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34579999999 579999987654 68999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+|++||||||+||+++.++.+||+|||+++....... .......++..|+|||++.+ ..++.++|
T Consensus 122 ~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 186 (261)
T cd05068 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY--------------EAREGAKFPIKWTAPEAALY-NRFSIKSD 186 (261)
T ss_pred CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc--------------cccCCCcCceeccCcccccc-CCCCchhh
Confidence 9999999999999999999999999999986531110 00111234568999999887 56899999
Q ss_pred hHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 661 MYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 661 IwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
+|||||++|||++ ||............ ..... ++.....+..+.+++.+||+.+|.+||++.++++
T Consensus 187 i~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 187 VWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYR-MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCC-CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999996 67654444333222 22222 2223345678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=331.56 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=195.1
Q ss_pred CCceEEeeeccCCceEEEEEEEc-----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNK-----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGV 497 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~ 497 (1239)
++|.+.++||+|+||.||+|++. .++..||||+++.... ......+.+|+.+|..+. |||||+++++|..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--- 112 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK--- 112 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence 56888899999999999999964 3456899999975432 233457889999999997 9999999998843
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-------------------
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD------------------- 557 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~------------------- 557 (1239)
...+|+|||||+ |+|.++++...
T Consensus 113 -------------------------------------~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 155 (401)
T cd05107 113 -------------------------------------GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLIS 155 (401)
T ss_pred -------------------------------------CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccc
Confidence 245799999996 69999886431
Q ss_pred -------------------------------------------------------------------------------C
Q 000880 558 -------------------------------------------------------------------------------H 558 (1239)
Q Consensus 558 -------------------------------------------------------------------------------~ 558 (1239)
.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (401)
T cd05107 156 GGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPA 235 (401)
T ss_pred cccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCC
Confidence 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccc
Q 000880 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV 638 (1239)
Q Consensus 559 l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (1239)
+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++.+...... .......
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~-------------~~~~~~~ 302 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY-------------ISKGSTF 302 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccc-------------ccCCCcC
Confidence 566778899999999999999999999999999999999999999999999864221100 0112346
Q ss_pred cCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccC
Q 000880 639 GTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 639 GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~ 714 (1239)
+++.|+|||++.+ ..++.++|||||||++|||++ ||......+.....+. .+..++.....+.++.+|+.+||.
T Consensus 303 ~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~l~~li~~cl~ 380 (401)
T cd05107 303 LPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK-RGYRMAKPAHASDEIYEIMQKCWE 380 (401)
T ss_pred CCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcC
Confidence 7889999999987 568999999999999999985 6654433333333322 222233334566799999999999
Q ss_pred CCCCCCCCHHHHHhc
Q 000880 715 PSPSDRPSATELLQD 729 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~ 729 (1239)
.+|.+||++.+|++.
T Consensus 381 ~~P~~RPs~~ell~~ 395 (401)
T cd05107 381 EKFEIRPDFSQLVHL 395 (401)
T ss_pred CChhHCcCHHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=313.51 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=193.0
Q ss_pred CCceEEeeeccCCceEEEEEEE----ccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKN----KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~----~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
.+|++++.||+|+||.||+|.. ..++..||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---- 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC----
Confidence 4788999999999999999984 457889999988643 334456789999999999999999999876432
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....+++||||++ ++|.+++... ..+++..++.++.||+.||+|
T Consensus 78 ----------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~ 123 (284)
T cd05081 78 ----------------------------------GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123 (284)
T ss_pred ----------------------------------CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHH
Confidence 1345799999996 6999998754 468999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++||+||||||+|||++.++.+||+|||++......... ........++..|+|||++.+ ..++.
T Consensus 124 LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~-~~~~~ 190 (284)
T cd05081 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY------------YKVREPGESPIFWYAPESLTE-SKFSV 190 (284)
T ss_pred HHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcc------------eeecCCCCCceEeeCHHHhcc-CCcCh
Confidence 99999999999999999999999999999999865321100 000112234556999999987 56899
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHH---------------HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMER---------------QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSD 719 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~---------------~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~ 719 (1239)
++|||||||++|||++ |+...... ......+. ....++.....+.++.+||.+||+.+|++
T Consensus 191 ~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05081 191 ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK-NNGRLPAPPGCPAEIYAIMKECWNNDPSQ 269 (284)
T ss_pred HHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999999986 22111000 00011111 12222333455678999999999999999
Q ss_pred CCCHHHHHhc
Q 000880 720 RPSATELLQD 729 (1239)
Q Consensus 720 RPta~eiL~~ 729 (1239)
|||+.++++.
T Consensus 270 Rpt~~ei~~~ 279 (284)
T cd05081 270 RPSFSELALQ 279 (284)
T ss_pred CCCHHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=311.10 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=196.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCc---EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGR---HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
.+|++.+.||+|+||.||+|.++.++. .+|+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 76 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK------ 76 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 578899999999999999999875544 79999886432 33445678999999999999999999988732
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
...+|++|||++ ++|.+++... ..+++.+++.++.||+.||.||
T Consensus 77 ----------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 122 (267)
T cd05066 77 ----------------------------------SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122 (267)
T ss_pred ----------------------------------CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345799999996 5899998764 4689999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|++|++||||||+|||++.++.++|+|||++........ .........++..|+|||.+.+ ..++.+
T Consensus 123 H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~~y~~pe~~~~-~~~~~~ 189 (267)
T cd05066 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE------------AAYTTRGGKIPIRWTAPEAIAY-RKFTSA 189 (267)
T ss_pred HHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc------------eeeecCCCccceeecCHhHhcc-CccCch
Confidence 999999999999999999999999999999986532110 0011122345678999999987 568999
Q ss_pred hhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 659 ADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 659 sDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
+|+|||||++||+++ ||......+...... ....++.....++.+.+++.+||+.+|.+||++.++++
T Consensus 190 ~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE--EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh--CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 999999999999874 665544433333222 22223333456778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=308.61 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=192.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..+|++.+.||+|+||.||++... |..||+|.++.. .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------- 71 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE------- 71 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-------
Confidence 468999999999999999999875 889999988532 2245788999999999999999999876432
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....|++|||++ ++|.+++.... .+++..++.++.||+.||+|||
T Consensus 72 --------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 119 (256)
T cd05082 72 --------------------------------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119 (256)
T ss_pred --------------------------------CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 245799999997 59999987644 4889999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++||||||+||+++.++.+||+|||++...... .....++..|+|||++.+ ..++.++
T Consensus 120 ~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~------------------~~~~~~~~~y~aPE~~~~-~~~~~~~ 180 (256)
T cd05082 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------------------QDTGKLPVKWTAPEALRE-KKFSTKS 180 (256)
T ss_pred hCCEeccccchheEEEcCCCcEEecCCccceecccc------------------CCCCccceeecCHHHHcc-CCCCchh
Confidence 999999999999999999999999999998753211 012245678999999887 5689999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|||||||++|||++ ||............ . ....+......++.+.++|.+||+.+|++|||+.++++.
T Consensus 181 Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-E-KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-h-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999985 66543333322222 1 122222234556789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=310.71 Aligned_cols=253 Identities=21% Similarity=0.322 Sum_probs=197.4
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCc---EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGR---HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
.++|++.+.||+|+||.||+|.++.+++ .||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----- 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----- 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----
Confidence 3578999999999999999999987765 5999998643 234455789999999999999999999987632
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~y 577 (1239)
...++++|||++ ++|.+++... +.+++..++.++.|++.||.|
T Consensus 77 -----------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~ 121 (269)
T cd05065 77 -----------------------------------SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121 (269)
T ss_pred -----------------------------------CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Confidence 345799999996 5899888753 568999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++|++||||||+||+++.++.+||+|||++.......... . ........++..|+|||++.+ ..++.
T Consensus 122 lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~--~--------~~~~~~~~~~~~y~~PE~~~~-~~~~~ 190 (269)
T cd05065 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP--T--------YTSSLGGKIPIRWTAPEAIAY-RKFTS 190 (269)
T ss_pred HHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc--c--------cccccCCCcceeecCHhHhcc-Ccccc
Confidence 999999999999999999999999999999987653221000 0 000111223568999999987 56899
Q ss_pred chhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
++|||||||++|||++ ||............ ... ...+.....++.+.+++.+||..+|.+||++.++++.
T Consensus 191 ~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQD-YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred hhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999874 77655444333332 212 2222334566789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=317.93 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=194.9
Q ss_pred CCceEEeeeccCCceEEEEEEEcc-------CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeec
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKL-------DGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFET 495 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~-------~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~ 495 (1239)
++|.+.+.||+|+||.||+|++.. ++..||+|.++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 679999999999999999998753 2357999998743 2333456788999999999 79999999988732
Q ss_pred CccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------------CC
Q 000880 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------DH 558 (1239)
Q Consensus 496 ~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~~ 558 (1239)
...+|+||||++ ++|.+++... ..
T Consensus 96 ---------------------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~ 136 (307)
T cd05098 96 ---------------------------------------DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136 (307)
T ss_pred ---------------------------------------CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCcccc
Confidence 345799999996 5999999753 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccc
Q 000880 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV 638 (1239)
Q Consensus 559 l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (1239)
+++.+++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++........ .......
T Consensus 137 l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~-------------~~~~~~~ 203 (307)
T cd05098 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-------------KKTTNGR 203 (307)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchh-------------hccccCC
Confidence 788999999999999999999999999999999999999999999999998754321100 0112234
Q ss_pred cCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccC
Q 000880 639 GTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 639 GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~ 714 (1239)
+++.|+|||++.+ ..++.++|||||||++|||++ ||..... ......+. ....++.....+.++.+||.+||.
T Consensus 204 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 280 (307)
T cd05098 204 LPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWH 280 (307)
T ss_pred CccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcc
Confidence 5678999999987 568999999999999999985 5644333 22232332 222233334556789999999999
Q ss_pred CCCCCCCCHHHHHhc
Q 000880 715 PSPSDRPSATELLQD 729 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~ 729 (1239)
.+|.+|||+.+++++
T Consensus 281 ~~p~~Rps~~evl~~ 295 (307)
T cd05098 281 AVPSQRPTFKQLVED 295 (307)
T ss_pred cChhhCcCHHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=329.47 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=206.0
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccC-C--cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLD-G--RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~-g--~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
-.++..+.++||+|.||.|++|.|... | ..||||+++..... .....|++|+.+|.+|+|||++++||....
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~---- 182 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLD---- 182 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeecc----
Confidence 345667778999999999999999754 3 35999999754333 267789999999999999999999998742
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES--YDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL 575 (1239)
..+.||||+|+ |+|.+.|+. ...|.......|+.||+.||
T Consensus 183 -------------------------------------qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM 225 (1039)
T KOG0199|consen 183 -------------------------------------QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAM 225 (1039)
T ss_pred -------------------------------------chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHH
Confidence 34579999997 799999986 34588889999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 655 (1239)
.||.++++|||||..+|+|+-....|||||||+.+.+...+.. ........-...|+|||.|.. ..+
T Consensus 226 ~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~------------Yvm~p~rkvPfAWCaPEsLrh-~kF 292 (1039)
T KOG0199|consen 226 QYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM------------YVMAPQRKVPFAWCAPESLRH-RKF 292 (1039)
T ss_pred HHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc------------eEecCCCcCcccccCHhHhcc-ccc
Confidence 9999999999999999999999999999999999987544311 111122334568999999997 679
Q ss_pred CcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 656 DEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+.++|+|+|||++|||++ ||.+....+++..+- .+...+-...++.++.++++.||..+|.+|||+..|...
T Consensus 293 ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD--~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 293 SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID--AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc--ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 999999999999999997 888877776665443 455555556777899999999999999999999999754
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=314.99 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=195.4
Q ss_pred CCceEEeeeccCCceEEEEEEEc-----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNK-----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.. ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD---- 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc----
Confidence 57899999999999999999864 2456799998753 233344678899999999999999999988732
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------------CCCCH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------DHFDK 561 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~~l~~ 561 (1239)
...+++||||++ ++|.+++... ..+++
T Consensus 79 ------------------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 122 (291)
T cd05094 79 ------------------------------------GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122 (291)
T ss_pred ------------------------------------CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCH
Confidence 345799999996 6999998653 23789
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCc
Q 000880 562 ELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTY 641 (1239)
Q Consensus 562 ~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 641 (1239)
..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++....... ........|++
T Consensus 123 ~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~-------------~~~~~~~~~~~ 189 (291)
T cd05094 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-------------YRVGGHTMLPI 189 (291)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCce-------------eecCCCCCcce
Confidence 99999999999999999999999999999999999999999999999975432110 01122346788
Q ss_pred cCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCC
Q 000880 642 FYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717 (1239)
Q Consensus 642 ~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP 717 (1239)
.|+|||++.+ ..++.++|||||||++|||++ ||............ . .+..+......+..+.+++.+||+.||
T Consensus 190 ~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~P 266 (291)
T cd05094 190 RWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-T-QGRVLERPRVCPKEVYDIMLGCWQREP 266 (291)
T ss_pred eecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-h-CCCCCCCCccCCHHHHHHHHHHcccCh
Confidence 9999999887 568999999999999999986 66544443332222 1 233333333456789999999999999
Q ss_pred CCCCCHHHHHhc
Q 000880 718 SDRPSATELLQD 729 (1239)
Q Consensus 718 ~~RPta~eiL~~ 729 (1239)
.+|||+.++++.
T Consensus 267 ~~Rpt~~~v~~~ 278 (291)
T cd05094 267 QQRLNIKEIYKI 278 (291)
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=312.31 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=199.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
..+|++.++||.|+||.||+|.++. ++.+|+|++..... .....+.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------- 73 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSV-------- 73 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEec--------
Confidence 3578999999999999999999986 89999999875432 235678899999999999999999987632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...+|++|||++ ++|.+++... ..+++..++.++.||+.||.|||
T Consensus 74 --------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 121 (261)
T cd05148 74 --------------------------------GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121 (261)
T ss_pred --------------------------------CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345799999997 5999998753 45899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++||||||+|||++.++.+||+|||++........ ......+++.|+|||++.+ ..++.++
T Consensus 122 ~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~---------------~~~~~~~~~~~~~PE~~~~-~~~~~~~ 185 (261)
T cd05148 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY---------------LSSDKKIPYKWTAPEAASH-GTFSTKS 185 (261)
T ss_pred HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc---------------cccCCCCceEecCHHHHcc-CCCCchh
Confidence 99999999999999999999999999999986532110 0123356788999999887 5689999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
||||||+++|+|++ ||......+...... ....++.....++.+.++|.+||+.||.+|||+.++++.
T Consensus 186 DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~ 257 (261)
T cd05148 186 DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT--AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREE 257 (261)
T ss_pred hHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH--hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99999999999985 665554444433332 222233345667789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=308.71 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=196.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCc---EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGR---HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
++|+..+.||+|+||.||+|+++.++. .+|+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 77 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK------ 77 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc------
Confidence 578889999999999999999986665 79999886432 23345678999999999999999999988732
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
....|++|||++ ++|.+++... ..+++..+..++.|++.||+||
T Consensus 78 ----------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~l 123 (268)
T cd05063 78 ----------------------------------FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123 (268)
T ss_pred ----------------------------------CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 245799999997 5899888753 5689999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|++|++||||||+||+++.++.+||+|||++........ ..........++.|+|||++.+ ..++.+
T Consensus 124 H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~y~~PE~~~~-~~~~~~ 190 (268)
T cd05063 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE------------GTYTTSGGKIPIRWTAPEAIAY-RKFTSA 190 (268)
T ss_pred HHCCeeccccchhhEEEcCCCcEEECCCccceecccccc------------cceeccCCCcCceecCHHHhhc-CCcChH
Confidence 999999999999999999999999999999876432110 0001122234568999999887 568999
Q ss_pred hhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 659 ADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 659 sDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+|||||||++|||++ ||...........+ .. ....+.....++.+.+++.+||+.+|++||++.++++.
T Consensus 191 ~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i-~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-ND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-hc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999875 77554443333222 22 22333334567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=317.41 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=195.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEc-------cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNK-------LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFE 494 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~-------~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e 494 (1239)
..+|.+.+.||+|+||.||+|++. .++..||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 468899999999999999999863 23457999988632 2334456789999999999 89999999988732
Q ss_pred cCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------------C
Q 000880 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------D 557 (1239)
Q Consensus 495 ~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~ 557 (1239)
...+|++|||++ ++|.+++... .
T Consensus 93 ----------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 132 (304)
T cd05101 93 ----------------------------------------DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132 (304)
T ss_pred ----------------------------------------CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcc
Confidence 346799999996 5999998753 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCccc
Q 000880 558 HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637 (1239)
Q Consensus 558 ~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (1239)
.++...+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....... .......
T Consensus 133 ~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~-------------~~~~~~~ 199 (304)
T cd05101 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDY-------------YKKTTNG 199 (304)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccc-------------cccccCC
Confidence 467788999999999999999999999999999999999999999999999986532110 0111233
Q ss_pred ccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHcc
Q 000880 638 VGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 638 ~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L 713 (1239)
.+++.|+|||++.+ ..++.++|||||||++|+|++ ||......+. ...+.. ...+......+.++.+||.+||
T Consensus 200 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~li~~cl 276 (304)
T cd05101 200 RLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKE-GHRMDKPANCTNELYMMMRDCW 276 (304)
T ss_pred CCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-HHHHHc-CCcCCCCCCCCHHHHHHHHHHc
Confidence 56788999999987 568999999999999999986 5544333332 222222 2222233456678999999999
Q ss_pred CCCCCCCCCHHHHHhc
Q 000880 714 SPSPSDRPSATELLQD 729 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~ 729 (1239)
..+|.+|||+.++++.
T Consensus 277 ~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 277 HAIPSHRPTFKQLVED 292 (304)
T ss_pred ccChhhCCCHHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=321.36 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=202.9
Q ss_pred ceEEeeeccCCceEEEEEEEccC--C--cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLD--G--RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~--g--~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
....+.||.|.||.||+|....- | -.||||..+ .+++.+..+.|+.|..+|++++|||||+++|.|.+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK-~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------- 462 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCK-TDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------- 462 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhc-cCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-------
Confidence 34456799999999999987522 2 358889765 44666678899999999999999999999999854
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...|||||+++ |.|..+|+.+. .++......|+.||+.||+|||
T Consensus 463 ----------------------------------~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe 508 (974)
T KOG4257|consen 463 ----------------------------------QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE 508 (974)
T ss_pred ----------------------------------cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH
Confidence 34699999998 79999998654 5888999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+..+|||||..+|||+.+..-|||+|||+++.+....... .+...-..-|||||.++- ..++.++
T Consensus 509 SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk--------------aS~~kLPIKWmaPESINf-RrFTtAS 573 (974)
T KOG4257|consen 509 SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK--------------ASRGKLPIKWMAPESINF-RRFTTAS 573 (974)
T ss_pred hhchhhhhhhhhheeecCcceeeecccchhhhccccchhh--------------ccccccceeecCccccch-hcccchh
Confidence 9999999999999999999999999999999876443221 122234557999999886 6799999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
|||.|||++||++. ||....+......+ +++..+|-++.++|.+..|+.+||+.||.+||++.+|..
T Consensus 574 DVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i--EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 574 DVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI--ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred hHHHHHHHHHHHHHhcCCccccccccceEEEe--cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 99999999999985 99877665544322 367777778889999999999999999999999999864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=308.71 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=192.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.++||+|+||.||+|++..+ ..||+|+++..... ...+.+|+.+++.++||||+++++.+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~---------- 71 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS---------- 71 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC----------
Confidence 5799999999999999999998755 56999998743332 356889999999999999999987651
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
....|++|||++ ++|.+++... ..+++..++.++.|++.||+|||+
T Consensus 72 -------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~ 120 (262)
T cd05071 72 -------------------------------EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120 (262)
T ss_pred -------------------------------CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 134589999997 5999998753 358899999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
++++||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+ ..++.++|
T Consensus 121 ~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~--------------~~~~~~~~~~y~~PE~~~~-~~~~~~~D 185 (262)
T cd05071 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--------------ARQGAKFPIKWTAPEAALY-GRFTIKSD 185 (262)
T ss_pred CCccccccCcccEEEcCCCcEEeccCCceeeccccccc--------------cccCCcccceecCHhHhcc-CCCCchhh
Confidence 99999999999999999999999999999765322100 0112346778999999876 56899999
Q ss_pred hHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 661 MYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 661 IwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
||||||++|||++ ||.............. . ..++.....+..+.++|.+||+.||.+||++.++++
T Consensus 186 vwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-G-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-C-CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999997 6765544433332221 1 122223455678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=296.78 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=201.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
-++|++.+.||.|||+-||++++..++..||+|++.+.. .+..+..++|+...++++|||++++++..+...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~------ 91 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE------ 91 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh------
Confidence 468999999999999999999999999999999998654 456778999999999999999999987653320
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESY----DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~y 577 (1239)
.......||++.|. .|+|.+.+... ..+++.+++.++.+|++||++
T Consensus 92 -----------------------------~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~ 142 (302)
T KOG2345|consen 92 -----------------------------KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEA 142 (302)
T ss_pred -----------------------------ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHH
Confidence 01245689999998 58999988643 469999999999999999999
Q ss_pred HHhCC--ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC--C
Q 000880 578 IHGQG--IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW--P 653 (1239)
Q Consensus 578 LHs~g--IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~ 653 (1239)
||+.. ++||||||.|||+.+++.++|.|||.++.....-..+... ..-.......-|.-|.|||.+.-+ .
T Consensus 143 lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a------~~lQe~a~e~Ct~pyRAPELf~vk~~~ 216 (302)
T KOG2345|consen 143 LHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQA------LRLQEWAEERCTIPYRAPELFNVKSHC 216 (302)
T ss_pred HhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHH------HHHHHHHHHhCCCcccCchheecccCc
Confidence 99998 9999999999999999999999999998642211000000 000011233467889999988653 3
Q ss_pred CCCcchhhHHHHHHHHHhhc---CCchhHHHHHH--HHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 654 KIDEKADMYSLGIVFFELWH---PFSTAMERQIV--LSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 654 ~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
..+.++|||||||+||+|+. ||........- +........+|... ..+..+.++|+.||+.||.+||++.+++.
T Consensus 217 ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 217 TITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred ccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 46899999999999999984 88644332111 11122122334332 25668899999999999999999999987
Q ss_pred c
Q 000880 729 D 729 (1239)
Q Consensus 729 ~ 729 (1239)
+
T Consensus 296 ~ 296 (302)
T KOG2345|consen 296 K 296 (302)
T ss_pred H
Confidence 5
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=326.92 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=197.6
Q ss_pred CCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCc
Q 000880 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 419 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~ 497 (1239)
+..+..+|++...+|.|+|+.|..|.+..+++.+++|++..... +..+|+.++... +||||+++++.+.
T Consensus 317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~---- 386 (612)
T KOG0603|consen 317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYE---- 386 (612)
T ss_pred cCCcchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceec----
Confidence 34567889999999999999999999999999999999975421 234567665555 8999999998872
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
+..+.|+|||++.| -+.+.+.....+. .++..|+.+|+.|+.
T Consensus 387 ------------------------------------~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~ 429 (612)
T KOG0603|consen 387 ------------------------------------DGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVD 429 (612)
T ss_pred ------------------------------------CCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHH
Confidence 35788999999975 5555555544444 788889999999999
Q ss_pred HHHhCCccccCCCcccEEE-cCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFF-DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl-~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 655 (1239)
|||++|+|||||||+|||+ ++.++++|+|||+++..... -.+.+.|..|.|||++.. ..|
T Consensus 430 ~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~------------------~~tp~~t~~y~APEvl~~-~~y 490 (612)
T KOG0603|consen 430 YLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS------------------CDTPALTLQYVAPEVLAI-QEY 490 (612)
T ss_pred HHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh------------------hcccchhhcccChhhhcc-CCC
Confidence 9999999999999999999 58899999999999875432 123478999999999996 789
Q ss_pred CcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 656 DEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+.+|||||||++||+|++ ||.........+..+ ..++.-...+.++++||..||+.||.+||++.+++.|+|+
T Consensus 491 t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 491 TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 999999999999999996 666554442222222 2222225677899999999999999999999999999999
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=312.70 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=194.1
Q ss_pred CCceEEeeeccCCceEEEEEEEc-----cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNK-----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.+|.+.++||+|+||.||++... .++..+|+|.+.. ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 78 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTE---- 78 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec----
Confidence 57888999999999999999753 3467899998763 233445679999999999999999999987732
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC---------------CCCHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD---------------HFDKE 562 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~---------------~l~~~ 562 (1239)
....+++|||++ ++|.+++.... .+++.
T Consensus 79 ------------------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~ 122 (280)
T cd05092 79 ------------------------------------GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122 (280)
T ss_pred ------------------------------------CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHH
Confidence 345799999996 68999887542 47899
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCcc
Q 000880 563 LAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF 642 (1239)
Q Consensus 563 ~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 642 (1239)
.++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....... ........+++.
T Consensus 123 ~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-------------~~~~~~~~~~~~ 189 (280)
T cd05092 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-------------YRVGGRTMLPIR 189 (280)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCce-------------eecCCCcccccc
Confidence 9999999999999999999999999999999999999999999999875421110 001122346788
Q ss_pred CCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCC
Q 000880 643 YTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718 (1239)
Q Consensus 643 Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~ 718 (1239)
|+|||++.+ ..++.++|||||||++|||++ ||............. .+..+......++.+.++|.+||+.||.
T Consensus 190 y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~P~ 266 (280)
T cd05092 190 WMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--QGRELERPRTCPPEVYAIMQGCWQREPQ 266 (280)
T ss_pred ccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH--cCccCCCCCCCCHHHHHHHHHHccCChh
Confidence 999999887 568999999999999999986 665444433332222 2222233345678899999999999999
Q ss_pred CCCCHHHHHh
Q 000880 719 DRPSATELLQ 728 (1239)
Q Consensus 719 ~RPta~eiL~ 728 (1239)
+||++.++++
T Consensus 267 ~Rp~~~~l~~ 276 (280)
T cd05092 267 QRMVIKDIHS 276 (280)
T ss_pred hCCCHHHHHH
Confidence 9999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=319.69 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=194.7
Q ss_pred eeccC--CceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 431 PLGHG--GFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 431 ~LG~G--~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
+||+| ++|.||+++++.+++.||||+++...........+.+|+.+++.++||||++++++|..
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-------------- 70 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-------------- 70 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--------------
Confidence 34444 55667777777789999999998664555566789999999999999999999988743
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGIIH 585 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~gIiH 585 (1239)
....|++||||+ ++|.+++... ..+++..+..++.||+.||+|||+++|+|
T Consensus 71 --------------------------~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH 124 (314)
T cd08216 71 --------------------------DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124 (314)
T ss_pred --------------------------CCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 346799999997 6898888753 45899999999999999999999999999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC-CCCCcchhhHHH
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW-PKIDEKADMYSL 664 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~ksDIwSl 664 (1239)
|||||+|||++.++.+||+|||.+..+........ ..........++..|+|||++.+. ..++.++|||||
T Consensus 125 ~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~ 196 (314)
T cd08216 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR--------VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196 (314)
T ss_pred CCCCcceEEEecCCceEEecCccceeecccccccc--------ccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence 99999999999999999999999876532211000 001112345688899999998753 348899999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhhhhcC-------CCCC------------------------ccccCCHHHHHHHH
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDLKQKG-------ELPP------------------------SWVAKFSEQESLLR 710 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~~~~~-------~~p~------------------------~~~~~~~e~~~LI~ 710 (1239)
||++|||++ ||................. ..+. .....++++.+||.
T Consensus 197 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 276 (314)
T cd08216 197 GITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE 276 (314)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHH
Confidence 999999996 7765544333322221100 0000 00011246789999
Q ss_pred HccCCCCCCCCCHHHHHhccCCCCch
Q 000880 711 RLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
+||..||++|||+.++++||||.++.
T Consensus 277 ~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 277 LCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred HHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 99999999999999999999988663
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=307.94 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=193.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||+|+||.||+|.+. ++..||+|.++..... ...+.+|+.+++.++||||+++++.+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~--------- 71 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS--------- 71 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC---------
Confidence 367899999999999999999876 6678999998754332 356889999999999999999987651
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....|++|||++ ++|.+++... ..+++..++.++.|++.||+|||
T Consensus 72 --------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH 119 (260)
T cd05070 72 --------------------------------EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119 (260)
T ss_pred --------------------------------CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 123589999996 5999988753 35899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++||||||+||+++.++.++|+|||++........ .......++..|+|||++.+ ..++.++
T Consensus 120 ~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~ 184 (260)
T cd05070 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY--------------TARQGAKFPIKWTAPEAALY-GRFTIKS 184 (260)
T ss_pred HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc--------------ccccCCCCCccccChHHHhc-CCCcchh
Confidence 99999999999999999999999999999976432110 00112245678999999876 5689999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
||||||+++|+|++ ||......+..... . ....++.....+..+.+|+.+||..+|.+|||+.++++
T Consensus 185 Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQV-E-RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-H-cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999986 66554443333222 2 12222333455678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=305.59 Aligned_cols=241 Identities=23% Similarity=0.383 Sum_probs=195.3
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||.|+||.||+|... |+.||||.++.... ...++.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------- 71 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-------- 71 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--------
Confidence 468899999999999999999875 89999999874322 45679999999999999999999988632
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....|+||||++ ++|.+++.... .+++..++.++.|++.||.|||
T Consensus 72 --------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh 119 (256)
T cd05039 72 --------------------------------GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119 (256)
T ss_pred --------------------------------CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345799999997 59999997665 6999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++||||||+||+++.++.+||+|||+++...... ....++..|+|||++.+ ..++.++
T Consensus 120 ~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~------------------~~~~~~~~~~ape~~~~-~~~~~~~ 180 (256)
T cd05039 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------------------DSGKLPVKWTAPEALRE-KKFSTKS 180 (256)
T ss_pred hCCccchhcccceEEEeCCCCEEEccccccccccccc------------------ccCCCcccccCchhhcC-CcCCcHH
Confidence 9999999999999999999999999999998642111 12234667999999876 5688999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
||||||+++|||++ ||......... ..+.. ...+......++++.++|.+||..+|.+|||+.++++.
T Consensus 181 Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVV-PHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhc-CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 99999999999985 66554433322 22221 11222223456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=314.83 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=191.5
Q ss_pred CCceEEeeeccCCceEEEEEEEcc----------------CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceee
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKL----------------DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~----------------~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~ 487 (1239)
++|++.+.||+|+||.||+|++.. ++..||+|+++.. ........+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 578999999999999999997542 3457999988643 23334567899999999999999999
Q ss_pred eeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC---------
Q 000880 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--------- 557 (1239)
Q Consensus 488 l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--------- 557 (1239)
+++++.. ....|++|||++ ++|.+++....
T Consensus 84 ~~~~~~~----------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 123 (296)
T cd05095 84 LLAVCIT----------------------------------------SDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123 (296)
T ss_pred EEEEEec----------------------------------------CCccEEEEEeCCCCcHHHHHHhcCccccccccc
Confidence 9988733 245799999996 69999886532
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCc
Q 000880 558 --HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGT 635 (1239)
Q Consensus 558 --~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (1239)
.+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||+++.+...... ....
T Consensus 124 ~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-------------~~~~ 190 (296)
T cd05095 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY-------------RIQG 190 (296)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcce-------------eccC
Confidence 3677889999999999999999999999999999999999999999999999764221100 0011
Q ss_pred ccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc-----CCchhHHHHHHHHhh---hh--cCCCCCccccCCHHH
Q 000880 636 GQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH-----PFSTAMERQIVLSDL---KQ--KGELPPSWVAKFSEQ 705 (1239)
Q Consensus 636 ~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt-----Pf~~~~~~~~~~~~~---~~--~~~~p~~~~~~~~e~ 705 (1239)
...+++.|+|||+..+ ..++.++|||||||++|||++ ||......+...... .. .....+.....++.+
T Consensus 191 ~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (296)
T cd05095 191 RAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSL 269 (296)
T ss_pred cCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHH
Confidence 2345678999998776 568999999999999999985 665444333222110 00 111122233455789
Q ss_pred HHHHHHccCCCCCCCCCHHHHHh
Q 000880 706 ESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 706 ~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
.+||.+||+.||.+||++.+|++
T Consensus 270 ~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 270 YKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=329.97 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=209.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCc---EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGR---HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~---~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
.+...+.++||.|.||+|++|+.+..|+ .||||.++.. -+.....+|+.|..||-+++||||+++.|+..
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT------ 700 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT------ 700 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe------
Confidence 4556788999999999999999997774 6999999743 34556678999999999999999999998862
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~y 577 (1239)
...-+.||+|||. |+|..+|+.+ +.|+.-+..-+++.|+.||+|
T Consensus 701 ----------------------------------ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkY 746 (996)
T KOG0196|consen 701 ----------------------------------KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKY 746 (996)
T ss_pred ----------------------------------cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHH
Confidence 2456789999995 7999999865 569999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
|-++|+|||||..+|||++.+..+|++|||+++.+.... ...+ +..+..-..+|.|||++.. .+++.
T Consensus 747 Lsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~---~~~y---------tt~GGKIPiRWTAPEAIa~-RKFTs 813 (996)
T KOG0196|consen 747 LSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---EAAY---------TTLGGKIPIRWTAPEAIAY-RKFTS 813 (996)
T ss_pred HhhcCchhhhhhhhheeeccceEEEeccccceeecccCC---Cccc---------cccCCccceeecChhHhhh-cccCc
Confidence 999999999999999999999999999999999874332 1111 1122234578999999987 67999
Q ss_pred chhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
++|||||||+|||.++ |+++..+.+....+ .+..++|+ +.+++..+..||..||++|-..||.+.+|+.+
T Consensus 814 ASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 814 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred hhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999996 99988777665444 43455554 45778899999999999999999999999875
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=306.32 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=193.0
Q ss_pred eeeccCCceEEEEEEEcc-CCc--EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcC
Q 000880 430 QPLGHGGFGHVVLCKNKL-DGR--HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~-~g~--~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
+.||+|+||.||+|.+.. .++ .||||.++..... .....+.+|+.++++++||||+++++.+.
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------------- 66 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVL------------- 66 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEc-------------
Confidence 368999999999999865 333 6999998754433 55678999999999999999999998762
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
. ..++++|||++ ++|.+++.... .+++..++.++.||+.||+|||++|+
T Consensus 67 ---------------------------~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 118 (257)
T cd05040 67 ---------------------------T-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118 (257)
T ss_pred ---------------------------C-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1 46799999996 69999987654 68999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+||+++.++.+||+|||++..+..... .........++..|+|||++.+ ..++.++||||
T Consensus 119 ~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~s 185 (257)
T cd05040 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNED------------HYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWM 185 (257)
T ss_pred cccccCcccEEEecCCEEEecccccccccccccc------------ceecccCCCCCceecCHHHhcc-cCcCchhhhHH
Confidence 9999999999999999999999999987532210 0011123467889999999887 56899999999
Q ss_pred HHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 664 LGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 664 lGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|||++|||++ ||......+....... .....+.....+..+.+++.+||+.+|++|||+.++++.
T Consensus 186 lG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 186 FGVTLWEMFTYGEEPWAGLSGSQILKKIDK-EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHH
Confidence 9999999986 6654444443333222 222222223456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=306.49 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=194.3
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|+++++||+|+||.||+|..+ +++.||+|.+...... ...+.+|+.+++.++||||+++++.+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--------- 71 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT--------- 71 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc---------
Confidence 468999999999999999999876 6789999998744332 457889999999999999999987641
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...+|++|||+. ++|.+++... ..+++.+++.++.|++.||+|||
T Consensus 72 --------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH 119 (260)
T cd05067 72 --------------------------------QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119 (260)
T ss_pred --------------------------------cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 234689999996 6999988653 35899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++||||||+||+++.++.++|+|||++........ .......++..|+|||++.+ ..++.++
T Consensus 120 ~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~y~~pe~~~~-~~~~~~~ 184 (260)
T cd05067 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY--------------TAREGAKFPIKWTAPEAINY-GTFTIKS 184 (260)
T ss_pred cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc--------------ccccCCcccccccCHHHhcc-CCcCccc
Confidence 99999999999999999999999999999976432110 01123356788999999887 5689999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
||||||+++|||++ ||........... +. ....++.....+.++.++|.+||+.+|++|||+++++.
T Consensus 185 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 185 DVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LE-RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred chHHHHHHHHHHHhCCCCCCCCCChHHHHHH-HH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999996 6755443333222 22 22222333445678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=312.41 Aligned_cols=248 Identities=22% Similarity=0.302 Sum_probs=192.5
Q ss_pred CceEEeeeccCCceEEEEEEEcc-----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~-----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
+|++.+.||+|+||.||+|.+.. ....+|+|.+... ........+.+|+.+++.++||||++++++|..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----- 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----
Confidence 47788999999999999998753 2357889887633 333345678999999999999999999988732
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------------------
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY---------------------- 556 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~---------------------- 556 (1239)
....|++|||++ ++|.+++...
T Consensus 75 -----------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (290)
T cd05045 75 -----------------------------------DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119 (290)
T ss_pred -----------------------------------CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCc
Confidence 234689999997 6899887642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccC
Q 000880 557 --DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG 634 (1239)
Q Consensus 557 --~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (1239)
..+++..++.++.|++.||+|||+++++||||||+|||+++++.+||+|||+++....... ....
T Consensus 120 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~-------------~~~~ 186 (290)
T cd05045 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-------------YVKR 186 (290)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccc-------------hhcc
Confidence 2478889999999999999999999999999999999999999999999999975422110 0011
Q ss_pred cccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHH
Q 000880 635 TGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLR 710 (1239)
Q Consensus 635 ~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~ 710 (1239)
....++..|+|||++.+ ..++.++||||||+++|||++ ||......... .... ....++.....+.++.+++.
T Consensus 187 ~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~i~ 263 (290)
T cd05045 187 SKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF-NLLK-TGYRMERPENCSEEMYNLML 263 (290)
T ss_pred cCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHh-CCCCCCCCCCCCHHHHHHHH
Confidence 22356778999999877 568999999999999999986 67554433322 2222 22222233455678999999
Q ss_pred HccCCCCCCCCCHHHHHhc
Q 000880 711 RLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 711 ~~L~~dP~~RPta~eiL~~ 729 (1239)
+||+.+|.+||++.++++.
T Consensus 264 ~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 264 TCWKQEPDKRPTFADISKE 282 (290)
T ss_pred HHccCCcccCCCHHHHHHH
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=315.69 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=199.4
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
|....+||+|+||.||++.++.+|+.||||++.... ......+.+|+.+++.++||||+++++.+..
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------- 88 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV----------- 88 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----------
Confidence 333468999999999999999999999999886432 2345678999999999999999999988732
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
....|++|||+++ +|.+++. ...+++..++.++.|++.||+|||++|++
T Consensus 89 -----------------------------~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~giv 138 (292)
T cd06657 89 -----------------------------GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVI 138 (292)
T ss_pred -----------------------------CCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3578999999975 7877664 45689999999999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
||||||+||+++.++.++|+|||++....... .......||+.|+|||++.+ ..++.++|+|||
T Consensus 139 H~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---------------~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~sl 202 (292)
T cd06657 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---------------PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSL 202 (292)
T ss_pred cCCCCHHHEEECCCCCEEEcccccceeccccc---------------ccccccccCccccCHHHhcC-CCCCchhhHHHH
Confidence 99999999999999999999999987542110 01133568999999999876 568899999999
Q ss_pred HHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 665 GIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 665 GviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
|+++|+|++ ||..........................++.+.++|.+||+.||.+||++.++++|+||....
T Consensus 203 Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 999999996 776543333222111111111122334567899999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=310.42 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=197.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEcc----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.. .........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 3678999999999999999999985 358899998763 33444567789999999999999999999887432
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--------CCCCHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--------DHFDKELAWHLFR 569 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--------~~l~~~~~~~i~~ 569 (1239)
....+++++|++ ++|.+++... ..+++..++.++.
T Consensus 81 ------------------------------------~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~ 124 (280)
T cd05043 81 ------------------------------------GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124 (280)
T ss_pred ------------------------------------CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHH
Confidence 235689999996 6999988653 4588999999999
Q ss_pred HHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccc
Q 000880 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649 (1239)
Q Consensus 570 qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 649 (1239)
||+.||+|||+++++||||||+||+++.++.+||+|||+++.+...... .......++..|+|||++
T Consensus 125 ~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~-------------~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------------CLGDNENRPVKWMALESL 191 (280)
T ss_pred HHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE-------------EeCCCCCcchhccCHHHH
Confidence 9999999999999999999999999999999999999999864322100 001223467789999999
Q ss_pred cCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 650 QGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 650 ~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
.+ ..++.++|||||||++||+++ ||.......... .+. ....++.....++++.+++.+||..||++|||+.+
T Consensus 192 ~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 268 (280)
T cd05043 192 VN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQ 268 (280)
T ss_pred hc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-HHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 87 568999999999999999986 676544433322 222 22222333445678999999999999999999999
Q ss_pred HHhc
Q 000880 726 LLQD 729 (1239)
Q Consensus 726 iL~~ 729 (1239)
+++.
T Consensus 269 ~~~~ 272 (280)
T cd05043 269 LVQC 272 (280)
T ss_pred HHHH
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=308.89 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=197.1
Q ss_pred CCceEEeeeccCCceEEEEEEEccC-----CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLD-----GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
++|+.++.||.|+||.||+|+++.+ .+.||+|.+.... .......+.+|+.+++.++||||+++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE---- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC----
Confidence 5789999999999999999997643 4679999875322 22345679999999999999999999987622
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC---------CCCHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD---------HFDKELAWHLF 568 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~---------~l~~~~~~~i~ 568 (1239)
....|+||||++ ++|.+++.... .+++..++.++
T Consensus 80 ------------------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~ 123 (275)
T cd05046 80 ------------------------------------AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123 (275)
T ss_pred ------------------------------------CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHH
Confidence 345699999997 69999997655 68999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccc
Q 000880 569 RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648 (1239)
Q Consensus 569 ~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~ 648 (1239)
.||+.||+|||+++|+||||||+|||++.++.++|+|||++....... ........+++.|+|||.
T Consensus 124 ~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~--------------~~~~~~~~~~~~y~~PE~ 189 (275)
T cd05046 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE--------------YYKLRNALIPLRWLAPEA 189 (275)
T ss_pred HHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccc--------------ccccCCceeEEeecChhh
Confidence 999999999999999999999999999999999999999987432111 111233467888999999
Q ss_pred ccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHH
Q 000880 649 EQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSAT 724 (1239)
Q Consensus 649 l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~ 724 (1239)
+.+ ..++.++||||||+++|+|++ ||................... +.....+..+.+++.+||+.+|.+|||+.
T Consensus 190 ~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~ 267 (275)
T cd05046 190 VQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFS 267 (275)
T ss_pred hcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 887 467899999999999999985 776554444333332212111 12234557899999999999999999999
Q ss_pred HHHhc
Q 000880 725 ELLQD 729 (1239)
Q Consensus 725 eiL~~ 729 (1239)
++++.
T Consensus 268 ~~l~~ 272 (275)
T cd05046 268 ELVSA 272 (275)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=306.67 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=186.8
Q ss_pred eeeccCCceEEEEEEEcc---CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcC
Q 000880 430 QPLGHGGFGHVVLCKNKL---DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
+.||+|+||.||+|.+.. ++..||||.+... ........+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----------- 68 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----------- 68 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-----------
Confidence 368999999999999753 3457999987532 2333456788999999999999999999876421
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGII 584 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gIi 584 (1239)
....+++|||+. ++|.+++... ...++..+..++.||+.||+|||+++++
T Consensus 69 ----------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 120 (262)
T cd05058 69 ----------------------------EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120 (262)
T ss_pred ----------------------------CCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 234689999996 6999998754 3467788889999999999999999999
Q ss_pred ccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHH
Q 000880 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664 (1239)
Q Consensus 585 HrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSl 664 (1239)
||||||+|||++.++.+||+|||+++......... ........+++.|+|||.+.+ ..++.++|||||
T Consensus 121 H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~sl 188 (262)
T cd05058 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS-----------VHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSF 188 (262)
T ss_pred ccccCcceEEEcCCCcEEECCccccccccCCccee-----------ecccccCcCCccccChhHhcc-CccchHHHHHHH
Confidence 99999999999999999999999997543211000 001123456788999999887 568999999999
Q ss_pred HHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 665 GIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 665 GviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
||++|||++ ||........... +. .+..++.....++.+.+++.+||..+|++||++.++++.
T Consensus 189 G~~l~el~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 189 GVLLWELMTRGAPPYPDVDSFDITVY-LL-QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHH-Hh-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999986 4443333332222 22 222222223446789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=315.34 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=193.1
Q ss_pred CCceEEeeeccCCceEEEEEEEcc-------CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeec
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKL-------DGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFET 495 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~-------~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~ 495 (1239)
++|.+.+.||+|+||.||+|++.. ....||+|.++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 578899999999999999998642 3457999988643 2334456788999999999 69999999988732
Q ss_pred CccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----------------CC
Q 000880 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------DH 558 (1239)
Q Consensus 496 ~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~~ 558 (1239)
...+|++|||++ ++|.+++... ..
T Consensus 90 ---------------------------------------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~ 130 (314)
T cd05099 90 ---------------------------------------EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130 (314)
T ss_pred ---------------------------------------CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccc
Confidence 345799999996 6999998653 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccc
Q 000880 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV 638 (1239)
Q Consensus 559 l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (1239)
+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++........ .......
T Consensus 131 l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-------------~~~~~~~ 197 (314)
T cd05099 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY-------------KKTSNGR 197 (314)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccc-------------cccccCC
Confidence 788899999999999999999999999999999999999999999999999864321100 0011223
Q ss_pred cCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccC
Q 000880 639 GTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 639 GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~ 714 (1239)
+++.|||||++.+ ..++.++|||||||++|||++ ||......... ..+. ....+......+.++.++|.+||+
T Consensus 198 ~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~l~~li~~cl~ 274 (314)
T cd05099 198 LPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF-KLLR-EGHRMDKPSNCTHELYMLMRECWH 274 (314)
T ss_pred CCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH-cCCCCCCCCCCCHHHHHHHHHHcC
Confidence 4578999999987 568999999999999999986 56544333322 2222 222222334556789999999999
Q ss_pred CCCCCCCCHHHHHhc
Q 000880 715 PSPSDRPSATELLQD 729 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~ 729 (1239)
.||.+|||+.++++.
T Consensus 275 ~~p~~Rps~~~ll~~ 289 (314)
T cd05099 275 AVPTQRPTFKQLVEA 289 (314)
T ss_pred CCcccCcCHHHHHHH
Confidence 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=312.50 Aligned_cols=235 Identities=20% Similarity=0.335 Sum_probs=183.9
Q ss_pred eeeccCCceEEEEEEEccCCc-------EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGR-------HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~-------~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+.||+|+||.||+|.++.++. .||+|.+... .....+.+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-------- 70 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-------- 70 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--------
Confidence 369999999999999875544 4888887532 22345678899999999999999999988743
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
....++|||||+ |+|.+++.... .+++..++.++.||+.||+|||+
T Consensus 71 --------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (258)
T cd05078 71 --------------------------------GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118 (258)
T ss_pred --------------------------------CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 235689999996 58999987644 58999999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCC--------EEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC
Q 000880 581 QGIIHRDLTPNNIFFDARND--------IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~--------vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
+||+||||||+|||++.++. ++++|||++..... .....+++.|+|||++.+.
T Consensus 119 ~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-------------------KEILLERIPWVPPECIENP 179 (258)
T ss_pred CCeecCCCccceEEEecccccccCCCceEEecccccccccCC-------------------chhccccCCccCchhccCC
Confidence 99999999999999987765 69999998864321 1234688899999999875
Q ss_pred CCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 653 PKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 653 ~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
..++.++|||||||++|||++ ||....... ..........+|. ..++++.+||.+||+.||++|||+.++++
T Consensus 180 ~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 180 QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KLQFYEDRHQLPA---PKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HHHHHHccccCCC---CCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 568999999999999999987 333322222 2222222223332 34468999999999999999999999987
Q ss_pred c
Q 000880 729 D 729 (1239)
Q Consensus 729 ~ 729 (1239)
.
T Consensus 256 ~ 256 (258)
T cd05078 256 D 256 (258)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=312.59 Aligned_cols=257 Identities=19% Similarity=0.318 Sum_probs=189.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccC---CcEEEEEEEecCCCCchhH---------HHHHHHHHHHHhcCCCceeeeeee
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLD---GRHYAVKKIRLKDKSLPVN---------DRILREVATLSRLQHQHVVRYYQA 491 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAVK~i~~~~~~~~~~---------~~~~~Ev~iL~~L~HpnIv~l~~~ 491 (1239)
++|++.++||+|+||+||+|.+..+ +..+|+|+........... .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5899999999999999999999877 6778888654433221110 112334455667799999999987
Q ss_pred eeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHH
Q 000880 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQI 571 (1239)
Q Consensus 492 ~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI 571 (1239)
+.... ....+.|++|+++..++.+.+......++..++.++.||
T Consensus 92 ~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 135 (294)
T PHA02882 92 GSFKR------------------------------------CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDM 135 (294)
T ss_pred eeEec------------------------------------CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHH
Confidence 63220 112356889999988888888776667899999999999
Q ss_pred HHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC
Q 000880 572 VEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651 (1239)
Q Consensus 572 ~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 651 (1239)
+.||+|||+++|+||||||+|||++.++.++|+|||+|+.+........ . .........||+.|+|||++.+
T Consensus 136 ~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~--~------~~~~~~~~~gt~~y~ape~~~~ 207 (294)
T PHA02882 136 LTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIE--Y------SKEQKDLHRGTLYYAGLDAHNG 207 (294)
T ss_pred HHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccc--c------ccccccccCCCccccCHHHhCC
Confidence 9999999999999999999999999999999999999986532211000 0 0011233579999999999987
Q ss_pred CCCCCcchhhHHHHHHHHHhhc---CCchhHHHHH--------HHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCC
Q 000880 652 WPKIDEKADMYSLGIVFFELWH---PFSTAMERQI--------VLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720 (1239)
Q Consensus 652 ~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~--------~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~R 720 (1239)
..++.++|||||||++|||++ ||........ ....+. .+.. .....++++.++++.||..+|.+|
T Consensus 208 -~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~r 283 (294)
T PHA02882 208 -ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH-EGKI--KIKNANKFIYDFIECVTKLSYEEK 283 (294)
T ss_pred -CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh-hhhh--ccCCCCHHHHHHHHHHHhCCCCCC
Confidence 568999999999999999996 8865522111 111111 1111 123345789999999999999999
Q ss_pred CCHHHHHh
Q 000880 721 PSATELLQ 728 (1239)
Q Consensus 721 Pta~eiL~ 728 (1239)
|++.++++
T Consensus 284 p~~~~l~~ 291 (294)
T PHA02882 284 PDYDALIK 291 (294)
T ss_pred CCHHHHHH
Confidence 99999975
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=311.20 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=203.9
Q ss_pred CceEEeeeccCCceEEEEEEEc---cCCcEEEEEEEecCCC--CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCcc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNK---LDGRHYAVKKIRLKDK--SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAVK~i~~~~~--~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~ 498 (1239)
+|++.+.||.|+||.||+|++. .+|..||+|+++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----- 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence 4788999999999999999985 4789999999874321 222345688899999999 6999999987762
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....+|+||||++ ++|.+++.....+++..+..++.||+.||.|
T Consensus 76 -----------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~ 120 (290)
T cd05613 76 -----------------------------------TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120 (290)
T ss_pred -----------------------------------cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 2356899999997 5999999888889999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC-CCCC
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW-PKID 656 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~ 656 (1239)
||++|++||||||+|||++.++.+||+|||++........ .......|+..|+|||.+.+. ..++
T Consensus 121 lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 186 (290)
T cd05613 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--------------ERAYSFCGTIEYMAPDIVRGGDGGHD 186 (290)
T ss_pred HHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc--------------cccccccCCcccCChhhccCCCCCCC
Confidence 9999999999999999999999999999999876432110 011235689999999998652 2467
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHH---HHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC-----CHHH
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAME---RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATE 725 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~---~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP-----ta~e 725 (1239)
.++||||||+++|+|++ ||..... .......... ..++......+.+.+++.+||+.||.+|| ++.+
T Consensus 187 ~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~ 264 (290)
T cd05613 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADE 264 (290)
T ss_pred ccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 89999999999999997 6642211 1111111111 11222234567889999999999999997 8999
Q ss_pred HHhccCCCCchHHHH
Q 000880 726 LLQDALPPQMEYELL 740 (1239)
Q Consensus 726 iL~~~~~~~~~~~~~ 740 (1239)
++.|+||....++.+
T Consensus 265 l~~~~~~~~~~~~~~ 279 (290)
T cd05613 265 IKKHPFFQKINWDDL 279 (290)
T ss_pred HHcCcccccCCHHHH
Confidence 999999999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=310.03 Aligned_cols=235 Identities=16% Similarity=0.252 Sum_probs=180.2
Q ss_pred eeeccCCceEEEEEEEccC------------CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 430 QPLGHGGFGHVVLCKNKLD------------GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~------------g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
+.||+|+||.||+|++... ...+|+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 3689999999999986422 2358889875432 2344578899999999999999999988743
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHH
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL 575 (1239)
....+++|||++ ++|..++.. ...+++..++.++.||+.||
T Consensus 76 -------------------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l 118 (262)
T cd05077 76 -------------------------------------DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASAL 118 (262)
T ss_pred -------------------------------------CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 234589999997 577777764 35699999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCCCC-------EEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccc
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDARND-------IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~~~-------vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~ 648 (1239)
+|||+++|+||||||+|||++.++. ++++|||++..... .....|+..|+|||+
T Consensus 119 ~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~-------------------~~~~~~~~~y~aPE~ 179 (262)
T cd05077 119 SYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS-------------------RQECVERIPWIAPEC 179 (262)
T ss_pred HHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC-------------------cccccccccccChhh
Confidence 9999999999999999999987654 89999999865321 123467889999999
Q ss_pred ccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHH
Q 000880 649 EQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSAT 724 (1239)
Q Consensus 649 l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~ 724 (1239)
+.+...++.++|||||||++|||++ ||......+.. .... ...+ ......+++.+||.+||+.||.+||++.
T Consensus 180 ~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~--~~~~-~~~~~~~~~~~li~~cl~~dp~~Rp~~~ 255 (262)
T cd05077 180 VEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE--GQCM-LVTPSCKELADLMTHCMNYDPNQRPFFR 255 (262)
T ss_pred hcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh--cCcc-CCCCChHHHHHHHHHHcCCChhhCcCHH
Confidence 8754668999999999999999973 55443322211 1111 1111 1122346889999999999999999999
Q ss_pred HHHhc
Q 000880 725 ELLQD 729 (1239)
Q Consensus 725 eiL~~ 729 (1239)
+|+++
T Consensus 256 ~il~~ 260 (262)
T cd05077 256 AIMRD 260 (262)
T ss_pred HHHHh
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=307.08 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=184.3
Q ss_pred eeeccCCceEEEEEEEc--cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCC
Q 000880 430 QPLGHGGFGHVVLCKNK--LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~--~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
+.||+|+||.||+|.+. .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------------- 66 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE------------- 66 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-------------
Confidence 36899999999999875 3456899998865432 2334578899999999999999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-----HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-----~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+|+||||++ ++|.+++.... ..++..+..++.|++.||+|||++
T Consensus 67 ---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 119 (269)
T cd05087 67 ---------------------------VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119 (269)
T ss_pred ---------------------------CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 245689999997 69999886432 356778889999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC------CC
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP------KI 655 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~ 655 (1239)
+++||||||+||+++.++++||+|||+++...... .........|++.|+|||++.+.. .+
T Consensus 120 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 186 (269)
T cd05087 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED-------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ 186 (269)
T ss_pred CEeccccCcceEEEcCCCcEEECCccccccccCcc-------------eeecCCCcCCcccccCHhHhccccccccccCC
Confidence 99999999999999999999999999987432111 011122346788999999986421 35
Q ss_pred CcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhc-CCC--CCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 656 DEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQK-GEL--PPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~-~~~--p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
+.++|||||||++|||++ ||....+.+......... ... |......++.+.++|.+|| .+|++|||+++|+.
T Consensus 187 ~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 187 TKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 789999999999999985 776555444332222211 111 2222234567889999999 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=306.71 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=196.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccC---CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLD---GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~---g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
++|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++.+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 5688899999999999999998644 3468999876432 23455679999999999999999999987621
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yL 578 (1239)
...|++|||++ ++|.+++.... .+++..++.++.||+.||+||
T Consensus 79 -----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l 123 (270)
T cd05056 79 -----------------------------------NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123 (270)
T ss_pred -----------------------------------CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23589999996 69999997644 589999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|++|++||||||+|||++.++.+||+|||+++....... ...+...+++.|+|||.+.+ ..++.+
T Consensus 124 H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~-~~~~~~ 188 (270)
T cd05056 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY--------------YKASKGKLPIKWMAPESINF-RRFTSA 188 (270)
T ss_pred HhCCeeccccChheEEEecCCCeEEccCceeeecccccc--------------eecCCCCccccccChhhhcc-CCCCch
Confidence 999999999999999999999999999999976532210 01122345678999999876 568999
Q ss_pred hhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 659 ADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 659 sDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+|||||||++|||++ ||......+...... ....++.+...++++.++|.+||..+|.+|||+.+++..
T Consensus 189 ~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 189 SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE--NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999874 786665544443322 222333344567799999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=307.42 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=182.2
Q ss_pred eeccCCceEEEEEEEcc--CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 431 PLGHGGFGHVVLCKNKL--DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~--~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
.||+|+||+||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++.+..
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-------------- 66 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-------------- 66 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--------------
Confidence 68999999999997542 3457888876532 233345678899999999999999999988732
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-----HFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-----~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
...+|+||||++ ++|.+++.... ..++..++.++.||+.||+|||++|
T Consensus 67 --------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (269)
T cd05042 67 --------------------------SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120 (269)
T ss_pred --------------------------CCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 345799999996 69999987543 2467888999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC------CCCCC
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG------WPKID 656 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~~~ 656 (1239)
|+||||||+|||++.++.+||+|||++........ ........+++.|+|||++.. ...++
T Consensus 121 ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 187 (269)
T cd05042 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQT 187 (269)
T ss_pred EecccccHhheEecCCCcEEEeccccccccccchh-------------eeccCCCCCcccccCHHHHhhccccccccccc
Confidence 99999999999999999999999999865321110 001123356788999998743 13468
Q ss_pred cchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcC-CC--CCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 657 EKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKG-EL--PPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~-~~--p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
.++|||||||++|||++ ||....+.+.......... .. |......++...+++..|| .||++|||+++|++
T Consensus 188 ~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 188 KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 89999999999999986 6665544444333332221 11 1122345567788999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=304.46 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=191.9
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ....+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~---------- 71 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS---------- 71 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc----------
Confidence 5688999999999999999998744 4699998764332 2456889999999999999999987651
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
....|++|||++ ++|.+++.... .+++..+..++.||+.||.|||+
T Consensus 72 -------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~ 120 (260)
T cd05069 72 -------------------------------EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120 (260)
T ss_pred -------------------------------CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 123589999997 59999987543 47899999999999999999999
Q ss_pred CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchh
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksD 660 (1239)
+|++||||||+||+++.++.++|+|||+++........ ......++..|+|||++.+ ..++.++|
T Consensus 121 ~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~y~~Pe~~~~-~~~~~~~D 185 (260)
T cd05069 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT--------------ARQGAKFPIKWTAPEAALY-GRFTIKSD 185 (260)
T ss_pred CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc--------------ccCCCccchhhCCHHHhcc-CCcChHHH
Confidence 99999999999999999999999999999764321100 0112346778999999876 56899999
Q ss_pred hHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 661 MYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 661 IwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
||||||++|||++ ||............ ... ..++.....+..+.+++++||..||.+||+++++++
T Consensus 186 i~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERG-YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcC-CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999996 67654444333222 212 222233455678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=313.92 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=195.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCc----EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGR----HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.++|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++.|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS---- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC----
Confidence 4678899999999999999999987776 46888876332 22334568899999999999999999988732
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~ 576 (1239)
...+++++|++ |+|.+++.... .+++..++.++.||+.||+
T Consensus 81 -------------------------------------~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~ 123 (303)
T cd05110 81 -------------------------------------PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123 (303)
T ss_pred -------------------------------------CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence 12468999997 68999887644 5899999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++||+||||||+|||++.++.+||+|||+++....... ........++..|+|||++.+ ..++
T Consensus 124 ~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~~PE~~~~-~~~~ 189 (303)
T cd05110 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK-------------EYNADGGKMPIKWMALECIHY-RKFT 189 (303)
T ss_pred HHhhcCeeccccccceeeecCCCceEEccccccccccCccc-------------ccccCCCccccccCCHHHhcc-CCCC
Confidence 99999999999999999999999999999999986532110 001123456789999999887 5689
Q ss_pred cchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 657 EKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
.++|||||||++|||++ ||........ ...+. ....++.....+..+.+++.+||..+|++||++.++++.
T Consensus 190 ~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLE-KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999975 6654433222 22222 233333334456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=310.31 Aligned_cols=234 Identities=17% Similarity=0.259 Sum_probs=181.1
Q ss_pred eeccCCceEEEEEEEccC------------------------CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCcee
Q 000880 431 PLGHGGFGHVVLCKNKLD------------------------GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVV 486 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~~------------------------g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv 486 (1239)
.||+|+||.||+|.+..+ ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999986432 235889987533 223456788999999999999999
Q ss_pred eeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHH
Q 000880 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELA 564 (1239)
Q Consensus 487 ~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~ 564 (1239)
++++++.+ ....|+|||||+ ++|..++.. .+.+++..+
T Consensus 80 ~~~~~~~~----------------------------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~ 119 (274)
T cd05076 80 FVHGVCVR----------------------------------------GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK 119 (274)
T ss_pred eEEEEEEe----------------------------------------CCceEEEEecCCCCcHHHHHHhcCCCCCHHHH
Confidence 99998743 245689999997 578888865 456899999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC-------CEEEeecCcchhccccccccCCCCCCCCCCccccCccc
Q 000880 565 WHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN-------DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637 (1239)
Q Consensus 565 ~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~-------~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (1239)
..++.||+.||+|||++||+||||||+|||++..+ .+||+|||++..... ....
T Consensus 120 ~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~-------------------~~~~ 180 (274)
T cd05076 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS-------------------REER 180 (274)
T ss_pred HHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc-------------------cccc
Confidence 99999999999999999999999999999997643 389999998864311 1223
Q ss_pred ccCccCCCcccccCCCCCCcchhhHHHHHHHHHhh-c---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHcc
Q 000880 638 VGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW-H---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 638 ~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELl-t---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L 713 (1239)
.+++.|+|||.+.+...++.++|||||||++|||+ + ||......+.. .........|. ...+++.++|.+||
T Consensus 181 ~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~li~~cl 256 (274)
T cd05076 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFYEKKHRLPE---PSCKELATLISQCL 256 (274)
T ss_pred ccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-HHHHhccCCCC---CCChHHHHHHHHHc
Confidence 57888999999876556899999999999999996 2 66544332221 11221222222 23468899999999
Q ss_pred CCCCCCCCCHHHHHhc
Q 000880 714 SPSPSDRPSATELLQD 729 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~ 729 (1239)
+.+|.+|||+.+++++
T Consensus 257 ~~~p~~Rps~~~il~~ 272 (274)
T cd05076 257 TYEPTQRPSFRTILRD 272 (274)
T ss_pred ccChhhCcCHHHHHHh
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=317.16 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=193.7
Q ss_pred CCceEEeeeccCCceEEEEEEEccC-------CcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeec
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLD-------GRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFET 495 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~-------g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~ 495 (1239)
.+|++.+.||+|+||.||+|++... +..||+|.++.. ........+.+|+.+++++ +||||++++++|..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4688999999999999999987532 236899987633 2334456789999999999 89999999988732
Q ss_pred CccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC----------------C
Q 000880 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD----------------H 558 (1239)
Q Consensus 496 ~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~----------------~ 558 (1239)
...+|++|||++ ++|.+++.... .
T Consensus 90 ---------------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~ 130 (334)
T cd05100 90 ---------------------------------------DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130 (334)
T ss_pred ---------------------------------------CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCcccc
Confidence 345799999996 59999986532 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccc
Q 000880 559 FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV 638 (1239)
Q Consensus 559 l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (1239)
++...+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....... ........
T Consensus 131 l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-------------~~~~~~~~ 197 (334)
T cd05100 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY-------------YKKTTNGR 197 (334)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccc-------------cccccCCC
Confidence 77888999999999999999999999999999999999999999999999975432110 00112234
Q ss_pred cCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccC
Q 000880 639 GTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 639 GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~ 714 (1239)
++..|+|||++.+ ..++.++|||||||++|||++ ||......... ..+. ....++.....+.++.++|.+||+
T Consensus 198 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~l~~li~~cl~ 274 (334)
T cd05100 198 LPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-KLLK-EGHRMDKPANCTHELYMIMRECWH 274 (334)
T ss_pred cCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 5678999999987 568999999999999999985 66544333332 2222 222233334556789999999999
Q ss_pred CCCCCCCCHHHHHhc
Q 000880 715 PSPSDRPSATELLQD 729 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~ 729 (1239)
.+|.+|||+.+++++
T Consensus 275 ~~p~~Rps~~ell~~ 289 (334)
T cd05100 275 AVPSQRPTFKQLVED 289 (334)
T ss_pred cChhhCcCHHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=301.66 Aligned_cols=245 Identities=24% Similarity=0.407 Sum_probs=193.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|++.+.||.|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 70 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--------- 70 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc---------
Confidence 57899999999999999999886 5778999988643332 3568899999999999999999987632
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
....|++|||+. ++|.+++... ..++++.++.++.|++.||+|||++
T Consensus 71 -------------------------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (256)
T cd05112 71 -------------------------------RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119 (256)
T ss_pred -------------------------------CCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345799999996 5898888754 4689999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
+++||||||+||+++.++.+||+|||++........ .......++..|+|||++.+ ..++.++||
T Consensus 120 ~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--------------~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv 184 (256)
T cd05112 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--------------TSSTGTKFPVKWSSPEVFSF-SKYSSKSDV 184 (256)
T ss_pred CccccccccceEEEcCCCeEEECCCcceeecccCcc--------------cccCCCccchhhcCHhHhcc-CCcChHHHH
Confidence 999999999999999999999999999875422110 00122345678999999987 568999999
Q ss_pred HHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 662 YSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 662 wSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|||||++|||++ ||.......... .+..... +......+..+.+|+.+||+.+|++|||+.+++++
T Consensus 185 ~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 185 WSFGVLMWEVFSEGKTPYENRSNSEVVE-TINAGFR-LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHhCCCC-CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 999999999986 665444333222 2221111 11112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=301.02 Aligned_cols=241 Identities=23% Similarity=0.326 Sum_probs=189.5
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSG 509 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g 509 (1239)
+.||+|+||.||+|... ++..||+|.++.. ........+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------------- 63 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--------------- 63 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec---------------
Confidence 36899999999999865 7889999988643 233344578899999999999999999987732
Q ss_pred cccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 510 TLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 510 ~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
....++||||++ ++|.+++... ..+++..++.++.|++.||.|||++|++|||
T Consensus 64 -------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~d 118 (250)
T cd05085 64 -------------------------RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118 (250)
T ss_pred -------------------------CCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 245799999996 6898888653 4589999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|||+||+++.++.+||+|||++........ .......+++.|+|||++.+ ..++.++||||||++
T Consensus 119 l~p~nili~~~~~~~l~d~g~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~l 183 (250)
T cd05085 119 LAARNCLVGENNVLKISDFGMSRQEDDGIY--------------SSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGIL 183 (250)
T ss_pred cChheEEEcCCCeEEECCCccceecccccc--------------ccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHH
Confidence 999999999999999999999875321110 00112244678999999987 568999999999999
Q ss_pred HHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 668 FFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 668 L~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+|+|++ ||............ . ....+......++.+.+++.+||+.+|.+||++.++++.
T Consensus 184 l~~~~~~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 184 LWETFSLGVCPYPGMTNQQAREQV-E-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHH-H-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999986 77655443332222 2 222222334456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=302.36 Aligned_cols=245 Identities=25% Similarity=0.361 Sum_probs=194.6
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||+|+||.||+|.+. +++.||||.+..... ...++.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 72 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-------- 72 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeec--------
Confidence 478999999999999999999986 568899999874433 24578999999999999999999987622
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...+|++|||++ ++|.+++.... .+++..+..++.||+.||.|||
T Consensus 73 --------------------------------~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh 120 (261)
T cd05034 73 --------------------------------EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120 (261)
T ss_pred --------------------------------CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 245799999996 59999987643 6899999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++
T Consensus 121 ~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--------------~~~~~~~~~~y~~PE~~~~-~~~~~~~ 185 (261)
T cd05034 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT--------------AREGAKFPIKWTAPEAANY-GRFTIKS 185 (261)
T ss_pred hCCcccCCcchheEEEcCCCCEEECccccceeccchhhh--------------hhhccCCCccccCHHHhcc-CCcCchh
Confidence 999999999999999999999999999998765321100 0012234678999999987 5689999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
|||||||++|+|++ ||.............. .. .++.....+.++.+++.+||+.+|.+||++.++++
T Consensus 186 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 186 DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GY-RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999996 6655444333333221 21 22222344678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=306.20 Aligned_cols=239 Identities=23% Similarity=0.354 Sum_probs=185.5
Q ss_pred eeccCCceEEEEEEEccCCc--EEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcCC
Q 000880 431 PLGHGGFGHVVLCKNKLDGR--HYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~~g~--~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~~ 507 (1239)
.||+|+||.||+|+++.++. .+|+|.++. .........+.+|+.++.++ +||||+++++++..
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------------- 67 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH------------- 67 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccc-cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-------------
Confidence 58999999999999988776 468887752 22334456788999999999 89999999988732
Q ss_pred CCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC----------------CCCHHHHHHHHHH
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD----------------HFDKELAWHLFRQ 570 (1239)
Q Consensus 508 ~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~----------------~l~~~~~~~i~~q 570 (1239)
...+|++|||++ ++|.+++.... .+++..++.++.|
T Consensus 68 ---------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 120 (270)
T cd05047 68 ---------------------------RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120 (270)
T ss_pred ---------------------------CCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHH
Confidence 235699999996 69999986532 4788999999999
Q ss_pred HHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc
Q 000880 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650 (1239)
Q Consensus 571 I~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 650 (1239)
++.||+|||++|++||||||+|||++.++.+||+|||++...... ........++.|+|||++.
T Consensus 121 i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~----------------~~~~~~~~~~~y~apE~~~ 184 (270)
T cd05047 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY----------------VKKTMGRLPVRWMAIESLN 184 (270)
T ss_pred HHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchh----------------hhccCCCCccccCChHHHc
Confidence 999999999999999999999999999999999999998632100 0011123467899999987
Q ss_pred CCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHH
Q 000880 651 GWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATEL 726 (1239)
Q Consensus 651 ~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~ei 726 (1239)
+ ..++.++|||||||++|||++ ||............ . ....++.....+.++.+++.+||+.||.+|||+.++
T Consensus 185 ~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 185 Y-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred c-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-h-CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 6 568999999999999999985 77544333322222 1 111222233456789999999999999999999999
Q ss_pred Hhc
Q 000880 727 LQD 729 (1239)
Q Consensus 727 L~~ 729 (1239)
++.
T Consensus 262 l~~ 264 (270)
T cd05047 262 LVS 264 (270)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=298.49 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=203.1
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
++++-+..||.|+||+|++..|+.+|+..|||.|+.... .....+++.|.....+- +.||||++||+++..|
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG------ 136 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG------ 136 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC------
Confidence 345556789999999999999999999999999986544 34567788888776555 7899999999986542
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE-----SYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~-----~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
..||.||+|+-||..+.. +...+++...-.+...++.||.|
T Consensus 137 ----------------------------------dcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~y 182 (361)
T KOG1006|consen 137 ----------------------------------DCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDY 182 (361)
T ss_pred ----------------------------------ceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHH
Confidence 359999999988766543 34579999999999999999999
Q ss_pred HHh-CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC-C
Q 000880 578 IHG-QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK-I 655 (1239)
Q Consensus 578 LHs-~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~ 655 (1239)
|-. ..|||||+||+|||++..|.+||||||++-.+... +..+.-.|...|||||.+..... |
T Consensus 183 LK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S----------------iAkT~daGCrpYmAPERi~p~~~gy 246 (361)
T KOG1006|consen 183 LKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS----------------IAKTVDAGCRPYMAPERIDPSDKGY 246 (361)
T ss_pred HHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH----------------HHhhhccCCccccChhccCCccCCc
Confidence 986 47999999999999999999999999999876422 12244578999999999876544 9
Q ss_pred CcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCC-----CccccCCHHHHHHHHHccCCCCCCCCCHHHHH
Q 000880 656 DEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRRLMSPSPSDRPSATELL 727 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p-----~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL 727 (1239)
+-++|+|||||+|||+.| |+..++..-..+..+. .+..| ....+.+..+..+|..||.+|-++||...+++
T Consensus 247 DiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk 325 (361)
T KOG1006|consen 247 DIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLK 325 (361)
T ss_pred chhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhh
Confidence 999999999999999998 7777766433333322 22222 12234567899999999999999999999999
Q ss_pred hccCCCCc
Q 000880 728 QDALPPQM 735 (1239)
Q Consensus 728 ~~~~~~~~ 735 (1239)
.++|..-.
T Consensus 326 ~~~fyr~y 333 (361)
T KOG1006|consen 326 KFPFYRMY 333 (361)
T ss_pred cCchhhhh
Confidence 99876544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=315.21 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=201.7
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+.....+||-|.||.||.|.|+.-...||||.++- +.-..++|+.|..+|+.++|||+|+++|+|.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT----------- 333 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT----------- 333 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhc-----------
Confidence 55667899999999999999999999999998862 2234678999999999999999999999983
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~--l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...-+|||+|||. |+|.++|++..+ ++.-..+.++.||.+||+||..+
T Consensus 334 -----------------------------~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk 384 (1157)
T KOG4278|consen 334 -----------------------------HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK 384 (1157)
T ss_pred -----------------------------cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh
Confidence 2456899999985 899999987654 77777889999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
++|||||..+|+|+.++..|||+|||+++++...... .+-+..-..-|.|||-|.- ..++.|+||
T Consensus 385 nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT--------------AHAGAKFPIKWTAPEsLAy-NtFSiKSDV 449 (1157)
T KOG4278|consen 385 NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT--------------AHAGAKFPIKWTAPESLAY-NTFSIKSDV 449 (1157)
T ss_pred hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee--------------cccCccCcccccCcccccc-cccccchhh
Confidence 9999999999999999999999999999987543211 1112233457999998876 679999999
Q ss_pred HHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 662 YSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 662 wSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
|+|||+|||+.| |+.+..-.++ .. +..++.......++++....||+.||+.+|.+||++.+|-+
T Consensus 450 WAFGVLLWEIATYGMsPYPGidlSqV-Y~-LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 450 WAFGVLLWEIATYGMSPYPGIDLSQV-YG-LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHHHHHhcCCCCCCCccHHHH-HH-HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 999999999986 7655443332 22 33456666667788999999999999999999999999865
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=305.52 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=195.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCc----EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGR----HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
.+|++.+.||+|+||.||+|.++.+|. .||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 578999999999999999999887765 5899987643 233445678999999999999999999988731
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~y 577 (1239)
...+++|||++ ++|.+++... ..+++..++.++.||+.||+|
T Consensus 81 ------------------------------------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~ 124 (279)
T cd05057 81 ------------------------------------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124 (279)
T ss_pred ------------------------------------CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 35689999996 6999988764 469999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++|++||||||+|||++.++.+||+|||+++....... ........++..|+|||.+.. ..++.
T Consensus 125 LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~~PE~~~~-~~~~~ 190 (279)
T cd05057 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-------------EYHAEGGKVPIKWMALESILH-RIYTH 190 (279)
T ss_pred HHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc-------------ceecCCCcccccccCHHHhhc-CCcCc
Confidence 9999999999999999999999999999999986532110 001112234678999999876 56899
Q ss_pred chhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
++|+|||||++||+++ ||......+.... +. .....+.....+.++.+++.+||..||..||++.++++
T Consensus 191 ~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-LE-KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-Hh-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999986 6655444333322 22 22222223345578999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=304.42 Aligned_cols=233 Identities=19% Similarity=0.305 Sum_probs=183.4
Q ss_pred eeeccCCceEEEEEEEccCC----------cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 430 QPLGHGGFGHVVLCKNKLDG----------RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g----------~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 36899999999999998776 35888876543221 5678999999999999999999988732
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~y 577 (1239)
...++||||++ ++|.+++.... .+++..+..++.||+.||+|
T Consensus 73 ------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~ 116 (259)
T cd05037 73 ------------------------------------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHY 116 (259)
T ss_pred ------------------------------------CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHH
Confidence 23489999996 68999988665 79999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCC-------CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARN-------DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~-------~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 650 (1239)
||++||+||||||+|||++.++ .+||+|||++..... .....++..|+|||++.
T Consensus 117 LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-------------------~~~~~~~~~y~aPE~~~ 177 (259)
T cd05037 117 LEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-------------------REERVERIPWIAPECIR 177 (259)
T ss_pred HhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc-------------------ccccccCCCccChhhhc
Confidence 9999999999999999999887 799999999986421 12235677899999998
Q ss_pred CC-CCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 651 GW-PKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 651 ~~-~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
+. ..++.++|||||||++|||++ ||......... .........+.. ....+.++|.+||..+|.+|||+.+
T Consensus 178 ~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (259)
T cd05037 178 NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-RFYQDQHRLPMP---DCAELANLINQCWTYDPTKRPSFRA 253 (259)
T ss_pred CCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-HHHhcCCCCCCC---CchHHHHHHHHHhccChhhCCCHHH
Confidence 74 368999999999999999985 45443222211 111112222211 1268899999999999999999999
Q ss_pred HHhc
Q 000880 726 LLQD 729 (1239)
Q Consensus 726 iL~~ 729 (1239)
+++.
T Consensus 254 il~~ 257 (259)
T cd05037 254 ILRD 257 (259)
T ss_pred HHHh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=300.47 Aligned_cols=245 Identities=25% Similarity=0.348 Sum_probs=195.3
Q ss_pred ceEEeeeccCCceEEEEEEEccCC----cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDG----RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g----~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
|++.+.||.|+||.||+|.+..++ ..||+|+++... .......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTE------- 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-------
Confidence 356689999999999999998766 899999986432 22245688999999999999999999988732
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDH--FDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~--l~~~~~~~i~~qI~~gL~yL 578 (1239)
....|++|||++ ++|.+++..... +++..++.++.||+.||+||
T Consensus 73 ---------------------------------~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l 119 (258)
T smart00219 73 ---------------------------------EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119 (258)
T ss_pred ---------------------------------CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH
Confidence 246899999996 599999876544 99999999999999999999
Q ss_pred HhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|++|++||||||+||+++.++.++|+|||+++........ ......+++.|+|||.+.+ ..++.+
T Consensus 120 h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~y~~Pe~~~~-~~~~~~ 184 (258)
T smart00219 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--------------KKKGGKLPIRWMAPESLKD-GKFTSK 184 (258)
T ss_pred hcCCeeecccccceEEEccCCeEEEcccCCceeccccccc--------------ccccCCCcccccChHHhcc-CCCCcc
Confidence 9999999999999999999999999999999865322110 0011237889999999866 678999
Q ss_pred hhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 659 ADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 659 sDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
+||||||+++|+|++ ||............ . ....++.....+.++.+++.+||+.||.+|||+.++++
T Consensus 185 ~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 185 SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL-K-KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-h-cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999985 55543333332222 2 22233333446778999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-32 Score=299.54 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=190.0
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSG 509 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g 509 (1239)
++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------------- 63 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--------------- 63 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec---------------
Confidence 369999999999999986 999999988754332 345679999999999999999999987632
Q ss_pred cccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 000880 510 TLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587 (1239)
Q Consensus 510 ~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrD 587 (1239)
....|++|||++ ++|.+++.. ...++...+..++.|++.||+|||+++++|||
T Consensus 64 -------------------------~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~d 118 (251)
T cd05041 64 -------------------------KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118 (251)
T ss_pred -------------------------CCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhh
Confidence 345799999996 589998865 34688999999999999999999999999999
Q ss_pred CCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHH
Q 000880 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667 (1239)
Q Consensus 588 LKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGvi 667 (1239)
|||+|||++.++.+||+|||+++....... ........++..|+|||++.+ ..++.++|+|||||+
T Consensus 119 i~p~nili~~~~~~~l~d~g~~~~~~~~~~-------------~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i 184 (251)
T cd05041 119 LAARNCLVGENNVLKISDFGMSREEEGGIY-------------TVSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGIL 184 (251)
T ss_pred cCcceEEEcCCCcEEEeeccccccccCCcc-------------eeccccCcceeccCChHhhcc-CCCCcchhHHHHHHH
Confidence 999999999999999999999975431110 001112234677999999887 568999999999999
Q ss_pred HHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 668 FFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 668 L~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+|||++ ||........... +. ....++.....+.++.++|.+||..+|.+|||+.++++.
T Consensus 185 ~~~l~t~~~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 185 LWETFSLGDTPYPGMSNQQTRER-IE-SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred HHHHHhccCCCCccCCHHHHHHH-Hh-cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 999996 5654443322222 21 111222233456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=303.55 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=195.7
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecC---CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK---DKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~---~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
+|.+.+.||+|+||.||++++..++..+++|+++.. .........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 73 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE------- 73 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-------
Confidence 478889999999999999999888777777776532 2222334567789999999999999999987632
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~ 576 (1239)
....+++|||++ ++|.+++.. ...+++..++.++.|++.||.
T Consensus 74 ---------------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (260)
T cd08222 74 ---------------------------------RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120 (260)
T ss_pred ---------------------------------CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHH
Confidence 345799999997 588887753 356999999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
|||++|++|+||||+||+++. +.+||+|||++........ ......|++.|+|||.+.+ ..++
T Consensus 121 ~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~---------------~~~~~~~~~~~~~pe~~~~-~~~~ 183 (260)
T cd08222 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD---------------LATTFTGTPYYMSPEALKH-QGYD 183 (260)
T ss_pred HHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcc---------------cccCCCCCcCccCHHHHcc-CCCC
Confidence 999999999999999999975 6799999999876432110 1123468899999999876 5688
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
.++|+||||+++|+|++ ||............. .+..+......++++.++|.+||..||++||++.++++|||+
T Consensus 184 ~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 184 SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV--EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 89999999999999986 665444333333322 223333333456789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=306.70 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=202.0
Q ss_pred CceEEeeeccCCceEEEEEEEc---cCCcEEEEEEEecCCC--CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCcc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNK---LDGRHYAVKKIRLKDK--SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~---~~g~~vAVK~i~~~~~--~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~ 498 (1239)
+|++.+.||+|+||.||++++. .++..||||+++.... .......+.+|+.++..+ +||||+++++++.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~----- 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ----- 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-----
Confidence 4788999999999999999864 4678999999874322 122345688999999999 6999999987762
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....+|+||||++ ++|.+++.....+++..++.++.|++.||.|
T Consensus 76 -----------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~ 120 (288)
T cd05583 76 -----------------------------------TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120 (288)
T ss_pred -----------------------------------cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHH
Confidence 2356899999996 5999998877789999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC-CCC
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP-KID 656 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~ 656 (1239)
||+.+++||||||.||+++.++.++|+|||+++...... ........|++.|+|||.+.+.. ..+
T Consensus 121 lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 186 (288)
T cd05583 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE--------------EERAYSFCGTIEYMAPEVIRGGSGGHD 186 (288)
T ss_pred HHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc--------------ccccccccCCccccCHHHhcCCCCCCc
Confidence 999999999999999999999999999999987643211 00112346899999999987632 368
Q ss_pred cchhhHHHHHHHHHhhc---CCchhH----HHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC---HHHH
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAM----ERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS---ATEL 726 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~----~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt---a~ei 726 (1239)
.++|+||||+++|||++ ||.... ............ ++......+.+.++|.+||+.||++||| +.++
T Consensus 187 ~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 187 KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEI 263 (288)
T ss_pred chhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHH
Confidence 89999999999999997 664221 111111222211 2222345578999999999999999998 5677
Q ss_pred HhccCCCCchHHHH
Q 000880 727 LQDALPPQMEYELL 740 (1239)
Q Consensus 727 L~~~~~~~~~~~~~ 740 (1239)
|+|+|+.+..++.+
T Consensus 264 l~~~~~~~~~~~~~ 277 (288)
T cd05583 264 KNHPFFQGIDWDDL 277 (288)
T ss_pred hcCcccccCCHHHH
Confidence 99999999887543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=303.14 Aligned_cols=244 Identities=21% Similarity=0.363 Sum_probs=182.7
Q ss_pred eeccCCceEEEEEEEccCC--cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 431 PLGHGGFGHVVLCKNKLDG--RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~~g--~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
.||+|+||.||+|.+..++ ..+++|.+... ........+.+|+.+++.++||||+++++.|..
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-------------- 66 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-------------- 66 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecC--------------
Confidence 5999999999999865332 34667766533 223345689999999999999999999988732
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----DHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....|+|||||+ ++|.+++... ..++...++.++.||+.||+|||++++
T Consensus 67 --------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 120 (268)
T cd05086 67 --------------------------AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120 (268)
T ss_pred --------------------------CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345799999997 6999998753 346677888999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC------CCCCc
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW------PKIDE 657 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~~~~ 657 (1239)
+||||||+|||++.++.+||+|||++........ .......+|++.|+|||++... ..++.
T Consensus 121 ~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 187 (268)
T cd05086 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTK 187 (268)
T ss_pred eccCCccceEEEcCCccEEecccccccccCcchh-------------hhcccCCcCcccccCchhcccccCccccCCCCC
Confidence 9999999999999999999999999864211100 0112345788999999987531 23578
Q ss_pred chhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCC---CCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGE---LPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~---~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
++|||||||++|||++ ||....+.+.....+..... .|.......+.+.+++..|| .+|++||++.++++.
T Consensus 188 ~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~ 265 (268)
T cd05086 188 PSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRL 265 (268)
T ss_pred cchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence 9999999999999984 77655544444333322211 12222334567889999999 679999999999763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=303.61 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=193.3
Q ss_pred ceEEeeeccCCceEEEEEEEcc---CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKL---DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
|.+.+.||+|+||.||+|.++. +++.||||++...........++.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----- 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRA----- 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCC-----
Confidence 5667899999999999998753 57899999997655455556778999999999999999999987743210
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY------DHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~------~~l~~~~~~~i~~qI~~gL 575 (1239)
.......+++++|+. ++|.+++... ..++...++.++.||+.||
T Consensus 76 -----------------------------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l 126 (273)
T cd05074 76 -----------------------------KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126 (273)
T ss_pred -----------------------------CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Confidence 001234578899996 6888776422 2478899999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~ 655 (1239)
+|||++||+||||||+||+++.++.+||+|||+++....... ........+++.|++||.+.+ ..+
T Consensus 127 ~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~~~~~~pe~~~~-~~~ 192 (273)
T cd05074 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY-------------YRQGCASKLPVKWLALESLAD-NVY 192 (273)
T ss_pred HHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcc-------------eecCCCccCchhhcCHhHHhc-Ccc
Confidence 999999999999999999999999999999999986532110 001122346678999999887 568
Q ss_pred CcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 656 DEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
+.++|||||||++|||++ ||.............. ...+......++.+.+++.+||+.+|++|||+.+++++
T Consensus 193 ~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 193 TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK--GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc--CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999985 5554433333222221 12222223456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=300.22 Aligned_cols=242 Identities=32% Similarity=0.473 Sum_probs=198.3
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCc
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGT 510 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~ 510 (1239)
||.|+||.||++.+..+++.||+|+++..... ......+.+|+.+++.++||||+++++.+.
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----------------- 63 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ----------------- 63 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----------------
Confidence 69999999999999988999999998754332 224567889999999999999999987762
Q ss_pred ccccccccccccccccccccccccccEEEEEeecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 000880 511 LASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589 (1239)
Q Consensus 511 ~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLK 589 (1239)
....+|++|||+ +++|.+++.....+++..++.++.||+.||.|||+++++|+|||
T Consensus 64 -----------------------~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~ 120 (250)
T cd05123 64 -----------------------TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120 (250)
T ss_pred -----------------------cCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 246789999999 57999999888789999999999999999999999999999999
Q ss_pred cccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHH
Q 000880 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFF 669 (1239)
Q Consensus 590 p~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ 669 (1239)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ...+.++|+||||+++|
T Consensus 121 p~ni~~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~ 184 (250)
T cd05123 121 PENILLDADGHIKLTDFGLAKELSSEG---------------SRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLY 184 (250)
T ss_pred cceEEEcCCCcEEEeecCcceecccCC---------------CcccCCcCCccccChHHhCC-CCCCchhhHHHHHHHHH
Confidence 999999999999999999997643211 01133568899999999887 45788999999999999
Q ss_pred Hhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH---HHHHhccCC
Q 000880 670 ELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA---TELLQDALP 732 (1239)
Q Consensus 670 ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta---~eiL~~~~~ 732 (1239)
+|++ ||...................| ...+..+.++|++||..||++||++ .++++||||
T Consensus 185 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 185 EMLTGKPPFYAEDRKEIYEKILKDPLRFP---EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHCCCCCCCCCHHHHHHHHhcCCCCCC---CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9996 7755544333333332222222 2335688999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=306.12 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=195.3
Q ss_pred CCceEEeeeccCCceEEEEEEEcc----CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKL----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~----~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~ 499 (1239)
.+|++.+.||+|+||.||+|.+.. ++..||||+++..... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---- 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP---- 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC----
Confidence 467888999999999999999753 4789999998754433 3467899999999999999999999876321
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~y 577 (1239)
.....+++|||++ ++|.+++.... .+++..++.++.||+.||+|
T Consensus 79 ----------------------------------~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~ 124 (284)
T cd05038 79 ----------------------------------GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124 (284)
T ss_pred ----------------------------------CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHH
Confidence 1356799999996 59999987654 59999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||++|++||||||+|||++.++.++|+|||++......... ........++..|+|||.+.+ ..++.
T Consensus 125 lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~~~~~Pe~~~~-~~~~~ 191 (284)
T cd05038 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY------------YYVKEPGESPIFWYAPECLRT-SKFSS 191 (284)
T ss_pred HHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcc------------eeccCCCCCcccccCcHHHcc-CCCCc
Confidence 99999999999999999999999999999999865321100 000112345667999999877 46889
Q ss_pred chhhHHHHHHHHHhhc---CCchhHHHH--------------HHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCC
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQ--------------IVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~--------------~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~R 720 (1239)
++|||||||++|||++ ||....... .....+. .....+.....+.++.+++.+||+.+|.+|
T Consensus 192 ~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05038 192 ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270 (284)
T ss_pred ccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhC
Confidence 9999999999999997 544321111 1111111 222222233455789999999999999999
Q ss_pred CCHHHHHhc
Q 000880 721 PSATELLQD 729 (1239)
Q Consensus 721 Pta~eiL~~ 729 (1239)
||+.++++.
T Consensus 271 pt~~ei~~~ 279 (284)
T cd05038 271 PSFADLILI 279 (284)
T ss_pred CCHHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=300.47 Aligned_cols=239 Identities=24% Similarity=0.377 Sum_probs=190.8
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++|++.+.||+|+||.||++.. +++.||+|+++... ....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------- 70 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH-------- 70 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--------
Confidence 36799999999999999999874 68899999886422 24578899999999999999999987622
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...|++|||++ ++|.+++.... .+++..++.++.|++.||.|||
T Consensus 71 ---------------------------------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (254)
T cd05083 71 ---------------------------------NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117 (254)
T ss_pred ---------------------------------CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 22589999996 59999987543 4889999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
++|++||||||+||+++.++.+||+|||++...... ......+..|+|||.+.+ ..++.++
T Consensus 118 ~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~------------------~~~~~~~~~y~~pe~~~~-~~~~~~~ 178 (254)
T cd05083 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG------------------VDNSKLPVKWTAPEALKH-KKFSSKS 178 (254)
T ss_pred hCCeeccccCcceEEEcCCCcEEECCCccceecccc------------------CCCCCCCceecCHHHhcc-CCcCchh
Confidence 999999999999999999999999999998753211 011234568999999876 5689999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|||||||++|||++ ||......+.... .. ....++.....++.+.+++.+||+.+|.+||++.+++..
T Consensus 179 Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VE-KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-Hh-CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999985 6655444333222 22 222222334556789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=324.52 Aligned_cols=259 Identities=22% Similarity=0.385 Sum_probs=213.7
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+-|++.++||.|.+|+||+++++.+|+.+|||+..... +..+++..|.++|+.+ .|||++.+||+|.-..
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~------ 89 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD------ 89 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEec------
Confidence 56899999999999999999999999999999886433 3345677889999888 7999999999985431
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES--YDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
......+|+|||||+ ||.-+++.. ..++.|+.+..|++.++.|+.|||
T Consensus 90 -----------------------------~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH 140 (953)
T KOG0587|consen 90 -----------------------------PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH 140 (953)
T ss_pred -----------------------------CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh
Confidence 134678999999996 688888764 456999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCC----CC
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP----KI 655 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~~ 655 (1239)
.+.++|||||-.|||++.++.|||+|||.+..+... .....+.+|||.|||||++...+ .|
T Consensus 141 ~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT---------------~grRnT~iGtP~WMAPEViac~e~~d~ty 205 (953)
T KOG0587|consen 141 NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST---------------VGRRNTFIGTPYWMAPEVIACDESPDATY 205 (953)
T ss_pred hcceeeecccCceEEEeccCcEEEeeeeeeeeeecc---------------cccccCcCCCcccccceeeecccCCCCCc
Confidence 999999999999999999999999999999876321 12345679999999999986533 47
Q ss_pred CcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 656 DEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 656 ~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
+..+|+|||||+..||.- |+.+.+++-.++.+.+..+.-...+...+.++.++|..||.+|-.+||+..++|+|||.
T Consensus 206 d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 206 DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 889999999999999984 78888877776665543222222344455688999999999999999999999999998
Q ss_pred CCc
Q 000880 733 PQM 735 (1239)
Q Consensus 733 ~~~ 735 (1239)
...
T Consensus 286 ~e~ 288 (953)
T KOG0587|consen 286 TEQ 288 (953)
T ss_pred ccc
Confidence 743
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=312.98 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=198.2
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
.+.+.++||+|-||+|.+|.-. .+..||||+++.... ......|.+|+++|.+|+|||||+++|+|..
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~---------- 606 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQ---------- 606 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeec----------
Confidence 4567789999999999999876 468999999874333 3345789999999999999999999999954
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
+..++++|||+. |+|.+++... .....+...+++.||+.||+||.+.
T Consensus 607 ------------------------------DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~ 656 (807)
T KOG1094|consen 607 ------------------------------DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL 656 (807)
T ss_pred ------------------------------CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh
Confidence 345789999995 8999999876 3345667788999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDI 661 (1239)
++|||||.+.|||++.++++||+|||+++-+...... .-....+-...|||||.+.. ++++.++|+
T Consensus 657 nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy-------------~vqgr~vlpiRwmawEsill-gkFttaSDv 722 (807)
T KOG1094|consen 657 NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY-------------RVQGRAVLPIRWMAWESILL-GKFTTASDV 722 (807)
T ss_pred chhhccccccceeecCcccEEecCcccccccccCCce-------------eeecceeeeeeehhHHHHHh-ccccchhhh
Confidence 9999999999999999999999999999965322211 01122356789999998765 679999999
Q ss_pred HHHHHHHHHhhc-----CCchhHHHHHHHHhhh---hcC--CCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 662 YSLGIVFFELWH-----PFSTAMERQIVLSDLK---QKG--ELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 662 wSlGviL~ELlt-----Pf~~~~~~~~~~~~~~---~~~--~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|+||+++||+++ ||....+.+.....-. ..+ ..++.+.-++..+.++|.+||..|-.+||+++++..+
T Consensus 723 WafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 723 WAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred hhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 999999999984 9988777665543211 111 1223333455688999999999999999999998654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=297.63 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=193.2
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|++.+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-------- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--------
Confidence 478999999999999999999865 56779999876322 234678899999999999999999877621
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
...|++|||++ ++|.+++... ..+++..++.++.||+.||.|||
T Consensus 73 ---------------------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH 119 (260)
T cd05073 73 ---------------------------------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119 (260)
T ss_pred ---------------------------------CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH
Confidence 34689999996 6999998753 35788899999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+.|++||||||+||+++.++.+||+|||++........ .......++..|+|||++.+ ..++.++
T Consensus 120 ~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--------------~~~~~~~~~~~y~~PE~~~~-~~~~~~~ 184 (260)
T cd05073 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--------------TAREGAKFPIKWTAPEAINF-GSFTIKS 184 (260)
T ss_pred hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc--------------ccccCCcccccccCHhHhcc-CCcCccc
Confidence 99999999999999999999999999999976432110 01122346678999999987 5689999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
|+|||||++|++++ ||........... +. .....+.....+.++.+++.+||+.+|++||++.++++
T Consensus 185 Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-Hh-CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999996 7765443333222 22 22222333456678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=301.86 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=187.9
Q ss_pred eeccCCceEEEEEEEccCC------cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 431 PLGHGGFGHVVLCKNKLDG------RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~~g------~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
.||+|+||.||+|+++... +.||||.+... ........+.+|+.+++.++||||++++++|..
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 70 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL---------- 70 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC----------
Confidence 5899999999999987543 68999988643 222345678899999999999999999988732
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHH
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-------DHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-------~~l~~~~~~~i~~qI~~gL~ 576 (1239)
....|++|||++ ++|.+++... ..+++..++.++.||+.||+
T Consensus 71 ------------------------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 71 ------------------------------NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred ------------------------------CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 245799999996 6999988642 33788999999999999999
Q ss_pred HHHhCCccccCCCcccEEEcCCC-----CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARN-----DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILl~~~~-----~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 651 (1239)
|||+++++|+||||+|||++.++ .++|+|||+++........ .......++..|+|||++.+
T Consensus 121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~ 187 (269)
T cd05044 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY-------------RKEGEGLLPVRWMAPESLLD 187 (269)
T ss_pred HHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccccccccc-------------ccCcccCCCccccCHHHHcc
Confidence 99999999999999999999877 8999999999765322110 01122356788999999987
Q ss_pred CCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHH
Q 000880 652 WPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELL 727 (1239)
Q Consensus 652 ~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL 727 (1239)
..++.++|||||||++|||++ ||......+..... . ....+......++.+.++|.+||..+|.+||++.+++
T Consensus 188 -~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 264 (269)
T cd05044 188 -GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-T-AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264 (269)
T ss_pred -CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-h-cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 568999999999999999985 66544443332222 2 1222233344567889999999999999999999997
Q ss_pred hc
Q 000880 728 QD 729 (1239)
Q Consensus 728 ~~ 729 (1239)
+.
T Consensus 265 ~~ 266 (269)
T cd05044 265 EI 266 (269)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=298.59 Aligned_cols=247 Identities=30% Similarity=0.512 Sum_probs=194.1
Q ss_pred CceEEeeeccCCceEEEEEEEcc-CCcEEEEEEEecCC--------CCchhHHHHHHHHHHHHh-cCCCceeeeeeeeee
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKL-DGRHYAVKKIRLKD--------KSLPVNDRILREVATLSR-LQHQHVVRYYQAWFE 494 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~-~g~~vAVK~i~~~~--------~~~~~~~~~~~Ev~iL~~-L~HpnIv~l~~~~~e 494 (1239)
+|++.+.||+|+||.||+|.++. +++.+|+|.+.... .......++.+|+.+++. ++||||+++++.+.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999987 68899999986432 122234567889988875 799999999988732
Q ss_pred cCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh----cCCCCHHHHHHHHH
Q 000880 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFR 569 (1239)
Q Consensus 495 ~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~ 569 (1239)
....|++|||++ ++|.+++.. ...+++..++.++.
T Consensus 81 ----------------------------------------~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 120 (269)
T cd08528 81 ----------------------------------------NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120 (269)
T ss_pred ----------------------------------------CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHH
Confidence 356899999996 488887743 34689999999999
Q ss_pred HHHHHHHHHHh-CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccc
Q 000880 570 QIVEGLAHIHG-QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648 (1239)
Q Consensus 570 qI~~gL~yLHs-~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~ 648 (1239)
|++.||.|||+ .+++|+||||+|||++.++.+||+|||++....... ......|+..|+|||.
T Consensus 121 ~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~~~~Pe~ 184 (269)
T cd08528 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----------------KLTSVVGTILYSCPEI 184 (269)
T ss_pred HHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc----------------ccccccCcccCcChhh
Confidence 99999999996 789999999999999999999999999997643211 1234568999999999
Q ss_pred ccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 649 EQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 649 l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
+.+ ..++.++|+||||+++|+|++ ||.............. ....|......++++.++|.+||+.||++||++.+
T Consensus 185 ~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e 262 (269)
T cd08528 185 VKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE-AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQ 262 (269)
T ss_pred hcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh-ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence 987 568999999999999999996 7655443333222221 21122222245678999999999999999999999
Q ss_pred HHhc
Q 000880 726 LLQD 729 (1239)
Q Consensus 726 iL~~ 729 (1239)
+..+
T Consensus 263 ~~~~ 266 (269)
T cd08528 263 VSAM 266 (269)
T ss_pred HHHH
Confidence 9764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=302.63 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=196.8
Q ss_pred CCCCCCCCCCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHh--cCCCceeee
Q 000880 411 GSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSR--LQHQHVVRY 488 (1239)
Q Consensus 411 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l 488 (1239)
++....+.......+..+++.||+|.||+||+|+|+ |+.||||++...+ .....||.++... |+|+||+.+
T Consensus 198 GSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 198 GSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred CCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhh
Confidence 333333344445578889999999999999999998 9999999997443 3446677777655 499999998
Q ss_pred eeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHH
Q 000880 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHL 567 (1239)
Q Consensus 489 ~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i 567 (1239)
+++ .++++|+ -..+|+|++|.+ |||.|+|.. ..++.+...++
T Consensus 271 Iaa------------D~~~~gs------------------------~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~L 313 (513)
T KOG2052|consen 271 IAA------------DNKDNGS------------------------WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKL 313 (513)
T ss_pred hhc------------cccCCCc------------------------eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHH
Confidence 855 2333332 367999999996 899999987 67999999999
Q ss_pred HHHHHHHHHHHHhC--------CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCccccc
Q 000880 568 FRQIVEGLAHIHGQ--------GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639 (1239)
Q Consensus 568 ~~qI~~gL~yLHs~--------gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 639 (1239)
+..++.||+|||-. .|.|||||+.|||+..++.+.|+|+|+|-..... +.......+..+|
T Consensus 314 alS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~-----------t~~idi~~N~rVG 382 (513)
T KOG2052|consen 314 ALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD-----------TDTIDIPPNPRVG 382 (513)
T ss_pred HHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc-----------CCcccCCCCCccc
Confidence 99999999999952 4999999999999999999999999999764322 1223344567899
Q ss_pred CccCCCcccccCCCC---C--CcchhhHHHHHHHHHhh-------------cCCchhHHH----HHHHH---hhhhcCCC
Q 000880 640 TYFYTAPEIEQGWPK---I--DEKADMYSLGIVFFELW-------------HPFSTAMER----QIVLS---DLKQKGEL 694 (1239)
Q Consensus 640 T~~Y~APE~l~~~~~---~--~~ksDIwSlGviL~ELl-------------tPf~~~~~~----~~~~~---~~~~~~~~ 694 (1239)
|.+|||||+|...-. + -..+||||||.++||+. .||.+..+. +...+ ..+..+.+
T Consensus 383 TKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~i 462 (513)
T KOG2052|consen 383 TKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNI 462 (513)
T ss_pred eeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCC
Confidence 999999999875211 1 14689999999999996 177644221 11111 12223445
Q ss_pred CCccccCC--HHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 695 PPSWVAKF--SEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 695 p~~~~~~~--~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
|..|.... ..+.++|+.||..||..|.|+-.|-+
T Consensus 463 pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 463 PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 55555432 25678999999999999999887754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=295.86 Aligned_cols=228 Identities=21% Similarity=0.300 Sum_probs=179.2
Q ss_pred CCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCccccc
Q 000880 435 GGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASS 514 (1239)
Q Consensus 435 G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~~~s~ 514 (1239)
|.||.||+|+++.+|+.||+|+++... .+.+|...+....||||+++++++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~-------------------- 56 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS-------------------- 56 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--------------------
Confidence 899999999999999999999987432 23345555666689999999987632
Q ss_pred ccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccE
Q 000880 515 TFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNI 593 (1239)
Q Consensus 515 ~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NI 593 (1239)
....|++|||++ ++|.+++.....+++..+..++.|++.||+|||++||+||||||+||
T Consensus 57 --------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Ni 116 (237)
T cd05576 57 --------------------EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116 (237)
T ss_pred --------------------CCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 356899999996 59999998877899999999999999999999999999999999999
Q ss_pred EEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc
Q 000880 594 FFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH 673 (1239)
Q Consensus 594 Ll~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt 673 (1239)
+++.++.++|+|||++...... ..+..++..|+|||++.+ ..++.++|+||+||++|||++
T Consensus 117 l~~~~~~~~l~df~~~~~~~~~------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~ 177 (237)
T cd05576 117 LLDDRGHIQLTYFSRWSEVEDS------------------CDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLT 177 (237)
T ss_pred EEcCCCCEEEecccchhccccc------------------cccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999988654211 122356778999999876 568899999999999999997
Q ss_pred CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCH-----HHHHhccCC
Q 000880 674 PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA-----TELLQDALP 732 (1239)
Q Consensus 674 Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta-----~eiL~~~~~ 732 (1239)
.............. .....+| ...++.++++|.+||+.||++||++ +++++||||
T Consensus 178 g~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 178 GKTLVECHPSGINT-HTTLNIP---EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcchhhcCchhccc-ccccCCc---ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 33211100000000 0011122 2345789999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=329.77 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=176.0
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccC----CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCc
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLD----GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~----g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~ 497 (1239)
..++|++.+.||+|+||.||+|++..+ +..||||++..... .+....| .++...+.+++.++..+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~- 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPV- 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccc-
Confidence 468999999999999999999999988 89999998753221 1111111 223333444444433321110
Q ss_pred cccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCC------------------
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDH------------------ 558 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~------------------ 558 (1239)
.......+++||||++ ++|.+++.....
T Consensus 203 ---------------------------------~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~ 249 (566)
T PLN03225 203 ---------------------------------SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG 249 (566)
T ss_pred ---------------------------------ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhcccc
Confidence 0123467899999997 589888864321
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCc
Q 000880 559 --FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGT 635 (1239)
Q Consensus 559 --l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (1239)
.....+..++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+|+.+.... .....
T Consensus 250 ~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~--------------~~~~~ 315 (566)
T PLN03225 250 LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI--------------NYIPK 315 (566)
T ss_pred chhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--------------ccCCc
Confidence 123456789999999999999999999999999999986 5799999999998542211 11124
Q ss_pred ccccCccCCCcccccCCC---------------------CCCcchhhHHHHHHHHHhhcCCchhHHH-HHHHHhhhhcCC
Q 000880 636 GQVGTYFYTAPEIEQGWP---------------------KIDEKADMYSLGIVFFELWHPFSTAMER-QIVLSDLKQKGE 693 (1239)
Q Consensus 636 ~~~GT~~Y~APE~l~~~~---------------------~~~~ksDIwSlGviL~ELltPf~~~~~~-~~~~~~~~~~~~ 693 (1239)
..+||+.|||||++.... .++.++|||||||+||||++|....... ......+.....
T Consensus 316 ~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~ 395 (566)
T PLN03225 316 EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDY 395 (566)
T ss_pred ccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCC
Confidence 468999999999764311 2445679999999999999854332221 111111111110
Q ss_pred ------------CCCcc-------ccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 694 ------------LPPSW-------VAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 694 ------------~p~~~-------~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
..+.. ........+||++||+.||.+|||+.++|+||||.+..
T Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 396 DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 00000 00112345899999999999999999999999998764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=297.57 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=192.3
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCC--Cc----eeeeeeeeeec
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH--QH----VVRYYQAWFET 495 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~H--pn----Iv~l~~~~~e~ 495 (1239)
..++|.++..+|+|.||.|..|.+..++..||||+++.- ....+...-|+.+|.++.+ |+ +|.+.++|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--- 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--- 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh---
Confidence 367899999999999999999999999999999998732 2334556779999999932 32 44444433
Q ss_pred CccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc--CCCCHHHHHHHHHHHHH
Q 000880 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY--DHFDKELAWHLFRQIVE 573 (1239)
Q Consensus 496 ~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~ 573 (1239)
....+.+||+|.++-|+.+++..+ .+++...++.+++|+++
T Consensus 161 -------------------------------------dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~ 203 (415)
T KOG0671|consen 161 -------------------------------------DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLE 203 (415)
T ss_pred -------------------------------------hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHH
Confidence 235678999999999999999764 46999999999999999
Q ss_pred HHHHHHhCCccccCCCcccEEEcC--------------------CCCEEEeecCcchhccccccccCCCCCCCCCCcccc
Q 000880 574 GLAHIHGQGIIHRDLTPNNIFFDA--------------------RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633 (1239)
Q Consensus 574 gL~yLHs~gIiHrDLKp~NILl~~--------------------~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~ 633 (1239)
+|+|||+++++|-||||+|||+.+ +..|||+|||.|++-.. .
T Consensus 204 sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e------------------~ 265 (415)
T KOG0671|consen 204 SVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE------------------H 265 (415)
T ss_pred HHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc------------------C
Confidence 999999999999999999999842 23589999999986321 1
Q ss_pred CcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhcCCc---hhHHHH--HHHHhhhhcCCCCCc-----------
Q 000880 634 GTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFS---TAMERQ--IVLSDLKQKGELPPS----------- 697 (1239)
Q Consensus 634 ~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELltPf~---~~~~~~--~~~~~~~~~~~~p~~----------- 697 (1239)
+++.+-|..|.|||++.+ -.++.++||||+||||+|+++++. ...+.+ ..++.+. +.+|..
T Consensus 266 hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl--Gp~P~~mi~r~~~~Kyf 342 (415)
T KOG0671|consen 266 HSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL--GPIPSRMIKKTRKEKYF 342 (415)
T ss_pred cceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh--CCCcHHHhhhhhhHhhh
Confidence 356789999999999999 469999999999999999997443 222222 1111111 111110
Q ss_pred ------cc-----------------------cCC---HHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 698 ------WV-----------------------AKF---SEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 698 ------~~-----------------------~~~---~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
|. ... -++.+||++||..||.+|+|+.|+|+||||...
T Consensus 343 ~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 343 RRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred hcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 00 000 135699999999999999999999999999865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=314.94 Aligned_cols=246 Identities=30% Similarity=0.437 Sum_probs=185.6
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
-|..-+.||+|+||.||+++++.+|..||||.++... .....+...+|+++|++|+|||||++++.=...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~--------- 83 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETK--------- 83 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCcc---------
Confidence 3445578999999999999999999999999987433 445667888999999999999999998652110
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY---DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLHs 580 (1239)
.. | .-.....++||||. |||...+++. ..+++.+.+.++.+++.||.|||.
T Consensus 84 -~~-~-----------------------~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE 138 (732)
T KOG4250|consen 84 -FL-G-----------------------LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE 138 (732)
T ss_pred -cc-C-----------------------cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 00 0 01234579999995 6999999753 459999999999999999999999
Q ss_pred CCccccCCCcccEEEcC--CCC--EEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 581 QGIIHRDLTPNNIFFDA--RND--IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 581 ~gIiHrDLKp~NILl~~--~~~--vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
+||+||||||.||++-. +|. -||+|||.|+-+..+. ..++.+||+.|++||.+.....|+
T Consensus 139 n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s----------------~~~S~vGT~~YLhPel~E~q~~y~ 202 (732)
T KOG4250|consen 139 NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS----------------LFTSLVGTEEYLHPELYERQKKYT 202 (732)
T ss_pred cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC----------------eeeeecCchhhcChHHHhhccCcC
Confidence 99999999999999843 343 7999999999765332 236789999999999998546799
Q ss_pred cchhhHHHHHHHHHhhc---CCchhH----HHHHHHHhhhhcCC-------------------CCCccccCCH----HHH
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAM----ERQIVLSDLKQKGE-------------------LPPSWVAKFS----EQE 706 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~----~~~~~~~~~~~~~~-------------------~p~~~~~~~~----e~~ 706 (1239)
..+|.|||||++|++.| ||-+.. ..+....++..+.. +|. ..+.++ .+.
T Consensus 203 ~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~ 281 (732)
T KOG4250|consen 203 ATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLT 281 (732)
T ss_pred ceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC-cccccHHHHhhhh
Confidence 99999999999999998 665432 22233333222111 111 111122 345
Q ss_pred HHHHHccCCCCCCCCC
Q 000880 707 SLLRRLMSPSPSDRPS 722 (1239)
Q Consensus 707 ~LI~~~L~~dP~~RPt 722 (1239)
.++..+|..+|.+|..
T Consensus 282 kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 282 KWLASMLEWNPRKRGH 297 (732)
T ss_pred HHHHHHHhhhHHHhCC
Confidence 7788888999988884
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=294.96 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=188.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHh--cCCCceeeeeeeeeecCcccc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSR--LQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~--L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
+....+.++||+|.||.||+|... ++.||||+++.. ..+.+..|-.+.+. ++|+||++++++=- .
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek-r----- 275 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEK-R----- 275 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhc-c-----
Confidence 456677899999999999999886 799999999743 34557777666655 48999999986521 0
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
| ......+++|++|.+ |+|.++|.. ..+++....+++.-+++||+|||
T Consensus 276 --------~----------------------t~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LH 324 (534)
T KOG3653|consen 276 --------G----------------------TADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLH 324 (534)
T ss_pred --------C----------------------CccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhc
Confidence 0 012456899999997 899999976 45999999999999999999999
Q ss_pred h---------CCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc
Q 000880 580 G---------QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650 (1239)
Q Consensus 580 s---------~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 650 (1239)
+ ..|+|||||++||||.+|+++.|+|||+|..+....- ..+..+.+||.+|||||+|.
T Consensus 325 ee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~-------------~~d~~~qVGT~RYMAPEvLE 391 (534)
T KOG3653|consen 325 EELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKP-------------QGDTHGQVGTRRYMAPEVLE 391 (534)
T ss_pred ccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCC-------------CcchhhhhhhhhhcCHHHHh
Confidence 7 2599999999999999999999999999998752210 11224479999999999998
Q ss_pred CCCCCC-----cchhhHHHHHHHHHhhc---------------CCch-------hHHHHHHHHhhhhcCCCCCccccCC-
Q 000880 651 GWPKID-----EKADMYSLGIVFFELWH---------------PFST-------AMERQIVLSDLKQKGELPPSWVAKF- 702 (1239)
Q Consensus 651 ~~~~~~-----~ksDIwSlGviL~ELlt---------------Pf~~-------~~~~~~~~~~~~~~~~~p~~~~~~~- 702 (1239)
|.-++. .+.||||+|.+||||++ ||.. ..+++.....-+..+.+|..|....
T Consensus 392 gainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~ 471 (534)
T KOG3653|consen 392 GAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAG 471 (534)
T ss_pred hhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCcc
Confidence 843333 46899999999999973 2321 1122222222233455677776542
Q ss_pred -HHHHHHHHHccCCCCCCCCCHHHHHh
Q 000880 703 -SEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 703 -~e~~~LI~~~L~~dP~~RPta~eiL~ 728 (1239)
.-+++.+..||+.||+.|.|+.=+-+
T Consensus 472 ~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 472 MAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred HHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 25689999999999999999865543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=296.49 Aligned_cols=263 Identities=29% Similarity=0.459 Sum_probs=206.6
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC-----chhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-----LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~-----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
++|-++..||+|||++||+|.+....+.||||+-.....- ........+|..+.+.|.||.||++|++|.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs----- 537 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS----- 537 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee-----
Confidence 5677889999999999999999988999999986543211 112345778999999999999999999872
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
.+...++-|+|||+| +|.-+|.....+++.+|+.|+.||+.||.|
T Consensus 538 ----------------------------------lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~Y 583 (775)
T KOG1151|consen 538 ----------------------------------LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKY 583 (775)
T ss_pred ----------------------------------eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHH
Confidence 134567899999986 898899999999999999999999999999
Q ss_pred HHhC--CccccCCCcccEEEcC---CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc-C
Q 000880 578 IHGQ--GIIHRDLTPNNIFFDA---RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ-G 651 (1239)
Q Consensus 578 LHs~--gIiHrDLKp~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~ 651 (1239)
|... .|||.||||.|||+-+ -|.+||+|||+++........... +.. -++-..||.||++||.+. +
T Consensus 584 LNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vd-------Gme-LTSQgAGTYWYLPPEcFvVg 655 (775)
T KOG1151|consen 584 LNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVD-------GME-LTSQGAGTYWYLPPECFVVG 655 (775)
T ss_pred HhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCccc-------cee-eecccCceeeecCcceeecC
Confidence 9976 5999999999999954 377999999999987544322110 000 123457999999999754 2
Q ss_pred --CCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHh---hh-hcCCCCCccccCCHHHHHHHHHccCCCCCCCCC
Q 000880 652 --WPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSD---LK-QKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722 (1239)
Q Consensus 652 --~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~---~~-~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt 722 (1239)
.+..+.++||||+|||+|.++. ||......+..+.. +. ....+|+. +..++++++||++||+..-.+|..
T Consensus 656 kePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 656 KEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred CCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhh
Confidence 3568999999999999999996 89866554433321 11 12335543 456789999999999999999999
Q ss_pred HHHHHhccCCCC
Q 000880 723 ATELLQDALPPQ 734 (1239)
Q Consensus 723 a~eiL~~~~~~~ 734 (1239)
..++..||++..
T Consensus 735 V~qLA~dpyllP 746 (775)
T KOG1151|consen 735 VQQLACDPYLLP 746 (775)
T ss_pred HHHHccCccccc
Confidence 999999987643
|
|
| >PRK09194 prolyl-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=310.70 Aligned_cols=433 Identities=13% Similarity=0.121 Sum_probs=265.2
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc--CCCccccccEEEEeccCCCeeeecCCCcHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL--GDCPQFKRNTVKLLTHGGDLLELSHELRLP 855 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~--~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~ 855 (1239)
+.+.|+++|+|.+++++++|++.+++.++++||++|.||.| ++. ++++...++||+|.|++|+.++|||+.+.+
T Consensus 34 ~~~~G~~~~lP~g~~~~~~i~~~i~~~~~~~G~~ei~~P~l~~~~l~~~sg~~~~~~~emf~~~d~~~~~l~LrPt~e~~ 113 (565)
T PRK09194 34 KLASGIYTYLPLGLRVLRKIENIVREEMNKIGAQEVLMPALQPAELWQESGRWEEYGPELLRLKDRHGRDFVLGPTHEEV 113 (565)
T ss_pred ccCCCeeEECccHHHHHHHHHHHHHHHHHHcCCEEEECcccCcHHHHhhcCCccccchhceEEecCCCCEEEECCCChHH
Confidence 46799999999999999999999999999999999999999 332 235667889999999999999999977665
Q ss_pred HHHHHHh----CCCCceeEEeecCeEEcC-CCCCC---CCceeEEeEEEeCCCCcccHH---HHHHHHHHHHHhcCCCCc
Q 000880 856 FIRWAIS----NQKSSFKRYEISSVYRRA-IGHSP---PNRYLQGDFDIIGGASALTEA---EVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 856 iaR~~~~----~~~~P~r~~Y~g~VfR~e-~~~~~---~~ef~Q~GvEiiG~~s~~aDa---Evi~la~~~l~~lgi~~~ 924 (1239)
++.++.. ++..|+|+||+|++||+| +|+.| .+||+|.|+++||.++..+|+ +++.++.+++++||++
T Consensus 114 ~~~~~~~~~~s~~~LP~r~yqi~~~fR~E~rp~~Gl~R~reF~q~d~~~f~~~~~~a~~~~~~~~~~~~~i~~~lgl~-- 191 (565)
T PRK09194 114 ITDLVRNEIKSYKQLPLNLYQIQTKFRDEIRPRFGLMRGREFIMKDAYSFHADEESLDETYDAMYQAYSRIFDRLGLD-- 191 (565)
T ss_pred HHHHHHhhhhhcccCCeEEEEeeCCccCCCCCCCcccccccEEEeeEEEEcCChHHHHHHHHHHHHHHHHHHHHhCCc--
Confidence 5544443 345799999999999998 88865 457999999999999888998 6677779999999993
Q ss_pred eEEEECcHHHHHHHHH------------------HcCCCHHHHHHHHHHHHhhc---CCCCCcccccchHHHHHHHHH--
Q 000880 925 CDIHLNHGDLLEAIWS------------------WAGIKAEHREKVAELLAMMG---SLRPQSSEWKSKWVVIRRQLL-- 981 (1239)
Q Consensus 925 ~~i~lg~~~i~~~ll~------------------~lgl~~~~~~~l~~~l~~~d---~~~~~~~~~~~~~~~~~~~l~-- 981 (1239)
|.+.+++++.+.+... .++...+...+-...-...+ .+...........+++...+-
T Consensus 192 ~~~~~~~~g~~gg~~s~e~~~~~~~g~~~~~~c~~c~~~~n~e~a~~~~~~~~~~~~~~~~v~~p~~~t~~e~a~~lg~~ 271 (565)
T PRK09194 192 FRAVEADSGAIGGSASHEFMVLADSGEDTIVYSDESDYAANIEKAEALPPPRAAAEEALEKVDTPNAKTIEELAEFLNVP 271 (565)
T ss_pred cEEEEcccccCCCceeEEEEEecCCCceEEEEeCCCCcchhhhhhcccCCCCccccccceeecCCCCCcHHHHHHHhCCC
Confidence 9999888665543221 11111100000000000000 000000000000001000000
Q ss_pred -----HhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhccCCC---ChhHHHHHHHH------HHHHccCc--ccEEEccC
Q 000880 982 -----QELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPA---DKPTRKALDEL------YLRIWRIE--KNIYIDAL 1045 (1239)
Q Consensus 982 -----~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~~---~~~~~~~l~~l------~l~~~~~~--~~i~~Dl~ 1045 (1239)
+..=+..+. . + ++..+.|+..--+.++++.+.. .....+.+.++ .+.-+|.. -.+.+|.+
T Consensus 272 ~~~~~KtLi~~~~~-~-~--~lvvvp~d~~vn~~kl~~~lg~~~l~~a~~eel~~~~g~~~G~v~P~Gl~~~v~viiD~s 347 (565)
T PRK09194 272 AEKTVKTLLVKADG-E-L--VAVLVRGDHELNEVKLENLLGAAPLELATEEEIRAALGAVPGFLGPVGLPKDVPIIADRS 347 (565)
T ss_pred HHHeeEEEEEEeCC-e-E--EEEEeecchhhhHHHHHhhcCCcccccCCHHHHHHhhCCCCCccCcccCCCCceEEEecc
Confidence 000000000 0 0 0001122222222223322211 00111122221 11122221 24677887
Q ss_pred CCCCCCcccee-----EE-EE----------E----e--cCCCCccc---c-----cccc-cccccccccchhhhccccc
Q 000880 1046 MPPIESYHRNL-----FF-QV----------F----S--VKEKYPAT---L-----VEGT-LLAVGGRYDYLLHRMWDRE 1094 (1239)
Q Consensus 1046 ~~rgl~YYtG~-----vF-e~----------~----~--~~~~~~~~---~-----~~~~-~i~~GGRYD~L~~~fg~~~ 1094 (1239)
+...-.+|+|- -| .+ + . .+...|.- + -+.+ ..--|=+|-. .|+..
T Consensus 348 l~~~~~~~~gan~~g~h~~~~~~~~d~~~~~~~d~~~~~~g~~c~~c~~~l~~~~~iEvGh~f~lG~~ys~---~~~~~- 423 (565)
T PRK09194 348 VADMSNFVVGANEDDYHYVGVNWGRDFPVPEVADLRNVVEGDPSPDGGGTLKIARGIEVGHIFQLGTKYSE---AMNAT- 423 (565)
T ss_pred ccccccccccCCCCCceeeCCccCcCCCcccccchhhhhcCCCCCCCCceeEEeeeEEEEEEecCCcchhh---ccCCE-
Confidence 77666666541 11 00 0 0 00000000 0 0000 1112444442 23221
Q ss_pred cccccCCCCCCceeeeeccHHHHHhhCC-C-----CCcCCCCCCCceEEEEecC--CCccHHHHHHHHHHHHHcCCeEEE
Q 000880 1095 YVGYASRTNPPSGVGASLALETIIQHYP-V-----DFKPVRNEAGTSVLVCSRG--GGGLLVERMELVAELWEENIKAQF 1166 (1239)
Q Consensus 1095 ~~~~~g~~~~~pAvGfaigldrl~~~L~-~-----~~~~~~~~~~~~v~v~~~~--~~~~~~~a~~ia~~Lr~~G~~ve~ 1166 (1239)
+...-|+...+....|+||++||+.++. + +..++...+|.+|+|++.+ ++.....|.++++.||+.|++|++
T Consensus 424 ~~~~~g~~~~~~m~~~gIGv~Rli~al~e~~~d~~gl~~P~~iaP~~v~Iv~~~~~~~~~~~~a~~i~~~L~~~gi~v~~ 503 (565)
T PRK09194 424 VLDENGKAQPLIMGCYGIGVSRLVAAAIEQNHDEKGIIWPKAIAPFDVHIVPVNMKDEEVKELAEKLYAELQAAGIEVLL 503 (565)
T ss_pred EECCCCCEEeEEEeeEechHHHHHHHHHHhhccccCccCCCccCCceEEEEECCCCcHHHHHHHHHHHHHHhccCCeEEE
Confidence 0111222332333567999999988874 2 4344445688999999984 234678999999999999999998
Q ss_pred eeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHH
Q 000880 1167 VPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLL 1225 (1239)
Q Consensus 1167 ~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~ 1225 (1239)
++. +.++++++++|+..|+|++|+||++|+++|+|+||++.+|+|..|+++++++.+.
T Consensus 504 Ddr-~~~~g~k~~~ad~~GiP~~iiiG~~e~~~~~v~v~~r~~ge~~~v~~~~l~~~i~ 561 (565)
T PRK09194 504 DDR-KERPGVKFADADLIGIPHRIVVGDRGLAEGIVEYKDRRTGEKEEVPVDELVEFLK 561 (565)
T ss_pred ECC-CCCHHHHHHHHHhcCCCEEEEEcCccccCCeEEEEECCCCceEEEeHHHHHHHHH
Confidence 776 5799999999999999999999999999999999999999999999999998876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=316.38 Aligned_cols=247 Identities=34% Similarity=0.484 Sum_probs=190.9
Q ss_pred EeeeccCCceE-EEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCCCCcC
Q 000880 429 LQPLGHGGFGH-VVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 429 ~~~LG~G~fG~-Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
-+.+|.|+.|+ ||+|... |+.||||.+-. +...-..+|+..|+.- .|||||++|+. +
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~--E------------ 572 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCS--E------------ 572 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEee--c------------
Confidence 35689999987 7999886 89999997642 2234577999999888 79999999854 2
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DH---FDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~---l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
.+..++||..|+|..+|.+++... .. ......+.++.|++.||+|||+.+
T Consensus 573 --------------------------~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~ 626 (903)
T KOG1027|consen 573 --------------------------QDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK 626 (903)
T ss_pred --------------------------cCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc
Confidence 346789999999999999999874 11 111345788999999999999999
Q ss_pred ccccCCCcccEEEcC---C--CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCc
Q 000880 583 IIHRDLTPNNIFFDA---R--NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 583 IiHrDLKp~NILl~~---~--~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ 657 (1239)
||||||||.||||+. + ..++|+|||+++.+..... .++. ..+..||-+|+|||++.. ..-+.
T Consensus 627 iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s-----------S~~r-~s~~sGt~GW~APE~L~~-~~~~~ 693 (903)
T KOG1027|consen 627 IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS-----------SFSR-LSGGSGTSGWQAPEQLRE-DRKTQ 693 (903)
T ss_pred cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc-----------hhhc-ccCCCCcccccCHHHHhc-cccCc
Confidence 999999999999976 3 3589999999998743321 1111 355679999999999998 45677
Q ss_pred chhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
++||||+||++|..++ ||.....++.-+ +........--+..-.++.+||.+|++++|..||+|.++|.||||-
T Consensus 694 avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--l~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 694 AVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--LTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ccchhhcCceEEEEecCCccCCCchHHhhhhh--hcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 9999999999999985 999887765432 2222221110000011899999999999999999999999999988
Q ss_pred CchH
Q 000880 734 QMEY 737 (1239)
Q Consensus 734 ~~~~ 737 (1239)
..+.
T Consensus 772 ~~ek 775 (903)
T KOG1027|consen 772 DSEK 775 (903)
T ss_pred ChHH
Confidence 7654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=285.04 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=202.0
Q ss_pred EeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 429 ~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
-+.||-|+||.||.+.+..+|+.||+|++..-........++.+|+++|..++|.|++..++...-+ ..+
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp-h~d--------- 127 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA-NPS--------- 127 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC-Cch---------
Confidence 4779999999999999999999999999876555555678899999999999999999988664221 110
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDL 588 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDL 588 (1239)
--..+|+++|++..+|..++.+...++...++-+++||++||+|||+.+|.||||
T Consensus 128 -------------------------fFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDI 182 (449)
T KOG0664|consen 128 -------------------------FFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDI 182 (449)
T ss_pred -------------------------HHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccC
Confidence 0124689999999999999998899999999999999999999999999999999
Q ss_pred CcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHH
Q 000880 589 TPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVF 668 (1239)
Q Consensus 589 Kp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL 668 (1239)
||.|.|++++..+||||||+|+.....+ +..++..+-|..|.|||++.|...|+.+.||||+|||+
T Consensus 183 KPGNLLVNSNCvLKICDFGLARvee~d~--------------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF 248 (449)
T KOG0664|consen 183 KPGNLLVNSNCILKICDFGLARTWDQRD--------------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF 248 (449)
T ss_pred CCccEEeccCceEEecccccccccchhh--------------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence 9999999999999999999999753322 12245567889999999999988899999999999999
Q ss_pred HHhhc---CCchhHHHH---------------H-------HHHhhhhcCCCCCccc---------cCCHHHHHHHHHccC
Q 000880 669 FELWH---PFSTAMERQ---------------I-------VLSDLKQKGELPPSWV---------AKFSEQESLLRRLMS 714 (1239)
Q Consensus 669 ~ELlt---Pf~~~~~~~---------------~-------~~~~~~~~~~~p~~~~---------~~~~e~~~LI~~~L~ 714 (1239)
.||+. -|....+.+ . ....+...+..+|+.. ....+...++..++.
T Consensus 249 aELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~ 328 (449)
T KOG0664|consen 249 AELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLH 328 (449)
T ss_pred HHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhC
Confidence 99973 121111110 0 0111111222233222 122366789999999
Q ss_pred CCCCCCCCHHHHHhccCCCCc
Q 000880 715 PSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 715 ~dP~~RPta~eiL~~~~~~~~ 735 (1239)
.||++|.+.++.+.|++....
T Consensus 329 ~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 329 FDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred CCCcccccHhhhccccccccc
Confidence 999999999999999876544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=311.83 Aligned_cols=271 Identities=26% Similarity=0.451 Sum_probs=219.7
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
.++|+.+.++|.|.||.||+++++.+++..|+|+++..... ...-+..|+-+++..+|||||.|++.+..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr-------- 83 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLR-------- 83 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhh--------
Confidence 37899999999999999999999999999999999875432 34557789999999999999999988732
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
...+||.||||+ |+|++..+-.+.+++-++...++..+.|++|||++
T Consensus 84 --------------------------------~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~ 131 (829)
T KOG0576|consen 84 --------------------------------RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ 131 (829)
T ss_pred --------------------------------hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC
Confidence 456899999997 59999998889999999999999999999999999
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccc--cCCCCCCcch
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE--QGWPKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l--~~~~~~~~ks 659 (1239)
|=+|||||-.|||+++.|.+|++|||.+..+.. +-....++.|||.|||||+- .....|...+
T Consensus 132 gk~hRdiKGanilltd~gDvklaDfgvsaqita---------------ti~KrksfiGtpywmapEvaaverkggynqlc 196 (829)
T KOG0576|consen 132 GKIHRDIKGANILLTDEGDVKLADFGVSAQITA---------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 196 (829)
T ss_pred CcccccccccceeecccCceeecccCchhhhhh---------------hhhhhhcccCCccccchhHHHHHhcccccccc
Confidence 999999999999999999999999999986531 12234678999999999973 3345699999
Q ss_pred hhHHHHHHHHHhh--c-CCchhHHHHHHHHhhhhcCCCCCc---cccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 660 DMYSLGIVFFELW--H-PFSTAMERQIVLSDLKQKGELPPS---WVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 660 DIwSlGviL~ELl--t-Pf~~~~~~~~~~~~~~~~~~~p~~---~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
|+|++|++..|+- + |..+.+++....-.-. .+.-|+. ....++.+.+|++.+|.++|++|||++.+|+|+|..
T Consensus 197 diwa~gitAiel~eLqpplfdlhpmr~l~LmTk-S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs 275 (829)
T KOG0576|consen 197 DIWALGITAIELGELQPPLFDLHPMRALFLMTK-SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS 275 (829)
T ss_pred cccccccchhhhhhcCCcccccchHHHHHHhhc-cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence 9999999999985 3 6666666655443322 3333332 233456788999999999999999999999999876
Q ss_pred Cch-HHHHHHHHHhcCCCC
Q 000880 734 QME-YELLDNILRMMHSSE 751 (1239)
Q Consensus 734 ~~~-~~~~~~~~~~~~~~~ 751 (1239)
+-. ....-.++....+++
T Consensus 276 ~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 276 QTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred cchhhHHHHHHHHHccCCC
Confidence 652 333344555555554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=270.53 Aligned_cols=253 Identities=21% Similarity=0.387 Sum_probs=199.6
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCcccc
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~ 500 (1239)
..++|++++++|+|-|++||-|.+..+++.++||+++.. ....+.+|+.+|..|. ||||+++++...++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp----- 105 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDP----- 105 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCc-----
Confidence 468999999999999999999999999999999998632 3457999999999996 99999999876443
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
......+++||+.. +...+. ..++.-.++.++.+++.||.|||
T Consensus 106 ---------------------------------~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCH 149 (338)
T KOG0668|consen 106 ---------------------------------ESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCH 149 (338)
T ss_pred ---------------------------------cccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHH
Confidence 23445789999975 555543 45778889999999999999999
Q ss_pred hCCccccCCCcccEEEcCC-CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcc
Q 000880 580 GQGIIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~k 658 (1239)
|+||+|||+||.|+|||.. ..++|+|+|+|.++.... .-+.++.+..|--||.+-..+.|+..
T Consensus 150 S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~----------------eYnVRVASRyfKGPELLVdy~~YDYS 213 (338)
T KOG0668|consen 150 SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----------------EYNVRVASRYFKGPELLVDYQMYDYS 213 (338)
T ss_pred hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc----------------eeeeeeehhhcCCchheeechhcccc
Confidence 9999999999999999975 569999999999875332 12445778889999999988889999
Q ss_pred hhhHHHHHHHHHhhc---CCchhH-HHHHHHHhhh-------------hcCCCCCc------------c--------cc-
Q 000880 659 ADMYSLGIVFFELWH---PFSTAM-ERQIVLSDLK-------------QKGELPPS------------W--------VA- 700 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~-~~~~~~~~~~-------------~~~~~p~~------------~--------~~- 700 (1239)
-|||||||+|..|+- ||.... +.....++.. -...++|. | ..
T Consensus 214 LD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl 293 (338)
T KOG0668|consen 214 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHL 293 (338)
T ss_pred HHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccccc
Confidence 999999999999984 775332 2222111110 00011111 1 11
Q ss_pred CCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCch
Q 000880 701 KFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 701 ~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~~ 736 (1239)
.+|++.+|+.++|..|..+|+||.+++.||||....
T Consensus 294 ~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 294 VSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred CChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 247899999999999999999999999999987653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=284.17 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=199.2
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+|.-++.+|.|.- .|..+-+...++.||+|+...........++..+|..++..++|+||++++.+|.-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP--------- 86 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP--------- 86 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc---------
Confidence 45666788999987 78888898899999999987665555566789999999999999999999988732
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
+........+|+|||||..+|.+.+. -.++.....+++.|++.|++|||+.||
T Consensus 87 -------------------------~~~l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~I 139 (369)
T KOG0665|consen 87 -------------------------QKTLEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGI 139 (369)
T ss_pred -------------------------cccHHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcce
Confidence 12223446789999999999999887 447888999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+||||||+||++..++.+||.|||+|+... ..+..+.++.|..|.|||++.+.+ |...+||||
T Consensus 140 ihRdLkPsnivv~~~~~lKi~dfg~ar~e~----------------~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwS 202 (369)
T KOG0665|consen 140 IHRDLKPSNIVVNSDCTLKILDFGLARTED----------------TDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWS 202 (369)
T ss_pred eecccCcccceecchhheeeccchhhcccC----------------cccccCchhheeeccCchheeccC-Ccccchhhh
Confidence 999999999999999999999999998531 224567789999999999999955 999999999
Q ss_pred HHHHHHHhhc---CCchhHHHHHH--------------HH-------h----------hhhcCCCCC-ccc-------cC
Q 000880 664 LGIVFFELWH---PFSTAMERQIV--------------LS-------D----------LKQKGELPP-SWV-------AK 701 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~--------------~~-------~----------~~~~~~~p~-~~~-------~~ 701 (1239)
+||++.||++ -|.+....... +. + ......+|. .|. ..
T Consensus 203 vGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~ 282 (369)
T KOG0665|consen 203 VGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLD 282 (369)
T ss_pred hhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccc
Confidence 9999999974 12111110000 00 0 000011111 010 11
Q ss_pred CHHHHHHHHHccCCCCCCCCCHHHHHhccCCC
Q 000880 702 FSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 702 ~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~ 733 (1239)
...+++++.+||..||++|.++.++|+||+++
T Consensus 283 ~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 283 CSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 23568999999999999999999999999887
|
|
| >PLN02908 threonyl-tRNA synthetase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=316.33 Aligned_cols=352 Identities=14% Similarity=0.133 Sum_probs=259.0
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ec--cCCCccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YL--LGDCPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~--~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
.+.|+++|+|..+.+++.+.+.+++.+.++||++|.||.| ++ .++.+...++||.| |.+++.++|||+.|+++
T Consensus 309 ~~~G~~~~lP~g~~i~~~l~~~~~~~~~~~G~~ev~tP~l~~~~l~~~sGh~~~~~~~mf~~-~~~~~~~~Lrp~~~~~~ 387 (686)
T PLN02908 309 LSPGSCFFLPHGARIYNKLMDFIREQYWERGYDEVITPNIYNMDLWETSGHAAHYKENMFVF-EIEKQEFGLKPMNCPGH 387 (686)
T ss_pred CCCcceEEechHHHHHHHHHHHHHHHHHHcCCEEEECCccccHHHHhhcCCccccchhccEE-ecCCeeEEEcCCCcHHH
Confidence 3579999999999999999999999999999999999999 22 33456688999998 66789999999999999
Q ss_pred HHHHHhCC----CCceeEEeecCeEEcCCCC-----CCCCceeEEeEEEeCCC-CcccHH-HHHHHHHHHHHhcCCCCce
Q 000880 857 IRWAISNQ----KSSFKRYEISSVYRRAIGH-----SPPNRYLQGDFDIIGGA-SALTEA-EVLKVTMDIVTRFFHAESC 925 (1239)
Q Consensus 857 aR~~~~~~----~~P~r~~Y~g~VfR~e~~~-----~~~~ef~Q~GvEiiG~~-s~~aDa-Evi~la~~~l~~lgi~~~~ 925 (1239)
+++++... ..|+|+|++|+|||+|.+. .|.+||+|+++++||.. ...+|+ |++.++.++++.||+. +
T Consensus 388 ~~~~~~~~~s~r~LPlr~~~~g~~fR~E~~~~l~Gl~RvReF~q~d~~if~~~~q~~~e~~~~l~~~~~v~~~lG~~--~ 465 (686)
T PLN02908 388 CLMFAHRVRSYRELPLRLADFGVLHRNELSGALTGLTRVRRFQQDDAHIFCREDQIKDEVKGVLDFLDYVYEVFGFT--Y 465 (686)
T ss_pred HHHHhccccChhhCCHhHEEeeccccCCCCcCCcCccccccEEEeeEEEEcCHHHHHHHHHHHHHHHHHHHHHCCCc--E
Confidence 99888732 4599999999999998873 25567999999999995 457888 9999999999999993 9
Q ss_pred EEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCCh
Q 000880 926 DIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAA 1005 (1239)
Q Consensus 926 ~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~ 1005 (1239)
.+.|+++. +.++..++.-+.....+..++++.++. +. + ...+ . .+.|+.
T Consensus 466 ~~~ls~r~--~~~~g~~~~w~~ae~~l~~~ld~~~~~------~~---------~---~~g~-------~----afygpk 514 (686)
T PLN02908 466 ELKLSTRP--EKYLGDLETWDKAEAALTEALNAFGKP------WQ---------L---NEGD-------G----AFYGPK 514 (686)
T ss_pred EEEEeCCc--cccCCCHHHHHHHHHHHHHHHHHcCCC------cE---------E---CCCc-------e----eecccc
Confidence 99999975 555443333333344466666665421 00 0 0000 0 111221
Q ss_pred hhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCC--CCCccceeEEEEEecCCCCcccccccccccccccc
Q 000880 1006 DQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPP--IESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRY 1083 (1239)
Q Consensus 1006 ~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~r--gl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRY 1083 (1239)
. +..+..++.++ .. ...+.+|+.+.. +++||| |... .
T Consensus 515 i------------d~~~~d~l~r~----~~-~~t~q~df~lp~~f~L~Y~~----e~~~---~----------------- 553 (686)
T PLN02908 515 I------------DITVSDALKRK----FQ-CATVQLDFQLPIRFKLSYSA----EDEA---K----------------- 553 (686)
T ss_pred e------------EEEEEeccCCE----ee-ccceeecccCHhhcCCEEEC----CCCC---c-----------------
Confidence 0 00111222222 00 013445555433 577777 1100 0
Q ss_pred cchhhhccccccccccCCCCCCceeeeec--cHHHHHhhCC-C--CCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHH
Q 000880 1084 DYLLHRMWDREYVGYASRTNPPSGVGASL--ALETIIQHYP-V--DFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELW 1158 (1239)
Q Consensus 1084 D~L~~~fg~~~~~~~~g~~~~~pAvGfai--gldrl~~~L~-~--~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr 1158 (1239)
..+ ...+.-|+ ++||++.+|. . +..+.|. .+.+|+|++.+ +....+|+++++.||
T Consensus 554 -----------------~~~-pv~ihrai~GsiERli~iL~e~~~g~~p~wl-sp~qv~Vipv~-~~~~~~A~~va~~LR 613 (686)
T PLN02908 554 -----------------IER-PVMIHRAILGSVERMFAILLEHYAGKWPFWL-SPRQAIVVPIS-EKSQDYAEEVRAQLH 613 (686)
T ss_pred -----------------CCC-CEEEEeCceEhHHHHHHHHHHHcCCCCCCCC-CCceEEEEEEC-HHHHHHHHHHHHHHH
Confidence 000 01221222 7999998884 2 4444443 47799999996 677899999999999
Q ss_pred HcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHh
Q 000880 1159 EENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIAS 1230 (1239)
Q Consensus 1159 ~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~ 1230 (1239)
++|++|+++.. ++++++++++|++.|+++++|+|++|.++|+|+||++.+++|.+++++++++.+++..+.
T Consensus 614 ~~Gi~vevd~~-~~~l~kkir~A~~~g~~~viivG~~E~~~~~V~vr~~~~~~q~~i~l~el~~~l~~~~~~ 684 (686)
T PLN02908 614 AAGFYVDVDVT-DRKIQKKVREAQLAQYNYILVVGEAEAATGTVNVRTRDNVVHGEKKIEELLTEFKEERAE 684 (686)
T ss_pred HCCCEEEEECC-CCCHHHHHHHHHHcCCCEEEEECchHHhCCEEEEEECCCCceeeeeHHHHHHHHHHHHhh
Confidence 99999998776 679999999999999999999999999999999999999999999999999999877654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=275.19 Aligned_cols=239 Identities=33% Similarity=0.564 Sum_probs=193.5
Q ss_pred CceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCcccccc
Q 000880 436 GFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASST 515 (1239)
Q Consensus 436 ~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~~~s~~ 515 (1239)
+||.||+|.+..+|+.+|+|++........ ...+.+|+..++.++|+||+++++.+..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--------------------- 58 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--------------------- 58 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee---------------------
Confidence 689999999998899999999875443221 5789999999999999999999987632
Q ss_pred cccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEE
Q 000880 516 FSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594 (1239)
Q Consensus 516 ~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NIL 594 (1239)
....+++|||+++ +|..++.....++...++.++.+++.++.|||+.+++|+||+|.||+
T Consensus 59 -------------------~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~ 119 (244)
T smart00220 59 -------------------EDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENIL 119 (244)
T ss_pred -------------------CCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeE
Confidence 2567999999986 99999987666999999999999999999999999999999999999
Q ss_pred EcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc-
Q 000880 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH- 673 (1239)
Q Consensus 595 l~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt- 673 (1239)
++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 120 ~~~~~~~~l~d~~~~~~~~~~~----------------~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~ 182 (244)
T smart00220 120 LDEDGHVKLADFGLARQLDPGG----------------LLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTG 182 (244)
T ss_pred ECCCCcEEEccccceeeecccc----------------ccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999998753221 1234568899999999886 567889999999999999996
Q ss_pred --CCchhHHHHHHHHhhhhcCC-CCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 674 --PFSTAMERQIVLSDLKQKGE-LPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 674 --Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
||.................. ........+.++.+++.+||..+|++||++.++++|+|+
T Consensus 183 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 183 KPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 77553333333333321111 111211156689999999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=300.89 Aligned_cols=268 Identities=18% Similarity=0.238 Sum_probs=182.0
Q ss_pred cccCCceEEeeeccCCceEEEEEEEc----------------cCCcEEEEEEEecCCCCch------------hHHHHHH
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNK----------------LDGRHYAVKKIRLKDKSLP------------VNDRILR 472 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~----------------~~g~~vAVK~i~~~~~~~~------------~~~~~~~ 472 (1239)
...++|++.++||+|+||.||+|.+. ..++.||||.+........ ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34689999999999999999999752 2456899999865322100 1122344
Q ss_pred HHHHHHhcCCCce-----eeeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-
Q 000880 473 EVATLSRLQHQHV-----VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP- 546 (1239)
Q Consensus 473 Ev~iL~~L~HpnI-----v~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~- 546 (1239)
|+..+.+++|.++ ++++++|.... .+........|+||||++
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~--------------------------------~~g~~~~~~~~LV~Ey~~~ 269 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNT--------------------------------ADGAFTKGSQWLVWKFESD 269 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhccccc--------------------------------ccccccCCceEEEEEcCCC
Confidence 6777777766654 44555442210 001112345799999996
Q ss_pred CCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEE
Q 000880 547 RTLRQVFESY------------------------DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602 (1239)
Q Consensus 547 gsL~~~l~~~------------------------~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vK 602 (1239)
++|.++++.. ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus 270 gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~k 349 (507)
T PLN03224 270 ATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVK 349 (507)
T ss_pred CcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEE
Confidence 5898888632 1245678889999999999999999999999999999999999999
Q ss_pred EeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC-------------------C--Ccchhh
Q 000880 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK-------------------I--DEKADM 661 (1239)
Q Consensus 603 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-------------------~--~~ksDI 661 (1239)
|+|||+++...... ........+|+.|+|||++..... | ..+.||
T Consensus 350 L~DFGla~~~~~~~--------------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dv 415 (507)
T PLN03224 350 IIDFGAAVDMCTGI--------------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDS 415 (507)
T ss_pred EEeCcCccccccCC--------------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccch
Confidence 99999997542110 001122345899999998764211 1 134799
Q ss_pred HHHHHHHHHhhc----CCchhHH--HHH-----HHH---hhhhcCCCCCccccCCHHHHHHHHHccCCCC---CCCCCHH
Q 000880 662 YSLGIVFFELWH----PFSTAME--RQI-----VLS---DLKQKGELPPSWVAKFSEQESLLRRLMSPSP---SDRPSAT 724 (1239)
Q Consensus 662 wSlGviL~ELlt----Pf~~~~~--~~~-----~~~---~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP---~~RPta~ 724 (1239)
||+||++|+|++ ||..... .+. ... .........+.+...++...+|+.+||..+| .+|+|+.
T Consensus 416 wSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ 495 (507)
T PLN03224 416 YTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVG 495 (507)
T ss_pred hhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHH
Confidence 999999999986 4432111 000 000 0110111122345567789999999999876 6899999
Q ss_pred HHHhccCCCC
Q 000880 725 ELLQDALPPQ 734 (1239)
Q Consensus 725 eiL~~~~~~~ 734 (1239)
++|+||||.+
T Consensus 496 eaL~Hp~f~~ 505 (507)
T PLN03224 496 QALSHRFFLP 505 (507)
T ss_pred HHhCCCCcCC
Confidence 9999999964
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=310.05 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=199.0
Q ss_pred CceEEeeeccCCceEEEEEEEcc-------CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKL-------DGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~-------~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~ 496 (1239)
++.+.+.||.|.||.|++|..+. ....||||.++..... .....+..|+++|+.+ .||||+.++|+|..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 34556699999999999997541 1457999998754444 6678899999999999 69999999999833
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC----------------CC
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD----------------HF 559 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~----------------~l 559 (1239)
...+++|+|||. |+|..+++... .+
T Consensus 374 --------------------------------------~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L 415 (609)
T KOG0200|consen 374 --------------------------------------DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDAL 415 (609)
T ss_pred --------------------------------------CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCc
Confidence 356799999996 79999987654 38
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCccccc
Q 000880 560 DKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639 (1239)
Q Consensus 560 ~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 639 (1239)
+....+.++.||+.||+||++..+|||||-.+|||+..+..+||+|||+|+........ ..++..|
T Consensus 416 ~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y--------------~~~~~~~ 481 (609)
T KOG0200|consen 416 TTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYY--------------RTKSSAG 481 (609)
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCce--------------EecCCCC
Confidence 88899999999999999999999999999999999999999999999999854322211 0011122
Q ss_pred --CccCCCcccccCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHcc
Q 000880 640 --TYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 640 --T~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L 713 (1239)
...|||||.+.. ..|+.++|||||||+|||+++ |+............+ ..+.....+..+++++.++|+.||
T Consensus 482 ~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l-~~G~r~~~P~~c~~eiY~iM~~CW 559 (609)
T KOG0200|consen 482 TLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL-KEGNRMEQPEHCSDEIYDLMKSCW 559 (609)
T ss_pred ccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHh
Confidence 345999999998 789999999999999999996 877644233334433 356666666677889999999999
Q ss_pred CCCCCCCCCHHHHHhc
Q 000880 714 SPSPSDRPSATELLQD 729 (1239)
Q Consensus 714 ~~dP~~RPta~eiL~~ 729 (1239)
+.+|++||++.++...
T Consensus 560 ~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 560 NADPEDRPTFSECVEF 575 (609)
T ss_pred CCCcccCCCHHHHHHH
Confidence 9999999999999863
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=296.20 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=200.2
Q ss_pred ceEEeeeccCCceEEEEEEEccCCc----EEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGR----HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~----~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~ 501 (1239)
++..++||.|+||+||+|.|...|+ +||||++. ...+......+++|+.+|.++.|||++++++.|...
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~-~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------ 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLI-EFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------ 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEee-ccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence 4446899999999999999976665 68999886 344555678899999999999999999999998432
Q ss_pred CCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 502 ~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
.+-||++|++ |.|.++++.. +.+-....+.|..||++||.|||
T Consensus 771 -----------------------------------~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe 815 (1177)
T KOG1025|consen 771 -----------------------------------TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE 815 (1177)
T ss_pred -----------------------------------hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 2568999998 7999998754 56888889999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
.++++||||-.+|||+....++||.|||+|+.+....... ......-.+-|||-|.+.. ..|+.++
T Consensus 816 ~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey-------------~~~~gK~pikwmale~i~~-~~~thqS 881 (1177)
T KOG1025|consen 816 EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY-------------SAPGGKVPIKWMALESIRI-RKYTHQS 881 (1177)
T ss_pred hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc-------------cccccccCcHHHHHHHhhc-cCCCchh
Confidence 9999999999999999999999999999999875433211 1122334567999998887 6799999
Q ss_pred hhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
|||||||++||++| |+......++. .+...+...+.++.++-++..++.+||..|+..||+|+++...
T Consensus 882 DVWsfGVtiWElmTFGa~Py~gi~~~eI~--dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 882 DVWSFGVTIWELMTFGAKPYDGIPAEEIP--DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred hhhhhhhhHHHHHhcCCCccCCCCHHHhh--HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHH
Confidence 99999999999997 77666555543 2333555555556667789999999999999999999998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=273.60 Aligned_cols=135 Identities=23% Similarity=0.380 Sum_probs=117.0
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-----CC---ceeeeeeeeeec
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-----HQ---HVVRYYQAWFET 495 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-----Hp---nIv~l~~~~~e~ 495 (1239)
.+|.++++||.|.|++||+|.+..+.+.||+|+.+. .....+..+.|+++|++++ |+ +||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 689999999999999999999999999999999873 2234567889999999982 43 699999988654
Q ss_pred CccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh--cCCCCHHHHHHHHHHHHH
Q 000880 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES--YDHFDKELAWHLFRQIVE 573 (1239)
Q Consensus 496 ~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~ 573 (1239)
| .+..+++||+|+++.+|..+|.. +..++...++.|++||+.
T Consensus 155 G------------------------------------pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~ 198 (590)
T KOG1290|consen 155 G------------------------------------PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLT 198 (590)
T ss_pred C------------------------------------CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHH
Confidence 4 24678999999999999999975 456999999999999999
Q ss_pred HHHHHHh-CCccccCCCcccEEEcC
Q 000880 574 GLAHIHG-QGIIHRDLTPNNIFFDA 597 (1239)
Q Consensus 574 gL~yLHs-~gIiHrDLKp~NILl~~ 597 (1239)
||.|||. .||||-||||+|||+..
T Consensus 199 GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 199 GLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred HHHHHHHhcCccccCCCcceeeeec
Confidence 9999997 59999999999999953
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=283.62 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=197.1
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCC------CceeeeeeeeeecC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH------QHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~H------pnIv~l~~~~~e~~ 496 (1239)
-+.|.+....|+|-|++|.+|++..-|+.||||+|+..+. ....=++|+.+|++|+. -|+++++..|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--- 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--- 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh---
Confidence 4679999999999999999999999999999999984432 34456789999999952 37788776653
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCC---CCHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH---FDKELAWHLFRQIVE 573 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~---l~~~~~~~i~~qI~~ 573 (1239)
...++|||+|-+..+|.++|.+++. +....++.|+.|+..
T Consensus 505 -------------------------------------hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLfl 547 (752)
T KOG0670|consen 505 -------------------------------------HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFL 547 (752)
T ss_pred -------------------------------------hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHH
Confidence 3578999999999999999998764 888999999999999
Q ss_pred HHHHHHhCCccccCCCcccEEEcCC-CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC
Q 000880 574 GLAHIHGQGIIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 574 gL~yLHs~gIiHrDLKp~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
||..|-..||+|.||||.|||+++. ..+||||||.|.+...+++ +.+.-+..|.|||++.|
T Consensus 548 ALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei-----------------tPYLVSRFYRaPEIiLG- 609 (752)
T KOG0670|consen 548 ALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI-----------------TPYLVSRFYRAPEIILG- 609 (752)
T ss_pred HHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccc-----------------cHHHHHHhccCcceeec-
Confidence 9999999999999999999999876 5689999999987654432 23445667999999999
Q ss_pred CCCCcchhhHHHHHHHHHhhc---CCchhHHHHHH--HHh----------------------------------------
Q 000880 653 PKIDEKADMYSLGIVFFELWH---PFSTAMERQIV--LSD---------------------------------------- 687 (1239)
Q Consensus 653 ~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~--~~~---------------------------------------- 687 (1239)
-.|+...|+||+||+||||+| -|.+..+.+.+ ...
T Consensus 610 ~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~ 689 (752)
T KOG0670|consen 610 LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKR 689 (752)
T ss_pred CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeE
Confidence 569999999999999999987 23333222211 110
Q ss_pred ---------------hhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 688 ---------------LKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 688 ---------------~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
+.....+|........++.+|+..||..||++|.|..++|+|||+..
T Consensus 690 ~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 690 TVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred EEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00111112222222235679999999999999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=251.76 Aligned_cols=200 Identities=27% Similarity=0.441 Sum_probs=165.1
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+++..+..||+|++|.|-+.+|..+|...|+|.++..-.+ ....+.++|+.+..+. ..|++|.+||+++.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-------- 116 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-------- 116 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhc--------
Confidence 5566678899999999999999999999999999865443 4456788898887666 79999999998754
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHH----HHhcCCCCHHHHHHHHHHHHHHHHHH
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQV----FESYDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~----l~~~~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
...+||.||.|..||..+ +.....+++...-+++..++.||.||
T Consensus 117 --------------------------------egdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L 164 (282)
T KOG0984|consen 117 --------------------------------EGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFL 164 (282)
T ss_pred --------------------------------cccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHH
Confidence 345799999999887665 45667899999999999999999999
Q ss_pred HhC-CccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC---CC
Q 000880 579 HGQ-GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW---PK 654 (1239)
Q Consensus 579 Hs~-gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~ 654 (1239)
|++ .+||||+||+||||+.+|++|+||||++-.+...- ..+-..|...|||||.+... ..
T Consensus 165 ~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi----------------Akt~daGCkpYmaPEri~~e~n~~g 228 (282)
T KOG0984|consen 165 HSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI----------------AKTMDAGCKPYMAPERINPELNQKG 228 (282)
T ss_pred HHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh----------------HHHHhcCCCccCChhhcCcccCccc
Confidence 986 79999999999999999999999999998764321 12234688889999987642 35
Q ss_pred CCcchhhHHHHHHHHHhhc---CCchhHH
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAME 680 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt---Pf~~~~~ 680 (1239)
|+-++||||||++++||.+ |+..+..
T Consensus 229 Y~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 229 YSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred ceeehhhhhhhhhhhhhhhccccccccCC
Confidence 8999999999999999985 6655533
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=324.87 Aligned_cols=236 Identities=21% Similarity=0.331 Sum_probs=178.3
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
..|.....||+|+||.||+|+++.+|..||||.++..... ...|+..+++++|||||+++++|.+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~--------- 754 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS--------- 754 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc---------
Confidence 4566678899999999999999989999999988633221 2346889999999999999999843
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH--- 579 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH--- 579 (1239)
....|+|||||+ |+|.++++. +++..+..++.||+.||+|||
T Consensus 755 -------------------------------~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~ 800 (968)
T PLN00113 755 -------------------------------EKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRC 800 (968)
T ss_pred -------------------------------CCCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCC
Confidence 234689999996 699999863 889999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcch
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ks 659 (1239)
+.+|+||||||+||+++.++..++. ||.+.... ......||+.|||||++.+ ..++.++
T Consensus 801 ~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~-~~~~~~s 859 (968)
T PLN00113 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-------------------TDTKCFISSAYVAPETRET-KDITEKS 859 (968)
T ss_pred CCCeecCCCCHHhEEECCCCceEEE-eccccccc-------------------cCCCccccccccCcccccC-CCCCccc
Confidence 6799999999999999999888876 66544321 0123368999999999987 5699999
Q ss_pred hhHHHHHHHHHhhc---CCchhHHH----HHHHHhhhh--------cCCCCCc---cccCCHHHHHHHHHccCCCCCCCC
Q 000880 660 DMYSLGIVFFELWH---PFSTAMER----QIVLSDLKQ--------KGELPPS---WVAKFSEQESLLRRLMSPSPSDRP 721 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~----~~~~~~~~~--------~~~~p~~---~~~~~~e~~~LI~~~L~~dP~~RP 721 (1239)
|||||||++|||++ ||...... ......... .+..... ......++.+++.+||+.||.+||
T Consensus 860 Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 939 (968)
T PLN00113 860 DIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939 (968)
T ss_pred chhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc
Confidence 99999999999997 66322110 000000000 0011000 011123567899999999999999
Q ss_pred CHHHHHhc
Q 000880 722 SATELLQD 729 (1239)
Q Consensus 722 ta~eiL~~ 729 (1239)
|+.++++.
T Consensus 940 t~~evl~~ 947 (968)
T PLN00113 940 CANDVLKT 947 (968)
T ss_pred CHHHHHHH
Confidence 99999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=285.33 Aligned_cols=197 Identities=29% Similarity=0.492 Sum_probs=170.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC------chhHHHHHHHHHHHHhcC---CCceeeeeeeee
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS------LPVNDRILREVATLSRLQ---HQHVVRYYQAWF 493 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~------~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~ 493 (1239)
..+|..++.||.|+||.|++|.++.+...|+||.|.+...- .+....+--|+.+|+.|+ |+||+++++.|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 56799999999999999999999999999999999754311 111224667999999997 99999999887
Q ss_pred ecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-C-CHHHHHHhcCCCCHHHHHHHHHHH
Q 000880 494 ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-R-TLRQVFESYDHFDKELAWHLFRQI 571 (1239)
Q Consensus 494 e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-g-sL~~~l~~~~~l~~~~~~~i~~qI 571 (1239)
++..++||+||-.+ | +|.+++.....+++.++..|++||
T Consensus 639 ---------------------------------------Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV 679 (772)
T KOG1152|consen 639 ---------------------------------------EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQV 679 (772)
T ss_pred ---------------------------------------ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHH
Confidence 34678999999985 5 899999999999999999999999
Q ss_pred HHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC
Q 000880 572 VEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651 (1239)
Q Consensus 572 ~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 651 (1239)
+.|+++||++||||||||-+|++++.+|-+||+|||.|...+.. ....++||..|.|||++.|
T Consensus 680 ~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg-----------------pfd~f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 680 VAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG-----------------PFDVFVGTVDYAAPEVLGG 742 (772)
T ss_pred HhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCC-----------------CcceeeeeccccchhhhCC
Confidence 99999999999999999999999999999999999999865322 1245799999999999999
Q ss_pred CCCCCcchhhHHHHHHHHHhhc---CCc
Q 000880 652 WPKIDEKADMYSLGIVFFELWH---PFS 676 (1239)
Q Consensus 652 ~~~~~~ksDIwSlGviL~ELlt---Pf~ 676 (1239)
.+..+..-|||++||+||-++. ||+
T Consensus 743 ~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 743 EKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CccCCCcchhhhhhheeeEEEeccCCCc
Confidence 7777899999999999999874 664
|
|
| >PRK12325 prolyl-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=276.41 Aligned_cols=371 Identities=11% Similarity=0.090 Sum_probs=242.0
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc--CCCccccccEEEEeccCCCeeeecC---CC
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL--GDCPQFKRNTVKLLTHGGDLLELSH---EL 852 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~--~~~~~~~~~~~~~~D~~G~~l~LRP---D~ 852 (1239)
..+.|+.+|+|....+++.|++.+++.+.++||++|.||.| ++. ++++...++||+|.|.+++.++||| ++
T Consensus 34 ~~~~G~~~~lP~g~~i~~~i~~~i~~~~~~~G~~ev~~P~l~~~~l~~~sg~~~~~~~emf~~~d~~~~~~~L~Pt~e~~ 113 (439)
T PRK12325 34 QQAAGIYSWLPLGLKVLKKIENIVREEQNRAGAIEILMPTIQPADLWRESGRYDAYGKEMLRIKDRHDREMLYGPTNEEM 113 (439)
T ss_pred ccCCceEEECCcHHHHHHHHHHHHHHHHHHcCCEEEECCccccHHHHhhcCCccccchhheEEecCCCCEEEEcCCCcHH
Confidence 35899999999999999999999999999999999999999 222 3356788999999999999999999 77
Q ss_pred cHHHHHHHHh-CCCCceeEEeecCeEEcC-CCCC---CCCceeEEeEEEeCCCC---cccHHHHHHHHHHHHHhcCCCCc
Q 000880 853 RLPFIRWAIS-NQKSSFKRYEISSVYRRA-IGHS---PPNRYLQGDFDIIGGAS---ALTEAEVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 853 T~~iaR~~~~-~~~~P~r~~Y~g~VfR~e-~~~~---~~~ef~Q~GvEiiG~~s---~~aDaEvi~la~~~l~~lgi~~~ 924 (1239)
|++++|.... ++..|+|+||+|+|||+| +|+. |.+||+|-++.+|+.+. ..+..+++.+..++++.||+..
T Consensus 114 ~~~~~~~~~~syrdLPlrl~q~~~~fR~E~~~~~GL~R~reF~~~D~h~f~~~~~~a~~~~~~~~~~~~~i~~~lgl~~- 192 (439)
T PRK12325 114 ITDIFRSYVKSYKDLPLNLYHIQWKFRDEIRPRFGVMRGREFLMKDAYSFDLDEEGARHSYNRMFVAYLRTFARLGLKA- 192 (439)
T ss_pred HHHHHHHHhhhchhhchHheEecCEecCCCCCCCCccccceEeEeccEEEeCCHHHHHHHHHHHHHHHHHHHHHcCCce-
Confidence 8888885554 567899999999999998 6664 45679999999998763 2466799999999999999974
Q ss_pred eEEEECcHHHHHHH-------HHHcCCCHHHHHHHHH-HHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHH
Q 000880 925 CDIHLNHGDLLEAI-------WSWAGIKAEHREKVAE-LLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQT 996 (1239)
Q Consensus 925 ~~i~lg~~~i~~~l-------l~~lgl~~~~~~~l~~-~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~ 996 (1239)
+.+.++... +.+. ....|-++. ..+. +.+... .. . .. ..+ . ..+..
T Consensus 193 ~~v~~~~~~-~gg~~s~ef~~~~~~Ge~~~---~~c~~~~~~~~-~~-~----~~-------------~~~--~-~~l~~ 246 (439)
T PRK12325 193 IPMRADTGP-IGGDLSHEFIILAETGESTV---FYDKDFLDLLV-PG-E----DI-------------DFD--V-ADLQP 246 (439)
T ss_pred EEEEEccCC-CCCCcceeeEeecCCCCceE---EEcCCchhhcc-CC-C----cc-------------cCC--H-HHHHH
Confidence 555554321 1000 000011000 0000 000000 00 0 00 000 0 11111
Q ss_pred HHHHhcCChhhHHHHHhccCCCChhHHHHHHHHH-HHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccc
Q 000880 997 VGLRFCGAADQALPRLRGALPADKPTRKALDELY-LRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGT 1075 (1239)
Q Consensus 997 l~~~~~g~~~~~l~~l~~~~~~~~~~~~~l~~l~-l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~ 1075 (1239)
++.. +......+ .++. -.+.....++ |+...++.. .|.+|.. +
T Consensus 247 ~l~~-----------~~~~~~~~-------~~~~~~~~~~~~~~~--~~~~~~~ie--vg~~~~l---g----------- 290 (439)
T PRK12325 247 IVDE-----------WTSLYAAT-------EEMHDEAAFAAVPEE--RRLSARGIE--VGHIFYF---G----------- 290 (439)
T ss_pred HHhh-----------hcccccch-------hhhhccCCCCcCCCc--ceeecceEE--EEeeecC---c-----------
Confidence 1100 00000000 0000 0000000011 222222222 3333332 1
Q ss_pred cccccccccchhhhccccccccccCCCCCCceeeeeccHHHHHhhCC-C-----CCcCCCCCCCceEEEEecC--CCccH
Q 000880 1076 LLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYP-V-----DFKPVRNEAGTSVLVCSRG--GGGLL 1147 (1239)
Q Consensus 1076 ~i~~GGRYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~-~-----~~~~~~~~~~~~v~v~~~~--~~~~~ 1147 (1239)
=+| .+.||.. +...-|....+--.-|++|++||+.+|. . +...+...+|.+|+|++.. ++...
T Consensus 291 -----~~y---s~~f~~~-y~d~~g~~~~i~~~~~GiGieRli~~l~e~~~d~~g~~~P~~iaP~qV~Iipi~~~~~~~~ 361 (439)
T PRK12325 291 -----TKY---SEPMNAK-VQGPDGKEVPVHMGSYGIGVSRLVAAIIEASHDDKGIIWPESVAPFKVGIINLKQGDEACD 361 (439)
T ss_pred -----ccc---cHhcCCE-EECCCCCEEeEEEeeeECCHHHHHHHHHHHhCccCCCcCCCCcCCeEEEEEecCCCCHHHH
Confidence 112 2333321 0111122222334467899999998885 2 3333334468899999983 25567
Q ss_pred HHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHH
Q 000880 1148 VERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLL 1225 (1239)
Q Consensus 1148 ~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~ 1225 (1239)
.+|.+++..||+.|++|+++.. +.++++++++|+..|+|++|+||++|+++|+|+||++.++++..++++++++.++
T Consensus 362 ~~a~~i~~~L~~~Gi~v~~D~~-~~~lg~ki~~a~~~giP~~iiVG~~e~~~~~V~vr~r~~~~~~~v~~~el~~~i~ 438 (439)
T PRK12325 362 AACEKLYAALSAAGIDVLYDDT-DERPGAKFATMDLIGLPWQIIVGPKGLAEGKVELKDRKTGEREELSVEAAINRLT 438 (439)
T ss_pred HHHHHHHHHHHHCCCEEEEECC-CCCHhHHHHHHHHcCCCEEEEECCcccccCeEEEEEcCCCceEEEEHHHHHHHHh
Confidence 8999999999999999998776 6799999999999999999999999999999999999999999999999988764
|
|
| >TIGR00409 proS_fam_II prolyl-tRNA synthetase, family II | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-27 Score=284.97 Aligned_cols=430 Identities=12% Similarity=0.102 Sum_probs=266.4
Q ss_pred ccccccccCCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc--CCCccccccEEEEeccCCCeee
Q 000880 774 HAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL--GDCPQFKRNTVKLLTHGGDLLE 847 (1239)
Q Consensus 774 ~~~~~~ld~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~--~~~~~~~~~~~~~~D~~G~~l~ 847 (1239)
.++.++ ..+.|+.+|+|...++++.|++.+++.+.++||++|.||.| ++. +.++...++||+|.|++|+.++
T Consensus 28 rag~i~--~~~~G~~~~lP~g~rv~~~I~~~i~~~~~~~G~~ei~~P~l~~~el~~~sg~~~~~~~emf~~~dr~~~~l~ 105 (568)
T TIGR00409 28 RAGFIR--RLGSGLYNWLPLGLRVLKKVENIVREEMNKDGAIEVLLPALQPAELWQESGRWDTYGPELLRLKDRKGREFV 105 (568)
T ss_pred hCCCcc--ccCCceEEECChHHHHHHHHHHHHHHHHHHcCCEEEECCccchHHHHhhcCCCCccchhcEEEecCCCCEEE
Confidence 345443 56799999999999999999999999999999999999999 222 2356678999999999999999
Q ss_pred ecCC----CcHHHHHHHHhCCCCceeEEeecCeEEcC-CCCCC---CCceeEEeEEEeCCCCcccHHHHHHH---HHHHH
Q 000880 848 LSHE----LRLPFIRWAISNQKSSFKRYEISSVYRRA-IGHSP---PNRYLQGDFDIIGGASALTEAEVLKV---TMDIV 916 (1239)
Q Consensus 848 LRPD----~T~~iaR~~~~~~~~P~r~~Y~g~VfR~e-~~~~~---~~ef~Q~GvEiiG~~s~~aDaEvi~l---a~~~l 916 (1239)
|||+ +|..++|.+.+++..|+|+||+|++||+| +|+.| .+||+|.|+++||.+...+|+|+..+ ..+++
T Consensus 106 LrPT~Ee~~t~~~~~~i~syr~LPlrlyqi~~~fR~E~rpr~Gl~R~REF~~~d~~~f~~~~~~a~~e~~~~~~~y~~if 185 (568)
T TIGR00409 106 LGPTHEEVITDLARNEIKSYKQLPLNLYQIQTKFRDEIRPRFGLMRGREFIMKDAYSFHSDEESLDATYQKMYQAYSNIF 185 (568)
T ss_pred EcCCCcHHHHHHHHHHHhhccccCeEEEEeeCEeeCCCCCCCCccccccEEEEEEEEEeCChHHHHHHHHHHHHHHHHHH
Confidence 9997 88888889888888899999999999998 88864 45799999999999989999888755 59999
Q ss_pred HhcCCCCceEEEECcHHHHHHHHH------------------HcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHH
Q 000880 917 TRFFHAESCDIHLNHGDLLEAIWS------------------WAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRR 978 (1239)
Q Consensus 917 ~~lgi~~~~~i~lg~~~i~~~ll~------------------~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~ 978 (1239)
++||+. |.+..++++.+.+... .++...+...+.. . ......... ...+
T Consensus 186 ~~LgL~--~~~v~~~~g~~gg~~s~ef~~~~~~ge~~i~~c~~~~y~an~e~a~~--~--~~~~~~~~~---~~~~---- 252 (568)
T TIGR00409 186 SRLGLD--FRPVQADSGAIGGSASHEFMVLAESGEDTIVYSDESDYAANIELAEA--L--APGERNAPT---AELD---- 252 (568)
T ss_pred HHhCCc--ceEEEeccccCCCccceEEeEecCCCceEEEEecCcccchhhhhhcc--c--Ccccccccc---ccce----
Confidence 999994 8888777655433211 0111110000000 0 000000000 0000
Q ss_pred HHHHhcCCCHHHHHHHHHHHH------------------------HhcCChhhHHHHHhccCCC----ChhHHHHHHHH-
Q 000880 979 QLLQELNLAEAVVNRLQTVGL------------------------RFCGAADQALPRLRGALPA----DKPTRKALDEL- 1029 (1239)
Q Consensus 979 ~l~~~~~l~~~~~~~l~~l~~------------------------~~~g~~~~~l~~l~~~~~~----~~~~~~~l~~l- 1029 (1239)
.+. --....++.+..++. .+.|+.+--..+++..+.. .....+.+...
T Consensus 253 -~~~--tp~~~ti~~~~~~~~~~~~~~~k~~~~~~~~~~~~~v~v~~rgd~~vn~~k~~~~~g~~~~~~~a~~~~~~~~~ 329 (568)
T TIGR00409 253 -KVD--TPNTKTIAELVECFNLPAEKVVKTLLVKAVDKSEPLVALLVRGDHELNEVKAPNLLLVAQVLELATEEEIFQKI 329 (568)
T ss_pred -eec--CCCCCcHHHHHHHhCCCHhHeeeEEEEEecCCccceEEEEecCcchhhHHHHHHHhccCcccccCCHHHHHHhh
Confidence 000 000111222222210 1123222222222222100 00111111111
Q ss_pred -----HHHHccCc--ccEEEccCCCCCCCc----------cceeEEE----------E--EecCCCCcc--------ccc
Q 000880 1030 -----YLRIWRIE--KNIYIDALMPPIESY----------HRNLFFQ----------V--FSVKEKYPA--------TLV 1072 (1239)
Q Consensus 1030 -----~l~~~~~~--~~i~~Dl~~~rgl~Y----------YtG~vFe----------~--~~~~~~~~~--------~~~ 1072 (1239)
++.-.|+. -++..|.+....-++ |++..+. + ...|...|. +.-
T Consensus 330 g~~~g~~gpv~~~~~~~i~~D~~~~~~~~~~~gan~~~~h~~~~~~~rd~~~~~~~d~~~~~eGd~cp~c~~~l~~~rgI 409 (568)
T TIGR00409 330 ASGPGSLGPVNINGGIPVLIDQTVALMSDFAAGANADDKHYFNVNWDRDVAIPEVADIRKVKEGDPSPDGQGTLKIARGI 409 (568)
T ss_pred CCCCCccCccccccCceEEechhhhcccccccccCCCCceeecccccccCCccccchhhhhhccCCCCCCCCcccccceE
Confidence 11111111 134555554333333 2222211 0 001111110 000
Q ss_pred ccc-cccccccccchhhhccccccccccCCCCCCceeeeeccHHHHHhhCC------CCCcCCCCCCCceEEEEecCCC-
Q 000880 1073 EGT-LLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYP------VDFKPVRNEAGTSVLVCSRGGG- 1144 (1239)
Q Consensus 1073 ~~~-~i~~GGRYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L~------~~~~~~~~~~~~~v~v~~~~~~- 1144 (1239)
+.+ ..--|=||-.- ||.. +...-|+..++...-++||++||+.++- .+..++...+|.+|.|++....
T Consensus 410 EvGhiF~LG~kYS~~---~~~~-~~d~~g~~~~~~mgcyGIGvsRli~aiie~~~D~~Gl~wP~~iAP~qV~Iip~~~~~ 485 (568)
T TIGR00409 410 EVGHIFQLGTKYSEA---LKAT-FLDENGKNQFMTMGCYGIGVSRLVSAIAEQHHDERGIIWPKAIAPYDVVIVVMNMKD 485 (568)
T ss_pred EEEEeccchhhhHHh---cCCE-EECCCCCEEEEEEeCCcchHHHHHHHHHHHhCccCCCcCChhhCCeEEEEEEcCCCh
Confidence 111 11123455433 3221 1112233333344455799999977762 3445555678999999987422
Q ss_pred -ccHHHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHH
Q 000880 1145 -GLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRF 1223 (1239)
Q Consensus 1145 -~~~~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~ 1223 (1239)
+....|.++.+.|.+.|++|.++.. +.+++++++.|+..|+|+.|+||.+++++|+|+|+++.++++..|+++++++.
T Consensus 486 ~~~~~~a~~l~~~L~~~gi~v~~DDr-~~~~G~K~~dadliGiP~~i~vG~~~l~~~~Vei~~R~~~~~~~v~~~~l~~~ 564 (568)
T TIGR00409 486 EEQQQLAEELYSELLAQGVDVLLDDR-NERAGVKFADSELIGIPLRVVVGKKNLDNGEIEVKKRRNGEKQLIKKDELVEC 564 (568)
T ss_pred HHHHHHHHHHHHHHHhCCCEEEEECC-CCCHHHHHHhhhhcCCCEEEEECCCcccCCeEEEEEcCCCceEEEEHHHHHHH
Confidence 4566788899999999999997776 56899999999999999999999999999999999999999999999999988
Q ss_pred HHH
Q 000880 1224 LLD 1226 (1239)
Q Consensus 1224 i~~ 1226 (1239)
|..
T Consensus 565 i~~ 567 (568)
T TIGR00409 565 LEE 567 (568)
T ss_pred Hhh
Confidence 754
|
Prolyl-tRNA synthetase is a class II tRNA synthetase and is recognized by pfam model tRNA-synt_2b, which recognizes tRNA synthetases for Gly, His, Ser, and Pro. The prolyl-tRNA synthetases are divided into two widely divergent groups. This group includes enzymes from Escherichia coli, Bacillus subtilis, Aquifex aeolicus, the spirochete Treponema pallidum, Synechocystis PCC6803, and one of the two prolyL-tRNA synthetases of Saccharomyces cerevisiae. The other group includes the Pro-specific domain of a human multifunctional tRNA ligase and the prolyl-tRNA synthetases from the Archaea, the Mycoplasmas, and the spirochete Borrelia burgdorferi. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=239.22 Aligned_cols=212 Identities=38% Similarity=0.710 Sum_probs=181.3
Q ss_pred eccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCcc
Q 000880 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTL 511 (1239)
Q Consensus 432 LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~~ 511 (1239)
||.|++|.||++....+|+.+++|++....... ....+.+|+..++.++|++|+++++.+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----------------- 62 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED----------------- 62 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec-----------------
Confidence 689999999999998889999999987543321 34679999999999999999999987632
Q ss_pred cccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 000880 512 ASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589 (1239)
Q Consensus 512 ~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLK 589 (1239)
....+++||+++ ++|.+++... ..++...++.++.+++.++.|||++|++|+||+
T Consensus 63 -----------------------~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~ 119 (215)
T cd00180 63 -----------------------ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119 (215)
T ss_pred -----------------------CCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 256799999998 6999998766 578999999999999999999999999999999
Q ss_pred cccEEEcC-CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHH
Q 000880 590 PNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVF 668 (1239)
Q Consensus 590 p~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL 668 (1239)
|.||+++. ++.++|+|||.+........ ......++..|++||.+.....++.++|+|++|+++
T Consensus 120 ~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~ 184 (215)
T cd00180 120 PENILLDSDNGKVKLADFGLSKLLTSDKS---------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184 (215)
T ss_pred HhhEEEeCCCCcEEEecCCceEEccCCcc---------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHH
Confidence 99999999 89999999999986432210 113346788999999987733688999999999999
Q ss_pred HHhhcCCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhcc
Q 000880 669 FELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 669 ~ELltPf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~ 730 (1239)
++| ..+.+++..|++.||.+||++.++++++
T Consensus 185 ~~l-------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 185 YEL-------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHH-------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 999 4788899999999999999999999763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=261.44 Aligned_cols=267 Identities=24% Similarity=0.391 Sum_probs=196.4
Q ss_pred cCCceEEeeeccCCceEEEEEEEcc---CCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCcc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL---DGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~ 498 (1239)
.+.|..+.+||.|.|++||++.+.. .++.||+|.|..... ..++.+|++.|..+ -|.||+++.+|+-
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~r----- 105 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFR----- 105 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhc-----
Confidence 3678889999999999999999887 688999999875433 34689999999999 6899999998872
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
......+||||.+. ...+++.. ++-.++..|++.++.||+|
T Consensus 106 -----------------------------------nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~ 147 (418)
T KOG1167|consen 106 -----------------------------------NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAH 147 (418)
T ss_pred -----------------------------------cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhh
Confidence 35678999999986 56666543 6688999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCC-CCEEEeecCcchhcccccc---ccC----CCCC-------C-------CCCCc-----
Q 000880 578 IHGQGIIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLKLEQL---DQD----AAFP-------T-------DTGGV----- 630 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~-~~vKL~DFGlA~~~~~~~~---~~~----~~~~-------~-------~~~~~----- 630 (1239)
+|.+|||||||||+|+|.+.. +.-.|.|||+|........ ... ...+ . ...+.
T Consensus 148 ~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~ 227 (418)
T KOG1167|consen 148 LHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCN 227 (418)
T ss_pred hhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccC
Confidence 999999999999999999865 6788999999984321110 000 0001 0 00000
Q ss_pred ---cccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHH-HHH------------HHhhhhc
Q 000880 631 ---SVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMER-QIV------------LSDLKQK 691 (1239)
Q Consensus 631 ---~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~-~~~------------~~~~~~~ 691 (1239)
...+-...||++|.|||++...+.-+.++||||.|||+.-+++ ||....+. ... .+.....
T Consensus 228 ~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~ 307 (418)
T KOG1167|consen 228 DGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALP 307 (418)
T ss_pred CCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcC
Confidence 0112345899999999999998889999999999999999985 77532210 000 0000000
Q ss_pred CC-----------------------------------CCCccccCCH-HHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 692 GE-----------------------------------LPPSWVAKFS-EQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 692 ~~-----------------------------------~p~~~~~~~~-e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
+. .+..+....+ .+.+|+.+||..||.+|.|++++|+||||...
T Consensus 308 g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 308 GRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred CceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00 0112222222 67899999999999999999999999999854
Q ss_pred h
Q 000880 736 E 736 (1239)
Q Consensus 736 ~ 736 (1239)
.
T Consensus 388 ~ 388 (418)
T KOG1167|consen 388 D 388 (418)
T ss_pred h
Confidence 3
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-27 Score=301.38 Aligned_cols=198 Identities=25% Similarity=0.403 Sum_probs=141.7
Q ss_pred cEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccc
Q 000880 536 TYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKL 614 (1239)
Q Consensus 536 ~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~ 614 (1239)
..++.+|||++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||||+..+.+|++|||++.....
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~ 132 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS 132 (793)
T ss_pred chhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc
Confidence 457888999999999999753 4599999999999999999999999999999999999997655555555554433211
Q ss_pred cccc-----------------cC--CCCCC-CCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhcC
Q 000880 615 EQLD-----------------QD--AAFPT-DTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHP 674 (1239)
Q Consensus 615 ~~~~-----------------~~--~~~~~-~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELltP 674 (1239)
.... .. ..... ............+||+.|||||++.+ ..|+.++|||||||+||||++|
T Consensus 133 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 133 DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-SSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-CCCCchhhhhhHHHHHHHHhhC
Confidence 0000 00 00000 00000111233579999999999987 5689999999999999999997
Q ss_pred CchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCCc
Q 000880 675 FSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 675 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~~ 735 (1239)
+.+.......+..+.. ...|+......+...+++.+||++||.+||++.++++|||+...
T Consensus 212 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 212 VSSREEKSRTMSSLRH-RVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CCchhhHHHHHHHHHH-hhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 7665443333332221 22333333445677899999999999999999999999999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=250.49 Aligned_cols=249 Identities=17% Similarity=0.215 Sum_probs=196.4
Q ss_pred CCceEEeeeccCCceEEEEEEEccC-----CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLD-----GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~-----g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.+++....+-+|.||.||.|.|+.. .+.|-+|.++ ...+.-....++.|...|..+.|||+.++.+.+.+.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~--- 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED--- 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec---
Confidence 4567777899999999999988743 2346677665 334555667899999999999999999999988653
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhc--------CCCCHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--------DHFDKELAWHLFR 569 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--------~~l~~~~~~~i~~ 569 (1239)
....++++.+++ |+|..++... ..++..+...++.
T Consensus 360 ------------------------------------~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~mas 403 (563)
T KOG1024|consen 360 ------------------------------------YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMAS 403 (563)
T ss_pred ------------------------------------cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHH
Confidence 234577788887 7999988722 2377888899999
Q ss_pred HHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccc
Q 000880 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649 (1239)
Q Consensus 570 qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 649 (1239)
|++.||+|||++|+||.||..+|++|++...+||+|=.+++.+-+.+. .+-+.+.-....|||||.+
T Consensus 404 Qla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DY-------------hcLGDnEnRPvkWMslEal 470 (563)
T KOG1024|consen 404 QLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDY-------------HCLGDNENRPVKWMSLEAL 470 (563)
T ss_pred HHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccc-------------cccCCCCCCcccccCHHHH
Confidence 999999999999999999999999999999999999999986533221 1111222345679999999
Q ss_pred cCCCCCCcchhhHHHHHHHHHhhc----CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 650 QGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 650 ~~~~~~~~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
+. ..|+.++|+|||||+||||+| |+..-++.+..... ..+.....+.+++.++..+|..||..+|++||+++|
T Consensus 471 ~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl--kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 471 QN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL--KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred hh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 98 689999999999999999996 88766554433222 244444455677889999999999999999999999
Q ss_pred HHh
Q 000880 726 LLQ 728 (1239)
Q Consensus 726 iL~ 728 (1239)
+..
T Consensus 548 lv~ 550 (563)
T KOG1024|consen 548 LVI 550 (563)
T ss_pred HHH
Confidence 875
|
|
| >PRK04173 glycyl-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=267.89 Aligned_cols=322 Identities=15% Similarity=0.115 Sum_probs=225.1
Q ss_pred CCcccccchhhhhHHHHHHHHHHHHHHH--cCCccccccce------eccCCCccccccEEEEe--------c-------
Q 000880 784 NTSSIQYSDLDTELRDYVVQVTKEMFRQ--HCAKHLEIEPM------YLLGDCPQFKRNTVKLL--------T------- 840 (1239)
Q Consensus 784 ~~G~~D~lp~ea~~~~~i~~~i~~~f~~--~Gy~~I~tP~~------~~~~~~~~~~~~~~~~~--------D------- 840 (1239)
..|+.|++|..+.+++.|++.|++.|.. +||.+|.||++ ..+|+.+.+.+.||... |
T Consensus 27 ~~g~~d~~P~G~~l~~~i~~~~r~~~~~~~~~~~ev~tp~i~~~~l~~~SGH~~~f~d~m~~~~~~~~~~r~d~~~~~~~ 106 (456)
T PRK04173 27 LAGFWDYGPLGVELKNNIKRAWWKSFVQEREDVVGIDSPIIMPPEVWEASGHVDNFSDPLVECKKCKKRYRADHLIEELG 106 (456)
T ss_pred hhcccccChhhHHHHHHHHHHHHHHHHhccCCEEEEeccccCCHHHHhhcCCccccCCceeEeCCCCCEeechhhhHHHh
Confidence 5799999999999999999999999988 89999999999 33455566666666653 1
Q ss_pred ------------------------------------------------cCCCeeeecCCCcH----HHHHHHHhCC-CCc
Q 000880 841 ------------------------------------------------HGGDLLELSHELRL----PFIRWAISNQ-KSS 867 (1239)
Q Consensus 841 ------------------------------------------------~~G~~l~LRPD~T~----~iaR~~~~~~-~~P 867 (1239)
.++..+.||||..- .+.+.+-+++ ..|
T Consensus 107 ~~~~~~~~~~~~~~~~~~~m~cp~~~~~~~~~~~~f~l~f~~~~g~~~~~~~~~~lRpetaqg~~~~f~~~~~syr~dLP 186 (456)
T PRK04173 107 IDAEGLSNEELKELIRENDIKCPECGGENWTEVRQFNLMFKTFIGPVEDSKSLGYLRPETAQGIFVNFKNVLRTARKKLP 186 (456)
T ss_pred hhhccccHHHHHHHHHHhCCCCCCCCCCCCcCccchhhceeecccCccCCCcceeeccccchhHHHHHHHHHHhccccCC
Confidence 11224567886552 2445565666 779
Q ss_pred eeEEeecCeEEcCCCCC----CCCceeEEeEEEeCCCCcccHH--HHHHHHHHHHHhcCCCCceEEEECcHHHHHHHHHH
Q 000880 868 FKRYEISSVYRRAIGHS----PPNRYLQGDFDIIGGASALTEA--EVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSW 941 (1239)
Q Consensus 868 ~r~~Y~g~VfR~e~~~~----~~~ef~Q~GvEiiG~~s~~aDa--Evi~la~~~l~~lgi~~~~~i~lg~~~i~~~ll~~ 941 (1239)
+|++++|+|||+|.... |.+||+|.++++|+.++...+. .+|.++.+++..||+..
T Consensus 187 lr~aq~g~~~RnE~s~~~gL~RvReF~q~e~hiF~~peq~~~e~~~~l~~~~~~l~~lG~~~------------------ 248 (456)
T PRK04173 187 FGIAQIGKSFRNEITPRNFIFRTREFEQMELEFFVKPGTDNEWFAYWIELRKNWLLDLGIDP------------------ 248 (456)
T ss_pred eeeeEEchhHhCccCCCCCceeeceeeeeEEEEEECcChHHHHHHHHHHHHHHHHHHcCCCc------------------
Confidence 99999999999986432 4467999999999987743111 22333333333333321
Q ss_pred cCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCChhhHHHHHhccCCCChh
Q 000880 942 AGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKP 1021 (1239)
Q Consensus 942 lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~~~~~ 1021 (1239)
T Consensus 249 -------------------------------------------------------------------------------- 248 (456)
T PRK04173 249 -------------------------------------------------------------------------------- 248 (456)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCC-CCcccccccccccccccccchhh--hccccccccc
Q 000880 1022 TRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKE-KYPATLVEGTLLAVGGRYDYLLH--RMWDREYVGY 1098 (1239)
Q Consensus 1022 ~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~-~~~~~~~~~~~i~~GGRYD~L~~--~fg~~~~~~~ 1098 (1239)
.++.++....++++||++.+|++.+... +. .-.....+++||+|| |.. .|++.+ +.+
T Consensus 249 ----------------~~~~~s~~~~~e~~~ys~~~wd~e~~~~~g~--~~~e~~g~~~~~dyd-L~~~~~~s~~d-l~y 308 (456)
T PRK04173 249 ----------------ENLRFREHLPEELAHYSKATWDIEYKFPFGR--FWGELEGIANRTDYD-LSRHSKHSGED-LSY 308 (456)
T ss_pred ----------------cceEEEecCcchhhccHHHHHhHHHhCCCCC--cEEEEeeeeccchhh-cccchhhcCCC-eEE
Confidence 2355555555566666666665532110 10 000112478899999 653 343332 222
Q ss_pred c--C--CCCCCc-eeeeeccHHHH-HhhCCCC---------------CcCCCCCCCceEEEEecCCC-ccHHHHHHHHHH
Q 000880 1099 A--S--RTNPPS-GVGASLALETI-IQHYPVD---------------FKPVRNEAGTSVLVCSRGGG-GLLVERMELVAE 1156 (1239)
Q Consensus 1099 ~--g--~~~~~p-AvGfaigldrl-~~~L~~~---------------~~~~~~~~~~~v~v~~~~~~-~~~~~a~~ia~~ 1156 (1239)
. + .....| .+|+|+|+||| +.+|++. ..|. ..+|.+|+|++.+++ .....|.++++.
T Consensus 309 ~~~~~~~~~~~P~vi~~siGieRl~~ail~~~~~~~~~~~~~~r~~l~~P~-~lAP~qV~Iipi~~~~e~~~~A~~la~~ 387 (456)
T PRK04173 309 FDDETTGEKYIPYVIEPSAGLDRLLLAFLEDAYTEEELGGGDKRTVLRLPP-ALAPVKVAVLPLVKKEKLSEKAREIYAE 387 (456)
T ss_pred EecCCCCceeeeEEEEecccHHHHHHHHHHHHcccccccCCcceeEEECCC-cCCCCEEEEEEecCcHHHHHHHHHHHHH
Confidence 2 1 111234 55999999996 4444421 2343 357889999998632 367899999999
Q ss_pred HHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHH
Q 000880 1157 LWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDA 1227 (1239)
Q Consensus 1157 Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~ 1227 (1239)
||+. ++|+++ . ..++++++++|++.|+|++|+||++|+++++|+||++.+++|..++++++++.+++.
T Consensus 388 LR~~-irVelD-~-~~slgkkir~A~~~Gip~~IIIG~~El~~g~VtvR~r~t~eq~~v~l~el~~~l~~~ 455 (456)
T PRK04173 388 LRKD-FNVDYD-D-SGSIGKRYRRQDEIGTPFCITVDFDTLEDNTVTIRDRDTMEQVRVKIDELKDYLAEK 455 (456)
T ss_pred HHhc-CEEEEe-C-CCCHHHHHHHHHHcCCCEEEEECCchhhCCEEEEEECCCCceEEEeHHHHHHHHHhh
Confidence 9999 999987 3 368999999999999999999999999999999999999999999999998888653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=240.45 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=190.6
Q ss_pred CCCCCCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 000880 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWF 493 (1239)
Q Consensus 415 ~~~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~ 493 (1239)
..++.-.+.+.|.+.+.||+|.||.+.+|+|+.+++.+|+|.+..... ...+|.+|...--.| .|.||+.-|..-+
T Consensus 15 ~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 15 EELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred ccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 344555667899999999999999999999999999999999875433 356799998765555 5899998776543
Q ss_pred ecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHH
Q 000880 494 ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIV 572 (1239)
Q Consensus 494 e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~ 572 (1239)
++ ..+++++||||| |+|..-+.. ..+-+.-...++.|++
T Consensus 92 qt---------------------------------------~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~ 131 (378)
T KOG1345|consen 92 QT---------------------------------------SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLL 131 (378)
T ss_pred hc---------------------------------------CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHH
Confidence 32 457889999998 788877655 4588888999999999
Q ss_pred HHHHHHHhCCccccCCCcccEEEcC-C-CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCccccc
Q 000880 573 EGLAHIHGQGIIHRDLTPNNIFFDA-R-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650 (1239)
Q Consensus 573 ~gL~yLHs~gIiHrDLKp~NILl~~-~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 650 (1239)
+|+.|+|++++||||||.+||||-. | ..|||||||+++..+.- -...-.+..|.+||...
T Consensus 132 SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t------------------V~~~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 132 SAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT------------------VKYLEYVNNYHAPELCD 193 (378)
T ss_pred HHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce------------------ehhhhhhcccCCcHHHh
Confidence 9999999999999999999999953 3 46999999998754210 01123566799999754
Q ss_pred CC----CCCCcchhhHHHHHHHHHhhc---CCchhHHH-----HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCC
Q 000880 651 GW----PKIDEKADMYSLGIVFFELWH---PFSTAMER-----QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPS 718 (1239)
Q Consensus 651 ~~----~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~-----~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~ 718 (1239)
.. -...+.+|+|.|||++|.++| ||....-+ +-.....+.....|..+...++.+..+.++-|.++|+
T Consensus 194 ~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~ 273 (378)
T KOG1345|consen 194 TVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFK 273 (378)
T ss_pred hccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccc
Confidence 32 225678999999999999998 66422111 1111122234456777778888999999999999999
Q ss_pred CC---CCHHHHHh
Q 000880 719 DR---PSATELLQ 728 (1239)
Q Consensus 719 ~R---Pta~eiL~ 728 (1239)
+| .++.....
T Consensus 274 drcki~~~kk~rk 286 (378)
T KOG1345|consen 274 DRCKIWTAKKMRK 286 (378)
T ss_pred ccchhHHHHHHHH
Confidence 99 44444433
|
|
| >TIGR00408 proS_fam_I prolyl-tRNA synthetase, family I | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=259.12 Aligned_cols=325 Identities=9% Similarity=0.087 Sum_probs=224.9
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCC---CccccccEEEEeccC----CCeeeecC
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD---CPQFKRNTVKLLTHG----GDLLELSH 850 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~---~~~~~~~~~~~~D~~----G~~l~LRP 850 (1239)
..+.|+++|+|....+++.|++.+++.++++||++|.||.| ++... .+...++||.+.|.+ ++.++|||
T Consensus 25 ~~~~G~~~~lP~g~~i~~~I~~~i~~~~~~~G~~ev~~P~l~~~~~~~~~~~h~~~f~~e~f~v~~~g~~~~~e~l~LrP 104 (472)
T TIGR00408 25 YPVKGCYVWLPYGFKIWKNIQKILRNILDEIGHEEVYFPMLIPESELAKEKDHIKGFEPEVYWITHGGLSKLDEPLALRP 104 (472)
T ss_pred cCCCceEEECcCHHHHHHHHHHHHHHHHHHcCCEEEECCccCCHHHHHhhcchhhhcchhcEEEecCCCCccCCcEEEeC
Confidence 35799999999999999999999999999999999999999 33322 344588999999987 48999999
Q ss_pred CCcHHHHHHHHh----CCCCceeEEeecCeEEcCCCC----CCCCceeEEeEEEeCCCCcccHH---HHHHHHHHHHH-h
Q 000880 851 ELRLPFIRWAIS----NQKSSFKRYEISSVYRRAIGH----SPPNRYLQGDFDIIGGASALTEA---EVLKVTMDIVT-R 918 (1239)
Q Consensus 851 D~T~~iaR~~~~----~~~~P~r~~Y~g~VfR~e~~~----~~~~ef~Q~GvEiiG~~s~~aDa---Evi~la~~~l~-~ 918 (1239)
+.|++++.+++. ++..|+|+|++|+|||+|.++ .|.+||+|.+++.+-.....++. +++.+..++++ .
T Consensus 105 t~e~~i~~~~~~~i~S~rdLPlr~~q~~~vfR~E~~~~~gl~R~rEF~~~e~h~~~~~~e~a~~e~~~~l~~y~~i~~~~ 184 (472)
T TIGR00408 105 TSETAMYPMFKKWVKSYTDLPLKINQWVNVFRYETKHTRPFLRTREFTWQEAHTAHATAEEAEEQVLRALDIYKEFIENS 184 (472)
T ss_pred CCcHHHHHHHhccccChhhcCHHHhheeeeecCCCCCCCCcceeeeeehhhhhhhhCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 999999955544 456799999999999998764 35567999999843333333333 45566666665 6
Q ss_pred cCCCCceEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHH
Q 000880 919 FFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVG 998 (1239)
Q Consensus 919 lgi~~~~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~ 998 (1239)
||+. +.+... ++ + ++
T Consensus 185 lglp--~~~~~~--------------~~-~-----------ek------------------------------------- 199 (472)
T TIGR00408 185 LAIP--YFVGRK--------------PE-W-----------EK------------------------------------- 199 (472)
T ss_pred cCCe--EEEEec--------------Cc-h-----------hh-------------------------------------
Confidence 6663 322110 00 0 00
Q ss_pred HHhcCChhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCccccccccccc
Q 000880 999 LRFCGAADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLA 1078 (1239)
Q Consensus 999 ~~~~g~~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~ 1078 (1239)
+.|.. ....++..+.-|-..-.|++|.. +.
T Consensus 200 --~~ga~--------------------------------~~~~~e~~~~dgr~~q~~t~~~L---g~------------- 229 (472)
T TIGR00408 200 --FAGAE--------------------------------YTWAFETIMPDGRTLQIATSHNL---GQ------------- 229 (472)
T ss_pred --cCCcc--------------------------------ceEEEeEEEcCCCEEEEeeeecc---cc-------------
Confidence 00000 00111111111111123333322 00
Q ss_pred ccccccchhhhccccccccccC-CCCCCceeeeeccH-HHHHhhC-----C-CCCcCCCCCCCceEEEEec--CC---Cc
Q 000880 1079 VGGRYDYLLHRMWDREYVGYAS-RTNPPSGVGASLAL-ETIIQHY-----P-VDFKPVRNEAGTSVLVCSR--GG---GG 1145 (1239)
Q Consensus 1079 ~GGRYD~L~~~fg~~~~~~~~g-~~~~~pAvGfaigl-drl~~~L-----~-~~~~~~~~~~~~~v~v~~~--~~---~~ 1145 (1239)
++.++|+-. +.+ .+......-+++|+ +|++.+| + .+...+...+|.+|+|+++ ++ +.
T Consensus 230 ------~~sk~f~i~----y~~~~g~~~~~h~~s~Gi~eRli~~lie~~~d~~gl~~P~~iaP~qV~Iipi~~~~~~~~~ 299 (472)
T TIGR00408 230 ------NFAKTFEIK----FETPTGDKEYAYQTSYGISTRVIGALIAIHSDEKGLVLPPRVAPIQVVIIPIIFKKKENEK 299 (472)
T ss_pred ------cccHhcCCE----EECCCCCEEeeEEccccHHHHHHHHHHHHhCCCCceeeChhhCcceEEEEEccCCCCCCHH
Confidence 122222211 111 11222344477887 9998887 2 2322233457889999996 32 24
Q ss_pred cHHHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHH
Q 000880 1146 LLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLL 1225 (1239)
Q Consensus 1146 ~~~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~ 1225 (1239)
....|.++++.||+.|++|+++.. +.++++++++|++.|+|++|+||++|+++|+|+||++++++|..++++++++.+.
T Consensus 300 ~~~~A~~l~~~Lr~~girv~lD~r-~~s~gkk~k~Ae~~GvP~~IiIG~~Ele~~~V~ik~rdt~eq~~v~l~el~~~l~ 378 (472)
T TIGR00408 300 VMEAAREVRSRLKKAGFRVHIDDR-DNRPGRKFYQWEIKGIPLRIEVGPNDIEKNIAVISRRDTGEKYQVSLDQLEERVV 378 (472)
T ss_pred HHHHHHHHHHHHHHCCCEEEEECC-CCCHHHHHHHHHHCCCCEEEEECcchhhCCeEEEEECCCCceEEEEHHHHHHHHH
Confidence 688999999999999999998876 4599999999999999999999999999999999999999999999999999988
Q ss_pred HHHHhhc
Q 000880 1226 DAIASQF 1232 (1239)
Q Consensus 1226 ~~l~~~~ 1232 (1239)
++++...
T Consensus 379 ~~l~~~~ 385 (472)
T TIGR00408 379 ELLNNIQ 385 (472)
T ss_pred HHHHHHH
Confidence 7776543
|
Prolyl-tRNA synthetase is a class II tRNA synthetase and is recognized by pfam model tRNA-synt_2b, which recognizes tRNA synthetases for Gly, His, Ser, and Pro. The prolyl-tRNA synthetases are divided into two widely divergent families. This family includes the archaeal enzyme, the Pro-specific domain of a human multifunctional tRNA ligase, and the enzyme from the spirochete Borrelia burgdorferi. The other family includes enzymes from Escherichia coli, Bacillus subtilis, Synechocystis PCC6803, and one of the two prolyL-tRNA synthetases of Saccharomyces cerevisiae. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-24 Score=230.56 Aligned_cols=209 Identities=33% Similarity=0.569 Sum_probs=170.8
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCc
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----------- 68 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED----------- 68 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec-----------
Confidence 56778999999999999999988999999998754332 245688899999999999999999987632
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~-l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....++++||+++ +|.+++..... +++..++.++.+++.++.|||++++
T Consensus 69 -----------------------------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 119 (225)
T smart00221 69 -----------------------------PEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI 119 (225)
T ss_pred -----------------------------CCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 2467899999986 99999987766 8999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
+|+||+|.||+++.++.++|+|||++........ .......++..|++||.+.+...++.++|+||
T Consensus 120 ~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~ 185 (225)
T smart00221 120 VHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWS 185 (225)
T ss_pred ecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--------------ccccceeccCCcCCHhHhcCCCCCCchhhHHH
Confidence 9999999999999999999999999986532210 01234578889999999833356788999999
Q ss_pred HHHHHHHhhc---CCch-hHHHHHHHHhhh
Q 000880 664 LGIVFFELWH---PFST-AMERQIVLSDLK 689 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~-~~~~~~~~~~~~ 689 (1239)
||+++|+|++ ||.. ..+.......+.
T Consensus 186 lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 186 LGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred HHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 9999999996 7865 344444444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK08661 prolyl-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-23 Score=250.29 Aligned_cols=325 Identities=12% Similarity=0.110 Sum_probs=224.5
Q ss_pred CCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc---CCCccccccEEEEeccC----CCeeeecCCC
Q 000880 784 NTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL---GDCPQFKRNTVKLLTHG----GDLLELSHEL 852 (1239)
Q Consensus 784 ~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~---~~~~~~~~~~~~~~D~~----G~~l~LRPD~ 852 (1239)
+.|+.+++|..+.+++.|++.+++.|+++||++|.||+| ++. ++.+...++||.+.+.+ ++.++|||+.
T Consensus 33 v~G~~~~~P~g~~i~~~i~~~~~~~~~~~G~~ev~~P~l~~~~~~~~~~~h~~~f~~e~~~v~~~~~~~~~e~l~LrPts 112 (477)
T PRK08661 33 VKGCMVIKPYGYAIWENIQKILDKLFKETGHENVYFPLLIPESLLEKEKEHVEGFAPEVAWVTHGGGEKLEEKLALRPTS 112 (477)
T ss_pred CCceEEECccHHHHHHHHHHHHHHHHHHcCCEEEECCccCCHHHHhhhcCchhhcccccEEEEccCCCccCceEEEecCC
Confidence 689999999999999999999999999999999999999 332 23455689999999877 5689999998
Q ss_pred ----cHHHHHHHHhCCCCceeEEeecCeEEcCCCCC---CCCceeEEeEEEeCCCCcccHHH---HHHHHHHHH-HhcCC
Q 000880 853 ----RLPFIRWAISNQKSSFKRYEISSVYRRAIGHS---PPNRYLQGDFDIIGGASALTEAE---VLKVTMDIV-TRFFH 921 (1239)
Q Consensus 853 ----T~~iaR~~~~~~~~P~r~~Y~g~VfR~e~~~~---~~~ef~Q~GvEiiG~~s~~aDaE---vi~la~~~l-~~lgi 921 (1239)
|..++|.+.+++..|+|+|++|+|||+|.... |.+||+|.+.+.+-.....++.| ++.+..+++ +.||+
T Consensus 113 E~~i~~~~~~~i~SyrdLPlrl~q~~~vfR~E~~~rgl~R~rEF~~~E~h~~~~~~eea~~e~~~~l~~y~~i~~~~Lgl 192 (477)
T PRK08661 113 ETIIYPMYKKWIQSYRDLPLLYNQWVNVVRWETKTRPFLRTREFLWQEGHTAHATEEEAEEETLEMLEIYKEFFEDYLAI 192 (477)
T ss_pred cHHHHHHHHhhhcchhhcCHHHhcccceeeCCCCCCCcceeeeEEEcceeeeeCCHHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 78888888888778999999999999976543 45579999999865444444443 445555555 55555
Q ss_pred CCceEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHh
Q 000880 922 AESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRF 1001 (1239)
Q Consensus 922 ~~~~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~ 1001 (1239)
. +.+..- ++ ++ .+
T Consensus 193 p--~~~~~~--------------~~--------------------------~e---------------------kf---- 205 (477)
T PRK08661 193 P--VIIGKK--------------TE--------------------------WE---------------------KF---- 205 (477)
T ss_pred e--EEEEec--------------Ch--------------------------HH---------------------hh----
Confidence 3 211110 00 00 00
Q ss_pred cCChhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccccccccccccc
Q 000880 1002 CGAADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGG 1081 (1239)
Q Consensus 1002 ~g~~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GG 1081 (1239)
.|. .....+|..+..|-..-.|++|..- .
T Consensus 206 ~ga--------------------------------~~~~~ie~~~~dgr~~q~gt~~~Lg---~---------------- 234 (477)
T PRK08661 206 AGA--------------------------------DYTYTIEAMMPDGKALQAGTSHYLG---Q---------------- 234 (477)
T ss_pred CCC--------------------------------cceeEEEEEeCCCCEEEEEEecccc---c----------------
Confidence 010 0011222222223233344444221 0
Q ss_pred cccchhhhccccccccccCCCCCCceeeeeccH-HHHHhhCC------CCCcCCCCCCCceEEEEecC-----CCccHHH
Q 000880 1082 RYDYLLHRMWDREYVGYASRTNPPSGVGASLAL-ETIIQHYP------VDFKPVRNEAGTSVLVCSRG-----GGGLLVE 1149 (1239)
Q Consensus 1082 RYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigl-drl~~~L~------~~~~~~~~~~~~~v~v~~~~-----~~~~~~~ 1149 (1239)
++.++|+-. +...-|... ...=.++|+ +|++.+|- .+...+...+|.+|+|++.. .+.....
T Consensus 235 ---~~s~~f~i~-y~d~~g~~~--~v~~~s~G~~~R~i~alie~~~D~~Gl~lP~~iAP~qV~Iipi~~~~~~~~~~~~~ 308 (477)
T PRK08661 235 ---NFAKAFDIK-FQDKDGKLE--YVHQTSWGVSTRLIGALIMTHGDDKGLVLPPKIAPIQVVIVPIFKKEEKKEEVLEY 308 (477)
T ss_pred ---chhHhcCCE-EECCCCCEe--eeEEecccHHHHHHHHHHHHhCccCCCccCcccCCCeEEEEEecCCCcCCHHHHHH
Confidence 112222211 000011111 122224554 99987763 22222334568899999982 1456788
Q ss_pred HHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHH
Q 000880 1150 RMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIA 1229 (1239)
Q Consensus 1150 a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~ 1229 (1239)
|.++++.||+.|++|+++...+.++++++++|++.|+|++|+||++|+++|+|+|+++.++++..++++++++.+++.++
T Consensus 309 a~~l~~~Lr~~GirV~lD~r~~~s~gkK~~~ae~~GvP~~IiIG~~ele~~~V~ik~rdtgek~~v~~~el~~~l~~~l~ 388 (477)
T PRK08661 309 AKELAEELKKAGIRVKLDDRSDKTPGWKFNEWELKGVPLRIEIGPRDLENNTVVLVRRDTLEKETVPLDELVEKVPELLE 388 (477)
T ss_pred HHHHHHHHHHCCCEEEEECCCCCCHHHHHHHHHHCCCCEEEEECcchhhcCeEEEEECCCCceEEEEHHHHHHHHHHHHH
Confidence 99999999999999998873467999999999999999999999999999999999999999999999999999887776
Q ss_pred hhc
Q 000880 1230 SQF 1232 (1239)
Q Consensus 1230 ~~~ 1232 (1239)
...
T Consensus 389 ~~~ 391 (477)
T PRK08661 389 EIQ 391 (477)
T ss_pred HHH
Confidence 443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=257.11 Aligned_cols=298 Identities=39% Similarity=0.667 Sum_probs=225.1
Q ss_pred CCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 419 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.+++.++|+....+|.|+||+|+.+..+.++..+|||.|..++.. ....+.++|+..+..+.|++|+++.++|...+..
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e-~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~~~ 122 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNRE-ESRSRVLREVSSLAEFEHPGIKRYFHAWYERPPL 122 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchh-hhhhhhhccccchhhhcccchhhheeceecCCCC
Confidence 688999999999999999999999999989999999999876543 3456788999999999999999999999887642
Q ss_pred ccCC---------C---------Cc--------------CCC----------------------Cc-----cc-------
Q 000880 499 DFDG---------D---------SM--------------WGS----------------------GT-----LA------- 512 (1239)
Q Consensus 499 ~~~~---------~---------~~--------------~~~----------------------g~-----~~------- 512 (1239)
.+.. . .+ |.+ +. ..
T Consensus 123 ~~qe~~d~~~l~~~~~~~~~~l~sl~~~~~~~~q~~~~~~~~~A~e~s~~~~~~~v~~~~~s~s~~~~~s~s~~~~~~~~ 202 (516)
T KOG1033|consen 123 GWQEEMDLKLLDDETSSERSNLPSLSERRTSKRQTAELPRVSAAAESSFHVFRAIVPVENQSHSQESSSSISQHNGSRSE 202 (516)
T ss_pred cccchhhhhhhhccCCcchhccccccchhccchhhhhcccccccchhhhccccccCchhhcccCcccccchhhcccchhh
Confidence 1000 0 00 000 00 00
Q ss_pred --------ccccccccc-------------------------------cc-------------------c--------cc
Q 000880 513 --------SSTFSNRAA-------------------------------SS-------------------A--------DV 526 (1239)
Q Consensus 513 --------s~~~~~~~~-------------------------------~~-------------------~--------~v 526 (1239)
...|..... +. . ++
T Consensus 203 ~rk~s~~k~~~~~~~~~tdsd~~ed~~~~~~s~~~~~~~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~ 282 (516)
T KOG1033|consen 203 FRKTSVSKASRFEGPDCTDSDLEEDEMQGSDSKESSRHEESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV 282 (516)
T ss_pred hhhhhhccccccCCCccccccccccccccCcccCcccccccccccccccccccccCCchhhhhcccchhhhhccchhhhc
Confidence 000000000 00 0 00
Q ss_pred --------------------------ccc-----------cccccccEEEEEeeccC-CCHHHHHHhcC---CCCHHHHH
Q 000880 527 --------------------------TGQ-----------ENKLESTYLYIQMEYCP-RTLRQVFESYD---HFDKELAW 565 (1239)
Q Consensus 527 --------------------------~~~-----------~~~~~~~~l~iVmEy~~-gsL~~~l~~~~---~l~~~~~~ 565 (1239)
... .......++||+|++|. .+|.+||.... ..+.....
T Consensus 283 d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~ 362 (516)
T KOG1033|consen 283 DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLML 362 (516)
T ss_pred cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHH
Confidence 000 00001247999999996 69999997543 36677888
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCC
Q 000880 566 HLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA 645 (1239)
Q Consensus 566 ~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 645 (1239)
.++.|++.|++| ++.+|||+||.||+...+..+||+|||+......... .......++..+||.+||+
T Consensus 363 ~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~---------~~~~~a~~t~~~gt~~Yms 430 (516)
T KOG1033|consen 363 DIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDET---------VAPAAASHTQQVGTLLYMS 430 (516)
T ss_pred HHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCc---------ccchhhhhhhcccccccCC
Confidence 999999999999 9999999999999999999999999999876432220 0111234677899999999
Q ss_pred cccccCCCCCCcchhhHHHHHHHHHhhcCCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 646 PEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 646 PE~l~~~~~~~~ksDIwSlGviL~ELltPf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
||++.+ ..|+.++||||||+||+||+++|...+++...+..++ .+.+|+.+....|+...|+.+|+.+.|.+||++.+
T Consensus 431 PEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r-~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 431 PEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIR-DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhh-cCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 999998 6899999999999999999999999999988888887 67788777777788899999999999999997766
Q ss_pred HHhccC
Q 000880 726 LLQDAL 731 (1239)
Q Consensus 726 iL~~~~ 731 (1239)
.--|.|
T Consensus 509 ~~~~~~ 514 (516)
T KOG1033|consen 509 VALHEF 514 (516)
T ss_pred Hhhhhh
Confidence 655554
|
|
| >PLN02837 threonine-tRNA ligase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-23 Score=255.87 Aligned_cols=353 Identities=15% Similarity=0.145 Sum_probs=246.2
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce------eccCCCccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM------YLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~------~~~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
...|+..|+|..+.+++.+++.+++...++||++|.||.+ ...++++...++||++.|..++.++||| +++|.
T Consensus 235 ~g~G~~~~~p~G~~l~~~L~~~~~~~~~~~G~~~v~tP~l~~~~l~~~sGh~~~~~~~mf~~~~~~~~~y~l~p-~~~p~ 313 (614)
T PLN02837 235 AGGGLVFWHPKGAIVRHIIEDSWKKMHFEHGYDLLYTPHVAKADLWKTSGHLDFYKENMYDQMDIEDELYQLRP-MNCPY 313 (614)
T ss_pred cCCcceEEechHHHHHHHHHHHHHHHHHHCCCEEEECCccCCHHHHhhcCCcccchhhcccccCCCCceEEECC-CCcHH
Confidence 4578999999999999999999999999999999999999 3345577889999999998889999999 55555
Q ss_pred -HHHHHh----CCCCceeEEeecCeEEcCCCC-----CCCCceeEEeEEEeCCCCcccH--HHHHHHHHHHHHhcCCCCc
Q 000880 857 -IRWAIS----NQKSSFKRYEISSVYRRAIGH-----SPPNRYLQGDFDIIGGASALTE--AEVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 857 -aR~~~~----~~~~P~r~~Y~g~VfR~e~~~-----~~~~ef~Q~GvEiiG~~s~~aD--aEvi~la~~~l~~lgi~~~ 924 (1239)
+-++.. ++..|+|++++|+|||+|..+ -|.++|+|.+.++|...+...+ .+++.++.++++.||+..
T Consensus 314 ~~~~~~~~~~SyrdLPlr~~~~~~~~R~E~~g~~~GL~RvreF~~~e~h~f~~~~q~~~e~~~~l~~~~~~~~~lg~~~- 392 (614)
T PLN02837 314 HILVYKRKLHSYRDLPIRVAELGTVYRYELSGSLHGLFRVRGFTQDDAHIFCLEDQIKDEIRGVLDLTEEILKQFGFSK- 392 (614)
T ss_pred HHHHHhCccCChhHCCHhhEeecccccCCCCCCCcCcccccceEECeEEEEeCHHHHHHHHHHHHHHHHHHHHHcCCCe-
Confidence 444443 234699999999999998743 2556799999999988765222 277899999999999975
Q ss_pred eEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCC
Q 000880 925 CDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGA 1004 (1239)
Q Consensus 925 ~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~ 1004 (1239)
+.+.++.+. -+.+|-++.|.+.-+.+-.. ++..++.-.....-.+
T Consensus 393 ~~~~~~t~~-----~~~~g~~~~w~~~~~~l~~~----------------------l~~~~~~~~~~~g~~a-------- 437 (614)
T PLN02837 393 YEINLSTRP-----EKSVGSDDIWEKATTALRDA----------------------LDDKGWEYKVDEGGGA-------- 437 (614)
T ss_pred EEEEecCCc-----hhccCCHHHHHHHHHHHHHH----------------------HHHcCCCceeCCCccc--------
Confidence 788888753 24456555553332221111 1111110000000000
Q ss_pred hhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCccccccccccccccccc
Q 000880 1005 ADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYD 1084 (1239)
Q Consensus 1005 ~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD 1084 (1239)
.+| .++.+-+...-|-.+-.|++--.|. -+-|||
T Consensus 438 ----------------------------fyg--pkid~~~~d~~gr~~q~~tiqldf~----------------~~~~f~ 471 (614)
T PLN02837 438 ----------------------------FYG--PKIDLKIEDALGRKWQCSTIQVDFN----------------LPERFD 471 (614)
T ss_pred ----------------------------ccC--cceeeEeeccCCceeeecceeEeec----------------chhhcC
Confidence 011 1232222222244444555421111 122333
Q ss_pred chhhhccccccccccCCCCCCc-eeeeec--cHHHHHhhCCC---CCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHH
Q 000880 1085 YLLHRMWDREYVGYASRTNPPS-GVGASL--ALETIIQHYPV---DFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELW 1158 (1239)
Q Consensus 1085 ~L~~~fg~~~~~~~~g~~~~~p-AvGfai--gldrl~~~L~~---~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr 1158 (1239)
| .| ...-|... .| -+.-++ ++||++.+|.+ +..|.+. +|.+|+|++.+ +....+|.++++.||
T Consensus 472 -l--~y-----~~~d~~~~-~pv~ih~~~~G~~eRlia~Lie~~~g~~P~~l-aP~qV~IIpi~-~~~~~~A~~Ia~~Lr 540 (614)
T PLN02837 472 -I--TY-----VDSNSEKK-RPIMIHRAILGSLERFFGVLIEHYAGDFPLWL-APVQARVLPVT-DNELEYCKEVVAKLK 540 (614)
T ss_pred -c--EE-----ECCCCCcc-CCEEEEcCCccCHHHHHHHHHHHcCCCCCCCC-CCccEEEEEeC-hHHHHHHHHHHHHHH
Confidence 1 01 11112111 22 222233 69999987752 5555544 68899999985 667899999999999
Q ss_pred HcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHhh
Q 000880 1159 EENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1159 ~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~~ 1231 (1239)
+.|++|++ .. +.++++++++|++.|+|++|+||++|.++|+|+||++.++++..++++++++.|.+.+++.
T Consensus 541 ~~GirVev-~~-~~slgkkir~A~~~gip~~IiIG~~E~e~~~VtVr~r~~geq~~v~~~el~~~l~~~~~~~ 611 (614)
T PLN02837 541 AKGIRAEV-CH-GERLPKLIRNAETQKIPLMAVVGPKEVETRTLTVRSRHGGELGTMPVDDFINRIQLAVENR 611 (614)
T ss_pred HCCCEEEE-eC-CCCHHHHHHHHHHcCCCEEEEEcchhhhcCEEEEEECCCCceeEeeHHHHHHHHHHHHhhc
Confidence 99999998 45 5799999999999999999999999999999999999999999999999999998877643
|
|
| >PRK03991 threonyl-tRNA synthetase; Validated | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-21 Score=240.75 Aligned_cols=347 Identities=13% Similarity=0.117 Sum_probs=236.3
Q ss_pred CCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce------eccCCCccccccEEEEeccCCCeeeecCCCcHHHH
Q 000880 784 NTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM------YLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFI 857 (1239)
Q Consensus 784 ~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~------~~~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~ia 857 (1239)
..|..-|+|..+.+++.|.+.+++.+.++||++|.||.+ ...++.+....+||.+. .+++.++|||.-+.+.+
T Consensus 216 ~~G~~~~~P~G~~i~~~L~~~~~~~~~~~G~~~V~tP~~~~~~~~~~sgh~~~f~e~my~v~-~~~e~l~Lrp~~c~~~~ 294 (613)
T PRK03991 216 DVGHMRYYPKGRLIRDLLEDYVYNLVVELGAMPVETPIMYDLSHPAIREHADKFGERQYRVK-SDKKDLMLRFAACFGQF 294 (613)
T ss_pred CeeeEEEEcHHHHHHHHHHHHHHHHHHHCCCEEEECCeecChhHHhhcccccccchhceEec-CCCceEEEecCCCHHHH
Confidence 467888999999999999999999999999999999998 33345667788999984 44689999997777766
Q ss_pred HHHHh----CCCCceeEEeecC-eEEcCCCCC-----CCCceeEEeEEEeCCCCcccHH---HHHHHHHHHHHhcCCCCc
Q 000880 858 RWAIS----NQKSSFKRYEISS-VYRRAIGHS-----PPNRYLQGDFDIIGGASALTEA---EVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 858 R~~~~----~~~~P~r~~Y~g~-VfR~e~~~~-----~~~ef~Q~GvEiiG~~s~~aDa---Evi~la~~~l~~lgi~~~ 924 (1239)
-+... ++..|+|+|.+|+ +||+|.++. |.++|+|.++++|+.+...+.. +++.++.++++.||+.
T Consensus 295 ~~~~~~~~SyrdLPlr~~e~~~~~fR~E~~g~l~GL~RvReF~~~D~h~f~~~~eqa~~e~~~~l~~~~~i~~~lGl~-- 372 (613)
T PRK03991 295 LMLKDMTISYKNLPLKMYELSTYSFRLEQRGELVGLKRLRAFTMPDMHTLCKDMEQAMEEFEKQYEMILETGEDLGRD-- 372 (613)
T ss_pred HHHhCCcCchhhCChhhheecchheeCCCCCCCcCcccccceEeeeEEEEECCHHHHHHHHHHHHHHHHHHHHHcCCC--
Confidence 55443 3346999999999 999987542 4557999999999985222222 7789999999999995
Q ss_pred eEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCC
Q 000880 925 CDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGA 1004 (1239)
Q Consensus 925 ~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~ 1004 (1239)
+.+.++... .+. +-. ...|..++.... ++- ++....|.
T Consensus 373 ~~~~~~~t~---df~---~~~---~~~l~~~l~~~g-------------------------~~~--------~~~~~~g~ 410 (613)
T PRK03991 373 YEVAIRFTE---DFY---EEN---KDWIVELVKREG-------------------------KPV--------LLEILPER 410 (613)
T ss_pred eEEEecCHH---HHh---hhH---HHHHHHHHHHcC-------------------------CCE--------EecccCCc
Confidence 787776531 111 100 111211222111 000 00000000
Q ss_pred hhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCccccccccccccccccc
Q 000880 1005 ADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYD 1084 (1239)
Q Consensus 1005 ~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD 1084 (1239)
. .-+| .++.+.....-|-..-.|+ +=-|+.|
T Consensus 411 ~--------------------------~~yg--~kie~~~~d~~gr~~q~~T--------------------~qld~~~- 441 (613)
T PRK03991 411 K--------------------------HYWV--LKVEFAFIDSLGRPIENPT--------------------VQIDVEN- 441 (613)
T ss_pred c--------------------------ccCc--CcEEEEEeCCCCCEEEEee--------------------eecCccc-
Confidence 0 0001 1233222211111122221 1122333
Q ss_pred chhhhccccccccccCCCCCCc-eeeee-cc-HHHHHhhCC---CCC--------cCCCCCCCceEEEEecCCCccHHHH
Q 000880 1085 YLLHRMWDREYVGYASRTNPPS-GVGAS-LA-LETIIQHYP---VDF--------KPVRNEAGTSVLVCSRGGGGLLVER 1150 (1239)
Q Consensus 1085 ~L~~~fg~~~~~~~~g~~~~~p-AvGfa-ig-ldrl~~~L~---~~~--------~~~~~~~~~~v~v~~~~~~~~~~~a 1150 (1239)
.++|+-. +...-|... .| -+|.+ +| ++|++.+|- .+. .|.+ -+|.+|+|++.+ +.....|
T Consensus 442 --~~~f~l~-y~d~~g~~~-~Pviih~~~~GsieR~i~aliE~~~~~~~~g~gl~~P~~-lAP~qV~IIpi~-e~~~~~A 515 (613)
T PRK03991 442 --AERFGIK-YVDENGEEK-YPIILHCSPTGSIERVIYALLEKAAKEEEEGKVPMLPTW-LSPTQVRVIPVS-ERHLDYA 515 (613)
T ss_pred --chhCCCE-EECCCCCEe-eCEEEEECCEeHHHHHHHHHHHHhCCccccCceeEcCcc-ccCceEEEEEeC-HHHHHHH
Confidence 2344321 011112221 34 44654 65 999987773 121 3433 468899999995 7788999
Q ss_pred HHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHh
Q 000880 1151 MELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIAS 1230 (1239)
Q Consensus 1151 ~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~ 1230 (1239)
.++++.||+.|++|+++.. +.++++++++|++.|+|++|+||++|+++|+|+||++.++++..++++++++.+++.+++
T Consensus 516 ~eIa~~Lr~~GirV~lDdr-~~slgkKir~A~~~GiP~iIVIG~kEle~g~VtVr~R~t~eq~~v~l~eli~~l~~~~~~ 594 (613)
T PRK03991 516 EEVADKLEAAGIRVDVDDR-DESLGKKIRDAGKEWIPYVVVIGDKEMESGKLTVTIREESEKVEMTLEELIERIKEETKG 594 (613)
T ss_pred HHHHHHHHhCCCEEEEECC-CCCHHHHHHHHHHcCCCEEEEECcchhhCCeEEEEECCCCceEEeeHHHHHHHHHHHHhc
Confidence 9999999999999998776 679999999999999999999999999999999999999999999999999999988864
Q ss_pred h
Q 000880 1231 Q 1231 (1239)
Q Consensus 1231 ~ 1231 (1239)
.
T Consensus 595 ~ 595 (613)
T PRK03991 595 Y 595 (613)
T ss_pred C
Confidence 3
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=218.28 Aligned_cols=157 Identities=25% Similarity=0.366 Sum_probs=121.3
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCC
Q 000880 547 RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPT 625 (1239)
Q Consensus 547 gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 625 (1239)
|+|.+++... ..+++.+++.++.||+.||+|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----------- 61 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----------- 61 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence 6789999864 45999999999999999999999999 999999999999999 999876421
Q ss_pred CCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhc-CCC-C---Cc
Q 000880 626 DTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQK-GEL-P---PS 697 (1239)
Q Consensus 626 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~-~~~-p---~~ 697 (1239)
....||+.|||||++.+ ..|+.++|||||||++|||++ ||............+... ... + +.
T Consensus 62 ---------~~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (176)
T smart00750 62 ---------EQSRVDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSN 131 (176)
T ss_pred ---------ccCCCcccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccccc
Confidence 11268999999999988 568999999999999999997 775443322222222111 111 1 11
Q ss_pred cccCCH--HHHHHHHHccCCCCCCCCCHHHHHhccCC
Q 000880 698 WVAKFS--EQESLLRRLMSPSPSDRPSATELLQDALP 732 (1239)
Q Consensus 698 ~~~~~~--e~~~LI~~~L~~dP~~RPta~eiL~~~~~ 732 (1239)
...... ++.++|.+||..||.+||++.++++|+|.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 111222 58999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=233.98 Aligned_cols=174 Identities=20% Similarity=0.126 Sum_probs=129.6
Q ss_pred cccCCceEEeeeccCCceEEEEEEEcc-CCcEEEEEEEecCCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeecC
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKL-DGRHYAVKKIRLKDK---SLPVNDRILREVATLSRLQHQHVVRYYQAWFETG 496 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-~g~~vAVK~i~~~~~---~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~ 496 (1239)
...++|.+.+.||+|+||+||+|+++. +++.||||++..... .......+.+|+.+|+.++|+||++.+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346789999999999999999999886 678889998753211 222345689999999999999998643211
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL 575 (1239)
...|+|||||+| +|. .+.. .. ...++.|++.||
T Consensus 91 ---------------------------------------~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL 124 (365)
T PRK09188 91 ---------------------------------------GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRAL 124 (365)
T ss_pred ---------------------------------------CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHH
Confidence 125899999975 675 2211 11 146789999999
Q ss_pred HHHHhCCccccCC-CcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC
Q 000880 576 AHIHGQGIIHRDL-TPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651 (1239)
Q Consensus 576 ~yLHs~gIiHrDL-Kp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 651 (1239)
.|||++||+|||| ||+|||++.++.+||+|||+|+.+.......... ...+-++.++++.|+|||.+..
T Consensus 125 ~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~-------~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 125 RDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIA-------AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred HHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhh-------hhhhhhhhhccCccCCcccCCh
Confidence 9999999999999 9999999999999999999999764321110000 0011246689999999998865
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=214.26 Aligned_cols=202 Identities=22% Similarity=0.347 Sum_probs=168.8
Q ss_pred CCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCccccCC
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
-.|++.++||+|+||+.+.|++..+++.||||.-+.+.. ..++..|....+.| ..+.|..+|.+-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFG---------- 93 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFG---------- 93 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeec----------
Confidence 479999999999999999999999999999997654433 34677888888888 468888776221
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLHs~ 581 (1239)
++..+-.+|||+++.||.+++.-+ .+|+...+..++.|++.-++|+|++
T Consensus 94 ------------------------------qeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k 143 (449)
T KOG1165|consen 94 ------------------------------QEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK 143 (449)
T ss_pred ------------------------------cccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc
Confidence 234566799999999999999854 5699999999999999999999999
Q ss_pred CccccCCCcccEEEcCCC-----CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC
Q 000880 582 GIIHRDLTPNNIFFDARN-----DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~-----~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~ 656 (1239)
.+|+|||||+|+||...+ .|.|+|||+|+.+..+...+...+ ..+.+..||..||+--...| ..-+
T Consensus 144 ~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPY--------rE~KSLsGTARYMSINTHlG-rEQS 214 (449)
T KOG1165|consen 144 DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPY--------REHKSLSGTARYMSINTHLG-REQS 214 (449)
T ss_pred ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcc--------ccccccccceeeeEeecccc-chhh
Confidence 999999999999997644 489999999999887766554443 34678899999999999888 5689
Q ss_pred cchhhHHHHHHHHHhhc---CCchh
Q 000880 657 EKADMYSLGIVFFELWH---PFSTA 678 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~ 678 (1239)
...|+-|||.+++.++. ||.+.
T Consensus 215 RRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 215 RRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhhhHHHhhhhhhhhccCCCccccc
Confidence 99999999999988884 77654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-20 Score=209.79 Aligned_cols=253 Identities=30% Similarity=0.501 Sum_probs=193.4
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCch-hHHHHHHHHHHHHhcCCC-ceeeeeeeeeecCccccCCC
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-VNDRILREVATLSRLQHQ-HVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~-~~~~~~~Ev~iL~~L~Hp-nIv~l~~~~~e~~~~~~~~~ 503 (1239)
|.+.+.||.|+||.||++.+. ..+|+|.+........ ....+.+|+.+++.+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--------- 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--------- 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec---------
Confidence 678899999999999999997 8899999976554433 567899999999999988 79999987722
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD---HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
....+++++|+. +++.+++.... .+....+..++.|++.++.|+|
T Consensus 70 -------------------------------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H 118 (384)
T COG0515 70 -------------------------------EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118 (384)
T ss_pred -------------------------------CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 223799999997 47777776654 7999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCC-CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC--CCCC
Q 000880 580 GQGIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW--PKID 656 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~ 656 (1239)
+.+++||||||+||+++..+ .++++|||+++........... .......+||+.|+|||.+.+. ..+.
T Consensus 119 ~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~---------~~~~~~~~~t~~~~~pe~~~~~~~~~~~ 189 (384)
T COG0515 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI---------PALPSTSVGTPGYMAPEVLLGLSLAYAS 189 (384)
T ss_pred hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccc---------cccccccccccccCCHHHhcCCCCCCCC
Confidence 99999999999999999988 7999999999854322111000 0123567899999999999874 4688
Q ss_pred cchhhHHHHHHHHHhhc---CCchhHH---HHHHHHhhhhcC-C-CCCccccC-----CHHHHHHHHHccCCCCCCCCCH
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAME---RQIVLSDLKQKG-E-LPPSWVAK-----FSEQESLLRRLMSPSPSDRPSA 723 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~---~~~~~~~~~~~~-~-~p~~~~~~-----~~e~~~LI~~~L~~dP~~RPta 723 (1239)
...|+||+|++++++++ ||..... .......+.... . ........ ...+.+++.+|+..+|..|.+.
T Consensus 190 ~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 269 (384)
T COG0515 190 SSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269 (384)
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCH
Confidence 99999999999999885 6554442 222222222111 1 11111111 1367899999999999999999
Q ss_pred HHHHhcc
Q 000880 724 TELLQDA 730 (1239)
Q Consensus 724 ~eiL~~~ 730 (1239)
.....++
T Consensus 270 ~~~~~~~ 276 (384)
T COG0515 270 SSDLSHD 276 (384)
T ss_pred HHHhhch
Confidence 9888773
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=196.79 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=189.9
Q ss_pred CCCcccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCC-CceeeeeeeeeecC
Q 000880 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH-QHVVRYYQAWFETG 496 (1239)
Q Consensus 418 ~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~e~~ 496 (1239)
+.-...+.|.++++||.|+||.+|.|.+..+|..||||+-+.+.. ..++..|..+.+.|+| ..|..+..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~---- 80 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYG---- 80 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhc----
Confidence 344456889999999999999999999999999999998653322 2357889999999976 4555554332
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES-YDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL 575 (1239)
.+..+-.+||++.+.||.+++.- ...|+..+++.++-|++.-+
T Consensus 81 ------------------------------------~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~Ri 124 (341)
T KOG1163|consen 81 ------------------------------------TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRI 124 (341)
T ss_pred ------------------------------------cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHH
Confidence 23456689999999999999974 45699999999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCC---CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDAR---NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~---~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
+|+|.+++|||||||+|+|..-+ ..+.|+|||+|+.+..........+ ...+...||..|++--++.+
T Consensus 125 EyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpy--------re~r~ltGTaRYASinAh~g- 195 (341)
T KOG1163|consen 125 EYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPY--------REDRNLTGTARYASINAHLG- 195 (341)
T ss_pred HHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCcc--------ccCCccceeeeehhhhhhhh-
Confidence 99999999999999999999755 3488999999998765443332222 23456789999999988877
Q ss_pred CCCCcchhhHHHHHHHHHhhc---CCchhHHH---HHHHHhhhhcCCCCC--ccccCCHHHHHHHHHccCCCCCCCCCHH
Q 000880 653 PKIDEKADMYSLGIVFFELWH---PFSTAMER---QIVLSDLKQKGELPP--SWVAKFSEQESLLRRLMSPSPSDRPSAT 724 (1239)
Q Consensus 653 ~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~---~~~~~~~~~~~~~p~--~~~~~~~e~~~LI~~~L~~dP~~RPta~ 724 (1239)
-.-+...|+-|+|.+|..+.. ||.+.... +...++...+-..|. .+.+.+.++.-.+.-|-..-=++-|...
T Consensus 196 ~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 196 IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 456889999999988877753 88765432 222333333333332 3344555777788777666666666654
Q ss_pred HH
Q 000880 725 EL 726 (1239)
Q Consensus 725 ei 726 (1239)
-+
T Consensus 276 yl 277 (341)
T KOG1163|consen 276 YL 277 (341)
T ss_pred HH
Confidence 43
|
|
| >COG0441 ThrS Threonyl-tRNA synthetase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=226.26 Aligned_cols=354 Identities=15% Similarity=0.169 Sum_probs=253.4
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce------eccCCCccccccEEEEeccCCCeeeecCCCcHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM------YLLGDCPQFKRNTVKLLTHGGDLLELSHELRLP 855 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~------~~~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~ 855 (1239)
....|+..|+|..+.+++.+++.++.....+||++|.||.+ ..+++++.+.+.||.+... ++.++|||--++.
T Consensus 207 ~~~~G~~~~~pkG~~ir~~le~y~~~~~~~~Gy~~V~TP~~~~~~l~~~SGH~~~y~e~mf~~~~~-~~~~~lKpmNCpg 285 (589)
T COG0441 207 EEGPGLPFWHPKGATIRNLLEDYVRTKLRSYGYQEVKTPVLADLELWELSGHWDNYKEDMFLTESD-DREYALKPMNCPG 285 (589)
T ss_pred ccCCcceEECCCcccHHHHHHHHHHHHHHhcCceEecCCeeeecccchhccchhhccccceeeccC-ChhheeeeccCHh
Confidence 46789999999999999999999999999999999999999 3445567789999987654 4999999955544
Q ss_pred HHHHHHh----CCCCceeEEeecCeEEcCCCC---C--CCCceeEEeEEEeCCCCcccHH--HHHHHHHHHHHhcCCCCc
Q 000880 856 FIRWAIS----NQKSSFKRYEISSVYRRAIGH---S--PPNRYLQGDFDIIGGASALTEA--EVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 856 iaR~~~~----~~~~P~r~~Y~g~VfR~e~~~---~--~~~ef~Q~GvEiiG~~s~~aDa--Evi~la~~~l~~lgi~~~ 924 (1239)
-+..+.+ ++..|+|++..|.|||+|..+ + +.|.|+|-+++||+..++..|. +++.++..+++.+|+++
T Consensus 286 h~~ifk~~~~SYR~LP~r~~E~g~v~R~E~SGal~GL~RvR~ftqdDaHifc~~dQi~~E~~~~~~~i~~v~~~fg~~~- 364 (589)
T COG0441 286 HILIFKSGLRSYRELPLRLAEFGYVYRYEKSGALHGLMRVRGFTQDDAHIFCTPDQIKDEFKGILELILEVYKDFGFTD- 364 (589)
T ss_pred HHHHHhcCCcceeccchhhhhcceeecccCcchhhccccccceeecccceeccHHHHHHHHHHHHHHHHHHHHhcCCce-
Confidence 4455544 334699999999999999876 2 4556999999999997775444 88999999999999985
Q ss_pred eEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCC
Q 000880 925 CDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGA 1004 (1239)
Q Consensus 925 ~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~ 1004 (1239)
+.+.++.+. +.+|..+.|-.+...+...++. .++.-.....-. .+.|+
T Consensus 365 y~~~ls~r~------k~ig~d~~W~~a~~~l~~al~~----------------------~~~~~~~~~G~~----aFyGP 412 (589)
T COG0441 365 YEVKLSTRP------KFIGSDEMWDKAEAALREALKE----------------------IGVEYVEEPGEG----AFYGP 412 (589)
T ss_pred EEEEEecCC------cccCChhhhHHHHHHHHHHHHh----------------------hCceeeecCCce----EEECc
Confidence 999999976 4556666654433222222111 110000000000 11122
Q ss_pred hhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCccccccccccccccccc
Q 000880 1005 ADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYD 1084 (1239)
Q Consensus 1005 ~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD 1084 (1239)
++.|-+...-|-..-.|+|.--|.. .-|+|
T Consensus 413 ----------------------------------Kid~~v~Dalgr~~q~~TIQlDf~l----------------peRF~ 442 (589)
T COG0441 413 ----------------------------------KIDFQVKDALGREWQLGTIQLDFNL----------------PERFD 442 (589)
T ss_pred ----------------------------------ccceEEEeccCcceecceEEEecCC----------------hhhce
Confidence 2222222222333334554333211 12222
Q ss_pred chhhhccccccccc-cCCCCCCceeeeecc--HHHHHhhCC---CCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHH
Q 000880 1085 YLLHRMWDREYVGY-ASRTNPPSGVGASLA--LETIIQHYP---VDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELW 1158 (1239)
Q Consensus 1085 ~L~~~fg~~~~~~~-~g~~~~~pAvGfaig--ldrl~~~L~---~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr 1158 (1239)
-.. ++. .+..+++ .+.-|+. ++|.+.+|. .+.+|.|. +|.+|.|++.+ ++...+|.++++.|+
T Consensus 443 -------l~Y-v~~d~~~~~Pv-miHrai~GSiERfi~iLiE~~~G~~P~WL-aPvQv~VipV~-~~~~~ya~~v~~~L~ 511 (589)
T COG0441 443 -------LEY-VDEDGEKKRPV-IIHRAILGSIERFIGILLEHYAGALPTWL-APVQVRVIPVA-DEHLDYAKEVAEKLR 511 (589)
T ss_pred -------EEE-EcCCCCccCCE-EEEeccchhHHHHHHHHHHhccCCCcccC-CccEEEEEEeC-hHHHHHHHHHHHHHH
Confidence 100 111 1112222 4445554 899987774 56677776 68999999996 677899999999999
Q ss_pred HcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHhh
Q 000880 1159 EENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1159 ~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~~ 1231 (1239)
+.|++|+++.. +.++.+.++.|....+|+++++|++|.++++|++|...++++..++++++++.|+..+++.
T Consensus 512 ~~giRvdvD~~-~e~l~kKIR~a~~~kipyiiVvG~kE~e~~~v~vR~r~~~~~~~~~l~e~i~~ik~e~~~~ 583 (589)
T COG0441 512 KAGIRVDIDDR-NEKLGKKIREAGTQKIPYVIVVGDKEVETGTVVVRRRGGKQQKSMTLEELVEELKKEIEGR 583 (589)
T ss_pred HcCCeeeeccc-ccchHHHHHHHHhcCCCEEEEEchhhhccCceEEEEccCCccccccHHHHHHHHHHHhhcc
Confidence 99999998887 6799999999999999999999999999999999999999999999999999998888654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-22 Score=247.44 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=191.2
Q ss_pred EEeeeccCCceEEEEEEEccCCcEEEEEEEecC---CCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 428 ELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK---DKSLP-VNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 428 ~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~---~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
....+|.|++|.|+.+......+.++.|..+.+ ..+.. ....+..|+.+-..|.|||++..+..+.+
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--------- 392 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--------- 392 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh---------
Confidence 457899999999988888877777777765532 11212 22236778888888999999776544322
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....+-.||||+++|..++.....++...+..++.|++.|+.|||++||
T Consensus 393 -------------------------------~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Gi 441 (601)
T KOG0590|consen 393 -------------------------------IDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGL 441 (601)
T ss_pred -------------------------------cccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCc
Confidence 1112223999988999999888889999999999999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHH
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwS 663 (1239)
.||||||+|+++..+|.+||+|||.+.....+. ........+.+|+..|+|||++.+...-...+||||
T Consensus 442 ahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~-----------e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS 510 (601)
T KOG0590|consen 442 AHRDLKLENLLVTENGILKIIDFGAASVFRYPW-----------EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWS 510 (601)
T ss_pred eeccCccccEEEecCCceEEeecCcceeeccCc-----------chhhhhhcCcccCCcCcCcccccccccCcchhhhhh
Confidence 999999999999999999999999998653221 111233466799999999999998543446799999
Q ss_pred HHHHHHHhhc---CCchhHHHHHHHHhhhhc--CCC----CCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccCCCC
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQK--GEL----PPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~--~~~----p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~~~~ 734 (1239)
.||++..|.+ ||................ ... -..+...+.+.+.+|.+||+.||.+|.|+++|++++|++.
T Consensus 511 ~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 511 CGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred ccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 9999999986 554332221110000000 000 1122333446789999999999999999999999999998
Q ss_pred chHH
Q 000880 735 MEYE 738 (1239)
Q Consensus 735 ~~~~ 738 (1239)
...+
T Consensus 591 i~~c 594 (601)
T KOG0590|consen 591 IECC 594 (601)
T ss_pred cceE
Confidence 7644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-20 Score=215.14 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=184.1
Q ss_pred CceEEeeeccCCceEEEEEEEccCC-cEEEEEEEecCCCCchhHHHHHHHHHHHHhcCC----CceeeeeeeeeecCccc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDG-RHYAVKKIRLKDKSLPVNDRILREVATLSRLQH----QHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g-~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~H----pnIv~l~~~~~e~~~~~ 499 (1239)
.|.+.++||+|+||.||+|.+..++ ..+|+|.......... . .+..|+.++..+.+ +++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~------ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-S-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR------ 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-c-cchhHHHHHHHHhhhcCCCCCCEEEEecc------
Confidence 7999999999999999999998664 6889998765432211 1 57788999998873 46777665431
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESY--DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....+-||||+.++.+|.++.... +.++...+..++.|++.+|++
T Consensus 91 ---------------------------------~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~ 137 (322)
T KOG1164|consen 91 ---------------------------------STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALED 137 (322)
T ss_pred ---------------------------------CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHH
Confidence 124577999999999999988644 579999999999999999999
Q ss_pred HHhCCccccCCCcccEEEcCC-----CCEEEeecCcchhccccccccCCCCCCCCCCcccc-CcccccCccCCCcccccC
Q 000880 578 IHGQGIIHRDLTPNNIFFDAR-----NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD-GTGQVGTYFYTAPEIEQG 651 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~-----~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~GT~~Y~APE~l~~ 651 (1239)
||+.|++||||||.|+++... ..+.|.|||+|+............ ..... .....||..|+++.+..+
T Consensus 138 lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~------~~~r~~~~~~rGT~ry~S~~~H~~ 211 (322)
T KOG1164|consen 138 LHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNL------RPPRPQKGLFRGTLRYASINVHLG 211 (322)
T ss_pred HHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCccc------ccCCCCccCCCCccccccHHHhCC
Confidence 999999999999999999865 469999999999432111110000 00011 134569999999999998
Q ss_pred CCCCCcchhhHHHHHHHHHhhc---CCchhHHH---HHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHH
Q 000880 652 WPKIDEKADMYSLGIVFFELWH---PFSTAMER---QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE 725 (1239)
Q Consensus 652 ~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~e 725 (1239)
...+++.|+||++.++.||+. ||...... ........ ...........+.++..+...+-..+...+|....
T Consensus 212 -~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~ 289 (322)
T KOG1164|consen 212 -IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR-KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEK 289 (322)
T ss_pred -CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh-hhccccccCCChHHHHHHHHHhhccCCcCCCCHHH
Confidence 578999999999999999985 77543321 11111111 11111112223346677777777789999998888
Q ss_pred HHhc
Q 000880 726 LLQD 729 (1239)
Q Consensus 726 iL~~ 729 (1239)
+...
T Consensus 290 ~~~~ 293 (322)
T KOG1164|consen 290 LAEL 293 (322)
T ss_pred HHHH
Confidence 7653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-22 Score=236.56 Aligned_cols=241 Identities=28% Similarity=0.411 Sum_probs=195.9
Q ss_pred eeccCCceEEEEEEEc---cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccCCCCcC
Q 000880 431 PLGHGGFGHVVLCKNK---LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~---~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~~~~~~ 506 (1239)
++|.|+||.|++++.. ..|..||+|+.+..............|..++..++ ||.+|+++.+|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq------------- 67 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ------------- 67 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-------------
Confidence 4799999999887643 45788999998765433233334556778888886 999999997763
Q ss_pred CCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585 (1239)
Q Consensus 507 ~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiH 585 (1239)
....+|++++|.. |.|...+.....+++.....+...++.|++++|+.+|+|
T Consensus 68 ---------------------------t~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiy 120 (612)
T KOG0603|consen 68 ---------------------------TDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAY 120 (612)
T ss_pred ---------------------------cccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHH
Confidence 2456789999995 588888888888999999999999999999999999999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhHHHH
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIwSlG 665 (1239)
||+|++||+++.+|++++.|||+++..-.. +..|||..|||||++.+ ...++|+||||
T Consensus 121 rd~k~enilld~~Ghi~~tdfglske~v~~-------------------~~~cgt~eymApEI~~g---h~~a~D~ws~g 178 (612)
T KOG0603|consen 121 RDYKLENVLLLLEGHIKLTDFGLSKEAVKE-------------------KIACGTYEYRAPEIING---HLSAADWWSFG 178 (612)
T ss_pred hcccccceeecccCccccCCchhhhHhHhh-------------------hhcccchhhhhhHhhhc---cCCcccchhhh
Confidence 999999999999999999999999865322 22399999999999985 57899999999
Q ss_pred HHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCC-----HHHHHhccCCCCchH
Q 000880 666 IVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDALPPQMEY 737 (1239)
Q Consensus 666 viL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPt-----a~eiL~~~~~~~~~~ 737 (1239)
++++||+| ||.. +....++..+...|. ..++.+++++..++..+|..|.. ..++++|+||.+..|
T Consensus 179 vl~felltg~~pf~~----~~~~~Il~~~~~~p~---~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 179 VLAFELLTGTLPFGG----DTMKRILKAELEMPR---ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred hhHHHHhhCCCCCch----HHHHHHhhhccCCch---hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 99999997 8877 344444444555554 34568999999999999999975 578999999999987
Q ss_pred HHH
Q 000880 738 ELL 740 (1239)
Q Consensus 738 ~~~ 740 (1239)
.-+
T Consensus 252 ~~l 254 (612)
T KOG0603|consen 252 NEL 254 (612)
T ss_pred hhH
Confidence 744
|
|
| >KOG4018 consensus Uncharacterized conserved protein, contains RWD domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=200.80 Aligned_cols=119 Identities=29% Similarity=0.422 Sum_probs=106.7
Q ss_pred CCCCHHHHHHHHHHHhhhcCCce-eeecCCCCeEEEEEcCCCCCCCCCCCcE-EEEEEEEcCCCCCCCCCccccccCCCC
Q 000880 27 TVDDNELLSEEITALCAIFQEDC-KVVSGSPPQILVKLRPYSKDMGYEDLDV-SALLLVRCLPGYPYKCPKLQITPEKGL 104 (1239)
Q Consensus 27 ~~~~~eeq~~ElEaL~sIy~d~~-~~~~~~~~~~~i~i~~~~~~~~~~~~~~-~~~L~v~~p~~YP~~~P~~~~~~~~~l 104 (1239)
|+.+ |+|++|+|||+|||||+| +|.+..|+.|+|.|.... ++.+.+. ++.|.|+||++||+++|.+.+....++
T Consensus 1 Ms~~-EeQe~E~EaLeSIY~de~~~i~~~~~~~f~v~iq~e~---~e~d~~~~~~~l~~s~tEnYPDe~Pli~~~~~~~~ 76 (215)
T KOG4018|consen 1 MSQY-EEQEEELEALESIYPDEFKHINSEDPPIFEVTIQYEE---GENDEPKGSFILVFSLTENYPDEAPLIEAFENENL 76 (215)
T ss_pred CCcH-HHHHHHHHHHHHhccchhhhhhccCCccceeeeeccc---ccCCCccccEEEEEEccCCCCCCCcceeccccccc
Confidence 5545 999999999999999999 777778888999998776 4444444 899999999999999999999999999
Q ss_pred CHHHHHHHHHHHHHHHHHhCCCCceeeehHHHHHHHHHHhhccCCCC
Q 000880 105 TKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFLSEIVPLGQS 151 (1239)
Q Consensus 105 ~~~~~~~l~~~L~e~~~e~~~~G~~mif~lv~~lke~L~~~~~~~~~ 151 (1239)
.+.++..|+..|+..+++|| ||+|||+||+.+||||++++.++..
T Consensus 77 ~~~~i~~i~~~l~~~aeenL--GmaMiftLvss~ke~l~e~~~q~~~ 121 (215)
T KOG4018|consen 77 EDAEIEGILEKLQQEAEENL--GMAMIFTLVSSAKEELNEIVEQQKA 121 (215)
T ss_pred cHHHHHHHHHHHHHHHHHhc--chHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999 9999999999999999999876664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.3e-21 Score=233.11 Aligned_cols=237 Identities=24% Similarity=0.379 Sum_probs=175.3
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
-.+|+.++.|-.|+||.||+++|+.+.+.+|+| |+.... ++|- +|.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------
Confidence 478999999999999999999999999999995 432211 1111 12222222222
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
|+-..++...++++... +.+++|||+.|
T Consensus 136 --------------------------------------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg 163 (1205)
T KOG0606|consen 136 --------------------------------------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG 163 (1205)
T ss_pred --------------------------------------------chhhhhcccCCCCcchh--------hHHhHhhccCC
Confidence 22233344334444332 78999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCCcchhhH
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~ksDIw 662 (1239)
|+|||+||+|.+|+.-|++|++|||+++............-.-.....-+.....||||.|.|||++.. ..|+..+|||
T Consensus 164 ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdww 242 (1205)
T KOG0606|consen 164 IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWW 242 (1205)
T ss_pred eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHH
Confidence 999999999999999999999999999864322111000000000111123455699999999999876 5699999999
Q ss_pred HHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCC---CHHHHHhccCCCCch
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP---SATELLQDALPPQME 736 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RP---ta~eiL~~~~~~~~~ 736 (1239)
++|+|+||++- ||....+.+.+-..+......|..-....++++++|.++|..+|..|. .+.++.+|.||+.+.
T Consensus 243 amGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 243 AMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred HHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 99999999984 999888888777777777777877677788999999999999999996 678899999999998
Q ss_pred HH
Q 000880 737 YE 738 (1239)
Q Consensus 737 ~~ 738 (1239)
|.
T Consensus 323 w~ 324 (1205)
T KOG0606|consen 323 WK 324 (1205)
T ss_pred cc
Confidence 86
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-21 Score=233.81 Aligned_cols=272 Identities=21% Similarity=0.272 Sum_probs=195.5
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCC--CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCC
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD--KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~--~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~ 502 (1239)
+|...+.||.+.|=+|.+|++. .| .|+||++-+.. .+.+...+-++|++ .+.++|||.+++.-.-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~---------- 90 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL---------- 90 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH----------
Confidence 6777899999999999999987 34 49999986554 23344455566666 6677999999876331
Q ss_pred CCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
......|||-+|+-.+|+|.+..+.-+..-+.+.|+.||+.||..+|..|
T Consensus 91 ------------------------------~t~kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g 140 (1431)
T KOG1240|consen 91 ------------------------------VTDKAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG 140 (1431)
T ss_pred ------------------------------HhhHHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 22455689999999999999998888888999999999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCC-CCCccccCcccccCccCCCcccccCC---------
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTD-TGGVSVDGTGQVGTYFYTAPEIEQGW--------- 652 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~GT~~Y~APE~l~~~--------- 652 (1239)
|+|+|||.+||||++..++.|+||..-+.... |.+ .+.+.+...+...-.+|.|||.+...
T Consensus 141 VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL---------PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~ 211 (1431)
T KOG1240|consen 141 VCHGDIKSENILITSWNWLYLTDFASFKPTYL---------PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQD 211 (1431)
T ss_pred ccccccccceEEEeeechhhhhcccccCCccC---------CCCCcccceEEEecCCceeeecChHhhhccccccccCCc
Confidence 99999999999999999999999986653221 111 11222111122233479999986531
Q ss_pred -CCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccC--CHHHHHHHHHccCCCCCCCCCHHHH
Q 000880 653 -PKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAK--FSEQESLLRRLMSPSPSDRPSATEL 726 (1239)
Q Consensus 653 -~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~--~~e~~~LI~~~L~~dP~~RPta~ei 726 (1239)
+..+++.||||+||++.||++ |......--.+ -......+...... ...+++||..|++.||.+|.+|++.
T Consensus 212 ~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY---r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedy 288 (1431)
T KOG1240|consen 212 APLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY---RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDY 288 (1431)
T ss_pred ccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH---hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHH
Confidence 125789999999999999996 33332221111 11111111100000 1267899999999999999999999
Q ss_pred Hhc---cCCCCchHHHHHHHHHhcCCCC
Q 000880 727 LQD---ALPPQMEYELLDNILRMMHSSE 751 (1239)
Q Consensus 727 L~~---~~~~~~~~~~~~~~~~~~~~~~ 751 (1239)
|+. -+|+...+.++..++..+.+..
T Consensus 289 L~~yrG~~FP~yFy~FL~~Y~~~~~~~~ 316 (1431)
T KOG1240|consen 289 LQKYRGLVFPEYFYSFLYDYLDRFVPLT 316 (1431)
T ss_pred HHhhhccccHHHHHHHHHHHHHhcCCcc
Confidence 987 3778888888888877665443
|
|
| >cd00670 Gly_His_Pro_Ser_Thr_tRS_core Gly_His_Pro_Ser_Thr_tRNA synthetase class II core domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=200.36 Aligned_cols=137 Identities=9% Similarity=0.129 Sum_probs=119.7
Q ss_pred hhHHHHHHHHHHHHHHHcCCccccccce----eccC--CCccccccEEEEeccC----CCeeeecCCCcHHHHHHHHhC-
Q 000880 795 TELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLG--DCPQFKRNTVKLLTHG----GDLLELSHELRLPFIRWAISN- 863 (1239)
Q Consensus 795 a~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~--~~~~~~~~~~~~~D~~----G~~l~LRPD~T~~iaR~~~~~- 863 (1239)
+.+++.|++.+++.|.++||++|.||+| ++.. +++...++||+|.|.+ |+.++||||.|+|++|+++++
T Consensus 2 ~~~~~~l~~~~~~~~~~~G~~ei~~P~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LrP~~~~~i~~~~~~~~ 81 (235)
T cd00670 2 TALWRALERFLDDRMAEYGYQEILFPFLAPTVLFFKGGHLDGYRKEMYTFEDKGRELRDTDLVLRPAACEPIYQIFSGEI 81 (235)
T ss_pred HHHHHHHHHHHHHHHHHcCCEEEECCeEcCHHHHhhcCCcccchhhcCeeccCcccccCCeEEEecCCCHHHHHHHhccC
Confidence 5678999999999999999999999999 2222 2577789999999998 899999999999999998874
Q ss_pred ---CCCceeEEeecCeEEcCCCC---C-CCCceeEEeEEEeCCC--CcccHHHHHHHHHHHHHhcCCCCceEEEECcHH
Q 000880 864 ---QKSSFKRYEISSVYRRAIGH---S-PPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRFFHAESCDIHLNHGD 933 (1239)
Q Consensus 864 ---~~~P~r~~Y~g~VfR~e~~~---~-~~~ef~Q~GvEiiG~~--s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~~ 933 (1239)
...|+|+||+|+|||+|.++ . +.+||+|+|+|+||.+ +..+++|++.++.++++.||+. +.+.+++.+
T Consensus 82 ~~~~~lP~r~~~~g~~fR~E~~~~~gl~R~reF~q~e~~~~~~~~~~~~~~~e~~~~~~~~l~~lgl~--~~i~~~~~~ 158 (235)
T cd00670 82 LSYRALPLRLDQIGPCFRHEPSGRRGLMRVREFRQVEYVVFGEPEEAEEERREWLELAEEIARELGLP--VRVVVADDP 158 (235)
T ss_pred ccchhcCeeeeeecccccCCCCCCCCChhheeeeeceEEEEcCHHHHHHHHHHHHHHHHHHHHHcCCc--EEEEEccCh
Confidence 24599999999999998766 2 4457999999999998 6789999999999999999983 999999854
|
This domain is the core catalytic domain of tRNA synthetases of the subgroup containing glycyl, histidyl, prolyl, seryl and threonyl tRNA synthetases. It is primarily responsible for ATP-dependent formation of the enzyme bound aminoacyl-adenylate. These enzymes belong to class II aminoacyl-tRNA synthetases (aaRS) based upon their structure and the presence of three characteristic sequence motifs in the core domain. This domain is also found at the C-terminus of eukaryotic GCN2 protein kinase and at the N-terminus of the ATP phosphoribosyltransferase accessory subunit, HisZ and the accessory subunit of mitochondrial polymerase gamma (Pol gamma b) . Most class II tRNA synthetases are dimers, with this subgroup consisting of mostly homodimers. These enzymes attach a specific amino acid to the 3' OH group of ribose of the appropriate tRNA. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=200.22 Aligned_cols=282 Identities=24% Similarity=0.288 Sum_probs=184.8
Q ss_pred CCcccCCceEEeeeccCCceEEEEEEEccCCc-----------------------------------EEEEEEEec-CC-
Q 000880 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGR-----------------------------------HYAVKKIRL-KD- 461 (1239)
Q Consensus 419 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~-----------------------------------~vAVK~i~~-~~- 461 (1239)
++-.+++|++...||+|....||.++...+|. +.|||.+-. ..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 34457899999999999999999998764321 245554421 11
Q ss_pred -CCchhHHHHHHHH------HHH--------Hh--------cCCCceeeeeeeeeecCccccCCCCcCCCCccccccccc
Q 000880 462 -KSLPVNDRILREV------ATL--------SR--------LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSN 518 (1239)
Q Consensus 462 -~~~~~~~~~~~Ev------~iL--------~~--------L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~ 518 (1239)
.+....+.+.+|. ..+ +. -.|||||+++++|.+....--++ ... .
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda-------~~~-----Y 299 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDA-------IER-----Y 299 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCch-------hhh-----C
Confidence 1111223333332 111 11 26999999999997643210000 000 0
Q ss_pred ccccccccccccccccccEEEEEeeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEc--
Q 000880 519 RAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD-- 596 (1239)
Q Consensus 519 ~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~-- 596 (1239)
+.+....+ ......+...+|+||.-.+.+|..++..+. .+.....-++.|+++|+.|||.+||.|||||++||||.
T Consensus 300 Pdalp~R~-~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~Eld 377 (598)
T KOG4158|consen 300 PDALPARW-YPSGAGEPKTLYLVMKRYRQTLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELD 377 (598)
T ss_pred ccccccee-cccccCCCceEEEehhcchhhHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEec
Confidence 00000001 112234567899999999999999987644 56667778999999999999999999999999999994
Q ss_pred CCC--CEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC-----CCcchhhHHHHHHHH
Q 000880 597 ARN--DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK-----IDEKADMYSLGIVFF 669 (1239)
Q Consensus 597 ~~~--~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-----~~~ksDIwSlGviL~ 669 (1239)
+|+ .+.|+|||.+-.-.... ...|. ....-...|+-.-||||+....+. .-.++|.|+.|.+.|
T Consensus 378 dD~~P~LVvaDFGCcLAd~~hG----lqlpy-----~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaY 448 (598)
T KOG4158|consen 378 DDEIPQLVVADFGCCLADDNHG----LQLPY-----ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAY 448 (598)
T ss_pred CCCCcEEEEcccceeeeccccc----ccccc-----ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHH
Confidence 333 47899999875322111 11111 111234568889999999765432 235899999999999
Q ss_pred Hhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHH
Q 000880 670 ELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSAT 724 (1239)
Q Consensus 670 ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~ 724 (1239)
|+++ ||+..-++...... .+..++|+-...+++.+++++..+|+.||++|+++.
T Consensus 449 EIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 449 EIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred HHhccCCcccccchheechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 9996 99874333322222 224556777778889999999999999999999854
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=194.85 Aligned_cols=139 Identities=14% Similarity=0.127 Sum_probs=107.4
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchh------------------------HHHHHHHHHHHHhcCCCce
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPV------------------------NDRILREVATLSRLQHQHV 485 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~------------------------~~~~~~Ev~iL~~L~HpnI 485 (1239)
..||+|+||.||+|.+. +|+.||||+++....+... .....+|+..|..+.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 67999999999999997 8999999999754321111 1123459999999988776
Q ss_pred eeeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHH
Q 000880 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELA 564 (1239)
Q Consensus 486 v~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~ 564 (1239)
....... ....+|||||++| ++.........++...+
T Consensus 82 ~~p~~~~------------------------------------------~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~ 119 (190)
T cd05147 82 PCPEPIL------------------------------------------LKSHVLVMEFIGDDGWAAPRLKDAPLSESKA 119 (190)
T ss_pred CCCcEEE------------------------------------------ecCCEEEEEEeCCCCCcchhhhcCCCCHHHH
Confidence 3322110 0112799999986 44444344567999999
Q ss_pred HHHHHHHHHHHHHH-HhCCccccCCCcccEEEcCCCCEEEeecCcchhc
Q 000880 565 WHLFRQIVEGLAHI-HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612 (1239)
Q Consensus 565 ~~i~~qI~~gL~yL-Hs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~ 612 (1239)
..++.||+.+|.|+ |+.||+||||||+|||++ ++.++|+|||+|...
T Consensus 120 ~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 120 RELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99999999999999 799999999999999998 588999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.1e-19 Score=188.18 Aligned_cols=141 Identities=22% Similarity=0.191 Sum_probs=109.9
Q ss_pred EeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchh------------------------HHHHHHHHHHHHhcCCCc
Q 000880 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPV------------------------NDRILREVATLSRLQHQH 484 (1239)
Q Consensus 429 ~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~------------------------~~~~~~Ev~iL~~L~Hpn 484 (1239)
.+.||+|+||+||+|.+. +|+.||||+++........ ...+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 368999999999999988 9999999999864321100 123457999999999998
Q ss_pred eeeeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCC-HHHHHHhcCCCCHHH
Q 000880 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRT-LRQVFESYDHFDKEL 563 (1239)
Q Consensus 485 Iv~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gs-L~~~l~~~~~l~~~~ 563 (1239)
|......+. ...|+||||++|. +.........++...
T Consensus 81 i~~p~~~~~------------------------------------------~~~~lVmE~~~g~~~~~~~l~~~~~~~~~ 118 (190)
T cd05145 81 VPVPEPILL------------------------------------------KKNVLVMEFIGDDGSPAPRLKDVPLEEEE 118 (190)
T ss_pred CCCceEEEe------------------------------------------cCCEEEEEEecCCCchhhhhhhccCCHHH
Confidence 743332210 1138999999863 433322345688899
Q ss_pred HHHHHHHHHHHHHHHHh-CCccccCCCcccEEEcCCCCEEEeecCcchhcc
Q 000880 564 AWHLFRQIVEGLAHIHG-QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLK 613 (1239)
Q Consensus 564 ~~~i~~qI~~gL~yLHs-~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~ 613 (1239)
+..++.|++.+|.++|+ +||+||||||+|||++ ++.++|+|||+|+...
T Consensus 119 ~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 119 AEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999999999 9999999999999998 8999999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.3e-19 Score=190.94 Aligned_cols=179 Identities=13% Similarity=0.150 Sum_probs=130.5
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCch-hHHH------HHHHHHHHHhcCCCceeeeeeeeeec
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-VNDR------ILREVATLSRLQHQHVVRYYQAWFET 495 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~-~~~~------~~~Ev~iL~~L~HpnIv~l~~~~~e~ 495 (1239)
-++|++++.||.|+||.||++.. ++..+|||+++......+ .... +.+|+..+.++.||+|..+...+...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 36899999999999999999655 477899999975433222 1122 57899999999999999988776432
Q ss_pred CccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 000880 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEG 574 (1239)
Q Consensus 496 ~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~g 574 (1239)
... ........+|+|||++| +|.++.. +++ ....+|+.+
T Consensus 108 ~~~--------------------------------~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~ 147 (232)
T PRK10359 108 ERK--------------------------------TLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKAS 147 (232)
T ss_pred ccc--------------------------------cccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHH
Confidence 100 00112457899999987 7877632 333 245699999
Q ss_pred HHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCC
Q 000880 575 LAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654 (1239)
Q Consensus 575 L~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 654 (1239)
|..||+.|++|||+||+||+++.++ ++|+|||.+........ + .-++.. ..
T Consensus 148 l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a--------------------~-------d~~vle-r~ 198 (232)
T PRK10359 148 IESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA--------------------K-------DRIDLE-RH 198 (232)
T ss_pred HHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhh--------------------H-------HHHHHH-hH
Confidence 9999999999999999999999888 99999998865321100 0 002222 34
Q ss_pred CCcchhhHHHHHHHHHhh
Q 000880 655 IDEKADMYSLGIVFFELW 672 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELl 672 (1239)
|+.++|+||||+++.-+.
T Consensus 199 y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 199 YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hcccccccceeEeehHHH
Confidence 678999999999887654
|
|
| >cd00771 ThrRS_core Threonyl-tRNA synthetase (ThrRS) class II core catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=195.66 Aligned_cols=149 Identities=13% Similarity=0.113 Sum_probs=128.0
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc--CCCccccccEEEEeccCCCeeeecCCCcHHH
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL--GDCPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~--~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~i 856 (1239)
.+.|+++++|.++.+++.|++.+++++.++||++|.||+| ++. ++.+...++||++. .+|+.++|||+.|+++
T Consensus 18 ~~~G~~~~~p~g~~l~~~l~~~~~~~~~~~Gy~ev~tP~l~~~~l~~~sg~~~~~~~~my~~~-~~~~~l~LRP~~~~~~ 96 (298)
T cd00771 18 AGPGLPFWLPKGAIIRNELEDFLRELQRKRGYQEVETPIIYNKELWETSGHWDHYRENMFPFE-EEDEEYGLKPMNCPGH 96 (298)
T ss_pred CCCcceEEcccHHHHHHHHHHHHHHHHHHcCCEEEECCeecCHHHHhhCCCccccccCceEec-cCCceEEEcccCCHHH
Confidence 5789999999999999999999999999999999999999 332 23455789999994 5678999999999999
Q ss_pred HHHHHhC----CCCceeEEeecCeEEcCCCC-----CCCCceeEEeEEEeCCCCc-ccHH-HHHHHHHHHHHhcCCCCce
Q 000880 857 IRWAISN----QKSSFKRYEISSVYRRAIGH-----SPPNRYLQGDFDIIGGASA-LTEA-EVLKVTMDIVTRFFHAESC 925 (1239)
Q Consensus 857 aR~~~~~----~~~P~r~~Y~g~VfR~e~~~-----~~~~ef~Q~GvEiiG~~s~-~aDa-Evi~la~~~l~~lgi~~~~ 925 (1239)
+|+++.. ...|+|+||+|+|||+|.++ .|.+||+|+|+|+||..+. .+++ |+|.++.++++.||+.. +
T Consensus 97 ~~~~~~~~~s~~~LPlr~~~~g~vfR~E~~~~~~Gl~R~reF~q~e~~i~~~~e~~~~e~~e~l~~~~~~l~~lgl~~-~ 175 (298)
T cd00771 97 CLIFKSKPRSYRDLPLRLAEFGTVHRYEQSGALHGLTRVRGFTQDDAHIFCTPDQIKEEIKGVLDLIKEVYSDFGFFD-Y 175 (298)
T ss_pred HHHHHhhccchhhCCeEEEEecCcccCCCCCCCCCccccccEEECCEEEEeCCcchHHHHHHHHHHHHHHHHHcCCCc-E
Confidence 9988863 24699999999999998775 3556899999999988755 3343 79999999999999986 9
Q ss_pred EEEECcHH
Q 000880 926 DIHLNHGD 933 (1239)
Q Consensus 926 ~i~lg~~~ 933 (1239)
.|.++++.
T Consensus 176 ~i~l~~~~ 183 (298)
T cd00771 176 KVELSTRP 183 (298)
T ss_pred EEEEEcCh
Confidence 99999986
|
ThrRS is a homodimer. It is responsible for the attachment of threonine to the 3' OH group of ribose of the appropriate tRNA. This domain is primarily responsible for ATP-dependent formation of the enzyme bound aminoacyl-adenylate. Class II assignment is based upon its structure and the presence of three characteristic sequence motifs in the core domain. |
| >cd00779 ProRS_core_prok Prolyl-tRNA synthetase (ProRS) class II core catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=7e-19 Score=196.71 Aligned_cols=152 Identities=10% Similarity=0.071 Sum_probs=130.9
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccC--CCccccccEEEEeccCCCeeeecCC----
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLG--DCPQFKRNTVKLLTHGGDLLELSHE---- 851 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~--~~~~~~~~~~~~~D~~G~~l~LRPD---- 851 (1239)
..++|+.+++|.++.+++.|++.+++.|+++||++|.||+| ++.. +.+...++||+|.|.+|+.++|||+
T Consensus 18 ~~~~G~~~~lP~g~~l~~~i~~~~~~~~~~~G~~ei~~P~l~~~~~~~~sg~~~~~~~emy~~~d~~~~~l~LrPt~e~~ 97 (255)
T cd00779 18 QTSSGLYSWLPLGLRVLKKIENIIREEMNKIGAQEILMPILQPAELWKESGRWDAYGPELLRLKDRHGKEFLLGPTHEEV 97 (255)
T ss_pred cCCCceEEECchHHHHHHHHHHHHHHHHHHcCCEEEECCccCCHHHHHhcCCccccCcccEEEecCCCCeEEEecCCcHH
Confidence 46899999999999999999999999999999999999999 3332 3446789999999999999999999
Q ss_pred CcHHHHHHHHhCCCCceeEEeecCeEEcC-CCCCC---CCceeEEeEEEeCCCCcccHH---HHHHHHHHHHHhcCCCCc
Q 000880 852 LRLPFIRWAISNQKSSFKRYEISSVYRRA-IGHSP---PNRYLQGDFDIIGGASALTEA---EVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 852 ~T~~iaR~~~~~~~~P~r~~Y~g~VfR~e-~~~~~---~~ef~Q~GvEiiG~~s~~aDa---Evi~la~~~l~~lgi~~~ 924 (1239)
+|..++|.+.+++..|+|+||+|+|||+| +|+.| .+||+|+|+++||.+...+|+ |++.++.++++.||++
T Consensus 98 ~t~~~~~~i~s~~~LPlr~~~~~~~FR~E~~~~~Gl~R~reF~q~e~~~~~~~~~~a~~~~~~i~~~~~~il~~Lgl~-- 175 (255)
T cd00779 98 ITDLVANEIKSYKQLPLNLYQIQTKFRDEIRPRFGLMRGREFLMKDAYSFDIDEESLEETYEKMYQAYSRIFKRLGLP-- 175 (255)
T ss_pred HHHHHHhccccHhhCCHHHHhCcceecCCCCCCCceeeeeeEeHhhheeccCCHHHHHHHHHHHHHHHHHHHHHcCCc--
Confidence 55566666665666799999999999999 88765 457999999999998888999 8888999999999994
Q ss_pred eEEEECcHHHH
Q 000880 925 CDIHLNHGDLL 935 (1239)
Q Consensus 925 ~~i~lg~~~i~ 935 (1239)
+.+..++.+.+
T Consensus 176 ~~~~~~~~~~~ 186 (255)
T cd00779 176 FVKVEADSGAI 186 (255)
T ss_pred EEEEEecCCCC
Confidence 88887776554
|
ProRS is a homodimer. It is responsible for the attachment of proline to the 3' OH group of ribose of the appropriate tRNA. This domain is primarily responsible for ATP-dependent formation of the enzyme bound aminoacyl-adenylate. Class II assignment is based upon its structure and the presence of three characteristic sequence motifs in the core domain. This subfamily contains the core domain of ProRS from prokaryotes and from the mitochondria of eukaryotes. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=190.64 Aligned_cols=248 Identities=20% Similarity=0.276 Sum_probs=149.3
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCC-CchhHHHHHHHHHHHHhcCC---C-------ceeeeeeeee
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQH---Q-------HVVRYYQAWF 493 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-~~~~~~~~~~Ev~iL~~L~H---p-------nIv~l~~~~~ 493 (1239)
.+...+.||.|+++.||.+++..||+.+|+|++..... +....+++.+|.-....+.+ | .++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45677899999999999999999999999999876553 23345667777655555433 1 1111111111
Q ss_pred ecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHH---hcCCC----CHHHHHH
Q 000880 494 ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE---SYDHF----DKELAWH 566 (1239)
Q Consensus 494 e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~---~~~~l----~~~~~~~ 566 (1239)
-++ ...+ + ..........-.+.+++|+-+.++|.+++. ..... .......
T Consensus 93 i~~------~~~~---------~--------~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~ 149 (288)
T PF14531_consen 93 IPG------KPPF---------F--------ERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLS 149 (288)
T ss_dssp ETT------S-SE---------E--------EECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHH
T ss_pred EcC------CCcc---------e--------ecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHH
Confidence 000 0000 0 000000000112567888888888888764 22222 1222345
Q ss_pred HHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCc
Q 000880 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP 646 (1239)
Q Consensus 567 i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 646 (1239)
+..|+++.+++||+.|++|+||||+|+|++.+|.++|+||+.....+... .....+..|.+|
T Consensus 150 lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~------------------~~~~~~~~~~PP 211 (288)
T PF14531_consen 150 LTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY------------------RCSEFPVAFTPP 211 (288)
T ss_dssp HHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE------------------EGGGS-TTTS-H
T ss_pred HHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCcee------------------eccCCCcccCCh
Confidence 56899999999999999999999999999999999999999877543211 002345789999
Q ss_pred ccccCC-------CCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCC
Q 000880 647 EIEQGW-------PKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716 (1239)
Q Consensus 647 E~l~~~-------~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~d 716 (1239)
|..... -.++.+.|.|+||+++|.|++ ||............ -..+.+.+...+.||+.+|+.|
T Consensus 212 e~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~~-------f~~C~~~Pe~v~~LI~~lL~~~ 284 (288)
T PF14531_consen 212 ELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEWD-------FSRCRDMPEPVQFLIRGLLQRN 284 (288)
T ss_dssp HHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGGG-------GTTSS---HHHHHHHHHHT-SS
T ss_pred hhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccccc-------chhcCCcCHHHHHHHHHHccCC
Confidence 976431 237889999999999999997 87643321111000 1122244457899999999999
Q ss_pred CCCC
Q 000880 717 PSDR 720 (1239)
Q Consensus 717 P~~R 720 (1239)
|.+|
T Consensus 285 ~~~R 288 (288)
T PF14531_consen 285 PEDR 288 (288)
T ss_dssp GGGS
T ss_pred cccC
Confidence 9988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-17 Score=177.27 Aligned_cols=137 Identities=19% Similarity=0.267 Sum_probs=105.7
Q ss_pred EeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-----CCCceeeeeeeeeecCccccCCC
Q 000880 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-----QHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 429 ~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-----~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
.+.||+|+||.||. +..++.. +||++..... .....+.+|+.+++.+ .||||+++++++...
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~-------- 73 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD-------- 73 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--------
Confidence 47899999999995 7777666 6999875432 2346789999999999 579999999987432
Q ss_pred CcCCCCcccccccccccccccccccccccccccE-EEEEeeccC---CCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHH
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTY-LYIQMEYCP---RTLRQVFESYDHFDKELAWHLFRQIVEGL-AHI 578 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~-l~iVmEy~~---gsL~~~l~~~~~l~~~~~~~i~~qI~~gL-~yL 578 (1239)
..... +.+||||++ ++|.+++.+. .+++. ..++.|++.++ +||
T Consensus 74 -----------------------------~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yL 121 (210)
T PRK10345 74 -----------------------------CGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYL 121 (210)
T ss_pred -----------------------------CCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHH
Confidence 01123 347899954 5999999763 56666 35678888877 999
Q ss_pred HhCCccccCCCcccEEEcC----CCCEEEeecCcch
Q 000880 579 HGQGIIHRDLTPNNIFFDA----RNDIKIGDFGLAK 610 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~----~~~vKL~DFGlA~ 610 (1239)
|+++|+||||||+|||++. ++.++|+||+.+.
T Consensus 122 h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 122 LDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred HHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 9999999999999999974 3479999944443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.2e-17 Score=171.38 Aligned_cols=191 Identities=15% Similarity=0.114 Sum_probs=131.5
Q ss_pred EEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCch--hHHHHHHHHHHHHhcC-CCceeeeeeeeeecCccccCCCC
Q 000880 428 ELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP--VNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 428 ~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~--~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
+...|++|+||+||.+.. .+..++.+.+.....-.. ....+.+|+.+|++|+ |++|++++++.
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------------ 71 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------------ 71 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------------
Confidence 457899999999997766 578888887653332111 1125789999999995 57888887531
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
..|++|+|+.| +|.+.+.. . ...++.|++.+|.++|++||
T Consensus 72 --------------------------------~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GI 112 (218)
T PRK12274 72 --------------------------------GRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGV 112 (218)
T ss_pred --------------------------------CEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcC
Confidence 24899999976 67544321 1 23578899999999999999
Q ss_pred cccCC-CcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCCCCCC-cchhh
Q 000880 584 IHRDL-TPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID-EKADM 661 (1239)
Q Consensus 584 iHrDL-Kp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~-~ksDI 661 (1239)
+|||| ||+|||++.++.++|+|||+|............ .....-.+-..+ -..+++.|++|+...-....+ ...++
T Consensus 113 vHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~-L~~rDl~~llk~-~~~y~~~~l~~~~~~~l~~~~~~~~~w 190 (218)
T PRK12274 113 AHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL-LAREDLRHLLKH-KRMYCPAALTPVERRVLKRTSWIRELW 190 (218)
T ss_pred ccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH-HHHHHHHHHHHH-HHhcCCCCCCHHHHhhhccchhHHHHH
Confidence 99999 799999999999999999999854321100000 000000000011 124889999999644322233 67899
Q ss_pred HHHHHHHHHhhc
Q 000880 662 YSLGIVFFELWH 673 (1239)
Q Consensus 662 wSlGviL~ELlt 673 (1239)
++.|+-+|.++|
T Consensus 191 ~~~g~~~~~~~~ 202 (218)
T PRK12274 191 FATGKPVYRFVT 202 (218)
T ss_pred HHhcchHHHHHh
Confidence 999999999997
|
|
| >smart00591 RWD domain in RING finger and WD repeat containing proteins and DEXDc-like helicases subfamily related to the UBCc domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=154.98 Aligned_cols=104 Identities=40% Similarity=0.572 Sum_probs=92.9
Q ss_pred HHHHHhhhcCCceeeecCCCC--eEEEEEcCCCCCCCCCCCcEEEEEEEEcCCCCCCCCCccccccCCCCCHHHHHHHHH
Q 000880 37 EITALCAIFQEDCKVVSGSPP--QILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLC 114 (1239)
Q Consensus 37 ElEaL~sIy~d~~~~~~~~~~--~~~i~i~~~~~~~~~~~~~~~~~L~v~~p~~YP~~~P~~~~~~~~~l~~~~~~~l~~ 114 (1239)
|+|||+|||+|++..++.++. .|+|++++.+. +..+..+.+.|+|.+|++||+.+|.+.+.+..||+..++..|..
T Consensus 1 EieaL~sIy~~~~~~~~~~~~~~~~~i~l~~~~~--~~~~~~~~~~l~~~~p~~YP~~~P~i~~~~~~~l~~~~~~~l~~ 78 (107)
T smart00591 1 ELEALESIYPEDFEVIDEDARIPEITIKLSPSSD--EGEDQYVSLTLQVKLPENYPDEAPPISLLNSEGLSDEQLAELLK 78 (107)
T ss_pred ChHHHHhhccceeEEecCCCCccEEEEEEecCCC--CCCccceEEEEEEECCCCCCCCCCCeEEECCCCCCHHHHHHHHH
Confidence 799999999999988887666 89999977652 12233588999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCceeeehHHHHHHHHHHh
Q 000880 115 LLQDQANSNAREGRVMIFNLVEAAQEFLSE 144 (1239)
Q Consensus 115 ~L~e~~~e~~~~G~~mif~lv~~lke~L~~ 144 (1239)
.|.+.++++. |++|||+|++++||+|++
T Consensus 79 ~l~~~~~e~~--g~~~if~~v~~~~e~l~~ 106 (107)
T smart00591 79 KLEEIAEENL--GEVMIFELVEKLQEFLSE 106 (107)
T ss_pred HHHHHHHHhC--CCEEhhHHHHHHHHHHhc
Confidence 9999999999 999999999999999986
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.1e-17 Score=177.98 Aligned_cols=143 Identities=20% Similarity=0.154 Sum_probs=110.4
Q ss_pred CceEEeeeccCCceEEEEEE-EccCCcEEEEEEEecCCCCch----------------------hHHHHHHHHHHHHhcC
Q 000880 425 DFEELQPLGHGGFGHVVLCK-NKLDGRHYAVKKIRLKDKSLP----------------------VNDRILREVATLSRLQ 481 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~-~~~~g~~vAVK~i~~~~~~~~----------------------~~~~~~~Ev~iL~~L~ 481 (1239)
.|.+.+.||+|+||.||+|. +..+|+.||||+++....... ....+.+|+..+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46777899999999999999 667999999999975431100 1123568999999997
Q ss_pred CCc--eeeeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCC
Q 000880 482 HQH--VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDH 558 (1239)
Q Consensus 482 Hpn--Iv~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~ 558 (1239)
+.+ +++++.. ...|+||||++| +|.........
T Consensus 109 ~~~i~~p~~~~~--------------------------------------------~~~~lV~E~~~g~~L~~~~~~~~~ 144 (237)
T smart00090 109 EAGVPVPKPIAW--------------------------------------------RRNVLVMEFIGGDGLPAPRLKDVE 144 (237)
T ss_pred hcCCCCCeeeEe--------------------------------------------cCceEEEEEecCCcccccccccCC
Confidence 633 2333211 113799999987 56554434445
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCcccEEEcCCCCEEEeecCcchhc
Q 000880 559 FDKELAWHLFRQIVEGLAHIHGQG-IIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612 (1239)
Q Consensus 559 l~~~~~~~i~~qI~~gL~yLHs~g-IiHrDLKp~NILl~~~~~vKL~DFGlA~~~ 612 (1239)
+....+..++.||+.+|.+||++| ++||||||+||+++ ++.++|+|||.|+..
T Consensus 145 ~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 145 PEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 667778899999999999999999 99999999999999 889999999998854
|
|
| >KOG1637 consensus Threonyl-tRNA synthetase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-15 Score=171.99 Aligned_cols=351 Identities=15% Similarity=0.098 Sum_probs=233.3
Q ss_pred CCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce------eccCCCccccccEEEEeccCCCeeeecCCCcHH
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM------YLLGDCPQFKRNTVKLLTHGGDLLELSHELRLP 855 (1239)
Q Consensus 782 ~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~------~~~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~ 855 (1239)
....|+-.++|..+.+.+.+.+.++.-|++.||++|.||.+ .-+++++.+.++||+|.-. .++.+|.|.-++.
T Consensus 179 ~lSPGS~FflP~G~~iyN~Lv~fir~ey~~rGf~EVitPniy~~~LWe~SGHwqnY~enmF~~e~e-ke~~~LKPMNCPg 257 (560)
T KOG1637|consen 179 ELSPGSCFFLPHGTRIYNTLVDFIRAEYRKRGFTEVITPNIYNKKLWETSGHWQNYSENMFKFEVE-KEEFALKPMNCPG 257 (560)
T ss_pred cCCCcceeeccCcchHHHHHHHHHHHHHHhcCCceecCcchhhhhhhhhccchhhhhhhceeeeec-hhhhccCccCCCc
Confidence 45679999999999999999999999999999999999999 5566788999999999763 4569999966655
Q ss_pred HHHHHHhC----CCCceeEEeecCeEEcCCCC-----CCCCceeEEeEEEeCCCCc-ccHH-HHHHHHHHHHHhcCCCCc
Q 000880 856 FIRWAISN----QKSSFKRYEISSVYRRAIGH-----SPPNRYLQGDFDIIGGASA-LTEA-EVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 856 iaR~~~~~----~~~P~r~~Y~g~VfR~e~~~-----~~~~ef~Q~GvEiiG~~s~-~aDa-Evi~la~~~l~~lgi~~~ 924 (1239)
-.=+..++ +..|+|+.-+|.+.|+|..+ .+.|+|+|-+++||+..++ ..+. -++..+..++.-+|..
T Consensus 258 HcLmf~~r~rS~reLPlR~aDFg~LHRnE~SGaLsGLTRvRrFqQDDaHIFCt~~Qi~~Eik~~l~fl~~vY~~fgf~-- 335 (560)
T KOG1637|consen 258 HCLMFAHRDRSYRELPLRFADFGVLHRNEASGALSGLTRVRRFQQDDAHIFCTPDQVKEEIKGCLDFLDYVYGVFGFT-- 335 (560)
T ss_pred cccccccCCccHhhCCccccCcceeeeccccccccccceeeeecccCceEEecCccHHHHHHHHHHHHHHHHHhcccc--
Confidence 44333332 23599999999999998755 3566799999999999887 4444 5666666666666764
Q ss_pred eEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCC
Q 000880 925 CDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGA 1004 (1239)
Q Consensus 925 ~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~ 1004 (1239)
+.+.|+.+. + +.+|.-+.|-++-..+=..++ +.|-+-.....=. .+.|+
T Consensus 336 f~l~lSTRP--e---~~lG~l~~Wd~AE~~L~~al~----------------------e~g~pw~lN~GDG----AFYGP 384 (560)
T KOG1637|consen 336 FKLNLSTRP--E---KFLGDLETWDEAEFKLEEALN----------------------ESGEPWVLNPGDG----AFYGP 384 (560)
T ss_pred ceeEeccCh--H---HhccCHHHHHHHHHHHHHHHH----------------------HhCCCceecCCCc----ccccc
Confidence 889999864 2 344544444332221111111 1110000000000 11222
Q ss_pred hhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCccccccccccccccccc
Q 000880 1005 ADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYD 1084 (1239)
Q Consensus 1005 ~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD 1084 (1239)
+|.+-+....+-..-+.++---|.
T Consensus 385 ----------------------------------KIDi~l~Dal~r~hQcaTIQLDFq---------------------- 408 (560)
T KOG1637|consen 385 ----------------------------------KIDITLDDALGRKHQCATIQLDFQ---------------------- 408 (560)
T ss_pred ----------------------------------eeeeEhhhhcCcccceeeeeeccc----------------------
Confidence 222222222222222333211110
Q ss_pred chhhhccccccccccCCCCCCc-eeeeec-c-HHHHHhhCC---CCCcCCCCCCCceEEEEecCCCccHHHHHHHHHHHH
Q 000880 1085 YLLHRMWDREYVGYASRTNPPS-GVGASL-A-LETIIQHYP---VDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELW 1158 (1239)
Q Consensus 1085 ~L~~~fg~~~~~~~~g~~~~~p-AvGfai-g-ldrl~~~L~---~~~~~~~~~~~~~v~v~~~~~~~~~~~a~~ia~~Lr 1158 (1239)
|..+|.-+ +....|. ...| -|.-|| | ++|++++|. .+..|.|. .|.++.||+.+ +..+.+|-++...|+
T Consensus 409 -LP~rFdL~-y~~~~g~-~erPVmIHRAIlGSvERmiaiL~E~~~gkwPFWl-SPRq~~vIpVs-e~~~~ya~~V~~ql~ 483 (560)
T KOG1637|consen 409 -LPIRFDLE-YETEDGD-LERPVMIHRAILGSVERMIAILLESYGGKWPFWL-SPRQAVVIPVS-EGPLDYATSVQKQLE 483 (560)
T ss_pred -ChhhcCce-eeccccc-ccchhhHHHHHhhhHHHHHHHHHHHhCCCCCeee-ccceEEEEECC-CcchhHHHHHHHHHH
Confidence 11111000 0000000 0112 223333 3 899999986 33344444 56788999996 788899999999999
Q ss_pred HcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEc---cCCcccccchHHHHHHHHHHH
Q 000880 1159 EENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHL---DVKKEKEVQRESLVRFLLDAI 1228 (1239)
Q Consensus 1159 ~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l---~~~~q~~v~~~el~~~i~~~l 1228 (1239)
..|+-+++... ...+.+.++.|.-.++.++++||++|.+.++|.||.+ +++.+..++++++.+.++++-
T Consensus 484 ~a~f~~Dld~t-~~tl~kkir~Aqla~yn~i~VVGdkE~~~~~vnVr~Rd~~~~~~~~~~tie~~~~~~~~l~ 555 (560)
T KOG1637|consen 484 EAGFYVDLDPT-DSTLRKKIRNAQLAHYNFIFVVGDKEVETGRVNVRTRDNRDNKTESEMTIEELSDEFKELK 555 (560)
T ss_pred hhhceeecCCc-cchHHHHHhhhhhcceeEEEEEchhhhhcCceeeeccccccccccceeeHHHHHHHHHHhH
Confidence 99998998777 4789999999999999999999999999999999997 455566888999888877654
|
|
| >TIGR00389 glyS_dimeric glycyl-tRNA synthetase, dimeric type | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-15 Score=177.66 Aligned_cols=121 Identities=17% Similarity=0.169 Sum_probs=99.1
Q ss_pred Ccee-eeeccHHHHHhhCCC-CCc-------------CCCCCCCceEEEEecCCC-ccHHHHHHHHHHHHHcCCeEEEee
Q 000880 1105 PSGV-GASLALETIIQHYPV-DFK-------------PVRNEAGTSVLVCSRGGG-GLLVERMELVAELWEENIKAQFVP 1168 (1239)
Q Consensus 1105 ~pAv-Gfaigldrl~~~L~~-~~~-------------~~~~~~~~~v~v~~~~~~-~~~~~a~~ia~~Lr~~G~~ve~~~ 1168 (1239)
+|-| --|+|+|||+.+|.+ ... .+...+|.+|+|++.+++ .....|.++++.||..|++|+++.
T Consensus 414 ~P~VIepS~GIdRIi~ALle~~~~e~~~~~~~r~vL~lp~~lAP~kV~VIpl~~~~el~~~A~eIa~~LR~~GI~VeiD~ 493 (551)
T TIGR00389 414 IPHVIEPSFGIDRIIYALLEHSYQEEVLDGEEREVLRLPPHLAPIKVAVLPLVNKEELKEIAKEIFQALRKTGIRIKYDD 493 (551)
T ss_pred cceEEEcccCHHHHHHHHHHhhCccccccccccceeccCCccCCceEEEEEecCcHHHHHHHHHHHHHHHHCCCEEEEEC
Confidence 4544 778999999866531 111 111226889999998522 267899999999999999999877
Q ss_pred CCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHH
Q 000880 1169 VPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDA 1227 (1239)
Q Consensus 1169 ~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~ 1227 (1239)
. . ++++++++|++.|+|++|+||++|+++|+|+||++++++|..++++++.+.+.++
T Consensus 494 s-~-sIGKq~rrADeiGiPf~IIIG~~EledgtVTIRdRdT~eQ~~I~ldeL~~~L~e~ 550 (551)
T TIGR00389 494 S-G-TIGKRYRRADEIGTPFCVTIDFETLEDETVTIRERDSMKQVRVKIKELPSYIKKL 550 (551)
T ss_pred C-C-CHHHHHHHHHHcCCCEEEEECCchhhCCEEEEEECCCCceEEeeHHHHHHHHHhh
Confidence 5 4 5999999999999999999999999999999999999999999999998887654
|
This model describes a glycyl-tRNA synthetase distinct from the two alpha and two beta chains of the tetrameric E. coli glycyl-tRNA synthetase. This enzyme is a homodimeric class II tRNA synthetase and is recognized by pfam model tRNA-synt_2b, which recognizes His, Ser, Pro, and this set of glycyl-tRNA synthetases. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.4e-16 Score=185.34 Aligned_cols=234 Identities=26% Similarity=0.419 Sum_probs=165.7
Q ss_pred HHhcCCCceeeeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHh
Q 000880 477 LSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES 555 (1239)
Q Consensus 477 L~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~ 555 (1239)
|+.+.|.|+.+++|.++. ...+++|.+||. |+|.+.+..
T Consensus 1 l~~l~h~n~~~f~g~~~~----------------------------------------~~~~~~i~~~c~rGsl~D~i~~ 40 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD----------------------------------------GPEMIVIWEYCSRGSLLDILSN 40 (484)
T ss_pred CcccchhhhhhheeeEec----------------------------------------CCceEEEEeeecCccHHhHHhc
Confidence 467899999999999854 256789999997 799999976
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCcccEEEcCCCCEEEeecCcchhccccccccCCCCCCCCCCcccc
Q 000880 556 -YDHFDKELAWHLFRQIVEGLAHIHGQGI-IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633 (1239)
Q Consensus 556 -~~~l~~~~~~~i~~qI~~gL~yLHs~gI-iHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~ 633 (1239)
.-.+++-....++++|+.||+|||...| .|+.|++.|++++....+||+|||+........ .. ..
T Consensus 41 ~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~------------~~ 107 (484)
T KOG1023|consen 41 EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA-EP------------EA 107 (484)
T ss_pred cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccc-cc------------cc
Confidence 4468888899999999999999999876 999999999999999999999999988753200 00 00
Q ss_pred CcccccCccCCCcccccCCC--C----CCcchhhHHHHHHHHHhhc---CCchh----HHHHHHHHhhh-h-cCCCCCcc
Q 000880 634 GTGQVGTYFYTAPEIEQGWP--K----IDEKADMYSLGIVFFELWH---PFSTA----MERQIVLSDLK-Q-KGELPPSW 698 (1239)
Q Consensus 634 ~~~~~GT~~Y~APE~l~~~~--~----~~~ksDIwSlGviL~ELlt---Pf~~~----~~~~~~~~~~~-~-~~~~p~~~ 698 (1239)
.....-...|.|||.+.+.. . .+.++|+||||++++|+++ ||... ...++...... . ....|..+
T Consensus 108 ~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~ 187 (484)
T KOG1023|consen 108 HHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIE 187 (484)
T ss_pred cchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchh
Confidence 11223456799999987631 1 4678999999999999995 77642 22233333222 1 11233222
Q ss_pred c--cCCHHHHHHHHHccCCCCCCCCCHHHHHhcc--CCCC--chHHHHHHHHHhcCCCCCCcchhhhccccccchhh
Q 000880 699 V--AKFSEQESLLRRLMSPSPSDRPSATELLQDA--LPPQ--MEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETL 769 (1239)
Q Consensus 699 ~--~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~--~~~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~e~~~ 769 (1239)
. ...+++..+++.||..+|.+||+++++-... .... ....+++..++++. .|...++..+++.+.
T Consensus 188 ~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~m~~~le------~Y~~nLe~~v~eRt~ 258 (484)
T KOG1023|consen 188 LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDSLFRMLE------SYADNLEKLVDERTA 258 (484)
T ss_pred hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHHHHHHHH------HHHhhhHHHHHHHHH
Confidence 1 3345688999999999999999999985432 2222 12356666666553 366666666666443
|
|
| >cd00772 ProRS_core Prolyl-tRNA synthetase (ProRS) class II core catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=169.63 Aligned_cols=148 Identities=14% Similarity=0.145 Sum_probs=124.0
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----eccCCCcc---ccccEEEEeccCC----CeeeecCC
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGDCPQ---FKRNTVKLLTHGG----DLLELSHE 851 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~~~~~~---~~~~~~~~~D~~G----~~l~LRPD 851 (1239)
.++|+.+++|....+++.|++.+++.++++||++|.||.| ++.+.|.. ..++||.+.|.+| +.++|||+
T Consensus 20 ~~~G~~~~lP~g~~i~~~I~~~i~~~~~~~G~~ev~~P~l~~~~~~~~~g~~~~~~~~e~~~~~~~~~~~~~~~l~LrPt 99 (264)
T cd00772 20 PGRGIINFLPLAKAILDKIENVLDKMFKEHGAQNALFPFFILASFLEKEAEHDEGFSKELAVFKDAGDEELEEDFALRPT 99 (264)
T ss_pred CCCCEEEECCcHHHHHHHHHHHHHHHHHHcCCeEEECCeeccHHHHhhcCCcccccCccceEEEeCCCCccCceEEECCC
Confidence 4789999999999999999999999999999999999999 33222322 3478999999887 89999999
Q ss_pred CcHHHHHHHHhC----CCCceeEEeecCeEEcC-CCCC---CCCceeEEeEEEeCCCCcccHHHHHHHH---HHHHHhcC
Q 000880 852 LRLPFIRWAISN----QKSSFKRYEISSVYRRA-IGHS---PPNRYLQGDFDIIGGASALTEAEVLKVT---MDIVTRFF 920 (1239)
Q Consensus 852 ~T~~iaR~~~~~----~~~P~r~~Y~g~VfR~e-~~~~---~~~ef~Q~GvEiiG~~s~~aDaEvi~la---~~~l~~lg 920 (1239)
.|++++++++.. +..|+|+||+|+|||+| +++. |.+||+|.++++|+.....+|+|+..+. .++++.||
T Consensus 100 ~e~~~~~~~~~~i~s~~~LPlrl~~~~~~fR~E~r~~~Gl~R~reF~~~e~~~~~~~~e~a~~e~~~~~~~~~~i~~~l~ 179 (264)
T cd00772 100 LEENIGEIAAKFIKSWKDLPQHLNQIGNKFRDEIRPRFGFLRAREFIMKDGHSAHADAEEADEEFLNMLSAYAEIARDLA 179 (264)
T ss_pred CCHHHHHHHHhhhhhhhccCeeEEEEeCeEeCcCCCCCCcceeeEEEEeeeEEecCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 999999988763 35699999999999998 7754 4457999999999988888888776665 89999999
Q ss_pred -CCCceEEEECcH
Q 000880 921 -HAESCDIHLNHG 932 (1239)
Q Consensus 921 -i~~~~~i~lg~~ 932 (1239)
+. +.+.....
T Consensus 180 ~lp--~~~~~~~~ 190 (264)
T cd00772 180 AID--FIEGEADE 190 (264)
T ss_pred Ccc--EEEEEcCC
Confidence 53 77766553
|
ProRS is a homodimer. It is responsible for the attachment of proline to the 3' OH group of ribose of the appropriate tRNA. This domain is primarily responsible for ATP-dependent formation of the enzyme bound aminoacyl-adenylate. Class II assignment is based upon its structure and the presence of three characteristic sequence motifs in the core domain. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-15 Score=162.71 Aligned_cols=135 Identities=27% Similarity=0.342 Sum_probs=107.8
Q ss_pred eeeccCCceEEEEEEEccCCcEEEEEEEecCCCCch------hHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCC
Q 000880 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP------VNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~------~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~ 503 (1239)
+.||+|++|.||+|.+ +|..+++|+......... ....+.+|+.++..+.|++|+....++..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--------- 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--------- 70 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe---------
Confidence 5799999999999988 588899998653322111 12457889999999999988655444321
Q ss_pred CcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~g 582 (1239)
....+++|||++| +|.+++..... ....++.+++.+|.++|+.|
T Consensus 71 -------------------------------~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~ 115 (211)
T PRK14879 71 -------------------------------PENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG 115 (211)
T ss_pred -------------------------------CCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC
Confidence 2345899999975 89888865332 77889999999999999999
Q ss_pred ccccCCCcccEEEcCCCCEEEeecCcchh
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKF 611 (1239)
Q Consensus 583 IiHrDLKp~NILl~~~~~vKL~DFGlA~~ 611 (1239)
++|||++|.|||++ ++.++|+|||++..
T Consensus 116 i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 116 IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999999 78999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.1e-15 Score=162.84 Aligned_cols=136 Identities=26% Similarity=0.226 Sum_probs=104.2
Q ss_pred ceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCch--------------------hHHHHHHHHHHHHhcCCCce
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP--------------------VNDRILREVATLSRLQHQHV 485 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~--------------------~~~~~~~Ev~iL~~L~HpnI 485 (1239)
|.+.+.||+|+||.||+|.+. +|+.||||+++....... ......+|..++..+.|+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 556688999999999999886 899999999875431110 11236678889998888753
Q ss_pred --eeeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHH
Q 000880 486 --VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKE 562 (1239)
Q Consensus 486 --v~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~ 562 (1239)
+..++ ....+++|||++| +|..+.. ..
T Consensus 96 ~v~~~~~--------------------------------------------~~~~~lv~e~~~g~~L~~~~~------~~ 125 (198)
T cd05144 96 PVPKPID--------------------------------------------WNRHAVVMEYIDGVELYRVRV------LE 125 (198)
T ss_pred CCCceee--------------------------------------------cCCceEEEEEeCCcchhhccc------cc
Confidence 22221 1123899999976 6655432 13
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhc
Q 000880 563 LAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612 (1239)
Q Consensus 563 ~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~ 612 (1239)
....++.+|+.++.++|+.||+||||||+||+++.++.++|+|||++...
T Consensus 126 ~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 126 DPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 45678899999999999999999999999999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF05773 RWD: RWD domain; InterPro: IPR006575 The RWD eukaryotic domain is found in RING finger (IPR001841 from INTERPRO) and WD repeat (IPR001680 from INTERPRO) containing proteins and DEXDc-like helicase (IPR001410 from INTERPRO) subfamily related to the ubiquitin-conjugating enzymes domain (IPR000608 from INTERPRO) | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.6e-15 Score=148.34 Aligned_cols=112 Identities=32% Similarity=0.390 Sum_probs=88.9
Q ss_pred CCHHHHHHHHHHHhhhcCCce-eeecCCCCeEEEEEcCCCCCCCCCCCcEEEEEEEEcCCCCCCCCCccccccCCCCCHH
Q 000880 29 DDNELLSEEITALCAIFQEDC-KVVSGSPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKS 107 (1239)
Q Consensus 29 ~~~eeq~~ElEaL~sIy~d~~-~~~~~~~~~~~i~i~~~~~~~~~~~~~~~~~L~v~~p~~YP~~~P~~~~~~~~~l~~~ 107 (1239)
|+.|+|++|++||+|||++++ ......+..+++++.+.... ........+.|+|+||++||+.+|.+.+.+..++...
T Consensus 1 e~~e~~~~EieaL~sIy~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~l~~~~p~~YP~~~P~i~l~~~~~~~~~ 79 (113)
T PF05773_consen 1 ECEEQQEEEIEALQSIYPDDFIEIESKSPPSLEVKLDESSSS-FESSSFPSVTLHFTLPPGYPESPPKISLESPKNSRNE 79 (113)
T ss_dssp HHHHHHHHHHHHHHHHSSSSESSSTSSSSEEEEEEE--CEEC-CTTTTSEEEEEEEEE-SSTTSS--EEEEEEESSSHCH
T ss_pred CCHHHHHHHHHHHHHHcCCCccccccCCCCceeeeecccccc-cccccceeEEEEEeCCCcCCCcCCEEEEEcCCCCCHH
Confidence 357899999999999999998 44455566888888432211 2233357899999999999988999999988888778
Q ss_pred HHHHHHHHHHHHHHHhCCCCceeeehHHHHHHHHH
Q 000880 108 DADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFL 142 (1239)
Q Consensus 108 ~~~~l~~~L~e~~~e~~~~G~~mif~lv~~lke~L 142 (1239)
++..|.+.|.+.++++.. |++|||++++++||+|
T Consensus 80 ~~~~l~~~l~~~~~~~~~-G~~~i~~ii~~~qe~~ 113 (113)
T PF05773_consen 80 QIEKLNKELEQIAEENRQ-GEPCIFQIIEWLQENL 113 (113)
T ss_dssp HHHHHHHHHHHHHHHSTT-TS-CHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCC-CcCHHHHHHHHHHhhC
Confidence 999999999999999987 9999999999999986
|
; GO: 0005515 protein binding; PDB: 2EBM_A 2EBK_A 2DAX_A 2DAW_A 2DAY_A 2DMF_A 1UKX_A 2YZ0_A. |
| >cd00774 GlyRS-like_core Glycyl-tRNA synthetase (GlyRS)-like class II core catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.6e-15 Score=167.86 Aligned_cols=133 Identities=15% Similarity=0.157 Sum_probs=113.7
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcC--CccccccceeccCCCccccccEEEEe----ccCCCeeeecCCCc---
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHC--AKHLEIEPMYLLGDCPQFKRNTVKLL----THGGDLLELSHELR--- 853 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~G--y~~I~tP~~~~~~~~~~~~~~~~~~~----D~~G~~l~LRPD~T--- 853 (1239)
.+.|+.|++|.++.+++.|++.+++.|.++| |++|.||++... +||++. |.+++.++||||.|
T Consensus 20 ~~~G~~d~~P~g~~l~~~i~~~~~~~~~~~g~~~~~i~tP~i~~~--------~mf~~~~g~~d~~~~~~~Lrp~~~~~~ 91 (254)
T cd00774 20 GVAGFYDYGPLGVELKNNIKSAWRKSFVLEEEDMLEIDSPIITPE--------LMFKTSIGPVESGGNLGYLRPETAQGI 91 (254)
T ss_pred ChhcccccCchHHHHHHHHHHHHHHHHHhcCCCeEEEeccccCCH--------HHheeeecccCCCCcccccCCcccchH
Confidence 4789999999999999999999999999996 999999998433 677775 55678999999999
Q ss_pred -HHHHHHHHhCC-CCceeEEeecCeEEcCCCC----CCCCceeEEeEEEeCCCCcccH--HHHHHHHHHHHHhcCCCC
Q 000880 854 -LPFIRWAISNQ-KSSFKRYEISSVYRRAIGH----SPPNRYLQGDFDIIGGASALTE--AEVLKVTMDIVTRFFHAE 923 (1239)
Q Consensus 854 -~~iaR~~~~~~-~~P~r~~Y~g~VfR~e~~~----~~~~ef~Q~GvEiiG~~s~~aD--aEvi~la~~~l~~lgi~~ 923 (1239)
++++|.+.++. ..|+|+||+|+|||+|.++ .+.+||+|+|+|+||.++...+ ..++.+..+++.++|+..
T Consensus 92 ~~~~~~~~~~~~~~lP~~~~qig~~fR~E~~~~~gl~R~ReF~q~d~~~f~~~~~~~e~~~~v~~~~~~~l~~~G~~~ 169 (254)
T cd00774 92 FVNFKNLLEFNRRKLPFGVAQIGKSFRNEISPRNGLFRVREFTQAEIEFFVDPEKSHPWFDYWADQRLKWLPKFAQSP 169 (254)
T ss_pred HHHHHHHHHHhCCCCCchhhhhchhhccccCcccceeeeccchhhheeeeECCCCchHHHHHHHHHHHHHHHHcCCCc
Confidence 79999888754 7799999999999998755 3667899999999998765332 278999999999999853
|
GlyRS functions as a homodimer in eukaryotes, archaea and some bacteria and as a heterotetramer in the remainder of prokaryotes. It is responsible for the attachment of glycine to the 3' OH group of ribose of the appropriate tRNA. This domain is primarily responsible for ATP binding and hydrolysis. This alignment contains only sequences from the GlyRS form which homodimerizes. The heterotetramer glyQ is in a different family of class II aaRS. Class II assignment is based upon its structure and the presence of three characteristic sequence motifs. This domain is also found at the N-terminus of the accessory subunit of mitochondrial polymerase gamma (Pol gamma b). Pol gamma b stimulates processive DNA synthesis and is functional as a homodimer, which can associate with the catalytic subunit Pol gamma alpha to form a heterotrimer. Despite significant both structural and sequence similarity with Gly |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.3e-15 Score=186.14 Aligned_cols=237 Identities=20% Similarity=0.299 Sum_probs=163.9
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC---CCceeeeeeeeeecCccc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ---HQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~---HpnIv~l~~~~~e~~~~~ 499 (1239)
...|.+.+.||+|+||+||+|.+.. |+.||+|+-+....- +|+--.+++.+|+ -+-|..+..+++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~------ 764 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHV------ 764 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHc------
Confidence 4678899999999999999999985 999999987543321 1222334455555 122333322221
Q ss_pred cCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 500 ~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yL 578 (1239)
-.+.-++|+||.+ |+|.+++...+.+++..+..++.|++.-+++|
T Consensus 765 ----------------------------------~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~l 810 (974)
T KOG1166|consen 765 ----------------------------------FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHL 810 (974)
T ss_pred ----------------------------------cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHH
Confidence 1223379999997 89999999888899999999999999999999
Q ss_pred HhCCccccCCCcccEEEcC-------CCCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccC
Q 000880 579 HGQGIIHRDLTPNNIFFDA-------RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILl~~-------~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 651 (1239)
|.++|||+||||+|+||.. ...++|+|||-|--+..-. . + ...+..++|-.+--+|.+.|
T Consensus 811 H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp--------~---~--~~F~~~~~td~f~C~EM~~g 877 (974)
T KOG1166|consen 811 HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP--------D---G--TKFKAVWHTDLFDCIEMREG 877 (974)
T ss_pred HhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC--------C---C--cEEeeeeccccchhHHHhcC
Confidence 9999999999999999943 2359999999986542110 0 0 12245678888999999999
Q ss_pred CCCCCcchhhHHHHHHHHHhhcCCchhHHHHHHHHhhhhcCC-CCCccccCCH-H-HHHHHHHccCCCCCCCCCHHHHH
Q 000880 652 WPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGE-LPPSWVAKFS-E-QESLLRRLMSPSPSDRPSATELL 727 (1239)
Q Consensus 652 ~~~~~~ksDIwSlGviL~ELltPf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~-e-~~~LI~~~L~~dP~~RPta~eiL 727 (1239)
..++..+|.|.|+.+++-|+ |+..+. ....... .+..++..+. + ..+++..+|+.|-..=|...++.
T Consensus 878 -rpWtYq~DyfGlAa~~h~mL--FG~y~q------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 878 -RPWTYQIDYFGLAATVHVML--FGKYME------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred -CCCchhhhhHHHHHHHHHHH--HHHHHH------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 56899999999999999998 444443 1111111 1111122111 2 24788888885444445555543
|
|
| >COG0423 GRS1 Glycyl-tRNA synthetase (class II) [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.5e-14 Score=165.52 Aligned_cols=125 Identities=18% Similarity=0.162 Sum_probs=102.5
Q ss_pred Ccee-eeeccHHHHHhhC-C-----CCC------c-CCCCCCCceEEEEecCC-CccHHHHHHHHHHHHHcCCeEEEeeC
Q 000880 1105 PSGV-GASLALETIIQHY-P-----VDF------K-PVRNEAGTSVLVCSRGG-GGLLVERMELVAELWEENIKAQFVPV 1169 (1239)
Q Consensus 1105 ~pAv-Gfaigldrl~~~L-~-----~~~------~-~~~~~~~~~v~v~~~~~-~~~~~~a~~ia~~Lr~~G~~ve~~~~ 1169 (1239)
+|.| -=|+||||++-++ + ... + .++..+|.++.|+|+-. ++....|.++.+.||+.|+.|....
T Consensus 415 iP~VIEPSfGidRi~y~~l~~ay~~ee~~e~R~vLrl~p~lAPikvaVlPL~~k~~l~~~a~~i~~~L~~~~~~v~yDd- 493 (558)
T COG0423 415 IPHVIEPSFGIDRIFYALLEHAYTEEEVEEKRIVLRLPPDLAPIKVAVLPLVKKDELVEIAKEIFEKLRELGFNVDYDD- 493 (558)
T ss_pred cCceeccCCCchHHHHHHHHHhhcccccccceeEEecCcccCceEEEEEeeecccchhHHHHHHHHHHHhcCceEEecC-
Confidence 5655 7799999995443 2 111 0 12235788899998842 2378899999999999999998433
Q ss_pred CCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHhh
Q 000880 1170 PDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1170 ~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~~ 1231 (1239)
..+++++++++++.|.||.|.+--+.+++++||||++++.+|+.|+++++..+|.+.+.+.
T Consensus 494 -sGsIGrRYrR~DEIGtPfcVTvD~eTleD~tVTiReRDs~~QvRv~i~el~~~l~~~~~~~ 554 (558)
T COG0423 494 -SGSIGRRYRRQDEIGTPFCVTVDFETLEDNTVTIRERDSMEQVRVKIEELADYLRELIKGG 554 (558)
T ss_pred -CCcHhhhhhhccccCCceEEEecCCcccCCcEEEeecCchheeeeeHHHHHHHHHHHhccc
Confidence 4599999999999999999999999999999999999999999999999999999988754
|
|
| >PRK14894 glycyl-tRNA synthetase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-13 Score=161.19 Aligned_cols=97 Identities=19% Similarity=0.198 Sum_probs=86.1
Q ss_pred CCCceEEEEecCCC--ccHHHHHHHHHHHHHcCC-eEEEeeCCCCCHHHHHHHHHhCCCcEEEEE-------cCCcccCC
Q 000880 1131 EAGTSVLVCSRGGG--GLLVERMELVAELWEENI-KAQFVPVPDPSLTEQYEYASEHDIKCLVIL-------TDTGAQKG 1200 (1239)
Q Consensus 1131 ~~~~~v~v~~~~~~--~~~~~a~~ia~~Lr~~G~-~ve~~~~~~~~l~k~~~~A~~~g~~~~vii-------g~~E~~~~ 1200 (1239)
-+|.+|.|+++.++ ....+|.++++.|++.|+ +|+++. +.+++++++.|+..|+||+|+| |++|.+++
T Consensus 432 LAPvQVaVLPLs~~~~~l~eyAkeI~~~L~~~Gi~rv~~Dd--sesIGKKyRraDeiGiPy~ITVD~~Tl~dGdkE~e~g 509 (539)
T PRK14894 432 LAPIKVAVFPLKRNHEGLVATAKAVRRQLQVGGRMRTVYDD--TGAIGKLYRRQDEIGTPFCITVDFDTIGQGKDPALAG 509 (539)
T ss_pred CCCceEEEEeccccccchHHHHHHHHHHHHHCCCceEEEcC--CCCHhHHHHhhhccCCCEEEEEeccccccccchhhcC
Confidence 46889999998621 234899999999999998 999665 4599999999999999999999 89999999
Q ss_pred eEEEEEccCCcccccchHHHHHHHHHHHH
Q 000880 1201 LVKVRHLDVKKEKEVQRESLVRFLLDAIA 1229 (1239)
Q Consensus 1201 ~v~vk~l~~~~q~~v~~~el~~~i~~~l~ 1229 (1239)
+|+||++++++|..++++++++.|++.+.
T Consensus 510 TVTVR~RDs~eQ~rV~ideli~~L~~~~~ 538 (539)
T PRK14894 510 TVTVRDRDTMAQERVPISELEAYLRDRVS 538 (539)
T ss_pred eEEEEEeCCCeEEEEEHHHHHHHHHHHhc
Confidence 99999999999999999999999988764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-14 Score=157.13 Aligned_cols=131 Identities=27% Similarity=0.322 Sum_probs=101.1
Q ss_pred eeccCCceEEEEEEEccCCcEEEEEEEecCCCCc-h-----hHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCC
Q 000880 431 PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-P-----VNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDS 504 (1239)
Q Consensus 431 ~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~-~-----~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~ 504 (1239)
.||+|+||.||+|.+ +|..+++|+........ . ...++.+|+.+++.+.|+++....-.+..
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---------- 68 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD---------- 68 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE----------
Confidence 389999999999985 57899999865332111 1 12567889999999998875433322211
Q ss_pred cCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 000880 505 MWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 505 ~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~gI 583 (1239)
....+++|||++| +|.+++..... .++.+++.+|.+||+.|+
T Consensus 69 ------------------------------~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi 111 (199)
T TIGR03724 69 ------------------------------PDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGI 111 (199)
T ss_pred ------------------------------CCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCe
Confidence 2234899999975 88887754321 789999999999999999
Q ss_pred cccCCCcccEEEcCCCCEEEeecCcchh
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKF 611 (1239)
Q Consensus 584 iHrDLKp~NILl~~~~~vKL~DFGlA~~ 611 (1239)
+|||++|.|||++ ++.+++.|||++..
T Consensus 112 ~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 112 VHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN02734 glycyl-tRNA synthetase | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.2e-14 Score=174.62 Aligned_cols=122 Identities=19% Similarity=0.173 Sum_probs=98.9
Q ss_pred Ccee-eeeccHHHHHhhC-CCCC------------cCCCCCCCceEEEEecCCC-ccHHHHHHHHHHHHHcCCeEEEeeC
Q 000880 1105 PSGV-GASLALETIIQHY-PVDF------------KPVRNEAGTSVLVCSRGGG-GLLVERMELVAELWEENIKAQFVPV 1169 (1239)
Q Consensus 1105 ~pAv-Gfaigldrl~~~L-~~~~------------~~~~~~~~~~v~v~~~~~~-~~~~~a~~ia~~Lr~~G~~ve~~~~ 1169 (1239)
+|.| --++||+||+.++ ++.. ..+...+|.+|.|+++..+ .....|.++++.||+.|++|+++..
T Consensus 528 iP~VIEPS~GIgRIl~AilE~s~~~~~~De~R~~L~~Pp~IAP~qVaIlPL~~~ee~~~~A~eLa~~LR~~GIrVelDd~ 607 (684)
T PLN02734 528 TPSVIEPSFGIGRIIYCLFEHSFYTRPGDEQLNVFRFPPLVAPIKCTVFPLVQNQQLNAVAKVISKELTAAGISHKIDIT 607 (684)
T ss_pred cCceEecCccHHHHHHHHHHHHhccccCCCcceEEecCcccCCcEEEEEEecCChHHHHHHHHHHHHHHhCCCEEEEECC
Confidence 5655 7789999997665 3111 1223356778777776422 4678999999999999999998765
Q ss_pred CCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcccccchHHHHHHHHHHHHhh
Q 000880 1170 PDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1170 ~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i~~~l~~~ 1231 (1239)
..++++++++|++.|+|++|+||. +|+|+||++.+++|..++++++++.|...+++.
T Consensus 608 -~~SIGKRyrrADeiGIPf~ItIG~----dgtVTIRdRdsgeQ~rV~ldeLv~~I~~li~~~ 664 (684)
T PLN02734 608 -GTSIGKRYARTDELGVPFAVTVDS----DGSVTIRERDSKDQVRVPVEEVASVVKDLTDGR 664 (684)
T ss_pred -CCCHhHHHHHHHHcCCCEEEEECC----CCeEEEEECCCCceEEeeHHHHHHHHHHHHcCC
Confidence 569999999999999999999997 799999999999999999999999998887643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-16 Score=194.60 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=199.0
Q ss_pred cCCceEEeeeccCCceEEEEEEEccC-CcEEEEEEEecCCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeecCcccc
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLD-GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~-g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~e~~~~~~ 500 (1239)
...|.+.+.||+|+|+.|-.+....+ ...+|+|.+.....+......+..|..+-+.+. |+|++.+++...+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~------ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS------ 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC------
Confidence 35677788899999999988877533 456788877766555555566777888888887 9999999877532
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVF-ESYD-HFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l-~~~~-~l~~~~~~~i~~qI~~gL~y 577 (1239)
....++.++|.. +++...+ .... ..+...+..++.|+..++.|
T Consensus 93 ----------------------------------~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~ 138 (601)
T KOG0590|consen 93 ----------------------------------PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSY 138 (601)
T ss_pred ----------------------------------CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccc
Confidence 456688889975 4777777 5444 67888899999999999999
Q ss_pred HH-hCCccccCCCcccEEEcCCC-CEEEeecCcchhccccccccCCCCCCCCCCccccCccccc-CccCCCcccccCCCC
Q 000880 578 IH-GQGIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG-TYFYTAPEIEQGWPK 654 (1239)
Q Consensus 578 LH-s~gIiHrDLKp~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G-T~~Y~APE~l~~~~~ 654 (1239)
+| ..++.||||||+|.+++..+ .++++|||+|..+... .+........+| ++.|+|||.+.+...
T Consensus 139 ~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~ 206 (601)
T KOG0590|consen 139 LHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK------------NGAERSLKDRCGSSPPYGAPEHLSGKAY 206 (601)
T ss_pred cCcccccccCCCCCccchhccCCCcccCCCchhhcccccc------------CCcceeeecccCCCCCCCCcccccchhh
Confidence 99 99999999999999999999 9999999999876431 111122344578 999999999988556
Q ss_pred CCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcC-C-CCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhc
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKG-E-LPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 655 ~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~-~-~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~ 729 (1239)
..+..|+||.|+++.-+++ |+................. . ....|........+++.+++..+|..|.+.+++-.+
T Consensus 207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 207 RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 7789999999999999985 5544333222211111111 1 234566777788999999999999999999999999
Q ss_pred cCCCC
Q 000880 730 ALPPQ 734 (1239)
Q Consensus 730 ~~~~~ 734 (1239)
+|...
T Consensus 287 ~~~~~ 291 (601)
T KOG0590|consen 287 NWLSS 291 (601)
T ss_pred ccccc
Confidence 98876
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-14 Score=178.03 Aligned_cols=136 Identities=26% Similarity=0.282 Sum_probs=105.3
Q ss_pred CceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCC-CCc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeeecCcc
Q 000880 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSL-----PVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 425 ~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~-~~~-----~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~ 498 (1239)
.|...+.||+|+||+||+|.+. +..+++|+...+. ... .....+.+|+.+++.++|++|+..+.++..
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---- 407 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD---- 407 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe----
Confidence 3456789999999999999876 4445555432221 111 123568899999999999998876544422
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~y 577 (1239)
....++||||++| +|.+++. ....++.|++.+|.|
T Consensus 408 ------------------------------------~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~ 443 (535)
T PRK09605 408 ------------------------------------PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAK 443 (535)
T ss_pred ------------------------------------CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHH
Confidence 1235799999975 8888875 356789999999999
Q ss_pred HHhCCccccCCCcccEEEcCCCCEEEeecCcchh
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKF 611 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~ 611 (1239)
||++|++||||||+|||+ .++.++|+|||+|+.
T Consensus 444 lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 444 LHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999999999999 678999999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=153.68 Aligned_cols=160 Identities=21% Similarity=0.265 Sum_probs=94.8
Q ss_pred EeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCC
Q 000880 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGS 508 (1239)
Q Consensus 429 ~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~ 508 (1239)
.+.||+|+||+||+|.+. +|+.||||+++............. +...+....|++...+...+........ ..+...
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~e~~~l--~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYR-TGDYRFGRKKSNWRYLSRLWAEKEFRNL--KRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhh-HHHHHhccCCcchhhhhhHHHHHHHHHH--HHHHHc
Confidence 367999999999999987 899999999875433221111111 0123333334443332222111000000 000000
Q ss_pred CcccccccccccccccccccccccccccEEEEEeeccCC-CHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Q 000880 509 GTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLR-QVFESYDHFDKELAWHLFRQIVEGLAHIHG-QGIIH 585 (1239)
Q Consensus 509 g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~-~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs-~gIiH 585 (1239)
+.. +. .. ......+++|||+++ ++. ..+.... . ...+..++.+++.++.++|. +||+|
T Consensus 78 ~~~--------------~~-~~--~~~~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH 138 (187)
T cd05119 78 GVP--------------VP-KP--IDLNRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVH 138 (187)
T ss_pred CCC--------------CC-ce--EecCCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCc
Confidence 000 00 00 001124899999976 221 1222111 1 16678999999999999999 99999
Q ss_pred cCCCcccEEEcCCCCEEEeecCcchhc
Q 000880 586 RDLTPNNIFFDARNDIKIGDFGLAKFL 612 (1239)
Q Consensus 586 rDLKp~NILl~~~~~vKL~DFGlA~~~ 612 (1239)
|||||+||+++ ++.++|+|||.+...
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-14 Score=172.44 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=191.6
Q ss_pred CCceEEeeecc--CCceEEEEEEE--ccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecCcc
Q 000880 424 NDFEELQPLGH--GGFGHVVLCKN--KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 424 ~~y~~~~~LG~--G~fG~Vy~a~~--~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~~~ 498 (1239)
..|.....+|. |.+|.||.++. ..++..+|+|.-+...........-++|+...+++ .|+|.++.+..|.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~---- 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG---- 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc----
Confidence 34445577888 99999999999 88999999998544433323334456777777777 69999997766632
Q ss_pred ccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH-FDKELAWHLFRQIVE---- 573 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~-l~~~~~~~i~~qI~~---- 573 (1239)
...+|+.+|+|+.+|..+.+.... ++...++..+.+...
T Consensus 190 ------------------------------------~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~ 233 (524)
T KOG0601|consen 190 ------------------------------------SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVT 233 (524)
T ss_pred ------------------------------------CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccc
Confidence 456799999999999988876655 889999999999999
Q ss_pred HHHHHHhCCccccCCCcccEEEcCC-CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCCCcccccCC
Q 000880 574 GLAHIHGQGIIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 574 gL~yLHs~gIiHrDLKp~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
||.++|+.+++|-|+||.||++..+ ..++++|||+...+........ ........|...|++||.+++
T Consensus 234 al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~----------~~~~~r~~~~~~Y~~ke~~~~- 302 (524)
T KOG0601|consen 234 ALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSV----------FKVSKRPEGDCIYAAKELLNG- 302 (524)
T ss_pred cccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccc----------eeeeecCCCCceEeChhhhcc-
Confidence 9999999999999999999999999 8899999999987654432211 111122367888999999987
Q ss_pred CCCCcchhhHHHHHHHHHhhcCCchhHHHH-HHHHhhhhcCCCCCcc-ccCCHHHHHHHHHccCCCCCCCCCHHHHHhcc
Q 000880 653 PKIDEKADMYSLGIVFFELWHPFSTAMERQ-IVLSDLKQKGELPPSW-VAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 653 ~~~~~ksDIwSlGviL~ELltPf~~~~~~~-~~~~~~~~~~~~p~~~-~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~ 730 (1239)
.++.+.|+||+|.++.+..+.+....... .....+ ....+|..+ ...+.++...+..|++.+|..|+++..++.+.
T Consensus 303 -l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~ 380 (524)
T KOG0601|consen 303 -LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALN 380 (524)
T ss_pred -ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccc
Confidence 58999999999999988764111100000 000001 122233332 24455677799999999999999999999998
Q ss_pred CCCCch
Q 000880 731 LPPQME 736 (1239)
Q Consensus 731 ~~~~~~ 736 (1239)
+.+.+.
T Consensus 381 ~i~s~~ 386 (524)
T KOG0601|consen 381 VIHSKL 386 (524)
T ss_pred cccchh
Confidence 777443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.7e-13 Score=148.63 Aligned_cols=139 Identities=19% Similarity=0.246 Sum_probs=104.1
Q ss_pred eeec-cCCceEEEEEEEccCCcEEEEEEEecCCC-----------CchhHHHHHHHHHHHHhcCCCce--eeeeeeeeec
Q 000880 430 QPLG-HGGFGHVVLCKNKLDGRHYAVKKIRLKDK-----------SLPVNDRILREVATLSRLQHQHV--VRYYQAWFET 495 (1239)
Q Consensus 430 ~~LG-~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~-----------~~~~~~~~~~Ev~iL~~L~HpnI--v~l~~~~~e~ 495 (1239)
..|| .||.|+||++... +..+|||.+..... +.....++.+|+.++..|.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4687 8899999988775 78899998854221 11223568899999999999885 5555443211
Q ss_pred CccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC--CHHHHHHhcCCCCHHHHHHHHHHHHH
Q 000880 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR--TLRQVFESYDHFDKELAWHLFRQIVE 573 (1239)
Q Consensus 496 ~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g--sL~~~l~~~~~l~~~~~~~i~~qI~~ 573 (1239)
. ......++|||+++| +|.+++.. ..+++.. +.||+.
T Consensus 115 ~------------------------------------~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~ 153 (239)
T PRK01723 115 H------------------------------------GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQ 153 (239)
T ss_pred c------------------------------------CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHH
Confidence 0 001224699999975 78888764 3455543 578999
Q ss_pred HHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchh
Q 000880 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKF 611 (1239)
Q Consensus 574 gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~ 611 (1239)
+|.+||++||+||||||.|||++.++.++|+|||.+..
T Consensus 154 ~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 154 LIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999999999999989999999999875
|
|
| >TIGR02367 PylS pyrrolysyl-tRNA synthetase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.2e-13 Score=155.92 Aligned_cols=123 Identities=11% Similarity=0.155 Sum_probs=101.8
Q ss_pred HHHHHHHHHHHHHHHcCCcccccccee---c---cCC--CccccccEEEEeccCCCeeeecCCCcHHHHHHHHhCC---C
Q 000880 797 LRDYVVQVTKEMFRQHCAKHLEIEPMY---L---LGD--CPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQ---K 865 (1239)
Q Consensus 797 ~~~~i~~~i~~~f~~~Gy~~I~tP~~~---~---~~~--~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~~~~---~ 865 (1239)
-.+.+++.++++|..+||++|.||+|. + ++. +....++||++. +.++||||+|++++|+++.+. .
T Consensus 241 ~~~~Led~IRevfvg~GFqEV~TPtLt~eE~~E~m~~~~g~eI~n~Iyk~e----e~lvLRPdLTPsLaR~La~N~~~l~ 316 (453)
T TIGR02367 241 YLGKLERDITKFFVDRGFLEIKSPILIPAEYIERMGIDNDTELSKQIFRVD----KNFCLRPMLAPNLYNYLRKLDRALP 316 (453)
T ss_pred HHHHHHHHHHHHHHHCCCEEEECCeecchHHHHhhcCccCCcccccceEec----CceEecccCHHHHHHHHHHhhhhcc
Confidence 357899999999999999999999992 2 122 344677999873 368999999999999988743 4
Q ss_pred CceeEEeecCeEEcCCCCCC-CCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEE
Q 000880 866 SSFKRYEISSVYRRAIGHSP-PNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDI 927 (1239)
Q Consensus 866 ~P~r~~Y~g~VfR~e~~~~~-~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i 927 (1239)
.|+|+||+|+|||+|.++.+ .+||+|+|++++|.....+|+| .++.++|+.||+. +.+
T Consensus 317 ~PqKIFEIGkVFR~E~~~~thlREF~QL~~eIaG~~atfaDle--alL~e~Lr~LGId--fei 375 (453)
T TIGR02367 317 DPIKIFEIGPCYRKESDGKEHLEEFTMLNFCQMGSGCTRENLE--AIIKDFLDHLEID--FEI 375 (453)
T ss_pred CCeeEEEEcCeEecCCCCCCCcCeEEEEEEEEECCCCCHHHHH--HHHHHHHHHCCCc--eEE
Confidence 59999999999999876654 4589999999999998888777 5999999999983 666
|
PylS is the archaeal enzyme responsible for charging the pyrrolysine tRNA, PylT, by ligating a free molecule of pyrrolysine. Pyrrolysine is encoded at an in-frame UAG (amber) at least in several corrinoid-dependent methyltransferases of the archaeal genera Methanosarcina and Methanococcoides, such as trimethylamine methyltransferase. |
| >PF00587 tRNA-synt_2b: tRNA synthetase class II core domain (G, H, P, S and T) This Prosite entry contains all class II enzymes | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.7e-13 Score=143.26 Aligned_cols=136 Identities=15% Similarity=0.185 Sum_probs=110.9
Q ss_pred HHHHHHHHHHHHHH-HcCCccccccce----ec--cCCCccccccEEEEeccCCCeeeecCCCcHHHHHHHHh-----CC
Q 000880 797 LRDYVVQVTKEMFR-QHCAKHLEIEPM----YL--LGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAIS-----NQ 864 (1239)
Q Consensus 797 ~~~~i~~~i~~~f~-~~Gy~~I~tP~~----~~--~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~~-----~~ 864 (1239)
+++.|.+.+++.+. ++||++|.||+| .+ .++.....++||++.|.+++.++|||+.+.++++++.. ++
T Consensus 1 l~~~l~~~~~~~~~~~~G~~ev~~P~l~~~~~~~~sg~~~~~~~~~~~~~~~~~~~~~L~pt~~~~~~~~~~~~~~~~~~ 80 (173)
T PF00587_consen 1 LRNALERFIREEFVLKFGFQEVDTPILIPSEVWEKSGHWDNFSDEMFKVKDRGDEEYCLRPTSEPGIYSLFKNEIRSSYR 80 (173)
T ss_dssp HHHHHHHHHHHHHHHHTTEEEEB--SEEEHHHHHHHSHHHHHGGGSEEEEETTTEEEEE-SSSHHHHHHHHHHHEEBHGG
T ss_pred CHHHHHHHHHHHhHHhcCCEEEECCeEEehHHhhhccccccccCCeeeeeecccccEEeccccccceeeeecceeeeccc
Confidence 46789999999999 999999999999 22 23345567889999999999999999999999998877 23
Q ss_pred CCceeEEeecCeEEcC-CCC---CCCCceeEEeEEEeCCC--CcccHHHHHHHHHHHHHhcCCCCceEEEECcHH
Q 000880 865 KSSFKRYEISSVYRRA-IGH---SPPNRYLQGDFDIIGGA--SALTEAEVLKVTMDIVTRFFHAESCDIHLNHGD 933 (1239)
Q Consensus 865 ~~P~r~~Y~g~VfR~e-~~~---~~~~ef~Q~GvEiiG~~--s~~aDaEvi~la~~~l~~lgi~~~~~i~lg~~~ 933 (1239)
..|+|+|++|++||+| .+. .+.+||+|.++++||.+ ......+++.++.++++.||+.+ +.+.+++++
T Consensus 81 ~LP~~~~~~g~~fR~E~~~~~gl~R~reF~~~e~~~f~~~~~~~~~~~~~~~~~~~i~~~lgl~~-~~~~~~~~~ 154 (173)
T PF00587_consen 81 DLPLKLYQIGTCFRNEARPTRGLFRLREFTMDEMHIFCTPEQSEEEFEELLELYKEILEKLGLEP-YRIVLSSSG 154 (173)
T ss_dssp GSSEEEEEEEEEEBSSSSSBSTTTS-SEEEEEEEEEEESSHHHHHHHHHHHHHHHHHHHHTTSGC-EEEEEEETC
T ss_pred cCCeEEeecccccccccccccccceeeEeeeeceEEEeCCcccHHHHHHHHHHHHHHHHHcCCce-EEEEEcCCC
Confidence 4699999999999998 444 34457999999999998 34677799999999999999953 999998854
|
seryl tRNA synthetase structure; InterPro: IPR002314 The aminoacyl-tRNA synthetases (6.1.1. from EC) catalyse the attachment of an amino acid to its cognate transfer RNA molecule in a highly specific two-step reaction. These proteins differ widely in size and oligomeric state, and have limited sequence homology []. The 20 aminoacyl-tRNA synthetases are divided into two classes, I and II. Class I aminoacyl-tRNA synthetases contain a characteristic Rossman fold catalytic domain and are mostly monomeric []. Class II aminoacyl-tRNA synthetases share an anti-parallel beta-sheet fold flanked by alpha-helices [], and are mostly dimeric or multimeric, containing at least three conserved regions [, , ]. However, tRNA binding involves an alpha-helical structure that is conserved between class I and class II synthetases. In reactions catalysed by the class I aminoacyl-tRNA synthetases, the aminoacyl group is coupled to the 2'-hydroxyl of the tRNA, while, in class II reactions, the 3'-hydroxyl site is preferred. The synthetases specific for arginine, cysteine, glutamic acid, glutamine, isoleucine, leucine, methionine, tyrosine, tryptophan and valine belong to class I synthetases. The synthetases specific for alanine, asparagine, aspartic acid, glycine, histidine, lysine, phenylalanine, proline, serine, and threonine belong to class-II synthetases []. Based on their mode of binding to the tRNA acceptor stem, both classes of tRNA synthetases have been subdivided into three subclasses, designated 1a, 1b, 1c and 2a, 2b, 2c. This domain includes the glycine, histidine, proline, threonine and serine tRNA synthetases.; GO: 0000166 nucleotide binding, 0004812 aminoacyl-tRNA ligase activity, 0005524 ATP binding, 0006418 tRNA aminoacylation for protein translation, 0005737 cytoplasm; PDB: 3UH0_A 3UGT_C 3UGQ_A 1B76_B 1GGM_B 1ATI_A 1ADY_C 1ADJ_C 2I4O_A 2I4M_B .... |
| >KOG2324 consensus Prolyl-tRNA synthetase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.3e-13 Score=144.72 Aligned_cols=356 Identities=11% Similarity=0.119 Sum_probs=202.2
Q ss_pred cccccccCCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce------eccCCCccccccEEEEeccCCCeeee
Q 000880 775 AGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM------YLLGDCPQFKRNTVKLLTHGGDLLEL 848 (1239)
Q Consensus 775 ~~~~~ld~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~------~~~~~~~~~~~~~~~~~D~~G~~l~L 848 (1239)
-++++ +...|+.-++|...+..+++.+.+..-+..-|.+.|..|++ .-.+.++....+||+|.|+.|+.+||
T Consensus 34 ~GfI~--ps~~G~yq~LPlg~R~~~K~~~~l~~~mqs~Ga~kIslp~ls~~~LWekTgRw~~~gsEl~rl~Dr~gkq~cL 111 (457)
T KOG2324|consen 34 VGFIR--PSSPGLYQLLPLGLRVLNKLCRLLDNEMQSGGAQKISLPILSSKELWEKTGRWDAMGSELFRLHDRKGKQMCL 111 (457)
T ss_pred hCccc--cCCCCceeeccchHHHHHHHHHHHHHHHHhccCeeEeecccChHHHHHhcCcccccchhheEeeccCCCEecc
Confidence 34444 56789999999999999999999999999999999999999 33445777889999999999999999
Q ss_pred cCCCcHHHHHHHHh-----CCCCceeEEeecCeEEcC-CCCC---CCCceeEEeEEEeCCCCcccHHHHHHH--------
Q 000880 849 SHELRLPFIRWAIS-----NQKSSFKRYEISSVYRRA-IGHS---PPNRYLQGDFDIIGGASALTEAEVLKV-------- 911 (1239)
Q Consensus 849 RPD~T~~iaR~~~~-----~~~~P~r~~Y~g~VfR~e-~~~~---~~~ef~Q~GvEiiG~~s~~aDaEvi~l-------- 911 (1239)
-|----.|.+.+++ ++..|+++|++|+-||+| +|+. |.|||+.-|. .+...|.|...-
T Consensus 112 ~pThEE~iT~lmat~~~lsykqlPi~vYQigrKfRDElrpRfGLlRgREFlMKDm-----YsFd~~~etA~qTy~~v~~a 186 (457)
T KOG2324|consen 112 TPTHEEDITALMATYIPLSYKQLPIRVYQIGRKFRDELRPRFGLLRGREFLMKDM-----YSFDSDEETAQQTYQLVDQA 186 (457)
T ss_pred CCchHHHHHHHHHhcCccccccCcEEeeeechhhhhccCccccchhhHHHHHhhh-----hcccCCHHHHHHHHHHHHHH
Confidence 99544455566665 445699999999999996 5664 3457999988 555555554333
Q ss_pred HHHHHHhcCCCCceEEEECcHHHHHHHHHHcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHHhcCCCHHHH
Q 000880 912 TMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVV 991 (1239)
Q Consensus 912 a~~~l~~lgi~~~~~i~lg~~~i~~~ll~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~~~~l~~~~~ 991 (1239)
-..+++.||+. |.-.=.+.+.+.+- ++-+ +.-. .++.++..
T Consensus 187 Y~~iFkqL~~p--fVkv~AdsG~iGG~-----vShE--------fhl~------------------------~~vgED~l 227 (457)
T KOG2324|consen 187 YDRIFKQLGLP--FVKVWADSGDIGGE-----VSHE--------FHLI------------------------HPVGEDTL 227 (457)
T ss_pred HHHHHHHcCCC--eEEEeecccccCce-----eeee--------Eecc------------------------CccCccce
Confidence 33444444443 22211121111110 0000 0000 00001000
Q ss_pred HHHHHHHHHhcCChhhHHHHHhccCCCChhHHHHHHHHHHHHccCcccEEEccCCCCCCCccceeEEEEEecCCCCcccc
Q 000880 992 NRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATL 1071 (1239)
Q Consensus 992 ~~l~~l~~~~~g~~~~~l~~l~~~~~~~~~~~~~l~~l~l~~~~~~~~i~~Dl~~~rgl~YYtG~vFe~~~~~~~~~~~~ 1071 (1239)
..... +.+.++ .+.++.=+..-+ +.. .. =++.-+++.+ .|.+|-.
T Consensus 228 ~~C~~--C~~s~n-~e~~~~sk~~~C--p~C--------------~~---~~L~~~~~IE--VgHtF~L----------- 272 (457)
T KOG2324|consen 228 MSCPS--CGYSKN-SEDLDLSKIASC--PKC--------------NE---GRLTKTKSIE--VGHTFLL----------- 272 (457)
T ss_pred eecCc--CCccCc-hhhhcCCccccC--Ccc--------------cC---CCcccccceE--EEEEEEe-----------
Confidence 00000 000011 011110000000 000 00 0222222222 2333221
Q ss_pred cccccccccccccchhhhccccccccccCCCCCCceeeeeccHHHHHhhC----C--CCCcCCCCCCCceE-EEEecCCC
Q 000880 1072 VEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHY----P--VDFKPVRNEAGTSV-LVCSRGGG 1144 (1239)
Q Consensus 1072 ~~~~~i~~GGRYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl~~~L----~--~~~~~~~~~~~~~v-~v~~~~~~ 1144 (1239)
|--|..- ||.. ++..-|+.+-+-.-.++||+.||+.+. . .+..++...+|.+| +|.+.. .
T Consensus 273 --------G~kYS~~---lna~-f~~~~gKpe~l~MgCyGIGVtRllaAa~evls~~~~lrwP~~iAPy~vcli~pk~-~ 339 (457)
T KOG2324|consen 273 --------GTKYSKP---LNAK-FVNVEGKPEFLHMGCYGIGVTRLLAAAAEVLSDDKGLRWPSLIAPYKVCLIGPKK-G 339 (457)
T ss_pred --------ccccccc---cCce-eeeecCCcceEEecceeccHHHHHHHHHHHhccccccccccccCcceeEEeccCC-c
Confidence 2222211 1111 011122221112224589999997654 2 33344445678888 666653 4
Q ss_pred ccHHHHHHHHHHHHHcCC------eEEEeeCCCCCHHHHHHHHHhCCCcEEEEEc-CCcccCCeEEEEEccCCcccccch
Q 000880 1145 GLLVERMELVAELWEENI------KAQFVPVPDPSLTEQYEYASEHDIKCLVILT-DTGAQKGLVKVRHLDVKKEKEVQR 1217 (1239)
Q Consensus 1145 ~~~~~a~~ia~~Lr~~G~------~ve~~~~~~~~l~k~~~~A~~~g~~~~viig-~~E~~~~~v~vk~l~~~~q~~v~~ 1217 (1239)
.....+.+++.+|-.... .+-+.+.....++++++-|++.|+|++||+| ..-..+..+.|+-...|+...+..
T Consensus 340 ~~~q~~~ev~~el~~~~~~~~l~~~iLlddr~~ltiG~Ri~dA~~lG~PfviVvg~s~~~~~~~~EV~~~~~ge~~~l~~ 419 (457)
T KOG2324|consen 340 SKSQRAQEVISELLNDEAVGNLHGEILLDDREELTIGKRIKDANRLGIPFVIVVGNSASWDNPEIEVRTIRWGESAELDK 419 (457)
T ss_pred chhhhHHHHHHHhhcchhhhhhccceeccchhhhhhHHhhhhHHhcCCCEEEEEcccccCCCceEEEEEeecCceeccch
Confidence 555666777776544211 1222333335789999999999999999999 455567899999999998888777
Q ss_pred HHHHHHH
Q 000880 1218 ESLVRFL 1224 (1239)
Q Consensus 1218 ~el~~~i 1224 (1239)
+.+.+.+
T Consensus 420 ~~~~~l~ 426 (457)
T KOG2324|consen 420 DGFMKLL 426 (457)
T ss_pred hhHHHHh
Confidence 7665544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=168.94 Aligned_cols=281 Identities=22% Similarity=0.252 Sum_probs=204.3
Q ss_pred ccCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeecCcccc
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-VNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~-~~~~~~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~ 500 (1239)
..+++.+.+-+-+|.++.++.++-..+|...++|+......-.. ..+....+-.++-...||-++...-.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s--------- 872 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS--------- 872 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC---------
Confidence 46788899999999999999999888888888886643221110 11222222222222233444432211
Q ss_pred CCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH 579 (1239)
| .....++++|+|.+ ++|...++..+..+.+-++.++..+..+++|||
T Consensus 873 ---------------~----------------~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~ 921 (1205)
T KOG0606|consen 873 ---------------F----------------PCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH 921 (1205)
T ss_pred ---------------C----------------CCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccc
Confidence 0 12456799999996 589999999888999999999999999999999
Q ss_pred hCCccccCCCcccEEEcCCCCEEEeecCcchhccccccccCC----------CCC--CCCC----CccccCcccccCccC
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDA----------AFP--TDTG----GVSVDGTGQVGTYFY 643 (1239)
Q Consensus 580 s~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~----------~~~--~~~~----~~~~~~~~~~GT~~Y 643 (1239)
+..+.|||++|.|+|+..+++.+++|||.......-...... .+. .... .........+||+.|
T Consensus 922 s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~ 1001 (1205)
T KOG0606|consen 922 SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDY 1001 (1205)
T ss_pred cchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcc
Confidence 999999999999999999999999999955433211000000 000 0000 011223456899999
Q ss_pred CCcccccCCCCCCcchhhHHHHHHHHHhhc---CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCC
Q 000880 644 TAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720 (1239)
Q Consensus 644 ~APE~l~~~~~~~~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~R 720 (1239)
.+||.+.+ ......+|+|++|++++|.++ ||.......++..++......|......++++++++.+++..+|.+|
T Consensus 1002 laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1002 LAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred cCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhc
Confidence 99999998 567889999999999999996 78777777777666655555565666677899999999999999999
Q ss_pred CCHH---HHHhccCCCCchHHHHHHH
Q 000880 721 PSAT---ELLQDALPPQMEYELLDNI 743 (1239)
Q Consensus 721 Pta~---eiL~~~~~~~~~~~~~~~~ 743 (1239)
..+. ++-.|+||+...|+.+..-
T Consensus 1081 ~~a~~~~e~k~~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1081 LGAKGAAEVKGHPFFQDVDWENLALQ 1106 (1205)
T ss_pred cCcccccccccCCccCCCCccccccc
Confidence 9887 8899999999998877553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=132.24 Aligned_cols=131 Identities=28% Similarity=0.328 Sum_probs=105.1
Q ss_pred EEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhcCC--CceeeeeeeeeecCccccCCCCc
Q 000880 428 ELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH--QHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 428 ~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~e~~~~~~~~~~~ 505 (1239)
+++.||.|.++.||++... +..+++|....... ...+.+|+..++.++| +++++++....
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~------------ 63 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGE------------ 63 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcC------------
Confidence 3578999999999999986 47899998764322 4568899999999976 47887775531
Q ss_pred CCCCcccccccccccccccccccccccccccEEEEEeeccCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ--- 581 (1239)
Q Consensus 506 ~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLHs~--- 581 (1239)
.....|++|||+++ .+..+ +......++.+++.+|++||..
T Consensus 64 ----------------------------~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~ 108 (155)
T cd05120 64 ----------------------------SDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLL 108 (155)
T ss_pred ----------------------------CCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCce
Confidence 12457999999976 44332 4566677889999999999985
Q ss_pred CccccCCCcccEEEcCCCCEEEeecCcchh
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKF 611 (1239)
Q Consensus 582 gIiHrDLKp~NILl~~~~~vKL~DFGlA~~ 611 (1239)
+++|+||+|.|||++..+.+++.|||.++.
T Consensus 109 ~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCCcceEEEECCcEEEEEecccccC
Confidence 699999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04172 pheS phenylalanyl-tRNA synthetase subunit alpha; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-12 Score=157.12 Aligned_cols=140 Identities=10% Similarity=0.058 Sum_probs=113.9
Q ss_pred ccCCCCcccccchhhhhHHHHHHHHHHHHHHHcCCcccccccee---------cc----------C----CC-c--cc--
Q 000880 780 LNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPMY---------LL----------G----DC-P--QF-- 831 (1239)
Q Consensus 780 ld~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~~---------~~----------~----~~-~--~~-- 831 (1239)
.|-...| +|++|.+...+.++.+.++++|..+||++|.||.|+ +. . +. . ..
T Consensus 218 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~f~~~Gf~e~~~p~vE~~~~nfd~lf~p~~hpaR~~~dtf~~~~~~~~~~~~ 296 (489)
T PRK04172 218 YNVKAPP-PKIYPGKKHPYREFIDEVRDILVEMGFEEMKGPLVETEFWNFDALFQPQDHPAREMQDTFYLKYPGIGDLPE 296 (489)
T ss_pred ceeCCCC-CCCCCCCCChHHHHHHHHHHHHHHCCCEEeeCCeeeecCcccccccCCCCCCCCCccceEEECCcccccCcH
Confidence 3344455 889999999999999999999999999999999993 11 0 00 0 00
Q ss_pred ------------------cccEEEEeccCCCeeeecCCCcHHHHHHHHhCCCCceeEEeecCeEEcCCCCCC-CCceeEE
Q 000880 832 ------------------KRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSP-PNRYLQG 892 (1239)
Q Consensus 832 ------------------~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~~~~~~P~r~~Y~g~VfR~e~~~~~-~~ef~Q~ 892 (1239)
..=+|.|.++.++.++|||++|++++|+++++...|+|+|++|+|||++.++.+ .+||+|+
T Consensus 297 ~~~~~v~~~he~g~~~~~~~~~y~~~~~~~~~~~LR~~~T~~~~r~l~~~~~~p~rlFeiGrVFR~e~~d~~~l~Ef~ql 376 (489)
T PRK04172 297 ELVERVKEVHEHGGDTGSRGWGYKWDEDIAKRLVLRTHTTALSARYLASRPEPPQKYFSIGRVFRPDTIDATHLPEFYQL 376 (489)
T ss_pred HHHHHHHHHHhccCCCCCccccCCcchhhhhccccccCChHHHHHHHHhcCCCCeEEEEecceEcCCCCCcccCCchheE
Confidence 001577777778999999999999999999887789999999999999876644 4689999
Q ss_pred eEEEeCCCCcccHHHHHHHHHHHHHhcCCC
Q 000880 893 DFDIIGGASALTEAEVLKVTMDIVTRFFHA 922 (1239)
Q Consensus 893 GvEiiG~~s~~aDaEvi~la~~~l~~lgi~ 922 (1239)
++.++|.. ...++++.++.+++..+|+.
T Consensus 377 ~~~i~G~~--~~f~elkg~l~~ll~~lGi~ 404 (489)
T PRK04172 377 EGIVMGED--VSFRDLLGILKEFYKRLGFE 404 (489)
T ss_pred EEEEEeCC--CCHHHHHHHHHHHHHHhCCc
Confidence 99999974 34789999999999999885
|
|
| >COG0442 ProS Prolyl-tRNA synthetase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.2e-12 Score=149.13 Aligned_cols=407 Identities=13% Similarity=0.111 Sum_probs=235.5
Q ss_pred ccccccccCCCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce---ec---cCCCccccccEEEEeccCCCeee
Q 000880 774 HAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM---YL---LGDCPQFKRNTVKLLTHGGDLLE 847 (1239)
Q Consensus 774 ~~~~~~ld~d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~---~~---~~~~~~~~~~~~~~~D~~G~~l~ 847 (1239)
.++.++ +..+|+..|+|...++++.|++.+++.+++.|.+++..|+| .+ .++++....+||+++|++++.++
T Consensus 28 rAg~i~--~~~~G~y~~lP~g~rv~~kI~~iir~em~~~G~~Evl~P~L~p~eLwkEs~r~~~f~~El~~v~drg~~~l~ 105 (500)
T COG0442 28 RAGMIR--KPVKGLYVWLPLGLRVLEKIENIIREEMDKIGAQEVLFPTLIPAELWKESGRWEGFGPELFRVKDRGDRPLA 105 (500)
T ss_pred hcCcee--cccCceEEECccHHHHHHHHHHHHHHHHHhcCceEEechhcCHHHHHHHhChhhhcchhhEEEEccCCceee
Confidence 445555 37899999999999999999999999999999999999999 22 33467788999999999999999
Q ss_pred ecCC----CcHHHHHHHHhCCCCceeEEeecCeEEcCC-CC---CCCCceeEEeEEEeCCCCcccHHH---HHHHHHHHH
Q 000880 848 LSHE----LRLPFIRWAISNQKSSFKRYEISSVYRRAI-GH---SPPNRYLQGDFDIIGGASALTEAE---VLKVTMDIV 916 (1239)
Q Consensus 848 LRPD----~T~~iaR~~~~~~~~P~r~~Y~g~VfR~e~-~~---~~~~ef~Q~GvEiiG~~s~~aDaE---vi~la~~~l 916 (1239)
|||- +|.=+..++.+++..|+++|+++++||+|. |. .|.|||+--++.-|=.+...++.+ ++.+-.+++
T Consensus 106 L~PTsEe~it~~~~~~i~SYkdLPl~lYQi~~kfRdE~rpr~gllR~REF~mkdaySfh~~~e~a~~~y~~~~~~Y~~if 185 (500)
T COG0442 106 LRPTSEEVITDMFRKWIRSYKDLPLKLYQIQSKFRDEKRPRFGLLRGREFLMKDAYSFHADEEDAEETYEKMLDAYSRIF 185 (500)
T ss_pred eCCCcHHHHHHHHHHHhhhhhhCCcceeeeeeEEeccccCCCCccchheeeecccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 9994 344444578789999999999999999964 44 356689988887776665566664 455567788
Q ss_pred HhcCCCCceEEEECcHHHHHHHHH-------------HcCCCHHHHHHHHHHHHhhcCCCCCcccccchHHHHHHHHHH-
Q 000880 917 TRFFHAESCDIHLNHGDLLEAIWS-------------WAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQ- 982 (1239)
Q Consensus 917 ~~lgi~~~~~i~lg~~~i~~~ll~-------------~lgl~~~~~~~l~~~l~~~d~~~~~~~~~~~~~~~~~~~l~~- 982 (1239)
.++|+. +....-+.++..+-.. .++.+..--..+-.++ . + ....... . ...+...
T Consensus 186 ~~i~l~--~~~~~ad~g~~Gg~~S~eF~~l~pd~ge~qi~ts~~y~aN~e~a~-~-~-~~~~~~~-~-----~~~~~v~t 254 (500)
T COG0442 186 LRLPLI--FGPVPADEGFIGGSYSHEFEALMPDGGEDQIATSHHYGANFEKAF-I-D-IKFEDEE-E-----GELEYVHT 254 (500)
T ss_pred HhCCce--EEeecccCCCCCCccceEEEEEccCCCccEEEEecchHHhHHHhc-c-C-CCccccc-c-----ccceEecc
Confidence 888874 5555544333321110 0011111111111111 0 0 0000000 0 0000000
Q ss_pred -hcCCCHHHHHHHHHHHHHhcCC-------hhhHHHHHhc---cCCCChh---HHHHHHHH--HHHHccCcccEEEc-cC
Q 000880 983 -ELNLAEAVVNRLQTVGLRFCGA-------ADQALPRLRG---ALPADKP---TRKALDEL--YLRIWRIEKNIYID-AL 1045 (1239)
Q Consensus 983 -~~~l~~~~~~~l~~l~~~~~g~-------~~~~l~~l~~---~~~~~~~---~~~~l~~l--~l~~~~~~~~i~~D-l~ 1045 (1239)
..+++... +..++ .+.|+ +.-+-.++.. ....+.. ..+.-.++ .+.. +...+..| .+
T Consensus 255 ~s~~~s~r~---~~~~i-~i~GDn~G~v~Pp~vA~~qV~~~~~~~~ga~~h~~~~~~~rd~~~~l~~--~~~~~~~D~~~ 328 (500)
T COG0442 255 TSYGISTRI---IGAAI-LIHGDNEGLVLPPIVADIQVVIVPIFIKGANEHYKVVNYGRDVAEPLEK--LGIRVEGDDRS 328 (500)
T ss_pred cceEEEeee---eeEEE-EEecCCCCccCCchhccceEEEEeccccCcchhhhhhhhhhhhhhhhhh--cceEEeccccC
Confidence 01111111 11111 12222 1000000000 0001100 11111111 1222 22245556 32
Q ss_pred -CCCCCCcc------ceeEEEEEecCCCCcccccccccccccccccchhhhccccccccccCCCCCCceeeeeccHHHH-
Q 000880 1046 -MPPIESYH------RNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETI- 1117 (1239)
Q Consensus 1046 -~~rgl~YY------tG~vFe~~~~~~~~~~~~~~~~~i~~GGRYD~L~~~fg~~~~~~~~g~~~~~pAvGfaigldrl- 1117 (1239)
...|.-|| .|++|++ |=||-.-.. .. +...-|...+.-.+-+++|++|+
T Consensus 329 ~~~~G~kl~~~e~ieVghif~l-------------------G~kyse~~~---a~-v~~r~g~~~~~~mg~ygigvsr~v 385 (500)
T COG0442 329 PDGPGFKLNIWEGIEVGHIFEL-------------------GTKYSEAMN---AT-VLDRDGKEQPKTMGCYGIGVSRLV 385 (500)
T ss_pred CCCCCceeeeeeccccCEEEEE-------------------CchhhhhCe---eE-EEecCCCccceEEEehhhhhhhHH
Confidence 22232222 3455555 444532211 00 01222333323455568999995
Q ss_pred HhhCC-----CCCcCCCCCCCceEEEEecCCCc--cHHHHHHHHHHHHHcC-CeEEEeeCCCCCHHHHHHHHHhCCCcEE
Q 000880 1118 IQHYP-----VDFKPVRNEAGTSVLVCSRGGGG--LLVERMELVAELWEEN-IKAQFVPVPDPSLTEQYEYASEHDIKCL 1189 (1239)
Q Consensus 1118 ~~~L~-----~~~~~~~~~~~~~v~v~~~~~~~--~~~~a~~ia~~Lr~~G-~~ve~~~~~~~~l~k~~~~A~~~g~~~~ 1189 (1239)
.++++ .+..+....++.++.|+..+..+ ....|-++...|..+| ..|.+... +...+-.+.-|+-.|+|+.
T Consensus 386 ~a~ieq~~d~~gi~w~~a~apf~~~iv~~n~~~~~~~~~~~~~~~~l~~~G~~e~~~ddr-~er~g~k~~~a~liGiP~~ 464 (500)
T COG0442 386 AALLEQIHDENGIIWPKAIAPFDVHIVPVNTKDFKQAEAAEKLYVELPWCGTVEVLLDDR-DERPGVKFADADLIGIPLR 464 (500)
T ss_pred HHHHHHhcccccCccccccCcceeEEEEcCchhHHHHHHhhhHHHHHHhCCchhhhhhhh-ccccCccccCCeEecccce
Confidence 45554 23333335678888888875321 2233445677888899 88876655 5567777888999999999
Q ss_pred EEEcCCcccCCeEEEEEccCCcccccchHHHHHHH
Q 000880 1190 VILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFL 1224 (1239)
Q Consensus 1190 viig~~E~~~~~v~vk~l~~~~q~~v~~~el~~~i 1224 (1239)
+++|.+ .+.|.|.+|...+|+...++...+...+
T Consensus 465 ~~~g~~-~~~g~~e~k~r~~ge~~~~~~~~l~~~~ 498 (500)
T COG0442 465 IVVGKR-LAEGEVEVKCRKCGEKEAVTIEALFARL 498 (500)
T ss_pred eeeccc-ccCCceeEEecCCCchhhccHHHHHHHh
Confidence 999988 8889999999999999988877776654
|
|
| >cd00778 ProRS_core_arch_euk Prolyl-tRNA synthetase (ProRS) class II core catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.6e-12 Score=146.12 Aligned_cols=139 Identities=10% Similarity=0.138 Sum_probs=113.0
Q ss_pred CCCcccccchhhhhHHHHHHHHHHHHHHHcCCccccccce----ecc---CCCccccccEEEEeccCCC----eeeecCC
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL---GDCPQFKRNTVKLLTHGGD----LLELSHE 851 (1239)
Q Consensus 783 d~~G~~D~lp~ea~~~~~i~~~i~~~f~~~Gy~~I~tP~~----~~~---~~~~~~~~~~~~~~D~~G~----~l~LRPD 851 (1239)
.+.|+.+++|..+.+.+.|++.+++.+.++||++|.||.+ .+. ++.+...++||++.|.+++ .++|||+
T Consensus 20 ~~~G~~~~lP~g~~l~~~l~~~~~~~~~~~G~~ev~~P~l~~~~~~~~~sg~~~~f~~~~f~~~~~~~~~~~~~~~L~Pt 99 (261)
T cd00778 20 PVKGCMVFRPYGYAIWENIQKILDKEIKETGHENVYFPLLIPESELEKEKEHIEGFAPEVAWVTHGGLEELEEPLALRPT 99 (261)
T ss_pred CCCCeEEEcccHHHHHHHHHHHHHHHHHHcCCEEEECCccccHHHhhhhhcchhhcCcceEEEEecCCcccCCcEEEcCC
Confidence 3679999999999999999999999999999999999999 222 2244558899999997754 7999999
Q ss_pred ----CcHHHHHHHHhCCCCceeEEeecCeEEcCCCC----CCCCceeEEeEEE-eCCCCcccHH---HHHHHHHHHHHhc
Q 000880 852 ----LRLPFIRWAISNQKSSFKRYEISSVYRRAIGH----SPPNRYLQGDFDI-IGGASALTEA---EVLKVTMDIVTRF 919 (1239)
Q Consensus 852 ----~T~~iaR~~~~~~~~P~r~~Y~g~VfR~e~~~----~~~~ef~Q~GvEi-iG~~s~~aDa---Evi~la~~~l~~l 919 (1239)
+|..+++.+.+++..|+|+|++|+|||+|.++ .|.+||+|.++.. +...+. ++. +++.+..++++.|
T Consensus 100 ~e~~~~~~~~~~i~s~r~LPlr~~~~~~~fR~E~~~~~Gl~R~reF~~~d~h~~~~~~e~-~~~~~~~~~~~~~~i~~~l 178 (261)
T cd00778 100 SETAIYPMFSKWIRSYRDLPLKINQWVNVFRWETKTTRPFLRTREFLWQEGHTAHATEEE-AEEEVLQILDLYKEFYEDL 178 (261)
T ss_pred CCHHHHHHHHhhccchhhcCHHHHhhhhhccCCCCCCCceeEeeeeeeeceeeccCCHHH-HHHHHHHHHHHHHHHHHHh
Confidence 77888888877777899999999999998654 2445799999975 554432 332 6678888888888
Q ss_pred -CCC
Q 000880 920 -FHA 922 (1239)
Q Consensus 920 -gi~ 922 (1239)
|++
T Consensus 179 lgl~ 182 (261)
T cd00778 179 LAIP 182 (261)
T ss_pred CCCe
Confidence 885
|
ProRS is a homodimer. It is responsible for the attachment of proline to the 3' OH group of ribose of the appropriate tRNA. This domain is primarily responsible for ATP-dependent formation of the enzyme bound aminoacyl-adenylate. Class II assignment is based upon its structure and the presence of three characteristic sequence motifs in the core domain. This subfamily contains the core domain of ProRS from archaea, the cytoplasm of eukaryotes and some bacteria. |
| >PF03129 HGTP_anticodon: Anticodon binding domain; InterPro: IPR004154 tRNA synthetases, or tRNA ligases are involved in protein synthesis | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.8e-12 Score=118.57 Aligned_cols=90 Identities=24% Similarity=0.419 Sum_probs=84.1
Q ss_pred eEEEEecCCC---ccHHHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCc
Q 000880 1135 SVLVCSRGGG---GLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKK 1211 (1239)
Q Consensus 1135 ~v~v~~~~~~---~~~~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~ 1211 (1239)
+|+|++.+ . +....|.++++.||+.|+++++.+. +.++++++++|++.|+||++++|++|.++|+|+||++.+++
T Consensus 1 qv~Ii~~~-~~~~~~~~~a~~l~~~L~~~gi~v~~d~~-~~~~~k~~~~a~~~g~p~~iiiG~~e~~~~~v~vk~~~~~~ 78 (94)
T PF03129_consen 1 QVVIIPVG-KKDEEIIEYAQELANKLRKAGIRVELDDS-DKSLGKQIKYADKLGIPFIIIIGEKELENGTVTVKDRDTGE 78 (94)
T ss_dssp SEEEEESS-CSHHHHHHHHHHHHHHHHHTTSEEEEESS-SSTHHHHHHHHHHTTESEEEEEEHHHHHTTEEEEEETTTTE
T ss_pred CEEEEEeC-CCcHHHHHHHHHHHHHHHHCCCEEEEECC-CCchhHHHHHHhhcCCeEEEEECchhHhCCEEEEEECCCCc
Confidence 47888886 5 6788999999999999999998885 78999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHH
Q 000880 1212 EKEVQRESLVRFLLD 1226 (1239)
Q Consensus 1212 q~~v~~~el~~~i~~ 1226 (1239)
+.++++++|+++|++
T Consensus 79 ~~~v~~~el~~~l~~ 93 (94)
T PF03129_consen 79 QETVSLEELIEYLKE 93 (94)
T ss_dssp EEEEECCHHHHHHHH
T ss_pred EEEEEHHHHHHHHhh
Confidence 999999999999876
|
This domain is found in histidyl, glycyl, threonyl and prolyl tRNA synthetases [] it is probably the anticodon binding domain [].; GO: 0004812 aminoacyl-tRNA ligase activity, 0005524 ATP binding; PDB: 1KOG_B 1EVL_D 1EVK_B 1QF6_A 1FYF_B 2I4O_A 2I4M_A 2I4N_A 2I4L_A 1HC7_D .... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-12 Score=154.64 Aligned_cols=250 Identities=25% Similarity=0.265 Sum_probs=181.9
Q ss_pred CCcccCCceEEeeeccCCceEEEEEEEc-cCCcEEEEEEEecCCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeecC
Q 000880 419 SSRYLNDFEELQPLGHGGFGHVVLCKNK-LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 419 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~e~~ 496 (1239)
.++++.+|.++..||.|.|+.|+.+... .++..|++|-+............-+.|+.+...+ .|.++++++..|.+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-- 337 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-- 337 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--
Confidence 5778899999999999999999988766 6789999998764444333334456788877777 69999999888843
Q ss_pred ccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGL 575 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL 575 (1239)
....||..|||. +++...+.....+++...+++..|++.++
T Consensus 338 --------------------------------------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 --------------------------------------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred --------------------------------------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 245579999995 55554444445588889999999999999
Q ss_pred HHHHhCCccccCCCcccEEEcCC-CCEEEeecCcchhccccccccCCCCCCCCCCccccCcccccCccCC-CcccccCCC
Q 000880 576 AHIHGQGIIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYT-APEIEQGWP 653 (1239)
Q Consensus 576 ~yLHs~gIiHrDLKp~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~-APE~l~~~~ 653 (1239)
.++|++.++|+|+||+||++..+ +..+++|||.+..+... ......+-+++ .+|++....
T Consensus 380 ~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~------------------~~~~~~~~r~~p~~~~~~e~~ 441 (524)
T KOG0601|consen 380 NVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS------------------SGVFHHIDRLYPIAEILLEDY 441 (524)
T ss_pred ccccchhhhcccccccceeeccchhhhhcccccccccccee------------------cccccccccccccchhhcccc
Confidence 99999999999999999999886 78899999998742111 11122333344 356555546
Q ss_pred CCCcchhhHHHHHHHHHhhc--CCchhHHHHHHHHhhhhcCCCCCccccCCHHHHHHHHHccCCCCCCCCCHHHHHhccC
Q 000880 654 KIDEKADMYSLGIVFFELWH--PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731 (1239)
Q Consensus 654 ~~~~ksDIwSlGviL~ELlt--Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~e~~~LI~~~L~~dP~~RPta~eiL~~~~ 731 (1239)
.+..++|++|||..+.+..+ |+..... ....+ ..+..|... ....++..+.+.++.+++..||.+.++..|.-
T Consensus 442 ~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--~~~~i--~~~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 442 PHLSKADIFSLGLSVDEAITGSPLSESGV--QSLTI--RSGDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccccccccccccccccccccCcccCcccc--cceee--ecccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 68899999999999999886 3322211 11111 122222222 22257788999999999999999999987753
|
|
| >KOG4445 consensus Uncharacterized conserved protein, contains RWD domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.6e-12 Score=136.05 Aligned_cols=106 Identities=20% Similarity=0.247 Sum_probs=87.9
Q ss_pred HHHHHhhhcCCceeeecC----CCCeEEEEEcCCCCCCCCCCCcEEEEEEEEcCCCCCCCCCccccccCCCCCHHHHHHH
Q 000880 37 EITALCAIFQEDCKVVSG----SPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNL 112 (1239)
Q Consensus 37 ElEaL~sIy~d~~~~~~~----~~~~~~i~i~~~~~~~~~~~~~~~~~L~v~~p~~YP~~~P~~~~~~~~~l~~~~~~~l 112 (1239)
|.+.+++||.|++.+... .+-++.+++-|-++++++.++ ++|+|+++.|++||.++|.+.+.+++||++.++..|
T Consensus 2 e~~~~e~~~ld~i~~~~~~~s~~~~~i~~t~hpit~eedesqy-vcvtl~m~vs~gYP~esPtvtl~nPRGl~d~~~~~i 80 (368)
T KOG4445|consen 2 ESADGEIEALDSIWDGVHVESKLEASIRYTKHPITSEEDESQY-VCVTLEMTVSEGYPAESPTVTLSNPRGLGDPEFREI 80 (368)
T ss_pred cccchhhHhhhhHhhccCCCCCChhhheeeeccccccccccee-EEEEEEEecCCCCCCcCCceEecCCCCCCcHHHHHH
Confidence 444555555555444332 233667777777766666666 999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCceeeehHHHHHHHHHHhh
Q 000880 113 LCLLQDQANSNAREGRVMIFNLVEAAQEFLSEI 145 (1239)
Q Consensus 113 ~~~L~e~~~e~~~~G~~mif~lv~~lke~L~~~ 145 (1239)
+..+++++++|+ ||||||+||+.++|+|++.
T Consensus 81 ~~~~~~iikq~~--g~pii~~lie~~~e~LT~n 111 (368)
T KOG4445|consen 81 QRQIQEIIKQNS--GMPIICQLIEHCSEFLTEN 111 (368)
T ss_pred HHHHHHHHHhcC--CCchhHHHHHHHHHHcccC
Confidence 999999999999 9999999999999999973
|
|
| >cd00861 ProRS_anticodon_short ProRS Prolyl-anticodon binding domain, short version found predominantly in bacteria | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.4e-11 Score=113.65 Aligned_cols=91 Identities=15% Similarity=0.178 Sum_probs=81.8
Q ss_pred CceEEEEecCCC--ccHHHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCC
Q 000880 1133 GTSVLVCSRGGG--GLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVK 1210 (1239)
Q Consensus 1133 ~~~v~v~~~~~~--~~~~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~ 1210 (1239)
|.+|.|++.+.+ .....|++++..||+.|++|++++. .+++++++++|++.|+++++++|++|.++++|+||++.++
T Consensus 1 P~qv~i~p~~~~~~~~~~~a~~la~~Lr~~g~~v~~d~~-~~~l~k~i~~a~~~g~~~~iiiG~~e~~~~~v~vk~~~~~ 79 (94)
T cd00861 1 PFDVVIIPMNMKDEVQQELAEKLYAELQAAGVDVLLDDR-NERPGVKFADADLIGIPYRIVVGKKSAAEGIVEIKVRKTG 79 (94)
T ss_pred CeEEEEEEcCCCcHHHHHHHHHHHHHHHHCCCEEEEECC-CCCcccchhHHHhcCCCEEEEECCchhhCCEEEEEECCCC
Confidence 457888888521 4678999999999999999998877 5799999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHH
Q 000880 1211 KEKEVQRESLVRFL 1224 (1239)
Q Consensus 1211 ~q~~v~~~el~~~i 1224 (1239)
++..++++++.+.+
T Consensus 80 ~~~~~~~~~~~~~l 93 (94)
T cd00861 80 EKEEISIDELLEFL 93 (94)
T ss_pred cceEEeHHHHHHhh
Confidence 99999999987765
|
ProRS belongs to class II aminoacyl-tRNA synthetases (aaRS). This alignment contains the anticodon binding domain, which is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only. |
| >cd00860 ThrRS_anticodon ThrRS Threonyl-anticodon binding domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.1e-11 Score=111.60 Aligned_cols=90 Identities=18% Similarity=0.194 Sum_probs=82.2
Q ss_pred CceEEEEecCCCccHHHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccCCcc
Q 000880 1133 GTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKE 1212 (1239)
Q Consensus 1133 ~~~v~v~~~~~~~~~~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~~~q 1212 (1239)
|.+|+|++.+ +.....|+++++.||+.|++|++++. .+++++++++|++.|+++++++|++|..+++++++||.++++
T Consensus 1 p~~v~ii~~~-~~~~~~a~~~~~~Lr~~g~~v~~d~~-~~~~~~~~~~a~~~g~~~~iiig~~e~~~~~v~lk~~~~~~~ 78 (91)
T cd00860 1 PVQVVVIPVT-DEHLDYAKEVAKKLSDAGIRVEVDLR-NEKLGKKIREAQLQKIPYILVVGDKEVETGTVSVRTRDGGDL 78 (91)
T ss_pred CeEEEEEeeC-chHHHHHHHHHHHHHHCCCEEEEECC-CCCHHHHHHHHHHcCCCEEEEECcchhhCCEEEEEECCCCcc
Confidence 4578888875 66789999999999999999998877 679999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHH
Q 000880 1213 KEVQRESLVRFL 1224 (1239)
Q Consensus 1213 ~~v~~~el~~~i 1224 (1239)
..++++++++.+
T Consensus 79 ~~~~~~~~~~~~ 90 (91)
T cd00860 79 GSMSLDEFIEKL 90 (91)
T ss_pred ceEcHHHHHHHh
Confidence 999999987655
|
ThrRS belongs to class II aminoacyl-tRNA synthetases (aaRS). This alignment contains the anticodon binding domain, which is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only. |
| >cd00858 GlyRS_anticodon GlyRS Glycyl-anticodon binding domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.9e-11 Score=117.18 Aligned_cols=96 Identities=22% Similarity=0.207 Sum_probs=85.8
Q ss_pred CCCceEEEEecCC-CccHHHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccC
Q 000880 1131 EAGTSVLVCSRGG-GGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDV 1209 (1239)
Q Consensus 1131 ~~~~~v~v~~~~~-~~~~~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~ 1209 (1239)
.++.+|+|++.+. +.....|++++..||+.|++|++.+. +++++++++|++.|+++++++|++|.++++|+||++.+
T Consensus 24 lap~~v~Ii~~~~~~~~~~~a~~la~~LR~~gi~v~~d~~--~sl~kqlk~A~k~g~~~~iiiG~~e~~~~~v~lk~l~~ 101 (121)
T cd00858 24 LAPIKVAVLPLVKRDELVEIAKEISEELRELGFSVKYDDS--GSIGRRYARQDEIGTPFCVTVDFDTLEDGTVTIRERDS 101 (121)
T ss_pred cCCcEEEEEecCCcHHHHHHHHHHHHHHHHCCCEEEEeCC--CCHHHHHHHhHhcCCCEEEEECcCchhCCEEEEEECCC
Confidence 3578899998741 44678999999999999999998776 69999999999999999999999999999999999999
Q ss_pred CcccccchHHHHHHHHHHH
Q 000880 1210 KKEKEVQRESLVRFLLDAI 1228 (1239)
Q Consensus 1210 ~~q~~v~~~el~~~i~~~l 1228 (1239)
+++.+++++++.+.+..++
T Consensus 102 ~~~~~v~l~~l~~~l~~~~ 120 (121)
T cd00858 102 MRQVRVKIEELPSYLRELI 120 (121)
T ss_pred CceEEEEHHHHHHHHHHHh
Confidence 9999999999988887654
|
GlyRS belongs to class II aminoacyl-tRNA synthetases (aaRS). This alignment contains the anticodon binding domain, which is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only. |
| >PRK09537 pylS pyrolysyl-tRNA synthetase; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.3e-11 Score=138.63 Aligned_cols=123 Identities=11% Similarity=0.141 Sum_probs=98.8
Q ss_pred HHHHHHHHHHHHHHcCCcccccccee---c---cCC--CccccccEEEEeccCCCeeeecCCCcHHHHHHHHhC---CCC
Q 000880 798 RDYVVQVTKEMFRQHCAKHLEIEPMY---L---LGD--CPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISN---QKS 866 (1239)
Q Consensus 798 ~~~i~~~i~~~f~~~Gy~~I~tP~~~---~---~~~--~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~~~---~~~ 866 (1239)
...+++.++++|..+||.+|.||.|. . .+. +....+.||.+ ++.++|||++|++++|+++.+ ...
T Consensus 206 ~s~Le~aIR~~f~~~GF~EV~TPtLt~ee~~e~~g~~~g~~i~~~my~i----deel~LRpsLtPsLlr~la~n~k~~~~ 281 (417)
T PRK09537 206 LGKLERDITKFFVDRGFLEIKSPILIPAEYIERMGIDNDTELSKQIFRV----DKNFCLRPMLAPGLYNYLRKLDRILPD 281 (417)
T ss_pred HHHHHHHHHHHHHHCCCEEEECCeeecHHHHHHhCCCCcccchhhheee----CCceEehhhhHHHHHHHHHhhhhcccC
Confidence 56899999999999999999999991 1 111 23445788876 247999999999999988764 345
Q ss_pred ceeEEeecCeEEcCCCCCC-CCceeEEeEEEeCCCCcccHHHHHHHHHHHHHhcCCCCceEEE
Q 000880 867 SFKRYEISSVYRRAIGHSP-PNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIH 928 (1239)
Q Consensus 867 P~r~~Y~g~VfR~e~~~~~-~~ef~Q~GvEiiG~~s~~aDaEvi~la~~~l~~lgi~~~~~i~ 928 (1239)
|+|+||+|+|||++.++.+ .+||+|+|++++|.....+| +..++.++|+.||+. |++.
T Consensus 282 P~RIFEIG~VFR~E~~g~~hlrEf~Ql~~~iiGs~~~f~d--L~~lleeLL~~LGI~--f~i~ 340 (417)
T PRK09537 282 PIKIFEIGPCYRKESDGKEHLEEFTMVNFCQMGSGCTREN--LENIIDDFLKHLGID--YEII 340 (417)
T ss_pred CeeEEEEeceEecCCCCCCCcceEEEEEEEEeCCchHHHH--HHHHHHHHHHHCCCC--cEEe
Confidence 9999999999999876544 45799999999997766655 669999999999984 6665
|
|
| >PTZ00326 phenylalanyl-tRNA synthetase alpha chain; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-10 Score=138.70 Aligned_cols=147 Identities=10% Similarity=0.049 Sum_probs=114.3
Q ss_pred HHHHHHHHHHHHHHcCCccccccc-e---------eccCCCc--cccccEEEEecc------------------------
Q 000880 798 RDYVVQVTKEMFRQHCAKHLEIEP-M---------YLLGDCP--QFKRNTVKLLTH------------------------ 841 (1239)
Q Consensus 798 ~~~i~~~i~~~f~~~Gy~~I~tP~-~---------~~~~~~~--~~~~~~~~~~D~------------------------ 841 (1239)
...+.+.++++|..-||+++.+|. + ++..... -.....|-+.++
T Consensus 231 l~~~~~~i~~if~~mGF~e~~~~~~ves~f~NFDaL~~PqdHPARd~~DTFyl~~~~~~~~~~~p~~~~~~Vk~~He~G~ 310 (494)
T PTZ00326 231 LLKVRREFREILLEMGFEEMPTNRYVESSFWNFDALFQPQQHPARDAQDTFFLSKPETSKVNDLDDDYVERVKKVHEVGG 310 (494)
T ss_pred HHHHHHHHHHHHHhCCCEEecCCCCccccchhhhhhcCCCCCCCCCcCceEEEcCccccccccCcHHHHHHHHHHhccCC
Confidence 457888999999999999998773 3 1211111 112445555431
Q ss_pred -------------CCCeeeecCCCcHHHHHHHHhCC-------C-CceeEEeecCeEEcCCCCCC-CCceeEEeEEEeCC
Q 000880 842 -------------GGDLLELSHELRLPFIRWAISNQ-------K-SSFKRYEISSVYRRAIGHSP-PNRYLQGDFDIIGG 899 (1239)
Q Consensus 842 -------------~G~~l~LRPD~T~~iaR~~~~~~-------~-~P~r~~Y~g~VfR~e~~~~~-~~ef~Q~GvEiiG~ 899 (1239)
..+.++||+++|++.+|+++++. . .|+|+|++|+|||++.++.+ ..||+|+++.++|.
T Consensus 311 ~gS~Gw~y~W~~e~a~~~vLRtHtTa~~aR~l~~~~~~~~~~~~~~P~k~fsigrVfR~d~~DatH~~eFhQ~Eg~vi~~ 390 (494)
T PTZ00326 311 YGSIGWRYDWKLEEARKNILRTHTTAVSARMLYKLAQEYKKTGPFKPKKYFSIDRVFRNETLDATHLAEFHQVEGFVIDR 390 (494)
T ss_pred cCCcccccccccchhccccccCCCCHHHHHHHHhhccccccccCCCCceEEecCCEecCCCCCCCcCceeEEEEEEEEeC
Confidence 11478999999999999999852 2 39999999999999886654 45799999999997
Q ss_pred CCcccHHHHHHHHHHHHHhcCCCC-ceE-----------------------EEECcHHHHH-HHHHHcCCCH
Q 000880 900 ASALTEAEVLKVTMDIVTRFFHAE-SCD-----------------------IHLNHGDLLE-AIWSWAGIKA 946 (1239)
Q Consensus 900 ~s~~aDaEvi~la~~~l~~lgi~~-~~~-----------------------i~lg~~~i~~-~ll~~lgl~~ 946 (1239)
.. ++++++.++.++++++|+.+ .|. |+|++.++++ .+++.+|+++
T Consensus 391 ~~--s~~~L~~~l~~f~~~lG~~~~RfrP~yfPfTEPS~Ev~v~~~~~gkWIEIgg~Gm~rpevL~~~Gi~~ 460 (494)
T PTZ00326 391 NL--TLGDLIGTIREFFRRIGITKLRFKPAFNPYTEPSMEIFGYHPGLKKWVEVGNSGIFRPEMLRPMGFPE 460 (494)
T ss_pred CC--CHHHHHHHHHHHHHhcCCCceEEecCCCCCCCCeeEEEEEecCCCcEEEEeCcCccCHHHHHhcCCCC
Confidence 75 78999999999999999853 265 8999999998 9999999964
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-10 Score=140.37 Aligned_cols=72 Identities=26% Similarity=0.351 Sum_probs=55.9
Q ss_pred EEEEeeccCC-CHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCccccCCCcccEEEcCCCCEEEeecCcchhc
Q 000880 538 LYIQMEYCPR-TLRQVFESY-DHFDKELAWHLFRQIVE-GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612 (1239)
Q Consensus 538 l~iVmEy~~g-sL~~~l~~~-~~l~~~~~~~i~~qI~~-gL~yLHs~gIiHrDLKp~NILl~~~~~vKL~DFGlA~~~ 612 (1239)
-++||||++| +|.++.... ...+ ...++.+++. .+..+|..|++|+|+||.||+++.++.++|+|||++..+
T Consensus 233 ~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 233 RVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 4899999976 777665421 1222 2345556655 478899999999999999999999999999999999764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00862 ProRS_anticodon_zinc ProRS Prolyl-anticodon binding domain, long version found predominantly in eukaryotes and archaea | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.7e-10 Score=121.87 Aligned_cols=103 Identities=15% Similarity=0.092 Sum_probs=91.9
Q ss_pred CCCCceEEEEecCCCc------cHHHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEE
Q 000880 1130 NEAGTSVLVCSRGGGG------LLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVK 1203 (1239)
Q Consensus 1130 ~~~~~~v~v~~~~~~~------~~~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~ 1203 (1239)
..+|.+|+|++.+ +. ...+|.++++.||+.|++|+++.....++++++++|+.+|+|++|+||++|+++|+|+
T Consensus 7 ~iAP~qVvIipi~-~~~~~~~~~~~~a~~i~~~Lr~~Girv~~D~r~~~s~g~K~~~ae~~GvP~~I~IG~~Ele~g~V~ 85 (202)
T cd00862 7 RVAPIQVVIVPIG-IKDEKREEVLEAADELAERLKAAGIRVHVDDRDNYTPGWKFNDWELKGVPLRIEIGPRDLEKNTVV 85 (202)
T ss_pred hhcCceEEEEEec-CCccchHHHHHHHHHHHHHHHHCCCEEEEECCCCCCHhHHHHHHHhCCCCEEEEECcchhhCCEEE
Confidence 4578899999985 33 6789999999999999999998874339999999999999999999999999999999
Q ss_pred EEEccCCcccccchHHHHHHHHHHHHhhcc
Q 000880 1204 VRHLDVKKEKEVQRESLVRFLLDAIASQFR 1233 (1239)
Q Consensus 1204 vk~l~~~~q~~v~~~el~~~i~~~l~~~~~ 1233 (1239)
|+++.++++..++++++++.+...+..+.+
T Consensus 86 v~~Rd~~ek~~v~~~el~~~i~~ll~~i~~ 115 (202)
T cd00862 86 IVRRDTGEKKTVPLAELVEKVPELLDEIQE 115 (202)
T ss_pred EEEecCCcceEEEHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999888776544
|
ProRS belongs to class II aminoacyl-tRNA synthetases (aaRS). This alignment contains the anticodon binding domain, which is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only, and an additional C-terminal zinc-binding domain specific to this subfamily of aaRSs. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.8e-11 Score=145.41 Aligned_cols=154 Identities=19% Similarity=0.298 Sum_probs=92.5
Q ss_pred cCCceEEeeeccCCceEEEEEEEccCCcEEEEEEEecCCCC----------------------------c----hhHHHH
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS----------------------------L----PVNDRI 470 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~~g~~vAVK~i~~~~~~----------------------------~----~~~~~~ 470 (1239)
..+|+. +.||+|++|+||+|+.+.+|+.||||+++..-.. . +....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456666 7899999999999999977999999999743100 0 111223
Q ss_pred HHHHHHHHhcCCCceeeeeeeeeecCccccCCCCcCCCCcccccccccccccccccccccccccccEEEEEeeccCC-CH
Q 000880 471 LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TL 549 (1239)
Q Consensus 471 ~~Ev~iL~~L~HpnIv~l~~~~~e~~~~~~~~~~~~~~g~~~s~~~~~~~~~~~~v~~~~~~~~~~~l~iVmEy~~g-sL 549 (1239)
.+|+...+.. +|+.++...|..... -.....+| .....-+||||||.| .+
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~-v~VP~v~~--------------------------d~st~~VLvmE~i~G~~l 248 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDM-LYVPEVYW--------------------------DYCSETVMVMERMYGIPV 248 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCC-eecceeec--------------------------ccCCCceEEEeeecCccH
Confidence 3333333322 233333322211000 00000000 012345799999976 67
Q ss_pred HHH--HHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcccEEEcCCC----CEEEeecCcchhcc
Q 000880 550 RQV--FESYD----HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN----DIKIGDFGLAKFLK 613 (1239)
Q Consensus 550 ~~~--l~~~~----~l~~~~~~~i~~qI~~gL~yLHs~gIiHrDLKp~NILl~~~~----~vKL~DFGlA~~~~ 613 (1239)
.++ +...+ .+.+..+..++.|| +..|++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 249 ~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 249 SDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 653 33322 13333444444454 468999999999999999888 89999999998664
|
|
| >cd00768 class_II_aaRS-like_core Class II tRNA amino-acyl synthetase-like catalytic core domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.4e-10 Score=122.21 Aligned_cols=130 Identities=13% Similarity=0.127 Sum_probs=101.6
Q ss_pred HHHHHHHHHHHHHHcCCccccccceec----cCCCccccccEEEEeccCCCeeeecCCCcHHHHHHHHhCC-CCceeEEe
Q 000880 798 RDYVVQVTKEMFRQHCAKHLEIEPMYL----LGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQ-KSSFKRYE 872 (1239)
Q Consensus 798 ~~~i~~~i~~~f~~~Gy~~I~tP~~~~----~~~~~~~~~~~~~~~D~~G~~l~LRPD~T~~iaR~~~~~~-~~P~r~~Y 872 (1239)
++.+++.++++|..+||++|.||.|.. ...+.. .+.+..+.+..++..+|||++|+++++.++.|. ..|+|+||
T Consensus 2 ~~~~~~~~r~~l~~~Gf~Ev~t~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~LR~s~~~~l~~~~~~n~~~~~~~lfe 80 (211)
T cd00768 2 RSKIEQKLRRFMAELGFQEVETPIVEREPLLEKAGHE-PKDLLPVGAENEEDLYLRPTLEPGLVRLFVSHIRKLPLRLAE 80 (211)
T ss_pred HHHHHHHHHHHHHHcCCEEeEcceecHHHHHHHcCcc-HhheeeeecCCCCEEEECCCCcHHHHHHHHhhcccCCEEEEE
Confidence 567899999999999999999999922 111211 245666677788999999999999999988764 45999999
Q ss_pred ecCeEEcCCCCC---CCCceeEEeEEEeCCCCc--ccHHHHHHHHHHHHHhcCCCCceEEE
Q 000880 873 ISSVYRRAIGHS---PPNRYLQGDFDIIGGASA--LTEAEVLKVTMDIVTRFFHAESCDIH 928 (1239)
Q Consensus 873 ~g~VfR~e~~~~---~~~ef~Q~GvEiiG~~s~--~aDaEvi~la~~~l~~lgi~~~~~i~ 928 (1239)
+|+|||.+.... +.+||+|+|++++|.... ....+++.++.++++.+|+..++.+.
T Consensus 81 ig~vfr~e~~~~~~~~~~ef~~l~~~~~g~~~~~~~~~~~~~~~~~~~l~~lg~~~~~~~~ 141 (211)
T cd00768 81 IGPAFRNEGGRRGLRRVREFTQLEGEVFGEDGEEASEFEELIELTEELLRALGIKLDIVFV 141 (211)
T ss_pred EcceeecCCCccccccceeEEEcCEEEEcCCchhHHHHHHHHHHHHHHHHHcCCCcceEEE
Confidence 999999865432 345899999999997653 25779999999999999974224443
|
Class II amino acyl-tRNA synthetases (aaRS) share a common fold and generally attach an amino acid to the 3' OH of ribose of the appropriate tRNA. PheRS is an exception in that it attaches the amino acid at the 2'-OH group, like class I aaRSs. These enzymes are usually homodimers. This domain is primarily responsible for ATP-dependent formation of the enzyme bound aminoacyl-adenylate. The substrate specificity of this reaction is further determined by additional domains. Intererestingly, this domain is also found is asparagine synthase A (AsnA), in the accessory subunit of mitochondrial polymerase gamma and in the bacterial ATP phosphoribosyltransferase regulatory subunit HisZ. |
| >cd00738 HGTP_anticodon HGTP anticodon binding domain, as found at the C-terminus of histidyl, glycyl, threonyl and prolyl tRNA synthetases, which are classified as a group of class II aminoacyl-tRNA synthetases (aaRS) | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.1e-10 Score=106.06 Aligned_cols=90 Identities=14% Similarity=0.233 Sum_probs=81.1
Q ss_pred CceEEEEecCCC---ccHHHHHHHHHHHHHcCCeEEEeeCCCCCHHHHHHHHHhCCCcEEEEEcCCcccCCeEEEEEccC
Q 000880 1133 GTSVLVCSRGGG---GLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDV 1209 (1239)
Q Consensus 1133 ~~~v~v~~~~~~---~~~~~a~~ia~~Lr~~G~~ve~~~~~~~~l~k~~~~A~~~g~~~~viig~~E~~~~~v~vk~l~~ 1209 (1239)
|.+++|++.+ + .....|+++++.||..|++|++.+. ..++++++++|++.|+++++++|++|+.+++|++|++.+
T Consensus 1 p~~v~ii~~~-~~~~~~~~~a~~~~~~Lr~~g~~v~~~~~-~~~~~k~~~~a~~~g~~~~iiig~~e~~~~~v~i~~~~~ 78 (94)
T cd00738 1 PIDVAIVPLT-DPRVEAREYAQKLLNALLANGIRVLYDDR-ERKIGKKFREADLRGVPFAVVVGEDELENGKVTVKSRDT 78 (94)
T ss_pred CeEEEEEECC-CCcHHHHHHHHHHHHHHHHCCCEEEecCC-CcCHhHHHHHHHhCCCCEEEEECCChhhCCEEEEEECCC
Confidence 3578888875 5 6789999999999999999998776 579999999999999999999999999999999999999
Q ss_pred CcccccchHHHHHHH
Q 000880 1210 KKEKEVQRESLVRFL 1224 (1239)
Q Consensus 1210 ~~q~~v~~~el~~~i 1224 (1239)
+++..++++++.+.+
T Consensus 79 ~~~~~~~~~~~~~~i 93 (94)
T cd00738 79 GESETLHVDELPEFL 93 (94)
T ss_pred CceeEEEHHHHHhhc
Confidence 999999999887654
|
In aaRSs, the anticodon binding domain is responsible for specificity in tRNA-binding, so that the activated amino acid is transferred to a ribose 3' OH group of the appropriate tRNA only. This domain is also found in the accessory subunit of mitochondrial polymerase gamma (Pol gamma b). |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1239 | ||||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-47 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-47 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-44 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-40 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-39 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-30 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-27 | ||
| 4g84_A | 464 | Crystal Structure Of Human Hisrs Length = 464 | 1e-26 | ||
| 4g85_A | 517 | Crystal Structure Of Human Hisrs Length = 517 | 3e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-21 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-12 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-12 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-12 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-12 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 2ebm_A | 128 | Solution Structure Of The Rwd Domain Of Human Rwd D | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-06 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 2dmf_A | 137 | An Extended Conformation Of The Rwd Domain Of Human | 1e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 1ukx_A | 137 | Solution Structure Of The Rwd Domain Of Mouse Gcn2 | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-05 | ||
| 2day_A | 128 | Solution Structure Of The Rwd Domain Of Human Ring | 9e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-04 |
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G84|A Chain A, Crystal Structure Of Human Hisrs Length = 464 | Back alignment and structure |
|
| >pdb|4G85|A Chain A, Crystal Structure Of Human Hisrs Length = 517 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EBM|A Chain A, Solution Structure Of The Rwd Domain Of Human Rwd Domain Containing Protein 1 Length = 128 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2DMF|A Chain A, An Extended Conformation Of The Rwd Domain Of Human Ring Finger Protein 25 Length = 137 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1UKX|A Chain A, Solution Structure Of The Rwd Domain Of Mouse Gcn2 Length = 137 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DAY|A Chain A, Solution Structure Of The Rwd Domain Of Human Ring Finger Protein 25 Length = 128 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1239 | |||
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-109 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-104 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-100 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-87 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-68 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-62 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-61 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-60 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-60 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-57 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-50 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-49 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-48 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-48 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-47 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-47 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-46 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-46 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-45 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-45 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-45 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-45 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-45 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-44 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-44 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-44 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-44 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-43 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 9e-42 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-41 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-41 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-41 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-41 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 6e-41 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-41 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-40 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-40 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-40 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-39 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 6e-39 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-39 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-38 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-38 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-38 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-38 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-38 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-38 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-38 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-38 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-38 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-37 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-37 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-37 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-37 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-37 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-37 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-37 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-37 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-37 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-37 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-36 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-36 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-36 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-36 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-36 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-36 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-36 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-36 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-36 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-36 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-36 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-36 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-36 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-36 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 8e-36 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-35 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-35 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-35 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-35 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-35 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 6e-35 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 7e-35 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-35 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 8e-35 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-34 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-34 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-34 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-34 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-34 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-34 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-34 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 6e-34 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 8e-34 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-33 | |
| 3net_A | 465 | Histidyl-tRNA synthetase; aminoacyl-tRNA synthetas | 6e-33 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 9e-33 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 9e-33 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-32 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-32 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-32 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-32 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-32 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-32 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-32 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-31 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-31 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-31 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 6e-31 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 8e-31 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 9e-31 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-30 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-30 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-30 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-30 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-30 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 4e-30 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 7e-30 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-29 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-29 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-29 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-29 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-29 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-29 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-29 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 5e-29 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-28 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-28 | |
| 3lc0_A | 456 | Histidyl-tRNA synthetase; tRNA-ligase, aminoacyl-t | 1e-28 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-28 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-28 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-28 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-28 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-28 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 6e-28 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-28 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-26 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-26 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-26 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 6e-26 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-25 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-25 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-25 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-25 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-25 | |
| 2ebm_A | 128 | RWD domain-containing protein 1; alpha+beta sandwi | 5e-25 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-25 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-24 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-24 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-24 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-24 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 8e-24 | |
| 2day_A | 128 | Ring finger protein 25; ligase, metal-binding, UB1 | 1e-23 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-23 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-22 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-22 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 4e-22 | |
| 1ukx_A | 137 | GCN2, GCN2 EIF2alpha kinase; UBC-like fold, triple | 4e-22 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-22 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-22 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-21 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-21 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-21 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-20 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-20 | |
| 2ebk_A | 128 | RWD domain-containing protein 3; alpha+beta sandwi | 5e-20 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-19 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-19 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-19 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-19 | |
| 2yz0_A | 138 | Serine/threonine-protein kinase GCN2; A-B-B-B-B-A- | 2e-19 | |
| 1wu7_A | 434 | Histidyl-tRNA synthetase; ligase, structural genom | 4e-19 | |
| 3od1_A | 400 | ATP phosphoribosyltransferase regulatory subunit; | 2e-18 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-17 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-17 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-17 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 4e-17 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-16 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-16 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-15 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-15 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-15 | |
| 3rac_A | 373 | Histidine-tRNA ligase; structural genomics, PSI-bi | 5e-15 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-15 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-14 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-07 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-14 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-14 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-14 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-13 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-13 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-13 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-05 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-13 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-13 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 3e-06 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-13 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-13 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-13 | |
| 1usy_A | 275 | ATP phosphoribosyltransferase regulatory subunit; | 5e-13 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-13 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-12 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-12 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-12 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-12 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-12 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-12 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-12 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-12 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-12 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-12 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-12 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 6e-12 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-12 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-12 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-11 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-11 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-11 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-11 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-11 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-11 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 7e-11 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-11 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-11 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-11 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-11 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-10 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-10 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-10 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 4e-10 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-10 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-09 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-05 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-08 | |
| 2dax_A | 152 | Protein C21ORF6; RWD domain, alpha+beta sandwich f | 1e-05 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 2e-04 |
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 344 bits (883), Expect = e-109
Identities = 108/334 (32%), Positives = 181/334 (54%), Gaps = 27/334 (8%)
Query: 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLS 478
+SRYL DFE +Q +G GGFG V KNK+D +YA+K+IRL ++ ++++REV L+
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALA 59
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLES--- 535
+L+H +VRY+ AW ET + + S+ + + S D + +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 536 --------------TYLYIQMEYCPR-TLRQVFESYDHF---DKELAWHLFRQIVEGLAH 577
YLYIQM+ C + L+ + + H+F QI E +
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637
+H +G++HRDL P+NIFF + +K+GDFGL + ++ +Q P TGQ
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA---THTGQ 236
Query: 638 VGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPS 697
VGT Y +PE G K D++SLG++ FEL + FST MER +++D++ + P
Sbjct: 237 VGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQMERVRIITDVR-NLKFPLL 294
Query: 698 WVAKFSEQESLLRRLMSPSPSDRPSATELLQDAL 731
+ K+ ++ +++ ++SPSP++RP AT+++++A+
Sbjct: 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-104
Identities = 130/334 (38%), Positives = 175/334 (52%), Gaps = 36/334 (10%)
Query: 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLS 478
S RY +DFEE+ LG G FG VV +N LD R+YA+KKIR ++ L IL EV L+
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLA 57
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
L HQ+VVRYY AW E V + + L
Sbjct: 58 SLNHQYVVRYYAAWLE---------------------------RRNFVKPMTAVKKKSTL 90
Query: 539 YIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
+IQMEYC TL + S + + ++ W LFRQI+E L++IH QGIIHRDL P NIF D
Sbjct: 91 FIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
++KIGDFGLAK + LD + G S + T +GT Y A E+ G +
Sbjct: 151 ESRNVKIGDFGLAKNVH-RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
Query: 657 EKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPS--WVAKFSEQESLLRRLMS 714
EK DMYSLGI+FFE+ +PFST MER +L L+ P K ++ ++R L+
Sbjct: 210 EKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLID 269
Query: 715 PSPSDRPSATELLQDA-LPPQMEYELLDNILRMM 747
P+ RP A LL LP + + E++ L+ +
Sbjct: 270 HDPNKRPGARTLLNSGWLPVKHQDEVIKEALKSL 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-100
Identities = 106/315 (33%), Positives = 168/315 (53%), Gaps = 38/315 (12%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL 480
RYL DFE +Q LG GGFG V KNK+D +YA+K+IRL ++ L ++++REV L++L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKL 60
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+H +VRY+ AW E + YLYI
Sbjct: 61 EHPGIVRYFNAWLEKN----------------------------TTEKLQPSSPKVYLYI 92
Query: 541 QMEYCPR-TLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
QM+ C + L+ + + ++ + H+F QI E + +H +G++HRDL P+NIFF
Sbjct: 93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+ +K+GDFGL + D++ TGQVGT Y +PE G
Sbjct: 153 MDDVVKVGDFGLVTAMD---QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YS 208
Query: 657 EKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716
K D++SLG++ FEL +PFST MER L+D++ + PP + K+ + +++ ++SPS
Sbjct: 209 HKVDIFSLGLILFELLYPFSTQMERVRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPS 267
Query: 717 PSDRPSATELLQDAL 731
P +RP A ++++A+
Sbjct: 268 PMERPEAINIIENAV 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-87
Identities = 92/313 (29%), Positives = 147/313 (46%), Gaps = 54/313 (17%)
Query: 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSR 479
R+ DF+E++ +G GGFG V K+++DG+ Y +K+++ N++ REV L++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAK 60
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
L H ++V Y W + ++ ++ L+
Sbjct: 61 LDHVNIVHYNGCWDGFD------------------------YDPETSSKNSSRSKTKCLF 96
Query: 540 IQMEYCPR-TLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
IQME+C + TL Q E + DK LA LF QI +G+ +IH + +I+RDL P+NIF
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+KIGDFGL L D GT Y +PE
Sbjct: 157 DTKQVKIGDFGLVT-----SLKNDGKRTR-----------SKGTLRYMSPEQISSQD-YG 199
Query: 657 EKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716
++ D+Y+LG++ EL H TA E +DL+ G + + K +LL++L+S
Sbjct: 200 KEVDLYALGLILAELLHVCDTAFETSKFFTDLR-DGIISDIFDKKEK---TLLQKLLSKK 255
Query: 717 PSDRPSATELLQD 729
P DRP+ +E+L+
Sbjct: 256 PEDRPNTSEILRT 268
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 8e-68
Identities = 100/361 (27%), Positives = 144/361 (39%), Gaps = 76/361 (21%)
Query: 380 SSQFNKTFNQVFHQKM--VSSRVSQFW---KPSVDSGSPNMSLPSSRYLNDFEELQPLGH 434
SS + ++ Q M + R F ++ S + S P S + F+ L LGH
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67
Query: 435 GGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWF 493
G +G V ++K DGR YAVK+ + R L EV + ++ QH VR QAW
Sbjct: 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 494 ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVF 553
E G LY+Q E C +L+Q
Sbjct: 128 EGG----------------------------------------ILYLQTELCGPSLQQHC 147
Query: 554 ESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFL 612
E++ + W R + LAH+H QG++H D+ P NIF R K+GDFGL
Sbjct: 148 EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-- 205
Query: 613 KLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL- 671
+L A Q G Y APE+ QG AD++SLG+ E+
Sbjct: 206 ---ELGTAGAGEV-----------QEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVA 249
Query: 672 ---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELL 727
P +Q+ +G LPP + A S + S+L ++ P P R +A LL
Sbjct: 250 CNMELPHGGEGWQQLR------QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALL 303
Query: 728 Q 728
Sbjct: 304 A 304
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-62
Identities = 72/356 (20%), Positives = 124/356 (34%), Gaps = 71/356 (19%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP 465
P L +F + +G G F V LDG A+KK+++ D
Sbjct: 14 PQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA 73
Query: 466 VNDR--ILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASS 523
R ++E+ L +L H +V++YY ++ E
Sbjct: 74 -KARADCIKEIDLLKQLNHPNVIKYYASFIEDN--------------------------- 105
Query: 524 ADVTGQENKLESTYLYIQMEYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHI 578
L I +E R ++ + + W F Q+ L H+
Sbjct: 106 -------------ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV 638
H + ++HRD+ P N+F A +K+GD GL + V
Sbjct: 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHS----------LV 197
Query: 639 GTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELP 695
GT +Y +PE + K+D++SLG + +E+ PF L ++ + P
Sbjct: 198 GTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256
Query: 696 PSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSS 750
P +SE+ L+ ++P P RP T + + + + L H
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV---AKRMHACTASSLEHHHHH 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-61
Identities = 80/347 (23%), Positives = 124/347 (35%), Gaps = 97/347 (27%)
Query: 411 GSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI 470
G+ M SRY +F EL+ +G G FG V C +LDG YA+K+ +
Sbjct: 1 GAMGMK---SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA 57
Query: 471 LREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQ 529
LREV + L QH HVVRY+ AW E
Sbjct: 58 LREVYAHAVLGQHSHVVRYFSAWAEDD--------------------------------- 84
Query: 530 ENKLESTYLYIQMEYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGII 584
++ IQ EYC + + + +F + L Q+ GL +IH ++
Sbjct: 85 -------HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137
Query: 585 HRDLTPNNIFFDARNDI-------------------KIGDFGLAKFLKLEQLDQDAAFPT 625
H D+ P+NIF + KIGD G + Q+
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-------- 189
Query: 626 DTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQ 682
+ G + A E+ Q KAD+++L + +
Sbjct: 190 -----------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 683 IVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQ 728
+ ++G LP S++ LL+ ++ P P RPSA L++
Sbjct: 239 EI-----RQGRLPRI-PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-60
Identities = 88/332 (26%), Positives = 142/332 (42%), Gaps = 71/332 (21%)
Query: 405 KPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL 464
VD G+ N+ S + + LQ +G G FG +L K+ DGR Y +K+I + S
Sbjct: 8 SSGVDLGTENLYFQS---MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 465 PVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSA 524
+ REVA L+ ++H ++V+Y +++
Sbjct: 65 KEREESRREVAVLANMKHPNIVQYRESF-------------------------------- 92
Query: 525 DVTGQENKLESTYLYIQMEYCPR-TLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQ 581
E+ LYI M+YC L + + F ++ F QI L H+H +
Sbjct: 93 --------EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTY 641
I+HRD+ NIF +++GDFG+A+ L+ +GT
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIAR-----VLNSTVEL-ARA---------CIGTP 189
Query: 642 FYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLK-QKGELPPS 697
+Y +PEI + P + K+D+++LG V +EL H F + +V LK G PP
Sbjct: 190 YYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV---LKIISGSFPP- 244
Query: 698 WVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQ 728
+S SL+ +L +P DRPS +L+
Sbjct: 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-60
Identities = 77/322 (23%), Positives = 137/322 (42%), Gaps = 73/322 (22%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
D+E L +G G +G + K DG+ K++ + ++ EV L L+H
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++VRYY + +T LYI M
Sbjct: 65 PNIVRYYDRIIDR--------------------------------------TNTTLYIVM 86
Query: 543 EYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH-----GQGIIHRDLTPNN 592
EYC + + + + D+E + Q+ L H G ++HRDL P N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 593 IFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652
+F D + ++K+GDFGLA+ L+ D +F T VGT +Y +PE
Sbjct: 147 VFLDGKQNVKLGDFGLAR-----ILNHDTSF-AKT---------FVGTPYYMSPEQMNRM 191
Query: 653 PKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLK-QKGELPPSWVAKFSEQ-ES 707
+EK+D++SLG + +EL PF+ ++++ K ++G+ ++S++
Sbjct: 192 S-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---GKIREGKFRR-IPYRYSDELNE 246
Query: 708 LLRRLMSPSPSDRPSATELLQD 729
++ R+++ RPS E+L++
Sbjct: 247 IITRMLNLKDYHRPSVEEILEN 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 4e-57
Identities = 69/350 (19%), Positives = 111/350 (31%), Gaps = 65/350 (18%)
Query: 405 KPSVDSGSPNMSLPSSRY---LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD 461
SG N+ + +Q LG GGF +V L + DG YA+K+I +
Sbjct: 7 HHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE 66
Query: 462 KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAA 521
+ + RE H +++R
Sbjct: 67 QQ--DREEAQREADMHRLFNHPNILRLVAYCLRE-------------------------- 98
Query: 522 SSADVTGQENKLESTYLYIQMEYCPR-----TLRQVFESYDHFDKELAWHLFRQIVEGLA 576
+ ++ + + R + ++ + + ++ L I GL
Sbjct: 99 ----------RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTG 636
IH +G HRDL P NI + D G + A D
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ------DWAA 202
Query: 637 QVGTYFYTAPEIEQGWP--KIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQK 691
Q T Y APE+ IDE+ D++SLG V + + P+ ++ ++ Q
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262
Query: 692 GELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELL------QDALPPQ 734
P + S LL +M+ P RP LL Q P Q
Sbjct: 263 QLSIPQS-PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-50
Identities = 67/314 (21%), Positives = 121/314 (38%), Gaps = 53/314 (16%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQH 484
+ L GGF V ++ GR YA+K++ ++ N I++EV + +L H +
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE--KNRAIIQEVCFMKKLSGHPN 87
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V++ S+A + +E+ + E
Sbjct: 88 IVQFC--------------------------------SAASIGKEESDTGQAEFLLLTEL 115
Query: 545 CPRTLRQVFESY---DHFDKELAWHLFRQIVEGLAHIHGQG--IIHRDLTPNNIFFDARN 599
C L + + + +F Q + H+H Q IIHRDL N+ +
Sbjct: 116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK--IDE 657
IK+ DFG A + D ++ + + + T Y PEI + I E
Sbjct: 176 TIKLCDFGSATTI---SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE 232
Query: 658 KADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714
K D+++LG + + L HPF + +IV P +++ SL+R ++
Sbjct: 233 KQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS-----IPPHDTQYTVFHSLIRAMLQ 287
Query: 715 PSPSDRPSATELLQ 728
+P +R S E++
Sbjct: 288 VNPEERLSIAEVVH 301
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-49
Identities = 77/317 (24%), Positives = 116/317 (36%), Gaps = 71/317 (22%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQ 483
F LGHG G +V + D R AVK+I + REV L +H
Sbjct: 25 SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHP 78
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V+RY+ + + YI +E
Sbjct: 79 NVIRYFCT-EKD---------------------------------------RQFQYIAIE 98
Query: 544 YCPRTLRQVFESYDHFDKEL-AWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND-- 600
C TL++ E D L L +Q GLAH+H I+HRDL P+NI N
Sbjct: 99 LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158
Query: 601 ---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI-- 655
I DFGL K L + + +G GT + APE+ K
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRR------------SGVPGTEGWIAPEMLSEDCKENP 206
Query: 656 DEKADMYSLGIVFFEL----WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR 711
D++S G VF+ + HPF +++RQ + + + L+ +
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEK 266
Query: 712 LMSPSPSDRPSATELLQ 728
+++ P RPSA +L+
Sbjct: 267 MIAMDPQKRPSAKHVLK 283
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-48
Identities = 86/352 (24%), Positives = 129/352 (36%), Gaps = 90/352 (25%)
Query: 410 SGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR 469
S N+ N + LG+G G VV GR AVK++ L D D
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRM-LIDF----CDI 54
Query: 470 ILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTG 528
L E+ L+ H +V+RYY + T
Sbjct: 55 ALMEIKLLTESDDHPNVIRYYCS-ETT--------------------------------- 80
Query: 529 QENKLESTYLYIQMEYCPRTLRQVFESYDHFDKEL-------AWHLFRQIVEGLAHIHGQ 581
+LYI +E C L+ + ES + D+ L L RQI G+AH+H
Sbjct: 81 ------DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 582 GIIHRDLTPNNIFFDARND-------------IKIGDFGLAKFLKLEQLDQDAAFPTDTG 628
IIHRDL P NI + I I DFGL K L ++F T+
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD----SGQSSFRTNLN 190
Query: 629 GVSVDGTGQVGTYFYTAPEI------EQGWPKIDEKADMYSLGIVFFEL----WHPFS-- 676
GT + APE+ Q ++ D++S+G VF+ + HPF
Sbjct: 191 NP-------SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 677 TAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
+ E I+ + +E L+ +++ P RP+A ++L+
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 4e-48
Identities = 79/436 (18%), Positives = 141/436 (32%), Gaps = 83/436 (19%)
Query: 369 SERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEE 428
L + S + Q M S + D S + + S +
Sbjct: 4 HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGT---DDDDKASSSANECISVKGRIYSI 60
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH--QHVV 486
L+ +G GG V N+ + YA+K + L++ D E+A L++LQ ++
Sbjct: 61 LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP 546
R Y + T Y+Y+ ME
Sbjct: 120 RLYD-YEIT---------------------------------------DQYIYMVMECGN 139
Query: 547 RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDF 606
L + D ++ ++E + IH GI+H DL P N +K+ DF
Sbjct: 140 IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDF 198
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----------EQGWPKID 656
G+A DT V D QVG Y PE + KI
Sbjct: 199 GIAN-----------QMQPDTTSVVKD--SQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713
K+D++SLG + + + + PF + + L + + + +L+ +
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCL 305
Query: 714 SPSPSDRPSATELLQD----------ALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSI 763
P R S ELL + E + +L + + K ++
Sbjct: 306 KRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTL 365
Query: 764 FDEETLDMKHHAGTLR 779
++ + H++ + +
Sbjct: 366 YEHYSGGESHNSSSSK 381
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-47
Identities = 71/340 (20%), Positives = 117/340 (34%), Gaps = 73/340 (21%)
Query: 407 SVDSGSPNMSLPSSRYLN-DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP 465
VD G+ N+ S + L+ +G GG V N+ + YA+K + L++
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ 68
Query: 466 VNDRILREVATLSRLQH--QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASS 523
D E+A L++LQ ++R Y + T
Sbjct: 69 TLDSYRNEIAYLNKLQQHSDKIIRLYD-YEIT---------------------------- 99
Query: 524 ADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583
Y+Y+ ME L + D ++ ++E + IH GI
Sbjct: 100 -----------DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFY 643
+H DL P N +K+ DFG+A + SV QVGT Y
Sbjct: 149 VHSDLKPANFLIV-DGMLKLIDFGIANQM-------------QPDTTSVVKDSQVGTVNY 194
Query: 644 TAPEI----------EQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQ 690
PE + KI K+D++SLG + + + + PF + + L +
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254
Query: 691 KGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
+ + +L+ + P R S ELL
Sbjct: 255 PNHEIEFP-DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-47
Identities = 66/321 (20%), Positives = 110/321 (34%), Gaps = 70/321 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH- 482
+ L+ +G GG V N+ + YA+K + L++ D E+A L++LQ
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 483 -QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
++R Y + T Y+Y+
Sbjct: 68 SDKIIRLYD-YEIT---------------------------------------DQYIYMV 87
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
ME L + D ++ ++E + IH GI+H DL P N +
Sbjct: 88 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 146
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----------EQG 651
K+ DFG+A + SV QVGT Y PE +
Sbjct: 147 KLIDFGIANQM-------------QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193
Query: 652 WPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESL 708
KI K+D++SLG + + + + PF + + L + + + +
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 253
Query: 709 LRRLMSPSPSDRPSATELLQD 729
L+ + P R S ELL
Sbjct: 254 LKCCLKRDPKQRISIPELLAH 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-46
Identities = 79/350 (22%), Positives = 142/350 (40%), Gaps = 68/350 (19%)
Query: 390 VFHQKMVSSRVSQFWKPSVDSGSPNMSL--PSSRYLNDFEELQPLGHGGFGHVVLCKNKL 447
+ H SS + +P M + ++ ++ LG G +G V+LC++K+
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 448 DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507
A+K IR S N ++L EVA L L H ++++ Y FE
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-FE------------- 106
Query: 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWH 566
+ Y+ ME L F++ A
Sbjct: 107 --------------------------DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV 140
Query: 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAF 623
+ +Q++ G+ ++H I+HRDL P N+ +++ IKI DFGL+ + ++ ++
Sbjct: 141 IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER-- 198
Query: 624 PTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAME 680
+GT +Y APE+ + K DEK D++S+G++ F L PF +
Sbjct: 199 --------------LGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
Query: 681 RQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
++I+ K K SE + L+++++ R SA + L+
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-46
Identities = 67/321 (20%), Positives = 114/321 (35%), Gaps = 69/321 (21%)
Query: 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATL 477
R+L E+ G G F V + A +++ + + R E L
Sbjct: 23 NDGRFLKFDIEI---GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML 79
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
LQH ++VR+Y +W T
Sbjct: 80 KGLQHPNIVRFYDSWEST------------------------------------VKGKKC 103
Query: 538 LYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG--IIHRDLTPNNIF 594
+ + E TL+ + + ++ RQI++GL +H + IIHRDL +NIF
Sbjct: 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163
Query: 595 FDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGW 652
+KIGD GLA + +V +GT + APE E+ +
Sbjct: 164 ITGPTGSVKIGDLGLATLK------------RASFAKAV-----IGTPEFMAPEMYEEKY 206
Query: 653 PKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFS-EQESL 708
DE D+Y+ G+ E+ +P+S + + G P S+ E + +
Sbjct: 207 ---DESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 709 LRRLMSPSPSDRPSATELLQD 729
+ + + +R S +LL
Sbjct: 263 IEGCIRQNKDERYSIKDLLNH 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 167 bits (423), Expect = 2e-45
Identities = 44/317 (13%), Positives = 88/317 (27%), Gaps = 50/317 (15%)
Query: 431 PLGHGGFGHVVLCKNKLDGRHYAVKKIRL-KDKSLPVNDRILREVATLSRLQHQHVVRYY 489
PL G V L ++ +A+K + + S +R+ +RL +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTL 549
+D + + S + + D N + M L
Sbjct: 129 DRRRLLLPSD--------AVAVQSQPPFAQLSPGQDDYAVAN------YLLLMPAASVDL 174
Query: 550 RQVFESYDHFDK-------ELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+F + D L Q++ A++ +G++H TP+N+F +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLM 234
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI-EQGWPKIDEKADM 661
+GD V G Y E +
Sbjct: 235 LGDVSALW------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNA 276
Query: 662 YSLGIVFFELW---HPF-----STAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRL 712
+ LG+ + +W PF + + L + ++L+ R
Sbjct: 277 WQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336
Query: 713 MSPSPSDRPSATELLQD 729
++ R E ++
Sbjct: 337 LNFDRRRRLLPLEAMET 353
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-45
Identities = 72/326 (22%), Positives = 126/326 (38%), Gaps = 78/326 (23%)
Query: 416 SLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKI-RLKDKSLPVNDRILREV 474
L R + + LG GGF + +A K + + +++ E+
Sbjct: 7 VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI 66
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
+ L HQHVV ++ +FE
Sbjct: 67 SIHRSLAHQHVVGFHG-FFED--------------------------------------- 86
Query: 535 STYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNI 593
+ ++++ +E C R +L ++ + + A + RQIV G ++H +IHRDL N+
Sbjct: 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 594 FFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQG 651
F + ++KIGDFGLA +++ D GT Y APE+ ++G
Sbjct: 147 FLNEDLEVKIGDFGLAT-----KVEYDGERKKVLC----------GTPNYIAPEVLSKKG 191
Query: 652 WPKIDEKADMYSLGIVFFEL---WHPFST----AMERQIVLSDLKQKGELP-PSWVAKFS 703
+ D++S+G + + L PF T +I K E P +
Sbjct: 192 H---SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK------KNEYSIPKHIN--P 240
Query: 704 EQESLLRRLMSPSPSDRPSATELLQD 729
SL+++++ P+ RP+ ELL D
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLND 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 76/324 (23%), Positives = 127/324 (39%), Gaps = 76/324 (23%)
Query: 416 SLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK--SLPVNDRILRE 473
S L DFE +PLG G FG+V L + K A+K + K + V ++ RE
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-KAQLEKAGVEHQLRRE 59
Query: 474 VATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKL 533
V S L+H +++R Y +F
Sbjct: 60 VEIQSHLRHPNILRLYG-YFHD-------------------------------------- 80
Query: 534 ESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
+T +Y+ +EY P T+ + + FD++ ++ L++ H + +IHRD+ P N
Sbjct: 81 -ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 139
Query: 593 IFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652
+ + ++KI DFG + + GT Y PE+ +G
Sbjct: 140 LLLGSAGELKIADFGWSVHAPSSRRT------D-----------LCGTLDYLPPEMIEGR 182
Query: 653 PKIDEKADMYSLGIVFFELWH---PFST----AMERQIVLSDLKQKGELPPSWVAKFSEQ 705
DEK D++SLG++ +E PF ++I + P +V
Sbjct: 183 MH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-----PDFVT--EGA 234
Query: 706 ESLLRRLMSPSPSDRPSATELLQD 729
L+ RL+ +PS RP E+L+
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLEH 258
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-45
Identities = 82/324 (25%), Positives = 141/324 (43%), Gaps = 67/324 (20%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN-DRILRE 473
+ ++ + + ++ + LG G FG V+LCK+K+ G+ AVK I + + + +LRE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 474 VATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKL 533
V L +L H ++++ Y+ FE
Sbjct: 77 VQLLKQLDHPNIMKLYEF-FE--------------------------------------- 96
Query: 534 ESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
+ Y Y+ E L S F + A + RQ++ G+ ++H I+HRDL P N
Sbjct: 97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPEN 156
Query: 593 IFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649
+ ++++ I+I DFGL+ + + +D +GT +Y APE+
Sbjct: 157 LLLESKSKDANIRIIDFGLSTHFEASKKMKDK----------------IGTAYYIAPEVL 200
Query: 650 QGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ- 705
G DEK D++S G++ + L PF+ A E I+ K K K SE
Sbjct: 201 HG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 706 ESLLRRLMSPSPSDRPSATELLQD 729
+ L+R++++ PS R SA + L
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDH 282
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-45
Identities = 74/349 (21%), Positives = 133/349 (38%), Gaps = 80/349 (22%)
Query: 393 QKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHY 452
V++ + P + P S + + LG GGF + +
Sbjct: 12 VPGVAAPGAPAAAPPAKEIPEVLVDPRS--RRRYVRGRFLGKGGFAKCFEISDADTKEVF 69
Query: 453 AVKKI-RLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTL 511
A K + + +++ E++ L HQHVV ++ +FE
Sbjct: 70 AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFED---------------- 112
Query: 512 ASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQ 570
+ ++++ +E C R +L ++ + + A + RQ
Sbjct: 113 -----------------------NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149
Query: 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGV 630
IV G ++H +IHRDL N+F + ++KIGDFGLA +++ D
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-----KVEYDGERKKVLC-- 202
Query: 631 SVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFST----AMER 681
GT Y APE+ ++G + D++S+G + + L PF T
Sbjct: 203 --------GTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251
Query: 682 QIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
+I +K E P + SL+++++ P+ RP+ ELL D
Sbjct: 252 RI------KKNEYSIPKHIN--PVAASLIQKMLQTDPTARPTINELLND 292
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-44
Identities = 65/329 (19%), Positives = 115/329 (34%), Gaps = 34/329 (10%)
Query: 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKI---RLKDKSLPVNDRILREV 474
+ +G G +G V + A+K + +++ + +RI EV
Sbjct: 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79
Query: 475 ATLSRLQHQHVVRYYQAWFETG-----VADFDGDSMWGSGTLAS--STFSNRAASSADVT 527
+ +L H ++ R Y+ +E V + G G L + F + + +
Sbjct: 80 RLMKKLHHPNIARLYEV-YEDEQYICLVMEL----CHG-GHLLDKLNVFIDDSTGKCAMD 133
Query: 528 GQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587
+ ++ + ++L ++ RQI L ++H QGI HRD
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRD 193
Query: 588 LTPNNIFFDARND--IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA 645
+ P N F IK+ DFGL+K + T + GT ++ A
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM-----------TTKAGTPYFVA 242
Query: 646 PEI-EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAK 701
PE+ K D +S G++ L PF + + L +K
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNV 302
Query: 702 FSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
S LL L++ + +R A LQ
Sbjct: 303 LSPLARDLLSNLLNRNVDERFDAMRALQH 331
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-44
Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 66/319 (20%)
Query: 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLS 478
+ + + LG G FG V+ CK+++ + YAVK I ILREV L
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+L H ++++ ++ E +S+
Sbjct: 77 KLDHPNIMKLFEI-LE---------------------------------------DSSSF 96
Query: 539 YIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
YI E L F + A + +Q+ G+ ++H I+HRDL P NI ++
Sbjct: 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156
Query: 598 RND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654
+ IKI DFGL+ + +D +GT +Y APE+ +G
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQNTKMKDR----------------IGTAYYIAPEVLRG--T 198
Query: 655 IDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLR 710
DEK D++S G++ + L PF E I+ K S+ + L+R
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 711 RLMSPSPSDRPSATELLQD 729
++++ PS R +AT+ L+
Sbjct: 259 KMLTFHPSLRITATQCLEH 277
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 76/338 (22%), Positives = 128/338 (37%), Gaps = 99/338 (29%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK---KIRLKDKSLPVNDRIL 471
++ + DF+ LG G F V ++ G A+K K + + R+
Sbjct: 2 LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--MVQRVQ 59
Query: 472 REVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQEN 531
EV +L+H ++ Y +FE
Sbjct: 60 NEVKIHCQLKHPSILELYN-YFED------------------------------------ 82
Query: 532 KLESTYLYIQMEYCPRTLRQVFESYDH-------FDKELAWHLFRQIVEGLAHIHGQGII 584
S Y+Y+ +E C E + F + A H QI+ G+ ++H GI+
Sbjct: 83 ---SNYVYLVLEMCHNG-----EMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL 134
Query: 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV-----G 639
HRDLT +N+ +IKI DFGLA + + G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLA--------------------TQLKMPHEKHYTLCG 174
Query: 640 TYFYTAPEIEQGWPKI-DEKADMYSLGIVFFEL---WHPFST----AMERQIVLSDLKQK 691
T Y +PEI ++D++SLG +F+ L PF T ++VL+D +
Sbjct: 175 TPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM- 231
Query: 692 GELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
PS+++ E + L+ +L+ +P+DR S + +L
Sbjct: 232 ----PSFLS--IEAKDLIHQLLRRNPADRLSLSSVLDH 263
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-44
Identities = 78/384 (20%), Positives = 147/384 (38%), Gaps = 86/384 (22%)
Query: 392 HQKMVSSRVSQFWKPSVDSGSPNMSL--PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDG 449
H S + + +P M + + + +++ LG G +G V+LCK K
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 450 RHYAVKKIRLKDKSLPVN-----------DRILREVATLSRLQHQHVVRYYQAWFETGVA 498
A+K I+ + I E++ L L H ++++ + FE
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF-DVFE---- 116
Query: 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD 557
+ Y Y+ E+ L + +
Sbjct: 117 -----------------------------------DKKYFYLVTEFYEGGELFEQIINRH 141
Query: 558 HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND---IKIGDFGLAKFLKL 614
FD+ A ++ +QI+ G+ ++H I+HRD+ P NI + +N IKI DFGL+ F
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 615 EQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL--- 671
+ +D +GT +Y APE+ + K +EK D++S G++ + L
Sbjct: 202 DYKLRDR----------------LGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCG 243
Query: 672 WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD- 729
+ PF ++ I+ K K + S++ + L++ +++ + R +A E L
Sbjct: 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303
Query: 730 ------ALPPQMEYELLDNILRMM 747
+ + + L L M
Sbjct: 304 WIKKYANNINKSDQKTLCGALSNM 327
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 75/332 (22%), Positives = 127/332 (38%), Gaps = 75/332 (22%)
Query: 412 SPNMSLPSSRYLNDFEEL-QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI 470
S +L ++D + LG G FG V L + + G +K I KD+S ++I
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN-KDRSQVPMEQI 67
Query: 471 LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQE 530
E+ L L H ++++ ++ FE
Sbjct: 68 EAEIEVLKSLDHPNIIKIFEV-FED----------------------------------- 91
Query: 531 NKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGII 584
+YI ME C R + + L +Q++ LA+ H Q ++
Sbjct: 92 ----YHNMYIVMETCEGGELLER-IVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVV 146
Query: 585 HRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTY 641
H+DL P NI F + IKI DFGLA+ K ++ +A GT
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA----------------AGTA 190
Query: 642 FYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSW 698
Y APE+ + + K D++S G+V + L PF+ ++ ++
Sbjct: 191 LYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248
Query: 699 VAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
+ Q LL+++++ P RPSA ++L
Sbjct: 249 -RPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-42
Identities = 70/322 (21%), Positives = 127/322 (39%), Gaps = 86/322 (26%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN--DRILREVATLSRL 480
++DF+ +PLG G FG+V L + K + A+K + K + ++ RE+ S L
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHL 71
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+H +++R Y +F +Y+
Sbjct: 72 RHPNILRMYN-YFHD---------------------------------------RKRIYL 91
Query: 541 QMEYCPRTLRQVFESYDH------FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
+E+ PR E Y FD++ + ++ + L + H + +IHRD+ P N+
Sbjct: 92 MLEFAPRG-----ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654
+ ++KI DFG + + T GT Y PE+ +G
Sbjct: 147 MGYKGELKIADFGWSVHAPSLRRR------T-----------MCGTLDYLPPEMIEGKTH 189
Query: 655 IDEKADMYSLGIVFFELWH---PF--STAME--RQIVLSDLKQKGELPPSWVAKFSEQES 707
DEK D++ G++ +E PF + E R+IV DLK P +++ +
Sbjct: 190 -DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF-----PPFLS--DGSKD 241
Query: 708 LLRRLMSPSPSDRPSATELLQD 729
L+ +L+ P R +++
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEH 263
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 72/311 (23%), Positives = 126/311 (40%), Gaps = 78/311 (25%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKI---RLKDKSLPVNDRILREVATLSRLQHQHVVRY 488
+G G +G V + K A KKI ++D DR +E+ + L H +++R
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-----DRFKQEIEIMKSLDHPNIIRL 71
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRT 548
Y+ FE +T +Y+ ME C T
Sbjct: 72 YET-FED---------------------------------------NTDIYLVMELC--T 89
Query: 549 LRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND---IK 602
++FE F + A + + ++ +A+ H + HRDL P N F + +K
Sbjct: 90 GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLK 149
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
+ DFGLA K ++ + VGT +Y +P++ +G + D +
Sbjct: 150 LIDFGLAARFKPGKMMRTK----------------VGTPYYVSPQVLEG--LYGPECDEW 191
Query: 663 SLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPS 718
S G++ + L + PFS + +++L + P S Q ESL+RRL++ SP
Sbjct: 192 SAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPK 251
Query: 719 DRPSATELLQD 729
R ++ + L+
Sbjct: 252 QRITSLQALEH 262
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-41
Identities = 71/368 (19%), Positives = 127/368 (34%), Gaps = 73/368 (19%)
Query: 369 SERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEE 428
S + LAS + + + + + + ++
Sbjct: 7 SGQAHSLASLAKT----WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRY 488
+G G FG V K+K G AVKK+RL+ + E+ + L +V
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPL 115
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-R 547
Y G+ E ++ I ME
Sbjct: 116 Y-----------------GA-----------------------VREGPWVNIFMELLEGG 135
Query: 548 TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR-NDIKIGDF 606
+L Q+ + ++ A + Q +EGL ++H + I+H D+ +N+ + + + DF
Sbjct: 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666
G A L D + G + GT + APE+ G P D K D++S
Sbjct: 196 GHAL-----CLQPDGLGKSLLTGDYI-----PGTETHMAPEVVMGKPC-DAKVDIWSSCC 244
Query: 667 VFFELW---HPFSTAMERQIVL---SDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
+ + HP++ + L S+ E+PPS ++ ++ + P R
Sbjct: 245 MMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ---AIQEGLRKEPVHR 301
Query: 721 PSATELLQ 728
SA EL +
Sbjct: 302 ASAMELRR 309
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 4e-41
Identities = 48/383 (12%), Positives = 102/383 (26%), Gaps = 59/383 (15%)
Query: 368 FSERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSP-NMSLPSSRYLNDF 426
F G + + ++ + + + M S+ S ++G P +
Sbjct: 16 FQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTL 75
Query: 427 EELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVV 486
LG + ++ G + V ++ + ++E RL
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP 546
+ + FD + V E + +
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMI------------RVRLDERDMWVLSRFFLYPRMQ 183
Query: 547 RTLRQVFES-------YDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
L+ E + L Q++ LA +H G++H L P +I D R
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----------E 649
+ + F +D A + + PE+
Sbjct: 244 GVFLTGFEHLV--------RDGARVVS-----------SVSRGFEPPELEARRATISYHR 284
Query: 650 QGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQE 706
+ D ++LG+V + +W P + + +P +
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP--VR----- 337
Query: 707 SLLRRLMSPSPSDRPSATELLQD 729
+LL + DR + ++
Sbjct: 338 ALLEGFLRYPKEDRLLPLQAMET 360
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 79/331 (23%), Positives = 132/331 (39%), Gaps = 74/331 (22%)
Query: 413 PNMSLPSSRYLNDFEEL----QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND 468
+ + + F E LG G FG V+ CK+++ + YAVK I
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 469 RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTG 528
ILREV L +L H ++++ ++ E
Sbjct: 67 TILREVELLKKLDHPNIMKLFEI-LED--------------------------------- 92
Query: 529 QENKLESTYLYIQMEYCPRTLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIH 585
S+ YI E T ++F+ F + A + +Q+ G+ ++H I+H
Sbjct: 93 ------SSSFYIVGELY--TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 586 RDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF 642
RDL P NI +++ IKI DFGL+ + +D +GT +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR----------------IGTAY 188
Query: 643 YTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWV 699
Y APE+ +G DEK D++S G++ + L PF E I+ K
Sbjct: 189 YIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246
Query: 700 AKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
S+ + L+R++++ PS R +AT+ L+
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-41
Identities = 78/351 (22%), Positives = 123/351 (35%), Gaps = 84/351 (23%)
Query: 395 MVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAV 454
M++ + P P + ++ LG GGFG V D A+
Sbjct: 2 MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAI 61
Query: 455 KKIR----LKDKSLPVNDRILREVATLSRL----QHQHVVRYYQAWFETGVADFDGDSMW 506
K I L L + EVA L ++ H V+R WFET
Sbjct: 62 KVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD-WFET----------- 109
Query: 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVF---ESYDHFDKEL 563
+ +E P + +F +
Sbjct: 110 ----------------------------QEGFMLVLER-PLPAQDLFDYITEKGPLGEGP 140
Query: 564 AWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAA 622
+ F Q+V + H H +G++HRD+ NI D R K+ DFG L D
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH------DEP 194
Query: 623 FPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAM 679
+ GT Y+ PE A ++SLGI+ +++ PF
Sbjct: 195 YTD-----------FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-- 241
Query: 680 ERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
+++I+ + EL P+ V+ + +L+RR ++P PS RPS E+L D
Sbjct: 242 DQEIL------EAELHFPAHVSP--DCCALIRRCLAPKPSSRPSLEEILLD 284
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-41
Identities = 84/390 (21%), Positives = 146/390 (37%), Gaps = 101/390 (25%)
Query: 405 KPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK---KIRLKD 461
+P ++ Y + + PLG G FG V +K + VK K ++ +
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 462 KSL---PVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSN 518
P ++ E+A LSR++H ++++ FE
Sbjct: 65 DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-FEN----------------------- 100
Query: 519 RAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH------FDKELAWHLFRQIV 572
+ + ME L + + D+ LA ++FRQ+V
Sbjct: 101 ----------------QGFFQLVMEKHGSGL----DLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 573 EGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSV 632
+ ++ + IIHRD+ NI IK+ DFG A +L+ + F T
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-----RGKLFYT------- 188
Query: 633 DGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLK 689
GT Y APE+ G P + +M+SLG+ + L +PF +L+
Sbjct: 189 ----FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF----------CELE 234
Query: 690 Q--KGEL-PPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP--QMEYELLDNIL 744
+ + + PP V+ E SL+ L+ P P R + +L+ D P L D
Sbjct: 235 ETVEAAIHPPYLVS--KELMSLVSGLLQPVPERRTTLEKLVTD---PWVTQPVNLAD--- 286
Query: 745 RMMHSSEDTSIYDKVVSSIFDEETLDMKHH 774
++ E+ +K S + +L+M +
Sbjct: 287 ---YTWEEVFRVNKPESGVLSAASLEMGNR 313
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 70/331 (21%), Positives = 128/331 (38%), Gaps = 68/331 (20%)
Query: 409 DSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND 468
+ + L ++ + LG G +G V ++ + A+K+I +D +
Sbjct: 7 EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY--SQ 64
Query: 469 RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTG 528
+ E+A L+H+++V+Y GS
Sbjct: 65 PLHEEIALHKHLKHKNIVQYL-----------------GS-------------------- 87
Query: 529 QENKLESTYLYIQMEYCPR-TLRQVFESYD---HFDKELAWHLFRQIVEGLAHIHGQGII 584
E+ ++ I ME P +L + S +++ +QI+EGL ++H I+
Sbjct: 88 ---FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 585 HRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFY 643
HRD+ +N+ + + +KI DFG +K L + + GT Y
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLA----------GINPCTETF-----TGTLQY 189
Query: 644 TAPE-IEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWV 699
APE I++G + AD++SLG E+ PF E Q + + ++ P
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIP 248
Query: 700 AKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
S + ++ + + P P R A +LL D
Sbjct: 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 67/331 (20%), Positives = 131/331 (39%), Gaps = 86/331 (25%)
Query: 416 SLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVA 475
S+ ++ F ++ LG G F V L K +L G+ +A+K I K + + E+A
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIA 58
Query: 476 TLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLES 535
L +++H+++V +E+ +
Sbjct: 59 VLKKIKHENIVTLED-IYES---------------------------------------T 78
Query: 536 TYLYIQMEYCPRTLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
T+ Y+ M+ + ++F+ + ++ A + +Q++ + ++H GI+HRDL P N
Sbjct: 79 THYYLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 593 IFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649
+ + + I I DFGL+K + + + GT Y APE+
Sbjct: 137 LLYLTPEENSKIMITDFGLSKMEQNGIM-----------------STACGTPGYVAPEVL 179
Query: 650 QGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGEL---PPSW----- 698
P + D +S+G++ + L + PF E + L + ++G P W
Sbjct: 180 AQKP-YSKAVDCWSIGVITYILLCGYPPFYE--ETESKLFEKIKEGYYEFESPFWDDISE 236
Query: 699 VAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
AK + L+ P++R + + L
Sbjct: 237 SAK-----DFICHLLEKDPNERYTCEKALSH 262
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 4e-40
Identities = 55/387 (14%), Positives = 108/387 (27%), Gaps = 52/387 (13%)
Query: 370 ERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNM--SLPSSRYLNDFE 427
+ G + + ++ + + + M S+ S ++G P S R
Sbjct: 23 DPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR-TLV 81
Query: 428 ELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVV 486
LG + ++ G + V ++ ++ EV L L+
Sbjct: 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141
Query: 487 RYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP 546
+ + D + V E + +
Sbjct: 142 KQAKVHLRFIFPF---DLVKDPQK----------KKMIRVRLDERDMWVLSRFFLYPRMQ 188
Query: 547 RTLRQVFE---SYDHFDKELAWH----LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
L+ E S+ K L H L Q++ LA +H G++H L P +I D R
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP----KI 655
+ + F A+ + G TA + +
Sbjct: 249 GVFLTGFEHLVRD-------GASAVSPIGRG-------FAPPETTAERMLPFGQHHPTLM 294
Query: 656 DEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRL 712
D ++LG+ + +W P + + +P +LL
Sbjct: 295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPV-------RALLEGF 347
Query: 713 MSPSPSDRPSATELLQDALPPQMEYEL 739
+ DR + ++ Q+ EL
Sbjct: 348 LRYPKEDRLLPLQAMETPEYEQLRTEL 374
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 77/360 (21%), Positives = 126/360 (35%), Gaps = 81/360 (22%)
Query: 384 NKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPS-SRYLNDFEELQPLGHGGFGHVVL 442
+ + H + R S + + + ++ LG GGFG V
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61
Query: 443 CKNKLDGRHYAVK---KIRLKDKS-LPVNDRILREVATLSRLQHQ--HVVRYYQAWFETG 496
D A+K K R+ D LP R+ EV L ++ V+R WFE
Sbjct: 62 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFER- 119
Query: 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVF--- 553
+ +E P ++ +F
Sbjct: 120 --------------------------------------PDSFVLILER-PEPVQDLFDFI 140
Query: 554 ESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA-RNDIKIGDFGLAKFL 612
+ELA F Q++E + H H G++HRD+ NI D R ++K+ DFG L
Sbjct: 141 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
Query: 613 KLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL- 671
K D + GT Y+ PE + A ++SLGI+ +++
Sbjct: 201 K------DTVYTD-----------FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243
Query: 672 --WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
PF + +I+ + V+ SE + L+R ++ PSDRP+ E+
Sbjct: 244 CGDIPFEH--DEEIIRGQVF-----FRQRVS--SECQHLIRWCLALRPSDRPTFEEIQNH 294
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 73/321 (22%), Positives = 131/321 (40%), Gaps = 65/321 (20%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREV 474
M++P ++ D++ +Q LG G +G V L N++ AVK + +++ + I +E+
Sbjct: 1 MAVP---FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEI 56
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
L H++VV++Y
Sbjct: 57 CINKMLNHENVVKFYGHR-RE--------------------------------------- 76
Query: 535 STYLYIQMEYCPRTLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPN 591
Y+ +EYC ++F+ + A F Q++ G+ ++HG GI HRD+ P
Sbjct: 77 GNIQYLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 592 NIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651
N+ D R+++KI DFGLA + +++ GT Y APE+ +
Sbjct: 135 NLLLDERDNLKISDFGLATVFR--YNNRERLLNK-----------MCGTLPYVAPELLKR 181
Query: 652 WPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESL 708
E D++S GIV + P+ + SD K+K W S +L
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 709 LRRLMSPSPSDRPSATELLQD 729
L +++ +PS R + ++ +D
Sbjct: 242 LHKILVENPSARITIPDIKKD 262
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 58/350 (16%), Positives = 111/350 (31%), Gaps = 99/350 (28%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ + LG G +V ++K G +A+K L D +RE L +L H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHK 67
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+ + E + + + ME
Sbjct: 68 NIVKLFAI-EEET-------------------------------------TTRHKVLIME 89
Query: 544 YCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF---- 595
+CP T+ + + + + R +V G+ H+ GI+HR++ P NI
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
D ++ K+ DFG A+ L+ D F + GT Y P++ +
Sbjct: 150 DGQSVYKLTDFGAARE-----LEDDEQFVS-----------LYGTEEYLHPDMYERAVLR 193
Query: 656 -------DEKADMYSLGIVFFELWH---PFSTA---------MERQI------VLSDLKQ 690
D++S+G+ F+ PF M + I +S +++
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253
Query: 691 KGELPPSWVAKF-----------SEQESLLRRLMSPSPSDRPSATELLQD 729
P W +L ++ + +
Sbjct: 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 68/324 (20%), Positives = 118/324 (36%), Gaps = 74/324 (22%)
Query: 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK---KIRLKDKSLPVNDRILREVAT 476
++ + + LG G +G V + AVK K +L+ + +E+
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPN-GEANVKKEIQL 59
Query: 477 LSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST 536
L RL+H++V++ DV E K
Sbjct: 60 LRRLRHKNVIQLV-----------------------------------DVLYNEEK---Q 81
Query: 537 YLYIQMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
+Y+ MEYC ++++ +S F A F Q+++GL ++H QGI+H+D+ P N+
Sbjct: 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL 141
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654
+KI G+A+ L D T G+ + PEI G
Sbjct: 142 LTTGGTLKISALGVAEA--LHPFAADDTCRT-----------SQGSPAFQPPEIANGLDT 188
Query: 655 ID-EKADMYSLGIVFFEL---WHPFS----TAMERQIVLSDLKQKGELP-PSWVAKFSEQ 705
K D++S G+ + + +PF + I KG P
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI------GKGSYAIPGDCG--PPL 240
Query: 706 ESLLRRLMSPSPSDRPSATELLQD 729
LL+ ++ P+ R S ++ Q
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQH 264
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 86/387 (22%), Positives = 151/387 (39%), Gaps = 98/387 (25%)
Query: 411 GSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK---KIRLKDKSLPVN 467
S ++ ++ L+ +G G F V L ++ L GR A+K K +L SL
Sbjct: 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL--- 58
Query: 468 DRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVT 527
++ REV + L H ++V+ ++ ET
Sbjct: 59 QKLFREVRIMKILNHPNIVKLFEVI-ET-------------------------------- 85
Query: 528 GQENKLESTYLYIQMEYCPRTLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGII 584
LY+ MEY +VF+ ++ ++ A FRQIV + + H + I+
Sbjct: 86 -------EKTLYLIMEYASG--GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYT 644
HRDL N+ DA +IKI DFG + + D G Y
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-------LDA---------FCGAPPYA 180
Query: 645 APEIEQGWPKIDEKADMYSLGIVFFEL---WHPFS----TAMERQIVLSDLKQKGELP-P 696
APE+ QG + D++SLG++ + L PF + +++ +G+ P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL------RGKYRIP 234
Query: 697 SWVAKFSEQESLLRRLMSPSPSDRPSATELLQD----------ALPPQMEYELL---DNI 743
+++ + E+LL+R + +P R + ++++D L P +E EL
Sbjct: 235 FYMST--DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKR 292
Query: 744 LRMMHS--SEDTSIYDKVVSSIFDEET 768
+ +M I + + +DE T
Sbjct: 293 IDIMVGMGYSQEEIQESLSKMKYDEIT 319
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 72/351 (20%), Positives = 136/351 (38%), Gaps = 82/351 (23%)
Query: 405 KPSVDSGSPNMSLPSSRYLNDFEEL---QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD 461
P+ ++ ++ + +L + +G G FG V + + G AVK + +D
Sbjct: 15 IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQD 72
Query: 462 KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAA 521
+ LREVA + RL+H ++V + G
Sbjct: 73 FHAERVNEFLREVAIMKRLRHPNIVLFM------GA------------------------ 102
Query: 522 SSADVTGQENKLESTYLYIQMEYCPR-TLRQVF---ESYDHFDKELAWHLFRQIVEGLAH 577
VT N L I EY R +L ++ + + D+ + + +G+ +
Sbjct: 103 ----VTQPPN------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 578 IHGQG--IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGT 635
+H + I+HR+L N+ D + +K+ DFGL++ +
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST---------------FLSSK 197
Query: 636 GQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKG 692
GT + APE+ + P +EK+D+YS G++ +EL P+ Q+V + +
Sbjct: 198 SAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256
Query: 693 --ELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE-------LLQDALPPQ 734
E+P + + + ++ + P RPS L++ A+PP
Sbjct: 257 RLEIPRNLNPQVAA---IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 70/348 (20%), Positives = 120/348 (34%), Gaps = 102/348 (29%)
Query: 416 SLPSSRYLNDFEEL----QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP------ 465
+LP S + F E + LG G V C +K + YAVK I +
Sbjct: 5 ALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ 64
Query: 466 -VNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASS 523
+ + L+EV L ++ H ++++ +ET
Sbjct: 65 ELREATLKEVDILRKVSGHPNIIQLKDT-YET---------------------------- 95
Query: 524 ADVTGQENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577
+T+ ++ + +V ++ + R ++E +
Sbjct: 96 -----------NTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICA 139
Query: 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637
+H I+HRDL P NI D +IK+ DFG + L + ++
Sbjct: 140 LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV---------------- 183
Query: 638 VGTYFYTAPEI-----EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLK 689
GT Y APEI P ++ DM+S G++ + L PF +Q+++ +
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--RKQMLMLRMI 241
Query: 690 QKGEL---PPSW-----VAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
G P W K L+ R + P R +A E L
Sbjct: 242 MSGNYQFGSPEWDDYSDTVK-----DLVSRFLVVQPQKRYTAEEALAH 284
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 79/363 (21%), Positives = 144/363 (39%), Gaps = 66/363 (18%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREV 474
M++P ++ D++ +Q LG G +G V L N++ AVK + +++ + I +E+
Sbjct: 1 MAVP---FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEI 56
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
L H++VV++Y
Sbjct: 57 CINKMLNHENVVKFYGHR-RE--------------------------------------- 76
Query: 535 STYLYIQMEYCPRTLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPN 591
Y+ +EYC ++F+ + A F Q++ G+ ++HG GI HRD+ P
Sbjct: 77 GNIQYLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 592 NIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651
N+ D R+++KI DFGLA + +++ GT Y APE+ +
Sbjct: 135 NLLLDERDNLKISDFGLATVFR--YNNRERLLNK-----------MCGTLPYVAPELLKR 181
Query: 652 WPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESL 708
E D++S GIV + P+ + SD K+K W S +L
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 709 LRRLMSPSPSDRPSATELLQDA-LPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEE 767
L +++ +PS R + ++ +D ++ + SE S + K + S D
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFS 301
Query: 768 TLD 770
++
Sbjct: 302 PVN 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 4e-38
Identities = 69/390 (17%), Positives = 128/390 (32%), Gaps = 109/390 (27%)
Query: 376 ASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEEL----QP 431
S +K+ ++ S P LP +F +
Sbjct: 42 RSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV 101
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLK------DKSLPVNDRILREVATLSRL-QHQH 484
+G G V C ++ G +AVK + + ++ V + RE L ++ H H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++ + +E+ S+++++ +
Sbjct: 162 IITLIDS-YES---------------------------------------SSFMFLVFDL 181
Query: 545 CP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
+V ++ + R ++E ++ +H I+HRDL P NI D
Sbjct: 182 MRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN 236
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI--- 655
I++ DFG + L+ + ++ GT Y APEI +
Sbjct: 237 MQIRLSDFGFSCHLEPGEKLREL----------------CGTPGYLAPEILKCSMDETHP 280
Query: 656 --DEKADMYSLGIVFFEL-------WHPFSTAMERQIVLSDLKQKGEL---PPSW----- 698
++ D+++ G++ F L WH M R I +G+ P W
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI------MEGQYQFSSPEWDDRSS 334
Query: 699 VAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
K L+ RL+ P R +A + LQ
Sbjct: 335 TVK-----DLISRLLQVDPEARLTAEQALQ 359
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 78/327 (23%), Positives = 125/327 (38%), Gaps = 83/327 (25%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-Q 481
D ++L +G G +G V +K G+ AVK+IR ++L ++ + R
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSD 79
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
++V++Y A F +GD +I
Sbjct: 80 CPYIVQFYGALFR------EGD----------------------------------CWIC 99
Query: 542 MEYC----PRTLRQVFESYDHFDKE--LAWHLFRQIVEGLAHIHGQG-IIHRDLTPNNIF 594
ME + + V+ D E L + V+ L H+ IIHRD+ P+NI
Sbjct: 100 MELMSTSFDKFYKYVYSVLDDVIPEEILG-KITLATVKALNHLKENLKIIHRDIKPSNIL 158
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWP 653
D +IK+ DFG++ QL S+ T G Y APE I+
Sbjct: 159 LDRSGNIKLCDFGISG-----QLVD-----------SIAKTRDAGCRPYMAPERIDPSAS 202
Query: 654 KI--DEKADMYSLGIVFFEL---------WHPFSTAMERQIVLSDLKQKGELPPSWVAKF 702
+ D ++D++SLGI +EL W+ + Q+V D Q L S +F
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT-QVVKGDPPQ---LSNSEEREF 258
Query: 703 SEQ-ESLLRRLMSPSPSDRPSATELLQ 728
S + + ++ S RP ELL+
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLK 285
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-38
Identities = 66/338 (19%), Positives = 111/338 (32%), Gaps = 70/338 (20%)
Query: 411 GSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI 470
G ++ +E + LG GGFG+V+ ++ G A+K+ R ++ S +R
Sbjct: 1 GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERW 59
Query: 471 LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQE 530
E+ + +L H +VV + + +
Sbjct: 60 CLEIQIMKKLNHPNVVSAREV-PDG---------------------------------LQ 85
Query: 531 NKLESTYLYIQMEYCPR-TLRQVFESYDH---FDKELAWHLFRQIVEGLAHIHGQGIIHR 586
+ + MEYC LR+ +++ + L I L ++H IIHR
Sbjct: 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR 145
Query: 587 DLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFY 643
DL P NI KI D G AK LDQ VGT Y
Sbjct: 146 DLKPENIVLQPGPQRLIHKIIDLGYAKE-----LDQGELCTE-----------FVGTLQY 189
Query: 644 TAPEIEQGWPKIDEKADMYSLGIVFFEL------WHPFSTAMERQIVLSDLKQKGELPPS 697
APE+ + K D +S G + FE + P ++ +++K
Sbjct: 190 LAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIV 245
Query: 698 WVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735
++ + P+P+ + M
Sbjct: 246 V--YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM 281
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-38
Identities = 55/357 (15%), Positives = 120/357 (33%), Gaps = 109/357 (30%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKI---------------RLKDKSLP 465
+Y+ND+ ++ L G F ++LC+ + YA+KK K
Sbjct: 28 KYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 466 VNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSAD 525
D E+ ++ +++++ +
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEG-IITN------------------------------ 114
Query: 526 VTGQENKLESTYLYIQMEYCP---------RTLRQVFESYDHFDKELAWHLFRQIVEGLA 576
+YI EY ++ + + ++ +
Sbjct: 115 ---------YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFS 165
Query: 577 HIHGQ-GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGT 635
+IH + I HRD+ P+NI D +K+ DFG ++++ +++
Sbjct: 166 YIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI-----------------K 208
Query: 636 GQVGTYFYTAPEIEQGWPKID-EKADMYSLGIVFFEL---WHPFST-----AMERQIVLS 686
G GTY + PE + K D++SLGI + + PFS + I
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268
Query: 687 DLK--------------QKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
+++ +K ++++ +E L+ + +P++R ++ + L+
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLS--NEDIDFLKLFLRKNPAERITSEDALKH 323
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 68/331 (20%), Positives = 127/331 (38%), Gaps = 89/331 (26%)
Query: 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLS 478
S+++ ++++ + LG G F V C +K G +A K I K S ++ RE
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+LQH ++VR + + + ++
Sbjct: 61 KLQHPNIVRLHDS-IQE---------------------------------------ESFH 80
Query: 539 YIQMEYCPRTLRQVFESYD------HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
Y+ + E ++ + + A H +QI+E +A+ H GI+HR+L P N
Sbjct: 81 YLVFDLVTG-----GELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 135
Query: 593 IFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649
+ ++ +K+ DFGLA + + GT Y +PE+
Sbjct: 136 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGF----------------AGTPGYLSPEVL 179
Query: 650 QGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGEL---PPSW----- 698
+ P + D+++ G++ + L + PF E Q L + G P W
Sbjct: 180 KKDP-YSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGAYDYPSPEWDTVTP 236
Query: 699 VAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
AK SL+ +++ +P R +A + L+
Sbjct: 237 EAK-----SLIDSMLTVNPKKRITADQALKV 262
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-37
Identities = 57/350 (16%), Positives = 111/350 (31%), Gaps = 99/350 (28%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ + LG G +V ++K G +A+K L D +RE L +L H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHK 67
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+ + E + + + ME
Sbjct: 68 NIVKLFAI-EEET-------------------------------------TTRHKVLIME 89
Query: 544 YCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF---- 595
+CP T+ + + + + R +V G+ H+ GI+HR++ P NI
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
D ++ K+ DFG A+ L+ D F + GT Y P++ +
Sbjct: 150 DGQSVYKLTDFGAARE-----LEDDEQFVS-----------LYGTEEYLHPDMYERAVLR 193
Query: 656 -------DEKADMYSLGIVFFEL------WHPFSTAMERQIVL------------SDLKQ 690
D++S+G+ F+ + PF + V+ S +++
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK 253
Query: 691 KGELPPSWVAKF-----------SEQESLLRRLMSPSPSDRPSATELLQD 729
P W +L ++ + +
Sbjct: 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 71/318 (22%), Positives = 114/318 (35%), Gaps = 72/318 (22%)
Query: 425 DFEELQ---PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ 481
++ +G G FG V K K G AVK + + + EV L + +
Sbjct: 22 PDGQITVGQRIGSGSFGTV--YKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +++ + G T + L I
Sbjct: 79 HVNILLFM------GY----------------------------STAPQ-------LAIV 97
Query: 542 MEYCPR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
++C +L + + F+ + + RQ G+ ++H + IIHRDL NNIF N
Sbjct: 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN 157
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDE 657
+KIGDFGLA G+ + APE+ Q
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQF-------------EQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM- 713
++D+Y+ GIV +EL P+S R ++ + +G L P S ++RLM
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-GRGSLSPDLSKVRSNCPKRMKRLMA 263
Query: 714 ---SPSPSDRPSATELLQ 728
+RPS +L
Sbjct: 264 ECLKKKRDERPSFPRILA 281
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 86/371 (23%), Positives = 140/371 (37%), Gaps = 91/371 (24%)
Query: 379 PSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRY--LNDFEEL-QPLGHG 435
SS + ++ Q M S S P S P+ + S L+DF E+ LG G
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASA--APGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64
Query: 436 GFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFET 495
V CK K + YA+K ++ + E+ L RL H ++++ + FET
Sbjct: 65 ATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKE-IFET 119
Query: 496 GVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE- 554
T + + +E T ++F+
Sbjct: 120 ---------------------------------------PTEISLVLELV--TGGELFDR 138
Query: 555 --SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND---IKIGDFGLA 609
++ + A +QI+E +A++H GI+HRDL P N+ + +KI DFGL+
Sbjct: 139 IVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198
Query: 610 KFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFF 669
K ++ + L + GT Y APEI +G + DM+S+GI+ +
Sbjct: 199 KIVEHQVLMKTV----------------CGTPGYCAPEILRGCA-YGPEVDMWSVGIITY 241
Query: 670 EL---WHPFSTAMERQIVLSDLKQKGEL---PPSW-----VAKFSEQESLLRRLMSPSPS 718
L + PF + E P W AK L+R+L+ P
Sbjct: 242 ILLCGFEPFY-DERGDQFMFRRILNCEYYFISPWWDEVSLNAK-----DLVRKLIVLDPK 295
Query: 719 DRPSATELLQD 729
R + + LQ
Sbjct: 296 KRLTTFQALQH 306
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-37
Identities = 72/331 (21%), Positives = 131/331 (39%), Gaps = 82/331 (24%)
Query: 416 SLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVA 475
++ +R+ +++ + LG G F V C L G+ YA I K S + ++ RE
Sbjct: 3 TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62
Query: 476 TLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLES 535
L+H ++VR +
Sbjct: 63 ICRLLKHPNIVRLHD-SISE---------------------------------------E 82
Query: 536 TYLYIQMEYCPRTLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
+ Y+ + T ++FE + +++ + A H +QI+E + H H G++HR+L P N
Sbjct: 83 GHHYLIFDLV--TGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPEN 140
Query: 593 IFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649
+ ++ +K+ DFGLA ++ EQ G GT Y +PE+
Sbjct: 141 LLLASKLKGAAVKLADFGLAIEVEGEQ---------------QAWFGFAGTPGYLSPEVL 185
Query: 650 QGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGEL---PPSW----- 698
+ P + D+++ G++ + L + PF E Q L + G P W
Sbjct: 186 RKDP-YGKPVDLWACGVILYILLVGYPPFWD--EDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 699 VAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
AK L+ ++++ +PS R +A E L+
Sbjct: 243 EAK-----DLINKMLTINPSKRITAAEALKH 268
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 70/355 (19%), Positives = 125/355 (35%), Gaps = 98/355 (27%)
Query: 411 GSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK---KIRLKDKSLPVN 467
GS S + LN + +G G +G V L N+ D +YA+K K +L ++
Sbjct: 1 GSSGSSGDCVQ-LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPR 59
Query: 468 ---------------------DRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506
+++ +E+A L +L H +VV+ +
Sbjct: 60 RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL-------------- 105
Query: 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH--FDKELA 564
+ +LY+ E + V E ++ A
Sbjct: 106 ------------------------DDPNEDHLYMVFELVNQ--GPVMEVPTLKPLSEDQA 139
Query: 565 WHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFP 624
F+ +++G+ ++H Q IIHRD+ P+N+ IKI DFG++ K DA
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK----GSDALLS 195
Query: 625 TDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI--DEKADMYSLGIVFFELWH---PFS--- 676
VGT + APE KI + D++++G+ + PF
Sbjct: 196 N-----------TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 677 -TAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
+ +I + L P + + L+ R++ +P R E+
Sbjct: 245 IMCLHSKI------KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 61/309 (19%), Positives = 108/309 (34%), Gaps = 76/309 (24%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
LG G FG V C + Y K +++K + +E++ L+ +H++++ +++
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHES 69
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP----- 546
FE+ L + E+
Sbjct: 70 -FES---------------------------------------MEELVMIFEFISGLDIF 89
Query: 547 -RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND--IKI 603
R + S ++ Q+ E L +H I H D+ P NI + R IKI
Sbjct: 90 ER----INTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKI 145
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
+FG A+ LK + Y APE+ Q + DM+S
Sbjct: 146 IEFGQARQLKPGDNFRLL----------------FTAPEYYAPEVHQHDV-VSTATDMWS 188
Query: 664 LGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSD 719
LG + + L +PF +QI+ + + + + S + + RL+
Sbjct: 189 LGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248
Query: 720 RPSATELLQ 728
R +A+E LQ
Sbjct: 249 RMTASEALQ 257
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-37
Identities = 74/351 (21%), Positives = 132/351 (37%), Gaps = 96/351 (27%)
Query: 411 GSPNMSLPSSRYLN------DFEEL----QPLGHGGFGHVVLCKNKLDGRHYAVKKI--- 457
GSP +S L+ FE++ + +G G F V C N+ G+ +AVK +
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 458 RLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFS 517
+ + + RE + L+H H+V + + +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLET-YSS---------------------- 97
Query: 518 NRAASSADVTGQENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQI 571
LY+ E+ +++ + + + A H RQI
Sbjct: 98 -----------------DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV-ASHYMRQI 139
Query: 572 VEGLAHIHGQGIIHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTG 628
+E L + H IIHRD+ P+ + ++ + +K+G FG+A L +
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG----ESGLVA----- 190
Query: 629 GVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPF---STAMERQ 682
G+VGT + APE+ + P + D++ G++ F L PF +
Sbjct: 191 ------GGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG 243
Query: 683 IVLSDLKQKGEL---PPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
I KG+ P W + SE + L+RR++ P++R + E L
Sbjct: 244 I------IKGKYKMNPRQW-SHISESAKDLVRRMLMLDPAERITVYEALNH 287
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-37
Identities = 72/333 (21%), Positives = 118/333 (35%), Gaps = 90/333 (27%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRY 488
LG G V C N + + YAVK I + + + R+ REV L + Q H++V+
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-- 546
+ FE E Y+ E
Sbjct: 77 IEF-FE---------------------------------------EEDRFYLVFEKMRGG 96
Query: 547 ----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND-- 600
++ HF++ A + + + L +H +GI HRDL P NI + N
Sbjct: 97 SILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVS 151
Query: 601 -IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPKI 655
+KI DF L +KL + P + G+ Y APE+ +
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTP--------ELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 656 DEKADMYSLGIVFF----------------ELWHPFSTAMERQIVLSDLKQKGEL---PP 696
D++ D++SLG++ + W Q +L + Q+G+
Sbjct: 204 DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263
Query: 697 SWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQ 728
W A S + L+ +L+ R SA ++LQ
Sbjct: 264 DW-AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-37
Identities = 66/345 (19%), Positives = 117/345 (33%), Gaps = 102/345 (29%)
Query: 418 PSSRYLNDFEEL----QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK------DKSLPVN 467
S Y + + LG G G V L + + A++ I + +
Sbjct: 125 DQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPA 184
Query: 468 DRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVT 527
+ E+ L +L H +++ +
Sbjct: 185 LNVETEIEILKKLNHPCIIKIKNFF----------------------------------- 209
Query: 528 GQENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581
++ YI +E + + + F Q++ + ++H
Sbjct: 210 ------DAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN 258
Query: 582 GIIHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV 638
GIIHRDL P N+ ++ + IKI DFG +K L + +
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG------ETSLMRTL----------C 302
Query: 639 GTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFS-----TAMERQIVLSDL 688
GT Y APE+ G + D +SLG++ F + PFS +++ QI
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----- 357
Query: 689 KQKGEL---PPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
G+ P W A+ SE+ L+++L+ P R + E L+
Sbjct: 358 -TSGKYNFIPEVW-AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-36
Identities = 72/364 (19%), Positives = 136/364 (37%), Gaps = 74/364 (20%)
Query: 378 KPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEEL-QPLGHGG 436
+ ++ V + VSS + P ++ D ++ + LG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 437 FGHVVLCKNKLDGRHYAVKKI---RLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWF 493
FG V + G ++A K + DK + + +E+ T+S L+H +V + A F
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEIQTMSVLRHPTLVNLHDA-F 223
Query: 494 ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP--RTLRQ 551
E + + E+ +
Sbjct: 224 ED---------------------------------------DNEMVMIYEFMSGGELFEK 244
Query: 552 VFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR--NDIKIGDFGLA 609
V + ++ ++ A RQ+ +GL H+H +H DL P NI F + N++K+ DFGL
Sbjct: 245 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 610 KFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFF 669
L +Q + GT + APE+ +G P + DM+S+G++ +
Sbjct: 305 AHLDPKQSVKVT----------------TGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSY 347
Query: 670 EL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATE 725
L PF + + + + + S + SE + +R+L+ P+ R + +
Sbjct: 348 ILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 407
Query: 726 LLQD 729
L+
Sbjct: 408 ALEH 411
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 75/354 (21%), Positives = 130/354 (36%), Gaps = 97/354 (27%)
Query: 420 SRYLNDFEELQ---PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVAT 476
S ++ D++E++ +G G FG V CK K + A+K+I + + E+
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESES----ERKAFIVELRQ 54
Query: 477 LSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST 536
LSR+ H ++V+ Y A
Sbjct: 55 LSRVNHPNIVKLYGACLNP----------------------------------------- 73
Query: 537 YLYIQMEYCPR-TLRQVF---ESYDHFDKELAWHLFRQIVEGLAHIHG---QGIIHRDLT 589
+ + MEY +L V E ++ A Q +G+A++H + +IHRDL
Sbjct: 74 -VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 590 PNNIFFDARND-IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648
P N+ A +KI DFG A ++ T G+ + APE+
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTHM------------------TNNKGSAAWMAPEV 174
Query: 649 EQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKG---ELPPSWVAKF 702
+G EK D++S GI+ +E+ PF + G L +
Sbjct: 175 FEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 703 SEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIY 756
L+ R S PS RPS E+++ ++ +++R +++ Y
Sbjct: 234 ES---LMTRCWSKDPSQRPSMEEIVK----------IMTHLMRYFPGADEPLQY 274
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 74/340 (21%), Positives = 128/340 (37%), Gaps = 76/340 (22%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEEL--QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS 463
VD G+ N+ S N+F L + LG G F V C +K G+ YA K ++ + +
Sbjct: 9 SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG 68
Query: 464 LPVNDRILREVATLSRLQHQ-HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAAS 522
IL E+A L + V+ ++ +E
Sbjct: 69 QDCRAEILHEIAVLELAKSCPRVINLHEV-YEN--------------------------- 100
Query: 523 SADVTGQENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLA 576
++ + + +EY L ++ E D L +QI+EG+
Sbjct: 101 ------------TSEIILILEYAAGGEIFSLCLPELAEMVSEND---VIRLIKQILEGVY 145
Query: 577 HIHGQGIIHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633
++H I+H DL P NI + IKI DFG+++ + ++
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI------------ 193
Query: 634 GTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQ 690
+GT Y APEI P I DM+++GI+ + L PF ++ L+ +
Sbjct: 194 ----MGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248
Query: 691 KGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
+ + S+ ++ L+ +P RP+A L
Sbjct: 249 NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 69/339 (20%), Positives = 119/339 (35%), Gaps = 88/339 (25%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK------DKSLPVND 468
MS+ +++ + LG G G V L + + A+K I + +
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 469 RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTG 528
+ E+ L +L H +++ +
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFF------------------------------------ 84
Query: 529 QENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582
++ YI +E + + + F Q++ + ++H G
Sbjct: 85 -----DAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG 134
Query: 583 IIHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639
IIHRDL P N+ ++ + IKI DFG +K L L + G
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL----------------CG 178
Query: 640 TYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGEL 694
T Y APE+ G + D +SLG++ F + PFS Q+ L D G+
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQVSLKDQITSGKY 237
Query: 695 ---PPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
P W A+ SE+ L+++L+ P R + E L+
Sbjct: 238 NFIPEVW-AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 73/344 (21%), Positives = 134/344 (38%), Gaps = 89/344 (25%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP 465
+ GS M S+++ ++++ + LG G F V C +K G +A K I K S
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70
Query: 466 VNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSAD 525
++ RE +LQH ++VR + + +
Sbjct: 71 DFQKLEREARICRKLQHPNIVRLHDS-IQE------------------------------ 99
Query: 526 VTGQENKLESTYLYIQMEYCPRTLRQVFESYD------HFDKELAWHLFRQIVEGLAHIH 579
++ Y+ + E ++ + + A H +QI+E +A+ H
Sbjct: 100 ---------ESFHYLVFDLVTG-----GELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 580 GQGIIHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTG 636
GI+HR+L P N+ ++ +K+ DFGLA + + A+ G
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----AW-----------HG 189
Query: 637 QVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGE 693
GT Y +PE+ + P + D+++ G++ + L + PF E Q L + G
Sbjct: 190 FAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWD--EDQHRLYAQIKAGA 246
Query: 694 L---PPSW-----VAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
P W AK SL+ +++ +P R +A + L+
Sbjct: 247 YDYPSPEWDTVTPEAK-----SLIDSMLTVNPKKRITADQALKV 285
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 79/320 (24%), Positives = 126/320 (39%), Gaps = 68/320 (21%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL---KDKSLPVNDRILREVATL 477
RY E + LG GG V L ++ D R AVK +R +D S R RE
Sbjct: 13 RY----ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSF--YLRFRREAQNA 66
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+ L H +V Y D G+
Sbjct: 67 AALNHPAIVAVY-----------------------------------DT-GEAETPAGPL 90
Query: 538 LYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
YI MEY TLR + + + A + + L H GIIHRD+ P NI
Sbjct: 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
A N +K+ DFG+A+ + T T V +GT Y +PE +G +D
Sbjct: 151 ATNAVKVMDFGIARA-----IADSGNSVTQTAAV-------IGTAQYLSPEQARGDS-VD 197
Query: 657 EKADMYSLGIVFFELW---HPFS--TAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLR 710
++D+YSLG V +E+ PF+ + + + +++ P + S ++++
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDPIPPSARHEGLSADLDAVVL 255
Query: 711 RLMSPSPSDRP-SATELLQD 729
+ ++ +P +R +A E+ D
Sbjct: 256 KALAKNPENRYQTAAEMRAD 275
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 64/321 (19%), Positives = 115/321 (35%), Gaps = 88/321 (27%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRY 488
Q LG G G V+ C ++ G+ A+K + S + +EV + H+V
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLL---YDS----PKARQEVDHHWQASGGPHIVCI 87
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-- 546
+E L I ME
Sbjct: 88 LDV-YENMHH-----------------------------------GKRCLLIIMECMEGG 111
Query: 547 ----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND-- 600
R + +++ + A + R I + +H I HRD+ P N+ + ++
Sbjct: 112 ELFSRIQERGDQAFTERE---AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA 168
Query: 601 -IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDE 657
+K+ DFG AK L T +Y APE+ + + D+
Sbjct: 169 VLKLTDFGFAKETTQNAL-----------------QTPCYTPYYVAPEVLGPEKY---DK 208
Query: 658 KADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQ--KGEL---PPSWVAKFSEQ-ESL 708
DM+SLG++ + L + PF + + I ++ G+ P W ++ SE + L
Sbjct: 209 SCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW-SEVSEDAKQL 267
Query: 709 LRRLMSPSPSDRPSATELLQD 729
+R L+ P++R + T+ +
Sbjct: 268 IRLLLKTDPTERLTITQFMNH 288
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-36
Identities = 71/320 (22%), Positives = 122/320 (38%), Gaps = 81/320 (25%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKI---RLKDKSLPVNDRILREVATLSRLQ 481
+ + LG G FG V C+ G A K I +KDK + + E++ +++L
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK-----EEVKNEISVMNQLD 144
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H ++++ Y A FE+ + +
Sbjct: 145 HANLIQLYDA-FES---------------------------------------KNDIVLV 164
Query: 542 MEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
MEY R + + + + + +QI EG+ H+H I+H DL P NI
Sbjct: 165 MEYVDGGELFDRIIDESY----NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220
Query: 596 DAR--NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653
R IKI DFGLA+ K + + GT + APE+
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVN----------------FGTPEFLAPEVVNYDF 264
Query: 654 KIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLL 709
+ DM+S+G++ + L PF + + + + L + +L SE+ + +
Sbjct: 265 -VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323
Query: 710 RRLMSPSPSDRPSATELLQD 729
+L+ S R SA+E L+
Sbjct: 324 SKLLIKEKSWRISASEALKH 343
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-36
Identities = 60/251 (23%), Positives = 107/251 (42%), Gaps = 29/251 (11%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ + LG G FG V + G+ +A+KK+ + RE+ + L H ++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNI 62
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
++ ++ TG D + N ++ + N ++ YL + MEY
Sbjct: 63 IKLVDYFYTTG--DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 546 PRTLRQVFESYDHFDKELAWHLFR----QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
P TL +V +S+ + + +L Q+ + IH GI HRD+ P N+ +++++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 602 -KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
K+ DFG AK L + + + FY APE+ G + D
Sbjct: 181 LKLCDFGSAKKLIPSE----------------PSVAYICSRFYRAPELMLGATEYTPSID 224
Query: 661 MYSLGIVFFEL 671
++S+G VF EL
Sbjct: 225 LWSIGCVFGEL 235
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 67/315 (21%), Positives = 120/315 (38%), Gaps = 80/315 (25%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKI---RLKDKSLPVN-DRILREVATLSRLQHQHVVR 487
LG G F V C+ K G+ YA K I RL V+ + I REV L ++H +++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP- 546
+ FE T + + +E
Sbjct: 73 LHDI-FEN---------------------------------------KTDVVLILELVSG 92
Query: 547 -----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN-- 599
+ + ++ A +QI++G+ ++H + I H DL P NI +N
Sbjct: 93 GELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVP 147
Query: 600 --DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
IK+ DFG+A ++ ++ GT + APEI P +
Sbjct: 148 NPRIKLIDFGIAHKIEAGNEFKNI----------------FGTPEFVAPEIVNYEP-LGL 190
Query: 658 KADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLM 713
+ADM+S+G++ + L PF +++ + + + + + SE + +RRL+
Sbjct: 191 EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLL 250
Query: 714 SPSPSDRPSATELLQ 728
P R + + L+
Sbjct: 251 VKDPKRRMTIAQSLE 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-36
Identities = 76/404 (18%), Positives = 149/404 (36%), Gaps = 79/404 (19%)
Query: 410 SGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR 469
+ + +P + ++ ++ +G G FG L ++KL AVK I ++ +++
Sbjct: 6 VTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDEN 62
Query: 470 ILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQ 529
+ RE+ L+H ++VR+ + T
Sbjct: 63 VQREIINHRSLRHPNIVRFKEVI-LT---------------------------------- 87
Query: 530 ENKLESTYLYIQMEYCPRTLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586
T+L I MEY +++E + F ++ A F+Q++ G+++ H I HR
Sbjct: 88 -----PTHLAIIMEYASG--GELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHR 140
Query: 587 DLTPNNIFFDA--RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYT 644
DL N D +KI DFG +K + + VGT Y
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSV-----LHSQPKS-----------TVGTPAYI 184
Query: 645 APEIEQGWPKIDEKADMYSLGIVFFEL---WHPF----STAMERQIVLSDLKQKGELPPS 697
APE+ + AD++S G+ + + +PF R+ + L K +P
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244
Query: 698 -WVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIY 756
++ E L+ R+ P+ R S E+ L +++ ++
Sbjct: 245 IRIS--PECCHLISRIFVADPATRISIPEIKTH---SWFLKNLPADLMNESNTGSQFQEP 299
Query: 757 DKVVSSIFDEETLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDY 800
++ + S+ + + +R + DLD ++ D+
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDF 343
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-36
Identities = 74/313 (23%), Positives = 120/313 (38%), Gaps = 74/313 (23%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKI---RLKDKSLPVN-DRILREVATLSRLQHQHVVR 487
LG G F V C+ K G YA K I R K V+ + I REV+ L +QH +V+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
++ +E T + + +E
Sbjct: 79 LHEV-YEN---------------------------------------KTDVILILELV-- 96
Query: 548 TLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN----D 600
++F+ + +E A +QI+ G+ ++H I H DL P NI RN
Sbjct: 97 AGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
IKI DFGLA + ++ GT + APEI P + +AD
Sbjct: 157 IKIIDFGLAHKIDFGNEFKNI----------------FGTPEFVAPEIVNYEP-LGLEAD 199
Query: 661 MYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPS 716
M+S+G++ + L PF +++ + + E + + S + +RRL+
Sbjct: 200 MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 259
Query: 717 PSDRPSATELLQD 729
P R + + LQ
Sbjct: 260 PKKRMTIQDSLQH 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 73/324 (22%), Positives = 125/324 (38%), Gaps = 81/324 (25%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVA-TLSRLQ 481
+D E + LG G +G V ++ G+ AVK+IR + R+L ++ ++ +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVD 64
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
V +Y A F +GD ++I
Sbjct: 65 CPFTVTFYGALFR------EGD----------------------------------VWIC 84
Query: 542 MEYCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG-IIHRDLTPNNIFFD 596
ME + +QV + +++ + IV+ L H+H + +IHRD+ P+N+ +
Sbjct: 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI- 655
A +K+ DFG++ L D A D G Y APE
Sbjct: 145 ALGQVKMCDFGISG-----YLVDDVAKDID-----------AGCKPYMAPERINPELNQK 188
Query: 656 --DEKADMYSLGIVFFEL------WHPFSTAME--RQIVLSDLKQKGELPPSWVAKFSEQ 705
K+D++SLGI EL + + T + +Q+V Q LP KFS +
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ---LPAD---KFSAE 242
Query: 706 -ESLLRRLMSPSPSDRPSATELLQ 728
+ + + +RP+ EL+Q
Sbjct: 243 FVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-36
Identities = 64/323 (19%), Positives = 115/323 (35%), Gaps = 80/323 (24%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-Q 481
+ND E L +G G G V + + G AVK++R + N RIL ++ + +
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLKSHD 82
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
++V+ + + + D ++I
Sbjct: 83 CPYIVQCFGTFIT------NTD----------------------------------VFIA 102
Query: 542 MEYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARN 599
ME ++ + + + + IV+ L ++ + G+IHRD+ P+NI D R
Sbjct: 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG 162
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI---- 655
IK+ DFG++ +L G Y APE
Sbjct: 163 QIKLCDFGISG-----RLVD-----------DKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 656 DEKADMYSLGIVFFEL---------WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ- 705
D +AD++SLGI EL + +++ + LP FS
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLT-KVLQEEPPL---LPGH--MGFSGDF 260
Query: 706 ESLLRRLMSPSPSDRPSATELLQ 728
+S ++ ++ RP +LL+
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLE 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 66/316 (20%), Positives = 120/316 (37%), Gaps = 80/316 (25%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVK---KIRLKDKSLPVN-DRILREVATLSRLQHQHVVR 487
LG G F V C+ K G YA K K + + V+ + I REV+ L ++ H +V+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP- 546
+ +E T + + +E
Sbjct: 80 LHDV-YEN---------------------------------------RTDVVLILELVSG 99
Query: 547 -----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN-- 599
++ + +E A +QI++G+ ++H + I H DL P NI +N
Sbjct: 100 GELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154
Query: 600 --DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
IK+ DFGLA ++ ++ GT + APEI P +
Sbjct: 155 IPHIKLIDFGLAHEIEDGVEFKNI----------------FGTPEFVAPEIVNYEP-LGL 197
Query: 658 KADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLM 713
+ADM+S+G++ + L PF +++ + + + + + SE + +R+L+
Sbjct: 198 EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLL 257
Query: 714 SPSPSDRPSATELLQD 729
R + E L+
Sbjct: 258 VKETRKRLTIQEALRH 273
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 69/369 (18%), Positives = 133/369 (36%), Gaps = 82/369 (22%)
Query: 376 ASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEEL-QPLGH 434
+ +K + + + +F++ P + D+ ++ + LG
Sbjct: 4 SHHHHHHGSKVRGK--YDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGS 61
Query: 435 GGFGHVVLCKNKLDGRHYAVKKI---RLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
G FG V C K GR + K I DK + E++ +++L H ++ + A
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINTPYPLDK-----YTVKNEISIMNQLHHPKLINLHDA 116
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRT--- 548
FE + + +E+ +
Sbjct: 117 -FED---------------------------------------KYEMVLILEFL--SGGE 134
Query: 549 L--RQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR--NDIKIG 604
L R E Y + E + RQ EGL H+H I+H D+ P NI + + + +KI
Sbjct: 135 LFDRIAAEDYKMSEAE-VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 193
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGLA L +++ + T + APEI P + DM+++
Sbjct: 194 DFGLATKLNPDEIVKVT----------------TATAEFAAPEIVDREP-VGFYTDMWAI 236
Query: 665 GIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDR 720
G++ + L PF+ + + + + + E + S + + ++ L+ P R
Sbjct: 237 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 296
Query: 721 PSATELLQD 729
+ + L+
Sbjct: 297 LTVHDALEH 305
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 70/385 (18%), Positives = 134/385 (34%), Gaps = 95/385 (24%)
Query: 397 SSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQ---PLGHGGFGHVVLCKNKLDGRHYA 453
+S S + S+ + FE+L+ +G G FG V + G A
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQV--YHGRWHG-EVA 59
Query: 454 VKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLAS 513
++ I ++ + REV + +H++VV + G
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM------GA---------------- 97
Query: 514 STFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVF-ESYDHFDKELAWHLFRQI 571
+ L I C TL V ++ D + ++I
Sbjct: 98 ------------CMSPPH------LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 572 VEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVS 631
V+G+ ++H +GI+H+DL N+F+D + I DFGL + Q +
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR----------E 188
Query: 632 VDGTGQVGTYFYTAPEIEQGWPKI--------DEKADMYSLGIVFFELWH---PFSTAME 680
Q G + APEI + + +D+++LG +++EL PF T
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
Query: 681 RQI---VLSDLKQKGELPPSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQDALPP 733
I + + +K L + K + ++ + +RP+ T+L+
Sbjct: 249 EAIIWQMGTGMKP--NLSQIGMGK------EISDILLFCWAFEQEERPTFTKLM------ 294
Query: 734 QMEYELLDNILRMMHSSEDTSIYDK 758
++L+ + + + K
Sbjct: 295 ----DMLEKLPKRNRRLSHPGHFWK 315
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-35
Identities = 68/324 (20%), Positives = 125/324 (38%), Gaps = 93/324 (28%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRY 488
+PLG G F C +K + +AVK I + + +E+ L + H ++V+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKL 71
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-- 546
++ F + ++ ME
Sbjct: 72 HEV-FHD---------------------------------------QLHTFLVMELLNGG 91
Query: 547 ----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND-- 600
R ++ HF + A ++ R++V ++H+H G++HRDL P N+ F ND
Sbjct: 92 ELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146
Query: 601 -IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDE 657
IKI DFG A+ + T T Y APE+ + G+ DE
Sbjct: 147 EIKIIDFGFARLKP----PDNQPLKT-----------PCFTLHYAAPELLNQNGY---DE 188
Query: 658 KADMYSLGIVFFEL---WHPFSTAMERQIVLSDLK-----QKGEL---PPSWVAKFSEQ- 705
D++SLG++ + + PF + S ++ +KG+ +W S++
Sbjct: 189 SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW-KNVSQEA 247
Query: 706 ESLLRRLMSPSPSDRPSATELLQD 729
+ L++ L++ P+ R + L +
Sbjct: 248 KDLIQGLLTVDPNKRLKMSGLRYN 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 52/320 (16%), Positives = 96/320 (30%), Gaps = 79/320 (24%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
L L G + K + G VK ++++D S + E L H
Sbjct: 9 FKQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+V+ G + + +
Sbjct: 67 PNVLPVL------GAC--------------------------------QSPPAPHPTLIT 88
Query: 543 EYCPR-TLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQG--IIHRDLTPNNIFFDA 597
+ P +L V + D+ A + G+A +H I L ++ D
Sbjct: 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE 148
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK--I 655
+I + G++ + APE Q P+
Sbjct: 149 DMTARISMADVKFSF--------------------QSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 656 DEKADMYSLGIVFFELW---HPFS--TAME--RQIVLSDLKQKGELPPSWVAKFSEQESL 708
ADM+S ++ +EL PF+ + ME ++ L L+ +PP S+ L
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIPPGISPHVSK---L 243
Query: 709 LRRLMSPSPSDRPSATELLQ 728
++ M+ P+ RP ++
Sbjct: 244 MKICMNEDPAKRPKFDMIVP 263
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-35
Identities = 77/384 (20%), Positives = 135/384 (35%), Gaps = 96/384 (25%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKI-RLKDKSLPVNDRILREVATLSRLQHQHVVRYYQ 490
LG G FG V L + + A+K I R K ++ R+ RE++ L L+H H+++ Y
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 491 AWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLR 550
T T + + +EY L
Sbjct: 77 VI-TT---------------------------------------PTDIVMVIEYAGGELF 96
Query: 551 QVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
++ F+QI+ + + H I+HRDL P N+ D ++KI DFGL+
Sbjct: 97 DYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN 156
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFE 670
+ T G+ Y APE+ G + D++S GIV +
Sbjct: 157 IMT-----DGNFLKT-----------SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYV 200
Query: 671 L---WHPFS----TAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPS 722
+ PF + +++ P +++ +SL+RR++ P R +
Sbjct: 201 MLVGRLPFDDEFIPNLFKKV------NSCVYVMPDFLS--PGAQSLIRRMIVADPMQRIT 252
Query: 723 ATELLQD---------ALPPQMEY-------ELLDNILRMMHSSEDTSIYDKVVSSIFDE 766
E+ +D L P E ++ + M SED I + + S +E
Sbjct: 253 IQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDY-IVEALRSDENNE 311
Query: 767 ET------LDMKHHAGTLRLNRDN 784
+ + L + +
Sbjct: 312 VKEAYNLLHENQVIQEKLEHHHHH 335
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-35
Identities = 66/312 (21%), Positives = 123/312 (39%), Gaps = 74/312 (23%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKI---RLKDKSLPVN-DRILREVATLSRLQHQHVVR 487
LG G F V C+ K G YA K I + + V + I REV+ L ++ H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
+ +E T + + +E
Sbjct: 80 LHDV-YEN---------------------------------------RTDVVLILELV-- 97
Query: 548 TLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN----D 600
+ ++F+ + +E A +QI++G+ ++H + I H DL P NI +N
Sbjct: 98 SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
IK+ DFGLA ++ ++ GT + APEI P + +AD
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNI----------------FGTPEFVAPEIVNYEP-LGLEAD 200
Query: 661 MYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPS 716
M+S+G++ + L PF +++ + + + + ++ SE + +R+L+
Sbjct: 201 MWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKE 260
Query: 717 PSDRPSATELLQ 728
R + E L+
Sbjct: 261 TRKRLTIQEALR 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-35
Identities = 70/350 (20%), Positives = 123/350 (35%), Gaps = 99/350 (28%)
Query: 405 KPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL 464
V S + S ++ + +E + +G G + C +K +AVK I DKS
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSK 59
Query: 465 PVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASS 523
E+ L R QH +++ ++
Sbjct: 60 ---RDPTEEIEILLRYGQHPNIITLKDV-YDD---------------------------- 87
Query: 524 ADVTGQENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577
Y+Y+ E + LRQ F + A + I + + +
Sbjct: 88 -----------GKYVYVVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEY 131
Query: 578 IHGQGIIHRDLTPNNIFFDARND----IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633
+H QG++HRDL P+NI + + I+I DFG AK L+ E
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-----GLLMTP------ 180
Query: 634 GTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPF-STAMERQIVLSD 687
T + APE+ QG+ D D++SLG++ + + + PF + + +
Sbjct: 181 ----CYTANFVAPEVLERQGY---DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233
Query: 688 LKQKGEL---PPSW-----VAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
G+ W AK L+ +++ P R +A +L+
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAK-----DLVSKMLHVDPHQRLTAALVLRH 278
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 67/340 (19%), Positives = 120/340 (35%), Gaps = 88/340 (25%)
Query: 412 SPNMSLPSSRYLNDFEEL-QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRI 470
+ + + ++D++ Q LG G G V+ NK +A+K + +
Sbjct: 49 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDC----PKA 101
Query: 471 LREVATLSRLQ-HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQ 529
REV R H+VR +E A
Sbjct: 102 RREVELHWRASQCPHIVRIVDV-YENLYA------------------------------- 129
Query: 530 ENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583
L I ME R + +++ + A + + I E + ++H I
Sbjct: 130 ----GRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---ASEIMKSIGEAIQYLHSINI 182
Query: 584 IHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
HRD+ P N+ + ++ +K+ DFG AK T
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP----------------CYT 226
Query: 641 YFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL-------WHPFSTAMERQIVLSDLKQK 691
+Y APE+ + + D+ DM+SLG++ + L + A+ + +
Sbjct: 227 PYYVAPEVLGPEKY---DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
Query: 692 GELP-PSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
E P P W ++ SE+ + L+R L+ P+ R + TE +
Sbjct: 284 YEFPNPEW-SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 64/342 (18%), Positives = 109/342 (31%), Gaps = 93/342 (27%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
D L+ +G G +G V + G + AVK +D+ + E+ L+H++
Sbjct: 9 DITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDEKSWFRET---ELYNTVMLRHEN 63
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++ + M ST L++ Y
Sbjct: 64 ILGFI------------ASDMTSRH------------------------SSTQLWLITHY 87
Query: 545 CPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ--------GIIHRDLTPNNIFF 595
+L + D + I GLAH+H + I HRDL NI
Sbjct: 88 HEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
I D GLA D +VGT Y APE+ ++
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGN-----------NPRVGTKRYMAPEVLDETIQV 195
Query: 656 D-----EKADMYSLGIVFFELW-------------HPFSTAMERQIVLSDLK----QKG- 692
D ++ D+++ G+V +E+ PF + D++
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 693 --ELPPSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQ 728
+P W + + L +LM +PS R +A + +
Sbjct: 256 RPNIPNRWFS--DPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 83/321 (25%), Positives = 130/321 (40%), Gaps = 75/321 (23%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL---KDKSLPVNDRILREVATL 477
RY + + LG GG V L ++ + A+K I + + + R REV
Sbjct: 12 RY----KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEET--LKRFEREVHNS 65
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
S+L HQ++V DV +E+
Sbjct: 66 SQLSHQNIVSMI-----------------------------------DV-DEEDDCY--- 86
Query: 538 LYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
Y+ MEY TL + ES+ + A + QI++G+ H H I+HRD+ P NI D
Sbjct: 87 -YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+ +KI DFG+AK L L T T V +GT Y +PE +G D
Sbjct: 146 SNKTLKIFDFGIAKALSETSL-------TQTNHV-------LGTVQYFSPEQAKGEA-TD 190
Query: 657 EKADMYSLGIVFFELW---HPFS--TAMERQIVLSDLKQKGELPPSWVAKF--SEQESLL 709
E D+YS+GIV +E+ PF+ TA+ I + ++ + V K +++
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAV--SIAIKHIQDSVPNVTTDVRKDIPQSLSNVI 248
Query: 710 RRLMSPSPSDRP-SATELLQD 729
R ++R + E+ D
Sbjct: 249 LRATEKDKANRYKTIQEMKDD 269
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 71/313 (22%), Positives = 120/313 (38%), Gaps = 84/313 (26%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKI-RLKDKSLPVNDRILREVATLSRLQHQHVVRYYQ 490
LG G FG V + +++L G AVK + R K +SL V +I RE+ L +H H+++ YQ
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 491 AWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLR 550
T T ++ MEY
Sbjct: 79 VI-ST---------------------------------------PTDFFMVMEYVSGG-- 96
Query: 551 QVFESYDH------FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
E +D+ ++ A LF+QI+ + + H ++HRDL P N+ DA + KI
Sbjct: 97 ---ELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 153
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGL+ + T G+ Y APE+ G + D++S
Sbjct: 154 DFGLSNMMS-----DGEFLRT-----------SCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 665 GIVFFELWH---PFS----TAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPS 716
G++ + L PF + ++I + G P ++ +LL ++
Sbjct: 198 GVILYALLCGTLPFDDEHVPTLFKKI------RGGVFYIPEYLN--RSVATLLMHMLQVD 249
Query: 717 PSDRPSATELLQD 729
P R + ++ +
Sbjct: 250 PLKRATIKDIREH 262
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 75/363 (20%), Positives = 120/363 (33%), Gaps = 97/363 (26%)
Query: 407 SVDSGSPNMSLPSSRYLNDFEELQ---PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS 463
S SGS LP +++Q +G G +G V K G AVK +++
Sbjct: 18 SQSSGS-GSGLPLLVQRTIAKQIQMVKQIGKGRYGEV--WMGKWRGEKVAVKVFFTTEEA 74
Query: 464 LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASS 523
+ E+ ++H++++ + AD G W
Sbjct: 75 SWFRET---EIYQTVLMRHENILGFI------A-ADIKGTGSW----------------- 107
Query: 524 ADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ- 581
T LY+ +Y +L +S D + L V GL H+H +
Sbjct: 108 ------------TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 582 -------GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG 634
I HRDL NI I D GLA F +DT V +
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK-----------FISDTNEVDIPP 203
Query: 635 TGQVGTYFYTAPEIEQGWPKI-----DEKADMYSLGIVFFELW-------------HPFS 676
+VGT Y PE+ ADMYS G++ +E+ P+
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 677 TAMERQIVLSDLK----QKG---ELPPSWVAKFSEQESLLRRLM----SPSPSDRPSATE 725
+ D++ K P W + E + +LM + +P+ R +A
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD--ECLRQMGKLMTECWAHNPASRLTALR 321
Query: 726 LLQ 728
+ +
Sbjct: 322 VKK 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 67/372 (18%), Positives = 120/372 (32%), Gaps = 97/372 (26%)
Query: 398 SRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQ---PLGHGGFGHVVLCKNKLDGRHYAV 454
+ + SGS LP + +G G FG V + K G AV
Sbjct: 14 TTLKDLIYDMTTSGS-GSGLPLLVQRTIARTIVLQESIGKGRFGEV--WRGKWRGEEVAV 70
Query: 455 KKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASS 514
K +++ + E+ L+H++++ + +GT
Sbjct: 71 KIFSSREER---SWFREAEIYQTVMLRHENILGFI------------AADNKDNGT---- 111
Query: 515 TFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVE 573
T L++ +Y +L Y E L
Sbjct: 112 --------------------WTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTAS 150
Query: 574 GLAHIHGQ--------GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPT 625
GLAH+H + I HRDL NI I D GLA D A
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA--- 207
Query: 626 DTGGVSVDGTGQVGTYFYTAPEIEQGWPKI-----DEKADMYSLGIVFFELW-------- 672
+VGT Y APE+ + ++AD+Y++G+VF+E+
Sbjct: 208 --------PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 673 -----HPFSTAMERQIVLSDLK----QKG---ELPPSWVAKFSEQESLLRRLM----SPS 716
P+ + + +++ ++ +P W + E ++ ++M +
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS--CEALRVMAKIMRECWYAN 317
Query: 717 PSDRPSATELLQ 728
+ R +A + +
Sbjct: 318 GAARLTALRIKK 329
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 71/344 (20%), Positives = 124/344 (36%), Gaps = 82/344 (23%)
Query: 409 DSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND 468
S + +R +D+E + +G G V A+K+I L +K D
Sbjct: 2 SEDSSALPWSINR--DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-EKCQTSMD 58
Query: 469 RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTG 528
+L+E+ +S+ H ++V YY ++ D +W
Sbjct: 59 ELLKEIQAMSQCHHPNIVSYYTSFV-------VKDELW---------------------- 89
Query: 529 QENKLESTYLYIQMEYCP---------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579
+ M+ + + D+ + R+++EGL ++H
Sbjct: 90 -----------LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ-- 637
G IHRD+ NI ++I DFG+ +AF G ++ + +
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGV------------SAFLATGGDITRNKVRKTF 186
Query: 638 VGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---------WHP----FSTAMERQIV 684
VGT + APE+ + D KAD++S GI EL + P T
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 685 LSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
L Q E+ + F + ++ + P RP+A ELL+
Sbjct: 247 LETGVQDKEMLKKYGKSFRK---MISLCLQKDPEKRPTAAELLR 287
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-33
Identities = 74/356 (20%), Positives = 130/356 (36%), Gaps = 92/356 (25%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP 465
VD G+ N+ + + +E L +G G +G V+ C+NK GR A+KK D
Sbjct: 10 SGVDLGTENLY---FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM 66
Query: 466 VNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSAD 525
V +RE+ L +L+H+++V +
Sbjct: 67 VKKIAMREIKLLKQLRHENLVNLL-----------------------------------E 91
Query: 526 VTGQENKLESTYLYIQMEYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGII 584
V ++ + Y+ E+ T+ E + + D ++ QI+ G+ H II
Sbjct: 92 VCKKKKRW-----YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYT 644
HRD+ P NI +K+ DFG A+ L A P + +V T +Y
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTL---------AAPGEV------YDDEVATRWYR 191
Query: 645 APEIEQGWPKIDEKADMYSLGIVFFELWH-----PFSTAMERQIVL-------------- 685
APE+ G K + D++++G + E++ P + ++ Q+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQE 250
Query: 686 --SDLKQ-KGELPPSWVAKFSEQE----------SLLRRLMSPSPSDRPSATELLQ 728
+ G P + + L ++ + P RP ELL
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306
|
| >3net_A Histidyl-tRNA synthetase; aminoacyl-tRNA synthetase, ligase, structural genomics, PSI- nostoc, protein structure initiative; 2.70A {Nostoc SP} Length = 465 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-33
Identities = 72/483 (14%), Positives = 157/483 (32%), Gaps = 91/483 (18%)
Query: 790 YSDLDTELRDYVVQVTKEMFRQHCAKHLE---IEPMYLL------GDCPQFK-------- 832
+ + L Y++ + ++ + +E +E + +L GD +
Sbjct: 21 FLPSEKRLELYLLDTIRRVYESYGFTPIETPAVERLEVLQAKGNQGDNIIYGLEPILPPN 80
Query: 833 --RNTVKLLTHGGDLLELSHELRLPFIRWAISNQKS---SFKRYEISSVYRRAIGHSP-P 886
K G + L + +P + + F RY++ V+R
Sbjct: 81 RQAEKDKSGDTGSEARALKFDQTVPLAAYIARHLNDLTFPFARYQMDVVFRG---ERAKD 137
Query: 887 NRY---LQGDFDIIG--GASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSW 941
R+ Q D D++G S L +A++ + +I + I +N+ +L +
Sbjct: 138 GRFRQFRQCDIDVVGREKLSLLYDAQMPAIITEIFEA-VNIGDFVIRINNRKVLTGFFQS 196
Query: 942 AGIKAEHREKVAELLAM-----MGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQT 996
I + + + +G V + L++ + ++
Sbjct: 197 LNISETQIKSC--ISIIDNLEKIG--------EAK--V---KLELEKEGINPEQTQKIID 241
Query: 997 VGLRFCGAADQALPRLR---GALPADKPTRKALDEL-----YLRIWRI-EKNIYIDA--- 1044
++ G+ D L +L+ LP + + EL +R + +K ID
Sbjct: 242 F-VKIDGSVDDVLDKLKHLSQTLPESEQFNLGVSELETVITGVRNLGVPDKRFCIDLAIA 300
Query: 1045 --LMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRT 1102
L +Y+ ++ + + GGRY+ L+ +
Sbjct: 301 RGL-----NYYTGTVYETTLIGH------EALGSICSGGRYEELVGTFIGEKM------- 342
Query: 1103 NPPSGVGASLALETIIQH-YPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEEN 1161
GVG S+ L +I V+V + L+ +++ +L +
Sbjct: 343 ---PGVGISIGLTRLISRLLKAGILNTLPPTPAQVVVVN-MQDELMPTYLKVSQQLRQAG 398
Query: 1162 IKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLV 1221
+ L +Q++ A + I+ VI+ A ++ L ++ EV L
Sbjct: 399 LNVITNFEK-RQLGKQFQAADKQGIRFCVIIGADEAAAQKSSLKDLQSGEQVEVALADLA 457
Query: 1222 RFL 1224
+
Sbjct: 458 EEI 460
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-33
Identities = 87/442 (19%), Positives = 149/442 (33%), Gaps = 107/442 (24%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKI-RLKDKSLPVNDRILREVATLSRLQHQHVVRYYQ 490
LG G FG V + K++L G AVK + R K +SL V +I RE+ L +H H+++ YQ
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 491 AWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLR 550
T + +++ MEY
Sbjct: 84 VI-ST---------------------------------------PSDIFMVMEYVSGG-- 101
Query: 551 QVFESYDHFDK------ELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
E +D+ K + + LF+QI+ G+ + H ++HRDL P N+ DA + KI
Sbjct: 102 ---ELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 158
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFGL+ + T G+ Y APE+ G + D++S
Sbjct: 159 DFGLSNMMS-----DGEFLRT-----------SCGSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 665 GIVFFELWH---PFS----TAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPS 716
G++ + L PF + ++I G P ++ SLL+ ++
Sbjct: 203 GVILYALLCGTLPFDDDHVPTLFKKI------CDGIFYTPQYLN--PSVISLLKHMLQVD 254
Query: 717 PSDRPSATELLQD----------ALPPQMEY-------ELLDNILRMMHSSEDTSIYDKV 759
P R + ++ + P Y E L + SE+ +
Sbjct: 255 PMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLY 314
Query: 760 VSSIFDEET------LDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHC 813
+ D +D + + TS D L + + +
Sbjct: 315 NRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETP 374
Query: 814 AKHLEIEPMYLLGDCPQFKRNT 835
++ + Q R
Sbjct: 375 RARHTLDELNPQKSKHQGVRKA 396
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-33
Identities = 66/315 (20%), Positives = 107/315 (33%), Gaps = 58/315 (18%)
Query: 425 DFEEL---QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ 481
+L + LG G FG K + L L+EV + L+
Sbjct: 8 RPSDLIHGEVLGKGCFGQA--IKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +V+++ GV + + L
Sbjct: 66 HPNVLKFI------GV----------------------------LYKDKR------LNFI 85
Query: 542 MEYCPR-TLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
EY TLR + +S D + + I G+A++H IIHRDL +N
Sbjct: 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK 145
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
++ + DFGLA+ + ++ Q + VG ++ APE+ G DEK
Sbjct: 146 NVVVADFGLARLMV-DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKV 203
Query: 660 DMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKG---ELPPSWVAKFSEQESLLRRLM 713
D++S GIV E+ + + R + + PP+ F + R
Sbjct: 204 DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFP---ITVRCC 260
Query: 714 SPSPSDRPSATELLQ 728
P RPS +L
Sbjct: 261 DLDPEKRPSFVKLEH 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 64/328 (19%), Positives = 113/328 (34%), Gaps = 85/328 (25%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRIL-----REVATL 477
N+ E + +G GGFG V + D A+K + L D REV +
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
S L H ++V+ Y G+ +
Sbjct: 78 SNLNHPNIVKLY------GL----------------------------MHNP-------- 95
Query: 538 LYIQMEYCPR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQG--IIHRDLTPNNI 593
+ ME+ P L H + L I G+ ++ Q I+HRDL NI
Sbjct: 96 PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI 155
Query: 594 FFDARND-----IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648
F + ++ K+ DFGL++ +G +G + + APE
Sbjct: 156 FLQSLDENAPVCAKVADFGLSQQ------------------SVHSVSGLLGNFQWMAPET 197
Query: 649 EQGWPKI-DEKADMYSLGIVFFELW---HPFSTAMERQI-VLSDLKQKG---ELPPSWVA 700
+ EKAD YS ++ + + PF +I ++ ++++G +P
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP 257
Query: 701 KFSEQESLLRRLMSPSPSDRPSATELLQ 728
+ ++ S P RP + +++
Sbjct: 258 RLRN---VIELCWSGDPKKRPHFSYIVK 282
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 67/340 (19%), Positives = 122/340 (35%), Gaps = 91/340 (26%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ +E++ +G G +G V C+N+ G+ A+KK + + LRE+ L +L+H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V +V ++ +L ++
Sbjct: 62 PNLVNLL-----------------------------------EVFRRKRRL-----HLVF 81
Query: 543 EYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
EYC T+ + Y + L + Q ++ + H IHRD+ P NI + I
Sbjct: 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVI 141
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKAD 660
K+ DFG A+ L D +V T +Y +PE+ G + D
Sbjct: 142 KLCDFGFARLL----------------TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVD 185
Query: 661 MYSLGIVFFELWH-----PFSTAMERQIVL----------------SDLKQ-KGELPPSW 698
++++G VF EL P + ++ Q+ L S + G P
Sbjct: 186 VWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244
Query: 699 VAKFSEQE----------SLLRRLMSPSPSDRPSATELLQ 728
+ LL+ + P++R + +LL
Sbjct: 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 68/327 (20%), Positives = 113/327 (34%), Gaps = 88/327 (26%)
Query: 425 DFEELQ---PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN--DRILREVATLSR 479
DF EL +G GGFG V + G AVK R + + +E +
Sbjct: 5 DFAELTLEEIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
L+H +++ GV + N L
Sbjct: 63 LKHPNIIALR------GV----------------------------CLKEPN------LC 82
Query: 540 IQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG---IIHRDLTPNNIFF 595
+ ME+ L +V ++ + QI G+ ++H + IIHRDL +NI
Sbjct: 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILI 141
Query: 596 D--------ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
+ +KI DFGLA+ G Y + APE
Sbjct: 142 LQKVENGDLSNKILKITDFGLAREWH-----------------RTTKMSAAGAYAWMAPE 184
Query: 648 IEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKG---ELPPSWVAK 701
+ + + +D++S G++ +EL PF ++ V + +P +
Sbjct: 185 VIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG-IDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 702 FSEQESLLRRLMSPSPSDRPSATELLQ 728
F++ L+ +P P RPS T +L
Sbjct: 243 FAK---LMEDCWNPDPHSRPSFTNILD 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 66/360 (18%), Positives = 117/360 (32%), Gaps = 95/360 (26%)
Query: 415 MSLPSSRYLNDFEELQ---PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRIL 471
M +S D + L+ +G G +G V K LD R AVK ++ +N++
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAV--YKGSLDERPVAVKVFSFANRQNFINEK-- 56
Query: 472 REVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQEN 531
+ + ++H ++ R+ +
Sbjct: 57 -NIYRVPLMEHDNIARFI------------VGDERVTADG-------------------- 83
Query: 532 KLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ--------- 581
+ MEY P +L + + D + L + GLA++H +
Sbjct: 84 ---RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKP 139
Query: 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTY 641
I HRDL N+ I DFGL+ L G +VGT
Sbjct: 140 AISHRDLNSRNVLVKNDGTCVISDFGLSMRL-------TGNRLVRPGEEDNAAISEVGTI 192
Query: 642 FYTAPEI------EQGWPKIDEKADMYSLGIVFFELW------HPFSTAMERQIVLSDL- 688
Y APE+ + ++ DMY+LG++++E++ P + E Q+
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252
Query: 689 ----------------KQKGELPPSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQ 728
KQ+ + P +W + S L+ + R +A +
Sbjct: 253 GNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 69/321 (21%), Positives = 107/321 (33%), Gaps = 75/321 (23%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL---KDKSLPVNDRILREVATL 477
Y + +G GG G V ++ + R A+K + D R+ RE T
Sbjct: 35 PY----RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF--RTRMQREARTA 88
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
RLQ HVV + D G+ +
Sbjct: 89 GRLQEPHVVPIH-----------------------------------DF-GEIDGQ---- 108
Query: 538 LYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
LY+ M L + A + RQI L H G HRD+ P NI
Sbjct: 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
A + + DFG+A T G VGT +Y APE
Sbjct: 169 ADDFAYLVDFGIASAT-------TDEKLTQLGNT-------VGTLYYMAPERFSESH-AT 213
Query: 657 EKADMYSLGIVFFEL---WHPF---STAMERQIVLSDLKQKGELPPSWVAKFSEQESLLR 710
+AD+Y+L V +E P+ ++ + + + + P F ++++
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF---DAVIA 270
Query: 711 RLMSPSPSDR-PSATELLQDA 730
R M+ +P DR + +L A
Sbjct: 271 RGMAKNPEDRYVTCGDLSAAA 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 84/354 (23%), Positives = 140/354 (39%), Gaps = 98/354 (27%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
F +L+ +G G FG V + + A+K I L++ + D I +E+ LS+ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPY 81
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
V +YY ++ + +W I MEY
Sbjct: 82 VTKYYGSYLK-------DTKLW---------------------------------IIMEY 101
Query: 545 C----------PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIF 594
P L + + + R+I++GL ++H + IHRD+ N+
Sbjct: 102 LGGGSALDLLEPGPLDETQIAT----------ILREILKGLDYLHSEKKIHRDIKAANVL 151
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWP 653
++K+ DFG+A L + + F VGT F+ APE I+Q
Sbjct: 152 LSEHGEVKLADFGVAGQLT-DTQIKRNTF--------------VGTPFWMAPEVIKQS-- 194
Query: 654 KIDEKADMYSLGIVFFELWH---PFST--AMERQIVLSDLKQKGELPPSWVAKFSEQ-ES 707
D KAD++SLGI EL P S M+ VL + + PP+ +S+ +
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIPKNN--PPTLEGNYSKPLKE 249
Query: 708 LLRRLMSPSPSDRPSATELLQ------DALPPQMEYELLD--NILRMMHSSEDT 753
+ ++ PS RP+A ELL+ +A EL+D + S +D+
Sbjct: 250 FVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDS 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-32
Identities = 56/315 (17%), Positives = 101/315 (32%), Gaps = 79/315 (25%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCK-NKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSR 479
+Y E + HGG G + L ++GR +K + + + E L+
Sbjct: 81 QY----EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ-AMAMAERQFLAE 135
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
+ H +V+ + + ++ Y
Sbjct: 136 VVHPSIVQIF-----------------------------------NFVEHTDRHGDPVGY 160
Query: 540 IQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
I MEY ++L++ A +I+ L+++H G+++ DL P NI
Sbjct: 161 IVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-E 217
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
+K+ D G + G + GT + APEI + P
Sbjct: 218 EQLKLIDLGAVSRI------------NSFGYL-------YGTPGFQAPEIVRTGP--TVA 256
Query: 659 ADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSP 715
D+Y++G L + + D + S+ LLRR + P
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP--VLKTYDSY-------GRLLRRAIDP 307
Query: 716 SPSDRP-SATELLQD 729
P R +A E+
Sbjct: 308 DPRQRFTTAEEMSAQ 322
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 5e-32
Identities = 69/328 (21%), Positives = 124/328 (37%), Gaps = 78/328 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+DFE++ LG G G V +K G A K I L+ K + ++I+RE+ L
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNS 90
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V +Y A++ G + I M
Sbjct: 91 PYIVGFYGAFYSDG----------------------------------------EISICM 110
Query: 543 EYCPRT-LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG-IIHRDLTPNNIFFDARND 600
E+ L QV + +++ + +++GL ++ + I+HRD+ P+NI ++R +
Sbjct: 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 170
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
IK+ DFG++ L D+ S VGT Y +PE QG ++D
Sbjct: 171 IKLCDFGVSGQL------------IDSMANSF-----VGTRSYMSPERLQG-THYSVQSD 212
Query: 661 MYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
++S+G+ E+ +P + + + E
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPP--------------DAKELELMFGCQVEGDAAETPPRPR 258
Query: 718 SDRPSATELLQDALPPQMEYELLDNILR 745
+ + D+ PP +ELLD I+
Sbjct: 259 TPGRPLNKFGMDSRPPMAIFELLDYIVN 286
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 58/251 (23%), Positives = 95/251 (37%), Gaps = 61/251 (24%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ + + +G+G FG V K G A+KK+ + RE+ + +L H ++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNI 109
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
VR ++ +G K + YL + ++Y
Sbjct: 110 VRLRYFFYSSG----------------------------------EKKDEVYLNLVLDYV 135
Query: 546 PRTLRQVFESYDHFDKELAWHLFR----QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
P T+ +V Y + L + Q+ LA+IH GI HRD+ P N+ D +
Sbjct: 136 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
Query: 602 -KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
K+ DFG AK QL + + + +Y APE+ G D
Sbjct: 196 LKLCDFGSAK-----QLVRGEPN-----------VSYICSRYYRAPELIFGATDYTSSID 239
Query: 661 MYSLGIVFFEL 671
++S G V EL
Sbjct: 240 VWSAGCVLAEL 250
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 75/367 (20%), Positives = 124/367 (33%), Gaps = 111/367 (30%)
Query: 407 SVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPV 466
VD G+ N+ S + L+ G FG V K +L + AVK ++DK
Sbjct: 11 GVDLGTENLYFQS----MPLQLLEVKARGRFGCV--WKAQLLNEYVAVKIFPIQDKQSWQ 64
Query: 467 NDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADV 526
N+ EV +L ++H++++++ G G+
Sbjct: 65 NEY---EVYSLPGMKHENILQFI------------GAEKRGTSV---------------- 93
Query: 527 TGQENKLESTYLYIQMEYCPR-TLRQVFESYDH-FDKELAWHLFRQIVE----GLAHIHG 580
L++ + + +L D ++W+ I E GLA++H
Sbjct: 94 --------DVDLWLITAFHEKGSL------SDFLKANVVSWNELCHIAETMARGLAYLHE 139
Query: 581 Q----------GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGV 630
I HRD+ N+ I DFGLA + G
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF-------------EAGKS 186
Query: 631 SVDGTGQVGTYFYTAPEIEQGWPKI----DEKADMYSLGIVFFELW-------------- 672
+ D GQVGT Y APE+ +G + DMY++G+V +EL
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 673 HPFSTAMERQIVLSDLK----QKG---ELPPSWVAKFSEQESLLRRLM----SPSPSDRP 721
PF + + L D++ K L W ++L + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK--HAGMAMLCETIEECWDHDAEARL 304
Query: 722 SATELLQ 728
SA + +
Sbjct: 305 SAGCVGE 311
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 78/363 (21%), Positives = 135/363 (37%), Gaps = 95/363 (26%)
Query: 410 SGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR 469
S +L + +++L+ +G G +G V K+ GR A+K+IRL + +
Sbjct: 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPST 65
Query: 470 ILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQ 529
+RE++ L L H ++V DV
Sbjct: 66 AIREISLLKELHHPNIVSLI-----------------------------------DVIHS 90
Query: 530 ENKLESTYLYIQMEYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDL 588
E L + E+ + L++V + Q++ G+AH H I+HRDL
Sbjct: 91 ERCL-----TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 589 TPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPE 647
P N+ ++ +K+ DFGLA+ AF G+ V T +V T +Y AP+
Sbjct: 146 KPQNLLINSDGALKLADFGLAR-----------AF-----GIPVRSYTHEVVTLWYRAPD 189
Query: 648 IEQGWPKIDEKADMYSLGIVFFELWH-----PFSTAMERQIVL----------------S 686
+ G K D++S+G +F E+ P T + Q+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQ 248
Query: 687 DLKQ-KGELPPSW--------VAKFSEQ-ESLLRRLMSPSPSDRPSATELLQ----DALP 732
+L K + + F ++ LL ++ P+ R SA + + L
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
Query: 733 PQM 735
PQ+
Sbjct: 309 PQI 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 64/251 (25%), Positives = 109/251 (43%), Gaps = 58/251 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ +E+L+ +G G +G V KN+ A+K++RL D V LRE+ L L+H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+++VR + DV + KL +
Sbjct: 61 KNIVRLH-----------------------------------DVLHSDKKL-----TLVF 80
Query: 543 EYCPRTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
E+C + L++ F+S D E+ Q+++GL H + ++HRDL P N+ + ++
Sbjct: 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKAD 660
K+ +FGLA+ AF G+ V + +V T +Y P++ G D
Sbjct: 141 KLANFGLAR-----------AF-----GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 661 MYSLGIVFFEL 671
M+S G +F EL
Sbjct: 185 MWSAGCIFAEL 195
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-31
Identities = 44/360 (12%), Positives = 94/360 (26%), Gaps = 88/360 (24%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVAT-L 477
LG G F V + + + +K + P I ++ L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIGTQLMERL 121
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+++Y A
Sbjct: 122 KPSMQHMFMKFYSA-HLF---------------------------------------QNG 141
Query: 538 LYIQMEYCPR-TLRQVFESYDH-----FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPN 591
+ E TL Y + + L +++ + +H IIH D+ P+
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201
Query: 592 NIFF-----------DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
N D + + D G + +KL + F T + T
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL--FPKGTIF-----------TAKCET 248
Query: 641 YFYTAPEI--EQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSW 698
+ E+ + W + + D + + + + F T M+ + + K +G
Sbjct: 249 SGFQCVEMLSNKPW---NYQIDYFGVAATVYCML--FGTYMKVKNEGGECKPEGLFRRLP 303
Query: 699 VAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDK 758
+++ + +LL+ L + + I + + + K
Sbjct: 304 --HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECK 361
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 55/263 (20%), Positives = 102/263 (38%), Gaps = 62/263 (23%)
Query: 416 SLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVA 475
+ PS+ ++ + + LG G +G V + + A+K+IRL+ + V +REV+
Sbjct: 26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS 85
Query: 476 TLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLES 535
L LQH++++ V ++L
Sbjct: 86 LLKELQHRNIIELK-----------------------------------SVIHHNHRL-- 108
Query: 536 TYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
++ EY L++ + + Q++ G+ H + +HRDL P N+
Sbjct: 109 ---HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL 165
Query: 596 DARND-----IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIE 649
+ +KIGDFGLA+ AF G+ + T ++ T +Y PEI
Sbjct: 166 SVSDASETPVLKIGDFGLAR-----------AF-----GIPIRQFTHEIITLWYRPPEIL 209
Query: 650 QGWPKIDEKADMYSLGIVFFELW 672
G D++S+ ++ E+
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEML 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 72/338 (21%), Positives = 120/338 (35%), Gaps = 91/338 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ + +G+G FG V K A+KK+ DK RE+ + ++H +V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ-DK-----RFKNRELQIMRIVKHPNV 94
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V ++ G +K + +L + +EY
Sbjct: 95 VDLKAFFYSNG----------------------------------DKKDEVFLNLVLEYV 120
Query: 546 PRTLRQVFESYDHFDKELAWHLFR----QIVEGLAHIHGQGIIHRDLTPNNIFFDARND- 600
P T+ + Y + + L + Q++ LA+IH GI HRD+ P N+ D +
Sbjct: 121 PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV 180
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+K+ DFG AK L + + + +Y APE+ G D
Sbjct: 181 LKLIDFGSAKILI----------AGEP------NVSYICSRYYRAPELIFGATNYTTNID 224
Query: 661 MYSLGIVFFELW--HP-FS----------------TAMERQI-VLSDLKQKGELPP---- 696
++S G V EL P F T QI ++ + + P
Sbjct: 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPH 284
Query: 697 SWVAKFSEQES-----LLRRLMSPSPSDRPSATELLQD 729
+ F + L+ RL+ +PS R +A E L
Sbjct: 285 PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 76/344 (22%), Positives = 123/344 (35%), Gaps = 106/344 (30%)
Query: 406 PSVDSGSPNMSLPSSRY----LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIR--- 458
P +GS + P + DF+ + LG G F VVL + R YA+K +
Sbjct: 8 PRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH 67
Query: 459 -LKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFS 517
+K+ + + RE +SRL H V+ Y F+
Sbjct: 68 IIKENKV---PYVTRERDVMSRLDHPFFVKLYFT-FQD---------------------- 101
Query: 518 NRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFR-------- 569
LY + Y + EL ++ +
Sbjct: 102 -----------------DEKLYFGLSYAK-------------NGELLKYIRKIGSFDETC 131
Query: 570 ------QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAF 623
+IV L ++HG+GIIHRDL P NI + I+I DFG AK +
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK----VLSPESKQA 187
Query: 624 PTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTA 678
++ VGT Y +PE+ E+ K +D+++LG + ++L PF
Sbjct: 188 RANSF---------VGTAQYVSPELLTEKSACK---SSDLWALGCIIYQLVAGLPPFRAG 235
Query: 679 MERQIVLSDLKQKGELPP--SWVAKFSEQESLLRRLMSPSPSDR 720
E I +K + + P A+ L+ +L+ + R
Sbjct: 236 NEYLIFQKIIKLEYDFPEKFFPKAR-----DLVEKLLVLDATKR 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 76/364 (20%), Positives = 132/364 (36%), Gaps = 95/364 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR-ILREVATLSRLQHQH 484
F +L+ +GHG FG V ++ + A+KK+ K + I++EV L +L+H +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++Y + + W + MEY
Sbjct: 116 TIQYRGCYLR-------EHTAW---------------------------------LVMEY 135
Query: 545 CPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
C + + E + + + ++GLA++H +IHRD+ NI +K+
Sbjct: 136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 195
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI--DEKADM 661
GDFG A + +F VGT ++ APE+ + D K D+
Sbjct: 196 GDFGSA-----SIMAPANSF--------------VGTPYWMAPEVILAMDEGQYDGKVDV 236
Query: 662 YSLGIVFFEL---------WHPFSTAMERQIVLSDLKQKGELPPS-----WVAKFSEQES 707
+SLGI EL + S L + Q P+ W F
Sbjct: 237 WSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNE--SPALQSGHWSEYFRN--- 284
Query: 708 LLRRLMSPSPSDRPSATELLQ-----DALPPQMEYELLDNILRMMHSSEDTSIYDKVVSS 762
+ + P DRP++ LL+ PP + +L+ + ++ Y K+
Sbjct: 285 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ-YRKMKKI 343
Query: 763 IFDE 766
+F E
Sbjct: 344 LFQE 347
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 59/261 (22%)
Query: 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATL 477
S + ++ F+ + G G FG V L K K G A+KK+ D +R L+ + L
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-DPRF--RNRELQIMQDL 73
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+ L H ++V+ ++ G D D+ Y
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRR-----------------------DI----------Y 100
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKELAWHLFR----QIVEGLAHIH--GQGIIHRDLTPN 591
L + MEY P TL + +Y L + Q++ + +H + HRD+ P+
Sbjct: 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH 160
Query: 592 NIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650
N+ + + +K+ DFG AK L P++ + + +Y APE+
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKL----------SPSEP------NVAYICSRYYRAPELIF 204
Query: 651 GWPKIDEKADMYSLGIVFFEL 671
G D++S+G +F E+
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEM 225
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-30
Identities = 74/348 (21%), Positives = 121/348 (34%), Gaps = 91/348 (26%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP---VNDRIL 471
M+L +E+L LG G F V ++K + A+KKI+L +S +N L
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 472 REVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQEN 531
RE+ L L H +++ D G ++
Sbjct: 61 REIKLLQELSHPNIIGLL-----------------------------------DAFGHKS 85
Query: 532 KLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTP 590
+ + ++ L + + ++GL ++H I+HRDL P
Sbjct: 86 NI-----SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140
Query: 591 NNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIE 649
NN+ D +K+ DFGLAK +F G T QV T +Y APE+
Sbjct: 141 NNLLLDENGVLKLADFGLAK-----------SF-----GSPNRAYTHQVVTRWYRAPELL 184
Query: 650 QGWPKIDEKADMYSLGIVFFELW--HPF---STAMERQIVL----------------SDL 688
G DM+++G + EL PF + ++ Q+ L
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSL 243
Query: 689 KQKGELPP----SWVAKFSEQES----LLRRLMSPSPSDRPSATELLQ 728
FS L++ L +P R +AT+ L+
Sbjct: 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 73/352 (20%), Positives = 129/352 (36%), Gaps = 97/352 (27%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQ 481
+ + +L LG G + V K+KL A+K+IRL+ + P +REV+ L L+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--AIREVSLLKDLK 58
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H ++V + D+ E L +
Sbjct: 59 HANIVTLH-----------------------------------DIIHTEKSL-----TLV 78
Query: 542 MEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
EY + L+Q + + Q++ GLA+ H Q ++HRDL P N+ + R +
Sbjct: 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE 138
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKA 659
+K+ DFGLA+ A + +V T +Y P+I G +
Sbjct: 139 LKLADFGLAR-----------AK-----SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 660 DMYSLGIVFFELWH-----PFSTAMERQIVL----------------SDLKQ-KGELPPS 697
DM+ +G +F+E+ P ST E Q+ ++ K P
Sbjct: 183 DMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEFKTYNYPK 241
Query: 698 W--------VAKFSEQ-ESLLRRLMSPSPSDRPSATELLQ----DALPPQME 736
+ + LL +L+ +R SA + ++ +L ++
Sbjct: 242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 60/261 (22%), Positives = 95/261 (36%), Gaps = 60/261 (22%)
Query: 420 SRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL---KDKSLPVNDRILREVAT 476
S + +E + +G G +G V ++ G A+K +R+ + +REVA
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 477 LSRLQ---HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKL 533
L RL+ H +VVR DV
Sbjct: 65 LRRLEAFEHPNVVRLM-----------------------------------DVCATSRTD 89
Query: 534 ESTYLYIQMEYCPRTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPN 591
+ + E+ + LR + E L RQ + GL +H I+HRDL P
Sbjct: 90 REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149
Query: 592 NIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG 651
NI + +K+ DFGLA+ + + T V T +Y APE+
Sbjct: 150 NILVTSGGTVKLADFGLAR-----------IY-----SYQMALTPVVVTLWYRAPEVLLQ 193
Query: 652 WPKIDEKADMYSLGIVFFELW 672
DM+S+G +F E++
Sbjct: 194 -STYATPVDMWSVGCIFAEMF 213
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 68/344 (19%), Positives = 117/344 (34%), Gaps = 108/344 (31%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEEL-QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL 464
P V SG + + + ++D++ Q LG G G V+ NK +A+K +
Sbjct: 2 PHVKSG---LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDC- 54
Query: 465 PVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASS 523
+ REV R Q H+VR +E A
Sbjct: 55 ---PKARREVELHWRASQCPHIVRIVDV-YENLYA------------------------- 85
Query: 524 ADVTGQENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577
L I ME R + +++ + A + + I E + +
Sbjct: 86 ----------GRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---ASEIMKSIGEAIQY 132
Query: 578 IHGQGIIHRDLTPNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG 634
+H I HRD+ P N+ + ++ +K+ DFG
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------------- 166
Query: 635 TGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL-------WHPFSTAMERQIVLSD 687
A E K D+ DM+SLG++ + L + A+ +
Sbjct: 167 ----------AKETTGE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214
Query: 688 LKQKGELP-PSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
+ E P P W ++ SE+ + L+R L+ P+ R + TE +
Sbjct: 215 RMGQYEFPNPEW-SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 67/318 (21%), Positives = 124/318 (38%), Gaps = 85/318 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
F+ L+ LG G +G V +K G+ A+K++ ++ I++E++ + + HV
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL----QEIIKEISIMQQCDSPHV 86
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V+YY ++F+ +W I MEYC
Sbjct: 87 VKYYGSYFK-------NTDLW---------------------------------IVMEYC 106
Query: 546 PR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
++ + + ++ + + ++GL ++H IHRD+ NI + K+
Sbjct: 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKL 166
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
DFG+A L + + + +GT F+ APE+ Q + AD++S
Sbjct: 167 ADFGVAGQLT-DTMAKRNTV--------------IGTPFWMAPEVIQEIG-YNCVADIWS 210
Query: 664 LGIVFFEL---------WHPFSTAMERQIVLSDLKQKG----ELPPSWVAKFSEQESLLR 710
LGI E+ HP + + P W F++ ++
Sbjct: 211 LGITAIEMAEGKPPYADIHPMR-------AIFMIPTNPPPTFRKPELWSDNFTD---FVK 260
Query: 711 RLMSPSPSDRPSATELLQ 728
+ + SP R +AT+LLQ
Sbjct: 261 QCLVKSPEQRATATQLLQ 278
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 49/281 (17%)
Query: 405 KPSVDSGSPNMSLPSSRY--LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK 462
+ + +M P S + + +E +G G +GHV +KL+ R A+KKI +
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 463 SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAAS 522
L RILRE+A L+RL H HVV+
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVL--------------------------------- 118
Query: 523 SADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582
D+ ++ + LY+ +E +++F + + + L ++ G+ ++H G
Sbjct: 119 --DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176
Query: 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-------- 634
I+HRDL P N + +K+ DFGLA+ + + +
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236
Query: 635 ----TGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
TG V T +Y APE+ E D++S+G +F EL
Sbjct: 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 62/433 (14%), Positives = 122/433 (28%), Gaps = 116/433 (26%)
Query: 396 VSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHG--GFGHVVLCKNKLDGRHYA 453
++ + G + Y E L +G G V L + K G +
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGGCY----ELLTVIGKGFEDLMTVNLARYKPTGEYVT 56
Query: 454 VKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLAS 513
V++I L+ S + + E+ H ++V Y +
Sbjct: 57 VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF--------------------- 95
Query: 514 STFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESY--DHFDKELAWHLFRQ 570
+ L++ + + + + ++ D ++ ++ +
Sbjct: 96 -------------------IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136
Query: 571 IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG- 629
+++ L +IH G +HR + ++I + + G
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS------------NLSMISHGQR 184
Query: 630 ---VSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELWH---PFS------ 676
V V + +PE ++Q D K+D+YS+GI EL + PF
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244
Query: 677 -------------------------TAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR 711
+ R + S L + R
Sbjct: 245 MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR 304
Query: 712 LMSPS------------PSDRPSATELLQDA----LPPQMEYELLDNILRMMHSSEDTSI 755
SP P RPSA+ LL + + + L + + + +
Sbjct: 305 TFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGS 364
Query: 756 YDKVVSSIFDEET 768
+ S IF T
Sbjct: 365 QSQDHSGIFGLVT 377
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 50/251 (19%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ +L+PLG GG G V + + A+KKI L D LRE+ + RL H ++
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALREIKIIRRLDHDNI 70
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V+ + + + + S + E +YI EY
Sbjct: 71 VKVF-------------EIL-------------GPSGSQLTDDVGSLTELNSVYIVQEYM 104
Query: 546 PRTLRQVFES----YDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN-D 600
L V E +H Q++ GL +IH ++HRDL P N+F + +
Sbjct: 105 ETDLANVLEQGPLLEEHAR-----LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+KIGDFGLA+ + + + + T +Y +P + + D
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHL------------SEGLVTKWYRSPRLLLSPNNYTKAID 207
Query: 661 MYSLGIVFFEL 671
M++ G +F E+
Sbjct: 208 MWAAGCIFAEM 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 54/263 (20%), Positives = 99/263 (37%), Gaps = 48/263 (18%)
Query: 413 PNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK--DKSLPVNDRI 470
++ P ++ +E+L +G G FG V +++ G+ A+KK+ ++ + P+
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--A 63
Query: 471 LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQE 530
LRE+ L L+H++VV E
Sbjct: 64 LREIKILQLLKHENVVN----LIEICRTK----------------------------ASP 91
Query: 531 NKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589
+Y+ ++C L + + F + + ++ GL +IH I+HRD+
Sbjct: 92 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151
Query: 590 PNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIE 649
N+ +K+ DFGLA+ AF T +V T +Y PE+
Sbjct: 152 AANVLITRDGVLKLADFGLAR-----------AFSLAKNSQPNRYTNRVVTLWYRPPELL 200
Query: 650 QGWPKIDEKADMYSLGIVFFELW 672
G D++ G + E+W
Sbjct: 201 LGERDYGPPIDLWGAGCIMAEMW 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 59/251 (23%), Positives = 111/251 (44%), Gaps = 59/251 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ + L+ +G G +G V +N G +A+KKIRL+ + + +RE++ L L+H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V+ Y DV + +L +
Sbjct: 60 SNIVKLY-----------------------------------DVIHTKKRL-----VLVF 79
Query: 543 EYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
E+ + L+++ + + + A Q++ G+A+ H + ++HRDL P N+ + ++
Sbjct: 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKIDEKAD 660
KI DFGLA+ AF G+ V T ++ T +Y AP++ G K D
Sbjct: 140 KIADFGLAR-----------AF-----GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 661 MYSLGIVFFEL 671
++S+G +F E+
Sbjct: 184 IWSVGCIFAEM 194
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 64/257 (24%), Positives = 112/257 (43%), Gaps = 66/257 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL-KDKSLPVNDRILREVATLSRLQH 482
+ F++L+ LG+G + V NK G + A+K+++L ++ P +RE++ + L+H
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST--AIREISLMKELKH 62
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+++VR Y DV ENKL +
Sbjct: 63 ENIVRLY-----------------------------------DVIHTENKL-----TLVF 82
Query: 543 EYCPRTLRQVFESY------DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
E+ L++ +S + L + Q+++GLA H I+HRDL P N+ +
Sbjct: 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN 142
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG-TGQVGTYFYTAPEIEQGWPKI 655
R +K+GDFGLA+ AF G+ V+ + +V T +Y AP++ G
Sbjct: 143 KRGQLKLGDFGLAR-----------AF-----GIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 656 DEKADMYSLGIVFFELW 672
D++S G + E+
Sbjct: 187 STSIDIWSCGCILAEMI 203
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 63/316 (19%), Positives = 117/316 (37%), Gaps = 81/316 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ + +G G G V + G+ A++++ L+ + P + I+ E+ + ++ ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNI 79
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V Y ++ GD +W + MEY
Sbjct: 80 VNYLDSYLV-------GDELW---------------------------------VVMEYL 99
Query: 546 PR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
+L V + ++A + R+ ++ L +H +IHRD+ +NI +K+
Sbjct: 100 AGGSLTDVVTETCMDEGQIA-AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFG + + + + VGT ++ APE+ K D++SL
Sbjct: 159 DFGFCAQIT-PEQSKRSTM--------------VGTPYWMAPEVVTRKA-YGPKVDIWSL 202
Query: 665 GIVFFEL---------WHPFSTAMERQIVLSD---LKQKGELPPSWVAKFSEQESLLRRL 712
GI+ E+ +P A+ I + L+ P A F + L R
Sbjct: 203 GIMAIEMIEGEPPYLNENPLR-AL-YLIATNGTPELQN----PEKLSAIFRD---FLNRC 253
Query: 713 MSPSPSDRPSATELLQ 728
+ R SA ELLQ
Sbjct: 254 LEMDVEKRGSAKELLQ 269
|
| >3lc0_A Histidyl-tRNA synthetase; tRNA-ligase, aminoacyl-tRNA synthetase, ligase, structural G medical structural genomics of pathogenic protozoa; HET: HIS; 1.80A {Trypanosoma cruzi} PDB: 3hrk_A* 3hri_A Length = 456 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 69/447 (15%), Positives = 138/447 (30%), Gaps = 66/447 (14%)
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLE---IEPMYLL----GDCPQFKRNTVKLLTHGGDLL 846
R ++ V + + + +E L G+ +T GG +
Sbjct: 42 AMRCRRHLFDVFHATAKTFGFEEYDAPVLESEELYIRKAGEEIT--EQMFNFITKGGHRV 99
Query: 847 ELSHELRLPFIRWAISNQKSS---FKRYEISSVYRRAIGHSP-PNRY---LQGDFDIIGG 899
L E+ R + +S K Y I +R + R Q + DI+G
Sbjct: 100 ALRPEMTPSLARLLLGKGRSLLLPAKWYSIPQCWRY---EAITRGRRREHYQWNMDIVGV 156
Query: 900 ASALTEAEVLKVTMDIVTRF-FHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAM 958
S E E++ + ++ I +N +L+ + AG+ ++ V ++
Sbjct: 157 KSVSAEVELVCAACWAMRSLGLSSKDVGIKVNSRKVLQTVVEQAGVTSDKFAPVCVIVDK 216
Query: 959 MGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPA 1018
M K + L L L VV+ + T + +++ + +
Sbjct: 217 ME---------KIPREEV-EAQLAVLGLEPTVVDAITTT------LSLKSIDEIAQRVGE 260
Query: 1019 DKPTRKALDEL--YLRIWRIEKNIYIDA-----LMPPIESYHRNLFFQVFSVKEKYPATL 1071
+ K L + + + + DA L +Y+ + F+ F + K+
Sbjct: 261 EHEAVKELRQFFEQVEAYGYGDWVLFDASVVRGL-----AYYTGIVFEGFDREGKF---- 311
Query: 1072 VEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPVDFKPVRNE 1131
L GGRYD L + P G I++
Sbjct: 312 --RALCG-GGRYDNL---------LTTYGSPTPIPCAGFGFGDCVIVELLQEKRLLPDIP 359
Query: 1132 AGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVI 1191
+V + + ++ L + A + + + + YA V+
Sbjct: 360 HVVDDVVIPF-DESMRPHALAVLRRLRDAGRSADIILD-KKKVVQAFNYADRVGAVRAVL 417
Query: 1192 LTDTGAQKGLVKVRHLDVKKEKEVQRE 1218
+ ++G V+V+ L KE
Sbjct: 418 VAPEEWERGEVQVKMLREGTGKEEGGA 444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 67/334 (20%), Positives = 124/334 (37%), Gaps = 86/334 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ +G G G V L + K GR AVK + L+ + + + EV + QH +V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNV 104
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V Y+++ G+ +W + ME+
Sbjct: 105 VEMYKSYLV-------GEELW---------------------------------VLMEFL 124
Query: 546 PR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
L + ++++A + +++ LA++H QG+IHRD+ ++I +K+
Sbjct: 125 QGGALTDIVSQVRLNEEQIA-TVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLS 183
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
DFG + + + + + VGT ++ APE+ + D++SL
Sbjct: 184 DFGFCAQIS-KDVPKRKSL--------------VGTPYWMAPEVISRSL-YATEVDIWSL 227
Query: 665 GIVFFEL---------WHPFSTAMERQIVLSD---LKQKGELPPSWVAKFSEQESLLRRL 712
GI+ E+ P AM +++ S LK + L R+
Sbjct: 228 GIMVIEMVDGEPPYFSDSPVQ-AM-KRLRDSPPPKLKN----SHKVSPVLRD---FLERM 278
Query: 713 MSPSPSDRPSATELLQ-----DALPPQMEYELLD 741
+ P +R +A ELL P+ L+
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGLPECLVPLIQ 312
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 69/310 (22%), Positives = 110/310 (35%), Gaps = 72/310 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRL 480
DFE L+ +G G FG V + K K + +A+K + K + L + E L
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNG 131
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+ + + A F+ LY+
Sbjct: 132 DSKWITTLHYA-FQD---------------------------------------DNNLYL 151
Query: 541 QMEYCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
M+Y TL FE D +E+A ++V + +H +HRD+ P+NI D
Sbjct: 152 VMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
I++ DFG +L +D + VGT Y +PEI Q
Sbjct: 210 MNGHIRLADFGSCL-----KLMEDGTVQSSV---------AVGTPDYISPEILQAMEGGK 255
Query: 657 EK----ADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQ-ES 707
+ D +SLG+ +E+ PF + + K P+ V SE +
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 708 LLRRLMSPSP 717
L+RRL+
Sbjct: 316 LIRRLICSRE 325
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-28
Identities = 85/392 (21%), Positives = 135/392 (34%), Gaps = 98/392 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRLQHQ 483
F+ LG G +G V +K G A+KKI DK L R LRE+ L +H+
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKILKHFKHE 69
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+++ + +F+ +YI E
Sbjct: 70 NIITIFNIQRPDSFENFNE-----------------------------------VYIIQE 94
Query: 544 YCPRTLRQVFE----SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
L +V S DH + Q + + +HG +IHRDL P+N+ ++
Sbjct: 95 LMQTDLHRVISTQMLSDDHIQ-----YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC 149
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
D+K+ DFGLA+ +D+ AA ++ G V T +Y APE+ K
Sbjct: 150 DLKVCDFGLAR-----IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204
Query: 660 DMYSLGIVFFELWH-----------------------PFSTAMERQI----VLSDLKQKG 692
D++S G + EL+ P S R I +K
Sbjct: 205 DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLP 264
Query: 693 ELPP-SWVAKFSEQES----LLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMM 747
P F LL+R++ P+ R +A E L+ Y L+
Sbjct: 265 MYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH------PY------LQTY 312
Query: 748 HSSEDTSIYDKVVSSIFDEETLDMKHHAGTLR 779
H D + + S F+ + L+
Sbjct: 313 HDPNDEPEGEPIPPSFFEFDHYKEALTTKDLK 344
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 76/339 (22%), Positives = 127/339 (37%), Gaps = 89/339 (26%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+E + LG G FG V KNK G A K I K + + + E+ L+ H ++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYI 78
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V+ A++ +W I +E+C
Sbjct: 79 VKLLGAYYH-------DGKLW---------------------------------IMIEFC 98
Query: 546 PR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
P + + D + + RQ++E L +H + IIHRDL N+ DI++
Sbjct: 99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRL 158
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI----EQGWPKIDEKA 659
DFG++ + L + +F +GT ++ APE+ D KA
Sbjct: 159 ADFGVSAKNL-KTLQKRDSF--------------IGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 660 DMYSLGIVFFEL---------WHPFSTAMERQIVLSD---LKQKGELPPSWVAKFSEQES 707
D++SLGI E+ +P + +I SD L + W +F +
Sbjct: 204 DIWSLGITLIEMAQIEPPHHELNPMR-VL-LKIAKSDPPTLLTPSK----WSVEFRD--- 254
Query: 708 LLRRLMSPSPSDRPSATELLQ-----DALPPQMEYELLD 741
L+ + +P RPSA +LL+ + EL+
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVA 293
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 72/347 (20%), Positives = 137/347 (39%), Gaps = 88/347 (25%)
Query: 407 SVDSGSPNMSLPSSRYLND----FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK 462
+ DS + ++ L D FE ++ +G+G +G V ++ G+ A+K + +
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 463 SLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAA 521
+ I +E+ L + H+++ YY A+ + D D +W
Sbjct: 63 --EEEE-IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD-DQLW--------------- 103
Query: 522 SSADVTGQENKLESTYLYIQMEYCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577
+ ME+C L + + ++ +A ++ R+I+ GL+H
Sbjct: 104 ------------------LVMEFCGAGSVTDLIKNTKGNTLKEEWIA-YICREILRGLSH 144
Query: 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637
+H +IHRD+ N+ ++K+ DFG++ L + + F
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTF-------------- 189
Query: 638 VGTYFYTAPEI----EQGWPKIDEKADMYSLGIVFFEL---------WHPFSTAMERQIV 684
+GT ++ APE+ E D K+D++SLGI E+ HP A+ I
Sbjct: 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-AL-FLIP 247
Query: 685 LSD---LKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
+ LK W KF + + + S RP+ +L++
Sbjct: 248 RNPAPRLK-----SKKWSKKFQS---FIESCLVKNHSQRPATEQLMK 286
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-28
Identities = 69/315 (21%), Positives = 108/315 (34%), Gaps = 75/315 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRL 480
+DFE L+ +G G F V + K K G+ YA+K + K L + E L
Sbjct: 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN-KWDMLKRGEVSCFREERDVLVNG 118
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+ + + + A F+ YLY+
Sbjct: 119 DRRWITQLHFA-FQD---------------------------------------ENYLYL 138
Query: 541 QMEYCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
MEY TL F + E+A +IV + +H G +HRD+ P+NI D
Sbjct: 139 VMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD 196
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPK 654
I++ DFG L+ + + VGT Y +PEI G
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVA--------------VGTPDYLSPEILQAVGGGP 242
Query: 655 IDEK----ADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQ- 705
D ++LG+ +E+ PF + + K L P E+
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 706 ESLLRRLMSPSPSDR 720
++RL+ P R
Sbjct: 303 RDFIQRLLC-PPETR 316
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 42/253 (16%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ +G G +G+V L +K ++ A+KK+ + L RILRE+ L+RL+ ++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+R Y D+ ++ L+ LYI +E
Sbjct: 88 IRLY-----------------------------------DLIIPDDLLKFDELYIVLEIA 112
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L+++F++ +E + ++ G IH GIIHRDL P N + +K+ D
Sbjct: 113 DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDG-------TGQVGTYFYTAPEIEQGWPKIDEK 658
FGLA+ + E+ + T V T +Y APE+ +
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 659 ADMYSLGIVFFEL 671
D++S G +F EL
Sbjct: 233 IDIWSTGCIFAEL 245
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-28
Identities = 70/340 (20%), Positives = 126/340 (37%), Gaps = 103/340 (30%)
Query: 405 KPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL 464
P V + +++ + FE L+ +G G FG V + + + YA+K + K K +
Sbjct: 2 MPPVFDENEDVNF------DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCV 54
Query: 465 PVND--RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAAS 522
N+ + +E+ + L+H +V +W S F +
Sbjct: 55 ERNEVRNVFKELQIMQGLEHPFLVN-----------------LWYS-------FQDE--- 87
Query: 523 SADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFR------------- 569
+++ ++ +L +HL +
Sbjct: 88 -------------EDMFMVVDLLL-------------GGDLRYHLQQNVHFKEETVKLFI 121
Query: 570 -QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTG 628
++V L ++ Q IIHRD+ P+NI D + I DF +A P +T
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM-----------LPRETQ 170
Query: 629 GVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPF---STAME 680
++ GT Y APE+ + D +SLG+ +EL P+ S+
Sbjct: 171 ITTM-----AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 681 RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
++IV + P +W E SLL++L+ P+P R
Sbjct: 226 KEIVHTFETTVVTYPSAWS---QEMVSLLKKLLEPNPDQR 262
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 64/312 (20%), Positives = 112/312 (35%), Gaps = 75/312 (24%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRL 480
D+E ++ +G G FG V L ++K + YA+K + K + + +D E ++
Sbjct: 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFA 126
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
VV+ + A F+ YLY+
Sbjct: 127 NSPWVVQLFYA-FQD---------------------------------------DRYLYM 146
Query: 541 QMEYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
MEY P + ++ A ++V L IH G IHRD+ P+N+
Sbjct: 147 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI---EQGW 652
D +K+ DFG +++++ DT VGT Y +PE+ + G
Sbjct: 202 DKSGHLKLADFGTCM-----KMNKEGMVRCDTA---------VGTPDYISPEVLKSQGGD 247
Query: 653 PKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESL 708
+ D +S+G+ +E+ PF + K L P E ++L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 709 LRRLMSPSPSDR 720
+ ++ R
Sbjct: 308 ICAFLT-DREVR 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 67/381 (17%), Positives = 128/381 (33%), Gaps = 103/381 (27%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ +G G +G V +K G A+KK+ +S R RE+ L +QH++V
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ + D Y+ M +
Sbjct: 86 IGLLDVFTPASSLRNFYD----------------------------------FYLVMPFM 111
Query: 546 PRTLRQVFE---SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
L+++ S + +L Q+++GL +IH G++HRDL P N+ + ++K
Sbjct: 112 QTDLQKIMGLKFSEEKIQ-----YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELK 166
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
I DFGLA+ + TG V T +Y APE+ W ++ D++
Sbjct: 167 ILDFGLAR------------------HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 208
Query: 663 SLGIVFFELW-----------------------HPFSTAMER---QIVLSDLKQKGELPP 696
S+G + E+ P + +++ + S ++ + P
Sbjct: 209 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 268
Query: 697 -SWVAKFSEQES----LLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSE 751
+ F LL +++ R +A + L + E
Sbjct: 269 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH------PF------FEPFRDPE 316
Query: 752 DTSIYDKVVSSIFDEETLDMK 772
+ + + + E L +
Sbjct: 317 EETEAQQPFDDSLEHEKLTVD 337
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 59/260 (22%), Positives = 98/260 (37%), Gaps = 58/260 (22%)
Query: 419 SSRYLNDFEELQPLGHGGFGHVVLCKN-KLDGRHYAVKKIRLKDKSLPVNDRILREVATL 477
R +E + +G G +G V ++ K GR A+K++R++ + +REVA L
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 478 SRLQ---HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
L+ H +VVR + DV
Sbjct: 66 RHLETFEHPNVVRLF-----------------------------------DVCTVSRTDR 90
Query: 535 STYLYIQMEYCPRTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
T L + E+ + L + E + Q++ GL +H ++HRDL P N
Sbjct: 91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 150
Query: 593 IFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652
I + IK+ DFGLA+ + + T V T +Y APE+
Sbjct: 151 ILVTSSGQIKLADFGLAR-----------IY-----SFQMALTSVVVTLWYRAPEVLLQ- 193
Query: 653 PKIDEKADMYSLGIVFFELW 672
D++S+G +F E++
Sbjct: 194 SSYATPVDLWSVGCIFAEMF 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 77/321 (23%), Positives = 120/321 (37%), Gaps = 103/321 (32%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN--DRILREVATLSRL 480
L+ F+ ++ LG G FG V+L K+K G HYA+K + K K + + + L E L +
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAV 98
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+V+ + S F + ++ LY+
Sbjct: 99 NFPFLVK-----------------LEFS-------FKD----------------NSNLYM 118
Query: 541 QMEYCPRTLRQVFESYDHFDKELAWHLFR--------------QIVEGLAHIHGQGIIHR 586
MEY E+ HL R QIV ++H +I+R
Sbjct: 119 VMEYVA-------------GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV-GTYFYTA 645
DL P N+ D + I++ DFG AK +K T + GT A
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVK-------------------GRTWTLCGTPEALA 206
Query: 646 PEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVA 700
PEI +G+ K D ++LG++ +E+ + PF QI + K P
Sbjct: 207 PEIILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--- 260
Query: 701 KFSEQ-ESLLRRLMSPSPSDR 720
FS + LLR L+ + R
Sbjct: 261 -FSSDLKDLLRNLLQVDLTKR 280
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 44/251 (17%), Positives = 89/251 (35%), Gaps = 65/251 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-H 482
+D++ ++ LG G + V N + VK ++ K +I RE+ L L+
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGG 90
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+++ D+ ++
Sbjct: 91 PNIITLA-----------------------------------DIVKDPVSRTPALVF--- 112
Query: 543 EYCPRT-LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN-D 600
E+ T +Q+ Y +I++ L + H GI+HRD+ P+N+ D +
Sbjct: 113 EHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK 169
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+++ D+GLA+F + +V + ++ PE+ + D D
Sbjct: 170 LRLIDWGLAEF----------------YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 213
Query: 661 MYSLGIVFFEL 671
M+SLG + +
Sbjct: 214 MWSLGCMLASM 224
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 55/249 (22%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ +LQP+G G +G V + G A+KK+ +S R RE+ L ++H+
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLES-TYLYIQM 542
+V+ DV + L+ T Y+ M
Sbjct: 85 NVIGLL-----------------------------------DVFTPDETLDDFTDFYLVM 109
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+ L ++ + + ++ L Q+++GL +IH GIIHRDL P N+ + ++K
Sbjct: 110 PFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK 168
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
I DFGLA+ + TG V T +Y APE+ W + + D++
Sbjct: 169 ILDFGLAR------------------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIW 210
Query: 663 SLGIVFFEL 671
S+G + E+
Sbjct: 211 SVGCIMAEM 219
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 53/246 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
++ L P+G G +G V + G AVKK+ +S+ R RE+ L ++H++V
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ + + D +Y+
Sbjct: 91 IGLLDVFTPARSLEEFND----------------------------------VYLVTHLM 116
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L + + D + + ++ QI+ GL +IH IIHRDL P+N+ + ++KI D
Sbjct: 117 GADLNNIVKCQKLTDDHVQFLIY-QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FGLA+ + + TG V T +Y APEI W ++ D++S+G
Sbjct: 176 FGLAR------------------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 666 IVFFEL 671
+ EL
Sbjct: 218 CIMAEL 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 77/321 (23%), Positives = 125/321 (38%), Gaps = 103/321 (32%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRL 480
L DF+ L+ LG G FG V L +++ +GR+YA+K ++ K+ + + E LS +
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIV 63
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H ++R MWG+ F + + +++
Sbjct: 64 THPFIIR-----------------MWGT-------FQD----------------AQQIFM 83
Query: 541 QMEYCPRTLRQVFESYDHFDKELAWHLFR--------------QIVEGLAHIHGQGIIHR 586
M+Y EL L + ++ L ++H + II+R
Sbjct: 84 IMDYIE-------------GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYR 130
Query: 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQV-GTYFYTA 645
DL P NI D IKI DFG AK++ D T + GT Y A
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKYVP-------------------DVTYTLCGTPDYIA 171
Query: 646 PEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVA 700
PE+ + + K D +S GI+ +E+ + PF + + L + PP
Sbjct: 172 PEVVSTKPYNK---SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF--- 225
Query: 701 KFSEQ-ESLLRRLMSPSPSDR 720
F+E + LL RL++ S R
Sbjct: 226 -FNEDVKDLLSRLITRDLSQR 245
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 53/246 (21%), Positives = 92/246 (37%), Gaps = 49/246 (19%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ L +G G +G V + L+ A+KKI + R LRE+ L R +H+++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENI 87
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ + +YI +
Sbjct: 88 IGINDIIRAPTIEQMKD-----------------------------------VYIVQDLM 112
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L ++ ++ H + + QI+ GL +IH ++HRDL P+N+ + D+KI D
Sbjct: 113 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FGLA+ + T V T +Y APEI + D++S+G
Sbjct: 172 FGLARVADPDHDHTGFL------------TEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219
Query: 666 IVFFEL 671
+ E+
Sbjct: 220 CILAEM 225
|
| >2ebm_A RWD domain-containing protein 1; alpha+beta sandwich fold, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 128 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 42/124 (33%), Positives = 59/124 (47%), Gaps = 5/124 (4%)
Query: 23 HSSSTVDDNELLSEEITALCAIFQEDCKVVSGSPPQILVKLRPYSKDMGYEDLDVSALLL 82
SS D E E+ AL +I+ + V+S +PP + + + G D V L
Sbjct: 4 GSSGMTDYGEEQRNELEALESIYPDSFTVLSENPPSFTITVTS---EAGENDETVQTTLK 60
Query: 83 VRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFL 142
YP + P +I ++ L +D ++L LL QA N G VMIF LV A QE L
Sbjct: 61 FTYSEKYPDEAPLYEIFSQENLEDNDVSDILKLLALQAEENL--GMVMIFTLVTAVQEKL 118
Query: 143 SEIV 146
+EIV
Sbjct: 119 NEIV 122
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-25
Identities = 78/367 (21%), Positives = 124/367 (33%), Gaps = 123/367 (33%)
Query: 388 NQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKL 447
VF + + S + ++F + + ++++ NDF + +G GGFG V C+
Sbjct: 159 GDVFQKFIESDKFTRFCQWKNVELNIHLTM------NDFSVHRIIGRGGFGEVYGCRKAD 212
Query: 448 DGRHYAVKKIRLKDKSLPVND---------RILREVATLSRLQHQHVVRYYQAWFETGVA 498
G+ YA+K L K + + +L V S +V A F T
Sbjct: 213 TGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLV---STGDCPFIVCMSYA-FHT--- 263
Query: 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDH 558
L ++
Sbjct: 264 ------------------------------------PDKLSFILDLMN------------ 275
Query: 559 FDKELAWHLFR--------------QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
+L +HL + +I+ GL H+H + +++RDL P NI D ++I
Sbjct: 276 -GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 334
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSL 664
D GLA ++ VGT+ Y APE+ Q D AD +SL
Sbjct: 335 DLGLACDFSKKK--------PHA---------SVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 665 GIVFFEL---WHPFSTA-------MERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLM 713
G + F+L PF ++R L ELP FS + SLL L+
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMT----LTMAVELPD----SFSPELRSLLEGLL 429
Query: 714 SPSPSDR 720
+ R
Sbjct: 430 QRDVNRR 436
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 55/250 (22%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
L ++ L+P+G G G V + + R+ A+KK+ ++ R RE+ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLES-TYLYIQ 541
++++ +V + LE +YI
Sbjct: 84 KNIIGLL-----------------------------------NVFTPQKSLEEFQDVYIV 108
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
ME L QV + D E +L Q++ G+ H+H GIIHRDL P+NI + +
Sbjct: 109 MELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
KI DFGLA+ T G S T V T +Y APE+ G E D+
Sbjct: 167 KILDFGLAR----------------TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDI 209
Query: 662 YSLGIVFFEL 671
+S+G + E+
Sbjct: 210 WSVGCIMGEM 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 60/301 (19%)
Query: 377 SKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNM---SLPSSRY--LNDFEELQP 431
S+P+ F Q F +++ S +++ + S + S + L ++ L+P
Sbjct: 10 SEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKP 69
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQA 491
+G G G V + + R+ A+KK+ ++ R RE+ + + H++++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL-- 127
Query: 492 WFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLES-TYLYIQMEYCPRTLR 550
+V + LE +Y+ ME L
Sbjct: 128 ---------------------------------NVFTPQKTLEEFQDVYLVMELMDANLC 154
Query: 551 QVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
QV + D E +L Q++ G+ H+H GIIHRDL P+NI + +KI DFGLA+
Sbjct: 155 QVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 611 FLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFE 670
T + T V T +Y APE+ G E D++S+G + E
Sbjct: 213 -------------TAGTSFMM---TPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGE 255
Query: 671 L 671
+
Sbjct: 256 M 256
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 53/261 (20%), Positives = 84/261 (32%), Gaps = 72/261 (27%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND---------RILREVAT 476
+ + + G +G V + +G A+K++ + R+LRE+
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 477 LSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST 536
L+ H +++ +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHK---------------------------------- 108
Query: 537 YLYIQMEYCPRTLRQVFESY------DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTP 590
LY+ E L QV H + I+ GL +H G++HRDL P
Sbjct: 109 -LYLVTELMRTDLAQVIHDQRIVISPQHIQ-----YFMYHILLGLHVLHEAGVVHRDLHP 162
Query: 591 NNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650
NI NDI I DF LA+ + DA T V +Y APE+
Sbjct: 163 GNILLADNNDITICDFNLAR-----EDTADANK-----------THYVTHRWYRAPELVM 206
Query: 651 GWPKIDEKADMYSLGIVFFEL 671
+ + DM+S G V E+
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEM 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 54/257 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQH 484
+E ++ LG G +G V ++ G AVKKI ++ R RE+ L+ L H++
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V +V +N + +Y+ +Y
Sbjct: 71 IVNLL-----------------------------------NVLRADNDRD---VYLVFDY 92
Query: 545 CPRTLRQVFES----YDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
L V + H ++ Q+++ + ++H G++HRD+ P+NI +A
Sbjct: 93 METDLHAVIRANILEPVHKQ-----YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH 147
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG------TGQVGTYFYTAPEIEQGWPK 654
+K+ DFGL++ + + + T V T +Y APEI G K
Sbjct: 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207
Query: 655 IDEKADMYSLGIVFFEL 671
+ DM+SLG + E+
Sbjct: 208 YTKGIDMWSLGCILGEI 224
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-24
Identities = 73/317 (23%), Positives = 112/317 (35%), Gaps = 84/317 (26%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRL 480
+ F + + LG GGFG V C+ K G+ YA KK+ K + + E L+++
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN-KKRLKKRKGYQGAMVEKKILAKV 242
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+ +V A FET T L +
Sbjct: 243 HSRFIVSLAYA-FET---------------------------------------KTDLCL 262
Query: 541 QMEYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
M + V E F + A QIV GL H+H + II+RDL P N+
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
D +++I D GLA G GT + APE+ G
Sbjct: 323 DDDGNVRISDLGLAV-----------ELKAGQTKTK----GYAGTPGFMAPELLLGEE-Y 366
Query: 656 DEKADMYSLGIVFFEL---WHPF--------STAMERQIVLSDLKQKGELPPSWVAKFS- 703
D D ++LG+ +E+ PF + +++++ L+Q P KFS
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV----LEQAVTYPD----KFSP 418
Query: 704 EQESLLRRLMSPSPSDR 720
+ L+ P R
Sbjct: 419 ASKDFCEALLQKDPEKR 435
|
| >2day_A Ring finger protein 25; ligase, metal-binding, UB1 conjugation, UB1 conjugation pathway, RWD domain, alpha+beta sandwich fold, structural genomics; NMR {Homo sapiens} SCOP: d.20.1.3 PDB: 2dmf_A Length = 128 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-23
Identities = 31/126 (24%), Positives = 63/126 (50%), Gaps = 7/126 (5%)
Query: 24 SSSTVDDNELLSEEITALCAIFQEDCKVVSG----SPPQILVKLRPYSKDMGYEDLDVSA 79
S S+ +++ +L E+ L +I+ ++ +V+ G SP +I + L P + + V
Sbjct: 3 SGSSGEEDWVLPSEVEVLESIYLDELQVIKGNGRTSPWEIYITLHP-ATAEDQDSQYVCF 61
Query: 80 LLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQ 139
L+++ YP++ P++ I +GL+ +L +L A + G M++ L+E +
Sbjct: 62 TLVLQVPAEYPHEVPQISIRNPRGLSDEQIHTILQVLGHVAKAGL--GTAMLYELIEKGK 119
Query: 140 EFLSEI 145
E LS
Sbjct: 120 EILSGP 125
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 70/310 (22%), Positives = 116/310 (37%), Gaps = 73/310 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR--ILREVATLSRL 480
N F + + LG GGFG V C+ + G+ YA KK+ K + L E L ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGEAMALNEKQILEKV 241
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+ VV A +ET L +
Sbjct: 242 NSRFVVSLAYA-YET---------------------------------------KDALCL 261
Query: 541 QMEYCP-----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
+ + + + F + A +I GL +H + I++RDL P NI
Sbjct: 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
D I+I D GLA + Q +VGT Y APE+ +
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQ-------TIKG---------RVGTVGYMAPEVVKNERY- 362
Query: 656 DEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQK-GELPPSWVAKFSEQ-ESLLR 710
D ++LG + +E+ PF +++I ++++ E+P + +FS Q SL
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 711 RLMSPSPSDR 720
+L+ P++R
Sbjct: 422 QLLCKDPAER 431
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-22
Identities = 83/323 (25%), Positives = 124/323 (38%), Gaps = 102/323 (31%)
Query: 423 LNDFEELQPLGHGGFGHVVLCK---NKLDGRHYAVKKIRLKDKSLPVNDRI--LREVATL 477
+ FE L+ LG G FG V L K + YA+K LK +L V DR+ E L
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDIL 80
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+ H +V+ + A F+T E KL
Sbjct: 81 VEVNHPFIVKLHYA-FQT----------------------------------EGKL---- 101
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKELAWHLFR--------------QIVEGLAHIHGQGI 583
Y+ +++ +L L + ++ L H+H GI
Sbjct: 102 -YLILDFLR-------------GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 147
Query: 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFY 643
I+RDL P NI D IK+ DFGL+K E +D + + GT Y
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEK--KAYS---------FCGTVEY 192
Query: 644 TAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSW 698
APE+ +G + AD +S G++ FE+ PF ++ + LK K +P
Sbjct: 193 MAPEVVNRRGH---TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 248
Query: 699 VAKFS-EQESLLRRLMSPSPSDR 720
S E +SLLR L +P++R
Sbjct: 249 ---LSPEAQSLLRMLFKRNPANR 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-22
Identities = 75/319 (23%), Positives = 117/319 (36%), Gaps = 96/319 (30%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--RILREVATLSRL 480
+NDF+ L+ LG G FG V+L + K GR+YA+K +R K+ + ++ + E L
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNT 62
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+H + A F+T L
Sbjct: 63 RHPFLTALKYA-FQT---------------------------------------HDRLCF 82
Query: 541 QMEYCPRTLRQVFESYDHFDKELAWHLFRQ--------------IVEGLAHIHGQGIIHR 586
MEY EL +HL R+ IV L ++H + +++R
Sbjct: 83 VMEYANG-------------GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP 646
D+ N+ D IKI DFGL K E + A T GT Y AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCK----EGISDGA--TMKT---------FCGTPEYLAP 174
Query: 647 EI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAK 701
E+ + + D + LG+V +E+ PF ++ L ++ P ++
Sbjct: 175 EVLEDNDY---GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR-TLSP 230
Query: 702 FSEQESLLRRLMSPSPSDR 720
E +SLL L+ P R
Sbjct: 231 --EAKSLLAGLLKKDPKQR 247
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-22
Identities = 76/346 (21%), Positives = 128/346 (36%), Gaps = 111/346 (32%)
Query: 405 KPSVDSGSPNMSLPSSRY--LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK 462
P S N+ S+ + +DF L+ +G G FG V+L ++K + YAVK ++ K
Sbjct: 17 PPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ-KKA 75
Query: 463 SLPVND--------RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASS 514
L + +L L ++H +V + + F+T
Sbjct: 76 ILKKKEEKHIMSERNVL-----LKNVKHPFLVGLHFS-FQT------------------- 110
Query: 515 TFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ---- 570
+ LY ++Y EL +HL R+
Sbjct: 111 --------------------ADKLYFVLDYIN-------------GGELFYHLQRERCFL 137
Query: 571 ----------IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQD 620
I L ++H I++RDL P NI D++ I + DFGL K E ++ +
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHN 193
Query: 621 AAFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPF 675
+ T T GT Y APE+ +Q + D D + LG V +E+ PF
Sbjct: 194 S--TTST---------FCGTPEYLAPEVLHKQPY---DRTVDWWCLGAVLYEMLYGLPPF 239
Query: 676 STAMERQIVLSDLKQKGELPPSWVAKFS-EQESLLRRLMSPSPSDR 720
+ ++ + L + +L P+ + LL L+ + R
Sbjct: 240 YSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQKDRTKR 281
|
| >1ukx_A GCN2, GCN2 EIF2alpha kinase; UBC-like fold, triple beta-turns, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: d.20.1.3 Length = 137 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 4e-22
Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 8/127 (6%)
Query: 24 SSSTVDDN-ELLSEEITALCAIFQEDCKVVSGSPPQIL-----VKLRPYSKDMGYEDLDV 77
SS ++ + E+ AL AI+ D + + + + L Y + + E++ V
Sbjct: 4 GSSGMESYSQRQDHELQALEAIYGSDFQDLRPDARGRVREPPEINLVLYPQGLAGEEVYV 63
Query: 78 SALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEA 137
L V+C P YP P++ + KGL+ + L L++ A G VMIF L
Sbjct: 64 QVELRVKCPPTYPDVVPEIDLKNAKGLSNESVNLLKSHLEELAKKQC--GEVMIFELAHH 121
Query: 138 AQEFLSE 144
Q FLSE
Sbjct: 122 VQSFLSE 128
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-22
Identities = 81/340 (23%), Positives = 125/340 (36%), Gaps = 98/340 (28%)
Query: 406 PSVDSGSPNMSLPSSRY-----LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK 460
PS +SG+ M + ++ +N+FE L+ LG G FG V+L K K GR+YA+K ++ K
Sbjct: 125 PSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-K 183
Query: 461 DKSLPVND--RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSN 518
+ + ++ L E L +H + + F+T
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-FQT----------------------- 219
Query: 519 RAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ-------- 570
L MEY EL +HL R+
Sbjct: 220 ----------------HDRLCFVMEYANG-------------GELFFHLSRERVFSEDRA 250
Query: 571 ------IVEGLAHIHGQ-GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAF 623
IV L ++H + +++RDL N+ D IKI DFGL K E + A
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGAT- 305
Query: 624 PTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAME 680
T GT Y APE+ + D + LG+V +E+ PF
Sbjct: 306 -MKT---------FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDH 354
Query: 681 RQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
++ L ++ P + E +SLL L+ P R
Sbjct: 355 EKLFELILMEEIRFPR-TLGP--EAKSLLSGLLKKDPKQR 391
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 8e-22
Identities = 79/339 (23%), Positives = 120/339 (35%), Gaps = 105/339 (30%)
Query: 411 GSPNMSLPSSRY---LNDFEELQPLGHGGFGHVVLCK---NKLDGRHYAVKKIRLKDKSL 464
GS S+ FE L+ LG GG+G V + G+ +A+K ++ K +
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-KAMIV 59
Query: 465 PVND---RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAA 521
E L ++H +V A F+T
Sbjct: 60 RNAKDTAHTKAERNILEEVKHPFIVDLIYA-FQT-------------------------- 92
Query: 522 SSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ----------- 570
KL Y+ +EY EL L R+
Sbjct: 93 --------GGKL-----YLILEYLS-------------GGELFMQLEREGIFMEDTACFY 126
Query: 571 ---IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDT 627
I L H+H +GII+RDL P NI + + +K+ DFGL K E + T T
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK----ESIHDGT--VTHT 180
Query: 628 GGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQ 682
GT Y APEI G + D +SLG + +++ PF+ ++
Sbjct: 181 ---------FCGTIEYMAPEILMRSGH---NRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
Query: 683 IVLSDLKQKGELPPSWVAKFS-EQESLLRRLMSPSPSDR 720
+ LK K LPP + E LL++L+ + + R
Sbjct: 229 TIDKILKCKLNLPPY----LTQEARDLLKKLLKRNAASR 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-21
Identities = 75/345 (21%), Positives = 122/345 (35%), Gaps = 110/345 (31%)
Query: 405 KPSVDSGSPNMSLPSSRY-LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS 463
K S G+ S+R +++FE ++ LG G FG V+L + K G YAVK ++ KD
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK-KDVI 61
Query: 464 LPVND--------RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASST 515
L +D RIL H + + + F+T
Sbjct: 62 LQDDDVECTMTEKRILSLAR-----NHPFLTQLFCC-FQT-------------------- 95
Query: 516 FSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ----- 570
L+ ME+ +L +H+ +
Sbjct: 96 -------------------PDRLFFVMEFVN-------------GGDLMFHIQKSRRFDE 123
Query: 571 ---------IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDA 621
I+ L +H +GII+RDL +N+ D K+ DFG+ K E +
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGICNGV 179
Query: 622 AFPTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFS 676
T T GT Y APEI E + D +++G++ +E+ PF
Sbjct: 180 --TTAT---------FCGTPDYIAPEILQEMLYGP---AVDWWAMGVLLYEMLCGHAPFE 225
Query: 677 TAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDR 720
E + + L + P E +L+ M+ +P+ R
Sbjct: 226 AENEDDLFEAILNDEVVYPTW----LHEDATGILKSFMTKNPTMR 266
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 76/328 (23%), Positives = 123/328 (37%), Gaps = 102/328 (31%)
Query: 423 LNDFEELQPLGHGGFGHVVLCK---NKLDGRHYAVK-----KIRLKDKSLPVNDRILREV 474
+ +FE L+ LG G +G V L + G+ YA+K I K K+ + E
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT---EHTRTER 109
Query: 475 ATLSRLQHQH-VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKL 533
L ++ +V + A F+T
Sbjct: 110 QVLEHIRQSPFLVTLHYA-FQT-------------------------------------- 130
Query: 534 ESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ--------------IVEGLAHIH 579
T L++ ++Y EL HL ++ IV L H+H
Sbjct: 131 -ETKLHLILDYIN-------------GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639
GII+RD+ NI D+ + + DFGL+K ++ ++ F G
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF--------------CG 222
Query: 640 TYFYTAPEIEQGWPKIDEKA-DMYSLGIVFFEL---WHPFSTAMERQIV--LSDLKQKGE 693
T Y AP+I +G +KA D +SLG++ +EL PF+ E+ +S K E
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 694 LP-PSWVAKFSEQESLLRRLMSPSPSDR 720
P P ++ + L++RL+ P R
Sbjct: 283 PPYPQEMSA--LAKDLIQRLLMKDPKKR 308
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 4e-21
Identities = 82/394 (20%), Positives = 132/394 (33%), Gaps = 98/394 (24%)
Query: 346 QSTGSLTDALPQIATELYNLGIFSERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWK 405
L Q E +N+ + G + + +F + + + K
Sbjct: 270 AGVDGWFKLLSQEEGEYFNVPV-PPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 406 PSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP 465
+ M L DF L LG G FG V+L + K YAVK ++ KD +
Sbjct: 329 FDNNGNRDRMKL------TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQ 381
Query: 466 VND--------RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFS 517
+D R+L + + + + F+T
Sbjct: 382 DDDVECTMVEKRVLALPG-----KPPFLTQLHSC-FQT---------------------- 413
Query: 518 NRAASSADVTGQENKLESTYLYIQMEYCP------RTLRQVFESYDHFDKELAWHLFRQI 571
LY MEY + F + A +I
Sbjct: 414 -----------------MDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEI 451
Query: 572 VEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVS 631
GL + +GII+RDL +N+ D+ IKI DFG+ K E + T T
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVT--TKT---- 501
Query: 632 VDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLS 686
GT Y APEI Q + K D ++ G++ +E+ PF E ++ S
Sbjct: 502 -----FCGTPDYIAPEIIAYQPYGK---SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553
Query: 687 DLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDR 720
++ P ++K E ++ + LM+ P R
Sbjct: 554 IMEHNVAYPK-SMSK--EAVAICKGLMTKHPGKR 584
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-21
Identities = 73/323 (22%), Positives = 114/323 (35%), Gaps = 103/323 (31%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--------RILREV 474
L DF L LG G FG V+L + K YAVK ++ KD + +D R+L
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALP 77
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
+ + + + F+T
Sbjct: 78 G-----KPPFLTQLHSC-FQT--------------------------------------- 92
Query: 535 STYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ--------------IVEGLAHIHG 580
LY MEY +L +H+ + I GL +
Sbjct: 93 MDRLYFVMEYVN-------------GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
+GII+RDL +N+ D+ IKI DFG+ K E + T T GT
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVT--TKT---------FCGT 184
Query: 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPS 697
Y APEI P + D ++ G++ +E+ PF E ++ S ++ P
Sbjct: 185 PDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK- 242
Query: 698 WVAKFSEQESLLRRLMSPSPSDR 720
++K E ++ + LM+ P R
Sbjct: 243 SMSK--EAVAICKGLMTKHPGKR 263
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 39/338 (11%), Positives = 73/338 (21%), Gaps = 100/338 (29%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP 465
P P + + RY L G + R A+ + +
Sbjct: 17 PDDVQLVPGARIANGRY----RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD 72
Query: 466 -VNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSA 524
V L LSR+ V R
Sbjct: 73 DVLQETLSRTLRLSRIDKPGVARVL----------------------------------- 97
Query: 525 DVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583
DV + E+ +L++V ++ A + + H G+
Sbjct: 98 DV-VHTR----AGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGV 150
Query: 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFY 643
P+ + D+ +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-----------------------------------T 175
Query: 644 TAPEIEQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPP---S 697
+ + D+ +G + L P A R + + P
Sbjct: 176 MPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPAD 227
Query: 698 WVAKFSEQ-ESLLRRLMSPSPSDRPSAT--ELLQDALP 732
Q ++ R + R ++T L+Q A
Sbjct: 228 IDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATA 265
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 75/343 (21%), Positives = 119/343 (34%), Gaps = 111/343 (32%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP 465
P ++ P++ + + DF + LG G FG V L + K + +A+K ++ KD L
Sbjct: 1 PELNKERPSLQIKLK--IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLM 57
Query: 466 VND--------RILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFS 517
+D R+L +H + + F+T
Sbjct: 58 DDDVECTMVEKRVLSLAW-----EHPFLTHMFCT-FQT---------------------- 89
Query: 518 NRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ------- 570
L+ MEY +L +H+
Sbjct: 90 -----------------KENLFFVMEYLN-------------GGDLMYHIQSCHKFDLSR 119
Query: 571 -------IVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAF 623
I+ GL +H +GI++RDL +NI D IKI DFG+ K E + DA
Sbjct: 120 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAK- 174
Query: 624 PTDTGGVSVDGTGQVGTYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTA 678
T+T GT Y APEI Q + D +S G++ +E+ PF
Sbjct: 175 -TNT---------FCGTPDYIAPEILLGQKYNH---SVDWWSFGVLLYEMLIGQSPFHGQ 221
Query: 679 MERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDR 720
E ++ S P ++ + LL +L P R
Sbjct: 222 DEEELFHSIRMDNPFYPRW----LEKEAKDLLVKLFVREPEKR 260
|
| >2ebk_A RWD domain-containing protein 3; alpha+beta sandwich fold, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 128 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-20
Identities = 33/124 (26%), Positives = 52/124 (41%), Gaps = 4/124 (3%)
Query: 24 SSSTVDDNELLSEEITALCAIFQEDCKVVSGSPPQI-LVKLRPYSKDMGYEDLDVSALLL 82
SS + E + EE++ L AIF + S + R ++K G+ D D+ L+
Sbjct: 2 SSGSSGMAEPVQEELSVLAAIFCRPHEWEVLSRSETDGTVFRIHTKAEGFMDADIPLELV 61
Query: 83 VRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFL 142
YP P + I E LT++ + L +QA S M+ LV Q+ L
Sbjct: 62 FHLPVNYPSCLPGISINSE-QLTRAQCVTVKEKLLEQAESLL--SEPMVHELVLWIQQNL 118
Query: 143 SEIV 146
I+
Sbjct: 119 RHIL 122
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 65/333 (19%), Positives = 117/333 (35%), Gaps = 114/333 (34%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND--------RILREV 474
L DF+ L+ +G G + V+L + K R YA+K ++ K+ D + +
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQA 66
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
+ H +V + F+T
Sbjct: 67 S-----NHPFLVGLHSC-FQT--------------------------------------- 81
Query: 535 STYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ--------------IVEGLAHIHG 580
+ L+ +EY +L +H+ RQ I L ++H
Sbjct: 82 ESRLFFVIEYVN-------------GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
+GII+RDL +N+ D+ IK+ D+G+ K E L T T GT
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGD--TTST---------FCGT 173
Query: 641 YFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQ----- 690
Y APEI + + D ++LG++ FE+ PF + +
Sbjct: 174 PNYIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230
Query: 691 --KGELP-PSWVAKFSEQESLLRRLMSPSPSDR 720
+ ++ P ++ + S+L+ ++ P +R
Sbjct: 231 ILEKQIRIPRSLSV--KAASVLKSFLNKDPKER 261
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 74/359 (20%), Positives = 127/359 (35%), Gaps = 92/359 (25%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEELQP--------LGHGGFGHVVLCK----NKLDGRHYA 453
P+ ++ ++ S+ D + + LG G FG V +C+ G A
Sbjct: 15 PTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA 74
Query: 454 VKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLAS 513
VKK L+ + RE+ L LQH ++V+Y GV
Sbjct: 75 VKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYK------GV---------------- 110
Query: 514 STFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQ-VFESYDHFDKELAWHLFRQI 571
+ L + MEY P +LR + + + D QI
Sbjct: 111 ------------CYSAGRR----NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 572 VEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVS 631
+G+ ++ + IHRDL NI + N +KIGDFGL K L D++ + G
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP---QDKEYYKVKEPGESP 211
Query: 632 VDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQ 690
+ F+ APE + + K +D++S G+V L+ F+ + + ++ +
Sbjct: 212 I---------FWYAPESLTES--KFSVASDVWSFGVV---LYELFTYIEKSKSPPAEFMR 257
Query: 691 KGELPPSWVAKFSEQESLLRR----------------LM----SPSPSDRPSATELLQD 729
LL+ +M + + + RPS +L
Sbjct: 258 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 72/328 (21%), Positives = 118/328 (35%), Gaps = 84/328 (25%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
LQ LG G FG V +C+ + AVKK L+ + RE+ L LQH +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V+Y GV + L + MEY
Sbjct: 73 IVKYK------GV----------------------------CYSAGRR----NLKLIMEY 94
Query: 545 CPR-TLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
P +LR + + + D QI +G+ ++ + IHRDL NI + N +K
Sbjct: 95 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 154
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADM 661
IGDFGL K L D++ + G + F+ APE + + K +D+
Sbjct: 155 IGDFGLTKVLP---QDKEFFKVKEPGESPI---------FWYAPESLTES--KFSVASDV 200
Query: 662 YSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR---------- 711
+S G+V L+ F+ + + ++ + LL+
Sbjct: 201 WSFGVV---LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 257
Query: 712 ------LM----SPSPSDRPSATELLQD 729
+M + + + RPS +L
Sbjct: 258 PDEIYMIMTECWNNNVNQRPSFRDLALR 285
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 52/256 (20%), Positives = 93/256 (36%), Gaps = 69/256 (26%)
Query: 432 LGHGGFGHVVLCKNK--LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYY 489
+G G +GHV K K D + YA+K+I ++ RE+A L L+H +V+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQ 84
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTL 549
+ ++ +++ +Y L
Sbjct: 85 KV----------------------------------FLSHADR----KVWLLFDYAEHDL 106
Query: 550 RQVFESYDH---------FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
+ + + + + L QI++G+ ++H ++HRDL P NI
Sbjct: 107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 166
Query: 601 ----IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
+KI D G A+ P D V T++Y APE+ G
Sbjct: 167 ERGRVKIADMGFARLFNS---------PLKPLA---DLDPVVVTFWYRAPELLLGARHYT 214
Query: 657 EKADMYSLGIVFFELW 672
+ D++++G +F EL
Sbjct: 215 KAIDIWAIGCIFAELL 230
|
| >2yz0_A Serine/threonine-protein kinase GCN2; A-B-B-B-B-A-A, amino acid starvation signal response, EIF2alpha kinase, transferase; NMR {Saccharomyces cerevisiae} Length = 138 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 2e-19
Identities = 31/130 (23%), Positives = 56/130 (43%), Gaps = 11/130 (8%)
Query: 24 SSSTVDDN-ELLSEEITALCAIFQEDCKVVSGSP------PQILVKLRPYSKDMGYEDLD 76
S T+D E+ E+ A+ +I+ +D ++ PQI+ ++ S D E ++
Sbjct: 4 SHLTLDQYYEIQCNELEAIRSIYMDDFTDLTKRKSSWDKQPQIIFEITLRSVD--KEPVE 61
Query: 77 VSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVE 136
S L P YPY P+++ + + S L + N++ G+ +IF +
Sbjct: 62 SSITLHFAMTPMYPYTAPEIEFKNVQNVMDSQLQMLKSEFKKIHNTS--RGQEIIFEITS 119
Query: 137 AAQEFLSEIV 146
QE L E
Sbjct: 120 FTQEKLDEFQ 129
|
| >1wu7_A Histidyl-tRNA synthetase; ligase, structural genomics, dimer; 2.40A {Thermoplasma acidophilum} SCOP: c.51.1.1 d.104.1.1 Length = 434 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-19
Identities = 71/463 (15%), Positives = 148/463 (31%), Gaps = 92/463 (19%)
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLE---IEPMYLL----GDCPQFKRNTV-----KLLTH 841
D ++ ++ + +E + ++ +E + L G+ + +
Sbjct: 19 DMDVEKFIFKTAEEAAEAFGFRRIDFPSLEYLDLYRIKSGE-------ELLQQTYSFVDK 71
Query: 842 GGDLLELSHELRLPFIRWAISNQKSS--FKRYEISSVYRRAIGHSPPN--RY---LQGDF 894
GG + L E +R S + + Y V+R + P RY Q +
Sbjct: 72 GGREVTLIPEATPSTVRMVTSRKDLQRPLRWYSFPKVWR----YEEPQAGRYREHYQFNA 127
Query: 895 DIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAE 954
DI G S +AEV+ + I+ R + +I +N ++E I G+ + V
Sbjct: 128 DIFGSDSPEADAEVIALASSILDRLGLQDIYEIRINSRKIMEEI--IGGMTSSDPFSVFS 185
Query: 955 LLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRG 1014
++ + + L+ + E V+ + + + + + +
Sbjct: 186 IIDRYHKISREEF----------VDQLRSAGIGEDGVSMIADL-----CSGTRGIDEMAR 230
Query: 1015 ALPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFF---------QVFSVKE 1065
+ + + + +++ + VF +
Sbjct: 231 ITGKSSEEIARMAAVED---------LLASY--GVKNVRYDFSIVRGLSYYTGIVFEAYD 279
Query: 1066 KYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPP-SGVGASLALETII---QHY 1121
+ +L GGRYD L M + VG + I +
Sbjct: 280 RSGQ---FRAILG-GGRYDNLASLM-----------SGESVPAVGFGMGDAVISLLLKRE 324
Query: 1122 PVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYA 1181
V SV +C G E +L E + + + L+ Q +YA
Sbjct: 325 NVQIP----REKKSVYICRVGKINSS-IMNEYSRKLRERGMNVTVEIM-ERGLSAQLKYA 378
Query: 1182 SEHDIKCLVILTDTGAQKGLVKVRHLDVKKEKEVQRESLVRFL 1224
S VI + ++G+V +R++ ++ V +S+V L
Sbjct: 379 SAIGADFAVIFGERDLERGVVTIRNMYTGSQENVGLDSVVEHL 421
|
| >3od1_A ATP phosphoribosyltransferase regulatory subunit; structural genomics, PSI-2, protein structure initiative; 1.97A {Bacillus halodurans} Length = 400 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 59/356 (16%), Positives = 116/356 (32%), Gaps = 58/356 (16%)
Query: 837 KLLTHGGDLLELSHELRLPFIRWAISNQKSS---FKRYEISSVYRRAIGHSPP--NRY-- 889
KLL G+ L L ++ P R S+ K + S+VYR +
Sbjct: 70 KLLDQQGNTLVLRPDMTAPIARLVASSLKDRAYPLRLAYQSNVYR----AQQNEGGKPAE 125
Query: 890 -LQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEH 948
Q ++IG +A + EV+ + + + R + + H + A+ +
Sbjct: 126 FEQLGVELIGDGTASADGEVIALMIAALKR-AGLSEFKVAIGHVGYVNALLMDVVGNEQR 184
Query: 949 REKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQA 1008
+++ L K V R+ ++ LNL+ +RL + L G A
Sbjct: 185 ADRLRRFLY-------------EKNYVGYREHVKSLNLSTIDKSRLMNL-LSLRGGRA-A 229
Query: 1009 LPRLRGALPADKPTRKALDEL-----YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSV 1063
+ R L + + AL E+ L + + + D + SY+ + F+ +
Sbjct: 230 IEEAR-GLIQTEKGKTALAEMTKLYEVLESYGASEYVKFDLTLVLHMSYYTGVVFEGYG- 287
Query: 1064 KEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPV 1123
+ L GGRYD LL + P G + ++ +++
Sbjct: 288 -NRLGVP------LCSGGRYDELLSKF-----------HRPAQATGFGVRIDLLVEALNG 329
Query: 1124 DFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYE 1179
+ +E + E +EL + + + +
Sbjct: 330 EIISNGHEQ---TCILF--SNERRFEAIELARKKRANGEAVVLQDLAGVTDVDAMS 380
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 71/350 (20%), Positives = 125/350 (35%), Gaps = 96/350 (27%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDR-ILREVATLS 478
+ ++ LG G FG V LC+ +G + AVK LK +S + + +E+ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILR 78
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
L H+++V+Y G+ T +
Sbjct: 79 NLYHENIVKYK------GI----------------------------CTEDGGNG----I 100
Query: 539 YIQMEYCPR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
+ ME+ P +L++ + + + QI +G+ ++ + +HRDL N+ +
Sbjct: 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 160
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKI 655
+ + +KIGDFGL K + + D++ D V F+ APE + Q K
Sbjct: 161 SEHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPV---------FWYAPECLMQS--KF 206
Query: 656 DEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR---- 711
+D++S G+ EL T + L K P + + L+
Sbjct: 207 YIASDVWSFGVTLHELL----TYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262
Query: 712 ------------LM----SPSPSDRPSATELLQDALPPQMEYELLDNILR 745
LM PS+R S L E + +L+
Sbjct: 263 PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL----------IEGFEALLK 302
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 63/334 (18%), Positives = 119/334 (35%), Gaps = 116/334 (34%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND---------RILRE 473
L DF+ L+ +G G + V+L + K R YA+ ++ +K + + ++ + +
Sbjct: 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAM-RV-VKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 474 VATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKL 533
+ H +V + F+T
Sbjct: 109 AS-----NHPFLVGLHSC-FQT-------------------------------------- 124
Query: 534 ESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQ--------------IVEGLAHIH 579
+ L+ +EY +L +H+ RQ I L ++H
Sbjct: 125 -ESRLFFVIEYVN-------------GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639
+GII+RDL +N+ D+ IK+ D+G+ K E L T T G
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGD--TTST---------FCG 215
Query: 640 TYFYTAPEI--EQGWPKIDEKADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQ---- 690
T Y APEI + + D ++LG++ FE+ PF + +
Sbjct: 216 TPNYIAPEILRGEDY---GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272
Query: 691 ---KGELP-PSWVAKFSEQESLLRRLMSPSPSDR 720
+ ++ P ++ + S+L+ ++ P +R
Sbjct: 273 VILEKQIRIPRSLSV--KAASVLKSFLNKDPKER 304
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 59/266 (22%), Positives = 91/266 (34%), Gaps = 84/266 (31%)
Query: 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL 480
RY E L+ +G G FG VV + +H A+K +R + + + E+ L L
Sbjct: 98 RY----EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH---RQAAEEIRILEHL 150
Query: 481 QHQ------HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
+ Q +V+ + F F N
Sbjct: 151 RKQDKDNTMNVIHMLE-NFT---------------------FRN---------------- 172
Query: 535 STYLYIQMEYCPRTLRQVFE--SYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
++ + E L ++ + + F L I++ L +H IIH DL P N
Sbjct: 173 --HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPEN 230
Query: 593 IFF--DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTY----FYTAP 646
I R+ IK+ DFG + + +V TY FY AP
Sbjct: 231 ILLKQQGRSGIKVIDFGSSCYE----------------------HQRVYTYIQSRFYRAP 268
Query: 647 EIEQGWPKIDEKADMYSLGIVFFELW 672
E+ G DM+SLG + EL
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELL 293
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 81/356 (22%), Positives = 120/356 (33%), Gaps = 107/356 (30%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
+ LG G FG V LC+ G + AVK+ L+ RE+ L L
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDF 85
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V+Y GV+ G L + MEY
Sbjct: 86 IVKYR------GVSYGPGRQS--------------------------------LRLVMEY 107
Query: 545 CPR-TLRQ-VFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
P LR + D QI +G+ ++ + +HRDL NI ++ +K
Sbjct: 108 LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVK 167
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADM 661
I DFGLAK L LD+D + G + F+ APE + ++D+
Sbjct: 168 IADFGLAKLL---PLDKDYYVVREPGQSPI---------FWYAPESLSDN--IFSRQSDV 213
Query: 662 YSLGIVFFELW-----------------HPFSTAMERQIVLSDLKQKGELP-----PSWV 699
+S G+V +EL+ +L L++ LP P+ V
Sbjct: 214 WSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEV 273
Query: 700 AKFSEQESLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSE 751
LM +PSP DRPS + L LD + E
Sbjct: 274 ----------HELMKLCWAPSPQDRPSFSALGPQ----------LDMLWSGSRGCE 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 53/276 (19%), Positives = 91/276 (32%), Gaps = 82/276 (29%)
Query: 417 LPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVAT 476
+RY ++ LG G F V L K+ ++ H A+K +R + E+
Sbjct: 16 YKDARY----ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKL 68
Query: 477 LSRLQ-----------HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSAD 525
L R+ H+++ F + G
Sbjct: 69 LQRVNDADNTKEDSMGANHILKLLD-HF-----NHKGP---------------------- 100
Query: 526 VTGQENKLESTYLYIQMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQ-G 582
++ + E L + + Y+H + +Q++ GL ++H + G
Sbjct: 101 --------NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG 152
Query: 583 IIHRDLTPNNIFFD------ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTG 636
IIH D+ P N+ + IKI D G A + T
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY------------------TN 194
Query: 637 QVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW 672
+ T Y +PE+ G P AD++S + FEL
Sbjct: 195 SIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELI 229
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-16
Identities = 65/323 (20%), Positives = 112/323 (34%), Gaps = 87/323 (26%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
D + +G G FG V + + D AVK R + + + L+E L + H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHP 172
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++VR GV T ++ +YI ME
Sbjct: 173 NIVRLI------GV----------------------------CTQKQ------PIYIVME 192
Query: 544 YCPR-----TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
LR + + G+ ++ + IHRDL N +
Sbjct: 193 LVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK 249
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPE-IEQGWPK 654
N +KI DFG+++ D + G Q +TAPE + G +
Sbjct: 250 NVLKISDFGMSREEA------------DGVYAASGGLRQ----VPVKWTAPEALNYG--R 291
Query: 655 IDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQ 705
++D++S GI+ +E + P+ + Q +++ G LP P V +
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYP-NLSNQQTREFVEKGGRLPCPELCPDAVFR---- 346
Query: 706 ESLLRRLMSPSPSDRPSATELLQ 728
L+ + + P RPS + + Q
Sbjct: 347 --LMEQCWAYEPGQRPSFSTIYQ 367
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 76/328 (23%), Positives = 114/328 (34%), Gaps = 86/328 (26%)
Query: 429 LQPLGHGGFGHVVLCK----NKLDGRHYAVKKIRLKDKSLPVNDR-ILREVATLSRLQHQ 483
++ LG G FG V L N G AVK LK + P + +E+ L L H+
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
H+++Y G + G + L + ME
Sbjct: 94 HIIKYK------GCCEDAGAAS--------------------------------LQLVME 115
Query: 544 YCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
Y P +LR + +L +QI EG+A++H Q IHRDL N+ D +K
Sbjct: 116 YVPLGSLRDYLPRHSIGLAQL-LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVK 174
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADM 661
IGDFGLAK + + + G V F+ APE +++ K +D+
Sbjct: 175 IGDFGLAKAVP---EGHEYYRVREDGDSPV---------FWYAPECLKEY--KFYYASDV 220
Query: 662 YSLGIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR---------- 711
+S G+ +EL T + + LL R
Sbjct: 221 WSFGVTLYELL----THCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKC 276
Query: 712 ------LM----SPSPSDRPSATELLQD 729
LM S RP+ L+
Sbjct: 277 PAEVYHLMKNCWETEASFRPTFENLIPI 304
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 55/263 (20%), Positives = 86/263 (32%), Gaps = 82/263 (31%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ-- 483
+E +G G FG VV ++++ A+K I+ K L ++ EV L +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---NQAQIEVRLLELMNKHDT 112
Query: 484 ----HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
++V + F F N +L
Sbjct: 113 EMKYYIVHLKR-HFM---------------------FRN------------------HLC 132
Query: 540 IQMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQ--GIIHRDLTPNNIFF 595
+ E L + + + L +Q+ L + IIH DL P NI
Sbjct: 133 LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192
Query: 596 --DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTY----FYTAPEIE 649
R+ IKI DFG + L ++ Y FY +PE+
Sbjct: 193 CNPKRSAIKIVDFGSSCQL----------------------GQRIYQYIQSRFYRSPEVL 230
Query: 650 QGWPKIDEKADMYSLGIVFFELW 672
G P D DM+SLG + E+
Sbjct: 231 LGMP-YDLAIDMWSLGCILVEMH 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 78.8 bits (193), Expect = 1e-15
Identities = 51/331 (15%), Positives = 93/331 (28%), Gaps = 44/331 (13%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDR------ILREVATL 477
+ + +G G FG V A+K I ++ L IL E+
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 478 SRLQ---------HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTG 528
L + + G W N SA+
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAW--------DHYNSTKGSANDRP 129
Query: 529 QENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRD 587
K + ++ ++ E+ L Q+ A + Q+ LA HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRD 187
Query: 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
L N+ + K+ K + + T V +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 648 IEQGWPKIDEKADMYSL----GIVFFELWHPFSTAMERQIVLSDLKQKGELPPSWVAKFS 703
+ G D + D+Y L + +HP+S + + + ++
Sbjct: 248 LFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM 305
Query: 704 EQ-----ESLLRRLMSPSPSDRPSATELLQD 729
+Q + R +++ S SAT+LL
Sbjct: 306 KQIKRKIQEFHRTMLNFS-----SATDLLCQ 331
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 73/337 (21%), Positives = 117/337 (34%), Gaps = 100/337 (29%)
Query: 432 LGHGGFGHVVLCKNKLDGRHY-----AVKKIRLKDKSLP-VNDRILREVATLSRLQHQHV 485
LG G FG V + + D AVK ++ S P D +REV + L H+++
Sbjct: 26 LGDGSFGVV--RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+R Y GV V + + E
Sbjct: 84 IRLY------GV----------------------------VLTPP-------MKMVTELA 102
Query: 546 PR-----TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
P LR + HF Q+ EG+ ++ + IHRDL N+ R+
Sbjct: 103 PLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL 159
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKA 659
+KIGDFGL + L + D + V + APE ++ +
Sbjct: 160 VKIGDFGLMRALP---QNDDHYVMQEHRKVPF---------AWCAPESLKTR--TFSHAS 205
Query: 660 DMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGE-LP-----PSWVAKFSEQESLL 709
D + G+ +E++ P+ + +L + ++GE LP P +
Sbjct: 206 DTWMFGVTLWEMFTYGQEPWI-GLNGSQILHKIDKEGERLPRPEDCPQDI---------- 254
Query: 710 RRLM----SPSPSDRPSATEL---LQDALPPQMEYEL 739
+M + P DRP+ L L +A P M E
Sbjct: 255 YNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAEF 291
|
| >3rac_A Histidine-tRNA ligase; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, PSI-BIO; 2.30A {Alicyclobacillus acidocaldarius subsp} Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 63/353 (17%), Positives = 98/353 (27%), Gaps = 56/353 (15%)
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLEIEP-------MYLLGDCPQFKRNTVKLLTHGGDLL 846
+ R V + + L P+ R+ ++L GGD +
Sbjct: 36 FAKRRRAVETRLLSFVEDAGYE--PVTSGLFEYVDTLLRARSPESSRDWIRLFDGGGDAV 93
Query: 847 ELSHELRLPFIRWAISNQKSS---FKRYEISSVYRR----AIGHSPPNRY---LQGDFDI 896
L E+ R A + + VYRR A + Q +
Sbjct: 94 ALRPEMTPSIARMAAPRVAAGRTPIRWCYCERVYRRTDDPASLSWASGKAAESTQVGIER 153
Query: 897 IGG-ASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAEL 955
IG AS + +VL++ + I ++H L+ + GI A
Sbjct: 154 IGEEASVDVDMDVLRLLHEASAAA-GVRHHRIVVSHARLVPRLLDALGISASLSRAFLAC 212
Query: 956 LAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGA 1015
L Q E LL L +AL R
Sbjct: 213 LTSGN--YVQFRELWQLHAAKDVDLLANLLTWSPAERDAAKRSREASDRELEALLRDAVD 270
Query: 1016 LPADKPTRKALDEL-----YLRIWRI-EKNIYIDALMPPIE----SYHRNLFFQVFSVKE 1065
A R A L L + + D Y+ L F++F+
Sbjct: 271 PRAAADVRDAWRYLCRLAEALHDSGLASDVVTFD----LALHRELDYYTGLVFEMFA--P 324
Query: 1066 KYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETII 1118
A +A GGRYD LL + P VG + +E ++
Sbjct: 325 GVGAP------IAQGGRYDELLAQF---------GAGAP--AVGFAFEVERVM 360
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 63/342 (18%), Positives = 114/342 (33%), Gaps = 98/342 (28%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDRILREVATLSR 479
+F++++ LG G FG V +G A+K++R + S N IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMAS 73
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
+ + HV R G+ +
Sbjct: 74 VDNPHVCRLL------GI----------------------------CLTST-------VQ 92
Query: 540 IQMEYCPR-TLRQ-VFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
+ + P L V E D+ + + QI +G+ ++ + ++HRDL N+
Sbjct: 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKID 656
+KI DFGLAK L ++ + + G V + + A E I
Sbjct: 153 PQHVKITDFGLAKLLG----AEEKEYHAEGGKVPI---------KWMALESILHR--IYT 197
Query: 657 EKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQES 707
++D++S G+ +EL P+ + + S L++ LP
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPPICTID--------- 247
Query: 708 LLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILR 745
+ +M RP EL+ + R
Sbjct: 248 -VYMIMRKCWMIDADSRPKFRELI----------IEFSKMAR 278
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 45/192 (23%)
Query: 573 EGLAHIHGQG---IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG 629
GLA++H IIHRD+ NI D + +GDFGLAK
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-----------MDYKDTH 190
Query: 630 VSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL------WHPFSTAMERQI 683
V+ T GT + APE K EK D++ G++ EL + A + +
Sbjct: 191 VT---TAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 684 VLSD----LKQKGELP----PSWVAKFSEQESLLRRLM-------SPSPSDRPSATELLQ 728
+L D L ++ +L + ++E + +L+ SP +RP +E+++
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 729 ----DALPPQME 736
D L + E
Sbjct: 305 MLEGDGLAERWE 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 6/66 (9%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKL-DGRHYAVKKIRLKDKSLPVNDR-ILREVATLSRLQ 481
++F LG GGFG V K +L DG AVK RLK++ + EV +S
Sbjct: 30 DNFSNKNILGRGGFGKVY--KGRLADGTLVAVK--RLKEERTQGGELQFQTEVEMISMAV 85
Query: 482 HQHVVR 487
H++++R
Sbjct: 86 HRNLLR 91
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 3e-14
Identities = 69/357 (19%), Positives = 124/357 (34%), Gaps = 111/357 (31%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
D LG G +G V K AVK LK+ ++ V + L+E A + ++H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEE-FLKEAAVMKEIKHP 276
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+ GV T YI E
Sbjct: 277 NLVQLL------GV----------------------------CT------REPPFYIITE 296
Query: 544 YCPRT-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
+ LR+ + + ++ QI + ++ + IHR+L N
Sbjct: 297 FMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN 354
Query: 599 NDIKIGDFGLAKFLKLEQ--LDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKI 655
+ +K+ DFGL++ + + A FP +TAPE + K
Sbjct: 355 HLVKVADFGLSRLMTGDTYTAHAGAKFP----------------IKWTAPESLAYN--KF 396
Query: 656 DEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQE 706
K+D+++ G++ +E+ P+ ++ V L++ + P V +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKDYRMERPEGCPEKVYE----- 450
Query: 707 SLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDKV 759
LM +PSDRPS E+ Q + + + ++SI D+V
Sbjct: 451 -----LMRACWQWNPSDRPSFAEIHQA----------FETMFQ------ESSISDEV 486
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 45/280 (16%), Positives = 92/280 (32%), Gaps = 56/280 (20%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYY 489
+ +G GGFG + L A ++++ + + E+ R+ +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKD---CI 96
Query: 490 QAWFETGVADFDG-DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRT 548
+ W E D+ G +GSG +Y ++ ME
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFK-------------------GRSYRFMVMERLGID 137
Query: 549 LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND--IKIGDF 606
L+++ F K L ++++ L +IH +H D+ N+ +N + + D+
Sbjct: 138 LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADY 197
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA----PEIEQGWPKIDEKADMY 662
GL+ + + + G GT +T+ + ++D+
Sbjct: 198 GLSYRYCPNGNHKQ--YQEN------PRKGHNGTIEFTSLDAHKGVALSR-----RSDVE 244
Query: 663 SLGIVFFEL------WH-----PFSTAMERQIVLSDLKQK 691
LG W P + + +L +L Q
Sbjct: 245 ILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQS 284
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 69/367 (18%), Positives = 131/367 (35%), Gaps = 82/367 (22%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDRILREVATLSR 479
+F++++ LG G FG V +G A+K++R + S N IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMAS 73
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
+ + HV R G+ +
Sbjct: 74 VDNPHVCRLL------GI----------------------------CLTST-------VQ 92
Query: 540 IQMEYCPR-TLRQ-VFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
+ + P L V E D+ + + QI +G+ ++ + ++HRDL N+
Sbjct: 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKID 656
+KI DFGLAK L ++ + + G V + + A E I
Sbjct: 153 PQHVKITDFGLAKLLG----AEEKEYHAEGGKVPIK---------WMALESILHR--IYT 197
Query: 657 EKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRL 712
++D++S G+ +EL P+ + + S L++ LP + + +
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPPICTID-----VYMI 251
Query: 713 M----SPSPSDRPSATELLQD----ALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIF 764
M RP EL+ + A PQ + + + S D++ Y ++
Sbjct: 252 MVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEED 311
Query: 765 DEETLDM 771
++ +D
Sbjct: 312 MDDVVDA 318
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 68/340 (20%), Positives = 121/340 (35%), Gaps = 91/340 (26%)
Query: 432 LGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRY 488
+G G G V + ++ G+ A+K ++ + L E + + + H +++R
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRT 548
GV VT I EY
Sbjct: 116 E------GV----------------------------VTRGRL------AMIVTEYMENG 135
Query: 549 -----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
LR F + R + G+ ++ G +HRDL N+ D+ K+
Sbjct: 136 SLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMY 662
DFGL++ L + D DAA+ T G + + +TAPE I +D++
Sbjct: 193 SDFGLSRVL---EDDPDAAYTTTGGKIPIR---------WTAPEAIAFR--TFSSASDVW 238
Query: 663 SLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM----S 714
S G+V +E+ P+ M + V+S +++ LP + L +LM
Sbjct: 239 SFGVVMWEVLAYGERPYW-NMTNRDVISSVEEGYRLPAPMGCPHA-----LHQLMLDCWH 292
Query: 715 PSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTS 754
+ RP +++ +LD ++R S T+
Sbjct: 293 KDRAQRPRFSQI----------VSVLDALIRSPESLRATA 322
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 49/252 (19%), Positives = 88/252 (34%), Gaps = 69/252 (27%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ LG G FG V K + AVK ++ + + D +L E + +L + ++
Sbjct: 23 KELGSGNFGTV--KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
VR G+ + + ME
Sbjct: 81 VRMI------GI----------------------------CEAES-------WMLVMEMA 99
Query: 546 PR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIG 604
L + + H + L Q+ G+ ++ +HRDL N+ ++ KI
Sbjct: 100 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 159
Query: 605 DFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPE-IEQGWPKIDEKAD 660
DFGL+K L + D++ Q + + APE I K K+D
Sbjct: 160 DFGLSKAL---RADENYY------------KAQTHGKWPVKWYAPECINYY--KFSSKSD 202
Query: 661 MYSLGIVFFELW 672
++S G++ +E +
Sbjct: 203 VWSFGVLMWEAF 214
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 33/98 (33%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633
G+ +H IHRD+ NI D KI DFGLA+ + +V
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS-------------EKFAQTVM 191
Query: 634 GTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFEL 671
+ VGT Y APE +G +I K+D+YS G+V E+
Sbjct: 192 TSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEI 227
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 1e-05
Identities = 15/58 (25%), Positives = 30/58 (51%), Gaps = 4/58 (6%)
Query: 432 LGHGGFGHVVLCKNKLDGRHYAVKK--IRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
+G GGFG V K ++ AVKK + + + + +E+ +++ QH+++V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 78/382 (20%), Positives = 130/382 (34%), Gaps = 106/382 (27%)
Query: 391 FHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEEL---QPLGHGGFGHVVLCKNKL 447
++ K + S L + E L LG G FG V
Sbjct: 148 YYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEV--WMGTW 205
Query: 448 DGRHY-AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506
+G A+K LK ++ L+E + +L+H+ +V+ Y V
Sbjct: 206 NGTTRVAIKT--LKPGTMSPEA-FLQEAQVMKKLRHEKLVQLY------AV--------- 247
Query: 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRT-----LRQVFESYDHFDK 561
V+ + +YI EY + L+ Y +
Sbjct: 248 -------------------VSEE-------PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 562 ELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQ--LDQ 619
+ QI G+A++ +HRDL NI K+ DFGLA+ ++ + Q
Sbjct: 282 LVDM--AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 620 DAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HP 674
A FP +TAPE G + K+D++S GI+ EL P
Sbjct: 340 GAKFP----------------IKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVP 381
Query: 675 FSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRRLM----SPSPSDRPSATE 725
+ M + VL +++ +P P + LM P +RP+
Sbjct: 382 YP-GMVNREVLDQVERGYRMPCPPECPESLHD----------LMCQCWRKEPEERPTFEY 430
Query: 726 L---LQDALP-PQMEYELLDNI 743
L L+D + +Y+ +N+
Sbjct: 431 LQAFLEDYFTSTEPQYQPGENL 452
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 37/176 (21%)
Query: 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG-VSV 632
GL ++H + IIHRD+ NI D KI DFG++K +S
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK-----------KGTELDQTHLS- 198
Query: 633 DGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMER-QIVLSD- 687
T GT Y PE ++ EK+D+YS G+V FE+ ++ R + L++
Sbjct: 199 --TVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 688 ---LKQKGELP----PSWVAKFSEQESLLRRLM-------SPSPSDRPSATELLQD 729
G+L P+ K + LR+ + S DRPS ++L
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPES--LRKFGDTAVKCLALSSEDRPSMGDVLWK 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-06
Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 15/103 (14%)
Query: 396 VSSRVSQFWKPSVDSGSPNMSLPSSRYL----------NDFEELQPLGHGGFGHVVLCKN 445
+ S+ S+ D+ S + +P Y N+F+ +GHG FG V K
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVY--KG 58
Query: 446 KL-DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
L DG A+K R +S + E+ TLS +H H+V
Sbjct: 59 VLRDGAKVALK--RRTPESSQGIEEFETEIETLSFCRHPHLVS 99
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 61/353 (17%), Positives = 104/353 (29%), Gaps = 102/353 (28%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKSLPVNDRI--LREVATLSRLQHQ 483
+ LG G FG V + K + + AVK LK + +D LRE A + H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMKEFDHP 85
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
HV + GV K + +
Sbjct: 86 HVAKLV------GV----------------------------SLRSRAKGRLPIPMVILP 111
Query: 544 YCP--------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
+ R ++ + L I G+ ++ + IHRDL N
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLV-RFMVDIACGMEYLSSRNFIHRDLAARNCML 170
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPK 654
+ + DFGL++ + D + V + A E +
Sbjct: 171 AEDMTVCVADFGLSRKIY----SGDYYRQGCASKLPVK---------WLALESLADN--L 215
Query: 655 IDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGEL------PPSWVAKFSE 704
+D+++ G+ +E+ P++ +E + + L L
Sbjct: 216 YTVHSDVWAFGVTMWEIMTRGQTPYA-GIENAEIYNYLIGGNRLKQPPECMEE------- 267
Query: 705 QESLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDT 753
+ LM S P RPS T L + L+NIL + +
Sbjct: 268 ----VYDLMYQCWSADPKQRPSFTCLRME----------LENILGHLSVLSTS 306
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 70/334 (20%), Positives = 121/334 (36%), Gaps = 95/334 (28%)
Query: 432 LGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRY 488
+G G FG V + KL + A+K ++ + L E + + + H +++R
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR- 547
GV VT + + I EY
Sbjct: 112 E------GV----------------------------VTKSKP------VMIVTEYMENG 131
Query: 548 TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDF 606
+L +D F + R I G+ ++ G +HRDL NI ++ K+ DF
Sbjct: 132 SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF 191
Query: 607 GLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLG 665
GL + L + D +AA+ T G + + +T+PE I K +D++S G
Sbjct: 192 GLGRVL---EDDPEAAYTTRGGKIPIR---------WTSPEAIAYR--KFTSASDVWSYG 237
Query: 666 IVFFELWH----PFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRRLM--- 713
IV +E+ P+ M Q V+ + + LP P + L +LM
Sbjct: 238 IVLWEVMSYGERPYW-EMSNQDVIKAVDEGYRLPPPMDCP----------AALYQLMLDC 286
Query: 714 -SPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
++RP ++ +LD ++R
Sbjct: 287 WQKDRNNRPKFEQI----------VSILDKLIRN 310
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 66/343 (19%), Positives = 105/343 (30%), Gaps = 118/343 (34%)
Query: 429 LQPLGHGGFGHVVLC--KNKLDGRHY---AVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ LG G FG V L N + AVK LKD +L RE L+ LQH+
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA--LKDPTLAARKDFQREAELLTNLQHE 77
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
H+V++Y GV + L + E
Sbjct: 78 HIVKFY------GV----------------------------CG------DGDPLIMVFE 97
Query: 544 YCP--------RTLRQVFESYDHFDKELAWHLF---------RQIVEGLAHIHGQGIIHR 586
Y R A QI G+ ++ Q +HR
Sbjct: 98 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR 157
Query: 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQD-------AAFPTDTGGVSVDGTGQVG 639
DL N A +KIGDFG+++ + D P +
Sbjct: 158 DLATRNCLVGANLLVKIGDFGMSRDV----YSTDYYRVGGHTMLP-----IR-------- 200
Query: 640 TYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGEL 694
+ PE I K ++D++S G++ +E++ P+ + V+ + Q L
Sbjct: 201 ---WMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWF-QLSNTEVIECITQGRVL 254
Query: 695 P-----PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQ 728
P + +M P R + E+ +
Sbjct: 255 ERPRVCPKE----------VYDVMLGCWQREPQQRLNIKEIYK 287
|
| >1usy_A ATP phosphoribosyltransferase regulatory subunit; aminoacyl-tRNA synthetase; HET: HIS; 2.52A {Thermotoga maritima} SCOP: d.104.1.1 PDB: 1usy_C* Length = 275 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 38/260 (14%), Positives = 74/260 (28%), Gaps = 49/260 (18%)
Query: 837 KLLTHGGDLLELSHELRLPFIRWAISNQKSS-FKRYEISSVYRRAIGHSPPNRYLQGDFD 895
L G+L + + + S K + VYR + Q +
Sbjct: 39 FFLDRKGNLFSIREDFTKTVLNHRKRYSPDSQIKVWYADFVYRYSGSD--LVAEYQLGLE 96
Query: 896 IIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAEL 955
+ S EVL++ ++ + F + + H + E + I + EKV L
Sbjct: 97 KVPRNSLDDSLEVLEIIVESASE-FFEGPVIVEIGHTGVYEDL--LKEIPKDLHEKVLNL 153
Query: 956 LAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGA 1015
+ +K + L + + V ++ R +
Sbjct: 154 I-------------DTKNLAEIEFLSHMKKIDLSRVEKI------------IEDSIYRRS 188
Query: 1016 ---LPADKPTRKALDEL-----YLRIWRIEKNIYID-ALMPPIESYHRNLFFQVFSVKEK 1066
L ++L +L+ ++ ID L I + L F ++
Sbjct: 189 PEHLKTMDLPLSVREDLLSASSFLQEKFPTVSVEIDLTLARTI-EEYCGLIFTIYDTSSS 247
Query: 1067 YPATLVEGTLLAVGGRYDYL 1086
+A GG Y
Sbjct: 248 RL--------VAAGGEYTVN 259
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 63/342 (18%), Positives = 115/342 (33%), Gaps = 107/342 (31%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ + LQ +G G FG V G AVK +K+ + L E + +++L+H
Sbjct: 21 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKC--IKNDATA--QAFLAEASVMTQLRHS 74
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+ GV + ++ LYI E
Sbjct: 75 NLVQLL------GV----------------------------IVEEKG-----GLYIVTE 95
Query: 544 YCPRT-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
Y + LR + + E + ++ G +HRDL N+
Sbjct: 96 YMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 153
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDE 657
N K+ DFGL K + P +TAPE + + K
Sbjct: 154 NVAKVSDFGLTK--EASSTQDTGKLP----------------VKWTAPEALREK--KFST 193
Query: 658 KADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESL 708
K+D++S GI+ +E++ P+ + + V+ +++ ++ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGYKMDAPDGCPPA---------- 242
Query: 709 LRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
+ +M + RPS +L E L++I
Sbjct: 243 VYEVMKNCWHLDAAMRPSFLQLR----------EQLEHIKTH 274
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 73/396 (18%), Positives = 130/396 (32%), Gaps = 111/396 (28%)
Query: 410 SGSPNMSLPSSRYLNDFEEL--------QPLGHGGFGHVVLC--KNKLDGRHY---AVKK 456
S +P + Y+ D E+ + LG G FG V K + A+K
Sbjct: 3 SVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 62
Query: 457 IRLKDKSLPVNDRI--LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASS 514
+ + + + +RI L E + + HVVR GV
Sbjct: 63 --VNEAA-SMRERIEFLNEASVMKEFNCHHVVRLL------GV----------------- 96
Query: 515 TFSNRAASSADVTGQENKLESTYLYIQMEYCP--------RTLRQVFESYDHFDKELAWH 566
V+ + + ME R+LR +
Sbjct: 97 -----------VS------QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 567 LF---RQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAF 623
+ +I +G+A+++ +HRDL N +KIGDFG+ + + + D
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYR 195
Query: 624 PTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTA 678
G + V + +PE ++ G +D++S G+V +E+ P+
Sbjct: 196 KGGKGLLPVR---------WMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQ-G 243
Query: 679 MERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQDALPPQ 734
+ + VL + + G L + L LM +P RPS E+
Sbjct: 244 LSNEQVLRFVMEGGLLDKP--DNCPDM---LFELMRMCWQYNPKMRPSFLEI-------- 290
Query: 735 MEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLD 770
+ + + S Y + + + E LD
Sbjct: 291 --ISSIKEEME--PGFREVSFYYSEENKLPEPEELD 322
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 62/322 (19%), Positives = 108/322 (33%), Gaps = 96/322 (29%)
Query: 432 LGHGGFGHVVLCKNKLDGRHY------AVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+G G FG V K L A+K ++ + L E + + H ++
Sbjct: 52 IGAGEFGEV--YKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+R GV ++ + + I EY
Sbjct: 109 IRLE------GV----------------------------ISKYKP------MMIITEYM 128
Query: 546 PRT-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
LR+ F + R I G+ ++ +HRDL NI ++
Sbjct: 129 ENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV 185
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKA 659
K+ DFGL++ L + D +A + T G + + +TAPE I K +
Sbjct: 186 CKVSDFGLSRVL---EDDPEATYTTSGGKIPIR---------WTAPEAISYR--KFTSAS 231
Query: 660 DMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLR 710
D++S GIV +E+ P+ + V+ + LP P S +
Sbjct: 232 DVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGFRLPTPMDCP----------SAIY 280
Query: 711 RLM----SPSPSDRPSATELLQ 728
+LM + RP +++
Sbjct: 281 QLMMQCWQQERARRPKFADIVS 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 71/394 (18%), Positives = 128/394 (32%), Gaps = 91/394 (23%)
Query: 370 ERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEEL 429
++ + A + Q VS + + +D + Y E +
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392
Query: 430 ---QPLGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ +G G FG V A+K + S V ++ L+E T+ + H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHP 451
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
H+V+ GV +T ++I ME
Sbjct: 452 HIVKLI------GV----------------------------ITENP-------VWIIME 470
Query: 544 YCPR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
C LR + D Q+ LA++ + +HRD+ N+ + + +
Sbjct: 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKAD 660
K+GDFGL+++ ++ + G + + + APE I + +D
Sbjct: 531 KLGDFGLSRY-----MEDSTYYKASKGKLPI---------KWMAPESINFR--RFTSASD 574
Query: 661 MYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM--- 713
++ G+ +E+ PF ++ V+ ++ LP L LM
Sbjct: 575 VWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGERLPMP-----PNCPPTLYSLMTKC 628
Query: 714 -SPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
+ PS RP TEL L IL
Sbjct: 629 WAYDPSRRPRFTEL----------KAQLSTILEE 652
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 69/365 (18%), Positives = 113/365 (30%), Gaps = 111/365 (30%)
Query: 426 FEELQPLGHGGFGHVVLCKN-KLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ- 483
+E + LG G FG VV C + K GRH AVK ++ D+ + E+ L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR---YCEAARSEIQVLEHLNTTD 72
Query: 484 -----HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
V+ + WF + G ++
Sbjct: 73 PNSTFRCVQMLE-WF-----EHHG----------------------------------HI 92
Query: 539 YIQMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
I E + + F + + QI + + +H + H DL P NI F
Sbjct: 93 CIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFV 152
Query: 597 -------------------ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637
DIK+ DFG A + +
Sbjct: 153 QSDYTEAYNPKIKRDERTLINPDIKVVDFG------------SATYDDEH---------- 190
Query: 638 VGTY----FYTAPEI--EQGWPKIDEKADMYSLGIVFFELW--HP-FSTAMERQIVLSDL 688
T Y APE+ GW + D++S+G + E + F T ++ +
Sbjct: 191 HSTLVSTRHYRAPEVILALGW---SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 689 KQKGELPPSWVAK------FSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDN 742
+ G LP + K F S + L + L +E+E L +
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 743 ILRMM 747
+++ M
Sbjct: 308 LIQKM 312
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 66/320 (20%), Positives = 113/320 (35%), Gaps = 95/320 (29%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY-AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
L+ LG G FG V K G++ AVK +K+ S+ ++ +E T+ +L H +V+
Sbjct: 13 LKELGSGQFGVV--KLGKWKGQYDVAVKM--IKEGSMSEDE-FFQEAQTMMKLSHPKLVK 67
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
+Y GV + + +YI EY
Sbjct: 68 FY------GV----------------------------CSKEYP------IYIVTEYISN 87
Query: 548 -TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L S+ + + + EG+A + IHRDL N D +K+ D
Sbjct: 88 GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSD 147
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPE-IEQGWPKIDEKADM 661
FG+ +++ D VGT F ++APE K K+D+
Sbjct: 148 FGMTRYVL----DDQY-------------VSSVGTKFPVKWSAPEVFHYF--KYSSKSDV 188
Query: 662 YSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRRL 712
++ GI+ +E++ P+ V+ + Q L + ++
Sbjct: 189 WAFGILMWEVFSLGKMPY-DLYTNSEVVLKVSQGHRLYRPHLASDT----------IYQI 237
Query: 713 M----SPSPSDRPSATELLQ 728
M P RP+ +LL
Sbjct: 238 MYSCWHELPEKRPTFQQLLS 257
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 60/321 (18%), Positives = 104/321 (32%), Gaps = 97/321 (30%)
Query: 432 LGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
LG G FG V + R A+K ++ + + ++RE + +L + ++VR
Sbjct: 18 LGCGNFGSV--RQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
GV + L + ME
Sbjct: 75 LI------GV----------------------------CQAEA-------LMLVMEMAGG 93
Query: 548 -----TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
L + L Q+ G+ ++ + +HRDL N+ R+ K
Sbjct: 94 GPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK 150
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGG-VSVDGTGQVGTYFYTAPE-IEQGWPKIDEKAD 660
I DFGL+K L D+ + + G + + APE I K ++D
Sbjct: 151 ISDFGLSKALG----ADDSYYTARSAGKWPL---------KWYAPECINFR--KFSSRSD 195
Query: 661 MYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRR 711
++S G+ +E P+ M+ V++ ++Q + P L
Sbjct: 196 VWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQGKRMECPPECP----------PELYA 244
Query: 712 LM----SPSPSDRPSATELLQ 728
LM DRP + Q
Sbjct: 245 LMSDCWIYKWEDRPDFLTVEQ 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 78/382 (20%), Positives = 130/382 (34%), Gaps = 106/382 (27%)
Query: 391 FHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYLNDFEEL---QPLGHGGFGHVVLCKNKL 447
++ K + S L + E L LG G FG V
Sbjct: 231 YYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEV--WMGTW 288
Query: 448 DGRHY-AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMW 506
+G A+K LK ++ L+E + +L+H+ +V+ Y V
Sbjct: 289 NGTTRVAIKT--LKPGTMSPEA-FLQEAQVMKKLRHEKLVQLY------AV--------- 330
Query: 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRT-----LRQVFESYDHFDK 561
V+ + +YI EY + L+ Y +
Sbjct: 331 -------------------VSEE-------PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 364
Query: 562 ELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQ--LDQ 619
+ QI G+A++ +HRDL NI K+ DFGLA+ ++ + Q
Sbjct: 365 LVDM--AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 620 DAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HP 674
A FP +TAPE G + K+D++S GI+ EL P
Sbjct: 423 GAKFP----------------IKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVP 464
Query: 675 FSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRRLM----SPSPSDRPSATE 725
+ M + VL +++ +P P + LM P +RP+
Sbjct: 465 Y-PGMVNREVLDQVERGYRMPCPPECPESLHD----------LMCQCWRKEPEERPTFEY 513
Query: 726 L---LQDALP-PQMEYELLDNI 743
L L+D + +Y+ +N+
Sbjct: 514 LQAFLEDYFTSTEPQYQPGENL 535
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 66/352 (18%), Positives = 108/352 (30%), Gaps = 110/352 (31%)
Query: 429 LQPLGHGGFGHVVLCK-NKLDGRHY----AVKKIRLKDKSLPVNDRI--LREVATLSRL- 480
+ LG G FG VV L AVK LK + + +R + E+ LS L
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSA-HLTEREALMSELKVLSYLG 84
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H ++V G T +
Sbjct: 85 NHMNIVNLL------GA----------------------------CTIGG------PTLV 104
Query: 541 QMEYCP--------RTLRQVFESYDHFDKELAWHLF-----------RQIVEGLAHIHGQ 581
EYC R R F + Q+ +G+A + +
Sbjct: 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164
Query: 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPTDTGGVSVDGTGQV 638
IHRDL NI KI DFGLA+ +K + + +A P
Sbjct: 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP-------------- 210
Query: 639 GTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGE 693
+ APE I ++D++S GI +EL+ P+ +K+
Sbjct: 211 --VKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266
Query: 694 LP-PSWVAKFSEQESLLRRLM----SPSPSDRPSATEL---LQDALPPQMEY 737
+ P + + E + +M P RP+ ++ ++ + +
Sbjct: 267 MLSP----EHAPAE--MYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNH 312
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 51/266 (19%), Positives = 93/266 (34%), Gaps = 68/266 (25%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ-- 483
F ++ +G G FG V+LC++ + ++YAVK +R K E L ++Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---RSAKIEADILKKIQNDDI 93
Query: 484 ---HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
++V+Y+ F + ++ +
Sbjct: 94 NNNNIVKYHG-KF-----MYYD----------------------------------HMCL 113
Query: 541 QMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
E +L ++ ++ F E +I++ L ++ + H DL P NI
Sbjct: 114 IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL--- 170
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTG------GVSVDGTGQVGTY----FYTAPEI 648
+D + + TG G + + G+ Y APE+
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEV 230
Query: 649 --EQGWPKIDEKADMYSLGIVFFELW 672
GW D +DM+S G V EL+
Sbjct: 231 ILNLGW---DVSSDMWSFGCVLAELY 253
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 66/351 (18%), Positives = 120/351 (34%), Gaps = 105/351 (29%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
D LG G +G V K AVK LK+ ++ V + L+E A + ++H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEE-FLKEAAVMKEIKHP 69
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+ GV T + YI E
Sbjct: 70 NLVQLL------GV----------------------------CTREP------PFYIITE 89
Query: 544 YCPRT-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
+ LR+ + + ++ QI + ++ + IHRDL N
Sbjct: 90 FMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 147
Query: 599 NDIKIGDFGLAKFLKLEQ--LDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKI 655
+ +K+ DFGL++ + + A FP +TAPE + K
Sbjct: 148 HLVKVADFGLSRLMTGDTYTAHAGAKFP----------------IKWTAPESLAYN--KF 189
Query: 656 DEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQE 706
K+D+++ G++ +E+ P+ ++ V L++ + P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKDYRMERPEGCP---------- 238
Query: 707 SLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDT 753
+ LM +PSDRPS E+ Q + + + S++
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQA----------FETMFQESSISDEV 279
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 3e-12
Identities = 73/472 (15%), Positives = 138/472 (29%), Gaps = 103/472 (21%)
Query: 303 NNDGGDTEIDRLESFSFASLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQIATEL 362
+ G I E F +L Q ++ D ++ L S+ S
Sbjct: 215 QDKAGKYCIP--EGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPA 272
Query: 363 YNLGIFSERGRDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRY 422
+ + + R + K + P +
Sbjct: 273 HPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDT-SVFESPFSDPEELKDKKLF 331
Query: 423 LNDFEEL---QPLGHGGFGHVVLCKNKLDGRHY--AVKKIRLKDKSLPVNDRILREVATL 477
L L LG G FG V ++ + A+K ++ + + ++RE +
Sbjct: 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIM 390
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+L + ++VR GV +
Sbjct: 391 HQLDNPYIVRLI------GV----------------------------CQAEA------- 409
Query: 538 LYIQMEYCPR-TLRQVF-ESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
L + ME L + + L Q+ G+ ++ + +HR+L N+
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGG-VSVDGTGQVGTYFYTAPE-IEQGWP 653
R+ KI DFGL+K L D+ + + G + + APE I
Sbjct: 470 VNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPL---------KWYAPECINFR-- 514
Query: 654 KIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSE 704
K ++D++S G+ +E P+ M+ V++ ++Q + P
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQGKRMECPPECP-------- 565
Query: 705 QESLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSED 752
L LM DRP + + + + S +
Sbjct: 566 --PELYALMSDCWIYKWEDRPDFLTV----------EQRMRACYYSLASKVE 605
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-12
Identities = 52/255 (20%), Positives = 89/255 (34%), Gaps = 73/255 (28%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ + LQ +G G FG V G AVK +K+ + L E + +++L+H
Sbjct: 193 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVK--CIKNDATA--QAFLAEASVMTQLRHS 246
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V+ GV + ++ LYI E
Sbjct: 247 NLVQLL------GV----------------------------IVEEK-----GGLYIVTE 267
Query: 544 YCPRT-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
Y + LR + + E + ++ G +HRDL N+
Sbjct: 268 YMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 325
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDE 657
N K+ DFGL K + P +TAPE + + K
Sbjct: 326 NVAKVSDFGLTK--EASSTQDTGKLP----------------VKWTAPEALREK--KFST 365
Query: 658 KADMYSLGIVFFELW 672
K+D++S GI+ +E++
Sbjct: 366 KSDVWSFGILLWEIY 380
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 68/349 (19%), Positives = 122/349 (34%), Gaps = 106/349 (30%)
Query: 429 LQPLGHGGFGHVVLCK----NKLDGRHY-AVKKIRLKDKSLPVNDRI--LREVATLSRL- 480
+ LG G FG VV K D AVK LK + +++ + E+ +S L
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LKSTAHA-DEKEALMSELKIMSHLG 107
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
QH+++V G T + +
Sbjct: 108 QHENIVNLL------GA----------------------------CTHGG------PVLV 127
Query: 541 QMEYCP--------RTLRQVFESYDHFDKELAWHLFR-------QIVEGLAHIHGQGIIH 585
EYC R +V E+ F + R Q+ +G+A + + IH
Sbjct: 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH 187
Query: 586 RDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPTDTGGVSVDGTGQVGTYF 642
RD+ N+ + KIGDFGLA+ + + + +A P V
Sbjct: 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP-----VK----------- 231
Query: 643 YTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-P 696
+ APE I ++D++S GI+ +E++ +P+ + +K ++ P
Sbjct: 232 WMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 289
Query: 697 SWVAKFSEQESLLRRLM----SPSPSDRPSATEL---LQDALPPQMEYE 738
F+ + + +M + P+ RP+ ++ LQ+
Sbjct: 290 ----AFAPKN--IYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 58/338 (17%), Positives = 116/338 (34%), Gaps = 105/338 (31%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY-AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
L+ LG G FG V K G++ A+K +K+ S+ ++ + E + L H+ +V+
Sbjct: 29 LKELGTGQFGVV--KYGKWRGQYDVAIKM--IKEGSMSEDE-FIEEAKVMMNLSHEKLVQ 83
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
Y GV T Q ++I EY
Sbjct: 84 LY------GV----------------------------CTKQR------PIFIITEYMAN 103
Query: 548 -TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L H F + + + + E + ++ + +HRDL N + + +K+ D
Sbjct: 104 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSD 163
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPE-IEQGWPKIDEKADM 661
FGL++++ ++ T VG+ F ++ PE + K K+D+
Sbjct: 164 FGLSRYVLDDEY-----------------TSSVGSKFPVRWSPPEVLMYS--KFSSKSDI 204
Query: 662 YSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRRL 712
++ G++ +E++ P+ + Q L + +
Sbjct: 205 WAFGVLMWEIYSLGKMPYE-RFTNSETAEHIAQGLRLYRPHLAS----------EKVYTI 253
Query: 713 M----SPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
M +RP+ LL + +++
Sbjct: 254 MYSCWHEKADERPTFKILL----------SNILDVMDE 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 59/320 (18%), Positives = 109/320 (34%), Gaps = 95/320 (29%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY-AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
+Q +G G FG V + A+K +++ ++ D + E + +L H +V+
Sbjct: 13 VQEIGSGQFGLV--HLGYWLNKDKVAIKT--IREGAMSEED-FIEEAEVMMKLSHPKLVQ 67
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
Y GV Q + + E+
Sbjct: 68 LY------GV----------------------------CLEQA------PICLVTEFMEH 87
Query: 548 -TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L + F E + + EG+A++ +IHRDL N IK+ D
Sbjct: 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSD 147
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPE-IEQGWPKIDEKADM 661
FG+ +F+ +Q T GT F + +PE + K+D+
Sbjct: 148 FGMTRFVLDDQY-----------------TSSTGTKFPVKWASPEVFSFS--RYSSKSDV 188
Query: 662 YSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRRL 712
+S G++ +E++ P+ V+ D+ L + + ++
Sbjct: 189 WSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGFRLYKPRLASTH----------VYQI 237
Query: 713 M----SPSPSDRPSATELLQ 728
M P DRP+ + LL+
Sbjct: 238 MNHCWRERPEDRPAFSRLLR 257
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 69/368 (18%), Positives = 119/368 (32%), Gaps = 115/368 (31%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHY-AVKKIRLKDKSLPVNDRILREVATLSRLQHQ- 483
+E + LG G FG VV C + G+ A+K IR K + E+ L +++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAARLEINVLKKIKEKD 77
Query: 484 -----HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
V WF +F G ++
Sbjct: 78 KENKFLCVLMSD-WF-----NFHG----------------------------------HM 97
Query: 539 YIQMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF- 595
I E + + + + + H+ Q+ L +H + H DL P NI F
Sbjct: 98 CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFV 157
Query: 596 ------------------DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637
I++ DFG A F +
Sbjct: 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFG------------SATFDHEH---------- 195
Query: 638 VGTY----FYTAPEI--EQGWPKIDEKADMYSLGIVFFELW--HP-FSTAMERQIVLSDL 688
T Y PE+ E GW + D++S+G + FE + F T R+ ++
Sbjct: 196 HTTIVATRHYRPPEVILELGW---AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252
Query: 689 KQKGELPPSWV-----AKFSEQESLLRRLMSPS-----PSDRPSATELLQDALPPQMEYE 738
K G +P + K+ + L+ S + +P + +LQD+L ++
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312
Query: 739 LLDNILRM 746
L+ +L
Sbjct: 313 LMRRMLEF 320
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 64/340 (18%), Positives = 112/340 (32%), Gaps = 104/340 (30%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ +G G FG V A+K + S V ++ L+E T+ + H H+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V+ GV +T ++I ME C
Sbjct: 79 VKLI------GV----------------------------ITENP-------VWIIMELC 97
Query: 546 PR-----TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
L+ D Q+ LA++ + +HRD+ N+ + +
Sbjct: 98 TLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC 154
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKA 659
+K+GDFGL+++ ++ + G + + + APE I + +
Sbjct: 155 VKLGDFGLSRY-----MEDSTYYKASKGKLPI---------KWMAPESINFR--RFTSAS 198
Query: 660 DMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLR 710
D++ G+ +E+ PF ++ V+ ++ LP P L
Sbjct: 199 DVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGERLPMPPNCP----------PTLY 247
Query: 711 RLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
LM + PS RP TEL L IL
Sbjct: 248 SLMTKCWAYDPSRRPRFTEL----------KAQLSTILEE 277
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 63/368 (17%), Positives = 117/368 (31%), Gaps = 95/368 (25%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHY----AVKKIRLKDKSLP-VNDRILREVATLSRLQHQH 484
+ LG G FG V +G +K ++DKS + + + L H H
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+VR G+ G L + +Y
Sbjct: 77 IVRLL------GL----------------------------CPGSS-------LQLVTQY 95
Query: 545 CPR-TLRQ-VFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
P +L V + +L + QI +G+ ++ G++HR+L N+ + + ++
Sbjct: 96 LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQ 155
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADM 661
+ DFG+A L D + + A E I G K ++D+
Sbjct: 156 VADFGVADLLP----PDDKQLLYSEAKTPIK---------WMALESIHFG--KYTHQSDV 200
Query: 662 YSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLLRRL 712
+S G+ +EL P++ + V L++ L + +
Sbjct: 201 WSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEKGERLAQPQICTID----------VYMV 249
Query: 713 M----SPSPSDRPSATEL---LQDALPPQMEYELLDNILRM--MHSSEDTSIYDKVVSSI 763
M + RP+ EL Y ++ E + +K + +
Sbjct: 250 MVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEV 309
Query: 764 FDEETLDM 771
E LD+
Sbjct: 310 ELEPELDL 317
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 68/343 (19%), Positives = 120/343 (34%), Gaps = 110/343 (32%)
Query: 429 LQPLGHGGFGHV---VLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ LG G FG V V +K + + AVK + KD +L ++ + E + L H H+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
V+ G+ + + +I ME
Sbjct: 76 VKLI------GI----------------------------IEEEP-------TWIIMELY 94
Query: 546 PR-----TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
P L + + QI + +A++ +HRD+ NI +
Sbjct: 95 PYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC 151
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPE-IEQGWPKID 656
+K+GDFGL+++++ D+D T + +PE I +
Sbjct: 152 VKLGDFGLSRYIE----DEDY-------------YKASVTRLPIKWMSPESINFR--RFT 192
Query: 657 EKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQES 707
+D++ + +E+ PF +E + V+ L++ LP P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFF-WLENKDVIGVLEKGDRLPKPDLCP----------P 241
Query: 708 LLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
+L LM PSDRP TEL+ L ++ +M
Sbjct: 242 VLYTLMTRCWDYDPSDRPRFTELV----------CSLSDVYQM 274
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 66/341 (19%), Positives = 108/341 (31%), Gaps = 113/341 (33%)
Query: 429 LQPLGHGGFGHVVLC--KNKLDGRHY---AVKKIRLKDKSLPVNDRI--LREVATLSRLQ 481
++ LG FG V G A+K LKDK+ R E +RLQ
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKA-EGPLREEFRHEAMLRARLQ 70
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +VV GV VT + L +
Sbjct: 71 HPNVVCLL------GV----------------------------VTKDQP------LSMI 90
Query: 542 MEYCP--------RTLRQVFESYDHFDKELAWHLF---------RQIVEGLAHIHGQGII 584
YC + D QI G+ ++ ++
Sbjct: 91 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV 150
Query: 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPTDTGGVSVDGTGQVGTY 641
H+DL N+ + ++KI D GL + + +L ++ P
Sbjct: 151 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI---------------- 194
Query: 642 FYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP- 695
+ APE I G K +D++S G+V +E++ P+ Q V+ ++ + LP
Sbjct: 195 RWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYC-GYSNQDVVEMIRNRQVLPC 251
Query: 696 ----PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQ 728
P+W + LM + PS RP ++
Sbjct: 252 PDDCPAW----------VYALMIECWNEFPSRRPRFKDIHS 282
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 67/339 (19%), Positives = 106/339 (31%), Gaps = 109/339 (32%)
Query: 429 LQPLGHGGFGHVVLC--KNKLDGRHY---AVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
LG G FG V L N L + AVK LK+ S RE L+ LQHQ
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA--LKEASESARQDFQREAELLTMLQHQ 103
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
H+VR++ GV T E L + E
Sbjct: 104 HIVRFF------GV----------------------------CT------EGRPLLMVFE 123
Query: 544 YCP--------RTLRQVFESYDHFDKELAWHLF--------RQIVEGLAHIHGQGIIHRD 587
Y R+ + + L Q+ G+ ++ G +HRD
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183
Query: 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQ---LDQDAAFPTDTGGVSVDGTGQVGTYFYT 644
L N +KIGDFG+++ + + P + +
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP-----IR-----------WM 227
Query: 645 APE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP---- 695
PE I K ++D++S G+V +E++ P+ + + + Q EL
Sbjct: 228 PPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWY-QLSNTEAIDCITQGRELERPRA 284
Query: 696 -PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQD 729
P + +M P R S ++
Sbjct: 285 CPPE----------VYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 58/372 (15%), Positives = 104/372 (27%), Gaps = 114/372 (30%)
Query: 412 SPNMSLPSSRYLNDFEEL-----QPLGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKS 463
+P + + L + +G G FG V + AVK L +
Sbjct: 8 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRIT 65
Query: 464 LPVNDRI--LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAA 521
+ + L E + H +V+ G+
Sbjct: 66 -DIGEVSQFLTEGIIMKDFSHPNVLSLL------GI------------------------ 94
Query: 522 SSADVTGQENKLESTYLYIQMEYCP--------RTLRQVFESYDHFDKELAWHLFRQIVE 573
E + + Y R D Q+ +
Sbjct: 95 ----CLRSEGSP-----LVVLPYMKHGDLRNFIRNETHNPTVKDLI------GFGLQVAK 139
Query: 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVD 633
G+ ++ + +HRDL N D + +K+ DFGLA+ + + + + V
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVK 197
Query: 634 GTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDL 688
+ A E ++ K K+D++S G++ +EL P+ + + L
Sbjct: 198 ---------WMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYP-DVNTFDITVYL 245
Query: 689 KQKGELP-----PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQDALPPQMEYEL 739
Q L P L +M P RPS +EL+
Sbjct: 246 LQGRRLLQPEYCP----------DPLYEVMLKCWHPKAEMRPSFSELV----------SR 285
Query: 740 LDNILRMMHSSE 751
+ I
Sbjct: 286 ISAIFSTFIGEH 297
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 79/323 (24%), Positives = 112/323 (34%), Gaps = 101/323 (31%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY-AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
++ LG G FG V +G AVK LK S+ + L E + +LQHQ +VR
Sbjct: 18 VERLGAGQFGEV--WMGYYNGHTKVAVKS--LKQGSMSPDA-FLAEANLMKQLQHQRLVR 72
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
Y V VT + +YI EY
Sbjct: 73 LY------AV----------------------------VTQEP-------IYIITEYMEN 91
Query: 548 T-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
L+ S + QI EG+A I + IHRDL NI K
Sbjct: 92 GSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPE-IEQGWPKIDEK 658
I DFGLA+ ++ + T + G F +TAPE I G K
Sbjct: 150 IADFGLARLIEDN-----------------EYTAREGAKFPIKWTAPEAINYG--TFTIK 190
Query: 659 ADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVAKFSEQESLL 709
+D++S GI+ E+ P+ M V+ +L++ + P L
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERGYRMVRPDNCP----------EEL 239
Query: 710 RRLM----SPSPSDRPSATELLQ 728
+LM P DRP+ L
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRS 262
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 66/367 (17%), Positives = 117/367 (31%), Gaps = 108/367 (29%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHY--AVKKIRLKDKSLPVNDRI--LREVATLSRL-QHQH 484
+G G FG V+ + K DG A+K R+K+ + +D E+ L +L H +
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYA-SKDDHRDFAGELEVLCKLGHHPN 87
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++ G + YLY+ +EY
Sbjct: 88 IINLL------GA----------------------------CEHRG------YLYLAIEY 107
Query: 545 CP--------RTLRQVFESYDHFDKELAWHLF---------RQIVEGLAHIHGQGIIHRD 587
P R R + + G+ ++ + IHRD
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167
Query: 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
L NI KI DFGL++ Q+ G + V + A E
Sbjct: 168 LAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVR---------WMAIE 211
Query: 648 -IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKF 702
+ +D++S G++ +E+ P+ M + L Q L
Sbjct: 212 SLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLEKP--LNC 266
Query: 703 SEQESLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDK 758
++ + LM P +RPS ++ L+ +L + +T++Y+K
Sbjct: 267 DDE---VYDLMRQCWREKPYERPSFAQI----------LVSLNRMLEERKTYVNTTLYEK 313
Query: 759 VVSSIFD 765
+ D
Sbjct: 314 FTYAGID 320
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-11
Identities = 61/254 (24%), Positives = 88/254 (34%), Gaps = 77/254 (30%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHY-AVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVR 487
+ LG G FG V + AVK +K S+ V L E + LQH +V+
Sbjct: 193 EKKLGAGQFGEV--WMATYNKHTKVAVKT--MKPGSMSVEA-FLAEANVMKTLQHDKLVK 247
Query: 488 YYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR 547
+ V VT + +YI E+ +
Sbjct: 248 LH------AV----------------------------VTKEP-------IYIITEFMAK 266
Query: 548 T-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
L+ + QI EG+A I + IHRDL NI A K
Sbjct: 267 GSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCK 324
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF---YTAPE-IEQGWPKIDEK 658
I DFGLA+ ++ + T + G F +TAPE I G K
Sbjct: 325 IADFGLARVIEDN-----------------EYTAREGAKFPIKWTAPEAINFG--SFTIK 365
Query: 659 ADMYSLGIVFFELW 672
+D++S GI+ E+
Sbjct: 366 SDVWSFGILLMEIV 379
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 34/195 (17%), Positives = 57/195 (29%), Gaps = 51/195 (26%)
Query: 429 LQPLGHGGFGHVVLCK-NKLDGR--HYAVKKIRLKDKSLPVNDRI--LREVATLSRLQHQ 483
+ LG G FG V+ + DG AVK +K + + L E A + H
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V+R GV + + + +
Sbjct: 97 NVIRLL------GV----------------------------CI-EMSSQGIPKPMVILP 121
Query: 544 YCP--------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
+ R + L I G+ ++ + +HRDL N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLL-KFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 596 DARNDIKIGDFGLAK 610
+ + DFGL+K
Sbjct: 181 RDDMTVCVADFGLSK 195
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 64/361 (17%), Positives = 121/361 (33%), Gaps = 115/361 (31%)
Query: 429 LQPLGHGGFGHVVLCK-NKLDGRHY----AVKKIRLKDKSLPVNDRI--LREVATLSRL- 480
+ LG G FG V+ + AVK LK+K+ ++R + E+ +++L
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM--LKEKA-DSSEREALMSELKMMTQLG 106
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H+++V G T +Y+
Sbjct: 107 SHENIVNLL------GA----------------------------CTLSGP------IYL 126
Query: 541 QMEYCP--------RTLRQVFESYDHFDKELAWHLF----------------RQIVEGLA 576
EYC R+ R+ F + + Q+ +G+
Sbjct: 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 186
Query: 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPTDTGGVSVD 633
+ + +HRDL N+ +KI DFGLA+ + + + +A P V
Sbjct: 187 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP-----VK-- 239
Query: 634 GTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDL 688
+ APE + +G K+D++S GI+ +E++ +P+ +
Sbjct: 240 ---------WMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288
Query: 689 KQKGELP-PSWVAKFSEQESLLRRLM----SPSPSDRPSATEL---LQDALPPQMEYELL 740
+ ++ P ++ +E + +M + RPS L L L E
Sbjct: 289 QNGFKMDQP----FYATEE--IYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQ 342
Query: 741 D 741
+
Sbjct: 343 N 343
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 72/389 (18%), Positives = 125/389 (32%), Gaps = 122/389 (31%)
Query: 429 LQPLGHGGFGHVVLCK-NKLDGRHY------AVKKIRLKDKSLPVNDRI--LREVATLSR 479
+PLG G FG VVL + LD AVK LK + D + E+ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDATE-KDLSDLISEMEMMKM 130
Query: 480 L-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+ +H++++ G T L
Sbjct: 131 IGKHKNIINLL------GA----------------------------CTQDG------PL 150
Query: 539 YIQMEYCP--------RTLRQVFESYDH-FDKELAWHLF--------RQIVEGLAHIHGQ 581
Y+ +EY + R Y + L Q+ G+ ++ +
Sbjct: 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 210
Query: 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPTDTGGVSVDGTGQV 638
IHRDL N+ N +KI DFGLA+ + + + P V
Sbjct: 211 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP-----VK------- 258
Query: 639 GTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELWHPFSTA------MERQIVLSDLKQK 691
+ APE + ++D++S G++ LW F+ + + + LK+
Sbjct: 259 ----WMAPEALFDR--IYTHQSDVWSFGVL---LWEIFTLGGSPYPGVPVEELFKLLKEG 309
Query: 692 GELP-PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
+ PS + + L +M PS RP+ +L E LD I+ +
Sbjct: 310 HRMDKPSNC---TNE---LYMMMRDCWHAVPSQRPTFKQL----------VEDLDRIVAL 353
Query: 747 MHSSEDTSIYDKVVSSIFDEETLDMKHHA 775
+ E + T ++ +
Sbjct: 354 TSNQEMGYYHHHHHHDYDIPTTENLYFNG 382
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 8e-11
Identities = 53/398 (13%), Positives = 104/398 (26%), Gaps = 144/398 (36%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ------- 481
++ LG G F V L + + A+K ++ + + L E+ L ++
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY---TETALDEIRLLKSVRNSDPNDP 98
Query: 482 -HQHVVRYYQAWFE-TG--------VADFDGDSMWGSGTLASSTFSNRAASSADVTGQEN 531
+ VV+ F+ +G V + G +
Sbjct: 99 NREMVVQLL-DDFKISGVNGTHICMVFEVLGHHLL------------------------- 132
Query: 532 KLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ-GIIHRDLTP 590
Y + +Q+++GL ++H + IIH D+ P
Sbjct: 133 ----------------KWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKP 175
Query: 591 NNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG---------------- 634
NI A + + T +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 635 ---------------TGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFS 676
T + T Y + E+ G + AD++S + FEL + F
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFE 294
Query: 677 TAMERQIVLSD--LKQK----GELPPSWVAK----------------------------- 701
+ + + G++P +
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354
Query: 702 -----FSEQE-----SLLRRLMSPSPSDRPSATELLQD 729
+S++E L ++ P R +A E L+
Sbjct: 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 51/262 (19%), Positives = 79/262 (30%), Gaps = 76/262 (29%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK--KIRLKDKSLPVNDRILREVATLSRLQ 481
N + + +G G FG + L + G A+K ++ K L E +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH------IESKIYKMMQ 62
Query: 482 H-QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+ W G E Y +
Sbjct: 63 GGVGIPTIR--WC----------------------------------GAEGD----YNVM 82
Query: 541 QMEYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF---D 596
ME +L +F F + L Q++ + +IH + IHRD+ P+N
Sbjct: 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK 142
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSV---DGTGQVGTYFYTAP----EIE 649
N + I DFGLAK + + + GT Y + IE
Sbjct: 143 KGNLVYIIDFGLAK-----------KYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 191
Query: 650 QGWPKIDEKADMYSLGIVFFEL 671
Q + D+ SLG V
Sbjct: 192 QSR-----RDDLESLGYVLMYF 208
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 59/383 (15%), Positives = 107/383 (27%), Gaps = 114/383 (29%)
Query: 405 KPSVDSGSPNMSLPSSRYLNDFEEL-----QPLGHGGFGHVVLCKNKLDGRHY---AVKK 456
+ + +P + + L + +G G FG V + AVK
Sbjct: 65 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124
Query: 457 IRLKDKSLPVNDRI--LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASS 514
L + + + L E + H +V+ G+
Sbjct: 125 --LNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLL------GI----------------- 158
Query: 515 TFSNRAASSADVTGQENKLESTYLYIQMEYCP--------RTLRQVFESYDHFDKELAWH 566
E + + Y R D
Sbjct: 159 -----------CLRSEGSP-----LVVLPYMKHGDLRNFIRNETHNPTVKDLI------G 196
Query: 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTD 626
Q+ +G+ + + +HRDL N D + +K+ DFGLA+ + + D+
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVHNKT 254
Query: 627 TGGVSVDGTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMER 681
+ V + A E ++ K K+D++S G++ +EL P+ +
Sbjct: 255 GAKLPVK---------WMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYP-DVNT 302
Query: 682 QIVLSDLKQKGELP-----PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQDALP 732
+ L Q L P L +M P RPS +EL+
Sbjct: 303 FDITVYLLQGRRLLQPEYCP----------DPLYEVMLKCWHPKAEMRPSFSELVSR--- 349
Query: 733 PQMEYELLDNILRMMHSSEDTSI 755
+ I +
Sbjct: 350 -------ISAIFSTFIGEHYVHV 365
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 72/360 (20%), Positives = 123/360 (34%), Gaps = 112/360 (31%)
Query: 429 LQPLGHGGFGHVVLCK-NKLDGRHY----AVKKIRLKDK-SLPVNDRILREVATLSRL-Q 481
+PLG G FG V+ +D AVK LK+ + + ++ E+ L +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGH 89
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +VV G T L +
Sbjct: 90 HLNVVNLL------GA----------------------------CTKPGGPL-----MVI 110
Query: 542 MEYCP--------RTLRQVFESYDHFDKELAWHLF---------RQIVEGLAHIHGQGII 584
+E+C R+ R F Y ++L Q+ +G+ + + I
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170
Query: 585 HRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPTDTGGVSVDGTGQVGTY 641
HRDL NI +N +KI DFGLA+ + + DA P +
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP-----LK---------- 215
Query: 642 FYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP- 695
+ APE I ++D++S G++ +E++ P+ + LK+ +
Sbjct: 216 -WMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 696 PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSE 751
P ++ E + + M PS RP+ +EL E L N+L+ +
Sbjct: 273 P----DYTTPE--MYQTMLDCWHGEPSQRPTFSEL----------VEHLGNLLQANAQQD 316
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 47/270 (17%), Positives = 86/270 (31%), Gaps = 72/270 (26%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK--KIRLKDKSLPVNDRILR 472
MS ++ ++ + +G G FG + N L+ + A+K R L
Sbjct: 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR------D 54
Query: 473 EVATLSRLQH-QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQEN 531
E T L + Y +F GQE
Sbjct: 55 EYRTYKLLAGCTGIPNVY--YF----------------------------------GQEG 78
Query: 532 KLESTYLYIQMEYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTP 590
+ + ++ +L + + F + +Q++ + IH + +++RD+ P
Sbjct: 79 L----HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKP 134
Query: 591 NNIFFDAR-----NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA 645
+N N I + DFG+ KF + Q + + GT Y +
Sbjct: 135 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY--------REKKNLSGTARYMS 186
Query: 646 PE----IEQGWPKIDEKADMYSLGIVFFEL 671
EQ + D+ +LG VF
Sbjct: 187 INTHLGREQSR-----RDDLEALGHVFMYF 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 46/214 (21%), Positives = 68/214 (31%), Gaps = 75/214 (35%)
Query: 429 LQPLGHGGFGHVVLCK-NKLDGRHY----AVKKIRLKDKSLPVNDRI--LREVATLSRLQ 481
+ LG G FG VV L GR AVK LK+ + P ++ L E L ++
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASP-SELRDLLSEFNVLKQVN 84
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H HV++ Y G + L +
Sbjct: 85 HPHVIKLY------GA----------------------------CSQDG------PLLLI 104
Query: 542 MEYCP--------RTLRQVFESYDHFDKELAWHLF-----------------RQIVEGLA 576
+EY R R+V Y QI +G+
Sbjct: 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164
Query: 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
++ ++HRDL NI +KI DFGL++
Sbjct: 165 YLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 60/368 (16%), Positives = 116/368 (31%), Gaps = 117/368 (31%)
Query: 414 NMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKSLPVNDRI 470
++ +P R + +G G FG V + ++ A+K L + +
Sbjct: 13 DVLIPHER--VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRIT-EMQQVE 67
Query: 471 --LREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTG 528
LRE + L H +V+ G+ +
Sbjct: 68 AFLREGLLMRGLNHPNVLALI------GI----------------------------MLP 93
Query: 529 QENKLESTYLYIQMEYCP--------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580
E ++ + Y R+ ++ D Q+ G+ ++
Sbjct: 94 PEG-----LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS------FGLQVARGMEYLAE 142
Query: 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
Q +HRDL N D +K+ DFGLA+ + LD++
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDI----LDREYYSVQQHR----------HA 188
Query: 641 YF---YTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKG 692
+TA E ++ + K+D++S G++ +EL P+ ++ + L Q
Sbjct: 189 RLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYR-HIDPFDLTHFLAQGR 245
Query: 693 ELP-----PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNI 743
LP P L ++M P+ RP+ L+ ++ I
Sbjct: 246 RLPQPEYCP----------DSLYQVMQQCWEADPAVRPTFRVLV----------GEVEQI 285
Query: 744 LRMMHSSE 751
+ +
Sbjct: 286 VSALLGDH 293
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 52/257 (20%), Positives = 81/257 (31%), Gaps = 66/257 (25%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-H 482
N F + +G G FG + L N A+K +K K + ++L E LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGG 62
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+ WF G E Y + M
Sbjct: 63 TGIPNVR--WF----------------------------------GVEGD----YNVLVM 82
Query: 543 EYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF---DAR 598
+ +L +F + L Q++ + +H + +HRD+ P+N
Sbjct: 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP----EIEQGWPK 654
N + I DFGLAK + Q + + GT Y + IEQ
Sbjct: 143 NQVYIIDFGLAKKYRDTSTHQHIPYR--------ENKNLTGTARYASVNTHLGIEQSR-- 192
Query: 655 IDEKADMYSLGIVFFEL 671
+ D+ SLG V
Sbjct: 193 ---RDDLESLGYVLMYF 206
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 69/358 (19%), Positives = 119/358 (33%), Gaps = 115/358 (32%)
Query: 429 LQPLGHGGFGHVVLCK----NKLDGRHY---AVKKIRLKDKSLPVNDRI--LREVATLSR 479
+PLG G FG VV+ + +K + AVK LKD + D + E+ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATE-KDLSDLVSEMEMMKM 96
Query: 480 L-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+ +H++++ G T L
Sbjct: 97 IGKHKNIINLL------GA----------------------------CTQDG------PL 116
Query: 539 YIQMEYCP--------RTLRQVFESYDHFDKELAWHLF---------RQIVEGLAHIHGQ 581
Y+ +EY R R Y + + Q+ G+ ++ Q
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176
Query: 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLE---QLDQDAAFPTDTGGVSVDGTGQV 638
IHRDL N+ N +KI DFGLA+ + + + P V
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP-----VK------- 224
Query: 639 GTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELWHPFS------TAMERQIVLSDLKQK 691
+ APE + ++D++S G++ +W F+ + + + LK+
Sbjct: 225 ----WMAPEALFDR--VYTHQSDVWSFGVL---MWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 692 GELP-PSWVAKFSEQESLLRRLM----SPSPSDRPSATEL---LQDALPPQMEYELLD 741
+ P+ + + L +M PS RP+ +L L L E LD
Sbjct: 276 HRMDKPANC---TNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 38/190 (20%), Positives = 71/190 (37%), Gaps = 37/190 (19%)
Query: 430 QPLGHGGFGHV-----VLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
P+G GGFG + ++ VK + L E+ R
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL------FTELKFYQRAAKPE 94
Query: 485 VVRYYQAWFETGVADFDG-DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+ Q W T + G WGSG +K +Y ++ M+
Sbjct: 95 QI---QKWIRTRKLKYLGVPKYWGSGL-------------------HDKNGKSYRFMIMD 132
Query: 544 YCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND-- 600
L++++E+ F ++ L +I++ L +IH +H D+ +N+ + +N
Sbjct: 133 RFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192
Query: 601 IKIGDFGLAK 610
+ + D+GLA
Sbjct: 193 VYLVDYGLAY 202
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 50/332 (15%), Positives = 102/332 (30%), Gaps = 96/332 (28%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIR-----LKDKSLPVNDRILREVATLS 478
D + LG G F + + G + + + L ++ + +S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+L H+H+V Y GV +
Sbjct: 68 KLSHKHLVLNY------GV----------------------------CVCGDE------N 87
Query: 539 YIQMEYCPRT-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNI 593
+ E+ L+ ++ + + + +Q+ + + +IH ++ NI
Sbjct: 88 ILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNI 144
Query: 594 --------FFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYF--- 642
IK+ D G++ + L +D
Sbjct: 145 LLIREEDRKTGNPPFIKLSDPGISITV----LPKD------------------ILQERIP 182
Query: 643 YTAPEIEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-PS 697
+ PE + ++ D +S G +E+ P S A++ Q L + + +LP P
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-ALDSQRKLQFYEDRHQLPAPK 241
Query: 698 WVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729
+E +L+ M P RPS +++D
Sbjct: 242 A----AELANLINNCMDYEPDHRPSFRAIIRD 269
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 59/346 (17%), Positives = 112/346 (32%), Gaps = 70/346 (20%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK----DKSLPVNDRILREVATLSRL-QHQH 484
+PLG G FG V+ + + + +K + + ++ E+ L + H +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 485 VVRYYQAWFETG----------------------------VADFDGDSMWGSGTLASSTF 516
VV A + G G + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 517 SNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLA 576
+ + + Q + + D E Q+ +G+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQL---DQDAAFPTDTGGVSVD 633
+ + IHRDL NI +N +KI DFGLA+ + + DA P
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK------- 260
Query: 634 GTGQVGTYFYTAPE-IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDL 688
+ APE I ++D++S G++ +E++ P+ + L
Sbjct: 261 ---------WMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
Query: 689 KQKGELP-PSWVAKFSEQESLLRRLM----SPSPSDRPSATELLQD 729
K+ + P ++ E + + M PS RP+ +EL++
Sbjct: 310 KEGTRMRAP----DYTTPE--MYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 65/356 (18%), Positives = 120/356 (33%), Gaps = 97/356 (27%)
Query: 429 LQPLGHGGFGHVVLC--KNKLDGRHY---AVKKIRLKDKSLPVNDRI--LREVATLSRLQ 481
++ +G G FG V L + AVK LK+++ + + RE A ++
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEA-SADMQADFQREAALMAEFD 108
Query: 482 HQHVVRYYQAWFETGVADFDGDSMW------GSGTLASSTFSNRAASSADVTGQENKLES 535
+ ++V+ GV G M G L S + ++ + +
Sbjct: 109 NPNIVKLL------GVC-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 536 TYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
P L E + RQ+ G+A++ + +HRDL N
Sbjct: 162 RVSSPG----PPPLSC---------AEQL-CIARQVAAGMAYLSERKFVHRDLATRNCLV 207
Query: 596 DARNDIKIGDFGLAKFLKLEQLD-----QDAAFPTDTGGVSVDGTGQVGTYFYTAPE-IE 649
+KI DFGL++ + D + A P + + PE I
Sbjct: 208 GENMVVKIADFGLSR--NIYSADYYKADGNDAIP-----IR-----------WMPPESIF 249
Query: 650 QGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-----PSWVA 700
+ ++D+++ G+V +E++ P+ M + V+ ++ L P
Sbjct: 250 YN--RYTTESDVWAYGVVLWEIFSYGLQPYY-GMAHEEVIYYVRDGNILACPENCPLE-- 304
Query: 701 KFSEQESLLRRLM----SPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSED 752
L LM S P+DRPS + + +L + +
Sbjct: 305 --------LYNLMRLCWSKLPADRPSFCSI----------HRILQRMCERAEGTVG 342
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 67/331 (20%), Positives = 102/331 (30%), Gaps = 97/331 (29%)
Query: 429 LQPLGHGGFGHVV--LCKNKLDGRHY---AVKKIRLKDKSLPVNDRI--LREVATLSRLQ 481
++ LGHG FG V + AVK L + D + L E +S+
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC-SEQDELDFLMEALIISKFN 91
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
HQ++VR GV +S +I
Sbjct: 92 HQNIVRCI------GV----------------------------SL------QSLPRFIL 111
Query: 542 MEYCP--------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNI 593
ME R R H+ R I G ++ IHRD+ N
Sbjct: 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 171
Query: 594 FFDARND---IKIGDFGLAKFLKLEQ---LDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
KIGDFG+A+ + A P V + PE
Sbjct: 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP-----VK-----------WMPPE 215
Query: 648 -IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKF 702
+G K D +S G++ +E++ P+ + Q VL + G + P
Sbjct: 216 AFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTSGGRMDPPKNCP- 271
Query: 703 SEQESLLRRLM----SPSPSDRPSATELLQD 729
+ R+M P DRP+ +L+
Sbjct: 272 ----GPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 45/209 (21%), Positives = 69/209 (33%), Gaps = 70/209 (33%)
Query: 429 LQPLGHGGFGHVV------LCKNKLDGRHY-AVKKIRLKDKSLPVNDRI--LREVATLSR 479
+PLG G FG VV + K+K AVK LKD + D + E+ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATE-KDLSDLVSEMEMMKM 142
Query: 480 L-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+ +H++++ G T L
Sbjct: 143 IGKHKNIINLL------GA----------------------------CTQDG------PL 162
Query: 539 YIQMEYCP--------RTLRQVFESYDHFDKELAWHLF---------RQIVEGLAHIHGQ 581
Y+ +EY R R Y + + Q+ G+ ++ Q
Sbjct: 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 222
Query: 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAK 610
IHRDL N+ N +KI DFGLA+
Sbjct: 223 KCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 38/204 (18%), Positives = 69/204 (33%), Gaps = 55/204 (26%)
Query: 416 SLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK--KIRLKDKSLPVNDRILRE 473
S+ +F + +G G FG + L KN + A+K ++ + L E
Sbjct: 1 SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLH------LE 54
Query: 474 VATLSRLQH-QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENK 532
+L + + Y +F G K
Sbjct: 55 YRFYKQLGSGDGIPQVY--YF----------------------------------GPCGK 78
Query: 533 LESTYLYIQMEYCPRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPN 591
Y + +E +L +F+ D F + + Q++ + ++H + +I+RD+ P
Sbjct: 79 ----YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPE 134
Query: 592 NIFF-----DARNDIKIGDFGLAK 610
N + I I DF LAK
Sbjct: 135 NFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 6e-09
Identities = 95/728 (13%), Positives = 199/728 (27%), Gaps = 233/728 (32%)
Query: 69 DMGYEDLDVSALLLVRCLPGY--PYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNARE 126
+ G +L V + + C +Q P+ L+K + D+++ + +A
Sbjct: 10 ETGEHQYQYKDILSVF-EDAFVDNFDCKDVQDMPKSILSKEEIDHII------MSKDAVS 62
Query: 127 GRVMIFNLVEAAQEFLSEIVPLGQSNESVPGLVTESSSQSFEGSAVSASKSCSSKVPFVY 186
G + +F + + QE E+V Q F + + Y
Sbjct: 63 GTLRLFWTLLSKQE---EMV------------------QKFVEEVLRIN----------Y 91
Query: 187 GFIDLFSGCGESWHWGLGIDENRGVVPSVPSHASDGSNYEVMWRKIDKNVKPLMIPDANQ 246
F+ E R PS+ + Y ++ + +
Sbjct: 92 KFL------MSPIK-----TEQRQ--PSMMT-----RMYIEQRDRLYNDNQVF------- 126
Query: 247 GTALIPSAKLDTVKEENEDDNRSISTTDSSTSPMEEWVENGIKGENRDSL----LQDHGS 302
AK + + + + P + + +G+ G + + +
Sbjct: 127 -------AKYNVSRLQPYL---KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY-- 174
Query: 303 NNDGGDTEIDRLESFSFA----SLGQDQASQDIEKDLILVHLLRLACQSTGSLTDALPQI 358
F +L + +L L +L Q + T
Sbjct: 175 ---------KVQCKMDFKIFWLNLKNCN-----SPETVLEMLQKLLYQIDPNWTSRSDHS 220
Query: 359 ATELYNLGIFSERGRDL-ASKP------------SSQFNKTFNQVFHQKM-VSSR----- 399
+ + R L SKP +++ FN K+ +++R
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN--LSCKILLTTRFKQVT 278
Query: 400 ----VSQFWKPSVDSGSPNMSLPSS-----RYLN-DFEEL-------QPLGHGGFGHVVL 442
+ S+D S ++ +YL+ ++L P
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA--ES 336
Query: 443 CKNKLDG----RHYAVKKI-RLKDKSL----PVNDR-------ILRE-----VATLSRLQ 481
++ L +H K+ + + SL P R + LS +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI- 395
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY-I 540
WF+ + + + S + ++ K + + I
Sbjct: 396 ----------WFD-VIKSDVMVVV--------NKLHKY--SLVE---KQPKESTISIPSI 431
Query: 541 QMEYCPRTL------RQVFESYDHFDKELAWHLFRQIVEG-----LA-HIHGQGIIHRDL 588
+E + R + + Y+ + L ++ + H+ R
Sbjct: 432 YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMT 491
Query: 589 TPNNIFFDARNDIKIGDFGLAKFL--KLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP 646
+F D R FL K+ + + G ++ Q+ Y P
Sbjct: 492 LFRMVFLDFR------------FLEQKIRH----DSTAWNASGSILNTLQQLKFY---KP 532
Query: 647 EIEQGWPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLS---DLKQKGELPPSWVAKFS 703
I PK + + + F +E ++ S DL + + A F
Sbjct: 533 YICDNDPKYERLVN---------AILD-FLPKIEENLICSKYTDLLRIALMAED-EAIFE 581
Query: 704 EQESLLRR 711
E ++R
Sbjct: 582 EAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 7e-09
Identities = 95/697 (13%), Positives = 185/697 (26%), Gaps = 233/697 (33%)
Query: 477 LSRLQHQH--VVRYYQAWFETGVADFD----GDSMWGSGTLASSTFSNRAASSADVTGQE 530
Q+Q+ ++ ++ F V +FD D S S + +
Sbjct: 11 TGEHQYQYKDILSVFEDAF---VDNFDCKDVQDMP-------KSILSKEEID--HIIMSK 58
Query: 531 NKLESTY-LYIQMEYCPRTLRQVF-ESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDL 588
+ + T L+ + + Q F E + + + + + I RD
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 589 TPN-NIFFDARNDIKIGDFGLAKFLKLEQ-LDQDAAFPTDTGGVSVDGTGQVGTYFYTA- 645
N N F N + +LKL Q L + V +DG G +
Sbjct: 119 LYNDNQVFAKYN-VSRLQ----PYLKLRQALLEL----RPAKNVLIDGVLGSGKTWVALD 169
Query: 646 ----PEIEQG------WPKIDEKADMYSLGIVFFELWHPFSTAMERQIVLSDLKQKGELP 695
+++ W + ++ + +L + + + +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID---------PNWTSRSDHS 220
Query: 696 PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSI 755
+ + ++ LRRL+ +P LL +L N+ ++
Sbjct: 221 SNIKLRIHSIQAELRRLL----KSKPYENCLL-----------VLLNV-------QNAKA 258
Query: 756 YDKVVSSIFDEETLDMKHHAGTLRLNRDNTSSIQYSDLDTELRDYVVQV----------T 805
++ F+ L R + L ++
Sbjct: 259 WNA-----FN-------LSCKILLTTRF--KQV-TDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 806 KEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELS---HELRLPFIRWAIS 862
K + K+L+ P D P+ + LS +R W
Sbjct: 304 KSLL----LKYLDCRP----QDLPR--------EVLTTNPRRLSIIAESIRDGLATW--- 344
Query: 863 NQKSSFKRYEISSVYRRAIGHS----PPN----RY-----LQGDFDIIGGASALTEAEVL 909
++K + I S P + I +L
Sbjct: 345 ---DNWKHVNCDKL-TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI--------PTILL 392
Query: 910 KV---------TMDIVTRFFHAESC-------------DIHLN-----------HGDLLE 936
+ M +V + H S I+L H +++
Sbjct: 393 SLIWFDVIKSDVMVVVNK-LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
Query: 937 A--------------------IWSWAG---IKAEHREKVAELLAMMGSLRPQSSEW-KSK 972
+S G EH E++ + R + + K
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR-----FLEQK 506
Query: 973 WVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDELYLR 1032
IR N + +++N LQ L+F + + + P + L L
Sbjct: 507 ---IRHDSTA-WNASGSILNTLQQ--LKF----------YKPYICDNDPKYERLVNAILD 550
Query: 1033 -IWRIEKNIYID--------ALMPPIESYHRNLFFQV 1060
+ +IE+N+ ALM E+ QV
Sbjct: 551 FLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 3e-06
Identities = 60/416 (14%), Positives = 109/416 (26%), Gaps = 125/416 (30%)
Query: 868 FKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDI 927
F+ E Y+ + +FD K D+ E D
Sbjct: 9 FETGEHQYQYKDILSVFEDA--FVDNFDC-------------KDVQDMPKSILSKEEIDH 53
Query: 928 HLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEW-KSKWVVIRRQLLQELNL 986
+ D + +E++ + + + + ++ S +RQ +
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQ--KFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 987 AEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDELYLRIWRIEKNIYIDALM 1046
+RL F A + RL+ P K R+AL EL R KN+ ID +
Sbjct: 112 YIEQRDRLYNDNQVF---AKYNVSRLQ---PYLK-LRQALLEL-----RPAKNVLIDG-V 158
Query: 1047 PPI------------ESYHRNLFFQVF--SVKEKYPATLVEGTLLAVGGRYDYLLHRMWD 1092
+ F++F ++K V L LL+++ D
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK-------LLYQI-D 210
Query: 1093 REYVGYASRT-NPPSGVG-ASLALETIIQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVER 1150
+ + + N + L +++ KP N LLV
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKS-----KPYEN--------------CLLV-- 249
Query: 1151 MELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILT--DTGAQKGLV--KVRH 1206
+ + F ++ C ++LT L H
Sbjct: 250 ---LLNVQNAKAWNAF------------------NLSCKILLTTRFKQVTDFLSAATTTH 288
Query: 1207 LDVKKEKEV--QRESLVRF---------------------LLDAIASQFRN-PSLW 1238
+ + E L IA R+ + W
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 3e-05
Identities = 81/550 (14%), Positives = 155/550 (28%), Gaps = 184/550 (33%)
Query: 727 LQDALPPQMEYELLDNILRMMHSSEDTS-IYDKVVSSIFDEETLDMKHHAGTLRLNRD-N 784
+QD + E +D+I+ + T ++ ++S EE + K LR+N
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK--QEEMVQ-KFVEEVLRINYKFL 94
Query: 785 TSSIQYSDLDTEL--RDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHG 842
S I+ + R Y+ Q + L D F + V
Sbjct: 95 MSPIKTEQRQPSMMTRMYIEQRDR-----------------LYNDNQVFAKYNVS----- 132
Query: 843 GDLLELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSPPNRY--LQGDFDIIGGA 900
L+ +LR A+ + P + + G G+
Sbjct: 133 --RLQPYLKLRQ-----ALLELR--------------------PAKNVLIDGV----LGS 161
Query: 901 --SALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAM 958
+ + +V + + + I W +K + + +L M
Sbjct: 162 GKTWVA-LDVCL-SYKVQCKM----DFKIF------------WLNLKNCNSPE--TVLEM 201
Query: 959 MGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPA 1018
+ L I + + + R+ LR L
Sbjct: 202 LQKL----------LYQIDPNWTSRSDHSSNIKLRI-----------HSIQAELRRLL-K 239
Query: 1019 DKPTRKAL---DELY-LRIW-------RI-----EKNIYIDALMPPIESYHRNLFFQVFS 1062
KP L + + W +I K + D L ++ +
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV-TDFLSAATTTH-------ISL 291
Query: 1063 VKEKYPATLVEG-TLLAVGGRYDYLLHRMWD--REYVGYASRTNPP--SGVGASLALETI 1117
T E +LL YL R D RE TNP S + S+
Sbjct: 292 DHHSMTLTPDEVKSLLL-----KYLDCRPQDLPRE----VLTTNPRRLSIIAESIRDGLA 342
Query: 1118 IQHYPVDFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQF---------VP 1168
+K V + T+++ S + L + F
Sbjct: 343 TWDN---WKHVNCDKLTTIIESS-------------LNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 1169 VPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVR-----------HLDVKKEKEVQR 1217
+P L+ + + D+ ++ + + LV+ + +L++K + E
Sbjct: 387 IPTILLSLIWFDVIKSDVM---VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE-NE 442
Query: 1218 ESLVRFLLDA 1227
+L R ++D
Sbjct: 443 YALHRSIVDH 452
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 71/389 (18%), Positives = 120/389 (30%), Gaps = 99/389 (25%)
Query: 373 RDLASKPSSQFNKTFNQVFHQKMVSSRVSQFWKPSVDSGSPNMSLPSSRYL--NDFEELQ 430
+L + + + K+ +S + + P+ S+ + + + ++
Sbjct: 18 ENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIR 77
Query: 431 PLGHGGFGHVV--LCKNKLDGRHY---AVKKIRLKDKSLPVNDRI--LREVATLSRLQHQ 483
LGHG FG V + AVK L + D + L E +S+ HQ
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVC-SEQDELDFLMEALIISKFNHQ 134
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++VR GV +S +I +E
Sbjct: 135 NIVRCI------GV----------------------------SL------QSLPRFILLE 154
Query: 544 YCP--------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
R R H+ R I G ++ IHRD+ N
Sbjct: 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL 214
Query: 596 DARND---IKIGDFGLAKFLKLEQ---LDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE-I 648
KIGDFG+A+ + A P V + PE
Sbjct: 215 TCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP-----VK-----------WMPPEAF 258
Query: 649 EQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSE 704
+G K D +S G++ +E++ P+ + Q VL + G + P
Sbjct: 259 MEG--IFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTSGGRMDPPKNCP--- 312
Query: 705 QESLLRRLM----SPSPSDRPSATELLQD 729
+ R+M P DRP+ +L+
Sbjct: 313 --GPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 24/193 (12%), Positives = 61/193 (31%), Gaps = 43/193 (22%)
Query: 430 QPLGHGGFGHV--------VLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ 481
G + + C + + +++K + R+ E R
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-------LDAKDGRLFNEQNFFQRAA 100
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
V ++ + T + + G G ++K Y ++
Sbjct: 101 KPLQVNKWKKLYSTPLLAIP--TCMGFGV------------------HQDK----YRFLV 136
Query: 542 MEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA-- 597
+ R+L+ + + + ++++ L +H +H ++T NIF D
Sbjct: 137 LPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED 196
Query: 598 RNDIKIGDFGLAK 610
++ + + +G A
Sbjct: 197 QSQVTLAGYGFAF 209
|
| >2dax_A Protein C21ORF6; RWD domain, alpha+beta sandwich fold, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.20.1.3 Length = 152 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 19/148 (12%)
Query: 24 SSSTVDDNELLSEEITALCAIF-----------------QEDCKVVSGSPPQILVKLRPY 66
S S+ + E E+ L ++F ++ + + V
Sbjct: 3 SGSSGEQAEAQLAELDLLASMFPGENELIVNDQLAVAELKDCIEKKTMEGRSSKVYFTIN 62
Query: 67 SKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNARE 126
++ L YP P++ + L++S L L +
Sbjct: 63 MNLDVSDEKMAMFSLACILPFKYPAVLPEITVRSV-LLSRSQQTQLNTDLTAFLQKHCH- 120
Query: 127 GRVMIFNLVEAAQEFLSEIVPLGQSNES 154
G V I N E +E S V S+
Sbjct: 121 GDVCILNATEWVREHASGYVSRDTSSSG 148
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 24/73 (32%), Positives = 35/73 (47%), Gaps = 11/73 (15%)
Query: 540 IQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
I M Y + + V E + ++A +I E + +H +IH DLT +N FD
Sbjct: 416 IMMSYINGKLAKDVIED----NLDIA----YKIGEIVGKLHKNDVIHNDLTTSNFIFD-- 465
Query: 599 NDIKIGDFGLAKF 611
D+ I DFGL K
Sbjct: 466 KDLYIIDFGLGKI 478
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1239 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-51 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-49 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-25 | |
| d2daya1 | 115 | d.20.1.3 (A:8-122) E3 ubiquitin-protein ligase RNF | 6e-20 | |
| d1ukxa_ | 137 | d.20.1.3 (A:) EIF2-alpha kinase 4 (GCN2-like prote | 9e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-14 | |
| d1usya_ | 275 | d.104.1.1 (A:) ATP phosphoribosyltransferase regul | 2e-10 | |
| d2daxa1 | 140 | d.20.1.3 (A:8-147) Uncharacterized protein C21orf6 | 2e-08 | |
| d1h4vb2 | 324 | d.104.1.1 (B:2-325) Histidyl-tRNA synthetase (HisR | 4e-08 | |
| d1wu7a2 | 327 | d.104.1.1 (A:3-329) Histidyl-tRNA synthetase (HisR | 7e-08 | |
| d2dawa1 | 141 | d.20.1.3 (A:8-148) RWD domain-containing protein 2 | 8e-08 | |
| d2vgla_ | 584 | a.118.1.10 (A:) Adaptin alpha C subunit N-terminal | 1e-07 | |
| d1qe0a2 | 325 | d.104.1.1 (A:1-325) Histidyl-tRNA synthetase (HisR | 1e-05 | |
| d1kmma2 | 322 | d.104.1.1 (A:4-325) Histidyl-tRNA synthetase (HisR | 4e-05 | |
| d1z7ma1 | 318 | d.104.1.1 (A:6-323) ATP phosphoribosyltransferase | 2e-04 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-58
Identities = 72/312 (23%), Positives = 124/312 (39%), Gaps = 58/312 (18%)
Query: 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ 481
++ D++ +Q LG G +G V L N++ AVK + +++ + I +E+ L
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLN 61
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H++VV++Y E Y+
Sbjct: 62 HENVVKFYGHRRE----------------------------------------GNIQYLF 81
Query: 542 MEYCPRTL-RQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
+EYC E + A F Q++ G+ ++HG GI HRD+ P N+ D R++
Sbjct: 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 141
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+KI DFGLA + ++ GT Y APE+ + E D
Sbjct: 142 LKISDFGLATVFRYNNRERLL-------------NKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 661 MYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
++S GIV + P+ + SD K+K W S +LL +++ +P
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENP 248
Query: 718 SDRPSATELLQD 729
S R + ++ +D
Sbjct: 249 SARITIPDIKKD 260
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 71/312 (22%), Positives = 123/312 (39%), Gaps = 66/312 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQ 481
L DFE +PLG G FG+V L + K A+K + + V ++ REV S L+
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H +++R Y + + +T +Y+
Sbjct: 65 HPNILRLYGYFHD----------------------------------------ATRVYLI 84
Query: 542 MEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
+EY P T+ + + FD++ ++ L++ H + +IHRD+ P N+ + +
Sbjct: 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE 144
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+KI DFG + + GT Y PE+ +G DEK D
Sbjct: 145 LKIADFGWSVHAPSSRRTT-----------------LCGTLDYLPPEMIEGRM-HDEKVD 186
Query: 661 MYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
++SLG++ +E PF ++ + + P L+ RL+ +P
Sbjct: 187 LWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA---RDLISRLLKHNP 243
Query: 718 SDRPSATELLQD 729
S RP E+L+
Sbjct: 244 SQRPMLREVLEH 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 4e-55
Identities = 74/354 (20%), Positives = 127/354 (35%), Gaps = 75/354 (21%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN-DRILREVATLSRLQHQH 484
F +L+ +GHG FG V ++ + A+KK+ K I++EV L +L+H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++Y + ++ MEY
Sbjct: 77 TIQYRGCYLREH----------------------------------------TAWLVMEY 96
Query: 545 CPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
C + + E + + + ++GLA++H +IHRD+ NI +K+
Sbjct: 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 156
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP--KIDEKADM 661
GDFG A + VGT ++ APE+ + D K D+
Sbjct: 157 GDFGSASIMA-------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 662 YSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSP 717
+SLGI EL P + + E P +SE + + + P
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSAL--YHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255
Query: 718 SDRPSATELLQD-----ALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDE 766
DRP++ LL+ PP + +L+ + D Y K+ +F E
Sbjct: 256 QDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR-ELDNLQYRKMKKILFQE 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 74/318 (23%), Positives = 129/318 (40%), Gaps = 69/318 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
D+E L +G G +G + K DG+ K++ + ++ EV L L+H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+VRYY + +T LYI MEY
Sbjct: 65 IVRYYDRIIDR--------------------------------------TNTTLYIVMEY 86
Query: 545 CPRT-----LRQVFESYDHFDKELAWHLFRQIVEGLAHIH-----GQGIIHRDLTPNNIF 594
C + + + + D+E + Q+ L H G ++HRDL P N+F
Sbjct: 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 146
Query: 595 FDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654
D + ++K+GDFGLA+ L + + VGT +Y +PE
Sbjct: 147 LDGKQNVKLGDFGLARILNHD---------------TSFAKAFVGTPYYMSPEQMNRMS- 190
Query: 655 IDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR 711
+EK+D++SLG + +EL PF+ ++++ + K P + E ++ R
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD--ELNEIITR 248
Query: 712 LMSPSPSDRPSATELLQD 729
+++ RPS E+L++
Sbjct: 249 MLNLKDYHRPSVEEILEN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-53
Identities = 65/320 (20%), Positives = 112/320 (35%), Gaps = 67/320 (20%)
Query: 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATL 477
R+L F+ +G G F V + A +++ + + R E L
Sbjct: 6 NDGRFL-KFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML 62
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
LQH ++VR+Y +W T
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGK------------------------------------KC 86
Query: 538 LYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIH--GQGIIHRDLTPNNIF 594
+ + E TL+ + + ++ RQI++GL +H IIHRDL +NIF
Sbjct: 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 146
Query: 595 FDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653
+KIGD GLA + +GT + APE+ +
Sbjct: 147 ITGPTGSVKIGDLGLATLKRASFA-----------------KAVIGTPEFMAPEMYEE-- 187
Query: 654 KIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLL 709
K DE D+Y+ G+ E+ +P+S + + G P S+ + + ++
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-SGVKPASFDKVAIPEVKEII 246
Query: 710 RRLMSPSPSDRPSATELLQD 729
+ + +R S +LL
Sbjct: 247 EGCIRQNKDERYSIKDLLNH 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 5e-52
Identities = 61/316 (19%), Positives = 110/316 (34%), Gaps = 67/316 (21%)
Query: 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATL 477
P +Y + +G G G V + G+ A++++ L+ + P + I+ E+ +
Sbjct: 18 PKKKY----TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVM 71
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
++ ++V Y ++
Sbjct: 72 RENKNPNIVNYLDSYLVGD----------------------------------------E 91
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
L++ MEY + D+ + R+ ++ L +H +IHRD+ +NI
Sbjct: 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
+K+ DFG + EQ + + VGT ++ APE+
Sbjct: 152 DGSVKLTDFGFCAQITPEQSKR---------------STMVGTPYWMAPEVVTRKA-YGP 195
Query: 658 KADMYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLM 713
K D++SLGI+ E+ P+ + L + G K S L R +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 714 SPSPSDRPSATELLQD 729
R SA ELLQ
Sbjct: 255 DMDVEKRGSAKELLQH 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (466), Expect = 1e-51
Identities = 63/323 (19%), Positives = 125/323 (38%), Gaps = 67/323 (20%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREV 474
+ + L+ ++ + LG G FG V + G ++A K + +S + + +E+
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEI 74
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
T+S L+H +V + A+ +
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDN-------------------------------------- 96
Query: 535 STYLYIQMEYCPRT--LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
+ + E+ +V + ++ ++ A RQ+ +GL H+H +H DL P N
Sbjct: 97 --EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154
Query: 593 IFFDARND--IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQ 650
I F + +K+ DFGL L +Q + GT + APE+ +
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKV----------------TTGTAEFAAPEVAE 198
Query: 651 GWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-E 706
G P + DM+S+G++ + L PF + + + + + S + SE +
Sbjct: 199 GKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 707 SLLRRLMSPSPSDRPSATELLQD 729
+R+L+ P+ R + + L+
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEH 280
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 2e-51
Identities = 64/314 (20%), Positives = 111/314 (35%), Gaps = 66/314 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
+E + LG G FG V +NK A K I K + + + E+ L+ H +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPN 70
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
+V+ A++ L+I +E+
Sbjct: 71 IVKLLDAFYYEN----------------------------------------NLWILIEF 90
Query: 545 CPRTL--RQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
C + E + + +Q ++ L ++H IIHRDL NI F DIK
Sbjct: 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIK 150
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW----PKIDEK 658
+ DFG++ + +GT ++ APE+ D K
Sbjct: 151 LADFGVSAKNTRTIQRR---------------DSFIGTPYWMAPEVVMCETSKDRPYDYK 195
Query: 659 ADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSP 715
AD++SLGI E+ P +++L K + S + L++ +
Sbjct: 196 ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK 255
Query: 716 SPSDRPSATELLQD 729
+ R + ++LLQ
Sbjct: 256 NVDARWTTSQLLQH 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 4e-51
Identities = 66/351 (18%), Positives = 125/351 (35%), Gaps = 105/351 (29%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+DFE++ LG G G V +K G A K I L+ K + ++I+RE+ L
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIRELQVLHECNSP 64
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V +Y A++ G + I ME
Sbjct: 65 YIVGFYGAFYSDG----------------------------------------EISICME 84
Query: 544 YCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIH-GQGIIHRDLTPNNIFFDARNDI 601
+ +L QV + +++ + +++GL ++ I+HRD+ P+NI ++R +I
Sbjct: 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
K+ DFG++ L VGT Y +PE QG ++D+
Sbjct: 145 KLCDFGVSGQLIDSMA-----------------NSFVGTRSYMSPERLQGTH-YSVQSDI 186
Query: 662 YSLGIVFFELW---HPFSTAMERQIV---------------------------------- 684
+S+G+ E+ +P +++
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRP 246
Query: 685 ------LSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQ 728
L D P FS + + + + + +P++R +L+
Sbjct: 247 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 9e-51
Identities = 59/348 (16%), Positives = 115/348 (33%), Gaps = 76/348 (21%)
Query: 415 MSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREV 474
+ P ++ +E+L +G G FG V +++ G+ A+KK+ ++++ LRE+
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 475 ATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
L L+H++VV +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKG------------------------------ 90
Query: 535 STYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNI 593
+Y+ ++C + F + + ++ GL +IH I+HRD+ N+
Sbjct: 91 --SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 148
Query: 594 FFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653
+K+ DFGLA+ L + Q + +V T +Y PE+ G
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTN-----------RVVTLWYRPPELLLGER 197
Query: 654 KIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQE---- 706
D++ G + E+W E+ + + G + P E
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257
Query: 707 -------------------------SLLRRLMSPSPSDRPSATELLQD 729
L+ +L+ P+ R + + L
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 1e-49
Identities = 74/316 (23%), Positives = 115/316 (36%), Gaps = 62/316 (19%)
Query: 418 PSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVAT 476
P + DF+ + LG G F VVL + R YA+K + + + RE
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 477 LSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST 536
+SRL H V+ Y + +
Sbjct: 62 MSRLDHPFFVKLYFTFQDDE---------------------------------------- 81
Query: 537 YLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
LY + Y L + FD+ +IV L ++HG+GIIHRDL P NI
Sbjct: 82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 141
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKI 655
+ I+I DFG AK L E A VGT Y +PE+
Sbjct: 142 NEDMHIQITDFGTAKVLSPESKQARA-------------NSFVGTAQYVSPELLTEKS-A 187
Query: 656 DEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRL 712
+ +D+++LG + ++L PF E I +K + + P + F + L+ +L
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF---FPKARDLVEKL 244
Query: 713 MSPSPSDRPSATELLQ 728
+ + R E+
Sbjct: 245 LVLDATKRLGCEEMEG 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 2e-49
Identities = 59/315 (18%), Positives = 116/315 (36%), Gaps = 67/315 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ ++ L+ LG G FG V C K GR + K I + E++ +++L H
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHH 85
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++ + A+ + + + +
Sbjct: 86 PKLINLHDAFEDKY----------------------------------------EMVLIL 105
Query: 543 EYCP-RTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
E+ L + D+ + + RQ EGL H+H I+H D+ P NI + +
Sbjct: 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA 165
Query: 601 --IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
+KI DFGLA L +++ + T + APEI P +
Sbjct: 166 SSVKIIDFGLATKLNPDEIVKV----------------TTATAEFAAPEIVDREP-VGFY 208
Query: 659 ADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMS 714
DM+++G++ + L PF+ + + + + + E + S + + ++ L+
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 268
Query: 715 PSPSDRPSATELLQD 729
P R + + L+
Sbjct: 269 KEPRKRLTVHDALEH 283
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 62/315 (19%), Positives = 107/315 (33%), Gaps = 67/315 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
Q +G G FG V K AVK + + + EV L + +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+++ + + L I +
Sbjct: 65 NILLFMGYS-----------------------------------------TAPQLAIVTQ 83
Query: 544 YCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
+C +L + F+ + RQ +G+ ++H + IIHRDL NNIF +
Sbjct: 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTV 143
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK--IDEKA 659
KIGDFGLA S G+ + APE+ + K ++
Sbjct: 144 KIGDFGLATVK-------------SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 660 DMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELP--PSWVAKFSEQ-ESLLRRLM 713
D+Y+ GIV +EL P+S R ++ + + P + + + L+ +
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250
Query: 714 SPSPSDRPSATELLQ 728
+RP ++L
Sbjct: 251 KKKRDERPLFPQILA 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 7e-49
Identities = 62/323 (19%), Positives = 113/323 (34%), Gaps = 74/323 (22%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-------VNDRILREVATL 477
++E + LG G V C +K + YAVK I + + + L+EV L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 478 SRLQ-HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST 536
++ H ++++ +ET T
Sbjct: 64 RKVSGHPNIIQLKD-TYETN---------------------------------------T 83
Query: 537 YLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
+ ++ + + L ++ + R ++E + +H I+HRDL P NI
Sbjct: 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL 143
Query: 596 DARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW--- 652
D +IK+ DFG + L + GT Y APEI +
Sbjct: 144 DDDMNIKLTDFGFSCQLDPGEKL----------------REVCGTPSYLAPEIIECSMND 187
Query: 653 --PKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-E 706
P ++ DM+S G++ + L PF + ++ + + +S+ +
Sbjct: 188 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 247
Query: 707 SLLRRLMSPSPSDRPSATELLQD 729
L+ R + P R +A E L
Sbjct: 248 DLVSRFLVVQPQKRYTAEEALAH 270
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 2e-48
Identities = 66/351 (18%), Positives = 130/351 (37%), Gaps = 69/351 (19%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ ++ LG G F V+L ++K + A+K I K + E+A L +++H
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHP 67
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
++V + G +LY+ M+
Sbjct: 68 NIVALDDIYESGG----------------------------------------HLYLIMQ 87
Query: 544 YCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND-- 600
L + + A L Q+++ + ++H GI+HRDL P N+ + + ++
Sbjct: 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS 147
Query: 601 -IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
I I DFGL+K + + GT Y APE+ P +
Sbjct: 148 KIMISDFGLSKMEDPGSVL----------------STACGTPGYVAPEVLAQKP-YSKAV 190
Query: 660 DMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSP 715
D +S+G++ + L PF + ++ LK + E + S+ + +R LM
Sbjct: 191 DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK 250
Query: 716 SPSDRPSATELLQD---ALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSI 763
P R + + LQ A ++ + ++ + + S + + ++
Sbjct: 251 DPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNAT 301
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (431), Expect = 6e-48
Identities = 70/314 (22%), Positives = 117/314 (37%), Gaps = 55/314 (17%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP-VNDRILREVATLSRLQH 482
+ +E + LG GG V L ++ R AVK +R P R RE + L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+V Y + YI M
Sbjct: 67 PAIVAVYDTG------------------------------------EAETPAGPLPYIVM 90
Query: 543 EYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
EY TLR + + + A + + L H GIIHRD+ P NI A N +
Sbjct: 91 EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV 150
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
K+ DFG+A+ + D+G +GT Y +PE +G +D ++D+
Sbjct: 151 KVMDFGIARAIA------------DSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDV 197
Query: 662 YSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPSP 717
YSLG V +E+ PF+ + +++ P + S ++++ + ++ +P
Sbjct: 198 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNP 257
Query: 718 SDRPSATELLQDAL 731
+R ++ L
Sbjct: 258 ENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-48
Identities = 58/313 (18%), Positives = 109/313 (34%), Gaps = 68/313 (21%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH 484
+ + LG G FG V C + Y K +++K + +E++ L+ +H++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRN 62
Query: 485 VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEY 544
++ ++++ L + E+
Sbjct: 63 ILHLHESFESME----------------------------------------ELVMIFEF 82
Query: 545 CP-RTLRQ-VFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND-- 600
+ + + S ++ Q+ E L +H I H D+ P NI + R
Sbjct: 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST 142
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
IKI +FG A+ LK + Y APE+ Q + D
Sbjct: 143 IKIIEFGQARQLKPGD----------------NFRLLFTAPEYYAPEVHQHDV-VSTATD 185
Query: 661 MYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRRLMSPS 716
M+SLG + + L +PF +QI+ + + + + S + + RL+
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245
Query: 717 PSDRPSATELLQD 729
R +A+E LQ
Sbjct: 246 RKSRMTASEALQH 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-46
Identities = 70/319 (21%), Positives = 117/319 (36%), Gaps = 70/319 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK----DKSLPVNDRILREVATLSR 479
+ ++ + LG G F V C+ K G YA K I+ + + + I REV+ L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
+QH +V+ ++ + T +
Sbjct: 70 IQHPNVITLHEVY----------------------------------------ENKTDVI 89
Query: 540 IQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
+ +E L + +E A +QI+ G+ ++H I H DL P NI R
Sbjct: 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 149
Query: 599 ND----IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654
N IKI DFGLA + GT + APEI P
Sbjct: 150 NVPKPRIKIIDFGLAHKIDFGNEF----------------KNIFGTPEFVAPEIVNYEP- 192
Query: 655 IDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLR 710
+ +ADM+S+G++ + L PF +++ + + E + + S + +R
Sbjct: 193 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 252
Query: 711 RLMSPSPSDRPSATELLQD 729
RL+ P R + + LQ
Sbjct: 253 RLLVKDPKKRMTIQDSLQH 271
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 50/312 (16%), Positives = 106/312 (33%), Gaps = 67/312 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
D L+ LG G FG V K + A+K I+ S D + E + L H+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHE 59
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V+ Y + ++I E
Sbjct: 60 KLVQLYGVCTKQR----------------------------------------PIFIITE 79
Query: 544 YCPR--TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
Y L + E F + + + + E + ++ + +HRDL N + + +
Sbjct: 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 139
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
K+ DFGL++++ ++ G ++ PE+ K K+D+
Sbjct: 140 KVSDFGLSRYVLDDEYTSS--------------VGSKFPVRWSPPEVLMY-SKFSSKSDI 184
Query: 662 YSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
++ G++ +E++ P+ + + P ++ + +++
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE--KVYTIMYSCWHEKA 242
Query: 718 SDRPSATELLQD 729
+RP+ LL +
Sbjct: 243 DERPTFKILLSN 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 6e-46
Identities = 79/358 (22%), Positives = 129/358 (36%), Gaps = 68/358 (18%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN-DRILREVATLSR-L 480
+ DF + LG G FG V L + K + +A+K ++ + + + + E LS
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
+H + + + L+
Sbjct: 61 EHPFLTHMFCTFQTKE----------------------------------------NLFF 80
Query: 541 QMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
MEY L +S FD A +I+ GL +H +GI++RDL +NI D
Sbjct: 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 140
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
IKI DFG+ K L GT Y APEI G +
Sbjct: 141 HIKIADFGMCKENMLGDAKT---------------NTFCGTPDYIAPEILLGQK-YNHSV 184
Query: 660 DMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716
D +S G++ +E+ PF E ++ ++ P W+ K E + LL +L
Sbjct: 185 DWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMDNPFYPRWLEK--EAKDLLVKLFVRE 241
Query: 717 PSDRPSAT-ELLQDALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLDMKH 773
P R ++ Q L ++ +E L+ + + + S FD+E L+ K
Sbjct: 242 PEKRLGVRGDIRQHPLFREINWEELER--KEIDPPFRPKVKSPFDCSNFDKEFLNEKP 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 61/313 (19%), Positives = 107/313 (34%), Gaps = 73/313 (23%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ + + LQ +G G FG V+L + G AVK I+ + L E + +++L+H
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA----QAFLAEASVMTQLRH 59
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V+ E E LYI
Sbjct: 60 SNLVQLLGVIVE---------------------------------------EKGGLYIVT 80
Query: 543 EYCPR-TLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
EY + +L S + + E + ++ G +HRDL N+ N
Sbjct: 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 140
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
K+ DFGL K S +TAPE + K K+
Sbjct: 141 VAKVSDFGLTKEA------------------SSTQDTGKLPVKWTAPEALREK-KFSTKS 181
Query: 660 DMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSP 715
D++S GI+ +E++ P+ + +V +KG + +++
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVV--PRVEKGYKMDAPDGCPPAVYEVMKNCWHL 239
Query: 716 SPSDRPSATELLQ 728
+ RPS +L +
Sbjct: 240 DAAMRPSFLQLRE 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 71/333 (21%), Positives = 115/333 (34%), Gaps = 83/333 (24%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRL----KDKSLPVNDRILREVATLSR 479
+ ++ LG GGFG V D A+K + LP R+ EV L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 480 LQHQH--VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+ V+R +
Sbjct: 64 VSSGFSGVIRLLDWFERPD----------------------------------------S 83
Query: 538 LYIQMEYCP--RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF 595
+ +E + L +ELA F Q++E + H H G++HRD+ NI
Sbjct: 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 143
Query: 596 DA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654
D R ++K+ DFG LK T GT Y+ PE +
Sbjct: 144 DLNRGELKLIDFGSGALLKDTVY-----------------TDFDGTRVYSPPEWIRYHRY 186
Query: 655 IDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRR 711
A ++SLGI+ +++ PF + +I+ + + + E + L+R
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVFFRQRVSS-------ECQHLIRW 237
Query: 712 LMSPSPSDRPSATELL-----QDALPPQMEYEL 739
++ PSDRP+ E+ QD L PQ E+
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-44
Identities = 63/335 (18%), Positives = 106/335 (31%), Gaps = 87/335 (25%)
Query: 427 EELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLP---VNDRILREVATLSRLQHQ 483
E+L LG G F V ++K + A+KKI+L +S +N LRE+ L L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+++ A+ + + +
Sbjct: 61 NIIGLLDAFGHKS----------------------------------------NISLVFD 80
Query: 544 YCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+ + ++ ++GL ++H I+HRDL PNN+ D +K
Sbjct: 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLK 140
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
+ DFGLAK T QV T +Y APE+ G DM+
Sbjct: 141 LADFGLAKSFGSPNRAY---------------THQVVTRWYRAPELLFGARMYGVGVDMW 185
Query: 663 SLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQE------------- 706
++G + EL + + + G
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245
Query: 707 ------------SLLRRLMSPSPSDRPSATELLQD 729
L++ L +P R +AT+ L+
Sbjct: 246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 2e-44
Identities = 59/332 (17%), Positives = 111/332 (33%), Gaps = 73/332 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHY---AVKKIRLKDKSLPVNDRILREVATLSR 479
++ + Q +G G FG V KL G+ A+K ++ + L E + + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQ 83
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
H +V+ + ST +
Sbjct: 84 FDHPNVIHLEGVVTK----------------------------------------STPVM 103
Query: 540 IQMEYCPRTLRQVF--ESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
I E+ F ++ F + R I G+ ++ +HRDL NI ++
Sbjct: 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 163
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
K+ DFGL++FL+ + G +TAPE Q K
Sbjct: 164 NLVCKVSDFGLSRFLE----------DDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTS 212
Query: 658 KADMYSLGIVFFEL----WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713
+D++S GIV +E+ P+ + ++ + ++ P + S L+
Sbjct: 213 ASDVWSYGIVMWEVMSYGERPYWDMTNQDVI--NAIEQDYRLPPPMDCPSALHQLMLDCW 270
Query: 714 SPSPSDRPSATELLQDALPPQMEYELLDNILR 745
+ RP +++ LD ++R
Sbjct: 271 QKDRNHRPKFGQIVNT----------LDKMIR 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-44
Identities = 75/382 (19%), Positives = 131/382 (34%), Gaps = 84/382 (21%)
Query: 415 MSLPSSRYLNDFEEL-QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILRE 473
+ + + ++D++ Q LG G G V+ NK +A+K ++ + RE
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARRE 54
Query: 474 VATLSRL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENK 532
V R Q H+VR + +
Sbjct: 55 VELHWRASQCPHIVRIVDVY------------------------------------ENLY 78
Query: 533 LESTYLYIQMEYCP-RTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLT 589
L I ME L + F + A + + I E + ++H I HRD+
Sbjct: 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 138
Query: 590 PNNIFFDARND---IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP 646
P N+ + ++ +K+ DFG AK + T +Y AP
Sbjct: 139 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----------------TPYYVAP 182
Query: 647 EIEQGWPKIDEKADMYSLGIVFFELW---HPF----STAMERQIVLSDLKQKGELPPSWV 699
E+ D+ DM+SLG++ + L PF A+ + + E P
Sbjct: 183 EVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 700 AKFSEQ-ESLLRRLMSPSPSDRPSATELL------QDALPPQMEYELLDNILRMMHSSED 752
++ SE+ + L+R L+ P+ R + TE + Q PQ + ED
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 301
Query: 753 T--SIYDKVVSSIFDEETLDMK 772
+ + + D E + +K
Sbjct: 302 VKEEMTSALATMRVDYEQIKIK 323
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (410), Expect = 5e-44
Identities = 70/364 (19%), Positives = 119/364 (32%), Gaps = 79/364 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVND----RILREVATLS 478
+NDF + +G GGFG V C+ G+ YA+K + K + + ++ +S
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+V A+ L
Sbjct: 63 TGDCPFIVCMSYAFHTPD----------------------------------------KL 82
Query: 539 YIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
++ L + F + +I+ GL H+H + +++RDL P NI D
Sbjct: 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 142
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
++I D GLA ++ VGT+ Y APE+ Q D
Sbjct: 143 HGHVRISDLGLACDFSKKKP-----------------HASVGTHGYMAPEVLQKGVAYDS 185
Query: 658 KADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714
AD +SLG + F+L PF + D + E SLL L+
Sbjct: 186 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 245
Query: 715 PSPSDRPS-----ATELLQDALPPQMEYELLDN------ILRMMHSSEDTSIYDKVVSSI 763
+ R A E+ + ++++++ ++ +D
Sbjct: 246 RDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD---IGS 302
Query: 764 FDEE 767
FDEE
Sbjct: 303 FDEE 306
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-44
Identities = 69/312 (22%), Positives = 101/312 (32%), Gaps = 69/312 (22%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ ++ LG G FG V + AVK ++ S D L E + +LQHQ
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQ 68
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+VR Y + +YI E
Sbjct: 69 RLVRLYAVVTQEP-----------------------------------------IYIITE 87
Query: 544 YCPRTLRQVF---ESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
Y F S + QI EG+A I + IHRDL NI
Sbjct: 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS 147
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
KI DFGLA+ ++ + G +TAPE K+D
Sbjct: 148 CKIADFGLARLIEDNEYTAR--------------EGAKFPIKWTAPEAINYGT-FTIKSD 192
Query: 661 MYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPS 716
++S GI+ E+ M V+ +L++ + P + E L+R
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKER 250
Query: 717 PSDRPSATELLQ 728
P DRP+ L
Sbjct: 251 PEDRPTFDYLRS 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 6e-44
Identities = 53/314 (16%), Positives = 104/314 (33%), Gaps = 41/314 (13%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLS 478
N+ E ++ +G G FG V + AVK ++ ++ S + RE A ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMA 71
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
+ ++V+ + M G L S T
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAY-GDLNEFLRSMS--------------PHTVC 116
Query: 539 YIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
+ R + RQ+ G+A++ + +HRDL N
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 176
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
+KI DFGL++ + + + PE +
Sbjct: 177 MVVKIADFGLSRNI-------------YSADYYKADGNDAIPIRWMPPESIFYNR-YTTE 222
Query: 659 ADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714
+D+++ G+V +E++ P+ +++ + G + E +L+R S
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVI--YYVRDGNILACPENCPLELYNLMRLCWS 280
Query: 715 PSPSDRPSATELLQ 728
P+DRPS + +
Sbjct: 281 KLPADRPSFCSIHR 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 8e-44
Identities = 56/311 (18%), Positives = 104/311 (33%), Gaps = 67/311 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
++ +Q +G G FG V L + A+K IR + + + E + +L H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 60
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V+ Y E + + E
Sbjct: 61 KLVQLYGVCLEQA----------------------------------------PICLVFE 80
Query: 544 YCPR-TLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
+ L + F E + + EG+A++ +IHRDL N I
Sbjct: 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 140
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
K+ DFG+ +F+ +Q TG + +PE+ + K+D+
Sbjct: 141 KVSDFGMTRFVLDDQYTSS--------------TGTKFPVKWASPEVFSFS-RYSSKSDV 185
Query: 662 YSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSP 717
+S G++ +E++ V+ D+ L P + ++ P
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST--HVYQIMNHCWKERP 243
Query: 718 SDRPSATELLQ 728
DRP+ + LL+
Sbjct: 244 EDRPAFSRLLR 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 73/338 (21%), Positives = 122/338 (36%), Gaps = 86/338 (25%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ +F++++ +G G +G V +NKL G A+KKIRL ++ V +RE++ L L H
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V+ LY+
Sbjct: 61 PNIVKLLDVIHTEN----------------------------------------KLYLVF 80
Query: 543 EYCPRTLRQVFES--YDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
E+ + L++ ++ L Q+++GLA H ++HRDL P N+ +
Sbjct: 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 140
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
IK+ DFGLA+ + T +V T +Y APEI G D
Sbjct: 141 IKLADFGLARAFGVPVRTY---------------THEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 661 MYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELP-----------------PSWVA 700
++SLG +F E+ F E + + G P W
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWAR 245
Query: 701 KF---------SEQESLLRRLMSPSPSDRPSATELLQD 729
+ + SLL +++ P+ R SA L
Sbjct: 246 QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-43
Identities = 71/359 (19%), Positives = 124/359 (34%), Gaps = 74/359 (20%)
Query: 425 DFEELQPLGHGGFGHVVLCKNKLDGRHYAVK---KIRLKDKSLPVNDRILREVATLSRLQ 481
+F++++ LG G FG V +G + K + S N IL E ++ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
+ HV R + + +
Sbjct: 70 NPHVCRLLGICLTST-----------------------------------------VQLI 88
Query: 542 MEYCPR--TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
+ P L V E D+ + + QI +G+ ++ + ++HRDL N+
Sbjct: 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 148
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
+KI DFGLAK L E+ + A G + A E ++
Sbjct: 149 HVKITDFGLAKLLGAEEKEYHA-------------EGGKVPIKWMALESILHRI-YTHQS 194
Query: 660 DMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSP 715
D++S G+ +EL P+ +I + +KGE P + ++ +
Sbjct: 195 DVWSYGVTVWELMTFGSKPYDGIPASEIS--SILEKGERLPQPPICTIDVYMIMVKCWMI 252
Query: 716 SPSDRPSATELLQD----ALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEETLD 770
RP EL+ + A PQ Y ++ RM S S + ++ DEE +D
Sbjct: 253 DADSRPKFRELIIEFSKMARDPQ-RYLVIQGDERMHLPSPTDSNFY---RALMDEEDMD 307
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-43
Identities = 67/359 (18%), Positives = 115/359 (32%), Gaps = 91/359 (25%)
Query: 405 KPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL 464
K + +P P + + + +G+G FG V K G A+KK+ +
Sbjct: 2 KVTTVVATPGQG-PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-- 58
Query: 465 PVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSA 524
RE+ + +L H ++VR ++ +G
Sbjct: 59 ----FKNRELQIMRKLDHCNIVRLRYFFYSSG---------------------------- 86
Query: 525 DVTGQENKLESTYLYIQMEYCP----RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580
K + YL + ++Y P R R + Q+ LA+IH
Sbjct: 87 ------EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 581 QGIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639
GI HRD+ P N+ D +K+ DFG AK L + + +
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----------------YIC 184
Query: 640 TYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPP 696
+ +Y APE+ G D++S G V EL F ++ +K G
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 697 SWVAKFSEQE--------------------------SLLRRLMSPSPSDRPSATELLQD 729
+ + + +L RL+ +P+ R + E
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-43
Identities = 55/304 (18%), Positives = 104/304 (34%), Gaps = 63/304 (20%)
Query: 432 LGHGGFGHVVLC--KNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYY 489
LG G FG V + K + AVK ++ + + D +L E + +L + ++VR
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-T 548
G+ + + + ME
Sbjct: 75 ------GICEAES-----------------------------------WMLVMEMAELGP 93
Query: 549 LRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGL 608
L + + H + L Q+ G+ ++ +HRDL N+ ++ KI DFGL
Sbjct: 94 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 609 AKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVF 668
+K L+ ++ A T + APE + K+D++S G++
Sbjct: 154 SKALRADENYYKA------------QTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLM 200
Query: 669 FELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSAT 724
+E + P+ ++ + +KGE E L+ + +RP
Sbjct: 201 WEAFSYGQKPYRGMKGSEVT--AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFA 258
Query: 725 ELLQ 728
+
Sbjct: 259 AVEL 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 6e-43
Identities = 78/366 (21%), Positives = 135/366 (36%), Gaps = 84/366 (22%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKD-KSLPVNDRILREVATLSRLQ 481
L DF+ L+ LG G FG V L +++ +GR+YA+K ++ + L + E LS +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H ++R + + + +++
Sbjct: 63 HPFIIRMWGTFQDAQ----------------------------------------QIFMI 82
Query: 542 MEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
M+Y L + F +A ++ L ++H + II+RDL P NI D
Sbjct: 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH 142
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
IKI DFG AK++ GT Y APE+ P ++ D
Sbjct: 143 IKITDFGFAKYVPDVT------------------YTLCGTPDYIAPEVVSTKP-YNKSID 183
Query: 661 MYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
+S GI+ +E+ PF + + L + PP + + LL RL++
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD---LLSRLITRDL 240
Query: 718 SDR-----PSATELLQDALPPQMEYELLDN-------ILRMMHSSEDTSIYDKVVSSIFD 765
S R ++ ++ +E L + + DTS +DK +
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-----YP 295
Query: 766 EETLDM 771
EE ++
Sbjct: 296 EEDINY 301
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 8e-43
Identities = 61/350 (17%), Positives = 110/350 (31%), Gaps = 56/350 (16%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN-DRILREVATLSRL- 480
ND + +G G FG V+ + K DG R+K+ + + E+ L +L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H +++ A G + L
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHG-----------------------NLLDFLRKS 105
Query: 541 QMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
++ + + H + G+ ++ + IHRDL NI
Sbjct: 106 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
KI DFGL++ + V V T + A E +D
Sbjct: 166 AKIADFGLSRGQE----------------VYVKKTMGRLPVRWMAIESLNYSV-YTTNSD 208
Query: 661 MYSLGIVFFEL---WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
++S G++ +E+ M + L Q G + E L+R+ P
Sbjct: 209 VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKP 267
Query: 718 SDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYDKVVSSIFDEE 767
+RPS ++L L+ +L + +T++Y+K + D
Sbjct: 268 YERPSFAQILVS----------LNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 1e-42
Identities = 62/337 (18%), Positives = 123/337 (36%), Gaps = 86/337 (25%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ + L+ +G G +G V +N G +A+KKIRL+ + + +RE++ L L+H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V+ Y L +
Sbjct: 60 SNIVKLYDVIHT----------------------------------------KKRLVLVF 79
Query: 543 EYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
E+ + L+++ + + + A Q++ G+A+ H + ++HRDL P N+ + ++
Sbjct: 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139
Query: 602 KIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661
KI DFGLA+ + ++ T +Y AP++ G K D+
Sbjct: 140 KIADFGLARAFGIPVRKYT---------------HEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 662 YSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQE------------ 706
+S+G +F E+ F E ++ + G +E
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244
Query: 707 --------------SLLRRLMSPSPSDRPSATELLQD 729
LL +++ P+ R +A + L+
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 61/316 (19%), Positives = 108/316 (34%), Gaps = 65/316 (20%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLD---GRHYAVKKIRLKDKSLP-VNDRILREVATLS 478
D L+ LG G FG V + AVK ++ S P D +REV +
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
L H++++R Y + +
Sbjct: 67 SLDHRNLIRLYGVV-----------------------------------------LTPPM 85
Query: 539 YIQMEYCPR--TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
+ E P L ++ + HF Q+ EG+ ++ + IHRDL N+
Sbjct: 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA 145
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
R+ +KIGDFGL + L V + + + APE +
Sbjct: 146 TRDLVKIGDFGLMRALP------------QNDDHYVMQEHRKVPFAWCAPESLKTRT-FS 192
Query: 657 EKADMYSLGIVFFEL----WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRL 712
+D + G+ +E+ P+ + +L + ++GE P + +++ +
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWI-GLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQC 251
Query: 713 MSPSPSDRPSATELLQ 728
+ P DRP+ L
Sbjct: 252 WAHKPEDRPTFVALRD 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 2e-42
Identities = 67/346 (19%), Positives = 110/346 (31%), Gaps = 75/346 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
N + + +G G FG + L + G A+K +K K + ++ E +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGG 62
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+ + G Y + ME
Sbjct: 63 VGIPTIRWCGAEG---------------------------------------DYNVMVME 83
Query: 544 YCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFF---DARN 599
+L +F F + L Q++ + +IH + IHRD+ P+N N
Sbjct: 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN 143
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
+ I DFGLAK + + Q + + GT Y + G +
Sbjct: 144 LVYIIDFGLAKKYRDARTHQHIPYRENKNL--------TGTARYASINTHLGIE-QSRRD 194
Query: 660 DMYSLGIVFFEL------WHPFSTAMERQIVLSDLKQKGELPPSWVAKF--SEQESLLRR 711
D+ SLG V W A +RQ ++K P + K SE + L
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 712 LMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYD 757
S D+P + L +L N+ S D ++D
Sbjct: 255 CRSLRFDDKPDYSYL----------RQLFRNLFHRQGFSYD-YVFD 289
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-42
Identities = 60/335 (17%), Positives = 109/335 (32%), Gaps = 80/335 (23%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ L +G G +G V + ++ A+KKI + R LRE+ L R +H+++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENI 68
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ + +Y+
Sbjct: 69 IGINDIIRAPTIEQMK-----------------------------------DVYLVTHLM 93
Query: 546 PRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGD 605
L ++ ++ H + + QI+ GL +IH ++HRDL P+N+ + D+KI D
Sbjct: 94 GADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 152
Query: 606 FGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLG 665
FGLA+ + T V T +Y APEI + D++S+G
Sbjct: 153 FGLARVADPDHDHTGF------------LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 200
Query: 666 IVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKF-------------------- 702
+ E+ F + L G +
Sbjct: 201 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 260
Query: 703 --------SEQESLLRRLMSPSPSDRPSATELLQD 729
S+ LL ++++ +P R + L
Sbjct: 261 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 9e-42
Identities = 57/316 (18%), Positives = 113/316 (35%), Gaps = 44/316 (13%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGR-----HYAVKKIRLKDKSLPVNDRILREVATLS 478
+ E + LG G FG V+ + AVK ++ + + ++ E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMT 95
Query: 479 RL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+L H+++V A +G + G L + S R S D
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCY-GDLLNYLRSKREKFSED------------ 142
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
++EY + + E + E Q+ +G+ + + +HRDL N+
Sbjct: 143 ---EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
+KI DFGLA+ + + V + APE
Sbjct: 200 GKVVKICDFGLARDI-------------MSDSNYVVRGNARLPVKWMAPESLFEGI-YTI 245
Query: 658 KADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRL 712
K+D++S GI+ +E++ +P+ ++ ++ P + + E +++
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE--EIYIIMQSC 303
Query: 713 MSPSPSDRPSATELLQ 728
+ RPS L
Sbjct: 304 WAFDSRKRPSFPNLTS 319
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 9e-42
Identities = 71/337 (21%), Positives = 124/337 (36%), Gaps = 84/337 (24%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
+ +LQP+G G +G V + G A+KK+ +S R RE+ L ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V+ + E + T Y+ M
Sbjct: 78 NVIGLLDVFTP----------------------------------DETLDDFTDFYLVMP 103
Query: 544 YCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
+ L ++ + ++ ++ L Q+++GL +IH GIIHRDL P N+ + ++KI
Sbjct: 104 FMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 162
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
DFGLA+ E TG V T +Y APE+ W + + D++S
Sbjct: 163 LDFGLARQADSEM------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWS 204
Query: 664 LGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQES------------- 707
+G + E+ F + + +K G P +V + E+
Sbjct: 205 VGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 264
Query: 708 ---------------LLRRLMSPSPSDRPSATELLQD 729
LL +++ R +A E L
Sbjct: 265 DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 9e-42
Identities = 69/316 (21%), Positives = 110/316 (34%), Gaps = 69/316 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVN-DRILREVATLSRLQ 481
+NDF+ L+ LG G FG V+L + K GR+YA+K +R + + E L +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
H + A+ L
Sbjct: 64 HPFLTALKYAFQTHD----------------------------------------RLCFV 83
Query: 542 MEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
MEY L F +E A +IV L ++H + +++RD+ N+ D
Sbjct: 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
IKI DFGL K + GT Y APE+ + D
Sbjct: 144 IKITDFGLCKEGISDGATMK---------------TFCGTPEYLAPEVLEDND-YGRAVD 187
Query: 661 MYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
+ LG+V +E+ PF ++ L ++ P + + +SLL L+ P
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA---KSLLAGLLKKDP 244
Query: 718 SDRPS-----ATELLQ 728
R A E+++
Sbjct: 245 KQRLGGGPSDAKEVME 260
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-41
Identities = 69/346 (19%), Positives = 117/346 (33%), Gaps = 89/346 (25%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
+ +E+L+ +G G +G V KN+ A+K++RL D V LRE+ L L+H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+++VR + + +
Sbjct: 61 KNIVRLHDVLHS---------------------------------------DKKLTLVFE 81
Query: 543 EYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIK 602
+ D E+ Q+++GL H + ++HRDL P N+ + ++K
Sbjct: 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELK 141
Query: 603 IGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662
+ +FGLA+ + + +V T +Y P++ G DM+
Sbjct: 142 LANFGLARAFGIPVRCY---------------SAEVVTLWYRPPDVLFGAKLYSTSIDMW 186
Query: 663 SLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPS---------------------- 697
S G +F EL P + L + + P
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246
Query: 698 ----WVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQ-----DALPP 733
V K + LL+ L+ +P R SA E LQ D PP
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (386), Expect = 1e-41
Identities = 61/333 (18%), Positives = 110/333 (33%), Gaps = 69/333 (20%)
Query: 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH 482
D LG G +G V K AVK ++ + + L+E A + ++H
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKH 72
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
++V+ YI
Sbjct: 73 PNLVQLLGVCTREP----------------------------------------PFYIIT 92
Query: 543 EYCPRTLRQVF---ESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN 599
E+ + + + ++ QI + ++ + IHRDL N +
Sbjct: 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH 152
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
+K+ DFGL++ + TG G +TAPE K K+
Sbjct: 153 LVKVADFGLSRLM--------------TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKS 197
Query: 660 DMYSLGIVFFELW---HPFSTAMERQIVLSDLKQ--KGELPPSWVAKFSEQESLLRRLMS 714
D+++ G++ +E+ ++ V L++ + E P K E L+R
Sbjct: 198 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE---LMRACWQ 254
Query: 715 PSPSDRPSATELLQDALPPQMEYELLDNILRMM 747
+PSDRPS E+ Q E + D + + +
Sbjct: 255 WNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 59/311 (18%), Positives = 98/311 (31%), Gaps = 67/311 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
LG G FG V + A+K ++ S + L+E + +L+H+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHE 72
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V+ Y +YI E
Sbjct: 73 KLVQLYAVV-----------------------------------------SEEPIYIVTE 91
Query: 544 YCPR---TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARND 600
Y + E+ + + QI G+A++ +HRDL NI
Sbjct: 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV 151
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
K+ DFGLA+ ++ + G +TAPE + K+D
Sbjct: 152 CKVADFGLARLIEDNEYTAR--------------QGAKFPIKWTAPEAALYG-RFTIKSD 196
Query: 661 MYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSP 717
++S GI+ EL M + VL D ++G P L+ + P
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGYRMPCPPECPESLHDLMCQCWRKEP 255
Query: 718 SDRPSATELLQ 728
+RP+ L
Sbjct: 256 EERPTFEYLQA 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-41
Identities = 50/305 (16%), Positives = 94/305 (30%), Gaps = 65/305 (21%)
Query: 432 LGHGGFGHVVLCKNKL--DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYY 489
LG G FG V ++ A+K ++ + + ++RE + +L + ++VR
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-T 548
++ L + ME
Sbjct: 76 GVC-----------------------------------------QAEALMLVMEMAGGGP 94
Query: 549 LRQV-FESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFG 607
L + + L Q+ G+ ++ + +HRDL N+ R+ KI DFG
Sbjct: 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154
Query: 608 LAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIV 667
L+K L + + APE ++D++S G+
Sbjct: 155 LSKAL------------GADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVT 201
Query: 668 FFEL----WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSA 723
+E P+ +++ + K P E +L+ DRP
Sbjct: 202 MWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP--ELYALMSDCWIYKWEDRPDF 259
Query: 724 TELLQ 728
+ Q
Sbjct: 260 LTVEQ 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 8e-41
Identities = 58/332 (17%), Positives = 110/332 (33%), Gaps = 65/332 (19%)
Query: 406 PSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHV---VLCKNKLDGRHYAVKKIRLKDK 462
P + ++ + S + F E+ +G G FG V L N H AVK + +
Sbjct: 11 PELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RIT 67
Query: 463 SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAAS 522
+ + L E + H +V+ +
Sbjct: 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS--------------------------- 100
Query: 523 SADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAW--HLFRQIVEGLAHIHG 580
+ + Y + F + + + Q+ +G+ +
Sbjct: 101 ------------EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
+ +HRDL N D + +K+ DFGLA+ + ++ D + TG
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-----------VHNKTGAKLP 197
Query: 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPP 696
+ A E Q K+D++S G++ +EL P+ I + L+ + L P
Sbjct: 198 VKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256
Query: 697 SWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728
+ ++ + P RPS +EL+
Sbjct: 257 EYCPD--PLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-40
Identities = 67/322 (20%), Positives = 120/322 (37%), Gaps = 69/322 (21%)
Query: 423 LNDFEELQPLGHGGFGHVVLCK---NKLDGRHYAVKKIRLKD--KSLPVNDRILREVATL 477
+ +FE L+ LG G +G V L + G+ YA+K ++ + + E L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 478 SRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
++ + F+T T
Sbjct: 83 EHIRQSPFLVTLHYAFQTE---------------------------------------TK 103
Query: 538 LYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFD 596
L++ ++Y L + F + +IV L H+H GII+RD+ NI D
Sbjct: 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 163
Query: 597 ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK-I 655
+ + + DFGL+K ++ ++ F GT Y AP+I +G
Sbjct: 164 SNGHVVLTDFGLSKEFVADETERAYDFC--------------GTIEYMAPDIVRGGDSGH 209
Query: 656 DEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQ-ESLLRR 711
D+ D +SLG++ +EL PF+ E+ ++ + P + + S + L++R
Sbjct: 210 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 269
Query: 712 LMSPSPSDRPS-----ATELLQ 728
L+ P R A E+ +
Sbjct: 270 LLMKDPKKRLGCGPRDADEIKE 291
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (368), Expect = 2e-39
Identities = 51/346 (14%), Positives = 106/346 (30%), Gaps = 77/346 (22%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
++ + +G G FG + N L+ + A+K + + ++ E T L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTG 62
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ + + G + + ++
Sbjct: 63 IPNVYYFGQEG---------------------------------------LHNVLVIDLL 83
Query: 546 PRTLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA-----RN 599
+L + + F + +Q++ + IH + +++RD+ P+N N
Sbjct: 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 143
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659
I + DFG+ KF + T + GT Y + G +
Sbjct: 144 MIYVVDFGMVKFYR--------DPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRD 194
Query: 660 DMYSLGIVFFEL-----WHPFSTAMERQIVLSDLKQKGELPP--SWVAKFSEQ-ESLLRR 711
D+ +LG VF A + + +K + P A F E+ +
Sbjct: 195 DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHY 254
Query: 712 LMSPSPSDRPSATELLQDALPPQMEYELLDNILRMMHSSEDTSIYD 757
+ + P L L +L ++++ED +D
Sbjct: 255 ARNLAFDATPDYDYL----------QGLFSKVLERLNTTED-ENFD 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 6e-39
Identities = 57/315 (18%), Positives = 103/315 (32%), Gaps = 68/315 (21%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLD---GRHYAVKKIRLKDKSLPVNDRILREVATLSRL 480
E + +G G FG V A+K + S V ++ L+E T+ +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65
Query: 481 QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYI 540
H H+V+ E ++I
Sbjct: 66 DHPHIVKLIGVITEN-----------------------------------------PVWI 84
Query: 541 QMEYCPR-TLRQVFESYDH-FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDAR 598
ME C LR + + D Q+ LA++ + +HRD+ N+ +
Sbjct: 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN 144
Query: 599 NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658
+ +K+GDFGL+++++ + + APE +
Sbjct: 145 DCVKLGDFGLSRYME--------------DSTYYKASKGKLPIKWMAPESINFR-RFTSA 189
Query: 659 ADMYSLGIVFFEL----WHPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714
+D++ G+ +E+ PF ++ + GE P SL+ + +
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRIENGERLPMPPNCPPTLYSLMTKCWA 247
Query: 715 PSPSDRPSATELLQD 729
PS RP TEL
Sbjct: 248 YDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 8e-39
Identities = 53/314 (16%), Positives = 97/314 (30%), Gaps = 64/314 (20%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDG----RHYAVKKIRLKDKSLPVNDRILREVATLSR 479
+ + +G G FG V K A+K ++ + L E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQ 65
Query: 480 LQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLY 539
H +++R + +
Sbjct: 66 FSHHNIIRLEGVISKYK----------------------------------------PMM 85
Query: 540 IQMEYCPRTLRQVF--ESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
I EY F E F + R I G+ ++ +HRDL NI ++
Sbjct: 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 145
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
K+ DFGL++ L+ D + +G +TAPE K
Sbjct: 146 NLVCKVSDFGLSRVLE------------DDPEATYTTSGGKIPIRWTAPEAISYR-KFTS 192
Query: 658 KADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714
+D++S GIV +E+ + V+ + G P+ + S L+ +
Sbjct: 193 ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPMDCPSAIYQLMMQCWQ 251
Query: 715 PSPSDRPSATELLQ 728
+ RP +++
Sbjct: 252 QERARRPKFADIVS 265
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 71/344 (20%), Positives = 120/344 (34%), Gaps = 85/344 (24%)
Query: 419 SSRYLNDFEELQPLGHGGFGHVVLCKN-KLDGRHYAVKKIRLKDKSLPVNDRILREVATL 477
R +E + +G G +G V ++ K GR A+K++R++ + +REVA L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 478 SRL---QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLE 534
L +H +VVR + DV
Sbjct: 62 RHLETFEHPNVVRLF-----------------------------------DVCTVSRTDR 86
Query: 535 STYLYIQMEYCPRTLRQVFESYDH--FDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNN 592
T L + E+ + L + E + Q++ GL +H ++HRDL P N
Sbjct: 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146
Query: 593 IFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652
I + IK+ DFGLA+ + T V T +Y APE+
Sbjct: 147 ILVTSSGQIKLADFGLARIYSFQM----------------ALTSVVVTLWYRAPEVLLQS 190
Query: 653 PKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKG----------------- 692
D++S+G +F E++ F + + + L G
Sbjct: 191 S-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 693 ------ELPPSWVAKFSEQ-ESLLRRLMSPSPSDRPSATELLQD 729
+ +V E + LL + ++ +P+ R SA L
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-38
Identities = 88/418 (21%), Positives = 150/418 (35%), Gaps = 120/418 (28%)
Query: 401 SQFWKPSVDSGSPNMSLPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK 460
+QF+ SV+ G ++ L ++ L+P+G G G V + + R+ A+KK+
Sbjct: 1 NQFY--SVEVGDSTFTV-----LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53
Query: 461 DKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRA 520
++ R RE+ + + H++++ + +
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE--------------------- 92
Query: 521 ASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580
E +Y+ ME L QV + D E +L Q++ G+ H+H
Sbjct: 93 -------------EFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS 137
Query: 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640
GIIHRDL P+NI + +KI DFGLA+ + T V T
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----------------TPYVVT 181
Query: 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPS 697
+Y APE+ G E D++S+G + E+ F ++Q G P
Sbjct: 182 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 698 WVAKF---------------------------------------SEQESLLRRLMSPSPS 718
++ K S+ LL +++ P+
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 719 DRPSATELLQD-------------ALPPQMEYELLDNILRMMHSSED--TSIYDKVVS 761
R S + LQ A PPQ+ + LD H+ E+ IY +V++
Sbjct: 301 KRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDE---REHTIEEWKELIYKEVMN 355
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-38
Identities = 70/337 (20%), Positives = 112/337 (33%), Gaps = 84/337 (24%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQ 483
++ L P+G G +G V + G AVKK+ +S+ R RE+ L ++H+
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 484 HVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQME 543
+V+ DV LE +
Sbjct: 78 NVIGLL-----------------------------------DVFTPARSLEEFNDVYLVT 102
Query: 544 YCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKI 603
+ + L QI+ GL +IH IIHRDL P+N+ + ++KI
Sbjct: 103 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 162
Query: 604 GDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663
DFGLA+ E TG V T +Y APEI W ++ D++S
Sbjct: 163 LDFGLARHTDDEM------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWS 204
Query: 664 LGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQES------------- 707
+G + EL F + L+ G + K S + +
Sbjct: 205 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 264
Query: 708 ---------------LLRRLMSPSPSDRPSATELLQD 729
LL +++ R +A + L
Sbjct: 265 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 4e-38
Identities = 74/391 (18%), Positives = 130/391 (33%), Gaps = 83/391 (21%)
Query: 398 SRVSQFWKPSVDSGSPNMSLPSSRY--LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVK 455
V +F + + PS L+ F+ ++ LG G FG V+L K+K G HYA+K
Sbjct: 13 ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 456 KIRLKD-KSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASS 514
+ + L + L E L + +V+ ++ +
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN------------------- 113
Query: 515 TFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEG 574
S + + F + A QIV
Sbjct: 114 --------------------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 575 LAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDG 634
++H +I+RDL P N+ D + I++ DFG AK +K
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT------------------ 195
Query: 635 TGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQK 691
GT APEI ++ D ++LG++ +E+ PF QI + K
Sbjct: 196 WTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
Query: 692 GELPPSWVAKFSEQESLLRRLMSPSPSDR-----PSATELLQDALPPQMEYELLDN---- 742
P + S+ + LLR L+ + R ++ ++ +
Sbjct: 255 VRFPSHF---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311
Query: 743 --ILRMMHSSEDTSIYDKVVSSIFDEETLDM 771
+ DTS +D ++EE + +
Sbjct: 312 APFIPKFKGPGDTSNFDD-----YEEEEIRV 337
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 62/314 (19%), Positives = 100/314 (31%), Gaps = 45/314 (14%)
Query: 424 NDFEELQPLGHGGFGHVVLCK-----NKLDGRHYAVKKIRLKDKSLPVNDRILREVATLS 478
N + LG G FG VV AVK ++ L + ++ E+ LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLS 81
Query: 479 RL-QHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
L H ++V A G + G L + R + T +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCY-GDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
D E Q+ +G+A + + IHRDL NI
Sbjct: 141 --------------------ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
KI DFGLA+ +K V + APE
Sbjct: 181 GRITKICDFGLARDIK-------------NDSNYVVKGNARLPVKWMAPESIFNCV-YTF 226
Query: 658 KADMYSLGIVFFELW---HPFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMS 714
++D++S GI +EL+ M + ++G S +E +++
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
Query: 715 PSPSDRPSATELLQ 728
P RP+ +++Q
Sbjct: 287 ADPLKRPTFKQIVQ 300
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-36
Identities = 60/336 (17%), Positives = 116/336 (34%), Gaps = 89/336 (26%)
Query: 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRY 488
+ +G G FG V + K G AVK +++ + E+ L+H++++ +
Sbjct: 8 QESIGKGRFGEV--WRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGF 62
Query: 489 YQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR- 547
A ++ T L++ +Y
Sbjct: 63 IAAD------------------------------------NKDNGTWTQLWLVSDYHEHG 86
Query: 548 TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ--------GIIHRDLTPNNIFFDARN 599
+L Y E L GLAH+H + I HRDL NI
Sbjct: 87 SLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145
Query: 600 DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP-----K 654
I D GLA + T + + +VGT Y APE+ +
Sbjct: 146 TCCIADLGLAVR-----------HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 194
Query: 655 IDEKADMYSLGIVFFELW-------------HPFSTAMERQIVLSDLKQ---KGELPPSW 698
++AD+Y++G+VF+E+ P+ + + ++++ + +L P+
Sbjct: 195 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 254
Query: 699 VAKFSEQES------LLRRLMSPSPSDRPSATELLQ 728
++ E+ ++R + + R +A + +
Sbjct: 255 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 138 bits (348), Expect = 3e-36
Identities = 55/347 (15%), Positives = 110/347 (31%), Gaps = 103/347 (29%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-H 482
+D++ ++ LG G + V N + VK ++ K +I RE+ L L+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGG 89
Query: 483 QHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQM 542
+++ + S +
Sbjct: 90 PNIITLADIVKDP--------------------------------------VSRTPALVF 111
Query: 543 EYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARN-D 600
E+ +Q++++ +I++ L + H GI+HRD+ P+N+ D +
Sbjct: 112 EHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK 168
Query: 601 IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660
+++ D+GLA+F Q + +V + ++ PE+ + D D
Sbjct: 169 LRLIDWGLAEFYHPGQ----------------EYNVRVASRYFKGPELLVDYQMYDYSLD 212
Query: 661 MYSLGIVFFELW---HPFSTAMERQIVLSDL--------------KQKGELPPSWVAKFS 703
M+SLG + + PF + L + K EL P +
Sbjct: 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272
Query: 704 EQE---------------------SLLRRLMSPSPSDRPSATELLQD 729
L +L+ R +A E ++
Sbjct: 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 62/316 (19%), Positives = 108/316 (34%), Gaps = 50/316 (15%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLS 478
+ + +PLG G FG V+ R AVK ++ + + + ++ E+ L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILI 71
Query: 479 RLQHQH-VVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTY 537
+ H VV A + G G L++ S R
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR------------------ 113
Query: 538 LYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDA 597
E+ P + D E Q+ +G+ + + IHRDL NI
Sbjct: 114 ----NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169
Query: 598 RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657
+N +KI DFGLA+ + V + APE
Sbjct: 170 KNVVKICDFGLARDI-------------YKDPDYVRKGDARLPLKWMAPETIFDRV-YTI 215
Query: 658 KADMYSLGIVFFEL----WHPFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRL 712
++D++S G++ +E+ P+ + LK+ + P + E +
Sbjct: 216 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP--EMYQTMLDC 273
Query: 713 MSPSPSDRPSATELLQ 728
PS RP+ +EL++
Sbjct: 274 WHGEPSQRPTFSELVE 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 52/325 (16%), Positives = 91/325 (28%), Gaps = 77/325 (23%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLS 478
+ LG G FG V K A+K + + S+ L E + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMK 78
Query: 479 RLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYL 538
HVVR +
Sbjct: 79 EFNCHHVVRLLGVVSQGQ----------------------------------------PT 98
Query: 539 YIQMEYCP-----------RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRD 587
+ ME R + +I +G+A+++ +HRD
Sbjct: 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRD 158
Query: 588 LTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPE 647
L N +KIGDFG+ + + G + + +PE
Sbjct: 159 LAARNCMVAEDFTVKIGDFGMTRDI-------------YETDYYRKGGKGLLPVRWMSPE 205
Query: 648 IEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELPPSWVAKFS 703
+ +D++S G+V +E+ P+ Q++ +G L
Sbjct: 206 SLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--RFVMEGGLLDKPDNCPD 262
Query: 704 EQESLLRRLMSPSPSDRPSATELLQ 728
L+R +P RPS E++
Sbjct: 263 MLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-33
Identities = 56/351 (15%), Positives = 107/351 (30%), Gaps = 94/351 (26%)
Query: 424 NDFEELQPLGHGGFGHVVLCKNKLDGRH-------YAVKKIRLKDKSLPVNDRILREVAT 476
+ +PLG G FG VVL + + AVK ++ D + ++ E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEM 71
Query: 477 LSRLQHQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLEST 536
+ + +
Sbjct: 72 MKMIGKHKNIINLLGACTQD---------------------------------------G 92
Query: 537 YLYIQMEYCPRT-----------------LRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579
LY+ +EY + + + Q+ G+ ++
Sbjct: 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 152
Query: 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVG 639
+ IHRDL N+ N +KI DFGLA+ + T
Sbjct: 153 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-------------HHIDYYKKTTNGRL 199
Query: 640 TYFYTAPEIEQGWPKIDEKADMYSLGIVFFELW----HPFSTAMERQIVLSDLKQKGELP 695
+ APE ++D++S G++ +E++ P+ ++ L ++G
Sbjct: 200 PVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--KLLKEGHRM 256
Query: 696 PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEYELLDNILRM 746
+E ++R PS RP+ +L++D LD I+ +
Sbjct: 257 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED----------LDRIVAL 297
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (262), Expect = 9e-25
Identities = 64/361 (17%), Positives = 111/361 (30%), Gaps = 104/361 (28%)
Query: 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485
+ ++ LG G F V L K+ ++ H A+K +R + E+ L R+
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADN 71
Query: 486 VRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC 545
+ + D ++ + E
Sbjct: 72 TKEDSMGANHILKLLD-------------------------HFNHKGPNGVHVVMVFEVL 106
Query: 546 PRTLRQVFESYDHFDKEL--AWHLFRQIVEGLAHIHGQ-GIIHRDLTPNNIFFDARN--- 599
L + + Y+H L + +Q++ GL ++H + GIIH D+ P N+ + +
Sbjct: 107 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166
Query: 600 ---DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656
IKI D G A + + T Y +PE+ G P
Sbjct: 167 NLIQIKIADLGNACWYDEHYTNSI------------------QTREYRSPEVLLGAP-WG 207
Query: 657 EKADMYSLGIVFFELW---HPF------STAMERQIVLSDLKQKGELPPSWVA------- 700
AD++S + FEL F S + + ++ GELP +
Sbjct: 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT 267
Query: 701 ---------------------------KFSEQES-----LLRRLMSPSPSDRPSATELLQ 728
KFS+ E+ L ++ P R A L+
Sbjct: 268 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
Query: 729 D 729
Sbjct: 328 H 328
|
| >d2daya1 d.20.1.3 (A:8-122) E3 ubiquitin-protein ligase RNF25 {Human (Homo sapiens) [TaxId: 9606]} Length = 115 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: RWD domain domain: E3 ubiquitin-protein ligase RNF25 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (208), Expect = 6e-20
Identities = 27/118 (22%), Positives = 60/118 (50%), Gaps = 7/118 (5%)
Query: 29 DDNELLSEEITALCAIFQEDCKVVSGS----PPQILVKLRPYSKDMGYEDLDVSALLLVR 84
+++ +L E+ L +I+ ++ +V+ G+ P +I + L P + + + V L+++
Sbjct: 1 EEDWVLPSEVEVLESIYLDELQVIKGNGRTSPWEIYITLHPATAE-DQDSQYVCFTLVLQ 59
Query: 85 CLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFL 142
YP++ P++ I +GL+ +L +L A + G M++ L+E +E L
Sbjct: 60 VPAEYPHEVPQISIRNPRGLSDEQIHTILQVLGHVAKAGL--GTAMLYELIEKGKEIL 115
|
| >d1ukxa_ d.20.1.3 (A:) EIF2-alpha kinase 4 (GCN2-like protein) {Mouse (Mus musculus) [TaxId: 10090]} Length = 137 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: RWD domain domain: EIF2-alpha kinase 4 (GCN2-like protein) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 81.6 bits (201), Expect = 9e-19
Identities = 39/129 (30%), Positives = 58/129 (44%), Gaps = 12/129 (9%)
Query: 24 SSSTVDDN-ELLSEEITALCAIFQEDCKVVSGS-------PPQILVKLRPYSKDMGYEDL 75
SS ++ + E+ AL AI+ D + + PP+I + L P E++
Sbjct: 4 GSSGMESYSQRQDHELQALEAIYGSDFQDLRPDARGRVREPPEINLVLYPQGLAG--EEV 61
Query: 76 DVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLV 135
V L V+C P YP P++ + KGL+ + L L++ A G VMIF L
Sbjct: 62 YVQVELRVKCPPTYPDVVPEIDLKNAKGLSNESVNLLKSHLEELAKKQC--GEVMIFELA 119
Query: 136 EAAQEFLSE 144
Q FLSE
Sbjct: 120 HHVQSFLSE 128
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.2 bits (171), Expect = 3e-14
Identities = 25/191 (13%), Positives = 49/191 (25%), Gaps = 52/191 (27%)
Query: 430 QPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL--------PVNDRILREVATLSRLQ 481
+ +G G V C ++ VK ++ S + +R +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 482 HQHVVRYYQAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQ 541
+ + + A +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN------------------------------------AVL 88
Query: 542 MEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDI 601
ME + E + I+E +A + +GI+H DL+ N+ I
Sbjct: 89 MELID------AKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 141
Query: 602 KIGDFGLAKFL 612
I DF + +
Sbjct: 142 WIIDFPQSVEV 152
|
| >d1usya_ d.104.1.1 (A:) ATP phosphoribosyltransferase regulatory subunit HisZ {Thermotoga maritima [TaxId: 2336]} Length = 275 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: ATP phosphoribosyltransferase regulatory subunit HisZ species: Thermotoga maritima [TaxId: 2336]
Score = 60.6 bits (146), Expect = 2e-10
Identities = 36/249 (14%), Positives = 74/249 (29%), Gaps = 35/249 (14%)
Query: 841 HGGDLLELSHELRLPFIRWAISNQKSS-FKRYEISSVYRRAIGHSPPNRYLQGDFDIIGG 899
G+L + + + S K + VYR + S Q + +
Sbjct: 43 RKGNLFSIREDFTKTVLNHRKRYSPDSQIKVWYADFVYRYS--GSDLVAEYQLGLEKVPR 100
Query: 900 ASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMM 959
S EVL++ ++ + FF + + H + E + + EKV L+
Sbjct: 101 NSLDDSLEVLEIIVESASEFFE-GPVIVEIGHTGVYEDLLKEIPK--DLHEKVLNLI--- 154
Query: 960 GSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPAD 1019
+K + L + + V ++ + + P +
Sbjct: 155 ----------DTKNLAEIEFLSHMKKIDLSRVEKI------IEDSIYRRSPEHLKTMDLP 198
Query: 1020 KPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLL 1077
R+ L +L+ ++ ID + + L F ++ +
Sbjct: 199 LSVREDLLSASSFLQEKFPTVSVEIDLTLARTIEEYCGLIFTIYDTSSSRL--------V 250
Query: 1078 AVGGRYDYL 1086
A GG Y
Sbjct: 251 AAGGEYTVN 259
|
| >d2daxa1 d.20.1.3 (A:8-147) Uncharacterized protein C21orf6 {Human (Homo sapiens) [TaxId: 9606]} Length = 140 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: RWD domain domain: Uncharacterized protein C21orf6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (125), Expect = 2e-08
Identities = 22/118 (18%), Positives = 39/118 (33%), Gaps = 3/118 (2%)
Query: 29 DDNELLSEEITALCAIFQEDCKVVSGSPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPG 88
+NEL+ + A+ A ++ + + V ++ L
Sbjct: 19 GENELIVNDQLAV-AELKDCIEKKTMEGRSSKVYFTINMNLDVSDEKMAMFSLACILPFK 77
Query: 89 YPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFLSEIV 146
YP P++ + L++S L L + G V I N E +E S V
Sbjct: 78 YPAVLPEITV-RSVLLSRSQQTQLNTDLTAFLQKHCH-GDVCILNATEWVREHASGYV 133
|
| >d1h4vb2 d.104.1.1 (B:2-325) Histidyl-tRNA synthetase (HisRS) {Thermus thermophilus [TaxId: 274]} Length = 324 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Histidyl-tRNA synthetase (HisRS) species: Thermus thermophilus [TaxId: 274]
Score = 54.2 bits (129), Expect = 4e-08
Identities = 38/339 (11%), Positives = 88/339 (25%), Gaps = 53/339 (15%)
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLE---IEPMYLLG-----DCPQFKRNTVKLLTHGGDL 845
+ + +V +++ A L E + ++ GG
Sbjct: 15 ELRMHQRIVATARKVLEAAGALELVTPIFEETQVFEKGVGAATDIVRKEMFTFQDRGGRS 74
Query: 846 LELSHELRLPFIRWAISNQKSS-----FKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGA 900
L L E +R + + ++ Q +++ +G
Sbjct: 75 LTLRPEGTAAMVRAYLEHGMKVWPQPVRLWMAGPMFRAERPQKGRYRQFHQVNYEALGSE 134
Query: 901 SALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMG 960
+ + +AE + + + + + + L+ E + E E L+
Sbjct: 135 NPILDAEAVVLLYECL-KELGLRRLKVKLSSVGDPEDRARYNAYLREVLSPHREALSEDS 193
Query: 961 SLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADK 1020
R + + + R + + + L +
Sbjct: 194 KERLEENPMRILDSKSERD---------------------QALLKELGVRPMLDFLGEEA 232
Query: 1021 PTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVG 1080
E +L + ++ + Y+ F+V + + L G
Sbjct: 233 RAHLKEVERHLERLSV--PYELEPALVRGLDYYVRTAFEVHH------EEIGAQSALGGG 284
Query: 1081 GRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQ 1119
GRYD L + GVG + +E +
Sbjct: 285 GRYDGLSELLGGPRV----------PGVGFAFGVERVAL 313
|
| >d1wu7a2 d.104.1.1 (A:3-329) Histidyl-tRNA synthetase (HisRS) {Archaeon Thermoplasma acidophilum [TaxId: 2303]} Length = 327 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Histidyl-tRNA synthetase (HisRS) species: Archaeon Thermoplasma acidophilum [TaxId: 2303]
Score = 53.6 bits (127), Expect = 7e-08
Identities = 48/333 (14%), Positives = 99/333 (29%), Gaps = 41/333 (12%)
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLE---IEP--MYLLGDCPQFKRNTVKLLTHGGDLLEL 848
D ++ ++ + +E + ++ +E +Y + + + T + GG + L
Sbjct: 17 DMDVEKFIFKTAEEAAEAFGFRRIDFPSLEYLDLYRIKSGEELLQQTYSFVDKGGREVTL 76
Query: 849 SHELRLPFIRWAISNQ---KSSFKRYEISSVYRRAIGHSPPNRYLQGDFDIIGGASALTE 905
E +R S + + + Q + DI G S +
Sbjct: 77 IPEATPSTVRMVTSRKDLQRPLRWYSFPKVWRYEEPQAGRYREHYQFNADIFGSDSPEAD 136
Query: 906 AEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQ 965
AEV+ + I+ R + +I +N ++E I G+ + V + +
Sbjct: 137 AEVIALASSILDRLGLQDIYEIRINSRKIMEEII--GGMTSSDPFSV-FSIIDRYHKISR 193
Query: 966 SSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKA 1025
+ + R R G + + + R+
Sbjct: 194 EEFVDQLRSAGIGEDGVSMIADLCSGTRGIDEMARITGKSSEEIARMAAVEDL------- 246
Query: 1026 LDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDY 1085
L ++ R D + SY+ + F+ + ++ A + GGRYD
Sbjct: 247 LASYGVKNVRY------DFSIVRGLSYYTGIVFEAYDRSGQFRA-------ILGGGRYDN 293
Query: 1086 LLHRMWDREYVGYASRTNPPSGVGASLALETII 1118
L M VG + I
Sbjct: 294 LASLMSGESV----------PAVGFGMGDAVIS 316
|
| >d2dawa1 d.20.1.3 (A:8-148) RWD domain-containing protein 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: RWD domain domain: RWD domain-containing protein 2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (120), Expect = 8e-08
Identities = 21/136 (15%), Positives = 41/136 (30%), Gaps = 15/136 (11%)
Query: 24 SSSTVDDNELLSEEITALCAIFQEDCKVVSGSPPQILVKLR-------------PYSKDM 70
S+S + +L E+ L ++F +V + R + +
Sbjct: 2 SASVKESLQLQLLEMEMLFSMFPNQGEVKLEDVNALTNIKRYLEGTREALPPKIEFVITL 61
Query: 71 GYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVM 130
E+ V L V YPY +L L + L L + G +
Sbjct: 62 QIEEPKVKIDLQVTMPHSYPYLALQLFGR-SSELDRHQQLLLNKGLTSYIGTFDP-GELC 119
Query: 131 IFNLVEAAQEFLSEIV 146
+ ++ Q+ +
Sbjct: 120 VCAAIQWLQDNSASYF 135
|
| >d1qe0a2 d.104.1.1 (A:1-325) Histidyl-tRNA synthetase (HisRS) {Staphylococcus aureus [TaxId: 1280]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Histidyl-tRNA synthetase (HisRS) species: Staphylococcus aureus [TaxId: 1280]
Score = 46.5 bits (109), Expect = 1e-05
Identities = 48/344 (13%), Positives = 99/344 (28%), Gaps = 53/344 (15%)
Query: 790 YSDLDTELRDYVVQVTKEMFRQHCAKHLE---IEPMYLLG-----DCPQFKRNTVKLLTH 841
D++ Y+ E+ + K + E L ++
Sbjct: 11 ILPEDSKKWRYIENQLDELMTFYNYKEIRTPIFESTDLFARGVGDSTDVVQKEMYTFKDK 70
Query: 842 GGDLLELSHELRLPFIRWAISN-----QKSSFKRYEISSVYRRAIGHSPPNR-YLQGDFD 895
G + L E +R I + K Y ++R R + Q +
Sbjct: 71 GDRSITLRPEGTAAVVRSYIEHKMQGNPNQPIKLYYNGPMFRYERKQKGRYRQFNQFGVE 130
Query: 896 IIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAEL 955
IG + +AEVL + M I F + +N + + + +H E V
Sbjct: 131 AIGAENPSVDAEVLAMVMHIYQSFGLKH-LKLVINSVGDMASRKEYNEALVKHFEPVIHE 189
Query: 956 LAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGA 1015
R + R L +++ + + + + +++
Sbjct: 190 FCSDCQSRLHTDPM--------RILDCKVDRDKEAIKTAPRITDFLNEESKAYYEQVKAY 241
Query: 1016 LPADKPTRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGT 1075
L + D + Y+ + F++ Y +
Sbjct: 242 LDD-----------------LGIPYTEDPNLVRGLDYYTHTAFELMMDNPNYDGAITT-- 282
Query: 1076 LLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQ 1119
L GGRY+ LL + +G+G +L++E ++
Sbjct: 283 -LCGGGRYNGLLELLDGPSE----------TGIGFALSIERLLL 315
|
| >d1kmma2 d.104.1.1 (A:4-325) Histidyl-tRNA synthetase (HisRS) {Escherichia coli [TaxId: 562]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Histidyl-tRNA synthetase (HisRS) species: Escherichia coli [TaxId: 562]
Score = 45.0 bits (105), Expect = 4e-05
Identities = 50/338 (14%), Positives = 96/338 (28%), Gaps = 53/338 (15%)
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLE---IEPMYLLG-----DCPQFKRNTVKLLTHGGDL 845
+T + + K + + + +E L ++ GD
Sbjct: 15 ETAIWQRIEGTLKNVLGSYGYSEIRLPIVEQTPLFKRAIGEVTDVVEKEMYTFEDRNGDS 74
Query: 846 LELSHELRLPFIRWAISNQKSSFKRYEISSVYRRAIGHSP----PNRYLQGDFDIIGGAS 901
L L E +R I + + + + P ++ Q ++ G
Sbjct: 75 LTLRPEGTAGCVRAGIEHGLLYNQEQRLWYIGPMFRHERPQKGRYRQFHQLGCEVFGLQG 134
Query: 902 ALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGS 961
+AE++ +T +E + LN LEA ++ E+ E L
Sbjct: 135 PDIDAELIMLTARWWRALGISEHVTLELNSIGSLEARANYRDALVAFLEQHKEKL----- 189
Query: 962 LRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKP 1021
+ K + ++L N A P L L +
Sbjct: 190 ----DEDCKRRMYTNPLRVLDSKN--------------PEVQALLNDAPALGDYLDEESR 231
Query: 1022 TRKALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGG 1081
A L I ++ + Y+ F+ + T+ GG
Sbjct: 232 EHFAGLCKLLESAGI--AYTVNQRLVRGLDYYNRTVFEWVTNSLGSQGTV------CAGG 283
Query: 1082 RYDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQ 1119
RYD L+ ++ R VG ++ LE ++
Sbjct: 284 RYDGLVEQLGGRAT----------PAVGFAMGLERLVL 311
|
| >d1z7ma1 d.104.1.1 (A:6-323) ATP phosphoribosyltransferase regulatory subunit HisZ {Lactococcus lactis [TaxId: 1358]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: ATP phosphoribosyltransferase regulatory subunit HisZ species: Lactococcus lactis [TaxId: 1358]
Score = 42.7 bits (99), Expect = 2e-04
Identities = 44/336 (13%), Positives = 99/336 (29%), Gaps = 48/336 (14%)
Query: 794 DTELRDYVVQVTKEMFRQHCAKHLE---IEPMYLL-----GDCPQFKRNTVKLLTHGGDL 845
+ + +++F + + E L + + + H G
Sbjct: 14 QVKSLRQIEGRLRKLFSLKNYQEVMPPSFEYTQLYTALESNGKTFNQEKMFQFIKHEGQS 73
Query: 846 LELSHELRLPFIRWAISNQKSSFKRYEISSVYRRA--IGHSPPNRYLQGDFDIIGGASAL 903
+ L ++ LP +R + S+ RY R Q ++ G ++
Sbjct: 74 ITLRYDFTLPLVRLYSQIKDSTSARYSYFGKIFRKEKRHKGRSTENYQIGIELFGESADK 133
Query: 904 TEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLR 963
+E E+L + + ++ + + + + + A E ++ L
Sbjct: 134 SELEILSLALQVIEQLGLNK-TVFEIGSAKFFQRLCQLADGSTELLTEL---LLKKDLSG 189
Query: 964 PQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTR 1023
+ K+ + R LL+ + + + + + +
Sbjct: 190 LNAFIEKNNFSKELRGLLK------------EIFITNELSRLENLVTNTKDDVLISSFDQ 237
Query: 1024 KALDELYLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRY 1083
L + + D M P Y+ +L F+ +S P + GGRY
Sbjct: 238 LKEFSEKLSMIKPIII---DLGMVPKMDYYTDLMFKAYSSAANQP--------ILSGGRY 286
Query: 1084 DYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQ 1119
D LL +G ++TI++
Sbjct: 287 DQLLSNF-----------QEEAFAIGFCCHMDTILK 311
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1239 | |||
| d1wu7a2 | 327 | Histidyl-tRNA synthetase (HisRS) {Archaeon Thermop | 100.0 | |
| d1z7ma1 | 318 | ATP phosphoribosyltransferase regulatory subunit H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1h4vb2 | 324 | Histidyl-tRNA synthetase (HisRS) {Thermus thermoph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1qe0a2 | 325 | Histidyl-tRNA synthetase (HisRS) {Staphylococcus a | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1kmma2 | 322 | Histidyl-tRNA synthetase (HisRS) {Escherichia coli | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1usya_ | 275 | ATP phosphoribosyltransferase regulatory subunit H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ukxa_ | 137 | EIF2-alpha kinase 4 (GCN2-like protein) {Mouse (Mu | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d2daya1 | 115 | E3 ubiquitin-protein ligase RNF25 {Human (Homo sap | 99.87 | |
| d2dawa1 | 141 | RWD domain-containing protein 2 {Human (Homo sapie | 99.79 | |
| d2daxa1 | 140 | Uncharacterized protein C21orf6 {Human (Homo sapie | 99.79 | |
| d1nj8a3 | 268 | Prolyl-tRNA synthetase (ProRS) {Archaeon (Methanoc | 99.6 | |
| d1qf6a4 | 291 | Threonyl-tRNA synthetase (ThrRS) {Escherichia coli | 99.6 | |
| d1qf6a1 | 110 | Threonyl-tRNA synthetase (ThrRS), C-terminal domai | 99.57 | |
| d1kmma1 | 99 | Histidyl-tRNA synthetase (HisRS), C-terminal domai | 99.57 | |
| d1nyra4 | 291 | Threonyl-tRNA synthetase (ThrRS) {Staphylococcus a | 99.56 | |
| d1wu7a1 | 97 | Histidyl-tRNA synthetase (HisRS), C-terminal domai | 99.55 | |
| d1nyra1 | 113 | Threonyl-tRNA synthetase (ThrRS), C-terminal domai | 99.54 | |
| d1h4vb1 | 96 | Histidyl-tRNA synthetase (HisRS), C-terminal domai | 99.51 | |
| d1qe0a1 | 95 | Histidyl-tRNA synthetase (HisRS), C-terminal domai | 99.49 | |
| d1b76a2 | 331 | Glycyl-tRNA synthetase (GlyRS) {Thermus thermophil | 99.44 | |
| d1hc7a2 | 272 | Prolyl-tRNA synthetase (ProRS) {Thermus thermophil | 99.41 | |
| d1nj1a3 | 265 | Prolyl-tRNA synthetase (ProRS) {Arhaeon (Methanoth | 99.4 | |
| d1nj1a1 | 127 | Prolyl-tRNA synthetase (ProRS) domain {Arhaeon (Me | 99.37 | |
| d1g5ha1 | 127 | The aaRS-like accessory subunit of mitochondrial p | 99.34 | |
| d1nj8a1 | 126 | Prolyl-tRNA synthetase (ProRS) domain {Archaeon (M | 99.26 | |
| d1atia1 | 111 | Glycyl-tRNA synthetase (GlyRS), C-terminal domain | 99.18 | |
| d1hc7a1 | 127 | Prolyl-tRNA synthetase (ProRS) domain {Thermus the | 99.17 | |
| d1b8aa2 | 335 | Aspartyl-tRNA synthetase (AspRS) {Archaeon Pyrococ | 98.94 | |
| d1seta2 | 311 | Seryl-tRNA synthetase (SerRS) {Thermus thermophilu | 98.63 | |
| d1g5ha2 | 290 | The aaRS-like accessory subunit of mitochondrial p | 98.53 | |
| d1c0aa3 | 346 | Aspartyl-tRNA synthetase (AspRS) {Escherichia coli | 98.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.28 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.28 | |
| d1l0wa3 | 356 | Aspartyl-tRNA synthetase (AspRS) {Thermus thermoph | 98.23 | |
| d1e1oa2 | 342 | Lysyl-tRNA synthetase (LysRS) {Escherichia coli, g | 98.18 | |
| d1eova2 | 353 | Aspartyl-tRNA synthetase (AspRS) {Baker's yeast (S | 98.15 | |
| d1atia2 | 394 | Glycyl-tRNA synthetase (GlyRS) {Thermus thermophil | 98.12 | |
| d1nnha_ | 293 | Hypothetical protein PF1951 {Archaeon Pyrococcus f | 98.02 | |
| d1jjca_ | 266 | Phenyl-tRNA synthetase (PheRS) alpha subunit, PheS | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.84 | |
| d1n9wa2 | 304 | Aspartyl-tRNA synthetase (AspRS) {Thermus thermoph | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.32 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.09 | |
| d2a7la1 | 117 | Ubiquitin-protein ligase W (E2 W) {Human (Homo sap | 92.78 | |
| d1v95a_ | 130 | Nuclear receptor coactivator 5 (KIAA1637) {Human ( | 92.65 | |
| d1jjcb5 | 207 | Phenyl-tRNA synthetase (PheRS) beta subunit, PheT, | 89.26 | |
| d1z2ua1 | 147 | Ubiquitin conjugating enzyme, UBC {Caenorhabditis | 88.36 | |
| d1y8xa1 | 157 | Ubiquitin conjugating enzyme, UBC {Human (Homo sap | 86.45 | |
| d2uyza1 | 156 | Ubiquitin conjugating enzyme, UBC {Human (Homo sap | 85.28 | |
| d2awfa1 | 125 | Ubiquitin conjugating enzyme, UBC {Human (Homo sap | 84.65 | |
| d1yrva1 | 148 | Ubiquitin conjugating enzyme, UBC {Human (Homo sap | 81.84 | |
| d2fo3a1 | 109 | Putative ubiquitin-conjugating enzyme, E2 domain { | 80.35 |
| >d1wu7a2 d.104.1.1 (A:3-329) Histidyl-tRNA synthetase (HisRS) {Archaeon Thermoplasma acidophilum [TaxId: 2303]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Histidyl-tRNA synthetase (HisRS) species: Archaeon Thermoplasma acidophilum [TaxId: 2303]
Probab=100.00 E-value=0 Score=421.54 Aligned_cols=308 Identities=16% Similarity=0.193 Sum_probs=249.9
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECCCC-CCCCCCCEEEEECCCCCEEEECCCCCHHH
Q ss_conf 88886422331346677789889999999809940355520----01578-74334427898316997251047886889
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQFKRNTVKLLTHGGDLLELSHELRLPF 856 (1239)
Q Consensus 782 ~~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~~~-~~~~~~~~~~~~D~~g~~l~LRpD~T~~i 856 (1239)
..++|++|++|.++..++++++.++++|++|||++|+||+| .+... +++..++||+|.|++|+.++||||+|+|+
T Consensus 5 ~~~~G~~D~~p~~~~~~~~i~~~l~~~f~~~Gy~~I~tP~lE~~d~~~~~~g~~~~~~~~~f~D~~g~~l~LRpD~T~~i 84 (327)
T d1wu7a2 5 EKIRGFRDFYPEDMDVEKFIFKTAEEAAEAFGFRRIDFPSLEYLDLYRIKSGEELLQQTYSFVDKGGREVTLIPEATPST 84 (327)
T ss_dssp CCCTTCCCBCHHHHHHHHHHHHHHHHHHHHTTCEECBCCSEEETHHHHTTSCTTGGGGSCEEECTTSCEEEECSCSHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCHHHHCCCCCCHHHHHHHHHHHCCCCHHHCCCCCCCCHH
T ss_conf 79999866899999999999999999999859947677763517542556735688877654035410110101235215
Q ss_pred HHHHHHCC--CCCEEEEEECCEEECCCCCCCCC-CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEECCHH
Q ss_conf 99998399--98513796337587178899997-1437869996799951179999999999996399983299978499
Q 000880 857 IRWAISNQ--KSSFKRYEISSVYRRAIGHSPPN-RYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGD 933 (1239)
Q Consensus 857 aR~v~~~~--~~p~r~~y~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~s~~aDaEii~l~~~~l~~Lgi~~~~~i~ig~~~ 933 (1239)
||+++++. ..|+|+||+|+|||+++++.++. ||+|+|+|+||..+..+|+|+|.++.++++.+|+.+.+.|.|||+.
T Consensus 85 ar~~~~~~~~~~p~k~~y~g~VfR~~~~~~g~~re~~Q~G~EiiG~~~~~~D~Eii~l~~~~l~~~~~~~~~~i~l~~~~ 164 (327)
T d1wu7a2 85 VRMVTSRKDLQRPLRWYSFPKVWRYEEPQAGRYREHYQFNADIFGSDSPEADAEVIALASSILDRLGLQDIYEIRINSRK 164 (327)
T ss_dssp HHHHTTCTTCCSSEEEEECCEEECCCCSCSSCCSEEEEEEEEEESCCSHHHHHHHHHHHHHHHHHTTTTTSEEEEEEEHH
T ss_pred HHHHHHHHHCCCCCEEECCCCCEECCCCCCCCCCHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEECCCCHH
T ss_conf 66766521013652122247410024344687231123234333774128789999999998750265421000123266
Q ss_pred HHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCHHHHHHHHH
Q ss_conf 99999999099988999999999962588988631100099999999996199899999999998872699555999985
Q 000880 934 LLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLR 1013 (1239)
Q Consensus 934 i~~~l~~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~k~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~ 1013 (1239)
+++.+++.++.++. ......+++.+ +.....+...+.. .+...+....+..+. .... .+..+.
T Consensus 165 i~~~~l~~l~~~~~--~~~~~~~~~~~---------~~~~~~~~~~l~~-~~~~~~~~~~l~~~~-~~~~----~l~~~~ 227 (327)
T d1wu7a2 165 IMEEIIGGMTSSDP--FSVFSIIDRYH---------KISREEFVDQLRS-AGIGEDGVSMIADLC-SGTR----GIDEMA 227 (327)
T ss_dssp HHHHHHHTTCSSCH--HHHHHHHHTTT---------TSCHHHHHHHHHH-TTCCHHHHHHHHHHH-HSCB----CHHHHH
T ss_pred HHHHHHHHHHHHHH--HHHHHHHHHHH---------HHCCCHHHHHHHH-HHHHHHHHHHHHHHC-CCCH----HHHHHH
T ss_conf 69999986545677--88888878887---------6322002334433-335667776532101-3420----456787
Q ss_pred CCCCCCHHHHHHHHHH--HHHHCCCCCCEEECCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHCC
Q ss_conf 0199995689999999--99880686208982699998886434599999537777654334540002655531111102
Q 000880 1014 GALPADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMW 1091 (1239)
Q Consensus 1014 ~~~~~~~~~~~~l~~L--~l~~~~~~~~i~~Dls~~rgl~YYTG~vFe~~~~~~~~~~~~~~~~~I~~GGRYD~L~~~fg 1091 (1239)
............+..+ .+...++ +.|.+|++++||++||||+||++|..... ..+||+|||||+|++.|+
T Consensus 228 ~~~~~~~~~~~~l~~l~~~l~~~~~-~~i~~D~~~~r~~~YYtGivFe~~~~~~~-------~~~i~~GGRYD~L~~~f~ 299 (327)
T d1wu7a2 228 RITGKSSEEIARMAAVEDLLASYGV-KNVRYDFSIVRGLSYYTGIVFEAYDRSGQ-------FRAILGGGRYDNLASLMS 299 (327)
T ss_dssp HHTTCCCHHHHHHHHHHHHHHHTTC-CCCEECTTCCTTTTTCSSEEEEEEETTSS-------CSCSSEEEECTTHHHHHH
T ss_pred HHHCHHHHHHHHHHHHHHHHHHCCC-CCEEECCCCCCCCCCCCCEEEEEEECCCC-------CCEEEECCCCHHHHHHCC
T ss_conf 6401012679999998878876087-63467642378877768818999966897-------160543654268898649
Q ss_pred CCCCCCCCCCCCCCCEEEEECCHHHHHHHCCCC
Q ss_conf 100003468999996015642289998607799
Q 000880 1092 DREYVGYASRTNPPSGVGASLALETIIQHYPVD 1124 (1239)
Q Consensus 1092 ~~~~~~~~~~~~~~pavGfaiglerl~~~l~~~ 1124 (1239)
+. ++||||||+++|||+.+|+..
T Consensus 300 g~----------~~pAvGfsl~~~~l~~~l~~~ 322 (327)
T d1wu7a2 300 GE----------SVPAVGFGMGDAVISLLLKRE 322 (327)
T ss_dssp SC----------CCCEEEEEEEHHHHHHHHHHT
T ss_pred CC----------CCCEEEEEEEHHHHHHHHHHC
T ss_conf 99----------888688983299999999864
|
| >d1z7ma1 d.104.1.1 (A:6-323) ATP phosphoribosyltransferase regulatory subunit HisZ {Lactococcus lactis [TaxId: 1358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: ATP phosphoribosyltransferase regulatory subunit HisZ species: Lactococcus lactis [TaxId: 1358]
Probab=100.00 E-value=0 Score=409.75 Aligned_cols=300 Identities=15% Similarity=0.247 Sum_probs=244.1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECC---CCCCC-CCCCEEEEECCCCCEEEECCCCCH
Q ss_conf 8886422331346677789889999999809940355520----015---78743-344278983169972510478868
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL---GDCPQ-FKRNTVKLLTHGGDLLELSHELRL 854 (1239)
Q Consensus 783 ~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~---~~~~~-~~~~~~~~~D~~g~~l~LRpD~T~ 854 (1239)
.|+|++|++|.++..++.+++.++++|++|||++|.||+| ++. +.++. ..+++|+|.|++|+.++||||+|+
T Consensus 3 lP~g~~d~~~~~~~~~~~i~~~l~~~f~~~Gy~~I~tP~~E~~d~~~~~~~~~~~~~~~~~~~~~d~~g~~l~LRpD~T~ 82 (318)
T d1z7ma1 3 LPEESAEMTLNQVKSLRQIEGRLRKLFSLKNYQEVMPPSFEYTQLYTALESNGKTFNQEKMFQFIKHEGQSITLRYDFTL 82 (318)
T ss_dssp CCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSEEEHHHHHHHHCSSSCCCTTSCCEEECTTCCEEEECCCSHH
T ss_pred CCCCHHHHCHHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCHHHHHHCCCCCCCCCCCCCEEEEECCCCCEEEEECCCCC
T ss_conf 99832331988999999999999999998699798888665277764037886534434026732698637975233346
Q ss_pred HHHHHHHHCC-CCCEEEEEECCEEECCCCCCC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEECCH
Q ss_conf 8999998399-985137963375871788999-97143786999679995117999999999999639998329997849
Q 000880 855 PFIRWAISNQ-KSSFKRYEISSVYRRAIGHSP-PNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHG 932 (1239)
Q Consensus 855 ~iaR~v~~~~-~~p~r~~y~g~VfR~e~~~~~-~~ef~Q~GvEiiG~~s~~aDaEii~l~~~~l~~Lgi~~~~~i~ig~~ 932 (1239)
|+||+++++. ..|.|+||+|+|||+++++.+ .+||+|+|+|+||.+++.+|+|+|.++.++|+.+|+.+ +.|+|||+
T Consensus 83 ~iaR~~~~~~~~~~~r~~Y~g~vfR~~~~~~~r~rE~~Q~g~EiiG~~~~~ad~Eii~l~~e~l~~lgi~~-~~i~i~~~ 161 (318)
T d1z7ma1 83 PLVRLYSQIKDSTSARYSYFGKIFRKEKRHKGRSTENYQIGIELFGESADKSELEILSLALQVIEQLGLNK-TVFEIGSA 161 (318)
T ss_dssp HHHHHHHTCCSCCCEEEEEEEECCCCCC-------CCEEEEEEEESSCHHHHHHHHHHHHHHHHHHHTCSS-EEEEEEEH
T ss_pred HHHHHHHHHCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHHEECCCCCHHHHHHHHHHHHHHHHHHHHHCC-CCCCCHHH
T ss_conf 19999997303687002145621687453355420233332000212105677778999999999853214-40211024
Q ss_pred HHHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCHHHHHHHH
Q ss_conf 99999999909998899999999996258898863110009999999999619989999999999887269955599998
Q 000880 933 DLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRL 1012 (1239)
Q Consensus 933 ~i~~~l~~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~k~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l 1012 (1239)
++++.+++..+.+.+ .+..++.+++ + ..+ ..+++...+.......+..+. ..+........+
T Consensus 162 ~l~~~ll~~~~~~~e---~~~~~l~~k~---------~---~~l-~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~ 223 (318)
T d1z7ma1 162 KFFQRLCQLADGSTE---LLTELLLKKD---------L---SGL-NAFIEKNNFSKELRGLLKEIF--ITNELSRLENLV 223 (318)
T ss_dssp HHHHHHHHHTTTCHH---HHHHHHHTTC---------H---HHH-HHHHTTSCCCHHHHHHHHHHT--TCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHH---HHHHHHHHHH---------C---CCH-HHHHHHHHHHHHHHHHHHHCC--CCHHHHHHHHHH
T ss_conf 578888875320123---4578887640---------1---110-345554136889999886200--000367899876
Q ss_pred HCCCCCCHHHHHHHHHH--HHHHCCCCCCEEECCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHC
Q ss_conf 50199995689999999--9988068620898269999888643459999953777765433454000265553111110
Q 000880 1013 RGALPADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRM 1090 (1239)
Q Consensus 1013 ~~~~~~~~~~~~~l~~L--~l~~~~~~~~i~~Dls~~rgl~YYTG~vFe~~~~~~~~~~~~~~~~~I~~GGRYD~L~~~f 1090 (1239)
.. ..+......++++ ++..++....+.+|++++||++||||+||++|.++.+. +||+|||||+|++.|
T Consensus 224 ~~--~~~~~~~~~l~~l~~~~~~~~~~~~i~~d~~~~r~~~YYtG~vF~~~~~~~~~--------~i~~GGRYD~L~~~~ 293 (318)
T d1z7ma1 224 TN--TKDDVLISSFDQLKEFSEKLSMIKPIIIDLGMVPKMDYYTDLMFKAYSSAANQ--------PILSGGRYDQLLSNF 293 (318)
T ss_dssp HH--TTCHHHHHHHHHHHHHHHHHTTTSCCEECTTCCCSSTTCCSEEEEEEETTEEE--------EEEEEEECHHHHHTS
T ss_pred HH--HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCEEEEEEECCCCC--------EEEECCCHHHHHHHC
T ss_conf 42--13788887677776689886002322668101589757788089999789888--------478894457889850
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCHHHHHHHCC
Q ss_conf 21000034689999960156422899986077
Q 000880 1091 WDREYVGYASRTNPPSGVGASLALETIIQHYP 1122 (1239)
Q Consensus 1091 g~~~~~~~~~~~~~~pavGfaiglerl~~~l~ 1122 (1239)
|. ++||||||+++|||+.+|+
T Consensus 294 g~-----------~~~avGfsi~ld~i~~~l~ 314 (318)
T d1z7ma1 294 QE-----------EAFAIGFCCHMDTILKALE 314 (318)
T ss_dssp SS-----------CCCCEEEEEEHHHHHHHHH
T ss_pred CC-----------CCCEEEEEEEHHHHHHHHH
T ss_conf 99-----------9877999956999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=412.89 Aligned_cols=260 Identities=28% Similarity=0.484 Sum_probs=221.1
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
Q ss_conf 56892387533258966899999916994999999733899903689999999999926998624463144204754568
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~ 501 (1239)
++++|+++++||+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+++.++|||||++++++.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~------- 74 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE------- 74 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-------
T ss_conf 87460899897217480999999999997999999845664-1279999999999985799888469654046-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 988678885445444333466543235545555427999941268-8788998723999999999999999999999771
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
...+|+|||||+ |+|.+++.....+++..++.++.||+.||+|||+
T Consensus 75 ---------------------------------~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~ 121 (271)
T d1nvra_ 75 ---------------------------------GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121 (271)
T ss_dssp ---------------------------------TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------CCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf ---------------------------------74367988645898089997537999999999999999999999997
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 99312589766089868998899114720101011134578988888986445866556766789221259999995115
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksD 660 (1239)
++|+||||||+|||++.++.+||+|||+|+........ ...+..+||+.|||||++.+...++.++|
T Consensus 122 ~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~-------------~~~~~~~GT~~Y~APE~~~~~~~~~~~~D 188 (271)
T d1nvra_ 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-------------RLLNKMCGTLPYVAPELLKRREFHAEPVD 188 (271)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE-------------CCBCCCCSCGGGSCTHHHHCSSBCHHHHH
T ss_pred CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC-------------CCCCCEEECCCCCCHHHHCCCCCCCCCEE
T ss_conf 59835754689978878998798323142240468865-------------31113255747428728618999997101
Q ss_pred HHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf 6879999998403---89603789999996420599998100299999999998037999999999999723199985
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~~ 735 (1239)
|||+||++|||++ ||...................++.+...++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 189 iwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred EEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 617379999998299788889859999999863888788644699999999999767996689099999619845859
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.22 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=224.7
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
Q ss_conf 56892387533258966899999916994999999733899-90368999999999992699862446314420475456
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~ 500 (1239)
.+++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|+.++||||++++++|.
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~------- 75 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ------- 75 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-------
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC-------
T ss_conf 4474289889831768499999998999899999981565449799999999999998679998877876403-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 8988678885445444333466543235545555427999941268-878899872399999999999999999999977
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
+...+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||
T Consensus 76 ---------------------------------~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH 122 (337)
T d1o6la_ 76 ---------------------------------THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122 (337)
T ss_dssp ---------------------------------CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------CCCCCCCCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf ---------------------------------56421110003579860555532567759999999999965211343
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
+++|+||||||+|||++.++++||+|||+|+...... ......+||+.|||||++.+ ..|+.++
T Consensus 123 ~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~---------------~~~~~~~GT~~Y~aPE~~~~-~~y~~~~ 186 (337)
T d1o6la_ 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---------------ATMKTFCGTPEYLAPEVLED-NDYGRAV 186 (337)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT---------------CCBCCCEECGGGCCGGGGSS-SCBCTTH
T ss_pred HCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC---------------CCCCCCEECHHHHHHHHCCC-CCCCHHH
T ss_conf 1596224647778476589988882056520035678---------------62055100889966665048-9888333
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC-----HHHHHHCCC
Q ss_conf 56879999998403---8960378999999642059999810029999999999803799999999-----999972319
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQDAL 731 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPS-----a~eiL~h~~ 731 (1239)
||||+||++|||++ ||......+....+......+| ...++++.+||++||++||.+|++ +.++++|||
T Consensus 187 DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCC
T ss_conf 102230678899878999999699999999852899898---66899999999866638934422565234999972915
Q ss_pred CCCCHHHHH
Q ss_conf 998507889
Q 000880 732 PPQMEYELL 740 (1239)
Q Consensus 732 ~~~~~~~~~ 740 (1239)
|.++.|..+
T Consensus 264 f~~i~~~~l 272 (337)
T d1o6la_ 264 FLSINWQDV 272 (337)
T ss_dssp GTTCCHHHH
T ss_pred CCCCCHHHH
T ss_conf 036999999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.56 Aligned_cols=253 Identities=22% Similarity=0.387 Sum_probs=217.2
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCC
Q ss_conf 89238753325896689999991699499999973389990368999999999992699862446314420475456898
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~ 503 (1239)
++|+++++||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+++.++|||||+++++|.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--------- 88 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--------- 88 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE---------
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEE---------
T ss_conf 0538878981285829999999899989999998430172--79999999999986799988058577988---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 8678885445444333466543235545555427999941268-878899872399999999999999999999977199
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~g 582 (1239)
...+|+|||||+ |+|.+++.. ..+++..++.++.||+.||+|||++|
T Consensus 89 -------------------------------~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ 136 (293)
T d1yhwa1 89 -------------------------------GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136 (293)
T ss_dssp -------------------------------TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -------------------------------CCEEEEEEEECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf -------------------------------9998999970379808988641-59999999999999999999999879
Q ss_pred CCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 31258976608986899889911472010101113457898888898644586655676678922125999999511568
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDIw 662 (1239)
|+||||||+|||++.++++||+|||+|+.+.... ......+||+.|||||++.+ ..|+.++|||
T Consensus 137 iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~---------------~~~~~~~gt~~Y~aPE~~~~-~~~~~~~Diw 200 (293)
T d1yhwa1 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---------------SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIW 200 (293)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---------------CCBCCCCSCGGGCCHHHHSS-SCBCTHHHHH
T ss_pred CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC---------------CCCCCCCCCCCCCCHHHHCC-CCCCCHHCEE
T ss_conf 7226776888688789968642515641321366---------------64444444777368266447-9988012031
Q ss_pred HHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf 79999998403---89603789999996420599998100299999999998037999999999999723199985
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~~ 735 (1239)
|+||++|+|++ ||....................+.+...++++++||.+||..||.+|||+.++|+||||+..
T Consensus 201 SlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 3729999980488998997999999999857999888855379999999999866996689099999649965778
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=396.23 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=214.0
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCCCC
Q ss_conf 23875332589668999999169949999997338999036899999999999269986244631442047545689886
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~~~ 505 (1239)
|++.++||+|+||+||+|.++.++..||+|++............+.+|+.+|+.++|||||+++++|....
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--------- 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV--------- 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES---------
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC---------
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q ss_conf 78885445444333466543235545555427999941268-878899872399999999999999999999977199--
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG-- 582 (1239)
Q Consensus 506 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~g-- 582 (1239)
.....+|+|||||+ |+|.+++.....+++..++.++.||+.||+|||+++
T Consensus 82 ---------------------------~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~ 134 (270)
T d1t4ha_ 82 ---------------------------KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134 (270)
T ss_dssp ---------------------------SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred ---------------------------CCCCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf ---------------------------45888999995789894899975135546999999999999999999978997
Q ss_pred CCCCCCCCCCEEECC-CCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 312589766089868-9988991147201010111345789888889864458665567667892212599999951156
Q 000880 583 IIHRDLTPNNIFFDA-RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 583 IiHrDLKp~NILi~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDI 661 (1239)
|+||||||+|||++. ++.+||+|||+|+..... ...+.+||+.|||||++.+ .|+.++||
T Consensus 135 IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-----------------~~~~~~GT~~Y~aPE~~~~--~~~~~~DI 195 (270)
T d1t4ha_ 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----------------FAKAVIGTPEFMAPEMYEE--KYDESVDV 195 (270)
T ss_dssp CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----------------SBEESCSSCCCCCGGGGGT--CCCTHHHH
T ss_pred EEECCCCHHHCEEECCCCCEEEEECCCCEECCCC-----------------CCCCCCCCCCCCCHHHHCC--CCCCCCCH
T ss_conf 9968767435116679998898005765423687-----------------6677553813008988478--99986711
Q ss_pred HHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCC
Q ss_conf 879999998403---896037899999964205999981002999999999980379999999999997231999
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~ 733 (1239)
||+||++|||++ ||............+......+......++++.+||.+||.+||.+|||+.++|+||||+
T Consensus 196 wSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 196 YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 007999999987889998765599999999738998656755789999999997637975892999996775409
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=396.94 Aligned_cols=261 Identities=23% Similarity=0.411 Sum_probs=222.1
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
Q ss_conf 88775568923875332589668999999169949999997338999036899999999999269986244631442047
Q 000880 417 LPSSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETG 496 (1239)
Q Consensus 417 ~~~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~ 496 (1239)
+.....+++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.++|||||+++++|.+
T Consensus 19 l~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 94 (350)
T d1koaa2 19 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED-- 94 (350)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--
T ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 898878657589889840768199999988999899999984524--3169999999999986799799929999998--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHH-HCCCCCHHHHHHHHHHHHHH
Q ss_conf 54568988678885445444333466543235545555427999941268-87889987-23999999999999999999
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFE-SYDHFDKELAWHLFRQIVEG 574 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~-~~~~l~~~~~~~i~~qIl~a 574 (1239)
...+|+|||||+ |+|.+++. ..+.+++..++.++.||+.|
T Consensus 95 --------------------------------------~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~a 136 (350)
T d1koaa2 95 --------------------------------------DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136 (350)
T ss_dssp --------------------------------------TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHH
T ss_pred --------------------------------------CCEEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHH
T ss_conf --------------------------------------999999998579988999997623789999999999999999
Q ss_pred HHHHHHCCCCCCCCCCCCEEECC--CCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99977199312589766089868--9988991147201010111345789888889864458665567667892212599
Q 000880 575 LAHIHGQGIIHRDLTPNNIFFDA--RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 575 L~yLHs~gIiHrDLKp~NILi~~--~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
|+|||++||+||||||+|||++. ++.+||+|||+|+.+.... .....+||+.|||||++.+
T Consensus 137 L~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----------------~~~~~~gT~~Y~aPEv~~~- 199 (350)
T d1koaa2 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----------------SVKVTTGTAEFAAPEVAEG- 199 (350)
T ss_dssp HHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS----------------CEEEECSCTTTCCHHHHHT-
T ss_pred HHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC----------------CCCEECCCCCCCCHHHHCC-
T ss_conf 99997569760001546736416889869995452104425654----------------3200068624218899758-
Q ss_pred CCCCCCHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999951156879999998403---89603789999996420599998-10029999999999803799999999999972
Q 000880 653 PKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 653 ~~~s~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~ 728 (1239)
..|+.++||||+||++|+|++ ||......+....+.......+. .+...++++.+||++||..||.+|||+.++|+
T Consensus 200 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 99872676554659999998598998997999999999847889894223589999999999975689667908999862
Q ss_pred CCCCCCCH
Q ss_conf 31999850
Q 000880 729 DALPPQME 736 (1239)
Q Consensus 729 h~~~~~~~ 736 (1239)
||||....
T Consensus 280 hp~~~~~~ 287 (350)
T d1koaa2 280 HPWLTPGN 287 (350)
T ss_dssp STTTSCTT
T ss_pred CCCCCCCC
T ss_conf 91328898
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=396.42 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=211.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC-CHHHHHHHH---HHHHHHHCCCCCEEEEEEEEEECCCC
Q ss_conf 68923875332589668999999169949999997338999-036899999---99999926998624463144204754
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILR---EVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~~---Ev~iL~~L~HpnIv~l~~~~~~~~~~ 498 (1239)
+++|++++.||+|+||.||+|+++.+|+.||||++...... ......+.+ ++.+++.++|||||+++++|.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE----
T ss_conf 7768510188428890999999999997999999845875426679999999999999850899858899999998----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 568988678885445444333466543235545555427999941268-8788998723999999999999999999999
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~y 577 (1239)
...+|+|||||+ |+|.+++.....+++..++.++.||+.||+|
T Consensus 79 ------------------------------------~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~y 122 (364)
T d1omwa3 79 ------------------------------------PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122 (364)
T ss_dssp ------------------------------------SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHH
T ss_conf ------------------------------------99889999914898389998732553278999999999999999
Q ss_pred HHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 77199312589766089868998899114720101011134578988888986445866556766789221259999995
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ 657 (1239)
||+++|+||||||+|||++.++.+||+|||+|+...... ....+||+.|||||++.+...|+.
T Consensus 123 lH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-----------------~~~~~GT~~y~APE~~~~~~~~~~ 185 (364)
T d1omwa3 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----------------PHASVGTHGYMAPEVLQKGVAYDS 185 (364)
T ss_dssp HHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-----------------CCSCCSCGGGCCHHHHSTTCCCCT
T ss_pred HHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCCCC-----------------CCCCCCCCCCCHHHHHHCCCCCCC
T ss_conf 997796220444221678588967982201023337886-----------------433113455421687603899984
Q ss_pred CHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC-----HHHHHHC
Q ss_conf 1156879999998403---8960378999999642059999810029999999999803799999999-----9999723
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS-----ATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPS-----a~eiL~h 729 (1239)
++||||+||++|||++ ||...................+..+...++++.+||.+||..||.+||| ++++++|
T Consensus 186 ~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 186 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf 41046778999999859998888998999999986046888788778999999999985669888088743579999749
Q ss_pred CCCCCCHHHHH
Q ss_conf 19998507889
Q 000880 730 ALPPQMEYELL 740 (1239)
Q Consensus 730 ~~~~~~~~~~~ 740 (1239)
|||+++.|..+
T Consensus 266 p~f~~i~~~~~ 276 (364)
T d1omwa3 266 PFFRSLDWQMV 276 (364)
T ss_dssp GGGTTCCHHHH
T ss_pred CCCCCCCHHHH
T ss_conf 10237898799
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=397.43 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=219.8
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCC
Q ss_conf 89238753325896689999991699499999973389990368999999999992699862446314420475456898
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~ 503 (1239)
+.|++++.||+|+||+||+|+++.+|..||||+++... ......+.+|+.+++.++|||||+++++|.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------- 80 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--------- 80 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE---------
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE---------
T ss_conf 37598479930778199999999999399999987289--9999999999999986799998849889800---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 8678885445444333466543235545555427999941268-878899872-39999999999999999999997719
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 504 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qIl~aL~yLHs~ 581 (1239)
...+|+|||||+ |+|.+++.. ...+++..++.++.||+.||.|||++
T Consensus 81 -------------------------------~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~ 129 (288)
T d2jfla1 81 -------------------------------ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129 (288)
T ss_dssp -------------------------------TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred -------------------------------CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf -------------------------------9958999962799818899986289999999999999999999999988
Q ss_pred CCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCC
Q ss_conf 9312589766089868998899114720101011134578988888986445866556766789221259----999995
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG----WPKIDE 657 (1239)
Q Consensus 582 gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~s~ 657 (1239)
+|+||||||+|||++.++.+||+|||+|+........ ..+.+||+.|||||++.+ ...|+.
T Consensus 130 ~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~---------------~~~~~Gt~~y~APE~l~~~~~~~~~y~~ 194 (288)
T d2jfla1 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---------------RDSFIGTPYWMAPEVVMCETSKDRPYDY 194 (288)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH---------------HTCCCSCCTTCCHHHHTTCSTTTSSTTT
T ss_pred CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCCC---------------CCCCCCCCCCCCHHHHHHCCCCCCCCCH
T ss_conf 9887140700314878999899716123035778641---------------0010256264799998320257888880
Q ss_pred CHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 1156879999998403---8960378999999642059999810029999999999803799999999999972319998
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~ 734 (1239)
++||||+||++|||++ ||......+....+..........+...++++.+||++||+.||.+|||+.++++||||..
T Consensus 195 k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 195 KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 66578789999998208899999899999999970799877765669999999999976699668919999962923188
Q ss_pred CHHHHHH
Q ss_conf 5078899
Q 000880 735 MEYELLD 741 (1239)
Q Consensus 735 ~~~~~~~ 741 (1239)
.....+.
T Consensus 275 ~~~~p~~ 281 (288)
T d2jfla1 275 DSNKPIR 281 (288)
T ss_dssp CCCHHHH
T ss_pred CCCCCCH
T ss_conf 9899847
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=396.81 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=223.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
Q ss_conf 6892387533258966899999916994999999733899-903689999999999926998624463144204754568
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~ 501 (1239)
+++|++++.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+++.++|||||++++++.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~------- 75 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD------- 75 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-------
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE-------
T ss_conf 5470888897207680899999989997999999845775488999999999999986369675330356852-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 988678885445444333466543235545555427999941268-8788998723999999999999999999999771
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
...+|+|||||. |+|..++.....+++..++.++.||+.||+|||+
T Consensus 76 ---------------------------------~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 122 (316)
T d1fota_ 76 ---------------------------------AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122 (316)
T ss_dssp ---------------------------------SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ---------------------------------CCEEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCC
T ss_conf ---------------------------------88005676503786322343222211100799999999876554124
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 99312589766089868998899114720101011134578988888986445866556766789221259999995115
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksD 660 (1239)
++|+||||||+|||++.++.+||+|||+|+..... ..+.+||+.|||||++.+ ..|+.++|
T Consensus 123 ~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~------------------~~~~~Gt~~Y~APE~l~~-~~y~~~~D 183 (316)
T d1fota_ 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------------------TYTLCGTPDYIAPEVVST-KPYNKSID 183 (316)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC------------------BCCCCSCTTTCCHHHHTT-CCBCTTHH
T ss_pred CCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC------------------CCCCCCCCCCCCHHHHCC-CCCCCHHH
T ss_conf 76770556810503868998898317521671245------------------643457634359999838-99980430
Q ss_pred HHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-----CHHHHHHCCCC
Q ss_conf 6879999998403---896037899999964205999981002999999999980379999999-----99999723199
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALP 732 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RP-----Sa~eiL~h~~~ 732 (1239)
|||+||++|||++ ||......+....+......+|+ ..++++.+++.+||..||.+|+ |++++++||||
T Consensus 184 iwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 184 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCC
T ss_conf 465333689997598999996999999999708988997---78999999999995449976664310219999819351
Q ss_pred CCCHHHHH
Q ss_conf 98507889
Q 000880 733 PQMEYELL 740 (1239)
Q Consensus 733 ~~~~~~~~ 740 (1239)
+++.|+.+
T Consensus 261 ~~i~~~~l 268 (316)
T d1fota_ 261 KEVVWEKL 268 (316)
T ss_dssp SSCCHHHH
T ss_pred CCCCHHHH
T ss_conf 46798999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=397.01 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=222.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
Q ss_conf 6892387533258966899999916994999999733899-903689999999999926998624463144204754568
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~ 501 (1239)
+++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||++++++..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~------- 112 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD------- 112 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC-------
T ss_conf 2370898896117680899999989998999999826774588999999999999997487727403444432-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 988678885445444333466543235545555427999941268-8788998723999999999999999999999771
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
...+|+||||+. |+|..++...+.+++..++.++.||+.||.|||+
T Consensus 113 ---------------------------------~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~ 159 (350)
T d1rdqe_ 113 ---------------------------------NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp ---------------------------------SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------CCCCCCCCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf ---------------------------------22223222233466226667515898999999999999998999985
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 99312589766089868998899114720101011134578988888986445866556766789221259999995115
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksD 660 (1239)
++|+||||||+|||++.++++||+|||+|+..... ....+||+.|||||++.+ ..|+.++|
T Consensus 160 ~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~------------------~~~~~Gt~~Y~APE~~~~-~~~~~~~D 220 (350)
T d1rdqe_ 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------------------TWTLCGTPEALAPEIILS-KGYNKAVD 220 (350)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC------------------BCCCEECGGGCCHHHHTT-CCBCTHHH
T ss_pred CCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC------------------CCCCCCCCCCCCHHHHCC-CCCCCCCC
T ss_conf 99861767999936077897886101033322566------------------643367635678899717-99885331
Q ss_pred HHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-----CHHHHHHCCCC
Q ss_conf 6879999998403---896037899999964205999981002999999999980379999999-----99999723199
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP-----SATELLQDALP 732 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RP-----Sa~eiL~h~~~ 732 (1239)
||||||++|||++ ||...........+.......| ...++++.+||++||..||.+|+ |+.++++||||
T Consensus 221 iwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred CCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCC
T ss_conf 14500789999758899899599999999861798897---668999999999983409986065534549999719051
Q ss_pred CCCHHHHHH
Q ss_conf 985078899
Q 000880 733 PQMEYELLD 741 (1239)
Q Consensus 733 ~~~~~~~~~ 741 (1239)
++..|..+.
T Consensus 298 ~~~~~~~~~ 306 (350)
T d1rdqe_ 298 ATTDWIAIY 306 (350)
T ss_dssp TTCCHHHHH
T ss_pred CCCCHHHHH
T ss_conf 589989998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=397.65 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=219.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.+.|++.+.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYES-------- 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--------
T ss_conf 66669988994065839999999999989999998157731-289999999999986799899919899998--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 88678885445444333466543235545555427999941268-87889987239999999999999999999997719
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~ 581 (1239)
...+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++
T Consensus 79 --------------------------------~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~ 126 (307)
T d1a06a_ 79 --------------------------------GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126 (307)
T ss_dssp --------------------------------SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred --------------------------------CCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf --------------------------------998889885268984888653036788789999999999998752413
Q ss_pred CCCCCCCCCCCEEEC---CCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 931258976608986---89988991147201010111345789888889864458665567667892212599999951
Q 000880 582 GIIHRDLTPNNIFFD---ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 582 gIiHrDLKp~NILi~---~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~k 658 (1239)
+|+||||||+|||+. .++.+||+|||+|+...... ...+.+||+.|||||++.+ ..|+.+
T Consensus 127 ~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~----------------~~~~~~GT~~y~APE~~~~-~~~~~~ 189 (307)
T d1a06a_ 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----------------VLSTACGTPGYVAPEVLAQ-KPYSKA 189 (307)
T ss_dssp TCCCSCCCGGGEEESSSSTTCCEEECCC----------------------------------CTTSCHHHHTT-CCCCTH
T ss_pred EEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCCC----------------EEEEEEECCCCCCCHHHCC-CCCCCH
T ss_conf 05568704630011046888249983154358725897----------------0440032842259188737-999807
Q ss_pred HHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 156879999998403---8960378999999642059999-810029999999999803799999999999972319998
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~ 734 (1239)
+||||+||++|||++ ||...........+.......+ +.+...++++.+||.+||..||.+|||+.++++||||.+
T Consensus 190 ~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 87345159999998597999998999999998616877787666678999999999976089757918999862984479
Q ss_pred C
Q ss_conf 5
Q 000880 735 M 735 (1239)
Q Consensus 735 ~ 735 (1239)
.
T Consensus 270 ~ 270 (307)
T d1a06a_ 270 D 270 (307)
T ss_dssp S
T ss_pred C
T ss_conf 9
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=395.38 Aligned_cols=258 Identities=22% Similarity=0.372 Sum_probs=220.9
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCC
Q ss_conf 77556892387533258966899999916994999999733899903689999999999926998624463144204754
Q 000880 419 SSRYLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 419 ~~~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 498 (1239)
.+...++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+|+.+|+.++|||||+++++|.+
T Consensus 24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~---- 97 (352)
T d1koba_ 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED---- 97 (352)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----
T ss_pred CCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE----
T ss_conf 9985403599899931778299999998999799999988726--4679999999999986799798919999998----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHH
Q ss_conf 568988678885445444333466543235545555427999941268-87889987239-9999999999999999999
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qIl~aL~ 576 (1239)
...+|+|||||+ |+|.+.+...+ .+++..++.++.||+.||+
T Consensus 98 ------------------------------------~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ 141 (352)
T d1koba_ 98 ------------------------------------KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141 (352)
T ss_dssp ------------------------------------SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------CCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHH
T ss_conf ------------------------------------99999999828998088889863899899999999999999999
Q ss_pred HHHHCCCCCCCCCCCCEEEC--CCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 97719931258976608986--8998899114720101011134578988888986445866556766789221259999
Q 000880 577 HIHGQGIIHRDLTPNNIFFD--ARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILi~--~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 654 (1239)
|||++||+||||||+|||++ .++.+||+|||+|+.+.... ......||+.|||||++.+ ..
T Consensus 142 ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----------------~~~~~~gt~~y~aPE~~~~-~~ 204 (352)
T d1koba_ 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----------------IVKVTTATAEFAAPEIVDR-EP 204 (352)
T ss_dssp HHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----------------CEEEECSSGGGCCHHHHTT-CC
T ss_pred HHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC----------------CEEECCCCCCCCCHHHHCC-CC
T ss_conf 999779265131445531134678848995256303437887----------------2010047645348999747-99
Q ss_pred CCCCHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCC
Q ss_conf 9951156879999998403---89603789999996420599998-1002999999999980379999999999997231
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 655 ~s~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~ 730 (1239)
|+.++||||+||++|+|++ ||.+.........+.......+. .+...++++.+||++||..||.+|||+.++|+||
T Consensus 205 ~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 89763338989999999968899899799999999984788989300247999999999997569966891899996097
Q ss_pred CCCCC
Q ss_conf 99985
Q 000880 731 LPPQM 735 (1239)
Q Consensus 731 ~~~~~ 735 (1239)
||++.
T Consensus 285 ~~~~~ 289 (352)
T d1koba_ 285 WLKGD 289 (352)
T ss_dssp TTSSC
T ss_pred HHCCC
T ss_conf 34888
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.00 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=211.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|+++++||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++|||||+++++|.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------- 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------- 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--------
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--------
T ss_conf 568889789712778099999998999699999987540-97899999999999986799999949999998--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-
Q ss_conf 88678885445444333466543235545555427999941268-8788998723999999999999999999999771-
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG- 580 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs- 580 (1239)
...+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||.|||+
T Consensus 76 --------------------------------~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~ 123 (322)
T d1s9ja_ 76 --------------------------------DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123 (322)
T ss_dssp --------------------------------SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf --------------------------------999999997679986899874249999999999999999999999985
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 99312589766089868998899114720101011134578988888986445866556766789221259999995115
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksD 660 (1239)
++|+||||||+|||++.++++||+|||+|+...... .++.+||+.|||||++.+ ..|+.++|
T Consensus 124 ~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-----------------~~~~~GT~~Y~APEvl~~-~~y~~~~D 185 (322)
T d1s9ja_ 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----------------ANSFVGTRSYMSPERLQG-THYSVQSD 185 (322)
T ss_dssp HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-----------------C---CCSSCCCCHHHHHC-SCCCTTHH
T ss_pred CCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCCC-----------------CCCCCCCCCCCCCHHHCC-CCCCCHHH
T ss_conf 999714457799468789989995487762567886-----------------211137714119468758-99894888
Q ss_pred HHHHHHHHHHHHC---CCCHHHHHHHHHH-----------------------------------------HHHHCCCCCC
Q ss_conf 6879999998403---8960378999999-----------------------------------------6420599998
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLS-----------------------------------------DLKQKGELPP 696 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~-----------------------------------------~~~~~~~~p~ 696 (1239)
|||+||++|||++ ||.+......... ... ....|.
T Consensus 186 iWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 264 (322)
T d1s9ja_ 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV-NEPPPK 264 (322)
T ss_dssp HHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHH-TSCCCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH-CCCCCC
T ss_conf 9989999999998889989988789999998875177545774212333221111222354134778876650-268766
Q ss_pred -CCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCCCHH
Q ss_conf -10029999999999803799999999999972319998507
Q 000880 697 -SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEY 737 (1239)
Q Consensus 697 -~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~~~~ 737 (1239)
.....++++.+||.+||..||.+|||+.++|+||||++..+
T Consensus 265 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 265 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCCC
T ss_conf 764448999999999986899467908999960986476982
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.56 Aligned_cols=252 Identities=29% Similarity=0.493 Sum_probs=217.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
Q ss_conf 56892387533258966899999916994999999733899-90368999999999992699862446314420475456
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~ 500 (1239)
.+++|++.+.||+|+||+||+|+++.+++.||+|++..... .......+.+|+.+++.++|||||++++++.+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~------ 77 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD------ 77 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------
T ss_conf 15376998898517785899999989994999999816885676899999999999985688888859999998------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 8988678885445444333466543235545555427999941268-878899872399999999999999999999977
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
...+|+|||||+ |+|.+++.....+++..++.++.||+.||+|||
T Consensus 78 ----------------------------------~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH 123 (263)
T d2j4za1 78 ----------------------------------ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123 (263)
T ss_dssp ----------------------------------SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf ----------------------------------9998999850479858988750489999999999999999999999
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
+++|+||||||+|||++.++.+||+|||+|+...... ....+||+.|||||++.+ ..|+.++
T Consensus 124 ~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-----------------~~~~~Gt~~Y~APE~~~~-~~~~~~~ 185 (263)
T d2j4za1 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----------------RTTLCGTLDYLPPEMIEG-RMHDEKV 185 (263)
T ss_dssp HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-----------------CEETTEEGGGCCHHHHTT-CCCCTTH
T ss_pred HCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC-----------------CCCCCCCCCCCCHHHHCC-CCCCCHH
T ss_conf 8894652202344146689987115556335448885-----------------235578876349999758-9989314
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 56879999998403---8960378999999642059999810029999999999803799999999999972319998
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~ 734 (1239)
|||||||++|||++ ||......+....+......+|. ..++++.+||.+||.+||.+|||+.++|+||||..
T Consensus 186 DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 186 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 4046759999983299998889999999999718999986---68999999999976479768909999971907078
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.17 Aligned_cols=262 Identities=29% Similarity=0.460 Sum_probs=223.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
Q ss_conf 56892387533258966899999916994999999733899-90368999999999992699862446314420475456
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~ 500 (1239)
..++|++.+.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+++.++||||++++++|.
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~------- 78 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ------- 78 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-------
T ss_pred CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-------
T ss_conf 9987789889850879099999998999799999986577557778999999999998768888617999999-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 8988678885445444333466543235545555427999941268-878899872399999999999999999999977
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
....+|+|||||+ |+|.+++...+.+++..++.++.|++.||+|||
T Consensus 79 ---------------------------------~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH 125 (288)
T d1uu3a_ 79 ---------------------------------DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125 (288)
T ss_dssp ---------------------------------CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------ECCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHC
T ss_conf ---------------------------------89988999970489877776531599999999999999999997621
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
+++|+||||||+|||++.++.+||+|||+|+.+...... ....+.+||+.|||||++.+ ..|+.++
T Consensus 126 ~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~-------------~~~~~~~GT~~Y~APE~~~~-~~~~~~~ 191 (288)
T d1uu3a_ 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-------------ARANSFVGTAQYVSPELLTE-KSACKSS 191 (288)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----------------------CCCCGGGCCHHHHHT-CCCCHHH
T ss_pred CCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCC-------------CCCCCCCCCCCCCCCEEECC-CCCCCCC
T ss_conf 650884767741236688853886032102422567764-------------33355567755258440026-8989666
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHH------HHHCC
Q ss_conf 56879999998403---8960378999999642059999810029999999999803799999999999------97231
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATE------LLQDA 730 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~e------iL~h~ 730 (1239)
||||+||++|||++ ||...........+......+| ...++++.+||++||+.||.+|||+++ +++||
T Consensus 192 DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hp 268 (288)
T d1uu3a_ 192 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268 (288)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSG
T ss_pred CEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCC
T ss_conf 230456999998038899899599999999971899998---54799999999998557976891978973778987697
Q ss_pred CCCCCHHHHH
Q ss_conf 9998507889
Q 000880 731 LPPQMEYELL 740 (1239)
Q Consensus 731 ~~~~~~~~~~ 740 (1239)
||+++.|+.+
T Consensus 269 ff~~i~w~~l 278 (288)
T d1uu3a_ 269 FFESVTWENL 278 (288)
T ss_dssp GGTTCCCTTG
T ss_pred CCCCCCHHHH
T ss_conf 6478998896
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=396.69 Aligned_cols=254 Identities=30% Similarity=0.543 Sum_probs=217.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|++++.||+|+||+||+|+++.+|+.||+|++............+.+|+.+++.++|||||+++++|.+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------- 75 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR------- 75 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--------
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-------
T ss_conf 3337996798308891999999999997999999874657979999999999999977899982489999917-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268-878899872----3999999999999999999999
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES----YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~----~~~l~~~~~~~i~~qIl~aL~y 577 (1239)
....+|+|||||+ |+|.+++.. ...+++..++.++.||+.||+|
T Consensus 76 -------------------------------~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~y 124 (269)
T d2java1 76 -------------------------------TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124 (269)
T ss_dssp ----------------------------------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred -------------------------------CCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf -------------------------------8998999995689993899998515457899999999999999999999
Q ss_pred HHHCC-----CCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 77199-----3125897660898689988991147201010111345789888889864458665567667892212599
Q 000880 578 IHGQG-----IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW 652 (1239)
Q Consensus 578 LHs~g-----IiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 652 (1239)
||+++ |+||||||+|||++.++.+||+|||+|+.+..... ..++.+||+.|||||++.+
T Consensus 125 lH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~---------------~~~~~~gt~~Y~APE~l~~- 188 (269)
T d2java1 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---------------FAKAFVGTPYYMSPEQMNR- 188 (269)
T ss_dssp HHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--------------------------CCCSCCCHHHHTT-
T ss_pred HHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEECCCCCC---------------CCCCCCCCCCCCCHHHHCC-
T ss_conf 997167788788586765425747888579800100032245777---------------5566778823279999839-
Q ss_pred CCCCCCHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 999951156879999998403---89603789999996420599998100299999999998037999999999999723
Q 000880 653 PKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 653 ~~~s~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
..|+.++|||||||++|||++ ||......+....+.. +..++.+...++++.+||++||..||.+|||+.++++|
T Consensus 189 ~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHC--CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 9999389887527899998018899899899999999971--89988974359999999999767995579189999729
Q ss_pred CCC
Q ss_conf 199
Q 000880 730 ALP 732 (1239)
Q Consensus 730 ~~~ 732 (1239)
||.
T Consensus 267 p~i 269 (269)
T d2java1 267 PLI 269 (269)
T ss_dssp TTC
T ss_pred CCC
T ss_conf 819
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=397.02 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=212.9
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 8923875332589668999999169949999997338999-036899999999999269986244631442047545689
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS-LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~-~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
..|+.+++||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+++.++|||||+++++|.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------- 86 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-------- 86 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--------
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--------
T ss_conf 856762797018880999999989993999999844443588999999999999997789998238999998--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCC-CHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 886788854454443334665432355455554279999412688-7889987239999999999999999999997719
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~ 581 (1239)
...+|+|||||++ +|..++.....+++..++.++.||+.||.|||++
T Consensus 87 --------------------------------~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~ 134 (309)
T d1u5ra_ 87 --------------------------------EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (309)
T ss_dssp --------------------------------TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred --------------------------------CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf --------------------------------998899998069994578997379999999999999999999999868
Q ss_pred CCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCH
Q ss_conf 93125897660898689988991147201010111345789888889864458665567667892212599--9999511
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW--PKIDEKA 659 (1239)
Q Consensus 582 gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~s~ks 659 (1239)
||+||||||+|||++.++.+||+|||+|+.... ....+||+.|||||++.+. ..|+.++
T Consensus 135 ~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~ 195 (309)
T d1u5ra_ 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------------------ANSFVGTPYWMAPEVILAMDEGQYDGKV 195 (309)
T ss_dssp TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-------------------BCCCCSCGGGCCHHHHTTTTSCCBCTHH
T ss_pred CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC-------------------CCCCCCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 976667884217987999789844365334677-------------------8731347663688998346788867214
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf 56879999998403---89603789999996420599998100299999999998037999999999999723199985
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~~ 735 (1239)
|||||||++|||++ ||......+....+... ...+......++++.+||.+||..||.+|||+.++|+|||+.+.
T Consensus 196 DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 5455899999998788999997999999999828-99988878889999999999773796579189999719975378
|
| >d1h4vb2 d.104.1.1 (B:2-325) Histidyl-tRNA synthetase (HisRS) {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Histidyl-tRNA synthetase (HisRS) species: Thermus thermophilus [TaxId: 274]
Probab=100.00 E-value=0 Score=395.59 Aligned_cols=299 Identities=14% Similarity=0.145 Sum_probs=219.8
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECCCC-CCC---CCCCEEEEECCCCCEEEECCCCC
Q ss_conf 88886422331346677789889999999809940355520----01578-743---34427898316997251047886
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQ---FKRNTVKLLTHGGDLLELSHELR 853 (1239)
Q Consensus 782 ~~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~~~-~~~---~~~~~~~~~D~~g~~l~LRpD~T 853 (1239)
+..+|++|++|.++..+++++++++++|++|||++|+||+| ++..+ |+. ..+.||+|.|.+|+.++||||+|
T Consensus 3 ~~~kG~rD~~p~~~~~~~~i~~~l~~~f~~~Gy~~I~tP~lE~~d~l~~~~g~~~~~~~~~~~~~~d~~g~~l~LRpD~T 82 (324)
T d1h4vb2 3 RAVRGTKDLFGKELRMHQRIVATARKVLEAAGALELVTPIFEETQVFEKGVGAATDIVRKEMFTFQDRGGRSLTLRPEGT 82 (324)
T ss_dssp CCCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSEEEGGGGCCCSCC------CCSCEEECTTSCEEEECCCSH
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 89999857899999999999999999999869967447764318776134687136778777543025773002466433
Q ss_pred HHHHHHHHHCC----CCCEEEEEECCEEECCCCCCCC-CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHCCCCCCEEEE
Q ss_conf 88999998399----9851379633758717889999-714378699967999511799999999999963999832999
Q 000880 854 LPFIRWAISNQ----KSSFKRYEISSVYRRAIGHSPP-NRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIH 928 (1239)
Q Consensus 854 ~~iaR~v~~~~----~~p~r~~y~g~VfR~e~~~~~~-~ef~Q~GvEiiG~~s~~aDaEii~l~~~~l~~Lgi~~~~~i~ 928 (1239)
+|+||+++.+. ..|+|+||+|+|||+++++.++ +||+|+|+|+||.++..+|+|+|.++.++++.+|+.+ +.+.
T Consensus 83 ~~iar~~~~~~~~~~~~p~r~~Y~g~VfR~~~~~~gr~re~~Q~g~EiiG~~~~~ad~Eii~l~~~~l~~l~~~~-~~~~ 161 (324)
T d1h4vb2 83 AAMVRAYLEHGMKVWPQPVRLWMAGPMFRAERPQKGRYRQFHQVNYEALGSENPILDAEAVVLLYECLKELGLRR-LKVK 161 (324)
T ss_dssp HHHHHHHHHTTGGGSSSSEEEEEEEEEECCCCC----CCEEEEEEEEEESCCCHHHHHHHHHHHHHHHHHTTCCS-CEEE
T ss_pred CHHHHHHHHHHHHHHCHHHHHEEECCCCCCCCCCCCCCCEECCCCCCCCCCCCHHHHHHHHHHHHHHHHHHCCCC-CCEE
T ss_conf 178889987666530106560444732036765688733002311234678986999999999999999841457-5426
Q ss_pred ECCHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCC--HHHHHHHHHHHHHHCCCHH
Q ss_conf 78499999999990999889999999999625889886311000999999999961998--9999999999887269955
Q 000880 929 LNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLA--EAVVNRLQTVGLRFCGAAD 1006 (1239)
Q Consensus 929 ig~~~i~~~l~~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~k~~~~~~~~~l~~~~~l~--~~~~~~l~~l~~~~~g~~~ 1006 (1239)
|+|.+++..+.....+..+. +..... .... +....+.+ ..+. ....+....++......
T Consensus 162 i~~~~~~~~~~~~~~~~~~~-------~~~~~~--------~~~~-~~~~~l~~-~~~~~~~~~~~~~~~ll~~~~~~-- 222 (324)
T d1h4vb2 162 LSSVGDPEDRARYNAYLREV-------LSPHRE--------ALSE-DSKERLEE-NPMRILDSKSERDQALLKELGVR-- 222 (324)
T ss_dssp EEECCCHHHHHHHHHHHHHH-------HGGGGG--------GSCH-HHHHHHHH-CGGGGGGCCCHHHHHHHHHHCCC--
T ss_pred EECCCCHHHHHHHHHHHHHH-------HHHHHH--------HHHH-HHHHHHHH-HHHHHHHHHHHHHHHHHHHHCCC--
T ss_conf 41058626778888889998-------888887--------6537-88999986-24454443457789999862384--
Q ss_pred HHHHHHHCCCCCCHHHHHHHHHH--HHHHCCCCCCEEECCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 59999850199995689999999--9988068620898269999888643459999953777765433454000265553
Q 000880 1007 QALPRLRGALPADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYD 1084 (1239)
Q Consensus 1007 ~~l~~l~~~~~~~~~~~~~l~~L--~l~~~~~~~~i~~Dls~~rgl~YYTG~vFe~~~~~~~~~~~~~~~~~I~~GGRYD 1084 (1239)
..++ ..+......++++ .+..+++ .+.+||+++||++||||+||++|+.+.+. .++||+|||||
T Consensus 223 ~~~~------~l~~~~~~~~~~~~~~~~~l~~--~i~iD~~~~rg~~YYtG~vFe~~~~~~g~------~~~i~~GGRYD 288 (324)
T d1h4vb2 223 PMLD------FLGEEARAHLKEVERHLERLSV--PYELEPALVRGLDYYVRTAFEVHHEEIGA------QSALGGGGRYD 288 (324)
T ss_dssp CGGG------GCCHHHHHHHHHHHHHHHHTTC--CEEECTTCCCCSTTCEEEEEEEEC------------CEEEEEEECT
T ss_pred HHHH------HHHHHHHHHHHHHHHHHHHCCE--EEEECCCCCCCCCCCCCEEEEEEECCCCC------CCEEECCCCCH
T ss_conf 5888------8748888778887777763324--89986422568756168189999789886------57152177637
Q ss_pred CHHHHCCCCCCCCCCCCCCCCCEEEEECCHHHHHHHCC-CC
Q ss_conf 11111021000034689999960156422899986077-99
Q 000880 1085 YLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYP-VD 1124 (1239)
Q Consensus 1085 ~L~~~fg~~~~~~~~~~~~~~pavGfaiglerl~~~l~-~~ 1124 (1239)
+|++.||++ ++||||||+++|||+.+|+ ++
T Consensus 289 ~L~~~f~~~----------~~pAvGfsi~ld~l~~~l~~~g 319 (324)
T d1h4vb2 289 GLSELLGGP----------RVPGVGFAFGVERVALALEAEG 319 (324)
T ss_dssp THHHHTTCC----------CCCEEEEEEEHHHHHHHHHHTT
T ss_pred HHHHHCCCC----------CCCEEEEEEEHHHHHHHHHHCC
T ss_conf 899864999----------9975899953999999999659
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=389.46 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=221.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC----CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCC
Q ss_conf 68923875332589668999999169949999997338999----03689999999999926998624463144204754
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS----LPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~----~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 498 (1239)
.+.|++.++||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|+.++|||||+++++|.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE----
T ss_conf 5677982798117895999999999998999999875663213406899999999999986799899938899997----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 568988678885445444333466543235545555427999941268-8788998723999999999999999999999
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~y 577 (1239)
...+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|
T Consensus 85 ------------------------------------~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~y 128 (293)
T d1jksa_ 85 ------------------------------------KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128 (293)
T ss_dssp ------------------------------------SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------CCEEEEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf ------------------------------------99899999867786431001035642155789999999999876
Q ss_pred HHHCCCCCCCCCCCCEEECCCC----CEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 7719931258976608986899----889911472010101113457898888898644586655676678922125999
Q 000880 578 IHGQGIIHRDLTPNNIFFDARN----DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILi~~~~----~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 653 (1239)
||+++|+||||||+|||++.++ .+||+|||+|+...... ......||+.|+|||++.+ .
T Consensus 129 LH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~----------------~~~~~~~t~~y~APE~~~~-~ 191 (293)
T d1jksa_ 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----------------EFKNIFGTPEFVAPEIVNY-E 191 (293)
T ss_dssp HHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC----------------BCSCCCCCGGGCCHHHHTT-C
T ss_pred HHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCCCCC----------------CCCCCCCCCCCCCHHHHCC-C
T ss_conf 6625422113330127982589866646964334421057776----------------3122477774309999818-9
Q ss_pred CCCCCHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 99951156879999998403---89603789999996420599998-100299999999998037999999999999723
Q 000880 654 KIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 654 ~~s~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
.|+.++||||+||++|||++ ||......+....+.......++ .+...++++.+||++||..||.+|||+.++++|
T Consensus 192 ~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99976652214099999970889988999999999998168888701047889999999999863896689199999619
Q ss_pred CCCCCCHHH
Q ss_conf 199985078
Q 000880 730 ALPPQMEYE 738 (1239)
Q Consensus 730 ~~~~~~~~~ 738 (1239)
|||+...+.
T Consensus 272 p~~~~~~~~ 280 (293)
T d1jksa_ 272 PWIKPKDTQ 280 (293)
T ss_dssp TTTCC----
T ss_pred CCCCCCCHH
T ss_conf 041888705
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.77 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=218.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHH-HCCCCCEEEEEEEEEECCCCCC
Q ss_conf 6892387533258966899999916994999999733899-9036899999999999-2699862446314420475456
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLS-RLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~~Ev~iL~-~L~HpnIv~l~~~~~~~~~~~~ 500 (1239)
+++|++.++||+|+||+||+|+++.+|+.||||+++.... .......+.+|..++. .++|||||+++++|.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~------ 74 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT------ 74 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC------
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC------
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 8988678885445444333466543235545555427999941268-878899872399999999999999999999977
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
...+|+|||||+ |+|.+++.....+++..++.++.||+.||+|||
T Consensus 75 ----------------------------------~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH 120 (320)
T d1xjda_ 75 ----------------------------------KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120 (320)
T ss_dssp ----------------------------------SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------CCCEEEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf ----------------------------------9831677750379808998640478999999999999999999998
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
+++|+||||||+|||++.++++||+|||+|+...... ...+..+||+.|+|||++.+ ..|+.++
T Consensus 121 ~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 184 (320)
T d1xjda_ 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---------------AKTNTFCGTPDYIAPEILLG-QKYNHSV 184 (320)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---------------CCBCCCCSCGGGCCHHHHTT-CCBCTHH
T ss_pred HCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCC---------------CCCCCCCCCCCCCCHHHHCC-CCCCCHH
T ss_conf 6893403476540444489963015553023235665---------------33454578777689999827-9988323
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHH-HHHHCCCCCCC
Q ss_conf 56879999998403---896037899999964205999981002999999999980379999999999-99723199985
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSAT-ELLQDALPPQM 735 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~-eiL~h~~~~~~ 735 (1239)
||||+||++|||++ ||.+....+....+......+| ...++++.+||.+||..||.+||++. ++++||||+++
T Consensus 185 DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 185 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHHCCC
T ss_conf 201122789898738899999899999999971899897---56799999999996544898783889999809013158
Q ss_pred HHHHH
Q ss_conf 07889
Q 000880 736 EYELL 740 (1239)
Q Consensus 736 ~~~~~ 740 (1239)
.|+.+
T Consensus 262 ~~~~l 266 (320)
T d1xjda_ 262 NWEEL 266 (320)
T ss_dssp CHHHH
T ss_pred CHHHH
T ss_conf 99999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=379.45 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=221.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCC-------HHHHHHHHHHHHHHHCC-CCCEEEEEEEEE
Q ss_conf 5689238753325896689999991699499999973389990-------36899999999999269-986244631442
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL-------PVNDRILREVATLSRLQ-HQHVVRYYQAWF 493 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~-------~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~ 493 (1239)
|.++|++.+.||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+++.++ ||||++++++|.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CCCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECC
T ss_conf 96638885288417684999999999998999999962446411478889999999999999998507997479976214
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHH
Q ss_conf 04754568988678885445444333466543235545555427999941268-87889987239999999999999999
Q 000880 494 ETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIV 572 (1239)
Q Consensus 494 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl 572 (1239)
+...+|+|||||+ |+|.+++...+.+++..++.++.||+
T Consensus 81 ----------------------------------------~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~ 120 (277)
T d1phka_ 81 ----------------------------------------TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120 (277)
T ss_dssp ----------------------------------------CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHH
T ss_pred ----------------------------------------CCCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHH
T ss_conf ----------------------------------------6760599997689866899998659999999999999999
Q ss_pred HHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-
Q ss_conf 9999977199312589766089868998899114720101011134578988888986445866556766789221259-
Q 000880 573 EGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQG- 651 (1239)
Q Consensus 573 ~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~- 651 (1239)
.||+|||+++|+||||||+|||++.++.+||+|||+|+...... ..+..+||+.|+|||++.+
T Consensus 121 ~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~----------------~~~~~~gt~~y~~PE~~~~~ 184 (277)
T d1phka_ 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----------------KLREVCGTPSYLAPEIIECS 184 (277)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC----------------CBCCCCSCGGGCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEECCCCC----------------CEEEEECCCCCCCHHHHHCC
T ss_conf 99999987599432346254898689983871240316726887----------------21345246788898886053
Q ss_pred ----CCCCCCCHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHCCCCCCCCCCCH
Q ss_conf ----9999951156879999998403---8960378999999642059999-8100299999999998037999999999
Q 000880 652 ----WPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDRPSA 723 (1239)
Q Consensus 652 ----~~~~s~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~LI~~lL~~dP~~RPSa 723 (1239)
...++.++||||+||++|+|++ ||...........+.......+ +.+...++++.+|+++||++||.+|||+
T Consensus 185 ~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~ 264 (277)
T d1phka_ 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264 (277)
T ss_dssp HCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 44567889923318565602310322888988999999999998189888985434689999999999765896689199
Q ss_pred HHHHHCCCCCCC
Q ss_conf 999723199985
Q 000880 724 TELLQDALPPQM 735 (1239)
Q Consensus 724 ~eiL~h~~~~~~ 735 (1239)
.++|+||||++.
T Consensus 265 ~eil~h~~~~~~ 276 (277)
T d1phka_ 265 EEALAHPFFQQY 276 (277)
T ss_dssp HHHTTSGGGCTT
T ss_pred HHHHCCHHHHHH
T ss_conf 999739787975
|
| >d1qe0a2 d.104.1.1 (A:1-325) Histidyl-tRNA synthetase (HisRS) {Staphylococcus aureus [TaxId: 1280]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Histidyl-tRNA synthetase (HisRS) species: Staphylococcus aureus [TaxId: 1280]
Probab=100.00 E-value=0 Score=389.72 Aligned_cols=302 Identities=15% Similarity=0.151 Sum_probs=219.6
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECCCC-CCC---CCCCEEEEECCCCCEEEECCC
Q ss_conf 4688886422331346677789889999999809940355520----01578-743---344278983169972510478
Q 000880 780 LNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-CPQ---FKRNTVKLLTHGGDLLELSHE 851 (1239)
Q Consensus 780 ~n~~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~~~-~~~---~~~~~~~~~D~~g~~l~LRpD 851 (1239)
|-+.|+|++|++|.++..+++++++++++|++|||++|.||+| ++..+ |+. ..+++|+|.|++|+.++||||
T Consensus 1 ~~~lP~G~rD~lp~~~~~~~~i~~~l~~~f~~~Gy~~I~tP~lE~~d~l~~~~g~~~~~~~~~~~~~~d~~~~~~~lr~d 80 (325)
T d1qe0a2 1 MIKIPRGTQDILPEDSKKWRYIENQLDELMTFYNYKEIRTPIFESTDLFARGVGDSTDVVQKEMYTFKDKGDRSITLRPE 80 (325)
T ss_dssp CCCCCTTCCCBCHHHHHHHHHHHHHHHHHHHHHTCEECBCCSEEEHHHHCC-----------CCEEECHHHHCCEEECSC
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCHHHHCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 98889988377999999999999999999998699686676421188750536870467888876542011111224544
Q ss_pred CCHHHHHHHHHCC-----CCCEEEEEECCEEECCCCCCCC-CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHCCCCCCE
Q ss_conf 8688999998399-----9851379633758717889999-714378699967999511799999999999963999832
Q 000880 852 LRLPFIRWAISNQ-----KSSFKRYEISSVYRRAIGHSPP-NRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESC 925 (1239)
Q Consensus 852 ~T~~iaR~v~~~~-----~~p~r~~y~g~VfR~e~~~~~~-~ef~Q~GvEiiG~~s~~aDaEii~l~~~~l~~Lgi~~~~ 925 (1239)
+|+|++|.++.+. ..|+|+||+|+|||+++++.++ +||+|+|+|+||..++.+|+|+|.++.++++.+|+.+ +
T Consensus 81 ~t~~~~r~~~~~~~~~~~~~p~R~~Y~g~VfR~~~~~~~~~rE~~Q~G~EiiG~~~~~ad~Eii~l~~~~l~~~g~~~-~ 159 (325)
T d1qe0a2 81 GTAAVVRSYIEHKMQGNPNQPIKLYYNGPMFRYERKQKGRYRQFNQFGVEAIGAENPSVDAEVLAMVMHIYQSFGLKH-L 159 (325)
T ss_dssp SHHHHHHHHHHTTGGGCSSCSEEEEEEEEEECC-------CCEEEEEEEEEESCCCHHHHHHHHHHHHHHHHHTTCCC-E
T ss_pred CCCCHHHHHHHHCCCCCCCCCHHHHEECCEEEECCCCCCCCCEEEECCEEECCCCCCHHHHHHHHHHHHHHHHHCCCC-C
T ss_conf 343078999860354335660665146214641555578621220020354278673999987899999998627767-4
Q ss_pred EEEECCHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCH
Q ss_conf 99978499999999990999889999999999625889886311000999999999961998999999999988726995
Q 000880 926 DIHLNHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAA 1005 (1239)
Q Consensus 926 ~i~ig~~~i~~~l~~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~k~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~ 1005 (1239)
.+.|||++++..+++......+ .+..+.... . +.......... +......+...
T Consensus 160 ~i~i~~~~~~~~~~~~~~~~~~-------~~~~~~~~~------~-------~~~~~~~~~~~-----~~~~~~~~~~~- 213 (325)
T d1qe0a2 160 KLVINSVGDMASRKEYNEALVK-------HFEPVIHEF------C-------SDCQSRLHTDP-----MRILDCKVDRD- 213 (325)
T ss_dssp EEEEEECCCHHHHHHHHHHHHH-------HHGGGGGGS------C-------HHHHHTTTTCG-----GGGC--------
T ss_pred CEEECCCCCHHHHHHHHHHHHH-------HHHHHHHHH------H-------HHHHHHHHCCH-----HHHHHHHCCHH-
T ss_conf 2355454408888888888888-------788888887------7-------77665530025-----66654313024-
Q ss_pred HHHHHHHHCCC-CCCHHHHHHHHHH--HHHHCCCCCCEEECCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 55999985019-9995689999999--99880686208982699998886434599999537777654334540002655
Q 000880 1006 DQALPRLRGAL-PADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGR 1082 (1239)
Q Consensus 1006 ~~~l~~l~~~~-~~~~~~~~~l~~L--~l~~~~~~~~i~~Dls~~rgl~YYTG~vFe~~~~~~~~~~~~~~~~~I~~GGR 1082 (1239)
...+..+.... .........++++ .+...++ .+.+||+++||++||||+||++|+.+.+. .+..++||+|||
T Consensus 214 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~--~~~~D~s~~rg~~YYTGivFe~~~~~~~~---~g~~~~i~~GGR 288 (325)
T d1qe0a2 214 KEAIKTAPRITDFLNEESKAYYEQVKAYLDDLGI--PYTEDPNLVRGLDYYTHTAFELMMDNPNY---DGAITTLCGGGR 288 (325)
T ss_dssp -----CCCCGGGCCCTTHHHHHHHHHHHHHHHTC--CCEECTTCCCCCTTEEEEEEEEEEECTTS---TTSEEEEEEEEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHCCCCCCCCCCCCCCEEEEEEECCCCC---CCCCCCEECCCC
T ss_conf 7899751330334556679999999998875232--22106554568778678089999657777---776473540535
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCEEEEECCHHHHHHHCCC
Q ss_conf 53111110210000346899999601564228999860779
Q 000880 1083 YDYLLHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPV 1123 (1239)
Q Consensus 1083 YD~L~~~fg~~~~~~~~~~~~~~pavGfaiglerl~~~l~~ 1123 (1239)
||+|++.|++. +.||||||+++|||+.+|+.
T Consensus 289 YD~L~~~f~~~----------~~pAvGfsi~ld~L~~~l~~ 319 (325)
T d1qe0a2 289 YNGLLELLDGP----------SETGIGFALSIERLLLALEE 319 (325)
T ss_dssp EESHHHHTTCC----------CCEEEEEEEEHHHHHHHHHH
T ss_pred HHHHHHHCCCC----------CCCEEEEEEEHHHHHHHHHH
T ss_conf 77799970899----------99868999659999999997
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.90 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=213.9
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
+++|+++++||+|+||+||+|+++.+|+.||||+++...........+.+|+.+++.++|||||+++++|.+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-------- 72 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-------- 72 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--------
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--------
T ss_conf 999776517723768099999999999799999980222575899999999999986799838874453322--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268878899872--3999999999999999999999771
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFES--YDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~~--~~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
...+|+|||||++++.+.+.. ...+++..++.++.||+.||+|||+
T Consensus 73 --------------------------------~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~ 120 (298)
T d1gz8a_ 73 --------------------------------ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120 (298)
T ss_dssp --------------------------------TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCCEEEEEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHC
T ss_conf --------------------------------432037886237744555442025688889999999999999998652
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 99312589766089868998899114720101011134578988888986445866556766789221259999995115
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksD 660 (1239)
++|+||||||+|||++.++.+||+|||+|+....... .....+||+.|+|||++.....++.++|
T Consensus 121 ~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~---------------~~~~~~gt~~y~apE~~~~~~~~~~~~D 185 (298)
T d1gz8a_ 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---------------TYTHEVVTLWYRAPEILLGCKYYSTAVD 185 (298)
T ss_dssp TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB---------------CTTCCBCCCTTCCHHHHTTCSSCCTHHH
T ss_pred CCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCC---------------CCEEECCCCEEEEHHHHCCCCCCCCCCC
T ss_conf 8899213571140113467621035786134368864---------------1001036521541122136657774221
Q ss_pred HHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCC--------------------------CCCCCCCHHHHHHHHH
Q ss_conf 6879999998403---8960378999999642059999--------------------------8100299999999998
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP--------------------------PSWVAKFSEQESLLRR 711 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p--------------------------~~~~~~~~~~~~LI~~ 711 (1239)
|||+||++|+|++ ||...........+....+... ......++++.+||++
T Consensus 186 iwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~ 265 (298)
T d1gz8a_ 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ 265 (298)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHH
T ss_conf 03333134279668799898899999999998328983331444222421243454322220444166789999999999
Q ss_pred CCCCCCCCCCCHHHHHHCCCCCCCH
Q ss_conf 0379999999999997231999850
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 lL~~dP~~RPSa~eiL~h~~~~~~~ 736 (1239)
||..||.+|||+.++|+||||+++.
T Consensus 266 mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 266 MLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp HTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 7639955791899996787014699
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.92 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=218.2
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
Q ss_conf 56892387533258966899999916994999999733899903689999999999926998624463144204754568
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~ 501 (1239)
..++|++.+.||+|+||+||+|.++.+|+.||||+++... .....+.+|+.+|+.++|||||+++++|.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~------- 72 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES------- 72 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEE-------
T ss_conf 7010588789831778399999998999699999975786---659999999999985799798909899988-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 988678885445444333466543235545555427999941268-87889987239-9999999999999999999977
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 502 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~-~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
...+|+|||||+ |+|.+++...+ .+++..++.++.||+.||+|||
T Consensus 73 ---------------------------------~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH 119 (321)
T d1tkia_ 73 ---------------------------------MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119 (321)
T ss_dssp ---------------------------------TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf ---------------------------------99889999538998088998753899999999999999999999998
Q ss_pred HCCCCCCCCCCCCEEECCC--CCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 1993125897660898689--98899114720101011134578988888986445866556766789221259999995
Q 000880 580 GQGIIHRDLTPNNIFFDAR--NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~--~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ 657 (1239)
++||+||||||+|||++.+ ..+||+|||+++...... ......||+.|+|||.+.+ ..|+.
T Consensus 120 ~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~----------------~~~~~~~t~~y~ape~~~~-~~~~~ 182 (321)
T d1tkia_ 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----------------NFRLLFTAPEYYAPEVHQH-DVVST 182 (321)
T ss_dssp HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----------------EEEEEESCGGGSCHHHHTT-CEECH
T ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCC----------------CCCCCCCCCCCCCCHHCCC-CCCCC
T ss_conf 769975135544434437885189976441110034677----------------5321223322234021048-77784
Q ss_pred CHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCC
Q ss_conf 1156879999998403---89603789999996420599998-1002999999999980379999999999997231999
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPP 733 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~ 733 (1239)
++||||+||++|+|++ ||...........+......++. .+...++++.+||++||..||.+|||+.++++||||+
T Consensus 183 ~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 01130279999999828999999899999999983899988022367899999999998669966890999996399656
Q ss_pred CC
Q ss_conf 85
Q 000880 734 QM 735 (1239)
Q Consensus 734 ~~ 735 (1239)
+.
T Consensus 263 ~~ 264 (321)
T d1tkia_ 263 QK 264 (321)
T ss_dssp SC
T ss_pred CC
T ss_conf 67
|
| >d1kmma2 d.104.1.1 (A:4-325) Histidyl-tRNA synthetase (HisRS) {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Histidyl-tRNA synthetase (HisRS) species: Escherichia coli [TaxId: 562]
Probab=100.00 E-value=0 Score=379.71 Aligned_cols=298 Identities=16% Similarity=0.163 Sum_probs=209.4
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECCCC-C---CCCCCCEEEEECCCCCEEEECCCCC
Q ss_conf 88886422331346677789889999999809940355520----01578-7---4334427898316997251047886
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD-C---PQFKRNTVKLLTHGGDLLELSHELR 853 (1239)
Q Consensus 782 ~~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~~~-~---~~~~~~~~~~~D~~g~~l~LRpD~T 853 (1239)
+.++|++|++|.++..++++++.++++|++|||++|+||+| ++... | +...+.+|+|.|.+|+.++||||+|
T Consensus 3 ~~~~G~~D~lp~~~~~~~~i~~~l~~~f~~~Gy~~I~tP~lE~~d~~~~~~g~~~~~~~~~~~~~~d~~g~~l~Lr~D~T 82 (322)
T d1kmma2 3 QAIRGMNDYLPGETAIWQRIEGTLKNVLGSYGYSEIRLPIVEQTPLFKRAIGEVTDVVEKEMYTFEDRNGDSLTLRPEGT 82 (322)
T ss_dssp CCCTTCCCBCHHHHHHHHHHHHHHHHHHHTTTCEECBCCSEEEHHHHHHHHCTTSHHHHHTCEEEECTTSCEEEECSCSH
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 99999887899999999999999999999879947677654528886231576215667777544311453113463223
Q ss_pred HHHHHHHHHCC---CCCEEEEEECCEEECCCCCCCCC-CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEE
Q ss_conf 88999998399---98513796337587178899997-143786999679995117999999999999639998329997
Q 000880 854 LPFIRWAISNQ---KSSFKRYEISSVYRRAIGHSPPN-RYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHL 929 (1239)
Q Consensus 854 ~~iaR~v~~~~---~~p~r~~y~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~s~~aDaEii~l~~~~l~~Lgi~~~~~i~i 929 (1239)
+|+||+++++. ..|.|+||+|+|||+++++.++. ||+|+|+|+||..+..+|+|+|.++.++|+.+|+.+...+.+
T Consensus 83 ~~iaR~~~~~~~~~~~p~r~~y~g~v~r~~~~~~gr~re~~Q~g~EiiG~~~~~ad~Eii~l~~~~l~~lgl~~~~~~~~ 162 (322)
T d1kmma2 83 AGCVRAGIEHGLLYNQEQRLWYIGPMFRHERPQKGRYRQFHQLGCEVFGLQGPDIDAELIMLTARWWRALGISEHVTLEL 162 (322)
T ss_dssp HHHHHHHHHTTCSTTCCEEEEEEEEEECCCCCBTTBCSEEEEEEEEEESCCSHHHHHHHHHHHHHHHHHHTCGGGCEEEE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEC
T ss_conf 20568887510321003567531542235788888621456655777636630657999999999998618875058713
Q ss_pred CCHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCHHHHH
Q ss_conf 84999999999909998899999999996258898863110009999999999619989999999999887269955599
Q 000880 930 NHGDLLEAIWSWAGIKAEHREKVAELLAMMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQAL 1009 (1239)
Q Consensus 930 g~~~i~~~l~~~lgl~~~~~~~l~~~l~~~d~~~~~~~~~k~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l 1009 (1239)
++........ .....+...+.+...... + .....+. ...+..+. ...+......
T Consensus 163 ~~~~~~~~~~-------~~~~~l~~~~~~~~~~l~-----~----~~~~~~~---------~~~~~~l~-~~~~~~~~~~ 216 (322)
T d1kmma2 163 NSIGSLEARA-------NYRDALVAFLEQHKEKLD-----E----DCKRRMY---------TNPLRVLD-SKNPEVQALL 216 (322)
T ss_dssp EECCCHHHHH-------HHHHHHHHHHHHC--------------------------------------------------
T ss_pred CCCCHHHHHH-------HHHHHHHHHHHHHHHHHH-----H----HHHHHHH---------HHHHHHHH-CCCHHHHHHH
T ss_conf 5400087888-------889999999998887663-----9----9999886---------51566653-0364789999
Q ss_pred HHHHCCC-CCCHHHHHHHHHH--HHHHCCCCCCEEECCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 9985019-9995689999999--998806862089826999988864345999995377776543345400026555311
Q 000880 1010 PRLRGAL-PADKPTRKALDEL--YLRIWRIEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYL 1086 (1239)
Q Consensus 1010 ~~l~~~~-~~~~~~~~~l~~L--~l~~~~~~~~i~~Dls~~rgl~YYTG~vFe~~~~~~~~~~~~~~~~~I~~GGRYD~L 1086 (1239)
..+.... .........+..+ .+...++ .+.+|++++||++||||+||++|+.+.+. .++||+|||||+|
T Consensus 217 ~~~~~~~~~~~~~~~~~l~~~~~~l~~~~i--~~~id~~~~r~~~YYtGivFe~~~~~~g~------~~~i~~GGRYD~L 288 (322)
T d1kmma2 217 NDAPALGDYLDEESREHFAGLCKLLESAGI--AYTVNQRLVRGLDYYNRTVFEWVTNSLGS------QGTVCAGGRYDGL 288 (322)
T ss_dssp ----CGGGTCCHHHHHHHHHHHHHHHHHTC--CEEECTTCCCSSSCCCSEEEEEECTTCSS------SSEEEEEEECTTH
T ss_pred HHHHHCCHHHHHHHHHHHHHHHHHHHHCCE--EEEEECCCCCCCCCCCCCEEEEEECCCCC------CCEEECCCCHHHH
T ss_conf 887631014556778899888887651330--01333133568878788289999678897------5735226542789
Q ss_pred HHHCCCCCCCCCCCCCCCCCEEEEECCHHHHHHHCCC
Q ss_conf 1110210000346899999601564228999860779
Q 000880 1087 LHRMWDREYVGYASRTNPPSGVGASLALETIIQHYPV 1123 (1239)
Q Consensus 1087 ~~~fg~~~~~~~~~~~~~~pavGfaiglerl~~~l~~ 1123 (1239)
++.||++ ++|||||||++|||+.+|+.
T Consensus 289 ~~~f~g~----------~~pAvGfsi~ld~l~~~l~~ 315 (322)
T d1kmma2 289 VEQLGGR----------ATPAVGFAMGLERLVLLVQA 315 (322)
T ss_dssp HHHTTSC----------CCCEEEEEEEHHHHHHHHHH
T ss_pred HHHCCCC----------CCCEEEEEECHHHHHHHHHH
T ss_conf 9863899----------99757899529999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.57 Aligned_cols=262 Identities=26% Similarity=0.404 Sum_probs=215.4
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
Q ss_conf 56892387533258966899999916994999999733899903689999999999926998624463144204754568
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~ 501 (1239)
+.++|+++++||+|+||+||+|.++.+|+.||||+++...........+.+|+.+|+.++|||||+++++|...+.
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~---- 91 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET---- 91 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS----
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCC----
T ss_conf 4771899889801778199999999999899999985222596999999999999986689875479998635765----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 98867888544544433346654323554555542799994126887889987239999999999999999999997719
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 502 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~ 581 (1239)
......+|+|||||+.+|..++. ...+++..++.++.||+.||+|||++
T Consensus 92 ------------------------------~~~~~~~~lv~e~~~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~ 140 (346)
T d1cm8a_ 92 ------------------------------LDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA 140 (346)
T ss_dssp ------------------------------TTTCCCCEEEEECCSEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ------------------------------CCCCCEEEEEEECCCCCHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf ------------------------------55541599998405521899987-40226999999999999999998737
Q ss_pred CCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 93125897660898689988991147201010111345789888889864458665567667892212599999951156
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDI 661 (1239)
||+||||||+|||++.++.+||+|||+|+..... .+..+||+.|+|||++.+...++.++||
T Consensus 141 ~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di 202 (346)
T d1cm8a_ 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------------------MTGYVVTRWYRAPEVILNWMRYTQTVDI 202 (346)
T ss_dssp TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHH
T ss_pred CCCCCCCCCCHHHCCCCCCCCCCCCCCEECCCCC------------------CCCCCCCCCCCCHHHHCCCCCCCCCCHH
T ss_conf 8764566851111210012211343102206876------------------3102455333588998178789965010
Q ss_pred HHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCC----------------------------CCCCCCCCCHHHHHHHH
Q ss_conf 879999998403---89603789999996420599----------------------------99810029999999999
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE----------------------------LPPSWVAKFSEQESLLR 710 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~----------------------------~p~~~~~~~~~~~~LI~ 710 (1239)
||+||++|+|++ ||................+. .+......++++.+||+
T Consensus 203 wSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 282 (346)
T d1cm8a_ 203 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 282 (346)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHH
T ss_pred HCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHH
T ss_conf 30038999999786998889768999999850378848888653000344331157866655667755689999999999
Q ss_pred HCCCCCCCCCCCHHHHHHCCCCCCCH
Q ss_conf 80379999999999997231999850
Q 000880 711 RLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 711 ~lL~~dP~~RPSa~eiL~h~~~~~~~ 736 (1239)
+||..||.+|||+.++|+||||+++.
T Consensus 283 ~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 283 KMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 97729955792999996396237587
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.32 Aligned_cols=255 Identities=26% Similarity=0.350 Sum_probs=205.8
Q ss_pred EEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCC
Q ss_conf 38753325896689999991699499999973389990---368999999999992699862446314420475456898
Q 000880 427 EELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL---PVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 427 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~---~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~ 503 (1239)
+.+++||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+++.++|||||+++++|..
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--------- 71 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--------- 71 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---------
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC---------
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCH-HHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 8678885445444333466543235545555427999941268878-899872399999999999999999999977199
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTL-RQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL-~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~g 582 (1239)
...+|+|||||.+++ ..+......+++..++.++.||+.||+|||+++
T Consensus 72 -------------------------------~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~ 120 (299)
T d1ua2a_ 72 -------------------------------KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120 (299)
T ss_dssp -------------------------------TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred -------------------------------CCCEEEHHHHHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC
T ss_conf -------------------------------8740220455345077655412667789999999999999998863163
Q ss_pred CCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 31258976608986899889911472010101113457898888898644586655676678922125999999511568
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDIw 662 (1239)
|+||||||+|||++.++.+||+|||+|+...... ......+||+.|+|||++.+...|+.++|||
T Consensus 121 iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 185 (299)
T d1ua2a_ 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185 (299)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHH
T ss_pred EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC---------------CCCCCEECCHHHCCHHHHCCCCCCCHHHHHH
T ss_conf 5503577625885377841146576100057875---------------5433020473336399972677888056436
Q ss_pred HHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCC--------------------CC-----CCCCCCHHHHHHHHHCCC
Q ss_conf 79999998403---896037899999964205999--------------------98-----100299999999998037
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL--------------------PP-----SWVAKFSEQESLLRRLMS 714 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~--------------------p~-----~~~~~~~~~~~LI~~lL~ 714 (1239)
|+||++|||++ ||....+.+....+....+.. +. .+...++++.+||++||.
T Consensus 186 SlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~ 265 (299)
T d1ua2a_ 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265 (299)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHC
T ss_pred HCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCC
T ss_conf 30428999985969999999999999999851899725452100021344303478988678565689999999999763
Q ss_pred CCCCCCCCHHHHHHCCCCCCCH
Q ss_conf 9999999999997231999850
Q 000880 715 PSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 715 ~dP~~RPSa~eiL~h~~~~~~~ 736 (1239)
.||.+|||+.++|+||||++.+
T Consensus 266 ~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 266 FNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp SSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCHHHCCCHHHHHCCHHHCCCC
T ss_conf 8945690899996799657899
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.59 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=208.4
Q ss_pred CCCCCCCCCCEEEE-EECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEE
Q ss_conf 88775568923875-33258966899999916994999999733899903689999999999926-99862446314420
Q 000880 417 LPSSRYLNDFEELQ-PLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFE 494 (1239)
Q Consensus 417 ~~~~~~~~~y~~~~-~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~ 494 (1239)
+.....+++|.++. .||+|+||+||+|+++.+++.||||+++. ...+.+|+.++.++ +|||||+++++|..
T Consensus 4 ~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 4 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp CBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCCCCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 78997014879810796545486999999889998999999897-------47799999999986699997829899950
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC--CCCCHHHHHHHHHHH
Q ss_conf 4754568988678885445444333466543235545555427999941268-8788998723--999999999999999
Q 000880 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQI 571 (1239)
Q Consensus 495 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qI 571 (1239)
.. ....++|+|||||+ |+|.+++... ..+++..++.++.||
T Consensus 77 ~~------------------------------------~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi 120 (335)
T d2ozaa1 77 LY------------------------------------AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120 (335)
T ss_dssp EE------------------------------------TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHH
T ss_pred CC------------------------------------CCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 34------------------------------------689789999977899849999986278775799999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99999977199312589766089868---998899114720101011134578988888986445866556766789221
Q 000880 572 VEGLAHIHGQGIIHRDLTPNNIFFDA---RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEI 648 (1239)
Q Consensus 572 l~aL~yLHs~gIiHrDLKp~NILi~~---~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~ 648 (1239)
+.||+|||+++|+||||||+|||++. ++.+||+|||+|+...... .....+||+.|||||+
T Consensus 121 ~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----------------~~~~~~gt~~y~aPE~ 184 (335)
T d2ozaa1 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----------------SLTTPCYTPYYVAPEV 184 (335)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----------------CCCCCSCCCSSCCCCC
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC----------------CCCCCCCCCCCCCCHH
T ss_conf 999999997698644410022011355556631135455123336888----------------6432267756379277
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHC---CCCHHHHHHHHH----HHHHHCCCCC-CCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 2599999951156879999998403---896037899999----9642059999-8100299999999998037999999
Q 000880 649 EQGWPKIDEKADMYSLGIVFFELWH---PFSTAMERQIVL----SDLKQKGELP-PSWVAKFSEQESLLRRLMSPSPSDR 720 (1239)
Q Consensus 649 l~~~~~~s~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~----~~~~~~~~~p-~~~~~~~~~~~~LI~~lL~~dP~~R 720 (1239)
+.+ ..|+.++||||+||++|+|++ ||.......... .+......+| +.+...++++.+||++||..||.+|
T Consensus 185 ~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 263 (335)
T d2ozaa1 185 LGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 263 (335)
T ss_dssp CCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTS
T ss_pred HCC-CCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 748-9888888887645167788658899889887788999999985388888985434699999999999756996579
Q ss_pred CCHHHHHHCCCCCCC
Q ss_conf 999999723199985
Q 000880 721 PSATELLQDALPPQM 735 (1239)
Q Consensus 721 PSa~eiL~h~~~~~~ 735 (1239)
||+.++++||||.+.
T Consensus 264 ~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 264 MTITEFMNHPWIMQS 278 (335)
T ss_dssp CCHHHHHHSHHHHTT
T ss_pred CCHHHHHCCHHHHCC
T ss_conf 099999709876178
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.78 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=208.5
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCC-CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHC---CCCCEEEEEEEEEECC
Q ss_conf 5568923875332589668999999169-94999999733899903689999999999926---9986244631442047
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLD-GRHYAVKKIRLKDKSLPVNDRILREVATLSRL---QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~t-g~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L---~HpnIv~l~~~~~~~~ 496 (1239)
+..++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+++.+ +||||++++++|....
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 87589798889921558699999998889989999998023245167999999999999874258988023663221466
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHH--HCCCCCHHHHHHHHHHHHHH
Q ss_conf 5456898867888544544433346654323554555542799994126887889987--23999999999999999999
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE--SYDHFDKELAWHLFRQIVEG 574 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~--~~~~l~~~~~~~i~~qIl~a 574 (1239)
......+|++||||++++..+.. ....+++..++.++.|++.|
T Consensus 84 -----------------------------------~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 128 (305)
T d1blxa_ 84 -----------------------------------TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128 (305)
T ss_dssp -----------------------------------CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHH
T ss_pred -----------------------------------CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHH
T ss_conf -----------------------------------666746999997405871444443037899989999999999999
Q ss_pred HHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99977199312589766089868998899114720101011134578988888986445866556766789221259999
Q 000880 575 LAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPK 654 (1239)
Q Consensus 575 L~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 654 (1239)
|+|||+++|+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+ ..
T Consensus 129 L~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~gT~~Y~APE~~~~-~~ 191 (305)
T d1blxa_ 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----------------ALTSVVVTLWYRAPEVLLQ-SS 191 (305)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG----------------GGCCCCCCCTTCCHHHHTT-CC
T ss_pred HHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHHHHHCCCC----------------CCCCCCCCHHHCCCCHHCC-CC
T ss_conf 999975889835798627898589975421000101100234----------------5777654851148310017-98
Q ss_pred CCCCHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCC------------------------CCCCCCCCCHHHHH
Q ss_conf 9951156879999998403---89603789999996420599------------------------99810029999999
Q 000880 655 IDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGE------------------------LPPSWVAKFSEQES 707 (1239)
Q Consensus 655 ~s~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~------------------------~p~~~~~~~~~~~~ 707 (1239)
|+.++||||+||++|||++ ||...........+....+. .+..+...++.+.+
T Consensus 192 y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 271 (305)
T d1blxa_ 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 271 (305)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHH
T ss_pred CCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHH
T ss_conf 88111000328999999878799899898999999998407996110532111103330223456454404458999999
Q ss_pred HHHHCCCCCCCCCCCHHHHHHCCCCCCCH
Q ss_conf 99980379999999999997231999850
Q 000880 708 LLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 708 LI~~lL~~dP~~RPSa~eiL~h~~~~~~~ 736 (1239)
||++||..||.+|||+.++|+||||+.+.
T Consensus 272 li~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 272 LLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHCCCCHHHCCCHHHHHCCHHHCCCH
T ss_conf 99998748966791899996696340752
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=373.91 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=206.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|++.++||+|+||+||+|.++.+++.||||+++.... ...++.+|+.+++.++|||||+++++|.+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~-------- 84 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-------- 84 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--------
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC---HHHHHHHHHHHHHHCCCCCEECCCCCEEE--------
T ss_conf 7993986598208880899999999996999999777610---39999999999986799988267752745--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268-8788998723--99999999999999999999977
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
...+|++||||+ |+|.+++... ..+++..++.++.||+.||+|||
T Consensus 85 --------------------------------~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH 132 (287)
T d1opja_ 85 --------------------------------EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132 (287)
T ss_dssp --------------------------------SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf --------------------------------785478763146760677753035541579999999999999788898
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
+++|+||||||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+ ..|+.++
T Consensus 133 ~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~-~~~~~k~ 197 (287)
T d1opja_ 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--------------TAHAGAKFPIKWTAPESLAY-NKFSIKS 197 (287)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS--------------EEETTEEECGGGCCHHHHHH-CCCSHHH
T ss_pred HCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC--------------EEECCCCCCCCCCCHHHHCC-CCCCCHH
T ss_conf 78930576045768998999289832445465378872--------------21035566546669278727-9998104
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 56879999998403---89603789999996420599998100299999999998037999999999999723
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
|||||||++|||++ ||............+. .+..++.+...++++.+||.+||+.||.+|||+.++++.
T Consensus 198 DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~ 269 (287)
T d1opja_ 198 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269 (287)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 302178999999867998877425999999985-588888874330999999999757797689399999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=370.57 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=207.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCC---EEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
Q ss_conf 6892387533258966899999916994---9999997338999036899999999999269986244631442047545
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGR---HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~---~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 499 (1239)
.++|++.+.||+|+||+||+|.++.+++ .||||.+... ........+.+|+.+|+.++|||||+++++|.+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----- 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----- 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE-----
T ss_conf 00427856980278829999999579978899999997844-598999999999999985799888618999962-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHH
Q ss_conf 68988678885445444333466543235545555427999941268-8788998723-999999999999999999999
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qIl~aL~y 577 (1239)
...+|+|||||+ |+|.+++... +.+++..++.++.||+.||+|
T Consensus 99 -----------------------------------~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~y 143 (299)
T d1jpaa_ 99 -----------------------------------STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143 (299)
T ss_dssp -----------------------------------SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------CCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf -----------------------------------887799997227985300210456799999999999999998898
Q ss_pred HHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 77199312589766089868998899114720101011134578988888986445866556766789221259999995
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ 657 (1239)
||+++++||||||+|||++.++++||+|||+|+.......... ........||+.|||||++.+ ..|+.
T Consensus 144 LH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~----------~~~~~~~~~t~~y~aPE~~~~-~~~~~ 212 (299)
T d1jpaa_ 144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT----------YTSALGGKIPIRWTAPEAIQY-RKFTS 212 (299)
T ss_dssp HHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------------------CGGGSCHHHHHS-CCCCH
T ss_pred HHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCCCCCCE----------EEECCCCCCCCCCCCHHHHHC-CCCCC
T ss_conf 8527983576150448988999199888443157567777653----------650256668830038788836-99786
Q ss_pred CHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 1156879999998403----89603789999996420599998100299999999998037999999999999723
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
++|||||||++|||+| ||......+....+. .+..++.+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 213 ~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 213 ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE--QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH--CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 12144535789999867999999999999999997--378899974226999999999758797689299999999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.11 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=205.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCC-----EEEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 6892387533258966899999916994-----999999733899903689999999999926-9986244631442047
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGR-----HYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~-----~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~ 496 (1239)
.++|++.++||+|+||+||+|+++.+++ .||+|++.... .......+.+|+.+++.+ +|||||+++++|.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--
T ss_conf 89939701983078819999998578855420499999966335-878999999999999971589968687788862--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC-------------------
Q ss_conf 54568988678885445444333466543235545555427999941268-8788998723-------------------
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY------------------- 556 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~------------------- 556 (1239)
...+|+|||||+ |+|.+++...
T Consensus 113 --------------------------------------~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~ 154 (325)
T d1rjba_ 113 --------------------------------------SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154 (325)
T ss_dssp --------------------------------------SSSCEEEEECCTTCBHHHHHHTTTTCC---------------
T ss_pred --------------------------------------CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf --------------------------------------995899997279995999998625777510221000012220
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf ----9999999999999999999997719931258976608986899889911472010101113457898888898644
Q 000880 557 ----DHFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSV 632 (1239)
Q Consensus 557 ----~~l~~~~~~~i~~qIl~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~ 632 (1239)
..+++..++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+........ .
T Consensus 155 ~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-------------~ 221 (325)
T d1rjba_ 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-------------V 221 (325)
T ss_dssp ------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-------------E
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCE-------------E
T ss_conf 012577899999999999999999997399050527032144345982898514222204577861-------------5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 58665567667892212599999951156879999998403----89603789999996420599998100299999999
Q 000880 633 DGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESL 708 (1239)
Q Consensus 633 ~~~~~~GT~~Y~APE~l~~~~~~s~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~L 708 (1239)
...+..||+.|||||++.+ ..|+.++|||||||++|||+| ||............+. .+..++.+...++++.+|
T Consensus 222 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~-~~~~~~~p~~~~~~l~~l 299 (325)
T d1rjba_ 222 VRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-NGFKMDQPFYATEEIYII 299 (325)
T ss_dssp EETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred EECCCCCCCCCCCHHHHCC-CCCCCCEECCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCHHHHHH
T ss_conf 6234357876578388727-99996330300039999998389999999898999999985-699899887678999999
Q ss_pred HHHCCCCCCCCCCCHHHHHHC
Q ss_conf 998037999999999999723
Q 000880 709 LRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 709 I~~lL~~dP~~RPSa~eiL~h 729 (1239)
|.+||+.||.+|||+.+|++|
T Consensus 300 i~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 300 MQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHH
T ss_conf 999758896689399999999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.13 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=207.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.-+|+.+++||+|+||+||+|+++.+|+.||||++...... ..+|+.+|+.++||||++++++|...+.
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~----- 87 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGE----- 87 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH------HHHHHHHHHHCCCCCCCCEEEEEEECCC-----
T ss_conf 67767516982176839999999999979999998816068------9999999986689898738789974476-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 8867888544544433346654323554555542799994126887889987----239999999999999999999997
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE----SYDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~----~~~~l~~~~~~~i~~qIl~aL~yL 578 (1239)
.....++|+|||||++++...+. ....+++..++.++.||+.||+||
T Consensus 88 -----------------------------~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL 138 (350)
T d1q5ka_ 88 -----------------------------KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138 (350)
T ss_dssp -----------------------------CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------CCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf -----------------------------577318999984168860788886310368999999999999999999999
Q ss_pred HHCCCCCCCCCCCCEEECCCC-CEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 719931258976608986899-8899114720101011134578988888986445866556766789221259999995
Q 000880 579 HGQGIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILi~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ 657 (1239)
|++||+||||||+|||++.++ .+||+|||+|+...... ...+.+||+.|+|||.+.+...|+.
T Consensus 139 H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (350)
T d1q5ka_ 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----------------PNVSYICSRYYRAPELIFGATDYTS 202 (350)
T ss_dssp HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS----------------CCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred HHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHCCCCC----------------CCCCCCCCCCCCCHHHHHCCCCCCC
T ss_conf 866876457886037873589711673366054404776----------------5320025555568277640468882
Q ss_pred CHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCC-----------------CCC---------CCCCCCCHHHHHH
Q ss_conf 1156879999998403---8960378999999642059-----------------999---------8100299999999
Q 000880 658 KADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKG-----------------ELP---------PSWVAKFSEQESL 708 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~-----------------~~p---------~~~~~~~~~~~~L 708 (1239)
++||||+||++|||++ ||...........+....+ .++ ......++++.+|
T Consensus 203 ~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 282 (350)
T d1q5ka_ 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282 (350)
T ss_dssp HHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHH
T ss_pred CEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHH
T ss_conf 10002465277855028799898799999999999748981776543062101103554456744443156899999999
Q ss_pred HHHCCCCCCCCCCCHHHHHHCCCCCCCHH
Q ss_conf 99803799999999999972319998507
Q 000880 709 LRRLMSPSPSDRPSATELLQDALPPQMEY 737 (1239)
Q Consensus 709 I~~lL~~dP~~RPSa~eiL~h~~~~~~~~ 737 (1239)
|.+||..||.+|||+.++|+||||+++..
T Consensus 283 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 283 CSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 99976589557929999966984524667
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.60 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=205.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|++.++||+|+||+||+|+++ ..||||+++...........+.+|+.+++.++|||||++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~--------- 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--------- 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---------
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---------
T ss_conf 451899889830788589999999---98999999734699899999999999998479987864567971---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268-8788998723-999999999999999999999771
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
...+|+|||||+ |+|.+++... ..+++..++.++.||+.||+|||+
T Consensus 75 --------------------------------~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~ 122 (276)
T d1uwha_ 75 --------------------------------APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122 (276)
T ss_dssp --------------------------------SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHC
T ss_conf --------------------------------558999996589988899985235789999999999999999888750
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCC
Q ss_conf 993125897660898689988991147201010111345789888889864458665567667892212599--999951
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGW--PKIDEK 658 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~s~k 658 (1239)
++|+||||||+|||++.++++||+|||+|+........ ...++..||+.|||||++.+. ..|+.+
T Consensus 123 ~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~-------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ 189 (276)
T d1uwha_ 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189 (276)
T ss_dssp TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------------------------CCCCGGGCCHHHHTTCSSCCCCHH
T ss_pred CCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC-------------CCCCCCCCCCCCCCHHHHHCCCCCCCCCH
T ss_conf 99951614789979818997887500221333556776-------------31256655743179999950568999953
Q ss_pred HHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCC---CCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 156879999998403---8960378999999642059999---8100299999999998037999999999999723
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP---PSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
+|||||||++|||+| ||............+......| .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 190 sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 15163599999999788998998969999999965888986000365554999999999758897689299999999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.67 Aligned_cols=271 Identities=22% Similarity=0.372 Sum_probs=215.2
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
Q ss_conf 56892387533258966899999916994999999733899903689999999999926998624463144204754568
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~ 501 (1239)
-+++|+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++.+......
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~--- 84 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP--- 84 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC---
T ss_conf 62798899997227482999999989997999999842224637899999999999983599966067654024654---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHH-HHHHCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 98867888544544433346654323554555542799994126887889-98723999999999999999999999771
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQ-VFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~-~l~~~~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
.......+|++||||++++.. .......+++..++.++.||+.||.|||+
T Consensus 85 -----------------------------~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~ 135 (318)
T d3blha1 85 -----------------------------YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135 (318)
T ss_dssp -----------------------------------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------CCCCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCC
T ss_conf -----------------------------444576389998535787410122203443308999999999999988522
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 99312589766089868998899114720101011134578988888986445866556766789221259999995115
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksD 660 (1239)
++|+||||||+|||++.++.+||+|||+|+.......... ....+.+||+.|+|||++.+...|+.++|
T Consensus 136 ~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~-----------~~~~~~~gT~~Y~aPE~~~~~~~~~~k~D 204 (318)
T d3blha1 136 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP-----------NRYTNRVVTLWYRPPELLLGERDYGPPID 204 (318)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----C-----------CCCCSCCSCGGGCCHHHHTTCSSCCTHHH
T ss_pred CCEEECCCCCHHEEECCCCCEEEEECCEEEECCCCCCCCC-----------CCCCCEECCHHHHHHHHHCCCCCCCCHHH
T ss_conf 9988567672220366899687631350022355444321-----------13566024978742899707999891787
Q ss_pred HHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCC-----------------------------CCCCHHHHHH
Q ss_conf 6879999998403---8960378999999642059999810-----------------------------0299999999
Q 000880 661 MYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSW-----------------------------VAKFSEQESL 708 (1239)
Q Consensus 661 IwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~-----------------------------~~~~~~~~~L 708 (1239)
|||+||++|||++ ||.+..+......+....+..++.. ...++++.+|
T Consensus 205 iwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL 284 (318)
T d3blha1 205 LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284 (318)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHH
T ss_pred CCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHH
T ss_conf 00678646617448799899899999999998418998255344320344433201334455503340444599899999
Q ss_pred HHHCCCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf 998037999999999999723199985
Q 000880 709 LRRLMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 709 I~~lL~~dP~~RPSa~eiL~h~~~~~~ 735 (1239)
|.+||..||.+|||+.++|+||||+..
T Consensus 285 l~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 285 IDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred HHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 999873896589099999749501569
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=368.00 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=210.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
+++|+++++||+|+||+||+|+++ +|+.||||+++...........+.+|+.+|+.++|||||+++++|..
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-------- 71 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-------- 71 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--------
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC--------
T ss_conf 999634318722778189999968-99999999981232685899999999999986799868766012046--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHH-HHHHCCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 8867888544544433346654323554555542799994126887889-987239999999999999999999997719
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQ-VFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~-~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~ 581 (1239)
....|++|+|+.+++.. +....+.+++..++.++.||+.||+|||++
T Consensus 72 --------------------------------~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 119 (286)
T d1ob3a_ 72 --------------------------------KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119 (286)
T ss_dssp --------------------------------SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred --------------------------------CCCEEEEEEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCC
T ss_conf --------------------------------773158997400456789986047751445689999999999986057
Q ss_pred CCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 93125897660898689988991147201010111345789888889864458665567667892212599999951156
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDI 661 (1239)
+|+||||||+|||++.++.+||+|||.|........ ......|++.|+|||.+.+...++.++||
T Consensus 120 ~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---------------~~~~~~~~~~y~~pE~~~~~~~~~~~~Di 184 (286)
T d1ob3a_ 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184 (286)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------------------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC---------------CCCEECCCCHHHHHHHHHCCCCCCCCEEE
T ss_conf 488267877505686899787323664301146765---------------41010243110137887178888841002
Q ss_pred HHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCC--------------------------CCCCCCCCHHHHHHHHHC
Q ss_conf 879999998403---896037899999964205999--------------------------981002999999999980
Q 000880 662 YSLGIVFFELWH---PFSTAMERQIVLSDLKQKGEL--------------------------PPSWVAKFSEQESLLRRL 712 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~--------------------------p~~~~~~~~~~~~LI~~l 712 (1239)
||+||++|||++ ||.+..+.+....+....+.. +......++++.+||++|
T Consensus 185 wslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 264 (286)
T d1ob3a_ 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264 (286)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHH
T ss_pred HHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHH
T ss_conf 11175899997797998988989999999986389971104212333221433333567646665125899999999998
Q ss_pred CCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 3799999999999972319998
Q 000880 713 MSPSPSDRPSATELLQDALPPQ 734 (1239)
Q Consensus 713 L~~dP~~RPSa~eiL~h~~~~~ 734 (1239)
|..||.+|||+.++|+||||++
T Consensus 265 L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 265 LKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCCCHHHCCCHHHHHCCCCCCC
T ss_conf 6689668909999856922074
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.98 Aligned_cols=246 Identities=22% Similarity=0.370 Sum_probs=202.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|++.++||+|+||+||+|+++ +++.||||+++.... ...++.+|+.+++.++|||||+++++|.+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-------- 71 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-------- 71 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--------
T ss_pred HHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCCCCCEECC--------
T ss_conf 699588889820888299999988-999999999878867---68999999999996689975653524315--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268-8788998723-999999999999999999999771
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
...+|+|||||+ |+|.+++... ..+++..++.++.||+.||+|||+
T Consensus 72 --------------------------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~ 119 (263)
T d1sm2a_ 72 --------------------------------QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119 (263)
T ss_dssp --------------------------------SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHC
T ss_conf --------------------------------993379998369991899752013478899999999999998776531
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 99312589766089868998899114720101011134578988888986445866556766789221259999995115
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksD 660 (1239)
++|+||||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+ ..|+.++|
T Consensus 120 ~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~--------------~~~~~~gt~~y~aPE~l~~-~~~~~k~D 184 (263)
T d1sm2a_ 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--------------SSTGTKFPVKWASPEVFSF-SRYSSKSD 184 (263)
T ss_dssp TTCCCTTCSGGGEEECGGGCEEECSCC--------------------------------CTTSCCHHHHTT-CCCCHHHH
T ss_pred CCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE--------------EECCEECCCCCCCHHHHCC-CCCCCHHH
T ss_conf 64310443153266668877686553210023688733--------------5043001766678578607-99984033
Q ss_pred HHHHHHHHHHHHC---C-CCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 6879999998403---8-9603789999996420599998100299999999998037999999999999723
Q 000880 661 MYSLGIVFFELWH---P-FSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 661 IwSlGviL~ELlt---P-f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
||||||++|||+| | |......+....+ . .+..++.+...++++.+|+.+||+.||.+|||+.+++++
T Consensus 185 VwS~Gvil~el~t~~~~~~~~~~~~~~~~~i-~-~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-S-TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH-H-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH-H-HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 2105999999987898887789999999999-8-068889954367999999999765797689199999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.93 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=210.3
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCC
Q ss_conf 89238753325896689999991699499999973389990368999999999992699862446314420475456898
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~ 503 (1239)
.+|++++.||+|+||+||+|.++.+|+.||||+++... .......+.+|+.+|+.++||||+++++++.....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~------ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI------ 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST------
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCC------
T ss_conf 98599789940648099999999999499999980310-95899999999999997689898858889950564------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 86788854454443334665432355455554279999412688788998723999999999999999999999771993
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 504 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~gI 583 (1239)
....++|+++++++++|.+++.. ..+++..++.++.||+.||+|||++||
T Consensus 81 -----------------------------~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~i 130 (345)
T d1pmea_ 81 -----------------------------EQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 130 (345)
T ss_dssp -----------------------------TTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred -----------------------------CCCCEEEEEEEECCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf -----------------------------55414999996259865664405-899999999999999999999997898
Q ss_pred CCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 12589766089868998899114720101011134578988888986445866556766789221259999995115687
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDIwS 663 (1239)
+||||||+|||++.++.+||+|||+|+......... ......+||+.|+|||++.....++.++||||
T Consensus 131 iHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwS 198 (345)
T d1pmea_ 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198 (345)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHH
T ss_pred CCCCCCCCEEEECCCCCEEECCCCCEEECCCCCCCC------------EEECCCCCCCEECHHHHHHCCCCCCCHHHHHC
T ss_conf 677787643788799977875457056504777641------------01011026520003878604788874101004
Q ss_pred HHHHHHHHHC---CCCHHHHHHHHHHHHHH------------------------CCCCC----CCCCCCCHHHHHHHHHC
Q ss_conf 9999998403---89603789999996420------------------------59999----81002999999999980
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQ------------------------KGELP----PSWVAKFSEQESLLRRL 712 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~------------------------~~~~p----~~~~~~~~~~~~LI~~l 712 (1239)
+||++|+|++ ||............... ....+ ..+...++++.+|+.+|
T Consensus 199 lG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 278 (345)
T d1pmea_ 199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278 (345)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHH
T ss_pred CCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHH
T ss_conf 67013377669799788888999998765206997566423433222202446775577877783789999999999997
Q ss_pred CCCCCCCCCCHHHHHHCCCCCCCH
Q ss_conf 379999999999997231999850
Q 000880 713 MSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 713 L~~dP~~RPSa~eiL~h~~~~~~~ 736 (1239)
|..||.+|||+.++|+||||++..
T Consensus 279 L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 279 LTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp SCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 648956790899986198655588
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.70 Aligned_cols=245 Identities=27% Similarity=0.352 Sum_probs=201.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|++.++||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.+++.++|||||++++++.+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-------- 79 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-------- 79 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--------
T ss_pred HHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEECC--------
T ss_conf 899388679810798289999999-999999999864768---88999999999986799988578731045--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268-8788998723--99999999999999999999977
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY--DHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~--~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
..+|+|||||+ |+|.+++... ..+++..++.++.||+.||+|||
T Consensus 80 ---------------------------------~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH 126 (272)
T d1qpca_ 80 ---------------------------------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126 (272)
T ss_dssp ---------------------------------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf ---------------------------------97699999578982888875147898878899999999999999997
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
+++|+||||||+|||++.++.+||+|||+|+....... .......||+.|||||++.+ ..|+.++
T Consensus 127 ~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~--------------~~~~~~~gt~~y~APE~~~~-~~~~~~s 191 (272)
T d1qpca_ 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--------------TAREGAKFPIKWTAPEAINY-GTFTIKS 191 (272)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--------------ECCTTCCCCTTTSCHHHHHH-CEECHHH
T ss_pred HCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC--------------CCCCCCCCCCCCCCHHHHHC-CCCCCHH
T ss_conf 48954675642251562024404234101477358864--------------42035677444458289837-9998245
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 56879999998403---8960378999999642059999810029999999999803799999999999972
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~ 728 (1239)
|||||||++|||+| |+............+. .+..++.....++++.+|+.+||+.||.+|||+.++++
T Consensus 192 DvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-HCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 645257999999968988888889999999997-06888896557199999999975889768939999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.93 Aligned_cols=243 Identities=22% Similarity=0.293 Sum_probs=202.1
Q ss_pred EEECCCCCEEEEEEEECC--CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCCCCCC
Q ss_conf 533258966899999916--994999999733899903689999999999926998624463144204754568988678
Q 000880 430 QPLGHGGFGHVVLCKNKL--DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSMWG 507 (1239)
Q Consensus 430 ~~LG~G~fG~Vy~a~~~~--tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~~~~~ 507 (1239)
++||+|+||+||+|.++. +++.||||+++....+......+.+|+.+++.++|||||+++++|..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------------- 79 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------------- 79 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-------------
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-------------
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-------------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 885445444333466543235545555427999941268-8788998723999999999999999999999771993125
Q 000880 508 SGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQGIIHR 586 (1239)
Q Consensus 508 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~gIiHr 586 (1239)
...|+|||||+ |+|.+++.....+++..++.++.||+.||+|||+++|+||
T Consensus 80 ----------------------------~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr 131 (277)
T d1xbba_ 80 ----------------------------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131 (277)
T ss_dssp ----------------------------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ----------------------------CCEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf ----------------------------9779999747889689997522578999999999999999766874795567
Q ss_pred CCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 89766089868998899114720101011134578988888986445866556766789221259999995115687999
Q 000880 587 DLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGI 666 (1239)
Q Consensus 587 DLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDIwSlGv 666 (1239)
||||+|||++.++.+||+|||+|+........ ........||+.|||||++.+ ..|+.++|||||||
T Consensus 132 DlKp~Nill~~~~~~kl~DFGla~~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv 198 (277)
T d1xbba_ 132 DLAARNVLLVTQHYAKISDFGLSKALRADENY------------YKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGV 198 (277)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCSE------------EEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHH
T ss_pred CCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCC------------CCCCCCCCCCCEECCCHHHCC-CCCCCHHHHCCCHH
T ss_conf 77611310235675123413453313432344------------322445677842039166537-99984344303403
Q ss_pred HHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9998403----8960378999999642059999810029999999999803799999999999972
Q 000880 667 VFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 667 iL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~ 728 (1239)
++|||++ ||......+....+. .+..++.+..+++++.+||.+||+.||.+|||+.++++
T Consensus 199 ~l~ellt~g~~Pf~~~~~~~~~~~i~--~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 199 LMWEAFSYGQKPYRGMKGSEVTAMLE--KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp HHHHHHTTTCCSSTTCCHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHH--CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 13289658999999989999999998--28999998656799999999975889768909899999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.39 Aligned_cols=261 Identities=27% Similarity=0.361 Sum_probs=211.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
+++|+++++||+|+||+||+|+++.+|+.||||+++..........++.+|+.+++.++|||||+++++|...+.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~----- 90 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT----- 90 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS-----
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC-----
T ss_conf 377599889621758599999999999899999988233697999999999999986489876489989702564-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 88678885445444333466543235545555427999941268878899872399999999999999999999977199
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~g 582 (1239)
......+|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++|
T Consensus 91 -----------------------------~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g 139 (355)
T d2b1pa1 91 -----------------------------LEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG 139 (355)
T ss_dssp -----------------------------TTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -----------------------------CCCCCEEEEEEECCCHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf -----------------------------34576269998414467787650--38999999999999999998865221
Q ss_pred CCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 31258976608986899889911472010101113457898888898644586655676678922125999999511568
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDIw 662 (1239)
|+||||||+|||++.++.+|++|||+++...... ..+..+||+.|+|||++.+ ..++.++|||
T Consensus 140 iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~----------------~~~~~~~t~~y~aPE~l~~-~~~~~~~Diw 202 (355)
T d2b1pa1 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----------------MMTPYVVTRYYRAPEVILG-MGYKENVDIW 202 (355)
T ss_dssp CCCSCCCGGGEEECTTCCEEECCCCC-------------------------------CCTTCCHHHHTT-CCCCTTHHHH
T ss_pred CCCCCCCCCCCCCCCCCCEEEECHHHHHCCCCCC----------------CCCCCCCCCCCCCHHHHCC-CCCCCCCCCC
T ss_conf 1245677632113654431320102321146665----------------5332214655558133147-7778774333
Q ss_pred HHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCC---------------------------------------CCCCC
Q ss_conf 79999998403---8960378999999642059999---------------------------------------81002
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP---------------------------------------PSWVA 700 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p---------------------------------------~~~~~ 700 (1239)
|+||++|+|++ ||...........+.......+ .....
T Consensus 203 SlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (355)
T d2b1pa1 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282 (355)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHH
T ss_pred CCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 56625789865989988897788999999720589879998765667777641754356664212643335432101333
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCCCH
Q ss_conf 999999999980379999999999997231999850
Q 000880 701 KFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 701 ~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~~~ 736 (1239)
.++++.+||++||..||.+|||++++|+||||+...
T Consensus 283 ~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 283 KASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 799999999998769945790899996694208788
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.30 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=204.3
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCC----CEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCC
Q ss_conf 689238753325896689999991699----4999999733899903689999999999926998624463144204754
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDG----RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg----~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 498 (1239)
.++|++.+.||+|+||+||+|.++.++ ..||||+++.. ........+.+|+.+++.++|||||+++++|.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~---- 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK---- 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC----
T ss_conf 899686159811779099999996899878799999998844-596899999999999985689878323677833----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC-CCCCHHHHHHHHHHHHHHHH
Q ss_conf 568988678885445444333466543235545555427999941268-8788998723-99999999999999999999
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qIl~aL~ 576 (1239)
...++++||||. +++.+.+... ..+++..++.++.||+.||+
T Consensus 81 ------------------------------------~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~ 124 (283)
T d1mqba_ 81 ------------------------------------YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124 (283)
T ss_dssp ------------------------------------SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------CCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf ------------------------------------88038999721357402221023454208999999999998541
Q ss_pred HHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 97719931258976608986899889911472010101113457898888898644586655676678922125999999
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s 656 (1239)
|||+++|+||||||+|||++.++.+||+|||+|+........ ........||+.|||||++.+ ..|+
T Consensus 125 ~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~------------~~~~~~~~gt~~Y~APE~l~~-~~~~ 191 (283)
T d1mqba_ 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA------------TYTTSGGKIPIRWTAPEAISY-RKFT 191 (283)
T ss_dssp HHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------------------CCCGGGSCHHHHHS-CCCC
T ss_pred HCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCCCCC------------CEEECCCCCCCCCCCHHHHCC-CCCC
T ss_conf 212123425765644278889984998455103003578765------------267426777734348888704-9999
Q ss_pred CCHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 51156879999998403---89603789999996420599998100299999999998037999999999999723
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
.++|||||||++|||++ |+............+. .+..++.....++++.+||.+||+.||.+|||+.++++.
T Consensus 192 ~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~ 266 (283)
T d1mqba_ 192 SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 266 (283)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 735563448989999967988655689999999986-357899850457999999999776797689399999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=362.13 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=215.7
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
Q ss_conf 56892387533258966899999916994999999733899-90368999999999992699862446314420475456
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~ 500 (1239)
..++|++.+.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~---- 80 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET---- 80 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC----
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC----
T ss_conf 0620698689960899299999999999899999985566469899999999999998569998873114354326----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 8988678885445444333466543235545555427999941268-878899872399999999999999999999977
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
.....+|+|||||+ ++|.+++...+.+++..++.++.||+.||+|||
T Consensus 81 --------------------------------~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH 128 (277)
T d1o6ya_ 81 --------------------------------PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128 (277)
T ss_dssp --------------------------------SSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCCCEEEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf --------------------------------887669999977889871011203589999999999999999999998
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
++||+||||||+|||++.++.++|+|||.+......... .......+||+.|||||++.+ ..|+.++
T Consensus 129 ~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~ 195 (277)
T d1o6ya_ 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS------------VTQTAAVIGTAQYLSPEQARG-DSVDARS 195 (277)
T ss_dssp HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------------------TTCCHHHHTT-CCCCHHH
T ss_pred HCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCCCC------------CCCCCCCCCCCCCCCHHHHCC-CCCCCCE
T ss_conf 579527634675566575432010034443221235443------------333464257624369999839-9999663
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHCCCCCCCCCC-CHHHHHH
Q ss_conf 56879999998403---89603789999996420599998-1002999999999980379999999-9999972
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPP-SWVAKFSEQESLLRRLMSPSPSDRP-SATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~LI~~lL~~dP~~RP-Sa~eiL~ 728 (1239)
||||+||++|||+| ||......+....++......+. .+...++++.++|++||.+||.+|| |++++++
T Consensus 196 DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 196 DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHH
T ss_conf 20265289999976979989969999999998469999710034789999999999866797677739999999
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.42 Aligned_cols=249 Identities=20% Similarity=0.266 Sum_probs=203.8
Q ss_pred CCCEEEE-EECCCCCEEEEEEEECCC--CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
Q ss_conf 8923875-332589668999999169--9499999973389990368999999999992699862446314420475456
Q 000880 424 NDFEELQ-PLGHGGFGHVVLCKNKLD--GRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 424 ~~y~~~~-~LG~G~fG~Vy~a~~~~t--g~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~ 500 (1239)
++|.+.. +||+|+||+||+|.++.+ +..||||+++.. ........+.+|+.+|+.++|||||+++++|..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC------
T ss_conf 4718878487306080999999960897689999998820-397899999999999986799888068656036------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 8988678885445444333466543235545555427999941268-878899872-39999999999999999999997
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAHI 578 (1239)
Q Consensus 501 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qIl~aL~yL 578 (1239)
..+|+|||||+ |+|.+++.. ...+++..++.++.||+.||+||
T Consensus 81 -----------------------------------~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl 125 (285)
T d1u59a_ 81 -----------------------------------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125 (285)
T ss_dssp -----------------------------------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf -----------------------------------807999980789968997521256999999999999999987899
Q ss_pred HHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 71993125897660898689988991147201010111345789888889864458665567667892212599999951
Q 000880 579 HGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 579 Hs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~k 658 (1239)
|+++|+||||||+|||++.++.+||+|||+|+........ ........||+.|||||++.+ ..++.+
T Consensus 126 H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k 192 (285)
T d1u59a_ 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------------YTARSAGKWPLKWYAPECINF-RKFSSR 192 (285)
T ss_dssp HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE------------ECCCCSSCCCGGGCCHHHHHH-CEECHH
T ss_pred HHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCCC------------CCCCCCCCCCCCCCCHHHHHC-CCCCCC
T ss_conf 8688105767646604546885420331342115543432------------113562113743358688727-999954
Q ss_pred HHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 156879999998403----89603789999996420599998100299999999998037999999999999723
Q 000880 659 ADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 659 sDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
+|||||||++|||+| ||......+....+. .+..++.+..+++++.+||.+||+.||.+|||+.++++.
T Consensus 193 sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~--~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~ 265 (285)
T d1u59a_ 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE--QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 265 (285)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH--CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 1232201789999938999999979999999998--189999997678999999999757797689099999999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.93 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=205.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCC----HHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
Q ss_conf 689238753325896689999991699499999973389990----36899999999999269--986244631442047
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSL----PVNDRILREVATLSRLQ--HQHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~----~~~~~~~~Ev~iL~~L~--HpnIv~l~~~~~~~~ 496 (1239)
.++|++.+.||+|+||+||+|+++.+|+.||||++....... ....++.+|+.+++.++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE--
T ss_conf 883799679840878399999999999799999985688443345567999999999999743589881279999830--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC--CCHHHHHHHCCCCCHHHHHHHHHHHHHH
Q ss_conf 54568988678885445444333466543235545555427999941268--8788998723999999999999999999
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP--RTLRQVFESYDHFDKELAWHLFRQIVEG 574 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~--gsL~~~l~~~~~l~~~~~~~i~~qIl~a 574 (1239)
...+|+||||+. +++.+++.....+++..++.++.||+.|
T Consensus 81 --------------------------------------~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~a 122 (273)
T d1xwsa_ 81 --------------------------------------PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122 (273)
T ss_dssp --------------------------------------SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHH
T ss_pred --------------------------------------CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHH
T ss_conf --------------------------------------996899998336862289998615899999999999999999
Q ss_pred HHHHHHCCCCCCCCCCCCEEECCC-CCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 999771993125897660898689-9889911472010101113457898888898644586655676678922125999
Q 000880 575 LAHIHGQGIIHRDLTPNNIFFDAR-NDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653 (1239)
Q Consensus 575 L~yLHs~gIiHrDLKp~NILi~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 653 (1239)
|+|||+++|+||||||+|||++.+ +.+||+|||+|+..... ..+..+||+.|+|||++.+..
T Consensus 123 l~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-----------------~~~~~~GT~~y~aPE~~~~~~ 185 (273)
T d1xwsa_ 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----------------VYTDFDGTRVYSPPEWIRYHR 185 (273)
T ss_dssp HHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-----------------CBCCCCSCGGGSCHHHHHHSC
T ss_pred HHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEECCCC-----------------CCCCCCCCCCCCCHHHHCCCC
T ss_conf 999987797556676111477447884897754653532444-----------------556656587747999984899
Q ss_pred CCCCCHHHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCC
Q ss_conf 99951156879999998403---896037899999964205999981002999999999980379999999999997231
Q 000880 654 KIDEKADMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 654 ~~s~ksDIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~ 730 (1239)
.++.++||||+||++|||++ ||..... +......++ ...++++.+||++||..||.+|||+.++++||
T Consensus 186 ~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~~~~~---~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCCCCCCEEEEHHHHHCCCCCCCCHH------HHHCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 788653325540345367568899887367------761544778---77999999999997608975893999985398
Q ss_pred CCCCCHH
Q ss_conf 9998507
Q 000880 731 LPPQMEY 737 (1239)
Q Consensus 731 ~~~~~~~ 737 (1239)
||++...
T Consensus 257 ~~~~~~~ 263 (273)
T d1xwsa_ 257 WMQDVLL 263 (273)
T ss_dssp GGSSCCC
T ss_pred HHCCCCC
T ss_conf 6678878
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.63 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=202.2
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCC----EEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
Q ss_conf 892387533258966899999916994----9999997338999036899999999999269986244631442047545
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGR----HYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~----~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 499 (1239)
++|+++++||+|+||+||+|.+..+|+ .||+|+++.. .+......+.+|+.+++.++|||||+++++|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----- 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-----
T ss_conf 99978319820899299999995899889899999996513-497999999999999986799888158999961-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECC-CCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 6898867888544544433346654323554555542799994126-8878899872-3999999999999999999999
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC-PRTLRQVFES-YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~-~gsL~~~l~~-~~~l~~~~~~~i~~qIl~aL~y 577 (1239)
...+++++|+ +++|.+.+.. ...+++..++.++.||+.||+|
T Consensus 83 ------------------------------------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~y 126 (317)
T d1xkka_ 83 ------------------------------------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126 (317)
T ss_dssp ------------------------------------SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------CCEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf ------------------------------------98369998426874010111334579999999999999999999
Q ss_pred HHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 77199312589766089868998899114720101011134578988888986445866556766789221259999995
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ 657 (1239)
||+++|+||||||+|||++.++++||+|||+|+....... ........||+.|||||++.+ ..|+.
T Consensus 127 LH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~-~~~~~ 192 (317)
T d1xkka_ 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-------------EYHAEGGKVPIKWMALESILH-RIYTH 192 (317)
T ss_dssp HHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC---------------------CCTTTSCHHHHHH-CCCCH
T ss_pred HHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCCC-------------CCCCCCCCCCCCCCCHHHHHC-CCCCH
T ss_conf 9876950476212031167998758602552223354445-------------322365105864467088746-99983
Q ss_pred CHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCC
Q ss_conf 1156879999998403----896037899999964205999981002999999999980379999999999997231
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~ 730 (1239)
++|||||||++|||+| ||......+.. ..+. .+..++....+++++.+|+.+||+.||.+|||+.++++|.
T Consensus 193 ~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 193 QSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHH-HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 5654407999999997799999999989999-9997-5998999855689999999984789934691999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.11 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=211.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|+++++||+|+||+||+|+++.+|+.||||+++....+......+.+|+.+|+.++|||||++++++.....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~----- 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----- 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS-----
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC-----
T ss_conf 987188889831788399999999999799999988200286899999999999986689874259999963464-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 88678885445444333466543235545555427999941268878899872399999999999999999999977199
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~g 582 (1239)
.......++++++++|+|.+++.. ..+++..++.++.||+.||+|||++|
T Consensus 92 -----------------------------~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g 141 (348)
T d2gfsa1 92 -----------------------------LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD 141 (348)
T ss_dssp -----------------------------TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred -----------------------------CCCCCEEEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf -----------------------------566864999996258862320022-45309999999999999999997388
Q ss_pred CCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 31258976608986899889911472010101113457898888898644586655676678922125999999511568
Q 000880 583 IIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMY 662 (1239)
Q Consensus 583 IiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDIw 662 (1239)
|+||||||+|||++.++.+|++|||+|...... ..+..||+.|+|||++.+...++.++|||
T Consensus 142 iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~------------------~~~~~g~~~y~apE~~~~~~~~~~~~Diw 203 (348)
T d2gfsa1 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIW 203 (348)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCC----CCTGG------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCC------------------CCCCCCCCCCCCCHHHCCCCCCCCCCCHH
T ss_conf 765166776334554322001321000125754------------------44434543555835533775678551243
Q ss_pred HHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCC----------------------------CCCCCCCHHHHHHHHH
Q ss_conf 79999998403---8960378999999642059999----------------------------8100299999999998
Q 000880 663 SLGIVFFELWH---PFSTAMERQIVLSDLKQKGELP----------------------------PSWVAKFSEQESLLRR 711 (1239)
Q Consensus 663 SlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p----------------------------~~~~~~~~~~~~LI~~ 711 (1239)
|+||++|+|++ ||.+.........+....+..+ ..+...++++.+||++
T Consensus 204 SlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 283 (348)
T d2gfsa1 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283 (348)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHH
T ss_conf 20589999976889978898899999999730799757732001024454443035578755566267899999999999
Q ss_pred CCCCCCCCCCCHHHHHHCCCCCCCH
Q ss_conf 0379999999999997231999850
Q 000880 712 LMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 712 lL~~dP~~RPSa~eiL~h~~~~~~~ 736 (1239)
||..||.+|||+.++|+||||++..
T Consensus 284 mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 284 MLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 7758834593899985599548799
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.99 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=211.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
+++|+++++||+|+||+||+|+++.+++.||||+++..........++.+|+.+++.++||||++++++|..
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-------- 72 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-------- 72 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--------
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--------
T ss_conf 999786269712868199999999999699999980321786899999999999985675788821354444--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCC-CHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 886788854454443334665432355455554279999412688-7889987239999999999999999999997719
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs~ 581 (1239)
....+++++++.+ ++..++...+.+++..++.++.|++.||+|||++
T Consensus 73 --------------------------------~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~ 120 (292)
T d1unla_ 73 --------------------------------DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120 (292)
T ss_dssp --------------------------------SSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred --------------------------------CCCEEEEEEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC
T ss_conf --------------------------------431158863023322211212356540367899999999998774339
Q ss_pred CCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 93125897660898689988991147201010111345789888889864458665567667892212599999951156
Q 000880 582 GIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADM 661 (1239)
Q Consensus 582 gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDI 661 (1239)
+|+||||||+|||++.++.+||+|||.|+....... ......+++.|+|||++.+...++.++||
T Consensus 121 ~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~---------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di 185 (292)
T d1unla_ 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS---------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHH
T ss_pred CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC---------------CCEEECCCCCHHHHHHHCCCCCCCCHHHC
T ss_conf 986001467612113378266520460110468875---------------10010344310146675069888804440
Q ss_pred HHHHHHHHHHHC---CCCHHH-HHHHHHHHHHHCC--------------------------CCCCCCCCCCHHHHHHHHH
Q ss_conf 879999998403---896037-8999999642059--------------------------9998100299999999998
Q 000880 662 YSLGIVFFELWH---PFSTAM-ERQIVLSDLKQKG--------------------------ELPPSWVAKFSEQESLLRR 711 (1239)
Q Consensus 662 wSlGviL~ELlt---Pf~~~~-~~~~~~~~~~~~~--------------------------~~p~~~~~~~~~~~~LI~~ 711 (1239)
||+||++|||++ ||.... ..+.........+ .........++.+.+||++
T Consensus 186 wSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~ 265 (292)
T d1unla_ 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265 (292)
T ss_dssp HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHH
T ss_conf 26541889985189999889999999999986118997355134432221133444544310433065689999999999
Q ss_pred CCCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf 037999999999999723199985
Q 000880 712 LMSPSPSDRPSATELLQDALPPQM 735 (1239)
Q Consensus 712 lL~~dP~~RPSa~eiL~h~~~~~~ 735 (1239)
||..||.+|||+.++|+||||++.
T Consensus 266 mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 266 LLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 864996689099999649534079
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=358.28 Aligned_cols=254 Identities=20% Similarity=0.311 Sum_probs=203.1
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCCCC
Q ss_conf 568923875332589668999999169949999997338999036899999999999269-9862446314420475456
Q 000880 422 YLNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADF 500 (1239)
Q Consensus 422 ~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~~ 500 (1239)
..++|+++++||+|+||+||+|+++.+|+.||||+++.. ...++.+|+.+|+.++ ||||++++++|...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~----- 102 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP----- 102 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT-----
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC-----
T ss_conf 986718978983174819999998899979999998889-----9999999999998515799876799999816-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 8988678885445444333466543235545555427999941268-878899872399999999999999999999977
Q 000880 501 DGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 501 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
....+|+|||||+ ++|.... ..+++..++.++.||+.||+|||
T Consensus 103 ---------------------------------~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH 146 (328)
T d3bqca1 103 ---------------------------------VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146 (328)
T ss_dssp ---------------------------------TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------CCCCEEEEEEECCCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHH
T ss_conf ---------------------------------877126888631798589974---68999999999999999998876
Q ss_pred HCCCCCCCCCCCCEEECCCC-CEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 19931258976608986899-88991147201010111345789888889864458665567667892212599999951
Q 000880 580 GQGIIHRDLTPNNIFFDARN-DIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEK 658 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~k 658 (1239)
++||+||||||+|||++.++ .+||+|||+|+...... .....+||+.|+|||++.+...++.+
T Consensus 147 ~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~ 210 (328)
T d3bqca1 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----------------EYNVRVASRYFKGPELLVDYQMYDYS 210 (328)
T ss_dssp HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC----------------CCCSCCSCGGGCCHHHHTTCCCCCTH
T ss_pred HCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC----------------CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 43344345644123774899836641565426646887----------------44432248642476102688888845
Q ss_pred HHHHHHHHHHHHHHC---CCCHHHHHH-HHHHHHH-------------HC---------------------CCCCCCCCC
Q ss_conf 156879999998403---896037899-9999642-------------05---------------------999981002
Q 000880 659 ADMYSLGIVFFELWH---PFSTAMERQ-IVLSDLK-------------QK---------------------GELPPSWVA 700 (1239)
Q Consensus 659 sDIwSlGviL~ELlt---Pf~~~~~~~-~~~~~~~-------------~~---------------------~~~p~~~~~ 700 (1239)
+||||+||++|+|++ ||....... ....+.. .. .........
T Consensus 211 ~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (328)
T d3bqca1 211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL 290 (328)
T ss_dssp HHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGG
T ss_pred CCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCC
T ss_conf 23233545558760488999887601899999999878841555554225444743000003334331121155211244
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCCCHH
Q ss_conf 9999999999803799999999999972319998507
Q 000880 701 KFSEQESLLRRLMSPSPSDRPSATELLQDALPPQMEY 737 (1239)
Q Consensus 701 ~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~~~~ 737 (1239)
.++++.+||++||..||.+|||++++|+||||+.+.+
T Consensus 291 ~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 291 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 8999999999986699568908999964935588797
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.13 Aligned_cols=247 Identities=20% Similarity=0.361 Sum_probs=207.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|++.++||+|+||+||+|+++ ++..||||+++..... ...+.+|+.+++.++||||++++++|.+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-------- 70 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK-------- 70 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECC--------
T ss_pred HHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCEEEEEEEEEE--------
T ss_conf 699799689820788399999988-9989999998747577---8999999999996689860158899850--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268-87889987-23999999999999999999999771
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFE-SYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~-~~~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
...+|+|||||+ |+|.+++. ....+++..++.++.|++.||+|||+
T Consensus 71 --------------------------------~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~ 118 (258)
T d1k2pa_ 71 --------------------------------QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118 (258)
T ss_dssp --------------------------------SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCCEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf --------------------------------781699997048993888641024677689999999999999998754
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 99312589766089868998899114720101011134578988888986445866556766789221259999995115
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKAD 660 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksD 660 (1239)
++|+||||||+|||++.++.+||+|||+|+....... .......||+.|+|||++.+ ..|+.++|
T Consensus 119 ~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~-~~~~~ksD 183 (258)
T d1k2pa_ 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--------------TSSVGSKFPVRWSPPEVLMY-SKFSSKSD 183 (258)
T ss_dssp TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--------------CCCCCSCCCGGGCCHHHHHH-CCCCHHHH
T ss_pred CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC--------------EEECCCCCCCCCCCCHHHCC-CCCCCCEE
T ss_conf 6843466541358876998479886144202357872--------------25246578877578078637-99885210
Q ss_pred HHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCC
Q ss_conf 6879999998403----896037899999964205999981002999999999980379999999999997231
Q 000880 661 MYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDA 730 (1239)
Q Consensus 661 IwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~ 730 (1239)
||||||++|||+| ||......+....+. .+..++.+...++++.+||++||+.||.+|||+.++++|.
T Consensus 184 iwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~--~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 184 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIA--QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHH--HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 33643246739755999988999999999998--0797899654659999999997668976893999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=356.57 Aligned_cols=250 Identities=20% Similarity=0.309 Sum_probs=207.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
Q ss_conf 6892387533258966899999916-----99499999973389990368999999999992699862446314420475
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 497 (1239)
.++|++++.||+|+||+||+|+++. ++..||||+++.. .......++.+|+.+++.++||||++++++|..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--- 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV--- 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH-CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC---
T ss_conf 8893886798207883999999888765778829999998821-085799999999999996689976552466605---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCC-------------------
Q ss_conf 4568988678885445444333466543235545555427999941268-87889987239-------------------
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD------------------- 557 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~------------------- 557 (1239)
...++++|||++ |+|.+++....
T Consensus 88 -------------------------------------~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 130 (301)
T d1lufa_ 88 -------------------------------------GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130 (301)
T ss_dssp -------------------------------------SSSCEEEEECCTTCBHHHHHHHTCC------------------
T ss_pred -------------------------------------CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf -------------------------------------9803899981589929999985275542100001110012103
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf -----999999999999999999997719931258976608986899889911472010101113457898888898644
Q 000880 558 -----HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSV 632 (1239)
Q Consensus 558 -----~l~~~~~~~i~~qIl~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~ 632 (1239)
.+++..++.++.|++.||+|||+++++||||||+|||++.++++||+|||+|+........ .
T Consensus 131 ~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~-------------~ 197 (301)
T d1lufa_ 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-------------K 197 (301)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-------------C
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEEECCCCCEEECCCHHHEECCCCCCC-------------C
T ss_conf 467889899999999999999855413578685488401168989992898331442113677641-------------1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 58665567667892212599999951156879999998403----89603789999996420599998100299999999
Q 000880 633 DGTGQVGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESL 708 (1239)
Q Consensus 633 ~~~~~~GT~~Y~APE~l~~~~~~s~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~L 708 (1239)
..++..||+.|+|||++.+ ..|+.++|||||||++|||++ ||......+...... .+..++.+...++++.+|
T Consensus 198 ~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~--~~~~~~~p~~~~~~~~~l 274 (301)
T d1lufa_ 198 ADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR--DGNILACPENCPLELYNL 274 (301)
T ss_dssp ----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TTCCCCCCTTCCHHHHHH
T ss_pred CCCCCCCCCCCCCHHHHCC-CCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCHHHHHHHHH--CCCCCCCCCCCHHHHHHH
T ss_conf 1577776767679899726-8898056302523629999806899999989999999997--399788873252999999
Q ss_pred HHHCCCCCCCCCCCHHHHHHC
Q ss_conf 998037999999999999723
Q 000880 709 LRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 709 I~~lL~~dP~~RPSa~eiL~h 729 (1239)
|.+||+.||.+|||+.+|++.
T Consensus 275 i~~cl~~~P~~RPt~~ev~~~ 295 (301)
T d1lufa_ 275 MRLCWSKLPADRPSFCSIHRI 295 (301)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHH
T ss_conf 999748896579399999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.22 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=203.7
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCC-----CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCC
Q ss_conf 8923875332589668999999169-----94999999733899903689999999999926-99862446314420475
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLD-----GRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 497 (1239)
++|++.++||+|+||.||+|.+... ++.||||+++.. ........+.+|...+.++ +|+||+.+++++.+.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC--
T ss_conf 997984498416783999999867775557839999998600-17178999999999988614998499741154047--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC----------------CCCC
Q ss_conf 4568988678885445444333466543235545555427999941268-8788998723----------------9999
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------DHFD 560 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~~l~ 560 (1239)
...++++||||+ |+|.+++... ..++
T Consensus 90 -------------------------------------~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~ 132 (299)
T d1ywna1 90 -------------------------------------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132 (299)
T ss_dssp -------------------------------------TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBC
T ss_pred -------------------------------------CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCC
T ss_conf -------------------------------------9757999984589929999985366666532220233214689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99999999999999999771993125897660898689988991147201010111345789888889864458665567
Q 000880 561 KELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640 (1239)
Q Consensus 561 ~~~~~~i~~qIl~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 640 (1239)
+..++.++.||+.||+|||+++|+||||||+|||++.++++||+|||+|+....... ....+...||
T Consensus 133 ~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~-------------~~~~~~~~gt 199 (299)
T d1ywna1 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-------------YVRKGDARLP 199 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTT-------------SCCTTSCCCG
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCHHHCCCCCC-------------CCCCCCEEEC
T ss_conf 999999999999999988737971786773106577998289845752001135665-------------2224751667
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 667892212599999951156879999998403----8960378999999642059999810029999999999803799
Q 000880 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716 (1239)
Q Consensus 641 ~~Y~APE~l~~~~~~s~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~d 716 (1239)
+.|||||++.+ ..|+.++|||||||++|||++ ||............+. .+..++.+...++++.++|.+||+.|
T Consensus 200 ~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~d 277 (299)
T d1ywna1 200 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGE 277 (299)
T ss_dssp GGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCCCHHHHHC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 21020368646-88996632213678999998688999989998999999996-38988888657899999999976779
Q ss_pred CCCCCCHHHHHHC
Q ss_conf 9999999999723
Q 000880 717 PSDRPSATELLQD 729 (1239)
Q Consensus 717 P~~RPSa~eiL~h 729 (1239)
|.+|||+.++++|
T Consensus 278 P~~Rpt~~eil~~ 290 (299)
T d1ywna1 278 PSQRPTFSELVEH 290 (299)
T ss_dssp GGGSCCHHHHHHH
T ss_pred HHHCCCHHHHHHH
T ss_conf 6679199999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.70 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=206.0
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCCCCE--EEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECCC
Q ss_conf 5568923875332589668999999169949--99999733899903689999999999926-99862446314420475
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNKLDGRH--YAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~--vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~~ 497 (1239)
...++|++.++||+|+||+||+|.++.+|.. ||||.++.. ........+.+|+.+|+.+ +|||||+++++|.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--- 82 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--- 82 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE---
T ss_pred CCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC---
T ss_conf 687996887798207882899999989996999999997823-3857999999999999862289988367888841---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC----------------CCCC
Q ss_conf 4568988678885445444333466543235545555427999941268-8788998723----------------9999
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------DHFD 560 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~~l~ 560 (1239)
...+|+|||||+ |+|.+++... ..++
T Consensus 83 -------------------------------------~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~ 125 (309)
T d1fvra_ 83 -------------------------------------RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125 (309)
T ss_dssp -------------------------------------TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSC
T ss_pred -------------------------------------CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCC
T ss_conf -------------------------------------8736999980289869999864035555512310123457899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99999999999999999771993125897660898689988991147201010111345789888889864458665567
Q 000880 561 KELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGT 640 (1239)
Q Consensus 561 ~~~~~~i~~qIl~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 640 (1239)
+..++.++.||+.||.|||+++++||||||+|||++.++.+||+|||+|+...... ......||
T Consensus 126 ~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~----------------~~~~~~gt 189 (309)
T d1fvra_ 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----------------KKTMGRLP 189 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC----------------CC----CC
T ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCEEECCCCCCCCCCCCC----------------CCCCEECC
T ss_conf 99999999999999876630895455505204898688763874344322444223----------------45530137
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 667892212599999951156879999998403----8960378999999642059999810029999999999803799
Q 000880 641 YFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPS 716 (1239)
Q Consensus 641 ~~Y~APE~l~~~~~~s~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~d 716 (1239)
+.|+|||.+.+ ..|+.++|||||||++|||++ ||......+....+. .+..++.+...++++.+||.+||+.|
T Consensus 190 ~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~li~~cl~~d 266 (309)
T d1fvra_ 190 VRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--QGYRLEKPLNCDDEVYDLMRQCWREK 266 (309)
T ss_dssp TTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG--GTCCCCCCTTBCHHHHHHHHHHTCSS
T ss_pred CCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH--HCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 75555387526-9999622153138899999836899999999999999998--26888887667899999999976789
Q ss_pred CCCCCCHHHHHHC
Q ss_conf 9999999999723
Q 000880 717 PSDRPSATELLQD 729 (1239)
Q Consensus 717 P~~RPSa~eiL~h 729 (1239)
|++|||+.+++++
T Consensus 267 P~~RPs~~eil~~ 279 (309)
T d1fvra_ 267 PYERPSFAQILVS 279 (309)
T ss_dssp GGGSCCHHHHHHH
T ss_pred HHHCCCHHHHHHH
T ss_conf 6689499999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.72 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=204.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|++.+.||+|+||+||+|+++ ++..||||+++.... ....+.+|+.+++.++|||||+++++|.+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-------- 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-------- 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--------
T ss_pred HHHEEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEEC--------
T ss_conf 799798469930798099999999-999999999880448---88999999999986666788689999823--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268-878899872--399999999999999999999977
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES--YDHFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~--~~~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
..+|+|||||+ |+|..++.. ...+++..++.++.||+.||+|||
T Consensus 84 ---------------------------------~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH 130 (285)
T d1fmka3 84 ---------------------------------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130 (285)
T ss_dssp ---------------------------------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf ---------------------------------97599999447994354200003553059999999999999999875
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
+++|+||||||+|||++.++++||+|||+|+....... .......||+.|+|||++.+ ..++.++
T Consensus 131 ~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~-~~~~~ks 195 (285)
T d1fmka3 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--------------TARQGAKFPIKWTAPEAALY-GRFTIKS 195 (285)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------------------------CCGGGSCHHHHHH-CCCCHHH
T ss_pred HHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC--------------EEECCCCCCCCCCCHHHHHC-CCCCCHH
T ss_conf 41143353123079998999299844255542568873--------------35245455665458089837-9989177
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH--CCCCCC
Q ss_conf 56879999998403---8960378999999642059999810029999999999803799999999999972--319998
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ--DALPPQ 734 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~--h~~~~~ 734 (1239)
|||||||++|||++ |+............+. .+..++....+++++.++|.+||+.||++|||+.+|++ ++||..
T Consensus 196 DI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 196 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH-HCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 413235899999868999998888999999998-2689999832379999999997566975891999999987666238
Q ss_pred C
Q ss_conf 5
Q 000880 735 M 735 (1239)
Q Consensus 735 ~ 735 (1239)
.
T Consensus 275 ~ 275 (285)
T d1fmka3 275 T 275 (285)
T ss_dssp S
T ss_pred C
T ss_conf 9
|
| >d1usya_ d.104.1.1 (A:) ATP phosphoribosyltransferase regulatory subunit HisZ {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: ATP phosphoribosyltransferase regulatory subunit HisZ species: Thermotoga maritima [TaxId: 2336]
Probab=100.00 E-value=0 Score=354.60 Aligned_cols=262 Identities=18% Similarity=0.202 Sum_probs=201.9
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCEECCCCCCCCCCCEEEEECCCCCEEEECCCCCHHHHHHHHHCC-CCCEEEEEECCEE
Q ss_conf 789889999999809940355520015787433442789831699725104788688999998399-9851379633758
Q 000880 799 DYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQ-KSSFKRYEISSVY 877 (1239)
Q Consensus 799 ~~I~~~l~~~f~~~Gy~~I~tP~l~~~~~~~~~~~~~~~~~D~~g~~l~LRpD~T~~iaR~v~~~~-~~p~r~~y~g~Vf 877 (1239)
+++.. +.++++++||++|.||+|+.... .... .|.|++|+.++||||+|+|+||+++++. ..|.|+||+|+||
T Consensus 7 ek~~s-f~~~~~~~Gy~~i~tP~~E~~e~---~~~~--~F~D~~g~~l~LRpD~T~~iaR~~~~~~~~~p~k~~Y~g~Vf 80 (275)
T d1usya_ 7 EKVFS-FYSKATKKGFSPFFVPALEKAEE---PAGN--FFLDRKGNLFSIREDFTKTVLNHRKRYSPDSQIKVWYADFVY 80 (275)
T ss_dssp HHHHH-HHHHHHHTTCEECCCCSEEECSS---CCSS--CEEETTSCEEEECCCHHHHHHHHHTTCTTCCCEEEECCEEEE
T ss_pred HHHHH-HHHHHHHCCCCEEECCCCCCCCC---CCCC--EEECCCCCEEEECCCCCHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf 99999-99999985996435676322302---1266--538599999987897739999999975999980335772089
Q ss_pred ECCCCCCCCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHCCCCCCEEEEECCHHHHHHHHHHCCCCHHHHHHHHHHHH
Q ss_conf 71788999971437869996799951179999999999996399983299978499999999990999889999999999
Q 000880 878 RRAIGHSPPNRYLQGDFDIIGGASALTEAEVLKVTMDIVTRFFHAESCDIHLNHGDLLEAIWSWAGIKAEHREKVAELLA 957 (1239)
Q Consensus 878 R~e~~~~~~~ef~Q~GvEiiG~~s~~aDaEii~l~~~~l~~Lgi~~~~~i~ig~~~i~~~l~~~lgl~~~~~~~l~~~l~ 957 (1239)
|+++++ .+||+|+|+|+||.+++.+|+|+|.++.++|+.+|+++ ++|+|||+++++.+++. ++.+..+++..+++
T Consensus 81 R~~~~~--~re~~Q~G~EiiG~~~~~aD~Evi~l~~~~l~~lgi~~-~~i~l~~~~i~~~ll~~--l~~~~~~~l~~~l~ 155 (275)
T d1usya_ 81 RYSGSD--LVAEYQLGLEKVPRNSLDDSLEVLEIIVESASEFFEGP-VIVEIGHTGVYEDLLKE--IPKDLHEKVLNLID 155 (275)
T ss_dssp EEETTE--EEEEEEEEEEEESCCSHHHHHHHHHHHHHHHHHHCCSC-EEEEEEETTHHHHHHTT--SCGGGHHHHHHHHH
T ss_pred EECCCC--CCCEEECCCEEECHHHHHHHHHHHHHHHHHHHHHCCCC-CEEEECCCCHHHHHHHH--CCCHHHHHHHHHHH
T ss_conf 827986--45425558145322457889999999999998623035-47775571058787652--25057899999988
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCHHHHHHHHHCCCCCCHHHHHHHHHH--HHHHCC
Q ss_conf 625889886311000999999999961998999999999988726995559999850199995689999999--998806
Q 000880 958 MMGSLRPQSSEWKSKWVVIRRQLLQELNLAEAVVNRLQTVGLRFCGAADQALPRLRGALPADKPTRKALDEL--YLRIWR 1035 (1239)
Q Consensus 958 ~~d~~~~~~~~~k~~~~~~~~~l~~~~~l~~~~~~~l~~l~~~~~g~~~~~l~~l~~~~~~~~~~~~~l~~L--~l~~~~ 1035 (1239)
+++. .++ +.+....+++......+.... .+.+.... +. . ..........+.++ .+....
T Consensus 156 ~k~~------------~~l-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-l~---~-~~~~~~~~~~L~~~~~~l~~~~ 216 (275)
T d1usya_ 156 TKNL------------AEI-EFLSHMKKIDLSRVEKIIEDS-IYRRSPEH-LK---T-MDLPLSVREDLLSASSFLQEKF 216 (275)
T ss_dssp TTCH------------HHH-HHHHHHTCCCCTHHHHHHHHH-HHCCSGGG-GG---T-SCCCHHHHHHHHHHHHHHHHHC
T ss_pred HCCH------------HHH-HHHHHHCCCCHHHHHHHHHHH-HHCCCHHH-HH---H-HHHHHHHHHHHHHHHHHHHHHC
T ss_conf 4266------------659-998765599977888776320-00468666-65---1-5778888999999999998638
Q ss_pred CCCCEEECCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCEEEEECCHH
Q ss_conf 86208982699998886434599999537777654334540002655531111102100003468999996015642289
Q 000880 1036 IEKNIYIDALMPPIESYHRNLFFQVFSVKEKYPATLVEGTLLAVGGRYDYLLHRMWDREYVGYASRTNPPSGVGASLALE 1115 (1239)
Q Consensus 1036 ~~~~i~~Dls~~rgl~YYTG~vFe~~~~~~~~~~~~~~~~~I~~GGRYD~L~~~fg~~~~~~~~~~~~~~pavGfaigle 1115 (1239)
...++.+|++++||++||||+||++|.++.+. +||+|||||.|.. +|||||+++|
T Consensus 217 ~~~~i~~D~~~~rgldYYtGivFe~~~~~~~~--------~I~~GGRYD~l~e-----------------~~~G~si~ld 271 (275)
T d1usya_ 217 PTVSVEIDLTLARTIEEYCGLIFTIYDTSSSR--------LVAAGGEYTVNGE-----------------KGVGGSIFLE 271 (275)
T ss_dssp SSSEEEECCCCGGGGGTCSSEEEEEEETTTTE--------EEEEEEEEEETTE-----------------EEEEEEEEEE
T ss_pred CCCEEEECCCCCCCCCCCCCEEEEEEECCCCC--------EEEECCCCCCCCC-----------------EEEEEEEEEE
T ss_conf 78609982652579766698599999999889--------6876141168778-----------------7046899740
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.87 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=204.5
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCC---CEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
Q ss_conf 689238753325896689999991699---49999997338999036899999999999269986244631442047545
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDG---RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVAD 499 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~ 499 (1239)
.++|++.+.||+|+||.||+|.+..++ ..||||.++.. ........+.+|+.+++.++|||||++++++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-----
T ss_conf 89969877993078829999999369964499999993656-687999999999999986899998569889953-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 68988678885445444333466543235545555427999941268-878899872-3999999999999999999999
Q 000880 500 FDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLAH 577 (1239)
Q Consensus 500 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qIl~aL~y 577 (1239)
..+|+|||||+ |+|.+++.. ...+++..++.++.||+.||+|
T Consensus 80 ------------------------------------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 123 (273)
T d1mp8a_ 80 ------------------------------------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123 (273)
T ss_dssp ------------------------------------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf ------------------------------------74799998406980776542247899999999999999877523
Q ss_pred HHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 77199312589766089868998899114720101011134578988888986445866556766789221259999995
Q 000880 578 IHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDE 657 (1239)
Q Consensus 578 LHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ 657 (1239)
||+++++||||||+|||++.++.+||+|||+|+....... ...+...||+.|+|||++.+ ..|+.
T Consensus 124 lH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~--------------~~~~~~~gt~~y~apE~l~~-~~~~~ 188 (273)
T d1mp8a_ 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--------------YKASKGKLPIKWMAPESINF-RRFTS 188 (273)
T ss_dssp HHHTTCCCSCCSGGGEEEEETTEEEECC---------------------------------CCGGGCCHHHHHH-CCCSH
T ss_pred HCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCCCC--------------EECCCEECCCCCCHHHHHCC-CCCCC
T ss_conf 0226744141026553206789678765034213367762--------------33054005831032667516-99887
Q ss_pred CHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 1156879999998403----89603789999996420599998100299999999998037999999999999723
Q 000880 658 KADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 658 ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
++|||||||++|||++ ||......+....+. .+..++.+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 189 ~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE--NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH--CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 45244424789999826999988899999999998--189998987779999999999768797689299999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.52 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=213.4
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEEC---CCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEE
Q ss_conf 55689238753325896689999991---6994999999733899--90368999999999992699-862446314420
Q 000880 421 RYLNDFEELQPLGHGGFGHVVLCKNK---LDGRHYAVKKIRLKDK--SLPVNDRILREVATLSRLQH-QHVVRYYQAWFE 494 (1239)
Q Consensus 421 ~~~~~y~~~~~LG~G~fG~Vy~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~ 494 (1239)
..+++|++++.||+|+||+||+|++. .+|+.||||+++.... .......+.+|+.+++.++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred CCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 45102599989832878399999987658879489999983677210168999999999999864679839996200024
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHH
Q ss_conf 4754568988678885445444333466543235545555427999941268-878899872399999999999999999
Q 000880 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVE 573 (1239)
Q Consensus 495 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~ 573 (1239)
...++++||||. |+|.+++...+.+.+..++.++.||+.
T Consensus 101 ----------------------------------------~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~ 140 (322)
T d1vzoa_ 101 ----------------------------------------ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140 (322)
T ss_dssp ----------------------------------------TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHH
T ss_pred ----------------------------------------CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHH
T ss_conf ----------------------------------------8730012312341179999873045437888888999999
Q ss_pred HHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99997719931258976608986899889911472010101113457898888898644586655676678922125999
Q 000880 574 GLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP 653 (1239)
Q Consensus 574 aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 653 (1239)
||+|||+++|+||||||+|||++.++.+||+|||+|+.+...... ......|++.|+|||.+.+..
T Consensus 141 al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~--------------~~~~~~g~~~~~~pe~~~~~~ 206 (322)
T d1vzoa_ 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE--------------RAYDFCGTIEYMAPDIVRGGD 206 (322)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG--------------GGCGGGSCCTTCCHHHHTTCC
T ss_pred HHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHCCCCCC--------------CCCCCCCCCCCCHHHHHHCCC
T ss_conf 998851499896547732012469998887413202220344443--------------221222333331068760577
Q ss_pred -CCCCCHHHHHHHHHHHHHHC---CCCHHHHH----HHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC----
Q ss_conf -99951156879999998403---89603789----9999964205999981002999999999980379999999----
Q 000880 654 -KIDEKADMYSLGIVFFELWH---PFSTAMER----QIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRP---- 721 (1239)
Q Consensus 654 -~~s~ksDIwSlGviL~ELlt---Pf~~~~~~----~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RP---- 721 (1239)
.++.++||||+||+||+|++ ||...... .+....... .++.+...++++.+||++||.+||.+||
T Consensus 207 ~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~ 283 (322)
T d1vzoa_ 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283 (322)
T ss_dssp ---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSST
T ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCC
T ss_conf 688713251777799999976899988887777999999833568---99886547999999999974458988199974
Q ss_pred -CHHHHHHCCCCCCCHHHHH
Q ss_conf -9999972319998507889
Q 000880 722 -SATELLQDALPPQMEYELL 740 (1239)
Q Consensus 722 -Sa~eiL~h~~~~~~~~~~~ 740 (1239)
+++|+++||||+++.+..+
T Consensus 284 ~t~~eil~Hpff~~i~~~~l 303 (322)
T d1vzoa_ 284 RDADEIKEHLFFQKINWDDL 303 (322)
T ss_dssp TTHHHHHTSGGGTTCCHHHH
T ss_pred CCHHHHHCCHHHCCCCHHHH
T ss_conf 50999974972348998899
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.08 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=200.0
Q ss_pred EEEECCCCCEEEEEEEECCCC---CEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCCCC
Q ss_conf 753325896689999991699---49999997338999036899999999999269986244631442047545689886
Q 000880 429 LQPLGHGGFGHVVLCKNKLDG---RHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGDSM 505 (1239)
Q Consensus 429 ~~~LG~G~fG~Vy~a~~~~tg---~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~~~ 505 (1239)
.++||+|+||+||+|.+..++ ..||||+++. ........++.+|+.++++++||||++++++|.+.
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---------- 100 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---------- 100 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----------
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC----------
T ss_conf 6698136880999999977998799999999884-36978999999999999867899986786789806----------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 78885445444333466543235545555427999941268-8788998723-999999999999999999999771993
Q 000880 506 WGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY-DHFDKELAWHLFRQIVEGLAHIHGQGI 583 (1239)
Q Consensus 506 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~-~~l~~~~~~~i~~qIl~aL~yLHs~gI 583 (1239)
...+++|||||+ ++|.+++... ..+++..++.++.|++.||.|||+++|
T Consensus 101 -----------------------------~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~i 151 (311)
T d1r0pa_ 101 -----------------------------EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151 (311)
T ss_dssp -----------------------------TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred -----------------------------CCCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf -----------------------------994389998740674144210134540489999999998876520033676
Q ss_pred CCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 12589766089868998899114720101011134578988888986445866556766789221259999995115687
Q 000880 584 IHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKADMYS 663 (1239)
Q Consensus 584 iHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ksDIwS 663 (1239)
+||||||+|||++.++.+||+|||+++......... ........||+.|+|||++.+ ..++.++||||
T Consensus 152 iHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S 219 (311)
T d1r0pa_ 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-----------VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWS 219 (311)
T ss_dssp CCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC-----------TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHH
T ss_pred CCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCC-----------CEECCCCCCCCCCCCHHHHHC-CCCCCHHHHHH
T ss_conf 257766875767799988991065232255665553-----------100256555645567688743-79997457466
Q ss_pred HHHHHHHHHC---CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 9999998403---89603789999996420599998100299999999998037999999999999723
Q 000880 664 LGIVFFELWH---PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 664 lGviL~ELlt---Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
||+++|||++ ||............+. .+..++....+++++.+||.+||..||.+||++.+++++
T Consensus 220 fGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 220 FGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 19999999978999988899999999998-089889964475999999999768897689399999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.43 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=205.9
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCC-------CEEEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEE
Q ss_conf 689238753325896689999991699-------4999999733899903689999999999926-99862446314420
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDG-------RHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFE 494 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg-------~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~ 494 (1239)
.++|++.+.||+|+||.||+|++..++ ..||||+++.. ........+.+|+..+..+ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 899697009851678289999985787555667549999998811-2868899999999999981399969734652201
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC----------------C
Q ss_conf 4754568988678885445444333466543235545555427999941268-8788998723----------------9
Q 000880 495 TGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------------D 557 (1239)
Q Consensus 495 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------------~ 557 (1239)
...+|+|||||. |+|.+++... .
T Consensus 91 ----------------------------------------~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~ 130 (299)
T d1fgka_ 91 ----------------------------------------DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130 (299)
T ss_dssp ----------------------------------------SSSCEEEECCCTTCBHHHHHHTTSCC------------CC
T ss_pred ----------------------------------------CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf ----------------------------------------8868999973699909999986067764322233457434
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99999999999999999999771993125897660898689988991147201010111345789888889864458665
Q 000880 558 HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637 (1239)
Q Consensus 558 ~l~~~~~~~i~~qIl~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (1239)
.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus 131 ~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~ 197 (299)
T d1fgka_ 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-------------KKTTNG 197 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTT-------------CCCTTS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEEECCCCCEEECCCHHHCCCCCCCCC-------------CCCCCC
T ss_conf 6799999999999999998766379786302210224547897676221110113555554-------------314667
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 567667892212599999951156879999998403----8960378999999642059999810029999999999803
Q 000880 638 VGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 638 ~GT~~Y~APE~l~~~~~~s~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL 713 (1239)
.||+.|+|||.+.+ ..|+.++|||||||++|||++ ||......+.. ..+. .+..++.+...++++.+||.+||
T Consensus 198 ~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-~~i~-~~~~~~~p~~~~~~l~~li~~cl 274 (299)
T d1fgka_ 198 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-KLLK-EGHRMDKPSNCTNELYMMMRDCW 274 (299)
T ss_dssp CCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHH-TTCCCCCCSSCCHHHHHHHHHHT
T ss_pred CCCHHHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHH-HHHH-CCCCCCCCCCCHHHHHHHHHHHC
T ss_conf 88846632667517-988825554775888887401798989999999999-9997-28888987435299999999976
Q ss_pred CCCCCCCCCHHHHHHC
Q ss_conf 7999999999999723
Q 000880 714 SPSPSDRPSATELLQD 729 (1239)
Q Consensus 714 ~~dP~~RPSa~eiL~h 729 (1239)
+.||.+|||+.++++.
T Consensus 275 ~~dP~~Rps~~eil~~ 290 (299)
T d1fgka_ 275 HAVPSQRPTFKQLVED 290 (299)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCCHHHCCCHHHHHHH
T ss_conf 6797679399999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.03 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=206.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCC-C--CEEEEEEEECCCC-CCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCC
Q ss_conf 68923875332589668999999169-9--4999999733899-903689999999999926998624463144204754
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLD-G--RHYAVKKIRLKDK-SLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVA 498 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~t-g--~~vAIK~i~~~~~-~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~ 498 (1239)
.++|++++.||+|+||+||+|++..+ + ..||||++..... .......+.+|+.+++.++||||++++++|.+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE----
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHH-CCCCCHHHHHHHHHHHHHHHH
Q ss_conf 568988678885445444333466543235545555427999941268-878899872-399999999999999999999
Q 000880 499 DFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFES-YDHFDKELAWHLFRQIVEGLA 576 (1239)
Q Consensus 499 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~-~~~l~~~~~~~i~~qIl~aL~ 576 (1239)
..+++|||||+ |++.+.+.. .+.+++..++.++.||+.||.
T Consensus 83 -------------------------------------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 125 (273)
T d1u46a_ 83 -------------------------------------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125 (273)
T ss_dssp -------------------------------------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHH
T ss_pred -------------------------------------CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf -------------------------------------1001146542386125444212689999999999999999998
Q ss_pred HHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 97719931258976608986899889911472010101113457898888898644586655676678922125999999
Q 000880 577 HIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 577 yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s 656 (1239)
|||+++|+||||||+|||++.++.+||+|||+++........ ........|++.|+|||++.+ ..++
T Consensus 126 ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~-~~~~ 192 (273)
T d1u46a_ 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------------YVMQEHRKVPFAWCAPESLKT-RTFS 192 (273)
T ss_dssp HHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE------------EEC-----CCGGGCCHHHHHH-CEEE
T ss_pred HHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCCCCC------------CEECCCCCCCCCCCCHHHHHC-CCCC
T ss_conf 752178752056688815655654332561155530358875------------265476325731079999837-9999
Q ss_pred CCHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 51156879999998403----8960378999999642059999810029999999999803799999999999972
Q 000880 657 EKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~ 728 (1239)
.++|||||||++|||+| ||......+....+.. .+..++.+...++++.+||.+||+.||.+|||+.+|++
T Consensus 193 ~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 4215661489999999689999999699999999984-79999985445399999999976889667929999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.18 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=202.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269986244631442047545689
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~ 502 (1239)
.++|++.++||+|+||.||+|+++ |..||||+++... ..+.+.+|+.++++++||||++++++|.+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------- 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE------- 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-------
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCHH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-------
T ss_conf 899488579820798089999999--9099999988577----799999999999867898985498788723-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 88678885445444333466543235545555427999941268-87889987239--9999999999999999999977
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD--HFDKELAWHLFRQIVEGLAHIH 579 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~--~l~~~~~~~i~~qIl~aL~yLH 579 (1239)
...+|+|||||+ |+|.+++.... .+++..++.++.||+.||+|||
T Consensus 73 --------------------------------~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH 120 (262)
T d1byga_ 73 --------------------------------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120 (262)
T ss_dssp ----------------------------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCC
T ss_conf --------------------------------892899996369998999987457888899999999999985232113
Q ss_pred HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 19931258976608986899889911472010101113457898888898644586655676678922125999999511
Q 000880 580 GQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 580 s~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
+++++||||||+|||++.++++||+|||+++..... .....+|+.|+|||++.+ ..++.++
T Consensus 121 ~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~------------------~~~~~~~~~y~aPE~l~~-~~~t~~s 181 (262)
T d1byga_ 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------------------QDTGKLPVKWTAPEALRE-KKFSTKS 181 (262)
T ss_dssp HTTCCCSCCSGGGEEECTTSCEEECCCCC------------------------------CCTTTSCHHHHHH-CCCCHHH
T ss_pred CCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCC------------------CCCCCCCCCCCCHHHHHC-CCCCHHH
T ss_conf 376553666567601468997763245600344787------------------765566646778178727-9888588
Q ss_pred HHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 56879999998403----89603789999996420599998100299999999998037999999999999723
Q 000880 660 DMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 660 DIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
|||||||++|||+| ||......+....+. .+..++.....++++.+||.+||+.||.+|||+.+++++
T Consensus 182 DIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH--CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 777579999999978999999999999999998--089999976579999999999756697689399999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.36 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=203.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEEC-----CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEECC
Q ss_conf 689238753325896689999991-----6994999999733899903689999999999926-9986244631442047
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNK-----LDGRHYAVKKIRLKDKSLPVNDRILREVATLSRL-QHQHVVRYYQAWFETG 496 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L-~HpnIv~l~~~~~~~~ 496 (1239)
.++|++.++||+|+||.||+|+++ .++..||||+++.. ........+.+|+.+++.+ +|||||+++++|.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE--
T ss_conf 8996985498206882999999806644778869999998742-4877999999999998762699988789989831--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCC------------------
Q ss_conf 54568988678885445444333466543235545555427999941268-87889987239------------------
Q 000880 497 VADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYD------------------ 557 (1239)
Q Consensus 497 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~------------------ 557 (1239)
...+|++||||+ |+|.+++....
T Consensus 99 --------------------------------------~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 140 (311)
T d1t46a_ 99 --------------------------------------GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140 (311)
T ss_dssp --------------------------------------SSSCEEEEECCTTEEHHHHHHHTTTTC--------------C
T ss_pred --------------------------------------CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf --------------------------------------997899997379987999998535665444445332223345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99999999999999999999771993125897660898689988991147201010111345789888889864458665
Q 000880 558 HFDKELAWHLFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQ 637 (1239)
Q Consensus 558 ~l~~~~~~~i~~qIl~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (1239)
.+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++....... .......
T Consensus 141 ~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-------------~~~~~~~ 207 (311)
T d1t46a_ 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-------------YVVKGNA 207 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT-------------SEECSSS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCCCCCCCHHEECCCCCC-------------CEEEEEC
T ss_conf 889999999999999999988757926662410210000257521023401023367886-------------1586201
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC---C-CCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 567667892212599999951156879999998403---8-960378999999642059999810029999999999803
Q 000880 638 VGTYFYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---P-FSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLM 713 (1239)
Q Consensus 638 ~GT~~Y~APE~l~~~~~~s~ksDIwSlGviL~ELlt---P-f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL 713 (1239)
+||+.|+|||++.+ ..++.++|||||||++|||+| | |............+. .+..+......++++.+||.+||
T Consensus 208 ~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~Li~~cl 285 (311)
T d1t46a_ 208 RLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-EGFRMLSPEHAPAEMYDIMKTCW 285 (311)
T ss_dssp EECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHT
T ss_pred CCCHHHCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHC
T ss_conf 35968767788617-99997400102589999998589988778998999999986-68988985436599999999975
Q ss_pred CCCCCCCCCHHHHHH
Q ss_conf 799999999999972
Q 000880 714 SPSPSDRPSATELLQ 728 (1239)
Q Consensus 714 ~~dP~~RPSa~eiL~ 728 (1239)
+.||.+|||+.++++
T Consensus 286 ~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 286 DADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCCHHHCCCHHHHHH
T ss_conf 779657929999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.57 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=206.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
Q ss_conf 6892387533258966899999916-----99499999973389990368999999999992699862446314420475
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKL-----DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGV 497 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~ 497 (1239)
.++|++.++||+|+||+||+|.++. ++..||||+++.. ........+.+|+.+++.++||||++++++|..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--- 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---
T ss_conf 8991883598207881899999878644778968999998701-286899999999999997699988412547842---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHC----------CCCCHHHHHH
Q ss_conf 4568988678885445444333466543235545555427999941268-8788998723----------9999999999
Q 000880 498 ADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESY----------DHFDKELAWH 566 (1239)
Q Consensus 498 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~----------~~l~~~~~~~ 566 (1239)
...+++|||||+ |+|.+++... ..+++..+..
T Consensus 95 -------------------------------------~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (308)
T d1p4oa_ 95 -------------------------------------GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137 (308)
T ss_dssp -------------------------------------SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHH
T ss_pred -------------------------------------CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf -------------------------------------8810677760489988999875033211344468879999999
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99999999999771993125897660898689988991147201010111345789888889864458665567667892
Q 000880 567 LFRQIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAP 646 (1239)
Q Consensus 567 i~~qIl~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 646 (1239)
++.|++.||.|||+++|+||||||+|||++.++++||+|||+|+........ .......||+.|+||
T Consensus 138 i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~-------------~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-------------RKGGKGLLPVRWMSP 204 (308)
T ss_dssp HHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE-------------EGGGSSEECGGGCCH
T ss_pred HHHHHHHHHHHHHHCCEEECEECCCCEEECCCCEEEEEECCCCEECCCCCCE-------------EECCCEECCCCCCCH
T ss_conf 9999999999876479654328677540359964999424542023577630-------------313402316323788
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 212599999951156879999998403----8960378999999642059999810029999999999803799999999
Q 000880 647 EIEQGWPKIDEKADMYSLGIVFFELWH----PFSTAMERQIVLSDLKQKGELPPSWVAKFSEQESLLRRLMSPSPSDRPS 722 (1239)
Q Consensus 647 E~l~~~~~~s~ksDIwSlGviL~ELlt----Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPS 722 (1239)
|.+.+ ..++.++||||||+++|||+| ||......+....+. .+..++.....++.+.++|.+||+.||.+|||
T Consensus 205 e~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~--~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 281 (308)
T d1p4oa_ 205 ESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 281 (308)
T ss_dssp HHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH--HCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCC
T ss_conf 88736-9988333444378999999968999999989999999998--08888886335399999999975779658939
Q ss_pred HHHHHHC
Q ss_conf 9999723
Q 000880 723 ATELLQD 729 (1239)
Q Consensus 723 a~eiL~h 729 (1239)
+.+++++
T Consensus 282 ~~~il~~ 288 (308)
T d1p4oa_ 282 FLEIISS 288 (308)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
T ss_conf 9999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=331.42 Aligned_cols=253 Identities=23% Similarity=0.253 Sum_probs=197.0
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCC
Q ss_conf 89238753325896689999991699499999973389990368999999999992699862446314420475456898
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~ 503 (1239)
++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+|+.+++.++|+|++..+..+..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~--------- 73 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA--------- 73 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEE---------
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEE---------
T ss_conf 8899968985078809999999889989999997210058----889999999997038996017999995---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 867888544544433346654323554555542799994126887889987-2399999999999999999999977199
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFE-SYDHFDKELAWHLFRQIVEGLAHIHGQG 582 (1239)
Q Consensus 504 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~-~~~~l~~~~~~~i~~qIl~aL~yLHs~g 582 (1239)
.....++|||||++++.+.+. ....+++..+..++.|++.||+|||+++
T Consensus 74 ------------------------------~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (299)
T d1ckia_ 74 ------------------------------EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123 (299)
T ss_dssp ------------------------------ETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ------------------------------CCCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf ------------------------------19877899987387133324430688768999999999999999999799
Q ss_pred CCCCCCCCCCEEECC---CCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 312589766089868---99889911472010101113457898888898644586655676678922125999999511
Q 000880 583 IIHRDLTPNNIFFDA---RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKIDEKA 659 (1239)
Q Consensus 583 IiHrDLKp~NILi~~---~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s~ks 659 (1239)
|+||||||+|||++. +..+||+|||+|+.+......... ........+||+.|||||++.+ ..++.++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 194 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI--------PYRENKNLTGTARYASINTHLG-IEQSRRD 194 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC--------CCCBCCSCCCCSSSCCHHHHTT-BCCCHHH
T ss_pred EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCCCCE--------ECCCCCCCCCCCCCCCHHHHHC-CCCCCHH
T ss_conf 442667876606433577761565046751342554455410--------0013577678735329999918-9989832
Q ss_pred HHHHHHHHHHHHHC---CCCHHHHHHHHHHH---HHH--CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 56879999998403---89603789999996---420--59999810029999999999803799999999999972
Q 000880 660 DMYSLGIVFFELWH---PFSTAMERQIVLSD---LKQ--KGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 660 DIwSlGviL~ELlt---Pf~~~~~~~~~~~~---~~~--~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~ 728 (1239)
|||||||++|||++ ||............ ... ....+......++++.++|.+||+.+|.+||++.++.+
T Consensus 195 DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred HEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 18861778999984987665530577999999852356789835753478899999999984399557919999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.68 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=189.0
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCC
Q ss_conf 89238753325896689999991699499999973389990368999999999992699862446314420475456898
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHVVRYYQAWFETGVADFDGD 503 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnIv~l~~~~~~~~~~~~~~~ 503 (1239)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... ........|+..++.++|||||+++++|.+..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~------- 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN------- 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-------
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC-------
T ss_conf 6899988982078819999999--99899999987200---46799999999996279986832688998379-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH--
Q ss_conf 8678885445444333466543235545555427999941268-8788998723999999999999999999999771--
Q 000880 504 SMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCP-RTLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG-- 580 (1239)
Q Consensus 504 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~-gsL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs-- 580 (1239)
.....+|+|||||+ |+|.+++.+. .+++...+.++.|++.||+|+|+
T Consensus 71 -----------------------------~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~ 120 (303)
T d1vjya_ 71 -----------------------------GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp -----------------------------SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred -----------------------------CCCEEEEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf -----------------------------8604899999646698989998658-9998999999999999999988766
Q ss_pred ------CCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-
Q ss_conf ------9931258976608986899889911472010101113457898888898644586655676678922125999-
Q 000880 581 ------QGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWP- 653 (1239)
Q Consensus 581 ------~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~- 653 (1239)
++|+||||||+|||++.++.+||+|||+++......... .......+||+.|||||++.+..
T Consensus 121 ~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~ 189 (303)
T d1vjya_ 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI-----------DIAPNHRVGTKRYMAPEVLDDSIN 189 (303)
T ss_dssp CSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE-----------CC----CCSCGGGCCHHHHTTCSC
T ss_pred HHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE-----------ECCCCCEECCCCCCCHHHCCCCCC
T ss_conf 520468986615317313578688776887638662346777620-----------013552503547678221056545
Q ss_pred ----CCCCCHHHHHHHHHHHHHHC---CCCHH--------------HHHHHHHHHHHHCCCC---CCCCCC--CCHHHHH
Q ss_conf ----99951156879999998403---89603--------------7899999964205999---981002--9999999
Q 000880 654 ----KIDEKADMYSLGIVFFELWH---PFSTA--------------MERQIVLSDLKQKGEL---PPSWVA--KFSEQES 707 (1239)
Q Consensus 654 ----~~s~ksDIwSlGviL~ELlt---Pf~~~--------------~~~~~~~~~~~~~~~~---p~~~~~--~~~~~~~ 707 (1239)
.++.++|||||||+||||+| ||... ................ |..+.. ....+.+
T Consensus 190 ~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~ 269 (303)
T d1vjya_ 190 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 269 (303)
T ss_dssp TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 46777675012201599999996289988766311241012255643099999987502468887765577689999999
Q ss_pred HHHHCCCCCCCCCCCHHHHHHC
Q ss_conf 9998037999999999999723
Q 000880 708 LLRRLMSPSPSDRPSATELLQD 729 (1239)
Q Consensus 708 LI~~lL~~dP~~RPSa~eiL~h 729 (1239)
|+.+||+.||.+|||+.+++++
T Consensus 270 li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 270 IMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999760698589599999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=321.08 Aligned_cols=252 Identities=18% Similarity=0.219 Sum_probs=196.9
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEECCCCCCCC
Q ss_conf 89238753325896689999991699499999973389990368999999999992699-86244631442047545689
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH-QHVVRYYQAWFETGVADFDG 502 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~H-pnIv~l~~~~~~~~~~~~~~ 502 (1239)
++|++.++||+|+||+||+|+++.+|+.||||+++..... ..+.+|+..++.++| +|++.+++++.+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~-------- 72 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE-------- 72 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCEEEEEEEC--------
T ss_conf 8069979984178829999999889979999997502582----9999999999996489998779999601--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC
Q ss_conf 8867888544544433346654323554555542799994126887889987239-999999999999999999997719
Q 000880 503 DSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYD-HFDKELAWHLFRQIVEGLAHIHGQ 581 (1239)
Q Consensus 503 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~-~l~~~~~~~i~~qIl~aL~yLHs~ 581 (1239)
....|+|||||+++|.+++...+ .++...+..++.|++.||+|||++
T Consensus 73 --------------------------------~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~ 120 (293)
T d1csna_ 73 --------------------------------GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120 (293)
T ss_dssp --------------------------------TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred --------------------------------CCCCEEEEEECCCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf --------------------------------881179999648887999975203110689999999999999999977
Q ss_pred CCCCCCCCCCCEEECC-----CCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9312589766089868-----99889911472010101113457898888898644586655676678922125999999
Q 000880 582 GIIHRDLTPNNIFFDA-----RNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTAPEIEQGWPKID 656 (1239)
Q Consensus 582 gIiHrDLKp~NILi~~-----~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~s 656 (1239)
||+||||||+|||++. ++.+||+|||+|+.+......... ......+.+||+.|||||++.+ ..++
T Consensus 121 giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~--------~~~~~~~~~GT~~y~aPE~~~~-~~~~ 191 (293)
T d1csna_ 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI--------PYREKKNLSGTARYMSINTHLG-REQS 191 (293)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBC--------CCCCCCCCCSCTTTCCHHHHTT-CCCC
T ss_pred CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCCCCCCCE--------EECCCCCEEECHHHCCHHHHCC-CCCC
T ss_conf 966266771315234754344795687236605771467665411--------1024676277510267989648-8888
Q ss_pred CCHHHHHHHHHHHHHHC---CCCHHH---HHHHHHHHHH--HCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 51156879999998403---896037---8999999642--059999810029999999999803799999999999972
Q 000880 657 EKADMYSLGIVFFELWH---PFSTAM---ERQIVLSDLK--QKGELPPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQ 728 (1239)
Q Consensus 657 ~ksDIwSlGviL~ELlt---Pf~~~~---~~~~~~~~~~--~~~~~p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~ 728 (1239)
.++|||||||++|||++ ||.... .......+.. .....+......++++.+++..|+..+|.+||++..+.+
T Consensus 192 ~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 192 RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 69998983199999986987678853021999999997056799958965799899999999984399300859999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=310.63 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=188.6
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-----------CCEEEEEEEE
Q ss_conf 89238753325896689999991699499999973389990368999999999992699-----------8624463144
Q 000880 424 NDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH-----------QHVVRYYQAW 492 (1239)
Q Consensus 424 ~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~H-----------pnIv~l~~~~ 492 (1239)
++|+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+++.++| +||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEE
T ss_conf 8579989975077818999999999979999998343---1336899999999998401455555422767647899876
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECC--CCCHHHHH--HHCCCCCHHHHHHHH
Q ss_conf 20475456898867888544544433346654323554555542799994126--88788998--723999999999999
Q 000880 493 FETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYC--PRTLRQVF--ESYDHFDKELAWHLF 568 (1239)
Q Consensus 493 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~--~gsL~~~l--~~~~~l~~~~~~~i~ 568 (1239)
... .....+++|.++ .++..... .....+++..++.++
T Consensus 90 ~~~--------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~ 131 (362)
T d1q8ya_ 90 NHK--------------------------------------GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131 (362)
T ss_dssp EEE--------------------------------------ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred EEC--------------------------------------CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHH
T ss_conf 312--------------------------------------565202343200035420000012234678689999999
Q ss_pred HHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCC------EEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 999999999771-99312589766089868998------89911472010101113457898888898644586655676
Q 000880 569 RQIVEGLAHIHG-QGIIHRDLTPNNIFFDARND------IKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTY 641 (1239)
Q Consensus 569 ~qIl~aL~yLHs-~gIiHrDLKp~NILi~~~~~------vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 641 (1239)
.||+.||+|||+ .||+||||||+|||++.++. ++++|||.|...... ....+||+
T Consensus 132 ~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~------------------~~~~~gt~ 193 (362)
T d1q8ya_ 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------------------YTNSIQTR 193 (362)
T ss_dssp HHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC------------------CCSCCSCG
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCCCEEEEEECCCCCCCCCC------------------CCCCCCCC
T ss_conf 999999888764058646567705705630576564430567531442123445------------------42236652
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC---CCCHHHH------HHHHHHHHHHCCCC------------------
Q ss_conf 67892212599999951156879999998403---8960378------99999964205999------------------
Q 000880 642 FYTAPEIEQGWPKIDEKADMYSLGIVFFELWH---PFSTAME------RQIVLSDLKQKGEL------------------ 694 (1239)
Q Consensus 642 ~Y~APE~l~~~~~~s~ksDIwSlGviL~ELlt---Pf~~~~~------~~~~~~~~~~~~~~------------------ 694 (1239)
.|+|||++.+ ..|+.++||||+||++++|++ ||.+... ...........+..
T Consensus 194 ~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~ 272 (362)
T d1q8ya_ 194 EYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 272 (362)
T ss_dssp GGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC-
T ss_pred CCCCHHHCCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCC
T ss_conf 1057132146-677764320123789999987889989875543210268999999983799878862453220001320
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHCCCCCCCH
Q ss_conf ---------------------981002999999999980379999999999997231999850
Q 000880 695 ---------------------PPSWVAKFSEQESLLRRLMSPSPSDRPSATELLQDALPPQME 736 (1239)
Q Consensus 695 ---------------------p~~~~~~~~~~~~LI~~lL~~dP~~RPSa~eiL~h~~~~~~~ 736 (1239)
...+...++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp -CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 122024323577644421000156743589999999998779945790899996693407898
|
| >d1ukxa_ d.20.1.3 (A:) EIF2-alpha kinase 4 (GCN2-like protein) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: RWD domain domain: EIF2-alpha kinase 4 (GCN2-like protein) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.91 E-value=7.3e-24 Score=166.87 Aligned_cols=121 Identities=32% Similarity=0.466 Sum_probs=105.8
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCEEEECCC-------CCEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCC
Q ss_conf 34478879999999999741059850331289-------99499997389888998897479999998189999989865
Q 000880 24 SSSTVDDNELLSEEITALCAIFQEDCKVVSGS-------PPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKL 96 (1239)
Q Consensus 24 ~~~~~~~~eeq~~EiEAL~sIY~d~~~~~~~~-------~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~ 96 (1239)
.+.|+++.|+|++|+|||+|||+|+|+++... +..|.|++.+...+ +....+.+.|.|+||++||+++|++
T Consensus 5 ~~~~~~~~E~Q~~EleaL~SIY~dd~~~~~~~~~~~~~~~~~~~i~i~~~~~~--~~~~~~~i~L~~~lp~~YP~~~P~i 82 (137)
T d1ukxa_ 5 SSGMESYSQRQDHELQALEAIYGSDFQDLRPDARGRVREPPEINLVLYPQGLA--GEEVYVQVELRVKCPPTYPDVVPEI 82 (137)
T ss_dssp SCCCCCHHHHHHHHHHHHHHHTSSSEEECCCCCSSSCCCCCCEEEEECCTTSC--SSSCSCEEEEEECCCTTTTSSCCCC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCCCCCEEEEEEECCCCC--CCCCEEEEEEEEECCCCCCCCCCEE
T ss_conf 77754679999999999998768860881465456435897399999516777--7652179999997788887644427
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEEEEHHHHHHHHHHHHHCCC
Q ss_conf 2024899999889999999999998838799614114899999999852368
Q 000880 97 QITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFLSEIVPL 148 (1239)
Q Consensus 97 ~~~~~~~l~~~~~~~l~~~L~e~~~e~~~~G~~mif~l~e~lke~L~~~~~~ 148 (1239)
.+.+..||+...+..|.+.|++.+++++ |++|||+||+++||||+++...
T Consensus 83 ~~~~~~~l~~~~~~~L~~~l~~~~~e~~--G~~mif~lv~~lqe~L~e~n~~ 132 (137)
T d1ukxa_ 83 DLKNAKGLSNESVNLLKSHLEELAKKQC--GEVMIFELAHHVQSFLSEHNKS 132 (137)
T ss_dssp EEEEEESSSSSHHHHHHHHHHHHHHHHT--TSCCHHHHHHHHHHHHHHHCCC
T ss_pred EEECCCCCCHHHHHHHHHHHHHHHHHCC--CCEEHHHHHHHHHHHHHHHCCC
T ss_conf 8753789899999999999999999848--9774999999999999970899
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.7e-24 Score=167.57 Aligned_cols=167 Identities=19% Similarity=0.096 Sum_probs=119.4
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC----------------CHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 23875332589668999999169949999997338999----------------03689999999999926998624463
Q 000880 426 FEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKS----------------LPVNDRILREVATLSRLQHQHVVRYY 489 (1239)
Q Consensus 426 y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~----------------~~~~~~~~~Ev~iL~~L~HpnIv~l~ 489 (1239)
+.+.++||+|+||+||+|.+. +|+.||||+++....+ ........+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHH
Q ss_conf 14420475456898867888544544433346654323554555542799994126887889987239999999999999
Q 000880 490 QAWFETGVADFDGDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPRTLRQVFESYDHFDKELAWHLFR 569 (1239)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~gsL~~~l~~~~~l~~~~~~~i~~ 569 (1239)
++. ..+++|||+++... ..++...+..++.
T Consensus 81 ~~~--------------------------------------------~~~lvme~~~~~~~------~~l~~~~~~~i~~ 110 (191)
T d1zara2 81 AWE--------------------------------------------GNAVLMELIDAKEL------YRVRVENPDEVLD 110 (191)
T ss_dssp EEE--------------------------------------------TTEEEEECCCCEEG------GGCCCSCHHHHHH
T ss_pred EEC--------------------------------------------CCEEEEEEECCCCC------CCHHHHHHHHHHH
T ss_conf 862--------------------------------------------88899995045654------2001578999999
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----
Q ss_conf 9999999977199312589766089868998899114720101011134578988888986445866556766789----
Q 000880 570 QIVEGLAHIHGQGIIHRDLTPNNIFFDARNDIKIGDFGLAKFLKLEQLDQDAAFPTDTGGVSVDGTGQVGTYFYTA---- 645 (1239)
Q Consensus 570 qIl~aL~yLHs~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A---- 645 (1239)
|++.+|+|||++||+||||||+|||++. ..++|+|||.|.....+.. ..|..
T Consensus 111 ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDFG~a~~~~~~~~-----------------------~~~l~rd~~ 166 (191)
T d1zara2 111 MILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGW-----------------------REILERDVR 166 (191)
T ss_dssp HHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCCTTCEETTSTTH-----------------------HHHHHHHHH
T ss_pred HHHHHHHHHHHCCEEECCCCHHHEEEEC-CCEEEEECCCCCCCCCCCC-----------------------HHHHHHHHH
T ss_conf 9999999982688898368903611428-9899987788430899870-----------------------999987799
Q ss_pred --CCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf --221259999995115687999999
Q 000880 646 --PEIEQGWPKIDEKADMYSLGIVFF 669 (1239)
Q Consensus 646 --PE~l~~~~~~s~ksDIwSlGviL~ 669 (1239)
.+.+. ..|+.++|+||+.--+.
T Consensus 167 ~~~~~f~--r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 167 NIITYFS--RTYRTEKDINSAIDRIL 190 (191)
T ss_dssp HHHHHHH--HHHCCCCCHHHHHHHHH
T ss_pred HHHHHHC--CCCCCCCCHHHHHHHHH
T ss_conf 9999975--78998446899999874
|
| >d2daya1 d.20.1.3 (A:8-122) E3 ubiquitin-protein ligase RNF25 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: RWD domain domain: E3 ubiquitin-protein ligase RNF25 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=4.8e-22 Score=155.22 Aligned_cols=108 Identities=24% Similarity=0.472 Sum_probs=95.2
Q ss_pred HHHHHHHHHHHHHCCCCEEEECCCC----CEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 9999999997410598503312899----949999738988899889747999999818999998986520248999998
Q 000880 32 ELLSEEITALCAIFQEDCKVVSGSP----PQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKGLTKS 107 (1239)
Q Consensus 32 eeq~~EiEAL~sIY~d~~~~~~~~~----~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~~~~~~~~l~~~ 107 (1239)
+-+++|+|||+|||+|+|+++..++ ..|+|++.+..++++ .+..+.+.|+|.+|++||+++|++.+++++||+..
T Consensus 4 ~~~~~EleaL~SIY~d~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~v~L~~~~p~~YP~~~P~i~~~~~~~l~~~ 82 (115)
T d2daya1 4 WVLPSEVEVLESIYLDELQVIKGNGRTSPWEIYITLHPATAEDQ-DSQYVCFTLVLQVPAEYPHEVPQISIRNPRGLSDE 82 (115)
T ss_dssp CHHHHHHHHHHHHSTTTEEEECCTTSSCCEEEEEEECCSCCSSS-SCCCCEEEEEEEECSSTTSSCCEEEEEEEESSCHH
T ss_pred HHHHHHHHHHHHHCCCCEEEECCCCCCCCEEEEEEEECCCCCCC-CCCCEEEEEEEECCCCCCCCCCCEEEECCCCCCHH
T ss_conf 32899999999678996699446877777189999704777777-65535899999768988788896786556789999
Q ss_pred HHHHHHHHHHHHHHHHCCCCCEEEEHHHHHHHHHH
Q ss_conf 89999999999998838799614114899999999
Q 000880 108 DADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFL 142 (1239)
Q Consensus 108 ~~~~l~~~L~e~~~e~~~~G~~mif~l~e~lke~L 142 (1239)
++..|++.|++.++++. |++|||+|++++||+|
T Consensus 83 ~~~~L~~~l~~~~~e~~--G~~mif~lv~~~qE~L 115 (115)
T d2daya1 83 QIHTILQVLGHVAKAGL--GTAMLYELIEKGKEIL 115 (115)
T ss_dssp HHHHHHHHHHHHHHHTT--TSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCC--CCEEHHHHHHHHHHHC
T ss_conf 99999999999999739--9887999999998649
|
| >d2dawa1 d.20.1.3 (A:8-148) RWD domain-containing protein 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: RWD domain domain: RWD domain-containing protein 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.5e-19 Score=139.24 Aligned_cols=119 Identities=18% Similarity=0.143 Sum_probs=94.8
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCEEEECC------------------CCCEEEEEECCCCCCCCCCCCCEEEEEEEEC
Q ss_conf 3447887999999999974105985033128------------------9994999973898889988974799999981
Q 000880 24 SSSTVDDNELLSEEITALCAIFQEDCKVVSG------------------SPPQILVKLRPYSKDMGYEDLDVSALLLVRC 85 (1239)
Q Consensus 24 ~~~~~~~~eeq~~EiEAL~sIY~d~~~~~~~------------------~~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~ 85 (1239)
.+++.++.|.|.+|+|||+|||||+.++... .|..+.+.+.... . +..+.+.|.|.+
T Consensus 2 ~~~~~e~~e~Q~~ElEaL~SIY~~e~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~---~--~~~~~i~L~~~l 76 (141)
T d2dawa1 2 SASVKESLQLQLLEMEMLFSMFPNQGEVKLEDVNALTNIKRYLEGTREALPPKIEFVITLQI---E--EPKVKIDLQVTM 76 (141)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCCSTTSEEESCGGGTHHHHHHHHTSCCSCCCCEEEEEEEEE---T--TTTEEEEEEEEE
T ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCHHHHHHHHHHCCCCCCCCCCEEEEEECCC---C--CCCCEEEEEEEE
T ss_conf 63366729999999999996689998798538126667777524765455764489985156---7--765048999986
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-CCCCCEEEEHHHHHHHHHHHHHCCCCC
Q ss_conf 89999989865202489999988999999999999883-879961411489999999985236898
Q 000880 86 LPGYPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSN-AREGRVMIFNLVEAAQEFLSEIVPLGQ 150 (1239)
Q Consensus 86 p~~YP~~~P~~~~~~~~~l~~~~~~~l~~~L~e~~~e~-~~~G~~mif~l~e~lke~L~~~~~~~~ 150 (1239)
|++||+++|++++.+ .|++...+..|+..|.+.++++ . |++|||+||+++||....+..+.+
T Consensus 77 p~~YP~~~P~i~~~~-~~l~~~~~~~l~~~l~~~~~e~~~--Ge~mif~lv~~lqe~~~~~l~~~~ 139 (141)
T d2dawa1 77 PHSYPYLALQLFGRS-SELDRHQQLLLNKGLTSYIGTFDP--GELCVCAAIQWLQDNSASYFLNRK 139 (141)
T ss_dssp CSSTTSSCCEEEEEC-SSSCHHHHHHHHHHHHHHHTTSCT--TSCSHHHHHHHHHHTTHHHHCCCC
T ss_pred CCCCCCCCCCCEEEC-CCCCHHHHHHHHHHHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHCC
T ss_conf 788887799724236-666889999999999999998448--865999999999997999986335
|
| >d2daxa1 d.20.1.3 (A:8-147) Uncharacterized protein C21orf6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: RWD domain domain: Uncharacterized protein C21orf6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1e-18 Score=133.95 Aligned_cols=116 Identities=19% Similarity=0.185 Sum_probs=92.8
Q ss_pred CHHHHHHHHHHHHHHCCCCEEEECC---------------------CCCEEEEEECCCCCCCCCCCCCEEEEEEEECCCC
Q ss_conf 7999999999974105985033128---------------------9994999973898889988974799999981899
Q 000880 30 DNELLSEEITALCAIFQEDCKVVSG---------------------SPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPG 88 (1239)
Q Consensus 30 ~~eeq~~EiEAL~sIY~d~~~~~~~---------------------~~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~ 88 (1239)
+.|+|.+|||||+|||+++.++... ....|.+++.... ..+..+.+.|+|++|++
T Consensus 2 ~~E~Q~~EleaL~SIY~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~l~~~~----~~~~~~~l~L~~~lP~~ 77 (140)
T d2daxa1 2 QAEAQLAELDLLASMFPGENELIVNDQLAVAELKDCIEKKTMEGRSSKVYFTINMNLDV----SDEKMAMFSLACILPFK 77 (140)
T ss_dssp HHHHHHHHHHHHHHHCCSSSSEEESCHHHHHHHHHHHHHTCCCCCCSCEEEEEEEEEEC----STTCEEEEEEEEEECSS
T ss_pred CHHHHHHHHHHHHHHCCCCCEEEECCCCHHHHHHHCCCCCCCCCCCCCEEEEEEECCCC----CCCCCCEEEEEEEECCC
T ss_conf 37889999999997679997687516401556654025554567887515898622576----66657169999980686
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEEEEHHHHHHHHHHHHHCCCCCC
Q ss_conf 999898652024899999889999999999998838799614114899999999852368988
Q 000880 89 YPYKCPKLQITPEKGLTKSDADNLLCLLQDQANSNAREGRVMIFNLVEAAQEFLSEIVPLGQS 151 (1239)
Q Consensus 89 YP~~~P~~~~~~~~~l~~~~~~~l~~~L~e~~~e~~~~G~~mif~l~e~lke~L~~~~~~~~~ 151 (1239)
||+++|.+++.+. +++......++..|.+.+.++. .|++|||+|++++||.+..+....++
T Consensus 78 YP~~~P~i~l~~~-~l~~~~~~~l~~~l~~~~~~~~-~Ge~~if~lve~lqe~~~~~~~~~~~ 138 (140)
T d2daxa1 78 YPAVLPEITVRSV-LLSRSQQTQLNTDLTAFLQKHC-HGDVCILNATEWVREHASGYVSRDTS 138 (140)
T ss_dssp TTSSCCCCEEECT-TSCHHHHHHHHHHHHHHHHHSS-CSSCCSHHHHHHHHHHHHHHCCCCCC
T ss_pred CCCCCCCEECCCC-CCCHHHHHHHHHHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 8886985565077-7888999999999999999834-99768999999999989998646878
|
| >d1nj8a3 d.104.1.1 (A:0-267) Prolyl-tRNA synthetase (ProRS) {Archaeon (Methanocaldococcus jannaschii) [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Prolyl-tRNA synthetase (ProRS) species: Archaeon (Methanocaldococcus jannaschii) [TaxId: 2190]
Probab=99.60 E-value=1.5e-14 Score=107.18 Aligned_cols=144 Identities=10% Similarity=0.096 Sum_probs=107.1
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----EC--CCC-CCCCCCCEEEEECC----CCCEEE
Q ss_conf 34688886422331346677789889999999809940355520----01--578-74334427898316----997251
Q 000880 779 RLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YL--LGD-CPQFKRNTVKLLTH----GGDLLE 847 (1239)
Q Consensus 779 ~~n~~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~--~~~-~~~~~~~~~~~~D~----~g~~l~ 847 (1239)
....+.+|+..|+|....+++.|++.+++.+.++||++|.||.+ ++ ++. ......+||..... .++.++
T Consensus 19 d~~~~v~G~~~~lP~G~~i~~~i~~~i~~~~~~~G~~ev~~P~l~~~~l~~ks~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (268)
T d1nj8a3 19 DVRYPIKGCGVYLPYGFKIRRYTFEIIRNLLDESGHDEALFPMLIPEDLLAKEAEHIKGFEDEVYWVTHGGKTQLDVKLA 98 (268)
T ss_dssp BCCSTTSSCCBBCHHHHHHHHHHHHHHHHHHHHTTCEECBCCSEEEHHHHHHHCSSSGGGGGGCEEEEESSSSEEEEEEE
T ss_pred CCCCCCCCCEEECCCHHHHHHHHHHHHHHHHHHCCCEEEEEHHHHHHHHHHCCCCCCCCCCCCEEEEECCCCCCCHHHHH
T ss_conf 34899986378890189999999999999999849869820233315766032787556653014774032122024430
Q ss_pred ECCCCCHHHHHHHHHC----CCCCEEEEEECCEEECCCCC----CCCCCEEE-EEEEEECCCCCCCHH---HHHHHHHHH
Q ss_conf 0478868899999839----99851379633758717889----99971437-869996799951179---999999999
Q 000880 848 LSHELRLPFIRWAISN----QKSSFKRYEISSVYRRAIGH----SPPNRYLQ-GDFDIIGGASALTEA---EVLKVTMDI 915 (1239)
Q Consensus 848 LRpD~T~~iaR~v~~~----~~~p~r~~y~g~VfR~e~~~----~~~~ef~Q-~GvEiiG~~s~~aDa---Eii~l~~~~ 915 (1239)
|||..+++++.++... +..|+|+|++|++||+|... .|++||+| -++.+|......++. .++....++
T Consensus 99 L~P~~~~~~~~i~~~~~~Syr~LP~r~~e~~~~fR~E~~~~~GllR~reF~~~dd~~~~~~~~~~~~~~~~~~~~~y~~i 178 (268)
T d1nj8a3 99 LRPTSETPIYYMMKLWVKVHTDLPIKIYQIVNTFRYETKHTRPLIRLREIMTFKEAHTAHSTKEEAENQVKEAISIYKKF 178 (268)
T ss_dssp ECSSSHHHHHHHHHTTCCBTTSCCCCEEEEECCBCCCCSCCBTTTBCSBCSCEEEEEEEESSHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHCCCHHHHHEEEEECCCCCCCCCCCCCCCEEEEEEEEECHHCEECCCCCHHHHHHHHHHHHHHHH
T ss_conf 24577730577654312341212147751163110355556666157887642000331366430267888889999999
Q ss_pred HHHCCCC
Q ss_conf 9963999
Q 000880 916 VTRFFHA 922 (1239)
Q Consensus 916 l~~Lgi~ 922 (1239)
++.||+.
T Consensus 179 f~~l~l~ 185 (268)
T d1nj8a3 179 FDTLGIP 185 (268)
T ss_dssp HHHHTCC
T ss_pred HHHCCCC
T ss_conf 9751754
|
| >d1qf6a4 d.104.1.1 (A:242-532) Threonyl-tRNA synthetase (ThrRS) {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Threonyl-tRNA synthetase (ThrRS) species: Escherichia coli [TaxId: 562]
Probab=99.60 E-value=5.1e-15 Score=110.18 Aligned_cols=152 Identities=9% Similarity=0.084 Sum_probs=123.9
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE------ECCCCCCCCCCCEEEEECCCCCEEEECCCC
Q ss_conf 34688886422331346677789889999999809940355520------015787433442789831699725104788
Q 000880 779 RLNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM------YLLGDCPQFKRNTVKLLTHGGDLLELSHEL 852 (1239)
Q Consensus 779 ~~n~~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l------~~~~~~~~~~~~~~~~~D~~g~~l~LRpD~ 852 (1239)
-+++...|...|+|..+.+++.|.+.+++.+.+.||++|.||.+ .-+++++.+..+||.+.+. ++.++|||--
T Consensus 14 ~~~~~~~G~~~~lP~G~~l~~~L~~~i~e~~~~~G~~eV~~P~L~~~~l~~~sG~~~~~~~~~~~~~~~-~~~~~L~Pt~ 92 (291)
T d1qf6a4 14 HMQEEAPGMVFWHNDGWTIFRELEVFVRSKLKEYQYQEVKGPFMMDRVLWEKTGHWDNYKDAMFTTSSE-NREYCIKPMN 92 (291)
T ss_dssp ECCTTSTTCCEECHHHHHHHHHHHHHHHHHHHHTTCEECCCCSEEETHHHHHHSHHHHHGGGCEEEEET-TEEEEECSSS
T ss_pred CCCCCCCCCEEECCCHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCHHHHHHHCHHHHCCCHHCCCCCC-CHHHCCCCCC
T ss_conf 446777854487338999999999999999998599899766456466775521054146301034333-1221114667
Q ss_pred CHHHHHHHHH----CCCCCEEEEEECCEEECCC-CC--C--CCCCEEEEEEEEECCCCCCCHH--HHHHHHHHHHHHCCC
Q ss_conf 6889999983----9998513796337587178-89--9--9971437869996799951179--999999999996399
Q 000880 853 RLPFIRWAIS----NQKSSFKRYEISSVYRRAI-GH--S--PPNRYLQGDFDIIGGASALTEA--EVLKVTMDIVTRFFH 921 (1239)
Q Consensus 853 T~~iaR~v~~----~~~~p~r~~y~g~VfR~e~-~~--~--~~~ef~Q~GvEiiG~~s~~aDa--Eii~l~~~~l~~Lgi 921 (1239)
.++++.++.. ++..|+|+|+++++||+|. +. + |.++|+|.++.+|..+...++. +++.++.++++.+|+
T Consensus 93 e~~~~~~~~~~~~sy~~LPl~~~q~~~~fR~E~~~~~~Gl~R~reF~~~d~h~f~~~e~~~~e~~~~~~~~~~i~~~lGl 172 (291)
T d1qf6a4 93 CPGHVQIFNQGLKSYRDLPLRMAEFGSCHRNEPSGSLHGLMRVRGFTQDDAHIFCTEEQIRDEVNGCIRLVYDMYSTFGF 172 (291)
T ss_dssp HHHHHHHHTTSCEEGGGCSEEEEEEEEEECCCCGGGCBTTTBCSEEEEEEEEEEECGGGHHHHHHHHHHHHHHHHGGGTC
T ss_pred CHHHHHHHHCCCCCHHHCCEEEEECCEEEECCCCCCCCCCCCCCCCEECCCEEEECCHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 67899998721530432372575403354125666654666664643322056736465699999999999999997599
Q ss_pred CCCEEEEECCH
Q ss_conf 98329997849
Q 000880 922 AESCDIHLNHG 932 (1239)
Q Consensus 922 ~~~~~i~ig~~ 932 (1239)
+. +.+.++.+
T Consensus 173 ~~-~~v~~s~~ 182 (291)
T d1qf6a4 173 EK-IVVKLSTR 182 (291)
T ss_dssp CC-CEEEEECC
T ss_pred CE-EEEEEECC
T ss_conf 64-99998668
|
| >d1qf6a1 c.51.1.1 (A:533-642) Threonyl-tRNA synthetase (ThrRS), C-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Threonyl-tRNA synthetase (ThrRS), C-terminal domain species: Escherichia coli [TaxId: 562]
Probab=99.57 E-value=3.2e-14 Score=105.13 Aligned_cols=102 Identities=15% Similarity=0.097 Sum_probs=94.0
Q ss_pred CCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEEEEEECCCC
Q ss_conf 78735999963897609999999999998399189950799998999999994899699998477335770899995678
Q 000880 1131 EAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVK 1210 (1239)
Q Consensus 1131 ~~~~~vlv~~~~~~~~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i~vk~l~~~ 1210 (1239)
-+|.+|+|++.+ ++....|.+++..||..|++|.++.. +.++++++++|+..|+||++++|++|+++|+|++|+|.++
T Consensus 5 laP~Qv~iipi~-~~~~~~a~~i~~~Lr~~gi~v~~d~~-~~~l~~ki~~a~~~g~p~~iiiG~~E~~~~~V~ir~~~~~ 82 (110)
T d1qf6a1 5 LAPVQVVIMNIT-DSQSEYVNELTQKLSNAGIRVKADLR-NEKIGFKIREHTLRRVPYMLVCGDKEVESGKVAVRTRRGK 82 (110)
T ss_dssp TCSSCEEEEESS-HHHHHHHHHHHHHHHTTTCCEEEECC-SSCHHHHHHHHHHTTCSEEEEECTTTGGGCCEEEEESSSC
T ss_pred CCCCEEEEEECC-HHHHHHHHHHHHHHHHHHCCCCCCCC-CCCHHHHHHHHHHCCCCEEEEECCHHHHCCEEEEEECCCC
T ss_conf 587148999616-88888889999999885325544477-6500078999998699899997751776898999988899
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCC
Q ss_conf 421102578999999999831069
Q 000880 1211 KEKEVQRESLVRFLLDAIASQFRN 1234 (1239)
Q Consensus 1211 ~q~~v~~~el~~~l~~~l~~~~~~ 1234 (1239)
+|..++++++++.++..+++....
T Consensus 83 ~q~~i~~~e~i~~l~~~i~~r~~~ 106 (110)
T d1qf6a1 83 DLGSMDVNEVIEKLQQEIRSRSLK 106 (110)
T ss_dssp EEEEECHHHHHHHHHHHHHTTCSS
T ss_pred CEEEEEHHHHHHHHHHHHHHHHHH
T ss_conf 567765999999999999987787
|
| >d1kmma1 c.51.1.1 (A:326-424) Histidyl-tRNA synthetase (HisRS), C-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Histidyl-tRNA synthetase (HisRS), C-terminal domain species: Escherichia coli [TaxId: 562]
Probab=99.57 E-value=8.3e-15 Score=108.84 Aligned_cols=95 Identities=17% Similarity=0.263 Sum_probs=88.9
Q ss_pred CCCEEEEEECCCCCCHHHHHHHHHHHHHC--CCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEEEEEECCC
Q ss_conf 87359999638976099999999999983--9918995079999899999999489969999847733577089999567
Q 000880 1132 AGTSVLVCSRGGGGLLVERMELVAELWEE--NIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDV 1209 (1239)
Q Consensus 1132 ~~~~vlv~~~~~~~~~~~a~~la~~Lr~~--G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i~vk~l~~ 1209 (1239)
+.+|++|++.+ ++....|+.+++.||+. |++|++++. ..++++++++|++.|+||++++|++|++++++++|+|.+
T Consensus 2 p~vdv~vi~~~-~~~~~~a~~la~~LR~~~~gi~v~~~~~-~~~l~kq~k~A~~~~~~~~iiiG~~E~~~~~v~vk~l~~ 79 (99)
T d1kmma1 2 PVVDIYLVASG-ADTQSAAMALAERLRDELPGVKLMTNHG-GGNFKKQFARADKWGARVAVVLGESEVANGTAVVKDLRS 79 (99)
T ss_dssp CSCSEEEECCS-TTHHHHHHHHHHHHHHHSTTCCEEECCS-CCCHHHHHHHHHHHTCSEEEECCHHHHHTTEEEEEETTT
T ss_pred CCCEEEEEECC-HHHHHHHHHHHHHHHHCCCCEEEEEECC-CCCHHHHHHHHHHHCCCHHHHCCCHHHHCCEEEEEECCC
T ss_conf 98879999778-7999999999999984499829999689-987879999997847874421181112146799999999
Q ss_pred CCCCCCCHHHHHHHHHHHH
Q ss_conf 8421102578999999999
Q 000880 1210 KKEKEVQRESLVRFLLDAI 1228 (1239)
Q Consensus 1210 ~~q~~v~~~el~~~l~~~l 1228 (1239)
++|..++++++++++++.+
T Consensus 80 ~~q~~v~~~el~~~l~~~L 98 (99)
T d1kmma1 80 GEQTAVAQDSVAAHLRTLL 98 (99)
T ss_dssp CCEEEEEHHHHHHHHHHHH
T ss_pred CCEEEEEHHHHHHHHHHHH
T ss_conf 9779976999999999974
|
| >d1nyra4 d.104.1.1 (A:242-532) Threonyl-tRNA synthetase (ThrRS) {Staphylococcus aureus [TaxId: 1280]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Threonyl-tRNA synthetase (ThrRS) species: Staphylococcus aureus [TaxId: 1280]
Probab=99.56 E-value=9.9e-15 Score=108.34 Aligned_cols=149 Identities=9% Similarity=0.057 Sum_probs=119.9
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE------ECCCCCCCCCCCEEEEECC-CCCEEEECCCCCHH
Q ss_conf 8886422331346677789889999999809940355520------0157874334427898316-99725104788688
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM------YLLGDCPQFKRNTVKLLTH-GGDLLELSHELRLP 855 (1239)
Q Consensus 783 ~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l------~~~~~~~~~~~~~~~~~D~-~g~~l~LRpD~T~~ 855 (1239)
...|...|+|..+.+++.+++.+++.+.++||++|.||.+ .-.++++....+||++.+. +++.++|||--.++
T Consensus 18 ~g~G~~~~~p~G~~l~~~L~~~~~~~~~~~G~~eV~~P~l~~~~l~~~sG~~~~~~~~~~~~~~~~~~~~~~L~pt~e~~ 97 (291)
T d1nyra4 18 VGAGLPLWLPNGATIRREIERYIVDKEVSMGYDHVYTPVLANVDLYKTSGHWDHYQEDMFPPMQLDETESMVLRPMNCPH 97 (291)
T ss_dssp TEEEEEEECHHHHHHHHHHHHHHHHHHHHTTEEECBCCSEEETHHHHHHTHHHHCTTSSCCCEEETTTEEEEECSSSHHH
T ss_pred CCCCCEEEEHHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCHHHHHHHCCCCCCCCCEEEEEECCCCCCCCCCCCCHHH
T ss_conf 05850588323999999999999999998699899776023566752314565335404998622544320135563457
Q ss_pred HHHHHHHC----CCCCEEEEEECCEEECCCCC---C--CCCCEEEEEEEEECCCCCCCH--HHHHHHHHHHHHHCCCCCC
Q ss_conf 99999839----99851379633758717889---9--997143786999679995117--9999999999996399983
Q 000880 856 FIRWAISN----QKSSFKRYEISSVYRRAIGH---S--PPNRYLQGDFDIIGGASALTE--AEVLKVTMDIVTRFFHAES 924 (1239)
Q Consensus 856 iaR~v~~~----~~~p~r~~y~g~VfR~e~~~---~--~~~ef~Q~GvEiiG~~s~~aD--aEii~l~~~~l~~Lgi~~~ 924 (1239)
++.++... +..|+|+|.++++||+|... | |.++|+|.+..+|+.++...+ .+++.++.++++.||+..
T Consensus 98 ~~~~~~~~~~sy~dLPlr~~~~~~~fR~E~~~~~~Gl~Rvr~F~~~d~~~f~~~eq~~~e~~~~~~~~~~i~~~lGl~~- 176 (291)
T d1nyra4 98 HMMIYANKPHSYRELPIRIAELGTMHRYEASGAVSGLQRVRGMTLNDSHIFVRPDQIKEEFKRVVNMIIDVYKDFGFED- 176 (291)
T ss_dssp HHHHHHTSCCBGGGCCEEEEEEEEEECCCCTTTCBTTTBCSEEEEEEEEEEECGGGHHHHHHHHHHHHHHHHHHTTCCC-
T ss_pred HHHHHHCEECCCCCCCEEEEECCCEEECCCCCCCCCCCCEEEEEEEEHEEECCCCCCHHHHHHHHHHHHHHHHHCCCCC-
T ss_conf 8775545863422243678613322416877665542003656631110005875419999999999999862117673-
Q ss_pred EEEEECCH
Q ss_conf 29997849
Q 000880 925 CDIHLNHG 932 (1239)
Q Consensus 925 ~~i~ig~~ 932 (1239)
..+.++..
T Consensus 177 ~~v~~~~~ 184 (291)
T d1nyra4 177 YSFRLSYR 184 (291)
T ss_dssp EEEEEEEC
T ss_pred EEEEEECC
T ss_conf 69998438
|
| >d1wu7a1 c.51.1.1 (A:330-426) Histidyl-tRNA synthetase (HisRS), C-terminal domain {Archaeon Thermoplasma acidophilum [TaxId: 2303]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Histidyl-tRNA synthetase (HisRS), C-terminal domain species: Archaeon Thermoplasma acidophilum [TaxId: 2303]
Probab=99.55 E-value=2.5e-14 Score=105.80 Aligned_cols=93 Identities=23% Similarity=0.328 Sum_probs=87.1
Q ss_pred CCEEEEEECCCCCCHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 73599996389760999999999999839918995079999899999999489969999847733577089999567842
Q 000880 1133 GTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKE 1212 (1239)
Q Consensus 1133 ~~~vlv~~~~~~~~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i~vk~l~~~~q 1212 (1239)
..+|+||+++ +.....+.+++..||+.|++|++++. .++++++|++|++.|+||++++|++|+++++|++|+|.+++|
T Consensus 3 ~~~V~i~~~g-~~~~~~~~~l~~~Lr~~gi~v~~d~~-~~~l~kq~~~A~~~~~~~~iiiG~~E~~~~~v~ik~l~~~~q 80 (97)
T d1wu7a1 3 KKSVYICRVG-KINSSIMNEYSRKLRERGMNVTVEIM-ERGLSAQLKYASAIGADFAVIFGERDLERGVVTIRNMYTGSQ 80 (97)
T ss_dssp SCEEEEEEES-SCCHHHHHHHHHHHHTTTCEEEECCS-CCCHHHHHHHHHHTTCSEEEEEEHHHHHTTEEEEEETTTCCE
T ss_pred CCEEEEEEEC-HHHHHHHHHHHHHHHHCCCEEEEECC-CCCHHHHHHHHHHCCCCEEEECCCCCCCCCCEEEEECCCCCE
T ss_conf 7639999908-79999999999999988998999878-882789999997417975884177334478528999999978
Q ss_pred CCCCHHHHHHHHHHH
Q ss_conf 110257899999999
Q 000880 1213 KEVQRESLVRFLLDA 1227 (1239)
Q Consensus 1213 ~~v~~~el~~~l~~~ 1227 (1239)
..+++++++++|...
T Consensus 81 ~~v~~~~l~~~l~~~ 95 (97)
T d1wu7a1 81 ENVGLDSVVEHLISQ 95 (97)
T ss_dssp EEEEGGGHHHHHHHC
T ss_pred EEEEHHHHHHHHHHC
T ss_conf 997699999999960
|
| >d1nyra1 c.51.1.1 (A:533-645) Threonyl-tRNA synthetase (ThrRS), C-terminal domain {Staphylococcus aureus [TaxId: 1280]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Threonyl-tRNA synthetase (ThrRS), C-terminal domain species: Staphylococcus aureus [TaxId: 1280]
Probab=99.54 E-value=2.7e-14 Score=105.56 Aligned_cols=106 Identities=15% Similarity=0.162 Sum_probs=93.4
Q ss_pred CCCCCCCCCCCEEEEEECCCCCCHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEEE
Q ss_conf 98687777873599996389760999999999999839918995079999899999999489969999847733577089
Q 000880 1124 DFKPVRNEAGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVK 1203 (1239)
Q Consensus 1124 ~~~~~~~~~~~~vlv~~~~~~~~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i~ 1203 (1239)
|..|. ..+|.+|.|++++.+.....|.+++..||+.|++|++++. +.++++++++|+..|+||+++||++|+++++|+
T Consensus 5 G~~P~-~lAP~qv~iipi~~~~~~~~a~~l~~~Lr~~gi~v~~D~~-~~~~g~k~~~a~~~g~p~~iiiG~~E~~~~~v~ 82 (113)
T d1nyra1 5 GAFPT-WLAPKQVQIIPVNVDLHYDYARQLQDELKSQGVRVSIDDR-NEKMGYKIREAQMQKIPYQIVVGDKEVENNQVN 82 (113)
T ss_dssp TCCCT-TTCSSCEEEEESSHHHHHHHHHHHHHHHHTTTCCEEECCS-SCCHHHHHHHHHHHTCSEEEEECHHHHHTTEEE
T ss_pred CCCCC-CCCCCEEEEEEECCHHHHHHHHHHHHHHHHHCCCEEECCC-CCCCCHHHHHHHHHCCEEEEEECCCCCCCCEEE
T ss_conf 87985-1289648999867178755678888776331041241152-010026788899849609999843600089999
Q ss_pred EEECCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 9995678421102578999999999831
Q 000880 1204 VRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1204 vk~l~~~~q~~v~~~el~~~l~~~l~~~ 1231 (1239)
+|++.+++|..++++++++.|...++..
T Consensus 83 vr~~~~~~q~~v~~~e~i~~l~~ei~~r 110 (113)
T d1nyra1 83 VRQYGSQDQETVEKDEFIWNLVDEIRLK 110 (113)
T ss_dssp EEETTSSCCCEEEHHHHHHHHHHHHHTT
T ss_pred EEECCCCCEEEEEHHHHHHHHHHHHHHH
T ss_conf 9997899578872999999999999875
|
| >d1h4vb1 c.51.1.1 (B:326-421) Histidyl-tRNA synthetase (HisRS), C-terminal domain {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Histidyl-tRNA synthetase (HisRS), C-terminal domain species: Thermus thermophilus [TaxId: 274]
Probab=99.51 E-value=2.5e-14 Score=105.75 Aligned_cols=93 Identities=17% Similarity=0.257 Sum_probs=86.3
Q ss_pred CCEEEEEECCCCCCHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 73599996389760999999999999839918995079999899999999489969999847733577089999567842
Q 000880 1133 GTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKKE 1212 (1239)
Q Consensus 1133 ~~~vlv~~~~~~~~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i~vk~l~~~~q 1212 (1239)
.++++|++.+ +.....+++++..||. |+++++++. .++++++|++|++.|++|++++|++|++++++++|+|.+++|
T Consensus 3 ~pdv~iv~~~-~~~~~~a~~i~~~LR~-~~~~~~~~~-~~~l~kq~k~A~~~~~~~~iiiG~~E~~~~~v~vK~l~~~~q 79 (96)
T d1h4vb1 3 GPDLYLIPLT-EEAVAEAFYLAEALRP-RLRAEYALA-PRKPAKGLEEALKRGAAFAGFLGEDELRAGEVTLKRLATGEQ 79 (96)
T ss_dssp CCSEEEEESS-HHHHHHHHHHHHHHTT-TSCEEECSS-CCCHHHHHHHHHHTTCSEEEEECHHHHHHTEEEEEETTTCCE
T ss_pred CCEEEEEECC-HHHHHHHHHHHHHHHC-CCEEEEECC-CCCHHHHHHHHHHCCCCEEEEECCHHHHCCCEEEEECCCCCE
T ss_conf 9889999769-7999999999999975-966999879-999899999999849997997561467559379999999957
Q ss_pred CCCCHHHHHHHHHHHH
Q ss_conf 1102578999999999
Q 000880 1213 KEVQRESLVRFLLDAI 1228 (1239)
Q Consensus 1213 ~~v~~~el~~~l~~~l 1228 (1239)
..+++++++++|+..+
T Consensus 80 ~~v~~~el~~~l~~~l 95 (96)
T d1h4vb1 80 VRLSREEVPGYLLQAL 95 (96)
T ss_dssp EEEEGGGHHHHHHHHC
T ss_pred EEEEHHHHHHHHHHHH
T ss_conf 9987999999999961
|
| >d1qe0a1 c.51.1.1 (A:326-420) Histidyl-tRNA synthetase (HisRS), C-terminal domain {Staphylococcus aureus [TaxId: 1280]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Histidyl-tRNA synthetase (HisRS), C-terminal domain species: Staphylococcus aureus [TaxId: 1280]
Probab=99.49 E-value=5.3e-14 Score=103.68 Aligned_cols=92 Identities=14% Similarity=0.252 Sum_probs=86.3
Q ss_pred CCCEEEEEECCCCCCHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEEEEEECCCCC
Q ss_conf 87359999638976099999999999983991899507999989999999948996999984773357708999956784
Q 000880 1132 AGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVKK 1211 (1239)
Q Consensus 1132 ~~~~vlv~~~~~~~~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i~vk~l~~~~ 1211 (1239)
...|++|++++ ++....+++++..||+.|++|++++. ..++++++++|++.|+||++++|++|++++++++|+|.+++
T Consensus 3 ~~~dv~ii~~~-~~~~~~a~~i~~~Lr~~gi~v~~d~~-~~~l~kq~~~A~~~~~~~~iiiG~~E~~~~~v~vk~l~~~~ 80 (95)
T d1qe0a1 3 ENLDLFIVTMG-DQADRYAVKLLNHLRHNGIKADKDYL-QRKIKGQMKQADRLGAKFTIVIGDQELENNKIDVKNMTTGE 80 (95)
T ss_dssp CCCSEEEEECH-HHHHHHHHHHHHHHHTTTCCEEECCS-CCCHHHHHHHHHHTTCSEEEEECHHHHHHTCEEEEETTTCC
T ss_pred CCCEEEEEEEC-HHHHHHHHHHHHHHHHCCCCEEECCC-CCCHHHHHHHHHHCCCCEEEEECCCHHHCCEEEEEECCCCC
T ss_conf 78849999948-78999999999999987991883277-89989999998754899999976514337979999999997
Q ss_pred CCCCCHHHHHHHHH
Q ss_conf 21102578999999
Q 000880 1212 EKEVQRESLVRFLL 1225 (1239)
Q Consensus 1212 q~~v~~~el~~~l~ 1225 (1239)
|..+++++++.+++
T Consensus 81 q~~i~~~el~~~l~ 94 (95)
T d1qe0a1 81 SETIELDALVEYFK 94 (95)
T ss_dssp EEEECTTHHHHHHH
T ss_pred EEEEEHHHHHHHHC
T ss_conf 89975999999962
|
| >d1b76a2 d.104.1.1 (A:1-394) Glycyl-tRNA synthetase (GlyRS) {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Glycyl-tRNA synthetase (GlyRS) species: Thermus thermophilus [TaxId: 274]
Probab=99.44 E-value=2.2e-13 Score=99.68 Aligned_cols=148 Identities=13% Similarity=0.061 Sum_probs=110.0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHH--HHCCCCCCCCCCE------ECCCCCCCCCCCEEEEECC-------------
Q ss_conf 888642233134667778988999999--9809940355520------0157874334427898316-------------
Q 000880 783 DNTSSIQYSDLDTELRDYVVQVTKEMF--RQHCAKHLEIEPM------YLLGDCPQFKRNTVKLLTH------------- 841 (1239)
Q Consensus 783 ~~~G~~D~lp~e~~~~~~I~~~l~~~f--~~~Gy~~I~tP~l------~~~~~~~~~~~~~~~~~D~------------- 841 (1239)
-..|+.||+|..+.+++.|++.+++.| .+.||.+|.||++ ..+|+.+.+...||...+.
T Consensus 27 g~~G~y~ygP~G~~l~~~i~~~wr~~~v~~~~~~~ev~tp~i~~~~lw~~SGH~~~f~d~m~~~~~~~~~~~~~~~~~~~ 106 (331)
T d1b76a2 27 GLQGVYDYGPLGVELKNNLKQAWWRRNVYERDDMEGLDASVLTHRLVLHYSGHEATFADPMVDNAKARYWTPPRYFNMMF 106 (331)
T ss_dssp CCTTCEEECHHHHHHHHHHHHHHHHHHTTSCSSEEEEBCCSEEEHHHHHHTSHHHHCEEEECBSSSCBCCCCCEEEECCE
T ss_pred CCEEEECCCCCHHHHHHHHHHHHHHHHHHCCCCEEEEECCCCCCHHHHCCCCCCCCCCCCEEEECCCCCCCCCCCHHHCC
T ss_conf 73367525872899999999999999875348859986665588678344752024577224422455666851021113
Q ss_pred ---------CCCEEEECCCCCHHHH----HH-HHHCCCCCEEEEEECCEEECCCC-C---CCCCCEEEEEEEEECCCCCC
Q ss_conf ---------9972510478868899----99-98399985137963375871788-9---99971437869996799951
Q 000880 842 ---------GGDLLELSHELRLPFI----RW-AISNQKSSFKRYEISSVYRRAIG-H---SPPNRYLQGDFDIIGGASAL 903 (1239)
Q Consensus 842 ---------~g~~l~LRpD~T~~ia----R~-v~~~~~~p~r~~y~g~VfR~e~~-~---~~~~ef~Q~GvEiiG~~s~~ 903 (1239)
.+...-|||.+..++. +. ..+++..|++++++|.+||+|.. . .|.|||+|.++++|..+...
T Consensus 107 ~~~~~~~~~~~~~~~lr~~t~~~~~~~~~~~~~~syk~LP~~~aqig~~fR~E~s~~~gl~RvReFtq~D~~~F~~~~q~ 186 (331)
T d1b76a2 107 QDLRGPRGGRGLLAYLRPETAQGIFVNFKNVLDATSRKLGFGIAQIGKAFRNEITPRNFIFRVREFEQMEIEYFVRPGED 186 (331)
T ss_dssp EEECSSSCCGGGEEEECSCTHHHHHTTHHHHHHHHTCCSSEEEEEEEEEECCCSSCCTTTTSCSEEEEEEEEEEECGGGH
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHCCCEECCCCCCCCCCCCCCHHHHHHHHHHCCCCCH
T ss_conf 53224212367751004753355899998677535443560322205232366555544332003111003420487520
Q ss_pred CHH--HHHHHHHHHHHHCCCCCCEEEEECC
Q ss_conf 179--9999999999963999832999784
Q 000880 904 TEA--EVLKVTMDIVTRFFHAESCDIHLNH 931 (1239)
Q Consensus 904 aDa--Eii~l~~~~l~~Lgi~~~~~i~ig~ 931 (1239)
.+. ..+..+.+.+..+|+.. ..+....
T Consensus 187 ~~~~~~~~~~~~~~~~~~g~~~-~~lr~~~ 215 (331)
T d1b76a2 187 EYWHRYWVEERLKWWQEMGLSR-ENLVPYQ 215 (331)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCG-GGEEEEE
T ss_pred HHHHHHHHHHHHHHHHHHHCCC-HHEEEEE
T ss_conf 6799999999999999862562-2136421
|
| >d1hc7a2 d.104.1.1 (A:5-276) Prolyl-tRNA synthetase (ProRS) {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Prolyl-tRNA synthetase (ProRS) species: Thermus thermophilus [TaxId: 274]
Probab=99.41 E-value=4.2e-12 Score=91.51 Aligned_cols=126 Identities=12% Similarity=0.090 Sum_probs=99.8
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECCCC---CCCCCCCEEEEECCCC----CEEEECC
Q ss_conf 88886422331346677789889999999809940355520----01578---7433442789831699----7251047
Q 000880 782 RDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD---CPQFKRNTVKLLTHGG----DLLELSH 850 (1239)
Q Consensus 782 ~~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~~~---~~~~~~~~~~~~D~~g----~~l~LRp 850 (1239)
++.+|+..|+|....+++.|++.+++.+.++||++|.||.+ ++... .+...++||++.+.++ +.++|||
T Consensus 27 ~~~~G~~~~lP~G~~l~~~l~~~~~~~~~~~G~~eV~~P~l~~~~l~~~sg~~~~~~~~~m~~~~~~~~~~~~~~~~L~p 106 (272)
T d1hc7a2 27 GPVRGTIVVRPYGYAIWENIQQVLDRMFKETGHQNAYFPLFIPMSFLRKEAEHVEGFSPELAVVTHAGGEELEEPLAVRP 106 (272)
T ss_dssp CSSTTCEEECHHHHHHHHHHHHHHHHHHHHTTCEECBCCSEEESTTC---------CCTTCEEEEEESSSEEEEEEEECS
T ss_pred CCCCCEEEECCCHHHHHHHHHHHHHHHHHHCCCEEEEECCCCCHHHHHHCCCCHHHCCCCEEEEECCCCCCCCCHHHCCC
T ss_conf 79997178884699999999999999998759768840334355776422562121365225642244344441122024
Q ss_pred CCCHHHHHHHHHC----CCCCEEEEEECCEEECCCCC-C--CCCCEEEEEEEEECCCCCCCHHH
Q ss_conf 8868899999839----99851379633758717889-9--99714378699967999511799
Q 000880 851 ELRLPFIRWAISN----QKSSFKRYEISSVYRRAIGH-S--PPNRYLQGDFDIIGGASALTEAE 907 (1239)
Q Consensus 851 D~T~~iaR~v~~~----~~~p~r~~y~g~VfR~e~~~-~--~~~ef~Q~GvEiiG~~s~~aDaE 907 (1239)
.-.++++.++... +..|+|+|+++++||+|... + ++++|.|.+++.+......++.|
T Consensus 107 t~e~~~~~~~~~~~~s~~~LPlr~~~~~~~fR~E~~~~g~~r~r~~~~~~~~~~~~~~~~~~~~ 170 (272)
T d1hc7a2 107 TSETVIGYMWSKWIRSWRDLPQLLNQWGNVVRWEMRTRPFLRTSEFLWQEGHTAHATREEAEEE 170 (272)
T ss_dssp CSHHHHHHHHHHHCCBGGGCCEEEEEEEEEECCCSSCBTTTBCSEEEEEEEEEEESSHHHHHHH
T ss_pred CCCCCEEEHHHCEECCCCCCCEEEEECCCCCCCCCCCCCCCCEEEEEEEHHHHHHCCCCCCHHH
T ss_conf 5444035201032055321112565213322566421220014899998245331001010367
|
| >d1nj1a3 d.104.1.1 (A:19-283) Prolyl-tRNA synthetase (ProRS) {Arhaeon (Methanothermobacter thermautotrophicus) [TaxId: 145262]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Prolyl-tRNA synthetase (ProRS) species: Arhaeon (Methanothermobacter thermautotrophicus) [TaxId: 145262]
Probab=99.40 E-value=1.5e-12 Score=94.42 Aligned_cols=142 Identities=6% Similarity=0.024 Sum_probs=101.6
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECCCC---CCCCCCCEEEEE----CCCCCEEEE
Q ss_conf 4688886422331346677789889999999809940355520----01578---743344278983----169972510
Q 000880 780 LNRDNTSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGD---CPQFKRNTVKLL----THGGDLLEL 848 (1239)
Q Consensus 780 ~n~~~~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~~~---~~~~~~~~~~~~----D~~g~~l~L 848 (1239)
...+.+|+..|+|..+.+++.|++.++... ..||++|.||.+ .+... ++....+||++. |+.++.++|
T Consensus 18 ~~~~~~G~~~~lP~G~~i~~~i~~~~~~~~-~~G~~ev~~P~l~~~~~l~~~sgh~~~~~~e~f~~~~~~~~~~~~~~~L 96 (265)
T d1nj1a3 18 QRYPVKGMHVWMPHGFMIRKNTLKILRRIL-DRDHEEVLFPLLVPEDELAKEAIHVKGFEDEVYWVTHGGLSKLQRKLAL 96 (265)
T ss_dssp CCCSSTTCCEECHHHHHHHHHHHHHHHHHH-TTTCEECCCCSEEEHHHHTTSHHHHHHTTTTCCEEEEETTEEEEEEEEE
T ss_pred CCCCCCCEEEECCCHHHHHHHHHHHHHHHH-HHCCCEEHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCCCCEEEEE
T ss_conf 478998429985109999999999999999-8168222245531056665302565664655102421675554105875
Q ss_pred CCCCCHHHHHHHHH----CCCCCEEEEEECCEEECCCC-CC---CCCCEEEEEEEEE-CCCCCCCHHH---HHHHHHHHH
Q ss_conf 47886889999983----99985137963375871788-99---9971437869996-7999511799---999999999
Q 000880 849 SHELRLPFIRWAIS----NQKSSFKRYEISSVYRRAIG-HS---PPNRYLQGDFDII-GGASALTEAE---VLKVTMDIV 916 (1239)
Q Consensus 849 RpD~T~~iaR~v~~----~~~~p~r~~y~g~VfR~e~~-~~---~~~ef~Q~GvEii-G~~s~~aDaE---ii~l~~~~l 916 (1239)
||.-.++++.++.. ++..|+|+|++|++||+|.. .. |.+||+|+....+ ......++.| ++....+++
T Consensus 97 ~pt~~~~~~~~~~~~~~SyrdLPlr~~q~~~~fR~E~~~~~Gl~R~reF~~~~d~~~~~~~~~~~~~e~~~~~~~~~~~~ 176 (265)
T d1nj1a3 97 RPTSETVMYPMFALWVRSHTDLPMRFYQVVNTFRYETKHTRPLIRVREITTFKEAHTIHATASEAEEQVERAVEIYKEFF 176 (265)
T ss_dssp CSSSHHHHHHHHHHHCCBTTTCCEEEEEEEEEECCCCSCCBTTTBCSEEEEEEEEEEEESSHHHHHHHHHHHHHHHHHHH
T ss_pred ECCCCCCEEEEEEEEECCCCCCCEEEEEECCCEEEECCCCCCCEEEEEEEEECCCEEECCCHHHHHHHHHHHHHHHHHHH
T ss_conf 21356535776410542444433588753011213536575777899999843350651777888887656689999999
Q ss_pred HHCCCC
Q ss_conf 963999
Q 000880 917 TRFFHA 922 (1239)
Q Consensus 917 ~~Lgi~ 922 (1239)
..+++.
T Consensus 177 ~~l~l~ 182 (265)
T d1nj1a3 177 NSLGIP 182 (265)
T ss_dssp HHHTCC
T ss_pred HHCCCC
T ss_conf 643975
|
| >d1nj1a1 c.51.1.1 (A:284-410) Prolyl-tRNA synthetase (ProRS) domain {Arhaeon (Methanothermobacter thermautotrophicus) [TaxId: 145262]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Prolyl-tRNA synthetase (ProRS) domain species: Arhaeon (Methanothermobacter thermautotrophicus) [TaxId: 145262]
Probab=99.37 E-value=1.4e-12 Score=94.62 Aligned_cols=104 Identities=12% Similarity=0.057 Sum_probs=90.2
Q ss_pred CCCCCCCCEEEEEECCC----CCCHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEE
Q ss_conf 87777873599996389----76099999999999983991899507999989999999948996999984773357708
Q 000880 1127 PVRNEAGTSVLVCSRGG----GGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLV 1202 (1239)
Q Consensus 1127 ~~~~~~~~~vlv~~~~~----~~~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i 1202 (1239)
++...+|.+|.|++++. ++....|.+++..|++.|++|.++.. +.+++++++.|+..|+||++++|++|+++++|
T Consensus 5 ~P~~iAP~qV~Iipi~~~~~~e~~~~~a~~l~~~L~~~gi~v~~D~r-~~~~g~K~~~a~~~giP~~iiiG~ke~~~~~v 83 (127)
T d1nj1a1 5 LPPDVAAHQVVIVPIIFKKAAEEVMEACRELRSRLEAAGFRVHLDDR-DIRAGRKYYEWEMRGVPLRVEIGPRDLEKGAA 83 (127)
T ss_dssp CCTTTSSCSEEEEECCSSSSHHHHHHHHHHHHHHHHTTTCCEEECCC-SSCHHHHHHHHHHEECSEEEEECHHHHTTTEE
T ss_pred CCCCCCCCEEEEEECCCCCCHHHHHHHHHHHHHHHHHCCCCEEEEEC-CCHHHHHHHHHHHHCCCHHEEECCCCCCCCEE
T ss_conf 78112893699997358886499999999999999865885698751-20277999998763275303553002006779
Q ss_pred EEEECCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 99995678421102578999999999831
Q 000880 1203 KVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1203 ~vk~l~~~~q~~v~~~el~~~l~~~l~~~ 1231 (1239)
+++++.++++..++++++.+++...++..
T Consensus 84 ~l~~r~~~~~~~v~~~~~~~~i~~ll~~i 112 (127)
T d1nj1a1 84 VISRRDTGEKVTADLQGIEETLRELMKDI 112 (127)
T ss_dssp EEEESSSCCEEEEETTTHHHHHHHHHHHH
T ss_pred EEEECCCCCEEEEEHHHHHHHHHHHHHHH
T ss_conf 99984799577864999999999999999
|
| >d1g5ha1 c.51.1.1 (A:343-469) The aaRS-like accessory subunit of mitochondrial polymerase gamma, C-terminal domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: The aaRS-like accessory subunit of mitochondrial polymerase gamma, C-terminal domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.34 E-value=5.1e-12 Score=90.96 Aligned_cols=103 Identities=23% Similarity=0.192 Sum_probs=88.0
Q ss_pred CCCCCCEEEEEECCCC--CCHHHHHHHHHHHHHCCCEEEEEEC--CCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEEEE
Q ss_conf 7778735999963897--6099999999999983991899507--99998999999994899699998477335770899
Q 000880 1129 RNEAGTSVLVCSRGGG--GLLVERMELVAELWEENIKAQFVPV--PDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKV 1204 (1239)
Q Consensus 1129 ~~~~~~~vlv~~~~~~--~~~~~a~~la~~Lr~~G~~v~~~~~--~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i~v 1204 (1239)
+.-+|.+|.|++.+.+ +....|.+++..|++.|++|.+... ...++++++++|++.|+||++++|++|+++|+|++
T Consensus 8 p~lAP~qV~Ii~~~~~~~e~~~~a~~l~~~L~~~gi~v~~~~~D~~~~~lg~k~~~a~~~giP~~iiiG~~e~~~~~V~i 87 (127)
T d1g5ha1 8 PCLAPIKVALDVGKGPTVELRQVCQGLLNELLENGISVWPGYSETVHSSLEQLHSKYDEMSVLFSVLVTETTLENGLIQL 87 (127)
T ss_dssp TTTCSCCEEEEECSSCHHHHHHHHHHHHHHHHHTTCCEEEGGGSCCCSCHHHHHHHHHHTTCSEEEEECHHHHHHCEEEE
T ss_pred CCCCCCEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCEEEEEECCCCCCHHHHHHHHHHHCCCEEEEECCCCCCCCEEEE
T ss_conf 24489469999468898789999999999999842741333412777689999999997099679999587552677999
Q ss_pred EECCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 995678421102578999999999831
Q 000880 1205 RHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1205 k~l~~~~q~~v~~~el~~~l~~~l~~~ 1231 (1239)
|++.+++|..++++++.+++.+.+.+.
T Consensus 88 r~r~t~~q~~i~i~~l~~~l~~~l~~~ 114 (127)
T d1g5ha1 88 RSRDTTMKEMMHISKLRDFLVKYLASA 114 (127)
T ss_dssp EETTTCCEEEEETTSHHHHHHHHHHHH
T ss_pred EECCCCCEEEEEHHHHHHHHHHHHHCC
T ss_conf 998898437888999999999999805
|
| >d1nj8a1 c.51.1.1 (A:268-393) Prolyl-tRNA synthetase (ProRS) domain {Archaeon (Methanocaldococcus jannaschii) [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Prolyl-tRNA synthetase (ProRS) domain species: Archaeon (Methanocaldococcus jannaschii) [TaxId: 2190]
Probab=99.26 E-value=2.2e-11 Score=86.96 Aligned_cols=106 Identities=8% Similarity=0.050 Sum_probs=87.9
Q ss_pred CCCCCCCCCCCEEEEEECCCCC----CHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCC
Q ss_conf 9868777787359999638976----099999999999983991899507999989999999948996999984773357
Q 000880 1124 DFKPVRNEAGTSVLVCSRGGGG----LLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQK 1199 (1239)
Q Consensus 1124 ~~~~~~~~~~~~vlv~~~~~~~----~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~ 1199 (1239)
|..++...+|.++.|++++.+. ....+.++.+.|+ .|++|.++.. +.+++++++.|+..|+||++++|++|+++
T Consensus 2 Glv~P~~lAP~qv~Iipi~~~~~~~~~~~~a~~l~~~L~-~~i~v~~D~~-~~~~g~k~~~a~~~giP~~iiiG~ke~~~ 79 (126)
T d1nj8a1 2 GLILPPIVAPIQVVIVPLIFKGKEDIVMEKAKEIYEKLK-GKFRVHIDDR-DIRPGRKFNDWEIKGVPLRIEVGPKDIEN 79 (126)
T ss_dssp BCCCCTTSCSSSEEEEECCCSSCHHHHHHHHHHHHHHHH-TTSCEEECCS-CSCHHHHHHHHHHTTCSEEEEECHHHHHT
T ss_pred CCCCCHHHCCCEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCEEEEEECC-CCHHHHHHHHHHHHHHHHHHHCCCCHHHC
T ss_conf 788854148845999963688732899999999998726-5305885065-12388999999888777887505100007
Q ss_pred CEEEEEECCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 70899995678421102578999999999831
Q 000880 1200 GLVKVRHLDVKKEKEVQRESLVRFLLDAIASQ 1231 (1239)
Q Consensus 1200 ~~i~vk~l~~~~q~~v~~~el~~~l~~~l~~~ 1231 (1239)
|+|+++++.++++..++++++.+.+.+.++..
T Consensus 80 ~~v~lr~R~~~~~~~v~~~~l~~~i~~~l~~~ 111 (126)
T d1nj8a1 80 KKITLFRRDTMEKFQVDETQLMEVVEKTLNNI 111 (126)
T ss_dssp TEEEEEETTTCCEEEEETTSHHHHHHHHHHHH
T ss_pred CEEEEEECCCCCEEEECHHHHHHHHHHHHHHH
T ss_conf 78999984899557872999999999999999
|
| >d1atia1 c.51.1.1 (A:395-505) Glycyl-tRNA synthetase (GlyRS), C-terminal domain {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Glycyl-tRNA synthetase (GlyRS), C-terminal domain species: Thermus thermophilus [TaxId: 274]
Probab=99.18 E-value=9.8e-11 Score=82.75 Aligned_cols=97 Identities=16% Similarity=0.116 Sum_probs=86.1
Q ss_pred CCCEEEEEECCC--CCCHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCCC---------
Q ss_conf 873599996389--760999999999999839918995079999899999999489969999847733577---------
Q 000880 1132 AGTSVLVCSRGG--GGLLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQKG--------- 1200 (1239)
Q Consensus 1132 ~~~~vlv~~~~~--~~~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~--------- 1200 (1239)
+|.++.|+++.. ++....|.++...|++.|++|.++.. +.++++.++.|+..|+||.+++|++|+++|
T Consensus 3 AP~qv~Iipi~~~~~~~~~~a~~l~~~L~~~gi~v~~Ddr-~~~~G~K~~~~~~~gvP~~iiIG~kel~~g~~~~~~~~n 81 (111)
T d1atia1 3 APIKVAVIPLVKNRPEITEYAKRLKARLLALGLGRVLYED-TGNIGKAYRRHDEVGTPFAVTVDYDTIGQSKDGTTRLKD 81 (111)
T ss_dssp CSCSEEEEESCSSCHHHHHHHHHHHHHHHTTCSSCEEECC-CSCHHHHHHHHHHTTCSEEEEECHHHHTCCTTSCCTTTT
T ss_pred CCCEEEEEECCCCCHHHHHHHHHHHHHHCCCCCEEEEECC-CCCHHHHHHHHHHCCCCEEEEECCHHHHCCCCCCCCCCC
T ss_conf 9867999975689778999999987543245304576469-898879999998719989999973786526343345675
Q ss_pred EEEEEECCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 08999956784211025789999999998
Q 000880 1201 LVKVRHLDVKKEKEVQRESLVRFLLDAIA 1229 (1239)
Q Consensus 1201 ~i~vk~l~~~~q~~v~~~el~~~l~~~l~ 1229 (1239)
+|++|++.++++..++++++.+++++.++
T Consensus 82 tV~ir~Rd~~~~~~v~i~e~~~~l~~~l~ 110 (111)
T d1atia1 82 TVTVRDRDTMEQIRLHVDELEGFLRERLR 110 (111)
T ss_dssp EEEEEETTTCCEEEEEHHHHHHHHHHHHC
T ss_pred EEEEEECCCCCEEEEEHHHHHHHHHHHHC
T ss_conf 69999868882678889999999999708
|
| >d1hc7a1 c.51.1.1 (A:277-403) Prolyl-tRNA synthetase (ProRS) domain {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Prolyl-tRNA synthetase (ProRS) domain species: Thermus thermophilus [TaxId: 274]
Probab=99.17 E-value=3.3e-10 Score=79.35 Aligned_cols=106 Identities=9% Similarity=0.019 Sum_probs=86.6
Q ss_pred CCCCCCCCCCCEEEEEECCCCC----CHHHHHHHHHHHHHCCCEEEEEECCCCCHHHHHHHHHHCCCCEEEEECCCCCCC
Q ss_conf 9868777787359999638976----099999999999983991899507999989999999948996999984773357
Q 000880 1124 DFKPVRNEAGTSVLVCSRGGGG----LLVERMELVAELWEENIKAQFVPVPDPSLTEQYEYASEHDIKCLVILTDTGAQK 1199 (1239)
Q Consensus 1124 ~~~~~~~~~~~~vlv~~~~~~~----~~~~a~~la~~Lr~~G~~v~~~~~~~~~l~k~l~~A~~~g~~~~viig~~e~~~ 1199 (1239)
|..++...+|.+|.|++++.+. ....|.++...|+..|++|.++....+.++++++.|+..|+|+++++|++|+++
T Consensus 2 Gl~~P~~lAP~qv~Iipi~~~~~~~~~~~~a~~i~~~L~~~girv~~Dd~~~~~~g~K~~~a~~~giP~~iiiG~~e~~~ 81 (127)
T d1hc7a1 2 GLVLPPRLAPIQVVIVPIYKDESRERVLEAAQGLRQALLAQGLRVHLDDRDQHTPGYKFHEWELKGVPFRVELGPKDLEG 81 (127)
T ss_dssp BCCCCTTTCSCSEEEEECCCTTTHHHHHHHHHHHHHHHHHTTCCEEECCCSSSCHHHHHHHHHHTTCSEEEEECHHHHHT
T ss_pred CCCCCHHHCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHHCCCEEEEECCCCHHHHHHHHHHHHHCCCEEEEECHHHHCC
T ss_conf 78884203892699998037702679999999999999971980578516520188999999861488067745255507
Q ss_pred CEEEEEECCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 7089999567842110257899999999983
Q 000880 1200 GLVKVRHLDVKKEKEVQRESLVRFLLDAIAS 1230 (1239)
Q Consensus 1200 ~~i~vk~l~~~~q~~v~~~el~~~l~~~l~~ 1230 (1239)
++|+++.+. +++..++++++.+.+...++.
T Consensus 82 ~~v~v~~R~-~~k~~i~~~~~~~~i~~~l~~ 111 (127)
T d1hc7a1 82 GQAVLASRL-GGKETLPLAALPEALPGKLDA 111 (127)
T ss_dssp TEEEEEETT-SCCCEEEGGGHHHHHHHHHHH
T ss_pred CEEEEEECC-CCCCEEEHHHHHHHHHHHHHH
T ss_conf 669999515-777435099999999999999
|
| >d1b8aa2 d.104.1.1 (A:104-438) Aspartyl-tRNA synthetase (AspRS) {Archaeon Pyrococcus kodakaraensis [TaxId: 311400]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Aspartyl-tRNA synthetase (AspRS) species: Archaeon Pyrococcus kodakaraensis [TaxId: 311400]
Probab=98.94 E-value=8.8e-08 Score=63.85 Aligned_cols=102 Identities=11% Similarity=0.012 Sum_probs=71.0
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCEECCCCCCCCCCCEEEEECCCCCEEEECCCCCHHHHHHHHHCCCCCEEEEE
Q ss_conf 34667778988999999980994035552001578743344278983169972510478868899999839998513796
Q 000880 793 LDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYE 872 (1239)
Q Consensus 793 ~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l~~~~~~~~~~~~~~~~~D~~g~~l~LRpD~T~~iaR~v~~~~~~p~r~~y 872 (1239)
.-.+.|..+.+.+++.|...||-||+||++....... ..+.|.+.. .++.+-||-.-....-|.++. .--|+|+
T Consensus 32 ~~l~~Rs~i~~~iR~ff~~~gflEV~TPil~~~~~~~--~~~~f~~~~-~~~~~yL~~SpE~~lkrll~~---g~~~if~ 105 (335)
T d1b8aa2 32 AIFKIRSSVFKAVRDFFHENGFIEIHTPKIIATATEG--GTELFPMKY-FEEDAFLAESPQLYKEIMMAS---GLDRVYE 105 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCEECCCCSEESCCCSS--SSSCCEEEE-TTEEEEECSCSHHHHHHGGGT---TCCEEEE
T ss_pred HHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCH--HHHHCCCCC-CCCCCCCCCCHHHHHHHHHHH---HHHHHHH
T ss_conf 9999999999999999998899998798657657721--332012112-234421236857877777764---0666878
Q ss_pred ECCEEECCCCCCC-CC-CEEEEEEEEECCC
Q ss_conf 3375871788999-97-1437869996799
Q 000880 873 ISSVYRRAIGHSP-PN-RYLQGDFDIIGGA 900 (1239)
Q Consensus 873 ~g~VfR~e~~~~~-~~-ef~Q~GvEiiG~~ 900 (1239)
+|++||+|..... .. ||+|...+.-...
T Consensus 106 i~~~FR~e~~~~~rh~~Ef~~le~~~~~~~ 135 (335)
T d1b8aa2 106 IAPIFRAEEHNTTRHLNEAWSIDSEMAFIE 135 (335)
T ss_dssp EEEEECCCSSCCSSCCSEEEEEEEEEESCS
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 330235222454310258876667888887
|
| >d1seta2 d.104.1.1 (A:111-421) Seryl-tRNA synthetase (SerRS) {Thermus thermophilus, strain hb27 [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Seryl-tRNA synthetase (SerRS) species: Thermus thermophilus, strain hb27 [TaxId: 274]
Probab=98.63 E-value=3.3e-07 Score=60.13 Aligned_cols=139 Identities=9% Similarity=0.124 Sum_probs=101.6
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECC--CCCCCCCCCEEEEECCCCCEEEECCCCCHHHHH
Q ss_conf 86422331346677789889999999809940355520----015--787433442789831699725104788688999
Q 000880 785 TSSIQYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLL--GDCPQFKRNTVKLLTHGGDLLELSHELRLPFIR 858 (1239)
Q Consensus 785 ~G~~D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~--~~~~~~~~~~~~~~D~~g~~l~LRpD~T~~iaR 858 (1239)
.+..-+.+..+.+.+.+.+...+...+.||++|.||.+ .+. +..+....++|+.. ++.+.|+|---++++-
T Consensus 46 ~rfy~l~g~~a~Le~AL~~~~ld~~~~~gy~~v~~P~lv~~~~~~~~G~~p~f~~~~y~~~---~~~~~LipTsE~~l~~ 122 (311)
T d1seta2 46 SRSYALKGDLALYELALLRFAMDFMARRGFLPMTLPSYAREKAFLGTGHFPAYRDQVWAIA---ETDLYLTGTAEVVLNA 122 (311)
T ss_dssp SSCCCEEHHHHHHHHHHHHHHHHHHHHTTCEEEECCSEEEHHHHHHHTCTTTTGGGSCBBT---TSSEEECSSTHHHHHH
T ss_pred CCEEEEECHHHHHHHHHHHHHHHHHHCCCCEEEEECHHHCCCHHHHCCCCCCCCCCCCCCC---CCCEEECCCCCCHHHH
T ss_conf 7537997889999999999998763103434886301111101432035300122110013---3200203655204555
Q ss_pred HHHHC----CCCCEEEEEECCEEECCCCC------C--CCCCEEEEEEEEECCCCC-CCHH---HHHHHHHHHHHHCCCC
Q ss_conf 99839----99851379633758717889------9--997143786999679995-1179---9999999999963999
Q 000880 859 WAISN----QKSSFKRYEISSVYRRAIGH------S--PPNRYLQGDFDIIGGASA-LTEA---EVLKVTMDIVTRFFHA 922 (1239)
Q Consensus 859 ~v~~~----~~~p~r~~y~g~VfR~e~~~------~--~~~ef~Q~GvEiiG~~s~-~aDa---Eii~l~~~~l~~Lgi~ 922 (1239)
+.... ...|+|++..+++||+|... + |.++|..+...++...++ .++. +++..+.++++.|++.
T Consensus 123 ~~~~~i~~~~~LPlr~~~~s~cfR~Eag~~g~~trGL~RvhQF~kvE~~~~~~~~~e~s~~~~~~~~~~~~~~~~~L~lp 202 (311)
T d1seta2 123 LHSGEILPYEALPLRYAGYAPAFRSEAGSFGKDVRGLMRVHQFHKVEQYVLTEASLEASDRAFQELLENAEEILRLLELP 202 (311)
T ss_dssp TTTTCEEEGGGCSEEEEEEEEEECCCCSCTTSSCSTTSSCSEEEEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHCCCEEEEECCCCHHHHCCCCCCCHHHHHHCCCCHHHHHEEECCCCCCCHHHHHHHHHHHHHHHHHHCCC
T ss_conf 56565332320450577633531132113454312000100332312201202443110238999999999987761786
Q ss_pred CCEEEE
Q ss_conf 832999
Q 000880 923 ESCDIH 928 (1239)
Q Consensus 923 ~~~~i~ 928 (1239)
+.+.
T Consensus 203 --yrvv 206 (311)
T d1seta2 203 --YRLV 206 (311)
T ss_dssp --EEEE
T ss_pred --CHHC
T ss_conf --0010
|
| >d1g5ha2 d.104.1.1 (A:41-330) The aaRS-like accessory subunit of mitochondrial polymerase gamma, N-terminal domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: The aaRS-like accessory subunit of mitochondrial polymerase gamma, N-terminal domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.53 E-value=1.2e-07 Score=62.93 Aligned_cols=135 Identities=10% Similarity=0.018 Sum_probs=85.1
Q ss_pred CCCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCE----ECCCCCCCCCCCEEEEE--------------------
Q ss_conf 8642-2331346677789889999999809940355520----01578743344278983--------------------
Q 000880 785 TSSI-QYSDLDTELRDYVVQVTKEMFRQHCAKHLEIEPM----YLLGDCPQFKRNTVKLL-------------------- 839 (1239)
Q Consensus 785 ~G~~-D~lp~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l----~~~~~~~~~~~~~~~~~-------------------- 839 (1239)
.|.. ||.|..+.+++.|.+.+++.|.. .+..|.+|-. .+...+... -|+..
T Consensus 27 ~g~~~dyGP~G~~Lk~ni~~~w~~~~v~-~~~~v~~~d~~~~~~~~~sgh~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (290)
T d1g5ha2 27 SGCHARFGPLGVELRKNLASQWWSSMVV-FREQVFAVDSLHQEPGSSQPRDS---AFRLVSPESIREILQDREPSKEQLV 102 (290)
T ss_dssp HCCSCCBCHHHHHHHHHHHHHHHHHHTT-TCTTEEECCCCSEECCCCSSCCC---CCEEECHHHHHHHHCC---CHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHH-CCCCEEECCCCCCCCCCCCCCCC---HHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf 3465302886799999999999999873-36855621312556677763334---2330013441002356640355442
Q ss_pred ----CCCCCEEEECCCCCHH----HHHHH-HHCCCCCEEEEEECCEEECCCCC-----C--CCCCEEEEEEEEECCCCCC
Q ss_conf ----1699725104788688----99999-83999851379633758717889-----9--9971437869996799951
Q 000880 840 ----THGGDLLELSHELRLP----FIRWA-ISNQKSSFKRYEISSVYRRAIGH-----S--PPNRYLQGDFDIIGGASAL 903 (1239)
Q Consensus 840 ----D~~g~~l~LRpD~T~~----iaR~v-~~~~~~p~r~~y~g~VfR~e~~~-----~--~~~ef~Q~GvEiiG~~s~~ 903 (1239)
.-++....|||+.... +.+.. .++...|++++++|++||+|... + |.+||.|+.+++|+.++..
T Consensus 103 ~~~~~~~~~~~yLRPetaqg~~~~fkn~~~~~~~~LPf~iaq~g~~fR~E~~~~~~~~gl~RvReF~q~E~~~F~~pe~~ 182 (290)
T d1g5ha2 103 AFLENLLKTSGKLRATLLHGALEHYVNCLDLVNRKLPFGLAQIGVCFHPVSNSNQTPSSVTRVGEKTEASLVWFTPTRTS 182 (290)
T ss_dssp HHHHHHHHHSCEECSCSHHHHHHTHHHHHHHTTTBSCEEEEEEEEEEEEEC---------CEEEEEEEEEEEEEECHHHH
T ss_pred CCEECCCCCCCEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCEEEEEEEEEEEEEECCCCH
T ss_conf 41201266444106656626899989887632478993799864433455556776413303247684135789677506
Q ss_pred C--HHHHHHHHHHHHHHCCCCC
Q ss_conf 1--7999999999999639998
Q 000880 904 T--EAEVLKVTMDIVTRFFHAE 923 (1239)
Q Consensus 904 a--DaEii~l~~~~l~~Lgi~~ 923 (1239)
. -...+..+.+.++.||+..
T Consensus 183 ~~~~~~~~~~~~~~~~~lGi~~ 204 (290)
T d1g5ha2 183 SQWLDFWLRHRLLWWRKFAMSP 204 (290)
T ss_dssp HHHHHHHHHHHHHHHHTTCSSG
T ss_pred HHHHHHHHHHHHHHHHHCCCCH
T ss_conf 7899999999999999739886
|
| >d1c0aa3 d.104.1.1 (A:107-287,A:421-585) Aspartyl-tRNA synthetase (AspRS) {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Aspartyl-tRNA synthetase (AspRS) species: Escherichia coli [TaxId: 562]
Probab=98.38 E-value=5.8e-06 Score=52.19 Aligned_cols=102 Identities=14% Similarity=0.104 Sum_probs=71.1
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCEECCCCCCCCCCCEEEE-ECCCCCEEEECCCCCHHHHHHHHHCCCCCEEEEE
Q ss_conf 466777898899999998099403555200157874334427898-3169972510478868899999839998513796
Q 000880 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRYE 872 (1239)
Q Consensus 794 e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l~~~~~~~~~~~~~~~~-~D~~g~~l~LRpD~T~~iaR~v~~~~~~p~r~~y 872 (1239)
-.+++..+.+.+++.|...||-+|+||++.-... +.. ...+.. .+..|+..-|+---....-|.++. .--|.|+
T Consensus 31 ilr~Rs~i~~~iR~ff~~~gFlEV~TPiL~~~~~-~g~-~~~~~~~~~~~~~~~~L~~Spel~lk~ll~~---g~~~Vf~ 105 (346)
T d1c0aa3 31 RLKTRAKITSLVRRFMDDHGFLDIETPMLTKATP-EGA-RDYLVPSRVHKGKFYALPQSPQLFKQLLMMS---GFDRYYQ 105 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCEECCCCSSBCCCS-SSS-CCCEEECSSSTTCEEECCSCSHHHHHHHHHT---TCCEEEE
T ss_pred HHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHC---CCCCEEE
T ss_conf 9999999999999999988989987985477787-645-4442121137996306771879999998634---8885489
Q ss_pred ECCEEECCCCCCCCC-CEEEEEEEEECCC
Q ss_conf 337587178899997-1437869996799
Q 000880 873 ISSVYRRAIGHSPPN-RYLQGDFDIIGGA 900 (1239)
Q Consensus 873 ~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~ 900 (1239)
+|++||.+....++. ||+++++|.-+.+
T Consensus 106 i~~~FR~E~~~~~H~~EFtmLE~e~a~~~ 134 (346)
T d1c0aa3 106 IVKCFRDEDLRADRQPEFTQIDVETSFMT 134 (346)
T ss_dssp EEEEECCCCCBTTBCSEEEEEEEEEESCC
T ss_pred EEEECCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 71240212368613567656313434553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.28 E-value=6.9e-06 Score=51.72 Aligned_cols=63 Identities=22% Similarity=0.210 Sum_probs=40.4
Q ss_pred EEEECCCCCEEEEEEEECCCCCEEEEEEEECC----CC-CCHHHHHHHHHHHHHHHCC-C--CCEEEEEEE
Q ss_conf 75332589668999999169949999997338----99-9036899999999999269-9--862446314
Q 000880 429 LQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLK----DK-SLPVNDRILREVATLSRLQ-H--QHVVRYYQA 491 (1239)
Q Consensus 429 ~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~----~~-~~~~~~~~~~Ev~iL~~L~-H--pnIv~l~~~ 491 (1239)
.+.||.|....||++....+++.+++|.-... .. ......+...|...|+.+. + ..+++++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.28 E-value=6.2e-06 Score=51.98 Aligned_cols=140 Identities=14% Similarity=0.089 Sum_probs=82.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCCCCC
Q ss_conf 68923875332589668999999169949999997338999036899999999999269-98624463144204754568
Q 000880 423 LNDFEELQPLGHGGFGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQ-HQHVVRYYQAWFETGVADFD 501 (1239)
Q Consensus 423 ~~~y~~~~~LG~G~fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~-HpnIv~l~~~~~~~~~~~~~ 501 (1239)
+..|+..+..+-++...||+... ++..+++|........ ....+.+|...+..+. +--+.+++....
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-------- 80 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFER-------- 80 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEE--------
T ss_pred HHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCC--CHHHHHHHHHHHHHHHCCCCCCCEEEEEE--------
T ss_conf 13527997678998771899990--8986999984887653--25569999999998760699872899975--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCC-CHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 9886788854454443334665432355455554279999412688-788998723999999999999999999999771
Q 000880 502 GDSMWGSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQVFESYDHFDKELAWHLFRQIVEGLAHIHG 580 (1239)
Q Consensus 502 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~g-sL~~~l~~~~~l~~~~~~~i~~qIl~aL~yLHs 580 (1239)
.....|+||++.+| .+....... .. ...++.+++..++.||+
T Consensus 81 --------------------------------~~~~~~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~ 123 (263)
T d1j7la_ 81 --------------------------------HDGWSNLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHS 123 (263)
T ss_dssp --------------------------------ETTEEEEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHT
T ss_pred --------------------------------CCCCEEEEEEECCCCCCCCCCCCC--CC---HHHHHHHHHHHHHHHHC
T ss_conf --------------------------------089649999860433435433440--26---99999989999999855
Q ss_pred -----------------------------------------------------------CCCCCCCCCCCCEEECCCCCE
Q ss_conf -----------------------------------------------------------993125897660898689988
Q 000880 581 -----------------------------------------------------------QGIIHRDLTPNNIFFDARNDI 601 (1239)
Q Consensus 581 -----------------------------------------------------------~gIiHrDLKp~NILi~~~~~v 601 (1239)
..++|+|+.|.|||++.++.+
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~ 203 (263)
T d1j7la_ 124 IDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVS 203 (263)
T ss_dssp SCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEE
T ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEE
T ss_conf 68421435764465655577899877655554303323200579999999984498678178986004764236499659
Q ss_pred EEEECCCCHH
Q ss_conf 9911472010
Q 000880 602 KIGDFGLAKF 611 (1239)
Q Consensus 602 KL~DFGlA~~ 611 (1239)
-|.||+.+..
T Consensus 204 ~lIDwe~a~~ 213 (263)
T d1j7la_ 204 GFIDLGRSGR 213 (263)
T ss_dssp EECCCTTCEE
T ss_pred EEEECHHCCC
T ss_conf 9960231441
|
| >d1l0wa3 d.104.1.1 (A:105-294,A:415-580) Aspartyl-tRNA synthetase (AspRS) {Thermus thermophilus, AspRS-1 [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Aspartyl-tRNA synthetase (AspRS) species: Thermus thermophilus, AspRS-1 [TaxId: 274]
Probab=98.23 E-value=3.4e-05 Score=47.27 Aligned_cols=103 Identities=12% Similarity=0.070 Sum_probs=70.8
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCEECCCCCCCCCCCEEEE-ECCCCCEEEECCCCCHHHHHHHHHCCCCCEEEE
Q ss_conf 3466777898899999998099403555200157874334427898-316997251047886889999983999851379
Q 000880 793 LDTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKL-LTHGGDLLELSHELRLPFIRWAISNQKSSFKRY 871 (1239)
Q Consensus 793 ~e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l~~~~~~~~~~~~~~~~-~D~~g~~l~LRpD~T~~iaR~v~~~~~~p~r~~ 871 (1239)
.-.++|..+.+.+++.|...||-+|+||++.-... +.. ...+.. .+..|...-|+----...-|.++. .--|.|
T Consensus 38 ~ilr~Rs~i~~~iR~ff~~~gfiEV~TP~L~~~~~-eg~-~~~~~~~~~~~~~~~yL~~Spel~lk~ll~~---g~~~Vf 112 (356)
T d1l0wa3 38 ENLRLRHRVIKAIWDFLDREGFVQVETPFLTKSTP-EGA-RDFLVPYRHEPGLFYALPQSPQLFKQMLMVA---GLDRYF 112 (356)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCEECCCCSSBCCCS-SSS-CCCEEECTTSTTEEEECCSCSHHHHHHHHHT---TCSEEE
T ss_pred HHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCC-CCC-CCCHHHHHCCCCCCCCCCCCHHHHHHHHHHC---CCCCEE
T ss_conf 99999999999999999888989998981246777-644-3200222113201117772856777775232---368679
Q ss_pred EECCEEECCCCCCCCC-CEEEEEEEEECCC
Q ss_conf 6337587178899997-1437869996799
Q 000880 872 EISSVYRRAIGHSPPN-RYLQGDFDIIGGA 900 (1239)
Q Consensus 872 y~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~ 900 (1239)
++|++||.|....++. ||+++.+|..+.+
T Consensus 113 ~i~~~FRaE~~~t~H~~EFtmLE~e~~~~~ 142 (356)
T d1l0wa3 113 QIARCFRDEDLRADRQPDFTQLDLEMSFVE 142 (356)
T ss_dssp EEEEEECCCCCCSSCCSEEEEEEEEEESCC
T ss_pred EEECCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 982123522268754045668877666788
|
| >d1e1oa2 d.104.1.1 (A:161-502) Lysyl-tRNA synthetase (LysRS) {Escherichia coli, gene lysU [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Lysyl-tRNA synthetase (LysRS) species: Escherichia coli, gene lysU [TaxId: 562]
Probab=98.18 E-value=2.9e-05 Score=47.74 Aligned_cols=102 Identities=10% Similarity=0.031 Sum_probs=67.4
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCEECCCCCCCCCCCEEEEE-CCCCCEEEECCCCCHHHHHHHHHCCCCCEEEEE
Q ss_conf 4667778988999999980994035552001578743344278983-169972510478868899999839998513796
Q 000880 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLL-THGGDLLELSHELRLPFIRWAISNQKSSFKRYE 872 (1239)
Q Consensus 794 e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l~~~~~~~~~~~~~~~~~-D~~g~~l~LRpD~T~~iaR~v~~~~~~p~r~~y 872 (1239)
..++|..+.+.+++.|...||-+|+||++.....+.. .+.|.+. +..+...-|.----...-+.++. .--|+|+
T Consensus 22 ~~r~Rs~i~~~iR~ff~~~gFiEV~TPil~~~~~~~~--~~~f~~~~~~~~~~~yL~~Spql~~k~~l~~---g~~~vf~ 96 (342)
T d1e1oa2 22 TFVVRSKILAAIRQFMVARGFMEVETPMMQVIPGGAS--ARPFITHHNALDLDMYLRIAPELYLKRLVVG---GFERVFE 96 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCEECCCCSEESSCCSSC--CCCCEEEETTTTEEEEECSCSHHHHHHHHHH---TCCEEEE
T ss_pred HHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCC--CCCEEECCCCCCCCCCCCHHHHHHHHHHHHH---CCCCEEE
T ss_conf 9999999999999999888899998987643279878--8642314667775120023267998987662---2462134
Q ss_pred ECCEEECCCCCCCCC-CEEEEEEEEECCC
Q ss_conf 337587178899997-1437869996799
Q 000880 873 ISSVYRRAIGHSPPN-RYLQGDFDIIGGA 900 (1239)
Q Consensus 873 ~g~VfR~e~~~~~~~-ef~Q~GvEiiG~~ 900 (1239)
+|++||.|....+.. ||+|+++|.-+.+
T Consensus 97 i~p~FR~E~~~~rHl~EFtmlE~e~a~~~ 125 (342)
T d1e1oa2 97 INRNFRNEGISVRHNPEFTMMELYMAYAD 125 (342)
T ss_dssp EEEEECCCCCCC-CCSEEEEEEEEEESCC
T ss_pred ECCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 20002455431111078887889987511
|
| >d1eova2 d.104.1.1 (A:205-557) Aspartyl-tRNA synthetase (AspRS) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Aspartyl-tRNA synthetase (AspRS) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.15 E-value=4.4e-05 Score=46.56 Aligned_cols=103 Identities=10% Similarity=0.071 Sum_probs=68.6
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCEECCCCCCCCCCCEEEEECCCCCEEEECCCCCHHHHHHHHHCCCCCEEEEEE
Q ss_conf 46677789889999999809940355520015787433442789831699725104788688999998399985137963
Q 000880 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEI 873 (1239)
Q Consensus 794 e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l~~~~~~~~~~~~~~~~~D~~g~~l~LRpD~T~~iaR~v~~~~~~p~r~~y~ 873 (1239)
-.+.|..|.+.+++.|.+.||-+|+||++.-...++ ..+.|...-.++ ..-||----...-|.++.. --|.|++
T Consensus 43 ilr~Rs~i~~~iR~ff~~~gflEV~TPiL~~~~~eg--~~~~f~~~~~~~-~~yL~~Spel~lk~ll~~g---~~~vf~I 116 (353)
T d1eova2 43 IFRIQAGVCELFREYLATKKFTEVHTPKLLGAPSEG--GSSVFEVTYFKG-KAYLAQSPQFNKQQLIVAD---FERVYEI 116 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCEECCCCSEESSCSSS--SSCCCEEEETTE-EEEECSCTHHHHHHHHHTT---CCEEEEE
T ss_pred HHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCC--HHCCCCCEEECC-CCEECCCHHHHHHHHHHCC---CCCCEEE
T ss_conf 999999999999999988899998897317778850--104541210077-5022132113456665316---5663353
Q ss_pred CCEEECCCCCCC-CC-CEEEEEEEEECCCCC
Q ss_conf 375871788999-97-143786999679995
Q 000880 874 SSVYRRAIGHSP-PN-RYLQGDFDIIGGASA 902 (1239)
Q Consensus 874 g~VfR~e~~~~~-~~-ef~Q~GvEiiG~~s~ 902 (1239)
|++||+|..... .. ||+|+.+|.-+.+..
T Consensus 117 ~~~FR~E~~~~~rH~pEFtmLE~y~a~~d~~ 147 (353)
T d1eova2 117 GPVFRAENSNTHRHMTEFTGLDMEMAFEEHY 147 (353)
T ss_dssp EEEECCCCCCCTTCCSEEEEEEEEEECSSCT
T ss_pred CHHHHCCCCCCCCCCCHHCCCCCCCCCCHHH
T ss_conf 0332303221211450102443011211466
|
| >d1atia2 d.104.1.1 (A:1-394) Glycyl-tRNA synthetase (GlyRS) {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Glycyl-tRNA synthetase (GlyRS) species: Thermus thermophilus [TaxId: 274]
Probab=98.12 E-value=1.5e-05 Score=49.57 Aligned_cols=91 Identities=13% Similarity=0.007 Sum_probs=57.7
Q ss_pred CCCEEEEEC-CCC---CEEEECCCCCH----HHHHHHHH-CCCCCEEEEEECCEEECCC-CC---CCCCCEEEEEEEEEC
Q ss_conf 442789831-699---72510478868----89999983-9998513796337587178-89---999714378699967
Q 000880 832 KRNTVKLLT-HGG---DLLELSHELRL----PFIRWAIS-NQKSSFKRYEISSVYRRAI-GH---SPPNRYLQGDFDIIG 898 (1239)
Q Consensus 832 ~~~~~~~~D-~~g---~~l~LRpD~T~----~iaR~v~~-~~~~p~r~~y~g~VfR~e~-~~---~~~~ef~Q~GvEiiG 898 (1239)
-+.||+..- ..+ ...-|||+..- .+.+.+-. +...|+-..++|+.||+|. |+ -|.|||.|+-+|.|.
T Consensus 165 FNLMF~T~iGp~~~~~~~~yLRPETAQGiFvnF~~~l~~~r~KlPFGiAQIGk~FRNEIsPr~~l~R~REF~q~EiE~Fv 244 (394)
T d1atia2 165 FNMMFQDLRGPRGGRGLLAYLRPETAQGIFVNFKNVLDATSRKLGFGIAQIGKAFRNEITPRNFIFRVREFEQMEIEYFV 244 (394)
T ss_dssp EECBEEEECSSCCCGGGEEEECSSSHHHHHHTHHHHHHHHTCCSSEEEEEEEEEEBCCSSCCTGGGSCSEEEEEEEEEEE
T ss_pred HHHHCCCCCCCCCCCCCEEEECHHHHHHHHHHHHHHHHHCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEEEEEEE
T ss_conf 21000123233456563367770130699997999999715678801124322114663765577563322120268998
Q ss_pred CCCCCCHH--HHHHHHHHHHHHCCCC
Q ss_conf 99951179--9999999999963999
Q 000880 899 GASALTEA--EVLKVTMDIVTRFFHA 922 (1239)
Q Consensus 899 ~~s~~aDa--Eii~l~~~~l~~Lgi~ 922 (1239)
.++-..+. .-+......+..+|+.
T Consensus 245 ~P~~~~~~~~yw~~~~~~f~~~lGi~ 270 (394)
T d1atia2 245 RPGEDEYWHRYWVEERLKWWQEMGLS 270 (394)
T ss_dssp CGGGHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ECCCCHHHHHHHHHHHHHHHHHHCCC
T ss_conf 17851577888999999999983688
|
| >d1nnha_ d.104.1.1 (A:) Hypothetical protein PF1951 {Archaeon Pyrococcus furiosus [TaxId: 2261]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Hypothetical protein PF1951 species: Archaeon Pyrococcus furiosus [TaxId: 2261]
Probab=98.02 E-value=7e-05 Score=45.26 Aligned_cols=117 Identities=12% Similarity=0.072 Sum_probs=74.0
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCEE--CCCC-CC--CCCCCEEEEECCCCCEEEECCCCCHHHHHHHHHCCCCCE
Q ss_conf 466777898899999998099403555200--1578-74--334427898316997251047886889999983999851
Q 000880 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPMY--LLGD-CP--QFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSF 868 (1239)
Q Consensus 794 e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l~--~~~~-~~--~~~~~~~~~~D~~g~~l~LRpD~T~~iaR~v~~~~~~p~ 868 (1239)
-.+.|..+.+.+++.|...||.+|+||++. ..+. .. ...-..++. +..|+.+-|+.---...-|.++.. --
T Consensus 13 il~~Rs~i~~~iR~ff~~~gf~EV~tPil~~~~~~~~~~~~~~~~~~~~~-~~~~~~~yL~~SPel~lk~lla~g---~~ 88 (293)
T d1nnha_ 13 TLDIQTKILEYMTDFFVKEGFKWLLPVIISPITDPLWPDPAGEGMEPAEV-EIYGVKMRLTHSMILHKQLAIAMG---LK 88 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCEEECCCCEESCCCCCCSCTTCCCCCCCEE-EETTEEEEECSCSHHHHHHHHHTT---CC
T ss_pred HHHHHHHHHHHHHHHHHHCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCEEECCCCHHHHHHHHHHHC---CC
T ss_conf 99999999999999999889999758734566777777655676646535-678965644668636479999722---33
Q ss_pred EEEEECCEEECCCCC--CCCC--CEEEEEEEEECCCCCCCHHHHHHHHHHHHHH
Q ss_conf 379633758717889--9997--1437869996799951179999999999996
Q 000880 869 KRYEISSVYRRAIGH--SPPN--RYLQGDFDIIGGASALTEAEVLKVTMDIVTR 918 (1239)
Q Consensus 869 r~~y~g~VfR~e~~~--~~~~--ef~Q~GvEiiG~~s~~aDaEii~l~~~~l~~ 918 (1239)
|.|++|++||+|... ++|. ||+|+.+|.-+.+ . .+++.++-+.+..
T Consensus 89 ~Vf~I~~~FR~E~~~s~t~RH~~EFtmLE~e~~~~d-~---~d~m~~~e~li~~ 138 (293)
T d1nnha_ 89 KIFVLSPNIRLESRQKDDGRHAYEFTQLDFEVERAK-M---EDIMRLIERLVYG 138 (293)
T ss_dssp EEEEEEEEECCCCGGGCSSSCCSEEEEEEEEEETCC-H---HHHHHHHHHHHHH
T ss_pred CCEEECHHHHCCCCCCCCCCCCHHHHHHCCCCCCCC-H---HHHHHHHHHHHHH
T ss_conf 210310233047556777756156651111233230-7---8899999999999
|
| >d1jjca_ d.104.1.1 (A:) Phenyl-tRNA synthetase (PheRS) alpha subunit, PheS {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Phenyl-tRNA synthetase (PheRS) alpha subunit, PheS species: Thermus thermophilus [TaxId: 274]
Probab=97.96 E-value=0.00018 Score=42.61 Aligned_cols=100 Identities=16% Similarity=0.140 Sum_probs=69.1
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCE---------ECCCCC-CC-CCCCEEEEECCC-----------CCEEEECCCCCHH
Q ss_conf 7789889999999809940355520---------015787-43-344278983169-----------9725104788688
Q 000880 798 RDYVVQVTKEMFRQHCAKHLEIEPM---------YLLGDC-PQ-FKRNTVKLLTHG-----------GDLLELSHELRLP 855 (1239)
Q Consensus 798 ~~~I~~~l~~~f~~~Gy~~I~tP~l---------~~~~~~-~~-~~~~~~~~~D~~-----------g~~l~LRpD~T~~ 855 (1239)
...+.+.+++.|...||++++.|.+ +..... +. ....+|-+.+.. ...+.||.-.|+-
T Consensus 19 l~~~~~~i~~if~~~GF~~~~gp~ies~~~NFDaLn~P~dHPAR~~~DTfYi~~~~~~~~~~~~~~~~~~~lLRTHTS~~ 98 (266)
T d1jjca_ 19 ITLMERELVEIFRALGYQAVEGPEVESEFFNFDALNIPEHHPARDMWDTFWLTGEGFRLEGPLGEEVEGRLLLRTHTSPM 98 (266)
T ss_dssp HHHHHHHHHHHHHTTTCEECCCCSEEEHHHHTGGGTCCTTSGGGGGSCCCBEECSSCCEECTTSCEECSCEEECSSSTHH
T ss_pred HHHHHHHHHHHHHHCCCEEEECCCCCCCHHHHHCCCCCCCCCHHCCCCEEEEECCCCCCCCCCCCCCHHHHHHCCCCCHH
T ss_conf 99999999999987698584088225514423220689312001024469982566445676431100000011477388
Q ss_pred HHHHHHHCCCCCEEEEEECCEEECCCC-CCCCCCEEEEEEEEEC
Q ss_conf 999998399985137963375871788-9999714378699967
Q 000880 856 FIRWAISNQKSSFKRYEISSVYRRAIG-HSPPNRYLQGDFDIIG 898 (1239)
Q Consensus 856 iaR~v~~~~~~p~r~~y~g~VfR~e~~-~~~~~ef~Q~GvEiiG 898 (1239)
-+|.+..+ ..|.|+++.|+|||++.. ....-+|+|++.=+++
T Consensus 99 q~r~~~~~-~~p~~~~~~g~VyRrd~iD~tH~p~FhQ~eg~~vd 141 (266)
T d1jjca_ 99 QVRYMVAH-TPPFRIVVPGRVFRFEQTDATHEAVFHQLEGLVVG 141 (266)
T ss_dssp HHHHHHHS-CSSEEEEEEEEEECCSCCCSSCCSEEEEEEEEEEE
T ss_pred HHHHHHCC-CCCCEEEECCCCEECCCCCCCCCCCCEEEEEEECC
T ss_conf 89998614-99814884032140478887526653021016524
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.84 E-value=8.3e-05 Score=44.77 Aligned_cols=135 Identities=16% Similarity=0.057 Sum_probs=72.6
Q ss_pred EEECCCCC-EEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC--CCEEEEEEEEEECCCCCCCCCCCC
Q ss_conf 53325896-689999991699499999973389990368999999999992699--862446314420475456898867
Q 000880 430 QPLGHGGF-GHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQH--QHVVRYYQAWFETGVADFDGDSMW 506 (1239)
Q Consensus 430 ~~LG~G~f-G~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~H--pnIv~l~~~~~~~~~~~~~~~~~~ 506 (1239)
+.+..|.. ..||+.... ++..+++|....... ..+..|...++.+.. -.+.+++.+..+
T Consensus 16 ~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~------------ 77 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE------------ 77 (255)
T ss_dssp EECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC------------
T ss_pred EECCCCCCCCEEEEEEEC-CCCEEEEEECCCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEECCC------------
T ss_conf 876786547758999938-987899995896677-----68999999999998659998861322245------------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEECCCC-CHHH-------H-------HHHCC-------CCC--HH
Q ss_conf 88854454443334665432355455554279999412688-7889-------9-------87239-------999--99
Q 000880 507 GSGTLASSTFSNRAASSADVTGQENKLESTYLYIQMEYCPR-TLRQ-------V-------FESYD-------HFD--KE 562 (1239)
Q Consensus 507 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~iVmEy~~g-sL~~-------~-------l~~~~-------~l~--~~ 562 (1239)
....|++|++++| ++.. . +.... .+. ..
T Consensus 78 ----------------------------~~~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~ 129 (255)
T d1nd4a_ 78 ----------------------------AGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAK 129 (255)
T ss_dssp ----------------------------SSCEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHH
T ss_pred ----------------------------CCCEEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCH
T ss_conf ----------------------------6615999874413554322126899999999999987368854488755412
Q ss_pred HHHHHH--------------------HHHHHHHHHHHH-------CCCCCCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf 999999--------------------999999999771-------993125897660898689988991147201
Q 000880 563 LAWHLF--------------------RQIVEGLAHIHG-------QGIIHRDLTPNNIFFDARNDIKIGDFGLAK 610 (1239)
Q Consensus 563 ~~~~i~--------------------~qIl~aL~yLHs-------~gIiHrDLKp~NILi~~~~~vKL~DFGlA~ 610 (1239)
....-. ......+..+.. ..++|+|+.|.|||++.+..+-|.||+.+.
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 130 HRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 468899999987541101134011213799999999871876579567867888763577379658999853326
|
| >d1n9wa2 d.104.1.1 (A:111-414) Aspartyl-tRNA synthetase (AspRS) {Thermus thermophilus, AspRS-2 [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Aspartyl-tRNA synthetase (AspRS) species: Thermus thermophilus, AspRS-2 [TaxId: 274]
Probab=97.51 E-value=0.00021 Score=42.21 Aligned_cols=100 Identities=14% Similarity=0.094 Sum_probs=65.0
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCEECCCCCCCCCCCEEEEECCCCCEEEECCCCCHHHHHHHHHCCCCCEEEEEE
Q ss_conf 46677789889999999809940355520015787433442789831699725104788688999998399985137963
Q 000880 794 DTELRDYVVQVTKEMFRQHCAKHLEIEPMYLLGDCPQFKRNTVKLLTHGGDLLELSHELRLPFIRWAISNQKSSFKRYEI 873 (1239)
Q Consensus 794 e~~~~~~I~~~l~~~f~~~Gy~~I~tP~l~~~~~~~~~~~~~~~~~D~~g~~l~LRpD~T~~iaR~v~~~~~~p~r~~y~ 873 (1239)
-.+.|..|...+++.|...||-+|+||++.-.+. +...+.|... .-|+.+-|+.--.. ..|.++.. --|.|++
T Consensus 14 ~l~~Rs~i~~~iR~ff~~~gf~Ev~TP~l~~~~~--e~~~~~f~~~-~~~~~~~L~~Spel-~k~ll~~g---~~~if~i 86 (304)
T d1n9wa2 14 PLKVQAALVRGFRRYLDRQDFTEIFTPKVVRAGA--EGGSGLFGVD-YFEKRAYLAQSPQL-YKQIMVGV---FERVYEV 86 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCEECCCC-------------------------------CHH-HHHHHHHH---HSEEEEE
T ss_pred HHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCC--CCCCCEECCC-CCCCCHHCCCCHHH-HHHHHHCC---CCCCEEE
T ss_conf 9999999999999999888999987986478888--9978507876-55530101453888-88875213---3542101
Q ss_pred CCEEECCCCCCC-C-CCEEEEEEEEECCC
Q ss_conf 375871788999-9-71437869996799
Q 000880 874 SSVYRRAIGHSP-P-NRYLQGDFDIIGGA 900 (1239)
Q Consensus 874 g~VfR~e~~~~~-~-~ef~Q~GvEiiG~~ 900 (1239)
|+|||.+..... . .||+|+.++.-...
T Consensus 87 ~~~FR~ee~~~~rh~~EF~~le~~~~~~~ 115 (304)
T d1n9wa2 87 APVWRMEEHHTSRHLNEYLSLDVEMGFIA 115 (304)
T ss_dssp EEC-------------CCEEEEEEEESCS
T ss_pred HHHCCCCCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 43312453555446517899999874213
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.32 E-value=0.0036 Score=34.29 Aligned_cols=45 Identities=27% Similarity=0.299 Sum_probs=30.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 6689999991699499999973389990368999999999992699862
Q 000880 437 FGHVVLCKNKLDGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQHV 485 (1239)
Q Consensus 437 fG~Vy~a~~~~tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~HpnI 485 (1239)
--.||++... +|..|++|+.+....+ ..++..|...+..|....+
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gi 79 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEV 79 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTC
T ss_pred CCEEEEEECC-CCCEEEEEEECCCCCC---HHHHHHHHHHHHHHHHCCC
T ss_conf 2026999838-9997999984787788---9999999999999985599
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.18 E-value=0.0037 Score=34.24 Aligned_cols=60 Identities=12% Similarity=0.246 Sum_probs=38.8
Q ss_pred EEEECCCCCEEEEEEEECC-------CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCC-EEEEEEEE
Q ss_conf 7533258966899999916-------9949999997338999036899999999999269986-24463144
Q 000880 429 LQPLGHGGFGHVVLCKNKL-------DGRHYAVKKIRLKDKSLPVNDRILREVATLSRLQHQH-VVRYYQAW 492 (1239)
Q Consensus 429 ~~~LG~G~fG~Vy~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~~~~Ev~iL~~L~Hpn-Iv~l~~~~ 492 (1239)
++.|+.|-.-.+|++.... ....|.+++.. . .. ......+|..+++.+.-.+ .+++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PE--TESHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CC--CHHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CC--HHHHHHHHHHHHHHHHHCCCCCEEEEEC
T ss_conf 9991785334348999688775445789817999659-9-61--1658999999999997579998089981
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.09 E-value=0.029 Score=28.50 Aligned_cols=31 Identities=35% Similarity=0.463 Sum_probs=27.5
Q ss_pred CCCCCCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf 9931258976608986899889911472010
Q 000880 581 QGIIHRDLTPNNIFFDARNDIKIGDFGLAKF 611 (1239)
Q Consensus 581 ~gIiHrDLKp~NILi~~~~~vKL~DFGlA~~ 611 (1239)
.|+||+|+.+.||+++.+...-|.||+.|+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 5033378636564020454126742221236
|
| >d2a7la1 d.20.1.1 (A:1-117) Ubiquitin-protein ligase W (E2 W) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: UBC-related domain: Ubiquitin-protein ligase W (E2 W) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.78 E-value=0.19 Score=23.31 Aligned_cols=67 Identities=21% Similarity=0.216 Sum_probs=40.8
Q ss_pred HHHHHHHHHHHHHHCCCCEEEE----CCCCCEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCC
Q ss_conf 9999999999741059850331----289994999973898889988974799999981899999898652024
Q 000880 31 NELLSEEITALCAIFQEDCKVV----SGSPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITP 100 (1239)
Q Consensus 31 ~eeq~~EiEAL~sIY~d~~~~~----~~~~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~~~~~ 100 (1239)
...+..|++.|..==++.+.+. .++-..+.+.+.+-. +..=+.-.+.+.|.+|++||..+|.+....
T Consensus 5 ~kRL~kEl~~l~~~~~~~~~~~~~~~~~~l~~w~~~i~Gp~---~tpy~gg~f~~~i~fp~~YP~~pP~v~F~t 75 (117)
T d2a7la1 5 QKRLQKELLALQNDPPPGMTLNEKSVQNSITQWIVDMEGAP---GTLYEGEKFQLLFKFSSRYPFDSPQVMFTG 75 (117)
T ss_dssp CHHHHHHHHHHHHSCCTTCCCCTTCCCCSCEEEEEEEECCT---TSTTTTCEEEEEEEECTTTTTSCCEEEEES
T ss_pred HHHHHHHHHHHHHCCCCCEEEEEECCCCCCEEEEEEEECCC---CCCCCCCEEEEEEECCCCCCCCCCEEEEEC
T ss_conf 89999999999668999859987068888108999994899---845138801689805765566887799968
|
| >d1v95a_ c.51.1.1 (A:) Nuclear receptor coactivator 5 (KIAA1637) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Anticodon-binding domain-like superfamily: Class II aaRS ABD-related family: Anticodon-binding domain of Class II aaRS domain: Nuclear receptor coactivator 5 (KIAA1637) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.65 E-value=0.19 Score=23.20 Aligned_cols=97 Identities=7% Similarity=0.013 Sum_probs=75.4
Q ss_pred CCCEEEEEECCCCCCHHHHHHHHHHHHHCCCEEEEEE-CCCCCHHHHHHHHHHCCCCEEEEECCCCCCCCEEEEEECCCC
Q ss_conf 8735999963897609999999999998399189950-799998999999994899699998477335770899995678
Q 000880 1132 AGTSVLVCSRGGGGLLVERMELVAELWEENIKAQFVP-VPDPSLTEQYEYASEHDIKCLVILTDTGAQKGLVKVRHLDVK 1210 (1239)
Q Consensus 1132 ~~~~vlv~~~~~~~~~~~a~~la~~Lr~~G~~v~~~~-~~~~~l~k~l~~A~~~g~~~~viig~~e~~~~~i~vk~l~~~ 1210 (1239)
.|.|--|+..+ .+...+|-.+-..|++.|..|++.+ ...-.+.+.+....+.|.+|+|++..++..-..+||.-|-.-
T Consensus 7 ~P~DCeIivvn-k~~~~YAe~Ie~rL~~~Gl~vd~lf~n~dv~l~~aL~~vs~~G~~faIlVt~qn~~~~S~TvnIL~g~ 85 (130)
T d1v95a_ 7 GPVDCSVIVVN-KQTKDYAESVGRKVRDLGMVVDLIFLNTEVSLSQALEDVSRGGSPFAIVITQQHQIHRSCTVNIMFGT 85 (130)
T ss_dssp CCCTEEEEESS-SGGGHHHHHHHHHHHTTTCCEEEEECTTSSCHHHHHHHHHHHTCSEEEEECHHHHHHTEEEEEECSSS
T ss_pred CCCCEEEEEEC-CCCCHHHHHHHHHHHHCCCEEEEEECCCCCCHHHHHHHHHHCCCCEEEEEECCCHHHCCEEEEEECCC
T ss_conf 99555999987-75443789999999864977889835875549999998875798369998124054454675200278
Q ss_pred CC--CCCCHHHHHHHHHHHHH
Q ss_conf 42--11025789999999998
Q 000880 1211 KE--KEVQRESLVRFLLDAIA 1229 (1239)
Q Consensus 1211 ~q--~~v~~~el~~~l~~~l~ 1229 (1239)
.| -..|+++....+.....
T Consensus 86 pqEHRNMPleDAl~lva~~f~ 106 (130)
T d1v95a_ 86 PQEHRNMPQADAMVLVARNYE 106 (130)
T ss_dssp CCEEEEEEHHHHHHHHHHHHH
T ss_pred HHHHHCCCHHHHHHHHHHHHH
T ss_conf 188878878899999999999
|
| >d1jjcb5 d.104.1.1 (B:475-681) Phenyl-tRNA synthetase (PheRS) beta subunit, PheT, central domain {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Class II aaRS and biotin synthetases superfamily: Class II aaRS and biotin synthetases family: Class II aminoacyl-tRNA synthetase (aaRS)-like, catalytic domain domain: Phenyl-tRNA synthetase (PheRS) beta subunit, PheT, central domain species: Thermus thermophilus [TaxId: 274]
Probab=89.26 E-value=0.41 Score=21.13 Aligned_cols=79 Identities=14% Similarity=0.048 Sum_probs=57.2
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCEECC---CCCCCCCCCEEEEECCC-CCEEEECCCCCHHHHHHHHHCC--C--CCEEEE
Q ss_conf 89889999999809940355520015---78743344278983169-9725104788688999998399--9--851379
Q 000880 800 YVVQVTKEMFRQHCAKHLEIEPMYLL---GDCPQFKRNTVKLLTHG-GDLLELSHELRLPFIRWAISNQ--K--SSFKRY 871 (1239)
Q Consensus 800 ~I~~~l~~~f~~~Gy~~I~tP~l~~~---~~~~~~~~~~~~~~D~~-g~~l~LRpD~T~~iaR~v~~~~--~--~p~r~~ 871 (1239)
..++++++.+...||.|+.|-+|.-. ..... .+...++..+- .+.-+||+.+.+++.+.++.|. + ...|+|
T Consensus 19 ~~~~~ir~~L~~~Gf~Ev~tysf~s~~~~~~~~~-~~~~i~l~NPis~e~~~lR~sLlpgLL~~~~~N~~r~~~~~~~lF 97 (207)
T d1jjcb5 19 RKEQRLREVLSGLGFQEVYTYSFMDPEDARRFRL-DPPRLLLLNPLAPEKAALRTHLFPGLVRVLKENLDLDRPERALLF 97 (207)
T ss_dssp HHHHHHHHHHHHHTCEECCCCSEECTTHHHHTTC-CCCSCEESSCSSGGGSEECSCSHHHHHHHHHHHHHHSCCSEEEEE
T ss_pred HHHHHHHHHHHHCCCCHHCCCCCCCHHHHHHHCC-CCCCEEEECCCCHHHHHHHHHCCHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 9999999999977961200777689899975068-877379738740022365440440778898747333333430367
Q ss_pred EECCEEEC
Q ss_conf 63375871
Q 000880 872 EISSVYRR 879 (1239)
Q Consensus 872 y~g~VfR~ 879 (1239)
.+|+||+.
T Consensus 98 EiG~vf~~ 105 (207)
T d1jjcb5 98 EVGRVFRE 105 (207)
T ss_dssp EEEEEESS
T ss_pred EEEEEEEC
T ss_conf 51106530
|
| >d1z2ua1 d.20.1.1 (A:1-147) Ubiquitin conjugating enzyme, UBC {Caenorhabditis elegans, E2 2 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: UBC-related domain: Ubiquitin conjugating enzyme, UBC species: Caenorhabditis elegans, E2 2 [TaxId: 6239]
Probab=88.36 E-value=0.47 Score=20.74 Aligned_cols=69 Identities=16% Similarity=0.206 Sum_probs=42.7
Q ss_pred CHHHHHHHHHHHHHHCCCCEEEE--CCCCCEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 79999999999741059850331--2899949999738988899889747999999818999998986520248
Q 000880 30 DNELLSEEITALCAIFQEDCKVV--SGSPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPE 101 (1239)
Q Consensus 30 ~~eeq~~EiEAL~sIY~d~~~~~--~~~~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~~~~~~ 101 (1239)
+...+..|+..|..==+..+.+. .++...+.+.+.+-.+ +.-.+ -.+.+.|.+|++||.++|.+.....
T Consensus 2 a~kRL~~E~~~l~~~~~~~i~~~~~~~n~~~w~~~i~gp~~-t~y~g--g~f~~~i~fp~~YP~~pP~v~f~t~ 72 (147)
T d1z2ua1 2 ALKRIQKELQDLGRDPPAQCSAGPVGDDLFHWQATIMGPPE-SPYQG--GVFFLTIHFPTDYPFKPPKVAFTTR 72 (147)
T ss_dssp HHHHHHHHHHHHHHSCCSSEEEEEETTEEEEEEEEEECCTT-STTTT--CEEEEEEECCTTTTSSCCEEEESSC
T ss_pred HHHHHHHHHHHHHHCCCCCEEEEECCCCHHHHHHEECCCCC-CCCCC--CCEEEEEECCCCCCCCCCEEEEECC
T ss_conf 79999999999976899986999888713446550159999-87579--8068999667678999855787258
|
| >d1y8xa1 d.20.1.1 (A:27-183) Ubiquitin conjugating enzyme, UBC {Human (Homo sapiens), E2 M [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: UBC-related domain: Ubiquitin conjugating enzyme, UBC species: Human (Homo sapiens), E2 M [TaxId: 9606]
Probab=86.45 E-value=0.6 Score=20.04 Aligned_cols=103 Identities=15% Similarity=0.140 Sum_probs=55.8
Q ss_pred HHHHHHHHHHHHHHCCCCEEEECC-CCCEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCC---CCH
Q ss_conf 999999999974105985033128-9994999973898889988974799999981899999898652024899---999
Q 000880 31 NELLSEEITALCAIFQEDCKVVSG-SPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEKG---LTK 106 (1239)
Q Consensus 31 ~eeq~~EiEAL~sIY~d~~~~~~~-~~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~~~~~~~~---l~~ 106 (1239)
.-....|++.|...-+..+.+.++ +-..+.+.+.|..+ --.+ -.+.+.|.+|++||..+|.+....... .+.
T Consensus 5 ~~Rl~kEl~~l~~~~~~~i~~~~~~~l~~w~~~i~p~~t--~Y~g--g~f~~~i~fp~~YP~~pP~V~f~t~i~HPnv~~ 80 (157)
T d1y8xa1 5 QLRIQKDINELNLPKTCDISFSDPDDLLNFKLVICPDEG--FYKS--GKFVFSFKVGQGYPHDPPKVKCETMVYHPNIDL 80 (157)
T ss_dssp HHHHHHHHHTCCCCTTEEEECSSTTCTTEEEEEECCSSS--TTTT--BCEEEEEECCTTTTTSCCEEEECSCCCBTTBCT
T ss_pred HHHHHHHHHHHCCCCCCCEEECCCCCCEEEEEEECCCCC--CCCC--CEEEEEEEECCCCCCCCCEEEECCCCCCCCCCC
T ss_conf 999999999847999992897698822189999878998--8679--769999995678778885355235577766524
Q ss_pred HHHHHHH-HHHHHHHHHHCCCCCEEEEHHHHHHHHHHHH
Q ss_conf 8899999-9999999883879961411489999999985
Q 000880 107 SDADNLL-CLLQDQANSNAREGRVMIFNLVEAAQEFLSE 144 (1239)
Q Consensus 107 ~~~~~l~-~~L~e~~~e~~~~G~~mif~l~e~lke~L~~ 144 (1239)
. -.++ ..+.+.|.- . --|.+++..++..|.+
T Consensus 81 ~--G~ic~~~~~~~W~p----~-~~i~~il~~I~~ll~~ 112 (157)
T d1y8xa1 81 E--GNVCLNILREDWKP----V-LTINSIIYGLQYLFLE 112 (157)
T ss_dssp T--CBBCCGGGTTTCCT----T-CCHHHHHHHHHHHHHS
T ss_pred C--CEEEEEECCCCCCC----C-CCHHHHHHHHHHHHCC
T ss_conf 5--32312102667898----7-7699999999999769
|
| >d2uyza1 d.20.1.1 (A:3-158) Ubiquitin conjugating enzyme, UBC {Human (Homo sapiens), ubc9 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: UBC-related domain: Ubiquitin conjugating enzyme, UBC species: Human (Homo sapiens), ubc9 [TaxId: 9606]
Probab=85.28 E-value=0.69 Score=19.68 Aligned_cols=108 Identities=17% Similarity=0.078 Sum_probs=57.6
Q ss_pred CCHHHHHHHHHHHHHHCCCCEEEECC-------CCCEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 87999999999974105985033128-------99949999738988899889747999999818999998986520248
Q 000880 29 DDNELLSEEITALCAIFQEDCKVVSG-------SPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPE 101 (1239)
Q Consensus 29 ~~~eeq~~EiEAL~sIY~d~~~~~~~-------~~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~~~~~~ 101 (1239)
|....+..|...|..=-+..+...-. +...+.+.|.+.. +..=..-.+.+.|.+|++||.++|.+.....
T Consensus 2 ~a~~Rl~~E~~~~~~~~~~g~~~~p~~~~~~~~n~~~W~~~i~gp~---gtpY~gg~f~~~i~fp~~YP~~pP~v~f~t~ 78 (156)
T d2uyza1 2 IALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKK---GTPWEGGLFKLRMLFKDDYPSSPPKCKFEPP 78 (156)
T ss_dssp HHHHHHHHHHHHHHHSCCTTCEEEEEECTTSCEEEEEEEEEEECCT---TSTTTTCEEEEEEECCTTTTSSCCEEEESSC
T ss_pred HHHHHHHHHHHHHHHCCCCCEEEEECCCCCCCCCCCEEEEEEECCC---CCCCCCCEEEEEEECCCCCCCCCCEEEECCC
T ss_conf 5899999999999878999849975678777775108999998699---9870698789998178666678863550365
Q ss_pred C---CCCHHHHHHHH-HHHHHHHHHHCCCCCEEEEHHHHHHHHHHHH
Q ss_conf 9---99998899999-9999999883879961411489999999985
Q 000880 102 K---GLTKSDADNLL-CLLQDQANSNAREGRVMIFNLVEAAQEFLSE 144 (1239)
Q Consensus 102 ~---~l~~~~~~~l~-~~L~e~~~e~~~~G~~mif~l~e~lke~L~~ 144 (1239)
. ++... -.+| ..|.. -+... +. -.|.+++..++..|.+
T Consensus 79 i~HPnV~~~--G~icl~~l~~-~~~W~-p~-~ti~~il~~i~~ll~~ 120 (156)
T d2uyza1 79 LFHPNVYPS--GTVSLSILEE-DKDWR-PA-ITIKQILLGIQELLNE 120 (156)
T ss_dssp CCSTTBCTT--SBBCCGGGCT-TTTCC-TT-CCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCC--CEEEECCCCC-CCCCC-CC-CCHHHHHHHHHHHHCC
T ss_conf 556664532--1232010276-11168-86-6699999999997408
|
| >d2awfa1 d.20.1.1 (A:7-131) Ubiquitin conjugating enzyme, UBC {Human (Homo sapiens), E2 G1 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: UBC-related domain: Ubiquitin conjugating enzyme, UBC species: Human (Homo sapiens), E2 G1 [TaxId: 9606]
Probab=84.65 E-value=0.73 Score=19.50 Aligned_cols=65 Identities=17% Similarity=0.108 Sum_probs=43.2
Q ss_pred HHHHHHHHHHHCCCCEEEE--CCC-CCEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 9999999741059850331--289-9949999738988899889747999999818999998986520248
Q 000880 34 LSEEITALCAIFQEDCKVV--SGS-PPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPE 101 (1239)
Q Consensus 34 q~~EiEAL~sIY~d~~~~~--~~~-~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~~~~~~ 101 (1239)
++.|+..|..--++.+.+. +++ ...+.+.|.+-.. ..-.+ -.+.++|.+|++||..+|.+.....
T Consensus 4 L~kEl~~l~~~~~~gi~~~~~~~~dl~~w~~~i~Gp~~-tpyeg--g~f~~~i~fp~~YP~~pP~v~f~t~ 71 (125)
T d2awfa1 4 LRRQLAELNKNPVEGFSAGLIDDNDLYRWEVLIIGPPD-TLYEG--GVFKAHLTFPKDYPLRPPKMKFITE 71 (125)
T ss_dssp HHHHHHHHHHSCCTTEEEEESSTTCTTEEEEEEECCTT-STTTT--CEEEEEEECCTTTTSSCCEEEECSC
T ss_pred HHHHHHHHHHCCCCCEEEEECCCCCCEEEEEEEECCCC-CCCCC--CEEEEEEECCCCCCCCCCEEEECCC
T ss_conf 99999999748999879996798871089999968987-56679--8267899547876788985885378
|
| >d1yrva1 d.20.1.1 (A:1-148) Ubiquitin conjugating enzyme, UBC {Human (Homo sapiens), E2 U [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: UBC-related domain: Ubiquitin conjugating enzyme, UBC species: Human (Homo sapiens), E2 U [TaxId: 9606]
Probab=81.84 E-value=0.95 Score=18.79 Aligned_cols=106 Identities=14% Similarity=0.087 Sum_probs=56.4
Q ss_pred HHHHHHHHHHHHHCCCCEEE--ECCCCCEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCC---CCCH
Q ss_conf 99999999974105985033--128999499997389888998897479999998189999989865202489---9999
Q 000880 32 ELLSEEITALCAIFQEDCKV--VSGSPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITPEK---GLTK 106 (1239)
Q Consensus 32 eeq~~EiEAL~sIY~d~~~~--~~~~~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~~~~~~~---~l~~ 106 (1239)
-.+..|+..|..-=+..+.+ ..++...+.+.|.+.. +..=+.-.+.++|.+|++||..+|.+...... +...
T Consensus 7 ~~L~kE~~~l~~~~~~gi~v~p~~~n~~~W~~~i~Gp~---~t~yegg~f~~~i~fp~~YP~~pP~v~f~t~i~HpnV~~ 83 (148)
T d1yrva1 7 LLLHRDFCDLKENNYKGITAKPVSEDMMEWEVEIEGLQ---NSVWQGLVFQLTIHFTSEYNYAPPVVKFITIPFHPNVDP 83 (148)
T ss_dssp HHHHHHHHHHHHHCCTTEEEEECSTTSCEEEEEEECCT---TSTTTTCEEEEEEECCTTBTTBCCEEEESSCCCCTTBCT
T ss_pred HHHHHHHHHHHHCCCCCEEEEECCCCCCEEEEEEEECC---CCCCCCCCEEEEEEECCCCCCCCCEEEECCCCCCCCEEC
T ss_conf 99999999998789998899987896218999998188---776679955788786344456886145045455574446
Q ss_pred HHHHHHH-HHHHHHHHHHCCCCCEEEEHHHHHHHHHHHH
Q ss_conf 8899999-9999999883879961411489999999985
Q 000880 107 SDADNLL-CLLQDQANSNAREGRVMIFNLVEAAQEFLSE 144 (1239)
Q Consensus 107 ~~~~~l~-~~L~e~~~e~~~~G~~mif~l~e~lke~L~~ 144 (1239)
.. -.+| +.|. ..++.- +. .-+.+++..++..|.+
T Consensus 84 ~~-G~iC~~~l~-~~~~W~-p~-~tl~~vL~~I~~ll~~ 118 (148)
T d1yrva1 84 HT-GQPCIDFLD-NPEKWN-TN-YTLSSILLALQVMLSN 118 (148)
T ss_dssp TT-CCBCCHHHH-CGGGCC-TT-CCHHHHHHHHHHHHTS
T ss_pred CC-CCCCCCCCC-CHHHCC-CC-CCHHHHHHHHHHHHHC
T ss_conf 76-420000137-600058-62-5599999999999858
|
| >d2fo3a1 d.20.1.1 (A:9-117) Putative ubiquitin-conjugating enzyme, E2 domain {Plasmodium chabaudi [TaxId: 5825]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: UBC-like superfamily: UBC-like family: UBC-related domain: Putative ubiquitin-conjugating enzyme, E2 domain species: Plasmodium chabaudi [TaxId: 5825]
Probab=80.35 E-value=1.1 Score=18.46 Aligned_cols=63 Identities=14% Similarity=0.099 Sum_probs=36.8
Q ss_pred HHHHHHHHHHCCCCEEE--ECCCCCEEEEEECCCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCCCCC
Q ss_conf 99999974105985033--1289994999973898889988974799999981899999898652024
Q 000880 35 SEEITALCAIFQEDCKV--VSGSPPQILVKLRPYSKDMGYEDLDVSALLLVRCLPGYPYKCPKLQITP 100 (1239)
Q Consensus 35 ~~EiEAL~sIY~d~~~~--~~~~~~~~~i~i~~~~~~~~~~~~~~~~~L~i~~p~~YP~~~P~~~~~~ 100 (1239)
..|+..|..==+..+.+ ..++...+.+.+.+.. +..=+.-.+.+.+++|++||.++|.+....
T Consensus 4 ~kEl~~l~~~~~~g~~~~~~~~~~~~w~~~i~gp~---~tpy~gg~f~~~i~fp~~YP~~pP~v~F~t 68 (109)
T d2fo3a1 4 QKELHNFLNNPPINCTLDVHPNNIRIWIVKYVGLE---NTIYANEVYKLKIIFPDDYPLKPPIVYFLQ 68 (109)
T ss_dssp HHHHHHHHHSCCTTEEEEECTTCTTEEEEEEECCT---TSTTTTCEEEEEEECCTTTTTSCCEEEECS
T ss_pred HHHHHHHHHCCCCCEEEEECCCCCCEEEEEEECCC---HHHHCCCCCEEEEEECCCCCCCCCEEEEEE
T ss_conf 99999997589998799975882069999996485---042359970689996254577898699995
|